
### [MONDO:0021194](http://purl.obolibrary.org/obo/MONDO_0021194)
**Label:** disease disrupting subcellular system

**Subclasses:** [MONDO:0017259](http://purl.obolibrary.org/obo/MONDO_0017259) (systemic diseases with anterior uveitis), [MONDO:0017258](http://purl.obolibrary.org/obo/MONDO_0017258) (idiopathic panuveitis), [MONDO:0018589](http://purl.obolibrary.org/obo/MONDO_0018589) (AApoAIV amyloidosis), [MONDO:0017255](http://purl.obolibrary.org/obo/MONDO_0017255) (panuveitis (disease)), [MONDO:0018588](http://purl.obolibrary.org/obo/MONDO_0018588) (ALECT2 amyloidosis), [MONDO:0017257](http://purl.obolibrary.org/obo/MONDO_0017257) (idiopathic posterior uveitis), [MONDO:0017256](http://purl.obolibrary.org/obo/MONDO_0017256) (idiopathic anterior uveitis), [MONDO:0017251](http://purl.obolibrary.org/obo/MONDO_0017251) (congenital pulmonary airway malformation type 3), [MONDO:0017250](http://purl.obolibrary.org/obo/MONDO_0017250) (congenital pulmonary airway malformation type 2), [MONDO:0018581](http://purl.obolibrary.org/obo/MONDO_0018581) (progressive encephalomyelitis with rigidity and myoclonus), [MONDO:0018582](http://purl.obolibrary.org/obo/MONDO_0018582) (GCGR-related hyperglucagonemia), [MONDO:0017252](http://purl.obolibrary.org/obo/MONDO_0017252) (congenital pulmonary airway malformation type 4), [MONDO:0018580](http://purl.obolibrary.org/obo/MONDO_0018580) (PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome), [MONDO:0005266](http://purl.obolibrary.org/obo/MONDO_0005266) (diabetic retinopathy), [MONDO:0006596](http://purl.obolibrary.org/obo/MONDO_0006596) (photoallergic dermatitis), [MONDO:0006595](http://purl.obolibrary.org/obo/MONDO_0006595) (perinatal jaundice due to hepatocellular damage), [MONDO:0005265](http://purl.obolibrary.org/obo/MONDO_0005265) (inflammatory bowel disease), [MONDO:0006594](http://purl.obolibrary.org/obo/MONDO_0006594) (pemphigus), [MONDO:0017248](http://purl.obolibrary.org/obo/MONDO_0017248) (congenital pulmonary airway malformation type 0), [MONDO:0017247](http://purl.obolibrary.org/obo/MONDO_0017247) (communicating congenital bronchopulmonary-foregut malformation), [MONDO:0018579](http://purl.obolibrary.org/obo/MONDO_0018579) (disorder of ketone body transport), [MONDO:0017249](http://purl.obolibrary.org/obo/MONDO_0017249) (congenital pulmonary airway malformation type 1), [MONDO:0018576](http://purl.obolibrary.org/obo/MONDO_0018576) (non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy), [MONDO:0017244](http://purl.obolibrary.org/obo/MONDO_0017244) (pseudoxanthomatous diffuse cutaneous mastocytosis), [MONDO:0018577](http://purl.obolibrary.org/obo/MONDO_0018577) (pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa), [MONDO:0017243](http://purl.obolibrary.org/obo/MONDO_0017243) (bullous diffuse cutaneous mastocytosis), [MONDO:0017246](http://purl.obolibrary.org/obo/MONDO_0017246) (Extralobar congenital pulmonary sequestration), [MONDO:0017245](http://purl.obolibrary.org/obo/MONDO_0017245) (Intralobar congenital pulmonary sequestration), [MONDO:0018575](http://purl.obolibrary.org/obo/MONDO_0018575) (microcephalic primordial dwarfism-insulin resistance syndrome), [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), [MONDO:0018572](http://purl.obolibrary.org/obo/MONDO_0018572) (severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome), [MONDO:0018573](http://purl.obolibrary.org/obo/MONDO_0018573) (intrauterine growth restriction-short stature-early adult-onset diabetes syndrome), [MONDO:0018570](http://purl.obolibrary.org/obo/MONDO_0018570) (hypophosphatasia), [MONDO:0018571](http://purl.obolibrary.org/obo/MONDO_0018571) (contractures-developmental delay-Pierre robin syndrome), [MONDO:0005278](http://purl.obolibrary.org/obo/MONDO_0005278) (serous adenocarcinoma), [MONDO:0005274](http://purl.obolibrary.org/obo/MONDO_0005274) (refractory anemia with ringed sideroblasts), [MONDO:0005271](http://purl.obolibrary.org/obo/MONDO_0005271) (allergic disease), [MONDO:0005272](http://purl.obolibrary.org/obo/MONDO_0005272) (refractory anemia), [MONDO:0018569](http://purl.obolibrary.org/obo/MONDO_0018569) (X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome), [MONDO:0017237](http://purl.obolibrary.org/obo/MONDO_0017237) (hereditary sensorimotor neuropathy with hyperelastic skin), [MONDO:0018567](http://purl.obolibrary.org/obo/MONDO_0018567) (autosomal dominant Charcot-Marie-tooth disease type 2 due to TFG mutation), [MONDO:0017239](http://purl.obolibrary.org/obo/MONDO_0017239) (familial progressive hyper- and hypopigmentation), [MONDO:0018568](http://purl.obolibrary.org/obo/MONDO_0018568) (COG2-CDG), [MONDO:0017238](http://purl.obolibrary.org/obo/MONDO_0017238) (hemoglobinopathy Toms River), [MONDO:0019896](http://purl.obolibrary.org/obo/MONDO_0019896) (Kleefstra syndrome due to 9q34 microdeletion), [MONDO:0018566](http://purl.obolibrary.org/obo/MONDO_0018566) (short stature-advanced bone age-early-onset osteoarthritis syndrome), [MONDO:0017235](http://purl.obolibrary.org/obo/MONDO_0017235) (familial omphalocele syndrome with facial dysmorphism), [MONDO:0018563](http://purl.obolibrary.org/obo/MONDO_0018563) (adactyly of foot), [MONDO:0018562](http://purl.obolibrary.org/obo/MONDO_0018562) (genetic otorhinolaryngological malformation), [MONDO:0017231](http://purl.obolibrary.org/obo/MONDO_0017231) (erythropoietic uroporphyria associated with myeloid malignancy), [MONDO:0018560](http://purl.obolibrary.org/obo/MONDO_0018560) (anterior urethral valve), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0005248](http://purl.obolibrary.org/obo/MONDO_0005248) (adrenocortical adenoma (disease)), [MONDO:0006573](http://purl.obolibrary.org/obo/MONDO_0006573) (lipodystrophy (disease)), [MONDO:0018559](http://purl.obolibrary.org/obo/MONDO_0018559) (fetal lower urinary tract obstruction), [MONDO:0017225](http://purl.obolibrary.org/obo/MONDO_0017225) (null syndrome), [MONDO:0018556](http://purl.obolibrary.org/obo/MONDO_0018556) (Lambert-Eaton myasthenic syndrome), [MONDO:0017228](http://purl.obolibrary.org/obo/MONDO_0017228) (autoimmune pancreatitis type 2), [MONDO:0017227](http://purl.obolibrary.org/obo/MONDO_0017227) (autoimmune pancreatitis type 1), [MONDO:0017222](http://purl.obolibrary.org/obo/MONDO_0017222) (Pelizaeus-Merzbacher disease, classic form), [MONDO:0018555](http://purl.obolibrary.org/obo/MONDO_0018555) (hypogonadotropic hypogonadism), [MONDO:0017221](http://purl.obolibrary.org/obo/MONDO_0017221) (Pelizaeus-Merzbacher disease, connatal form), [MONDO:0017224](http://purl.obolibrary.org/obo/MONDO_0017224) (Pelizaeus-Merzbacher disease in female carriers), [MONDO:0017223](http://purl.obolibrary.org/obo/MONDO_0017223) (Pelizaeus-Merzbacher disease, transitional form), [MONDO:0019884](http://purl.obolibrary.org/obo/MONDO_0019884) (distal trisomy 10q), [MONDO:0018550](http://purl.obolibrary.org/obo/MONDO_0018550) (spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder), [MONDO:0017220](http://purl.obolibrary.org/obo/MONDO_0017220) (laryngotracheoesophageal cleft type 0), [MONDO:0006584](http://purl.obolibrary.org/obo/MONDO_0006584) (neonatal jaundice), [MONDO:0005251](http://purl.obolibrary.org/obo/MONDO_0005251) (pauciarticular juvenile rheumatoid arthritis), [MONDO:0017299](http://purl.obolibrary.org/obo/MONDO_0017299) (acute annular outer retinopathy), [MONDO:0017298](http://purl.obolibrary.org/obo/MONDO_0017298) (acute zonal occult outer retinopathy), [MONDO:0017295](http://purl.obolibrary.org/obo/MONDO_0017295) (glycerol kinase deficiency, juvenile form), [MONDO:0017294](http://purl.obolibrary.org/obo/MONDO_0017294) (glycerol kinase deficiency, infantile form), [MONDO:0017296](http://purl.obolibrary.org/obo/MONDO_0017296) (glycerol kinase deficiency, adult form), [MONDO:0017293](http://purl.obolibrary.org/obo/MONDO_0017293) (small cell carcinoma of the bladder), [MONDO:0017292](http://purl.obolibrary.org/obo/MONDO_0017292) (well-differentiated fetal adenocarcinoma of the lung), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0017287](http://purl.obolibrary.org/obo/MONDO_0017287) (IgG4-related disease), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0017284](http://purl.obolibrary.org/obo/MONDO_0017284) (Xp22.13p22.2 duplication syndrome), [MONDO:0017283](http://purl.obolibrary.org/obo/MONDO_0017283) (facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion), [MONDO:0017281](http://purl.obolibrary.org/obo/MONDO_0017281) (renal caliceal diverticuli-deafness syndrome), [MONDO:0005288](http://purl.obolibrary.org/obo/MONDO_0005288) (intestinal polyp (disease)), [MONDO:0005289](http://purl.obolibrary.org/obo/MONDO_0005289) (paranasal sinus neoplasm (disease)), [MONDO:0005286](http://purl.obolibrary.org/obo/MONDO_0005286) (palatal neoplasm), [MONDO:0005284](http://purl.obolibrary.org/obo/MONDO_0005284) (chronic progressive multiple sclerosis), [MONDO:0005282](http://purl.obolibrary.org/obo/MONDO_0005282) (cutaneous lupus erythematosus), [MONDO:0005283](http://purl.obolibrary.org/obo/MONDO_0005283) (retinopathy), [MONDO:0018598](http://purl.obolibrary.org/obo/MONDO_0018598) (neonatal adrenoleukodystrophy), [MONDO:0018599](http://purl.obolibrary.org/obo/MONDO_0018599) (congenital oculomotor nerve palsy), [MONDO:0018596](http://purl.obolibrary.org/obo/MONDO_0018596) (systemic polyarteritis nodosa), [MONDO:0018594](http://purl.obolibrary.org/obo/MONDO_0018594) (secondary polyarteritis nodosa), [MONDO:0018595](http://purl.obolibrary.org/obo/MONDO_0018595) (single-organ polyarteritis nodosa), [MONDO:0017261](http://purl.obolibrary.org/obo/MONDO_0017261) (systemic diseases with panuveitis), [MONDO:0018592](http://purl.obolibrary.org/obo/MONDO_0018592) (cutaneous polyarteritis nodosa), [MONDO:0017264](http://purl.obolibrary.org/obo/MONDO_0017264) (syndromic recessive X-linked ichthyosis), [MONDO:0018593](http://purl.obolibrary.org/obo/MONDO_0018593) (primary polyarteritis nodosa), [MONDO:0018590](http://purl.obolibrary.org/obo/MONDO_0018590) (ABeta2M amyloidosis), [MONDO:0018591](http://purl.obolibrary.org/obo/MONDO_0018591) (ITM2B amyloidosis), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0005298](http://purl.obolibrary.org/obo/MONDO_0005298) (osteoporosis), [MONDO:0005296](http://purl.obolibrary.org/obo/MONDO_0005296) (sleep apnea (disease)), [MONDO:0005292](http://purl.obolibrary.org/obo/MONDO_0005292) (colitis (disease)), [MONDO:0007929](http://purl.obolibrary.org/obo/MONDO_0007929) (Epstein syndrome), [MONDO:0007928](http://purl.obolibrary.org/obo/MONDO_0007928) (Fechtner syndrome), [MONDO:0007927](http://purl.obolibrary.org/obo/MONDO_0007927) (congenital macroglossia), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0007925](http://purl.obolibrary.org/obo/MONDO_0007925) (chromosome 5q deletion syndrome), [MONDO:0007924](http://purl.obolibrary.org/obo/MONDO_0007924) (Bannayan-Riley-Ruvalcaba syndrome), [MONDO:0007922](http://purl.obolibrary.org/obo/MONDO_0007922) (lymphedema-distichiasis syndrome), [MONDO:0007920](http://purl.obolibrary.org/obo/MONDO_0007920) (Meige disease), [MONDO:0019915](http://purl.obolibrary.org/obo/MONDO_0019915) (maternal uniparental disomy of chromosome 14), [MONDO:0019916](http://purl.obolibrary.org/obo/MONDO_0019916) (maternal uniparental disomy of chromosome 16), [MONDO:0019913](http://purl.obolibrary.org/obo/MONDO_0019913) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 7), [MONDO:0007939](http://purl.obolibrary.org/obo/MONDO_0007939) (malignant hyperthermia, susceptibility to, 2), [MONDO:0007938](http://purl.obolibrary.org/obo/MONDO_0007938) (46,Xy sex reversal 4), [MONDO:0007937](http://purl.obolibrary.org/obo/MONDO_0007937) (renal hypomagnesemia 2), [MONDO:0007936](http://purl.obolibrary.org/obo/MONDO_0007936) (macular dystrophy, Fenestrated sheen type), [MONDO:0007935](http://purl.obolibrary.org/obo/MONDO_0007935) (cystoid macular edema), [MONDO:0007934](http://purl.obolibrary.org/obo/MONDO_0007934) (benign concentric annular macular dystrophy), [MONDO:0007933](http://purl.obolibrary.org/obo/MONDO_0007933) (VMD1), [MONDO:0007932](http://purl.obolibrary.org/obo/MONDO_0007932) (age related macular degeneration 2), [MONDO:0006600](http://purl.obolibrary.org/obo/MONDO_0006600) (pigmentation disease), [MONDO:0007931](http://purl.obolibrary.org/obo/MONDO_0007931) (best vitelliform macular dystrophy), [MONDO:0007930](http://purl.obolibrary.org/obo/MONDO_0007930) (Bernard-Soulier syndrome, type A2, autosomal dominant), [MONDO:0019907](http://purl.obolibrary.org/obo/MONDO_0019907) (ring chromosome 13), [MONDO:0019902](http://purl.obolibrary.org/obo/MONDO_0019902) (monosomy 13q34), [MONDO:0007909](http://purl.obolibrary.org/obo/MONDO_0007909) (familial multiple lipomatosis), [MONDO:0007907](http://purl.obolibrary.org/obo/MONDO_0007907) (lipoma of the conjunctiva), [MONDO:0007906](http://purl.obolibrary.org/obo/MONDO_0007906) (familial partial lipodystrophy, Dunnigan type), [MONDO:0007904](http://purl.obolibrary.org/obo/MONDO_0007904) (median nodule of the upper lip), [MONDO:0007903](http://purl.obolibrary.org/obo/MONDO_0007903) (Li-Fraumeni syndrome 1), [MONDO:0007919](http://purl.obolibrary.org/obo/MONDO_0007919) (lymphedema, hereditary, 1A), [MONDO:0007918](http://purl.obolibrary.org/obo/MONDO_0007918) (microcephaly with or without chorioretinopathy, lymphedema, or mental retardation), [MONDO:0007915](http://purl.obolibrary.org/obo/MONDO_0007915) (systemic lupus erythematosus (disease)), [MONDO:0019955](http://purl.obolibrary.org/obo/MONDO_0019955) (GRFoma), [MONDO:0018625](http://purl.obolibrary.org/obo/MONDO_0018625) (classic stiff person syndrome), [MONDO:0019954](http://purl.obolibrary.org/obo/MONDO_0019954) (pancreatic neuroendocrine tumor), [MONDO:0019951](http://purl.obolibrary.org/obo/MONDO_0019951) (rigid spine syndrome), [MONDO:0019952](http://purl.obolibrary.org/obo/MONDO_0019952) (congenital myopathy), [MONDO:0018621](http://purl.obolibrary.org/obo/MONDO_0018621) (lymphoplasmacytic lymphoma without IgM production), [MONDO:0019950](http://purl.obolibrary.org/obo/MONDO_0019950) (congenital muscular dystrophy), [MONDO:0006639](http://purl.obolibrary.org/obo/MONDO_0006639) (adrenal cortex carcinoma), [MONDO:0007969](http://purl.obolibrary.org/obo/MONDO_0007969) (Melkersson-Rosenthal syndrome), [MONDO:0006638](http://purl.obolibrary.org/obo/MONDO_0006638) (acute retinal necrosis syndrome), [MONDO:0007967](http://purl.obolibrary.org/obo/MONDO_0007967) (melanoma and neural system tumor syndrome), [MONDO:0005306](http://purl.obolibrary.org/obo/MONDO_0005306) (ankylosing spondylitis), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0005304](http://purl.obolibrary.org/obo/MONDO_0005304) (biliary tract neoplasm (disease)), [MONDO:0005301](http://purl.obolibrary.org/obo/MONDO_0005301) (multiple sclerosis), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0006632](http://purl.obolibrary.org/obo/MONDO_0006632) (osteoarthritis, hand), [MONDO:0007963](http://purl.obolibrary.org/obo/MONDO_0007963) (CMM1), [MONDO:0006631](http://purl.obolibrary.org/obo/MONDO_0006631) (osteoarthritis, toe), [MONDO:0006630](http://purl.obolibrary.org/obo/MONDO_0006630) (osteoarthritis, spine), [MONDO:0007960](http://purl.obolibrary.org/obo/MONDO_0007960) (megacystis-microcolon-intestinal hypoperistalsis syndrome), [MONDO:0019959](http://purl.obolibrary.org/obo/MONDO_0019959) (glucagonoma), [MONDO:0018628](http://purl.obolibrary.org/obo/MONDO_0018628) (HIV-associated cancer), [MONDO:0018629](http://purl.obolibrary.org/obo/MONDO_0018629) (focal stiff limb syndrome), [MONDO:0019957](http://purl.obolibrary.org/obo/MONDO_0019957) (PPoma), [MONDO:0018613](http://purl.obolibrary.org/obo/MONDO_0018613) (AH amyloidosis), [MONDO:0019942](http://purl.obolibrary.org/obo/MONDO_0019942) (distal arthrogryposis), [MONDO:0018611](http://purl.obolibrary.org/obo/MONDO_0018611) (early-onset lamellar cataract), [MONDO:0019943](http://purl.obolibrary.org/obo/MONDO_0019943) (hereditary continuous muscle fiber activity), [MONDO:0019940](http://purl.obolibrary.org/obo/MONDO_0019940) (hypertrichosis-acromegaloid facial appearance syndrome), [MONDO:0018610](http://purl.obolibrary.org/obo/MONDO_0018610) (early-onset posterior subcapsular cataract), [MONDO:0006649](http://purl.obolibrary.org/obo/MONDO_0006649) (anterior ischemic optic neuropathy), [MONDO:0007979](http://purl.obolibrary.org/obo/MONDO_0007979) (Metachondromatosis), [MONDO:0006646](http://purl.obolibrary.org/obo/MONDO_0006646) (angioleiomyoma), [MONDO:0005314](http://purl.obolibrary.org/obo/MONDO_0005314) (relapsing-remitting multiple sclerosis), [MONDO:0007977](http://purl.obolibrary.org/obo/MONDO_0007977) (mesomelic dysplasia, Kantaputra type), [MONDO:0005310](http://purl.obolibrary.org/obo/MONDO_0005310) (atrial flutter (disease)), [MONDO:0007971](http://purl.obolibrary.org/obo/MONDO_0007971) (delayed membranous cranial ossification), [MONDO:0007970](http://purl.obolibrary.org/obo/MONDO_0007970) (melorheostosis), [MONDO:0019948](http://purl.obolibrary.org/obo/MONDO_0019948) (reducing body myopathy), [MONDO:0019949](http://purl.obolibrary.org/obo/MONDO_0019949) (zebra body myopathy), [MONDO:0018618](http://purl.obolibrary.org/obo/MONDO_0018618) (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), [MONDO:0019946](http://purl.obolibrary.org/obo/MONDO_0019946) (ligneous conjunctivitis), [MONDO:0018616](http://purl.obolibrary.org/obo/MONDO_0018616) (central serous chorioretinopathy), [MONDO:0019947](http://purl.obolibrary.org/obo/MONDO_0019947) (rippling muscle disease 2), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0018603](http://purl.obolibrary.org/obo/MONDO_0018603) (interstitial lung disease due to SP-c deficiency), [MONDO:0018600](http://purl.obolibrary.org/obo/MONDO_0018600) (congenital abducens nerve palsy), [MONDO:0019931](http://purl.obolibrary.org/obo/MONDO_0019931) (leydig cell hypoplasia due to partial LH resistance), [MONDO:0018601](http://purl.obolibrary.org/obo/MONDO_0018601) (autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome), [MONDO:0019930](http://purl.obolibrary.org/obo/MONDO_0019930) (leydig cell hypoplasia due to complete LH resistance), [MONDO:0007949](http://purl.obolibrary.org/obo/MONDO_0007949) (Marshall syndrome), [MONDO:0007947](http://purl.obolibrary.org/obo/MONDO_0007947) (Marfan syndrome), [MONDO:0006616](http://purl.obolibrary.org/obo/MONDO_0006616) (toxicodendron dermatitis), [MONDO:0007946](http://purl.obolibrary.org/obo/MONDO_0007946) (jaw-winking syndrome), [MONDO:0006614](http://purl.obolibrary.org/obo/MONDO_0006614) (subcorneal pustular dermatosis), [MONDO:0006613](http://purl.obolibrary.org/obo/MONDO_0006613) (stromal corneal pigmentation), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0007943](http://purl.obolibrary.org/obo/MONDO_0007943) (Nager acrofacial dysostosis), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0007940](http://purl.obolibrary.org/obo/MONDO_0007940) (malignant hyperthermia, susceptibility to, 3), [MONDO:0018609](http://purl.obolibrary.org/obo/MONDO_0018609) (syndromic hereditary optic neuropathy), [MONDO:0018606](http://purl.obolibrary.org/obo/MONDO_0018606) (extensive peripapillary myelinated nerve fibers), [MONDO:0018607](http://purl.obolibrary.org/obo/MONDO_0018607) (combined hamartoma of the retina and retinal pigment epithelium), [MONDO:0019938](http://purl.obolibrary.org/obo/MONDO_0019938) (anorectal malformation), [MONDO:0018604](http://purl.obolibrary.org/obo/MONDO_0018604) (familial colorectal cancer type X), [MONDO:0018605](http://purl.obolibrary.org/obo/MONDO_0018605) (disorders of pentose/polyol metabolism), [MONDO:0019923](http://purl.obolibrary.org/obo/MONDO_0019923) (Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11), [MONDO:0006629](http://purl.obolibrary.org/obo/MONDO_0006629) (osteoarthritis, hip), [MONDO:0007959](http://purl.obolibrary.org/obo/MONDO_0007959) (medulloblastoma), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0007956](http://purl.obolibrary.org/obo/MONDO_0007956) (Pai syndrome), [MONDO:0007954](http://purl.obolibrary.org/obo/MONDO_0007954) (May-Hegglin anomaly), [MONDO:0006622](http://purl.obolibrary.org/obo/MONDO_0006622) (vulvar seborrheic keratosis), [MONDO:0007953](http://purl.obolibrary.org/obo/MONDO_0007953) (binder syndrome), [MONDO:0006621](http://purl.obolibrary.org/obo/MONDO_0006621) (vulvar inverted follicular keratosis), [MONDO:0006620](http://purl.obolibrary.org/obo/MONDO_0006620) (vulva fibroepithelial polyp), [MONDO:0007950](http://purl.obolibrary.org/obo/MONDO_0007950) (mastocytosis), [MONDO:0019928](http://purl.obolibrary.org/obo/MONDO_0019928) (48,XXXY syndrome), [MONDO:0019929](http://purl.obolibrary.org/obo/MONDO_0019929) (49,XXXXY syndrome), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0016005](http://purl.obolibrary.org/obo/MONDO_0016005) (indomethacin embryofetopathy), [MONDO:0019999](http://purl.obolibrary.org/obo/MONDO_0019999) (intestinal malformation), [MONDO:0017336](http://purl.obolibrary.org/obo/MONDO_0017336) (fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex i deficiency), [MONDO:0017335](http://purl.obolibrary.org/obo/MONDO_0017335) (Microtriplication 11q24.1), [MONDO:0016004](http://purl.obolibrary.org/obo/MONDO_0016004) (aminopterin/methotrexate embryofetopathy), [MONDO:0017338](http://purl.obolibrary.org/obo/MONDO_0017338) (fatal multiple mitochondrial dysfunctions syndrome), [MONDO:0016007](http://purl.obolibrary.org/obo/MONDO_0016007) (cocaine embryofetopathy), [MONDO:0018666](http://purl.obolibrary.org/obo/MONDO_0018666) (hepatoblastoma), [MONDO:0016006](http://purl.obolibrary.org/obo/MONDO_0016006) (Cockayne syndrome), [MONDO:0019998](http://purl.obolibrary.org/obo/MONDO_0019998) (gastroduodenal malformation), [MONDO:0017337](http://purl.obolibrary.org/obo/MONDO_0017337) (inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency), [MONDO:0016001](http://purl.obolibrary.org/obo/MONDO_0016001) (2-hydroxyglutaric aciduria), [MONDO:0017331](http://purl.obolibrary.org/obo/MONDO_0017331) (Pilotto syndrome), [MONDO:0016000](http://purl.obolibrary.org/obo/MONDO_0016000) (familial isolated hypoparathyroidism due to impaired PTH secretion), [MONDO:0018662](http://purl.obolibrary.org/obo/MONDO_0018662) (autosomal recessive brachyolmia), [MONDO:0016002](http://purl.obolibrary.org/obo/MONDO_0016002) (Ehlers-Danlos syndrome, kyphoscoliotic type), [MONDO:0018663](http://purl.obolibrary.org/obo/MONDO_0018663) (regressive spondylometaphyseal dysplasia), [MONDO:0018660](http://purl.obolibrary.org/obo/MONDO_0018660) (hemophilia), [MONDO:0019992](http://purl.obolibrary.org/obo/MONDO_0019992) (pseudohypoparathyroidism), [MONDO:0004018](http://purl.obolibrary.org/obo/MONDO_0004018) (liver carcinoma), [MONDO:0004019](http://purl.obolibrary.org/obo/MONDO_0004019) (oxyphilic endometrial endometrioid adenocarcinoma), [MONDO:0005347](http://purl.obolibrary.org/obo/MONDO_0005347) (hypertriglyceridemia (disease)), [MONDO:0004016](http://purl.obolibrary.org/obo/MONDO_0004016) (pineal region mature teratoma), [MONDO:0004017](http://purl.obolibrary.org/obo/MONDO_0004017) (pineal region immature teratoma), [MONDO:0004014](http://purl.obolibrary.org/obo/MONDO_0004014) (ethmoid sinus ectopic meningioma), [MONDO:0004015](http://purl.obolibrary.org/obo/MONDO_0004015) (pineal region teratoma), [MONDO:0006676](http://purl.obolibrary.org/obo/MONDO_0006676) (beriberi), [MONDO:0006675](http://purl.obolibrary.org/obo/MONDO_0006675) (benign monoclonal gammopathy), [MONDO:0004012](http://purl.obolibrary.org/obo/MONDO_0004012) (adult botryoid rhabdomyosarcoma), [MONDO:0004013](http://purl.obolibrary.org/obo/MONDO_0004013) (adult vagina botryoid rhabdomyosarcoma), [MONDO:0006674](http://purl.obolibrary.org/obo/MONDO_0006674) (benign fibrous mesothelioma), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0005341](http://purl.obolibrary.org/obo/MONDO_0005341) (skin basal cell carcinoma), [MONDO:0004010](http://purl.obolibrary.org/obo/MONDO_0004010) (infiltrating ureter transitional cell carcinoma), [MONDO:0005340](http://purl.obolibrary.org/obo/MONDO_0005340) (alopecia areata), [MONDO:0016009](http://purl.obolibrary.org/obo/MONDO_0016009) (fetal trimethadione syndrome), [MONDO:0016008](http://purl.obolibrary.org/obo/MONDO_0016008) (fetal hydantoin syndrome), [MONDO:0018657](http://purl.obolibrary.org/obo/MONDO_0018657) (pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome), [MONDO:0018658](http://purl.obolibrary.org/obo/MONDO_0018658) (19p13.3 microduplication syndrome), [MONDO:0017324](http://purl.obolibrary.org/obo/MONDO_0017324) (autosomal recessive hypophosphatemic rickets), [MONDO:0018655](http://purl.obolibrary.org/obo/MONDO_0018655) (hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome), [MONDO:0017327](http://purl.obolibrary.org/obo/MONDO_0017327) (primary non-gestational choriocarcinoma of ovary), [MONDO:0018656](http://purl.obolibrary.org/obo/MONDO_0018656) (tremor-ataxia-central hypomyelination syndrome), [MONDO:0018653](http://purl.obolibrary.org/obo/MONDO_0018653) (Polymerase proofreading-related adenomatous polyposis), [MONDO:0017321](http://purl.obolibrary.org/obo/MONDO_0017321) (pili torti-onychodysplasia syndrome), [MONDO:0018654](http://purl.obolibrary.org/obo/MONDO_0018654) (idiopathic dropped head syndrome), [MONDO:0017320](http://purl.obolibrary.org/obo/MONDO_0017320) (Phosphoenolpyruvate carboxykinase deficiency), [MONDO:0017323](http://purl.obolibrary.org/obo/MONDO_0017323) (Hypocalcemic rickets), [MONDO:0019982](http://purl.obolibrary.org/obo/MONDO_0019982) (bilateral multicystic dysplastic kidney), [MONDO:0017322](http://purl.obolibrary.org/obo/MONDO_0017322) (disorders of vitamin d metabolism), [MONDO:0019983](http://purl.obolibrary.org/obo/MONDO_0019983) (Multiloculated renal cyst), [MONDO:0019980](http://purl.obolibrary.org/obo/MONDO_0019980) (renal hypoplasia, bilateral), [MONDO:0019981](http://purl.obolibrary.org/obo/MONDO_0019981) (unilateral multicystic dysplastic kidney), [MONDO:0006689](http://purl.obolibrary.org/obo/MONDO_0006689) (carcinoid syndrome), [MONDO:0004028](http://purl.obolibrary.org/obo/MONDO_0004028) (small intestinal fibrosarcoma), [MONDO:0004024](http://purl.obolibrary.org/obo/MONDO_0004024) (spinal cord neuroblastoma), [MONDO:0004021](http://purl.obolibrary.org/obo/MONDO_0004021) (mediastinal malignant lymphoma), [MONDO:0004022](http://purl.obolibrary.org/obo/MONDO_0004022) (parasagittal meningioma), [MONDO:0004020](http://purl.obolibrary.org/obo/MONDO_0004020) (mediastinal gray zone lymphoma), [MONDO:0005351](http://purl.obolibrary.org/obo/MONDO_0005351) (anorexia nervosa), [MONDO:0006680](http://purl.obolibrary.org/obo/MONDO_0006680) (blue nevus), [MONDO:0017328](http://purl.obolibrary.org/obo/MONDO_0017328) (non-central nervous system-localized embryonal carcinoma), [MONDO:0017314](http://purl.obolibrary.org/obo/MONDO_0017314) (Ehlers-Danlos syndrome, vascular type), [MONDO:0019978](http://purl.obolibrary.org/obo/MONDO_0019978) (Robinow syndrome), [MONDO:0017313](http://purl.obolibrary.org/obo/MONDO_0017313) (disorder of folate metabolism and transport), [MONDO:0019975](http://purl.obolibrary.org/obo/MONDO_0019975) (pellagra), [MONDO:0017316](http://purl.obolibrary.org/obo/MONDO_0017316) (short stature-deafness-neutrophil dysfunction-dysmorphism syndrome), [MONDO:0018645](http://purl.obolibrary.org/obo/MONDO_0018645) (IgG4-related sclerosing cholangitis), [MONDO:0017315](http://purl.obolibrary.org/obo/MONDO_0017315) (short stature-webbed neck-heart disease syndrome), [MONDO:0019973](http://purl.obolibrary.org/obo/MONDO_0019973) (persistent placoid maculopathy), [MONDO:0018642](http://purl.obolibrary.org/obo/MONDO_0018642) (NIK deficiency), [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0019971](http://purl.obolibrary.org/obo/MONDO_0019971) (melanoma of soft tissue), [MONDO:0018641](http://purl.obolibrary.org/obo/MONDO_0018641) (paroxysmal nocturnal hemoglobinuria), [MONDO:0019972](http://purl.obolibrary.org/obo/MONDO_0019972) (dural sinus malformation), [MONDO:0019970](http://purl.obolibrary.org/obo/MONDO_0019970) (Sinding-larsen-Johansson disease), [MONDO:0005329](http://purl.obolibrary.org/obo/MONDO_0005329) (vascular sarcoma), [MONDO:0005328](http://purl.obolibrary.org/obo/MONDO_0005328) (eye disease), [MONDO:0007989](http://purl.obolibrary.org/obo/MONDO_0007989) (congenital microcoria), [MONDO:0006657](http://purl.obolibrary.org/obo/MONDO_0006657) (apparent mineralocorticoid excess syndrome), [MONDO:0007988](http://purl.obolibrary.org/obo/MONDO_0007988) (autosomal dominant microcephaly), [MONDO:0007987](http://purl.obolibrary.org/obo/MONDO_0007987) (Kniest dysplasia), [MONDO:0007986](http://purl.obolibrary.org/obo/MONDO_0007986) (Metatropic dysplasia), [MONDO:0005324](http://purl.obolibrary.org/obo/MONDO_0005324) (seasonal allergic rhinitis), [MONDO:0005321](http://purl.obolibrary.org/obo/MONDO_0005321) (Fuchs' endothelial dystrophy), [MONDO:0007984](http://purl.obolibrary.org/obo/MONDO_0007984) (metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome), [MONDO:0007983](http://purl.obolibrary.org/obo/MONDO_0007983) (Schmid metaphyseal chondrodysplasia), [MONDO:0006651](http://purl.obolibrary.org/obo/MONDO_0006651) (anterior uveitis (disease)), [MONDO:0007982](http://purl.obolibrary.org/obo/MONDO_0007982) (metaphyseal chondrodysplasia, Jansen type), [MONDO:0007981](http://purl.obolibrary.org/obo/MONDO_0007981) (metachromatic leukodystrophy, adult-onset, with normal arylsulfatase a), [MONDO:0017318](http://purl.obolibrary.org/obo/MONDO_0017318) (phakomatosis pigmentovascularis), [MONDO:0017317](http://purl.obolibrary.org/obo/MONDO_0017317) (phakomatosis pigmentokeratotica), [MONDO:0018648](http://purl.obolibrary.org/obo/MONDO_0018648) (Keratocystic odontogenic tumor), [MONDO:0019979](http://purl.obolibrary.org/obo/MONDO_0019979) (renal hypoplasia, unilateral), [MONDO:0018649](http://purl.obolibrary.org/obo/MONDO_0018649) (cerebral visual impairment), [MONDO:0017319](http://purl.obolibrary.org/obo/MONDO_0017319) (hereditary elliptocytosis), [MONDO:0018635](http://purl.obolibrary.org/obo/MONDO_0018635) (idiopathic phalangeal acro-osteolysis), [MONDO:0019967](http://purl.obolibrary.org/obo/MONDO_0019967) (Kienbock disease), [MONDO:0018636](http://purl.obolibrary.org/obo/MONDO_0018636) (autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome), [MONDO:0019964](http://purl.obolibrary.org/obo/MONDO_0019964) (thymic neuroendocrine tumor), [MONDO:0018633](http://purl.obolibrary.org/obo/MONDO_0018633) (20q11.2 microdeletion syndrome), [MONDO:0017305](http://purl.obolibrary.org/obo/MONDO_0017305) (syndromic oculocutaneous albinism), [MONDO:0017304](http://purl.obolibrary.org/obo/MONDO_0017304) (ocular albinism (disease)), [MONDO:0018634](http://purl.obolibrary.org/obo/MONDO_0018634) (hereditary amyloidosis), [MONDO:0019965](http://purl.obolibrary.org/obo/MONDO_0019965) (rare benign ovarian tumor), [MONDO:0019962](http://purl.obolibrary.org/obo/MONDO_0019962) (thyroid lymphoma), [MONDO:0018632](http://purl.obolibrary.org/obo/MONDO_0018632) (11q22.2q22.3 microdeletion syndrome), [MONDO:0019963](http://purl.obolibrary.org/obo/MONDO_0019963) (bronchial endocrine tumor), [MONDO:0017301](http://purl.obolibrary.org/obo/MONDO_0017301) (pericardial and diaphragmatic defect), [MONDO:0019960](http://purl.obolibrary.org/obo/MONDO_0019960) (VIPoma), [MONDO:0018630](http://purl.obolibrary.org/obo/MONDO_0018630) (hereditary nonpolyposis colon cancer), [MONDO:0004009](http://purl.obolibrary.org/obo/MONDO_0004009) (kidney pelvis sarcomatoid transitional cell carcinoma), [MONDO:0005338](http://purl.obolibrary.org/obo/MONDO_0005338) (open-angle glaucoma), [MONDO:0004007](http://purl.obolibrary.org/obo/MONDO_0004007) (breast intraductal proliferative lesion), [MONDO:0005339](http://purl.obolibrary.org/obo/MONDO_0005339) (androgenetic alopecia), [MONDO:0004008](http://purl.obolibrary.org/obo/MONDO_0004008) (flat ductal epithelial atypia), [MONDO:0006668](http://purl.obolibrary.org/obo/MONDO_0006668) (bacterial conjunctivitis), [MONDO:0004005](http://purl.obolibrary.org/obo/MONDO_0004005) (rete ovarii adenoma), [MONDO:0007999](http://purl.obolibrary.org/obo/MONDO_0007999) (holoprosencephaly 2), [MONDO:0004006](http://purl.obolibrary.org/obo/MONDO_0004006) (rete ovarii cystadenofibroma), [MONDO:0007998](http://purl.obolibrary.org/obo/MONDO_0007998) (Microspherophakia-metaphyseal dysplasia syndrome), [MONDO:0006667](http://purl.obolibrary.org/obo/MONDO_0006667) (b- and T-cell mixed leukemia), [MONDO:0004003](http://purl.obolibrary.org/obo/MONDO_0004003) (pancreatic solid pseudopapillary carcinoma), [MONDO:0005335](http://purl.obolibrary.org/obo/MONDO_0005335) (colorectal neoplasm), [MONDO:0004004](http://purl.obolibrary.org/obo/MONDO_0004004) (motor neuritis), [MONDO:0006664](http://purl.obolibrary.org/obo/MONDO_0006664) (atrial heart septal defect), [MONDO:0005332](http://purl.obolibrary.org/obo/MONDO_0005332) (growth hormone-secreting pituitary adenoma), [MONDO:0007995](http://purl.obolibrary.org/obo/MONDO_0007995) (MCOPCT1), [MONDO:0007994](http://purl.obolibrary.org/obo/MONDO_0007994) (micromelic bone dysplasia with cloverleaf skull), [MONDO:0007993](http://purl.obolibrary.org/obo/MONDO_0007993) (microgastria-limb reduction defect syndrome), [MONDO:0006661](http://purl.obolibrary.org/obo/MONDO_0006661) (ascorbic acid deficiency), [MONDO:0007992](http://purl.obolibrary.org/obo/MONDO_0007992) (microcornea-glaucoma-absent frontal sinuses syndrome), [MONDO:0004000](http://purl.obolibrary.org/obo/MONDO_0004000) (childhood pilocytic astrocytoma), [MONDO:0007991](http://purl.obolibrary.org/obo/MONDO_0007991) (microcephaly-deafness-intellectual disability syndrome), [MONDO:0006660](http://purl.obolibrary.org/obo/MONDO_0006660) (arthus reaction), [MONDO:0018639](http://purl.obolibrary.org/obo/MONDO_0018639) (caudal regression-sirenomelia spectrum), [MONDO:0017307](http://purl.obolibrary.org/obo/MONDO_0017307) (disorder of tyrosine metabolism), [MONDO:0017306](http://purl.obolibrary.org/obo/MONDO_0017306) (disorder of phenylalanine metabolism), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), [MONDO:0017308](http://purl.obolibrary.org/obo/MONDO_0017308) (Marfan syndrome type 2), [MONDO:0019969](http://purl.obolibrary.org/obo/MONDO_0019969) (Panner disease), [MONDO:0018638](http://purl.obolibrary.org/obo/MONDO_0018638) (pseudohypoaldosteronism), [MONDO:0016049](http://purl.obolibrary.org/obo/MONDO_0016049) (congenital myopathy, Paradas type), [MONDO:0016048](http://purl.obolibrary.org/obo/MONDO_0016048) (isolated autosomal dominant hypomagnesemia, Glaudemans type), [MONDO:0017376](http://purl.obolibrary.org/obo/MONDO_0017376) (reactive arthritis), [MONDO:0016045](http://purl.obolibrary.org/obo/MONDO_0016045) (Tetragametic chimerism), [MONDO:0016047](http://purl.obolibrary.org/obo/MONDO_0016047) (endophthalmitis), [MONDO:0017377](http://purl.obolibrary.org/obo/MONDO_0017377) (preaxial polydactyly-colobomata-intellectual disability syndrome), [MONDO:0016046](http://purl.obolibrary.org/obo/MONDO_0016046) (familial clubfoot with or without associated lower limb anomalies), [MONDO:0016041](http://purl.obolibrary.org/obo/MONDO_0016041) (congenital microgastria), [MONDO:0017371](http://purl.obolibrary.org/obo/MONDO_0017371) (rare head and neck tumor), [MONDO:0017373](http://purl.obolibrary.org/obo/MONDO_0017373) (poliomyelitis), [MONDO:0004056](http://purl.obolibrary.org/obo/MONDO_0004056) (bladder papillary urothelial carcinoma), [MONDO:0005388](http://purl.obolibrary.org/obo/MONDO_0005388) (primary biliary cholangitis), [MONDO:0004057](http://purl.obolibrary.org/obo/MONDO_0004057) (micropapillary variant infiltrating bladder urothelial carcinoma), [MONDO:0004054](http://purl.obolibrary.org/obo/MONDO_0004054) (acute canaliculitis), [MONDO:0004055](http://purl.obolibrary.org/obo/MONDO_0004055) (acute inflammation of lacrimal passage), [MONDO:0004052](http://purl.obolibrary.org/obo/MONDO_0004052) (rectal cloacogenic carcinoma), [MONDO:0004053](http://purl.obolibrary.org/obo/MONDO_0004053) (Bartholin's gland squamous cell carcinoma), [MONDO:0004050](http://purl.obolibrary.org/obo/MONDO_0004050) (telangiectatic osteogenic sarcoma), [MONDO:0004051](http://purl.obolibrary.org/obo/MONDO_0004051) (aleukemic monocytic leukemia cutis), [MONDO:0005382](http://purl.obolibrary.org/obo/MONDO_0005382) (bone paget disease), [MONDO:0005380](http://purl.obolibrary.org/obo/MONDO_0005380) (osteonecrosis), [MONDO:0016038](http://purl.obolibrary.org/obo/MONDO_0016038) (calcified aponeurotic fibroma), [MONDO:0016037](http://purl.obolibrary.org/obo/MONDO_0016037) (superficial fibromatosis), [MONDO:0018699](http://purl.obolibrary.org/obo/MONDO_0018699) (pseudohypoparathyroidism with Albright hereditary osteodystrophy), [MONDO:0016039](http://purl.obolibrary.org/obo/MONDO_0016039) (infantile digital fibromatosis), [MONDO:0018697](http://purl.obolibrary.org/obo/MONDO_0018697) (1p35.2 microdeletion syndrome), [MONDO:0017364](http://purl.obolibrary.org/obo/MONDO_0017364) (POEMS syndrome), [MONDO:0016033](http://purl.obolibrary.org/obo/MONDO_0016033) (Cornelia de Lange syndrome), [MONDO:0018698](http://purl.obolibrary.org/obo/MONDO_0018698) (hereditary neuroendocrine tumor of small intestine), [MONDO:0016036](http://purl.obolibrary.org/obo/MONDO_0016036) (Ledderhose disease), [MONDO:0017366](http://purl.obolibrary.org/obo/MONDO_0017366) (hereditary pheochromocytoma-paraganglioma), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0016030](http://purl.obolibrary.org/obo/MONDO_0016030) (Evans syndrome), [MONDO:0017360](http://purl.obolibrary.org/obo/MONDO_0017360) (vitamin B12-unresponsive methylmalonic acidemia type mut0), [MONDO:0018694](http://purl.obolibrary.org/obo/MONDO_0018694) (isolated tracheo-esophageal fistula), [MONDO:0017363](http://purl.obolibrary.org/obo/MONDO_0017363) (idiopathic chronic eosinophilic pneumonia), [MONDO:0016032](http://purl.obolibrary.org/obo/MONDO_0016032) (femoral agenesis/hypoplasia), [MONDO:0018691](http://purl.obolibrary.org/obo/MONDO_0018691) (endometrioid carcinoma of ovary), [MONDO:0016031](http://purl.obolibrary.org/obo/MONDO_0016031) (facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome), [MONDO:0018690](http://purl.obolibrary.org/obo/MONDO_0018690) (Holmes-Adie syndrome), [MONDO:0004069](http://purl.obolibrary.org/obo/MONDO_0004069) (inborn mitochondrial metabolism disorder), [MONDO:0004067](http://purl.obolibrary.org/obo/MONDO_0004067) (gallbladder mucinous adenocarcinoma), [MONDO:0005398](http://purl.obolibrary.org/obo/MONDO_0005398) (upper aerodigestive tract neoplasm), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0005393](http://purl.obolibrary.org/obo/MONDO_0005393) (gout), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), [MONDO:0004060](http://purl.obolibrary.org/obo/MONDO_0004060) (peripheral epithelioid sarcoma), [MONDO:0018688](http://purl.obolibrary.org/obo/MONDO_0018688) (Anti-p200 pemphigoid), [MONDO:0016029](http://purl.obolibrary.org/obo/MONDO_0016029) (esthesioneuroblastoma), [MONDO:0017359](http://purl.obolibrary.org/obo/MONDO_0017359) (3-methylglutaconic aciduria), [MONDO:0018689](http://purl.obolibrary.org/obo/MONDO_0018689) (plasma cell leukemia), [MONDO:0016023](http://purl.obolibrary.org/obo/MONDO_0016023) (ocular coloboma), [MONDO:0017354](http://purl.obolibrary.org/obo/MONDO_0017354) (infantile glycine encephalopathy), [MONDO:0016022](http://purl.obolibrary.org/obo/MONDO_0016022) (early myoclonic encephalopathy), [MONDO:0017353](http://purl.obolibrary.org/obo/MONDO_0017353) (neonatal glycine encephalopathy), [MONDO:0018687](http://purl.obolibrary.org/obo/MONDO_0018687) (progressive muscular atrophy), [MONDO:0017356](http://purl.obolibrary.org/obo/MONDO_0017356) (disorder of ornithine metabolism), [MONDO:0018684](http://purl.obolibrary.org/obo/MONDO_0018684) (idiopathic neonatal atrial flutter), [MONDO:0016024](http://purl.obolibrary.org/obo/MONDO_0016024) (shoulder and thorax deformity-congenital heart disease syndrome), [MONDO:0017355](http://purl.obolibrary.org/obo/MONDO_0017355) (disorder of proline metabolism), [MONDO:0018685](http://purl.obolibrary.org/obo/MONDO_0018685) (Incessant infant ventricular tachycardia), [MONDO:0017350](http://purl.obolibrary.org/obo/MONDO_0017350) (disorder of tryptophan metabolism), [MONDO:0017352](http://purl.obolibrary.org/obo/MONDO_0017352) (disorder of glutamine metabolism), [MONDO:0018680](http://purl.obolibrary.org/obo/MONDO_0018680) (cutaneous pseudolymphoma), [MONDO:0018681](http://purl.obolibrary.org/obo/MONDO_0018681) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome), [MONDO:0017351](http://purl.obolibrary.org/obo/MONDO_0017351) (disorder of lysine and hydroxylysine metabolism), [MONDO:0016020](http://purl.obolibrary.org/obo/MONDO_0016020) (frontal encephalocele), [MONDO:0005369](http://purl.obolibrary.org/obo/MONDO_0005369) (carcinoid tumor (disease)), [MONDO:0004039](http://purl.obolibrary.org/obo/MONDO_0004039) (papillary extrahepatic bile duct adenocarcinoma), [MONDO:0004036](http://purl.obolibrary.org/obo/MONDO_0004036) (predominantly cortical thymoma), [MONDO:0004037](http://purl.obolibrary.org/obo/MONDO_0004037) (retinal edema), [MONDO:0005365](http://purl.obolibrary.org/obo/MONDO_0005365) (hearing loss), [MONDO:0004034](http://purl.obolibrary.org/obo/MONDO_0004034) (eye lymphoma), [MONDO:0004035](http://purl.obolibrary.org/obo/MONDO_0004035) (glomangiomatosis), [MONDO:0004032](http://purl.obolibrary.org/obo/MONDO_0004032) (malignant ovarian mixed epithelial neoplasm), [MONDO:0005364](http://purl.obolibrary.org/obo/MONDO_0005364) (Graves disease), [MONDO:0004033](http://purl.obolibrary.org/obo/MONDO_0004033) (familial ovarian carcinoma), [MONDO:0004030](http://purl.obolibrary.org/obo/MONDO_0004030) (ureter transitional cell carcinoma), [MONDO:0004031](http://purl.obolibrary.org/obo/MONDO_0004031) (ovary mixed epithelial carcinoma), [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0016016](http://purl.obolibrary.org/obo/MONDO_0016016) (Toluene embryopathy), [MONDO:0018679](http://purl.obolibrary.org/obo/MONDO_0018679) (primary cutaneous plasmacytosis), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0016015](http://purl.obolibrary.org/obo/MONDO_0016015) (Phenobarbital embryopathy), [MONDO:0016018](http://purl.obolibrary.org/obo/MONDO_0016018) (diabetic embryopathy), [MONDO:0017349](http://purl.obolibrary.org/obo/MONDO_0017349) (Myopericytoma), [MONDO:0017348](http://purl.obolibrary.org/obo/MONDO_0017348) (lymphoepithelial-like carcinoma), [MONDO:0016017](http://purl.obolibrary.org/obo/MONDO_0016017) (Methimazole embryofetopathy), [MONDO:0016012](http://purl.obolibrary.org/obo/MONDO_0016012) (Diethylstilbestrol syndrome), [MONDO:0018675](http://purl.obolibrary.org/obo/MONDO_0018675) (IgG4-related ophthalmic disease), [MONDO:0017343](http://purl.obolibrary.org/obo/MONDO_0017343) (Epstein-Barr virus-associated malignant lymphoproliferative disorder), [MONDO:0018676](http://purl.obolibrary.org/obo/MONDO_0018676) (eosinophilic angiocentric fibrosis), [MONDO:0017342](http://purl.obolibrary.org/obo/MONDO_0017342) (Epstein-Barr virus-related tumor), [MONDO:0016011](http://purl.obolibrary.org/obo/MONDO_0016011) (fetal alcohol syndrome), [MONDO:0018673](http://purl.obolibrary.org/obo/MONDO_0018673) (IgG4-related pachymeningitis), [MONDO:0016014](http://purl.obolibrary.org/obo/MONDO_0016014) (fetal minoxidil syndrome), [MONDO:0017345](http://purl.obolibrary.org/obo/MONDO_0017345) (Epstein-Barr virus-associated mesenchymal tumor), [MONDO:0018674](http://purl.obolibrary.org/obo/MONDO_0018674) (IgG4-related submandibular gland disease), [MONDO:0016013](http://purl.obolibrary.org/obo/MONDO_0016013) (fetal methylmercury syndrome), [MONDO:0017344](http://purl.obolibrary.org/obo/MONDO_0017344) (Epstein-Barr virus-associated carcinoma), [MONDO:0018671](http://purl.obolibrary.org/obo/MONDO_0018671) (IgG4-related kidney disease), [MONDO:0018672](http://purl.obolibrary.org/obo/MONDO_0018672) (IgG4-related aortitis), [MONDO:0016010](http://purl.obolibrary.org/obo/MONDO_0016010) (vitamin K-antagonist embryofetopathy), [MONDO:0017341](http://purl.obolibrary.org/obo/MONDO_0017341) (rare virus associated tumor), [MONDO:0018670](http://purl.obolibrary.org/obo/MONDO_0018670) (symptomatic form of fragile X syndrome in female carrier), [MONDO:0017340](http://purl.obolibrary.org/obo/MONDO_0017340) (juvenile nasopharyngeal angiofibroma (disease)), [MONDO:0004047](http://purl.obolibrary.org/obo/MONDO_0004047) (sphenoidal sinus neoplasm), [MONDO:0004048](http://purl.obolibrary.org/obo/MONDO_0004048) (malignant gastric teratoma), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0004046](http://purl.obolibrary.org/obo/MONDO_0004046) (childhood brain meningioma), [MONDO:0004043](http://purl.obolibrary.org/obo/MONDO_0004043) (ureter inverted papilloma), [MONDO:0005374](http://purl.obolibrary.org/obo/MONDO_0005374) (bone marrow neoplasm), [MONDO:0004044](http://purl.obolibrary.org/obo/MONDO_0004044) (ureter urothelial papilloma), [MONDO:0005375](http://purl.obolibrary.org/obo/MONDO_0005375) (nasopharyngeal neoplasm), [MONDO:0004041](http://purl.obolibrary.org/obo/MONDO_0004041) (urothelial papilloma), [MONDO:0004042](http://purl.obolibrary.org/obo/MONDO_0004042) (urethra inverted papilloma), [MONDO:0004040](http://purl.obolibrary.org/obo/MONDO_0004040) (urinary bladder inverted papilloma), [MONDO:0016089](http://purl.obolibrary.org/obo/MONDO_0016089) (infantile Krabbe disease), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0016085](http://purl.obolibrary.org/obo/MONDO_0016085) (Cole-Carpenter syndrome), [MONDO:0016087](http://purl.obolibrary.org/obo/MONDO_0016087) (progressive non-infectious anterior vertebral fusion), [MONDO:0016086](http://purl.obolibrary.org/obo/MONDO_0016086) (osteochondritis of tarsal/metatarsal bone), [MONDO:0016080](http://purl.obolibrary.org/obo/MONDO_0016080) (congenital bronchobiliary fistula), [MONDO:0016082](http://purl.obolibrary.org/obo/MONDO_0016082) (Tracheo-esophageal fistula-hypospadias syndrome), [MONDO:0016090](http://purl.obolibrary.org/obo/MONDO_0016090) (late-infantile/juvenile Krabbe disease), [MONDO:0004098](http://purl.obolibrary.org/obo/MONDO_0004098) (malignant melanocytic peripheral nerve sheath tumor of mediastinum), [MONDO:0004099](http://purl.obolibrary.org/obo/MONDO_0004099) (adult cystic teratoma), [MONDO:0004096](http://purl.obolibrary.org/obo/MONDO_0004096) (spinal cord dermoid cyst), [MONDO:0004094](http://purl.obolibrary.org/obo/MONDO_0004094) (multiple skull base meningioma), [MONDO:0004095](http://purl.obolibrary.org/obo/MONDO_0004095) (B-cell neoplasm), [MONDO:0004092](http://purl.obolibrary.org/obo/MONDO_0004092) (thymus basaloid carcinoma), [MONDO:0004093](http://purl.obolibrary.org/obo/MONDO_0004093) (esophageal basaloid carcinoma), [MONDO:0004090](http://purl.obolibrary.org/obo/MONDO_0004090) (vulvar basaloid squamous cell carcinoma), [MONDO:0004091](http://purl.obolibrary.org/obo/MONDO_0004091) (basaloid squamous cell skin carcinoma), [MONDO:0016073](http://purl.obolibrary.org/obo/MONDO_0016073) (syndromic microphthalmia), [MONDO:0016070](http://purl.obolibrary.org/obo/MONDO_0016070) (gingival fibromatosis), [MONDO:0016071](http://purl.obolibrary.org/obo/MONDO_0016071) (juvenile hyaline fibromatosis), [MONDO:0017398](http://purl.obolibrary.org/obo/MONDO_0017398) (3MC syndrome), [MONDO:0017397](http://purl.obolibrary.org/obo/MONDO_0017397) (constitutional dyserythropoietic anemia), [MONDO:0016069](http://purl.obolibrary.org/obo/MONDO_0016069) (undifferentiated pleomorphic sarcoma), [MONDO:0016068](http://purl.obolibrary.org/obo/MONDO_0016068) (fibrochondrogenesis), [MONDO:0016063](http://purl.obolibrary.org/obo/MONDO_0016063) (Cowden disease), [MONDO:0017393](http://purl.obolibrary.org/obo/MONDO_0017393) (blepharophimosis-intellectual disability syndrome), [MONDO:0016065](http://purl.obolibrary.org/obo/MONDO_0016065) (cleft palate-short stature-vertebral anomalies syndrome), [MONDO:0017390](http://purl.obolibrary.org/obo/MONDO_0017390) (methylmalonic acidemia without homocystinuria), [MONDO:0016061](http://purl.obolibrary.org/obo/MONDO_0016061) (immunodeficiency with factor H anomaly), [MONDO:0017392](http://purl.obolibrary.org/obo/MONDO_0017392) (Pre-Descemet corneal dystrophy), [MONDO:0016060](http://purl.obolibrary.org/obo/MONDO_0016060) (laryngotracheoesophageal cleft), [MONDO:0017391](http://purl.obolibrary.org/obo/MONDO_0017391) (Grayson-Wilbrandt corneal dystrophy), [MONDO:0004078](http://purl.obolibrary.org/obo/MONDO_0004078) (mucinous intrahepatic cholangiocarcinoma), [MONDO:0004079](http://purl.obolibrary.org/obo/MONDO_0004079) (bronchial mucus gland adenoma), [MONDO:0004076](http://purl.obolibrary.org/obo/MONDO_0004076) (tendon sheath lipoma), [MONDO:0004077](http://purl.obolibrary.org/obo/MONDO_0004077) (lumbosacral lipoma), [MONDO:0004074](http://purl.obolibrary.org/obo/MONDO_0004074) (ovarian mucinous cystadenofibroma), [MONDO:0004075](http://purl.obolibrary.org/obo/MONDO_0004075) (infiltrating lipoma), [MONDO:0004071](http://purl.obolibrary.org/obo/MONDO_0004071) (childhood cerebral astrocytoma), [MONDO:0016059](http://purl.obolibrary.org/obo/MONDO_0016059) (cleft lip/palate-deafness-sacral lipoma syndrome), [MONDO:0016056](http://purl.obolibrary.org/obo/MONDO_0016056) (isolated congenital microcephaly), [MONDO:0017387](http://purl.obolibrary.org/obo/MONDO_0017387) (epithelioid sarcoma), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0017389](http://purl.obolibrary.org/obo/MONDO_0017389) (tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria), [MONDO:0016057](http://purl.obolibrary.org/obo/MONDO_0016057) (isolated encephalocele), [MONDO:0017383](http://purl.obolibrary.org/obo/MONDO_0017383) (familial clubfoot due to PITX1 point mutation), [MONDO:0017382](http://purl.obolibrary.org/obo/MONDO_0017382) (familial clubfoot due to 5q31 microdeletion), [MONDO:0016051](http://purl.obolibrary.org/obo/MONDO_0016051) (cleft lip-retinopathy syndrome), [MONDO:0016050](http://purl.obolibrary.org/obo/MONDO_0016050) (thiamine-responsive encephalopathy), [MONDO:0017380](http://purl.obolibrary.org/obo/MONDO_0017380) (juvenile polyposis syndrome), [MONDO:0004089](http://purl.obolibrary.org/obo/MONDO_0004089) (penis basaloid carcinoma), [MONDO:0004087](http://purl.obolibrary.org/obo/MONDO_0004087) (basaloid lung carcinoma), [MONDO:0004088](http://purl.obolibrary.org/obo/MONDO_0004088) (cervical basaloid squamous cell carcinoma), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0004083](http://purl.obolibrary.org/obo/MONDO_0004083) (Borst-Jadassohn intraepidermal carcinoma), [MONDO:0004081](http://purl.obolibrary.org/obo/MONDO_0004081) (bile duct clear cell adenocarcinoma), [MONDO:0004082](http://purl.obolibrary.org/obo/MONDO_0004082) (childhood immature teratoma of ovary), [MONDO:0004080](http://purl.obolibrary.org/obo/MONDO_0004080) (glottis squamous cell carcinoma), [MONDO:0016099](http://purl.obolibrary.org/obo/MONDO_0016099) (overlap myositis), [MONDO:0016096](http://purl.obolibrary.org/obo/MONDO_0016096) (malignant non-dysgerminomatous germ cell tumor of ovary), [MONDO:0016095](http://purl.obolibrary.org/obo/MONDO_0016095) (vaginal rhabdomyosarcoma), [MONDO:0016098](http://purl.obolibrary.org/obo/MONDO_0016098) (immune-mediated necrotizing myopathy), [MONDO:0016097](http://purl.obolibrary.org/obo/MONDO_0016097) (symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers), [MONDO:0016092](http://purl.obolibrary.org/obo/MONDO_0016092) (serous or mucinous cystadenoma of childhood), [MONDO:0016091](http://purl.obolibrary.org/obo/MONDO_0016091) (adult Krabbe disease), [MONDO:0016094](http://purl.obolibrary.org/obo/MONDO_0016094) (vaginal germ cell malignant tumor), [MONDO:0016093](http://purl.obolibrary.org/obo/MONDO_0016093) (borderline epithelial tumor of ovary), [MONDO:0018701](http://purl.obolibrary.org/obo/MONDO_0018701) (congenital nemaline myopathy), [MONDO:0018702](http://purl.obolibrary.org/obo/MONDO_0018702) (TAFRO syndrome), [MONDO:0018700](http://purl.obolibrary.org/obo/MONDO_0018700) (pseudohypoparathyroidism without Albright hereditary osteodystrophy), [MONDO:0006719](http://purl.obolibrary.org/obo/MONDO_0006719) (cystic lymphangioma), [MONDO:0006717](http://purl.obolibrary.org/obo/MONDO_0006717) (cutaneous fibrous histiocytoma), [MONDO:0006713](http://purl.obolibrary.org/obo/MONDO_0006713) (corneal neovascularization), [MONDO:0006712](http://purl.obolibrary.org/obo/MONDO_0006712) (corneal edema), [MONDO:0018708](http://purl.obolibrary.org/obo/MONDO_0018708) (squamous cell carcinoma of the oral tongue), [MONDO:0018705](http://purl.obolibrary.org/obo/MONDO_0018705) (infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome), [MONDO:0018706](http://purl.obolibrary.org/obo/MONDO_0018706) (syndromic sensorineural deafness due to combined oxidative phosphorylation defect), [MONDO:0018703](http://purl.obolibrary.org/obo/MONDO_0018703) (isolated splenogonadal fusion), [MONDO:0006727](http://purl.obolibrary.org/obo/MONDO_0006727) (diastolic heart failure), [MONDO:0006720](http://purl.obolibrary.org/obo/MONDO_0006720) (cystic, mucinous, and serous neoplasm), [MONDO:0006709](http://purl.obolibrary.org/obo/MONDO_0006709) (common bile duct neoplasm), [MONDO:0006704](http://purl.obolibrary.org/obo/MONDO_0006704) (CNS demyelinating autoimmune disease), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0006700](http://purl.obolibrary.org/obo/MONDO_0006700) (choroid cancer), [MONDO:0017413](http://purl.obolibrary.org/obo/MONDO_0017413) (Reunion island larsen syndrome), [MONDO:0018745](http://purl.obolibrary.org/obo/MONDO_0018745) (superficial pemphigus), [MONDO:0018746](http://purl.obolibrary.org/obo/MONDO_0018746) (mucous membrane pemphigoid), [MONDO:0018743](http://purl.obolibrary.org/obo/MONDO_0018743) (immune-mediated acquired neuromuscular junction disease), [MONDO:0017415](http://purl.obolibrary.org/obo/MONDO_0017415) (multiple pterygium syndrome), [MONDO:0018744](http://purl.obolibrary.org/obo/MONDO_0018744) (oligodendroglial tumor), [MONDO:0017414](http://purl.obolibrary.org/obo/MONDO_0017414) (rare nevus), [MONDO:0018742](http://purl.obolibrary.org/obo/MONDO_0018742) (familial gastric type 1 neuroendocrine tumor), [MONDO:0017411](http://purl.obolibrary.org/obo/MONDO_0017411) (neonatal inflammatory skin and bowel disease), [MONDO:0018740](http://purl.obolibrary.org/obo/MONDO_0018740) (drug-induced methemoglobinemia), [MONDO:0017410](http://purl.obolibrary.org/obo/MONDO_0017410) (porencephaly), [MONDO:0005422](http://purl.obolibrary.org/obo/MONDO_0005422) (nodular sclerosis Hodgkin lymphoma), [MONDO:0017417](http://purl.obolibrary.org/obo/MONDO_0017417) (renal-hepatic-pancreatic dysplasia), [MONDO:0018749](http://purl.obolibrary.org/obo/MONDO_0018749) (hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome), [MONDO:0017416](http://purl.obolibrary.org/obo/MONDO_0017416) (postpoliomyelitis syndrome), [MONDO:0017419](http://purl.obolibrary.org/obo/MONDO_0017419) (non-syndromic amelia), [MONDO:0018747](http://purl.obolibrary.org/obo/MONDO_0018747) (acquired epidermolysis bullosa), [MONDO:0018748](http://purl.obolibrary.org/obo/MONDO_0018748) (linear IgA dermatosis), [MONDO:0018734](http://purl.obolibrary.org/obo/MONDO_0018734) (verrucous hemangioma), [MONDO:0018735](http://purl.obolibrary.org/obo/MONDO_0018735) (multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome), [MONDO:0018732](http://purl.obolibrary.org/obo/MONDO_0018732) (primary central nervous system lymphoma), [MONDO:0018733](http://purl.obolibrary.org/obo/MONDO_0018733) (intellectual disability syndrome due to a DYRK1A point mutation), [MONDO:0018730](http://purl.obolibrary.org/obo/MONDO_0018730) (rare genetic venous malformation), [MONDO:0017400](http://purl.obolibrary.org/obo/MONDO_0017400) (hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome), [MONDO:0005439](http://purl.obolibrary.org/obo/MONDO_0005439) (familial hypercholesterolemia), [MONDO:0004108](http://purl.obolibrary.org/obo/MONDO_0004108) (diaphragma sellae meningioma), [MONDO:0004109](http://purl.obolibrary.org/obo/MONDO_0004109) (epiglottis neoplasm), [MONDO:0004106](http://purl.obolibrary.org/obo/MONDO_0004106) (testicular yolk sac tumor, macrocystic pattern), [MONDO:0005438](http://purl.obolibrary.org/obo/MONDO_0005438) (metastatic malignant neoplasm in the lymph nodes), [MONDO:0004107](http://purl.obolibrary.org/obo/MONDO_0004107) (splenic manifestation of leukemia), [MONDO:0005435](http://purl.obolibrary.org/obo/MONDO_0005435) (anti-neutrophil antibody associated vasculitis), [MONDO:0004104](http://purl.obolibrary.org/obo/MONDO_0004104) (splenic manifestation of hairy cell leukemia), [MONDO:0004105](http://purl.obolibrary.org/obo/MONDO_0004105) (childhood epithelioid sarcoma), [MONDO:0004102](http://purl.obolibrary.org/obo/MONDO_0004102) (columnar cell variant papillary carcinoma), [MONDO:0004103](http://purl.obolibrary.org/obo/MONDO_0004103) (tall cell variant thyroid gland papillary carcinoma), [MONDO:0004100](http://purl.obolibrary.org/obo/MONDO_0004100) (lung mixed small cell and squamous cell carcinoma), [MONDO:0006762](http://purl.obolibrary.org/obo/MONDO_0006762) (freemartinism), [MONDO:0004101](http://purl.obolibrary.org/obo/MONDO_0004101) (multicentric papillary thyroid carcinoma), [MONDO:0006760](http://purl.obolibrary.org/obo/MONDO_0006760) (fetal erythroblastosis), [MONDO:0017406](http://purl.obolibrary.org/obo/MONDO_0017406) (hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome), [MONDO:0018738](http://purl.obolibrary.org/obo/MONDO_0018738) (benign metanephric tumour), [MONDO:0018736](http://purl.obolibrary.org/obo/MONDO_0018736) (kaposiform lymphangiomatosis), [MONDO:0017408](http://purl.obolibrary.org/obo/MONDO_0017408) (Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome), [MONDO:0018737](http://purl.obolibrary.org/obo/MONDO_0018737) (catastrophic antiphospholipid syndrome), [MONDO:0017407](http://purl.obolibrary.org/obo/MONDO_0017407) (deficiency in anterior pituitary function-variable immunodeficiency syndrome), [MONDO:0018724](http://purl.obolibrary.org/obo/MONDO_0018724) (X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome), [MONDO:0005408](http://purl.obolibrary.org/obo/MONDO_0005408) (diabetes mellitus type 2 associated cataract), [MONDO:0006739](http://purl.obolibrary.org/obo/MONDO_0006739) (ehrlich tumor carcinoma), [MONDO:0005406](http://purl.obolibrary.org/obo/MONDO_0005406) (gestational diabetes), [MONDO:0006738](http://purl.obolibrary.org/obo/MONDO_0006738) (eccrine acrospiroma), [MONDO:0006734](http://purl.obolibrary.org/obo/MONDO_0006734) (benign duodenal neoplasm), [MONDO:0005402](http://purl.obolibrary.org/obo/MONDO_0005402) (lymphoid leukemia (disease)), [MONDO:0005403](http://purl.obolibrary.org/obo/MONDO_0005403) (neonatal systemic lupus erthematosus), [MONDO:0006733](http://purl.obolibrary.org/obo/MONDO_0006733) (dry eye syndrome), [MONDO:0005401](http://purl.obolibrary.org/obo/MONDO_0005401) (colonic neoplasm), [MONDO:0018729](http://purl.obolibrary.org/obo/MONDO_0018729) (rare genetic vascular tumor), [MONDO:0018728](http://purl.obolibrary.org/obo/MONDO_0018728) (rare genetic capillary malformation), [MONDO:0018725](http://purl.obolibrary.org/obo/MONDO_0018725) (corpus callosum agenesis-macrocephaly-hypertelorism syndrome), [MONDO:0018712](http://purl.obolibrary.org/obo/MONDO_0018712) (composite hemangioendothelioma), [MONDO:0018713](http://purl.obolibrary.org/obo/MONDO_0018713) (retiform hemangioendothelioma), [MONDO:0018710](http://purl.obolibrary.org/obo/MONDO_0018710) (megalencephaly-severe kyphoscoliosis-overgrowth syndrome), [MONDO:0018711](http://purl.obolibrary.org/obo/MONDO_0018711) (intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome), [MONDO:0006749](http://purl.obolibrary.org/obo/MONDO_0006749) (epithelioid and spindle cell nevus), [MONDO:0005417](http://purl.obolibrary.org/obo/MONDO_0005417) (wet macular degeneration), [MONDO:0005416](http://purl.obolibrary.org/obo/MONDO_0005416) (osteoarthritis, knee), [MONDO:0006745](http://purl.obolibrary.org/obo/MONDO_0006745) (endometrioid stromal sarcoma), [MONDO:0005411](http://purl.obolibrary.org/obo/MONDO_0005411) (gallbladder cancer), [MONDO:0006742](http://purl.obolibrary.org/obo/MONDO_0006742) (endemic goiter), [MONDO:0018718](http://purl.obolibrary.org/obo/MONDO_0018718) (vascular tumor with associated anomalies), [MONDO:0018719](http://purl.obolibrary.org/obo/MONDO_0018719) (rare capillary malformation with associated anomalies), [MONDO:0018716](http://purl.obolibrary.org/obo/MONDO_0018716) (Partially involuting congenital hemangioma), [MONDO:0018714](http://purl.obolibrary.org/obo/MONDO_0018714) (primary intralymphatic angioendothelioma), [MONDO:0018715](http://purl.obolibrary.org/obo/MONDO_0018715) (congenital hemangioma), [MONDO:0017457](http://purl.obolibrary.org/obo/MONDO_0017457) (preaxial polydactyly of toes), [MONDO:0016126](http://purl.obolibrary.org/obo/MONDO_0016126) (viral myositis), [MONDO:0017456](http://purl.obolibrary.org/obo/MONDO_0017456) (central polydactyly of fingers), [MONDO:0016125](http://purl.obolibrary.org/obo/MONDO_0016125) (infectious, fungal or parasitic myopathy), [MONDO:0017459](http://purl.obolibrary.org/obo/MONDO_0017459) (central polydactyly of toes), [MONDO:0016128](http://purl.obolibrary.org/obo/MONDO_0016128) (parasitic myositis), [MONDO:0017458](http://purl.obolibrary.org/obo/MONDO_0017458) (postaxial polydactyly of toes), [MONDO:0016127](http://purl.obolibrary.org/obo/MONDO_0016127) (bacterial myositis), [MONDO:0016122](http://purl.obolibrary.org/obo/MONDO_0016122) (periodic paralysis (disease)), [MONDO:0017453](http://purl.obolibrary.org/obo/MONDO_0017453) (fetal parvovirus syndrome), [MONDO:0016121](http://purl.obolibrary.org/obo/MONDO_0016121) (congenital myotonia), [MONDO:0017452](http://purl.obolibrary.org/obo/MONDO_0017452) (brachydactyly of toes), [MONDO:0016124](http://purl.obolibrary.org/obo/MONDO_0016124) (drug and/or toxic myopathy), [MONDO:0017455](http://purl.obolibrary.org/obo/MONDO_0017455) (hyperphalangy), [MONDO:0017454](http://purl.obolibrary.org/obo/MONDO_0017454) (triphalangeal thumb-polysyndactyly syndrome), [MONDO:0016123](http://purl.obolibrary.org/obo/MONDO_0016123) (muscular tumor), [MONDO:0018781](http://purl.obolibrary.org/obo/MONDO_0018781) (KID syndrome), [MONDO:0016120](http://purl.obolibrary.org/obo/MONDO_0016120) (myotonic syndrome), [MONDO:0017451](http://purl.obolibrary.org/obo/MONDO_0017451) (brachydactyly of fingers), [MONDO:0018780](http://purl.obolibrary.org/obo/MONDO_0018780) (congenital generalized hypercontractile muscle stiffness syndrome), [MONDO:0017450](http://purl.obolibrary.org/obo/MONDO_0017450) (split foot (disease)), [MONDO:0004139](http://purl.obolibrary.org/obo/MONDO_0004139) (normocytic anemia), [MONDO:0004137](http://purl.obolibrary.org/obo/MONDO_0004137) (hereditary conventional renal cell carcinoma), [MONDO:0006799](http://purl.obolibrary.org/obo/MONDO_0006799) (hypothalamic neoplasm), [MONDO:0005466](http://purl.obolibrary.org/obo/MONDO_0005466) (hypersomnia (disease)), [MONDO:0006798](http://purl.obolibrary.org/obo/MONDO_0006798) (hypervitaminosis a), [MONDO:0004136](http://purl.obolibrary.org/obo/MONDO_0004136) (ovarian endometrioid cystadenoma), [MONDO:0006797](http://purl.obolibrary.org/obo/MONDO_0006797) (hypertensive retinopathy), [MONDO:0005464](http://purl.obolibrary.org/obo/MONDO_0005464) (rhegmatogenous retinal detachment), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0004134](http://purl.obolibrary.org/obo/MONDO_0004134) (benign dermal neurilemmoma), [MONDO:0004131](http://purl.obolibrary.org/obo/MONDO_0004131) (anal Buschke-Lowenstein tumor), [MONDO:0005462](http://purl.obolibrary.org/obo/MONDO_0005462) (primitive neuroectodermal tumor), [MONDO:0006794](http://purl.obolibrary.org/obo/MONDO_0006794) (hypersensitivity vasculitis), [MONDO:0004132](http://purl.obolibrary.org/obo/MONDO_0004132) (anal canal squamous cell carcinoma), [MONDO:0004130](http://purl.obolibrary.org/obo/MONDO_0004130) (anus basaloid carcinoma), [MONDO:0005461](http://purl.obolibrary.org/obo/MONDO_0005461) (endometrium adenocarcinoma), [MONDO:0017446](http://purl.obolibrary.org/obo/MONDO_0017446) (Apodia), [MONDO:0016115](http://purl.obolibrary.org/obo/MONDO_0016115) (bulbospinal muscular atrophy of adult), [MONDO:0018778](http://purl.obolibrary.org/obo/MONDO_0018778) (intermediate Charcot-Marie-tooth disease), [MONDO:0018779](http://purl.obolibrary.org/obo/MONDO_0018779) (hypercontractile muscle stiffness syndrome), [MONDO:0017445](http://purl.obolibrary.org/obo/MONDO_0017445) (Acheiria), [MONDO:0016114](http://purl.obolibrary.org/obo/MONDO_0016114) (bulbospinal muscular atrophy of childhood), [MONDO:0018776](http://purl.obolibrary.org/obo/MONDO_0018776) (demyelinating hereditary motor and sensory neuropathy), [MONDO:0016117](http://purl.obolibrary.org/obo/MONDO_0016117) (muscular lipidosis), [MONDO:0017448](http://purl.obolibrary.org/obo/MONDO_0017448) (congenital absence/hypoplasia of fingers excluding thumb), [MONDO:0018777](http://purl.obolibrary.org/obo/MONDO_0018777) (autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome), [MONDO:0017447](http://purl.obolibrary.org/obo/MONDO_0017447) (congenital absence/hypoplasia of thumb), [MONDO:0016116](http://purl.obolibrary.org/obo/MONDO_0016116) (generalized bulbospinal muscular atrophy), [MONDO:0016111](http://purl.obolibrary.org/obo/MONDO_0016111) (non-dystrophic myopathy with collagen 6 anomaly), [MONDO:0017442](http://purl.obolibrary.org/obo/MONDO_0017442) (congenital absence of thigh and lower leg with foot present), [MONDO:0018775](http://purl.obolibrary.org/obo/MONDO_0018775) (axonal hereditary motor and sensory neuropathy), [MONDO:0016110](http://purl.obolibrary.org/obo/MONDO_0016110) (non-dystrophic myopathy), [MONDO:0017441](http://purl.obolibrary.org/obo/MONDO_0017441) (congenital absence of upper arm and forearm with hand present), [MONDO:0016113](http://purl.obolibrary.org/obo/MONDO_0016113) (bulbospinal muscular atrophy), [MONDO:0018772](http://purl.obolibrary.org/obo/MONDO_0018772) (Joubert syndrome), [MONDO:0017444](http://purl.obolibrary.org/obo/MONDO_0017444) (congenital absence of both lower leg and foot), [MONDO:0018773](http://purl.obolibrary.org/obo/MONDO_0018773) (autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome), [MONDO:0016112](http://purl.obolibrary.org/obo/MONDO_0016112) (inclusion myopathy), [MONDO:0017443](http://purl.obolibrary.org/obo/MONDO_0017443) (congenital absence of both forearm and hand), [MONDO:0018770](http://purl.obolibrary.org/obo/MONDO_0018770) (Jeune syndrome), [MONDO:0017440](http://purl.obolibrary.org/obo/MONDO_0017440) (humeral agenesis/hypoplasia), [MONDO:0004148](http://purl.obolibrary.org/obo/MONDO_0004148) (gallbladder papillary carcinoma), [MONDO:0005479](http://purl.obolibrary.org/obo/MONDO_0005479) (atrial tachycardia), [MONDO:0004149](http://purl.obolibrary.org/obo/MONDO_0004149) (gallbladder pleomorphic giant cell adenocarcinoma), [MONDO:0005477](http://purl.obolibrary.org/obo/MONDO_0005477) (ventricular tachycardia), [MONDO:0004146](http://purl.obolibrary.org/obo/MONDO_0004146) (transitional meningioma), [MONDO:0004147](http://purl.obolibrary.org/obo/MONDO_0004147) (noninvasive malignant thymoma), [MONDO:0005478](http://purl.obolibrary.org/obo/MONDO_0005478) (torsades de pointes), [MONDO:0004144](http://purl.obolibrary.org/obo/MONDO_0004144) (fibrous meningioma), [MONDO:0004145](http://purl.obolibrary.org/obo/MONDO_0004145) (meningothelial meningioma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0004143](http://purl.obolibrary.org/obo/MONDO_0004143) (psammomatous meningioma), [MONDO:0004140](http://purl.obolibrary.org/obo/MONDO_0004140) (intermediate malignant teratoma), [MONDO:0004141](http://purl.obolibrary.org/obo/MONDO_0004141) (melanomatosis), [MONDO:0017449](http://purl.obolibrary.org/obo/MONDO_0017449) (split hand (disease)), [MONDO:0016118](http://purl.obolibrary.org/obo/MONDO_0016118) (muscular glycogenosis), [MONDO:0017435](http://purl.obolibrary.org/obo/MONDO_0017435) (popliteal pterygium syndrome), [MONDO:0018767](http://purl.obolibrary.org/obo/MONDO_0018767) (severe primary trimethylaminuria), [MONDO:0017434](http://purl.obolibrary.org/obo/MONDO_0017434) (syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy), [MONDO:0017437](http://purl.obolibrary.org/obo/MONDO_0017437) (amelia of upper limb), [MONDO:0016106](http://purl.obolibrary.org/obo/MONDO_0016106) (progressive muscular dystrophy), [MONDO:0016105](http://purl.obolibrary.org/obo/MONDO_0016105) (acquired skeletal muscle disease), [MONDO:0017436](http://purl.obolibrary.org/obo/MONDO_0017436) (lethal congenital contracture syndrome), [MONDO:0017431](http://purl.obolibrary.org/obo/MONDO_0017431) (limb overgrowth), [MONDO:0016100](http://purl.obolibrary.org/obo/MONDO_0016100) (rippling muscle disease with myasthenia gravis), [MONDO:0018763](http://purl.obolibrary.org/obo/MONDO_0018763) (Tubulinopathy-associated dysgyria), [MONDO:0018764](http://purl.obolibrary.org/obo/MONDO_0018764) (microcephalic primordial dwarfism due to RTTN deficiency), [MONDO:0017430](http://purl.obolibrary.org/obo/MONDO_0017430) (congenital joint dislocations), [MONDO:0018761](http://purl.obolibrary.org/obo/MONDO_0018761) (SMARCA4-deficient sarcoma of thorax), [MONDO:0017433](http://purl.obolibrary.org/obo/MONDO_0017433) (dysostosis with combined reduction defects of upper and lower limbs), [MONDO:0017432](http://purl.obolibrary.org/obo/MONDO_0017432) (syndrome with limb reduction defects), [MONDO:0018760](http://purl.obolibrary.org/obo/MONDO_0018760) (WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome), [MONDO:0004117](http://purl.obolibrary.org/obo/MONDO_0004117) (ampulla of vater small cell carcinoma), [MONDO:0006778](http://purl.obolibrary.org/obo/MONDO_0006778) (halo nevus), [MONDO:0004115](http://purl.obolibrary.org/obo/MONDO_0004115) (gallbladder small cell carcinoma), [MONDO:0004116](http://purl.obolibrary.org/obo/MONDO_0004116) (esophagus small cell carcinoma), [MONDO:0005447](http://purl.obolibrary.org/obo/MONDO_0005447) (testicular cancer), [MONDO:0004114](http://purl.obolibrary.org/obo/MONDO_0004114) (urinary bladder small cell neuroendocrine carcinoma), [MONDO:0005442](http://purl.obolibrary.org/obo/MONDO_0005442) (type 1 diabetes nephropathy), [MONDO:0004111](http://purl.obolibrary.org/obo/MONDO_0004111) (refractory hematologic cancer), [MONDO:0005443](http://purl.obolibrary.org/obo/MONDO_0005443) (type 2 diabetes nephropathy), [MONDO:0006773](http://purl.obolibrary.org/obo/MONDO_0006773) (gonadal tissue neoplasm), [MONDO:0005440](http://purl.obolibrary.org/obo/MONDO_0005440) (embryonal carcinoma), [MONDO:0006772](http://purl.obolibrary.org/obo/MONDO_0006772) (glycogen storage disease VIII), [MONDO:0004110](http://purl.obolibrary.org/obo/MONDO_0004110) (refractory hairy cell leukemia), [MONDO:0006770](http://purl.obolibrary.org/obo/MONDO_0006770) (giant cell reparative granuloma), [MONDO:0016108](http://purl.obolibrary.org/obo/MONDO_0016108) (autosomal dominant distal myopathy), [MONDO:0017439](http://purl.obolibrary.org/obo/MONDO_0017439) (tetra-amelia), [MONDO:0016107](http://purl.obolibrary.org/obo/MONDO_0016107) (myotonic dystrophy), [MONDO:0017438](http://purl.obolibrary.org/obo/MONDO_0017438) (amelia of lower limb), [MONDO:0016109](http://purl.obolibrary.org/obo/MONDO_0016109) (autosomal recessive distal myopathy), [MONDO:0017424](http://purl.obolibrary.org/obo/MONDO_0017424) (non-syndromic brachydactyly), [MONDO:0018756](http://purl.obolibrary.org/obo/MONDO_0018756) (euthyroid Graves orbitopathy), [MONDO:0017423](http://purl.obolibrary.org/obo/MONDO_0017423) (split hand or/and split foot malformation), [MONDO:0017426](http://purl.obolibrary.org/obo/MONDO_0017426) (postaxial polydactyly of fingers), [MONDO:0017425](http://purl.obolibrary.org/obo/MONDO_0017425) (preaxial polydactyly of fingers), [MONDO:0017420](http://purl.obolibrary.org/obo/MONDO_0017420) (intercalary limb defects), [MONDO:0017422](http://purl.obolibrary.org/obo/MONDO_0017422) (Adactyly of hand), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0017421](http://purl.obolibrary.org/obo/MONDO_0017421) (non-syndromic terminal limb defects), [MONDO:0004128](http://purl.obolibrary.org/obo/MONDO_0004128) (lung occult large cell carcinoma), [MONDO:0004129](http://purl.obolibrary.org/obo/MONDO_0004129) (cloacogenic carcinoma), [MONDO:0004127](http://purl.obolibrary.org/obo/MONDO_0004127) (lung occult adenocarcinoma), [MONDO:0006788](http://purl.obolibrary.org/obo/MONDO_0006788) (hydrophthalmos), [MONDO:0006787](http://purl.obolibrary.org/obo/MONDO_0006787) (hidrocystoma), [MONDO:0004124](http://purl.obolibrary.org/obo/MONDO_0004124) (prostate stromal sarcoma), [MONDO:0004125](http://purl.obolibrary.org/obo/MONDO_0004125) (rectum leiomyoma), [MONDO:0004122](http://purl.obolibrary.org/obo/MONDO_0004122) (thymus small cell carcinoma), [MONDO:0006785](http://purl.obolibrary.org/obo/MONDO_0006785) (Henoch-Schoenlein purpura), [MONDO:0005454](http://purl.obolibrary.org/obo/MONDO_0005454) (lung neuroendocrine neoplasm), [MONDO:0006784](http://purl.obolibrary.org/obo/MONDO_0006784) (hemorrhagic disease of newborn), [MONDO:0004120](http://purl.obolibrary.org/obo/MONDO_0004120) (Bartholin's gland small cell carcinoma), [MONDO:0005451](http://purl.obolibrary.org/obo/MONDO_0005451) (eating disorder), [MONDO:0005452](http://purl.obolibrary.org/obo/MONDO_0005452) (bulimia nervosa), [MONDO:0017428](http://purl.obolibrary.org/obo/MONDO_0017428) (congenital deformities of fingers), [MONDO:0017427](http://purl.obolibrary.org/obo/MONDO_0017427) (congenital deformities of limbs), [MONDO:0018758](http://purl.obolibrary.org/obo/MONDO_0018758) (familial patent arterial duct), [MONDO:0018759](http://purl.obolibrary.org/obo/MONDO_0018759) (childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome), [MONDO:0017429](http://purl.obolibrary.org/obo/MONDO_0017429) (joint formation defects), [MONDO:0018349](http://purl.obolibrary.org/obo/MONDO_0018349) (MAN1B1-CDG), [MONDO:0019678](http://purl.obolibrary.org/obo/MONDO_0019678) (brachydactyly type A5), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0019679](http://purl.obolibrary.org/obo/MONDO_0019679) (brachydactyly type A7), [MONDO:0018345](http://purl.obolibrary.org/obo/MONDO_0018345) (T+ b+ severe combined immunodeficiency), [MONDO:0019676](http://purl.obolibrary.org/obo/MONDO_0019676) (brachydactyly type B), [MONDO:0019677](http://purl.obolibrary.org/obo/MONDO_0019677) (brachydactyly type E), [MONDO:0019674](http://purl.obolibrary.org/obo/MONDO_0019674) (postaxial polydactyly type B), [MONDO:0018343](http://purl.obolibrary.org/obo/MONDO_0018343) (periodic paralysis with later-onset distal motor neuropathy), [MONDO:0019675](http://purl.obolibrary.org/obo/MONDO_0019675) (spondyloepimetaphyseal dysplasia with joint laxity), [MONDO:0018344](http://purl.obolibrary.org/obo/MONDO_0018344) (periodic paralysis with transient compartment-like syndrome), [MONDO:0018341](http://purl.obolibrary.org/obo/MONDO_0018341) (3q27.3 microdeletion syndrome), [MONDO:0019672](http://purl.obolibrary.org/obo/MONDO_0019672) (fibular hemimelia), [MONDO:0019673](http://purl.obolibrary.org/obo/MONDO_0019673) (postaxial polydactyly type A (disease)), [MONDO:0018342](http://purl.obolibrary.org/obo/MONDO_0018342) (Joubert syndrome with Jeune asphyxiating thoracic dystrophy), [MONDO:0019670](http://purl.obolibrary.org/obo/MONDO_0019670) (ulnar hemimelia), [MONDO:0019671](http://purl.obolibrary.org/obo/MONDO_0019671) (radial hemimelia), [MONDO:0018340](http://purl.obolibrary.org/obo/MONDO_0018340) (hereditary isolated aplastic anemia), [MONDO:0005028](http://purl.obolibrary.org/obo/MONDO_0005028) (esophageal adenocarcinoma), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0006359](http://purl.obolibrary.org/obo/MONDO_0006359) (neoplasm with perivascular epithelioid cell differentiation), [MONDO:0005026](http://purl.obolibrary.org/obo/MONDO_0005026) (endometrioid adenocarcinoma), [MONDO:0006358](http://purl.obolibrary.org/obo/MONDO_0006358) (parotid gland squamous cell carcinoma), [MONDO:0006357](http://purl.obolibrary.org/obo/MONDO_0006357) (parotid gland carcinoma ex pleomorphic adenoma), [MONDO:0007688](http://purl.obolibrary.org/obo/MONDO_0007688) (Myhre syndrome), [MONDO:0006356](http://purl.obolibrary.org/obo/MONDO_0006356) (parotid gland adenoid cystic carcinoma), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0006355](http://purl.obolibrary.org/obo/MONDO_0006355) (parotid gland acinic cell carcinoma), [MONDO:0005023](http://purl.obolibrary.org/obo/MONDO_0005023) (ductal breast carcinoma in situ), [MONDO:0006353](http://purl.obolibrary.org/obo/MONDO_0006353) (paranasal sinus Schneiderian papilloma), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0007683](http://purl.obolibrary.org/obo/MONDO_0007683) (Grant syndrome), [MONDO:0006352](http://purl.obolibrary.org/obo/MONDO_0006352) (paranasal sinus adenoid cystic carcinoma), [MONDO:0006351](http://purl.obolibrary.org/obo/MONDO_0006351) (parachordoma), [MONDO:0006350](http://purl.obolibrary.org/obo/MONDO_0006350) (papillary transitional cell carcinoma), [MONDO:0007681](http://purl.obolibrary.org/obo/MONDO_0007681) (familial multinodular goiter), [MONDO:0007680](http://purl.obolibrary.org/obo/MONDO_0007680) (multinodular goiter-cystic kidney-polydactyly syndrome), [MONDO:0019669](http://purl.obolibrary.org/obo/MONDO_0019669) (hypochondrogenesis), [MONDO:0018338](http://purl.obolibrary.org/obo/MONDO_0018338) (Activated PI3K-delta syndrome), [MONDO:0018336](http://purl.obolibrary.org/obo/MONDO_0018336) (silver-Russell syndrome due to a point mutation), [MONDO:0019667](http://purl.obolibrary.org/obo/MONDO_0019667) (spondyloepiphyseal dysplasia tarda), [MONDO:0019668](http://purl.obolibrary.org/obo/MONDO_0019668) (adenoma of pancreas), [MONDO:0018337](http://purl.obolibrary.org/obo/MONDO_0018337) (severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency), [MONDO:0019665](http://purl.obolibrary.org/obo/MONDO_0019665) (monostotic fibrous dysplasia (disease)), [MONDO:0019666](http://purl.obolibrary.org/obo/MONDO_0019666) (spondyloepimetaphyseal dysplasia, PAPSS2 type), [MONDO:0018332](http://purl.obolibrary.org/obo/MONDO_0018332) (multiple acyl-CoA dehydrogenase deficiency, severe neonatal type), [MONDO:0019663](http://purl.obolibrary.org/obo/MONDO_0019663) (short rib-polydactyly syndrome, Saldino-Noonan type), [MONDO:0019664](http://purl.obolibrary.org/obo/MONDO_0019664) (short rib-polydactyly syndrome, Verma-Naumoff type), [MONDO:0018333](http://purl.obolibrary.org/obo/MONDO_0018333) (multiple acyl-CoA dehydrogenase deficiency, mild type), [MONDO:0018330](http://purl.obolibrary.org/obo/MONDO_0018330) (mucinous adenocarcinoma of the appendix), [MONDO:0019661](http://purl.obolibrary.org/obo/MONDO_0019661) (Pfeiffer syndrome type 3), [MONDO:0019662](http://purl.obolibrary.org/obo/MONDO_0019662) (short rib-polydactyly syndrome, Majewski type), [MONDO:0019660](http://purl.obolibrary.org/obo/MONDO_0019660) (Pfeiffer syndrome type 2), [MONDO:0005037](http://purl.obolibrary.org/obo/MONDO_0005037) (gastric intestinal type adenocarcinoma), [MONDO:0006369](http://purl.obolibrary.org/obo/MONDO_0006369) (pineal parenchymal tumor of intermediate differentiation), [MONDO:0007699](http://purl.obolibrary.org/obo/MONDO_0007699) (Hashimoto thyroiditis), [MONDO:0006368](http://purl.obolibrary.org/obo/MONDO_0006368) (phosphaturic mesenchymal tumor), [MONDO:0007698](http://purl.obolibrary.org/obo/MONDO_0007698) (hand-foot-genital syndrome), [MONDO:0006367](http://purl.obolibrary.org/obo/MONDO_0006367) (pharyngeal adenoid cystic carcinoma), [MONDO:0005035](http://purl.obolibrary.org/obo/MONDO_0005035) (ganglioneuroblastoma (disease)), [MONDO:0006366](http://purl.obolibrary.org/obo/MONDO_0006366) (Peutz-Jeghers polyp of the stomach), [MONDO:0005036](http://purl.obolibrary.org/obo/MONDO_0005036) (gastric adenocarcinoma), [MONDO:0005033](http://purl.obolibrary.org/obo/MONDO_0005033) (ganglioneuroma (disease)), [MONDO:0007696](http://purl.obolibrary.org/obo/MONDO_0007696) (Emery-Nelson syndrome), [MONDO:0006365](http://purl.obolibrary.org/obo/MONDO_0006365) (Peutz-Jeghers polyp), [MONDO:0006364](http://purl.obolibrary.org/obo/MONDO_0006364) (peritoneal well differentiated papillary mesothelioma), [MONDO:0005034](http://purl.obolibrary.org/obo/MONDO_0005034) (follicular thyroid carcinoma (disease)), [MONDO:0005031](http://purl.obolibrary.org/obo/MONDO_0005031) (fibromatosis), [MONDO:0006363](http://purl.obolibrary.org/obo/MONDO_0006363) (peritoneal multicystic mesothelioma), [MONDO:0005032](http://purl.obolibrary.org/obo/MONDO_0005032) (follicular thyroid adenoma), [MONDO:0006362](http://purl.obolibrary.org/obo/MONDO_0006362) (peritoneal mesothelioma (disease)), [MONDO:0007693](http://purl.obolibrary.org/obo/MONDO_0007693) (hypertrichosis cubiti-short stature syndrome), [MONDO:0006361](http://purl.obolibrary.org/obo/MONDO_0006361) (penile fibromatosis), [MONDO:0007691](http://purl.obolibrary.org/obo/MONDO_0007691) (Guillain-Barre syndrome), [MONDO:0006360](http://purl.obolibrary.org/obo/MONDO_0006360) (penile carcinoma), [MONDO:0018327](http://purl.obolibrary.org/obo/MONDO_0018327) (glomus tumor), [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0019659](http://purl.obolibrary.org/obo/MONDO_0019659) (Pfeiffer syndrome type 1), [MONDO:0018325](http://purl.obolibrary.org/obo/MONDO_0018325) (juvenile myasthenia gravis), [MONDO:0018326](http://purl.obolibrary.org/obo/MONDO_0018326) (transient neonatal myasthenia gravis), [MONDO:0018323](http://purl.obolibrary.org/obo/MONDO_0018323) (HSD10 disease, neonatal type), [MONDO:0018324](http://purl.obolibrary.org/obo/MONDO_0018324) (adult-onset myasthenia gravis), [MONDO:0018322](http://purl.obolibrary.org/obo/MONDO_0018322) (HSD10 disease, infantile type), [MONDO:0018320](http://purl.obolibrary.org/obo/MONDO_0018320) (primary microcephaly-mild intellectual disability-young-onset diabetes syndrome), [MONDO:0005008](http://purl.obolibrary.org/obo/MONDO_0005008) (colorectal adenocarcinoma), [MONDO:0005009](http://purl.obolibrary.org/obo/MONDO_0005009) (congestive heart failure), [MONDO:0006339](http://purl.obolibrary.org/obo/MONDO_0006339) (ovarian microcystic stromal tumor), [MONDO:0005006](http://purl.obolibrary.org/obo/MONDO_0005006) (clear cell sarcoma of kidney), [MONDO:0007669](http://purl.obolibrary.org/obo/MONDO_0007669) (renal cysts and diabetes syndrome), [MONDO:0005007](http://purl.obolibrary.org/obo/MONDO_0005007) (colon mucinous adenocarcinoma), [MONDO:0005004](http://purl.obolibrary.org/obo/MONDO_0005004) (clear cell adenocarcinoma), [MONDO:0007667](http://purl.obolibrary.org/obo/MONDO_0007667) (subependymoma), [MONDO:0006335](http://purl.obolibrary.org/obo/MONDO_0006335) (ovarian endometrioid adenocarcinoma), [MONDO:0005005](http://purl.obolibrary.org/obo/MONDO_0005005) (clear cell renal carcinoma), [MONDO:0007666](http://purl.obolibrary.org/obo/MONDO_0007666) (glaucoma-sleep apnea syndrome), [MONDO:0007665](http://purl.obolibrary.org/obo/MONDO_0007665) (primary open angle glaucoma), [MONDO:0007664](http://purl.obolibrary.org/obo/MONDO_0007664) (glaucoma 1, open angle, a), [MONDO:0007663](http://purl.obolibrary.org/obo/MONDO_0007663) (glaucoma with elevated episcleral venous pressure), [MONDO:0007662](http://purl.obolibrary.org/obo/MONDO_0007662) (iridogoniodysgenesis, type 2), [MONDO:0006330](http://purl.obolibrary.org/obo/MONDO_0006330) (ossifying fibromyxoid tumor), [MONDO:0007660](http://purl.obolibrary.org/obo/MONDO_0007660) (familial ossifying fibroma), [MONDO:0019648](http://purl.obolibrary.org/obo/MONDO_0019648) (achondrogenesis), [MONDO:0019645](http://purl.obolibrary.org/obo/MONDO_0019645) (renal dysplasia, bilateral), [MONDO:0018315](http://purl.obolibrary.org/obo/MONDO_0018315) (X-linked osteoporosis with fractures), [MONDO:0019643](http://purl.obolibrary.org/obo/MONDO_0019643) (transient pseudohypoaldosteronism), [MONDO:0019644](http://purl.obolibrary.org/obo/MONDO_0019644) (renal dysplasia, unilateral), [MONDO:0008990](http://purl.obolibrary.org/obo/MONDO_0008990) (cleft larynx, posterior), [MONDO:0018310](http://purl.obolibrary.org/obo/MONDO_0018310) (Langerhans cell histiocytosis), [MONDO:0008991](http://purl.obolibrary.org/obo/MONDO_0008991) (Verloove Vanhorick-Brubakk syndrome), [MONDO:0019642](http://purl.obolibrary.org/obo/MONDO_0019642) (hypocalcemic vitamin d-resistant rickets), [MONDO:0018311](http://purl.obolibrary.org/obo/MONDO_0018311) (Acromelanosis), [MONDO:0008992](http://purl.obolibrary.org/obo/MONDO_0008992) (Juberg-Hayward syndrome), [MONDO:0008993](http://purl.obolibrary.org/obo/MONDO_0008993) (cleft palate-stapes fixation-oligodontia syndrome), [MONDO:0019640](http://purl.obolibrary.org/obo/MONDO_0019640) (posterior urethral valve), [MONDO:0008994](http://purl.obolibrary.org/obo/MONDO_0008994) (cleidocranial dysplasia, recessive form), [MONDO:0008995](http://purl.obolibrary.org/obo/MONDO_0008995) (Yunis-Varon syndrome), [MONDO:0008996](http://purl.obolibrary.org/obo/MONDO_0008996) (Joubert syndrome with hepatic defect), [MONDO:0008998](http://purl.obolibrary.org/obo/MONDO_0008998) (Cockayne syndrome type 3), [MONDO:0008999](http://purl.obolibrary.org/obo/MONDO_0008999) (Cohen syndrome), [MONDO:0005019](http://purl.obolibrary.org/obo/MONDO_0005019) (diffuse scleroderma), [MONDO:0005017](http://purl.obolibrary.org/obo/MONDO_0005017) (diffuse gastric adenocarcinoma), [MONDO:0006349](http://purl.obolibrary.org/obo/MONDO_0006349) (papillary cystic neoplasm), [MONDO:0006348](http://purl.obolibrary.org/obo/MONDO_0006348) (pancreatic small cell neuroendocrine carcinoma), [MONDO:0007679](http://purl.obolibrary.org/obo/MONDO_0007679) (GMS syndrome), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0005015](http://purl.obolibrary.org/obo/MONDO_0005015) (diabetes mellitus (disease)), [MONDO:0005016](http://purl.obolibrary.org/obo/MONDO_0005016) (diabetic nephropathy), [MONDO:0006346](http://purl.obolibrary.org/obo/MONDO_0006346) (pancreatic acinar cell carcinoma), [MONDO:0005013](http://purl.obolibrary.org/obo/MONDO_0005013) (dedifferentiated chondrosarcoma), [MONDO:0006345](http://purl.obolibrary.org/obo/MONDO_0006345) (palmar fibromatosis), [MONDO:0006344](http://purl.obolibrary.org/obo/MONDO_0006344) (ovarian yolk sac tumor), [MONDO:0006343](http://purl.obolibrary.org/obo/MONDO_0006343) (ovarian transitional cell carcinoma), [MONDO:0005011](http://purl.obolibrary.org/obo/MONDO_0005011) (Crohn's disease), [MONDO:0005012](http://purl.obolibrary.org/obo/MONDO_0005012) (cutaneous melanoma (disease)), [MONDO:0007672](http://purl.obolibrary.org/obo/MONDO_0007672) (Glomuvenous malformation), [MONDO:0006340](http://purl.obolibrary.org/obo/MONDO_0006340) (ovarian serous adenofibroma), [MONDO:0007670](http://purl.obolibrary.org/obo/MONDO_0007670) (hypotrichosis-lymphedema-telangiectasia syndrome (grouping)), [MONDO:0018318](http://purl.obolibrary.org/obo/MONDO_0018318) (disorder of asparagine metabolism), [MONDO:0017057](http://purl.obolibrary.org/obo/MONDO_0017057) (hereditary thrombocytopenia with normal platelets), [MONDO:0017056](http://purl.obolibrary.org/obo/MONDO_0017056) (DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion), [MONDO:0017059](http://purl.obolibrary.org/obo/MONDO_0017059) (neural tube closure defect), [MONDO:0017058](http://purl.obolibrary.org/obo/MONDO_0017058) (autosomal recessive intermediate Charcot-Marie-tooth disease), [MONDO:0018385](http://purl.obolibrary.org/obo/MONDO_0018385) (osteochondrosis of genetic origin), [MONDO:0017053](http://purl.obolibrary.org/obo/MONDO_0017053) (intermittent maple syrup urine disease), [MONDO:0017052](http://purl.obolibrary.org/obo/MONDO_0017052) (intermediate maple syrup urine disease), [MONDO:0018383](http://purl.obolibrary.org/obo/MONDO_0018383) (osteonecrosis of genetic origin), [MONDO:0018384](http://purl.obolibrary.org/obo/MONDO_0018384) (avascular necrosis of genetic origin), [MONDO:0017054](http://purl.obolibrary.org/obo/MONDO_0017054) (thiamine-responsive maple syrup urine disease), [MONDO:0018381](http://purl.obolibrary.org/obo/MONDO_0018381) (osteochondrosis), [MONDO:0018382](http://purl.obolibrary.org/obo/MONDO_0018382) (epiphysiolysis of the hip), [MONDO:0017051](http://purl.obolibrary.org/obo/MONDO_0017051) (classic maple syrup urine disease), [MONDO:0017050](http://purl.obolibrary.org/obo/MONDO_0017050) (intraocular medulloepithelioma), [MONDO:0018380](http://purl.obolibrary.org/obo/MONDO_0018380) (idiopathic avascular necrosis), [MONDO:0005066](http://purl.obolibrary.org/obo/MONDO_0005066) (metabolic disease), [MONDO:0006398](http://purl.obolibrary.org/obo/MONDO_0006398) (retroperitoneal inflammatory myofibroblastic tumor), [MONDO:0006397](http://purl.obolibrary.org/obo/MONDO_0006397) (renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene Fusions), [MONDO:0005067](http://purl.obolibrary.org/obo/MONDO_0005067) (monophasic synovial sarcoma), [MONDO:0006396](http://purl.obolibrary.org/obo/MONDO_0006396) (rectal villous adenoma), [MONDO:0005065](http://purl.obolibrary.org/obo/MONDO_0005065) (mesothelioma), [MONDO:0006395](http://purl.obolibrary.org/obo/MONDO_0006395) (rectal tubulovillous adenoma), [MONDO:0005062](http://purl.obolibrary.org/obo/MONDO_0005062) (lymphoma), [MONDO:0006394](http://purl.obolibrary.org/obo/MONDO_0006394) (rectal tubular adenoma), [MONDO:0006393](http://purl.obolibrary.org/obo/MONDO_0006393) (rectal traditional serrated adenoma), [MONDO:0005063](http://purl.obolibrary.org/obo/MONDO_0005063) (medullary breast carcinoma), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0006392](http://purl.obolibrary.org/obo/MONDO_0006392) (rectal hyperplastic polyp), [MONDO:0006391](http://purl.obolibrary.org/obo/MONDO_0006391) (pyloric gland adenoma), [MONDO:0005061](http://purl.obolibrary.org/obo/MONDO_0005061) (lung adenocarcinoma), [MONDO:0006390](http://purl.obolibrary.org/obo/MONDO_0006390) (prostate small cell carcinoma), [MONDO:0017049](http://purl.obolibrary.org/obo/MONDO_0017049) (hypomyelination neuropathy-arthrogryposis syndrome), [MONDO:0018378](http://purl.obolibrary.org/obo/MONDO_0018378) (osteonecrosis of the jaw), [MONDO:0017046](http://purl.obolibrary.org/obo/MONDO_0017046) (neuroepithelioma), [MONDO:0017045](http://purl.obolibrary.org/obo/MONDO_0017045) (neuroectodermal-endocrine syndrome), [MONDO:0018379](http://purl.obolibrary.org/obo/MONDO_0018379) (primary avascular necrosis), [MONDO:0017048](http://purl.obolibrary.org/obo/MONDO_0017048) (pseudomyxoma peritonei), [MONDO:0018376](http://purl.obolibrary.org/obo/MONDO_0018376) (secondary non-traumatic avascular necrosis), [MONDO:0018377](http://purl.obolibrary.org/obo/MONDO_0018377) (rare hereditary disease with avascular necrosis), [MONDO:0018374](http://purl.obolibrary.org/obo/MONDO_0018374) (secondary avascular necrosis), [MONDO:0017042](http://purl.obolibrary.org/obo/MONDO_0017042) (thanatophoric dysplasia), [MONDO:0018375](http://purl.obolibrary.org/obo/MONDO_0018375) (traumatic avascular necrosis), [MONDO:0017041](http://purl.obolibrary.org/obo/MONDO_0017041) (osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome), [MONDO:0017043](http://purl.obolibrary.org/obo/MONDO_0017043) (congenital mesoblastic nephroma), [MONDO:0018373](http://purl.obolibrary.org/obo/MONDO_0018373) (avascular necrosis), [MONDO:0018370](http://purl.obolibrary.org/obo/MONDO_0018370) (KLHL9-related early-onset distal myopathy), [MONDO:0018371](http://purl.obolibrary.org/obo/MONDO_0018371) (nebulin-related early-onset distal myopathy), [MONDO:0005079](http://purl.obolibrary.org/obo/MONDO_0005079) (polyp), [MONDO:0005078](http://purl.obolibrary.org/obo/MONDO_0005078) (phyllodes tumor), [MONDO:0005075](http://purl.obolibrary.org/obo/MONDO_0005075) (papillary thyroid carcinoma (disease)), [MONDO:0005073](http://purl.obolibrary.org/obo/MONDO_0005073) (melanocytic nevus), [MONDO:0005074](http://purl.obolibrary.org/obo/MONDO_0005074) (papillary cystadenocarcinoma), [MONDO:0005072](http://purl.obolibrary.org/obo/MONDO_0005072) (neuroblastoma), [MONDO:0005070](http://purl.obolibrary.org/obo/MONDO_0005070) (neoplasm (disease)), [MONDO:0018369](http://purl.obolibrary.org/obo/MONDO_0018369) (immature ovarian teratoma), [MONDO:0019698](http://purl.obolibrary.org/obo/MONDO_0019698) (bent bone dysplasia), [MONDO:0019699](http://purl.obolibrary.org/obo/MONDO_0019699) (Slender bone dysplasia), [MONDO:0018368](http://purl.obolibrary.org/obo/MONDO_0018368) (primary peritoneal serous/papillary carcinoma), [MONDO:0019696](http://purl.obolibrary.org/obo/MONDO_0019696) (acromesomelic dysplasia), [MONDO:0018365](http://purl.obolibrary.org/obo/MONDO_0018365) (malignant non-epithelial tumor of ovary), [MONDO:0019697](http://purl.obolibrary.org/obo/MONDO_0019697) (mesomelic and rhizo-mesomelic dysplasia), [MONDO:0018366](http://purl.obolibrary.org/obo/MONDO_0018366) (mucinous adenocarcinoma of ovary), [MONDO:0018363](http://purl.obolibrary.org/obo/MONDO_0018363) (focal facial dermal dysplasia), [MONDO:0019694](http://purl.obolibrary.org/obo/MONDO_0019694) (Spondylodysplastic dysplasia), [MONDO:0019695](http://purl.obolibrary.org/obo/MONDO_0019695) (acromelic dysplasia), [MONDO:0018364](http://purl.obolibrary.org/obo/MONDO_0018364) (malignant epithelial tumor of ovary), [MONDO:0019692](http://purl.obolibrary.org/obo/MONDO_0019692) (multiple epiphyseal dysplasia and pseudoachondroplasia), [MONDO:0018361](http://purl.obolibrary.org/obo/MONDO_0018361) (neonatal scleroderma), [MONDO:0019693](http://purl.obolibrary.org/obo/MONDO_0019693) (multiple metaphyseal dysplasia), [MONDO:0019691](http://purl.obolibrary.org/obo/MONDO_0019691) (short rib dysplasia), [MONDO:0018360](http://purl.obolibrary.org/obo/MONDO_0018360) (neonatal lupus erythematosus), [MONDO:0005048](http://purl.obolibrary.org/obo/MONDO_0005048) (insulinoma (disease)), [MONDO:0006378](http://purl.obolibrary.org/obo/MONDO_0006378) (pleural epithelioid mesothelioma), [MONDO:0006377](http://purl.obolibrary.org/obo/MONDO_0006377) (pleural biphasic mesothelioma), [MONDO:0006375](http://purl.obolibrary.org/obo/MONDO_0006375) (placental hemangioma), [MONDO:0006374](http://purl.obolibrary.org/obo/MONDO_0006374) (placental choriocarcinoma), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0005040](http://purl.obolibrary.org/obo/MONDO_0005040) (germ cell tumor), [MONDO:0006372](http://purl.obolibrary.org/obo/MONDO_0006372) (pituicytoma), [MONDO:0005041](http://purl.obolibrary.org/obo/MONDO_0005041) (glaucoma (disease)), [MONDO:0018358](http://purl.obolibrary.org/obo/MONDO_0018358) (neonatal autoimmune hemolytic anemia), [MONDO:0018359](http://purl.obolibrary.org/obo/MONDO_0018359) (neonatal dermatomyositis), [MONDO:0018356](http://purl.obolibrary.org/obo/MONDO_0018356) (secondary neonatal autoimmune disease), [MONDO:0018357](http://purl.obolibrary.org/obo/MONDO_0018357) (neonatal antiphospholipid syndrome), [MONDO:0018354](http://purl.obolibrary.org/obo/MONDO_0018354) (Prader-Willi-like syndrome), [MONDO:0018355](http://purl.obolibrary.org/obo/MONDO_0018355) (Prader-Willi-like syndrome due to point mutation), [MONDO:0018352](http://purl.obolibrary.org/obo/MONDO_0018352) (squamous cell carcinoma of penis), [MONDO:0019683](http://purl.obolibrary.org/obo/MONDO_0019683) (syndactyly type 2), [MONDO:0019681](http://purl.obolibrary.org/obo/MONDO_0019681) (juvenile sialidosis type 2), [MONDO:0019682](http://purl.obolibrary.org/obo/MONDO_0019682) (congenital sialidosis type 2), [MONDO:0018351](http://purl.obolibrary.org/obo/MONDO_0018351) (adenocarcinoma of penis), [MONDO:0019680](http://purl.obolibrary.org/obo/MONDO_0019680) (genochondromatosis type 2), [MONDO:0005059](http://purl.obolibrary.org/obo/MONDO_0005059) (leukemia (disease)), [MONDO:0005057](http://purl.obolibrary.org/obo/MONDO_0005057) (large cell neuroendocrine carcinoma), [MONDO:0006389](http://purl.obolibrary.org/obo/MONDO_0006389) (prostate rhabdomyosarcoma), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0006388](http://purl.obolibrary.org/obo/MONDO_0006388) (prolactin-producing pituitary gland carcinoma), [MONDO:0005055](http://purl.obolibrary.org/obo/MONDO_0005055) (Kaposi's sarcoma (disease)), [MONDO:0006387](http://purl.obolibrary.org/obo/MONDO_0006387) (primary pulmonary diffuse large b-cell lymphoma), [MONDO:0005056](http://purl.obolibrary.org/obo/MONDO_0005056) (keratinizing squamous cell carcinoma), [MONDO:0006386](http://purl.obolibrary.org/obo/MONDO_0006386) (primary peritoneal serous adenocarcinoma), [MONDO:0006385](http://purl.obolibrary.org/obo/MONDO_0006385) (primary intraosseous squamous cell carcinoma), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large B-cell lymphoma, leg type), [MONDO:0005051](http://purl.obolibrary.org/obo/MONDO_0005051) (invasive lobular carcinoma), [MONDO:0006382](http://purl.obolibrary.org/obo/MONDO_0006382) (poorly differentiated thyroid gland carcinoma), [MONDO:0006381](http://purl.obolibrary.org/obo/MONDO_0006381) (plexiform ameloblastoma), [MONDO:0006380](http://purl.obolibrary.org/obo/MONDO_0006380) (pleural sarcomatoid mesothelioma), [MONDO:0005050](http://purl.obolibrary.org/obo/MONDO_0005050) (invasive ductal and lobular carcinoma), [MONDO:0017097](http://purl.obolibrary.org/obo/MONDO_0017097) (isolated focal cortical dysplasia type ib), [MONDO:0017096](http://purl.obolibrary.org/obo/MONDO_0017096) (isolated focal cortical dysplasia type Ia), [MONDO:0017099](http://purl.obolibrary.org/obo/MONDO_0017099) (facioscapulohumeral dystrophy), [MONDO:0017098](http://purl.obolibrary.org/obo/MONDO_0017098) (isolated focal cortical dysplasia type Ic), [MONDO:0017093](http://purl.obolibrary.org/obo/MONDO_0017093) (unilateral focal polymicrogyria), [MONDO:0017092](http://purl.obolibrary.org/obo/MONDO_0017092) (unilateral polymicrogyria), [MONDO:0017095](http://purl.obolibrary.org/obo/MONDO_0017095) (isolated focal cortical dysplasia type i), [MONDO:0017094](http://purl.obolibrary.org/obo/MONDO_0017094) (cerebral cortical dysplasia), [MONDO:0017089](http://purl.obolibrary.org/obo/MONDO_0017089) (isolated megalencephaly), [MONDO:0017086](http://purl.obolibrary.org/obo/MONDO_0017086) (primary tethered cord syndrome), [MONDO:0017085](http://purl.obolibrary.org/obo/MONDO_0017085) (malformation of the neurenteric canal, spinal cord and column), [MONDO:0017088](http://purl.obolibrary.org/obo/MONDO_0017088) (isolated amyelia), [MONDO:0017087](http://purl.obolibrary.org/obo/MONDO_0017087) (neurenteric cyst), [MONDO:0017082](http://purl.obolibrary.org/obo/MONDO_0017082) (basal encephalocele), [MONDO:0017081](http://purl.obolibrary.org/obo/MONDO_0017081) (parietal encephalocele), [MONDO:0017084](http://purl.obolibrary.org/obo/MONDO_0017084) (Leptomyelolipoma), [MONDO:0017083](http://purl.obolibrary.org/obo/MONDO_0017083) (lipoma associated with neurospinal dysraphism), [MONDO:0017091](http://purl.obolibrary.org/obo/MONDO_0017091) (bilateral polymicrogyria), [MONDO:0017090](http://purl.obolibrary.org/obo/MONDO_0017090) (midline cerebral malformation), [MONDO:0017079](http://purl.obolibrary.org/obo/MONDO_0017079) (cranial meningocele), [MONDO:0017078](http://purl.obolibrary.org/obo/MONDO_0017078) (Cephalocele (disease)), [MONDO:0017075](http://purl.obolibrary.org/obo/MONDO_0017075) (upper thoracic spina bifida cystica), [MONDO:0017074](http://purl.obolibrary.org/obo/MONDO_0017074) (Cervicothoracic spina bifida cystica), [MONDO:0017077](http://purl.obolibrary.org/obo/MONDO_0017077) (Myelocystocele), [MONDO:0017076](http://purl.obolibrary.org/obo/MONDO_0017076) (posterior meningocele), [MONDO:0017071](http://purl.obolibrary.org/obo/MONDO_0017071) (Thoracolumbosacral spina bifida cystica), [MONDO:0017070](http://purl.obolibrary.org/obo/MONDO_0017070) (total spina bifida cystica), [MONDO:0017073](http://purl.obolibrary.org/obo/MONDO_0017073) (cervical spina bifida cystica), [MONDO:0017072](http://purl.obolibrary.org/obo/MONDO_0017072) (lumbosacral spina bifida cystica), [MONDO:0017080](http://purl.obolibrary.org/obo/MONDO_0017080) (occipital encephalocele), [MONDO:0005089](http://purl.obolibrary.org/obo/MONDO_0005089) (sarcoma), [MONDO:0005086](http://purl.obolibrary.org/obo/MONDO_0005086) (renal cell carcinoma (disease)), [MONDO:0005085](http://purl.obolibrary.org/obo/MONDO_0005085) (pterygium), [MONDO:0005082](http://purl.obolibrary.org/obo/MONDO_0005082) (prostate adenocarcinoma), [MONDO:0017068](http://purl.obolibrary.org/obo/MONDO_0017068) (upper thoracic spina bifida aperta), [MONDO:0017067](http://purl.obolibrary.org/obo/MONDO_0017067) (Cervicothoracic spina bifida aperta), [MONDO:0017069](http://purl.obolibrary.org/obo/MONDO_0017069) (spina bifida cystica), [MONDO:0017064](http://purl.obolibrary.org/obo/MONDO_0017064) (Thoracolumbosacral spina bifida aperta), [MONDO:0017063](http://purl.obolibrary.org/obo/MONDO_0017063) (total spina bifida aperta), [MONDO:0017066](http://purl.obolibrary.org/obo/MONDO_0017066) (cervical spina bifida aperta), [MONDO:0018394](http://purl.obolibrary.org/obo/MONDO_0018394) (male infertility with teratozoospermia due to single gene mutation), [MONDO:0018395](http://purl.obolibrary.org/obo/MONDO_0018395) (male infertility due to sperm motility disorder), [MONDO:0017065](http://purl.obolibrary.org/obo/MONDO_0017065) (lumbosacral spina bifida aperta), [MONDO:0018392](http://purl.obolibrary.org/obo/MONDO_0018392) (male infertility with spermatogenesis disorder due to single gene mutation), [MONDO:0017060](http://purl.obolibrary.org/obo/MONDO_0017060) (open iniencephaly), [MONDO:0018393](http://purl.obolibrary.org/obo/MONDO_0018393) (male infertility with azoospermia or oligozoospermia due to single gene mutation), [MONDO:0017062](http://purl.obolibrary.org/obo/MONDO_0017062) (spina bifida aperta), [MONDO:0018391](http://purl.obolibrary.org/obo/MONDO_0018391) (male infertility with spermatogenesis disorder), [MONDO:0017061](http://purl.obolibrary.org/obo/MONDO_0017061) (Closed iniencephaly), [MONDO:0005097](http://purl.obolibrary.org/obo/MONDO_0005097) (squamous cell lung carcinoma), [MONDO:0005096](http://purl.obolibrary.org/obo/MONDO_0005096) (squamous cell carcinoma), [MONDO:0005094](http://purl.obolibrary.org/obo/MONDO_0005094) (hemangiopericytoma), [MONDO:0005092](http://purl.obolibrary.org/obo/MONDO_0005092) (signet ring cell carcinoma), [MONDO:0019713](http://purl.obolibrary.org/obo/MONDO_0019713) (non-syndromic limb reduction defect), [MONDO:0019714](http://purl.obolibrary.org/obo/MONDO_0019714) (non-syndromic polydactyly, syndactyly and/or hyperphalangy), [MONDO:0019711](http://purl.obolibrary.org/obo/MONDO_0019711) (dysostosis with predominant vertebral and costal involvement), [MONDO:0019712](http://purl.obolibrary.org/obo/MONDO_0019712) (patellar dysostosis), [MONDO:0019710](http://purl.obolibrary.org/obo/MONDO_0019710) (dysostosis with predominant craniofacial involvement), [MONDO:0007727](http://purl.obolibrary.org/obo/MONDO_0007727) (autosomal dominant familial periodic fever), [MONDO:0007726](http://purl.obolibrary.org/obo/MONDO_0007726) (hip dysplasia, Beukes type), [MONDO:0007724](http://purl.obolibrary.org/obo/MONDO_0007724) (Hirsutism-skeletal dysplasia-intellectual disability syndrome), [MONDO:0007723](http://purl.obolibrary.org/obo/MONDO_0007723) (Hirschsprung disease, susceptibility to, 1), [MONDO:0019717](http://purl.obolibrary.org/obo/MONDO_0019717) (chromosomal disease with overgrowth), [MONDO:0019718](http://purl.obolibrary.org/obo/MONDO_0019718) (lethal chondrodysplasia), [MONDO:0019715](http://purl.obolibrary.org/obo/MONDO_0019715) (syndrome with synostosis or other joint formation defect), [MONDO:0019716](http://purl.obolibrary.org/obo/MONDO_0019716) (overgrowth syndrome), [MONDO:0019702](http://purl.obolibrary.org/obo/MONDO_0019702) (neonatal osteosclerotic dysplasia), [MONDO:0019703](http://purl.obolibrary.org/obo/MONDO_0019703) (primary bone dysplasia with increased bone density), [MONDO:0019700](http://purl.obolibrary.org/obo/MONDO_0019700) (primary bone dysplasia with multiple joint dislocations), [MONDO:0019701](http://purl.obolibrary.org/obo/MONDO_0019701) (chondrodysplasia punctata), [MONDO:0006409](http://purl.obolibrary.org/obo/MONDO_0006409) (signet ring cell gastric adenocarcinoma), [MONDO:0007739](http://purl.obolibrary.org/obo/MONDO_0007739) (Huntington's disease), [MONDO:0006408](http://purl.obolibrary.org/obo/MONDO_0006408) (sex hormone-producing adrenal cortex adenoma), [MONDO:0007738](http://purl.obolibrary.org/obo/MONDO_0007738) (spondyloepiphyseal dysplasia with congenital joint dislocations), [MONDO:0006407](http://purl.obolibrary.org/obo/MONDO_0006407) (sarcomatoid mesothelioma), [MONDO:0007737](http://purl.obolibrary.org/obo/MONDO_0007737) (humeroradial synostosis (disease)), [MONDO:0006406](http://purl.obolibrary.org/obo/MONDO_0006406) (sarcomatoid carcinoma), [MONDO:0006405](http://purl.obolibrary.org/obo/MONDO_0006405) (salivary gland small cell carcinoma), [MONDO:0007735](http://purl.obolibrary.org/obo/MONDO_0007735) (congenital Horner syndrome (disease)), [MONDO:0006404](http://purl.obolibrary.org/obo/MONDO_0006404) (salivary gland large cell carcinoma), [MONDO:0006403](http://purl.obolibrary.org/obo/MONDO_0006403) (salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0007734](http://purl.obolibrary.org/obo/MONDO_0007734) (holoprosencephaly 4), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0007733](http://purl.obolibrary.org/obo/MONDO_0007733) (holoprosencephaly 3), [MONDO:0006401](http://purl.obolibrary.org/obo/MONDO_0006401) (salivary gland adenosquamous carcinoma), [MONDO:0007732](http://purl.obolibrary.org/obo/MONDO_0007732) (Holt-Oram syndrome), [MONDO:0006400](http://purl.obolibrary.org/obo/MONDO_0006400) (salivary gland acinic cell carcinoma), [MONDO:0019708](http://purl.obolibrary.org/obo/MONDO_0019708) (primary bone dysplasia with disorganized development of skeletal components), [MONDO:0019709](http://purl.obolibrary.org/obo/MONDO_0019709) (cleidocranial dysplasia and isolated cranial ossification defect), [MONDO:0019707](http://purl.obolibrary.org/obo/MONDO_0019707) (primary osteolysis), [MONDO:0019704](http://purl.obolibrary.org/obo/MONDO_0019704) (primary bone dysplasia with decreased bone density), [MONDO:0019705](http://purl.obolibrary.org/obo/MONDO_0019705) (primary bone dysplasia with defective bone mineralization), [MONDO:0007708](http://purl.obolibrary.org/obo/MONDO_0007708) (Kasabach-Merritt syndrome), [MONDO:0007707](http://purl.obolibrary.org/obo/MONDO_0007707) (hemangiomas of small intestine), [MONDO:0007706](http://purl.obolibrary.org/obo/MONDO_0007706) (cavernous hemangiomas of face-supraumbilical midline raphe syndrome), [MONDO:0007705](http://purl.obolibrary.org/obo/MONDO_0007705) (Heinz body anemia), [MONDO:0007704](http://purl.obolibrary.org/obo/MONDO_0007704) (osteoarthritis susceptibility 2), [MONDO:0007702](http://purl.obolibrary.org/obo/MONDO_0007702) (heart-hand syndrome type 3), [MONDO:0007701](http://purl.obolibrary.org/obo/MONDO_0007701) (progressive familial heart block type II), [MONDO:0007700](http://purl.obolibrary.org/obo/MONDO_0007700) (Hawkinsinuria), [MONDO:0007718](http://purl.obolibrary.org/obo/MONDO_0007718) (hepatic adenomas, familial), [MONDO:0007716](http://purl.obolibrary.org/obo/MONDO_0007716) (alpha thalassemia-intellectual disability syndrome type 1), [MONDO:0007712](http://purl.obolibrary.org/obo/MONDO_0007712) (Oculoauriculovertebral spectrum with radial defects), [MONDO:0007711](http://purl.obolibrary.org/obo/MONDO_0007711) (Bencze syndrome), [MONDO:0018426](http://purl.obolibrary.org/obo/MONDO_0018426) (AXIN2-related attenuated familial adenomatous polyposis), [MONDO:0019757](http://purl.obolibrary.org/obo/MONDO_0019757) (Alobar holoprosencephaly), [MONDO:0018427](http://purl.obolibrary.org/obo/MONDO_0018427) (fibrolamellar hepatocellular carcinoma), [MONDO:0019758](http://purl.obolibrary.org/obo/MONDO_0019758) (midline interhemispheric variant of holoprosencephaly), [MONDO:0018424](http://purl.obolibrary.org/obo/MONDO_0018424) (Lipoic acid biosynthesis defect), [MONDO:0019756](http://purl.obolibrary.org/obo/MONDO_0019756) (lobar holoprosencephaly), [MONDO:0019753](http://purl.obolibrary.org/obo/MONDO_0019753) (localized Castleman disease), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0019752](http://purl.obolibrary.org/obo/MONDO_0019752) (pediatric Castleman disease), [MONDO:0007769](http://purl.obolibrary.org/obo/MONDO_0007769) (hyperpigmentation of eyelid), [MONDO:0006438](http://purl.obolibrary.org/obo/MONDO_0006438) (synovial chondromatosis), [MONDO:0005105](http://purl.obolibrary.org/obo/MONDO_0005105) (melanoma (disease)), [MONDO:0007768](http://purl.obolibrary.org/obo/MONDO_0007768) (hyperparathyroidism-jaw tumor syndrome), [MONDO:0006436](http://purl.obolibrary.org/obo/MONDO_0006436) (submandibular gland adenoid cystic carcinoma), [MONDO:0005106](http://purl.obolibrary.org/obo/MONDO_0005106) (lipoma), [MONDO:0007767](http://purl.obolibrary.org/obo/MONDO_0007767) (hyperparathyroidism 1), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0006435](http://purl.obolibrary.org/obo/MONDO_0006435) (submandibular gland adenocarcinoma), [MONDO:0007766](http://purl.obolibrary.org/obo/MONDO_0007766) (Morgagni-Stewart-Morel syndrome), [MONDO:0005104](http://purl.obolibrary.org/obo/MONDO_0005104) (AJCC grade 1 sarcoma), [MONDO:0007765](http://purl.obolibrary.org/obo/MONDO_0007765) (hyperostosis cranialis interna (disease)), [MONDO:0005101](http://purl.obolibrary.org/obo/MONDO_0005101) (ulcerative colitis (disease)), [MONDO:0007764](http://purl.obolibrary.org/obo/MONDO_0007764) (autosomal dominant osteosclerosis, Worth type), [MONDO:0007763](http://purl.obolibrary.org/obo/MONDO_0007763) (nonpapillary renal cell carcinoma), [MONDO:0006432](http://purl.obolibrary.org/obo/MONDO_0006432) (stromal predominant kidney wilms tumor), [MONDO:0005102](http://purl.obolibrary.org/obo/MONDO_0005102) (undifferentiated (embryonal) sarcoma), [MONDO:0007762](http://purl.obolibrary.org/obo/MONDO_0007762) (hyperlipoproteinemia type V), [MONDO:0007761](http://purl.obolibrary.org/obo/MONDO_0007761) (hyperlipoproteinemia type IV), [MONDO:0005100](http://purl.obolibrary.org/obo/MONDO_0005100) (systemic scleroderma), [MONDO:0006430](http://purl.obolibrary.org/obo/MONDO_0006430) (splenic mantle cell lymphoma), [MONDO:0019759](http://purl.obolibrary.org/obo/MONDO_0019759) (Epispadias (disease)), [MONDO:0018428](http://purl.obolibrary.org/obo/MONDO_0018428) (9q31.1q31.3 microdeletion syndrome), [MONDO:0018429](http://purl.obolibrary.org/obo/MONDO_0018429) (14q24.1q24.3 microdeletion syndrome), [MONDO:0019746](http://purl.obolibrary.org/obo/MONDO_0019746) (cystinuria type B), [MONDO:0019745](http://purl.obolibrary.org/obo/MONDO_0019745) (cystinuria type A), [MONDO:0018414](http://purl.obolibrary.org/obo/MONDO_0018414) (female infertility due to an implantation defect of genetic origin), [MONDO:0019740](http://purl.obolibrary.org/obo/MONDO_0019740) (acquired thrombotic thrombocytopenic purpura), [MONDO:0007779](http://purl.obolibrary.org/obo/MONDO_0007779) (autosomal dominant Opitz G/BBB syndrome), [MONDO:0006448](http://purl.obolibrary.org/obo/MONDO_0006448) (testicular teratoma (disease)), [MONDO:0006447](http://purl.obolibrary.org/obo/MONDO_0006447) (testicular non-seminomatous germ cell tumor), [MONDO:0006446](http://purl.obolibrary.org/obo/MONDO_0006446) (testicular embryonal carcinoma), [MONDO:0007776](http://purl.obolibrary.org/obo/MONDO_0007776) (hypersensitivity pneumonitis, familial), [MONDO:0006445](http://purl.obolibrary.org/obo/MONDO_0006445) (testicular choriocarcinoma), [MONDO:0006444](http://purl.obolibrary.org/obo/MONDO_0006444) (teratoma with malignant transformation), [MONDO:0005112](http://purl.obolibrary.org/obo/MONDO_0005112) (malignant pleural mesothelioma), [MONDO:0006442](http://purl.obolibrary.org/obo/MONDO_0006442) (tendon sheath fibroma), [MONDO:0007772](http://purl.obolibrary.org/obo/MONDO_0007772) (pseudohypoaldosteronism type 2A), [MONDO:0007771](http://purl.obolibrary.org/obo/MONDO_0007771) (hyperpigmentation with or without hypopigmentation, familial progressive), [MONDO:0019749](http://purl.obolibrary.org/obo/MONDO_0019749) (rare renal tumor), [MONDO:0019735](http://purl.obolibrary.org/obo/MONDO_0019735) (polymyalgia rheumatica), [MONDO:0019733](http://purl.obolibrary.org/obo/MONDO_0019733) (AFib amyloidosis), [MONDO:0018403](http://purl.obolibrary.org/obo/MONDO_0018403) (female infertility due to an implantation defect), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0019731](http://purl.obolibrary.org/obo/MONDO_0019731) (AApoAI amyloidosis), [MONDO:0019732](http://purl.obolibrary.org/obo/MONDO_0019732) (ALys amyloidosis), [MONDO:0019730](http://purl.obolibrary.org/obo/MONDO_0019730) (light chain deposition disease), [MONDO:0006419](http://purl.obolibrary.org/obo/MONDO_0006419) (small intestinal intraepithelial neoplasia), [MONDO:0006418](http://purl.obolibrary.org/obo/MONDO_0006418) (small intestinal enteropathy-associated T-cell lymphoma), [MONDO:0006417](http://purl.obolibrary.org/obo/MONDO_0006417) (small intestinal diffuse large b-cell lymphoma), [MONDO:0006416](http://purl.obolibrary.org/obo/MONDO_0006416) (small intestinal Burkitt lymphoma), [MONDO:0006414](http://purl.obolibrary.org/obo/MONDO_0006414) (skin sarcoma), [MONDO:0007745](http://purl.obolibrary.org/obo/MONDO_0007745) (Gilbert syndrome), [MONDO:0006413](http://purl.obolibrary.org/obo/MONDO_0006413) (skin basosquamous cell carcinoma), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0006411](http://purl.obolibrary.org/obo/MONDO_0006411) (sinonasal undifferentiated carcinoma), [MONDO:0007741](http://purl.obolibrary.org/obo/MONDO_0007741) (congenital hydronephrosis), [MONDO:0007740](http://purl.obolibrary.org/obo/MONDO_0007740) (Wagner disease), [MONDO:0019739](http://purl.obolibrary.org/obo/MONDO_0019739) (atypical hemolytic-uremic syndrome with anti-factor H antibodies), [MONDO:0019737](http://purl.obolibrary.org/obo/MONDO_0019737) (thrombotic microangiopathy), [MONDO:0019738](http://purl.obolibrary.org/obo/MONDO_0019738) (atypical hemolytic-uremic syndrome with H factor anomaly), [MONDO:0019725](http://purl.obolibrary.org/obo/MONDO_0019725) (pediatric systemic lupus erythematosus), [MONDO:0019721](http://purl.obolibrary.org/obo/MONDO_0019721) (syndromic renal or urinary tract malformation), [MONDO:0006429](http://purl.obolibrary.org/obo/MONDO_0006429) (splenic Hodgkin lymphoma), [MONDO:0007759](http://purl.obolibrary.org/obo/MONDO_0007759) (hyperlipidemia, familial combined, LPL related), [MONDO:0006428](http://purl.obolibrary.org/obo/MONDO_0006428) (splenic diffuse large b-cell lymphoma), [MONDO:0006427](http://purl.obolibrary.org/obo/MONDO_0006427) (spindle cell melanoma), [MONDO:0006426](http://purl.obolibrary.org/obo/MONDO_0006426) (spinal cord primitive neuroectodermal tumor), [MONDO:0007757](http://purl.obolibrary.org/obo/MONDO_0007757) (hyperkeratosis-hyperpigmentation syndrome), [MONDO:0006424](http://purl.obolibrary.org/obo/MONDO_0006424) (soft tissue neoplasm), [MONDO:0006423](http://purl.obolibrary.org/obo/MONDO_0006423) (soft tissue chondroma), [MONDO:0006422](http://purl.obolibrary.org/obo/MONDO_0006422) (small intestinal tubulovillous adenoma), [MONDO:0006421](http://purl.obolibrary.org/obo/MONDO_0006421) (small intestinal tubular adenoma), [MONDO:0006420](http://purl.obolibrary.org/obo/MONDO_0006420) (small intestinal mucosa-associated lymphoid tissue lymphoma), [MONDO:0007751](http://purl.obolibrary.org/obo/MONDO_0007751) (hypercholesterolemia, autosomal dominant, type b), [MONDO:0007750](http://purl.obolibrary.org/obo/MONDO_0007750) (hypercholesterolemia, familial), [MONDO:0019728](http://purl.obolibrary.org/obo/MONDO_0019728) (heavy chain deposition disease), [MONDO:0019729](http://purl.obolibrary.org/obo/MONDO_0019729) (light and heavy chain deposition disease), [MONDO:0017138](http://purl.obolibrary.org/obo/MONDO_0017138) (Opitz G/BBB syndrome), [MONDO:0019799](http://purl.obolibrary.org/obo/MONDO_0019799) (hepatoerythropoietic porphyria), [MONDO:0017139](http://purl.obolibrary.org/obo/MONDO_0017139) (oromandibular-limb hypogenesis syndrome), [MONDO:0019797](http://purl.obolibrary.org/obo/MONDO_0019797) (acrodysostosis), [MONDO:0017134](http://purl.obolibrary.org/obo/MONDO_0017134) (odonto-onycho dysplasia-alopecia syndrome), [MONDO:0018467](http://purl.obolibrary.org/obo/MONDO_0018467) (nephropathic infantile cystinosis), [MONDO:0019798](http://purl.obolibrary.org/obo/MONDO_0019798) (acute hepatic porphyria), [MONDO:0017136](http://purl.obolibrary.org/obo/MONDO_0017136) (omodysplasia), [MONDO:0018464](http://purl.obolibrary.org/obo/MONDO_0018464) (severe phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0019796](http://purl.obolibrary.org/obo/MONDO_0019796) (acrocephalosyndactyly), [MONDO:0017135](http://purl.obolibrary.org/obo/MONDO_0017135) (olivopontocerebellar atrophy-deafness syndrome), [MONDO:0017130](http://purl.obolibrary.org/obo/MONDO_0017130) (genetic urogenital tumor), [MONDO:0019793](http://purl.obolibrary.org/obo/MONDO_0019793) (autosomal dominant cerebellar ataxia type 3), [MONDO:0019794](http://purl.obolibrary.org/obo/MONDO_0019794) (autosomal dominant cerebellar ataxia type 4), [MONDO:0018463](http://purl.obolibrary.org/obo/MONDO_0018463) (mild phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0017132](http://purl.obolibrary.org/obo/MONDO_0017132) (hereditary ATTR amyloidosis), [MONDO:0019791](http://purl.obolibrary.org/obo/MONDO_0019791) (recessive mitochondrial ataxia syndrome), [MONDO:0018460](http://purl.obolibrary.org/obo/MONDO_0018460) (Eales disease), [MONDO:0019792](http://purl.obolibrary.org/obo/MONDO_0019792) (autosomal dominant cerebellar ataxia type I), [MONDO:0017131](http://purl.obolibrary.org/obo/MONDO_0017131) (genetic cardiac anomaly), [MONDO:0005147](http://purl.obolibrary.org/obo/MONDO_0005147) (type 1 diabetes mellitus), [MONDO:0006479](http://purl.obolibrary.org/obo/MONDO_0006479) (undifferentiated pancreatic carcinoma with Osteoclast-like giant cells), [MONDO:0005148](http://purl.obolibrary.org/obo/MONDO_0005148) (type 2 diabetes mellitus), [MONDO:0006478](http://purl.obolibrary.org/obo/MONDO_0006478) (undifferentiated pancreatic carcinoma), [MONDO:0006477](http://purl.obolibrary.org/obo/MONDO_0006477) (undifferentiated ovarian carcinoma), [MONDO:0005145](http://purl.obolibrary.org/obo/MONDO_0005145) (sporadic amyotrophic lateral sclerosis), [MONDO:0006476](http://purl.obolibrary.org/obo/MONDO_0006476) (undifferentiated gallbladder carcinoma), [MONDO:0006475](http://purl.obolibrary.org/obo/MONDO_0006475) (unclassified renal cell carcinoma), [MONDO:0006474](http://purl.obolibrary.org/obo/MONDO_0006474) (transitional cell carcinoma), [MONDO:0005144](http://purl.obolibrary.org/obo/MONDO_0005144) (familial amyotrophic lateral sclerosis), [MONDO:0006471](http://purl.obolibrary.org/obo/MONDO_0006471) (tracheal adenoid cystic carcinoma), [MONDO:0005140](http://purl.obolibrary.org/obo/MONDO_0005140) (ovarian carcinoma), [MONDO:0006470](http://purl.obolibrary.org/obo/MONDO_0006470) (tonsillar squamous cell carcinoma), [MONDO:0018459](http://purl.obolibrary.org/obo/MONDO_0018459) (isolated glycerol kinase deficiency), [MONDO:0017127](http://purl.obolibrary.org/obo/MONDO_0017127) (genetic soft tissue tumor), [MONDO:0017126](http://purl.obolibrary.org/obo/MONDO_0017126) (Oculo-skeletal-renal syndrome), [MONDO:0017129](http://purl.obolibrary.org/obo/MONDO_0017129) (genetic cardiac tumor), [MONDO:0019788](http://purl.obolibrary.org/obo/MONDO_0019788) (non-secreting paraganglioma), [MONDO:0018457](http://purl.obolibrary.org/obo/MONDO_0018457) (rare genetic bone development disorder), [MONDO:0018458](http://purl.obolibrary.org/obo/MONDO_0018458) (familial hypocalciuric hypercalcemia), [MONDO:0017128](http://purl.obolibrary.org/obo/MONDO_0017128) (genetic digestive tract tumor), [MONDO:0019789](http://purl.obolibrary.org/obo/MONDO_0019789) (cytophagic histiocytic panniculitis), [MONDO:0019786](http://purl.obolibrary.org/obo/MONDO_0019786) (severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia), [MONDO:0017123](http://purl.obolibrary.org/obo/MONDO_0017123) (arthrogryposis-renal dysfunction-cholestasis syndrome), [MONDO:0018455](http://purl.obolibrary.org/obo/MONDO_0018455) (dysostosis of genetic origin with limb anomaly as a major feature), [MONDO:0017122](http://purl.obolibrary.org/obo/MONDO_0017122) (genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature), [MONDO:0019787](http://purl.obolibrary.org/obo/MONDO_0019787) (autoimmune enteropathy), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0019784](http://purl.obolibrary.org/obo/MONDO_0019784) (12q14 microdeletion syndrome), [MONDO:0017125](http://purl.obolibrary.org/obo/MONDO_0017125) (oculofaciocardiodental syndrome), [MONDO:0018453](http://purl.obolibrary.org/obo/MONDO_0018453) (familial atypical multiple mole melanoma syndrome), [MONDO:0018454](http://purl.obolibrary.org/obo/MONDO_0018454) (dysostosis of genetic origin), [MONDO:0018451](http://purl.obolibrary.org/obo/MONDO_0018451) (X-linked distal hereditary motor neuropathy), [MONDO:0019782](http://purl.obolibrary.org/obo/MONDO_0019782) (humero-ulnar synostosis), [MONDO:0019783](http://purl.obolibrary.org/obo/MONDO_0019783) (neovascular glaucoma), [MONDO:0019780](http://purl.obolibrary.org/obo/MONDO_0019780) (anotia), [MONDO:0019781](http://purl.obolibrary.org/obo/MONDO_0019781) (astrocytoma (excluding glioblastoma)), [MONDO:0018450](http://purl.obolibrary.org/obo/MONDO_0018450) (spinal muscular atrophy with respiratory distress type 2), [MONDO:0005159](http://purl.obolibrary.org/obo/MONDO_0005159) (prostate carcinoma), [MONDO:0006489](http://purl.obolibrary.org/obo/MONDO_0006489) (vaginal melanoma), [MONDO:0006488](http://purl.obolibrary.org/obo/MONDO_0006488) (vaginal carcinosarcoma), [MONDO:0006487](http://purl.obolibrary.org/obo/MONDO_0006487) (vaginal adenoid cystic carcinoma), [MONDO:0005157](http://purl.obolibrary.org/obo/MONDO_0005157) (lymphoid neoplasm), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0006485](http://purl.obolibrary.org/obo/MONDO_0006485) (uterine carcinosarcoma), [MONDO:0006484](http://purl.obolibrary.org/obo/MONDO_0006484) (usual ductal breast hyperplasia), [MONDO:0005153](http://purl.obolibrary.org/obo/MONDO_0005153) (cervical adenocarcinoma), [MONDO:0006483](http://purl.obolibrary.org/obo/MONDO_0006483) (urothelial dysplasia), [MONDO:0005150](http://purl.obolibrary.org/obo/MONDO_0005150) (age-related macular degeneration), [MONDO:0006482](http://purl.obolibrary.org/obo/MONDO_0006482) (ureter small cell carcinoma), [MONDO:0006481](http://purl.obolibrary.org/obo/MONDO_0006481) (ureter carcinoma), [MONDO:0006480](http://purl.obolibrary.org/obo/MONDO_0006480) (undifferentiated pleomorphic sarcoma, inflammatory variant), [MONDO:0019779](http://purl.obolibrary.org/obo/MONDO_0019779) (Renier-Gabreels-Jasper syndrome), [MONDO:0017116](http://purl.obolibrary.org/obo/MONDO_0017116) (congenital communicating hydrocephalus), [MONDO:0018448](http://purl.obolibrary.org/obo/MONDO_0018448) (clear cell papillary renal cell carcinoma), [MONDO:0018449](http://purl.obolibrary.org/obo/MONDO_0018449) (acquired cystic disease-associated renal cell carcinoma), [MONDO:0018446](http://purl.obolibrary.org/obo/MONDO_0018446) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome), [MONDO:0019777](http://purl.obolibrary.org/obo/MONDO_0019777) (Carpenter-Waziri syndrome), [MONDO:0019778](http://purl.obolibrary.org/obo/MONDO_0019778) (Smith-Fineman-Myers syndrome), [MONDO:0018447](http://purl.obolibrary.org/obo/MONDO_0018447) (chondromyxoid fibroma), [MONDO:0017117](http://purl.obolibrary.org/obo/MONDO_0017117) (congenital non-communicating hydrocephalus), [MONDO:0018444](http://purl.obolibrary.org/obo/MONDO_0018444) (female infertility due to fertilization defect), [MONDO:0019775](http://purl.obolibrary.org/obo/MONDO_0019775) (Chudley-Lowry-Hoar syndrome), [MONDO:0019776](http://purl.obolibrary.org/obo/MONDO_0019776) (Juberg-Marsidi syndrome), [MONDO:0018445](http://purl.obolibrary.org/obo/MONDO_0018445) (global developmental delay-lung cysts-overgrowth-wilms tumor syndrome), [MONDO:0017111](http://purl.obolibrary.org/obo/MONDO_0017111) (isolated Dandy-Walker malformation without hydrocephalus), [MONDO:0019773](http://purl.obolibrary.org/obo/MONDO_0019773) (myelomeningocele), [MONDO:0018443](http://purl.obolibrary.org/obo/MONDO_0018443) (FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome), [MONDO:0019774](http://purl.obolibrary.org/obo/MONDO_0019774) (Holmes-Gang syndrome), [MONDO:0018440](http://purl.obolibrary.org/obo/MONDO_0018440) (autosomal recessive distal renal tubular acidosis), [MONDO:0017110](http://purl.obolibrary.org/obo/MONDO_0017110) (isolated Dandy-Walker malformation with hydrocephalus), [MONDO:0005129](http://purl.obolibrary.org/obo/MONDO_0005129) (cataract (disease)), [MONDO:0006459](http://purl.obolibrary.org/obo/MONDO_0006459) (thymoma type B1), [MONDO:0006458](http://purl.obolibrary.org/obo/MONDO_0006458) (thymoma type B3), [MONDO:0007788](http://purl.obolibrary.org/obo/MONDO_0007788) (hypertriglyceridemia, familial), [MONDO:0007787](http://purl.obolibrary.org/obo/MONDO_0007787) (Ambras type hypertrichosis universalis congenita), [MONDO:0006456](http://purl.obolibrary.org/obo/MONDO_0006456) (thymoma (disease)), [MONDO:0006455](http://purl.obolibrary.org/obo/MONDO_0006455) (thymic undifferentiated carcinoma), [MONDO:0007784](http://purl.obolibrary.org/obo/MONDO_0007784) (selective pituitary resistance to thyroid hormone), [MONDO:0006452](http://purl.obolibrary.org/obo/MONDO_0006452) (thymic sarcomatoid carcinoma), [MONDO:0007783](http://purl.obolibrary.org/obo/MONDO_0007783) (malignant hyperthermia, susceptibility to, 1), [MONDO:0006451](http://purl.obolibrary.org/obo/MONDO_0006451) (thymic carcinoma), [MONDO:0006450](http://purl.obolibrary.org/obo/MONDO_0006450) (therapy-related myeloid neoplasm), [MONDO:0007780](http://purl.obolibrary.org/obo/MONDO_0007780) (hypertelorism, Teebi type), [MONDO:0017119](http://purl.obolibrary.org/obo/MONDO_0017119) (syndrome with microcephaly as major feature), [MONDO:0019768](http://purl.obolibrary.org/obo/MONDO_0019768) (X-linked intellectual disability, Golabi-Ito-hall type), [MONDO:0018437](http://purl.obolibrary.org/obo/MONDO_0018437) (acute myeloid leukemia with NPM1 somatic mutations), [MONDO:0019769](http://purl.obolibrary.org/obo/MONDO_0019769) (X-linked intellectual disability, Sutherland-Haan type), [MONDO:0019766](http://purl.obolibrary.org/obo/MONDO_0019766) (X-linked intellectual disability, Porteous type), [MONDO:0018435](http://purl.obolibrary.org/obo/MONDO_0018435) (acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)), [MONDO:0019767](http://purl.obolibrary.org/obo/MONDO_0019767) (Hamel cerebro-palato-cardiac syndrome), [MONDO:0018436](http://purl.obolibrary.org/obo/MONDO_0018436) (megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)), [MONDO:0018433](http://purl.obolibrary.org/obo/MONDO_0018433) (acute myeloid leukemia with t(6;9)(p23;q34)), [MONDO:0019764](http://purl.obolibrary.org/obo/MONDO_0019764) (laryngotracheoesophageal cleft type 4), [MONDO:0017101](http://purl.obolibrary.org/obo/MONDO_0017101) (isolated focal cortical dysplasia type IIa), [MONDO:0018434](http://purl.obolibrary.org/obo/MONDO_0018434) (acute myeloid leukemia with t(9;11)(p22;q23)), [MONDO:0017100](http://purl.obolibrary.org/obo/MONDO_0017100) (neutropenia-monocytopenia-deafness syndrome), [MONDO:0017103](http://purl.obolibrary.org/obo/MONDO_0017103) (Encephaloclastic disorder), [MONDO:0019762](http://purl.obolibrary.org/obo/MONDO_0019762) (laryngotracheoesophageal cleft type 2), [MONDO:0019763](http://purl.obolibrary.org/obo/MONDO_0019763) (laryngotracheoesophageal cleft type 3), [MONDO:0017102](http://purl.obolibrary.org/obo/MONDO_0017102) (isolated focal cortical dysplasia type IIb), [MONDO:0019760](http://purl.obolibrary.org/obo/MONDO_0019760) (terminal transverse defects of arm), [MONDO:0018430](http://purl.obolibrary.org/obo/MONDO_0018430) (partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome), [MONDO:0019761](http://purl.obolibrary.org/obo/MONDO_0019761) (laryngotracheoesophageal cleft type 1), [MONDO:0005138](http://purl.obolibrary.org/obo/MONDO_0005138) (lung carcinoma), [MONDO:0005139](http://purl.obolibrary.org/obo/MONDO_0005139) (morbid obesity), [MONDO:0006469](http://purl.obolibrary.org/obo/MONDO_0006469) (tibial adamantinoma), [MONDO:0006468](http://purl.obolibrary.org/obo/MONDO_0006468) (thyroid gland undifferentiated (anaplastic) carcinoma), [MONDO:0005137](http://purl.obolibrary.org/obo/MONDO_0005137) (nutritional disorder), [MONDO:0006467](http://purl.obolibrary.org/obo/MONDO_0006467) (thyroid gland squamous cell carcinoma), [MONDO:0007798](http://purl.obolibrary.org/obo/MONDO_0007798) (adult hypophosphatasia), [MONDO:0007797](http://purl.obolibrary.org/obo/MONDO_0007797) (hypoparathyroidism-deafness-renal disease syndrome), [MONDO:0005134](http://purl.obolibrary.org/obo/MONDO_0005134) (experimental autoimmune encephalomyelitis), [MONDO:0006466](http://purl.obolibrary.org/obo/MONDO_0006466) (thyroid gland spindle cell tumor with thymus-like differentiation), [MONDO:0006465](http://purl.obolibrary.org/obo/MONDO_0006465) (thyroid gland oncocytic follicular carcinoma), [MONDO:0007796](http://purl.obolibrary.org/obo/MONDO_0007796) (hypoparathyroidism, familial isolated), [MONDO:0007795](http://purl.obolibrary.org/obo/MONDO_0007795) (mullerian duct anomalies-limb anomalies syndrome), [MONDO:0006464](http://purl.obolibrary.org/obo/MONDO_0006464) (thyroid gland mucosa-associated lymphoid tissue lymphoma), [MONDO:0006463](http://purl.obolibrary.org/obo/MONDO_0006463) (thyroid gland mucoepidermoid carcinoma), [MONDO:0007794](http://purl.obolibrary.org/obo/MONDO_0007794) (hypogonadotropic hypogonadism 7 with or without anosmia), [MONDO:0007793](http://purl.obolibrary.org/obo/MONDO_0007793) (hypochondroplasia), [MONDO:0006462](http://purl.obolibrary.org/obo/MONDO_0006462) (thyroid gland diffuse large b-cell lymphoma), [MONDO:0005130](http://purl.obolibrary.org/obo/MONDO_0005130) (celiac disease), [MONDO:0007792](http://purl.obolibrary.org/obo/MONDO_0007792) (familial hypocalciuric hypercalcemia 2), [MONDO:0005131](http://purl.obolibrary.org/obo/MONDO_0005131) (cervical carcinoma), [MONDO:0007791](http://purl.obolibrary.org/obo/MONDO_0007791) (familial hypocalciuric hypercalcemia 1), [MONDO:0006460](http://purl.obolibrary.org/obo/MONDO_0006460) (thyroglossal duct cyst), [MONDO:0007790](http://purl.obolibrary.org/obo/MONDO_0007790) (Charcot-Marie-tooth disease type 3), [MONDO:0018439](http://purl.obolibrary.org/obo/MONDO_0018439) (eosinophilic colitis), [MONDO:0017178](http://purl.obolibrary.org/obo/MONDO_0017178) (osteochondritis dissecans (disease)), [MONDO:0017177](http://purl.obolibrary.org/obo/MONDO_0017177) (hemihyperplasia-multiple lipomatosis syndrome), [MONDO:0017174](http://purl.obolibrary.org/obo/MONDO_0017174) (Machado-Joseph disease type 1), [MONDO:0017173](http://purl.obolibrary.org/obo/MONDO_0017173) (non-syndromic male infertility due to sperm motility disorder), [MONDO:0017176](http://purl.obolibrary.org/obo/MONDO_0017176) (Machado-Joseph disease type 3), [MONDO:0017175](http://purl.obolibrary.org/obo/MONDO_0017175) (Machado-Joseph disease type 2), [MONDO:0017172](http://purl.obolibrary.org/obo/MONDO_0017172) (mucopolysaccharidosis type 6, slowly progressing), [MONDO:0017171](http://purl.obolibrary.org/obo/MONDO_0017171) (mucopolysaccharidosis type 6, rapidly progressing), [MONDO:0005188](http://purl.obolibrary.org/obo/MONDO_0005188) (iatrogenic Kaposi's sarcoma), [MONDO:0005185](http://purl.obolibrary.org/obo/MONDO_0005185) (chronic childhood arthritis), [MONDO:0005183](http://purl.obolibrary.org/obo/MONDO_0005183) (ovarian cystadenoma), [MONDO:0005184](http://purl.obolibrary.org/obo/MONDO_0005184) (pancreatic ductal adenocarcinoma), [MONDO:0005181](http://purl.obolibrary.org/obo/MONDO_0005181) (progressive external ophthalmoplegia), [MONDO:0005182](http://purl.obolibrary.org/obo/MONDO_0005182) (serous cystadenofibroma), [MONDO:0018499](http://purl.obolibrary.org/obo/MONDO_0018499) (double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy), [MONDO:0017167](http://purl.obolibrary.org/obo/MONDO_0017167) (malignant epithelial tumor of salivary glands), [MONDO:0017166](http://purl.obolibrary.org/obo/MONDO_0017166) (rare tumor of salivary glands), [MONDO:0017169](http://purl.obolibrary.org/obo/MONDO_0017169) (multiple endocrine neoplasia), [MONDO:0017168](http://purl.obolibrary.org/obo/MONDO_0017168) (benign epithelial tumor of salivary glands), [MONDO:0018498](http://purl.obolibrary.org/obo/MONDO_0018498) (double outlet right ventricle with subaortic or doubly committed ventricular septal defect), [MONDO:0018495](http://purl.obolibrary.org/obo/MONDO_0018495) (X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome), [MONDO:0017163](http://purl.obolibrary.org/obo/MONDO_0017163) (hemolytic disease due to fetomaternal alloimmunization), [MONDO:0017162](http://purl.obolibrary.org/obo/MONDO_0017162) (imperforate oropharynx-costo vetebral anomalies syndrome), [MONDO:0018496](http://purl.obolibrary.org/obo/MONDO_0018496) (ARX-related encephalopathy-brain malformation spectrum), [MONDO:0018493](http://purl.obolibrary.org/obo/MONDO_0018493) (malignant hyperthermia (disease)), [MONDO:0017165](http://purl.obolibrary.org/obo/MONDO_0017165) (bile acid CoA ligase deficiency and defective amidation), [MONDO:0018494](http://purl.obolibrary.org/obo/MONDO_0018494) (microcephaly-short stature-intellectual disability-facial dysmorphism syndrome), [MONDO:0017164](http://purl.obolibrary.org/obo/MONDO_0017164) (hemolytic disease of the newborn with Kell alloimmunization), [MONDO:0018491](http://purl.obolibrary.org/obo/MONDO_0018491) (3-phosphoglycerate dehydrogenase deficiency), [MONDO:0018492](http://purl.obolibrary.org/obo/MONDO_0018492) (hereditary clear cell renal cell carcinoma), [MONDO:0018490](http://purl.obolibrary.org/obo/MONDO_0018490) (Cono-spondylar dysplasia), [MONDO:0005198](http://purl.obolibrary.org/obo/MONDO_0005198) (vulvar intraepithelial neoplasia), [MONDO:0005197](http://purl.obolibrary.org/obo/MONDO_0005197) (thymus neoplasm), [MONDO:0005192](http://purl.obolibrary.org/obo/MONDO_0005192) (exocrine pancreatic carcinoma), [MONDO:0005193](http://purl.obolibrary.org/obo/MONDO_0005193) (prostate intraepithelial neoplasia), [MONDO:0005190](http://purl.obolibrary.org/obo/MONDO_0005190) (macroglobulinemia), [MONDO:0005191](http://purl.obolibrary.org/obo/MONDO_0005191) (metastatic melanoma), [MONDO:0018489](http://purl.obolibrary.org/obo/MONDO_0018489) (autoimmune encephalopathy with parasomnia and obstructive sleep apnea), [MONDO:0018486](http://purl.obolibrary.org/obo/MONDO_0018486) (visual snow syndrome), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0018482](http://purl.obolibrary.org/obo/MONDO_0018482) (squamous cell carcinoma of stomach), [MONDO:0018483](http://purl.obolibrary.org/obo/MONDO_0018483) (secondary pulmonary alveolar proteinosis), [MONDO:0018480](http://purl.obolibrary.org/obo/MONDO_0018480) (carcinoma of esophagus, salivary gland type), [MONDO:0018481](http://purl.obolibrary.org/obo/MONDO_0018481) (undifferentiated carcinoma of esophagus), [MONDO:0005169](http://purl.obolibrary.org/obo/MONDO_0005169) (neoplasm of mature T-cells or NK-cells), [MONDO:0005167](http://purl.obolibrary.org/obo/MONDO_0005167) (fibroma), [MONDO:0006499](http://purl.obolibrary.org/obo/MONDO_0006499) (hamartoma (disease)), [MONDO:0006498](http://purl.obolibrary.org/obo/MONDO_0006498) (adenomatous colon polyp), [MONDO:0005168](http://purl.obolibrary.org/obo/MONDO_0005168) (neoplasm of immature b and T cells), [MONDO:0005165](http://purl.obolibrary.org/obo/MONDO_0005165) (benign neoplasm), [MONDO:0005166](http://purl.obolibrary.org/obo/MONDO_0005166) (osteoma (disease)), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0006493](http://purl.obolibrary.org/obo/MONDO_0006493) (Warthin tumor), [MONDO:0006490](http://purl.obolibrary.org/obo/MONDO_0006490) (vaginal squamous cell carcinoma), [MONDO:0017148](http://purl.obolibrary.org/obo/MONDO_0017148) (heritable pulmonary arterial hypertension), [MONDO:0018479](http://purl.obolibrary.org/obo/MONDO_0018479) (congenital adrenal hyperplasia), [MONDO:0017145](http://purl.obolibrary.org/obo/MONDO_0017145) (beta-thalassemia and related diseases), [MONDO:0018477](http://purl.obolibrary.org/obo/MONDO_0018477) (bilirubin encephalopathy), [MONDO:0017144](http://purl.obolibrary.org/obo/MONDO_0017144) (alpha-thalassemia and related diseases), [MONDO:0017147](http://purl.obolibrary.org/obo/MONDO_0017147) (idiopathic pulmonary arterial hypertension), [MONDO:0017146](http://purl.obolibrary.org/obo/MONDO_0017146) (sickle cell disease and related diseases), [MONDO:0018473](http://purl.obolibrary.org/obo/MONDO_0018473) (hyperlipoproteinemia type 3), [MONDO:0017141](http://purl.obolibrary.org/obo/MONDO_0017141) (rare hemorrhagic disorder due to a constitutional thrombocytopenia), [MONDO:0018474](http://purl.obolibrary.org/obo/MONDO_0018474) (13q12.3 microdeletion syndrome), [MONDO:0017140](http://purl.obolibrary.org/obo/MONDO_0017140) (L1 syndrome), [MONDO:0018471](http://purl.obolibrary.org/obo/MONDO_0018471) (generalized eruptive keratoacanthoma), [MONDO:0017142](http://purl.obolibrary.org/obo/MONDO_0017142) (rare hemorrhagic disorder due to a qualitative platelet defect), [MONDO:0018470](http://purl.obolibrary.org/obo/MONDO_0018470) (renal agenesis (disease)), [MONDO:0005178](http://purl.obolibrary.org/obo/MONDO_0005178) (osteoarthritis), [MONDO:0005179](http://purl.obolibrary.org/obo/MONDO_0005179) (ovarian adenoma benign), [MONDO:0005177](http://purl.obolibrary.org/obo/MONDO_0005177) (serous cystadenoma), [MONDO:0005173](http://purl.obolibrary.org/obo/MONDO_0005173) (actinic keratosis (disease)), [MONDO:0005170](http://purl.obolibrary.org/obo/MONDO_0005170) (myeloid neoplasm), [MONDO:0005171](http://purl.obolibrary.org/obo/MONDO_0005171) (chronic myeloproliferative disorder), [MONDO:0017199](http://purl.obolibrary.org/obo/MONDO_0017199) (osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome), [MONDO:0017196](http://purl.obolibrary.org/obo/MONDO_0017196) (osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome), [MONDO:0017195](http://purl.obolibrary.org/obo/MONDO_0017195) (Bruck syndrome), [MONDO:0017198](http://purl.obolibrary.org/obo/MONDO_0017198) (osteopetrosis (disease)), [MONDO:0017197](http://purl.obolibrary.org/obo/MONDO_0017197) (osteopathia striata-pigmentary dermopathy-white forelock syndrome), [MONDO:0017192](http://purl.obolibrary.org/obo/MONDO_0017192) (sporadic secreting paraganglioma), [MONDO:0017191](http://purl.obolibrary.org/obo/MONDO_0017191) (sporadic pheochromocytoma), [MONDO:0017194](http://purl.obolibrary.org/obo/MONDO_0017194) (Blount disease), [MONDO:0017193](http://purl.obolibrary.org/obo/MONDO_0017193) (symptomatic form of Coffin-Lowry syndrome in female carriers), [MONDO:0017189](http://purl.obolibrary.org/obo/MONDO_0017189) (adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia), [MONDO:0017188](http://purl.obolibrary.org/obo/MONDO_0017188) (Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency), [MONDO:0017185](http://purl.obolibrary.org/obo/MONDO_0017185) (autosomal dominant hyperinsulinism due to Kir6.2 deficiency), [MONDO:0017184](http://purl.obolibrary.org/obo/MONDO_0017184) (autosomal dominant hyperinsulinism due to SUR1 deficiency), [MONDO:0017187](http://purl.obolibrary.org/obo/MONDO_0017187) (Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency), [MONDO:0017186](http://purl.obolibrary.org/obo/MONDO_0017186) (Diazoxide-resistant hyperinsulinism), [MONDO:0017183](http://purl.obolibrary.org/obo/MONDO_0017183) (hyperinsulinism due to UCP2 deficiency), [MONDO:0017182](http://purl.obolibrary.org/obo/MONDO_0017182) (familial hyperinsulinism), [MONDO:0017190](http://purl.obolibrary.org/obo/MONDO_0017190) (sporadic pheochromocytoma/secreting paraganglioma), [MONDO:0007804](http://purl.obolibrary.org/obo/MONDO_0007804) (Pallister-hall syndrome), [MONDO:0007800](http://purl.obolibrary.org/obo/MONDO_0007800) (chromosome 18p deletion syndrome), [MONDO:0007819](http://purl.obolibrary.org/obo/MONDO_0007819) (solitary median maxillary central incisor syndrome), [MONDO:0007818](http://purl.obolibrary.org/obo/MONDO_0007818) (Job's syndrome), [MONDO:0007817](http://purl.obolibrary.org/obo/MONDO_0007817) (Ige responsiveness, atopic), [MONDO:0007814](http://purl.obolibrary.org/obo/MONDO_0007814) (immune deficiency, familial variable), [MONDO:0007812](http://purl.obolibrary.org/obo/MONDO_0007812) (ichthyosis, lamellar, autosomal dominant), [MONDO:0018503](http://purl.obolibrary.org/obo/MONDO_0018503) (carcinoma of stomach, salivary gland type), [MONDO:0019835](http://purl.obolibrary.org/obo/MONDO_0019835) (primary hypophysitis), [MONDO:0018504](http://purl.obolibrary.org/obo/MONDO_0018504) (undifferentiated carcinoma of stomach), [MONDO:0018501](http://purl.obolibrary.org/obo/MONDO_0018501) (rare carcinoma of stomach), [MONDO:0018502](http://purl.obolibrary.org/obo/MONDO_0018502) (hereditary gastric cancer), [MONDO:0006519](http://purl.obolibrary.org/obo/MONDO_0006519) (rectal cancer), [MONDO:0007848](http://purl.obolibrary.org/obo/MONDO_0007848) (autosomal dominant keratitis), [MONDO:0006517](http://purl.obolibrary.org/obo/MONDO_0006517) (childhood malignant neoplasm), [MONDO:0007846](http://purl.obolibrary.org/obo/MONDO_0007846) (KBG syndrome), [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0006514](http://purl.obolibrary.org/obo/MONDO_0006514) (recalcitrant atopic dermatitis), [MONDO:0007844](http://purl.obolibrary.org/obo/MONDO_0007844) (hypogonadotropic hypogonadism 2 with or without anosmia), [MONDO:0006513](http://purl.obolibrary.org/obo/MONDO_0006513) (estrogen-receptor negative breast cancer), [MONDO:0006512](http://purl.obolibrary.org/obo/MONDO_0006512) (estrogen-receptor positive breast cancer), [MONDO:0007843](http://purl.obolibrary.org/obo/MONDO_0007843) (Kabuki syndrome 1), [MONDO:0007842](http://purl.obolibrary.org/obo/MONDO_0007842) (Ehlers-Danlos syndrome type 11), [MONDO:0006510](http://purl.obolibrary.org/obo/MONDO_0006510) (renal tubular transport disease), [MONDO:0007841](http://purl.obolibrary.org/obo/MONDO_0007841) (Coxopodopatellar syndrome), [MONDO:0018509](http://purl.obolibrary.org/obo/MONDO_0018509) (squamous cell carcinoma of the small intestine), [MONDO:0018507](http://purl.obolibrary.org/obo/MONDO_0018507) (microcephaly-complex motor and sensory axonal neuropathy syndrome), [MONDO:0019838](http://purl.obolibrary.org/obo/MONDO_0019838) (adenohypophysitis), [MONDO:0019839](http://purl.obolibrary.org/obo/MONDO_0019839) (panhypophysitis), [MONDO:0018508](http://purl.obolibrary.org/obo/MONDO_0018508) (rare carcinoma of small intestine), [MONDO:0018505](http://purl.obolibrary.org/obo/MONDO_0018505) (rare tumor of small intestine), [MONDO:0018506](http://purl.obolibrary.org/obo/MONDO_0018506) (mesenchymal tumor of small intestine), [MONDO:0006526](http://purl.obolibrary.org/obo/MONDO_0006526) (allergic urticaria), [MONDO:0006525](http://purl.obolibrary.org/obo/MONDO_0006525) (allergic contact dermatitis), [MONDO:0007852](http://purl.obolibrary.org/obo/MONDO_0007852) (palmoplantar keratoderma-deafness syndrome), [MONDO:0007851](http://purl.obolibrary.org/obo/MONDO_0007851) (keratoconus 1), [MONDO:0007850](http://purl.obolibrary.org/obo/MONDO_0007850) (autosomal dominant keratitis-ichthyosis-deafness syndrome), [MONDO:0019801](http://purl.obolibrary.org/obo/MONDO_0019801) (acute adrenal insufficiency), [MONDO:0019800](http://purl.obolibrary.org/obo/MONDO_0019800) (chronic hepatic porphyria), [MONDO:0006509](http://purl.obolibrary.org/obo/MONDO_0006509) (papillary carcinoma), [MONDO:0007839](http://purl.obolibrary.org/obo/MONDO_0007839) (Aase-Smith syndrome), [MONDO:0006507](http://purl.obolibrary.org/obo/MONDO_0006507) (hereditary hemochromatosis), [MONDO:0007838](http://purl.obolibrary.org/obo/MONDO_0007838) (Jacobsen syndrome), [MONDO:0007837](http://purl.obolibrary.org/obo/MONDO_0007837) (Johnson neuroectodermal syndrome), [MONDO:0006506](http://purl.obolibrary.org/obo/MONDO_0006506) (congenital nonspherocytic hemolytic anemia), [MONDO:0007836](http://purl.obolibrary.org/obo/MONDO_0007836) (IVIC syndrome), [MONDO:0006504](http://purl.obolibrary.org/obo/MONDO_0006504) (acquired metabolic disease), [MONDO:0006500](http://purl.obolibrary.org/obo/MONDO_0006500) (hemangioma), [MONDO:0019805](http://purl.obolibrary.org/obo/MONDO_0019805) (twin to twin transfusion syndrome), [MONDO:0019803](http://purl.obolibrary.org/obo/MONDO_0019803) (angioma serpiginosum), [MONDO:0019804](http://purl.obolibrary.org/obo/MONDO_0019804) (tracheomalacia), [MONDO:0017215](http://purl.obolibrary.org/obo/MONDO_0017215) (calciphylaxis), [MONDO:0019878](http://purl.obolibrary.org/obo/MONDO_0019878) (3q26 microduplication syndrome), [MONDO:0017214](http://purl.obolibrary.org/obo/MONDO_0017214) (vitamin B12-responsive methylmalonic acidemia), [MONDO:0017217](http://purl.obolibrary.org/obo/MONDO_0017217) (visceral calciphylaxis), [MONDO:0017216](http://purl.obolibrary.org/obo/MONDO_0017216) (calciphylaxis cutis), [MONDO:0018543](http://purl.obolibrary.org/obo/MONDO_0018543) (autosomal dominant hypocalcemia), [MONDO:0017211](http://purl.obolibrary.org/obo/MONDO_0017211) (infectious panuveitis), [MONDO:0019875](http://purl.obolibrary.org/obo/MONDO_0019875) (Beckwith-Wiedemann syndrome due to 11p15 microduplication), [MONDO:0018544](http://purl.obolibrary.org/obo/MONDO_0018544) (X-linked adrenoleukodystrophy), [MONDO:0017210](http://purl.obolibrary.org/obo/MONDO_0017210) (infectious anterior uveitis), [MONDO:0017212](http://purl.obolibrary.org/obo/MONDO_0017212) (paraneoplastic uveitis), [MONDO:0019873](http://purl.obolibrary.org/obo/MONDO_0019873) (4p16.3 microduplication syndrome), [MONDO:0018540](http://purl.obolibrary.org/obo/MONDO_0018540) (PFAPA syndrome), [MONDO:0019871](http://purl.obolibrary.org/obo/MONDO_0019871) (distal trisomy 2p), [MONDO:0006558](http://purl.obolibrary.org/obo/MONDO_0006558) (pemphigoid gestationis), [MONDO:0007888](http://purl.obolibrary.org/obo/MONDO_0007888) (hereditary leiomyomatosis and renal cell cancer), [MONDO:0006557](http://purl.obolibrary.org/obo/MONDO_0006557) (hemangioma of subcutaneous tissue), [MONDO:0005224](http://purl.obolibrary.org/obo/MONDO_0005224) (acute myeloblastic leukemia without maturation), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0007885](http://purl.obolibrary.org/obo/MONDO_0007885) (Legg-Calve-Perthes disease), [MONDO:0005223](http://purl.obolibrary.org/obo/MONDO_0005223) (minimally differentiated acute myeloblastic leukemia), [MONDO:0005220](http://purl.obolibrary.org/obo/MONDO_0005220) (collecting duct carcinoma), [MONDO:0005221](http://purl.obolibrary.org/obo/MONDO_0005221) (transitional cell carcinoma of kidney), [MONDO:0006550](http://purl.obolibrary.org/obo/MONDO_0006550) (fibroepithelial polyp of urethra), [MONDO:0007880](http://purl.obolibrary.org/obo/MONDO_0007880) (congenital laryngeal web), [MONDO:0017219](http://purl.obolibrary.org/obo/MONDO_0017219) (Microform holoprosencephaly), [MONDO:0017218](http://purl.obolibrary.org/obo/MONDO_0017218) (Septopreoptic holoprosencephaly), [MONDO:0018549](http://purl.obolibrary.org/obo/MONDO_0018549) (late-onset scapuloperoneal muscular dystrophy with hyaline bodies), [MONDO:0018536](http://purl.obolibrary.org/obo/MONDO_0018536) (adenocarcinoma of gallbladder and extrahepatic biliary tract), [MONDO:0017204](http://purl.obolibrary.org/obo/MONDO_0017204) (toxic maculopathy due to antimalarial drugs), [MONDO:0018537](http://purl.obolibrary.org/obo/MONDO_0018537) (squamous cell carcinoma of gallbladder and extrahepatic biliary tract), [MONDO:0017203](http://purl.obolibrary.org/obo/MONDO_0017203) (chronic endophthalmitis), [MONDO:0017206](http://purl.obolibrary.org/obo/MONDO_0017206) (primary intraocular lymphoma), [MONDO:0018534](http://purl.obolibrary.org/obo/MONDO_0018534) (squamous cell carcinoma of liver and intrahepatic biliary tract), [MONDO:0017205](http://purl.obolibrary.org/obo/MONDO_0017205) (primary oculocerebral lymphoma), [MONDO:0018535](http://purl.obolibrary.org/obo/MONDO_0018535) (biliary cystadenocarcinoma), [MONDO:0018532](http://purl.obolibrary.org/obo/MONDO_0018532) (adenocarcinoma of liver and intrahepatic biliary tract), [MONDO:0019863](http://purl.obolibrary.org/obo/MONDO_0019863) (Acro-renal-ocular syndrome), [MONDO:0018533](http://purl.obolibrary.org/obo/MONDO_0018533) (undifferentiated carcinoma of liver and intrahepatic biliary tract), [MONDO:0019861](http://purl.obolibrary.org/obo/MONDO_0019861) (thyroid hypoplasia), [MONDO:0017202](http://purl.obolibrary.org/obo/MONDO_0017202) (acute endophthalmitis), [MONDO:0018530](http://purl.obolibrary.org/obo/MONDO_0018530) (rare epithelial tumor of liver and intrahepatic biliary tract), [MONDO:0018531](http://purl.obolibrary.org/obo/MONDO_0018531) (carcinoma of liver and intrahepatic biliary tract), [MONDO:0017201](http://purl.obolibrary.org/obo/MONDO_0017201) (Spasmus nutans (disease)), [MONDO:0019860](http://purl.obolibrary.org/obo/MONDO_0019860) (thyroid hemiagenesis), [MONDO:0005238](http://purl.obolibrary.org/obo/MONDO_0005238) (round cell liposarcoma), [MONDO:0005235](http://purl.obolibrary.org/obo/MONDO_0005235) (asymptomatic myeloma), [MONDO:0006567](http://purl.obolibrary.org/obo/MONDO_0006567) (kernicterus due to isoimmunization), [MONDO:0005236](http://purl.obolibrary.org/obo/MONDO_0005236) (xanthoma (disease)), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0006565](http://purl.obolibrary.org/obo/MONDO_0006565) (juvenile dermatitis herpetiformis), [MONDO:0005233](http://purl.obolibrary.org/obo/MONDO_0005233) (non-small cell lung carcinoma (disease)), [MONDO:0007895](http://purl.obolibrary.org/obo/MONDO_0007895) (Platyspondylic dysplasia, Torrance type), [MONDO:0007894](http://purl.obolibrary.org/obo/MONDO_0007894) (Leri pleonosteosis), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0005232](http://purl.obolibrary.org/obo/MONDO_0005232) (large cell carcinoma), [MONDO:0006561](http://purl.obolibrary.org/obo/MONDO_0006561) (hypopigmentation of eyelid), [MONDO:0007892](http://purl.obolibrary.org/obo/MONDO_0007892) (Lenz-Majewski hyperostotic dwarfism), [MONDO:0007891](http://purl.obolibrary.org/obo/MONDO_0007891) (familial generalized lentiginosis), [MONDO:0017207](http://purl.obolibrary.org/obo/MONDO_0017207) (primary organ-specific lymphoma), [MONDO:0018538](http://purl.obolibrary.org/obo/MONDO_0018538) (inherited digestive cancer-predisposing syndrome), [MONDO:0017209](http://purl.obolibrary.org/obo/MONDO_0017209) (infectious posterior uveitis), [MONDO:0018539](http://purl.obolibrary.org/obo/MONDO_0018539) (rare epithelial tumor of small intestine), [MONDO:0018525](http://purl.obolibrary.org/obo/MONDO_0018525) (solid pseudopapillary carcinoma of pancreas), [MONDO:0018526](http://purl.obolibrary.org/obo/MONDO_0018526) (serous cystadenocarcinoma of pancreas), [MONDO:0019854](http://purl.obolibrary.org/obo/MONDO_0019854) (thyroid ectopia), [MONDO:0018523](http://purl.obolibrary.org/obo/MONDO_0018523) (pancreatic mucinous cystadenoma), [MONDO:0019855](http://purl.obolibrary.org/obo/MONDO_0019855) (Athyreosis), [MONDO:0018521](http://purl.obolibrary.org/obo/MONDO_0018521) (squamous cell carcinoma of pancreas), [MONDO:0018520](http://purl.obolibrary.org/obo/MONDO_0018520) (rare epithelial tumor of pancreas), [MONDO:0005208](http://purl.obolibrary.org/obo/MONDO_0005208) (amelanotic skin melanoma), [MONDO:0005206](http://purl.obolibrary.org/obo/MONDO_0005206) (renal carcinoma), [MONDO:0005207](http://purl.obolibrary.org/obo/MONDO_0005207) (choriocarcinoma (disease)), [MONDO:0006537](http://purl.obolibrary.org/obo/MONDO_0006537) (conjunctival pigmentation), [MONDO:0007868](http://purl.obolibrary.org/obo/MONDO_0007868) (hyperekplexia 1), [MONDO:0005204](http://purl.obolibrary.org/obo/MONDO_0005204) (primary antiphospholipid syndrome), [MONDO:0006536](http://purl.obolibrary.org/obo/MONDO_0006536) (congenital generalized lipodystrophy (disease)), [MONDO:0007866](http://purl.obolibrary.org/obo/MONDO_0007866) (Bart-Pumphrey syndrome), [MONDO:0005202](http://purl.obolibrary.org/obo/MONDO_0005202) (atopy), [MONDO:0007864](http://purl.obolibrary.org/obo/MONDO_0007864) (Klippel-Trenaunay syndrome), [MONDO:0007863](http://purl.obolibrary.org/obo/MONDO_0007863) (Kleine-Levin syndrome), [MONDO:0007862](http://purl.obolibrary.org/obo/MONDO_0007862) (Waardenburg syndrome type 3), [MONDO:0007861](http://purl.obolibrary.org/obo/MONDO_0007861) (isolated cloverleaf skull syndrome), [MONDO:0018527](http://purl.obolibrary.org/obo/MONDO_0018527) (osteoclastic giant cell tumor of pancreas), [MONDO:0018528](http://purl.obolibrary.org/obo/MONDO_0018528) (congenital myopathy with myasthenic-like onset), [MONDO:0018514](http://purl.obolibrary.org/obo/MONDO_0018514) (rare epithelial tumor of rectum), [MONDO:0018515](http://purl.obolibrary.org/obo/MONDO_0018515) (squamous cell carcinoma of rectum), [MONDO:0018512](http://purl.obolibrary.org/obo/MONDO_0018512) (rare epithelial tumor of colon), [MONDO:0018513](http://purl.obolibrary.org/obo/MONDO_0018513) (squamous cell carcinoma of colon), [MONDO:0018510](http://purl.obolibrary.org/obo/MONDO_0018510) (neuroendocrine tumor of the small intestine), [MONDO:0018511](http://purl.obolibrary.org/obo/MONDO_0018511) (epithelial tumor of the appendix), [MONDO:0019840](http://purl.obolibrary.org/obo/MONDO_0019840) (acropectororenal dysplasia), [MONDO:0005219](http://purl.obolibrary.org/obo/MONDO_0005219) (breast fibrocystic disease), [MONDO:0006549](http://purl.obolibrary.org/obo/MONDO_0006549) (fibroepithelial polyp of the anus), [MONDO:0007879](http://purl.obolibrary.org/obo/MONDO_0007879) (larynx atresia), [MONDO:0005215](http://purl.obolibrary.org/obo/MONDO_0005215) (vulvar carcinoma), [MONDO:0007878](http://purl.obolibrary.org/obo/MONDO_0007878) (congenital laryngomalacia), [MONDO:0005216](http://purl.obolibrary.org/obo/MONDO_0005216) (hypopharyngeal carcinoma), [MONDO:0007876](http://purl.obolibrary.org/obo/MONDO_0007876) (laryngeal abductor paralysis), [MONDO:0005213](http://purl.obolibrary.org/obo/MONDO_0005213) (uterine carcinoma), [MONDO:0005214](http://purl.obolibrary.org/obo/MONDO_0005214) (vulva sarcoma), [MONDO:0007875](http://purl.obolibrary.org/obo/MONDO_0007875) (larsen syndrome), [MONDO:0005211](http://purl.obolibrary.org/obo/MONDO_0005211) (ovarian serous adenocarcinoma), [MONDO:0007874](http://purl.obolibrary.org/obo/MONDO_0007874) (trichorhinophalangeal syndrome type II), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0007872](http://purl.obolibrary.org/obo/MONDO_0007872) (LADD syndrome), [MONDO:0005210](http://purl.obolibrary.org/obo/MONDO_0005210) (uterine corpus sarcoma), [MONDO:0007871](http://purl.obolibrary.org/obo/MONDO_0007871) (familial congenital nasolacrimal duct obstruction), [MONDO:0019847](http://purl.obolibrary.org/obo/MONDO_0019847) (congenital adrenal hypoplasia of maternal cause), [MONDO:0018516](http://purl.obolibrary.org/obo/MONDO_0018516) (epithelial tumor of anal canal), [MONDO:0015076](http://purl.obolibrary.org/obo/MONDO_0015076) (rare parathyroid tumor), [MONDO:0015077](http://purl.obolibrary.org/obo/MONDO_0015077) (adrenal/paraganglial tumor), [MONDO:0015078](http://purl.obolibrary.org/obo/MONDO_0015078) (Gastroenteropancreatic endocrine tumor), [MONDO:0015079](http://purl.obolibrary.org/obo/MONDO_0015079) (multiple polyglandular tumor), [MONDO:0015072](http://purl.obolibrary.org/obo/MONDO_0015072) (primary hepatic neuroendocrine carcinoma), [MONDO:0015073](http://purl.obolibrary.org/obo/MONDO_0015073) (gallbladder neuroendocrine tumor), [MONDO:0015074](http://purl.obolibrary.org/obo/MONDO_0015074) (thyroid tumor), [MONDO:0015075](http://purl.obolibrary.org/obo/MONDO_0015075) (thyroid gland carcinoma), [MONDO:0015070](http://purl.obolibrary.org/obo/MONDO_0015070) (laryngeal neuroendocrine neoplasm), [MONDO:0015071](http://purl.obolibrary.org/obo/MONDO_0015071) (middle ear neuroendocrine tumor), [MONDO:0003087](http://purl.obolibrary.org/obo/MONDO_0003087) (breast mucoepidermoid carcinoma), [MONDO:0003086](http://purl.obolibrary.org/obo/MONDO_0003086) (thymus mucoepidermoid carcinoma), [MONDO:0003089](http://purl.obolibrary.org/obo/MONDO_0003089) (bile duct mucoepidermoid carcinoma), [MONDO:0003088](http://purl.obolibrary.org/obo/MONDO_0003088) (intramuscular hemangioma), [MONDO:0003083](http://purl.obolibrary.org/obo/MONDO_0003083) (venous hemangioma), [MONDO:0003082](http://purl.obolibrary.org/obo/MONDO_0003082) (filamentary keratitis), [MONDO:0003085](http://purl.obolibrary.org/obo/MONDO_0003085) (keratitis), [MONDO:0015069](http://purl.obolibrary.org/obo/MONDO_0015069) (neuroendocrine tumor of the anal canal), [MONDO:0015065](http://purl.obolibrary.org/obo/MONDO_0015065) (ileal neuroendocrine tumor), [MONDO:0016396](http://purl.obolibrary.org/obo/MONDO_0016396) (pontocerebellar hypoplasia type 1), [MONDO:0015066](http://purl.obolibrary.org/obo/MONDO_0015066) (neuroendocrine tumor of the appendix), [MONDO:0015067](http://purl.obolibrary.org/obo/MONDO_0015067) (neuroendocrine tumor of the colon), [MONDO:0015068](http://purl.obolibrary.org/obo/MONDO_0015068) (neuroendocrine tumor of rectum), [MONDO:0016393](http://purl.obolibrary.org/obo/MONDO_0016393) (Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome), [MONDO:0015062](http://purl.obolibrary.org/obo/MONDO_0015062) (gastric neuroendocrine tumor), [MONDO:0015063](http://purl.obolibrary.org/obo/MONDO_0015063) (duodenal neuroendocrine tumor), [MONDO:0016395](http://purl.obolibrary.org/obo/MONDO_0016395) (foveal hypoplasia-presenile cataract syndrome), [MONDO:0015064](http://purl.obolibrary.org/obo/MONDO_0015064) (jejunal neuroendocrine tumor), [MONDO:0016391](http://purl.obolibrary.org/obo/MONDO_0016391) (neonatal diabetes mellitus), [MONDO:0016390](http://purl.obolibrary.org/obo/MONDO_0016390) (familial isolated hypoparathyroidism), [MONDO:0003098](http://purl.obolibrary.org/obo/MONDO_0003098) (mediastinal neural neoplasm), [MONDO:0003097](http://purl.obolibrary.org/obo/MONDO_0003097) (childhood mediastinal neurogenic neoplasm), [MONDO:0003093](http://purl.obolibrary.org/obo/MONDO_0003093) (mucoepidermoid esophageal carcinoma), [MONDO:0003096](http://purl.obolibrary.org/obo/MONDO_0003096) (deep angioma), [MONDO:0003095](http://purl.obolibrary.org/obo/MONDO_0003095) (laryngeal mucoepidermoid carcinoma), [MONDO:0003090](http://purl.obolibrary.org/obo/MONDO_0003090) (extrahepatic bile duct carcinoma), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0003091](http://purl.obolibrary.org/obo/MONDO_0003091) (cutaneous mucoepidermoid carcinoma), [MONDO:0016386](http://purl.obolibrary.org/obo/MONDO_0016386) (hypogonadotropic hypogonadism-retinitis pigmentosa syndrome), [MONDO:0015054](http://purl.obolibrary.org/obo/MONDO_0015054) (hereditary angioedema type 2), [MONDO:0015055](http://purl.obolibrary.org/obo/MONDO_0015055) (acquired angioedema type 2), [MONDO:0015056](http://purl.obolibrary.org/obo/MONDO_0015056) (acquired angioedema type 1), [MONDO:0016387](http://purl.obolibrary.org/obo/MONDO_0016387) (mitochondrial oxidative phosphorylation disorder), [MONDO:0015057](http://purl.obolibrary.org/obo/MONDO_0015057) (Renin-angiotensin-aldosterone system-blocker-induced angioedema), [MONDO:0015050](http://purl.obolibrary.org/obo/MONDO_0015050) (esophageal duplication cyst), [MONDO:0016381](http://purl.obolibrary.org/obo/MONDO_0016381) (hypertrichosis lanuginosa congenita), [MONDO:0015051](http://purl.obolibrary.org/obo/MONDO_0015051) (tubular duplication of the esophagus), [MONDO:0016384](http://purl.obolibrary.org/obo/MONDO_0016384) (hypogonadotropic hypogonadism-frontoparietal alopecia syndrome), [MONDO:0015053](http://purl.obolibrary.org/obo/MONDO_0015053) (hereditary angioedema type 1), [MONDO:0003065](http://purl.obolibrary.org/obo/MONDO_0003065) (nasal cavity inverting papilloma), [MONDO:0004397](http://purl.obolibrary.org/obo/MONDO_0004397) (benign mediastinal psammomatous neurilemmoma), [MONDO:0004398](http://purl.obolibrary.org/obo/MONDO_0004398) (mediastinal schwannoma), [MONDO:0003064](http://purl.obolibrary.org/obo/MONDO_0003064) (inverted transitional papilloma), [MONDO:0004396](http://purl.obolibrary.org/obo/MONDO_0004396) (cervical spinal canal and spinal cord meningioma), [MONDO:0004393](http://purl.obolibrary.org/obo/MONDO_0004393) (mixed astrocytoma-ependymoma), [MONDO:0003061](http://purl.obolibrary.org/obo/MONDO_0003061) (benign muscle neoplasm), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0003060](http://purl.obolibrary.org/obo/MONDO_0003060) (biliary tract cancer), [MONDO:0004391](http://purl.obolibrary.org/obo/MONDO_0004391) (adult extraosseous chondrosarcoma), [MONDO:0003062](http://purl.obolibrary.org/obo/MONDO_0003062) (intestinal benign neoplasm), [MONDO:0004392](http://purl.obolibrary.org/obo/MONDO_0004392) (intracranial chondrosarcoma), [MONDO:0004390](http://purl.obolibrary.org/obo/MONDO_0004390) (ocular hypotension), [MONDO:0016378](http://purl.obolibrary.org/obo/MONDO_0016378) (maternal hyperthermia induced birth defects), [MONDO:0015049](http://purl.obolibrary.org/obo/MONDO_0015049) (solitary necrotic nodule of the liver), [MONDO:0015043](http://purl.obolibrary.org/obo/MONDO_0015043) (extramedullary soft tissue plasmacytoma), [MONDO:0015044](http://purl.obolibrary.org/obo/MONDO_0015044) (mu-heavy chain disease), [MONDO:0015045](http://purl.obolibrary.org/obo/MONDO_0015045) (alpha-heavy chain disease), [MONDO:0015046](http://purl.obolibrary.org/obo/MONDO_0015046) (gamma-heavy chain disease), [MONDO:0015040](http://purl.obolibrary.org/obo/MONDO_0015040) (myelodysplastic syndrome with excess blasts-1), [MONDO:0015041](http://purl.obolibrary.org/obo/MONDO_0015041) (myelodysplastic syndrome with excess blasts-2), [MONDO:0015042](http://purl.obolibrary.org/obo/MONDO_0015042) (primary plasmacytoma of the bone), [MONDO:0003079](http://purl.obolibrary.org/obo/MONDO_0003079) (mastocytoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0003072](http://purl.obolibrary.org/obo/MONDO_0003072) (retinal cancer), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), [MONDO:0015099](http://purl.obolibrary.org/obo/MONDO_0015099) (unilateral hemispheric polymicrogyria), [MONDO:0015094](http://purl.obolibrary.org/obo/MONDO_0015094) (subependymal nodular heterotopia), [MONDO:0015095](http://purl.obolibrary.org/obo/MONDO_0015095) (Peters anomaly-cataract syndrome), [MONDO:0015096](http://purl.obolibrary.org/obo/MONDO_0015096) (familial hypofibrinogenemia), [MONDO:0015093](http://purl.obolibrary.org/obo/MONDO_0015093) (sub-cortical nodular heterotopia), [MONDO:0015083](http://purl.obolibrary.org/obo/MONDO_0015083) (nuclear oculomotor paralysis), [MONDO:0015086](http://purl.obolibrary.org/obo/MONDO_0015086) (cloverleaf skull-asphyxiating thoracic dysplasia syndrome), [MONDO:0015081](http://purl.obolibrary.org/obo/MONDO_0015081) (neuroendocrine tumor with other location), [MONDO:0005712](http://purl.obolibrary.org/obo/MONDO_0005712) (congenital nystagmus), [MONDO:0005710](http://purl.obolibrary.org/obo/MONDO_0005710) (composite lymphoma), [MONDO:0016401](http://purl.obolibrary.org/obo/MONDO_0016401) (energy metabolism disorder with epilepsy), [MONDO:0017732](http://purl.obolibrary.org/obo/MONDO_0017732) (alpha-mannosidosis, infantile form), [MONDO:0017731](http://purl.obolibrary.org/obo/MONDO_0017731) (glycoproteinosis), [MONDO:0016403](http://purl.obolibrary.org/obo/MONDO_0016403) (mitochondrial disease with peripheral neuropathy), [MONDO:0017734](http://purl.obolibrary.org/obo/MONDO_0017734) (sialidosis), [MONDO:0016402](http://purl.obolibrary.org/obo/MONDO_0016402) (mitochondrial disease with epilepsy), [MONDO:0017733](http://purl.obolibrary.org/obo/MONDO_0017733) (alpha-mannosidosis, adult form), [MONDO:0017730](http://purl.obolibrary.org/obo/MONDO_0017730) (metachromatic leukodystrophy, adult form), [MONDO:0004418](http://purl.obolibrary.org/obo/MONDO_0004418) (microcystic variant infiltrating bladder urothelial carcinoma), [MONDO:0004419](http://purl.obolibrary.org/obo/MONDO_0004419) (lymphoma-like variant infiltrating bladder urothelial carcinoma), [MONDO:0004416](http://purl.obolibrary.org/obo/MONDO_0004416) (plasmacytoid variant infiltrating bladder urothelial carcinoma), [MONDO:0004417](http://purl.obolibrary.org/obo/MONDO_0004417) (nested variant infiltrating bladder urothelial carcinoma), [MONDO:0004415](http://purl.obolibrary.org/obo/MONDO_0004415) (lipid-cell variant infiltrating bladder urothelial carcinoma), [MONDO:0004412](http://purl.obolibrary.org/obo/MONDO_0004412) (malignant spiradenoma), [MONDO:0005744](http://purl.obolibrary.org/obo/MONDO_0005744) (yolk sac tumor), [MONDO:0004413](http://purl.obolibrary.org/obo/MONDO_0004413) (cervical non-keratinizing squamous cell carcinoma), [MONDO:0005741](http://purl.obolibrary.org/obo/MONDO_0005741) (egg allergy), [MONDO:0004410](http://purl.obolibrary.org/obo/MONDO_0004410) (sarcomatoid penile squamous cell carcinoma), [MONDO:0004411](http://purl.obolibrary.org/obo/MONDO_0004411) (duodenal gastrinoma), [MONDO:0017739](http://purl.obolibrary.org/obo/MONDO_0017739) (disorder of lysosomal-related organelles), [MONDO:0016405](http://purl.obolibrary.org/obo/MONDO_0016405) (sterol metabolism disorder with epilepsy), [MONDO:0017736](http://purl.obolibrary.org/obo/MONDO_0017736) (disorder of sialic acid metabolism), [MONDO:0017738](http://purl.obolibrary.org/obo/MONDO_0017738) (lysosomal glycogen storage disease), [MONDO:0017737](http://purl.obolibrary.org/obo/MONDO_0017737) (intermediate severe Salla disease), [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0004429](http://purl.obolibrary.org/obo/MONDO_0004429) (skin meningioma), [MONDO:0004427](http://purl.obolibrary.org/obo/MONDO_0004427) (supraglottis neoplasm), [MONDO:0004428](http://purl.obolibrary.org/obo/MONDO_0004428) (alveoli adenoma), [MONDO:0004426](http://purl.obolibrary.org/obo/MONDO_0004426) (frontal convexity meningioma), [MONDO:0004423](http://purl.obolibrary.org/obo/MONDO_0004423) (central nervous system osteosarcoma), [MONDO:0004424](http://purl.obolibrary.org/obo/MONDO_0004424) (familial glomangioma), [MONDO:0005752](http://purl.obolibrary.org/obo/MONDO_0005752) (epidural abscess), [MONDO:0004421](http://purl.obolibrary.org/obo/MONDO_0004421) (sclerosing breast papilloma), [MONDO:0004422](http://purl.obolibrary.org/obo/MONDO_0004422) (cerebral falx meningioma), [MONDO:0004420](http://purl.obolibrary.org/obo/MONDO_0004420) (breast malignant eccrine spiradenoma), [MONDO:0017729](http://purl.obolibrary.org/obo/MONDO_0017729) (metachromatic leukodystrophy, late infantile form), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), [MONDO:0017712](http://purl.obolibrary.org/obo/MONDO_0017712) (combined pancreatic lipase-colipase deficiency), [MONDO:0017711](http://purl.obolibrary.org/obo/MONDO_0017711) (pancreatic colipase deficiency), [MONDO:0017718](http://purl.obolibrary.org/obo/MONDO_0017718) (mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes), [MONDO:0017717](http://purl.obolibrary.org/obo/MONDO_0017717) (metabolic disease due to other fatty acid oxidation disorder), [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719) (gangliosidosis), [MONDO:0017714](http://purl.obolibrary.org/obo/MONDO_0017714) (acyl-CoA dehydrogenase deficiency), [MONDO:0017713](http://purl.obolibrary.org/obo/MONDO_0017713) (disorder of fatty acid oxidation and ketogenesis), [MONDO:0017716](http://purl.obolibrary.org/obo/MONDO_0017716) (disorder of carnitine cycle and carnitine transport), [MONDO:0017715](http://purl.obolibrary.org/obo/MONDO_0017715) (3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0017701](http://purl.obolibrary.org/obo/MONDO_0017701) (glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form), [MONDO:0017700](http://purl.obolibrary.org/obo/MONDO_0017700) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form), [MONDO:0004409](http://purl.obolibrary.org/obo/MONDO_0004409) (nipple duct carcinoma), [MONDO:0004407](http://purl.obolibrary.org/obo/MONDO_0004407) (stroma-dominant and stroma-poor composite ganglioneuroblastoma), [MONDO:0004408](http://purl.obolibrary.org/obo/MONDO_0004408) (schwannian stroma-rich and stroma-poor composite ganglioneuroblastoma), [MONDO:0004405](http://purl.obolibrary.org/obo/MONDO_0004405) (Barrett adenocarcinoma), [MONDO:0004406](http://purl.obolibrary.org/obo/MONDO_0004406) (adult central nervous system mixed germ cell tumor), [MONDO:0004403](http://purl.obolibrary.org/obo/MONDO_0004403) (childhood precursor T-lymphoblastic lymphoma/leukemia), [MONDO:0004404](http://purl.obolibrary.org/obo/MONDO_0004404) (precursor T-lymphoblastic lymphoma/leukemia refractory), [MONDO:0004401](http://purl.obolibrary.org/obo/MONDO_0004401) (testis refractory cancer), [MONDO:0004402](http://purl.obolibrary.org/obo/MONDO_0004402) (testicular yolk sac tumor, glandular-alveolar pattern), [MONDO:0004400](http://purl.obolibrary.org/obo/MONDO_0004400) (malignant type A thymoma), [MONDO:0017706](http://purl.obolibrary.org/obo/MONDO_0017706) (disorder of carbohydrate absorption and transport), [MONDO:0017709](http://purl.obolibrary.org/obo/MONDO_0017709) (disorder of lipid absorption and transport), [MONDO:0017708](http://purl.obolibrary.org/obo/MONDO_0017708) (mevalonate kinase deficiency), [MONDO:0017703](http://purl.obolibrary.org/obo/MONDO_0017703) (disorder of glyoxylate metabolism), [MONDO:0017778](http://purl.obolibrary.org/obo/MONDO_0017778) (lamellar ichthyosis), [MONDO:0016446](http://purl.obolibrary.org/obo/MONDO_0016446) (acquired cutis laxa), [MONDO:0016441](http://purl.obolibrary.org/obo/MONDO_0016441) (acquired pseudoxanthoma elasticum), [MONDO:0015110](http://purl.obolibrary.org/obo/MONDO_0015110) (genetic cardiac rhythm disease), [MONDO:0017771](http://purl.obolibrary.org/obo/MONDO_0017771) (Mayer-Rokitansky-Kuster-Hauser syndrome), [MONDO:0017774](http://purl.obolibrary.org/obo/MONDO_0017774) (hypobetalipoproteinemia), [MONDO:0017773](http://purl.obolibrary.org/obo/MONDO_0017773) (hypoalphalipoproteinemia), [MONDO:0017770](http://purl.obolibrary.org/obo/MONDO_0017770) (Robinow-like syndrome), [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0003127](http://purl.obolibrary.org/obo/MONDO_0003127) (embryoma), [MONDO:0004458](http://purl.obolibrary.org/obo/MONDO_0004458) (bladder mixed adenocarcinoma), [MONDO:0004459](http://purl.obolibrary.org/obo/MONDO_0004459) (bladder hepatoid adenocarcinoma), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0003124](http://purl.obolibrary.org/obo/MONDO_0003124) (testicular leydig cell tumor), [MONDO:0004457](http://purl.obolibrary.org/obo/MONDO_0004457) (maxillary sinus Schneiderian papilloma), [MONDO:0003126](http://purl.obolibrary.org/obo/MONDO_0003126) (breast hemangioma), [MONDO:0004454](http://purl.obolibrary.org/obo/MONDO_0004454) (cellular congenital mesoblastic nephroma), [MONDO:0003125](http://purl.obolibrary.org/obo/MONDO_0003125) (testicular sex cord-stromal neoplasm), [MONDO:0004455](http://purl.obolibrary.org/obo/MONDO_0004455) (classic congenital mesoblastic nephroma), [MONDO:0003120](http://purl.obolibrary.org/obo/MONDO_0003120) (mixed testicular germ cell tumor), [MONDO:0004452](http://purl.obolibrary.org/obo/MONDO_0004452) (childhood central nervous system germinoma), [MONDO:0004453](http://purl.obolibrary.org/obo/MONDO_0004453) (testicular yolk sac tumor, myxomatous pattern), [MONDO:0003121](http://purl.obolibrary.org/obo/MONDO_0003121) (middle cranial fossa meningioma), [MONDO:0004451](http://purl.obolibrary.org/obo/MONDO_0004451) (sarcomatous intrahepatic cholangiocarcinoma), [MONDO:0015117](http://purl.obolibrary.org/obo/MONDO_0015117) (rare hepatic and biliary tract tumor), [MONDO:0017779](http://purl.obolibrary.org/obo/MONDO_0017779) (alpha-N-acetylgalactosaminidase deficiency), [MONDO:0015119](http://purl.obolibrary.org/obo/MONDO_0015119) (rare bronchopulmonary tumor), [MONDO:0017765](http://purl.obolibrary.org/obo/MONDO_0017765) (disorder of magnesium transport), [MONDO:0015102](http://purl.obolibrary.org/obo/MONDO_0015102) (non-secreting chemodectoma), [MONDO:0016433](http://purl.obolibrary.org/obo/MONDO_0016433) (dysmorphism-short stature-deafness-disorder of sex development syndrome), [MONDO:0017764](http://purl.obolibrary.org/obo/MONDO_0017764) (disorder of zinc metabolism), [MONDO:0015104](http://purl.obolibrary.org/obo/MONDO_0015104) (porphyria cutanea tarda), [MONDO:0017766](http://purl.obolibrary.org/obo/MONDO_0017766) (disorder of manganese transport), [MONDO:0017761](http://purl.obolibrary.org/obo/MONDO_0017761) (disorder of mineral absorption and transport), [MONDO:0017760](http://purl.obolibrary.org/obo/MONDO_0017760) (disorder of other vitamins and cofactors metabolism and transport), [MONDO:0016432](http://purl.obolibrary.org/obo/MONDO_0016432) (heart-hand syndrome), [MONDO:0017763](http://purl.obolibrary.org/obo/MONDO_0017763) (disorder of iron metabolism and transport), [MONDO:0015100](http://purl.obolibrary.org/obo/MONDO_0015100) (Aregenerative anemia), [MONDO:0015101](http://purl.obolibrary.org/obo/MONDO_0015101) (Marin-Amat syndrome), [MONDO:0017762](http://purl.obolibrary.org/obo/MONDO_0017762) (disorder of copper metabolism), [MONDO:0016431](http://purl.obolibrary.org/obo/MONDO_0016431) (autosomal dominant Charcot-Marie-tooth disease type 2M), [MONDO:0004469](http://purl.obolibrary.org/obo/MONDO_0004469) (pseudovascular skin squamous cell carcinoma), [MONDO:0004467](http://purl.obolibrary.org/obo/MONDO_0004467) (mature gastric teratoma), [MONDO:0004468](http://purl.obolibrary.org/obo/MONDO_0004468) (anal canal Paget's disease), [MONDO:0004465](http://purl.obolibrary.org/obo/MONDO_0004465) (periampullary adenocarcinoma), [MONDO:0004463](http://purl.obolibrary.org/obo/MONDO_0004463) (cellular phase chronic idiopathic myelofibrosis), [MONDO:0004464](http://purl.obolibrary.org/obo/MONDO_0004464) (nephrogenic adenoma of the urethra), [MONDO:0003130](http://purl.obolibrary.org/obo/MONDO_0003130) (mesoblastic nephroma), [MONDO:0004461](http://purl.obolibrary.org/obo/MONDO_0004461) (vaginal tubulovillous adenoma), [MONDO:0004462](http://purl.obolibrary.org/obo/MONDO_0004462) (extrahepatic bile duct cystadenoma), [MONDO:0004460](http://purl.obolibrary.org/obo/MONDO_0004460) (thyroid fetal adenoma), [MONDO:0015107](http://purl.obolibrary.org/obo/MONDO_0015107) (rare genetic eye disease), [MONDO:0017754](http://purl.obolibrary.org/obo/MONDO_0017754) (disorder of porphyrin and haem metabolism), [MONDO:0016422](http://purl.obolibrary.org/obo/MONDO_0016422) (autoimmune polyendocrinopathy type 3), [MONDO:0017753](http://purl.obolibrary.org/obo/MONDO_0017753) (disorder of peroxisomal alpha-, beta- and omega-oxidation), [MONDO:0017756](http://purl.obolibrary.org/obo/MONDO_0017756) (disorder of pterin metabolism), [MONDO:0016424](http://purl.obolibrary.org/obo/MONDO_0016424) (progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome), [MONDO:0017755](http://purl.obolibrary.org/obo/MONDO_0017755) (disorder of bilirubin metabolism and excretion), [MONDO:0017750](http://purl.obolibrary.org/obo/MONDO_0017750) (defect in conserved oligomeric Golgi complex), [MONDO:0017752](http://purl.obolibrary.org/obo/MONDO_0017752) (defect in v-ATPase), [MONDO:0016420](http://purl.obolibrary.org/obo/MONDO_0016420) (familial flecked retinopathy), [MONDO:0003109](http://purl.obolibrary.org/obo/MONDO_0003109) (foramen magnum meningioma), [MONDO:0003106](http://purl.obolibrary.org/obo/MONDO_0003106) (verrucous keratotic hemangioma), [MONDO:0004438](http://purl.obolibrary.org/obo/MONDO_0004438) (sporadic breast cancer), [MONDO:0004439](http://purl.obolibrary.org/obo/MONDO_0004439) (periocular meningioma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003108](http://purl.obolibrary.org/obo/MONDO_0003108) (cervicomedullary junction neoplasm), [MONDO:0003107](http://purl.obolibrary.org/obo/MONDO_0003107) (infratentorial cancer), [MONDO:0004435](http://purl.obolibrary.org/obo/MONDO_0004435) (liver fibrosarcoma), [MONDO:0004432](http://purl.obolibrary.org/obo/MONDO_0004432) (mature pericardial teratoma), [MONDO:0003104](http://purl.obolibrary.org/obo/MONDO_0003104) (epicardium cancer), [MONDO:0005764](http://purl.obolibrary.org/obo/MONDO_0005764) (follicular dendritic cell sarcoma), [MONDO:0004433](http://purl.obolibrary.org/obo/MONDO_0004433) (penis papillary carcinoma), [MONDO:0003103](http://purl.obolibrary.org/obo/MONDO_0003103) (nerve root neoplasm), [MONDO:0005761](http://purl.obolibrary.org/obo/MONDO_0005761) (filarial elephantiasis), [MONDO:0004430](http://purl.obolibrary.org/obo/MONDO_0004430) (penis mixed squamous cell carcinoma), [MONDO:0003100](http://purl.obolibrary.org/obo/MONDO_0003100) (nerve plexus neoplasm), [MONDO:0017758](http://purl.obolibrary.org/obo/MONDO_0017758) (disorder of vitamin and non-protein cofactor absorption and transportB), [MONDO:0017757](http://purl.obolibrary.org/obo/MONDO_0017757) (disorder of metabolite absorption and transport), [MONDO:0017759](http://purl.obolibrary.org/obo/MONDO_0017759) (disorder of catecholamine synthesis), [MONDO:0017743](http://purl.obolibrary.org/obo/MONDO_0017743) (disorder of O-N-acetylgalactosaminylglycan synthesis), [MONDO:0017742](http://purl.obolibrary.org/obo/MONDO_0017742) (disorder of O-xylosylglycan synthesis), [MONDO:0017745](http://purl.obolibrary.org/obo/MONDO_0017745) (disorder of O-mannosylglycan synthesis), [MONDO:0017744](http://purl.obolibrary.org/obo/MONDO_0017744) (disorder of O-xylosyl/N-acetylgalactosaminylglycan synthesis), [MONDO:0017741](http://purl.obolibrary.org/obo/MONDO_0017741) (disorder of protein O-glycosylation), [MONDO:0017740](http://purl.obolibrary.org/obo/MONDO_0017740) (disorder of protein N-glycosylation), [MONDO:0004449](http://purl.obolibrary.org/obo/MONDO_0004449) (intraductal breast myoepitheliosis), [MONDO:0004447](http://purl.obolibrary.org/obo/MONDO_0004447) (pituitary stalk meningioma), [MONDO:0003119](http://purl.obolibrary.org/obo/MONDO_0003119) (histiocytoid hemangioma), [MONDO:0004448](http://purl.obolibrary.org/obo/MONDO_0004448) (frontal sinus inverted papilloma), [MONDO:0003118](http://purl.obolibrary.org/obo/MONDO_0003118) (testicular Brenner tumor), [MONDO:0004445](http://purl.obolibrary.org/obo/MONDO_0004445) (bladder papillary clear cell adenocarcinoma), [MONDO:0003113](http://purl.obolibrary.org/obo/MONDO_0003113) (extragonadal germ cell cancer), [MONDO:0004446](http://purl.obolibrary.org/obo/MONDO_0004446) (olfactory groove meningioma), [MONDO:0003112](http://purl.obolibrary.org/obo/MONDO_0003112) (malignant gastric germ cell tumor), [MONDO:0004443](http://purl.obolibrary.org/obo/MONDO_0004443) (chest wall parachordoma), [MONDO:0003115](http://purl.obolibrary.org/obo/MONDO_0003115) (subglottic hemangioma), [MONDO:0003114](http://purl.obolibrary.org/obo/MONDO_0003114) (bone giant cell sarcoma), [MONDO:0004444](http://purl.obolibrary.org/obo/MONDO_0004444) (bladder tubulo-cystic clear cell adenocarcinoma), [MONDO:0005775](http://purl.obolibrary.org/obo/MONDO_0005775) (glucosephosphate dehydrogenase deficiency), [MONDO:0004441](http://purl.obolibrary.org/obo/MONDO_0004441) (childhood ovarian embryonal carcinoma), [MONDO:0004442](http://purl.obolibrary.org/obo/MONDO_0004442) (testis polyembryoma), [MONDO:0003111](http://purl.obolibrary.org/obo/MONDO_0003111) (gastric neuroendocrine neoplasm), [MONDO:0003110](http://purl.obolibrary.org/obo/MONDO_0003110) (skin hemangioma), [MONDO:0004440](http://purl.obolibrary.org/obo/MONDO_0004440) (pineal region meningioma), [MONDO:0016419](http://purl.obolibrary.org/obo/MONDO_0016419) (hereditary breast carcinoma), [MONDO:0017747](http://purl.obolibrary.org/obo/MONDO_0017747) (disorder of fucoglycosan synthesis), [MONDO:0017749](http://purl.obolibrary.org/obo/MONDO_0017749) (disorder of multiple glycosylation), [MONDO:0017748](http://purl.obolibrary.org/obo/MONDO_0017748) (disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation), [MONDO:0015157](http://purl.obolibrary.org/obo/MONDO_0015157) (human herpesvirus 8-related disorder), [MONDO:0016489](http://purl.obolibrary.org/obo/MONDO_0016489) (delta-beta-thalassemia), [MONDO:0016488](http://purl.obolibrary.org/obo/MONDO_0016488) (beta-thalassemia associated with another hemoglobin anomaly), [MONDO:0015159](http://purl.obolibrary.org/obo/MONDO_0015159) (multiple congenital anomalies/dysmorphic syndrome-intellectual disability), [MONDO:0016485](http://purl.obolibrary.org/obo/MONDO_0016485) (Usher syndrome type 3), [MONDO:0016484](http://purl.obolibrary.org/obo/MONDO_0016484) (Usher syndrome type 2), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0016481](http://purl.obolibrary.org/obo/MONDO_0016481) (silver-Russell syndrome due to 11p15 microduplication), [MONDO:0016480](http://purl.obolibrary.org/obo/MONDO_0016480) (silver-Russell syndrome due to an imprinting defect of 11p15), [MONDO:0015151](http://purl.obolibrary.org/obo/MONDO_0015151) (autosomal dominant limb-girdle muscular dystrophy), [MONDO:0015152](http://purl.obolibrary.org/obo/MONDO_0015152) (autosomal recessive limb-girdle muscular dystrophy), [MONDO:0016482](http://purl.obolibrary.org/obo/MONDO_0016482) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 11), [MONDO:0003168](http://purl.obolibrary.org/obo/MONDO_0003168) (pilocytic astrocytoma of cerebellum), [MONDO:0004498](http://purl.obolibrary.org/obo/MONDO_0004498) (sacral spinal canal and spinal cord meningioma), [MONDO:0003169](http://purl.obolibrary.org/obo/MONDO_0003169) (diencephalic astrocytomas), [MONDO:0004499](http://purl.obolibrary.org/obo/MONDO_0004499) (hilar lung carcinoma), [MONDO:0003164](http://purl.obolibrary.org/obo/MONDO_0003164) (cauda equina neoplasm), [MONDO:0003163](http://purl.obolibrary.org/obo/MONDO_0003163) (cauda equina intradural extramedullary astrocytoma), [MONDO:0004494](http://purl.obolibrary.org/obo/MONDO_0004494) (testicular yolk sac tumor, hepatoid pattern), [MONDO:0004495](http://purl.obolibrary.org/obo/MONDO_0004495) (myotonic cataract), [MONDO:0003165](http://purl.obolibrary.org/obo/MONDO_0003165) (cerebellar astrocytoma), [MONDO:0004493](http://purl.obolibrary.org/obo/MONDO_0004493) (testicular yolk sac tumor, papillary pattern), [MONDO:0004490](http://purl.obolibrary.org/obo/MONDO_0004490) (gestational uterine corpus choriocarcinoma), [MONDO:0004491](http://purl.obolibrary.org/obo/MONDO_0004491) (uterine corpus choriocarcinoma), [MONDO:0003161](http://purl.obolibrary.org/obo/MONDO_0003161) (benign ependymoma), [MONDO:0016478](http://purl.obolibrary.org/obo/MONDO_0016478) (Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion), [MONDO:0015146](http://purl.obolibrary.org/obo/MONDO_0015146) (classic lissencephaly), [MONDO:0016477](http://purl.obolibrary.org/obo/MONDO_0016477) (Beckwith-Wiedemann syndrome due to 11p15 microdeletion), [MONDO:0015147](http://purl.obolibrary.org/obo/MONDO_0015147) (other syndrome with lissencephaly as a major feature), [MONDO:0015148](http://purl.obolibrary.org/obo/MONDO_0015148) (lissencephaly type 3), [MONDO:0016479](http://purl.obolibrary.org/obo/MONDO_0016479) (silver-Russell syndrome due to 7p11.2p13 microduplication), [MONDO:0016474](http://purl.obolibrary.org/obo/MONDO_0016474) (drug-induced lupus erythematosus), [MONDO:0016473](http://purl.obolibrary.org/obo/MONDO_0016473) (familial rhabdoid tumor), [MONDO:0016476](http://purl.obolibrary.org/obo/MONDO_0016476) (Beckwith-Wiedemann syndrome due to CDKN1C mutation), [MONDO:0016475](http://purl.obolibrary.org/obo/MONDO_0016475) (Beckwith-Wiedemann syndrome due to imprinting defect of 11p15), [MONDO:0016470](http://purl.obolibrary.org/obo/MONDO_0016470) (Ehlers-Danlos/osteogenesis imperfecta syndrome), [MONDO:0016471](http://purl.obolibrary.org/obo/MONDO_0016471) (pachyonychia congenita), [MONDO:0003175](http://purl.obolibrary.org/obo/MONDO_0003175) (salivary gland adenoid cystic carcinoma), [MONDO:0003174](http://purl.obolibrary.org/obo/MONDO_0003174) (spinal cord astrocytoma), [MONDO:0003177](http://purl.obolibrary.org/obo/MONDO_0003177) (prostate adenoid cystic carcinoma), [MONDO:0003171](http://purl.obolibrary.org/obo/MONDO_0003171) (pineal gland astrocytoma), [MONDO:0003170](http://purl.obolibrary.org/obo/MONDO_0003170) (gliofibroma), [MONDO:0003173](http://purl.obolibrary.org/obo/MONDO_0003173) (brain stem astrocytic neoplasm), [MONDO:0003172](http://purl.obolibrary.org/obo/MONDO_0003172) (glomeruloid hemangioma), [MONDO:0016467](http://purl.obolibrary.org/obo/MONDO_0016467) (isotretinoin syndrome), [MONDO:0017797](http://purl.obolibrary.org/obo/MONDO_0017797) (rare odontologic tumor), [MONDO:0016469](http://purl.obolibrary.org/obo/MONDO_0016469) (Ehlers-Danlos syndrome, vascular-like type), [MONDO:0017799](http://purl.obolibrary.org/obo/MONDO_0017799) (Meigs syndrome), [MONDO:0016468](http://purl.obolibrary.org/obo/MONDO_0016468) (toxin-mediated infectious botulism), [MONDO:0015131](http://purl.obolibrary.org/obo/MONDO_0015131) (congenital combined immunodeficiency), [MONDO:0016463](http://purl.obolibrary.org/obo/MONDO_0016463) (syndromic agammaglobulinemia), [MONDO:0016462](http://purl.obolibrary.org/obo/MONDO_0016462) (isolated agammaglobulinemia), [MONDO:0015132](http://purl.obolibrary.org/obo/MONDO_0015132) (immunodeficiency predominantly affecting antibody production), [MONDO:0017793](http://purl.obolibrary.org/obo/MONDO_0017793) (marfanoid habitus-inguinal hernia-advanced bone age syndrome), [MONDO:0017795](http://purl.obolibrary.org/obo/MONDO_0017795) (ameloblastoma), [MONDO:0016464](http://purl.obolibrary.org/obo/MONDO_0016464) (insulin-resistance syndrome type b), [MONDO:0017790](http://purl.obolibrary.org/obo/MONDO_0017790) (gastric adenocarcinoma and proximal polyposis of the stomach), [MONDO:0017792](http://purl.obolibrary.org/obo/MONDO_0017792) (7p22.1 microduplication syndrome), [MONDO:0016460](http://purl.obolibrary.org/obo/MONDO_0016460) (Polyvalvular heart disease syndrome), [MONDO:0017791](http://purl.obolibrary.org/obo/MONDO_0017791) (high bone mass osteogenesis imperfecta), [MONDO:0015130](http://purl.obolibrary.org/obo/MONDO_0015130) (acquired chronic primary adrenal insufficiency), [MONDO:0004478](http://purl.obolibrary.org/obo/MONDO_0004478) (pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma), [MONDO:0003145](http://purl.obolibrary.org/obo/MONDO_0003145) (supratentorial primitive neuroectodermal tumor), [MONDO:0004479](http://purl.obolibrary.org/obo/MONDO_0004479) (malignant childhood germ cell neoplasm), [MONDO:0003148](http://purl.obolibrary.org/obo/MONDO_0003148) (SM-AHNMD), [MONDO:0004477](http://purl.obolibrary.org/obo/MONDO_0004477) (adrenal gland ganglioneuroblastoma), [MONDO:0004474](http://purl.obolibrary.org/obo/MONDO_0004474) (gallbladder lymphoma), [MONDO:0003142](http://purl.obolibrary.org/obo/MONDO_0003142) (intracranial primitive neuroectodermal tumor), [MONDO:0004475](http://purl.obolibrary.org/obo/MONDO_0004475) (thymus clear cell carcinoma), [MONDO:0003141](http://purl.obolibrary.org/obo/MONDO_0003141) (cerebellopontine angle primitive neuroectodermal), [MONDO:0004472](http://purl.obolibrary.org/obo/MONDO_0004472) (breast columnar cell mucinous carcinoma), [MONDO:0003144](http://purl.obolibrary.org/obo/MONDO_0003144) (medulloepithelioma), [MONDO:0004473](http://purl.obolibrary.org/obo/MONDO_0004473) (epiglottis cancer), [MONDO:0003143](http://purl.obolibrary.org/obo/MONDO_0003143) (angiokeratoma), [MONDO:0004471](http://purl.obolibrary.org/obo/MONDO_0004471) (septic arthritis), [MONDO:0017789](http://purl.obolibrary.org/obo/MONDO_0017789) (idiopathic linear interstitial keratitis), [MONDO:0017788](http://purl.obolibrary.org/obo/MONDO_0017788) (contractures-webbed neck-micrognathia-hypoplastic nipples syndrome), [MONDO:0016457](http://purl.obolibrary.org/obo/MONDO_0016457) (ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome), [MONDO:0015120](http://purl.obolibrary.org/obo/MONDO_0015120) (rare acquired eye disease), [MONDO:0016452](http://purl.obolibrary.org/obo/MONDO_0016452) (idiopathic hypersomnia without long sleep time), [MONDO:0015121](http://purl.obolibrary.org/obo/MONDO_0015121) (rare eye tumor), [MONDO:0016451](http://purl.obolibrary.org/obo/MONDO_0016451) (idiopathic hypersomnia with long sleep time), [MONDO:0015122](http://purl.obolibrary.org/obo/MONDO_0015122) (rare diabetes mellitus), [MONDO:0016454](http://purl.obolibrary.org/obo/MONDO_0016454) (severe early-onset axonal neuropathy due to NEFL deficiency), [MONDO:0017785](http://purl.obolibrary.org/obo/MONDO_0017785) (PENS syndrome), [MONDO:0016453](http://purl.obolibrary.org/obo/MONDO_0016453) (foodborne botulism), [MONDO:0015123](http://purl.obolibrary.org/obo/MONDO_0015123) (rare dyslipidemia), [MONDO:0017784](http://purl.obolibrary.org/obo/MONDO_0017784) (Epstein-Barr virus-associated gastric carcinoma), [MONDO:0016450](http://purl.obolibrary.org/obo/MONDO_0016450) (autoimmune hemolytic anemia, cold type), [MONDO:0017780](http://purl.obolibrary.org/obo/MONDO_0017780) (20p13 microdeletion syndrome), [MONDO:0004489](http://purl.obolibrary.org/obo/MONDO_0004489) (fallopian tube gestational choriocarcinoma), [MONDO:0004487](http://purl.obolibrary.org/obo/MONDO_0004487) (endometrial type cervical adenomyoma), [MONDO:0003158](http://purl.obolibrary.org/obo/MONDO_0003158) (myoepithelial carcinoma), [MONDO:0004488](http://purl.obolibrary.org/obo/MONDO_0004488) (cervical atypical polypoid adenomyoma), [MONDO:0003153](http://purl.obolibrary.org/obo/MONDO_0003153) (adult brain stem glioma), [MONDO:0003152](http://purl.obolibrary.org/obo/MONDO_0003152) (adult brainstem gliosarcoma), [MONDO:0004486](http://purl.obolibrary.org/obo/MONDO_0004486) (endocervical type cervical adenomyoma), [MONDO:0003155](http://purl.obolibrary.org/obo/MONDO_0003155) (cavernous hemangioma), [MONDO:0004483](http://purl.obolibrary.org/obo/MONDO_0004483) (thyroid gland oncocytic adenoma), [MONDO:0003154](http://purl.obolibrary.org/obo/MONDO_0003154) (hemangioma of peripheral nerve), [MONDO:0004484](http://purl.obolibrary.org/obo/MONDO_0004484) (gallbladder melanoma), [MONDO:0004481](http://purl.obolibrary.org/obo/MONDO_0004481) (pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma), [MONDO:0004482](http://purl.obolibrary.org/obo/MONDO_0004482) (fibroosseous pseudotumor of digits), [MONDO:0015128](http://purl.obolibrary.org/obo/MONDO_0015128) (primary adrenal insufficiency), [MONDO:0015129](http://purl.obolibrary.org/obo/MONDO_0015129) (chronic primary adrenal insufficiency), [MONDO:0015198](http://purl.obolibrary.org/obo/MONDO_0015198) (aniridia-ptosis-intellectual disability-familial obesity syndrome), [MONDO:0015199](http://purl.obolibrary.org/obo/MONDO_0015199) (aniridia-intellectual disability syndrome), [MONDO:0015194](http://purl.obolibrary.org/obo/MONDO_0015194) (sideroblastic anemia), [MONDO:0015195](http://purl.obolibrary.org/obo/MONDO_0015195) (atresia of urethra (disease)), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0015191](http://purl.obolibrary.org/obo/MONDO_0015191) (myopathic intestinal pseudoobstruction), [MONDO:0015192](http://purl.obolibrary.org/obo/MONDO_0015192) (unclassified intestinal pseudoobstruction), [MONDO:0015186](http://purl.obolibrary.org/obo/MONDO_0015186) (rare tumor of intestine), [MONDO:0015187](http://purl.obolibrary.org/obo/MONDO_0015187) (rare inflammatory bowel disease), [MONDO:0015188](http://purl.obolibrary.org/obo/MONDO_0015188) (metabolic disease with intestinal involvement), [MONDO:0015182](http://purl.obolibrary.org/obo/MONDO_0015182) (congenital enteropathy involving intestinal mucosa development), [MONDO:0015184](http://purl.obolibrary.org/obo/MONDO_0015184) (rare disease involving intestinal motility), [MONDO:0015185](http://purl.obolibrary.org/obo/MONDO_0015185) (intestinal polyposis syndrome), [MONDO:0015180](http://purl.obolibrary.org/obo/MONDO_0015180) (intestinal disease due to fat malabsorption), [MONDO:0015179](http://purl.obolibrary.org/obo/MONDO_0015179) (intestinal disease due to vitamin absorption anomaly), [MONDO:0015175](http://purl.obolibrary.org/obo/MONDO_0015175) (autoimmune pancreatitis), [MONDO:0015176](http://purl.obolibrary.org/obo/MONDO_0015176) (undetermined colitis), [MONDO:0015177](http://purl.obolibrary.org/obo/MONDO_0015177) (metaphyseal anadysplasia), [MONDO:0015178](http://purl.obolibrary.org/obo/MONDO_0015178) (congenital intestinal transport defect), [MONDO:0015171](http://purl.obolibrary.org/obo/MONDO_0015171) (congenital enterocyte heparan sulfate deficiency), [MONDO:0015172](http://purl.obolibrary.org/obo/MONDO_0015172) (Epithelio-exfoliative colitis-deafness syndrome), [MONDO:0015173](http://purl.obolibrary.org/obo/MONDO_0015173) (autoimmune enteropathy type 2), [MONDO:0015174](http://purl.obolibrary.org/obo/MONDO_0015174) (autoimmune enteropathy type 3), [MONDO:0015170](http://purl.obolibrary.org/obo/MONDO_0015170) (congenital sodium diarrhea), [MONDO:0003189](http://purl.obolibrary.org/obo/MONDO_0003189) (middle ear adenocarcinoma), [MONDO:0003186](http://purl.obolibrary.org/obo/MONDO_0003186) (esophageal adenoid cystic carcinoma), [MONDO:0003185](http://purl.obolibrary.org/obo/MONDO_0003185) (adenoid cystic breast carcinoma), [MONDO:0003187](http://purl.obolibrary.org/obo/MONDO_0003187) (Bartholin's gland adenoid cystic carcinoma), [MONDO:0003181](http://purl.obolibrary.org/obo/MONDO_0003181) (lung adenoid cystic carcinoma), [MONDO:0003184](http://purl.obolibrary.org/obo/MONDO_0003184) (trachea carcinoma), [MONDO:0003180](http://purl.obolibrary.org/obo/MONDO_0003180) (cutaneous adenocystic carcinoma), [MONDO:0015168](http://purl.obolibrary.org/obo/MONDO_0015168) (arthrogryposis multiplex congenita), [MONDO:0015169](http://purl.obolibrary.org/obo/MONDO_0015169) (chronic diarrhea due to glucoamylase deficiency), [MONDO:0015164](http://purl.obolibrary.org/obo/MONDO_0015164) (acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent), [MONDO:0015165](http://purl.obolibrary.org/obo/MONDO_0015165) (acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor), [MONDO:0015166](http://purl.obolibrary.org/obo/MONDO_0015166) (acute myeloid leukemia with t(8;21)(q22;q22) translocation), [MONDO:0015167](http://purl.obolibrary.org/obo/MONDO_0015167) (amniotic bands), [MONDO:0016492](http://purl.obolibrary.org/obo/MONDO_0016492) (beta-thalassemia with other manifestations), [MONDO:0016491](http://purl.obolibrary.org/obo/MONDO_0016491) (hemoglobin E-beta-thalassemia syndrome), [MONDO:0016490](http://purl.obolibrary.org/obo/MONDO_0016490) (hemoglobin c-beta-thalassemia syndrome), [MONDO:0003197](http://purl.obolibrary.org/obo/MONDO_0003197) (granular cell carcinoma), [MONDO:0003196](http://purl.obolibrary.org/obo/MONDO_0003196) (appendix carcinoma), [MONDO:0003199](http://purl.obolibrary.org/obo/MONDO_0003199) (anal carcinoma), [MONDO:0003198](http://purl.obolibrary.org/obo/MONDO_0003198) (small intestine adenocarcinoma), [MONDO:0003193](http://purl.obolibrary.org/obo/MONDO_0003193) (bile duct adenocarcinoma), [MONDO:0003192](http://purl.obolibrary.org/obo/MONDO_0003192) (rete ovarii neoplasm), [MONDO:0003195](http://purl.obolibrary.org/obo/MONDO_0003195) (peritoneal serous adenocarcinoma), [MONDO:0003194](http://purl.obolibrary.org/obo/MONDO_0003194) (hemangioma of lung), [MONDO:0003191](http://purl.obolibrary.org/obo/MONDO_0003191) (rete ovarii adenocarcinoma), [MONDO:0003190](http://purl.obolibrary.org/obo/MONDO_0003190) (middle ear carcinoma), [MONDO:0017811](http://purl.obolibrary.org/obo/MONDO_0017811) (severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion), [MONDO:0017810](http://purl.obolibrary.org/obo/MONDO_0017810) (variant ABeta2M amyloidosis), [MONDO:0005827](http://purl.obolibrary.org/obo/MONDO_0005827) (lipoatrophic diabetes), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0017813](http://purl.obolibrary.org/obo/MONDO_0017813) (van Maldergem syndrome), [MONDO:0017812](http://purl.obolibrary.org/obo/MONDO_0017812) (segmental progressive overgrowth syndrome with fibroadipose hyperplasia), [MONDO:0017815](http://purl.obolibrary.org/obo/MONDO_0017815) (acquired porencephaly), [MONDO:0017814](http://purl.obolibrary.org/obo/MONDO_0017814) (primary bone lymphoma), [MONDO:0017800](http://purl.obolibrary.org/obo/MONDO_0017800) (Pseudo-Meigs syndrome), [MONDO:0004509](http://purl.obolibrary.org/obo/MONDO_0004509) (intrahepatic biliary papillomatosis), [MONDO:0005837](http://purl.obolibrary.org/obo/MONDO_0005837) (mandibular cancer), [MONDO:0004506](http://purl.obolibrary.org/obo/MONDO_0004506) (microscopic breast papilloma), [MONDO:0004507](http://purl.obolibrary.org/obo/MONDO_0004507) (atypical breast papilloma), [MONDO:0005835](http://purl.obolibrary.org/obo/MONDO_0005835) (Lynch syndrome), [MONDO:0004504](http://purl.obolibrary.org/obo/MONDO_0004504) (penile urethral cancer), [MONDO:0005836](http://purl.obolibrary.org/obo/MONDO_0005836) (male reproductive organ cancer), [MONDO:0004505](http://purl.obolibrary.org/obo/MONDO_0004505) (central breast papilloma), [MONDO:0004502](http://purl.obolibrary.org/obo/MONDO_0004502) (parapharyngeal meningioma), [MONDO:0004503](http://purl.obolibrary.org/obo/MONDO_0004503) (upper clivus meningioma), [MONDO:0004500](http://purl.obolibrary.org/obo/MONDO_0004500) (lung superior sulcus carcinoma), [MONDO:0004501](http://purl.obolibrary.org/obo/MONDO_0004501) (fallopian tube cystadenofibroma), [MONDO:0017809](http://purl.obolibrary.org/obo/MONDO_0017809) (parkinsonism due to ATP13A2 deficiency), [MONDO:0017806](http://purl.obolibrary.org/obo/MONDO_0017806) (15q overgrowth syndrome), [MONDO:0017805](http://purl.obolibrary.org/obo/MONDO_0017805) (intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome), [MONDO:0017808](http://purl.obolibrary.org/obo/MONDO_0017808) (duplication of the pituitary gland), [MONDO:0017807](http://purl.obolibrary.org/obo/MONDO_0017807) (Growing teratoma syndrome), [MONDO:0017802](http://purl.obolibrary.org/obo/MONDO_0017802) (ovarian fibrothecoma), [MONDO:0017801](http://purl.obolibrary.org/obo/MONDO_0017801) (atypical Meigs syndrome), [MONDO:0017804](http://purl.obolibrary.org/obo/MONDO_0017804) (autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome), [MONDO:0005808](http://purl.obolibrary.org/obo/MONDO_0005808) (inclusion conjunctivitis), [MONDO:0005806](http://purl.obolibrary.org/obo/MONDO_0005806) (hypopharynx cancer), [MONDO:0005804](http://purl.obolibrary.org/obo/MONDO_0005804) (hyperprolactinemia (disease)), [MONDO:0005803](http://purl.obolibrary.org/obo/MONDO_0005803) (hyperinsulinemic hypoglycemia (disease)), [MONDO:0005800](http://purl.obolibrary.org/obo/MONDO_0005800) (hordeolum), [MONDO:0005815](http://purl.obolibrary.org/obo/MONDO_0005815) (pancreatic neuroendocrine neoplasm), [MONDO:0005813](http://purl.obolibrary.org/obo/MONDO_0005813) (interdigitating dendritic cell sarcoma), [MONDO:0005814](http://purl.obolibrary.org/obo/MONDO_0005814) (intestinal cancer), [MONDO:0017853](http://purl.obolibrary.org/obo/MONDO_0017853) (hypersensitivity pneumonitis), [MONDO:0017855](http://purl.obolibrary.org/obo/MONDO_0017855) (T-b- severe combined immunodeficiency), [MONDO:0016523](http://purl.obolibrary.org/obo/MONDO_0016523) (bronchogenic cyst (disease)), [MONDO:0016520](http://purl.obolibrary.org/obo/MONDO_0016520) (isolated Klippel-Feil syndrome), [MONDO:0017850](http://purl.obolibrary.org/obo/MONDO_0017850) (sirenomelia), [MONDO:0003209](http://purl.obolibrary.org/obo/MONDO_0003209) (thymus adenocarcinoma), [MONDO:0003208](http://purl.obolibrary.org/obo/MONDO_0003208) (breast secretory carcinoma), [MONDO:0004539](http://purl.obolibrary.org/obo/MONDO_0004539) (aortic malignant tumor), [MONDO:0003205](http://purl.obolibrary.org/obo/MONDO_0003205) (renal pelvis adenocarcinoma), [MONDO:0004537](http://purl.obolibrary.org/obo/MONDO_0004537) (intestinal variant cervical mucinous adenocarcinoma), [MONDO:0005868](http://purl.obolibrary.org/obo/MONDO_0005868) (myelophthisic anemia), [MONDO:0004538](http://purl.obolibrary.org/obo/MONDO_0004538) (endocervical type cervical mucinous adenocarcinoma), [MONDO:0003204](http://purl.obolibrary.org/obo/MONDO_0003204) (villous adenocarcinoma), [MONDO:0003207](http://purl.obolibrary.org/obo/MONDO_0003207) (eccrine adenocarcinoma), [MONDO:0004535](http://purl.obolibrary.org/obo/MONDO_0004535) (childhood choriocarcinoma of the ovary), [MONDO:0003206](http://purl.obolibrary.org/obo/MONDO_0003206) (acquired hemangioma), [MONDO:0005864](http://purl.obolibrary.org/obo/MONDO_0005864) (muscle cancer), [MONDO:0004533](http://purl.obolibrary.org/obo/MONDO_0004533) (perineural angioma), [MONDO:0003200](http://purl.obolibrary.org/obo/MONDO_0003200) (urethra adenocarcinoma), [MONDO:0005865](http://purl.obolibrary.org/obo/MONDO_0005865) (mushroom workers' lung), [MONDO:0004531](http://purl.obolibrary.org/obo/MONDO_0004531) (sclerosing adenosis of breast), [MONDO:0004532](http://purl.obolibrary.org/obo/MONDO_0004532) (auditory system cancer), [MONDO:0003202](http://purl.obolibrary.org/obo/MONDO_0003202) (pituitary gland basophilic carcinoma), [MONDO:0004530](http://purl.obolibrary.org/obo/MONDO_0004530) (early invasive cervical adenocarcinoma), [MONDO:0016529](http://purl.obolibrary.org/obo/MONDO_0016529) (duplication of urethra), [MONDO:0016526](http://purl.obolibrary.org/obo/MONDO_0016526) (trisomy 9p), [MONDO:0016525](http://purl.obolibrary.org/obo/MONDO_0016525) (familial hyperaldosteronism), [MONDO:0016527](http://purl.obolibrary.org/obo/MONDO_0016527) (glycogen storage disease due to lactate dehydrogenase deficiency), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0017842](http://purl.obolibrary.org/obo/MONDO_0017842) (Senior-Loken syndrome), [MONDO:0017841](http://purl.obolibrary.org/obo/MONDO_0017841) (autoimmune disease with skin involvement), [MONDO:0016510](http://purl.obolibrary.org/obo/MONDO_0016510) (epibulbar lipodermoid-preauricular appendage-polythelia syndrome), [MONDO:0017844](http://purl.obolibrary.org/obo/MONDO_0017844) (Sezary syndrome), [MONDO:0016513](http://purl.obolibrary.org/obo/MONDO_0016513) (alpha-thalassemia-related diseases), [MONDO:0016512](http://purl.obolibrary.org/obo/MONDO_0016512) (Kabuki syndrome), [MONDO:0017843](http://purl.obolibrary.org/obo/MONDO_0017843) (congenital pulmonary sequestration), [MONDO:0017840](http://purl.obolibrary.org/obo/MONDO_0017840) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form), [MONDO:0003219](http://purl.obolibrary.org/obo/MONDO_0003219) (gastroesophageal junction adenocarcinoma), [MONDO:0003216](http://purl.obolibrary.org/obo/MONDO_0003216) (ureter adenocarcinoma), [MONDO:0005879](http://purl.obolibrary.org/obo/MONDO_0005879) (ocular toxoplasmosis), [MONDO:0004548](http://purl.obolibrary.org/obo/MONDO_0004548) (adult type testicular granulosa cell tumor), [MONDO:0003215](http://purl.obolibrary.org/obo/MONDO_0003215) (apocrine sweat gland cancer), [MONDO:0003218](http://purl.obolibrary.org/obo/MONDO_0003218) (adenocarcinoma in situ), [MONDO:0004546](http://purl.obolibrary.org/obo/MONDO_0004546) (lumbar plexus neoplasm), [MONDO:0004547](http://purl.obolibrary.org/obo/MONDO_0004547) (reticular pattern testicular yolk sac tumor), [MONDO:0005878](http://purl.obolibrary.org/obo/MONDO_0005878) (ocular onchocerciasis), [MONDO:0003212](http://purl.obolibrary.org/obo/MONDO_0003212) (nasal cavity carcinoma), [MONDO:0004544](http://purl.obolibrary.org/obo/MONDO_0004544) (chordoid meningioma), [MONDO:0003211](http://purl.obolibrary.org/obo/MONDO_0003211) (nasal cavity adenocarcinoma), [MONDO:0004545](http://purl.obolibrary.org/obo/MONDO_0004545) (adult malignant schwannoma), [MONDO:0004542](http://purl.obolibrary.org/obo/MONDO_0004542) (glassy cell variant cervical adenosquamous carcinoma), [MONDO:0003214](http://purl.obolibrary.org/obo/MONDO_0003214) (apocrine adenocarcinoma), [MONDO:0004543](http://purl.obolibrary.org/obo/MONDO_0004543) (enteric pattern testicular yolk sac tumor), [MONDO:0004540](http://purl.obolibrary.org/obo/MONDO_0004540) (epithelioid malignant peripheral nerve sheath tumor), [MONDO:0004541](http://purl.obolibrary.org/obo/MONDO_0004541) (pseudoglandular variant testicular seminoma), [MONDO:0005872](http://purl.obolibrary.org/obo/MONDO_0005872) (nervous system cancer), [MONDO:0003210](http://purl.obolibrary.org/obo/MONDO_0003210) (intrahepatic cholangiocarcinoma), [MONDO:0016515](http://purl.obolibrary.org/obo/MONDO_0016515) (Kallmann syndrome-heart disease syndrome), [MONDO:0016516](http://purl.obolibrary.org/obo/MONDO_0016516) (Kenny-Caffey syndrome), [MONDO:0017831](http://purl.obolibrary.org/obo/MONDO_0017831) (mild Canavan disease), [MONDO:0017830](http://purl.obolibrary.org/obo/MONDO_0017830) (severe Canavan disease), [MONDO:0016502](http://purl.obolibrary.org/obo/MONDO_0016502) (Hermansky-Pudlak syndrome without pulmonary fibrosis), [MONDO:0017833](http://purl.obolibrary.org/obo/MONDO_0017833) (primary hypereosinophilic syndrome), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0004519](http://purl.obolibrary.org/obo/MONDO_0004519) (synovial angioma), [MONDO:0005849](http://purl.obolibrary.org/obo/MONDO_0005849) (milk allergic reaction), [MONDO:0004518](http://purl.obolibrary.org/obo/MONDO_0004518) (anterior urethra cancer), [MONDO:0004515](http://purl.obolibrary.org/obo/MONDO_0004515) (olfactory neural tumor), [MONDO:0004516](http://purl.obolibrary.org/obo/MONDO_0004516) (bulbomembranous urethral cancer), [MONDO:0005844](http://purl.obolibrary.org/obo/MONDO_0005844) (meibomian cyst), [MONDO:0004513](http://purl.obolibrary.org/obo/MONDO_0004513) (adult pleomorphic rhabdomyosarcoma), [MONDO:0004511](http://purl.obolibrary.org/obo/MONDO_0004511) (lower clivus meningioma), [MONDO:0005843](http://purl.obolibrary.org/obo/MONDO_0005843) (mediastinal cancer), [MONDO:0004512](http://purl.obolibrary.org/obo/MONDO_0004512) (meningeal melanomatosis), [MONDO:0005841](http://purl.obolibrary.org/obo/MONDO_0005841) (maxillary neoplasm), [MONDO:0004510](http://purl.obolibrary.org/obo/MONDO_0004510) (inflammatory liposarcoma), [MONDO:0017839](http://purl.obolibrary.org/obo/MONDO_0017839) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form), [MONDO:0016508](http://purl.obolibrary.org/obo/MONDO_0016508) (rare non surgically correctable form of primary aldosteronism), [MONDO:0017838](http://purl.obolibrary.org/obo/MONDO_0017838) (sclerosteosis), [MONDO:0016507](http://purl.obolibrary.org/obo/MONDO_0016507) (rare surgically correctable form of primary aldosteronism), [MONDO:0016509](http://purl.obolibrary.org/obo/MONDO_0016509) (microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome), [MONDO:0017835](http://purl.obolibrary.org/obo/MONDO_0017835) (lymphocytic hypereosinophilic syndrome), [MONDO:0016504](http://purl.obolibrary.org/obo/MONDO_0016504) (primary unilateral adrenal hyperplasia), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0016506](http://purl.obolibrary.org/obo/MONDO_0016506) (ectopic aldosterone-producing tumor), [MONDO:0017837](http://purl.obolibrary.org/obo/MONDO_0017837) (multiple sclerosis-ichthyosis-factor VIII deficiency syndrome), [MONDO:0016505](http://purl.obolibrary.org/obo/MONDO_0016505) (adrenocortical carcinoma with pure aldosterone hypersecretion), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0004528](http://purl.obolibrary.org/obo/MONDO_0004528) (lymph node palisaded myofibroblastoma), [MONDO:0004529](http://purl.obolibrary.org/obo/MONDO_0004529) (nonossifying fibromyxoid tumor), [MONDO:0004526](http://purl.obolibrary.org/obo/MONDO_0004526) (mixed endometrial stromal and smooth muscle tumor), [MONDO:0004527](http://purl.obolibrary.org/obo/MONDO_0004527) (congenital granular cell tumor), [MONDO:0005858](http://purl.obolibrary.org/obo/MONDO_0005858) (mucinous cystadenocarcinoma), [MONDO:0004524](http://purl.obolibrary.org/obo/MONDO_0004524) (atypical follicular adenoma), [MONDO:0005853](http://purl.obolibrary.org/obo/MONDO_0005853) (malignant mixed neoplasm), [MONDO:0004523](http://purl.obolibrary.org/obo/MONDO_0004523) (clear cell squamous cell skin carcinoma), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0004520](http://purl.obolibrary.org/obo/MONDO_0004520) (intratubular embryonal carcinoma), [MONDO:0004521](http://purl.obolibrary.org/obo/MONDO_0004521) (adult epithelioid sarcoma), [MONDO:0017827](http://purl.obolibrary.org/obo/MONDO_0017827) (malignant peripheral nerve sheath tumor), [MONDO:0017829](http://purl.obolibrary.org/obo/MONDO_0017829) (autosomal dominant proximal renal tubular acidosis), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), [MONDO:0015234](http://purl.obolibrary.org/obo/MONDO_0015234) (arachnodactyly-abnormal ossification-intellectual disability syndrome), [MONDO:0017896](http://purl.obolibrary.org/obo/MONDO_0017896) (familial nonmedullary thyroid carcinoma), [MONDO:0016565](http://purl.obolibrary.org/obo/MONDO_0016565) (syndromic obesity), [MONDO:0015235](http://purl.obolibrary.org/obo/MONDO_0015235) (arachnodactyly-intellectual disability-dysmorphism syndrome), [MONDO:0016568](http://purl.obolibrary.org/obo/MONDO_0016568) (Lowe-Kohn-Cohen syndrome), [MONDO:0015230](http://purl.obolibrary.org/obo/MONDO_0015230) (anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome), [MONDO:0016562](http://purl.obolibrary.org/obo/MONDO_0016562) (progressive supranuclear palsy-pure akinesia with gait freezing syndrome), [MONDO:0017893](http://purl.obolibrary.org/obo/MONDO_0017893) (inherited acute myeloid leukemia), [MONDO:0017892](http://purl.obolibrary.org/obo/MONDO_0017892) (autosomal recessive myogenic arthrogryposis multiplex congenita), [MONDO:0015231](http://purl.obolibrary.org/obo/MONDO_0015231) (Bartter syndrome), [MONDO:0015232](http://purl.obolibrary.org/obo/MONDO_0015232) (radial deficiency-tibial hypoplasia syndrome), [MONDO:0016564](http://purl.obolibrary.org/obo/MONDO_0016564) (progressive supranuclear palsy-progressive non-fluent aphasia syndrome), [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), [MONDO:0016563](http://purl.obolibrary.org/obo/MONDO_0016563) (progressive supranuclear palsy-corticobasal syndrome), [MONDO:0017894](http://purl.obolibrary.org/obo/MONDO_0017894) (acute myeloid leukemia with CEBPA somatic mutations), [MONDO:0015233](http://purl.obolibrary.org/obo/MONDO_0015233) (caudal appendage-deafness syndrome), [MONDO:0016560](http://purl.obolibrary.org/obo/MONDO_0016560) (ptosis-syndactyly-learning difficulties syndrome), [MONDO:0017891](http://purl.obolibrary.org/obo/MONDO_0017891) (inherited renal cancer-predisposing syndrome), [MONDO:0017890](http://purl.obolibrary.org/obo/MONDO_0017890) (tubulocystic renal cell carcinoma), [MONDO:0003249](http://purl.obolibrary.org/obo/MONDO_0003249) (pineal gland cancer), [MONDO:0003248](http://purl.obolibrary.org/obo/MONDO_0003248) (adult pineal parenchymal tumor), [MONDO:0004579](http://purl.obolibrary.org/obo/MONDO_0004579) (retinoschisis), [MONDO:0003245](http://purl.obolibrary.org/obo/MONDO_0003245) (aflatoxins-related hepatocellular carcinoma), [MONDO:0004577](http://purl.obolibrary.org/obo/MONDO_0004577) (corneal ulcer), [MONDO:0003244](http://purl.obolibrary.org/obo/MONDO_0003244) (central nervous system mesenchymal non-meningothelial tumor), [MONDO:0004578](http://purl.obolibrary.org/obo/MONDO_0004578) (flat retinoschisis), [MONDO:0004575](http://purl.obolibrary.org/obo/MONDO_0004575) (choline deficiency disease), [MONDO:0003246](http://purl.obolibrary.org/obo/MONDO_0003246) (sclerosing hepatic carcinoma), [MONDO:0003241](http://purl.obolibrary.org/obo/MONDO_0003241) (central nervous system hemangioma), [MONDO:0004573](http://purl.obolibrary.org/obo/MONDO_0004573) (ariboflavinosis), [MONDO:0004574](http://purl.obolibrary.org/obo/MONDO_0004574) (pyridoxine deficiency anemia), [MONDO:0003243](http://purl.obolibrary.org/obo/MONDO_0003243) (hepatocellular clear cell carcinoma), [MONDO:0015238](http://purl.obolibrary.org/obo/MONDO_0015238) (Arrhinia-choanal atresia-microphthalmia syndrome), [MONDO:0015223](http://purl.obolibrary.org/obo/MONDO_0015223) (rare anemia), [MONDO:0017886](http://purl.obolibrary.org/obo/MONDO_0017886) (MiT family translocation renal cell carcinoma), [MONDO:0017885](http://purl.obolibrary.org/obo/MONDO_0017885) (chromophobe renal cell carcinoma), [MONDO:0015225](http://purl.obolibrary.org/obo/MONDO_0015225) (arthrogryposis syndrome), [MONDO:0017888](http://purl.obolibrary.org/obo/MONDO_0017888) (renal medullary carcinoma), [MONDO:0017887](http://purl.obolibrary.org/obo/MONDO_0017887) (renal cell carcinoma associated with neuroblastoma), [MONDO:0016551](http://purl.obolibrary.org/obo/MONDO_0016551) (congenital primary megaureter, refluxing form), [MONDO:0016550](http://purl.obolibrary.org/obo/MONDO_0016550) (congenital primary megaureter, obstructed form), [MONDO:0016553](http://purl.obolibrary.org/obo/MONDO_0016553) (isolated congenital hypogonadotropic hypogonadism), [MONDO:0015221](http://purl.obolibrary.org/obo/MONDO_0015221) (non-syndromic respiratory or mediastinal malformation), [MONDO:0017884](http://purl.obolibrary.org/obo/MONDO_0017884) (papillary renal cell carcinoma), [MONDO:0016552](http://purl.obolibrary.org/obo/MONDO_0016552) (congenital primary megaureter, nonrefluxing and unobstructed form), [MONDO:0003256](http://purl.obolibrary.org/obo/MONDO_0003256) (neurohypophysis granular cell tumor), [MONDO:0004588](http://purl.obolibrary.org/obo/MONDO_0004588) (night blindness), [MONDO:0004589](http://purl.obolibrary.org/obo/MONDO_0004589) (hereditary retinal dystrophy), [MONDO:0003255](http://purl.obolibrary.org/obo/MONDO_0003255) (mediastinal granular cell myoblastoma), [MONDO:0004586](http://purl.obolibrary.org/obo/MONDO_0004586) (rheumatoid lung disease), [MONDO:0003258](http://purl.obolibrary.org/obo/MONDO_0003258) (hobnail hemangioma), [MONDO:0003257](http://purl.obolibrary.org/obo/MONDO_0003257) (posterior pituitary gland neoplasm), [MONDO:0004587](http://purl.obolibrary.org/obo/MONDO_0004587) (hereditary night blindness), [MONDO:0003252](http://purl.obolibrary.org/obo/MONDO_0003252) (granular cell cancer), [MONDO:0003251](http://purl.obolibrary.org/obo/MONDO_0003251) (esophageal granular cell tumor), [MONDO:0004582](http://purl.obolibrary.org/obo/MONDO_0004582) (rheumatic myocarditis), [MONDO:0003254](http://purl.obolibrary.org/obo/MONDO_0003254) (cardiac granular cell neoplasm), [MONDO:0003253](http://purl.obolibrary.org/obo/MONDO_0003253) (vulvar granular cell tumor), [MONDO:0004583](http://purl.obolibrary.org/obo/MONDO_0004583) (transient retinal arterial occlusion), [MONDO:0004580](http://purl.obolibrary.org/obo/MONDO_0004580) (retinal degeneration), [MONDO:0003250](http://purl.obolibrary.org/obo/MONDO_0003250) (benign granular cell tumor), [MONDO:0015227](http://purl.obolibrary.org/obo/MONDO_0015227) (non-syndromic limb malformation), [MONDO:0016559](http://purl.obolibrary.org/obo/MONDO_0016559) (glaucoma secondary to spherophakia/ectopia lentis and megalocornea), [MONDO:0015229](http://purl.obolibrary.org/obo/MONDO_0015229) (Bardet-Biedl syndrome), [MONDO:0015212](http://purl.obolibrary.org/obo/MONDO_0015212) (syndromic intestinal malformation), [MONDO:0016544](http://purl.obolibrary.org/obo/MONDO_0016544) (IgG4-related mesenteritis), [MONDO:0015213](http://purl.obolibrary.org/obo/MONDO_0015213) (non-syndromic visceral malformation), [MONDO:0016543](http://purl.obolibrary.org/obo/MONDO_0016543) (hyperphenylalaninemia), [MONDO:0015214](http://purl.obolibrary.org/obo/MONDO_0015214) (syndromic visceral malformation), [MONDO:0017871](http://purl.obolibrary.org/obo/MONDO_0017871) (bilateral massive adrenal hemorrhage), [MONDO:0016542](http://purl.obolibrary.org/obo/MONDO_0016542) (immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome), [MONDO:0015210](http://purl.obolibrary.org/obo/MONDO_0015210) (syndromic gastroduodenal malformation), [MONDO:0015211](http://purl.obolibrary.org/obo/MONDO_0015211) (non-syndromic intestinal malformation), [MONDO:0004559](http://purl.obolibrary.org/obo/MONDO_0004559) (malignant glandular tumor of peripheral nerve sheath), [MONDO:0004557](http://purl.obolibrary.org/obo/MONDO_0004557) (congenital fibrosarcoma), [MONDO:0004558](http://purl.obolibrary.org/obo/MONDO_0004558) (thyroid gland macrofollicular adenoma), [MONDO:0003223](http://purl.obolibrary.org/obo/MONDO_0003223) (meninges hemangiopericytoma), [MONDO:0004555](http://purl.obolibrary.org/obo/MONDO_0004555) (kidney angiomyolipoma), [MONDO:0003222](http://purl.obolibrary.org/obo/MONDO_0003222) (central nervous system melanocytic neoplasm), [MONDO:0004556](http://purl.obolibrary.org/obo/MONDO_0004556) (carcinoma arising in nasal papillomatosis), [MONDO:0005885](http://purl.obolibrary.org/obo/MONDO_0005885) (optic neuritis), [MONDO:0004554](http://purl.obolibrary.org/obo/MONDO_0004554) (childhood kidney angiomyolipoma), [MONDO:0004552](http://purl.obolibrary.org/obo/MONDO_0004552) (microinvasive cervical squamous cell carcinoma), [MONDO:0003221](http://purl.obolibrary.org/obo/MONDO_0003221) (sclerosing hemangioma), [MONDO:0003220](http://purl.obolibrary.org/obo/MONDO_0003220) (gallbladder carcinoma), [MONDO:0004550](http://purl.obolibrary.org/obo/MONDO_0004550) (malignant cornea melanoma), [MONDO:0015217](http://purl.obolibrary.org/obo/MONDO_0015217) (non-syndromic developmental defect of the eye), [MONDO:0016547](http://purl.obolibrary.org/obo/MONDO_0016547) (Beckwith-Wiedemann syndrome due to NSD1 mutation), [MONDO:0015218](http://purl.obolibrary.org/obo/MONDO_0015218) (syndromic developmental defect of the eye), [MONDO:0016549](http://purl.obolibrary.org/obo/MONDO_0016549) (primary megaureter, adult-onset form), [MONDO:0015201](http://purl.obolibrary.org/obo/MONDO_0015201) (ankyloblepharon filiforme-imperforate anus syndrome), [MONDO:0016533](http://purl.obolibrary.org/obo/MONDO_0016533) (apolipoprotein A-II amyloidosis), [MONDO:0016535](http://purl.obolibrary.org/obo/MONDO_0016535) (hypohidrotic ectodermal dysplasia), [MONDO:0015204](http://purl.obolibrary.org/obo/MONDO_0015204) (Microlissencephaly), [MONDO:0016534](http://purl.obolibrary.org/obo/MONDO_0016534) (infundibulo-neurohypophysitis), [MONDO:0016531](http://purl.obolibrary.org/obo/MONDO_0016531) (digestive duplication), [MONDO:0003238](http://purl.obolibrary.org/obo/MONDO_0003238) (cervical adenomyoma), [MONDO:0003237](http://purl.obolibrary.org/obo/MONDO_0003237) (adenomyoma of uterine corpus), [MONDO:0003234](http://purl.obolibrary.org/obo/MONDO_0003234) (optic nerve astrocytoma), [MONDO:0003236](http://purl.obolibrary.org/obo/MONDO_0003236) (atypical polypoid adenomyoma), [MONDO:0003235](http://purl.obolibrary.org/obo/MONDO_0003235) (optic nerve glioma), [MONDO:0005893](http://purl.obolibrary.org/obo/MONDO_0005893) (pancreatic endocrine carcinoma), [MONDO:0004562](http://purl.obolibrary.org/obo/MONDO_0004562) (breast apocrine carcinoma in situ), [MONDO:0004560](http://purl.obolibrary.org/obo/MONDO_0004560) (follicular infundibulum tumor), [MONDO:0004561](http://purl.obolibrary.org/obo/MONDO_0004561) (retinal melanoma), [MONDO:0003231](http://purl.obolibrary.org/obo/MONDO_0003231) (nonparalytic poliomyelitis), [MONDO:0015209](http://purl.obolibrary.org/obo/MONDO_0015209) (non-syndromic gastroduodenal malformation), [MONDO:0005890](http://purl.obolibrary.org/obo/MONDO_0005890) (osteitis fibrosa), [MONDO:0016537](http://purl.obolibrary.org/obo/MONDO_0016537) (lymphoproliferative syndrome), [MONDO:0017868](http://purl.obolibrary.org/obo/MONDO_0017868) (diencephalic-mesencephalic junction dysplasia), [MONDO:0015205](http://purl.obolibrary.org/obo/MONDO_0015205) (isolated lissencephaly type 1 without known genetic defects), [MONDO:0015206](http://purl.obolibrary.org/obo/MONDO_0015206) (short stature-heart defect-craniofacial anomalies syndrome), [MONDO:0017867](http://purl.obolibrary.org/obo/MONDO_0017867) (distal 17p13.1 microdeletion syndrome), [MONDO:0016536](http://purl.obolibrary.org/obo/MONDO_0016536) (autosomal recessive lymphoproliferative disease), [MONDO:0015207](http://purl.obolibrary.org/obo/MONDO_0015207) (non-syndromic esophageal malformation), [MONDO:0016539](http://purl.obolibrary.org/obo/MONDO_0016539) (atypical hypotonia-cystinuria syndrome), [MONDO:0015208](http://purl.obolibrary.org/obo/MONDO_0015208) (syndromic esophageal malformation), [MONDO:0016538](http://purl.obolibrary.org/obo/MONDO_0016538) (hypotonia-cystinuria syndrome type 1), [MONDO:0017869](http://purl.obolibrary.org/obo/MONDO_0017869) (chondroectodermal dysplasia with night blindness), [MONDO:0015278](http://purl.obolibrary.org/obo/MONDO_0015278) (familial pancreatic carcinoma), [MONDO:0015277](http://purl.obolibrary.org/obo/MONDO_0015277) (medullary thyroid gland carcinoma), [MONDO:0015270](http://purl.obolibrary.org/obo/MONDO_0015270) (Butyrylcholinesterase deficiency), [MONDO:0015271](http://purl.obolibrary.org/obo/MONDO_0015271) (idiopathic camptocormia), [MONDO:0015272](http://purl.obolibrary.org/obo/MONDO_0015272) (camptodactyly-taurinuria syndrome), [MONDO:0015273](http://purl.obolibrary.org/obo/MONDO_0015273) (complete atrioventricular canal), [MONDO:0003289](http://purl.obolibrary.org/obo/MONDO_0003289) (deep leiomyoma), [MONDO:0003288](http://purl.obolibrary.org/obo/MONDO_0003288) (bizarre leiomyoma), [MONDO:0003285](http://purl.obolibrary.org/obo/MONDO_0003285) (fallopian tube leiomyoma), [MONDO:0003284](http://purl.obolibrary.org/obo/MONDO_0003284) (mediastinum leiomyoma), [MONDO:0003287](http://purl.obolibrary.org/obo/MONDO_0003287) (central nervous system leiomyoma), [MONDO:0003286](http://purl.obolibrary.org/obo/MONDO_0003286) (extrahepatic bile duct leiomyoma), [MONDO:0003281](http://purl.obolibrary.org/obo/MONDO_0003281) (ovarian cystic teratoma), [MONDO:0003280](http://purl.obolibrary.org/obo/MONDO_0003280) (swayback), [MONDO:0003283](http://purl.obolibrary.org/obo/MONDO_0003283) (epididymal neoplasm), [MONDO:0015267](http://purl.obolibrary.org/obo/MONDO_0015267) (Feingold syndrome), [MONDO:0015268](http://purl.obolibrary.org/obo/MONDO_0015268) (medullary sponge kidney), [MONDO:0015263](http://purl.obolibrary.org/obo/MONDO_0015263) (Brugada syndrome), [MONDO:0016596](http://purl.obolibrary.org/obo/MONDO_0016596) (hyperphosphatasia-intellectual disability syndrome), [MONDO:0015262](http://purl.obolibrary.org/obo/MONDO_0015262) (brachyolmia), [MONDO:0003299](http://purl.obolibrary.org/obo/MONDO_0003299) (colorectal leiomyoma), [MONDO:0003296](http://purl.obolibrary.org/obo/MONDO_0003296) (cellular leiomyoma), [MONDO:0003295](http://purl.obolibrary.org/obo/MONDO_0003295) (leiomyomatosis), [MONDO:0003298](http://purl.obolibrary.org/obo/MONDO_0003298) (vulvar leiomyoma), [MONDO:0003297](http://purl.obolibrary.org/obo/MONDO_0003297) (gallbladder leiomyoma), [MONDO:0003292](http://purl.obolibrary.org/obo/MONDO_0003292) (anus leiomyoma), [MONDO:0003291](http://purl.obolibrary.org/obo/MONDO_0003291) (leiomyoma cutis), [MONDO:0003294](http://purl.obolibrary.org/obo/MONDO_0003294) (pericardium leiomyoma), [MONDO:0003293](http://purl.obolibrary.org/obo/MONDO_0003293) (lung leiomyoma), [MONDO:0015256](http://purl.obolibrary.org/obo/MONDO_0015256) (blepharoptosis-cleft palate-ectrodactyly-dental anomalies syndrome), [MONDO:0015257](http://purl.obolibrary.org/obo/MONDO_0015257) (Sino-auricular heart block), [MONDO:0015259](http://purl.obolibrary.org/obo/MONDO_0015259) (brachydactyly-mesomelia-intellectual disability-heart defects syndrome), [MONDO:0016589](http://purl.obolibrary.org/obo/MONDO_0016589) (progressive cerebello-cerebral atrophy), [MONDO:0015252](http://purl.obolibrary.org/obo/MONDO_0015252) (severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome), [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0015253](http://purl.obolibrary.org/obo/MONDO_0015253) (Diamond-Blackfan anemia), [MONDO:0016583](http://purl.obolibrary.org/obo/MONDO_0016583) (familial intestinal malrotation-facial anomalies syndrome), [MONDO:0016586](http://purl.obolibrary.org/obo/MONDO_0016586) (systemic mastocytosis), [MONDO:0015255](http://purl.obolibrary.org/obo/MONDO_0015255) (blepharophimosis-radioulnar synostosis syndrome), [MONDO:0016580](http://purl.obolibrary.org/obo/MONDO_0016580) (congenital pulmonary airway malformation), [MONDO:0015250](http://purl.obolibrary.org/obo/MONDO_0015250) (spinal atrophy-ophthalmoplegia-pyramidal syndrome), [MONDO:0003266](http://purl.obolibrary.org/obo/MONDO_0003266) (ependymal tumor), [MONDO:0004597](http://purl.obolibrary.org/obo/MONDO_0004597) (pulmonary embolism and infarction), [MONDO:0004598](http://purl.obolibrary.org/obo/MONDO_0004598) (acute cor pulmonale), [MONDO:0003268](http://purl.obolibrary.org/obo/MONDO_0003268) (mixed glioma), [MONDO:0003263](http://purl.obolibrary.org/obo/MONDO_0003263) (childhood cerebellar neoplasm), [MONDO:0004595](http://purl.obolibrary.org/obo/MONDO_0004595) (acute pulmonary heart disease), [MONDO:0003262](http://purl.obolibrary.org/obo/MONDO_0003262) (rhabdoid meningioma), [MONDO:0004596](http://purl.obolibrary.org/obo/MONDO_0004596) (cor pulmonale), [MONDO:0003264](http://purl.obolibrary.org/obo/MONDO_0003264) (basosquamous carcinoma), [MONDO:0003261](http://purl.obolibrary.org/obo/MONDO_0003261) (papillary meningioma of the cerebellum), [MONDO:0003260](http://purl.obolibrary.org/obo/MONDO_0003260) (adult cerebellar neoplasm), [MONDO:0016577](http://purl.obolibrary.org/obo/MONDO_0016577) (biliary atresia with splenic malformation syndrome), [MONDO:0015246](http://purl.obolibrary.org/obo/MONDO_0015246) (syndromic anorectal malformation), [MONDO:0016576](http://purl.obolibrary.org/obo/MONDO_0016576) (split hand-foot malformation), [MONDO:0015247](http://purl.obolibrary.org/obo/MONDO_0015247) (Opsoclonus-myoclonus syndrome), [MONDO:0016579](http://purl.obolibrary.org/obo/MONDO_0016579) (dominant hypophosphatemia with nephrolithiasis or osteoporosis), [MONDO:0016578](http://purl.obolibrary.org/obo/MONDO_0016578) (mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies), [MONDO:0015248](http://purl.obolibrary.org/obo/MONDO_0015248) (ataxia-photosensitivity-short stature syndrome), [MONDO:0015241](http://purl.obolibrary.org/obo/MONDO_0015241) (arthrogryposis-like syndrome), [MONDO:0016572](http://purl.obolibrary.org/obo/MONDO_0016572) (central bilateral macrogyria), [MONDO:0016575](http://purl.obolibrary.org/obo/MONDO_0016575) (primary ciliary dyskinesia), [MONDO:0015243](http://purl.obolibrary.org/obo/MONDO_0015243) (allergic bronchopulmonary aspergillosis), [MONDO:0016574](http://purl.obolibrary.org/obo/MONDO_0016574) (Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome), [MONDO:0015244](http://purl.obolibrary.org/obo/MONDO_0015244) (autosomal recessive cerebellar ataxia), [MONDO:0016571](http://purl.obolibrary.org/obo/MONDO_0016571) (macrocephaly-short stature-paraplegia syndrome), [MONDO:0016570](http://purl.obolibrary.org/obo/MONDO_0016570) (primary pulmonary lymphoma), [MONDO:0015240](http://purl.obolibrary.org/obo/MONDO_0015240) (digitotalar dysmorphism), [MONDO:0003278](http://purl.obolibrary.org/obo/MONDO_0003278) (inner ear cancer), [MONDO:0003277](http://purl.obolibrary.org/obo/MONDO_0003277) (malignant ear neoplasm), [MONDO:0003274](http://purl.obolibrary.org/obo/MONDO_0003274) (thoracic cancer), [MONDO:0003273](http://purl.obolibrary.org/obo/MONDO_0003273) (sternum cancer), [MONDO:0003275](http://purl.obolibrary.org/obo/MONDO_0003275) (middle ear cancer), [MONDO:0003272](http://purl.obolibrary.org/obo/MONDO_0003272) (mixed epithelial stromal tumour), [MONDO:0017497](http://purl.obolibrary.org/obo/MONDO_0017497) (congenital absence of thigh and lower leg with foot present, bilateral), [MONDO:0017496](http://purl.obolibrary.org/obo/MONDO_0017496) (congenital absence of thigh and lower leg with foot present, unilateral), [MONDO:0017499](http://purl.obolibrary.org/obo/MONDO_0017499) (congenital absence of both forearm and hand, bilateral), [MONDO:0016167](http://purl.obolibrary.org/obo/MONDO_0016167) (optic pathway glioma), [MONDO:0017498](http://purl.obolibrary.org/obo/MONDO_0017498) (congenital absence of both forearm and hand, unilateral), [MONDO:0017493](http://purl.obolibrary.org/obo/MONDO_0017493) (fibular hemimelia, bilateral), [MONDO:0016162](http://purl.obolibrary.org/obo/MONDO_0016162) (bilateral frontal polymicrogyria), [MONDO:0017492](http://purl.obolibrary.org/obo/MONDO_0017492) (fibular hemimelia, unilateral), [MONDO:0017495](http://purl.obolibrary.org/obo/MONDO_0017495) (congenital absence of upper arm and forearm with hand present, bilateral), [MONDO:0016164](http://purl.obolibrary.org/obo/MONDO_0016164) (Herpetiform pemphigus), [MONDO:0017494](http://purl.obolibrary.org/obo/MONDO_0017494) (congenital absence of upper arm and forearm with hand present, unilateral), [MONDO:0016163](http://purl.obolibrary.org/obo/MONDO_0016163) (autosomal dominant cerebellar ataxia type 2), [MONDO:0017491](http://purl.obolibrary.org/obo/MONDO_0017491) (tibial hemimelia, bilateral), [MONDO:0017490](http://purl.obolibrary.org/obo/MONDO_0017490) (tibial hemimelia, unilateral), [MONDO:0004177](http://purl.obolibrary.org/obo/MONDO_0004177) (benign urethral neoplasm), [MONDO:0004178](http://purl.obolibrary.org/obo/MONDO_0004178) (testicular yolk sac tumor, endodermal sinus pattern), [MONDO:0004175](http://purl.obolibrary.org/obo/MONDO_0004175) (mucin-rich endometrial endometrioid adenocarcinoma), [MONDO:0004176](http://purl.obolibrary.org/obo/MONDO_0004176) (childhood extraosseous osteosarcoma), [MONDO:0004173](http://purl.obolibrary.org/obo/MONDO_0004173) (adenocarcinoma of skene gland origin), [MONDO:0004174](http://purl.obolibrary.org/obo/MONDO_0004174) (secretory uterine corpus endometrioid adenocarcinoma), [MONDO:0004172](http://purl.obolibrary.org/obo/MONDO_0004172) (uterine corpus adenocarcinofibroma), [MONDO:0004170](http://purl.obolibrary.org/obo/MONDO_0004170) (nodular episcleritis), [MONDO:0016159](http://purl.obolibrary.org/obo/MONDO_0016159) (Gemignani syndrome), [MONDO:0016158](http://purl.obolibrary.org/obo/MONDO_0016158) (narcolepsy-cataplexy syndrome), [MONDO:0017489](http://purl.obolibrary.org/obo/MONDO_0017489) (ulnar hemimelia, unilateral), [MONDO:0017486](http://purl.obolibrary.org/obo/MONDO_0017486) (radial hemimelia, unilateral), [MONDO:0016155](http://purl.obolibrary.org/obo/MONDO_0016155) (qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan), [MONDO:0017485](http://purl.obolibrary.org/obo/MONDO_0017485) (femoral agenesis/hypoplasia, bilateral), [MONDO:0016157](http://purl.obolibrary.org/obo/MONDO_0016157) (qualitative or quantitative defects of fukutin), [MONDO:0017488](http://purl.obolibrary.org/obo/MONDO_0017488) (ulnar hemimelia, bilateral), [MONDO:0017487](http://purl.obolibrary.org/obo/MONDO_0017487) (radial hemimelia, bilateral), [MONDO:0016156](http://purl.obolibrary.org/obo/MONDO_0016156) (qualitative or quantitative defects of FKRP), [MONDO:0017482](http://purl.obolibrary.org/obo/MONDO_0017482) (humeral agenesis/hypoplasia, unilateral), [MONDO:0017481](http://purl.obolibrary.org/obo/MONDO_0017481) (amelia of lower limb, bilateral), [MONDO:0017484](http://purl.obolibrary.org/obo/MONDO_0017484) (femoral agenesis/hypoplasia, unilateral), [MONDO:0017483](http://purl.obolibrary.org/obo/MONDO_0017483) (humeral agenesis/hypoplasia, bilateral), [MONDO:0017480](http://purl.obolibrary.org/obo/MONDO_0017480) (amelia of lower limb, unilateral), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0004186](http://purl.obolibrary.org/obo/MONDO_0004186) (cranial nodular fasciitis), [MONDO:0004187](http://purl.obolibrary.org/obo/MONDO_0004187) (nodular fasciitis), [MONDO:0004185](http://purl.obolibrary.org/obo/MONDO_0004185) (ovarian serous cystadenofibroma), [MONDO:0004182](http://purl.obolibrary.org/obo/MONDO_0004182) (stage IVb bladder cancer), [MONDO:0004180](http://purl.obolibrary.org/obo/MONDO_0004180) (benign urinary system neoplasm), [MONDO:0017479](http://purl.obolibrary.org/obo/MONDO_0017479) (amelia of upper limb, bilateral), [MONDO:0017478](http://purl.obolibrary.org/obo/MONDO_0017478) (amelia of upper limb, unilateral), [MONDO:0017475](http://purl.obolibrary.org/obo/MONDO_0017475) (Macrodactyly of toes), [MONDO:0017474](http://purl.obolibrary.org/obo/MONDO_0017474) (Macrodactyly of fingers), [MONDO:0017477](http://purl.obolibrary.org/obo/MONDO_0017477) (lower limb hypertrophy), [MONDO:0017476](http://purl.obolibrary.org/obo/MONDO_0017476) (upper limb hypertrophy), [MONDO:0017471](http://purl.obolibrary.org/obo/MONDO_0017471) (congenital patella dislocation), [MONDO:0017470](http://purl.obolibrary.org/obo/MONDO_0017470) (congenital knee dislocation (disease)), [MONDO:0017473](http://purl.obolibrary.org/obo/MONDO_0017473) (patella aplasia/hypoplasia, bilateral), [MONDO:0017472](http://purl.obolibrary.org/obo/MONDO_0017472) (patella aplasia/hypoplasia, unilateral), [MONDO:0004159](http://purl.obolibrary.org/obo/MONDO_0004159) (pancreatic non-invasive mucinous cystadenocarcinoma), [MONDO:0004158](http://purl.obolibrary.org/obo/MONDO_0004158) (pancreatic invasive mucinous cystadenocarcinoma), [MONDO:0004155](http://purl.obolibrary.org/obo/MONDO_0004155) (adult central nervous system embryonal carcinoma), [MONDO:0004156](http://purl.obolibrary.org/obo/MONDO_0004156) (pancreatic colloid cystadenocarcinoma), [MONDO:0005484](http://purl.obolibrary.org/obo/MONDO_0005484) (colorectal adenoma), [MONDO:0004153](http://purl.obolibrary.org/obo/MONDO_0004153) (pediatric CNS embryonal cell carcinoma), [MONDO:0004151](http://purl.obolibrary.org/obo/MONDO_0004151) (spinal meninges cancer), [MONDO:0004152](http://purl.obolibrary.org/obo/MONDO_0004152) (postgerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma), [MONDO:0004150](http://purl.obolibrary.org/obo/MONDO_0004150) (breast giant fibroadenoma), [MONDO:0017468](http://purl.obolibrary.org/obo/MONDO_0017468) (congenital shoulder dislocation), [MONDO:0017467](http://purl.obolibrary.org/obo/MONDO_0017467) (tibio-fibular synostosis), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0017469](http://purl.obolibrary.org/obo/MONDO_0017469) (congenital elbow dislocation), [MONDO:0017464](http://purl.obolibrary.org/obo/MONDO_0017464) (congenital pseudoarthrosis of the fibula), [MONDO:0018796](http://purl.obolibrary.org/obo/MONDO_0018796) (isolated constitutional thrombocytopenia), [MONDO:0017463](http://purl.obolibrary.org/obo/MONDO_0017463) (congenital pseudoarthrosis of the femur), [MONDO:0018794](http://purl.obolibrary.org/obo/MONDO_0018794) (cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder), [MONDO:0017466](http://purl.obolibrary.org/obo/MONDO_0017466) (congenital pseudoarthrosis of the ulna), [MONDO:0018795](http://purl.obolibrary.org/obo/MONDO_0018795) (syndromic constitutional thrombocytopenia), [MONDO:0017465](http://purl.obolibrary.org/obo/MONDO_0017465) (congenital pseudoarthrosis of the radius), [MONDO:0017460](http://purl.obolibrary.org/obo/MONDO_0017460) (syndactyly type 6), [MONDO:0017462](http://purl.obolibrary.org/obo/MONDO_0017462) (congenital pseudoarthrosis of the tibia), [MONDO:0016131](http://purl.obolibrary.org/obo/MONDO_0016131) (spinal muscular atrophy associated with central nervous system anomaly), [MONDO:0016130](http://purl.obolibrary.org/obo/MONDO_0016130) (fungal myositis), [MONDO:0017461](http://purl.obolibrary.org/obo/MONDO_0017461) (familial isolated clinodactyly of fingers), [MONDO:0005499](http://purl.obolibrary.org/obo/MONDO_0005499) (brain glioma), [MONDO:0004168](http://purl.obolibrary.org/obo/MONDO_0004168) (cribriform variant testicular seminoma), [MONDO:0004166](http://purl.obolibrary.org/obo/MONDO_0004166) (hereditary fallopian tube carcinoma), [MONDO:0005498](http://purl.obolibrary.org/obo/MONDO_0005498) (botulism), [MONDO:0004164](http://purl.obolibrary.org/obo/MONDO_0004164) (lymphoepithelioma-like acinar prostate adenocarcinoma), [MONDO:0005496](http://purl.obolibrary.org/obo/MONDO_0005496) (bile duct carcinoma), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0005494](http://purl.obolibrary.org/obo/MONDO_0005494) (triple-negative breast carcinoma), [MONDO:0004163](http://purl.obolibrary.org/obo/MONDO_0004163) (bladder urachal urothelial carcinoma), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), [MONDO:0016184](http://purl.obolibrary.org/obo/MONDO_0016184) (qualitative or quantitative defects of protein O-mannosyltransferase 1), [MONDO:0016183](http://purl.obolibrary.org/obo/MONDO_0016183) (qualitative or quantitative defects of protein glycosyltransferase-like), [MONDO:0016185](http://purl.obolibrary.org/obo/MONDO_0016185) (qualitative or quantitative defects of protein O-mannosyltransferase 2), [MONDO:0016182](http://purl.obolibrary.org/obo/MONDO_0016182) (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase), [MONDO:0004199](http://purl.obolibrary.org/obo/MONDO_0004199) (vulvar keratinizing squamous cell carcinoma), [MONDO:0004197](http://purl.obolibrary.org/obo/MONDO_0004197) (male urethral cancer), [MONDO:0004198](http://purl.obolibrary.org/obo/MONDO_0004198) (testicular yolk sac tumor, solid pattern), [MONDO:0004196](http://purl.obolibrary.org/obo/MONDO_0004196) (rectal sarcomatoid carcinoma), [MONDO:0004193](http://purl.obolibrary.org/obo/MONDO_0004193) (pediatric ovarian dysgerminoma), [MONDO:0004191](http://purl.obolibrary.org/obo/MONDO_0004191) (nephrogenic adenoma), [MONDO:0004192](http://purl.obolibrary.org/obo/MONDO_0004192) (urethra cancer), [MONDO:0004190](http://purl.obolibrary.org/obo/MONDO_0004190) (nephrogenic adenoma of urinary bladder), [MONDO:0016175](http://purl.obolibrary.org/obo/MONDO_0016175) (cutis laxa), [MONDO:0006806](http://purl.obolibrary.org/obo/MONDO_0006806) (intermediate uveitis (disease)), [MONDO:0006804](http://purl.obolibrary.org/obo/MONDO_0006804) (inflammatory breast carcinoma), [MONDO:0006801](http://purl.obolibrary.org/obo/MONDO_0006801) (ileal neoplasm), [MONDO:0018822](http://purl.obolibrary.org/obo/MONDO_0018822) (global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome), [MONDO:0018823](http://purl.obolibrary.org/obo/MONDO_0018823) (X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome), [MONDO:0018820](http://purl.obolibrary.org/obo/MONDO_0018820) (recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome), [MONDO:0018821](http://purl.obolibrary.org/obo/MONDO_0018821) (X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability), [MONDO:0005509](http://purl.obolibrary.org/obo/MONDO_0005509) (histiocytoma), [MONDO:0005507](http://purl.obolibrary.org/obo/MONDO_0005507) (gingival cancer), [MONDO:0006839](http://purl.obolibrary.org/obo/MONDO_0006839) (Lutembacher's syndrome), [MONDO:0005508](http://purl.obolibrary.org/obo/MONDO_0005508) (hereditary multiple exostoses), [MONDO:0005505](http://purl.obolibrary.org/obo/MONDO_0005505) (dysembryoplastic neuroepithelial tumor), [MONDO:0006837](http://purl.obolibrary.org/obo/MONDO_0006837) (low tension glaucoma), [MONDO:0005506](http://purl.obolibrary.org/obo/MONDO_0005506) (eccrine sweat gland cancer), [MONDO:0006834](http://purl.obolibrary.org/obo/MONDO_0006834) (lip cancer), [MONDO:0005501](http://purl.obolibrary.org/obo/MONDO_0005501) (congenital disorder of glycosylation type II), [MONDO:0006832](http://purl.obolibrary.org/obo/MONDO_0006832) (limited scleroderma), [MONDO:0005500](http://purl.obolibrary.org/obo/MONDO_0005500) (congenital disorder of glycosylation type I), [MONDO:0018829](http://purl.obolibrary.org/obo/MONDO_0018829) (familial schizencephaly), [MONDO:0018826](http://purl.obolibrary.org/obo/MONDO_0018826) (Lewis-Sumner syndrome), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0018825](http://purl.obolibrary.org/obo/MONDO_0018825) (PYCR2-related microcephaly-progressive leukoencephalopathy), [MONDO:0018812](http://purl.obolibrary.org/obo/MONDO_0018812) (MSH3-related attenuated familial adenomatous polyposis), [MONDO:0018810](http://purl.obolibrary.org/obo/MONDO_0018810) (lethal hydranencephaly-diaphragmatic hernia syndrome), [MONDO:0005518](http://purl.obolibrary.org/obo/MONDO_0005518) (pseudohermaphroditism), [MONDO:0005519](http://purl.obolibrary.org/obo/MONDO_0005519) (renal pelvis carcinoma), [MONDO:0006848](http://purl.obolibrary.org/obo/MONDO_0006848) (marasmus), [MONDO:0005517](http://purl.obolibrary.org/obo/MONDO_0005517) (pharynx cancer), [MONDO:0006847](http://purl.obolibrary.org/obo/MONDO_0006847) (malignant lymphatic vessel tumor), [MONDO:0005514](http://purl.obolibrary.org/obo/MONDO_0005514) (nanophthalmia), [MONDO:0005515](http://purl.obolibrary.org/obo/MONDO_0005515) (oral cavity cancer), [MONDO:0006844](http://purl.obolibrary.org/obo/MONDO_0006844) (magnesium deficiency), [MONDO:0005512](http://purl.obolibrary.org/obo/MONDO_0005512) (malignant peritoneal mesothelioma), [MONDO:0005513](http://purl.obolibrary.org/obo/MONDO_0005513) (methylmalonic aciduria and homocystinuria type cblE), [MONDO:0006843](http://purl.obolibrary.org/obo/MONDO_0006843) (macular holes), [MONDO:0006842](http://purl.obolibrary.org/obo/MONDO_0006842) (lymphangiomyoma), [MONDO:0006841](http://purl.obolibrary.org/obo/MONDO_0006841) (lymphangioendothelioma), [MONDO:0005511](http://purl.obolibrary.org/obo/MONDO_0005511) (janus kinase-3 deficiency), [MONDO:0018819](http://purl.obolibrary.org/obo/MONDO_0018819) (fibular aplasia-tibial campomelia-oligosyndactyly syndrome), [MONDO:0018817](http://purl.obolibrary.org/obo/MONDO_0018817) (autosomal recessive limb-girdle muscular dystrophy type 2Z), [MONDO:0018815](http://purl.obolibrary.org/obo/MONDO_0018815) (aneurysmal bone cyst (disease)), [MONDO:0018813](http://purl.obolibrary.org/obo/MONDO_0018813) (high grade b-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement), [MONDO:0018814](http://purl.obolibrary.org/obo/MONDO_0018814) (non-severe combined immunodeficiency), [MONDO:0018800](http://purl.obolibrary.org/obo/MONDO_0018800) (Kallmann syndrome), [MONDO:0006818](http://purl.obolibrary.org/obo/MONDO_0006818) (keratoconjunctivitis sicca), [MONDO:0006817](http://purl.obolibrary.org/obo/MONDO_0006817) (juxtacortical osteosarcoma), [MONDO:0006815](http://purl.obolibrary.org/obo/MONDO_0006815) (jejunal cancer), [MONDO:0006814](http://purl.obolibrary.org/obo/MONDO_0006814) (iritis (disease)), [MONDO:0006813](http://purl.obolibrary.org/obo/MONDO_0006813) (intradermal nevus), [MONDO:0018804](http://purl.obolibrary.org/obo/MONDO_0018804) (MYO5B-related progressive familial intrahepatic cholestasis), [MONDO:0018802](http://purl.obolibrary.org/obo/MONDO_0018802) (progressive familial intrahepatic cholestasis type 5), [MONDO:0018803](http://purl.obolibrary.org/obo/MONDO_0018803) (progressive familial intrahepatic cholestasis type 4), [MONDO:0006829](http://purl.obolibrary.org/obo/MONDO_0006829) (leukemoid reaction), [MONDO:0006828](http://purl.obolibrary.org/obo/MONDO_0006828) (lethal midline granuloma), [MONDO:0006826](http://purl.obolibrary.org/obo/MONDO_0006826) (kwashiorkor), [MONDO:0006824](http://purl.obolibrary.org/obo/MONDO_0006824) (krebs 2 carcinoma), [MONDO:0006823](http://purl.obolibrary.org/obo/MONDO_0006823) (Klinefelter's syndrome), [MONDO:0018866](http://purl.obolibrary.org/obo/MONDO_0018866) (Aicardi-Goutieres syndrome), [MONDO:0016203](http://purl.obolibrary.org/obo/MONDO_0016203) (hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency), [MONDO:0017534](http://purl.obolibrary.org/obo/MONDO_0017534) (postaxial polydactyly type B, bilateral), [MONDO:0017533](http://purl.obolibrary.org/obo/MONDO_0017533) (postaxial polydactyly type B, unilateral), [MONDO:0016202](http://purl.obolibrary.org/obo/MONDO_0016202) (autosomal dominant rhegmatogenous retinal detachment), [MONDO:0017536](http://purl.obolibrary.org/obo/MONDO_0017536) (central polydactyly of fingers, bilateral), [MONDO:0016205](http://purl.obolibrary.org/obo/MONDO_0016205) (IRVAN syndrome), [MONDO:0017535](http://purl.obolibrary.org/obo/MONDO_0017535) (central polydactyly of fingers, unilateral), [MONDO:0017530](http://purl.obolibrary.org/obo/MONDO_0017530) (polysyndactyly, bilateral), [MONDO:0017532](http://purl.obolibrary.org/obo/MONDO_0017532) (postaxial polydactyly type A, bilateral), [MONDO:0017531](http://purl.obolibrary.org/obo/MONDO_0017531) (postaxial polydactyly type A, unilateral), [MONDO:0018861](http://purl.obolibrary.org/obo/MONDO_0018861) (Zellweger-like syndrome without peroxisomal anomalies), [MONDO:0005549](http://purl.obolibrary.org/obo/MONDO_0005549) (renal cell adenocarcinoma), [MONDO:0004218](http://purl.obolibrary.org/obo/MONDO_0004218) (childhood germ cell brain tumor), [MONDO:0004219](http://purl.obolibrary.org/obo/MONDO_0004219) (polyvesicular vitelline pattern testicular yolk sac tumor), [MONDO:0004216](http://purl.obolibrary.org/obo/MONDO_0004216) (pineal region germinoma), [MONDO:0006879](http://purl.obolibrary.org/obo/MONDO_0006879) (optic papillitis), [MONDO:0005547](http://purl.obolibrary.org/obo/MONDO_0005547) (desmoplastic medulloblastoma), [MONDO:0004217](http://purl.obolibrary.org/obo/MONDO_0004217) (childhood brain germinoma), [MONDO:0004214](http://purl.obolibrary.org/obo/MONDO_0004214) (ovarian endometrioid cystadenofibroma), [MONDO:0004212](http://purl.obolibrary.org/obo/MONDO_0004212) (vulvar keratoacanthoma-like carcinoma), [MONDO:0006875](http://purl.obolibrary.org/obo/MONDO_0006875) (ocular hypertension), [MONDO:0005543](http://purl.obolibrary.org/obo/MONDO_0005543) (autoimmune hepatitis type 1), [MONDO:0004213](http://purl.obolibrary.org/obo/MONDO_0004213) (vulvar non-keratinizing squamous cell carcinoma), [MONDO:0006873](http://purl.obolibrary.org/obo/MONDO_0006873) (nutritional deficiency disease), [MONDO:0004210](http://purl.obolibrary.org/obo/MONDO_0004210) (colonic L-cell glucagon-like peptide producing tumor), [MONDO:0004211](http://purl.obolibrary.org/obo/MONDO_0004211) (L-cell glucagon-like peptide producing tumor), [MONDO:0006872](http://purl.obolibrary.org/obo/MONDO_0006872) (nut allergic reaction), [MONDO:0006871](http://purl.obolibrary.org/obo/MONDO_0006871) (non-gestational choriocarcinoma), [MONDO:0017538](http://purl.obolibrary.org/obo/MONDO_0017538) (preaxial polydactyly of toes, bilateral), [MONDO:0016207](http://purl.obolibrary.org/obo/MONDO_0016207) (phacoanaphylactic uveitis), [MONDO:0017537](http://purl.obolibrary.org/obo/MONDO_0017537) (preaxial polydactyly of toes, unilateral), [MONDO:0016206](http://purl.obolibrary.org/obo/MONDO_0016206) (idiopathic uveal effusion syndrome), [MONDO:0018868](http://purl.obolibrary.org/obo/MONDO_0018868) (metachromatic leukodystrophy), [MONDO:0017539](http://purl.obolibrary.org/obo/MONDO_0017539) (postaxial polydactyly of toes, unilateral), [MONDO:0018869](http://purl.obolibrary.org/obo/MONDO_0018869) (cobblestone lissencephaly), [MONDO:0017523](http://purl.obolibrary.org/obo/MONDO_0017523) (polydactyly of a biphalangeal thumb, unilateral), [MONDO:0017522](http://purl.obolibrary.org/obo/MONDO_0017522) (hyperphalangy, bilateral), [MONDO:0018856](http://purl.obolibrary.org/obo/MONDO_0018856) (lichen amyloidosis), [MONDO:0017525](http://purl.obolibrary.org/obo/MONDO_0017525) (polydactyly of a triphalangeal thumb, unilateral), [MONDO:0018854](http://purl.obolibrary.org/obo/MONDO_0018854) (acquired purpura fulminans), [MONDO:0017524](http://purl.obolibrary.org/obo/MONDO_0017524) (polydactyly of a biphalangeal thumb, bilateral), [MONDO:0018851](http://purl.obolibrary.org/obo/MONDO_0018851) (familial keratoacanthoma), [MONDO:0018852](http://purl.obolibrary.org/obo/MONDO_0018852) (achromatopsia), [MONDO:0017521](http://purl.obolibrary.org/obo/MONDO_0017521) (hyperphalangy, unilateral), [MONDO:0017520](http://purl.obolibrary.org/obo/MONDO_0017520) (Symbrachydactyly of hand and foot, bilateral), [MONDO:0018850](http://purl.obolibrary.org/obo/MONDO_0018850) (proliferating trichilemmal cyst), [MONDO:0004229](http://purl.obolibrary.org/obo/MONDO_0004229) (acantholytic variant squamous cell breast carcinoma), [MONDO:0004227](http://purl.obolibrary.org/obo/MONDO_0004227) (epididymis adenomatoid tumor), [MONDO:0004225](http://purl.obolibrary.org/obo/MONDO_0004225) (monoclonal gammopathy of uncertain significance), [MONDO:0005557](http://purl.obolibrary.org/obo/MONDO_0005557) (calcium metabolic disease), [MONDO:0004226](http://purl.obolibrary.org/obo/MONDO_0004226) (diffuse intraductal papillomatosis), [MONDO:0005554](http://purl.obolibrary.org/obo/MONDO_0005554) (rheumatologic disorder), [MONDO:0006886](http://purl.obolibrary.org/obo/MONDO_0006886) (papillary follicular thyroid adenocarcinoma), [MONDO:0004223](http://purl.obolibrary.org/obo/MONDO_0004223) (polyp of middle ear), [MONDO:0005555](http://purl.obolibrary.org/obo/MONDO_0005555) (cycloplegia), [MONDO:0006885](http://purl.obolibrary.org/obo/MONDO_0006885) (panuveitis), [MONDO:0004221](http://purl.obolibrary.org/obo/MONDO_0004221) (uterine corpus perivascular epithelioid cell tumor), [MONDO:0005552](http://purl.obolibrary.org/obo/MONDO_0005552) (ocular vascular disease), [MONDO:0006884](http://purl.obolibrary.org/obo/MONDO_0006884) (panophthalmitis), [MONDO:0006883](http://purl.obolibrary.org/obo/MONDO_0006883) (Pancoast tumor), [MONDO:0004222](http://purl.obolibrary.org/obo/MONDO_0004222) (ovarian clear cell cystadenocarcinoma), [MONDO:0005551](http://purl.obolibrary.org/obo/MONDO_0005551) (eye allergy), [MONDO:0004220](http://purl.obolibrary.org/obo/MONDO_0004220) (endometrial endometrioid adenocarcinoma with spindled epithelial cells), [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859) (Leigh disease), [MONDO:0017527](http://purl.obolibrary.org/obo/MONDO_0017527) (polydactyly of an index finger, unilateral), [MONDO:0017526](http://purl.obolibrary.org/obo/MONDO_0017526) (polydactyly of a triphalangeal thumb, bilateral), [MONDO:0017529](http://purl.obolibrary.org/obo/MONDO_0017529) (polysyndactyly, unilateral), [MONDO:0017528](http://purl.obolibrary.org/obo/MONDO_0017528) (polydactyly of an index finger, bilateral), [MONDO:0017512](http://purl.obolibrary.org/obo/MONDO_0017512) (split hand, bilateral), [MONDO:0018845](http://purl.obolibrary.org/obo/MONDO_0018845) (focal myositis), [MONDO:0017511](http://purl.obolibrary.org/obo/MONDO_0017511) (split hand, unilateral), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0017514](http://purl.obolibrary.org/obo/MONDO_0017514) (split foot, bilateral), [MONDO:0018843](http://purl.obolibrary.org/obo/MONDO_0018843) (embryonal carcinoma of the central nervous system), [MONDO:0017513](http://purl.obolibrary.org/obo/MONDO_0017513) (split foot, unilateral), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0017510](http://purl.obolibrary.org/obo/MONDO_0017510) (Adactyly of foot, bilateral), [MONDO:0005529](http://purl.obolibrary.org/obo/MONDO_0005529) (methylmalonic aciduria and homocystinuria type cblG), [MONDO:0006859](http://purl.obolibrary.org/obo/MONDO_0006859) (mucinous cystadenoma), [MONDO:0005528](http://purl.obolibrary.org/obo/MONDO_0005528) (vitamin metabolic disorder), [MONDO:0005525](http://purl.obolibrary.org/obo/MONDO_0005525) (T-cell leukemia), [MONDO:0006856](http://purl.obolibrary.org/obo/MONDO_0006856) (mesothelial neoplasm), [MONDO:0005523](http://purl.obolibrary.org/obo/MONDO_0005523) (steroid inherited metabolic disorder), [MONDO:0006854](http://purl.obolibrary.org/obo/MONDO_0006854) (mesenchymoma), [MONDO:0005524](http://purl.obolibrary.org/obo/MONDO_0005524) (sweat gland carcinoma), [MONDO:0006853](http://purl.obolibrary.org/obo/MONDO_0006853) (mesenchymal chondrosarcoma), [MONDO:0005522](http://purl.obolibrary.org/obo/MONDO_0005522) (small intestine carcinoma), [MONDO:0005520](http://purl.obolibrary.org/obo/MONDO_0005520) (rickets (disease)), [MONDO:0006850](http://purl.obolibrary.org/obo/MONDO_0006850) (maxillary sinus neoplasm), [MONDO:0017519](http://purl.obolibrary.org/obo/MONDO_0017519) (Symbrachydactyly of hand and foot, unilateral), [MONDO:0018848](http://purl.obolibrary.org/obo/MONDO_0018848) (IgG4-related retroperitoneal fibrosis), [MONDO:0017516](http://purl.obolibrary.org/obo/MONDO_0017516) (brachydactyly of fingers, bilateral), [MONDO:0017515](http://purl.obolibrary.org/obo/MONDO_0017515) (brachydactyly of fingers, unilateral), [MONDO:0017518](http://purl.obolibrary.org/obo/MONDO_0017518) (brachydactyly of toes, bilateral), [MONDO:0017517](http://purl.obolibrary.org/obo/MONDO_0017517) (brachydactyly of toes, unilateral), [MONDO:0017501](http://purl.obolibrary.org/obo/MONDO_0017501) (congenital absence of both lower leg and foot, bilateral), [MONDO:0018833](http://purl.obolibrary.org/obo/MONDO_0018833) (rare idiopathic macular telangiectasia), [MONDO:0017500](http://purl.obolibrary.org/obo/MONDO_0017500) (congenital absence of both lower leg and foot, unilateral), [MONDO:0018834](http://purl.obolibrary.org/obo/MONDO_0018834) (Adenylosuccinate synthetase-like 1-related distal myopathy), [MONDO:0017503](http://purl.obolibrary.org/obo/MONDO_0017503) (Acheiria, bilateral), [MONDO:0017502](http://purl.obolibrary.org/obo/MONDO_0017502) (Acheiria, unilateral), [MONDO:0004209](http://purl.obolibrary.org/obo/MONDO_0004209) (cerebral primitive neuroectodermal tumor), [MONDO:0005538](http://purl.obolibrary.org/obo/MONDO_0005538) (proctitis), [MONDO:0004207](http://purl.obolibrary.org/obo/MONDO_0004207) (pulmonary artery leiomyosarcoma), [MONDO:0005539](http://purl.obolibrary.org/obo/MONDO_0005539) (small bowel Crohn's disease), [MONDO:0004208](http://purl.obolibrary.org/obo/MONDO_0004208) (superior vena cava leiomyosarcoma), [MONDO:0004205](http://purl.obolibrary.org/obo/MONDO_0004205) (lymphohistiocytoid mesothelioma), [MONDO:0005536](http://purl.obolibrary.org/obo/MONDO_0005536) (pancolitis), [MONDO:0005537](http://purl.obolibrary.org/obo/MONDO_0005537) (perianal Crohn's disease), [MONDO:0004206](http://purl.obolibrary.org/obo/MONDO_0004206) (pulmonary vein leiomyosarcoma), [MONDO:0005534](http://purl.obolibrary.org/obo/MONDO_0005534) (ileocolitis), [MONDO:0006866](http://purl.obolibrary.org/obo/MONDO_0006866) (neonatal myasthenia gravis), [MONDO:0004203](http://purl.obolibrary.org/obo/MONDO_0004203) (female urethral cancer), [MONDO:0005535](http://purl.obolibrary.org/obo/MONDO_0005535) (oral Crohn's disease), [MONDO:0004204](http://purl.obolibrary.org/obo/MONDO_0004204) (squamous cell papilloma of skin), [MONDO:0005532](http://purl.obolibrary.org/obo/MONDO_0005532) (Crohn's colitis), [MONDO:0004202](http://purl.obolibrary.org/obo/MONDO_0004202) (adrenal medulla carcinoma), [MONDO:0006863](http://purl.obolibrary.org/obo/MONDO_0006863) (myxosarcoma), [MONDO:0005533](http://purl.obolibrary.org/obo/MONDO_0005533) (distal colitis), [MONDO:0006861](http://purl.obolibrary.org/obo/MONDO_0006861) (myeloid sarcoma), [MONDO:0004200](http://purl.obolibrary.org/obo/MONDO_0004200) (superficial urinary bladder carcinoma), [MONDO:0006860](http://purl.obolibrary.org/obo/MONDO_0006860) (mucoepidermoid tumor), [MONDO:0017509](http://purl.obolibrary.org/obo/MONDO_0017509) (Adactyly of foot, unilateral), [MONDO:0017508](http://purl.obolibrary.org/obo/MONDO_0017508) (congenital absence/hypoplasia of fingers excluding thumb, bilateral), [MONDO:0018839](http://purl.obolibrary.org/obo/MONDO_0018839) (acquired schizencephaly), [MONDO:0017505](http://purl.obolibrary.org/obo/MONDO_0017505) (Apodia, bilateral), [MONDO:0018838](http://purl.obolibrary.org/obo/MONDO_0018838) (lissencephaly (disease)), [MONDO:0017504](http://purl.obolibrary.org/obo/MONDO_0017504) (Apodia, unilateral), [MONDO:0017507](http://purl.obolibrary.org/obo/MONDO_0017507) (congenital absence/hypoplasia of thumb, bilateral), [MONDO:0017506](http://purl.obolibrary.org/obo/MONDO_0017506) (congenital absence/hypoplasia of thumb, unilateral), [MONDO:0016247](http://purl.obolibrary.org/obo/MONDO_0016247) (malignant mixed mullerian tumor of the ovary), [MONDO:0017578](http://purl.obolibrary.org/obo/MONDO_0017578) (disorder of thiamine metabolism and transport), [MONDO:0016249](http://purl.obolibrary.org/obo/MONDO_0016249) (hereditary site-specific ovarian cancer syndrome), [MONDO:0016248](http://purl.obolibrary.org/obo/MONDO_0016248) (familial ovarian cancer), [MONDO:0017579](http://purl.obolibrary.org/obo/MONDO_0017579) (Baraitser-winter cerebrofrontofacial syndrome), [MONDO:0017574](http://purl.obolibrary.org/obo/MONDO_0017574) (chronic intestinal pseudoobstruction), [MONDO:0016243](http://purl.obolibrary.org/obo/MONDO_0016243) (hemoglobin E disease), [MONDO:0017573](http://purl.obolibrary.org/obo/MONDO_0017573) (46,XX disorder of sex development-anorectal anomalies syndrome), [MONDO:0016242](http://purl.obolibrary.org/obo/MONDO_0016242) (hemoglobin c disease), [MONDO:0016244](http://purl.obolibrary.org/obo/MONDO_0016244) (atypical hemolytic-uremic syndrome), [MONDO:0017575](http://purl.obolibrary.org/obo/MONDO_0017575) (mitochondrial neurogastrointestinal encephalomyopathy), [MONDO:0016240](http://purl.obolibrary.org/obo/MONDO_0016240) (hemimelia), [MONDO:0017571](http://purl.obolibrary.org/obo/MONDO_0017571) (Proteus-like syndrome), [MONDO:0004259](http://purl.obolibrary.org/obo/MONDO_0004259) (endocervical carcinoma), [MONDO:0004256](http://purl.obolibrary.org/obo/MONDO_0004256) (lumbar spinal canal and spinal cord meningioma), [MONDO:0004257](http://purl.obolibrary.org/obo/MONDO_0004257) (childhood central nervous system mixed germ cell tumor), [MONDO:0004254](http://purl.obolibrary.org/obo/MONDO_0004254) (focal intraductal papillomatosis), [MONDO:0004255](http://purl.obolibrary.org/obo/MONDO_0004255) (wolffian adnexal tumor), [MONDO:0005586](http://purl.obolibrary.org/obo/MONDO_0005586) (head and neck neoplasia), [MONDO:0004252](http://purl.obolibrary.org/obo/MONDO_0004252) (small intestinal L-cell glucagon-like peptide producing tumor), [MONDO:0004253](http://purl.obolibrary.org/obo/MONDO_0004253) (intraductal breast papillomatosis), [MONDO:0004250](http://purl.obolibrary.org/obo/MONDO_0004250) (extrahepatic bile duct papillary adenoma), [MONDO:0004251](http://purl.obolibrary.org/obo/MONDO_0004251) (small intestine neoplasm), [MONDO:0005582](http://purl.obolibrary.org/obo/MONDO_0005582) (binge eating), [MONDO:0005580](http://purl.obolibrary.org/obo/MONDO_0005580) (esophageal squamous cell carcinoma), [MONDO:0016236](http://purl.obolibrary.org/obo/MONDO_0016236) (kaposiform hemangioendothelioma), [MONDO:0017567](http://purl.obolibrary.org/obo/MONDO_0017567) (Macrodactyly of toes, bilateral), [MONDO:0017566](http://purl.obolibrary.org/obo/MONDO_0017566) (Macrodactyly of toes, unilateral), [MONDO:0017569](http://purl.obolibrary.org/obo/MONDO_0017569) (de Barsy syndrome), [MONDO:0016238](http://purl.obolibrary.org/obo/MONDO_0016238) (solitary fibrous tumor), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0016237](http://purl.obolibrary.org/obo/MONDO_0016237) (diffuse neonatal hemangiomatosis), [MONDO:0017568](http://purl.obolibrary.org/obo/MONDO_0017568) (Prata-Liberal-Goncalves syndrome), [MONDO:0018895](http://purl.obolibrary.org/obo/MONDO_0018895) (Plummer-Vinson syndrome), [MONDO:0017563](http://purl.obolibrary.org/obo/MONDO_0017563) (congenital patella dislocation, bilateral), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0017562](http://purl.obolibrary.org/obo/MONDO_0017562) (congenital patella dislocation, unilateral), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0016234](http://purl.obolibrary.org/obo/MONDO_0016234) (rare arteriovenous malformation), [MONDO:0017565](http://purl.obolibrary.org/obo/MONDO_0017565) (Macrodactyly of fingers, bilateral), [MONDO:0017564](http://purl.obolibrary.org/obo/MONDO_0017564) (Macrodactyly of fingers, unilateral), [MONDO:0018894](http://purl.obolibrary.org/obo/MONDO_0018894) (distal hereditary motor neuropathy), [MONDO:0018891](http://purl.obolibrary.org/obo/MONDO_0018891) (familial tumoral calcinosis), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0017561](http://purl.obolibrary.org/obo/MONDO_0017561) (congenital genu flexum), [MONDO:0017560](http://purl.obolibrary.org/obo/MONDO_0017560) (congenital genu recurvatum), [MONDO:0004269](http://purl.obolibrary.org/obo/MONDO_0004269) (breast cystic hypersecretory carcinoma), [MONDO:0004267](http://purl.obolibrary.org/obo/MONDO_0004267) (squamous papillomatosis), [MONDO:0005598](http://purl.obolibrary.org/obo/MONDO_0005598) (dopaminergic neuroblastoma), [MONDO:0004268](http://purl.obolibrary.org/obo/MONDO_0004268) (subareolar duct papillomatosis), [MONDO:0005599](http://purl.obolibrary.org/obo/MONDO_0005599) (malignant epithelioid mesothelioma), [MONDO:0005596](http://purl.obolibrary.org/obo/MONDO_0005596) (cystadenocarcinoma), [MONDO:0004266](http://purl.obolibrary.org/obo/MONDO_0004266) (anal gland adenocarcinoma), [MONDO:0005597](http://purl.obolibrary.org/obo/MONDO_0005597) (cystic renal cell carcinoma), [MONDO:0004263](http://purl.obolibrary.org/obo/MONDO_0004263) (pediatric infratentorial ependymoblastoma), [MONDO:0005595](http://purl.obolibrary.org/obo/MONDO_0005595) (laryngeal squamous cell carcinoma), [MONDO:0004261](http://purl.obolibrary.org/obo/MONDO_0004261) (periductal breast myoepitheliosis), [MONDO:0004262](http://purl.obolibrary.org/obo/MONDO_0004262) (breast myoepitheliosis), [MONDO:0005590](http://purl.obolibrary.org/obo/MONDO_0005590) (breast ductal adenocarcinoma), [MONDO:0016239](http://purl.obolibrary.org/obo/MONDO_0016239) (cystinosis), [MONDO:0018888](http://purl.obolibrary.org/obo/MONDO_0018888) (congenital cornea plana), [MONDO:0017556](http://purl.obolibrary.org/obo/MONDO_0017556) (Madelung deformity, unilateral), [MONDO:0018889](http://purl.obolibrary.org/obo/MONDO_0018889) (hyaline body myopathy), [MONDO:0016224](http://purl.obolibrary.org/obo/MONDO_0016224) (autosomal dominant proximal spinal muscular atrophy), [MONDO:0017555](http://purl.obolibrary.org/obo/MONDO_0017555) (radio-ulnar synostosis, bilateral), [MONDO:0017558](http://purl.obolibrary.org/obo/MONDO_0017558) (congenital elbow dislocation, unilateral), [MONDO:0018887](http://purl.obolibrary.org/obo/MONDO_0018887) (rare cutaneous lupus erythematosus), [MONDO:0017557](http://purl.obolibrary.org/obo/MONDO_0017557) (Madelung deformity, bilateral), [MONDO:0017552](http://purl.obolibrary.org/obo/MONDO_0017552) (Humero-ulnar synostosis, unilateral), [MONDO:0017551](http://purl.obolibrary.org/obo/MONDO_0017551) (Humero-radial synostosis, bilateral), [MONDO:0018885](http://purl.obolibrary.org/obo/MONDO_0018885) (orbital leiomyoma), [MONDO:0016223](http://purl.obolibrary.org/obo/MONDO_0016223) (infantile hemangioma of rare localization), [MONDO:0017554](http://purl.obolibrary.org/obo/MONDO_0017554) (radio-ulnar synostosis, unilateral), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0016222](http://purl.obolibrary.org/obo/MONDO_0016222) (spindle cell hemangioma), [MONDO:0017553](http://purl.obolibrary.org/obo/MONDO_0017553) (Humero-ulnar synostosis, bilateral), [MONDO:0018881](http://purl.obolibrary.org/obo/MONDO_0018881) (myelodysplastic syndrome), [MONDO:0017550](http://purl.obolibrary.org/obo/MONDO_0017550) (Humero-radial synostosis, unilateral), [MONDO:0004238](http://purl.obolibrary.org/obo/MONDO_0004238) (petrous apex meningioma), [MONDO:0004239](http://purl.obolibrary.org/obo/MONDO_0004239) (cervical keratinizing squamous cell carcinoma), [MONDO:0004236](http://purl.obolibrary.org/obo/MONDO_0004236) (duodenal somatostatinoma), [MONDO:0004237](http://purl.obolibrary.org/obo/MONDO_0004237) (large cell carcinoma with rhabdoid phenotype), [MONDO:0006898](http://purl.obolibrary.org/obo/MONDO_0006898) (periarthritis), [MONDO:0005565](http://purl.obolibrary.org/obo/MONDO_0005565) (blastoma), [MONDO:0004234](http://purl.obolibrary.org/obo/MONDO_0004234) (chronic NK-cell lymphocytosis), [MONDO:0006895](http://purl.obolibrary.org/obo/MONDO_0006895) (penile neoplasm), [MONDO:0005563](http://purl.obolibrary.org/obo/MONDO_0005563) (nut midline carcinoma), [MONDO:0004232](http://purl.obolibrary.org/obo/MONDO_0004232) (large cell keratinizing variant squamous cell breast carcinoma), [MONDO:0004233](http://purl.obolibrary.org/obo/MONDO_0004233) (childhood pleomorphic rhabdomyosarcoma), [MONDO:0005564](http://purl.obolibrary.org/obo/MONDO_0005564) (embryonal neoplasm), [MONDO:0004230](http://purl.obolibrary.org/obo/MONDO_0004230) (adenomatoid tumor), [MONDO:0004231](http://purl.obolibrary.org/obo/MONDO_0004231) (spindle cell variant squamous cell breast carcinoma), [MONDO:0005562](http://purl.obolibrary.org/obo/MONDO_0005562) (age-related hearing impairment), [MONDO:0006890](http://purl.obolibrary.org/obo/MONDO_0006890) (parathyroid gland adenoma), [MONDO:0016229](http://purl.obolibrary.org/obo/MONDO_0016229) (genetic vascular anomaly), [MONDO:0016228](http://purl.obolibrary.org/obo/MONDO_0016228) (rare vascular tumor), [MONDO:0017559](http://purl.obolibrary.org/obo/MONDO_0017559) (congenital elbow dislocation, bilateral), [MONDO:0017545](http://purl.obolibrary.org/obo/MONDO_0017545) (Zygodactyly type 4), [MONDO:0018877](http://purl.obolibrary.org/obo/MONDO_0018877) (retinitis punctata albescens), [MONDO:0017544](http://purl.obolibrary.org/obo/MONDO_0017544) (Zygodactyly type 3), [MONDO:0018878](http://purl.obolibrary.org/obo/MONDO_0018878) (branchiootic syndrome), [MONDO:0016213](http://purl.obolibrary.org/obo/MONDO_0016213) (leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome), [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875) (Li-Fraumeni syndrome), [MONDO:0016216](http://purl.obolibrary.org/obo/MONDO_0016216) (adult hepatocellular carcinoma), [MONDO:0017547](http://purl.obolibrary.org/obo/MONDO_0017547) (congenital vertical talus, bilateral), [MONDO:0018876](http://purl.obolibrary.org/obo/MONDO_0018876) (mantle cell lymphoma), [MONDO:0017546](http://purl.obolibrary.org/obo/MONDO_0017546) (congenital vertical talus, unilateral), [MONDO:0017541](http://purl.obolibrary.org/obo/MONDO_0017541) (central polydactyly of toes, unilateral), [MONDO:0017540](http://purl.obolibrary.org/obo/MONDO_0017540) (postaxial polydactyly of toes, bilateral), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0017543](http://purl.obolibrary.org/obo/MONDO_0017543) (Zygodactyly type 2), [MONDO:0018871](http://purl.obolibrary.org/obo/MONDO_0018871) (acute myelomonocytic leukemia M4), [MONDO:0017542](http://purl.obolibrary.org/obo/MONDO_0017542) (central polydactyly of toes, bilateral), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0016211](http://purl.obolibrary.org/obo/MONDO_0016211) (non-papillary transitional cell carcinoma of the bladder), [MONDO:0004249](http://purl.obolibrary.org/obo/MONDO_0004249) (pediatric supratentorial ependymoma), [MONDO:0005578](http://purl.obolibrary.org/obo/MONDO_0005578) (arthritis), [MONDO:0004248](http://purl.obolibrary.org/obo/MONDO_0004248) (pediatric infratentorial ependymoma), [MONDO:0004245](http://purl.obolibrary.org/obo/MONDO_0004245) (ependymal tumor of brain), [MONDO:0005576](http://purl.obolibrary.org/obo/MONDO_0005576) (cryoglobulinemia), [MONDO:0004243](http://purl.obolibrary.org/obo/MONDO_0004243) (vulvar proximal-type epithelioid sarcoma), [MONDO:0005575](http://purl.obolibrary.org/obo/MONDO_0005575) (colorectal cancer), [MONDO:0004244](http://purl.obolibrary.org/obo/MONDO_0004244) (central epithelioid sarcoma), [MONDO:0004241](http://purl.obolibrary.org/obo/MONDO_0004241) (Osgood-Schlatter's disease), [MONDO:0004240](http://purl.obolibrary.org/obo/MONDO_0004240) (posterior urethra cancer), [MONDO:0017549](http://purl.obolibrary.org/obo/MONDO_0017549) (Humero-radio-ulnar synostosis, bilateral), [MONDO:0017548](http://purl.obolibrary.org/obo/MONDO_0017548) (Humero-radio-ulnar synostosis, unilateral), [MONDO:0016219](http://purl.obolibrary.org/obo/MONDO_0016219) (dysmorphism-pectus carinatum-joint laxity syndrome), [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0016286](http://purl.obolibrary.org/obo/MONDO_0016286) (adenoid cystic carcinoma of the cervix uteri), [MONDO:0016289](http://purl.obolibrary.org/obo/MONDO_0016289) (malignant germ cell tumor of cervix uteri), [MONDO:0016288](http://purl.obolibrary.org/obo/MONDO_0016288) (glassy cell carcinoma of the cervix uteri), [MONDO:0016283](http://purl.obolibrary.org/obo/MONDO_0016283) (leiomyosarcoma of the cervix uteri), [MONDO:0016282](http://purl.obolibrary.org/obo/MONDO_0016282) (rhabdomyosarcoma of the cervix uteri), [MONDO:0016285](http://purl.obolibrary.org/obo/MONDO_0016285) (papillary carcinoma of the cervix uteri), [MONDO:0016284](http://purl.obolibrary.org/obo/MONDO_0016284) (primitive neuroectodermal tumor of the cervix uteri), [MONDO:0016281](http://purl.obolibrary.org/obo/MONDO_0016281) (46,XX ovotesticular disorder of sex development), [MONDO:0016280](http://purl.obolibrary.org/obo/MONDO_0016280) (sarcoma of cervix uteri), [MONDO:0004299](http://purl.obolibrary.org/obo/MONDO_0004299) (infiltrating bladder lymphoepithelioma-like carcinoma), [MONDO:0004296](http://purl.obolibrary.org/obo/MONDO_0004296) (cervical lymphoepithelioma-like carcinoma), [MONDO:0004297](http://purl.obolibrary.org/obo/MONDO_0004297) (lymphoepithelioma-like thymic carcinoma), [MONDO:0004294](http://purl.obolibrary.org/obo/MONDO_0004294) (gestational ovarian choriocarcinoma), [MONDO:0004295](http://purl.obolibrary.org/obo/MONDO_0004295) (asbestos-related lung carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0004293](http://purl.obolibrary.org/obo/MONDO_0004293) (supraglottis squamous cell carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0004291](http://purl.obolibrary.org/obo/MONDO_0004291) (subglottis squamous cell carcinoma), [MONDO:0016279](http://purl.obolibrary.org/obo/MONDO_0016279) (adenosarcoma of the cervix uteri), [MONDO:0016276](http://purl.obolibrary.org/obo/MONDO_0016276) (high-grade neuroendocrine carcinoma of the cervix uteri), [MONDO:0016275](http://purl.obolibrary.org/obo/MONDO_0016275) (adenocarcinoma of cervix uteri), [MONDO:0016278](http://purl.obolibrary.org/obo/MONDO_0016278) (carcinosarcoma of the cervix uteri), [MONDO:0016277](http://purl.obolibrary.org/obo/MONDO_0016277) (malignant mixed epithelial and mesenchymal tumor of cervix uteri), [MONDO:0016272](http://purl.obolibrary.org/obo/MONDO_0016272) (transitional cell carcinoma of the corpus uteri), [MONDO:0016271](http://purl.obolibrary.org/obo/MONDO_0016271) (adenoid cystic carcinoma of the corpus uteri), [MONDO:0016274](http://purl.obolibrary.org/obo/MONDO_0016274) (rare cancer of cervix uteri), [MONDO:0016273](http://purl.obolibrary.org/obo/MONDO_0016273) (malignant germ cell tumor of corpus uteri), [MONDO:0016270](http://purl.obolibrary.org/obo/MONDO_0016270) (low-grade neuroendocrine tumor of the corpus uteri), [MONDO:0016269](http://purl.obolibrary.org/obo/MONDO_0016269) (high-grade neuroendocrine carcinoma of the corpus uteri), [MONDO:0016268](http://purl.obolibrary.org/obo/MONDO_0016268) (papillary carcinoma of the corpus uteri), [MONDO:0017599](http://purl.obolibrary.org/obo/MONDO_0017599) (splenic diffuse red pulp small b-cell lymphoma), [MONDO:0017596](http://purl.obolibrary.org/obo/MONDO_0017596) (diffuse large B-cell lymphoma of the central nervous system), [MONDO:0016264](http://purl.obolibrary.org/obo/MONDO_0016264) (autoimmune hepatitis), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive B-cell non-Hodgkin lymphoma), [MONDO:0016267](http://purl.obolibrary.org/obo/MONDO_0016267) (undifferentiated carcinoma of the corpus uteri), [MONDO:0017598](http://purl.obolibrary.org/obo/MONDO_0017598) (primary cutaneous anaplastic large cell lymphoma), [MONDO:0016266](http://purl.obolibrary.org/obo/MONDO_0016266) (squamous cell carcinoma of the corpus uteri), [MONDO:0017597](http://purl.obolibrary.org/obo/MONDO_0017597) (T-cell/histiocyte rich large B cell lymphoma), [MONDO:0016260](http://purl.obolibrary.org/obo/MONDO_0016260) (uterine corpus rhabdomyosarcoma), [MONDO:0016263](http://purl.obolibrary.org/obo/MONDO_0016263) (primitive neuroectodermal tumor of the corpus uteri), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent B-cell non-Hodgkin lymphoma), [MONDO:0017593](http://purl.obolibrary.org/obo/MONDO_0017593) (juvenile amyotrophic lateral sclerosis), [MONDO:0016262](http://purl.obolibrary.org/obo/MONDO_0016262) (leiomyosarcoma of the corpus uteri), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), [MONDO:0004278](http://purl.obolibrary.org/obo/MONDO_0004278) (infiltrating bladder urothelial carcinoma sarcomatoid variant), [MONDO:0004279](http://purl.obolibrary.org/obo/MONDO_0004279) (glossopharyngeal motor neuropathy), [MONDO:0004276](http://purl.obolibrary.org/obo/MONDO_0004276) (ceruminoma), [MONDO:0004274](http://purl.obolibrary.org/obo/MONDO_0004274) (mixed epithelial/mesenchymal metaplastic breast carcinoma), [MONDO:0004275](http://purl.obolibrary.org/obo/MONDO_0004275) (osteosarcoma arising in bone Paget's disease), [MONDO:0004273](http://purl.obolibrary.org/obo/MONDO_0004273) (breast apocrine adenoma), [MONDO:0004270](http://purl.obolibrary.org/obo/MONDO_0004270) (breast ductal adenoma), [MONDO:0004271](http://purl.obolibrary.org/obo/MONDO_0004271) (pregnancy adenoma), [MONDO:0016258](http://purl.obolibrary.org/obo/MONDO_0016258) (uterine corpus carcinofibroma), [MONDO:0016257](http://purl.obolibrary.org/obo/MONDO_0016257) (adenosarcoma of the corpus uteri), [MONDO:0017588](http://purl.obolibrary.org/obo/MONDO_0017588) (rare nail tumor), [MONDO:0016259](http://purl.obolibrary.org/obo/MONDO_0016259) (carcinosarcoma of the corpus uteri), [MONDO:0017585](http://purl.obolibrary.org/obo/MONDO_0017585) (painful orbital and systemic neurofibromas-marfanoid habitus syndrome), [MONDO:0016254](http://purl.obolibrary.org/obo/MONDO_0016254) (rare variants of adenocarcinoma of the corpus uteri), [MONDO:0016253](http://purl.obolibrary.org/obo/MONDO_0016253) (rare cancer of corpus uteri), [MONDO:0016256](http://purl.obolibrary.org/obo/MONDO_0016256) (Hennekam syndrome), [MONDO:0017587](http://purl.obolibrary.org/obo/MONDO_0017587) (Onychomatricoma), [MONDO:0016255](http://purl.obolibrary.org/obo/MONDO_0016255) (uterine corpus mixed epithelial and mesenchymal neoplasm), [MONDO:0017586](http://purl.obolibrary.org/obo/MONDO_0017586) (Onychocytic matricoma), [MONDO:0016250](http://purl.obolibrary.org/obo/MONDO_0016250) (rare adenocarcinoma of the breast), [MONDO:0017580](http://purl.obolibrary.org/obo/MONDO_0017580) (11p15.4 microduplication syndrome), [MONDO:0016252](http://purl.obolibrary.org/obo/MONDO_0016252) (rare uterine cancer), [MONDO:0017583](http://purl.obolibrary.org/obo/MONDO_0017583) (mirror polydactyly-vertebral segmentation-limbs defects syndrome), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary adenocarcinoma (disease)), [MONDO:0016251](http://purl.obolibrary.org/obo/MONDO_0016251) (salivary gland type cancer of the breast), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0004287](http://purl.obolibrary.org/obo/MONDO_0004287) (pancreatic foamy gland adenocarcinoma), [MONDO:0004288](http://purl.obolibrary.org/obo/MONDO_0004288) (scirrhous breast carcinoma), [MONDO:0004285](http://purl.obolibrary.org/obo/MONDO_0004285) (pancreatic intraductal papillary-mucinous carcinoma), [MONDO:0004286](http://purl.obolibrary.org/obo/MONDO_0004286) (pancreatic intraductal papillary-mucinous neoplasm), [MONDO:0004283](http://purl.obolibrary.org/obo/MONDO_0004283) (vulvar clear cell hidradenocarcinoma), [MONDO:0004281](http://purl.obolibrary.org/obo/MONDO_0004281) (vulvar eccrine porocarcinoma), [MONDO:0004280](http://purl.obolibrary.org/obo/MONDO_0004280) (asymmetric motor neuropathy), [MONDO:0016298](http://purl.obolibrary.org/obo/MONDO_0016298) (postlingual non-syndromic genetic deafness), [MONDO:0016297](http://purl.obolibrary.org/obo/MONDO_0016297) (prelingual non-syndromic genetic deafness), [MONDO:0016294](http://purl.obolibrary.org/obo/MONDO_0016294) (Hirschsprung disease-type D brachydactyly syndrome), [MONDO:0016293](http://purl.obolibrary.org/obo/MONDO_0016293) (congenital stationary night blindness), [MONDO:0016296](http://purl.obolibrary.org/obo/MONDO_0016296) (holoprosencephaly), [MONDO:0016295](http://purl.obolibrary.org/obo/MONDO_0016295) (neuronal ceroid lipofuscinosis), [MONDO:0016290](http://purl.obolibrary.org/obo/MONDO_0016290) (Hern), [MONDO:0016292](http://purl.obolibrary.org/obo/MONDO_0016292) (nodular neuronal heterotopia), [MONDO:0016291](http://purl.obolibrary.org/obo/MONDO_0016291) (craniosynostosis, Herrmann-Opitz type), [MONDO:0006919](http://purl.obolibrary.org/obo/MONDO_0006919) (potassium deficiency), [MONDO:0006918](http://purl.obolibrary.org/obo/MONDO_0006918) (posterior uveitis), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0018908](http://purl.obolibrary.org/obo/MONDO_0018908) (non-Hodgkin lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0018902](http://purl.obolibrary.org/obo/MONDO_0018902) (hepatocellular adenoma), [MONDO:0006928](http://purl.obolibrary.org/obo/MONDO_0006928) (proliferative vitreoretinopathy), [MONDO:0006920](http://purl.obolibrary.org/obo/MONDO_0006920) (prediabetes syndrome), [MONDO:0006907](http://purl.obolibrary.org/obo/MONDO_0006907) (pilar sheath acanthoma), [MONDO:0006906](http://purl.obolibrary.org/obo/MONDO_0006906) (pigmented villonodular synovitis), [MONDO:0006905](http://purl.obolibrary.org/obo/MONDO_0006905) (pigmented spindle cell nevus), [MONDO:0006901](http://purl.obolibrary.org/obo/MONDO_0006901) (peritoneal neoplasm), [MONDO:0018943](http://purl.obolibrary.org/obo/MONDO_0018943) (myofibrillar myopathy (disease)), [MONDO:0017611](http://purl.obolibrary.org/obo/MONDO_0017611) (pituitary tumor), [MONDO:0018944](http://purl.obolibrary.org/obo/MONDO_0018944) (gestational trophoblastic neoplasm), [MONDO:0017612](http://purl.obolibrary.org/obo/MONDO_0017612) (junctional epidermolysis bullosa), [MONDO:0018942](http://purl.obolibrary.org/obo/MONDO_0018942) (macrophagic myofasciitis), [MONDO:0018940](http://purl.obolibrary.org/obo/MONDO_0018940) (congenital myasthenic syndrome), [MONDO:0005628](http://purl.obolibrary.org/obo/MONDO_0005628) (male breast carcinoma), [MONDO:0005626](http://purl.obolibrary.org/obo/MONDO_0005626) (epithelial neoplasm), [MONDO:0005627](http://purl.obolibrary.org/obo/MONDO_0005627) (head and neck malignant neoplasia), [MONDO:0005624](http://purl.obolibrary.org/obo/MONDO_0005624) (atrophic thyroiditis), [MONDO:0006955](http://purl.obolibrary.org/obo/MONDO_0006955) (rheumatic heart disease), [MONDO:0005623](http://purl.obolibrary.org/obo/MONDO_0005623) (autoimmune thyroid disease), [MONDO:0005620](http://purl.obolibrary.org/obo/MONDO_0005620) (cerebral amyloid angiopathy), [MONDO:0006952](http://purl.obolibrary.org/obo/MONDO_0006952) (retinopathy of prematurity), [MONDO:0006951](http://purl.obolibrary.org/obo/MONDO_0006951) (retinal vein occlusion), [MONDO:0006950](http://purl.obolibrary.org/obo/MONDO_0006950) (retinal vasculitis), [MONDO:0017619](http://purl.obolibrary.org/obo/MONDO_0017619) (congenital sucrase-isomaltase deficiency with minimal starch tolerance), [MONDO:0017618](http://purl.obolibrary.org/obo/MONDO_0017618) (congenital sucrase-isomaltase deficiency with starch intolerance), [MONDO:0018949](http://purl.obolibrary.org/obo/MONDO_0018949) (distal myopathy), [MONDO:0018947](http://purl.obolibrary.org/obo/MONDO_0018947) (centronuclear myopathy), [MONDO:0018948](http://purl.obolibrary.org/obo/MONDO_0018948) (multiminicore myopathy), [MONDO:0017614](http://purl.obolibrary.org/obo/MONDO_0017614) (X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome), [MONDO:0018945](http://purl.obolibrary.org/obo/MONDO_0018945) (McLeod neuroacanthocytosis syndrome), [MONDO:0017600](http://purl.obolibrary.org/obo/MONDO_0017600) (hairy cell leukemia variant), [MONDO:0018933](http://purl.obolibrary.org/obo/MONDO_0018933) (Mazabraud syndrome), [MONDO:0018930](http://purl.obolibrary.org/obo/MONDO_0018930) (monosomy 21), [MONDO:0017602](http://purl.obolibrary.org/obo/MONDO_0017602) (ALK-positive anaplastic large cell lymphoma), [MONDO:0018931](http://purl.obolibrary.org/obo/MONDO_0018931) (mucolipidosis type III), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0004308](http://purl.obolibrary.org/obo/MONDO_0004308) (meninges sarcoma), [MONDO:0004309](http://purl.obolibrary.org/obo/MONDO_0004309) (sarcomatosis), [MONDO:0004306](http://purl.obolibrary.org/obo/MONDO_0004306) (childhood intracortical osteosarcoma), [MONDO:0004307](http://purl.obolibrary.org/obo/MONDO_0004307) (sarcomatosis of the meninges), [MONDO:0004304](http://purl.obolibrary.org/obo/MONDO_0004304) (mixed cell type adenoma of parathyroid), [MONDO:0005635](http://purl.obolibrary.org/obo/MONDO_0005635) (adenomyoma), [MONDO:0005636](http://purl.obolibrary.org/obo/MONDO_0005636) (adenosarcoma), [MONDO:0004305](http://purl.obolibrary.org/obo/MONDO_0004305) (parathyroid oncocytic adenoma), [MONDO:0004302](http://purl.obolibrary.org/obo/MONDO_0004302) (chief cell adenoma), [MONDO:0004303](http://purl.obolibrary.org/obo/MONDO_0004303) (parathyroid gland clear cell adenoma), [MONDO:0006963](http://purl.obolibrary.org/obo/MONDO_0006963) (sebaceous gland neoplasm), [MONDO:0004300](http://purl.obolibrary.org/obo/MONDO_0004300) (intracortical osteogenic sarcoma), [MONDO:0006962](http://purl.obolibrary.org/obo/MONDO_0006962) (sebaceous adenocarcinoma), [MONDO:0004301](http://purl.obolibrary.org/obo/MONDO_0004301) (fibrosarcomatous osteosarcoma), [MONDO:0017608](http://purl.obolibrary.org/obo/MONDO_0017608) (dystrophic epidermolysis bullosa), [MONDO:0017607](http://purl.obolibrary.org/obo/MONDO_0017607) (caudal regression sequence), [MONDO:0018938](http://purl.obolibrary.org/obo/MONDO_0018938) (mucopolysaccharidosis type 4), [MONDO:0018939](http://purl.obolibrary.org/obo/MONDO_0018939) (muscle-eye-brain disease), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0018936](http://purl.obolibrary.org/obo/MONDO_0018936) (osteoblastoma (disease)), [MONDO:0018937](http://purl.obolibrary.org/obo/MONDO_0018937) (mucopolysaccharidosis type 3), [MONDO:0017603](http://purl.obolibrary.org/obo/MONDO_0017603) (ALK-negative anaplastic large cell lymphoma), [MONDO:0018935](http://purl.obolibrary.org/obo/MONDO_0018935) (hairy cell leukemia), [MONDO:0018921](http://purl.obolibrary.org/obo/MONDO_0018921) (Meckel syndrome), [MONDO:0018922](http://purl.obolibrary.org/obo/MONDO_0018922) (cold agglutinin disease), [MONDO:0005606](http://purl.obolibrary.org/obo/MONDO_0005606) (tubular adenocarcinoma), [MONDO:0005605](http://purl.obolibrary.org/obo/MONDO_0005605) (transitional cell papilloma), [MONDO:0006934](http://purl.obolibrary.org/obo/MONDO_0006934) (pulmonary sclerosing hemangioma), [MONDO:0005602](http://purl.obolibrary.org/obo/MONDO_0005602) (ovarian teratoma), [MONDO:0005603](http://purl.obolibrary.org/obo/MONDO_0005603) (pancreatic tubular adenocarcinoma), [MONDO:0006932](http://purl.obolibrary.org/obo/MONDO_0006932) (pulmonary edema), [MONDO:0006931](http://purl.obolibrary.org/obo/MONDO_0006931) (pulmonary coin lesion), [MONDO:0005601](http://purl.obolibrary.org/obo/MONDO_0005601) (ovarian mucinous adenocarcinoma), [MONDO:0006930](http://purl.obolibrary.org/obo/MONDO_0006930) (pseudobulbar palsy), [MONDO:0018929](http://purl.obolibrary.org/obo/MONDO_0018929) (medial condensing osteitis of the clavicle), [MONDO:0018923](http://purl.obolibrary.org/obo/MONDO_0018923) (22q11.2 deletion syndrome), [MONDO:0018924](http://purl.obolibrary.org/obo/MONDO_0018924) (microphthalmia, Lenz type), [MONDO:0018910](http://purl.obolibrary.org/obo/MONDO_0018910) (oculocutaneous albinism), [MONDO:0018911](http://purl.obolibrary.org/obo/MONDO_0018911) (maturity-onset diabetes of the young (disease)), [MONDO:0006949](http://purl.obolibrary.org/obo/MONDO_0006949) (retinal drusen), [MONDO:0005617](http://purl.obolibrary.org/obo/MONDO_0005617) (undifferentiated carcinoma), [MONDO:0006948](http://purl.obolibrary.org/obo/MONDO_0006948) (retinal artery occlusion), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0005616](http://purl.obolibrary.org/obo/MONDO_0005616) (pulmonary mucoepidermoid carcinoma), [MONDO:0005613](http://purl.obolibrary.org/obo/MONDO_0005613) (mesonephric adenocarcinoma), [MONDO:0005614](http://purl.obolibrary.org/obo/MONDO_0005614) (pancreatic adenosquamous carcinoma), [MONDO:0005611](http://purl.obolibrary.org/obo/MONDO_0005611) (bladder transitional cell carcinoma), [MONDO:0018918](http://purl.obolibrary.org/obo/MONDO_0018918) (carcinoma of gallbladder and extrahepatic biliary tract), [MONDO:0018919](http://purl.obolibrary.org/obo/MONDO_0018919) (McCune-Albright syndrome), [MONDO:0018916](http://purl.obolibrary.org/obo/MONDO_0018916) (isolated anorectal malformation), [MONDO:0018988](http://purl.obolibrary.org/obo/MONDO_0018988) (Iridocorneal endothelial syndrome), [MONDO:0016323](http://purl.obolibrary.org/obo/MONDO_0016323) (chronic respiratory distress with surfactant metabolism deficiency), [MONDO:0018983](http://purl.obolibrary.org/obo/MONDO_0018983) (Tolosa-Hunt syndrome), [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320) (rare hereditary thrombophilia), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0018980](http://purl.obolibrary.org/obo/MONDO_0018980) (acrofacial dysostosis, Kennedy-Teebi type), [MONDO:0004339](http://purl.obolibrary.org/obo/MONDO_0004339) (tuberculum sellae meningioma), [MONDO:0003007](http://purl.obolibrary.org/obo/MONDO_0003007) (childhood kidney cell carcinoma), [MONDO:0005668](http://purl.obolibrary.org/obo/MONDO_0005668) (bird fancier's lung), [MONDO:0004337](http://purl.obolibrary.org/obo/MONDO_0004337) (perianal skin Paget's disease), [MONDO:0003008](http://purl.obolibrary.org/obo/MONDO_0003008) (hereditary renal cell carcinoma), [MONDO:0004338](http://purl.obolibrary.org/obo/MONDO_0004338) (retinal cell cancer), [MONDO:0003003](http://purl.obolibrary.org/obo/MONDO_0003003) (cervical alveolar soft part sarcoma), [MONDO:0006998](http://purl.obolibrary.org/obo/MONDO_0006998) (tonsil cancer), [MONDO:0004336](http://purl.obolibrary.org/obo/MONDO_0004336) (rectum signet ring adenocarcinoma), [MONDO:0003002](http://purl.obolibrary.org/obo/MONDO_0003002) (dysgerminoma (disease)), [MONDO:0004333](http://purl.obolibrary.org/obo/MONDO_0004333) (pancreatic ACTH-producing neuroendocrine tumor), [MONDO:0003005](http://purl.obolibrary.org/obo/MONDO_0003005) (macular retinal edema), [MONDO:0003004](http://purl.obolibrary.org/obo/MONDO_0003004) (macular degeneration), [MONDO:0004334](http://purl.obolibrary.org/obo/MONDO_0004334) (non-functional pancreatic neuroendocrine tumor), [MONDO:0004331](http://purl.obolibrary.org/obo/MONDO_0004331) (bladder urachal adenocarcinoma), [MONDO:0004332](http://purl.obolibrary.org/obo/MONDO_0004332) (lung hilum cancer), [MONDO:0006993](http://purl.obolibrary.org/obo/MONDO_0006993) (systolic heart failure), [MONDO:0003001](http://purl.obolibrary.org/obo/MONDO_0003001) (seminoma), [MONDO:0003000](http://purl.obolibrary.org/obo/MONDO_0003000) (central nervous system germ cell tumor), [MONDO:0004330](http://purl.obolibrary.org/obo/MONDO_0004330) (leptomeninges sarcoma), [MONDO:0006990](http://purl.obolibrary.org/obo/MONDO_0006990) (suppurative uveitis), [MONDO:0016328](http://purl.obolibrary.org/obo/MONDO_0016328) (fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy), [MONDO:0016327](http://purl.obolibrary.org/obo/MONDO_0016327) (mitochondrial disease with hypertrophic cardiomyopathy), [MONDO:0018974](http://purl.obolibrary.org/obo/MONDO_0018974) (paraneoplastic pemphigus), [MONDO:0016315](http://purl.obolibrary.org/obo/MONDO_0016315) (mucopolysaccharidosis type 2, severe form), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis type 1), [MONDO:0016314](http://purl.obolibrary.org/obo/MONDO_0016314) (rare carcinoma of pancreas), [MONDO:0018972](http://purl.obolibrary.org/obo/MONDO_0018972) (rare epithelial tumor of stomach), [MONDO:0018973](http://purl.obolibrary.org/obo/MONDO_0018973) (patterned dystrophy of the retinal pigment epithelium), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0018971](http://purl.obolibrary.org/obo/MONDO_0018971) (isolated oxycephaly), [MONDO:0003017](http://purl.obolibrary.org/obo/MONDO_0003017) (malignant peritoneal solitary fibrous tumor), [MONDO:0004348](http://purl.obolibrary.org/obo/MONDO_0004348) (retinal telangiectasia), [MONDO:0004349](http://purl.obolibrary.org/obo/MONDO_0004349) (retina lymphoma), [MONDO:0003019](http://purl.obolibrary.org/obo/MONDO_0003019) (hypokalemia (disease)), [MONDO:0004346](http://purl.obolibrary.org/obo/MONDO_0004346) (signet ring cell intrahepatic cholangiocarcinoma), [MONDO:0004344](http://purl.obolibrary.org/obo/MONDO_0004344) (childhood malignant hemangiopericytoma), [MONDO:0004345](http://purl.obolibrary.org/obo/MONDO_0004345) (childhood malignant schwannoma), [MONDO:0003010](http://purl.obolibrary.org/obo/MONDO_0003010) (multilocular clear cell renal cell carcinoma), [MONDO:0004342](http://purl.obolibrary.org/obo/MONDO_0004342) (osteoclast-like giant cell neoplasm of the pancreas), [MONDO:0004343](http://purl.obolibrary.org/obo/MONDO_0004343) (acinar cell cystadenocarcinoma), [MONDO:0005674](http://purl.obolibrary.org/obo/MONDO_0005674) (bone giant cell tumor), [MONDO:0003012](http://purl.obolibrary.org/obo/MONDO_0003012) (sarcomatoid renal cell carcinoma), [MONDO:0004340](http://purl.obolibrary.org/obo/MONDO_0004340) (mixed ductal-endocrine carcinoma of pancreas), [MONDO:0003011](http://purl.obolibrary.org/obo/MONDO_0003011) (mucinous tubular and spindle renal cell carcinoma), [MONDO:0004341](http://purl.obolibrary.org/obo/MONDO_0004341) (colloid carcinoma of the pancreas), [MONDO:0016316](http://purl.obolibrary.org/obo/MONDO_0016316) (mucopolysaccharidosis type 2, attenuated form), [MONDO:0018978](http://purl.obolibrary.org/obo/MONDO_0018978) (IgG4-related mediastinitis), [MONDO:0018965](http://purl.obolibrary.org/obo/MONDO_0018965) (Alport syndrome), [MONDO:0016302](http://purl.obolibrary.org/obo/MONDO_0016302) (isolated congenitally uncorrected transposition of the great arteries), [MONDO:0017632](http://purl.obolibrary.org/obo/MONDO_0017632) (rare tumor of liver and intrahepatic biliary tract), [MONDO:0018963](http://purl.obolibrary.org/obo/MONDO_0018963) (hereditary methemoglobinemia), [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964) (homocystinuria without methylmalonic aciduria), [MONDO:0017634](http://purl.obolibrary.org/obo/MONDO_0017634) (non-infectious anterior uveitis), [MONDO:0016303](http://purl.obolibrary.org/obo/MONDO_0016303) (congenitally uncorrected transposition of the great arteries with cardiac malformation), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0018962](http://purl.obolibrary.org/obo/MONDO_0018962) (common mesentery), [MONDO:0017631](http://purl.obolibrary.org/obo/MONDO_0017631) (rare tumor of gallbladder and extrahepatic biliary tract), [MONDO:0017630](http://purl.obolibrary.org/obo/MONDO_0017630) (X-linked complicated spastic paraplegia type 1), [MONDO:0018960](http://purl.obolibrary.org/obo/MONDO_0018960) (congenital primary megaureter), [MONDO:0004319](http://purl.obolibrary.org/obo/MONDO_0004319) (hypercalcemic type ovarian small cell carcinoma), [MONDO:0004317](http://purl.obolibrary.org/obo/MONDO_0004317) (multiple spinal canal and spinal cord meningioma), [MONDO:0004318](http://purl.obolibrary.org/obo/MONDO_0004318) (pulmonary type ovarian small cell carcinoma), [MONDO:0006979](http://purl.obolibrary.org/obo/MONDO_0006979) (steatitis), [MONDO:0004315](http://purl.obolibrary.org/obo/MONDO_0004315) (cholangiolocellular carcinoma), [MONDO:0004316](http://purl.obolibrary.org/obo/MONDO_0004316) (acantholytic squamous cell skin carcinoma), [MONDO:0006976](http://purl.obolibrary.org/obo/MONDO_0006976) (somatostatinoma), [MONDO:0004313](http://purl.obolibrary.org/obo/MONDO_0004313) (Gasserian ganglion meningioma), [MONDO:0004314](http://purl.obolibrary.org/obo/MONDO_0004314) (malignant cutaneous granular cell skin tumor), [MONDO:0006975](http://purl.obolibrary.org/obo/MONDO_0006975) (smooth muscle tumor), [MONDO:0005642](http://purl.obolibrary.org/obo/MONDO_0005642) (atopic conjunctivitis), [MONDO:0006974](http://purl.obolibrary.org/obo/MONDO_0006974) (small cell sarcoma), [MONDO:0004311](http://purl.obolibrary.org/obo/MONDO_0004311) (carcinoma of cowper glands), [MONDO:0006973](http://purl.obolibrary.org/obo/MONDO_0006973) (skin appendage carcinoma), [MONDO:0004312](http://purl.obolibrary.org/obo/MONDO_0004312) (suprasellar meningioma), [MONDO:0006971](http://purl.obolibrary.org/obo/MONDO_0006971) (sigmoid neoplasm), [MONDO:0004310](http://purl.obolibrary.org/obo/MONDO_0004310) (adult ependymoblastoma), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0018969](http://purl.obolibrary.org/obo/MONDO_0018969) (Craniorachischisis (disease)), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0018967](http://purl.obolibrary.org/obo/MONDO_0018967) (short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), [MONDO:0018968](http://purl.obolibrary.org/obo/MONDO_0018968) (iniencephaly), [MONDO:0017622](http://purl.obolibrary.org/obo/MONDO_0017622) (congenital sucrase-isomaltase deficiency without sucrose intolerance), [MONDO:0018955](http://purl.obolibrary.org/obo/MONDO_0018955) (recurrent respiratory papillomatosis), [MONDO:0017621](http://purl.obolibrary.org/obo/MONDO_0017621) (congenital sucrase-isomaltase deficiency with starch and lactose intolerance), [MONDO:0017624](http://purl.obolibrary.org/obo/MONDO_0017624) (familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis), [MONDO:0018953](http://purl.obolibrary.org/obo/MONDO_0018953) (parietal foramina), [MONDO:0017623](http://purl.obolibrary.org/obo/MONDO_0017623) (PTEN hamartoma tumor syndrome), [MONDO:0018950](http://purl.obolibrary.org/obo/MONDO_0018950) (3-methylcrotonyl-CoA carboxylase deficiency), [MONDO:0018951](http://purl.obolibrary.org/obo/MONDO_0018951) (distal myopathy with vocal cord weakness), [MONDO:0017620](http://purl.obolibrary.org/obo/MONDO_0017620) (congenital sucrase-isomaltase deficiency without starch intolerance), [MONDO:0004328](http://purl.obolibrary.org/obo/MONDO_0004328) (maxillary sinus adenocarcinoma), [MONDO:0004329](http://purl.obolibrary.org/obo/MONDO_0004329) (pancreatic intraductal papillary-mucinous neoplasm with high grade dysplasia), [MONDO:0004326](http://purl.obolibrary.org/obo/MONDO_0004326) (sphenoid sinus inverted papilloma), [MONDO:0004327](http://purl.obolibrary.org/obo/MONDO_0004327) (sphenoid sinus Schneiderian papilloma), [MONDO:0004324](http://purl.obolibrary.org/obo/MONDO_0004324) (testicular fibroma), [MONDO:0004325](http://purl.obolibrary.org/obo/MONDO_0004325) (testicular thecoma), [MONDO:0004322](http://purl.obolibrary.org/obo/MONDO_0004322) (non-gestational ovarian choriocarcinoma), [MONDO:0004320](http://purl.obolibrary.org/obo/MONDO_0004320) (adult infiltrating astrocytic neoplasm), [MONDO:0004321](http://purl.obolibrary.org/obo/MONDO_0004321) (endometrial mixed adenocarcinoma), [MONDO:0006980](http://purl.obolibrary.org/obo/MONDO_0006980) (struma ovarii), [MONDO:0018958](http://purl.obolibrary.org/obo/MONDO_0018958) (nemaline myopathy), [MONDO:0017626](http://purl.obolibrary.org/obo/MONDO_0017626) (familial primary hypomagnesemia with normocalcuria), [MONDO:0018959](http://purl.obolibrary.org/obo/MONDO_0018959) (potassium-aggravated myotonia), [MONDO:0017625](http://purl.obolibrary.org/obo/MONDO_0017625) (familial primary hypomagnesemia with hypocalcuria), [MONDO:0017627](http://purl.obolibrary.org/obo/MONDO_0017627) (congenital hereditary facial paralysis-variable hearing loss syndrome), [MONDO:0017699](http://purl.obolibrary.org/obo/MONDO_0017699) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form), [MONDO:0016368](http://purl.obolibrary.org/obo/MONDO_0016368) (Rothmund-Thomson syndrome type 1), [MONDO:0015036](http://purl.obolibrary.org/obo/MONDO_0015036) (lissencephaly with cerebellar hypoplasia type C), [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0017698](http://purl.obolibrary.org/obo/MONDO_0017698) (glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form), [MONDO:0015037](http://purl.obolibrary.org/obo/MONDO_0015037) (lissencephaly with cerebellar hypoplasia type D), [MONDO:0015038](http://purl.obolibrary.org/obo/MONDO_0015038) (lissencephaly with cerebellar hypoplasia type E), [MONDO:0016369](http://purl.obolibrary.org/obo/MONDO_0016369) (Rothmund-Thomson syndrome type 2), [MONDO:0015039](http://purl.obolibrary.org/obo/MONDO_0015039) (lissencephaly with cerebellar hypoplasia type F), [MONDO:0016364](http://purl.obolibrary.org/obo/MONDO_0016364) (Joubert syndrome with ocular defect), [MONDO:0017695](http://purl.obolibrary.org/obo/MONDO_0017695) (glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form), [MONDO:0015032](http://purl.obolibrary.org/obo/MONDO_0015032) (intraneural perineurioma), [MONDO:0016363](http://purl.obolibrary.org/obo/MONDO_0016363) (rare hereditary hemochromatosis), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0015033](http://purl.obolibrary.org/obo/MONDO_0015033) (ABeta amyloidosis, dutch type), [MONDO:0016366](http://purl.obolibrary.org/obo/MONDO_0016366) (maternal phenylketonuria), [MONDO:0017697](http://purl.obolibrary.org/obo/MONDO_0017697) (glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form), [MONDO:0015034](http://purl.obolibrary.org/obo/MONDO_0015034) (lissencephaly with cerebellar hypoplasia type A), [MONDO:0016365](http://purl.obolibrary.org/obo/MONDO_0016365) (familial primary hyperparathyroidism), [MONDO:0017696](http://purl.obolibrary.org/obo/MONDO_0017696) (glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form), [MONDO:0015035](http://purl.obolibrary.org/obo/MONDO_0015035) (lissencephaly with cerebellar hypoplasia type B), [MONDO:0016360](http://purl.obolibrary.org/obo/MONDO_0016360) (macrothrombocytopenia with mitral valve insufficiency), [MONDO:0017691](http://purl.obolibrary.org/obo/MONDO_0017691) (erythrocyte galactose epimerase deficiency), [MONDO:0017690](http://purl.obolibrary.org/obo/MONDO_0017690) (disorder of galactose metabolism), [MONDO:0017693](http://purl.obolibrary.org/obo/MONDO_0017693) (glycogen storage disease due to glycogen synthase deficiency), [MONDO:0015030](http://purl.obolibrary.org/obo/MONDO_0015030) (sclerosing perineurioma), [MONDO:0016362](http://purl.obolibrary.org/obo/MONDO_0016362) (attenuated familial adenomatous polyposis), [MONDO:0016361](http://purl.obolibrary.org/obo/MONDO_0016361) (isolated hereditary giant platelet disorder), [MONDO:0017692](http://purl.obolibrary.org/obo/MONDO_0017692) (generalized galactose epimerase deficiency), [MONDO:0015031](http://purl.obolibrary.org/obo/MONDO_0015031) (Extraneural perineurioma), [MONDO:0003047](http://purl.obolibrary.org/obo/MONDO_0003047) (thymus large cell carcinoma), [MONDO:0004379](http://purl.obolibrary.org/obo/MONDO_0004379) (female breast carcinoma), [MONDO:0003046](http://purl.obolibrary.org/obo/MONDO_0003046) (anus neoplasm), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0004377](http://purl.obolibrary.org/obo/MONDO_0004377) (pancreatic non-functioning delta cell tumor), [MONDO:0004378](http://purl.obolibrary.org/obo/MONDO_0004378) (pediatric cerebral ependymoblastoma), [MONDO:0003043](http://purl.obolibrary.org/obo/MONDO_0003043) (extraskeletal mesenchymal chondrosarcoma), [MONDO:0004376](http://purl.obolibrary.org/obo/MONDO_0004376) (infiltrating nipple syringomatous adenoma), [MONDO:0003042](http://purl.obolibrary.org/obo/MONDO_0003042) (adult mesenchymal chondrosarcoma), [MONDO:0004373](http://purl.obolibrary.org/obo/MONDO_0004373) (adult papillary meningioma), [MONDO:0003045](http://purl.obolibrary.org/obo/MONDO_0003045) (anal gland neoplasm), [MONDO:0003044](http://purl.obolibrary.org/obo/MONDO_0003044) (extraosseous chondrosarcoma), [MONDO:0004374](http://purl.obolibrary.org/obo/MONDO_0004374) (adult extraskeletal osteosarcoma), [MONDO:0004371](http://purl.obolibrary.org/obo/MONDO_0004371) (spinal multifocal clear cell meningioma), [MONDO:0003041](http://purl.obolibrary.org/obo/MONDO_0003041) (pediatric mesenchymal chondrosarcoma), [MONDO:0004370](http://purl.obolibrary.org/obo/MONDO_0004370) (sphenocavernous meningioma), [MONDO:0003040](http://purl.obolibrary.org/obo/MONDO_0003040) (retrograde amnesia), [MONDO:0017688](http://purl.obolibrary.org/obo/MONDO_0017688) (disorder of glycolysis), [MONDO:0016357](http://purl.obolibrary.org/obo/MONDO_0016357) (dysplastic cortical hyperostosis), [MONDO:0017687](http://purl.obolibrary.org/obo/MONDO_0017687) (disorder of neutral amino acid transport), [MONDO:0016356](http://purl.obolibrary.org/obo/MONDO_0016356) (diffuse cutaneous systemic sclerosis), [MONDO:0015026](http://purl.obolibrary.org/obo/MONDO_0015026) (cerebroretinal microangiopathy with calcifications and cysts 2;), [MONDO:0015027](http://purl.obolibrary.org/obo/MONDO_0015027) (familial isolated hyperparathyroidism), [MONDO:0016359](http://purl.obolibrary.org/obo/MONDO_0016359) (limited systemic sclerosis), [MONDO:0015028](http://purl.obolibrary.org/obo/MONDO_0015028) (48,XXYY syndrome), [MONDO:0017689](http://purl.obolibrary.org/obo/MONDO_0017689) (disorder of fructose metabolism), [MONDO:0016358](http://purl.obolibrary.org/obo/MONDO_0016358) (limited cutaneous systemic sclerosis), [MONDO:0017684](http://purl.obolibrary.org/obo/MONDO_0017684) (disorder of beta and omega amino acid metabolism), [MONDO:0017683](http://purl.obolibrary.org/obo/MONDO_0017683) (methylcobalamin deficiency type cblDv1), [MONDO:0017686](http://purl.obolibrary.org/obo/MONDO_0017686) (aminoacylase deficiency), [MONDO:0015023](http://purl.obolibrary.org/obo/MONDO_0015023) (nemaline myopathy 11), [MONDO:0016355](http://purl.obolibrary.org/obo/MONDO_0016355) (Semilobar holoprosencephaly), [MONDO:0016354](http://purl.obolibrary.org/obo/MONDO_0016354) (xeroderma pigmentosum-Cockayne syndrome complex), [MONDO:0015024](http://purl.obolibrary.org/obo/MONDO_0015024) (ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type; ECTD12), [MONDO:0017685](http://purl.obolibrary.org/obo/MONDO_0017685) (vitamin B12-responsive methylmalonic acidemia, type cblDv2), [MONDO:0017682](http://purl.obolibrary.org/obo/MONDO_0017682) (intellectual disability-polydactyly-uncombable hair syndrome), [MONDO:0016350](http://purl.obolibrary.org/obo/MONDO_0016350) (hydrocephalus-blue sclerae-nephropathy syndrome), [MONDO:0003058](http://purl.obolibrary.org/obo/MONDO_0003058) (microcystic meningioma), [MONDO:0003057](http://purl.obolibrary.org/obo/MONDO_0003057) (pediatric meningioma), [MONDO:0003059](http://purl.obolibrary.org/obo/MONDO_0003059) (bile duct cancer), [MONDO:0003054](http://purl.obolibrary.org/obo/MONDO_0003054) (benign meningioma), [MONDO:0004386](http://purl.obolibrary.org/obo/MONDO_0004386) (uterine corpus atypical polypoid adenomyoma), [MONDO:0003053](http://purl.obolibrary.org/obo/MONDO_0003053) (choroid plexus meningioma), [MONDO:0004384](http://purl.obolibrary.org/obo/MONDO_0004384) (maxillary sinus inverted papilloma), [MONDO:0003056](http://purl.obolibrary.org/obo/MONDO_0003056) (lymphoplasmacyte-rich meningioma), [MONDO:0003055](http://purl.obolibrary.org/obo/MONDO_0003055) (secretory meningioma), [MONDO:0003050](http://purl.obolibrary.org/obo/MONDO_0003050) (lung large cell carcinoma), [MONDO:0004383](http://purl.obolibrary.org/obo/MONDO_0004383) (adult central nervous system germinoma), [MONDO:0004380](http://purl.obolibrary.org/obo/MONDO_0004380) (dendritic cell sarcoma), [MONDO:0004381](http://purl.obolibrary.org/obo/MONDO_0004381) (pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia), [MONDO:0015029](http://purl.obolibrary.org/obo/MONDO_0015029) (reticular perineurioma), [MONDO:0016346](http://purl.obolibrary.org/obo/MONDO_0016346) (hydrocephalus-obesity-hypogonadism syndrome), [MONDO:0015015](http://purl.obolibrary.org/obo/MONDO_0015015) (congenital bile acid synthesis defect 6), [MONDO:0016348](http://purl.obolibrary.org/obo/MONDO_0016348) (non-genetic cardiac rhythm disease), [MONDO:0015016](http://purl.obolibrary.org/obo/MONDO_0015016) (anterior segment dysgenesis 6; ASGD6), [MONDO:0016347](http://purl.obolibrary.org/obo/MONDO_0016347) (rare cardiac rhythm disease), [MONDO:0015017](http://purl.obolibrary.org/obo/MONDO_0015017) (anterior segment dysgenesis 8; ASGD8), [MONDO:0015010](http://purl.obolibrary.org/obo/MONDO_0015010) (atypical glycine encephalopathy), [MONDO:0015011](http://purl.obolibrary.org/obo/MONDO_0015011) (optic atrophy 11; OPA11), [MONDO:0015012](http://purl.obolibrary.org/obo/MONDO_0015012) (mucopolysaccharidosis-plus syndrome; MPSPS), [MONDO:0016344](http://purl.obolibrary.org/obo/MONDO_0016344) (hydranencephaly (disease)), [MONDO:0015013](http://purl.obolibrary.org/obo/MONDO_0015013) (retinitis pigmentosa 77; RP77), [MONDO:0003029](http://purl.obolibrary.org/obo/MONDO_0003029) (skin angiosarcoma), [MONDO:0003028](http://purl.obolibrary.org/obo/MONDO_0003028) (thyroid sarcoma), [MONDO:0004357](http://purl.obolibrary.org/obo/MONDO_0004357) (carcinoma of supraglottis), [MONDO:0003025](http://purl.obolibrary.org/obo/MONDO_0003025) (conventional angiosarcoma), [MONDO:0003024](http://purl.obolibrary.org/obo/MONDO_0003024) (breast angiosarcoma), [MONDO:0004358](http://purl.obolibrary.org/obo/MONDO_0004358) (subglottis carcinoma), [MONDO:0004355](http://purl.obolibrary.org/obo/MONDO_0004355) (childhood leukemia), [MONDO:0003027](http://purl.obolibrary.org/obo/MONDO_0003027) (thyroid angiosarcoma), [MONDO:0003026](http://purl.obolibrary.org/obo/MONDO_0003026) (gallbladder angiosarcoma), [MONDO:0004356](http://purl.obolibrary.org/obo/MONDO_0004356) (childhood multilocular cystic kidney neoplasm), [MONDO:0003021](http://purl.obolibrary.org/obo/MONDO_0003021) (central nervous system angiosarcoma), [MONDO:0005684](http://purl.obolibrary.org/obo/MONDO_0005684) (bulbar polio), [MONDO:0004353](http://purl.obolibrary.org/obo/MONDO_0004353) (extrahepatic biliary papillomatosis), [MONDO:0004354](http://purl.obolibrary.org/obo/MONDO_0004354) (neonatal leukemia), [MONDO:0003023](http://purl.obolibrary.org/obo/MONDO_0003023) (aorta angiosarcoma), [MONDO:0004351](http://purl.obolibrary.org/obo/MONDO_0004351) (intraocular lymphoma), [MONDO:0003022](http://purl.obolibrary.org/obo/MONDO_0003022) (pediatric angiosarcoma), [MONDO:0004352](http://purl.obolibrary.org/obo/MONDO_0004352) (adult brain ependymoma), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0016349](http://purl.obolibrary.org/obo/MONDO_0016349) (congenital hydrocephalus), [MONDO:0018998](http://purl.obolibrary.org/obo/MONDO_0018998) (Leber congenital amaurosis), [MONDO:0016335](http://purl.obolibrary.org/obo/MONDO_0016335) (mitochondrial disease with dilated cardiomyopathy), [MONDO:0016334](http://purl.obolibrary.org/obo/MONDO_0016334) (neuromuscular disease with dilated cardiomyopathy), [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0017668](http://purl.obolibrary.org/obo/MONDO_0017668) (intellectual disability-short stature-hypertelorism syndrome), [MONDO:0018996](http://purl.obolibrary.org/obo/MONDO_0018996) (spinocerebellar ataxia with axonal neuropathy type 2), [MONDO:0015005](http://purl.obolibrary.org/obo/MONDO_0015005) (epilepsy, early-onset, vitamin B6-dependent; EPVB6D), [MONDO:0018997](http://purl.obolibrary.org/obo/MONDO_0018997) (Noonan syndrome), [MONDO:0016336](http://purl.obolibrary.org/obo/MONDO_0016336) (fatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy), [MONDO:0018994](http://purl.obolibrary.org/obo/MONDO_0018994) (Charcot-Marie-tooth disease type X), [MONDO:0016331](http://purl.obolibrary.org/obo/MONDO_0016331) (infantile systemic hyalinosis), [MONDO:0018995](http://purl.obolibrary.org/obo/MONDO_0018995) (Charcot-Marie-tooth disease type 4), [MONDO:0018992](http://purl.obolibrary.org/obo/MONDO_0018992) (IgG4-related thyroid disease), [MONDO:0015001](http://purl.obolibrary.org/obo/MONDO_0015001) (atrial fibrillation, familial, 18; ATFB18), [MONDO:0018993](http://purl.obolibrary.org/obo/MONDO_0018993) (Charcot-Marie-tooth disease type 2), [MONDO:0004368](http://purl.obolibrary.org/obo/MONDO_0004368) (sphenoorbital meningioma), [MONDO:0003036](http://purl.obolibrary.org/obo/MONDO_0003036) (mucoepidermoid carcinoma), [MONDO:0003035](http://purl.obolibrary.org/obo/MONDO_0003035) (ovarian angiosarcoma), [MONDO:0004366](http://purl.obolibrary.org/obo/MONDO_0004366) (mixed astrocytoma-ependymoma-oligodendroglioma), [MONDO:0004367](http://purl.obolibrary.org/obo/MONDO_0004367) (petroclival meningioma), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0003032](http://purl.obolibrary.org/obo/MONDO_0003032) (superior vena cava angiosarcoma), [MONDO:0003031](http://purl.obolibrary.org/obo/MONDO_0003031) (cervix endometrial stromal tumor), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0003034](http://purl.obolibrary.org/obo/MONDO_0003034) (mediastinum angiosarcoma), [MONDO:0005694](http://purl.obolibrary.org/obo/MONDO_0005694) (cecal neoplasm), [MONDO:0003033](http://purl.obolibrary.org/obo/MONDO_0003033) (prostate angiosarcoma), [MONDO:0004363](http://purl.obolibrary.org/obo/MONDO_0004363) (adult spinal cord glioblastoma multiforme), [MONDO:0004360](http://purl.obolibrary.org/obo/MONDO_0004360) (breast osteosarcoma), [MONDO:0004361](http://purl.obolibrary.org/obo/MONDO_0004361) (adult spinal cord ependymoma), [MONDO:0003030](http://purl.obolibrary.org/obo/MONDO_0003030) (cervical endometrial stromal sarcoma), [MONDO:0009630](http://purl.obolibrary.org/obo/MONDO_0009630) (microphthalmia, isolated, with coloboma 4), [MONDO:0008300](http://purl.obolibrary.org/obo/MONDO_0008300) (Prader-Willi syndrome), [MONDO:0009631](http://purl.obolibrary.org/obo/MONDO_0009631) (isolated microphthalmia 1), [MONDO:0008301](http://purl.obolibrary.org/obo/MONDO_0008301) (Guttmacher syndrome), [MONDO:0009635](http://purl.obolibrary.org/obo/MONDO_0009635) (microvillus inclusion disease), [MONDO:0008305](http://purl.obolibrary.org/obo/MONDO_0008305) (Currarino triad), [MONDO:0009636](http://purl.obolibrary.org/obo/MONDO_0009636) (mitochondrial DNA depletion syndrome 3), [MONDO:0009637](http://purl.obolibrary.org/obo/MONDO_0009637) (mitochondrial myopathy), [MONDO:0008306](http://purl.obolibrary.org/obo/MONDO_0008306) (ABri amyloidosis), [MONDO:0009638](http://purl.obolibrary.org/obo/MONDO_0009638) (mitochondrial myopathy with a defect 1N Mitochondrial-protein transport), [MONDO:0009639](http://purl.obolibrary.org/obo/MONDO_0009639) (mitochondrial myopathy with lactic acidosis), [MONDO:0010626](http://purl.obolibrary.org/obo/MONDO_0010626) (X-linked hyper-IgM syndrome), [MONDO:0010627](http://purl.obolibrary.org/obo/MONDO_0010627) (X-linked lymphoproliferative syndrome), [MONDO:0011957](http://purl.obolibrary.org/obo/MONDO_0011957) (retinal macular dystrophy type 2), [MONDO:0011952](http://purl.obolibrary.org/obo/MONDO_0011952) (amyotrophic lateral sclerosis type 7), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0011951](http://purl.obolibrary.org/obo/MONDO_0011951) (amyotrophic lateral sclerosis type 6), [MONDO:0011950](http://purl.obolibrary.org/obo/MONDO_0011950) (infantile-onset autosomal recessive nonprogressive cerebellar ataxia), [MONDO:0010624](http://purl.obolibrary.org/obo/MONDO_0010624) (ichthyosis follicularis-alopecia-photophobia syndrome), [MONDO:0011955](http://purl.obolibrary.org/obo/MONDO_0011955) (diabetes mellitus, Noninsulin-dependent, 4), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), [MONDO:0009620](http://purl.obolibrary.org/obo/MONDO_0009620) (Say-Barber-Miller syndrome), [MONDO:0009621](http://purl.obolibrary.org/obo/MONDO_0009621) (microcephaly-cervical spine fusion anomalies syndrome), [MONDO:0009622](http://purl.obolibrary.org/obo/MONDO_0009622) (Jawad syndrome), [MONDO:0009623](http://purl.obolibrary.org/obo/MONDO_0009623) (Nijmegen breakage syndrome), [MONDO:0009624](http://purl.obolibrary.org/obo/MONDO_0009624) (microcephaly and chorioretinopathy 1), [MONDO:0010617](http://purl.obolibrary.org/obo/MONDO_0010617) (male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome), [MONDO:0010618](http://purl.obolibrary.org/obo/MONDO_0010618) (familial isolated hypoparathyroidism due to agenesis of parathyroid gland), [MONDO:0009629](http://purl.obolibrary.org/obo/MONDO_0009629) (Desbuquois dysplasia 1), [MONDO:0011948](http://purl.obolibrary.org/obo/MONDO_0011948) (pontocerebellar hypoplasia type 3), [MONDO:0011946](http://purl.obolibrary.org/obo/MONDO_0011946) (Diaphanospondylodysostosis), [MONDO:0010619](http://purl.obolibrary.org/obo/MONDO_0010619) (X-linked hypophosphatemic rickets), [MONDO:0011945](http://purl.obolibrary.org/obo/MONDO_0011945) (Gaucher's disease perinatal lethal), [MONDO:0010613](http://purl.obolibrary.org/obo/MONDO_0010613) (glycerol kinase deficiency), [MONDO:0010614](http://purl.obolibrary.org/obo/MONDO_0010614) (X-linked congenital generalized hypertrichosis), [MONDO:0011944](http://purl.obolibrary.org/obo/MONDO_0011944) (SLEN3), [MONDO:0010611](http://purl.obolibrary.org/obo/MONDO_0010611) (hydrocephalus with stenosis of the aqueduct of sylvius), [MONDO:0011943](http://purl.obolibrary.org/obo/MONDO_0011943) (SLEN2), [MONDO:0011942](http://purl.obolibrary.org/obo/MONDO_0011942) (SLEN1), [MONDO:0009610](http://purl.obolibrary.org/obo/MONDO_0009610) (3-methylglutaconic aciduria type 1), [MONDO:0009611](http://purl.obolibrary.org/obo/MONDO_0009611) (3-methylglutaconic aciduria type 4), [MONDO:0009612](http://purl.obolibrary.org/obo/MONDO_0009612) (methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency), [MONDO:0009613](http://purl.obolibrary.org/obo/MONDO_0009613) (methylmalonic acidemia cb1A type), [MONDO:0009614](http://purl.obolibrary.org/obo/MONDO_0009614) (methylmalonic acidemia cb1B type), [MONDO:0009615](http://purl.obolibrary.org/obo/MONDO_0009615) (methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency), [MONDO:0009616](http://purl.obolibrary.org/obo/MONDO_0009616) (microcephalic primordial dwarfism, Toriello type), [MONDO:0011938](http://purl.obolibrary.org/obo/MONDO_0011938) (atrial heart septal defect 2), [MONDO:0009617](http://purl.obolibrary.org/obo/MONDO_0009617) (microcephaly 1, primary, autosomal recessive), [MONDO:0009618](http://purl.obolibrary.org/obo/MONDO_0009618) (microcephaly-cardiomyopathy syndrome), [MONDO:0010604](http://purl.obolibrary.org/obo/MONDO_0010604) (hemophilia B), [MONDO:0011936](http://purl.obolibrary.org/obo/MONDO_0011936) (microphthalmia with brain and digit anomalies), [MONDO:0011935](http://purl.obolibrary.org/obo/MONDO_0011935) (retinitis pigmentosa 30), [MONDO:0011930](http://purl.obolibrary.org/obo/MONDO_0011930) (epilepsy, familial adult myoclonic, 2), [MONDO:0010602](http://purl.obolibrary.org/obo/MONDO_0010602) (hemophilia A), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0011933](http://purl.obolibrary.org/obo/MONDO_0011933) (ALG2-CDG), [MONDO:0010603](http://purl.obolibrary.org/obo/MONDO_0010603) (hemophilia A with vascular abnormality), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0010601](http://purl.obolibrary.org/obo/MONDO_0010601) (gynecomastia, familial), [MONDO:0011931](http://purl.obolibrary.org/obo/MONDO_0011931) (OVCAS1), [MONDO:0009601](http://purl.obolibrary.org/obo/MONDO_0009601) (metaphyseal dysplasia without hypotrichosis), [MONDO:0009603](http://purl.obolibrary.org/obo/MONDO_0009603) (neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency), [MONDO:0009604](http://purl.obolibrary.org/obo/MONDO_0009604) (methemoglobin reductase deficiency), [MONDO:0009605](http://purl.obolibrary.org/obo/MONDO_0009605) (methemoglobinemia type 4), [MONDO:0011927](http://purl.obolibrary.org/obo/MONDO_0011927) (tufted angioma (disease)), [MONDO:0009606](http://purl.obolibrary.org/obo/MONDO_0009606) (methemoglobinemia due to deficiency of methemoglobin reductase), [MONDO:0009607](http://purl.obolibrary.org/obo/MONDO_0009607) (brain demyelination due to methionine adenosyltransferase deficiency), [MONDO:0011925](http://purl.obolibrary.org/obo/MONDO_0011925) (congenital merosin-deficient muscular dystrophy 1A), [MONDO:0009609](http://purl.obolibrary.org/obo/MONDO_0009609) (methylcobalamin deficiency type cblG), [MONDO:0011928](http://purl.obolibrary.org/obo/MONDO_0011928) (caudal duplication), [MONDO:0011923](http://purl.obolibrary.org/obo/MONDO_0011923) (osteoarthritis susceptibility 3), [MONDO:0011921](http://purl.obolibrary.org/obo/MONDO_0011921) (Aural atresia, congenital), [MONDO:0011920](http://purl.obolibrary.org/obo/MONDO_0011920) (autosomal dominant nonsyndromic deafness 48), [MONDO:0009670](http://purl.obolibrary.org/obo/MONDO_0009670) (lethal congenital contracture syndrome 1), [MONDO:0009671](http://purl.obolibrary.org/obo/MONDO_0009671) (intellectual disability-myopathy-short stature-endocrine defect syndrome), [MONDO:0008340](http://purl.obolibrary.org/obo/MONDO_0008340) (congenital ptosis (disease)), [MONDO:0010661](http://purl.obolibrary.org/obo/MONDO_0010661) (severe X-linked intellectual disability, Gustavson type), [MONDO:0009672](http://purl.obolibrary.org/obo/MONDO_0009672) (juvenile spinal muscular atrophy), [MONDO:0011991](http://purl.obolibrary.org/obo/MONDO_0011991) (autosomal recessive nonsyndromic deafness 38), [MONDO:0008341](http://purl.obolibrary.org/obo/MONDO_0008341) (ptosis-strabismus-ectopic pupils syndrome), [MONDO:0009673](http://purl.obolibrary.org/obo/MONDO_0009673) (intermediate spinal muscular atrophy), [MONDO:0009675](http://purl.obolibrary.org/obo/MONDO_0009675) (autosomal recessive limb-girdle muscular dystrophy type 2A), [MONDO:0021311](http://purl.obolibrary.org/obo/MONDO_0021311) (malignant tumor of parathyroid gland), [MONDO:0009676](http://purl.obolibrary.org/obo/MONDO_0009676) (autosomal recessive limb-girdle muscular dystrophy type 2B), [MONDO:0021310](http://purl.obolibrary.org/obo/MONDO_0021310) (malignant tumor of neck), [MONDO:0008346](http://purl.obolibrary.org/obo/MONDO_0008346) (pulmonary hemosiderosis), [MONDO:0021313](http://purl.obolibrary.org/obo/MONDO_0021313) (eyelid cancer), [MONDO:0009677](http://purl.obolibrary.org/obo/MONDO_0009677) (autosomal recessive limb-girdle muscular dystrophy type 2C), [MONDO:0008347](http://purl.obolibrary.org/obo/MONDO_0008347) (idiopathic and/or familial pulmonary arterial hypertension), [MONDO:0021312](http://purl.obolibrary.org/obo/MONDO_0021312) (malignant tumor of adrenal cortex), [MONDO:0009678](http://purl.obolibrary.org/obo/MONDO_0009678) (Fukuyama congenital muscular dystrophy), [MONDO:0021315](http://purl.obolibrary.org/obo/MONDO_0021315) (malignant tumor of nasopharynx), [MONDO:0009679](http://purl.obolibrary.org/obo/MONDO_0009679) (arthrogryposis due to muscular dystrophy), [MONDO:0021317](http://purl.obolibrary.org/obo/MONDO_0021317) (cancer of cerebellum), [MONDO:0021316](http://purl.obolibrary.org/obo/MONDO_0021316) (malignant tumor of minor salivary gland), [MONDO:0007005](http://purl.obolibrary.org/obo/MONDO_0007005) (ulcerative proctosigmoiditis), [MONDO:0007004](http://purl.obolibrary.org/obo/MONDO_0007004) (hypersensitivity reaction type III disease), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0010665](http://purl.obolibrary.org/obo/MONDO_0010665) (Wilson-Turner syndrome), [MONDO:0011995](http://purl.obolibrary.org/obo/MONDO_0011995) (cataract-congenital heart disease-neural tube defect syndrome), [MONDO:0010662](http://purl.obolibrary.org/obo/MONDO_0010662) (paraplegia-intellectual disability-hyperkeratosis syndrome), [MONDO:0011994](http://purl.obolibrary.org/obo/MONDO_0011994) (autosomal dominant nonsyndromic deafness 41), [MONDO:0010663](http://purl.obolibrary.org/obo/MONDO_0010663) (X-linked intellectual disability-hypotonic face syndrome), [MONDO:0010668](http://purl.obolibrary.org/obo/MONDO_0010668) (skeletal dysplasia-intellectual disability syndrome), [MONDO:0010669](http://purl.obolibrary.org/obo/MONDO_0010669) (syndactyly type 8), [MONDO:0011998](http://purl.obolibrary.org/obo/MONDO_0011998) (autosomal dominant slowed nerve conduction velocity), [MONDO:0010666](http://purl.obolibrary.org/obo/MONDO_0010666) (Miles-Carpenter syndrome), [MONDO:0011997](http://purl.obolibrary.org/obo/MONDO_0011997) (Hermansky-Pudlak syndrome 2), [MONDO:0021309](http://purl.obolibrary.org/obo/MONDO_0021309) (malignant neoplasm of endocervix), [MONDO:0009660](http://purl.obolibrary.org/obo/MONDO_0009660) (mucopolysaccharidosis type 4B), [MONDO:0011981](http://purl.obolibrary.org/obo/MONDO_0011981) (autoimmune thyroid disease, susceptibility to, 2), [MONDO:0010650](http://purl.obolibrary.org/obo/MONDO_0010650) (Melnick-Needles syndrome), [MONDO:0009661](http://purl.obolibrary.org/obo/MONDO_0009661) (mucopolysaccharidosis type 6), [MONDO:0011980](http://purl.obolibrary.org/obo/MONDO_0011980) (autoimmune thyroid disease, susceptibility to, 1), [MONDO:0009662](http://purl.obolibrary.org/obo/MONDO_0009662) (mucopolysaccharidosis type 7), [MONDO:0008331](http://purl.obolibrary.org/obo/MONDO_0008331) (pseudopapilledema (disease)), [MONDO:0008332](http://purl.obolibrary.org/obo/MONDO_0008332) (platelet-type bleeding disorder 3), [MONDO:0021300](http://purl.obolibrary.org/obo/MONDO_0021300) (adenoid cystic carcinoma of oropharynx), [MONDO:0009664](http://purl.obolibrary.org/obo/MONDO_0009664) (mulibrey nanism), [MONDO:0008333](http://purl.obolibrary.org/obo/MONDO_0008333) (pseudoxanthoma elasticum, Forme Fruste), [MONDO:0009665](http://purl.obolibrary.org/obo/MONDO_0009665) (biotinidase deficiency), [MONDO:0008335](http://purl.obolibrary.org/obo/MONDO_0008335) (short stature-craniofacial anomalies-genital hypoplasia syndrome), [MONDO:0009666](http://purl.obolibrary.org/obo/MONDO_0009666) (holocarboxylase synthetase deficiency), [MONDO:0021301](http://purl.obolibrary.org/obo/MONDO_0021301) (adenoma of nipple), [MONDO:0009667](http://purl.obolibrary.org/obo/MONDO_0009667) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3), [MONDO:0008337](http://purl.obolibrary.org/obo/MONDO_0008337) (familial pterygium of the conjunctiva), [MONDO:0009668](http://purl.obolibrary.org/obo/MONDO_0009668) (lethal multiple pterygium syndrome), [MONDO:0009669](http://purl.obolibrary.org/obo/MONDO_0009669) (Werdnig-Hoffmann disease), [MONDO:0008338](http://purl.obolibrary.org/obo/MONDO_0008338) (autosomal dominant multiple pterygium syndrome), [MONDO:0021303](http://purl.obolibrary.org/obo/MONDO_0021303) (adenoma of small intestine), [MONDO:0007017](http://purl.obolibrary.org/obo/MONDO_0007017) (vitreous detachment), [MONDO:0007016](http://purl.obolibrary.org/obo/MONDO_0007016) (vitamin a deficiency (disease)), [MONDO:0010653](http://purl.obolibrary.org/obo/MONDO_0010653) (Renpenning syndrome), [MONDO:0011985](http://purl.obolibrary.org/obo/MONDO_0011985) (hyper-IgM syndrome type 4), [MONDO:0010654](http://purl.obolibrary.org/obo/MONDO_0010654) (Partington syndrome), [MONDO:0011984](http://purl.obolibrary.org/obo/MONDO_0011984) (synpolydactyly type 2), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0010651](http://purl.obolibrary.org/obo/MONDO_0010651) (Menkes disease), [MONDO:0011983](http://purl.obolibrary.org/obo/MONDO_0011983) (autoimmune thyroid disease, susceptibility to, 4), [MONDO:0011982](http://purl.obolibrary.org/obo/MONDO_0011982) (autoimmune thyroid disease, susceptibility to, 3), [MONDO:0010657](http://purl.obolibrary.org/obo/MONDO_0010657) (methylmalonic acidemia with homocystinuria, type cblX), [MONDO:0011987](http://purl.obolibrary.org/obo/MONDO_0011987) (cone-rod dystrophy 13), [MONDO:0010655](http://purl.obolibrary.org/obo/MONDO_0010655) (X-linked intellectual disability with marfanoid habitus), [MONDO:0011986](http://purl.obolibrary.org/obo/MONDO_0011986) (tropical pancreatitis), [MONDO:0009650](http://purl.obolibrary.org/obo/MONDO_0009650) (inclusion-cell disease), [MONDO:0009651](http://purl.obolibrary.org/obo/MONDO_0009651) (pseudo-Hurler polydystrophy), [MONDO:0009652](http://purl.obolibrary.org/obo/MONDO_0009652) (mucolipidosis type III gamma), [MONDO:0009653](http://purl.obolibrary.org/obo/MONDO_0009653) (mucolipidosis type IV), [MONDO:0008322](http://purl.obolibrary.org/obo/MONDO_0008322) (pseudoachondroplasia), [MONDO:0008323](http://purl.obolibrary.org/obo/MONDO_0008323) (Liddle syndrome), [MONDO:0009654](http://purl.obolibrary.org/obo/MONDO_0009654) (Mucopolysaccharidoses, unclassified types), [MONDO:0009655](http://purl.obolibrary.org/obo/MONDO_0009655) (Sanfilippo syndrome type A), [MONDO:0009656](http://purl.obolibrary.org/obo/MONDO_0009656) (Sanfilippo syndrome type B), [MONDO:0009657](http://purl.obolibrary.org/obo/MONDO_0009657) (Sanfilippo syndrome type C), [MONDO:0009658](http://purl.obolibrary.org/obo/MONDO_0009658) (Sanfilippo syndrome type D), [MONDO:0008327](http://purl.obolibrary.org/obo/MONDO_0008327) (exfoliation syndrome), [MONDO:0009659](http://purl.obolibrary.org/obo/MONDO_0009659) (mucopolysaccharidosis type 4A), [MONDO:0008328](http://purl.obolibrary.org/obo/MONDO_0008328) (glaucoma 1, open angle, P), [MONDO:0008329](http://purl.obolibrary.org/obo/MONDO_0008329) (autosomal dominant pseudohypoaldosteronism type 1), [MONDO:0011979](http://purl.obolibrary.org/obo/MONDO_0011979) (adult-onset foveomacular vitelliform dystrophy), [MONDO:0010649](http://purl.obolibrary.org/obo/MONDO_0010649) (isolated congenital megalocornea), [MONDO:0011974](http://purl.obolibrary.org/obo/MONDO_0011974) (retinitis pigmentosa 7), [MONDO:0010642](http://purl.obolibrary.org/obo/MONDO_0010642) (Lesch-Nyhan phenotype with normal Hgprt), [MONDO:0010643](http://purl.obolibrary.org/obo/MONDO_0010643) (acute leukemia (disease)), [MONDO:0010640](http://purl.obolibrary.org/obo/MONDO_0010640) (Leber optic atrophy, susceptibility to), [MONDO:0011971](http://purl.obolibrary.org/obo/MONDO_0011971) (hyper-IgM syndrome type 5), [MONDO:0010646](http://purl.obolibrary.org/obo/MONDO_0010646) (macular dystrophy, X-linked), [MONDO:0010647](http://purl.obolibrary.org/obo/MONDO_0010647) (spermatogenic failure, X-linked, 2), [MONDO:0011977](http://purl.obolibrary.org/obo/MONDO_0011977) (8q22.1 microdeletion syndrome), [MONDO:0011976](http://purl.obolibrary.org/obo/MONDO_0011976) (lipodystrophy-intellectual disability-deafness syndrome), [MONDO:0010645](http://purl.obolibrary.org/obo/MONDO_0010645) (oculocerebrorenal syndrome), [MONDO:0011975](http://purl.obolibrary.org/obo/MONDO_0011975) (paternal uniparental disomy of chromosome 14), [MONDO:0009640](http://purl.obolibrary.org/obo/MONDO_0009640) (mitochondrial complex I deficiency), [MONDO:0008310](http://purl.obolibrary.org/obo/MONDO_0008310) (progeria), [MONDO:0009641](http://purl.obolibrary.org/obo/MONDO_0009641) (mitochondrial complex II deficiency), [MONDO:0008311](http://purl.obolibrary.org/obo/MONDO_0008311) (progeria-short stature-pigmented nevi syndrome), [MONDO:0009642](http://purl.obolibrary.org/obo/MONDO_0009642) (orofaciodigital syndrome type II), [MONDO:0008312](http://purl.obolibrary.org/obo/MONDO_0008312) (autosomal dominant prognathism), [MONDO:0009643](http://purl.obolibrary.org/obo/MONDO_0009643) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type a), [MONDO:0009644](http://purl.obolibrary.org/obo/MONDO_0009644) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type b), [MONDO:0008315](http://purl.obolibrary.org/obo/MONDO_0008315) (prostate cancer), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein C deficiency, autosomal dominant), [MONDO:0009647](http://purl.obolibrary.org/obo/MONDO_0009647) (Morquio syndrome C), [MONDO:0008318](http://purl.obolibrary.org/obo/MONDO_0008318) (Proteus syndrome), [MONDO:0008319](http://purl.obolibrary.org/obo/MONDO_0008319) (protoporphyria, erythropoietic), [MONDO:0011969](http://purl.obolibrary.org/obo/MONDO_0011969) (ALG8-CDG), [MONDO:0010637](http://purl.obolibrary.org/obo/MONDO_0010637) (keratosis follicularis spinulosa decalvans, X-linked), [MONDO:0011968](http://purl.obolibrary.org/obo/MONDO_0011968) (autosomal recessive limb-girdle muscular dystrophy type 2D), [MONDO:0010631](http://purl.obolibrary.org/obo/MONDO_0010631) (Bloch-Sulzberger syndrome), [MONDO:0011963](http://purl.obolibrary.org/obo/MONDO_0011963) (Joubert syndrome 2), [MONDO:0011962](http://purl.obolibrary.org/obo/MONDO_0011962) (endometrial cancer), [MONDO:0011967](http://purl.obolibrary.org/obo/MONDO_0011967) (heterotopia, periventricular, associated with chromosome 5P anomalies), [MONDO:0010635](http://purl.obolibrary.org/obo/MONDO_0010635) (hypogonadotropic hypogonadism 1 with or without anosmia), [MONDO:0011966](http://purl.obolibrary.org/obo/MONDO_0011966) (periventricular heterotopia with microcephaly, autosomal recessive), [MONDO:0011964](http://purl.obolibrary.org/obo/MONDO_0011964) (DPAGT1-CDG), [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0008381](http://purl.obolibrary.org/obo/MONDO_0008381) (dominant pericentral pigmentary retinopathy), [MONDO:0008382](http://purl.obolibrary.org/obo/MONDO_0008382) (retinoschisis, autosomal dominant), [MONDO:0008383](http://purl.obolibrary.org/obo/MONDO_0008383) (rheumatoid arthritis), [MONDO:0019039](http://purl.obolibrary.org/obo/MONDO_0019039) (rare hemorrhagic disorder due to a constitutional coagulation factors defect), [MONDO:0008386](http://purl.obolibrary.org/obo/MONDO_0008386) (Axenfeld-Rieger syndrome type 1), [MONDO:0019037](http://purl.obolibrary.org/obo/MONDO_0019037) (progressive supranuclear palsy), [MONDO:0008387](http://purl.obolibrary.org/obo/MONDO_0008387) (ring dermoid of cornea), [MONDO:0021355](http://purl.obolibrary.org/obo/MONDO_0021355) (neoplasm of esophagus), [MONDO:0019034](http://purl.obolibrary.org/obo/MONDO_0019034) (accessory pancreas), [MONDO:0021354](http://purl.obolibrary.org/obo/MONDO_0021354) (tumor of adipose tissue), [MONDO:0008389](http://purl.obolibrary.org/obo/MONDO_0008389) (autosomal dominant Robinow syndrome 1), [MONDO:0021357](http://purl.obolibrary.org/obo/MONDO_0021357) (tumor of salivary gland), [MONDO:0020027](http://purl.obolibrary.org/obo/MONDO_0020027) (rare allergic disease), [MONDO:0020028](http://purl.obolibrary.org/obo/MONDO_0020028) (rare allergic respiratory disease), [MONDO:0019031](http://purl.obolibrary.org/obo/MONDO_0019031) (thrombocytopenia with congenital dyserythropoietic anemia), [MONDO:0021358](http://purl.obolibrary.org/obo/MONDO_0021358) (neoplasm of hypopharynx), [MONDO:0021351](http://purl.obolibrary.org/obo/MONDO_0021351) (neoplasm of neck), [MONDO:0021350](http://purl.obolibrary.org/obo/MONDO_0021350) (neoplasm of thorax), [MONDO:0021353](http://purl.obolibrary.org/obo/MONDO_0021353) (tumor of uterus), [MONDO:0007045](http://purl.obolibrary.org/obo/MONDO_0007045) (acrofacial dysostosis, Catania type), [MONDO:0007044](http://purl.obolibrary.org/obo/MONDO_0007044) (acrodysostosis 1 with or without hormone resistance), [MONDO:0007043](http://purl.obolibrary.org/obo/MONDO_0007043) (Pfeiffer syndrome), [MONDO:0007042](http://purl.obolibrary.org/obo/MONDO_0007042) (Saethre-Chotzen syndrome), [MONDO:0007041](http://purl.obolibrary.org/obo/MONDO_0007041) (Apert syndrome), [MONDO:0007040](http://purl.obolibrary.org/obo/MONDO_0007040) (Sakati-Nyhan syndrome), [MONDO:0008390](http://purl.obolibrary.org/obo/MONDO_0008390) (Rombo syndrome), [MONDO:0008370](http://purl.obolibrary.org/obo/MONDO_0008370) (reticular dystrophy of retinal pigment epithelium), [MONDO:0010690](http://purl.obolibrary.org/obo/MONDO_0010690) (congenital stationary night blindness 1A), [MONDO:0008371](http://purl.obolibrary.org/obo/MONDO_0008371) (Dowling-Degos disease), [MONDO:0008372](http://purl.obolibrary.org/obo/MONDO_0008372) (retinal aplasia), [MONDO:0010693](http://purl.obolibrary.org/obo/MONDO_0010693) (nystagmus 1, congenital, X-linked), [MONDO:0019027](http://purl.obolibrary.org/obo/MONDO_0019027) (otopalatodigital syndrome), [MONDO:0008374](http://purl.obolibrary.org/obo/MONDO_0008374) (retinal cone dystrophy type 1), [MONDO:0010694](http://purl.obolibrary.org/obo/MONDO_0010694) (nystagmus, myoclonic), [MONDO:0019025](http://purl.obolibrary.org/obo/MONDO_0019025) (extracutaneous mastocytoma), [MONDO:0010691](http://purl.obolibrary.org/obo/MONDO_0010691) (Norrie disease), [MONDO:0008375](http://purl.obolibrary.org/obo/MONDO_0008375) (retinal detachment), [MONDO:0019026](http://purl.obolibrary.org/obo/MONDO_0019026) (autosomal recessive malignant osteopetrosis), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), [MONDO:0008377](http://purl.obolibrary.org/obo/MONDO_0008377) (retinitis pigmentosa 1), [MONDO:0021343](http://purl.obolibrary.org/obo/MONDO_0021343) (carcinoma of floor of mouth), [MONDO:0019024](http://purl.obolibrary.org/obo/MONDO_0019024) (mast cell sarcoma), [MONDO:0008378](http://purl.obolibrary.org/obo/MONDO_0008378) (retinitis pigmentosa 9), [MONDO:0008379](http://purl.obolibrary.org/obo/MONDO_0008379) (retinitis pigmentosa 10), [MONDO:0019022](http://purl.obolibrary.org/obo/MONDO_0019022) (sensorineural hearing loss-early graying-essential tremor syndrome), [MONDO:0021345](http://purl.obolibrary.org/obo/MONDO_0021345) (carcinoma of pharynx), [MONDO:0021348](http://purl.obolibrary.org/obo/MONDO_0021348) (neoplasm of testis), [MONDO:0007059](http://purl.obolibrary.org/obo/MONDO_0007059) (acrorenal syndrome), [MONDO:0007058](http://purl.obolibrary.org/obo/MONDO_0007058) (acropectorovertebral dysplasia), [MONDO:0007057](http://purl.obolibrary.org/obo/MONDO_0007057) (acroosteolysis dominant type), [MONDO:0007056](http://purl.obolibrary.org/obo/MONDO_0007056) (acroosteolysis), [MONDO:0007055](http://purl.obolibrary.org/obo/MONDO_0007055) (acromicric dysplasia), [MONDO:0010698](http://purl.obolibrary.org/obo/MONDO_0010698) (early-onset X-linked optic atrophy), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0007051](http://purl.obolibrary.org/obo/MONDO_0007051) (acromegaloid facial appearance syndrome), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), [MONDO:0009690](http://purl.obolibrary.org/obo/MONDO_0009690) (congenital myasthenic syndrome 10), [MONDO:0009691](http://purl.obolibrary.org/obo/MONDO_0009691) (mycosis fungoides), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0019019](http://purl.obolibrary.org/obo/MONDO_0019019) (osteogenesis imperfecta), [MONDO:0019016](http://purl.obolibrary.org/obo/MONDO_0019016) (maternally-inherited progressive external ophthalmoplegia), [MONDO:0010682](http://purl.obolibrary.org/obo/MONDO_0010682) (myoclonic epilepsy, progressive), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0010683](http://purl.obolibrary.org/obo/MONDO_0010683) (X-linked centronuclear myopathy), [MONDO:0019017](http://purl.obolibrary.org/obo/MONDO_0019017) (short fifth metacarpals-insulin resistance syndrome), [MONDO:0009695](http://purl.obolibrary.org/obo/MONDO_0009695) (myeloproliferative disease, autosomal recessive), [MONDO:0010680](http://purl.obolibrary.org/obo/MONDO_0010680) (X-linked Emery-Dreifuss muscular dystrophy), [MONDO:0019012](http://purl.obolibrary.org/obo/MONDO_0019012) (Carpenter syndrome), [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0019013](http://purl.obolibrary.org/obo/MONDO_0019013) (non-histaminic angioedema), [MONDO:0019010](http://purl.obolibrary.org/obo/MONDO_0019010) (congenital isolated hyperinsulinism), [MONDO:0021335](http://purl.obolibrary.org/obo/MONDO_0021335) (carcinoma of duodenum), [MONDO:0008369](http://purl.obolibrary.org/obo/MONDO_0008369) (proximal renal tubular acidosis), [MONDO:0020004](http://purl.obolibrary.org/obo/MONDO_0020004) (rare eye disease), [MONDO:0019011](http://purl.obolibrary.org/obo/MONDO_0019011) (Charcot-Marie-tooth disease type 1), [MONDO:0021337](http://purl.obolibrary.org/obo/MONDO_0021337) (tonsil carcinoma), [MONDO:0021339](http://purl.obolibrary.org/obo/MONDO_0021339) (carcinoma of hard palate), [MONDO:0007029](http://purl.obolibrary.org/obo/MONDO_0007029) (branchio-oto-renal syndrome), [MONDO:0021331](http://purl.obolibrary.org/obo/MONDO_0021331) (carcinoma of parotid gland), [MONDO:0010686](http://purl.obolibrary.org/obo/MONDO_0010686) (N syndrome), [MONDO:0010684](http://purl.obolibrary.org/obo/MONDO_0010684) (X-linked myopathy with excessive autophagy), [MONDO:0007021](http://purl.obolibrary.org/obo/MONDO_0007021) (wheat allergic reaction), [MONDO:0010685](http://purl.obolibrary.org/obo/MONDO_0010685) (MYP1), [MONDO:0010689](http://purl.obolibrary.org/obo/MONDO_0010689) (Charcot-Marie-tooth disease X-linked recessive 4), [MONDO:0019009](http://purl.obolibrary.org/obo/MONDO_0019009) (isolated focal cortical dysplasia), [MONDO:0021329](http://purl.obolibrary.org/obo/MONDO_0021329) (carcinoma of soft palate), [MONDO:0009680](http://purl.obolibrary.org/obo/MONDO_0009680) (congenital muscular dystrophy-infantile cataract-hypogonadism syndrome), [MONDO:0009681](http://purl.obolibrary.org/obo/MONDO_0009681) (Ullrich congenital muscular dystrophy 1), [MONDO:0019008](http://purl.obolibrary.org/obo/MONDO_0019008) (benign recurrent intrahepatic cholestasis), [MONDO:0009682](http://purl.obolibrary.org/obo/MONDO_0009682) (muscular dystrophy, congenital, with Rapid Progression), [MONDO:0010671](http://purl.obolibrary.org/obo/MONDO_0010671) (microphthalmia, syndromic 1), [MONDO:0010672](http://purl.obolibrary.org/obo/MONDO_0010672) (microphthalmia with linear skin defects syndrome), [MONDO:0009683](http://purl.obolibrary.org/obo/MONDO_0009683) (autosomal recessive limb-girdle muscular dystrophy type 2H), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0008353](http://purl.obolibrary.org/obo/MONDO_0008353) (Pruritic urticarial papules and plaques of pregnancy), [MONDO:0019004](http://purl.obolibrary.org/obo/MONDO_0019004) (kidney Wilms tumor), [MONDO:0009685](http://purl.obolibrary.org/obo/MONDO_0009685) (Miyoshi myopathy), [MONDO:0021322](http://purl.obolibrary.org/obo/MONDO_0021322) (malignant tumor of meninges), [MONDO:0019002](http://purl.obolibrary.org/obo/MONDO_0019002) (Lhermitte-Duclos disease), [MONDO:0021321](http://purl.obolibrary.org/obo/MONDO_0021321) (malignant tumor of extrahepatic bile duct), [MONDO:0009687](http://purl.obolibrary.org/obo/MONDO_0009687) (myasthenia, congenital, refractory to acetylcholinesterase inhibitors), [MONDO:0021324](http://purl.obolibrary.org/obo/MONDO_0021324) (malignant neoplasm of abdominal esophagus), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0008357](http://purl.obolibrary.org/obo/MONDO_0008357) (radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome), [MONDO:0021323](http://purl.obolibrary.org/obo/MONDO_0021323) (malignant neoplasm of chest wall), [MONDO:0009689](http://purl.obolibrary.org/obo/MONDO_0009689) (congenital myasthenic syndrome 6), [MONDO:0008358](http://purl.obolibrary.org/obo/MONDO_0008358) (radial ray hypoplasia-choanal atresia syndrome), [MONDO:0021326](http://purl.obolibrary.org/obo/MONDO_0021326) (malignant neoplasm of cervical esophagus), [MONDO:0008359](http://purl.obolibrary.org/obo/MONDO_0008359) (radio-renal syndrome), [MONDO:0021325](http://purl.obolibrary.org/obo/MONDO_0021325) (malignant neoplasm of thoracic esophagus), [MONDO:0021327](http://purl.obolibrary.org/obo/MONDO_0021327) (carcinoma of urethra), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0007037](http://purl.obolibrary.org/obo/MONDO_0007037) (achondroplasia), [MONDO:0021320](http://purl.obolibrary.org/obo/MONDO_0021320) (malignant tumor of floor of mouth), [MONDO:0007035](http://purl.obolibrary.org/obo/MONDO_0007035) (acanthosis nigricans (disease)), [MONDO:0007034](http://purl.obolibrary.org/obo/MONDO_0007034) (Adams-Oliver syndrome), [MONDO:0010675](http://purl.obolibrary.org/obo/MONDO_0010675) (muscular dystrophy, cardiac type), [MONDO:0010676](http://purl.obolibrary.org/obo/MONDO_0010676) (muscular dystrophy, Hemizygous lethal type), [MONDO:0007032](http://purl.obolibrary.org/obo/MONDO_0007032) (prune belly syndome), [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis type 2), [MONDO:0010679](http://purl.obolibrary.org/obo/MONDO_0010679) (Duchenne muscular dystrophy), [MONDO:0010677](http://purl.obolibrary.org/obo/MONDO_0010677) (muscular dystrophy, Mabry type), [MONDO:0010678](http://purl.obolibrary.org/obo/MONDO_0010678) (muscular dystrophy, progressive Pectorodorsal), [MONDO:0019078](http://purl.obolibrary.org/obo/MONDO_0019078) (Ritscher-Schinzel syndrome), [MONDO:0019079](http://purl.obolibrary.org/obo/MONDO_0019079) (proximal spinal muscular atrophy), [MONDO:0021398](http://purl.obolibrary.org/obo/MONDO_0021398) (polyp of rectum), [MONDO:0019077](http://purl.obolibrary.org/obo/MONDO_0019077) (warty dyskeratoma), [MONDO:0019074](http://purl.obolibrary.org/obo/MONDO_0019074) (bilateral acute depigmentation of the iris), [MONDO:0019075](http://purl.obolibrary.org/obo/MONDO_0019075) (Bosley-Salih-Alorainy syndrome), [MONDO:0019073](http://purl.obolibrary.org/obo/MONDO_0019073) (hypotrichosis-lymphedema-telangiectasia-renal defect syndrome), [MONDO:0019082](http://purl.obolibrary.org/obo/MONDO_0019082) (bullous pemphigoid), [MONDO:0021390](http://purl.obolibrary.org/obo/MONDO_0021390) (polyp of ureter), [MONDO:0021392](http://purl.obolibrary.org/obo/MONDO_0021392) (polyp of large intestine), [MONDO:0020063](http://purl.obolibrary.org/obo/MONDO_0020063) (malformation syndrome with hamartosis), [MONDO:0021394](http://purl.obolibrary.org/obo/MONDO_0021394) (polyp of vagina), [MONDO:0021396](http://purl.obolibrary.org/obo/MONDO_0021396) (polyp of vulva), [MONDO:0020066](http://purl.obolibrary.org/obo/MONDO_0020066) (Ehlers-Danlos syndrome), [MONDO:0007086](http://purl.obolibrary.org/obo/MONDO_0007086) (autosomal dominant Alport syndrome), [MONDO:0007083](http://purl.obolibrary.org/obo/MONDO_0007083) (autosomal dominant palmoplantar keratoderma and congenital alopecia), [MONDO:0007082](http://purl.obolibrary.org/obo/MONDO_0007082) (alopecia areata 1), [MONDO:0021388](http://purl.obolibrary.org/obo/MONDO_0021388) (neoplasm of chest wall), [MONDO:0019065](http://purl.obolibrary.org/obo/MONDO_0019065) (amyloidosis (disease)), [MONDO:0021389](http://purl.obolibrary.org/obo/MONDO_0021389) (neoplasm of aortic body), [MONDO:0019066](http://purl.obolibrary.org/obo/MONDO_0019066) (syndrome with brachydactyly), [MONDO:0021380](http://purl.obolibrary.org/obo/MONDO_0021380) (neoplasm of myocardium), [MONDO:0019071](http://purl.obolibrary.org/obo/MONDO_0019071) (pure hair and nail ectodermal dysplasia), [MONDO:0021381](http://purl.obolibrary.org/obo/MONDO_0021381) (neoplasm of pericardium), [MONDO:0021383](http://purl.obolibrary.org/obo/MONDO_0021383) (neoplasm of floor of mouth), [MONDO:0021386](http://purl.obolibrary.org/obo/MONDO_0021386) (neoplasm of mediastinum), [MONDO:0021385](http://purl.obolibrary.org/obo/MONDO_0021385) (tumor of extrahepatic bile duct), [MONDO:0007099](http://purl.obolibrary.org/obo/MONDO_0007099) (familial visceral amyloidosis), [MONDO:0007098](http://purl.obolibrary.org/obo/MONDO_0007098) (ACys amyloidosis), [MONDO:0007097](http://purl.obolibrary.org/obo/MONDO_0007097) (Finnish type amyloidosis), [MONDO:0007095](http://purl.obolibrary.org/obo/MONDO_0007095) (ameloonychohypohidrotic syndrome), [MONDO:0020045](http://purl.obolibrary.org/obo/MONDO_0020045) (autosomal recessive cerebellar ataxia due to a DNA repair defect), [MONDO:0019056](http://purl.obolibrary.org/obo/MONDO_0019056) (neuromuscular disease), [MONDO:0019057](http://purl.obolibrary.org/obo/MONDO_0019057) (rare constitutional aplastic anemia), [MONDO:0020046](http://purl.obolibrary.org/obo/MONDO_0020046) (autosomal recessive degenerative and progressive cerebellar ataxia), [MONDO:0021379](http://purl.obolibrary.org/obo/MONDO_0021379) (neoplasm of epicardium), [MONDO:0020047](http://purl.obolibrary.org/obo/MONDO_0020047) (autosomal recessive syndromic cerebellar ataxia), [MONDO:0021378](http://purl.obolibrary.org/obo/MONDO_0021378) (neoplasm of endocardium), [MONDO:0019052](http://purl.obolibrary.org/obo/MONDO_0019052) (inborn errors of metabolism), [MONDO:0019053](http://purl.obolibrary.org/obo/MONDO_0019053) (peroxisomal disease), [MONDO:0019050](http://purl.obolibrary.org/obo/MONDO_0019050) (hemoglobinopathy), [MONDO:0019060](http://purl.obolibrary.org/obo/MONDO_0019060) (rare bone tumor), [MONDO:0021370](http://purl.obolibrary.org/obo/MONDO_0021370) (neoplasm of minor salivary gland), [MONDO:0020041](http://purl.obolibrary.org/obo/MONDO_0020041) (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), [MONDO:0021373](http://purl.obolibrary.org/obo/MONDO_0021373) (neoplasm of parietal lobe), [MONDO:0021372](http://purl.obolibrary.org/obo/MONDO_0021372) (neoplasm of temporal lobe), [MONDO:0020042](http://purl.obolibrary.org/obo/MONDO_0020042) (syndrome with 46,XY disorder of sex development), [MONDO:0021375](http://purl.obolibrary.org/obo/MONDO_0021375) (tumor of duodenum), [MONDO:0020043](http://purl.obolibrary.org/obo/MONDO_0020043) (autosomal recessive congenital cerebellar ataxia), [MONDO:0021374](http://purl.obolibrary.org/obo/MONDO_0021374) (neoplasm of cerebrum), [MONDO:0007068](http://purl.obolibrary.org/obo/MONDO_0007068) (Adenylosuccinate lyase deficiency), [MONDO:0020044](http://purl.obolibrary.org/obo/MONDO_0020044) (autosomal recessive metabolic cerebellar ataxia), [MONDO:0007067](http://purl.obolibrary.org/obo/MONDO_0007067) (pyruvate kinase hyperactivity), [MONDO:0007064](http://purl.obolibrary.org/obo/MONDO_0007064) (adenosine deaminase deficiency), [MONDO:0007063](http://purl.obolibrary.org/obo/MONDO_0007063) (long bone adamantinoma), [MONDO:0007062](http://purl.obolibrary.org/obo/MONDO_0007062) (congenital absence/hypoplasia of fingers excluding thumb, unilateral), [MONDO:0007060](http://purl.obolibrary.org/obo/MONDO_0007060) (spermatogenic failure 6), [MONDO:0008392](http://purl.obolibrary.org/obo/MONDO_0008392) (Roussy-LC)vy syndrome), [MONDO:0007080](http://purl.obolibrary.org/obo/MONDO_0007080) (glucocorticoid-remediable aldosteronism), [MONDO:0008393](http://purl.obolibrary.org/obo/MONDO_0008393) (Rubinstein-Taybi syndrome due to CREBBP mutations), [MONDO:0008394](http://purl.obolibrary.org/obo/MONDO_0008394) (Silver-Russell syndrome), [MONDO:0008395](http://purl.obolibrary.org/obo/MONDO_0008395) (Ruvalcaba syndrome), [MONDO:0008396](http://purl.obolibrary.org/obo/MONDO_0008396) (Oculodental syndrome, Rutherfurd type), [MONDO:0008397](http://purl.obolibrary.org/obo/MONDO_0008397) (aplasia of lacrimal and salivary glands), [MONDO:0019047](http://purl.obolibrary.org/obo/MONDO_0019047) (rare deafness), [MONDO:0021366](http://purl.obolibrary.org/obo/MONDO_0021366) (neoplasm of middle ear), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019045](http://purl.obolibrary.org/obo/MONDO_0019045) (rare sleep disorder), [MONDO:0020034](http://purl.obolibrary.org/obo/MONDO_0020034) (rare respiratory tumor), [MONDO:0020035](http://purl.obolibrary.org/obo/MONDO_0020035) (rare otorhinolaryngologic tumor), [MONDO:0020036](http://purl.obolibrary.org/obo/MONDO_0020036) (rare nervous system tumor), [MONDO:0021368](http://purl.obolibrary.org/obo/MONDO_0021368) (neoplasm of major salivary gland), [MONDO:0020037](http://purl.obolibrary.org/obo/MONDO_0020037) (rare gynecological tumor), [MONDO:0019044](http://purl.obolibrary.org/obo/MONDO_0019044) (tumor of hematopoietic and lymphoid tissues), [MONDO:0019041](http://purl.obolibrary.org/obo/MONDO_0019041) (rare genetic tumor), [MONDO:0021360](http://purl.obolibrary.org/obo/MONDO_0021360) (tumor of parathyroid gland), [MONDO:0020031](http://purl.obolibrary.org/obo/MONDO_0020031) (rare tumor), [MONDO:0021364](http://purl.obolibrary.org/obo/MONDO_0021364) (neoplasm of oropharynx), [MONDO:0020032](http://purl.obolibrary.org/obo/MONDO_0020032) (rare urinary tract tumor), [MONDO:0020033](http://purl.obolibrary.org/obo/MONDO_0020033) (rare digestive tumor), [MONDO:0007078](http://purl.obolibrary.org/obo/MONDO_0007078) (Albright's hereditary osteodystrophy), [MONDO:0007077](http://purl.obolibrary.org/obo/MONDO_0007077) (Tietz syndrome), [MONDO:0007075](http://purl.obolibrary.org/obo/MONDO_0007075) (alacrima, congenital, autosomal dominant), [MONDO:0007073](http://purl.obolibrary.org/obo/MONDO_0007073) (Hypoglossia-hypodactyly syndrome), [MONDO:0007072](http://purl.obolibrary.org/obo/MONDO_0007072) (adult syndrome), [MONDO:0007071](http://purl.obolibrary.org/obo/MONDO_0007071) (adrenocortical hypofunction, chronic primary congenital), [MONDO:0020098](http://purl.obolibrary.org/obo/MONDO_0020098) (constitutional anemia due to iron metabolism disorder), [MONDO:0020099](http://purl.obolibrary.org/obo/MONDO_0020099) (constitutional sideroblastic anemia), [MONDO:0020089](http://purl.obolibrary.org/obo/MONDO_0020089) (acquired lipodystrophy), [MONDO:0019098](http://purl.obolibrary.org/obo/MONDO_0019098) (autoimmune thrombocytopenia), [MONDO:0019099](http://purl.obolibrary.org/obo/MONDO_0019099) (rare soft tissue tumor), [MONDO:0019097](http://purl.obolibrary.org/obo/MONDO_0019097) (rare hemorrhagic disorder due to a constitutional platelet anomaly), [MONDO:0020081](http://purl.obolibrary.org/obo/MONDO_0020081) (macrophage or histiocytic tumor), [MONDO:0020082](http://purl.obolibrary.org/obo/MONDO_0020082) (dendritic cell tumor), [MONDO:0020083](http://purl.obolibrary.org/obo/MONDO_0020083) (immunodeficiency-associated lymphoproliferative disease), [MONDO:0020084](http://purl.obolibrary.org/obo/MONDO_0020084) (lymphoproliferative disease associated with primary immune disease), [MONDO:0020087](http://purl.obolibrary.org/obo/MONDO_0020087) (genetic lipodystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0020080](http://purl.obolibrary.org/obo/MONDO_0020080) (histiocytic and dendritic cell tumor), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0019088](http://purl.obolibrary.org/obo/MONDO_0019088) (post-transplant lymphoproliferative disease), [MONDO:0019085](http://purl.obolibrary.org/obo/MONDO_0019085) (vernal keratoconjunctivitis), [MONDO:0019086](http://purl.obolibrary.org/obo/MONDO_0019086) (carcinoma of esophagus), [MONDO:0019083](http://purl.obolibrary.org/obo/MONDO_0019083) (Leigh syndrome with cardiomyopathy), [MONDO:0019093](http://purl.obolibrary.org/obo/MONDO_0019093) (immunodeficiency due to selective anti-polysaccharide antibody deficiency), [MONDO:0019091](http://purl.obolibrary.org/obo/MONDO_0019091) (bronchopulmonary dysplasia), [MONDO:0020075](http://purl.obolibrary.org/obo/MONDO_0020075) (genetic non-syndromic obesity), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0020077](http://purl.obolibrary.org/obo/MONDO_0020077) (myelodysplastic/myeloproliferative disease), [MONDO:0009710](http://purl.obolibrary.org/obo/MONDO_0009710) (myotonia congenita), [MONDO:0009711](http://purl.obolibrary.org/obo/MONDO_0009711) (congenital fiber-type disproportion myopathy), [MONDO:0009712](http://purl.obolibrary.org/obo/MONDO_0009712) (congenital multicore myopathy with external ophthalmoplegia), [MONDO:0009713](http://purl.obolibrary.org/obo/MONDO_0009713) (MYP18), [MONDO:0009714](http://purl.obolibrary.org/obo/MONDO_0009714) (myosclerosis), [MONDO:0009715](http://purl.obolibrary.org/obo/MONDO_0009715) (myotonia congenita, autosomal recessive), [MONDO:0009716](http://purl.obolibrary.org/obo/MONDO_0009716) (Richieri Costa-da Silva syndrome), [MONDO:0009717](http://purl.obolibrary.org/obo/MONDO_0009717) (Schwartz-Jampel syndrome), [MONDO:0010703](http://purl.obolibrary.org/obo/MONDO_0010703) (ornithine carbamoyltransferase deficiency), [MONDO:0009719](http://purl.obolibrary.org/obo/MONDO_0009719) (familial atrial myxoma), [MONDO:0010704](http://purl.obolibrary.org/obo/MONDO_0010704) (Otopalatodigital syndrome type 1), [MONDO:0010708](http://purl.obolibrary.org/obo/MONDO_0010708) (W syndrome), [MONDO:0010702](http://purl.obolibrary.org/obo/MONDO_0010702) (orofaciodigital syndrome I), [MONDO:0009700](http://purl.obolibrary.org/obo/MONDO_0009700) (Carey-Fineman-Ziter  syndrome), [MONDO:0009703](http://purl.obolibrary.org/obo/MONDO_0009703) (myopathy with abnormal lipid metabolism), [MONDO:0009704](http://purl.obolibrary.org/obo/MONDO_0009704) (carnitine palmitoyl transferase II deficiency, myopathic form), [MONDO:0009705](http://purl.obolibrary.org/obo/MONDO_0009705) (carnitine palmitoyltransferase i deficiency), [MONDO:0009706](http://purl.obolibrary.org/obo/MONDO_0009706) (hereditary myopathy with lactic acidosis due to ISCU deficiency), [MONDO:0009708](http://purl.obolibrary.org/obo/MONDO_0009708) (myopathy, Myosin storage, autosomal recessive), [MONDO:0009709](http://purl.obolibrary.org/obo/MONDO_0009709) (myopathy, centronuclear, 2), [MONDO:0008421](http://purl.obolibrary.org/obo/MONDO_0008421) (flat face-microstomia-ear anomaly syndrome), [MONDO:0008422](http://purl.obolibrary.org/obo/MONDO_0008422) (autosomal dominant sideroblastic anemia), [MONDO:0008423](http://purl.obolibrary.org/obo/MONDO_0008423) (sinus node disease and myopia), [MONDO:0008425](http://purl.obolibrary.org/obo/MONDO_0008425) (omphalocele syndrome, Shprintzen-Goldberg type), [MONDO:0009756](http://purl.obolibrary.org/obo/MONDO_0009756) (Niemann-Pick disease type A), [MONDO:0008426](http://purl.obolibrary.org/obo/MONDO_0008426) (Shprintzen-Goldberg syndrome), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0009758](http://purl.obolibrary.org/obo/MONDO_0009758) (congenital stationary night blindness 1B), [MONDO:0008428](http://purl.obolibrary.org/obo/MONDO_0008428) (septooptic dysplasia), [MONDO:0009759](http://purl.obolibrary.org/obo/MONDO_0009759) (mosaic variegated aneuploidy syndrome 1), [MONDO:0010749](http://purl.obolibrary.org/obo/MONDO_0010749) (trigonocephaly-short stature-developmental delay syndrome), [MONDO:0008429](http://purl.obolibrary.org/obo/MONDO_0008429) (Singleton-Merten dysplasia), [MONDO:0010742](http://purl.obolibrary.org/obo/MONDO_0010742) (Pentalogy of Cantrell), [MONDO:0010745](http://purl.obolibrary.org/obo/MONDO_0010745) (beta-thalassemia-X-linked thrombocytopenia syndrome), [MONDO:0010743](http://purl.obolibrary.org/obo/MONDO_0010743) (X-linked thrombocytopenia with normal platelets), [MONDO:0009740](http://purl.obolibrary.org/obo/MONDO_0009740) (Neurofaciodigitorenal syndrome), [MONDO:0009741](http://purl.obolibrary.org/obo/MONDO_0009741) (neuroblastoma, susceptibility to), [MONDO:0008410](http://purl.obolibrary.org/obo/MONDO_0008410) (Scheuermann's disease), [MONDO:0009742](http://purl.obolibrary.org/obo/MONDO_0009742) (neuroectodermal melanolysosomal disease), [MONDO:0008411](http://purl.obolibrary.org/obo/MONDO_0008411) (ulnar-mammary syndrome), [MONDO:0009744](http://purl.obolibrary.org/obo/MONDO_0009744) (neuronal ceroid lipofuscinosis 1), [MONDO:0009745](http://purl.obolibrary.org/obo/MONDO_0009745) (neuronal ceroid lipofuscinosis 5), [MONDO:0009747](http://purl.obolibrary.org/obo/MONDO_0009747) (Navajo neurohepatopathy), [MONDO:0008417](http://purl.obolibrary.org/obo/MONDO_0008417) (sclerocornea, autosomal dominant), [MONDO:0010738](http://purl.obolibrary.org/obo/MONDO_0010738) (spondylometaphyseal dysplasia, golden type), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0010736](http://purl.obolibrary.org/obo/MONDO_0010736) (split hand-foot malformation 2), [MONDO:0010737](http://purl.obolibrary.org/obo/MONDO_0010737) (spondyloepiphyseal dysplasia tarda, X-linked), [MONDO:0010730](http://purl.obolibrary.org/obo/MONDO_0010730) (combined immunodeficiency, X-linked), [MONDO:0010731](http://purl.obolibrary.org/obo/MONDO_0010731) (Simpson-Golabi-Behmel syndrome), [MONDO:0010735](http://purl.obolibrary.org/obo/MONDO_0010735) (Kennedy's disease), [MONDO:0010732](http://purl.obolibrary.org/obo/MONDO_0010732) (spastic paraparesis-deafness syndrome), [MONDO:0010733](http://purl.obolibrary.org/obo/MONDO_0010733) (hereditary spastic paraplegia 2), [MONDO:0009730](http://purl.obolibrary.org/obo/MONDO_0009730) (Nephrosialidosis), [MONDO:0009731](http://purl.obolibrary.org/obo/MONDO_0009731) (nephrosis-deafness-urinary tract-digital malformations syndrome), [MONDO:0008401](http://purl.obolibrary.org/obo/MONDO_0008401) (pleomorphic adenoma), [MONDO:0008402](http://purl.obolibrary.org/obo/MONDO_0008402) (cleft palate-large ears-small head syndrome), [MONDO:0009734](http://purl.obolibrary.org/obo/MONDO_0009734) (hyperinsulinemic hypoglycemia, familial, 1), [MONDO:0008403](http://purl.obolibrary.org/obo/MONDO_0008403) (scalp defects-postaxial polydactyly syndrome), [MONDO:0009735](http://purl.obolibrary.org/obo/MONDO_0009735) (Netherton syndrome), [MONDO:0008404](http://purl.obolibrary.org/obo/MONDO_0008404) (scalp-ear-nipple syndrome), [MONDO:0009736](http://purl.obolibrary.org/obo/MONDO_0009736) (Neu-Laxova syndrome 1), [MONDO:0009737](http://purl.obolibrary.org/obo/MONDO_0009737) (Galactosialidosis), [MONDO:0008406](http://purl.obolibrary.org/obo/MONDO_0008406) (autosomal recessive Emery-Dreifuss muscular dystrophy), [MONDO:0009738](http://purl.obolibrary.org/obo/MONDO_0009738) (sialidosis type 2), [MONDO:0008407](http://purl.obolibrary.org/obo/MONDO_0008407) (neurogenic scapuloperoneal syndrome, Kaeser type), [MONDO:0010727](http://purl.obolibrary.org/obo/MONDO_0010727) (Russell-silver syndrome, X-linked), [MONDO:0010728](http://purl.obolibrary.org/obo/MONDO_0010728) (SCARF syndrome), [MONDO:0008408](http://purl.obolibrary.org/obo/MONDO_0008408) (scapuloperoneal spinal muscular atrophy), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0008409](http://purl.obolibrary.org/obo/MONDO_0008409) (MYH7-related late-onset scapuloperoneal muscular dystrophy), [MONDO:0010725](http://purl.obolibrary.org/obo/MONDO_0010725) (X-linked retinoschisis), [MONDO:0010720](http://purl.obolibrary.org/obo/MONDO_0010720) (partial androgen insensitivity syndrome), [MONDO:0010723](http://purl.obolibrary.org/obo/MONDO_0010723) (retinitis pigmentosa 2), [MONDO:0010722](http://purl.obolibrary.org/obo/MONDO_0010722) (X-linked retinal dysplasia), [MONDO:0009720](http://purl.obolibrary.org/obo/MONDO_0009720) (Keipert syndrome), [MONDO:0009721](http://purl.obolibrary.org/obo/MONDO_0009721) (Nathalie syndrome), [MONDO:0009722](http://purl.obolibrary.org/obo/MONDO_0009722) (Native american myopathy), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0009725](http://purl.obolibrary.org/obo/MONDO_0009725) (nemaline myopathy 2), [MONDO:0009727](http://purl.obolibrary.org/obo/MONDO_0009727) (atelosteogenesis type II), [MONDO:0010716](http://purl.obolibrary.org/obo/MONDO_0010716) (X-linked lethal multiple pterygium syndrome), [MONDO:0010717](http://purl.obolibrary.org/obo/MONDO_0010717) (pyruvate dehydrogenase E1-alpha deficiency), [MONDO:0009729](http://purl.obolibrary.org/obo/MONDO_0009729) (nephropathy-deafness-hyperparathyroidism syndrome), [MONDO:0010714](http://purl.obolibrary.org/obo/MONDO_0010714) (Pelizaeus-Merzbacher disease), [MONDO:0010718](http://purl.obolibrary.org/obo/MONDO_0010718) (absent radius-anogenital anomalies syndrome), [MONDO:0010712](http://purl.obolibrary.org/obo/MONDO_0010712) (panhypopituitarism, X-linked), [MONDO:0010710](http://purl.obolibrary.org/obo/MONDO_0010710) (Pierre robin syndrome-faciodigital anomaly syndrome), [MONDO:0010711](http://purl.obolibrary.org/obo/MONDO_0010711) (TARP syndrome), [MONDO:0020108](http://purl.obolibrary.org/obo/MONDO_0020108) (autoimmune hemolytic anemia), [MONDO:0019119](http://purl.obolibrary.org/obo/MONDO_0019119) (muscular channelopathy), [MONDO:0021439](http://purl.obolibrary.org/obo/MONDO_0021439) (benign neoplasm of pituitary gland), [MONDO:0020109](http://purl.obolibrary.org/obo/MONDO_0020109) (constitutional megaloblastic anemia due to vitamin B12 metabolism disorder), [MONDO:0008460](http://purl.obolibrary.org/obo/MONDO_0008460) (splenogonadal fusion-limb defects-micrognathia syndrome), [MONDO:0019118](http://purl.obolibrary.org/obo/MONDO_0019118) (retinal dystrophy), [MONDO:0009792](http://purl.obolibrary.org/obo/MONDO_0009792) (ichthyosis-oral and digital anomalies syndrome), [MONDO:0019115](http://purl.obolibrary.org/obo/MONDO_0019115) (obesity due to melanocortin 4 receptor deficiency), [MONDO:0019116](http://purl.obolibrary.org/obo/MONDO_0019116) (catecholamine-producing tumor), [MONDO:0009793](http://purl.obolibrary.org/obo/MONDO_0009793) (orofaciodigital syndrome III), [MONDO:0010782](http://purl.obolibrary.org/obo/MONDO_0010782) (myopathy, lactic acidosis, and sideroblastic anemia 3), [MONDO:0009794](http://purl.obolibrary.org/obo/MONDO_0009794) (orofaciodigital syndrome IV), [MONDO:0008464](http://purl.obolibrary.org/obo/MONDO_0008464) (split hand-foot malformation 1), [MONDO:0010780](http://purl.obolibrary.org/obo/MONDO_0010780) (mitochondrial myopathy with reversible cytochrome c oxidase deficiency), [MONDO:0009795](http://purl.obolibrary.org/obo/MONDO_0009795) (orofaciodigital syndrome IX), [MONDO:0020100](http://purl.obolibrary.org/obo/MONDO_0020100) (rare hemolytic anemia), [MONDO:0009796](http://purl.obolibrary.org/obo/MONDO_0009796) (gyrate atrophy), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0008465](http://purl.obolibrary.org/obo/MONDO_0008465) (Patterson-Stevenson-Fontaine syndrome), [MONDO:0021431](http://purl.obolibrary.org/obo/MONDO_0021431) (squamous cell carcinoma of buccal mucosa), [MONDO:0020101](http://purl.obolibrary.org/obo/MONDO_0020101) (rare constitutional hemolytic anemia due to a red cell membrane anomaly), [MONDO:0008466](http://purl.obolibrary.org/obo/MONDO_0008466) (Karsch-Neugebauer syndrome), [MONDO:0019112](http://purl.obolibrary.org/obo/MONDO_0019112) (cancer-associated retinopathy), [MONDO:0009797](http://purl.obolibrary.org/obo/MONDO_0009797) (orotic aciduria), [MONDO:0008467](http://purl.obolibrary.org/obo/MONDO_0008467) (Czeizel-Losonci syndrome), [MONDO:0020102](http://purl.obolibrary.org/obo/MONDO_0020102) (hereditary stomatocytosis), [MONDO:0009799](http://purl.obolibrary.org/obo/MONDO_0009799) (pachydermoperiostosis), [MONDO:0020103](http://purl.obolibrary.org/obo/MONDO_0020103) (constitutional hemolytic anemia due to acanthocytosis), [MONDO:0008469](http://purl.obolibrary.org/obo/MONDO_0008469) (spondyloepimetaphyseal dysplasia-hypotrichosis syndrome), [MONDO:0020104](http://purl.obolibrary.org/obo/MONDO_0020104) (rare constitutional hemolytic anemia due to an enzyme disorder), [MONDO:0020105](http://purl.obolibrary.org/obo/MONDO_0020105) (hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies), [MONDO:0020106](http://purl.obolibrary.org/obo/MONDO_0020106) (hemolytic anemia due to a disorder of glycolytic enzymes), [MONDO:0021437](http://purl.obolibrary.org/obo/MONDO_0021437) (lipoma of stomach), [MONDO:0020107](http://purl.obolibrary.org/obo/MONDO_0020107) (hemolytic anemia due to an erythrocyte nucleotide metabolism disorder), [MONDO:0007127](http://purl.obolibrary.org/obo/MONDO_0007127) (diffuse idiopathic skeletal hyperostosis), [MONDO:0007124](http://purl.obolibrary.org/obo/MONDO_0007124) (ankyloblepharon-ectodermal defects-cleft lip/palate syndrome), [MONDO:0007123](http://purl.obolibrary.org/obo/MONDO_0007123) (ankyloblepharon filiforme adnatum-cleft palate syndrome), [MONDO:0010785](http://purl.obolibrary.org/obo/MONDO_0010785) (maternally-inherited diabetes and deafness), [MONDO:0010786](http://purl.obolibrary.org/obo/MONDO_0010786) (chronic diarrhea with villous atrophy), [MONDO:0007120](http://purl.obolibrary.org/obo/MONDO_0007120) (aniridia-absent patella syndrome), [MONDO:0010789](http://purl.obolibrary.org/obo/MONDO_0010789) (MELAS syndrome), [MONDO:0010787](http://purl.obolibrary.org/obo/MONDO_0010787) (Kearns-Sayre syndrome), [MONDO:0010788](http://purl.obolibrary.org/obo/MONDO_0010788) (Leber hereditary optic neuropathy), [MONDO:0021429](http://purl.obolibrary.org/obo/MONDO_0021429) (squamous cell carcinoma of floor of mouth), [MONDO:0009780](http://purl.obolibrary.org/obo/MONDO_0009780) (lethal omphalocele-cleft palate syndrome), [MONDO:0019107](http://purl.obolibrary.org/obo/MONDO_0019107) (Rh deficiency syndrome), [MONDO:0008451](http://purl.obolibrary.org/obo/MONDO_0008451) (distal hereditary motor neuropathy type 1), [MONDO:0019105](http://purl.obolibrary.org/obo/MONDO_0019105) (renal nutcracker syndrome), [MONDO:0010771](http://purl.obolibrary.org/obo/MONDO_0010771) (histiocytoid cardiomyopathy), [MONDO:0009783](http://purl.obolibrary.org/obo/MONDO_0009783) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 1), [MONDO:0019102](http://purl.obolibrary.org/obo/MONDO_0019102) (dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome), [MONDO:0008452](http://purl.obolibrary.org/obo/MONDO_0008452) (spinal muscular atrophy, facioscapulohumeral type), [MONDO:0008453](http://purl.obolibrary.org/obo/MONDO_0008453) (adult-onset proximal spinal muscular atrophy, autosomal dominant), [MONDO:0019103](http://purl.obolibrary.org/obo/MONDO_0019103) (benign exophthalmos syndrome), [MONDO:0019100](http://purl.obolibrary.org/obo/MONDO_0019100) (neuromyelitis optica), [MONDO:0008454](http://purl.obolibrary.org/obo/MONDO_0008454) (spinal intradural arachnoid cysts), [MONDO:0009785](http://purl.obolibrary.org/obo/MONDO_0009785) (Opsismodysplasia), [MONDO:0021420](http://purl.obolibrary.org/obo/MONDO_0021420) (polyp of vocal cord), [MONDO:0019101](http://purl.obolibrary.org/obo/MONDO_0019101) (retinal capillary malformation), [MONDO:0008455](http://purl.obolibrary.org/obo/MONDO_0008455) (spinal muscular atrophy, segmental), [MONDO:0009786](http://purl.obolibrary.org/obo/MONDO_0009786) (OPA6), [MONDO:0009787](http://purl.obolibrary.org/obo/MONDO_0009787) (3-methylglutaconic aciduria type 3), [MONDO:0008457](http://purl.obolibrary.org/obo/MONDO_0008457) (spinocerebellar ataxia type 6), [MONDO:0008458](http://purl.obolibrary.org/obo/MONDO_0008458) (spinocerebellar ataxia type 2), [MONDO:0021424](http://purl.obolibrary.org/obo/MONDO_0021424) (hemangiopericytoma of skin), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0007138](http://purl.obolibrary.org/obo/MONDO_0007138) (anterior segment mesenchymal dysgenesis), [MONDO:0007136](http://purl.obolibrary.org/obo/MONDO_0007136) (genetic anorectal anomalies), [MONDO:0007135](http://purl.obolibrary.org/obo/MONDO_0007135) (nonsyndromic congenital nail disorder 6), [MONDO:0007134](http://purl.obolibrary.org/obo/MONDO_0007134) (Cooks syndrome), [MONDO:0010775](http://purl.obolibrary.org/obo/MONDO_0010775) (retinitis pigmentosa-deafness syndrome), [MONDO:0010772](http://purl.obolibrary.org/obo/MONDO_0010772) (Leber optic atrophy and dystonia), [MONDO:0007131](http://purl.obolibrary.org/obo/MONDO_0007131) (anonychia with flexural pigmentation), [MONDO:0010773](http://purl.obolibrary.org/obo/MONDO_0010773) (myopathy and diabetes mellitus), [MONDO:0010779](http://purl.obolibrary.org/obo/MONDO_0010779) (mitochondrial non-syndromic sensorineural deafness), [MONDO:0021418](http://purl.obolibrary.org/obo/MONDO_0021418) (polyp of ethmoidal sinus), [MONDO:0009770](http://purl.obolibrary.org/obo/MONDO_0009770) (3MC syndrome 1), [MONDO:0008440](http://purl.obolibrary.org/obo/MONDO_0008440) (spastic paraplegia-nephritis-deafness syndrome), [MONDO:0009771](http://purl.obolibrary.org/obo/MONDO_0009771) (Oculotrichodysplasia), [MONDO:0009773](http://purl.obolibrary.org/obo/MONDO_0009773) (Odonto-onycho-dermal dysplasia), [MONDO:0009774](http://purl.obolibrary.org/obo/MONDO_0009774) (cloacal exstrophy (disease)), [MONDO:0009775](http://purl.obolibrary.org/obo/MONDO_0009775) (Oguchi disease-1), [MONDO:0021412](http://purl.obolibrary.org/obo/MONDO_0021412) (polyp of maxillary sinus), [MONDO:0009776](http://purl.obolibrary.org/obo/MONDO_0009776) (SPGF1), [MONDO:0008445](http://purl.obolibrary.org/obo/MONDO_0008445) (delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome), [MONDO:0009777](http://purl.obolibrary.org/obo/MONDO_0009777) (Oliver syndrome), [MONDO:0008447](http://purl.obolibrary.org/obo/MONDO_0008447) (hereditary spherocytosis type 1), [MONDO:0008448](http://purl.obolibrary.org/obo/MONDO_0008448) (spheroid body myopathy), [MONDO:0009779](http://purl.obolibrary.org/obo/MONDO_0009779) (autosomal recessive omodysplasia), [MONDO:0021416](http://purl.obolibrary.org/obo/MONDO_0021416) (polyp of gallbladder), [MONDO:0008449](http://purl.obolibrary.org/obo/MONDO_0008449) (spina bifida (disease)), [MONDO:0007109](http://purl.obolibrary.org/obo/MONDO_0007109) (congenital dyserythropoietic anemia type III), [MONDO:0007108](http://purl.obolibrary.org/obo/MONDO_0007108) (anal canal carcinoma), [MONDO:0007105](http://purl.obolibrary.org/obo/MONDO_0007105) (frontotemporal dementia with motor neuron disease 1), [MONDO:0007103](http://purl.obolibrary.org/obo/MONDO_0007103) (amyotrophic lateral sclerosis type 1), [MONDO:0007101](http://purl.obolibrary.org/obo/MONDO_0007101) (familial primary localized cutaneous amyloidosis), [MONDO:0007100](http://purl.obolibrary.org/obo/MONDO_0007100) (familial amyloid neuropathy), [MONDO:0010763](http://purl.obolibrary.org/obo/MONDO_0010763) (spermatogenic failure, Y-linked, 1), [MONDO:0010764](http://purl.obolibrary.org/obo/MONDO_0010764) (DFNY1), [MONDO:0010761](http://purl.obolibrary.org/obo/MONDO_0010761) (retinitis pigmentosa Y-linked), [MONDO:0010762](http://purl.obolibrary.org/obo/MONDO_0010762) (lymphoma, Hodgkin, Y-linked pseudoautosomal), [MONDO:0010767](http://purl.obolibrary.org/obo/MONDO_0010767) (spermatogenic failure, Y-linked, 2), [MONDO:0010768](http://purl.obolibrary.org/obo/MONDO_0010768) (gonadoblastoma), [MONDO:0010765](http://purl.obolibrary.org/obo/MONDO_0010765) (46,XY complete gonadal dysgenesis), [MONDO:0010766](http://purl.obolibrary.org/obo/MONDO_0010766) (46,XX testicular disorder of sex development), [MONDO:0021408](http://purl.obolibrary.org/obo/MONDO_0021408) (polyp of frontal sinus), [MONDO:0009760](http://purl.obolibrary.org/obo/MONDO_0009760) (Norman-Roberts syndrome), [MONDO:0009761](http://purl.obolibrary.org/obo/MONDO_0009761) (cystic hygroma), [MONDO:0009762](http://purl.obolibrary.org/obo/MONDO_0009762) (nystagmus, congenital, autosomal recessive), [MONDO:0009764](http://purl.obolibrary.org/obo/MONDO_0009764) (ocular motor apraxia, Cogan type), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0008434](http://purl.obolibrary.org/obo/MONDO_0008434) (Smith-Magenis syndrome), [MONDO:0021400](http://purl.obolibrary.org/obo/MONDO_0021400) (polyp of colon), [MONDO:0009767](http://purl.obolibrary.org/obo/MONDO_0009767) (oculocerebral hypopigmentation syndrome, cross type), [MONDO:0008436](http://purl.obolibrary.org/obo/MONDO_0008436) (Sneddon syndrome), [MONDO:0009768](http://purl.obolibrary.org/obo/MONDO_0009768) (oculodentodigital dysplasia, autosomal recessive), [MONDO:0021402](http://purl.obolibrary.org/obo/MONDO_0021402) (polyp of external auditory canal), [MONDO:0009769](http://purl.obolibrary.org/obo/MONDO_0009769) (Oculo-palato-cerebral syndrome), [MONDO:0021404](http://purl.obolibrary.org/obo/MONDO_0021404) (polyp of sphenoidal sinus), [MONDO:0007119](http://purl.obolibrary.org/obo/MONDO_0007119) (isolated aniridia), [MONDO:0010758](http://purl.obolibrary.org/obo/MONDO_0010758) (intellectual disability-developmental delay-contractures syndrome), [MONDO:0007117](http://purl.obolibrary.org/obo/MONDO_0007117) (angioedema, hereditary, type 1/2), [MONDO:0010759](http://purl.obolibrary.org/obo/MONDO_0010759) (Wildervanck syndrome), [MONDO:0007116](http://purl.obolibrary.org/obo/MONDO_0007116) (hereditary neurocutaneous malformation), [MONDO:0007115](http://purl.obolibrary.org/obo/MONDO_0007115) (angioma serpiginosum, autosomal dominant), [MONDO:0007114](http://purl.obolibrary.org/obo/MONDO_0007114) (Angel-shaped phalango-epiphyseal dysplasia), [MONDO:0010752](http://purl.obolibrary.org/obo/MONDO_0010752) (Vacterl association, X-linked, with or without hydrocephalus), [MONDO:0010753](http://purl.obolibrary.org/obo/MONDO_0010753) (cardiac valvular dysplasia, X-linked), [MONDO:0007110](http://purl.obolibrary.org/obo/MONDO_0007110) (Diamond-Blackfan anemia 1), [MONDO:0010750](http://purl.obolibrary.org/obo/MONDO_0010750) (ulnar hypoplasia-split foot syndrome), [MONDO:0010756](http://purl.obolibrary.org/obo/MONDO_0010756) (Von Willebrand disease, X-linked form), [MONDO:0019157](http://purl.obolibrary.org/obo/MONDO_0019157) (acquired idiopathic sideroblastic anemia), [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155) (leydig cell hypoplasia), [MONDO:0021476](http://purl.obolibrary.org/obo/MONDO_0021476) (benign neoplasm of tongue), [MONDO:0021475](http://purl.obolibrary.org/obo/MONDO_0021475) (benign neoplasm of nasal cavity), [MONDO:0020145](http://purl.obolibrary.org/obo/MONDO_0020145) (developmental defect of the eye), [MONDO:0021478](http://purl.obolibrary.org/obo/MONDO_0021478) (benign neoplasm of nasopharynx), [MONDO:0019153](http://purl.obolibrary.org/obo/MONDO_0019153) (brain malformation-congenital heart disease-postaxial polydactyly syndrome), [MONDO:0020146](http://purl.obolibrary.org/obo/MONDO_0020146) (major induction processes eye anomaly), [MONDO:0019154](http://purl.obolibrary.org/obo/MONDO_0019154) (androgen insensitivity syndrome), [MONDO:0021477](http://purl.obolibrary.org/obo/MONDO_0021477) (benign neoplasm of sphenoidal sinus), [MONDO:0020147](http://purl.obolibrary.org/obo/MONDO_0020147) (anophthalmia-microphthalmia syndrome), [MONDO:0020148](http://purl.obolibrary.org/obo/MONDO_0020148) (syndromic aniridia), [MONDO:0019151](http://purl.obolibrary.org/obo/MONDO_0019151) (Oligocone trichromacy), [MONDO:0020149](http://purl.obolibrary.org/obo/MONDO_0020149) (rare eye disease due to a differentiation anomaly), [MONDO:0021479](http://purl.obolibrary.org/obo/MONDO_0021479) (benign neoplasm of oropharynx), [MONDO:0019152](http://purl.obolibrary.org/obo/MONDO_0019152) (Oguchi disease), [MONDO:0021470](http://purl.obolibrary.org/obo/MONDO_0021470) (benign neoplasm of pancreas), [MONDO:0021472](http://purl.obolibrary.org/obo/MONDO_0021472) (benign neoplasm of scrotum), [MONDO:0021471](http://purl.obolibrary.org/obo/MONDO_0021471) (benign neoplasm of endometrium), [MONDO:0007168](http://purl.obolibrary.org/obo/MONDO_0007168) (atelosteogenesis type III), [MONDO:0020142](http://purl.obolibrary.org/obo/MONDO_0020142) (metabolic disease with dementia), [MONDO:0021474](http://purl.obolibrary.org/obo/MONDO_0021474) (benign neoplasm of ear), [MONDO:0021473](http://purl.obolibrary.org/obo/MONDO_0021473) (benign neoplasm of epididymis), [MONDO:0007167](http://purl.obolibrary.org/obo/MONDO_0007167) (atelosteogenesis type i), [MONDO:0020143](http://purl.obolibrary.org/obo/MONDO_0020143) (cerebral lipidosis with dementia), [MONDO:0007161](http://purl.obolibrary.org/obo/MONDO_0007161) (SPGF2), [MONDO:0007160](http://purl.obolibrary.org/obo/MONDO_0007160) (Stickler syndrome type 1), [MONDO:0008490](http://purl.obolibrary.org/obo/MONDO_0008490) (Stickler syndrome type 3), [MONDO:0008491](http://purl.obolibrary.org/obo/MONDO_0008491) (stiff-person syndrome), [MONDO:0008493](http://purl.obolibrary.org/obo/MONDO_0008493) (Overhydrated hereditary stomatocytosis), [MONDO:0008494](http://purl.obolibrary.org/obo/MONDO_0008494) (hereditary cryohydrocytosis with normal stomatin), [MONDO:0019148](http://purl.obolibrary.org/obo/MONDO_0019148) (Wolman disease), [MONDO:0008495](http://purl.obolibrary.org/obo/MONDO_0008495) (platelet storage pool deficiency), [MONDO:0019149](http://purl.obolibrary.org/obo/MONDO_0019149) (cholesteryl ester storage disease), [MONDO:0008497](http://purl.obolibrary.org/obo/MONDO_0008497) (Stormorken syndrome), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0021465](http://purl.obolibrary.org/obo/MONDO_0021465) (benign neoplasm of appendix), [MONDO:0008499](http://purl.obolibrary.org/obo/MONDO_0008499) (short stature-wormian bones-dextrocardia syndrome), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein C deficiency), [MONDO:0021464](http://purl.obolibrary.org/obo/MONDO_0021464) (benign neoplasm of cecum), [MONDO:0019142](http://purl.obolibrary.org/obo/MONDO_0019142) (porphyria), [MONDO:0021467](http://purl.obolibrary.org/obo/MONDO_0021467) (benign neoplasm of renal pelvis), [MONDO:0020135](http://purl.obolibrary.org/obo/MONDO_0020135) (non-syndromic pontocerebellar hypoplasia), [MONDO:0021469](http://purl.obolibrary.org/obo/MONDO_0021469) (benign neoplasm of anus), [MONDO:0021468](http://purl.obolibrary.org/obo/MONDO_0021468) (benign neoplasm of adrenal medulla), [MONDO:0021461](http://purl.obolibrary.org/obo/MONDO_0021461) (benign neoplasm of hypopharynx), [MONDO:0021460](http://purl.obolibrary.org/obo/MONDO_0021460) (benign neoplasm of salivary gland), [MONDO:0021463](http://purl.obolibrary.org/obo/MONDO_0021463) (benign neoplasm of parathyroid gland), [MONDO:0007179](http://purl.obolibrary.org/obo/MONDO_0007179) (hypersensitivity reaction type II disease), [MONDO:0021462](http://purl.obolibrary.org/obo/MONDO_0021462) (benign neoplasm of rectum), [MONDO:0020132](http://purl.obolibrary.org/obo/MONDO_0020132) (cranial nerve and nuclear aplasia), [MONDO:0007177](http://purl.obolibrary.org/obo/MONDO_0007177) (Auriculoosteodysplasia), [MONDO:0007176](http://purl.obolibrary.org/obo/MONDO_0007176) (helicoid peripapillary chorioretinal degeneration), [MONDO:0007174](http://purl.obolibrary.org/obo/MONDO_0007174) (Lown-Ganong-Levine syndrome), [MONDO:0007173](http://purl.obolibrary.org/obo/MONDO_0007173) (atrial heart septal defect 7), [MONDO:0007172](http://purl.obolibrary.org/obo/MONDO_0007172) (atrial heart septal defect 1), [MONDO:0007171](http://purl.obolibrary.org/obo/MONDO_0007171) (atrial standstill 1), [MONDO:0007170](http://purl.obolibrary.org/obo/MONDO_0007170) (atresia of external auditory canal and conductive deafness), [MONDO:0008480](http://purl.obolibrary.org/obo/MONDO_0008480) (Odontochondrodysplasia), [MONDO:0019139](http://purl.obolibrary.org/obo/MONDO_0019139) (acquired hemophilia), [MONDO:0019137](http://purl.obolibrary.org/obo/MONDO_0019137) (non-24-hour sleep-wake syndrome), [MONDO:0008484](http://purl.obolibrary.org/obo/MONDO_0008484) (stapes ankylosis with broad thumbs and toes), [MONDO:0019138](http://purl.obolibrary.org/obo/MONDO_0019138) (bleeding diathesis due to a collagen receptor defect), [MONDO:0008486](http://purl.obolibrary.org/obo/MONDO_0008486) (steatocystoma multiplex-natal teeth syndrome), [MONDO:0019133](http://purl.obolibrary.org/obo/MONDO_0019133) (visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome), [MONDO:0020122](http://purl.obolibrary.org/obo/MONDO_0020122) (idiopathic inflammatory myopathy), [MONDO:0021454](http://purl.obolibrary.org/obo/MONDO_0021454) (benign neoplasm of eye), [MONDO:0008488](http://purl.obolibrary.org/obo/MONDO_0008488) (holoprosencephaly-radial heart renal anomalies syndrome), [MONDO:0019134](http://purl.obolibrary.org/obo/MONDO_0019134) (central neurocytoma), [MONDO:0021453](http://purl.obolibrary.org/obo/MONDO_0021453) (benign neoplasm of retina), [MONDO:0020123](http://purl.obolibrary.org/obo/MONDO_0020123) (metabolic myopathy), [MONDO:0020124](http://purl.obolibrary.org/obo/MONDO_0020124) (neuromuscular junction disease), [MONDO:0019131](http://purl.obolibrary.org/obo/MONDO_0019131) (ossification anomalies-psychomotor developmental delay syndrome), [MONDO:0021456](http://purl.obolibrary.org/obo/MONDO_0021456) (benign neoplasm of sternum), [MONDO:0021455](http://purl.obolibrary.org/obo/MONDO_0021455) (benign neoplasm of neck), [MONDO:0020125](http://purl.obolibrary.org/obo/MONDO_0020125) (acquired neuromuscular junction disease), [MONDO:0019132](http://purl.obolibrary.org/obo/MONDO_0019132) (spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome), [MONDO:0021458](http://purl.obolibrary.org/obo/MONDO_0021458) (benign neoplasm of penis), [MONDO:0021457](http://purl.obolibrary.org/obo/MONDO_0021457) (benign neoplasm of pleura), [MONDO:0020128](http://purl.obolibrary.org/obo/MONDO_0020128) (motor neuron disease), [MONDO:0020129](http://purl.obolibrary.org/obo/MONDO_0020129) (acquired motor neuron disease), [MONDO:0021459](http://purl.obolibrary.org/obo/MONDO_0021459) (benign neoplasm of esophagus), [MONDO:0021450](http://purl.obolibrary.org/obo/MONDO_0021450) (benign neoplasm of heart), [MONDO:0007147](http://purl.obolibrary.org/obo/MONDO_0007147) (obstructive sleep apnea (disease)), [MONDO:0020120](http://purl.obolibrary.org/obo/MONDO_0020120) (skeletal muscle disease), [MONDO:0021452](http://purl.obolibrary.org/obo/MONDO_0021452) (benign neoplasm of cornea), [MONDO:0021451](http://purl.obolibrary.org/obo/MONDO_0021451) (benign neoplasm of brain), [MONDO:0020121](http://purl.obolibrary.org/obo/MONDO_0020121) (muscular dystrophy), [MONDO:0007143](http://purl.obolibrary.org/obo/MONDO_0007143) (aortic arch anomaly-facial dysmorphism-intellectual disability syndrome), [MONDO:0007142](http://purl.obolibrary.org/obo/MONDO_0007142) (Townes-Brocks syndrome), [MONDO:0007140](http://purl.obolibrary.org/obo/MONDO_0007140) (antiphospholipid syndrome), [MONDO:0008471](http://purl.obolibrary.org/obo/MONDO_0008471) (spondyloepiphyseal dysplasia congenita), [MONDO:0010792](http://purl.obolibrary.org/obo/MONDO_0010792) (lethal infantile mitochondrial myopathy), [MONDO:0008472](http://purl.obolibrary.org/obo/MONDO_0008472) (spondyloepiphyseal dysplasia, MacDermot type), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0008473](http://purl.obolibrary.org/obo/MONDO_0008473) (spondyloepiphyseal dysplasia, Maroteaux type), [MONDO:0008474](http://purl.obolibrary.org/obo/MONDO_0008474) (spondyloepiphyseal dysplasia tarda, autosomal dominant), [MONDO:0010790](http://purl.obolibrary.org/obo/MONDO_0010790) (MERRF syndrome), [MONDO:0019125](http://purl.obolibrary.org/obo/MONDO_0019125) (relapsing polychondritis), [MONDO:0010791](http://purl.obolibrary.org/obo/MONDO_0010791) (myoglobinuria, recurrent), [MONDO:0019122](http://purl.obolibrary.org/obo/MONDO_0019122) (idiopathic acute eosinophilic pneumonia), [MONDO:0008476](http://purl.obolibrary.org/obo/MONDO_0008476) (spondyloepimetaphyseal dysplasia, Strudwick type), [MONDO:0021443](http://purl.obolibrary.org/obo/MONDO_0021443) (benign neoplasm of lymph node), [MONDO:0020111](http://purl.obolibrary.org/obo/MONDO_0020111) (constitutional megaloblastic anemia due to folate metabolism disorder), [MONDO:0008477](http://purl.obolibrary.org/obo/MONDO_0008477) (spondylometaphyseal dysplasia, Kozlowski type), [MONDO:0020112](http://purl.obolibrary.org/obo/MONDO_0020112) (vitamin B12- and folate-independent constitutional megaloblastic anemia), [MONDO:0008478](http://purl.obolibrary.org/obo/MONDO_0008478) (spondylometaphyseal dysplasia, Schmidt type), [MONDO:0021445](http://purl.obolibrary.org/obo/MONDO_0021445) (benign neoplasm of oral cavity), [MONDO:0020113](http://purl.obolibrary.org/obo/MONDO_0020113) (red cell aplasia), [MONDO:0008479](http://purl.obolibrary.org/obo/MONDO_0008479) (spondylometaphyseal dysplasia, 'corner fracture' type), [MONDO:0021444](http://purl.obolibrary.org/obo/MONDO_0021444) (benign neoplasm of large intestine), [MONDO:0021447](http://purl.obolibrary.org/obo/MONDO_0021447) (benign neoplasm of testis), [MONDO:0021446](http://purl.obolibrary.org/obo/MONDO_0021446) (benign neoplasm of epiglottis), [MONDO:0020116](http://purl.obolibrary.org/obo/MONDO_0020116) (rare blood coagulation disease), [MONDO:0020117](http://purl.obolibrary.org/obo/MONDO_0020117) (alpha granule disease), [MONDO:0021449](http://purl.obolibrary.org/obo/MONDO_0021449) (benign neoplasm of stomach), [MONDO:0020118](http://purl.obolibrary.org/obo/MONDO_0020118) (dense granule disease), [MONDO:0007159](http://purl.obolibrary.org/obo/MONDO_0007159) (arthrogryposis-like hand anomaly-sensorineural deafness syndrome), [MONDO:0007158](http://purl.obolibrary.org/obo/MONDO_0007158) (arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome), [MONDO:0021441](http://purl.obolibrary.org/obo/MONDO_0021441) (benign neoplasm of exocrine pancreas), [MONDO:0007157](http://purl.obolibrary.org/obo/MONDO_0007157) (arthrogryposis, distal, type 1A), [MONDO:0021440](http://purl.obolibrary.org/obo/MONDO_0021440) (benign neoplasm of skin), [MONDO:0020110](http://purl.obolibrary.org/obo/MONDO_0020110) (pulmonary agenesis), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0010797](http://purl.obolibrary.org/obo/MONDO_0010797) (Pearson syndrome), [MONDO:0010794](http://purl.obolibrary.org/obo/MONDO_0010794) (NARP syndrome), [MONDO:0010795](http://purl.obolibrary.org/obo/MONDO_0010795) (oncocytic neoplasm), [MONDO:0007150](http://purl.obolibrary.org/obo/MONDO_0007150) (arcus senilis), [MONDO:0010798](http://purl.obolibrary.org/obo/MONDO_0010798) (proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome), [MONDO:0010799](http://purl.obolibrary.org/obo/MONDO_0010799) (mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure), [MONDO:0020188](http://purl.obolibrary.org/obo/MONDO_0020188) (congenital absence of the eyebrow/eyelashes), [MONDO:0020189](http://purl.obolibrary.org/obo/MONDO_0020189) (eyebrow/eyelashes structural anomaly), [MONDO:0019197](http://purl.obolibrary.org/obo/MONDO_0019197) (Folinic acid-responsive seizures), [MONDO:0019198](http://purl.obolibrary.org/obo/MONDO_0019198) (sympathetic ophthalmia), [MONDO:0019195](http://purl.obolibrary.org/obo/MONDO_0019195) (hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome), [MONDO:0019196](http://purl.obolibrary.org/obo/MONDO_0019196) (Foix-Alajouanine syndrome), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0019194](http://purl.obolibrary.org/obo/MONDO_0019194) (localized lipodystrophy), [MONDO:0020180](http://purl.obolibrary.org/obo/MONDO_0020180) (palpebral piliary tumor), [MONDO:0020181](http://purl.obolibrary.org/obo/MONDO_0020181) (mesenchymatous palpebral tumor), [MONDO:0020182](http://purl.obolibrary.org/obo/MONDO_0020182) (palpebral tumor with a vascular malformation), [MONDO:0020183](http://purl.obolibrary.org/obo/MONDO_0020183) (neurogenic palpebral tumor), [MONDO:0020184](http://purl.obolibrary.org/obo/MONDO_0020184) (rare eyebrow/eyelashes anomaly), [MONDO:0020185](http://purl.obolibrary.org/obo/MONDO_0020185) (eyebrow/eyelashes hypertrichosis), [MONDO:0020186](http://purl.obolibrary.org/obo/MONDO_0020186) (eyebrow hypertrophy), [MONDO:0020187](http://purl.obolibrary.org/obo/MONDO_0020187) (eyelashes hypertrophy), [MONDO:0019188](http://purl.obolibrary.org/obo/MONDO_0019188) (Rubinstein-Taybi syndrome), [MONDO:0020177](http://purl.obolibrary.org/obo/MONDO_0020177) (pigmented palpebral tumor), [MONDO:0020178](http://purl.obolibrary.org/obo/MONDO_0020178) (palpebral lentiginosis), [MONDO:0019189](http://purl.obolibrary.org/obo/MONDO_0019189) (disorder of amino acid and other organic acid metabolism), [MONDO:0020179](http://purl.obolibrary.org/obo/MONDO_0020179) (palpebral nevus), [MONDO:0019187](http://purl.obolibrary.org/obo/MONDO_0019187) (Axenfeld-Rieger syndrome), [MONDO:0019182](http://purl.obolibrary.org/obo/MONDO_0019182) (genetic obesity), [MONDO:0019191](http://purl.obolibrary.org/obo/MONDO_0019191) (IgG4-related dacryoadenitis and sialadenitis), [MONDO:0019192](http://purl.obolibrary.org/obo/MONDO_0019192) (AKT2-related familial partial lipodystrophy), [MONDO:0020170](http://purl.obolibrary.org/obo/MONDO_0020170) (congenital upper palpebral retraction), [MONDO:0020172](http://purl.obolibrary.org/obo/MONDO_0020172) (palpebral epidermal tumor), [MONDO:0019190](http://purl.obolibrary.org/obo/MONDO_0019190) (juvenile polyposis of infancy), [MONDO:0020173](http://purl.obolibrary.org/obo/MONDO_0020173) (benign tumor of palpebral epidermis), [MONDO:0020174](http://purl.obolibrary.org/obo/MONDO_0020174) (precancerous lesion of palpebral epidermis), [MONDO:0020175](http://purl.obolibrary.org/obo/MONDO_0020175) (malignant tumor of palpebral epidermis), [MONDO:0020176](http://purl.obolibrary.org/obo/MONDO_0020176) (palpebral sebaceous gland tumor), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0021498](http://purl.obolibrary.org/obo/MONDO_0021498) (benign neoplasm of placenta), [MONDO:0019178](http://purl.obolibrary.org/obo/MONDO_0019178) (auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome), [MONDO:0020167](http://purl.obolibrary.org/obo/MONDO_0020167) (malposition of external canthus), [MONDO:0021497](http://purl.obolibrary.org/obo/MONDO_0021497) (benign neoplasm of cerebrum), [MONDO:0020168](http://purl.obolibrary.org/obo/MONDO_0020168) (Kinetic eyelid anomaly), [MONDO:0021499](http://purl.obolibrary.org/obo/MONDO_0021499) (benign neoplasm of cerebellum), [MONDO:0020169](http://purl.obolibrary.org/obo/MONDO_0020169) (rare disorder with ptosis), [MONDO:0019176](http://purl.obolibrary.org/obo/MONDO_0019176) (trichorhinophalangeal syndrome type 1 and 3), [MONDO:0019174](http://purl.obolibrary.org/obo/MONDO_0019174) (infantile Refsum disease), [MONDO:0019171](http://purl.obolibrary.org/obo/MONDO_0019171) (familial long QT syndrome), [MONDO:0019172](http://purl.obolibrary.org/obo/MONDO_0019172) (aniridia), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0021490](http://purl.obolibrary.org/obo/MONDO_0021490) (benign neoplasm of sebaceous gland), [MONDO:0021492](http://purl.obolibrary.org/obo/MONDO_0021492) (benign neoplasm of major salivary gland), [MONDO:0020160](http://purl.obolibrary.org/obo/MONDO_0020160) (secondary entropion), [MONDO:0021491](http://purl.obolibrary.org/obo/MONDO_0021491) (benign neoplasm of gum), [MONDO:0020161](http://purl.obolibrary.org/obo/MONDO_0020161) (congenital ectropion), [MONDO:0021494](http://purl.obolibrary.org/obo/MONDO_0021494) (benign neoplasm of parotid gland), [MONDO:0020162](http://purl.obolibrary.org/obo/MONDO_0020162) (secondary ectropion), [MONDO:0021493](http://purl.obolibrary.org/obo/MONDO_0021493) (benign neoplasm of minor salivary gland), [MONDO:0020163](http://purl.obolibrary.org/obo/MONDO_0020163) (Canthal anomaly), [MONDO:0021496](http://purl.obolibrary.org/obo/MONDO_0021496) (benign neoplasm of lip), [MONDO:0020164](http://purl.obolibrary.org/obo/MONDO_0020164) (Epicanthal fold), [MONDO:0021495](http://purl.obolibrary.org/obo/MONDO_0021495) (benign neoplasm of sublingual gland), [MONDO:0020165](http://purl.obolibrary.org/obo/MONDO_0020165) (syndromic epicanthus), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0007185](http://purl.obolibrary.org/obo/MONDO_0007185) (Banki syndrome), [MONDO:0007184](http://purl.obolibrary.org/obo/MONDO_0007184) (AGA1), [MONDO:0007182](http://purl.obolibrary.org/obo/MONDO_0007182) (Machado-Joseph disease), [MONDO:0007181](http://purl.obolibrary.org/obo/MONDO_0007181) (axial osteomalacia), [MONDO:0019169](http://purl.obolibrary.org/obo/MONDO_0019169) (pyruvate dehydrogenase deficiency), [MONDO:0021487](http://purl.obolibrary.org/obo/MONDO_0021487) (benign neoplasm of choroid), [MONDO:0020155](http://purl.obolibrary.org/obo/MONDO_0020155) (eyelid border anomaly), [MONDO:0020156](http://purl.obolibrary.org/obo/MONDO_0020156) (syndromic ankyloblepharon), [MONDO:0021486](http://purl.obolibrary.org/obo/MONDO_0021486) (benign neoplasm of ciliary body), [MONDO:0021489](http://purl.obolibrary.org/obo/MONDO_0021489) (benign neoplasm of sweat gland), [MONDO:0020157](http://purl.obolibrary.org/obo/MONDO_0020157) (syndromic palpebral coloboma), [MONDO:0019164](http://purl.obolibrary.org/obo/MONDO_0019164) (6q terminal deletion syndrome), [MONDO:0021488](http://purl.obolibrary.org/obo/MONDO_0021488) (benign neoplasm of lacrimal gland), [MONDO:0020158](http://purl.obolibrary.org/obo/MONDO_0020158) (eyelids malposition disorder), [MONDO:0019162](http://purl.obolibrary.org/obo/MONDO_0019162) (pseudohypoaldosteronism type 2), [MONDO:0020159](http://purl.obolibrary.org/obo/MONDO_0020159) (congenital entropion), [MONDO:0019161](http://purl.obolibrary.org/obo/MONDO_0019161) (pseudohypoaldosteronism type 1), [MONDO:0019170](http://purl.obolibrary.org/obo/MONDO_0019170) (polyarteritis nodosa), [MONDO:0021481](http://purl.obolibrary.org/obo/MONDO_0021481) (benign neoplasm of submandibular gland), [MONDO:0020150](http://purl.obolibrary.org/obo/MONDO_0020150) (rare palpebral, lacrimal system and conjunctival disease), [MONDO:0021480](http://purl.obolibrary.org/obo/MONDO_0021480) (benign neoplasm of soft palate), [MONDO:0020151](http://purl.obolibrary.org/obo/MONDO_0020151) (rare palpebral disease), [MONDO:0021483](http://purl.obolibrary.org/obo/MONDO_0021483) (benign neoplasm of frontal sinus), [MONDO:0021482](http://purl.obolibrary.org/obo/MONDO_0021482) (benign neoplasm of middle ear), [MONDO:0020152](http://purl.obolibrary.org/obo/MONDO_0020152) (eyelid malformation), [MONDO:0020153](http://purl.obolibrary.org/obo/MONDO_0020153) (cryptophthalmia), [MONDO:0021485](http://purl.obolibrary.org/obo/MONDO_0021485) (benign neoplasm of iris), [MONDO:0020154](http://purl.obolibrary.org/obo/MONDO_0020154) (Microblepharon-ablephara syndrome), [MONDO:0021484](http://purl.obolibrary.org/obo/MONDO_0021484) (benign neoplasm of maxillary sinus), [MONDO:0007198](http://purl.obolibrary.org/obo/MONDO_0007198) (Ascher syndrome), [MONDO:0007195](http://purl.obolibrary.org/obo/MONDO_0007195) (bifid nose, autosomal dominant), [MONDO:0007194](http://purl.obolibrary.org/obo/MONDO_0007194) (familial bicuspid aortic valve), [MONDO:0007193](http://purl.obolibrary.org/obo/MONDO_0007193) (primary biliary cholangitis 1), [MONDO:0020199](http://purl.obolibrary.org/obo/MONDO_0020199) (conjunctival vascular anomaly), [MONDO:0020191](http://purl.obolibrary.org/obo/MONDO_0020191) (eyebrow/eyelashes pigmentation anomaly), [MONDO:0020192](http://purl.obolibrary.org/obo/MONDO_0020192) (rare lacrimal system disease), [MONDO:0020193](http://purl.obolibrary.org/obo/MONDO_0020193) (secretory apparatus of the lacrimal system anomaly), [MONDO:0020194](http://purl.obolibrary.org/obo/MONDO_0020194) (congenital alacrima), [MONDO:0020195](http://purl.obolibrary.org/obo/MONDO_0020195) (excretory apparatus of the lacrimal system anomaly), [MONDO:0020196](http://purl.obolibrary.org/obo/MONDO_0020196) (anomaly of the secretory and excretory apparatus of the lacrimal system), [MONDO:0020197](http://purl.obolibrary.org/obo/MONDO_0020197) (EEC syndrome and related syndrome), [MONDO:0020198](http://purl.obolibrary.org/obo/MONDO_0020198) (rare conjunctival disease), [MONDO:0020190](http://purl.obolibrary.org/obo/MONDO_0020190) (eyebrow/eyelashes distichiasis), [MONDO:0009831](http://purl.obolibrary.org/obo/MONDO_0009831) (malignant pancreatic neoplasm), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0009832](http://purl.obolibrary.org/obo/MONDO_0009832) (pancreatic agenesis), [MONDO:0009833](http://purl.obolibrary.org/obo/MONDO_0009833) (Shwachman-Diamond syndrome), [MONDO:0008504](http://purl.obolibrary.org/obo/MONDO_0008504) (supravalvular aortic stenosis (disease)), [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0010827](http://purl.obolibrary.org/obo/MONDO_0010827) (retinitis pigmentosa 14), [MONDO:0009839](http://purl.obolibrary.org/obo/MONDO_0009839) (progressive supranuclear palsy-parkinsonism syndrome), [MONDO:0010824](http://purl.obolibrary.org/obo/MONDO_0010824) (disorder of sex development-intellectual disability syndrome), [MONDO:0010825](http://purl.obolibrary.org/obo/MONDO_0010825) (atrioventricular defect-blepharophimosis-radial and anal defect syndrome), [MONDO:0008509](http://purl.obolibrary.org/obo/MONDO_0008509) (distal symphalangism (disease)), [MONDO:0010828](http://purl.obolibrary.org/obo/MONDO_0010828) (retinitis pigmentosa 11), [MONDO:0010822](http://purl.obolibrary.org/obo/MONDO_0010822) (Warburg micro syndrome 1), [MONDO:0010823](http://purl.obolibrary.org/obo/MONDO_0010823) (rhizomelic chondrodysplasia punctata type 3), [MONDO:0009820](http://purl.obolibrary.org/obo/MONDO_0009820) (osteoporosis-pseudoglioma syndrome), [MONDO:0009821](http://purl.obolibrary.org/obo/MONDO_0009821) (lethal osteosclerotic bone dysplasia), [MONDO:0009822](http://purl.obolibrary.org/obo/MONDO_0009822) (Otoonychoperoneal syndrome), [MONDO:0009823](http://purl.obolibrary.org/obo/MONDO_0009823) (primary hyperoxaluria type 1), [MONDO:0009824](http://purl.obolibrary.org/obo/MONDO_0009824) (primary hyperoxaluria type 2), [MONDO:0009825](http://purl.obolibrary.org/obo/MONDO_0009825) (5-oxoprolinase deficiency (disease)), [MONDO:0009827](http://purl.obolibrary.org/obo/MONDO_0009827) (pachyonychia congenita, autosomal recessive), [MONDO:0010814](http://purl.obolibrary.org/obo/MONDO_0010814) (chondrodysplasia-pseudohermaphroditism syndrome), [MONDO:0010819](http://purl.obolibrary.org/obo/MONDO_0010819) (Stargardt disease 3), [MONDO:0010817](http://purl.obolibrary.org/obo/MONDO_0010817) (autosomal dominant nonsyndromic deafness 2A), [MONDO:0010818](http://purl.obolibrary.org/obo/MONDO_0010818) (retinitis pigmentosa 12), [MONDO:0010810](http://purl.obolibrary.org/obo/MONDO_0010810) (vitamin d Hydroxylation-deficient rickets, type 1B), [MONDO:0009810](http://purl.obolibrary.org/obo/MONDO_0009810) (autosomal recessive distal osteolysis syndrome), [MONDO:0009814](http://purl.obolibrary.org/obo/MONDO_0009814) (Osteopenia-intellectual disability-sparse hair syndrome), [MONDO:0009815](http://purl.obolibrary.org/obo/MONDO_0009815) (autosomal recessive osteopetrosis 1), [MONDO:0010804](http://purl.obolibrary.org/obo/MONDO_0010804) (BRCATA), [MONDO:0009816](http://purl.obolibrary.org/obo/MONDO_0009816) (autosomal recessive osteopetrosis 2), [MONDO:0010805](http://purl.obolibrary.org/obo/MONDO_0010805) (bladder exstrophy (disease)), [MONDO:0009817](http://purl.obolibrary.org/obo/MONDO_0009817) (autosomal recessive osteopetrosis 5), [MONDO:0010802](http://purl.obolibrary.org/obo/MONDO_0010802) (pancreatic hypoplasia-diabetes-congenital heart disease syndrome), [MONDO:0009818](http://purl.obolibrary.org/obo/MONDO_0009818) (autosomal recessive osteopetrosis 3), [MONDO:0010803](http://purl.obolibrary.org/obo/MONDO_0010803) (Eiken syndrome), [MONDO:0010808](http://purl.obolibrary.org/obo/MONDO_0010808) (fatal familial insomnia), [MONDO:0010809](http://purl.obolibrary.org/obo/MONDO_0010809) (familial chronic myelocytic leukemia-like syndrome), [MONDO:0010806](http://purl.obolibrary.org/obo/MONDO_0010806) (retinitis pigmentosa 13), [MONDO:0010807](http://purl.obolibrary.org/obo/MONDO_0010807) (autosomal recessive nonsyndromic deafness 2), [MONDO:0010800](http://purl.obolibrary.org/obo/MONDO_0010800) (Wolfram syndrome, mitochondrial form), [MONDO:0010801](http://purl.obolibrary.org/obo/MONDO_0010801) (Spondylocamptodactyly syndrome), [MONDO:0009800](http://purl.obolibrary.org/obo/MONDO_0009800) (Blount disease, adolescent), [MONDO:0009801](http://purl.obolibrary.org/obo/MONDO_0009801) (familial osteodysplasia, Anderson type), [MONDO:0009803](http://purl.obolibrary.org/obo/MONDO_0009803) (congenital osteogenesis imperfecta-microcephaly-cataracts syndrome), [MONDO:0009804](http://purl.obolibrary.org/obo/MONDO_0009804) (osteogenesis imperfecta type 3), [MONDO:0009805](http://purl.obolibrary.org/obo/MONDO_0009805) (osteogenesis imperfecta type 9), [MONDO:0009806](http://purl.obolibrary.org/obo/MONDO_0009806) (Bruck syndrome 1), [MONDO:0009807](http://purl.obolibrary.org/obo/MONDO_0009807) (osteosarcoma (disease)), [MONDO:0009808](http://purl.obolibrary.org/obo/MONDO_0009808) (osteoid Osteoma (disease)), [MONDO:0009809](http://purl.obolibrary.org/obo/MONDO_0009809) (multicentric osteolysis, Nodulosis, and arthropathy), [MONDO:0011718](http://purl.obolibrary.org/obo/MONDO_0011718) (primary ciliary dyskinesia 2), [MONDO:0011717](http://purl.obolibrary.org/obo/MONDO_0011717) (hyperinsulinism-hyperammonemia syndrome), [MONDO:0011715](http://purl.obolibrary.org/obo/MONDO_0011715) (Seckel syndrome 2), [MONDO:0011719](http://purl.obolibrary.org/obo/MONDO_0011719) (gastrointestinal stromal tumor), [MONDO:0011713](http://purl.obolibrary.org/obo/MONDO_0011713) (melanoma-pancreatic cancer syndrome), [MONDO:0011712](http://purl.obolibrary.org/obo/MONDO_0011712) (van der Woude syndrome 2), [MONDO:0011706](http://purl.obolibrary.org/obo/MONDO_0011706) (Kufor-Rakeb syndrome), [MONDO:0011705](http://purl.obolibrary.org/obo/MONDO_0011705) (lymphangioleiomyomatosis), [MONDO:0011704](http://purl.obolibrary.org/obo/MONDO_0011704) (GLC1B), [MONDO:0011709](http://purl.obolibrary.org/obo/MONDO_0011709) (split hand-foot malformation 5), [MONDO:0011708](http://purl.obolibrary.org/obo/MONDO_0011708) (autosomal dominant nonsyndromic deafness 36), [MONDO:0011701](http://purl.obolibrary.org/obo/MONDO_0011701) (inflammatory bowel disease 4), [MONDO:0011700](http://purl.obolibrary.org/obo/MONDO_0011700) (inflammatory bowel disease 6), [MONDO:0009430](http://purl.obolibrary.org/obo/MONDO_0009430) (hypophosphatemic rickets, autosomal recessive, 1), [MONDO:0009431](http://purl.obolibrary.org/obo/MONDO_0009431) (hereditary hypophosphatemic rickets with hypercalciuria), [MONDO:0008102](http://purl.obolibrary.org/obo/MONDO_0008102) (sick sinus syndrome 2, autosomal dominant), [MONDO:0009434](http://purl.obolibrary.org/obo/MONDO_0009434) (hypoproteinemia, Hypercatabolic), [MONDO:0008104](http://purl.obolibrary.org/obo/MONDO_0008104) (Noonan syndrome 1), [MONDO:0009435](http://purl.obolibrary.org/obo/MONDO_0009435) (hypospadias-intellectual disability, Goldblatt type syndrome), [MONDO:0009436](http://purl.obolibrary.org/obo/MONDO_0009436) (hypothalamic hamartomas), [MONDO:0008106](http://purl.obolibrary.org/obo/MONDO_0008106) (NYS2), [MONDO:0009437](http://purl.obolibrary.org/obo/MONDO_0009437) (Bamforth-Lazarus syndrome), [MONDO:0008107](http://purl.obolibrary.org/obo/MONDO_0008107) (nystagmus, hereditary vertical), [MONDO:0008108](http://purl.obolibrary.org/obo/MONDO_0008108) (Oculocerebrocutaneous syndrome), [MONDO:0008109](http://purl.obolibrary.org/obo/MONDO_0008109) (ocular cicatricial pemphigoid), [MONDO:0010428](http://purl.obolibrary.org/obo/MONDO_0010428) (chromosome Xp11.23-p11.22 duplication syndrome), [MONDO:0011759](http://purl.obolibrary.org/obo/MONDO_0011759) (Hurler-Scheie syndrome), [MONDO:0010420](http://purl.obolibrary.org/obo/MONDO_0010420) (X-linked erythropoietic protoporphyria), [MONDO:0010421](http://purl.obolibrary.org/obo/MONDO_0010421) (Bruton-type agammaglobulinemia), [MONDO:0010426](http://purl.obolibrary.org/obo/MONDO_0010426) (X-linked endothelial corneal dystrophy), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0011757](http://purl.obolibrary.org/obo/MONDO_0011757) (brachydactyly type A1B), [MONDO:0010424](http://purl.obolibrary.org/obo/MONDO_0010424) (surfactant metabolism dysfunction, pulmonary, 4), [MONDO:0011756](http://purl.obolibrary.org/obo/MONDO_0011756) (Senior-Loken syndrome 4), [MONDO:0010425](http://purl.obolibrary.org/obo/MONDO_0010425) (Lisch epithelial corneal dystrophy), [MONDO:0011755](http://purl.obolibrary.org/obo/MONDO_0011755) (SLSN3), [MONDO:0009424](http://purl.obolibrary.org/obo/MONDO_0009424) (Bartter disease type 2), [MONDO:0009425](http://purl.obolibrary.org/obo/MONDO_0009425) (Hypomandibular faciocranial dysostosis), [MONDO:0009426](http://purl.obolibrary.org/obo/MONDO_0009426) (hypoparathyroidism-retardation-dysmorphism syndrome), [MONDO:0009427](http://purl.obolibrary.org/obo/MONDO_0009427) (infantile hypophosphatasia), [MONDO:0009428](http://purl.obolibrary.org/obo/MONDO_0009428) (childhood hypophosphatasia), [MONDO:0010419](http://purl.obolibrary.org/obo/MONDO_0010419) (X-linked sideroblastic anemia), [MONDO:0011749](http://purl.obolibrary.org/obo/MONDO_0011749) (oculocutaneous albinism type 1B), [MONDO:0010417](http://purl.obolibrary.org/obo/MONDO_0010417) (syndromic X-linked intellectual disability Najm type), [MONDO:0011748](http://purl.obolibrary.org/obo/MONDO_0011748) (Usher syndrome type 1G), [MONDO:0011742](http://purl.obolibrary.org/obo/MONDO_0011742) (HSCR7), [MONDO:0011741](http://purl.obolibrary.org/obo/MONDO_0011741) (HSCR6), [MONDO:0011740](http://purl.obolibrary.org/obo/MONDO_0011740) (Carney-Stratakis syndrome), [MONDO:0010410](http://purl.obolibrary.org/obo/MONDO_0010410) (AGA2), [MONDO:0010415](http://purl.obolibrary.org/obo/MONDO_0010415) (myopathy, reducing body, X-linked, childhood-onset), [MONDO:0011744](http://purl.obolibrary.org/obo/MONDO_0011744) (primary intraosseous venous malformation), [MONDO:0010414](http://purl.obolibrary.org/obo/MONDO_0010414) (myopathy, reducing body, X-linked, early-onset, severe), [MONDO:0009410](http://purl.obolibrary.org/obo/MONDO_0009410) (Addison's disease), [MONDO:0009411](http://purl.obolibrary.org/obo/MONDO_0009411) (autoimmune polyendocrine syndrome type 1), [MONDO:0009412](http://purl.obolibrary.org/obo/MONDO_0009412) (scurvy), [MONDO:0009413](http://purl.obolibrary.org/obo/MONDO_0009413) (immunodeficiency, common variable, 2), [MONDO:0009414](http://purl.obolibrary.org/obo/MONDO_0009414) (glycogen storage disease due to hepatic glycogen synthase deficiency), [MONDO:0009416](http://purl.obolibrary.org/obo/MONDO_0009416) (Hypoinsulinemic hypoglycemia and body hemihypertrophy), [MONDO:0009417](http://purl.obolibrary.org/obo/MONDO_0009417) (hypergonadotropic hypogonadism-cataract syndrome), [MONDO:0010408](http://purl.obolibrary.org/obo/MONDO_0010408) (syndactyly-telecanthus-anogenital and renal malformations syndrome), [MONDO:0009419](http://purl.obolibrary.org/obo/MONDO_0009419) (Woodhouse-Sakati syndrome), [MONDO:0011739](http://purl.obolibrary.org/obo/MONDO_0011739) (pancreatic cancer, susceptibility to, 1), [MONDO:0011738](http://purl.obolibrary.org/obo/MONDO_0011738) (bilateral frontoparietal polymicrogyria), [MONDO:0011732](http://purl.obolibrary.org/obo/MONDO_0011732) (familial digital arthropathy-brachydactyly), [MONDO:0010400](http://purl.obolibrary.org/obo/MONDO_0010400) (X-linked scapuloperoneal muscular dystrophy), [MONDO:0011731](http://purl.obolibrary.org/obo/MONDO_0011731) (glucose-galactose malabsorption), [MONDO:0010401](http://purl.obolibrary.org/obo/MONDO_0010401) (X-linked myopathy with postural muscle atrophy), [MONDO:0011730](http://purl.obolibrary.org/obo/MONDO_0011730) (Fumaric aciduria), [MONDO:0011735](http://purl.obolibrary.org/obo/MONDO_0011735) (hyper-IgM syndrome type 3), [MONDO:0010405](http://purl.obolibrary.org/obo/MONDO_0010405) (HPCX2), [MONDO:0010402](http://purl.obolibrary.org/obo/MONDO_0010402) (syndromic X-linked intellectual disability 94), [MONDO:0010403](http://purl.obolibrary.org/obo/MONDO_0010403) (albinism-deafness syndrome), [MONDO:0009400](http://purl.obolibrary.org/obo/MONDO_0009400) (hyperprolinemia type 1), [MONDO:0009401](http://purl.obolibrary.org/obo/MONDO_0009401) (hyperprolinemia type 2), [MONDO:0009402](http://purl.obolibrary.org/obo/MONDO_0009402) (hypertelorism-hypospadias-polysyndactyly syndrome), [MONDO:0009404](http://purl.obolibrary.org/obo/MONDO_0009404) (hypertelorism, microtia, facial clefting syndrome), [MONDO:0009405](http://purl.obolibrary.org/obo/MONDO_0009405) (cervical hypertrichosis-peripheral neuropathy syndrome), [MONDO:0009406](http://purl.obolibrary.org/obo/MONDO_0009406) (hypertrichotic osteochondrodysplasia Cantu type), [MONDO:0011721](http://purl.obolibrary.org/obo/MONDO_0011721) (distal myopathy with anterior tibial onset), [MONDO:0011720](http://purl.obolibrary.org/obo/MONDO_0011720) (spermatogenic failure 3), [MONDO:0011725](http://purl.obolibrary.org/obo/MONDO_0011725) (Crigler-Najjar syndrome type 2), [MONDO:0011724](http://purl.obolibrary.org/obo/MONDO_0011724) (encephalopathy due to GLUT1 deficiency), [MONDO:0011723](http://purl.obolibrary.org/obo/MONDO_0011723) (hemifacial myohyperplasia), [MONDO:0011722](http://purl.obolibrary.org/obo/MONDO_0011722) (intellectual disability-obesity-prognathism-eye and skin anomalies syndrome), [MONDO:0011790](http://purl.obolibrary.org/obo/MONDO_0011790) (Amish lethal microcephaly), [MONDO:0009470](http://purl.obolibrary.org/obo/MONDO_0009470) (Baraitser-Winter syndrome 1), [MONDO:0009471](http://purl.obolibrary.org/obo/MONDO_0009471) (intrinsic factor and r binder, combined congenital deficiency of), [MONDO:0008142](http://purl.obolibrary.org/obo/MONDO_0008142) (Thiemann disease, familial form), [MONDO:0009473](http://purl.obolibrary.org/obo/MONDO_0009473) (isotretinoin-like syndrome), [MONDO:0011793](http://purl.obolibrary.org/obo/MONDO_0011793) (CELIAC5), [MONDO:0008143](http://purl.obolibrary.org/obo/MONDO_0008143) (osteoarthritis susceptibility 1), [MONDO:0009475](http://purl.obolibrary.org/obo/MONDO_0009475) (isovaleric acidemia), [MONDO:0010460](http://purl.obolibrary.org/obo/MONDO_0010460) (syndromic X-linked intellectual disability 17), [MONDO:0011792](http://purl.obolibrary.org/obo/MONDO_0011792) (thyroid dyshormonogenesis 6), [MONDO:0008145](http://purl.obolibrary.org/obo/MONDO_0008145) (Ollier disease), [MONDO:0009476](http://purl.obolibrary.org/obo/MONDO_0009476) (atresia of small intestine), [MONDO:0009477](http://purl.obolibrary.org/obo/MONDO_0009477) (Stromme syndrome), [MONDO:0008146](http://purl.obolibrary.org/obo/MONDO_0008146) (osteogenesis imperfecta type 1), [MONDO:0021113](http://purl.obolibrary.org/obo/MONDO_0021113) (respiratory failure), [MONDO:0009478](http://purl.obolibrary.org/obo/MONDO_0009478) (combined immunodeficiency due to DOCK8 deficiency), [MONDO:0008147](http://purl.obolibrary.org/obo/MONDO_0008147) (osteogenesis imperfecta type 2), [MONDO:0021112](http://purl.obolibrary.org/obo/MONDO_0021112) (scrotum cancer), [MONDO:0009479](http://purl.obolibrary.org/obo/MONDO_0009479) (Johanson-Blizzard syndrome), [MONDO:0008148](http://purl.obolibrary.org/obo/MONDO_0008148) (osteogenesis imperfecta type 4), [MONDO:0021114](http://purl.obolibrary.org/obo/MONDO_0021114) (bartholin gland neoplasm), [MONDO:0008149](http://purl.obolibrary.org/obo/MONDO_0008149) (osteogenesis imperfecta with opalescent teeth, blue sclerae and wormian bones but without fractures), [MONDO:0021117](http://purl.obolibrary.org/obo/MONDO_0021117) (lung neoplasm), [MONDO:0021116](http://purl.obolibrary.org/obo/MONDO_0021116) (luminal A breast carcinoma), [MONDO:0021119](http://purl.obolibrary.org/obo/MONDO_0021119) (non-functioning endocrine neoplasm), [MONDO:0021118](http://purl.obolibrary.org/obo/MONDO_0021118) (intestinal neoplasm), [MONDO:0021111](http://purl.obolibrary.org/obo/MONDO_0021111) (ureter neoplasm), [MONDO:0021110](http://purl.obolibrary.org/obo/MONDO_0021110) (sweat gland adenoma), [MONDO:0010466](http://purl.obolibrary.org/obo/MONDO_0010466) (multiple congenital anomalies-hypotonia-seizures syndrome 2), [MONDO:0011797](http://purl.obolibrary.org/obo/MONDO_0011797) (infantile-onset ascending hereditary spastic paralysis), [MONDO:0010464](http://purl.obolibrary.org/obo/MONDO_0010464) (X-linked cerebral-cerebellar-coloboma syndrome syndrome), [MONDO:0011795](http://purl.obolibrary.org/obo/MONDO_0011795) (anonychia-microcephaly syndrome), [MONDO:0010465](http://purl.obolibrary.org/obo/MONDO_0010465) (Kabuki syndrome 2), [MONDO:0011799](http://purl.obolibrary.org/obo/MONDO_0011799) (autosomal recessive nonsyndromic deafness 33), [MONDO:0021109](http://purl.obolibrary.org/obo/MONDO_0021109) (inverted urothelial papilloma), [MONDO:0008130](http://purl.obolibrary.org/obo/MONDO_0008130) (ophthalmoplegia-intellectual disability-lingua scrotalis syndrome), [MONDO:0009461](http://purl.obolibrary.org/obo/MONDO_0009461) (male infertility due to large-headed multiflagellar polyploid spermatozoa), [MONDO:0011783](http://purl.obolibrary.org/obo/MONDO_0011783) (ALG12-CDG), [MONDO:0008131](http://purl.obolibrary.org/obo/MONDO_0008131) (optic atrophy, hearing loss, and peripheral neuropathy, autosomal dominant), [MONDO:0011782](http://purl.obolibrary.org/obo/MONDO_0011782) (angioid streaks), [MONDO:0008132](http://purl.obolibrary.org/obo/MONDO_0008132) (optic atrophy with demyelinating disease of CNS), [MONDO:0011781](http://purl.obolibrary.org/obo/MONDO_0011781) (spinocerebellar ataxia type 17), [MONDO:0008133](http://purl.obolibrary.org/obo/MONDO_0008133) (autosomal dominant optic atrophy and cataract), [MONDO:0009465](http://purl.obolibrary.org/obo/MONDO_0009465) (multiple intestinal atresia), [MONDO:0008134](http://purl.obolibrary.org/obo/MONDO_0008134) (autosomal dominant optic atrophy, classic form), [MONDO:0021102](http://purl.obolibrary.org/obo/MONDO_0021102) (prostate phyllodes tumor), [MONDO:0009466](http://purl.obolibrary.org/obo/MONDO_0009466) (neuronal intestinal pseudoobstruction), [MONDO:0008136](http://purl.obolibrary.org/obo/MONDO_0008136) (isolated optic nerve hypoplasia), [MONDO:0009467](http://purl.obolibrary.org/obo/MONDO_0009467) (natal teeth-intestinal pseudoobstruction-patent ductus syndrome), [MONDO:0021101](http://purl.obolibrary.org/obo/MONDO_0021101) (appendix L-cell glucagon-like peptide-producing neuroendocrine tumor), [MONDO:0008137](http://purl.obolibrary.org/obo/MONDO_0008137) (orofaciodigital syndrome X), [MONDO:0009469](http://purl.obolibrary.org/obo/MONDO_0009469) (benign recurrent intrahepatic cholestasis type 1), [MONDO:0008138](http://purl.obolibrary.org/obo/MONDO_0008138) (syndromic orbital border hypoplasia), [MONDO:0008139](http://purl.obolibrary.org/obo/MONDO_0008139) (OSLAM syndrome), [MONDO:0021107](http://purl.obolibrary.org/obo/MONDO_0021107) (narcolepsy), [MONDO:0021100](http://purl.obolibrary.org/obo/MONDO_0021100) (breast neoplasm), [MONDO:0011787](http://purl.obolibrary.org/obo/MONDO_0011787) (autosomal recessive limb-girdle muscular dystrophy type 2I), [MONDO:0010455](http://purl.obolibrary.org/obo/MONDO_0010455) (X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia), [MONDO:0010456](http://purl.obolibrary.org/obo/MONDO_0010456) (renal cell carcinoma, Xp11-associated), [MONDO:0011786](http://purl.obolibrary.org/obo/MONDO_0011786) (allergic rhinitis), [MONDO:0010459](http://purl.obolibrary.org/obo/MONDO_0010459) (amyotrophic lateral sclerosis type 15), [MONDO:0011789](http://purl.obolibrary.org/obo/MONDO_0011789) (familial meningioma), [MONDO:0010457](http://purl.obolibrary.org/obo/MONDO_0010457) (Ogden syndrome), [MONDO:0011788](http://purl.obolibrary.org/obo/MONDO_0011788) (cloverleaf skull-multiple congenital anomalies syndrome), [MONDO:0009450](http://purl.obolibrary.org/obo/MONDO_0009450) (ciliary dyskinesia with excessively long cilia), [MONDO:0011772](http://purl.obolibrary.org/obo/MONDO_0011772) (B4GALT1-CDG), [MONDO:0008120](http://purl.obolibrary.org/obo/MONDO_0008120) (spinocerebellar ataxia type 7), [MONDO:0009451](http://purl.obolibrary.org/obo/MONDO_0009451) (Nezelof syndrome), [MONDO:0009452](http://purl.obolibrary.org/obo/MONDO_0009452) (Vici syndrome), [MONDO:0010441](http://purl.obolibrary.org/obo/MONDO_0010441) (CK syndrome), [MONDO:0011771](http://purl.obolibrary.org/obo/MONDO_0011771) (distal spinal muscular atrophy type 3), [MONDO:0009454](http://purl.obolibrary.org/obo/MONDO_0009454) (immunodeficiency-centromeric instability-facial anomalies syndrome 1), [MONDO:0008123](http://purl.obolibrary.org/obo/MONDO_0008123) (autosomal dominant omodysplasia), [MONDO:0009456](http://purl.obolibrary.org/obo/MONDO_0009456) (Immunoerythromyeloid hypoplasia), [MONDO:0009458](http://purl.obolibrary.org/obo/MONDO_0009458) (Schimke immuno-osseous dysplasia), [MONDO:0008127](http://purl.obolibrary.org/obo/MONDO_0008127) (Ophthalmomandibulomelic dysplasia), [MONDO:0011776](http://purl.obolibrary.org/obo/MONDO_0011776) (CINCA syndrome), [MONDO:0010444](http://purl.obolibrary.org/obo/MONDO_0010444) (X-linked dyserythropoetic anemia with abnormal platelets and neutropenia), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma, susceptibility to, 1), [MONDO:0011774](http://purl.obolibrary.org/obo/MONDO_0011774) (autosomal recessive nonsyndromic deafness 30), [MONDO:0010442](http://purl.obolibrary.org/obo/MONDO_0010442) (46,XX sex reversal 3), [MONDO:0011773](http://purl.obolibrary.org/obo/MONDO_0011773) (anauxetic dysplasia), [MONDO:0010443](http://purl.obolibrary.org/obo/MONDO_0010443) (macular degeneration, X-linked atrophic), [MONDO:0010448](http://purl.obolibrary.org/obo/MONDO_0010448) (Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome), [MONDO:0011778](http://purl.obolibrary.org/obo/MONDO_0011778) (multiple epiphyseal dysplasia, Al-Gazali type), [MONDO:0010446](http://purl.obolibrary.org/obo/MONDO_0010446) (X-linked cone dysfunction syndrome with myopia), [MONDO:0011761](http://purl.obolibrary.org/obo/MONDO_0011761) (autosomal dominant nonsyndromic deafness 21), [MONDO:0009440](http://purl.obolibrary.org/obo/MONDO_0009440) (ichthyosiform erythroderma, corneal involvement, and deafness), [MONDO:0011760](http://purl.obolibrary.org/obo/MONDO_0011760) (Scheie syndrome), [MONDO:0008111](http://purl.obolibrary.org/obo/MONDO_0008111) (oculodentodigital dysplasia), [MONDO:0008112](http://purl.obolibrary.org/obo/MONDO_0008112) (Goldenhar syndrome), [MONDO:0008113](http://purl.obolibrary.org/obo/MONDO_0008113) (Schilbach-Rott syndrome), [MONDO:0009444](http://purl.obolibrary.org/obo/MONDO_0009444) (ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome), [MONDO:0009446](http://purl.obolibrary.org/obo/MONDO_0009446) (ichthyosis-intellectual disability-dwarfism-renal impairment syndrome), [MONDO:0008115](http://purl.obolibrary.org/obo/MONDO_0008115) (Feingold syndrome type 1), [MONDO:0008116](http://purl.obolibrary.org/obo/MONDO_0008116) (oculopharyngeal muscular dystrophy), [MONDO:0008117](http://purl.obolibrary.org/obo/MONDO_0008117) (Oculopharyngodistal myopathy), [MONDO:0009448](http://purl.obolibrary.org/obo/MONDO_0009448) (Iminoglycinuria), [MONDO:0008118](http://purl.obolibrary.org/obo/MONDO_0008118) (Odontomatosis-aortae esophagus stenosis syndrome), [MONDO:0009449](http://purl.obolibrary.org/obo/MONDO_0009449) (ciliary dyskinesia with defective radial spokes), [MONDO:0008119](http://purl.obolibrary.org/obo/MONDO_0008119) (spinocerebellar ataxia type 1), [MONDO:0010433](http://purl.obolibrary.org/obo/MONDO_0010433) (SLEB15), [MONDO:0011765](http://purl.obolibrary.org/obo/MONDO_0011765) (multiple epiphyseal dysplasia type 5), [MONDO:0010434](http://purl.obolibrary.org/obo/MONDO_0010434) (synovial sarcoma (disease)), [MONDO:0010431](http://purl.obolibrary.org/obo/MONDO_0010431) (Joubert syndrome 10), [MONDO:0010432](http://purl.obolibrary.org/obo/MONDO_0010432) (thrombophilia, X-linked, due to factor 9 defect), [MONDO:0011762](http://purl.obolibrary.org/obo/MONDO_0011762) (autosomal recessive nonsyndromic deafness 22), [MONDO:0010437](http://purl.obolibrary.org/obo/MONDO_0010437) (severe X-linked mitochondrial encephalomyopathy), [MONDO:0010438](http://purl.obolibrary.org/obo/MONDO_0010438) (paroxysmal nocturnal hemoglobinuria 1), [MONDO:0011768](http://purl.obolibrary.org/obo/MONDO_0011768) (myasthenia gravis with thymus hyperplasia), [MONDO:0011767](http://purl.obolibrary.org/obo/MONDO_0011767) (autosomal recessive nonsyndromic deafness 31), [MONDO:0010435](http://purl.obolibrary.org/obo/MONDO_0010435) (nystagmus 6, congenital, X-linked), [MONDO:0010436](http://purl.obolibrary.org/obo/MONDO_0010436) (chromosome Xq28 duplication syndrome), [MONDO:0011766](http://purl.obolibrary.org/obo/MONDO_0011766) (46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome), [MONDO:0008182](http://purl.obolibrary.org/obo/MONDO_0008182) (Nasopalpebral lipoma-coloboma syndrome), [MONDO:0008183](http://purl.obolibrary.org/obo/MONDO_0008183) (annular pancreas), [MONDO:0008184](http://purl.obolibrary.org/obo/MONDO_0008184) (pancreas, dorsal, agenesis of), [MONDO:0008185](http://purl.obolibrary.org/obo/MONDO_0008185) (hereditary chronic pancreatitis), [MONDO:0021155](http://purl.obolibrary.org/obo/MONDO_0021155) (X-linked cone-rod dystrophy), [MONDO:0008192](http://purl.obolibrary.org/obo/MONDO_0008192) (paragangliomas 1), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0008172](http://purl.obolibrary.org/obo/MONDO_0008172) (PHOAD), [MONDO:0008173](http://purl.obolibrary.org/obo/MONDO_0008173) (pachyonychia congenita 1), [MONDO:0010490](http://purl.obolibrary.org/obo/MONDO_0010490) (SSR4-CDG), [MONDO:0008174](http://purl.obolibrary.org/obo/MONDO_0008174) (pachyonychia congenita 2), [MONDO:0010495](http://purl.obolibrary.org/obo/MONDO_0010495) (trichothiodystrophy 5, nonphotosensitive), [MONDO:0008175](http://purl.obolibrary.org/obo/MONDO_0008175) (Pacman dysplasia), [MONDO:0008176](http://purl.obolibrary.org/obo/MONDO_0008176) (Paget disease of bone 3), [MONDO:0010496](http://purl.obolibrary.org/obo/MONDO_0010496) (X-linked intellectual disability-short stature-overweight syndrome), [MONDO:0008177](http://purl.obolibrary.org/obo/MONDO_0008177) (extramammary Paget disease), [MONDO:0010493](http://purl.obolibrary.org/obo/MONDO_0010493) (Diamond-Blackfan anemia 14 with mandibulofacial dysostosis), [MONDO:0008178](http://purl.obolibrary.org/obo/MONDO_0008178) (inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1), [MONDO:0010494](http://purl.obolibrary.org/obo/MONDO_0010494) (linear skin defects with multiple congenital anomalies 3), [MONDO:0021148](http://purl.obolibrary.org/obo/MONDO_0021148) (female reproductive system neoplasm), [MONDO:0021147](http://purl.obolibrary.org/obo/MONDO_0021147) (disorder of development or morphogenesis), [MONDO:0021142](http://purl.obolibrary.org/obo/MONDO_0021142) (acquired rippling muscle disease), [MONDO:0021144](http://purl.obolibrary.org/obo/MONDO_0021144) (ovarian clear cell tumor), [MONDO:0021143](http://purl.obolibrary.org/obo/MONDO_0021143) (melanocytic neoplasm), [MONDO:0010499](http://purl.obolibrary.org/obo/MONDO_0010499) (Ritscher-Schinzel syndrome 2), [MONDO:0010498](http://purl.obolibrary.org/obo/MONDO_0010498) (MEND syndrome), [MONDO:0008180](http://purl.obolibrary.org/obo/MONDO_0008180) (congenital velopharyngeal incompetence), [MONDO:0009491](http://purl.obolibrary.org/obo/MONDO_0009491) (Haim-Munk syndrome), [MONDO:0010480](http://purl.obolibrary.org/obo/MONDO_0010480) (anemia, nonspherocytic hemolytic, due to G6Pd deficiency), [MONDO:0010481](http://purl.obolibrary.org/obo/MONDO_0010481) (angioedema), [MONDO:0008161](http://purl.obolibrary.org/obo/MONDO_0008161) (Otodental syndrome), [MONDO:0009492](http://purl.obolibrary.org/obo/MONDO_0009492) (Succinyl-CoA:3-ketoacid CoA transferase deficiency), [MONDO:0009493](http://purl.obolibrary.org/obo/MONDO_0009493) (Richards-Rundle syndrome), [MONDO:0008163](http://purl.obolibrary.org/obo/MONDO_0008163) (Otofaciocervical syndrome), [MONDO:0009495](http://purl.obolibrary.org/obo/MONDO_0009495) (Keutel syndrome), [MONDO:0010484](http://purl.obolibrary.org/obo/MONDO_0010484) (deafness, X-linked 6), [MONDO:0010485](http://purl.obolibrary.org/obo/MONDO_0010485) (X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome), [MONDO:0008165](http://purl.obolibrary.org/obo/MONDO_0008165) (Southeast Asian ovalocytosis), [MONDO:0008167](http://purl.obolibrary.org/obo/MONDO_0008167) (dermoid cyst of ovary), [MONDO:0009498](http://purl.obolibrary.org/obo/MONDO_0009498) (lethal Kniest-like dysplasia), [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499) (Krabbe disease), [MONDO:0008168](http://purl.obolibrary.org/obo/MONDO_0008168) (ovarian fibroma (disease)), [MONDO:0021134](http://purl.obolibrary.org/obo/MONDO_0021134) (acquired factor X deficiency), [MONDO:0021138](http://purl.obolibrary.org/obo/MONDO_0021138) (bone marrow cancer), [MONDO:0021131](http://purl.obolibrary.org/obo/MONDO_0021131) (frontal lobe ependymal tumor), [MONDO:0021130](http://purl.obolibrary.org/obo/MONDO_0021130) (disorder of sphingolipid biosynthesis), [MONDO:0021133](http://purl.obolibrary.org/obo/MONDO_0021133) (acquired factor XIII deficiency), [MONDO:0008170](http://purl.obolibrary.org/obo/MONDO_0008170) (ovarian cancer), [MONDO:0009480](http://purl.obolibrary.org/obo/MONDO_0009480) (Joubert syndrome with oculorenal defect), [MONDO:0008150](http://purl.obolibrary.org/obo/MONDO_0008150) (osteoglophonic dwarfism), [MONDO:0010470](http://purl.obolibrary.org/obo/MONDO_0010470) (Baratela-Scott syndrome), [MONDO:0009482](http://purl.obolibrary.org/obo/MONDO_0009482) (hypogonadotropic hypogonadism 3 with or without anosmia), [MONDO:0008151](http://purl.obolibrary.org/obo/MONDO_0008151) (Gnathodiaphyseal dysplasia), [MONDO:0009483](http://purl.obolibrary.org/obo/MONDO_0009483) (Kapur-Toriello syndrome), [MONDO:0008152](http://purl.obolibrary.org/obo/MONDO_0008152) (multicentric carpo-tarsal osteolysis with or without nephropathy), [MONDO:0008153](http://purl.obolibrary.org/obo/MONDO_0008153) (progressive osseous heteroplasia), [MONDO:0010473](http://purl.obolibrary.org/obo/MONDO_0010473) (X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome), [MONDO:0009484](http://purl.obolibrary.org/obo/MONDO_0009484) (primary ciliary dyskinesia 1), [MONDO:0008154](http://purl.obolibrary.org/obo/MONDO_0008154) (osteomas of mandible), [MONDO:0009485](http://purl.obolibrary.org/obo/MONDO_0009485) (oculocerebrofacial syndrome, Kaufman type), [MONDO:0010474](http://purl.obolibrary.org/obo/MONDO_0010474) (linear skin defects with multiple congenital anomalies 2), [MONDO:0010471](http://purl.obolibrary.org/obo/MONDO_0010471) (Cornelia de Lange syndrome 5), [MONDO:0009486](http://purl.obolibrary.org/obo/MONDO_0009486) (autosomal recessive Kenny-Caffey syndrome), [MONDO:0008155](http://purl.obolibrary.org/obo/MONDO_0008155) (osteomesopyknosis), [MONDO:0010472](http://purl.obolibrary.org/obo/MONDO_0010472) (ALG13-CDG), [MONDO:0008156](http://purl.obolibrary.org/obo/MONDO_0008156) (autosomal dominant osteopetrosis 2), [MONDO:0008157](http://purl.obolibrary.org/obo/MONDO_0008157) (Buschke-Ollendorff syndrome), [MONDO:0021123](http://purl.obolibrary.org/obo/MONDO_0021123) (Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone), [MONDO:0008158](http://purl.obolibrary.org/obo/MONDO_0008158) (dacryocystitis-osteopoikilosis syndrome), [MONDO:0008159](http://purl.obolibrary.org/obo/MONDO_0008159) (postmenopausal osteoporosis), [MONDO:0021129](http://purl.obolibrary.org/obo/MONDO_0021129) (microphthalmia), [MONDO:0021120](http://purl.obolibrary.org/obo/MONDO_0021120) (functioning endocrine neoplasm), [MONDO:0021121](http://purl.obolibrary.org/obo/MONDO_0021121) (hemangioendothelioma), [MONDO:0010477](http://purl.obolibrary.org/obo/MONDO_0010477) (blepharophimosis-intellectual disability syndrome, MKB type), [MONDO:0010478](http://purl.obolibrary.org/obo/MONDO_0010478) (SLC35A2-CDG), [MONDO:0010479](http://purl.obolibrary.org/obo/MONDO_0010479) (Charcot-Marie-tooth disease X-linked dominant 6), [MONDO:0009490](http://purl.obolibrary.org/obo/MONDO_0009490) (Papillon-Lefevre disease), [MONDO:0021193](http://purl.obolibrary.org/obo/MONDO_0021193) (neuroepithelial neoplasm), [MONDO:0021192](http://purl.obolibrary.org/obo/MONDO_0021192) (odontogenic neoplasm), [MONDO:0021195](http://purl.obolibrary.org/obo/MONDO_0021195) (disease disrupting biological or physiological process), [MONDO:0021197](http://purl.obolibrary.org/obo/MONDO_0021197) (disease disrupting function of subcellular component), [MONDO:0021196](http://purl.obolibrary.org/obo/MONDO_0021196) (disease disrupting molecular activity), [MONDO:0021191](http://purl.obolibrary.org/obo/MONDO_0021191) (malignant ependymoma), [MONDO:0021190](http://purl.obolibrary.org/obo/MONDO_0021190) (DNA repair disease), [MONDO:0021189](http://purl.obolibrary.org/obo/MONDO_0021189) (intestinal motility disease), [MONDO:0021181](http://purl.obolibrary.org/obo/MONDO_0021181) (inherited blood coagulation disorder), [MONDO:0021187](http://purl.obolibrary.org/obo/MONDO_0021187) (hyperlipidemia (disease)), [MONDO:0021180](http://purl.obolibrary.org/obo/MONDO_0021180) (acquired xanthinuria), [MONDO:0021179](http://purl.obolibrary.org/obo/MONDO_0021179) (proteostasis deficiencies), [MONDO:0021171](http://purl.obolibrary.org/obo/MONDO_0021171) (Timothy syndrome type 1 (disorder)), [MONDO:0021172](http://purl.obolibrary.org/obo/MONDO_0021172) (Timothy syndrome type 2 (disorder)), [MONDO:0021177](http://purl.obolibrary.org/obo/MONDO_0021177) (autoimmune hepatitis type 3), [MONDO:0021176](http://purl.obolibrary.org/obo/MONDO_0021176) (autoimmune hepatitis type 2), [MONDO:0008195](http://purl.obolibrary.org/obo/MONDO_0008195) (Paramyotonia congenita of von Eulenburg), [MONDO:0008196](http://purl.obolibrary.org/obo/MONDO_0008196) (Parastremmatic dwarfism), [MONDO:0008197](http://purl.obolibrary.org/obo/MONDO_0008197) (parietal foramina 1), [MONDO:0008198](http://purl.obolibrary.org/obo/MONDO_0008198) (parietal foramina with cleidocranial dysplasia), [MONDO:0021168](http://purl.obolibrary.org/obo/MONDO_0021168) (hibernoma), [MONDO:0021169](http://purl.obolibrary.org/obo/MONDO_0021169) (epithelioid hemangioma), [MONDO:0021162](http://purl.obolibrary.org/obo/MONDO_0021162) (carotenemia), [MONDO:0021163](http://purl.obolibrary.org/obo/MONDO_0021163) (kidney neoplasm), [MONDO:0021165](http://purl.obolibrary.org/obo/MONDO_0021165) (paget disease), [MONDO:0009510](http://purl.obolibrary.org/obo/MONDO_0009510) (Laron syndrome with immunodeficiency), [MONDO:0009511](http://purl.obolibrary.org/obo/MONDO_0009511) (larsen-like syndrome, B3GAT3 type), [MONDO:0009512](http://purl.obolibrary.org/obo/MONDO_0009512) (lethal larsen-like syndrome), [MONDO:0009513](http://purl.obolibrary.org/obo/MONDO_0009513) (laryngo-onycho-cutaneous syndrome), [MONDO:0009514](http://purl.obolibrary.org/obo/MONDO_0009514) (Laurence-Moon syndrome), [MONDO:0009515](http://purl.obolibrary.org/obo/MONDO_0009515) (Norum disease), [MONDO:0009516](http://purl.obolibrary.org/obo/MONDO_0009516) (absence deformity of leg-cataract syndrome), [MONDO:0009517](http://purl.obolibrary.org/obo/MONDO_0009517) (Donohue syndrome), [MONDO:0011839](http://purl.obolibrary.org/obo/MONDO_0011839) (Newfoundland cone-rod dystrophy), [MONDO:0009519](http://purl.obolibrary.org/obo/MONDO_0009519) (Letterer-Siwe disease), [MONDO:0011838](http://purl.obolibrary.org/obo/MONDO_0011838) (Bothnia retinal dystrophy), [MONDO:0010505](http://purl.obolibrary.org/obo/MONDO_0010505) (intellectual disability-balding-patella luxation-acromicria syndrome), [MONDO:0011837](http://purl.obolibrary.org/obo/MONDO_0011837) (vitamin K-dependent clotting factors, combined deficiency of, type 2), [MONDO:0011836](http://purl.obolibrary.org/obo/MONDO_0011836) (thyroid Hurthle cell carcinoma), [MONDO:0011830](http://purl.obolibrary.org/obo/MONDO_0011830) (lissencephaly due to LIS1 mutation), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0010503](http://purl.obolibrary.org/obo/MONDO_0010503) (Bartter disease type 5), [MONDO:0011834](http://purl.obolibrary.org/obo/MONDO_0011834) (spinocerebellar ataxia type 18), [MONDO:0011833](http://purl.obolibrary.org/obo/MONDO_0011833) (spinocerebellar ataxia type 21), [MONDO:0010501](http://purl.obolibrary.org/obo/MONDO_0010501) (syndromic X-linked intellectual disability 34), [MONDO:0011832](http://purl.obolibrary.org/obo/MONDO_0011832) (autosomal dominant nonsyndromic deafness 44), [MONDO:0009501](http://purl.obolibrary.org/obo/MONDO_0009501) (metabolic myopathy due to lactate transporter defect), [MONDO:0009502](http://purl.obolibrary.org/obo/MONDO_0009502) (pyruvate dehydrogenase E2 deficiency), [MONDO:0009503](http://purl.obolibrary.org/obo/MONDO_0009503) (pyruvate dehydrogenase E3-binding protein deficiency), [MONDO:0009504](http://purl.obolibrary.org/obo/MONDO_0009504) (mitochondrial DNA depletion syndrome 9), [MONDO:0009507](http://purl.obolibrary.org/obo/MONDO_0009507) (Lambert syndrome), [MONDO:0011827](http://purl.obolibrary.org/obo/MONDO_0011827) (patent ductus arteriosus), [MONDO:0011826](http://purl.obolibrary.org/obo/MONDO_0011826) (glucocorticoid deficiency 2), [MONDO:0011829](http://purl.obolibrary.org/obo/MONDO_0011829) (coenzyme Q10 deficiency, primary, 1), [MONDO:0011823](http://purl.obolibrary.org/obo/MONDO_0011823) (developmental malformations-deafness-dystonia syndrome), [MONDO:0011822](http://purl.obolibrary.org/obo/MONDO_0011822) (Bartter disease type 3), [MONDO:0011821](http://purl.obolibrary.org/obo/MONDO_0011821) (Meckel syndrome, type 3), [MONDO:0011816](http://purl.obolibrary.org/obo/MONDO_0011816) (Lathosterolosis), [MONDO:0011814](http://purl.obolibrary.org/obo/MONDO_0011814) (Smith-Mccort dysplasia 1), [MONDO:0011819](http://purl.obolibrary.org/obo/MONDO_0011819) (spinocerebellar ataxia type 19/22), [MONDO:0011818](http://purl.obolibrary.org/obo/MONDO_0011818) (isolated focal cortical dysplasia type II), [MONDO:0011813](http://purl.obolibrary.org/obo/MONDO_0011813) (polydactyly, postaxial, type A3), [MONDO:0011812](http://purl.obolibrary.org/obo/MONDO_0011812) (Duane-radial ray syndrome), [MONDO:0011811](http://purl.obolibrary.org/obo/MONDO_0011811) (autosomal recessive cerebellar ataxia-saccadic intrusion syndrome), [MONDO:0011810](http://purl.obolibrary.org/obo/MONDO_0011810) (horizontal gaze palsy with progressive scoliosis), [MONDO:0011804](http://purl.obolibrary.org/obo/MONDO_0011804) (autoimmune lymphoproliferative syndrome type 2B), [MONDO:0011803](http://purl.obolibrary.org/obo/MONDO_0011803) (hereditary spastic paraplegia 7), [MONDO:0011808](http://purl.obolibrary.org/obo/MONDO_0011808) (cataract 27), [MONDO:0011807](http://purl.obolibrary.org/obo/MONDO_0011807) (SLEH1), [MONDO:0011801](http://purl.obolibrary.org/obo/MONDO_0011801) (spinocerebellar ataxia type 1 with axonal neuropathy), [MONDO:0011800](http://purl.obolibrary.org/obo/MONDO_0011800) (GLM4), [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type B), [MONDO:0009550](http://purl.obolibrary.org/obo/MONDO_0009550) (renal hypomagnesemia 3), [MONDO:0008221](http://purl.obolibrary.org/obo/MONDO_0008221) (Prolidase deficiency), [MONDO:0008222](http://purl.obolibrary.org/obo/MONDO_0008222) (Andersen-Tawil syndrome), [MONDO:0009554](http://purl.obolibrary.org/obo/MONDO_0009554) (3MC syndrome 3), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0009556](http://purl.obolibrary.org/obo/MONDO_0009556) (malonic aciduria), [MONDO:0009557](http://purl.obolibrary.org/obo/MONDO_0009557) (mandibuloacral dysplasia with type A lipodystrophy), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0008227](http://purl.obolibrary.org/obo/MONDO_0008227) (peripheral dysostosis), [MONDO:0008228](http://purl.obolibrary.org/obo/MONDO_0008228) (pernicious anemia), [MONDO:0010549](http://purl.obolibrary.org/obo/MONDO_0010549) (Charcot-Marie-tooth disease X-linked dominant 1), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0010544](http://purl.obolibrary.org/obo/MONDO_0010544) (cataract 40), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0010541](http://purl.obolibrary.org/obo/MONDO_0010541) (X-linked calvarial hyperostosis), [MONDO:0011872](http://purl.obolibrary.org/obo/MONDO_0011872) (Griscelli syndrome type 2), [MONDO:0011879](http://purl.obolibrary.org/obo/MONDO_0011879) (neuronopathy, distal hereditary motor, type 7B), [MONDO:0011878](http://purl.obolibrary.org/obo/MONDO_0011878) (Worth's syndrome), [MONDO:0010545](http://purl.obolibrary.org/obo/MONDO_0010545) (Nance-Horan syndrome), [MONDO:0011877](http://purl.obolibrary.org/obo/MONDO_0011877) (autosomal dominant osteopetrosis 1), [MONDO:0008210](http://purl.obolibrary.org/obo/MONDO_0008210) (patterned macular dystrophy 1), [MONDO:0009543](http://purl.obolibrary.org/obo/MONDO_0009543) (prominent glabella-microcephaly-hypogenitalism syndrome), [MONDO:0008215](http://purl.obolibrary.org/obo/MONDO_0008215) (adult-onset autosomal dominant demyelinating leukodystrophy), [MONDO:0009547](http://purl.obolibrary.org/obo/MONDO_0009547) (macrosomia-microphthalmia-cleft palate syndrome), [MONDO:0008217](http://purl.obolibrary.org/obo/MONDO_0008217) (pelvis-shoulder dysplasia), [MONDO:0009548](http://purl.obolibrary.org/obo/MONDO_0009548) (renal hypomagnesemia 5 with ocular involvement), [MONDO:0008218](http://purl.obolibrary.org/obo/MONDO_0008218) (Hailey-Hailey disease), [MONDO:0009549](http://purl.obolibrary.org/obo/MONDO_0009549) (severe early-childhood-onset retinal dystrophy), [MONDO:0008219](http://purl.obolibrary.org/obo/MONDO_0008219) (pemphigus vulgaris), [MONDO:0010538](http://purl.obolibrary.org/obo/MONDO_0010538) (Mononen-Karnes-Senac syndrome), [MONDO:0010539](http://purl.obolibrary.org/obo/MONDO_0010539) (X-linked mandibulofacial dysostosis), [MONDO:0011864](http://purl.obolibrary.org/obo/MONDO_0011864) (immunodeficiency, common variable, 1), [MONDO:0010532](http://purl.obolibrary.org/obo/MONDO_0010532) (infantile-onset X-linked spinal muscular atrophy), [MONDO:0010533](http://purl.obolibrary.org/obo/MONDO_0010533) (Arts syndrome), [MONDO:0010530](http://purl.obolibrary.org/obo/MONDO_0010530) (anus, imperforate), [MONDO:0010531](http://purl.obolibrary.org/obo/MONDO_0010531) (contractures-ectodermal dysplasia-cleft lip/palate syndrome), [MONDO:0011868](http://purl.obolibrary.org/obo/MONDO_0011868) (lethal congenital contracture syndrome 2), [MONDO:0010537](http://purl.obolibrary.org/obo/MONDO_0010537) (Borjeson-Forssman-Lehmann syndrome), [MONDO:0011866](http://purl.obolibrary.org/obo/MONDO_0011866) (pontocerebellar hypoplasia type 1A), [MONDO:0010535](http://purl.obolibrary.org/obo/MONDO_0010535) (Bazex-DuprC)-Christol syndrome), [MONDO:0009530](http://purl.obolibrary.org/obo/MONDO_0009530) (lipoid proteinosis), [MONDO:0009532](http://purl.obolibrary.org/obo/MONDO_0009532) (Miller-Dieker lissencephaly syndrome), [MONDO:0009533](http://purl.obolibrary.org/obo/MONDO_0009533) (Dahlberg-borer-Newcomer syndrome), [MONDO:0009535](http://purl.obolibrary.org/obo/MONDO_0009535) (lymphedema, congenital recessive), [MONDO:0008204](http://purl.obolibrary.org/obo/MONDO_0008204) (patella aplasia, coxa vara, and tarsal synostosis), [MONDO:0008205](http://purl.obolibrary.org/obo/MONDO_0008205) (patella aplasia/hypoplasia), [MONDO:0008207](http://purl.obolibrary.org/obo/MONDO_0008207) (chondromalacia patellae), [MONDO:0009539](http://purl.obolibrary.org/obo/MONDO_0009539) (lymphoblastic leukemia, acute, with lymphomatous features), [MONDO:0008209](http://purl.obolibrary.org/obo/MONDO_0008209) (Char syndrome), [MONDO:0010527](http://purl.obolibrary.org/obo/MONDO_0010527) (microphthalmia-ankyloblepharon-intellectual disability syndrome), [MONDO:0011859](http://purl.obolibrary.org/obo/MONDO_0011859) (distal myopathy with early respiratory muscle involvement), [MONDO:0010520](http://purl.obolibrary.org/obo/MONDO_0010520) (X-linked Alport syndrome), [MONDO:0010525](http://purl.obolibrary.org/obo/MONDO_0010525) (neural tube defects, X-linked), [MONDO:0011857](http://purl.obolibrary.org/obo/MONDO_0011857) (atrial fibrillation, familial, 3), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0011856](http://purl.obolibrary.org/obo/MONDO_0011856) (spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome), [MONDO:0010523](http://purl.obolibrary.org/obo/MONDO_0010523) (X-linked reticulate pigmentary disorder), [MONDO:0011855](http://purl.obolibrary.org/obo/MONDO_0011855) (granular corneal dystrophy type II), [MONDO:0010524](http://purl.obolibrary.org/obo/MONDO_0010524) (X-linked sideroblastic anemia with ataxia), [MONDO:0009520](http://purl.obolibrary.org/obo/MONDO_0009520) (3-hydroxy-3-methylglutaric aciduria), [MONDO:0009522](http://purl.obolibrary.org/obo/MONDO_0009522) (Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome), [MONDO:0009525](http://purl.obolibrary.org/obo/MONDO_0009525) (split hand-foot malformation 3), [MONDO:0009528](http://purl.obolibrary.org/obo/MONDO_0009528) (chylomicron retention disease), [MONDO:0010518](http://purl.obolibrary.org/obo/MONDO_0010518) (Wiskott-Aldrich syndrome), [MONDO:0009529](http://purl.obolibrary.org/obo/MONDO_0009529) (pyruvate dehydrogenase E3 deficiency), [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), [MONDO:0011849](http://purl.obolibrary.org/obo/MONDO_0011849) (psoriatic arthritis), [MONDO:0010516](http://purl.obolibrary.org/obo/MONDO_0010516) (midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis; MFHIEN), [MONDO:0010517](http://purl.obolibrary.org/obo/MONDO_0010517) (ciliary dyskinesia, primary, 36, X-linked; CILD36), [MONDO:0011841](http://purl.obolibrary.org/obo/MONDO_0011841) (biotin-responsive basal ganglia disease), [MONDO:0011846](http://purl.obolibrary.org/obo/MONDO_0011846) (bulimia nervosa, susceptibility to, 1), [MONDO:0009590](http://purl.obolibrary.org/obo/MONDO_0009590) (metachromatic leukodystrophy due to saposin b deficiency), [MONDO:0010580](http://purl.obolibrary.org/obo/MONDO_0010580) (immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome), [MONDO:0009591](http://purl.obolibrary.org/obo/MONDO_0009591) (metachromatic leukodystrophy, juvenile form), [MONDO:0009592](http://purl.obolibrary.org/obo/MONDO_0009592) (metaphyseal acroscyphodysplasia), [MONDO:0008262](http://purl.obolibrary.org/obo/MONDO_0008262) (Poland syndrome), [MONDO:0009593](http://purl.obolibrary.org/obo/MONDO_0009593) (spondylometaphyseal dysplasia, Sedaghatian type), [MONDO:0009594](http://purl.obolibrary.org/obo/MONDO_0009594) (metaphyseal chondrodysplasia, Kaitila type), [MONDO:0010583](http://purl.obolibrary.org/obo/MONDO_0010583) (Dyggve-Melchior-Clausen syndrome, X-linked), [MONDO:0010584](http://purl.obolibrary.org/obo/MONDO_0010584) (dyskeratosis congenita, X-linked), [MONDO:0009595](http://purl.obolibrary.org/obo/MONDO_0009595) (cartilage-hair hypoplasia), [MONDO:0008266](http://purl.obolibrary.org/obo/MONDO_0008266) (polydactyly, postaxial, type A1), [MONDO:0009597](http://purl.obolibrary.org/obo/MONDO_0009597) (metaphyseal chondrodysplasia, Spahr type), [MONDO:0008267](http://purl.obolibrary.org/obo/MONDO_0008267) (orofaciodigital syndrome V), [MONDO:0021234](http://purl.obolibrary.org/obo/MONDO_0021234) (spinal cord neoplasm), [MONDO:0009598](http://purl.obolibrary.org/obo/MONDO_0009598) (metaphyseal chondrodysplasia-retinitis pigmentosa syndrome), [MONDO:0009599](http://purl.obolibrary.org/obo/MONDO_0009599) (metaphyseal dysostosis-intellectual disability-conductive deafness syndrome), [MONDO:0021233](http://purl.obolibrary.org/obo/MONDO_0021233) (ear neoplasm), [MONDO:0008268](http://purl.obolibrary.org/obo/MONDO_0008268) (polydactyly-myopia syndrome), [MONDO:0008269](http://purl.obolibrary.org/obo/MONDO_0008269) (polydactyly of a biphalangeal thumb), [MONDO:0021235](http://purl.obolibrary.org/obo/MONDO_0021235) (external ear neoplasm), [MONDO:0021238](http://purl.obolibrary.org/obo/MONDO_0021238) (cornea neoplasm), [MONDO:0021237](http://purl.obolibrary.org/obo/MONDO_0021237) (adrenal medulla neoplasm), [MONDO:0021239](http://purl.obolibrary.org/obo/MONDO_0021239) (urethra neoplasm), [MONDO:0021230](http://purl.obolibrary.org/obo/MONDO_0021230) (uterine cervix neoplasm), [MONDO:0021232](http://purl.obolibrary.org/obo/MONDO_0021232) (pineal body neoplasm), [MONDO:0021231](http://purl.obolibrary.org/obo/MONDO_0021231) (retina neoplasm), [MONDO:0010588](http://purl.obolibrary.org/obo/MONDO_0010588) (exudative vitreoretinopathy 2, X-linked), [MONDO:0010585](http://purl.obolibrary.org/obo/MONDO_0010585) (X-linked hypohidrotic ectodermal dysplasia), [MONDO:0010586](http://purl.obolibrary.org/obo/MONDO_0010586) (X-linked Ehlers-Danlos syndrome), [MONDO:0010589](http://purl.obolibrary.org/obo/MONDO_0010589) (Aarskog-Scott syndrome, X-linked), [MONDO:0009581](http://purl.obolibrary.org/obo/MONDO_0009581) (intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome), [MONDO:0009582](http://purl.obolibrary.org/obo/MONDO_0009582) (Mietens syndrome), [MONDO:0010572](http://purl.obolibrary.org/obo/MONDO_0010572) (occipital horn syndrome), [MONDO:0009583](http://purl.obolibrary.org/obo/MONDO_0009583) (blepharophimosis-intellectual disability syndrome, Ohdo type), [MONDO:0009584](http://purl.obolibrary.org/obo/MONDO_0009584) (intellectual disability, Buenos-Aires type), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0010571](http://purl.obolibrary.org/obo/MONDO_0010571) (Otopalatodigital syndrome type 2), [MONDO:0021223](http://purl.obolibrary.org/obo/MONDO_0021223) (digestive system neoplasm), [MONDO:0021222](http://purl.obolibrary.org/obo/MONDO_0021222) (lacrimal gland neoplasm), [MONDO:0009588](http://purl.obolibrary.org/obo/MONDO_0009588) (Langer mesomelic dysplasia), [MONDO:0009589](http://purl.obolibrary.org/obo/MONDO_0009589) (mesomelic dwarfism-cleft palate-camptodactyly syndrome), [MONDO:0021225](http://purl.obolibrary.org/obo/MONDO_0021225) (uvea neoplasm), [MONDO:0021224](http://purl.obolibrary.org/obo/MONDO_0021224) (iris neoplasm), [MONDO:0021227](http://purl.obolibrary.org/obo/MONDO_0021227) (adrenal gland neoplasm), [MONDO:0021229](http://purl.obolibrary.org/obo/MONDO_0021229) (ciliary body neoplasm), [MONDO:0021228](http://purl.obolibrary.org/obo/MONDO_0021228) (brainstem neoplasm), [MONDO:0021221](http://purl.obolibrary.org/obo/MONDO_0021221) (vestibulocochlear nerve neoplasm), [MONDO:0021220](http://purl.obolibrary.org/obo/MONDO_0021220) (eye neoplasm), [MONDO:0010576](http://purl.obolibrary.org/obo/MONDO_0010576) (X-linked mixed deafness with perilymphatic gusher), [MONDO:0010577](http://purl.obolibrary.org/obo/MONDO_0010577) (deafness, X-linked 1), [MONDO:0010574](http://purl.obolibrary.org/obo/MONDO_0010574) (syndromic X-linked intellectual disability 5), [MONDO:0010575](http://purl.obolibrary.org/obo/MONDO_0010575) (deafness-hypogonadism syndrome), [MONDO:0010578](http://purl.obolibrary.org/obo/MONDO_0010578) (deafness dystonia syndrome), [MONDO:0010579](http://purl.obolibrary.org/obo/MONDO_0010579) (X-linked corneal dermoid), [MONDO:0009570](http://purl.obolibrary.org/obo/MONDO_0009570) (McDonough syndrome), [MONDO:0009571](http://purl.obolibrary.org/obo/MONDO_0009571) (Meckel syndrome, type 1), [MONDO:0010561](http://purl.obolibrary.org/obo/MONDO_0010561) (Coffin-Lowry syndrome), [MONDO:0009572](http://purl.obolibrary.org/obo/MONDO_0009572) (autosomal recessive familial Mediterranean fever), [MONDO:0011893](http://purl.obolibrary.org/obo/MONDO_0011893) (autosomal dominant nonsyndromic deafness 52), [MONDO:0010562](http://purl.obolibrary.org/obo/MONDO_0010562) (colonic atresia (disease)), [MONDO:0009575](http://purl.obolibrary.org/obo/MONDO_0009575) (thiamine-responsive megaloblastic anemia syndrome), [MONDO:0008244](http://purl.obolibrary.org/obo/MONDO_0008244) (piebaldism), [MONDO:0011890](http://purl.obolibrary.org/obo/MONDO_0011890) (Charcot-Marie-tooth disease type 1D), [MONDO:0008245](http://purl.obolibrary.org/obo/MONDO_0008245) (piebald trait-neurologic defects syndrome), [MONDO:0009576](http://purl.obolibrary.org/obo/MONDO_0009576) (megalocornea (disease)), [MONDO:0009577](http://purl.obolibrary.org/obo/MONDO_0009577) (megalocornea-intellectual disability syndrome), [MONDO:0021211](http://purl.obolibrary.org/obo/MONDO_0021211) (brain neoplasm), [MONDO:0008246](http://purl.obolibrary.org/obo/MONDO_0008246) (pigmented paravenous retinochoroidal atrophy), [MONDO:0008247](http://purl.obolibrary.org/obo/MONDO_0008247) (robin sequence-oligodactyly syndrome), [MONDO:0009578](http://purl.obolibrary.org/obo/MONDO_0009578) (neurocutaneous melanocytosis), [MONDO:0009579](http://purl.obolibrary.org/obo/MONDO_0009579) (Frank-Ter Haar syndrome), [MONDO:0021218](http://purl.obolibrary.org/obo/MONDO_0021218) (placenta neoplasm), [MONDO:0021210](http://purl.obolibrary.org/obo/MONDO_0021210) (trachea neoplasm), [MONDO:0010565](http://purl.obolibrary.org/obo/MONDO_0010565) (red color blindness), [MONDO:0010566](http://purl.obolibrary.org/obo/MONDO_0010566) (X-linked cone-rod dystrophy 1), [MONDO:0010563](http://purl.obolibrary.org/obo/MONDO_0010563) (blue cone monochromacy), [MONDO:0011895](http://purl.obolibrary.org/obo/MONDO_0011895) (idiopathic hypereosinophilic syndrome), [MONDO:0010564](http://purl.obolibrary.org/obo/MONDO_0010564) (red-green color blindness), [MONDO:0011894](http://purl.obolibrary.org/obo/MONDO_0011894) (Charcot-Marie-tooth disease type 2E), [MONDO:0010569](http://purl.obolibrary.org/obo/MONDO_0010569) (X-linked complicated corpus callosum dysgenesis), [MONDO:0011899](http://purl.obolibrary.org/obo/MONDO_0011899) (Noonan syndrome-like disorder with loose anagen hair), [MONDO:0010567](http://purl.obolibrary.org/obo/MONDO_0010567) (cone dystrophy, X-linked, with Tapetal-like sheen), [MONDO:0010568](http://purl.obolibrary.org/obo/MONDO_0010568) (Aicardi syndrome), [MONDO:0011898](http://purl.obolibrary.org/obo/MONDO_0011898) (Charcot-Marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive), [MONDO:0021209](http://purl.obolibrary.org/obo/MONDO_0021209) (heart neoplasm), [MONDO:0021208](http://purl.obolibrary.org/obo/MONDO_0021208) (endocrine alopecia), [MONDO:0009560](http://purl.obolibrary.org/obo/MONDO_0009560) (oculotrichoanal syndrome), [MONDO:0009561](http://purl.obolibrary.org/obo/MONDO_0009561) (alpha-mannosidosis), [MONDO:0010550](http://purl.obolibrary.org/obo/MONDO_0010550) (Charcot-Marie-tooth disease X-linked recessive 2), [MONDO:0009562](http://purl.obolibrary.org/obo/MONDO_0009562) (beta-mannosidosis), [MONDO:0010551](http://purl.obolibrary.org/obo/MONDO_0010551) (Charcot-Marie-tooth disease X-linked recessive 3), [MONDO:0009563](http://purl.obolibrary.org/obo/MONDO_0009563) (maple syrup urine disease), [MONDO:0009564](http://purl.obolibrary.org/obo/MONDO_0009564) (Marden-Walker syndrome), [MONDO:0008233](http://purl.obolibrary.org/obo/MONDO_0008233) (phaeochromocytoma), [MONDO:0009565](http://purl.obolibrary.org/obo/MONDO_0009565) (microcephaly-glomerulonephritis-marfanoid habitus syndrome), [MONDO:0008234](http://purl.obolibrary.org/obo/MONDO_0008234) (multiple endocrine neoplasia type 2A), [MONDO:0009566](http://purl.obolibrary.org/obo/MONDO_0009566) (marfanoid habitus-autosomal recessive intellectual disability syndrome), [MONDO:0009567](http://purl.obolibrary.org/obo/MONDO_0009567) (Marinesco-SjC6gren syndrome), [MONDO:0008237](http://purl.obolibrary.org/obo/MONDO_0008237) (phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome), [MONDO:0021202](http://purl.obolibrary.org/obo/MONDO_0021202) (allergic otitis media), [MONDO:0009569](http://purl.obolibrary.org/obo/MONDO_0009569) (Hennekam-Beemer syndrome), [MONDO:0021207](http://purl.obolibrary.org/obo/MONDO_0021207) (Crohn jejunitis), [MONDO:0010554](http://purl.obolibrary.org/obo/MONDO_0010554) (Abruzzo-Erickson syndrome), [MONDO:0010555](http://purl.obolibrary.org/obo/MONDO_0010555) (X-linked chondrodysplasia punctata 1), [MONDO:0011885](http://purl.obolibrary.org/obo/MONDO_0011885) (tubulointerstitial nephritis and uveitis syndrome), [MONDO:0011884](http://purl.obolibrary.org/obo/MONDO_0011884) (hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome), [MONDO:0011883](http://purl.obolibrary.org/obo/MONDO_0011883) (curly hair-acral keratoderma-caries syndrome), [MONDO:0010558](http://purl.obolibrary.org/obo/MONDO_0010558) (choroideremia-deafness-obesity syndrome), [MONDO:0010559](http://purl.obolibrary.org/obo/MONDO_0010559) (MASA syndrome), [MONDO:0011889](http://purl.obolibrary.org/obo/MONDO_0011889) (Charcot-Marie-tooth disease type 2I), [MONDO:0010556](http://purl.obolibrary.org/obo/MONDO_0010556) (X-linked chondrodysplasia punctata), [MONDO:0010557](http://purl.obolibrary.org/obo/MONDO_0010557) (choroideremia), [MONDO:0021279](http://purl.obolibrary.org/obo/MONDO_0021279) (mucoepidermoid carcinoma of submandibular gland), [MONDO:0021271](http://purl.obolibrary.org/obo/MONDO_0021271) (villous adenoma of colon), [MONDO:0021273](http://purl.obolibrary.org/obo/MONDO_0021273) (leiomyoma of ciliary body), [MONDO:0021276](http://purl.obolibrary.org/obo/MONDO_0021276) (papilloma of buccal mucosa), [MONDO:0021275](http://purl.obolibrary.org/obo/MONDO_0021275) (papilloma of eyelid), [MONDO:0008294](http://purl.obolibrary.org/obo/MONDO_0008294) (acute intermittent porphyria), [MONDO:0008295](http://purl.obolibrary.org/obo/MONDO_0008295) (sporadic porphyria cutanea tarda), [MONDO:0008296](http://purl.obolibrary.org/obo/MONDO_0008296) (familial porphyria cutanea tarda), [MONDO:0008297](http://purl.obolibrary.org/obo/MONDO_0008297) (variegate porphyria), [MONDO:0008298](http://purl.obolibrary.org/obo/MONDO_0008298) (postaxial tetramelic oligodactyly), [MONDO:0008281](http://purl.obolibrary.org/obo/MONDO_0008281) (polyposis, intestinal, Scattered and discrete), [MONDO:0008283](http://purl.obolibrary.org/obo/MONDO_0008283) (Cronkhite-Canada syndrome), [MONDO:0008284](http://purl.obolibrary.org/obo/MONDO_0008284) (polyposis of gastric fundus without Polyposis coli), [MONDO:0008286](http://purl.obolibrary.org/obo/MONDO_0008286) (crossed polysyndactyly), [MONDO:0008287](http://purl.obolibrary.org/obo/MONDO_0008287) (Greig cephalopolysyndactyly syndrome), [MONDO:0008289](http://purl.obolibrary.org/obo/MONDO_0008289) (porencephaly 1), [MONDO:0021258](http://purl.obolibrary.org/obo/MONDO_0021258) (choroid neoplasm), [MONDO:0021257](http://purl.obolibrary.org/obo/MONDO_0021257) (glomus jugulare neoplasm), [MONDO:0021259](http://purl.obolibrary.org/obo/MONDO_0021259) (prostate neoplasm), [MONDO:0021250](http://purl.obolibrary.org/obo/MONDO_0021250) (tonsil neoplasm), [MONDO:0021251](http://purl.obolibrary.org/obo/MONDO_0021251) (endometrium neoplasm), [MONDO:0021254](http://purl.obolibrary.org/obo/MONDO_0021254) (corpus uteri neoplasm), [MONDO:0021253](http://purl.obolibrary.org/obo/MONDO_0021253) (gallbladder neoplasm), [MONDO:0008270](http://purl.obolibrary.org/obo/MONDO_0008270) (polydactyly of a triphalangeal thumb), [MONDO:0008271](http://purl.obolibrary.org/obo/MONDO_0008271) (polydactyly of an index finger), [MONDO:0010591](http://purl.obolibrary.org/obo/MONDO_0010591) (fingerprint body myopathy), [MONDO:0008272](http://purl.obolibrary.org/obo/MONDO_0008272) (polysyndactyly), [MONDO:0008274](http://purl.obolibrary.org/obo/MONDO_0008274) (polyostotic fibrous dysplasia), [MONDO:0010595](http://purl.obolibrary.org/obo/MONDO_0010595) (Sertoli cell-only syndrome), [MONDO:0008275](http://purl.obolibrary.org/obo/MONDO_0008275) (familial expansile osteolysis), [MONDO:0010592](http://purl.obolibrary.org/obo/MONDO_0010592) (focal dermal hypoplasia), [MONDO:0008276](http://purl.obolibrary.org/obo/MONDO_0008276) (generalized juvenile polyposis/juvenile polyposis coli), [MONDO:0008277](http://purl.obolibrary.org/obo/MONDO_0008277) (polyposis, gastric), [MONDO:0021245](http://purl.obolibrary.org/obo/MONDO_0021245) (oral cavity neoplasm), [MONDO:0008278](http://purl.obolibrary.org/obo/MONDO_0008278) (juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome), [MONDO:0021244](http://purl.obolibrary.org/obo/MONDO_0021244) (submandibular gland neoplasm), [MONDO:0021246](http://purl.obolibrary.org/obo/MONDO_0021246) (pharynx neoplasm), [MONDO:0021249](http://purl.obolibrary.org/obo/MONDO_0021249) (lip neoplasm), [MONDO:0021248](http://purl.obolibrary.org/obo/MONDO_0021248) (nervous system neoplasm), [MONDO:0021241](http://purl.obolibrary.org/obo/MONDO_0021241) (buccal mucosa neoplasm), [MONDO:0021240](http://purl.obolibrary.org/obo/MONDO_0021240) (tongue neoplasm), [MONDO:0021243](http://purl.obolibrary.org/obo/MONDO_0021243) (parotid gland neoplasm), [MONDO:0021242](http://purl.obolibrary.org/obo/MONDO_0021242) (sublingual gland neoplasm), [MONDO:0010598](http://purl.obolibrary.org/obo/MONDO_0010598) (glycogen storage disease IXa), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), [MONDO:0021299](http://purl.obolibrary.org/obo/MONDO_0021299) (carcinoma in situ of extrahepatic bile duct), [MONDO:0021292](http://purl.obolibrary.org/obo/MONDO_0021292) (carcinoma in situ of gastric body), [MONDO:0021291](http://purl.obolibrary.org/obo/MONDO_0021291) (carcinoma in situ of fundus of stomach), [MONDO:0021294](http://purl.obolibrary.org/obo/MONDO_0021294) (carcinoma in situ of gastric cardia), [MONDO:0021296](http://purl.obolibrary.org/obo/MONDO_0021296) (carcinoma in situ of renal pelvis), [MONDO:0021298](http://purl.obolibrary.org/obo/MONDO_0021298) (carcinoma in situ of oropharynx), [MONDO:0021297](http://purl.obolibrary.org/obo/MONDO_0021297) (carcinoma in situ of nasopharynx), [MONDO:0021290](http://purl.obolibrary.org/obo/MONDO_0021290) (carcinoma in situ of appendix), [MONDO:0021289](http://purl.obolibrary.org/obo/MONDO_0021289) (carcinoma in situ of cecum), [MONDO:0021288](http://purl.obolibrary.org/obo/MONDO_0021288) (carcinoma in situ of hypopharynx), [MONDO:0021281](http://purl.obolibrary.org/obo/MONDO_0021281) (cavernous hemangioma of retina), [MONDO:0021280](http://purl.obolibrary.org/obo/MONDO_0021280) (mucoepidermoid carcinoma of parotid gland), [MONDO:0021283](http://purl.obolibrary.org/obo/MONDO_0021283) (malignant teratoma of mediastinum), [MONDO:0021282](http://purl.obolibrary.org/obo/MONDO_0021282) (malignant teratoma of testis), [MONDO:0021285](http://purl.obolibrary.org/obo/MONDO_0021285) (carcinoma in situ of urethra), [MONDO:0021284](http://purl.obolibrary.org/obo/MONDO_0021284) (carcinoma in situ of ureter), [MONDO:0021287](http://purl.obolibrary.org/obo/MONDO_0021287) (carcinoma in situ of epiglottis), [MONDO:0011916](http://purl.obolibrary.org/obo/MONDO_0011916) (Charcot-Marie-tooth disease axonal type 2K), [MONDO:0011915](http://purl.obolibrary.org/obo/MONDO_0011915) (MMVP2), [MONDO:0011914](http://purl.obolibrary.org/obo/MONDO_0011914) (hypotrichosis-lymphedema-telangiectasia syndrome), [MONDO:0011919](http://purl.obolibrary.org/obo/MONDO_0011919) (autoimmune disease, susceptibility to, 1), [MONDO:0011912](http://purl.obolibrary.org/obo/MONDO_0011912) (autosomal recessive nonsyndromic deafness 37), [MONDO:0011911](http://purl.obolibrary.org/obo/MONDO_0011911) (Craniolenticulosutural dysplasia), [MONDO:0011910](http://purl.obolibrary.org/obo/MONDO_0011910) (autosomal dominant limb-girdle muscular dystrophy type 1C), [MONDO:0011905](http://purl.obolibrary.org/obo/MONDO_0011905) (familial hypercholanemia), [MONDO:0011903](http://purl.obolibrary.org/obo/MONDO_0011903) (Charcot-Marie-tooth disease type 2J), [MONDO:0011902](http://purl.obolibrary.org/obo/MONDO_0011902) (Charcot-Marie-tooth disease type 1F), [MONDO:0011909](http://purl.obolibrary.org/obo/MONDO_0011909) (Charcot-Marie-tooth disease dominant intermediate d), [MONDO:0011908](http://purl.obolibrary.org/obo/MONDO_0011908) (juvenile myelomonocytic leukemia), [MONDO:0011907](http://purl.obolibrary.org/obo/MONDO_0011907) (acrocapitofemoral dysplasia), [MONDO:0011906](http://purl.obolibrary.org/obo/MONDO_0011906) (congenital bile acid synthesis defect 1), [MONDO:0011901](http://purl.obolibrary.org/obo/MONDO_0011901) (Charcot-Marie-tooth disease axonal type 2H), [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019439](http://purl.obolibrary.org/obo/MONDO_0019439) (AA amyloidosis), [MONDO:0018105](http://purl.obolibrary.org/obo/MONDO_0018105) (Wolfram syndrome), [MONDO:0019436](http://purl.obolibrary.org/obo/MONDO_0019436) (psoriasis-related juvenile idiopathic arthritis), [MONDO:0018106](http://purl.obolibrary.org/obo/MONDO_0018106) (hereditary xanthinuria), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0019434](http://purl.obolibrary.org/obo/MONDO_0019434) (systemic-onset juvenile idiopathic arthritis), [MONDO:0008780](http://purl.obolibrary.org/obo/MONDO_0008780) (amyotrophic lateral sclerosis type 2), [MONDO:0018104](http://purl.obolibrary.org/obo/MONDO_0018104) (Torg-Winchester syndrome), [MONDO:0008781](http://purl.obolibrary.org/obo/MONDO_0008781) (juvenile amyotrophic lateral sclerosis with dementia), [MONDO:0019435](http://purl.obolibrary.org/obo/MONDO_0019435) (rheumatoid factor-positive polyarticular juvenile idiopathic arthritis), [MONDO:0008782](http://purl.obolibrary.org/obo/MONDO_0008782) (amyotrophic lateral sclerosis with polyglucosan bodies), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0018101](http://purl.obolibrary.org/obo/MONDO_0018101) (familial primary hypomagnesemia with normocalciuria and normocalcemia), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0018102](http://purl.obolibrary.org/obo/MONDO_0018102) (corneal dystrophy (disease)), [MONDO:0008785](http://purl.obolibrary.org/obo/MONDO_0008785) (pyridoxine-refractory autosomal recessive sideroblastic anemia), [MONDO:0018100](http://purl.obolibrary.org/obo/MONDO_0018100) (primary hypomagnesemia), [MONDO:0008786](http://purl.obolibrary.org/obo/MONDO_0008786) (pyridoxine-responsive sideroblastic anemia), [MONDO:0008787](http://purl.obolibrary.org/obo/MONDO_0008787) (microcytic anemia with liver iron overload), [MONDO:0008788](http://purl.obolibrary.org/obo/MONDO_0008788) (IRIDA syndrome), [MONDO:0008789](http://purl.obolibrary.org/obo/MONDO_0008789) (anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane), [MONDO:0006119](http://purl.obolibrary.org/obo/MONDO_0006119) (breast mucosa-associated lymphoid tissue lymphoma), [MONDO:0007449](http://purl.obolibrary.org/obo/MONDO_0007449) (Dermo-odonto dysplasia), [MONDO:0006118](http://purl.obolibrary.org/obo/MONDO_0006118) (breast fibrosis), [MONDO:0006117](http://purl.obolibrary.org/obo/MONDO_0006117) (breast diffuse large b-cell lymphoma), [MONDO:0006116](http://purl.obolibrary.org/obo/MONDO_0006116) (breast carcinoma by gene expression Profile), [MONDO:0006115](http://purl.obolibrary.org/obo/MONDO_0006115) (blast phase chronic myelogenous leukemia, BCR-ABL1 positive), [MONDO:0007445](http://purl.obolibrary.org/obo/MONDO_0007445) (Dermatopathia pigmentosa reticularis), [MONDO:0007443](http://purl.obolibrary.org/obo/MONDO_0007443) (congenital unilateral hypoplasia of depressor anguli oris), [MONDO:0006112](http://purl.obolibrary.org/obo/MONDO_0006112) (bladder inflammatory myofibroblastic tumor), [MONDO:0006111](http://purl.obolibrary.org/obo/MONDO_0006111) (bladder flat intraepithelial lesion), [MONDO:0019428](http://purl.obolibrary.org/obo/MONDO_0019428) (Fried syndrome), [MONDO:0019425](http://purl.obolibrary.org/obo/MONDO_0019425) (X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome), [MONDO:0019426](http://purl.obolibrary.org/obo/MONDO_0019426) (X-linked intellectual disability-corpus callosum agenesis-spastic quadriparesis syndrome), [MONDO:0019423](http://purl.obolibrary.org/obo/MONDO_0019423) (X-linked intellectual disability, Stoll type), [MONDO:0008771](http://purl.obolibrary.org/obo/MONDO_0008771) (amelogenesis imperfecta type 1G), [MONDO:0019422](http://purl.obolibrary.org/obo/MONDO_0019422) (X-linked intellectual disability, Stevenson type), [MONDO:0019420](http://purl.obolibrary.org/obo/MONDO_0019420) (X-linked intellectual disability, Pai type), [MONDO:0008774](http://purl.obolibrary.org/obo/MONDO_0008774) (2-aminoadipic 2-oxoadipic aciduria), [MONDO:0008777](http://purl.obolibrary.org/obo/MONDO_0008777) (gelatinous drop-like corneal dystrophy), [MONDO:0006128](http://purl.obolibrary.org/obo/MONDO_0006128) (central nervous system anaplastic large cell lymphoma), [MONDO:0007458](http://purl.obolibrary.org/obo/MONDO_0007458) (digitotalar dysmorphism; ulnar drift, hereditary), [MONDO:0006126](http://purl.obolibrary.org/obo/MONDO_0006126) (cecum neuroendocrine tumor G1), [MONDO:0007455](http://purl.obolibrary.org/obo/MONDO_0007455) (diabetes mellitus, Noninsulin-dependent), [MONDO:0006123](http://purl.obolibrary.org/obo/MONDO_0006123) (cardiac rhabdomyoma (disease)), [MONDO:0007454](http://purl.obolibrary.org/obo/MONDO_0007454) (type 1 diabetes mellitus 2), [MONDO:0007453](http://purl.obolibrary.org/obo/MONDO_0007453) (maturity-onset diabetes of the young type 2), [MONDO:0006122](http://purl.obolibrary.org/obo/MONDO_0006122) (calcifying nested epithelial stromal tumor of the liver), [MONDO:0007452](http://purl.obolibrary.org/obo/MONDO_0007452) (maturity-onset diabetes of the young type 1), [MONDO:0006121](http://purl.obolibrary.org/obo/MONDO_0006121) (calcifying fibrous tumor), [MONDO:0019416](http://purl.obolibrary.org/obo/MONDO_0019416) (X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome), [MONDO:0020406](http://purl.obolibrary.org/obo/MONDO_0020406) (complete atrioventricular canal-left heart obstruction syndrome), [MONDO:0019414](http://purl.obolibrary.org/obo/MONDO_0019414) (BRESEK syndrome), [MONDO:0020407](http://purl.obolibrary.org/obo/MONDO_0020407) (complete atrioventricular canal-ventricle hypoplasia syndrome), [MONDO:0019415](http://purl.obolibrary.org/obo/MONDO_0019415) (fetal and neonatal alloimmune thrombocytopenia), [MONDO:0020408](http://purl.obolibrary.org/obo/MONDO_0020408) (complete atrioventricular canal-tetralogy of fallot syndrome), [MONDO:0019412](http://purl.obolibrary.org/obo/MONDO_0019412) (dysspondyloenchondromatosis), [MONDO:0019413](http://purl.obolibrary.org/obo/MONDO_0019413) (Ischio-vertebral syndrome), [MONDO:0008760](http://purl.obolibrary.org/obo/MONDO_0008760) (beta-ketothiolase deficiency), [MONDO:0019410](http://purl.obolibrary.org/obo/MONDO_0019410) (Nodulosis-arthropathy-osteolysis syndrome), [MONDO:0019411](http://purl.obolibrary.org/obo/MONDO_0019411) (genochondromatosis type 1), [MONDO:0008762](http://purl.obolibrary.org/obo/MONDO_0008762) (autosomal recessive Alport syndrome), [MONDO:0008763](http://purl.obolibrary.org/obo/MONDO_0008763) (Alstrom syndrome), [MONDO:0008764](http://purl.obolibrary.org/obo/MONDO_0008764) (Leber congenital amaurosis 1), [MONDO:0008765](http://purl.obolibrary.org/obo/MONDO_0008765) (Leber congenital amaurosis 2), [MONDO:0008766](http://purl.obolibrary.org/obo/MONDO_0008766) (amaurosis-hypertrichosis syndrome), [MONDO:0008767](http://purl.obolibrary.org/obo/MONDO_0008767) (neuronal ceroid lipofuscinosis 3), [MONDO:0008768](http://purl.obolibrary.org/obo/MONDO_0008768) (neuronal ceroid lipofuscinosis 4A), [MONDO:0007429](http://purl.obolibrary.org/obo/MONDO_0007429) (optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy), [MONDO:0008769](http://purl.obolibrary.org/obo/MONDO_0008769) (neuronal ceroid lipofuscinosis 2), [MONDO:0007428](http://purl.obolibrary.org/obo/MONDO_0007428) (deafness-craniofacial syndrome), [MONDO:0007424](http://purl.obolibrary.org/obo/MONDO_0007424) (autosomal dominant nonsyndromic deafness 1), [MONDO:0007422](http://purl.obolibrary.org/obo/MONDO_0007422) (keratoderma hereditarium mutilans), [MONDO:0007421](http://purl.obolibrary.org/obo/MONDO_0007421) (deafness-ear malformation-facial palsy syndrome), [MONDO:0007420](http://purl.obolibrary.org/obo/MONDO_0007420) (autosomal dominant deafness-onychodystrophy syndrome), [MONDO:0019418](http://purl.obolibrary.org/obo/MONDO_0019418) (X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome), [MONDO:0019406](http://purl.obolibrary.org/obo/MONDO_0019406) (craniofacial conodysplasia), [MONDO:0019403](http://purl.obolibrary.org/obo/MONDO_0019403) (congenital dyserythropoietic anemia), [MONDO:0019404](http://purl.obolibrary.org/obo/MONDO_0019404) (perineurioma), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0008750](http://purl.obolibrary.org/obo/MONDO_0008750) (microcephaly-albinism-digital anomalies syndrome), [MONDO:0008752](http://purl.obolibrary.org/obo/MONDO_0008752) (Alexander disease), [MONDO:0008753](http://purl.obolibrary.org/obo/MONDO_0008753) (alkaptonuria), [MONDO:0008754](http://purl.obolibrary.org/obo/MONDO_0008754) (alopecia-contractures-dwarfism-intellectual disability syndrome), [MONDO:0008755](http://purl.obolibrary.org/obo/MONDO_0008755) (Moynahan syndrome), [MONDO:0006109](http://purl.obolibrary.org/obo/MONDO_0006109) (malignant biphasic mesothelioma), [MONDO:0008758](http://purl.obolibrary.org/obo/MONDO_0008758) (mitochondrial DNA depletion syndrome 4a), [MONDO:0006108](http://purl.obolibrary.org/obo/MONDO_0006108) (bile duct adenoma), [MONDO:0006107](http://purl.obolibrary.org/obo/MONDO_0006107) (benign thyroid gland neoplasm), [MONDO:0008759](http://purl.obolibrary.org/obo/MONDO_0008759) (Oxoglutaricaciduria), [MONDO:0006106](http://purl.obolibrary.org/obo/MONDO_0006106) (benign smooth muscle neoplasm), [MONDO:0006105](http://purl.obolibrary.org/obo/MONDO_0006105) (benign conjunctival neoplasm), [MONDO:0007435](http://purl.obolibrary.org/obo/MONDO_0007435) (dentatorubral-pallidoluysian atrophy), [MONDO:0006104](http://purl.obolibrary.org/obo/MONDO_0006104) (benign carotid body paraganglioma), [MONDO:0006103](http://purl.obolibrary.org/obo/MONDO_0006103) (benign adrenal gland pheochromocytoma), [MONDO:0006102](http://purl.obolibrary.org/obo/MONDO_0006102) (basaloid carcinoma), [MONDO:0007432](http://purl.obolibrary.org/obo/MONDO_0007432) (CADASIL), [MONDO:0019409](http://purl.obolibrary.org/obo/MONDO_0019409) (idiopathic juvenile osteoporosis), [MONDO:0019407](http://purl.obolibrary.org/obo/MONDO_0019407) (microcephalic osteodysplastic dysplasia, Saul-Wilson type), [MONDO:0019408](http://purl.obolibrary.org/obo/MONDO_0019408) (Astley-Kendall dysplasia), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0019478](http://purl.obolibrary.org/obo/MONDO_0019478) (adult nodular lymphocyte predominant Hodgkin lymphoma), [MONDO:0018147](http://purl.obolibrary.org/obo/MONDO_0018147) (idiopathic macular telangiectasia type 3), [MONDO:0018148](http://purl.obolibrary.org/obo/MONDO_0018148) (vasoproliferative tumor of retina), [MONDO:0019479](http://purl.obolibrary.org/obo/MONDO_0019479) (histiocytic sarcoma), [MONDO:0018145](http://purl.obolibrary.org/obo/MONDO_0018145) (congenital retinal arteriovenous communication), [MONDO:0019476](http://purl.obolibrary.org/obo/MONDO_0019476) (primary cutaneous peripheral T-cell lymphoma not otherwise specified), [MONDO:0018146](http://purl.obolibrary.org/obo/MONDO_0018146) (idiopathic macular telangiectasia type 1), [MONDO:0018143](http://purl.obolibrary.org/obo/MONDO_0018143) (pyruvate carboxylase deficiency, benign type), [MONDO:0019474](http://purl.obolibrary.org/obo/MONDO_0019474) (Hepatosplenic T-cell lymphoma), [MONDO:0020463](http://purl.obolibrary.org/obo/MONDO_0020463) (isolated congenital ectropion), [MONDO:0019475](http://purl.obolibrary.org/obo/MONDO_0019475) (subcutaneous panniculitis-like T-cell lymphoma), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), [MONDO:0020464](http://purl.obolibrary.org/obo/MONDO_0020464) (Euryblepharon), [MONDO:0018141](http://purl.obolibrary.org/obo/MONDO_0018141) (pyruvate carboxylase deficiency, infantile form), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0020465](http://purl.obolibrary.org/obo/MONDO_0020465) (congenital eyelid retraction), [MONDO:0020466](http://purl.obolibrary.org/obo/MONDO_0020466) (monosomy X), [MONDO:0018142](http://purl.obolibrary.org/obo/MONDO_0018142) (pyruvate carboxylase deficiency, severe neonatal type), [MONDO:0019473](http://purl.obolibrary.org/obo/MONDO_0019473) (enteropathy-associated T-cell lymphoma), [MONDO:0020467](http://purl.obolibrary.org/obo/MONDO_0020467) (mosaic monosomy X), [MONDO:0019470](http://purl.obolibrary.org/obo/MONDO_0019470) (aggressive NK-cell leukemia), [MONDO:0019471](http://purl.obolibrary.org/obo/MONDO_0019471) (adult T-cell leukemia/lymphoma), [MONDO:0006159](http://purl.obolibrary.org/obo/MONDO_0006159) (colorectal gastrointestinal stromal tumor), [MONDO:0006158](http://purl.obolibrary.org/obo/MONDO_0006158) (colorectal diffuse large b-cell lymphoma), [MONDO:0007489](http://purl.obolibrary.org/obo/MONDO_0007489) (dysplasia epiphysealis hemimelica), [MONDO:0006157](http://purl.obolibrary.org/obo/MONDO_0006157) (colorectal adenosquamous carcinoma), [MONDO:0020460](http://purl.obolibrary.org/obo/MONDO_0020460) (acquired von willebrand syndrome), [MONDO:0006156](http://purl.obolibrary.org/obo/MONDO_0006156) (colon sessile serrated adenoma/polyp), [MONDO:0020461](http://purl.obolibrary.org/obo/MONDO_0020461) (Epiblepharon), [MONDO:0006155](http://purl.obolibrary.org/obo/MONDO_0006155) (colon neuroendocrine tumor G1), [MONDO:0020462](http://purl.obolibrary.org/obo/MONDO_0020462) (tarsal kink syndrome), [MONDO:0007486](http://purl.obolibrary.org/obo/MONDO_0007486) (hereditary benign intraepithelial dyskeratosis), [MONDO:0006154](http://purl.obolibrary.org/obo/MONDO_0006154) (colon mucosa-associated lymphoid tissue lymphoma), [MONDO:0007485](http://purl.obolibrary.org/obo/MONDO_0007485) (dyskeratosis congenita, autosomal dominant 1), [MONDO:0006153](http://purl.obolibrary.org/obo/MONDO_0006153) (colon juvenile polyp), [MONDO:0007484](http://purl.obolibrary.org/obo/MONDO_0007484) (dyschromatosis universalis), [MONDO:0006152](http://purl.obolibrary.org/obo/MONDO_0006152) (colon inflammatory polyp), [MONDO:0007483](http://purl.obolibrary.org/obo/MONDO_0007483) (dyschromatosis symmetrica hereditaria), [MONDO:0007482](http://purl.obolibrary.org/obo/MONDO_0007482) (dyschondrosteosis-nephritis syndrome), [MONDO:0007481](http://purl.obolibrary.org/obo/MONDO_0007481) (Leri-Weill dyschondrosteosis), [MONDO:0006150](http://purl.obolibrary.org/obo/MONDO_0006150) (colon Burkitt lymphoma), [MONDO:0018138](http://purl.obolibrary.org/obo/MONDO_0018138) (ocular albinism with congenital sensorineural deafness), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0018136](http://purl.obolibrary.org/obo/MONDO_0018136) (minimal pigment oculocutaneous albinism type 1), [MONDO:0019467](http://purl.obolibrary.org/obo/MONDO_0019467) (CD4+/CD56+ hematodermic neoplasm), [MONDO:0018137](http://purl.obolibrary.org/obo/MONDO_0018137) (temperature-sensitive oculocutaneous albinism type 1), [MONDO:0019468](http://purl.obolibrary.org/obo/MONDO_0019468) (T-cell prolymphocytic leukemia), [MONDO:0019465](http://purl.obolibrary.org/obo/MONDO_0019465) (Nodal marginal zone b-cell lymphoma), [MONDO:0018134](http://purl.obolibrary.org/obo/MONDO_0018134) (disorder of melanin metabolism), [MONDO:0018135](http://purl.obolibrary.org/obo/MONDO_0018135) (oculocutaneous albinism type 1), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0019463](http://purl.obolibrary.org/obo/MONDO_0019463) (non-amyloid monoclonal immunoglobulin deposition disease), [MONDO:0018132](http://purl.obolibrary.org/obo/MONDO_0018132) (congenital muscular alpha-dystroglycanopathy with brain and eye anomalies), [MONDO:0019464](http://purl.obolibrary.org/obo/MONDO_0019464) (heavy chain disease), [MONDO:0018130](http://purl.obolibrary.org/obo/MONDO_0018130) (brain dopamine-serotonin vesicular transport disease), [MONDO:0019461](http://purl.obolibrary.org/obo/MONDO_0019461) (b-cell prolymphocytic leukemia), [MONDO:0019462](http://purl.obolibrary.org/obo/MONDO_0019462) (splenic marginal zone lymphoma), [MONDO:0018131](http://purl.obolibrary.org/obo/MONDO_0018131) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0020457](http://purl.obolibrary.org/obo/MONDO_0020457) (6-phosphogluconate dehydrogenase deficiency), [MONDO:0020458](http://purl.obolibrary.org/obo/MONDO_0020458) (hemolytic anemia due to erythrocyte adenosine deaminase overproduction), [MONDO:0020459](http://purl.obolibrary.org/obo/MONDO_0020459) (Unstable hemoglobin disease), [MONDO:0006168](http://purl.obolibrary.org/obo/MONDO_0006168) (common hematopoietic neoplasm), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0006165](http://purl.obolibrary.org/obo/MONDO_0006165) (colorectal squamous cell carcinoma), [MONDO:0006164](http://purl.obolibrary.org/obo/MONDO_0006164) (colorectal sessile serrated adenoma/polyp), [MONDO:0007495](http://purl.obolibrary.org/obo/MONDO_0007495) (dystonia 5), [MONDO:0006163](http://purl.obolibrary.org/obo/MONDO_0006163) (colorectal Serrated adenocarcinoma), [MONDO:0006162](http://purl.obolibrary.org/obo/MONDO_0006162) (colorectal neuroendocrine tumor G1), [MONDO:0006161](http://purl.obolibrary.org/obo/MONDO_0006161) (colorectal juvenile polyp), [MONDO:0006160](http://purl.obolibrary.org/obo/MONDO_0006160) (colorectal hamartoma), [MONDO:0007490](http://purl.obolibrary.org/obo/MONDO_0007490) (carpotarsal osteochondromatosis), [MONDO:0018129](http://purl.obolibrary.org/obo/MONDO_0018129) (autosomal recessive cerebellar ataxia with late-onset spasticity), [MONDO:0019458](http://purl.obolibrary.org/obo/MONDO_0019458) (acute basophilic leukemia), [MONDO:0018128](http://purl.obolibrary.org/obo/MONDO_0018128) (phalangeal microgeodic syndrome), [MONDO:0019456](http://purl.obolibrary.org/obo/MONDO_0019456) (acute myeloid leukemia with multilineage dysplasia), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (myelodysplastic syndrome with excess blasts), [MONDO:0018123](http://purl.obolibrary.org/obo/MONDO_0018123) (intellectual disability-obesity-brain malformations-facial dysmorphism syndrome), [MONDO:0018124](http://purl.obolibrary.org/obo/MONDO_0018124) (Oncogenic osteomalacia), [MONDO:0019455](http://purl.obolibrary.org/obo/MONDO_0019455) (acute panmyelosis with myelofibrosis), [MONDO:0018121](http://purl.obolibrary.org/obo/MONDO_0018121) (mitochondrial DNA maintenance syndrome), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (myeloproliferative neoplasm, unclassifiable), [MONDO:0019453](http://purl.obolibrary.org/obo/MONDO_0019453) (refractory cytopenia with multilineage dysplasia), [MONDO:0018122](http://purl.obolibrary.org/obo/MONDO_0018122) (digital anomalies-intellectual disability-short stature syndrome), [MONDO:0019450](http://purl.obolibrary.org/obo/MONDO_0019450) (lissencephaly with cerebellar hypoplasia), [MONDO:0019451](http://purl.obolibrary.org/obo/MONDO_0019451) (chronic neutrophilic leukemia), [MONDO:0018120](http://purl.obolibrary.org/obo/MONDO_0018120) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement), [MONDO:0006139](http://purl.obolibrary.org/obo/MONDO_0006139) (cervical metaplasia), [MONDO:0006138](http://purl.obolibrary.org/obo/MONDO_0006138) (cervical large cell neuroendocrine carcinoma), [MONDO:0006137](http://purl.obolibrary.org/obo/MONDO_0006137) (cervical intraepithelial neoplasia grade 2/3), [MONDO:0006135](http://purl.obolibrary.org/obo/MONDO_0006135) (cervical clear cell adenocarcinoma), [MONDO:0006134](http://purl.obolibrary.org/obo/MONDO_0006134) (cervical adenosquamous carcinoma), [MONDO:0007464](http://purl.obolibrary.org/obo/MONDO_0007464) (isolated distichiasis), [MONDO:0006133](http://purl.obolibrary.org/obo/MONDO_0006133) (cervical adenoid cystic carcinoma), [MONDO:0006132](http://purl.obolibrary.org/obo/MONDO_0006132) (cervical adenoid basal carcinoma), [MONDO:0007462](http://purl.obolibrary.org/obo/MONDO_0007462) (multiple sclerosis, susceptibility to), [MONDO:0006131](http://purl.obolibrary.org/obo/MONDO_0006131) (cerebellar liponeurocytoma), [MONDO:0007461](http://purl.obolibrary.org/obo/MONDO_0007461) (short stature-valvular heart disease-characteristic facies syndrome), [MONDO:0006130](http://purl.obolibrary.org/obo/MONDO_0006130) (central nervous system neoplasm), [MONDO:0019449](http://purl.obolibrary.org/obo/MONDO_0019449) (lissencephaly type 3-familial fetal akinesia sequence syndrome), [MONDO:0018118](http://purl.obolibrary.org/obo/MONDO_0018118) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement), [MONDO:0020439](http://purl.obolibrary.org/obo/MONDO_0020439) (patent foramen ovale (disease)), [MONDO:0018119](http://purl.obolibrary.org/obo/MONDO_0018119) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement), [MONDO:0018116](http://purl.obolibrary.org/obo/MONDO_0018116) (galactosemia), [MONDO:0008790](http://purl.obolibrary.org/obo/MONDO_0008790) (anemia, nonspherocytic hemolytic, possibly due to defect 1N porphyrin metabolism), [MONDO:0018117](http://purl.obolibrary.org/obo/MONDO_0018117) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis), [MONDO:0008791](http://purl.obolibrary.org/obo/MONDO_0008791) (isolated anencephaly/exencephaly), [MONDO:0019445](http://purl.obolibrary.org/obo/MONDO_0019445) (trichofolliculoma), [MONDO:0018114](http://purl.obolibrary.org/obo/MONDO_0018114) (isolated brachycephaly), [MONDO:0018115](http://purl.obolibrary.org/obo/MONDO_0018115) (epidermal nevus syndrome), [MONDO:0019443](http://purl.obolibrary.org/obo/MONDO_0019443) (dextro-looped transposition of the great arteries), [MONDO:0018112](http://purl.obolibrary.org/obo/MONDO_0018112) (isolated scaphocephaly), [MONDO:0019444](http://purl.obolibrary.org/obo/MONDO_0019444) (Trichinellosis), [MONDO:0018113](http://purl.obolibrary.org/obo/MONDO_0018113) (isolated plagiocephaly), [MONDO:0019441](http://purl.obolibrary.org/obo/MONDO_0019441) (ATTRV122I amyloidosis), [MONDO:0008795](http://purl.obolibrary.org/obo/MONDO_0008795) (aniridia-cerebellar ataxia-intellectual disability syndrome), [MONDO:0008796](http://purl.obolibrary.org/obo/MONDO_0008796) (aniridia-renal agenesis-psychomotor retardation syndrome), [MONDO:0008798](http://purl.obolibrary.org/obo/MONDO_0008798) (nonsyndromic congenital nail disorder 4), [MONDO:0019440](http://purl.obolibrary.org/obo/MONDO_0019440) (wild type ABeta2M amyloidosis), [MONDO:0008799](http://purl.obolibrary.org/obo/MONDO_0008799) (anophthalmia/microphthalmia-esophageal atresia syndrome), [MONDO:0020434](http://purl.obolibrary.org/obo/MONDO_0020434) (atrial septal defect, ostium secundum type), [MONDO:0020435](http://purl.obolibrary.org/obo/MONDO_0020435) (atrial septal defect, coronary sinus type), [MONDO:0020436](http://purl.obolibrary.org/obo/MONDO_0020436) (atrial septal defect, sinus venosus type), [MONDO:0020437](http://purl.obolibrary.org/obo/MONDO_0020437) (atrial septal defect, ostium primum type), [MONDO:0006149](http://purl.obolibrary.org/obo/MONDO_0006149) (clear cell papillary cystadenoma), [MONDO:0006147](http://purl.obolibrary.org/obo/MONDO_0006147) (chronic eosinophilic leukemia, not otherwise specified), [MONDO:0007478](http://purl.obolibrary.org/obo/MONDO_0007478) (autosomal dominant Kenny-Caffey syndrome), [MONDO:0007477](http://purl.obolibrary.org/obo/MONDO_0007477) (3-M syndrome), [MONDO:0006146](http://purl.obolibrary.org/obo/MONDO_0006146) (chondroid hamartoma), [MONDO:0006145](http://purl.obolibrary.org/obo/MONDO_0006145) (chondroid chordoma), [MONDO:0007476](http://purl.obolibrary.org/obo/MONDO_0007476) (familial Dupuytren contracture), [MONDO:0006144](http://purl.obolibrary.org/obo/MONDO_0006144) (cervical wilms tumor), [MONDO:0006143](http://purl.obolibrary.org/obo/MONDO_0006143) (cervical squamous cell carcinoma), [MONDO:0007473](http://purl.obolibrary.org/obo/MONDO_0007473) (Duane retraction syndrome), [MONDO:0006142](http://purl.obolibrary.org/obo/MONDO_0006142) (cervical small cell carcinoma), [MONDO:0007472](http://purl.obolibrary.org/obo/MONDO_0007472) (basal laminar drusen), [MONDO:0006141](http://purl.obolibrary.org/obo/MONDO_0006141) (cervical mucinous adenocarcinoma, villoglandular variant), [MONDO:0006140](http://purl.obolibrary.org/obo/MONDO_0006140) (cervical mucinous adenocarcinoma, minimal deviation variant), [MONDO:0007471](http://purl.obolibrary.org/obo/MONDO_0007471) (Doyne honeycomb retinal dystrophy), [MONDO:0007470](http://purl.obolibrary.org/obo/MONDO_0007470) (calvarial doughnut lesions-bone fragility syndrome), [MONDO:0018189](http://purl.obolibrary.org/obo/MONDO_0018189) (autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome), [MONDO:0018187](http://purl.obolibrary.org/obo/MONDO_0018187) (genetic syndromic Pierre robin syndrome), [MONDO:0018184](http://purl.obolibrary.org/obo/MONDO_0018184) (gastric linitis plastica), [MONDO:0018190](http://purl.obolibrary.org/obo/MONDO_0018190) (autosomal dominant childhood-onset proximal spinal muscular atrophy), [MONDO:0018191](http://purl.obolibrary.org/obo/MONDO_0018191) (tumor of testis and paratestis), [MONDO:0006199](http://purl.obolibrary.org/obo/MONDO_0006199) (endometrial undifferentiated carcinoma), [MONDO:0006198](http://purl.obolibrary.org/obo/MONDO_0006198) (endometrial squamous cell carcinoma), [MONDO:0006197](http://purl.obolibrary.org/obo/MONDO_0006197) (endometrial small cell carcinoma), [MONDO:0006196](http://purl.obolibrary.org/obo/MONDO_0006196) (endometrial serous adenocarcinoma), [MONDO:0006195](http://purl.obolibrary.org/obo/MONDO_0006195) (endometrial polyp), [MONDO:0006192](http://purl.obolibrary.org/obo/MONDO_0006192) (endometrial endometrioid adenocarcinoma), [MONDO:0006191](http://purl.obolibrary.org/obo/MONDO_0006191) (endometrial clear cell adenocarcinoma), [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), [MONDO:0018177](http://purl.obolibrary.org/obo/MONDO_0018177) (glioblastoma (disease)), [MONDO:0020497](http://purl.obolibrary.org/obo/MONDO_0020497) (Turcot syndrome with polyposis), [MONDO:0018174](http://purl.obolibrary.org/obo/MONDO_0018174) (hereditary glaucoma), [MONDO:0018175](http://purl.obolibrary.org/obo/MONDO_0018175) (combined deficiency of factor V and factor VIII), [MONDO:0018172](http://purl.obolibrary.org/obo/MONDO_0018172) (malignant sex cord stromal tumor of ovary), [MONDO:0018171](http://purl.obolibrary.org/obo/MONDO_0018171) (malignant germ cell tumor of ovary), [MONDO:0020491](http://purl.obolibrary.org/obo/MONDO_0020491) (subcortical band heterotopia), [MONDO:0020493](http://purl.obolibrary.org/obo/MONDO_0020493) (Haddad syndrome), [MONDO:0020494](http://purl.obolibrary.org/obo/MONDO_0020494) (Oculootodental syndrome), [MONDO:0020495](http://purl.obolibrary.org/obo/MONDO_0020495) (PEHO-like syndrome), [MONDO:0018169](http://purl.obolibrary.org/obo/MONDO_0018169) (morning glory syndrome), [MONDO:0019499](http://purl.obolibrary.org/obo/MONDO_0019499) (Turner syndrome), [MONDO:0020485](http://purl.obolibrary.org/obo/MONDO_0020485) (king-Denborough syndrome), [MONDO:0019496](http://purl.obolibrary.org/obo/MONDO_0019496) (neuroendocrine tumor), [MONDO:0019497](http://purl.obolibrary.org/obo/MONDO_0019497) (nonsyndromic deafness), [MONDO:0019494](http://purl.obolibrary.org/obo/MONDO_0019494) (primary pediatric heart tumor), [MONDO:0018163](http://purl.obolibrary.org/obo/MONDO_0018163) (autosomal recessive cutis laxa type 2A), [MONDO:0020488](http://purl.obolibrary.org/obo/MONDO_0020488) (atypical progressive supranuclear palsy syndrome), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0019492](http://purl.obolibrary.org/obo/MONDO_0019492) (desmoid tumor), [MONDO:0019493](http://purl.obolibrary.org/obo/MONDO_0019493) (primary adult heart tumor), [MONDO:0018162](http://purl.obolibrary.org/obo/MONDO_0018162) (neurometabolic disorder due to serine deficiency), [MONDO:0019490](http://purl.obolibrary.org/obo/MONDO_0019490) (progressive familial heart block), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0020480](http://purl.obolibrary.org/obo/MONDO_0020480) (sulfite oxidase deficiency due to molybdenum cofactor deficiency), [MONDO:0020481](http://purl.obolibrary.org/obo/MONDO_0020481) (myotonia fluctuans), [MONDO:0020482](http://purl.obolibrary.org/obo/MONDO_0020482) (myotonia permanens), [MONDO:0006179](http://purl.obolibrary.org/obo/MONDO_0006179) (desmoplastic ameloblastoma), [MONDO:0006178](http://purl.obolibrary.org/obo/MONDO_0006178) (dedifferentiated solitary fibrous tumor), [MONDO:0020483](http://purl.obolibrary.org/obo/MONDO_0020483) (Acetazolamide-responsive myotonia), [MONDO:0006176](http://purl.obolibrary.org/obo/MONDO_0006176) (cribriform carcinoma), [MONDO:0006174](http://purl.obolibrary.org/obo/MONDO_0006174) (cortisol-producing adrenal cortex adenoma), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0006172](http://purl.obolibrary.org/obo/MONDO_0006172) (conjunctival nevus), [MONDO:0006170](http://purl.obolibrary.org/obo/MONDO_0006170) (conjunctival disorder), [MONDO:0006190](http://purl.obolibrary.org/obo/MONDO_0006190) (endolymphatic sac tumor (disease)), [MONDO:0018158](http://purl.obolibrary.org/obo/MONDO_0018158) (mitochondrial DNA depletion syndrome), [MONDO:0018159](http://purl.obolibrary.org/obo/MONDO_0018159) (atypical hemolytic-uremic syndrome with DGKE deficiency), [MONDO:0018157](http://purl.obolibrary.org/obo/MONDO_0018157) (mitochondrial disorder due to a defect in mitochondrial protein synthesis), [MONDO:0020474](http://purl.obolibrary.org/obo/MONDO_0020474) (Cheirospondyloenchondromatosis), [MONDO:0018154](http://purl.obolibrary.org/obo/MONDO_0018154) (Madelung deformity), [MONDO:0018155](http://purl.obolibrary.org/obo/MONDO_0018155) (lateral sclerosis), [MONDO:0020475](http://purl.obolibrary.org/obo/MONDO_0020475) (Dermotrichic syndrome), [MONDO:0019483](http://purl.obolibrary.org/obo/MONDO_0019483) (Methotrexate-associated lymphoproliferative disorders), [MONDO:0018152](http://purl.obolibrary.org/obo/MONDO_0018152) (serpiginous choroiditis), [MONDO:0018153](http://purl.obolibrary.org/obo/MONDO_0018153) (Erdheim-Chester disease), [MONDO:0018150](http://purl.obolibrary.org/obo/MONDO_0018150) (Gaucher disease), [MONDO:0020478](http://purl.obolibrary.org/obo/MONDO_0020478) (Leber plus disease), [MONDO:0018151](http://purl.obolibrary.org/obo/MONDO_0018151) (coenzyme Q10 deficiency), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0019482](http://purl.obolibrary.org/obo/MONDO_0019482) (dendritic cell sarcoma not otherwise specified), [MONDO:0019480](http://purl.obolibrary.org/obo/MONDO_0019480) (Langerhans cell sarcoma), [MONDO:0020470](http://purl.obolibrary.org/obo/MONDO_0020470) (49,XYYYY syndrome), [MONDO:0020472](http://purl.obolibrary.org/obo/MONDO_0020472) (Turner syndrome due to structural X chromosome anomalies), [MONDO:0006189](http://purl.obolibrary.org/obo/MONDO_0006189) (eccrine porocarcinoma), [MONDO:0006188](http://purl.obolibrary.org/obo/MONDO_0006188) (EBV-positive T-cell lymphoproliferative disorder of childhood), [MONDO:0020473](http://purl.obolibrary.org/obo/MONDO_0020473) (Dappled diaphyseal dysplasia), [MONDO:0006187](http://purl.obolibrary.org/obo/MONDO_0006187) (duodenal villous adenoma), [MONDO:0006186](http://purl.obolibrary.org/obo/MONDO_0006186) (duodenal adenocarcinoma), [MONDO:0006185](http://purl.obolibrary.org/obo/MONDO_0006185) (ductal or Ductular proliferation), [MONDO:0006184](http://purl.obolibrary.org/obo/MONDO_0006184) (ductal breast carcinoma in situ and lobular carcinoma in situ), [MONDO:0006183](http://purl.obolibrary.org/obo/MONDO_0006183) (disseminated peritoneal leiomyomatosis), [MONDO:0006182](http://purl.obolibrary.org/obo/MONDO_0006182) (digestive system mixed Adenoneuroendocrine carcinoma), [MONDO:0006181](http://purl.obolibrary.org/obo/MONDO_0006181) (digestive system carcinoma), [MONDO:0006180](http://purl.obolibrary.org/obo/MONDO_0006180) (digestive system adenoma), [MONDO:0018197](http://purl.obolibrary.org/obo/MONDO_0018197) (mitochondrial DNA depletion syndrome, hepatocerebrorenal form), [MONDO:0018194](http://purl.obolibrary.org/obo/MONDO_0018194) (sex cord-stromal tumor of testis), [MONDO:0018192](http://purl.obolibrary.org/obo/MONDO_0018192) (paratesticular adenocarcinoma), [MONDO:0018193](http://purl.obolibrary.org/obo/MONDO_0018193) (testicular teratoma), [MONDO:0008822](http://purl.obolibrary.org/obo/MONDO_0008822) (arthrogryposis, renal dysfunction, and cholestasis 1), [MONDO:0008823](http://purl.obolibrary.org/obo/MONDO_0008823) (neurogenic arthrogryposis multiplex congenita), [MONDO:0008824](http://purl.obolibrary.org/obo/MONDO_0008824) (fetal akinesia deformation sequence), [MONDO:0008825](http://purl.obolibrary.org/obo/MONDO_0008825) (arthrogryposis multiplex congenita-whistling face syndrome), [MONDO:0008826](http://purl.obolibrary.org/obo/MONDO_0008826) (arthrogryposis-hyperkeratosis syndrome, lethal form), [MONDO:0008827](http://purl.obolibrary.org/obo/MONDO_0008827) (progressive pseudorheumatoid arthropathy of childhood), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein C-II deficiency), [MONDO:0008812](http://purl.obolibrary.org/obo/MONDO_0008812) (AREDYLD syndrome), [MONDO:0008813](http://purl.obolibrary.org/obo/MONDO_0008813) (arachnoid cyst), [MONDO:0008814](http://purl.obolibrary.org/obo/MONDO_0008814) (hyperargininemia), [MONDO:0008815](http://purl.obolibrary.org/obo/MONDO_0008815) (argininosuccinic aciduria), [MONDO:0008816](http://purl.obolibrary.org/obo/MONDO_0008816) (Arnold-Chiari malformation type II), [MONDO:0008818](http://purl.obolibrary.org/obo/MONDO_0008818) (arterial tortuosity syndrome), [MONDO:0008800](http://purl.obolibrary.org/obo/MONDO_0008800) (microphthalmia with limb anomalies), [MONDO:0008803](http://purl.obolibrary.org/obo/MONDO_0008803) (Antley-Bixler syndrome), [MONDO:0008806](http://purl.obolibrary.org/obo/MONDO_0008806) (Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome), [MONDO:0008807](http://purl.obolibrary.org/obo/MONDO_0008807) (apnea, central sleep), [MONDO:0008808](http://purl.obolibrary.org/obo/MONDO_0008808) (aplasia cutis congenita-intestinal lymphangiectasia syndrome), [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0019516](http://purl.obolibrary.org/obo/MONDO_0019516) (exudative vitreoretinopathy), [MONDO:0019513](http://purl.obolibrary.org/obo/MONDO_0019513) (esophageal malformation), [MONDO:0020508](http://purl.obolibrary.org/obo/MONDO_0020508) (primary syringomyelia), [MONDO:0008861](http://purl.obolibrary.org/obo/MONDO_0008861) (3-Methylcrotonyl-Coa carboxylase 1 deficiency), [MONDO:0008862](http://purl.obolibrary.org/obo/MONDO_0008862) (3-Methylcrotonyl-Coa carboxylase 2 deficiency), [MONDO:0008863](http://purl.obolibrary.org/obo/MONDO_0008863) (sitosterolemia), [MONDO:0008864](http://purl.obolibrary.org/obo/MONDO_0008864) (Biemond syndrome type 2), [MONDO:0008865](http://purl.obolibrary.org/obo/MONDO_0008865) (Bietti crystalline corneoretinal dystrophy), [MONDO:0008866](http://purl.obolibrary.org/obo/MONDO_0008866) (bifid nose, autosomal recessive), [MONDO:0008867](http://purl.obolibrary.org/obo/MONDO_0008867) (biliary atresia), [MONDO:0007528](http://purl.obolibrary.org/obo/MONDO_0007528) (Ehlers-Danlos syndrome, autosomal dominant, type unspecified), [MONDO:0007527](http://purl.obolibrary.org/obo/MONDO_0007527) (Ehlers-Danlos syndrome, periodontitis type), [MONDO:0007526](http://purl.obolibrary.org/obo/MONDO_0007526) (Ehlers-Danlos syndrome progeroid type), [MONDO:0008869](http://purl.obolibrary.org/obo/MONDO_0008869) (Seckel syndrome 1), [MONDO:0007525](http://purl.obolibrary.org/obo/MONDO_0007525) (Ehlers-Danlos syndrome, arthrochalasis type), [MONDO:0007524](http://purl.obolibrary.org/obo/MONDO_0007524) (autosomal dominant Ehlers-Danlos syndrome, vascular type), [MONDO:0007523](http://purl.obolibrary.org/obo/MONDO_0007523) (type III Ehlers-Danlos syndrome), [MONDO:0007522](http://purl.obolibrary.org/obo/MONDO_0007522) (Ehlers-Danlos syndrome, classic type), [MONDO:0007520](http://purl.obolibrary.org/obo/MONDO_0007520) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1), [MONDO:0019517](http://purl.obolibrary.org/obo/MONDO_0019517) (Waardenburg syndrome type 2), [MONDO:0019518](http://purl.obolibrary.org/obo/MONDO_0019518) (Waardenburg-Shah syndrome), [MONDO:0019504](http://purl.obolibrary.org/obo/MONDO_0019504) (superior limbic keratoconjunctivitis), [MONDO:0019505](http://purl.obolibrary.org/obo/MONDO_0019505) (hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome), [MONDO:0019503](http://purl.obolibrary.org/obo/MONDO_0019503) (anterior segment dysgenesis), [MONDO:0019500](http://purl.obolibrary.org/obo/MONDO_0019500) (extragonadal teratoma), [MONDO:0019501](http://purl.obolibrary.org/obo/MONDO_0019501) (Usher syndrome), [MONDO:0008850](http://purl.obolibrary.org/obo/MONDO_0008850) (Cooper-Jabs syndrome), [MONDO:0008852](http://purl.obolibrary.org/obo/MONDO_0008852) (congenital central hypoventilation syndrome), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), [MONDO:0008854](http://purl.obolibrary.org/obo/MONDO_0008854) (Bardet-Biedl syndrome 1), [MONDO:0006209](http://purl.obolibrary.org/obo/MONDO_0006209) (fibroblastic neoplasm), [MONDO:0008855](http://purl.obolibrary.org/obo/MONDO_0008855) (MHC class II deficiency), [MONDO:0006208](http://purl.obolibrary.org/obo/MONDO_0006208) (fallopian tube serous adenocarcinoma), [MONDO:0008857](http://purl.obolibrary.org/obo/MONDO_0008857) (Beemer-Ertbruggen syndrome), [MONDO:0006207](http://purl.obolibrary.org/obo/MONDO_0006207) (fallopian tube carcinosarcoma), [MONDO:0006206](http://purl.obolibrary.org/obo/MONDO_0006206) (fallopian tube carcinoma), [MONDO:0007537](http://purl.obolibrary.org/obo/MONDO_0007537) (lateral meningocele syndrome), [MONDO:0008858](http://purl.obolibrary.org/obo/MONDO_0008858) (Behr syndrome), [MONDO:0006203](http://purl.obolibrary.org/obo/MONDO_0006203) (extrahepatic bile duct squamous cell carcinoma), [MONDO:0007534](http://purl.obolibrary.org/obo/MONDO_0007534) (Beckwith-Wiedemann syndrome), [MONDO:0006202](http://purl.obolibrary.org/obo/MONDO_0006202) (extrahepatic bile duct adenosquamous carcinoma), [MONDO:0007533](http://purl.obolibrary.org/obo/MONDO_0007533) (elliptocytosis 2), [MONDO:0006201](http://purl.obolibrary.org/obo/MONDO_0006201) (ethmoid sinus adenoid cystic carcinoma), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0019508](http://purl.obolibrary.org/obo/MONDO_0019508) (van der Woude syndrome), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0008842](http://purl.obolibrary.org/obo/MONDO_0008842) (ataxia with oculomotor apraxia type 1), [MONDO:0007509](http://purl.obolibrary.org/obo/MONDO_0007509) (ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant), [MONDO:0007508](http://purl.obolibrary.org/obo/MONDO_0007508) (Rapp-Hodgkin syndrome), [MONDO:0008843](http://purl.obolibrary.org/obo/MONDO_0008843) (atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome), [MONDO:0008846](http://purl.obolibrary.org/obo/MONDO_0008846) (atransferrinemia), [MONDO:0007504](http://purl.obolibrary.org/obo/MONDO_0007504) (thickened earlobes-conductive deafness syndrome), [MONDO:0007503](http://purl.obolibrary.org/obo/MONDO_0007503) (ear without helix), [MONDO:0008830](http://purl.obolibrary.org/obo/MONDO_0008830) (aspartylglucosaminuria), [MONDO:0008831](http://purl.obolibrary.org/obo/MONDO_0008831) (asphyxiating thoracic dystrophy 1), [MONDO:0007519](http://purl.obolibrary.org/obo/MONDO_0007519) (Edinburgh malformation syndrome), [MONDO:0008832](http://purl.obolibrary.org/obo/MONDO_0008832) (right atrial isomerism (disease)), [MONDO:0008833](http://purl.obolibrary.org/obo/MONDO_0008833) (renal-hepatic-pancreatic dysplasia 1), [MONDO:0007514](http://purl.obolibrary.org/obo/MONDO_0007514) (ectopia lentis 1, isolated, autosomal dominant), [MONDO:0008838](http://purl.obolibrary.org/obo/MONDO_0008838) (ataxia-deafness-intellectual disability syndrome), [MONDO:0007511](http://purl.obolibrary.org/obo/MONDO_0007511) (ectodermal dysplasia, trichoodontoonychial type), [MONDO:0007510](http://purl.obolibrary.org/obo/MONDO_0007510) (Clouston syndrome), [MONDO:0018228](http://purl.obolibrary.org/obo/MONDO_0018228) (Bipartite talus), [MONDO:0020548](http://purl.obolibrary.org/obo/MONDO_0020548) (ocular pemphigoid), [MONDO:0019559](http://purl.obolibrary.org/obo/MONDO_0019559) (hypertrophic or verrucous lupus erythematosus), [MONDO:0020549](http://purl.obolibrary.org/obo/MONDO_0020549) (invasive hydatidiform mole), [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0019558](http://purl.obolibrary.org/obo/MONDO_0019558) (discoid lupus erythematosus), [MONDO:0019555](http://purl.obolibrary.org/obo/MONDO_0019555) (panniculitis and localized lipodystrophy), [MONDO:0018224](http://purl.obolibrary.org/obo/MONDO_0018224) (hydroa vacciniforme-like lymphoma), [MONDO:0019556](http://purl.obolibrary.org/obo/MONDO_0019556) (pressure-induced localized lipoatrophy), [MONDO:0018225](http://purl.obolibrary.org/obo/MONDO_0018225) (ALK-positive large b-cell lymphoma), [MONDO:0019553](http://purl.obolibrary.org/obo/MONDO_0019553) (drug-induced localized lipodystrophy), [MONDO:0018222](http://purl.obolibrary.org/obo/MONDO_0018222) (X-linked intellectual disability due to GRIA3 anomalies), [MONDO:0019554](http://purl.obolibrary.org/obo/MONDO_0019554) (idiopathic localized lipodystrophy), [MONDO:0018223](http://purl.obolibrary.org/obo/MONDO_0018223) (systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood), [MONDO:0018220](http://purl.obolibrary.org/obo/MONDO_0018220) (glycogen storage disease due to glucose-6-phosphatase deficiency), [MONDO:0020540](http://purl.obolibrary.org/obo/MONDO_0020540) (ovarian gynandroblastoma), [MONDO:0019551](http://purl.obolibrary.org/obo/MONDO_0019551) (hereditary motor and sensory neuropathy type 6), [MONDO:0019552](http://purl.obolibrary.org/obo/MONDO_0019552) (centrifugal lipodystrophy), [MONDO:0020541](http://purl.obolibrary.org/obo/MONDO_0020541) (maligant granulosa cell tumor of ovary), [MONDO:0020542](http://purl.obolibrary.org/obo/MONDO_0020542) (malignant Sertoli-leydig cell tumor of ovary), [MONDO:0019550](http://purl.obolibrary.org/obo/MONDO_0019550) (hereditary motor and sensory neuropathy with acrodystrophy), [MONDO:0020543](http://purl.obolibrary.org/obo/MONDO_0020543) (theca steroid-producing cell malignant tumor of ovary, not further specified), [MONDO:0006239](http://purl.obolibrary.org/obo/MONDO_0006239) (head and neck paraganglioma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0006237](http://purl.obolibrary.org/obo/MONDO_0006237) (granulocytic sarcoma), [MONDO:0007566](http://purl.obolibrary.org/obo/MONDO_0007566) (multiple self-healing squamous epithelioma), [MONDO:0006235](http://purl.obolibrary.org/obo/MONDO_0006235) (granular cell tumor), [MONDO:0006234](http://purl.obolibrary.org/obo/MONDO_0006234) (grade III prostatic intraepithelial neoplasia), [MONDO:0007565](http://purl.obolibrary.org/obo/MONDO_0007565) (familial cylindromatosis), [MONDO:0007564](http://purl.obolibrary.org/obo/MONDO_0007564) (pilomatrixoma), [MONDO:0006233](http://purl.obolibrary.org/obo/MONDO_0006233) (gonadal teratoma), [MONDO:0006232](http://purl.obolibrary.org/obo/MONDO_0006232) (giant cell tumor of soft tissue), [MONDO:0007562](http://purl.obolibrary.org/obo/MONDO_0007562) (multiple epiphyseal dysplasia, Beighton type), [MONDO:0006231](http://purl.obolibrary.org/obo/MONDO_0006231) (gastrointestinal hamartoma), [MONDO:0006230](http://purl.obolibrary.org/obo/MONDO_0006230) (gastric squamous cell carcinoma), [MONDO:0007561](http://purl.obolibrary.org/obo/MONDO_0007561) (multiple epiphyseal dysplasia type 1), [MONDO:0019548](http://purl.obolibrary.org/obo/MONDO_0019548) (autosomal dominant intermediate Charcot-Marie-tooth disease), [MONDO:0018217](http://purl.obolibrary.org/obo/MONDO_0018217) (Koolen-de Vries syndrome due to a point mutation), [MONDO:0020537](http://purl.obolibrary.org/obo/MONDO_0020537) (occupational allergic alveolitis), [MONDO:0019549](http://purl.obolibrary.org/obo/MONDO_0019549) (severe early-onset axonal neuropathy due to MFN2 deficiency), [MONDO:0020538](http://purl.obolibrary.org/obo/MONDO_0020538) (malignant dysgerminomatous germ cell tumor of ovary), [MONDO:0020539](http://purl.obolibrary.org/obo/MONDO_0020539) (extragonadal non-dysgerminomatous germ cell tumor), [MONDO:0018216](http://purl.obolibrary.org/obo/MONDO_0018216) (17q21.31 microdeletion syndrome), [MONDO:0008890](http://purl.obolibrary.org/obo/MONDO_0008890) (progressive bulbar palsy), [MONDO:0018213](http://purl.obolibrary.org/obo/MONDO_0018213) (hereditary sensory and autonomic neuropathy type 1), [MONDO:0008891](http://purl.obolibrary.org/obo/MONDO_0008891) (riboflavin transporter deficiency), [MONDO:0008892](http://purl.obolibrary.org/obo/MONDO_0008892) (progressive familial intrahepatic cholestasis type 1), [MONDO:0008893](http://purl.obolibrary.org/obo/MONDO_0008893) (c syndrome), [MONDO:0008894](http://purl.obolibrary.org/obo/MONDO_0008894) (cataract-hypertrichosis-intellectual disability syndrome), [MONDO:0018210](http://purl.obolibrary.org/obo/MONDO_0018210) (Alexander disease type II), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0020531](http://purl.obolibrary.org/obo/MONDO_0020531) (long chain acyl-CoA dehydrogenase deficiency), [MONDO:0008896](http://purl.obolibrary.org/obo/MONDO_0008896) (Campomelia, Cumming type), [MONDO:0008897](http://purl.obolibrary.org/obo/MONDO_0008897) (hyperphosphatemic familial tumoral calcinosis), [MONDO:0008898](http://purl.obolibrary.org/obo/MONDO_0008898) (camptodactyly syndrome, Guadalajara type 1), [MONDO:0008899](http://purl.obolibrary.org/obo/MONDO_0008899) (camptodactyly syndrome, Guadalajara type 2), [MONDO:0020535](http://purl.obolibrary.org/obo/MONDO_0020535) (house allergic alveolitis), [MONDO:0020536](http://purl.obolibrary.org/obo/MONDO_0020536) (pigeon-breeder lung disease), [MONDO:0006249](http://purl.obolibrary.org/obo/MONDO_0006249) (hyperplastic polyp), [MONDO:0006248](http://purl.obolibrary.org/obo/MONDO_0006248) (hydatidiform mole), [MONDO:0006247](http://purl.obolibrary.org/obo/MONDO_0006247) (histiocytic and dendritic cell neoplasm), [MONDO:0006246](http://purl.obolibrary.org/obo/MONDO_0006246) (high grade surface osteosarcoma), [MONDO:0006245](http://purl.obolibrary.org/obo/MONDO_0006245) (hidradenocarcinoma), [MONDO:0007576](http://purl.obolibrary.org/obo/MONDO_0007576) (esophageal cancer), [MONDO:0006244](http://purl.obolibrary.org/obo/MONDO_0006244) (HER2 positive breast carcinoma), [MONDO:0007574](http://purl.obolibrary.org/obo/MONDO_0007574) (spinocerebellar ataxia type 34), [MONDO:0006243](http://purl.obolibrary.org/obo/MONDO_0006243) (hepatoid adenocarcinoma), [MONDO:0007573](http://purl.obolibrary.org/obo/MONDO_0007573) (acute erythroleukemia, familial), [MONDO:0006241](http://purl.obolibrary.org/obo/MONDO_0006241) (hepatic granuloma), [MONDO:0018219](http://purl.obolibrary.org/obo/MONDO_0018219) (giant cell tumor of bone (disease)), [MONDO:0019537](http://purl.obolibrary.org/obo/MONDO_0019537) (hemoglobin d disease), [MONDO:0018206](http://purl.obolibrary.org/obo/MONDO_0018206) (childhood-onset autosomal recessive myopathy with external ophthalmoplegia), [MONDO:0020526](http://purl.obolibrary.org/obo/MONDO_0020526) (acute megakaryoblastic leukemia in down syndrome), [MONDO:0019538](http://purl.obolibrary.org/obo/MONDO_0019538) (Gaisbock syndrome), [MONDO:0018207](http://purl.obolibrary.org/obo/MONDO_0018207) (2p13.2 microdeletion syndrome), [MONDO:0018204](http://purl.obolibrary.org/obo/MONDO_0018204) (20q11.2 microduplication syndrome), [MONDO:0019535](http://purl.obolibrary.org/obo/MONDO_0019535) (drug-induced autoimmune hemolytic anemia), [MONDO:0019536](http://purl.obolibrary.org/obo/MONDO_0019536) (Typical hemolytic-uremic syndrome), [MONDO:0019533](http://purl.obolibrary.org/obo/MONDO_0019533) (paroxysmal cold hemoglobinuria), [MONDO:0018202](http://purl.obolibrary.org/obo/MONDO_0018202) (gonadal germ cell tumor), [MONDO:0018203](http://purl.obolibrary.org/obo/MONDO_0018203) (LMNA-related cardiocutaneous progeria syndrome), [MONDO:0019534](http://purl.obolibrary.org/obo/MONDO_0019534) (mixed-type autoimmune hemolytic anemia), [MONDO:0019531](http://purl.obolibrary.org/obo/MONDO_0019531) (hemolytic anemia due to glutathione reductase deficiency), [MONDO:0008881](http://purl.obolibrary.org/obo/MONDO_0008881) (Kyphomelic dysplasia), [MONDO:0008882](http://purl.obolibrary.org/obo/MONDO_0008882) (congenital bowing of long bones), [MONDO:0018201](http://purl.obolibrary.org/obo/MONDO_0018201) (extragonadal germ cell tumor), [MONDO:0019532](http://purl.obolibrary.org/obo/MONDO_0019532) (autoimmune hemolytic anemia, warm type), [MONDO:0019530](http://purl.obolibrary.org/obo/MONDO_0019530) (non-syndromic syndactyly), [MONDO:0008884](http://purl.obolibrary.org/obo/MONDO_0008884) (Oculoosteocutaneous syndrome), [MONDO:0008885](http://purl.obolibrary.org/obo/MONDO_0008885) (Branchioskeletogenital syndrome), [MONDO:0020520](http://purl.obolibrary.org/obo/MONDO_0020520) (adult pulmonary Langerhans cell histiocytosis), [MONDO:0020521](http://purl.obolibrary.org/obo/MONDO_0020521) (Ehlers-Danlos syndrome type 7A), [MONDO:0020522](http://purl.obolibrary.org/obo/MONDO_0020522) (Ehlers-Danlos syndrome type 7B), [MONDO:0020523](http://purl.obolibrary.org/obo/MONDO_0020523) (familial parathyroid adenoma), [MONDO:0006219](http://purl.obolibrary.org/obo/MONDO_0006219) (gallbladder small cell neuroendocrine carcinoma), [MONDO:0020524](http://purl.obolibrary.org/obo/MONDO_0020524) (primary parathyroid hyperplasia), [MONDO:0020525](http://purl.obolibrary.org/obo/MONDO_0020525) (transient neonatal diabetes mellitus (disease)), [MONDO:0007549](http://purl.obolibrary.org/obo/MONDO_0007549) (generalized dominant dystrophic epidermolysis bullosa), [MONDO:0006218](http://purl.obolibrary.org/obo/MONDO_0006218) (gallbladder biliary intraepithelial neoplasia), [MONDO:0007548](http://purl.obolibrary.org/obo/MONDO_0007548) (transient bullous dermolysis of the newborn), [MONDO:0006217](http://purl.obolibrary.org/obo/MONDO_0006217) (gallbladder adenosquamous carcinoma), [MONDO:0006216](http://purl.obolibrary.org/obo/MONDO_0006216) (gallbladder adenoma), [MONDO:0007546](http://purl.obolibrary.org/obo/MONDO_0007546) (myeloproliferative disorder, chronic, with eosinophilia), [MONDO:0006215](http://purl.obolibrary.org/obo/MONDO_0006215) (gallbladder adenocarcinoma), [MONDO:0006214](http://purl.obolibrary.org/obo/MONDO_0006214) (follicular variant thyroid gland papillary carcinoma), [MONDO:0006213](http://purl.obolibrary.org/obo/MONDO_0006213) (floor of mouth mucoepidermoid carcinoma), [MONDO:0007542](http://purl.obolibrary.org/obo/MONDO_0007542) (Camurati-Engelmann disease), [MONDO:0006211](http://purl.obolibrary.org/obo/MONDO_0006211) (fibrous hamartoma of infancy), [MONDO:0006210](http://purl.obolibrary.org/obo/MONDO_0006210) (fibrolamellar carcinoma), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), [MONDO:0018209](http://purl.obolibrary.org/obo/MONDO_0018209) (Alexander disease type i), [MONDO:0019527](http://purl.obolibrary.org/obo/MONDO_0019527) (undifferentiated connective tissue syndrome), [MONDO:0020516](http://purl.obolibrary.org/obo/MONDO_0020516) (thymic neuroendocrine carcinoma), [MONDO:0019524](http://purl.obolibrary.org/obo/MONDO_0019524) (infantile Bartter syndrome with sensorineural deafness), [MONDO:0020517](http://purl.obolibrary.org/obo/MONDO_0020517) (eosinophilic granuloma), [MONDO:0020518](http://purl.obolibrary.org/obo/MONDO_0020518) (Hashimoto-Pritzker syndrome), [MONDO:0020519](http://purl.obolibrary.org/obo/MONDO_0020519) (hand-SchC<ller-Christian disease), [MONDO:0019522](http://purl.obolibrary.org/obo/MONDO_0019522) (recessive dystrophic epidermolysis bullosa-generalized other), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0008870](http://purl.obolibrary.org/obo/MONDO_0008870) (bird headed-dwarfism, Montreal type), [MONDO:0019521](http://purl.obolibrary.org/obo/MONDO_0019521) (centripetalis recessive dystrophic epidermolysis bullosa), [MONDO:0008871](http://purl.obolibrary.org/obo/MONDO_0008871) (microcephalic osteodysplastic primordial dwarfism type i), [MONDO:0008872](http://purl.obolibrary.org/obo/MONDO_0008872) (microcephalic osteodysplastic primordial dwarfism type II), [MONDO:0008873](http://purl.obolibrary.org/obo/MONDO_0008873) (microcephalic osteodysplastic primordial dwarfism, type 3), [MONDO:0008875](http://purl.obolibrary.org/obo/MONDO_0008875) (blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome), [MONDO:0020510](http://purl.obolibrary.org/obo/MONDO_0020510) (idiopathic syringomyelia), [MONDO:0008876](http://purl.obolibrary.org/obo/MONDO_0008876) (Bloom syndrome), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0020512](http://purl.obolibrary.org/obo/MONDO_0020512) (precursor T-cell acute lymphoblastic leukemia), [MONDO:0008877](http://purl.obolibrary.org/obo/MONDO_0008877) (blue diaper syndrome), [MONDO:0020513](http://purl.obolibrary.org/obo/MONDO_0020513) (spermatocytic seminoma), [MONDO:0008878](http://purl.obolibrary.org/obo/MONDO_0008878) (bone dysplasia, lethal Holmgren type), [MONDO:0008879](http://purl.obolibrary.org/obo/MONDO_0008879) (Bowen-Conradi syndrome), [MONDO:0006229](http://purl.obolibrary.org/obo/MONDO_0006229) (gastric small cell neuroendocrine carcinoma), [MONDO:0006228](http://purl.obolibrary.org/obo/MONDO_0006228) (gastric papillary adenocarcinoma), [MONDO:0006227](http://purl.obolibrary.org/obo/MONDO_0006227) (gastric neuroendocrine tumor G1), [MONDO:0006226](http://purl.obolibrary.org/obo/MONDO_0006226) (gastric mucosa-associated lymphoid tissue lymphoma), [MONDO:0006225](http://purl.obolibrary.org/obo/MONDO_0006225) (gastric mantle cell lymphoma), [MONDO:0006224](http://purl.obolibrary.org/obo/MONDO_0006224) (gastric hamartomatous polyp), [MONDO:0006223](http://purl.obolibrary.org/obo/MONDO_0006223) (gastric diffuse large b-cell lymphoma), [MONDO:0006222](http://purl.obolibrary.org/obo/MONDO_0006222) (gastric choriocarcinoma), [MONDO:0006221](http://purl.obolibrary.org/obo/MONDO_0006221) (gastric adenoma), [MONDO:0007552](http://purl.obolibrary.org/obo/MONDO_0007552) (pretibial dystrophic epidermolysis bullosa), [MONDO:0006220](http://purl.obolibrary.org/obo/MONDO_0006220) (gallbladder squamous cell carcinoma), [MONDO:0019528](http://purl.obolibrary.org/obo/MONDO_0019528) (IgG4-related hepatopathy), [MONDO:0018268](http://purl.obolibrary.org/obo/MONDO_0018268) (Medich giant platelet syndrome), [MONDO:0018269](http://purl.obolibrary.org/obo/MONDO_0018269) (white platelet syndrome), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0019595](http://purl.obolibrary.org/obo/MONDO_0019595) (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), [MONDO:0018264](http://purl.obolibrary.org/obo/MONDO_0018264) (oculocutaneous albinism type 6), [MONDO:0019596](http://purl.obolibrary.org/obo/MONDO_0019596) (46,XY disorder of sex development due to testicular steroidogenesis defect), [MONDO:0019593](http://purl.obolibrary.org/obo/MONDO_0019593) (46,XX disorder of sex development induced by fetal androgens excess), [MONDO:0019594](http://purl.obolibrary.org/obo/MONDO_0019594) (46,XY disorder of sex development due to a testosterone synthesis defect), [MONDO:0019591](http://purl.obolibrary.org/obo/MONDO_0019591) (panhypopituitarism), [MONDO:0018260](http://purl.obolibrary.org/obo/MONDO_0018260) (scalp syndrome), [MONDO:0018261](http://purl.obolibrary.org/obo/MONDO_0018261) (NEVADA syndrome), [MONDO:0006279](http://purl.obolibrary.org/obo/MONDO_0006279) (lung sarcomatoid carcinoma), [MONDO:0006278](http://purl.obolibrary.org/obo/MONDO_0006278) (lung papilloma), [MONDO:0006277](http://purl.obolibrary.org/obo/MONDO_0006277) (lung lymphangioleiomyomatosis), [MONDO:0006276](http://purl.obolibrary.org/obo/MONDO_0006276) (lung inflammatory myofibroblastic tumor), [MONDO:0006275](http://purl.obolibrary.org/obo/MONDO_0006275) (lung giant cell carcinoma), [MONDO:0006274](http://purl.obolibrary.org/obo/MONDO_0006274) (low grade vulvar intraepithelial neoplasia), [MONDO:0006273](http://purl.obolibrary.org/obo/MONDO_0006273) (low grade fibromyxoid sarcoma with giant collagen Rosettes), [MONDO:0006272](http://purl.obolibrary.org/obo/MONDO_0006272) (low grade fibromyxoid sarcoma), [MONDO:0006271](http://purl.obolibrary.org/obo/MONDO_0006271) (low grade central osteosarcoma), [MONDO:0006270](http://purl.obolibrary.org/obo/MONDO_0006270) (lobular breast carcinoma in situ), [MONDO:0018259](http://purl.obolibrary.org/obo/MONDO_0018259) (Didymosis aplasticosebacea), [MONDO:0018257](http://purl.obolibrary.org/obo/MONDO_0018257) (familial syringomyelia), [MONDO:0019588](http://purl.obolibrary.org/obo/MONDO_0019588) (autosomal recessive nonsyndromic deafness), [MONDO:0019589](http://purl.obolibrary.org/obo/MONDO_0019589) (syndromic genetic deafness), [MONDO:0018258](http://purl.obolibrary.org/obo/MONDO_0018258) (Angora hair nevus), [MONDO:0019586](http://purl.obolibrary.org/obo/MONDO_0019586) (X-linked nonsyndromic deafness), [MONDO:0018255](http://purl.obolibrary.org/obo/MONDO_0018255) (spondylometaphyseal dysplasia, Czarny-Ratajczak type), [MONDO:0019587](http://purl.obolibrary.org/obo/MONDO_0019587) (autosomal dominant nonsyndromic deafness), [MONDO:0018256](http://purl.obolibrary.org/obo/MONDO_0018256) (acute myeloid leukemia with t(8;16)(p11;p13) translocation), [MONDO:0018253](http://purl.obolibrary.org/obo/MONDO_0018253) (intellectual disability-facial dysmorphism-hand anomalies syndrome), [MONDO:0018254](http://purl.obolibrary.org/obo/MONDO_0018254) (spondyloepimetaphyseal dysplasia, Isidor type), [MONDO:0018251](http://purl.obolibrary.org/obo/MONDO_0018251) (glycogen storage disease due to phosphorylase kinase deficiency), [MONDO:0006288](http://purl.obolibrary.org/obo/MONDO_0006288) (malignant adrenal gland pheochromocytoma), [MONDO:0006287](http://purl.obolibrary.org/obo/MONDO_0006287) (malignancy in giant cell tumor of bone), [MONDO:0006286](http://purl.obolibrary.org/obo/MONDO_0006286) (major salivary gland mucoepidermoid carcinoma), [MONDO:0006285](http://purl.obolibrary.org/obo/MONDO_0006285) (major salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006284](http://purl.obolibrary.org/obo/MONDO_0006284) (major salivary gland carcinoma), [MONDO:0006283](http://purl.obolibrary.org/obo/MONDO_0006283) (lymphoepithelioma-like lung carcinoma), [MONDO:0006282](http://purl.obolibrary.org/obo/MONDO_0006282) (lymphangiosarcoma), [MONDO:0006281](http://purl.obolibrary.org/obo/MONDO_0006281) (lung signet ring cell carcinoma), [MONDO:0006280](http://purl.obolibrary.org/obo/MONDO_0006280) (lung sclerosing hemangioma), [MONDO:0018248](http://purl.obolibrary.org/obo/MONDO_0018248) (intellectual disability-seizures-macrocephaly-obesity syndrome), [MONDO:0018249](http://purl.obolibrary.org/obo/MONDO_0018249) (finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome), [MONDO:0019577](http://purl.obolibrary.org/obo/MONDO_0019577) (anonychia-onychodystrophy syndrome), [MONDO:0018247](http://purl.obolibrary.org/obo/MONDO_0018247) (CADDS), [MONDO:0018244](http://purl.obolibrary.org/obo/MONDO_0018244) (obesity due to SIM1 deficiency), [MONDO:0019576](http://purl.obolibrary.org/obo/MONDO_0019576) (telangiectasia macularis eruptiva perstans), [MONDO:0019573](http://purl.obolibrary.org/obo/MONDO_0019573) (autosomal recessive cutis laxa type 2), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0019571](http://purl.obolibrary.org/obo/MONDO_0019571) (autosomal dominant cutis laxa), [MONDO:0019572](http://purl.obolibrary.org/obo/MONDO_0019572) (autosomal recessive cutis laxa type 1), [MONDO:0019570](http://purl.obolibrary.org/obo/MONDO_0019570) (Cockayne syndrome type 2), [MONDO:0020569](http://purl.obolibrary.org/obo/MONDO_0020569) (intermediate DEND syndrome), [MONDO:0007589](http://purl.obolibrary.org/obo/MONDO_0007589) (exudative vitreoretinopathy 1), [MONDO:0006258](http://purl.obolibrary.org/obo/MONDO_0006258) (juvenile polyp), [MONDO:0007588](http://purl.obolibrary.org/obo/MONDO_0007588) (extrasystoles-short stature-hyperpigmentation-microcephaly syndrome), [MONDO:0006257](http://purl.obolibrary.org/obo/MONDO_0006257) (jejunal neuroendocrine tumor G1), [MONDO:0007587](http://purl.obolibrary.org/obo/MONDO_0007587) (external auditory canal atresia-vertical talus-hypertelorism syndrome), [MONDO:0006256](http://purl.obolibrary.org/obo/MONDO_0006256) (invasive breast carcinoma), [MONDO:0020560](http://purl.obolibrary.org/obo/MONDO_0020560) (atypical teratoid rhabdoid tumor), [MONDO:0006255](http://purl.obolibrary.org/obo/MONDO_0006255) (Intimal sarcoma), [MONDO:0007586](http://purl.obolibrary.org/obo/MONDO_0007586) (exostoses, multiple, type 2), [MONDO:0006254](http://purl.obolibrary.org/obo/MONDO_0006254) (intestinal type adenocarcinoma), [MONDO:0007585](http://purl.obolibrary.org/obo/MONDO_0007585) (exostoses, multiple, type 1), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0007584](http://purl.obolibrary.org/obo/MONDO_0007584) (exostoses-anetodermia-brachydactyly type E syndrome), [MONDO:0006251](http://purl.obolibrary.org/obo/MONDO_0006251) (inclusion body fibromatosis (disease)), [MONDO:0006250](http://purl.obolibrary.org/obo/MONDO_0006250) (ileal neuroendocrine tumor G1), [MONDO:0020559](http://purl.obolibrary.org/obo/MONDO_0020559) (O'Sullivan-McLeod syndrome), [MONDO:0018237](http://purl.obolibrary.org/obo/MONDO_0018237) (acrofacial dysostosis), [MONDO:0019568](http://purl.obolibrary.org/obo/MONDO_0019568) (Ehlers-Danlos syndrome type 2), [MONDO:0019569](http://purl.obolibrary.org/obo/MONDO_0019569) (Cockayne syndrome type 1), [MONDO:0018235](http://purl.obolibrary.org/obo/MONDO_0018235) (dysostosis with limb anomaly as a major feature), [MONDO:0019566](http://purl.obolibrary.org/obo/MONDO_0019566) (Klippel-TrC)naunay syndrome), [MONDO:0018236](http://purl.obolibrary.org/obo/MONDO_0018236) (dysostosis with limb and face anomalies as a major feature), [MONDO:0019567](http://purl.obolibrary.org/obo/MONDO_0019567) (Ehlers-Danlos syndrome type 1), [MONDO:0018233](http://purl.obolibrary.org/obo/MONDO_0018233) (Otopalatodigital syndrome spectrum disorder), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0018234](http://purl.obolibrary.org/obo/MONDO_0018234) (dysostosis), [MONDO:0019565](http://purl.obolibrary.org/obo/MONDO_0019565) (von willebrand disease), [MONDO:0018231](http://purl.obolibrary.org/obo/MONDO_0018231) (primary bone dysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments), [MONDO:0019562](http://purl.obolibrary.org/obo/MONDO_0019562) (localized scleroderma), [MONDO:0018232](http://purl.obolibrary.org/obo/MONDO_0018232) (primary bone dysplasia with micromelia), [MONDO:0020552](http://purl.obolibrary.org/obo/MONDO_0020552) (placental site trophoblastic tumor), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0019560](http://purl.obolibrary.org/obo/MONDO_0019560) (lupus erythematosus tumidus), [MONDO:0019561](http://purl.obolibrary.org/obo/MONDO_0019561) (lupus erythematosus panniculitis), [MONDO:0018230](http://purl.obolibrary.org/obo/MONDO_0018230) (primary bone dysplasia), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0020558](http://purl.obolibrary.org/obo/MONDO_0020558) (autosomal dominant Charcot-Marie-tooth disease type 2K), [MONDO:0006268](http://purl.obolibrary.org/obo/MONDO_0006268) (liver diffuse large B-cell lymphoma), [MONDO:0006267](http://purl.obolibrary.org/obo/MONDO_0006267) (liver cavernous hemangioma), [MONDO:0006266](http://purl.obolibrary.org/obo/MONDO_0006266) (leydig cell tumor), [MONDO:0020550](http://purl.obolibrary.org/obo/MONDO_0020550) (gestational choriocarcinoma), [MONDO:0006265](http://purl.obolibrary.org/obo/MONDO_0006265) (laryngeal small cell carcinoma), [MONDO:0007595](http://purl.obolibrary.org/obo/MONDO_0007595) (factor VII and Factor VIII, combined deficiency of), [MONDO:0006264](http://purl.obolibrary.org/obo/MONDO_0006264) (laryngeal adenoid cystic carcinoma), [MONDO:0007594](http://purl.obolibrary.org/obo/MONDO_0007594) (factor 5 excess with spontaneous thrombosis), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), [MONDO:0006261](http://purl.obolibrary.org/obo/MONDO_0006261) (Krukenberg tumor), [MONDO:0006260](http://purl.obolibrary.org/obo/MONDO_0006260) (kidney medullary carcinoma), [MONDO:0007590](http://purl.obolibrary.org/obo/MONDO_0007590) (hemifacial hypertrophy), [MONDO:0018297](http://purl.obolibrary.org/obo/MONDO_0018297) (hypotonia-speech impairment-severe cognitive delay syndrome), [MONDO:0018298](http://purl.obolibrary.org/obo/MONDO_0018298) (multicentric osteolysis-nodulosis-arthropathy spectrum), [MONDO:0018295](http://purl.obolibrary.org/obo/MONDO_0018295) (congenital disorder of glycosylation with deafness as a major feature), [MONDO:0018296](http://purl.obolibrary.org/obo/MONDO_0018296) (congenital disorder of glycosylation with developmental anomaly), [MONDO:0018293](http://purl.obolibrary.org/obo/MONDO_0018293) (congenital disorder of glycosylation with skin involvement), [MONDO:0018294](http://purl.obolibrary.org/obo/MONDO_0018294) (congenital disorder of glycosylation with nephropathy as a major feature), [MONDO:0018291](http://purl.obolibrary.org/obo/MONDO_0018291) (congenital disorder of glycosylation with intestinal involvement), [MONDO:0018292](http://purl.obolibrary.org/obo/MONDO_0018292) (congenital disorder of glycosylation-related bone disorder), [MONDO:0018288](http://purl.obolibrary.org/obo/MONDO_0018288) (congenital disorder of glycosylation with hepatic involvement), [MONDO:0018289](http://purl.obolibrary.org/obo/MONDO_0018289) (congenital disorder of glycosylation with dilated cardiomyopathy), [MONDO:0018286](http://purl.obolibrary.org/obo/MONDO_0018286) (non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0018287](http://purl.obolibrary.org/obo/MONDO_0018287) (congenital disorder of glycosylation with epilepsy as a major feature), [MONDO:0018284](http://purl.obolibrary.org/obo/MONDO_0018284) (congenital disorder of glycosylation with neurological involvement), [MONDO:0018285](http://purl.obolibrary.org/obo/MONDO_0018285) (X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0018280](http://purl.obolibrary.org/obo/MONDO_0018280) (muscle-eye-brain disease with bilateral multicystic leucodystrophy), [MONDO:0018281](http://purl.obolibrary.org/obo/MONDO_0018281) (congenital muscular dystrophy with hyperlaxity), [MONDO:0018290](http://purl.obolibrary.org/obo/MONDO_0018290) (congenital disorder of glycosylation with cardiac malformation as a major feature), [MONDO:0006298](http://purl.obolibrary.org/obo/MONDO_0006298) (mediastinal malignant germ cell tumor), [MONDO:0006297](http://purl.obolibrary.org/obo/MONDO_0006297) (maxillary sinus adenoid cystic carcinoma), [MONDO:0006295](http://purl.obolibrary.org/obo/MONDO_0006295) (malignant urinary system neoplasm), [MONDO:0006294](http://purl.obolibrary.org/obo/MONDO_0006294) (pleural cancer), [MONDO:0006292](http://purl.obolibrary.org/obo/MONDO_0006292) (malignant mesothelioma (disease)), [MONDO:0006291](http://purl.obolibrary.org/obo/MONDO_0006291) (malignant jugulotympanic paraganglioma), [MONDO:0006290](http://purl.obolibrary.org/obo/MONDO_0006290) (malignant germ cell tumor), [MONDO:0018279](http://purl.obolibrary.org/obo/MONDO_0018279) (congenital muscular dystrophy without intellectual disability), [MONDO:0018277](http://purl.obolibrary.org/obo/MONDO_0018277) (congenital muscular dystrophy with cerebellar involvement), [MONDO:0018278](http://purl.obolibrary.org/obo/MONDO_0018278) (congenital muscular dystrophy with intellectual disability), [MONDO:0018275](http://purl.obolibrary.org/obo/MONDO_0018275) (salt and pepper syndrome), [MONDO:0018276](http://purl.obolibrary.org/obo/MONDO_0018276) (muscular dystrophy-dystroglycanopathy), [MONDO:0018273](http://purl.obolibrary.org/obo/MONDO_0018273) (XYLT1-CDG), [MONDO:0018274](http://purl.obolibrary.org/obo/MONDO_0018274) (GM3 synthase deficiency), [MONDO:0018271](http://purl.obolibrary.org/obo/MONDO_0018271) (peripheral primitive neuroectodermal tumor), [MONDO:0018270](http://purl.obolibrary.org/obo/MONDO_0018270) (extraskeletal Ewing sarcoma), [MONDO:0008901](http://purl.obolibrary.org/obo/MONDO_0008901) (Tel Hashomer camptodactyly syndrome), [MONDO:0008903](http://purl.obolibrary.org/obo/MONDO_0008903) (lung cancer), [MONDO:0008904](http://purl.obolibrary.org/obo/MONDO_0008904) (Camptomelic syndrome, long-limb type), [MONDO:0008907](http://purl.obolibrary.org/obo/MONDO_0008907) (PMM2-CDG), [MONDO:0008908](http://purl.obolibrary.org/obo/MONDO_0008908) (MGAT2-CDG), [MONDO:0008940](http://purl.obolibrary.org/obo/MONDO_0008940) (endosteal sclerosis-cerebellar hypoplasia syndrome), [MONDO:0007609](http://purl.obolibrary.org/obo/MONDO_0007609) (fibromatosis, gingival, 1), [MONDO:0007608](http://purl.obolibrary.org/obo/MONDO_0007608) (desmoid disease, hereditary), [MONDO:0007607](http://purl.obolibrary.org/obo/MONDO_0007607) (Birt-Hogg-Dube syndrome), [MONDO:0007606](http://purl.obolibrary.org/obo/MONDO_0007606) (fibrodysplasia ossificans progressiva), [MONDO:0008943](http://purl.obolibrary.org/obo/MONDO_0008943) (autosomal recessive spinocerebellar ataxia 2), [MONDO:0008944](http://purl.obolibrary.org/obo/MONDO_0008944) (Joubert syndrome 1), [MONDO:0007604](http://purl.obolibrary.org/obo/MONDO_0007604) (femoral-facial syndrome), [MONDO:0007603](http://purl.obolibrary.org/obo/MONDO_0007603) (Felty's syndrome), [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0007601](http://purl.obolibrary.org/obo/MONDO_0007601) (familial Mediterranean fever, autosomal dominant), [MONDO:0007600](http://purl.obolibrary.org/obo/MONDO_0007600) (primary Fanconi syndrome), [MONDO:0008930](http://purl.obolibrary.org/obo/MONDO_0008930) (celiac disease, susceptibility to, 1), [MONDO:0007619](http://purl.obolibrary.org/obo/MONDO_0007619) (isolated congenital adermatoglyphia), [MONDO:0008931](http://purl.obolibrary.org/obo/MONDO_0008931) (Cenani-Lenz syndactyly syndrome), [MONDO:0007618](http://purl.obolibrary.org/obo/MONDO_0007618) (Eng-Strom syndrome), [MONDO:0007617](http://purl.obolibrary.org/obo/MONDO_0007617) (Coffin-Siris syndrome 1), [MONDO:0007615](http://purl.obolibrary.org/obo/MONDO_0007615) (Laurin-Sandrow syndrome), [MONDO:0008934](http://purl.obolibrary.org/obo/MONDO_0008934) (cerebellar ataxia-ectodermal dysplasia syndrome), [MONDO:0007614](http://purl.obolibrary.org/obo/MONDO_0007614) (congenital fibrosis of extraocular muscles), [MONDO:0008935](http://purl.obolibrary.org/obo/MONDO_0008935) (cerebellar ataxia-hypogonadism syndrome), [MONDO:0007612](http://purl.obolibrary.org/obo/MONDO_0007612) (gingival fibromatosis-progressive deafness syndrome), [MONDO:0008938](http://purl.obolibrary.org/obo/MONDO_0008938) (early-onset cerebellar ataxia with retained tendon reflexes), [MONDO:0007610](http://purl.obolibrary.org/obo/MONDO_0007610) (gingival fibromatosis-hypertrichosis syndrome), [MONDO:0008921](http://purl.obolibrary.org/obo/MONDO_0008921) (Carnosinemia), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), [MONDO:0008923](http://purl.obolibrary.org/obo/MONDO_0008923) (autosomal recessive palmoplantar keratoderma and congenital alopecia), [MONDO:0008924](http://purl.obolibrary.org/obo/MONDO_0008924) (congenital cataract-ichthyosis syndrome), [MONDO:0008925](http://purl.obolibrary.org/obo/MONDO_0008925) (cataract 46 juvenile-onset), [MONDO:0008926](http://purl.obolibrary.org/obo/MONDO_0008926) (COFS syndrome), [MONDO:0008927](http://purl.obolibrary.org/obo/MONDO_0008927) (colobomatous optic disc-macular atrophy-chorioretinopathy syndrome), [MONDO:0008928](http://purl.obolibrary.org/obo/MONDO_0008928) (cataract-ataxia-deafness syndrome), [MONDO:0008929](http://purl.obolibrary.org/obo/MONDO_0008929) (cataract-intellectual disability-hypogonadism syndrome), [MONDO:0008911](http://purl.obolibrary.org/obo/MONDO_0008911) (cardiac lipidosis, familial), [MONDO:0008917](http://purl.obolibrary.org/obo/MONDO_0008917) (heart defects-limb shortening syndrome), [MONDO:0008918](http://purl.obolibrary.org/obo/MONDO_0008918) (carnitine-acylcarnitine translocase deficiency), [MONDO:0008919](http://purl.obolibrary.org/obo/MONDO_0008919) (systemic primary carnitine deficiency disease), [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0019636](http://purl.obolibrary.org/obo/MONDO_0019636) (renal agenesis, unilateral), [MONDO:0018306](http://purl.obolibrary.org/obo/MONDO_0018306) (Griscelli syndrome), [MONDO:0019637](http://purl.obolibrary.org/obo/MONDO_0019637) (renal hypoplasia (disease)), [MONDO:0018304](http://purl.obolibrary.org/obo/MONDO_0018304) (Schnitzler syndrome), [MONDO:0019630](http://purl.obolibrary.org/obo/MONDO_0019630) (congenital ectropion uveae), [MONDO:0008980](http://purl.obolibrary.org/obo/MONDO_0008980) (ataxia-hypogonadism-choroidal dystrophy syndrome), [MONDO:0019631](http://purl.obolibrary.org/obo/MONDO_0019631) (persistent hyperplastic primary vitreous), [MONDO:0008982](http://purl.obolibrary.org/obo/MONDO_0008982) (central areolar choroidal dystrophy), [MONDO:0008984](http://purl.obolibrary.org/obo/MONDO_0008984) (ciliary discoordination due to random ciliary orientation), [MONDO:0008985](http://purl.obolibrary.org/obo/MONDO_0008985) (ciliary dyskinesia with transposition of ciliary microtubules), [MONDO:0008988](http://purl.obolibrary.org/obo/MONDO_0008988) (citrullinemia type I), [MONDO:0007648](http://purl.obolibrary.org/obo/MONDO_0007648) (hereditary diffuse gastric cancer), [MONDO:0006317](http://purl.obolibrary.org/obo/MONDO_0006317) (neurothekeoma), [MONDO:0006316](http://purl.obolibrary.org/obo/MONDO_0006316) (neuroblastic tumor), [MONDO:0007646](http://purl.obolibrary.org/obo/MONDO_0007646) (Gamstorp-Wohlfart syndrome), [MONDO:0006315](http://purl.obolibrary.org/obo/MONDO_0006315) (neoplastic medium-sized B-lymphocyte with basophilic cytoplasm), [MONDO:0006314](http://purl.obolibrary.org/obo/MONDO_0006314) (nasal cavity polyp), [MONDO:0006313](http://purl.obolibrary.org/obo/MONDO_0006313) (nabothian cyst), [MONDO:0006312](http://purl.obolibrary.org/obo/MONDO_0006312) (myofibroma), [MONDO:0006311](http://purl.obolibrary.org/obo/MONDO_0006311) (myelodysplastic/myeloproliferative neoplasm), [MONDO:0006310](http://purl.obolibrary.org/obo/MONDO_0006310) (mucinuos carcinoma), [MONDO:0007640](http://purl.obolibrary.org/obo/MONDO_0007640) (Sorsby's fundus dystrophy), [MONDO:0018309](http://purl.obolibrary.org/obo/MONDO_0018309) (Hirschsprung's disease), [MONDO:0019638](http://purl.obolibrary.org/obo/MONDO_0019638) (renal dysplasia (disease)), [MONDO:0018308](http://purl.obolibrary.org/obo/MONDO_0018308) (hepatic cystic hamartoma), [MONDO:0019626](http://purl.obolibrary.org/obo/MONDO_0019626) (isolated ankyloblepharon filiforme adnatum), [MONDO:0019623](http://purl.obolibrary.org/obo/MONDO_0019623) (hereditary angioedema), [MONDO:0019624](http://purl.obolibrary.org/obo/MONDO_0019624) (acquired angioedema), [MONDO:0008970](http://purl.obolibrary.org/obo/MONDO_0008970) (chondrodysplasia blomstrand type), [MONDO:0019620](http://purl.obolibrary.org/obo/MONDO_0019620) (congenital esophageal diverticulum), [MONDO:0008972](http://purl.obolibrary.org/obo/MONDO_0008972) (rhizomelic chondrodysplasia punctata type 1), [MONDO:0008973](http://purl.obolibrary.org/obo/MONDO_0008973) (chondrodysplasia punctata, Toriello type), [MONDO:0008974](http://purl.obolibrary.org/obo/MONDO_0008974) (Greenberg dysplasia), [MONDO:0008975](http://purl.obolibrary.org/obo/MONDO_0008975) (otospondylomegaepiphyseal dysplasia), [MONDO:0008977](http://purl.obolibrary.org/obo/MONDO_0008977) (chondrosarcoma (disease)), [MONDO:0006329](http://purl.obolibrary.org/obo/MONDO_0006329) (olfactory neuroblastoma), [MONDO:0008978](http://purl.obolibrary.org/obo/MONDO_0008978) (chordoma (disease)), [MONDO:0006328](http://purl.obolibrary.org/obo/MONDO_0006328) (odontogenic cyst), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0007658](http://purl.obolibrary.org/obo/MONDO_0007658) (Spitz nevus), [MONDO:0006326](http://purl.obolibrary.org/obo/MONDO_0006326) (ocular melanoma with extraocular extension), [MONDO:0006325](http://purl.obolibrary.org/obo/MONDO_0006325) (ocular melanoma), [MONDO:0006324](http://purl.obolibrary.org/obo/MONDO_0006324) (normal breast-like subtype of Breast carcinoma), [MONDO:0006323](http://purl.obolibrary.org/obo/MONDO_0006323) (non-seminomatous lesion), [MONDO:0006321](http://purl.obolibrary.org/obo/MONDO_0006321) (non-functioning adrenal cortex adenoma), [MONDO:0007651](http://purl.obolibrary.org/obo/MONDO_0007651) (Gastrocutaneous syndrome), [MONDO:0006320](http://purl.obolibrary.org/obo/MONDO_0006320) (non-cutaneous melanoma), [MONDO:0007650](http://purl.obolibrary.org/obo/MONDO_0007650) (MALT lymphoma), [MONDO:0019629](http://purl.obolibrary.org/obo/MONDO_0019629) (sclerocornea (disease)), [MONDO:0019627](http://purl.obolibrary.org/obo/MONDO_0019627) (isolated congenital alacrima), [MONDO:0019628](http://purl.obolibrary.org/obo/MONDO_0019628) (Rieger anomaly), [MONDO:0019615](http://purl.obolibrary.org/obo/MONDO_0019615) (pituitary dermoid and epidermoid cysts), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019610](http://purl.obolibrary.org/obo/MONDO_0019610) (Zollinger-Ellison syndrome), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0008960](http://purl.obolibrary.org/obo/MONDO_0008960) (Charcot-Marie-tooth disease-deafness-intellectual disability syndrome), [MONDO:0008961](http://purl.obolibrary.org/obo/MONDO_0008961) (Charcot-Marie-tooth disease type 4A), [MONDO:0008962](http://purl.obolibrary.org/obo/MONDO_0008962) (Griscelli syndrome type 1), [MONDO:0008963](http://purl.obolibrary.org/obo/MONDO_0008963) (Chediak-Higashi syndrome), [MONDO:0008964](http://purl.obolibrary.org/obo/MONDO_0008964) (congenital secretory chloride diarrhea 1), [MONDO:0008965](http://purl.obolibrary.org/obo/MONDO_0008965) (CHARGE syndrome), [MONDO:0007627](http://purl.obolibrary.org/obo/MONDO_0007627) (focal facial dermal dysplasia type I), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0007626](http://purl.obolibrary.org/obo/MONDO_0007626) (familial congenital palsy of trochlear nerve), [MONDO:0007624](http://purl.obolibrary.org/obo/MONDO_0007624) (Flynn-Aird syndrome), [MONDO:0007622](http://purl.obolibrary.org/obo/MONDO_0007622) (Flood factor deficiency), [MONDO:0007621](http://purl.obolibrary.org/obo/MONDO_0007621) (Floating-Harbor syndrome), [MONDO:0007620](http://purl.obolibrary.org/obo/MONDO_0007620) (fish-eye disease), [MONDO:0019619](http://purl.obolibrary.org/obo/MONDO_0019619) (duplication of the esophagus), [MONDO:0019603](http://purl.obolibrary.org/obo/MONDO_0019603) (osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome), [MONDO:0019601](http://purl.obolibrary.org/obo/MONDO_0019601) (autosomal recessive axonal hereditary motor and sensory neuropathy), [MONDO:0019602](http://purl.obolibrary.org/obo/MONDO_0019602) (other inborn metabolic disease), [MONDO:0019600](http://purl.obolibrary.org/obo/MONDO_0019600) (xeroderma pigmentosum), [MONDO:0008950](http://purl.obolibrary.org/obo/MONDO_0008950) (cerebral sclerosis similar to Pelizaeus-Merzbacher disease), [MONDO:0008952](http://purl.obolibrary.org/obo/MONDO_0008952) (Cerebrofaciothoracic dysplasia), [MONDO:0008953](http://purl.obolibrary.org/obo/MONDO_0008953) (peroxisome biogenesis disorder 1A (Zellweger)), [MONDO:0006309](http://purl.obolibrary.org/obo/MONDO_0006309) (mucinous gastric adenocarcinoma), [MONDO:0008954](http://purl.obolibrary.org/obo/MONDO_0008954) (peroxisome biogenesis disorder 2A (Zellweger)), [MONDO:0006308](http://purl.obolibrary.org/obo/MONDO_0006308) (mixed tumor of the skin), [MONDO:0007639](http://purl.obolibrary.org/obo/MONDO_0007639) (fundus albipunctatus), [MONDO:0006307](http://purl.obolibrary.org/obo/MONDO_0006307) (mixed somatotroph-lactotroph pituitary gland adenoma), [MONDO:0008955](http://purl.obolibrary.org/obo/MONDO_0008955) (Cerebrooculofacioskeletal syndrome 1), [MONDO:0007637](http://purl.obolibrary.org/obo/MONDO_0007637) (corneal dystrophy, Fuchs endothelial, 1), [MONDO:0006306](http://purl.obolibrary.org/obo/MONDO_0006306) (mixed lobular and ductal breast carcinoma), [MONDO:0008956](http://purl.obolibrary.org/obo/MONDO_0008956) (congenital neuronal ceroid lipofuscinosis), [MONDO:0007636](http://purl.obolibrary.org/obo/MONDO_0007636) (Frontorhiny), [MONDO:0007635](http://purl.obolibrary.org/obo/MONDO_0007635) (Frasier syndrome), [MONDO:0006304](http://purl.obolibrary.org/obo/MONDO_0006304) (minor salivary gland adenocarcinoma), [MONDO:0008958](http://purl.obolibrary.org/obo/MONDO_0008958) (Klippel-Feil syndrome 2, autosomal recessive), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0006302](http://purl.obolibrary.org/obo/MONDO_0006302) (micropapillary serous carcinoma), [MONDO:0006301](http://purl.obolibrary.org/obo/MONDO_0006301) (metanephric adenoma), [MONDO:0006300](http://purl.obolibrary.org/obo/MONDO_0006300) (medullomyoblastoma with myogenic differentiation), [MONDO:0007630](http://purl.obolibrary.org/obo/MONDO_0007630) (North Carolina macular dystrophy), [MONDO:0019609](http://purl.obolibrary.org/obo/MONDO_0019609) (Zellweger syndrome), [MONDO:0019607](http://purl.obolibrary.org/obo/MONDO_0019607) (unspecified juvenile idiopathic arthritis), [MONDO:0019606](http://purl.obolibrary.org/obo/MONDO_0019606) (simple cryoglobulinemia), [MONDO:0021517](http://purl.obolibrary.org/obo/MONDO_0021517) (benign neoplasm of trachea), [MONDO:0021516](http://purl.obolibrary.org/obo/MONDO_0021516) (benign neoplasm of glottis), [MONDO:0021518](http://purl.obolibrary.org/obo/MONDO_0021518) (benign neoplasm of hard palate), [MONDO:0008540](http://purl.obolibrary.org/obo/MONDO_0008540) (extensor tendons of finger anomalies), [MONDO:0009872](http://purl.obolibrary.org/obo/MONDO_0009872) (Bjornstad syndrome), [MONDO:0009873](http://purl.obolibrary.org/obo/MONDO_0009873) (Pilodental dysplasia-refractive errors syndrome), [MONDO:0009874](http://purl.obolibrary.org/obo/MONDO_0009874) (Rabson-Mendenhall syndrome), [MONDO:0008544](http://purl.obolibrary.org/obo/MONDO_0008544) (tetramelic monodactyly), [MONDO:0021511](http://purl.obolibrary.org/obo/MONDO_0021511) (benign neoplasm of adrenal gland), [MONDO:0009875](http://purl.obolibrary.org/obo/MONDO_0009875) (achromatopsia 3), [MONDO:0021510](http://purl.obolibrary.org/obo/MONDO_0021510) (benign neoplasm of prostate), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0008546](http://purl.obolibrary.org/obo/MONDO_0008546) (thanatophoric dysplasia type 1), [MONDO:0021513](http://purl.obolibrary.org/obo/MONDO_0021513) (benign neoplasm of tonsil), [MONDO:0021512](http://purl.obolibrary.org/obo/MONDO_0021512) (benign neoplasm of thymus), [MONDO:0009878](http://purl.obolibrary.org/obo/MONDO_0009878) (pituitary hormone deficiency, combined, 2), [MONDO:0008547](http://purl.obolibrary.org/obo/MONDO_0008547) (thanatophoric dysplasia type 2), [MONDO:0021515](http://purl.obolibrary.org/obo/MONDO_0021515) (benign neoplasm of ethmoidal sinus), [MONDO:0007209](http://purl.obolibrary.org/obo/MONDO_0007209) (Weismann-Netter syndrome), [MONDO:0007208](http://purl.obolibrary.org/obo/MONDO_0007208) (Boomerang dysplasia), [MONDO:0021514](http://purl.obolibrary.org/obo/MONDO_0021514) (benign neoplasm of pericardium), [MONDO:0007207](http://purl.obolibrary.org/obo/MONDO_0007207) (BC6C6k syndrome), [MONDO:0007205](http://purl.obolibrary.org/obo/MONDO_0007205) (diaphyseal medullary stenosis-bone malignancy syndrome), [MONDO:0010868](http://purl.obolibrary.org/obo/MONDO_0010868) (RMD1), [MONDO:0007204](http://purl.obolibrary.org/obo/MONDO_0007204) (Cole-Carpenter syndrome 1), [MONDO:0007203](http://purl.obolibrary.org/obo/MONDO_0007203) (blue rubber bleb nevus), [MONDO:0007202](http://purl.obolibrary.org/obo/MONDO_0007202) (blepharoptosis-myopia-ectopia lentis syndrome), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0007200](http://purl.obolibrary.org/obo/MONDO_0007200) (blepharonasofacial malformation syndrome), [MONDO:0010862](http://purl.obolibrary.org/obo/MONDO_0010862) (type 1 diabetes mellitus 4), [MONDO:0010863](http://purl.obolibrary.org/obo/MONDO_0010863) (type 1 diabetes mellitus 5), [MONDO:0010860](http://purl.obolibrary.org/obo/MONDO_0010860) (autosomal recessive nonsyndromic deafness 3), [MONDO:0010861](http://purl.obolibrary.org/obo/MONDO_0010861) (type 1 diabetes mellitus 3), [MONDO:0010866](http://purl.obolibrary.org/obo/MONDO_0010866) (infantile osteopetrosis with neuroaxonal dysplasia), [MONDO:0010867](http://purl.obolibrary.org/obo/MONDO_0010867) (PARC syndrome), [MONDO:0010864](http://purl.obolibrary.org/obo/MONDO_0010864) (type 1 diabetes mellitus 7), [MONDO:0010865](http://purl.obolibrary.org/obo/MONDO_0010865) (Pseudoaminopterin syndrome), [MONDO:0021506](http://purl.obolibrary.org/obo/MONDO_0021506) (benign neoplasm of spinal cord), [MONDO:0021505](http://purl.obolibrary.org/obo/MONDO_0021505) (benign neoplasm of endocardium), [MONDO:0021508](http://purl.obolibrary.org/obo/MONDO_0021508) (benign neoplasm of epicardium), [MONDO:0021507](http://purl.obolibrary.org/obo/MONDO_0021507) (benign neoplasm of brain stem), [MONDO:0021509](http://purl.obolibrary.org/obo/MONDO_0021509) (benign neoplasm of myocardium), [MONDO:0009861](http://purl.obolibrary.org/obo/MONDO_0009861) (phenylketonuria), [MONDO:0009862](http://purl.obolibrary.org/obo/MONDO_0009862) (dihydropteridine reductase deficiency), [MONDO:0009863](http://purl.obolibrary.org/obo/MONDO_0009863) (Bh4-deficient hyperphenylalaninemia a), [MONDO:0021500](http://purl.obolibrary.org/obo/MONDO_0021500) (benign neoplasm of spleen), [MONDO:0009864](http://purl.obolibrary.org/obo/MONDO_0009864) (Phosphoenolpyruvate carboxykinase deficiency, mitochondrial), [MONDO:0009865](http://purl.obolibrary.org/obo/MONDO_0009865) (glycogen storage disease due to phosphoglycerate mutase deficiency), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0009866](http://purl.obolibrary.org/obo/MONDO_0009866) (Phosphoenolpyruvate carboxykinase deficiency, cytosolic), [MONDO:0009867](http://purl.obolibrary.org/obo/MONDO_0009867) (lethal congenital glycogen storage disease of heart), [MONDO:0021501](http://purl.obolibrary.org/obo/MONDO_0021501) (benign neoplasm of small intestine), [MONDO:0009868](http://purl.obolibrary.org/obo/MONDO_0009868) (glycogen storage disease IXb), [MONDO:0008537](http://purl.obolibrary.org/obo/MONDO_0008537) (telecanthus), [MONDO:0007219](http://purl.obolibrary.org/obo/MONDO_0007219) (brachydactyly type A6), [MONDO:0009869](http://purl.obolibrary.org/obo/MONDO_0009869) (Weissenbacher-Zweymuller syndrome), [MONDO:0021503](http://purl.obolibrary.org/obo/MONDO_0021503) (benign neoplasm of gallbladder), [MONDO:0007218](http://purl.obolibrary.org/obo/MONDO_0007218) (brachydactyly type A4), [MONDO:0007217](http://purl.obolibrary.org/obo/MONDO_0007217) (brachydactyly type A3), [MONDO:0007216](http://purl.obolibrary.org/obo/MONDO_0007216) (brachydactyly type A2), [MONDO:0010858](http://purl.obolibrary.org/obo/MONDO_0010858) (macrocephaly-spastic paraplegia-dysmorphism syndrome), [MONDO:0007215](http://purl.obolibrary.org/obo/MONDO_0007215) (brachydactyly type A1), [MONDO:0007214](http://purl.obolibrary.org/obo/MONDO_0007214) (brachydactyly-preaxial hallux varus syndrome), [MONDO:0007213](http://purl.obolibrary.org/obo/MONDO_0007213) (Ballard syndrome), [MONDO:0007212](http://purl.obolibrary.org/obo/MONDO_0007212) (brachydactyly-long thumb syndrome), [MONDO:0007211](http://purl.obolibrary.org/obo/MONDO_0007211) (brachydactyly-arterial hypertension syndrome), [MONDO:0010851](http://purl.obolibrary.org/obo/MONDO_0010851) (Lowry-MacLean syndrome), [MONDO:0010850](http://purl.obolibrary.org/obo/MONDO_0010850) (Tessier number 4 facial cleft), [MONDO:0010855](http://purl.obolibrary.org/obo/MONDO_0010855) (short tarsus-absence of lower eyelashes syndrome), [MONDO:0010854](http://purl.obolibrary.org/obo/MONDO_0010854) (Toriello-Lacassie-Droste syndrome), [MONDO:0008520](http://purl.obolibrary.org/obo/MONDO_0008520) (brachydactyly-elbow wrist dysplasia syndrome), [MONDO:0009852](http://purl.obolibrary.org/obo/MONDO_0009852) (congenital intrinsic factor deficiency), [MONDO:0008521](http://purl.obolibrary.org/obo/MONDO_0008521) (tarsal-carpal coalition syndrome), [MONDO:0009853](http://purl.obolibrary.org/obo/MONDO_0009853) (Imerslund-Grasbeck syndrome), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0009855](http://purl.obolibrary.org/obo/MONDO_0009855) (d-bifunctional protein deficiency), [MONDO:0009856](http://purl.obolibrary.org/obo/MONDO_0009856) (Peters plus syndrome), [MONDO:0008525](http://purl.obolibrary.org/obo/MONDO_0008525) (syringomyelia, isolated), [MONDO:0009857](http://purl.obolibrary.org/obo/MONDO_0009857) (persistent Mullerian duct syndrome), [MONDO:0009858](http://purl.obolibrary.org/obo/MONDO_0009858) (Pfeiffer-Palm-Teller syndrome), [MONDO:0009859](http://purl.obolibrary.org/obo/MONDO_0009859) (PHAVER syndrome), [MONDO:0010848](http://purl.obolibrary.org/obo/MONDO_0010848) (spinocerebellar ataxia type 5), [MONDO:0010846](http://purl.obolibrary.org/obo/MONDO_0010846) (EXT3), [MONDO:0010847](http://purl.obolibrary.org/obo/MONDO_0010847) (spinocerebellar ataxia type 4), [MONDO:0010841](http://purl.obolibrary.org/obo/MONDO_0010841) (Waardenburg syndrome type 2B), [MONDO:0010844](http://purl.obolibrary.org/obo/MONDO_0010844) (epiphyseal dysplasia, multiple, 2), [MONDO:0010845](http://purl.obolibrary.org/obo/MONDO_0010845) (macrothrombocytopenia and progressive sensorineural deafness), [MONDO:0010842](http://purl.obolibrary.org/obo/MONDO_0010842) (multiple cutaneous and mucosal venous malformations), [MONDO:0009841](http://purl.obolibrary.org/obo/MONDO_0009841) (PEHO syndrome), [MONDO:0008510](http://purl.obolibrary.org/obo/MONDO_0008510) (symphalangism with multiple anomalies of hands and feet), [MONDO:0008511](http://purl.obolibrary.org/obo/MONDO_0008511) (proximal symphalangism (disease)), [MONDO:0008512](http://purl.obolibrary.org/obo/MONDO_0008512) (syndactyly type 1), [MONDO:0008513](http://purl.obolibrary.org/obo/MONDO_0008513) (synpolydactyly type 1), [MONDO:0009845](http://purl.obolibrary.org/obo/MONDO_0009845) (Pelviscapular dysplasia), [MONDO:0008514](http://purl.obolibrary.org/obo/MONDO_0008514) (syndactyly type 3), [MONDO:0008515](http://purl.obolibrary.org/obo/MONDO_0008515) (syndactyly type 4), [MONDO:0009846](http://purl.obolibrary.org/obo/MONDO_0009846) (pentosuria), [MONDO:0008516](http://purl.obolibrary.org/obo/MONDO_0008516) (syndactyly type 5), [MONDO:0008517](http://purl.obolibrary.org/obo/MONDO_0008517) (syndactyly-polydactyly-ear lobe syndrome), [MONDO:0010837](http://purl.obolibrary.org/obo/MONDO_0010837) (primary hyperparathyroidism (disease)), [MONDO:0008518](http://purl.obolibrary.org/obo/MONDO_0008518) (calcaneonavicular coalition), [MONDO:0009849](http://purl.obolibrary.org/obo/MONDO_0009849) (Hyperimmunoglobulinemia d with periodic fever), [MONDO:0010835](http://purl.obolibrary.org/obo/MONDO_0010835) (pterygium colli-intellectual disability-digital anomalies syndrome), [MONDO:0008519](http://purl.obolibrary.org/obo/MONDO_0008519) (multiple synostoses syndrome 1), [MONDO:0010836](http://purl.obolibrary.org/obo/MONDO_0010836) (NNO1), [MONDO:0010839](http://purl.obolibrary.org/obo/MONDO_0010839) (autosomal dominant congenital benign spinal muscular atrophy), [MONDO:0010830](http://purl.obolibrary.org/obo/MONDO_0010830) (neuronal ceroid lipofuscinosis 8), [MONDO:0010833](http://purl.obolibrary.org/obo/MONDO_0010833) (Hirschsprung disease, susceptibility to, 2), [MONDO:0010834](http://purl.obolibrary.org/obo/MONDO_0010834) (HSCR5), [MONDO:0010831](http://purl.obolibrary.org/obo/MONDO_0010831) (familial caudal dysgenesis), [MONDO:0010832](http://purl.obolibrary.org/obo/MONDO_0010832) (Bardet-Biedl syndrome 3), [MONDO:0020229](http://purl.obolibrary.org/obo/MONDO_0020229) (cerebral disease with cataract), [MONDO:0019238](http://purl.obolibrary.org/obo/MONDO_0019238) (inborn disorder of pyrimidine metabolism), [MONDO:0019239](http://purl.obolibrary.org/obo/MONDO_0019239) (inborn disorder of serine or glycine metabolism), [MONDO:0019236](http://purl.obolibrary.org/obo/MONDO_0019236) (inborn disorder of purine metabolism), [MONDO:0008582](http://purl.obolibrary.org/obo/MONDO_0008582) (tooth and nail syndrome), [MONDO:0019237](http://purl.obolibrary.org/obo/MONDO_0019237) (inborn disorder of pyridoxine metabolism), [MONDO:0019234](http://purl.obolibrary.org/obo/MONDO_0019234) (peroxisome biogenesis disorder), [MONDO:0008585](http://purl.obolibrary.org/obo/MONDO_0008585) (HELLP syndrome), [MONDO:0019235](http://purl.obolibrary.org/obo/MONDO_0019235) (inborn disorder of phenylalanin or tyrosine metabolism), [MONDO:0019232](http://purl.obolibrary.org/obo/MONDO_0019232) (inborn disorder of peptide metabolism), [MONDO:0008586](http://purl.obolibrary.org/obo/MONDO_0008586) (esophageal atresia/tracheoesophageal fistula), [MONDO:0020221](http://purl.obolibrary.org/obo/MONDO_0020221) (secondary glaucoma due to a proliferation and differentiation anomaly), [MONDO:0019233](http://purl.obolibrary.org/obo/MONDO_0019233) (peroxisomal beta-oxidation disorder), [MONDO:0020222](http://purl.obolibrary.org/obo/MONDO_0020222) (rare disease with glaucoma as a major feature), [MONDO:0019230](http://purl.obolibrary.org/obo/MONDO_0019230) (inborn disorder of ornithine or proline metabolism), [MONDO:0020223](http://purl.obolibrary.org/obo/MONDO_0020223) (lens and zonula anomaly), [MONDO:0020224](http://purl.obolibrary.org/obo/MONDO_0020224) (rare cataract), [MONDO:0019231](http://purl.obolibrary.org/obo/MONDO_0019231) (inborn disorder of pentose phosphate metabolism), [MONDO:0020225](http://purl.obolibrary.org/obo/MONDO_0020225) (syndromic cataract), [MONDO:0020226](http://purl.obolibrary.org/obo/MONDO_0020226) (chromosomal anomaly with cataract), [MONDO:0020227](http://purl.obolibrary.org/obo/MONDO_0020227) (systemic disease with cataract), [MONDO:0020228](http://purl.obolibrary.org/obo/MONDO_0020228) (cataract associated with a metabolic disease), [MONDO:0007249](http://purl.obolibrary.org/obo/MONDO_0007249) (Camptobrachydactyly), [MONDO:0007247](http://purl.obolibrary.org/obo/MONDO_0007247) (basal ganglia calcification, idiopathic, childhood-onset), [MONDO:0007245](http://purl.obolibrary.org/obo/MONDO_0007245) (neurofibromatosis type 6), [MONDO:0007244](http://purl.obolibrary.org/obo/MONDO_0007244) (Caffey disease), [MONDO:0020220](http://purl.obolibrary.org/obo/MONDO_0020220) (Corneoiridogoniodysgenesis), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0007240](http://purl.obolibrary.org/obo/MONDO_0007240) (bundle branch block), [MONDO:0020218](http://purl.obolibrary.org/obo/MONDO_0020218) (goniodysgenesis), [MONDO:0019229](http://purl.obolibrary.org/obo/MONDO_0019229) (inborn disorder of ketolysis), [MONDO:0020219](http://purl.obolibrary.org/obo/MONDO_0020219) (corneogoniodysgenesis), [MONDO:0019227](http://purl.obolibrary.org/obo/MONDO_0019227) (inborn disorder of glycerol metabolism), [MONDO:0019228](http://purl.obolibrary.org/obo/MONDO_0019228) (inborn disorder of histidine metabolism), [MONDO:0008570](http://purl.obolibrary.org/obo/MONDO_0008570) (thyrotoxic periodic paralysis, susceptibility to, 1), [MONDO:0019225](http://purl.obolibrary.org/obo/MONDO_0019225) (gluconeogenesis disorder), [MONDO:0008571](http://purl.obolibrary.org/obo/MONDO_0008571) (Blount disease, infantile), [MONDO:0010891](http://purl.obolibrary.org/obo/MONDO_0010891) (lethal hemolytic anemia-genital anomalies syndrome), [MONDO:0019226](http://purl.obolibrary.org/obo/MONDO_0019226) (glucose transport disorder), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0019223](http://purl.obolibrary.org/obo/MONDO_0019223) (inborn disorder of fatty acid oxidation and ketone body metabolism), [MONDO:0019224](http://purl.obolibrary.org/obo/MONDO_0019224) (inborn disorder of gamma-aminobutyric acid metabolism), [MONDO:0010890](http://purl.obolibrary.org/obo/MONDO_0010890) (Acrocardiofacial syndrome), [MONDO:0020210](http://purl.obolibrary.org/obo/MONDO_0020210) (syndromic hyperopia), [MONDO:0021542](http://purl.obolibrary.org/obo/MONDO_0021542) (hemangioma of choroid), [MONDO:0020211](http://purl.obolibrary.org/obo/MONDO_0020211) (syndromic keratoconus), [MONDO:0021541](http://purl.obolibrary.org/obo/MONDO_0021541) (hemangioma of retina), [MONDO:0019222](http://purl.obolibrary.org/obo/MONDO_0019222) (inborn disorder of methionine cycle and sulfur amino acid metabolism), [MONDO:0020212](http://purl.obolibrary.org/obo/MONDO_0020212) (superficial corneal dystrophy), [MONDO:0021543](http://purl.obolibrary.org/obo/MONDO_0021543) (hemangioma of gingiva), [MONDO:0019220](http://purl.obolibrary.org/obo/MONDO_0019220) (inborn disorder of cobalamin metabolism and transport), [MONDO:0020213](http://purl.obolibrary.org/obo/MONDO_0020213) (stromal corneal dystrophy), [MONDO:0021546](http://purl.obolibrary.org/obo/MONDO_0021546) (ependymal tumor of spinal cord), [MONDO:0020214](http://purl.obolibrary.org/obo/MONDO_0020214) (posterior corneal dystrophy), [MONDO:0020215](http://purl.obolibrary.org/obo/MONDO_0020215) (syndromic corneal dystrophy), [MONDO:0021545](http://purl.obolibrary.org/obo/MONDO_0021545) (myomatous neoplasm), [MONDO:0020216](http://purl.obolibrary.org/obo/MONDO_0020216) (secondary dysgenetic glaucoma), [MONDO:0021548](http://purl.obolibrary.org/obo/MONDO_0021548) (total early-onset cataract), [MONDO:0020217](http://purl.obolibrary.org/obo/MONDO_0020217) (secondary dysgenetic glaucoma associated with neural crest cell migration anomaly), [MONDO:0007259](http://purl.obolibrary.org/obo/MONDO_0007259) (craniofaciofrontodigital syndrome), [MONDO:0007256](http://purl.obolibrary.org/obo/MONDO_0007256) (hepatocellular carcinoma), [MONDO:0021540](http://purl.obolibrary.org/obo/MONDO_0021540) (hamartoma of lung), [MONDO:0007254](http://purl.obolibrary.org/obo/MONDO_0007254) (breast cancer), [MONDO:0010896](http://purl.obolibrary.org/obo/MONDO_0010896) (pigment dispersion syndrome), [MONDO:0007252](http://purl.obolibrary.org/obo/MONDO_0007252) (Gordon syndrome), [MONDO:0010893](http://purl.obolibrary.org/obo/MONDO_0010893) (malignant hyperthermia, susceptibility to, 4), [MONDO:0007251](http://purl.obolibrary.org/obo/MONDO_0007251) (campomelic dysplasia), [MONDO:0010894](http://purl.obolibrary.org/obo/MONDO_0010894) (maturity-onset diabetes of the young type 3), [MONDO:0007250](http://purl.obolibrary.org/obo/MONDO_0007250) (camptodactyly of fingers), [MONDO:0020207](http://purl.obolibrary.org/obo/MONDO_0020207) (rare isolated myopia), [MONDO:0021539](http://purl.obolibrary.org/obo/MONDO_0021539) (hamartoma of skin appendage), [MONDO:0019218](http://purl.obolibrary.org/obo/MONDO_0019218) (inborn disorder of bile acid synthesis), [MONDO:0020208](http://purl.obolibrary.org/obo/MONDO_0020208) (syndromic myopia), [MONDO:0019219](http://purl.obolibrary.org/obo/MONDO_0019219) (inborn disorder of neurotransmitter metabolism and transport), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0019216](http://purl.obolibrary.org/obo/MONDO_0019216) (inborn disorder of amino acid absorption and transport), [MONDO:0020209](http://purl.obolibrary.org/obo/MONDO_0020209) (rare hyperopia and astigmatism), [MONDO:0009890](http://purl.obolibrary.org/obo/MONDO_0009890) (polycystic kidney disease, Potter type i, with Microbrachycephaly, hypertelorism, and Brachymelia), [MONDO:0019217](http://purl.obolibrary.org/obo/MONDO_0019217) (inborn disorder of urea cycle metabolism and ammonia detoxification), [MONDO:0009891](http://purl.obolibrary.org/obo/MONDO_0009891) (polycythemia vera), [MONDO:0008560](http://purl.obolibrary.org/obo/MONDO_0008560) (thrombophilia due to activated protein C resistance), [MONDO:0019214](http://purl.obolibrary.org/obo/MONDO_0019214) (inborn carbohydrate metabolic disorder), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0019215](http://purl.obolibrary.org/obo/MONDO_0019215) (classic organic aciduria), [MONDO:0010881](http://purl.obolibrary.org/obo/MONDO_0010881) (Mesomelia-synostoses syndrome), [MONDO:0008562](http://purl.obolibrary.org/obo/MONDO_0008562) (thumb deformity-alopecia-pigmentation anomaly syndrome), [MONDO:0009893](http://purl.obolibrary.org/obo/MONDO_0009893) (polydactyly, postaxial, type A5), [MONDO:0008563](http://purl.obolibrary.org/obo/MONDO_0008563) (thumb stiffness-brachydactyly-intellectual disability syndrome), [MONDO:0019213](http://purl.obolibrary.org/obo/MONDO_0019213) (cerebral organic aciduria), [MONDO:0009894](http://purl.obolibrary.org/obo/MONDO_0009894) (short-rib thoracic dysplasia 6 with or without polydactyly), [MONDO:0021531](http://purl.obolibrary.org/obo/MONDO_0021531) (fibroma of lung), [MONDO:0009895](http://purl.obolibrary.org/obo/MONDO_0009895) (postaxial polydactyly-dental and vertebral anomalies syndrome), [MONDO:0008564](http://purl.obolibrary.org/obo/MONDO_0008564) (DiGeorge syndrome), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0008565](http://purl.obolibrary.org/obo/MONDO_0008565) (familial thyroglossal duct cyst), [MONDO:0019211](http://purl.obolibrary.org/obo/MONDO_0019211) (isolated congenital anonychia), [MONDO:0021530](http://purl.obolibrary.org/obo/MONDO_0021530) (benign neoplasm of subglottis), [MONDO:0020200](http://purl.obolibrary.org/obo/MONDO_0020200) (conjunctival hemangioma or hemolymphangioma), [MONDO:0009897](http://purl.obolibrary.org/obo/MONDO_0009897) (adult polyglucosan body disease), [MONDO:0021533](http://purl.obolibrary.org/obo/MONDO_0021533) (carcinoid tumor of intestine), [MONDO:0008566](http://purl.obolibrary.org/obo/MONDO_0008566) (thyroid cancer, nonmedullary, 2), [MONDO:0020201](http://purl.obolibrary.org/obo/MONDO_0020201) (conjunctival telangiectasia (disease)), [MONDO:0008567](http://purl.obolibrary.org/obo/MONDO_0008567) (thyroid cancer, nonmedullary, 1), [MONDO:0021532](http://purl.obolibrary.org/obo/MONDO_0021532) (fibroma of prostate), [MONDO:0020202](http://purl.obolibrary.org/obo/MONDO_0020202) (conjunctival lymphangiectasia), [MONDO:0020203](http://purl.obolibrary.org/obo/MONDO_0020203) (pigmented conjunctival lesion), [MONDO:0021535](http://purl.obolibrary.org/obo/MONDO_0021535) (carcinoid tumor of pancreas), [MONDO:0020204](http://purl.obolibrary.org/obo/MONDO_0020204) (conjunctival tumor), [MONDO:0021534](http://purl.obolibrary.org/obo/MONDO_0021534) (carcinoid tumor of rectum), [MONDO:0008569](http://purl.obolibrary.org/obo/MONDO_0008569) (thyroid hormone resistance, generalized, autosomal dominant), [MONDO:0021537](http://purl.obolibrary.org/obo/MONDO_0021537) (undifferentiated carcinoma of nasopharynx), [MONDO:0020205](http://purl.obolibrary.org/obo/MONDO_0020205) (bulbar conjunctival dermoid or conjunctival dermolipoma), [MONDO:0020206](http://purl.obolibrary.org/obo/MONDO_0020206) (rare refraction anomaly), [MONDO:0007227](http://purl.obolibrary.org/obo/MONDO_0007227) (Sillence syndrome), [MONDO:0007226](http://purl.obolibrary.org/obo/MONDO_0007226) (brachydactyly-nystagmus-cerebellar ataxia syndrome), [MONDO:0007225](http://purl.obolibrary.org/obo/MONDO_0007225) (fibular aplasia-ectrodactyly syndrome), [MONDO:0007224](http://purl.obolibrary.org/obo/MONDO_0007224) (brachydactyly, type E, with atrial septal defect, Type 2), [MONDO:0007223](http://purl.obolibrary.org/obo/MONDO_0007223) (brachydactyly type E1), [MONDO:0007222](http://purl.obolibrary.org/obo/MONDO_0007222) (brachydactyly type D), [MONDO:0007221](http://purl.obolibrary.org/obo/MONDO_0007221) (brachydactyly type C), [MONDO:0010884](http://purl.obolibrary.org/obo/MONDO_0010884) (muscular dystrophy, Scapulohumeral), [MONDO:0007220](http://purl.obolibrary.org/obo/MONDO_0007220) (brachydactyly type B1), [MONDO:0010882](http://purl.obolibrary.org/obo/MONDO_0010882) (Aphalangy-syndactyly-microcephaly syndrome), [MONDO:0010883](http://purl.obolibrary.org/obo/MONDO_0010883) (pectus excavatum-macrocephaly-dysplastic nails syndrome), [MONDO:0010886](http://purl.obolibrary.org/obo/MONDO_0010886) (2q37 microdeletion syndrome), [MONDO:0019207](http://purl.obolibrary.org/obo/MONDO_0019207) (DEND syndrome), [MONDO:0021528](http://purl.obolibrary.org/obo/MONDO_0021528) (benign neoplasm of male breast), [MONDO:0021527](http://purl.obolibrary.org/obo/MONDO_0021527) (benign neoplasm of meninges), [MONDO:0019205](http://purl.obolibrary.org/obo/MONDO_0019205) (trichodysplasia-amelogenesis imperfecta syndrome), [MONDO:0019206](http://purl.obolibrary.org/obo/MONDO_0019206) (sparse hair-short stature-skin anomalies syndrome), [MONDO:0021529](http://purl.obolibrary.org/obo/MONDO_0021529) (benign neoplasm of chest wall), [MONDO:0010870](http://purl.obolibrary.org/obo/MONDO_0010870) (tibial muscular dystrophy), [MONDO:0008551](http://purl.obolibrary.org/obo/MONDO_0008551) (thoracolaryngopelvic dysplasia), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), [MONDO:0019202](http://purl.obolibrary.org/obo/MONDO_0019202) (myxofibrosarcoma), [MONDO:0009883](http://purl.obolibrary.org/obo/MONDO_0009883) (alpha-2-plasmin inhibitor deficiency), [MONDO:0008552](http://purl.obolibrary.org/obo/MONDO_0008552) (platelet-type bleeding disorder 16), [MONDO:0008553](http://purl.obolibrary.org/obo/MONDO_0008553) (platelet-type bleeding disorder 17), [MONDO:0021520](http://purl.obolibrary.org/obo/MONDO_0021520) (benign neoplasm of floor of mouth), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0019200](http://purl.obolibrary.org/obo/MONDO_0019200) (retinitis pigmentosa), [MONDO:0009885](http://purl.obolibrary.org/obo/MONDO_0009885) (Scott syndrome), [MONDO:0021522](http://purl.obolibrary.org/obo/MONDO_0021522) (benign neoplasm of lower jaw bone), [MONDO:0008555](http://purl.obolibrary.org/obo/MONDO_0008555) (thrombocytopenia 2), [MONDO:0021521](http://purl.obolibrary.org/obo/MONDO_0021521) (benign neoplasm of mediastinum), [MONDO:0021524](http://purl.obolibrary.org/obo/MONDO_0021524) (benign neoplasm of buccal mucosa), [MONDO:0008557](http://purl.obolibrary.org/obo/MONDO_0008557) (Paris-Trousseau thrombocytopenia), [MONDO:0021523](http://purl.obolibrary.org/obo/MONDO_0021523) (benign neoplasm of pharynx), [MONDO:0008558](http://purl.obolibrary.org/obo/MONDO_0008558) (autoimmune thrombocytopenic purpura), [MONDO:0008559](http://purl.obolibrary.org/obo/MONDO_0008559) (thrombophilia due to thrombin defect), [MONDO:0021525](http://purl.obolibrary.org/obo/MONDO_0021525) (benign neoplasm of corpus uteri), [MONDO:0010879](http://purl.obolibrary.org/obo/MONDO_0010879) (CODAS syndrome), [MONDO:0007236](http://purl.obolibrary.org/obo/MONDO_0007236) (branchiootorenal syndrome 1), [MONDO:0007235](http://purl.obolibrary.org/obo/MONDO_0007235) (branchiooculofacial syndrome), [MONDO:0007232](http://purl.obolibrary.org/obo/MONDO_0007232) (autosomal dominant brachyolmia), [MONDO:0010873](http://purl.obolibrary.org/obo/MONDO_0010873) (band heterotopia of brain), [MONDO:0007231](http://purl.obolibrary.org/obo/MONDO_0007231) (brachytelephalangy-dysmorphism-Kallmann syndrome), [MONDO:0007230](http://purl.obolibrary.org/obo/MONDO_0007230) (Brachymorphism-onychodysplasia-dysphalangism syndrome), [MONDO:0010877](http://purl.obolibrary.org/obo/MONDO_0010877) (Charcot-Marie-tooth disease type 5), [MONDO:0007290](http://purl.obolibrary.org/obo/MONDO_0007290) (cataract 5 multiple types), [MONDO:0020265](http://purl.obolibrary.org/obo/MONDO_0020265) (mitochondrial disease with eye involvement), [MONDO:0020266](http://purl.obolibrary.org/obo/MONDO_0020266) (genodermatosis with ocular features), [MONDO:0020267](http://purl.obolibrary.org/obo/MONDO_0020267) (genetic keratinization disorder associated with ocular features), [MONDO:0020268](http://purl.obolibrary.org/obo/MONDO_0020268) (ichthyosis associated with ocular features), [MONDO:0020269](http://purl.obolibrary.org/obo/MONDO_0020269) (syndromic ichthyosis associated with ocular features), [MONDO:0020260](http://purl.obolibrary.org/obo/MONDO_0020260) (myasthenic syndrome with eye involvement), [MONDO:0020261](http://purl.obolibrary.org/obo/MONDO_0020261) (abnormal eye movements), [MONDO:0020262](http://purl.obolibrary.org/obo/MONDO_0020262) (nervous system anomaly with eye involvement), [MONDO:0020263](http://purl.obolibrary.org/obo/MONDO_0020263) (spinocerebellar ataxia with oculomotor anomaly), [MONDO:0007289](http://purl.obolibrary.org/obo/MONDO_0007289) (cataract 13 with adult I phenotype), [MONDO:0020264](http://purl.obolibrary.org/obo/MONDO_0020264) (spinocerebellar degenerescence and spastic paraparesis with an oculomotor anomaly), [MONDO:0007288](http://purl.obolibrary.org/obo/MONDO_0007288) (cataract 6 multiple types), [MONDO:0007287](http://purl.obolibrary.org/obo/MONDO_0007287) (cataract 41), [MONDO:0007286](http://purl.obolibrary.org/obo/MONDO_0007286) (cataract 30), [MONDO:0007285](http://purl.obolibrary.org/obo/MONDO_0007285) (cataract 1 multiple types), [MONDO:0007284](http://purl.obolibrary.org/obo/MONDO_0007284) (cataract 20 multiple types), [MONDO:0007283](http://purl.obolibrary.org/obo/MONDO_0007283) (cataract 42), [MONDO:0007282](http://purl.obolibrary.org/obo/MONDO_0007282) (cataract 29), [MONDO:0007281](http://purl.obolibrary.org/obo/MONDO_0007281) (cataract 4 multiple types), [MONDO:0007280](http://purl.obolibrary.org/obo/MONDO_0007280) (cataract 8 multiple types), [MONDO:0019267](http://purl.obolibrary.org/obo/MONDO_0019267) (vitamin B12-unresponsive methylmalonic acidemia type mut-), [MONDO:0019265](http://purl.obolibrary.org/obo/MONDO_0019265) (diazoxide-resistant focal hyperinsulinism), [MONDO:0020254](http://purl.obolibrary.org/obo/MONDO_0020254) (craniostenosis associated with a strabismus), [MONDO:0020255](http://purl.obolibrary.org/obo/MONDO_0020255) (oculomotor palsy), [MONDO:0019263](http://purl.obolibrary.org/obo/MONDO_0019263) (autosomal erythropoietic protoporphyria), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0020256](http://purl.obolibrary.org/obo/MONDO_0020256) (congenital trochlear nerve palsy), [MONDO:0020257](http://purl.obolibrary.org/obo/MONDO_0020257) (supranuclear oculomotor palsy), [MONDO:0019264](http://purl.obolibrary.org/obo/MONDO_0019264) (alpha-N-acetylgalactosaminidase deficiency type 3), [MONDO:0019261](http://purl.obolibrary.org/obo/MONDO_0019261) (infantile neuronal ceroid lipofuscinosis), [MONDO:0020258](http://purl.obolibrary.org/obo/MONDO_0020258) (oculomotor apraxia or related oculomotor disease), [MONDO:0019262](http://purl.obolibrary.org/obo/MONDO_0019262) (juvenile neuronal ceroid lipofuscinosis), [MONDO:0020259](http://purl.obolibrary.org/obo/MONDO_0020259) (myopathy with eye involvement), [MONDO:0019260](http://purl.obolibrary.org/obo/MONDO_0019260) (adult neuronal ceroid lipofuscinosis), [MONDO:0021580](http://purl.obolibrary.org/obo/MONDO_0021580) (neoplasm of jaw), [MONDO:0021582](http://purl.obolibrary.org/obo/MONDO_0021582) (lentigo), [MONDO:0020250](http://purl.obolibrary.org/obo/MONDO_0020250) (autosomal dominant optic atrophy), [MONDO:0021581](http://purl.obolibrary.org/obo/MONDO_0021581) (connective tissue neoplasm), [MONDO:0020251](http://purl.obolibrary.org/obo/MONDO_0020251) (rare strabismus and restriction syndrome), [MONDO:0020252](http://purl.obolibrary.org/obo/MONDO_0020252) (essential strabismus), [MONDO:0021583](http://purl.obolibrary.org/obo/MONDO_0021583) (melanocytic skin neoplasm), [MONDO:0007299](http://purl.obolibrary.org/obo/MONDO_0007299) (Sotos syndrome 1), [MONDO:0020253](http://purl.obolibrary.org/obo/MONDO_0020253) (syndrome with a symptomatic strabismus), [MONDO:0007298](http://purl.obolibrary.org/obo/MONDO_0007298) (spinocerebellar ataxia type 29), [MONDO:0007297](http://purl.obolibrary.org/obo/MONDO_0007297) (ADan amyloidosis), [MONDO:0007296](http://purl.obolibrary.org/obo/MONDO_0007296) (spinocerebellar ataxia type 31), [MONDO:0007294](http://purl.obolibrary.org/obo/MONDO_0007294) (central core myopathy), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0019258](http://purl.obolibrary.org/obo/MONDO_0019258) (mild phenylketonuria), [MONDO:0019259](http://purl.obolibrary.org/obo/MONDO_0019259) (classic phenylketonuria), [MONDO:0019256](http://purl.obolibrary.org/obo/MONDO_0019256) (sterol metabolism disorder), [MONDO:0019257](http://purl.obolibrary.org/obo/MONDO_0019257) (hemochromatosis type 2), [MONDO:0019254](http://purl.obolibrary.org/obo/MONDO_0019254) (inborn disorder of purine or pyrimidine metabolism), [MONDO:0020243](http://purl.obolibrary.org/obo/MONDO_0020243) (colobomatous and areolar dystrophy), [MONDO:0019255](http://purl.obolibrary.org/obo/MONDO_0019255) (sphingolipidosis), [MONDO:0020244](http://purl.obolibrary.org/obo/MONDO_0020244) (unclassified primitive or secondary maculopathy), [MONDO:0021577](http://purl.obolibrary.org/obo/MONDO_0021577) (malignant mediastinal neural neoplasm), [MONDO:0020245](http://purl.obolibrary.org/obo/MONDO_0020245) (disease predisposing to age-related macular degeneration), [MONDO:0019252](http://purl.obolibrary.org/obo/MONDO_0019252) (other metabolic disease with skin involvement), [MONDO:0021576](http://purl.obolibrary.org/obo/MONDO_0021576) (fallopian tube endometrioid tumor), [MONDO:0019253](http://purl.obolibrary.org/obo/MONDO_0019253) (metabolic disease involving other neurotransmitter deficiency), [MONDO:0020246](http://purl.obolibrary.org/obo/MONDO_0020246) (vitreoretinopathy), [MONDO:0021579](http://purl.obolibrary.org/obo/MONDO_0021579) (neoplasm of femur), [MONDO:0019250](http://purl.obolibrary.org/obo/MONDO_0019250) (inborn disorder of biogenic amine metabolism and transport), [MONDO:0020247](http://purl.obolibrary.org/obo/MONDO_0020247) (congenital vitreoretinal dysplasia), [MONDO:0021578](http://purl.obolibrary.org/obo/MONDO_0021578) (sternal neoplasm), [MONDO:0019251](http://purl.obolibrary.org/obo/MONDO_0019251) (oligosaccharidosis), [MONDO:0020248](http://purl.obolibrary.org/obo/MONDO_0020248) (vitreoretinal degeneration), [MONDO:0020249](http://purl.obolibrary.org/obo/MONDO_0020249) (hereditary optic neuropathy), [MONDO:0021571](http://purl.obolibrary.org/obo/MONDO_0021571) (multiple sclerosis, susceptibility to 1), [MONDO:0021570](http://purl.obolibrary.org/obo/MONDO_0021570) (Hauptmann-Thannhauser muscular dystrophy), [MONDO:0020240](http://purl.obolibrary.org/obo/MONDO_0020240) (syndromic retinitis pigmentosa), [MONDO:0020241](http://purl.obolibrary.org/obo/MONDO_0020241) (unclassified familial retinal dystrophy), [MONDO:0020242](http://purl.obolibrary.org/obo/MONDO_0020242) (genetic macular dystrophy), [MONDO:0007265](http://purl.obolibrary.org/obo/MONDO_0007265) (cardiofaciocutaneous syndrome 1), [MONDO:0007264](http://purl.obolibrary.org/obo/MONDO_0007264) (sudden cardiac arrest), [MONDO:0007263](http://purl.obolibrary.org/obo/MONDO_0007263) (cardiac rhythm disease), [MONDO:0019249](http://purl.obolibrary.org/obo/MONDO_0019249) (mucopolysaccharidosis), [MONDO:0008592](http://purl.obolibrary.org/obo/MONDO_0008592) (Tricho-dento-osseous syndrome), [MONDO:0019248](http://purl.obolibrary.org/obo/MONDO_0019248) (mucolipidosis), [MONDO:0019245](http://purl.obolibrary.org/obo/MONDO_0019245) (lipid storage disorder), [MONDO:0019246](http://purl.obolibrary.org/obo/MONDO_0019246) (inborn disorder of lysosomal amino acid transport), [MONDO:0019243](http://purl.obolibrary.org/obo/MONDO_0019243) (inborn disorder of energy metabolism), [MONDO:0020232](http://purl.obolibrary.org/obo/MONDO_0020232) (musculoskeletal disease with cataract), [MONDO:0008597](http://purl.obolibrary.org/obo/MONDO_0008597) (trichorhinophalangeal syndrome, type 3), [MONDO:0020233](http://purl.obolibrary.org/obo/MONDO_0020233) (Dentocutaneous disease with cataract), [MONDO:0019241](http://purl.obolibrary.org/obo/MONDO_0019241) (inborn disorder of the gamma-glutamyl cycle), [MONDO:0020234](http://purl.obolibrary.org/obo/MONDO_0020234) (craniofacial anomaly with cataract), [MONDO:0019242](http://purl.obolibrary.org/obo/MONDO_0019242) (inborn disorder of branched-chain amino acid metabolism), [MONDO:0020235](http://purl.obolibrary.org/obo/MONDO_0020235) (lens size anomaly), [MONDO:0020236](http://purl.obolibrary.org/obo/MONDO_0020236) (lens position anomaly), [MONDO:0019240](http://purl.obolibrary.org/obo/MONDO_0019240) (sterol biosynthesis disorder), [MONDO:0020237](http://purl.obolibrary.org/obo/MONDO_0020237) (lens shape anomaly), [MONDO:0020238](http://purl.obolibrary.org/obo/MONDO_0020238) (genetic vitreous-retinal disease), [MONDO:0021569](http://purl.obolibrary.org/obo/MONDO_0021569) (Emery-Dreifuss muscular dystrophy 2, autosomal dominant), [MONDO:0007279](http://purl.obolibrary.org/obo/MONDO_0007279) (cataract 7), [MONDO:0020230](http://purl.obolibrary.org/obo/MONDO_0020230) (renal disease with cataract), [MONDO:0007278](http://purl.obolibrary.org/obo/MONDO_0007278) (cataract 32 multiple types), [MONDO:0007277](http://purl.obolibrary.org/obo/MONDO_0007277) (cataract-aberrant oral frenula-growth delay syndrome), [MONDO:0020231](http://purl.obolibrary.org/obo/MONDO_0020231) (cardiac disease with cataract), [MONDO:0007276](http://purl.obolibrary.org/obo/MONDO_0007276) (cat-eye syndrome), [MONDO:0007273](http://purl.obolibrary.org/obo/MONDO_0007273) (paragangliomas 4), [MONDO:0007272](http://purl.obolibrary.org/obo/MONDO_0007272) (hereditary hypercarotenemia and vitamin A deficiency), [MONDO:0020298](http://purl.obolibrary.org/obo/MONDO_0020298) (Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15), [MONDO:0020297](http://purl.obolibrary.org/obo/MONDO_0020297) (Noonan syndrome and Noonan-related syndrome), [MONDO:0019298](http://purl.obolibrary.org/obo/MONDO_0019298) (rare urticaria), [MONDO:0020280](http://purl.obolibrary.org/obo/MONDO_0020280) (metabolic disease with cataract), [MONDO:0020281](http://purl.obolibrary.org/obo/MONDO_0020281) (metabolic disease with pigmentary retinitis), [MONDO:0020282](http://purl.obolibrary.org/obo/MONDO_0020282) (metabolic disease with macular cherry-red spot), [MONDO:0020283](http://purl.obolibrary.org/obo/MONDO_0020283) (uveitis (disease)), [MONDO:0019289](http://purl.obolibrary.org/obo/MONDO_0019289) (hyperpigmentation of the skin), [MONDO:0019287](http://purl.obolibrary.org/obo/MONDO_0019287) (ectodermal dysplasia syndrome), [MONDO:0020276](http://purl.obolibrary.org/obo/MONDO_0020276) (pigmentation disorder with eye involvement, excluding albinism), [MONDO:0019288](http://purl.obolibrary.org/obo/MONDO_0019288) (pigmentation anomaly of the skin), [MONDO:0020277](http://purl.obolibrary.org/obo/MONDO_0020277) (ectodermal malformation syndrome associated with ocular features), [MONDO:0020278](http://purl.obolibrary.org/obo/MONDO_0020278) (metabolic disease associated with ocular features), [MONDO:0020279](http://purl.obolibrary.org/obo/MONDO_0020279) (metabolic disease with corneal opacity), [MONDO:0019290](http://purl.obolibrary.org/obo/MONDO_0019290) (hypopigmentation of the skin (disease)), [MONDO:0020270](http://purl.obolibrary.org/obo/MONDO_0020270) (pigmentation disorder with eye involvement), [MONDO:0020271](http://purl.obolibrary.org/obo/MONDO_0020271) (phakomatosis with eye involvement), [MONDO:0020272](http://purl.obolibrary.org/obo/MONDO_0020272) (connective tissue disease with eye involvement), [MONDO:0020273](http://purl.obolibrary.org/obo/MONDO_0020273) (disease with potential neoplastic degeneration associated with ocular features), [MONDO:0020274](http://purl.obolibrary.org/obo/MONDO_0020274) (onycho-patellar syndrome with eye involvement), [MONDO:0020275](http://purl.obolibrary.org/obo/MONDO_0020275) (oculocutaneous or ocular albinism), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0009914](http://purl.obolibrary.org/obo/MONDO_0009914) (Pseudodiastrophic dysplasia), [MONDO:0010903](http://purl.obolibrary.org/obo/MONDO_0010903) (craniosynostosis, Adelaide type), [MONDO:0009915](http://purl.obolibrary.org/obo/MONDO_0009915) (46,XX disorder of sex development-skeletal anomalies syndrome), [MONDO:0009916](http://purl.obolibrary.org/obo/MONDO_0009916) (46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency), [MONDO:0009917](http://purl.obolibrary.org/obo/MONDO_0009917) (autosomal recessive pseudohypoaldosteronism type 1), [MONDO:0010902](http://purl.obolibrary.org/obo/MONDO_0010902) (spondyloepiphyseal dysplasia, Reardon type), [MONDO:0009918](http://purl.obolibrary.org/obo/MONDO_0009918) (fundus dystrophy, pseudoinflammatory, recessive form), [MONDO:0010907](http://purl.obolibrary.org/obo/MONDO_0010907) (Hypertryptophanemia), [MONDO:0009919](http://purl.obolibrary.org/obo/MONDO_0009919) (peroxisomal acyl-CoA oxidase deficiency), [MONDO:0010905](http://purl.obolibrary.org/obo/MONDO_0010905) (cone-rod dystrophy 1), [MONDO:0010900](http://purl.obolibrary.org/obo/MONDO_0010900) (intrauterine growth retardation with increased mitomycin c sensitivity), [MONDO:0009900](http://purl.obolibrary.org/obo/MONDO_0009900) (polysyndactyly-cardiac malformation syndrome), [MONDO:0009901](http://purl.obolibrary.org/obo/MONDO_0009901) (Bartsocas-Papas syndrome), [MONDO:0009902](http://purl.obolibrary.org/obo/MONDO_0009902) (cutaneous porphyria), [MONDO:0009903](http://purl.obolibrary.org/obo/MONDO_0009903) (postaxial acrofacial dysostosis), [MONDO:0009904](http://purl.obolibrary.org/obo/MONDO_0009904) (Gitelman syndrome), [MONDO:0009905](http://purl.obolibrary.org/obo/MONDO_0009905) (urban-Rogers-Meyer syndrome), [MONDO:0009906](http://purl.obolibrary.org/obo/MONDO_0009906) (Prenatal bowing), [MONDO:0009908](http://purl.obolibrary.org/obo/MONDO_0009908) (dehydratase deficiency), [MONDO:0009950](http://purl.obolibrary.org/obo/MONDO_0009950) (pyruvate kinase deficiency of red cells), [MONDO:0008620](http://purl.obolibrary.org/obo/MONDO_0008620) (upper limb mesomelic dysplasia), [MONDO:0009952](http://purl.obolibrary.org/obo/MONDO_0009952) (radioulnar synostosis-developmental delay-hypotonia syndrome), [MONDO:0009953](http://purl.obolibrary.org/obo/MONDO_0009953) (leukocyte adhesion deficiency type II), [MONDO:0008622](http://purl.obolibrary.org/obo/MONDO_0008622) (Tricho-retino-dento-digital syndrome), [MONDO:0009954](http://purl.obolibrary.org/obo/MONDO_0009954) (Ramon syndrome), [MONDO:0009955](http://purl.obolibrary.org/obo/MONDO_0009955) (rapadilino syndrome), [MONDO:0008624](http://purl.obolibrary.org/obo/MONDO_0008624) (Upington disease), [MONDO:0009958](http://purl.obolibrary.org/obo/MONDO_0009958) (adult Refsum disease), [MONDO:0008627](http://purl.obolibrary.org/obo/MONDO_0008627) (ureter cancer), [MONDO:0009959](http://purl.obolibrary.org/obo/MONDO_0009959) (peroxisome biogenesis disorder type 3B), [MONDO:0010948](http://purl.obolibrary.org/obo/MONDO_0010948) (cataract 10 multiple types), [MONDO:0010945](http://purl.obolibrary.org/obo/MONDO_0010945) (retinitis pigmentosa 17), [MONDO:0010949](http://purl.obolibrary.org/obo/MONDO_0010949) (Charcot-Marie-tooth disease type 2B), [MONDO:0009940](http://purl.obolibrary.org/obo/MONDO_0009940) (pycnodysostosis), [MONDO:0008610](http://purl.obolibrary.org/obo/MONDO_0008610) (blue color blindness), [MONDO:0008611](http://purl.obolibrary.org/obo/MONDO_0008611) (humerus trochlea aplasia), [MONDO:0009942](http://purl.obolibrary.org/obo/MONDO_0009942) (Pyknoachondrogenesis), [MONDO:0009943](http://purl.obolibrary.org/obo/MONDO_0009943) (Pyle disease), [MONDO:0008612](http://purl.obolibrary.org/obo/MONDO_0008612) (tuberous sclerosis 1), [MONDO:0009945](http://purl.obolibrary.org/obo/MONDO_0009945) (pyridoxine-dependent epilepsy), [MONDO:0009946](http://purl.obolibrary.org/obo/MONDO_0009946) (hemolytic anemia due to pyrimidine 5' nucleotidase deficiency), [MONDO:0009947](http://purl.obolibrary.org/obo/MONDO_0009947) (glutathione synthetase deficiency with 5-oxoprolinuria), [MONDO:0008617](http://purl.obolibrary.org/obo/MONDO_0008617) (inflammatory bowel disease 11), [MONDO:0008618](http://purl.obolibrary.org/obo/MONDO_0008618) (mesomelic dwarfism, Reinhardt-Pfeiffer type), [MONDO:0009949](http://purl.obolibrary.org/obo/MONDO_0009949) (pyruvate carboxylase deficiency disease), [MONDO:0010935](http://purl.obolibrary.org/obo/MONDO_0010935) (neuronopathy, distal hereditary motor, type 5A), [MONDO:0008619](http://purl.obolibrary.org/obo/MONDO_0008619) (ulna metaphyseal dysplasia syndrome), [MONDO:0010938](http://purl.obolibrary.org/obo/MONDO_0010938) (T-b+ severe combined immunodeficiency due to JAK3 deficiency), [MONDO:0010932](http://purl.obolibrary.org/obo/MONDO_0010932) (progressive bifocal chorioretinal atrophy), [MONDO:0010933](http://purl.obolibrary.org/obo/MONDO_0010933) (autosomal recessive nonsyndromic deafness 4), [MONDO:0010930](http://purl.obolibrary.org/obo/MONDO_0010930) (anophthalmia plus syndrome), [MONDO:0010931](http://purl.obolibrary.org/obo/MONDO_0010931) (VDDR2B), [MONDO:0009930](http://purl.obolibrary.org/obo/MONDO_0009930) (pulmonary arteriovenous malformation (disease)), [MONDO:0008601](http://purl.obolibrary.org/obo/MONDO_0008601) (triglyceride storage disease, type 1), [MONDO:0008602](http://purl.obolibrary.org/obo/MONDO_0008602) (triglyceride storage disease, type 2), [MONDO:0009933](http://purl.obolibrary.org/obo/MONDO_0009933) (congenital pulmonary lymphangiectasia), [MONDO:0008603](http://purl.obolibrary.org/obo/MONDO_0008603) (trigonocephaly 1), [MONDO:0009935](http://purl.obolibrary.org/obo/MONDO_0009935) (pulmonary hypertension, primary, autosomal recessive), [MONDO:0010925](http://purl.obolibrary.org/obo/MONDO_0010925) (Velo-facial-skeletal syndrome), [MONDO:0009936](http://purl.obolibrary.org/obo/MONDO_0009936) (familial primary pulmonary hypoplasia), [MONDO:0008606](http://purl.obolibrary.org/obo/MONDO_0008606) (Say-field-Coldwell syndrome), [MONDO:0010926](http://purl.obolibrary.org/obo/MONDO_0010926) (familial hypocalciuric hypercalcemia 3), [MONDO:0008607](http://purl.obolibrary.org/obo/MONDO_0008607) (triphalangeal thumbs-brachyectrodactyly syndrome), [MONDO:0010924](http://purl.obolibrary.org/obo/MONDO_0010924) (D-2-hydroxyglutaric aciduria), [MONDO:0008608](http://purl.obolibrary.org/obo/MONDO_0008608) (down syndrome), [MONDO:0010929](http://purl.obolibrary.org/obo/MONDO_0010929) (craniosynostosis 4), [MONDO:0010922](http://purl.obolibrary.org/obo/MONDO_0010922) (Satoyoshi syndrome), [MONDO:0010920](http://purl.obolibrary.org/obo/MONDO_0010920) (microtia), [MONDO:0010909](http://purl.obolibrary.org/obo/MONDO_0010909) (UV-Sensitive syndrome 1), [MONDO:0009920](http://purl.obolibrary.org/obo/MONDO_0009920) (Acrootoocular syndrome), [MONDO:0009921](http://purl.obolibrary.org/obo/MONDO_0009921) (holoprosencephaly-postaxial polydactyly syndrome), [MONDO:0009923](http://purl.obolibrary.org/obo/MONDO_0009923) (46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency), [MONDO:0009924](http://purl.obolibrary.org/obo/MONDO_0009924) (Hypocalcemic vitamin d-dependent rickets), [MONDO:0009925](http://purl.obolibrary.org/obo/MONDO_0009925) (pseudoxanthoma elasticum), [MONDO:0010914](http://purl.obolibrary.org/obo/MONDO_0010914) (carnitine palmitoyl transferase II deficiency, severe infantile form), [MONDO:0009926](http://purl.obolibrary.org/obo/MONDO_0009926) (autosomal recessive multiple pterygium syndrome), [MONDO:0010915](http://purl.obolibrary.org/obo/MONDO_0010915) (autosomal dominant nonsyndromic deafness 4A), [MONDO:0009927](http://purl.obolibrary.org/obo/MONDO_0009927) (3MC syndrome 2), [MONDO:0010912](http://purl.obolibrary.org/obo/MONDO_0010912) (fibrosis of extraocular muscles, congenital, 3A, with or without Extraocular involvement), [MONDO:0010913](http://purl.obolibrary.org/obo/MONDO_0010913) (Caroli disease), [MONDO:0009929](http://purl.obolibrary.org/obo/MONDO_0009929) (neonatal acute respiratory distress due to SP-b deficiency), [MONDO:0010917](http://purl.obolibrary.org/obo/MONDO_0010917) (CCAL1), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0021638](http://purl.obolibrary.org/obo/MONDO_0021638) (low grade astrocytic tumor), [MONDO:0020306](http://purl.obolibrary.org/obo/MONDO_0020306) (absent tibia-polydactyly syndrome), [MONDO:0019317](http://purl.obolibrary.org/obo/MONDO_0019317) (follicular atrophoderma-basal cell carcinoma), [MONDO:0019318](http://purl.obolibrary.org/obo/MONDO_0019318) (inflammatory linear verrucous epidermal nevus), [MONDO:0021637](http://purl.obolibrary.org/obo/MONDO_0021637) (low grade glioma), [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0021639](http://purl.obolibrary.org/obo/MONDO_0021639) (grade II glioma), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (maculopapular cutaneous mastocytosis), [MONDO:0019313](http://purl.obolibrary.org/obo/MONDO_0019313) (hereditary lymphedema), [MONDO:0009990](http://purl.obolibrary.org/obo/MONDO_0009990) (Revesz syndrome), [MONDO:0008660](http://purl.obolibrary.org/obo/MONDO_0008660) (autosomal dominant hypophosphatemic rickets), [MONDO:0019314](http://purl.obolibrary.org/obo/MONDO_0019314) (cutaneous mastocytoma), [MONDO:0009992](http://purl.obolibrary.org/obo/MONDO_0009992) (myoglobinuria, acute recurrent, autosomal recessive), [MONDO:0019311](http://purl.obolibrary.org/obo/MONDO_0019311) (woolly hair nevus), [MONDO:0008661](http://purl.obolibrary.org/obo/MONDO_0008661) (vitiligo), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0019312](http://purl.obolibrary.org/obo/MONDO_0019312) (Hermansky-Pudlak syndrome), [MONDO:0008662](http://purl.obolibrary.org/obo/MONDO_0008662) (autosomal dominant vitreoretinochoroidopathy), [MONDO:0009994](http://purl.obolibrary.org/obo/MONDO_0009994) (alveolar rhabdomyosarcoma (disease)), [MONDO:0021630](http://purl.obolibrary.org/obo/MONDO_0021630) (lipoma of face), [MONDO:0008663](http://purl.obolibrary.org/obo/MONDO_0008663) (Snowflake vitreoretinal degeneration), [MONDO:0008664](http://purl.obolibrary.org/obo/MONDO_0008664) (autosomal dominant neovascular inflammatory vitreoretinopathy), [MONDO:0019310](http://purl.obolibrary.org/obo/MONDO_0019310) (recessive dystrophic epidermolysis bullosa inversa), [MONDO:0021632](http://purl.obolibrary.org/obo/MONDO_0021632) (primary brain neoplasm), [MONDO:0009996](http://purl.obolibrary.org/obo/MONDO_0009996) (rhizomelic syndrome, Urbach type), [MONDO:0008665](http://purl.obolibrary.org/obo/MONDO_0008665) (ptosis-vocal cord paralysis syndrome), [MONDO:0021631](http://purl.obolibrary.org/obo/MONDO_0021631) (brain astrocytoma), [MONDO:0009997](http://purl.obolibrary.org/obo/MONDO_0009997) (Roberts syndrome), [MONDO:0020301](http://purl.obolibrary.org/obo/MONDO_0020301) (Prader-Willi syndrome due to paternal 15q11q13 deletion), [MONDO:0008667](http://purl.obolibrary.org/obo/MONDO_0008667) (von Hippel-Lindau disease), [MONDO:0021634](http://purl.obolibrary.org/obo/MONDO_0021634) (epithelial skin neoplasm), [MONDO:0009998](http://purl.obolibrary.org/obo/MONDO_0009998) (Richieri Costa-Pereira syndrome), [MONDO:0021633](http://purl.obolibrary.org/obo/MONDO_0021633) (cerebral astrocytoma), [MONDO:0009999](http://purl.obolibrary.org/obo/MONDO_0009999) (autosomal recessive Robinow syndrome), [MONDO:0008668](http://purl.obolibrary.org/obo/MONDO_0008668) (von willebrand's disease 1), [MONDO:0021636](http://purl.obolibrary.org/obo/MONDO_0021636) (astrocytic tumor), [MONDO:0021635](http://purl.obolibrary.org/obo/MONDO_0021635) (neurocristopathy), [MONDO:0007327](http://purl.obolibrary.org/obo/MONDO_0007327) (chylomicronemia, familial, due to circulating inhibitor of lipoprotein lipase), [MONDO:0010989](http://purl.obolibrary.org/obo/MONDO_0010989) (Mayer-Rokitansky-KC<ster-Hauser syndrome type 2), [MONDO:0007322](http://purl.obolibrary.org/obo/MONDO_0007322) (chondrodysplasia punctata, tibial-metacarpal type), [MONDO:0007321](http://purl.obolibrary.org/obo/MONDO_0007321) (autosomal dominant chondrodysplasia punctata), [MONDO:0007320](http://purl.obolibrary.org/obo/MONDO_0007320) (chondrocalcinosis due to Apatite crystal deposition), [MONDO:0010984](http://purl.obolibrary.org/obo/MONDO_0010984) (Usher syndrome type 1D), [MONDO:0010981](http://purl.obolibrary.org/obo/MONDO_0010981) (absent tibia-polydactyly-arachnoid cyst syndrome), [MONDO:0010987](http://purl.obolibrary.org/obo/MONDO_0010987) (autosomal recessive nonsyndromic deafness 8), [MONDO:0010988](http://purl.obolibrary.org/obo/MONDO_0010988) (aplasia cutis-myopia syndrome), [MONDO:0010985](http://purl.obolibrary.org/obo/MONDO_0010985) (FAME1), [MONDO:0019319](http://purl.obolibrary.org/obo/MONDO_0019319) (verrucous nevus), [MONDO:0010986](http://purl.obolibrary.org/obo/MONDO_0010986) (autosomal recessive nonsyndromic deafness 9), [MONDO:0021627](http://purl.obolibrary.org/obo/MONDO_0021627) (eyelid capillary hemangioma), [MONDO:0019307](http://purl.obolibrary.org/obo/MONDO_0019307) (junctional epidermolysis bullosa non-Herlitz type), [MONDO:0021629](http://purl.obolibrary.org/obo/MONDO_0021629) (uterine ligament neoplasm), [MONDO:0019302](http://purl.obolibrary.org/obo/MONDO_0019302) (mucopolysaccharidosis with skin involvement), [MONDO:0019303](http://purl.obolibrary.org/obo/MONDO_0019303) (premature aging), [MONDO:0019300](http://purl.obolibrary.org/obo/MONDO_0019300) (rare skin tumor or hamartoma), [MONDO:0008650](http://purl.obolibrary.org/obo/MONDO_0008650) (posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome), [MONDO:0019301](http://purl.obolibrary.org/obo/MONDO_0019301) (metabolic disease with skin involvement), [MONDO:0008652](http://purl.obolibrary.org/obo/MONDO_0008652) (congenital vertical talus), [MONDO:0009983](http://purl.obolibrary.org/obo/MONDO_0009983) (retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome), [MONDO:0009984](http://purl.obolibrary.org/obo/MONDO_0009984) (late-adult onset retinitis pigmentosa), [MONDO:0008654](http://purl.obolibrary.org/obo/MONDO_0008654) (NYS4), [MONDO:0009987](http://purl.obolibrary.org/obo/MONDO_0009987) (autosomal recessive pericentral pigmentary retinopathy), [MONDO:0009988](http://purl.obolibrary.org/obo/MONDO_0009988) (retinoschisis of fovea), [MONDO:0009989](http://purl.obolibrary.org/obo/MONDO_0009989) (enhanced S-cone syndrome), [MONDO:0008659](http://purl.obolibrary.org/obo/MONDO_0008659) (transcobalamin i deficiency), [MONDO:0007339](http://purl.obolibrary.org/obo/MONDO_0007339) (Blepharo-cheilo-odontic syndrome), [MONDO:0007337](http://purl.obolibrary.org/obo/MONDO_0007337) (cleft palate-lateral synechia syndrome), [MONDO:0006006](http://purl.obolibrary.org/obo/MONDO_0006006) (verrucous carcinoma), [MONDO:0010979](http://purl.obolibrary.org/obo/MONDO_0010979) (Timothy syndrome), [MONDO:0006004](http://purl.obolibrary.org/obo/MONDO_0006004) (vasomotor rhinitis), [MONDO:0007334](http://purl.obolibrary.org/obo/MONDO_0007334) (autosomal dominant popliteal pterygium syndrome), [MONDO:0006003](http://purl.obolibrary.org/obo/MONDO_0006003) (uterine corpus cancer), [MONDO:0007333](http://purl.obolibrary.org/obo/MONDO_0007333) (van der Woude syndrome 1), [MONDO:0007332](http://purl.obolibrary.org/obo/MONDO_0007332) (SHFLD1), [MONDO:0010972](http://purl.obolibrary.org/obo/MONDO_0010972) (hydrocephalus-costovertebral dysplasia-sprengel anomaly syndrome), [MONDO:0007330](http://purl.obolibrary.org/obo/MONDO_0007330) (congenital pseudoarthrosis of clavicle), [MONDO:0010973](http://purl.obolibrary.org/obo/MONDO_0010973) (autosomal dominant nonsyndromic deafness 5), [MONDO:0010971](http://purl.obolibrary.org/obo/MONDO_0010971) (infundibulopelvic stenosis-multicystic kidney syndrome), [MONDO:0010977](http://purl.obolibrary.org/obo/MONDO_0010977) (Brody myopathy), [MONDO:0019308](http://purl.obolibrary.org/obo/MONDO_0019308) (junctional epidermolysis bullosa inversa), [MONDO:0019309](http://purl.obolibrary.org/obo/MONDO_0019309) (late-onset junctional epidermolysis bullosa), [MONDO:0009970](http://purl.obolibrary.org/obo/MONDO_0009970) (renal tubular dysgenesis of genetic origin), [MONDO:0009971](http://purl.obolibrary.org/obo/MONDO_0009971) (newborn respiratory distress syndrome), [MONDO:0008641](http://purl.obolibrary.org/obo/MONDO_0008641) (retinal vasculopathy and cerebral leukoencephalopathy), [MONDO:0009973](http://purl.obolibrary.org/obo/MONDO_0009973) (reticular dysgenesis), [MONDO:0008642](http://purl.obolibrary.org/obo/MONDO_0008642) (VACTERL/vater association), [MONDO:0009974](http://purl.obolibrary.org/obo/MONDO_0009974) (familial hemophagocytic lymphohistiocytosis type 1), [MONDO:0008644](http://purl.obolibrary.org/obo/MONDO_0008644) (velocardiofacial syndrome), [MONDO:0009975](http://purl.obolibrary.org/obo/MONDO_0009975) (reticulum cell sarcoma), [MONDO:0008645](http://purl.obolibrary.org/obo/MONDO_0008645) (ventricular extrasystoles with syncopal episodes-perodactyly-robin sequence syndrome), [MONDO:0007309](http://purl.obolibrary.org/obo/MONDO_0007309) (Charcot-Marie-tooth disease type 1A), [MONDO:0009977](http://purl.obolibrary.org/obo/MONDO_0009977) (Knobloch syndrome), [MONDO:0008646](http://purl.obolibrary.org/obo/MONDO_0008646) (long QT syndrome 1), [MONDO:0009978](http://purl.obolibrary.org/obo/MONDO_0009978) (retinal degeneration-nanophthalmos-glaucoma syndrome), [MONDO:0007308](http://purl.obolibrary.org/obo/MONDO_0007308) (Charcot-Marie-tooth disease type 2A1), [MONDO:0007307](http://purl.obolibrary.org/obo/MONDO_0007307) (Charcot-Marie-tooth disease type 1B), [MONDO:0008648](http://purl.obolibrary.org/obo/MONDO_0008648) (ventricular tachycardia, familial), [MONDO:0009979](http://purl.obolibrary.org/obo/MONDO_0009979) (reticular dystrophy of the retinal pigment epithelium), [MONDO:0007306](http://purl.obolibrary.org/obo/MONDO_0007306) (Klippel-Feil syndrome 1, autosomal dominant), [MONDO:0010969](http://purl.obolibrary.org/obo/MONDO_0010969) (cone-rod dystrophy 5), [MONDO:0010967](http://purl.obolibrary.org/obo/MONDO_0010967) (autosomal recessive nonsyndromic deafness 7), [MONDO:0010968](http://purl.obolibrary.org/obo/MONDO_0010968) (GLC3B), [MONDO:0007301](http://purl.obolibrary.org/obo/MONDO_0007301) (cerebrocostomandibular syndrome), [MONDO:0007300](http://purl.obolibrary.org/obo/MONDO_0007300) (cerebral sarcoma), [MONDO:0010961](http://purl.obolibrary.org/obo/MONDO_0010961) (obesity due to prohormone convertase i deficiency), [MONDO:0010965](http://purl.obolibrary.org/obo/MONDO_0010965) (autosomal recessive nonsyndromic deafness 6), [MONDO:0010966](http://purl.obolibrary.org/obo/MONDO_0010966) (achondrogenesis type ib), [MONDO:0010963](http://purl.obolibrary.org/obo/MONDO_0010963) (autosomal dominant nonsyndromic deafness 6), [MONDO:0010964](http://purl.obolibrary.org/obo/MONDO_0010964) (epiphyseal dysplasia, multiple, 3), [MONDO:0021605](http://purl.obolibrary.org/obo/MONDO_0021605) (benign eyelid neoplasm), [MONDO:0021607](http://purl.obolibrary.org/obo/MONDO_0021607) (eyelid seborrheic keratosis), [MONDO:0009960](http://purl.obolibrary.org/obo/MONDO_0009960) (inflammatory bowel disease 1), [MONDO:0009962](http://purl.obolibrary.org/obo/MONDO_0009962) (Senior-Loken syndrome 1), [MONDO:0009963](http://purl.obolibrary.org/obo/MONDO_0009963) (Ulbright-Hodes syndrome), [MONDO:0009964](http://purl.obolibrary.org/obo/MONDO_0009964) (short-rib thoracic dysplasia 9 with or without polydactyly), [MONDO:0009965](http://purl.obolibrary.org/obo/MONDO_0009965) (Perlman syndrome), [MONDO:0009966](http://purl.obolibrary.org/obo/MONDO_0009966) (NPHP3-related Meckel-like syndrome), [MONDO:0009967](http://purl.obolibrary.org/obo/MONDO_0009967) (renal tubular acidosis 3), [MONDO:0008636](http://purl.obolibrary.org/obo/MONDO_0008636) (double uterus-hemivagina-renal agenesis syndrome), [MONDO:0007319](http://purl.obolibrary.org/obo/MONDO_0007319) (familial calcium pyrophosphate deposition), [MONDO:0007318](http://purl.obolibrary.org/obo/MONDO_0007318) (Alagille syndrome), [MONDO:0009968](http://purl.obolibrary.org/obo/MONDO_0009968) (renal tubular acidosis, distal, with progressive nerve deafness), [MONDO:0009969](http://purl.obolibrary.org/obo/MONDO_0009969) (renal-genital-middle ear anomalies), [MONDO:0010958](http://purl.obolibrary.org/obo/MONDO_0010958) (cardiac arrhythmia, Ankyrin-b-related), [MONDO:0010959](http://purl.obolibrary.org/obo/MONDO_0010959) (van den Ende-Gupta syndrome), [MONDO:0007316](http://purl.obolibrary.org/obo/MONDO_0007316) (Arnold-Chiari malformation type i), [MONDO:0007315](http://purl.obolibrary.org/obo/MONDO_0007315) (cherubism), [MONDO:0007311](http://purl.obolibrary.org/obo/MONDO_0007311) (Charcot-Marie-tooth disease type 1E), [MONDO:0007310](http://purl.obolibrary.org/obo/MONDO_0007310) (Charcot-Marie-tooth disease, Guadalajara neuronal type), [MONDO:0010950](http://purl.obolibrary.org/obo/MONDO_0010950) (type 1 diabetes mellitus 8), [MONDO:0010954](http://purl.obolibrary.org/obo/MONDO_0010954) (Wiskott-Aldrich syndrome, autosomal dominant form), [MONDO:0010952](http://purl.obolibrary.org/obo/MONDO_0010952) (hereditary hyperferritinemia with congenital cataracts), [MONDO:0010953](http://purl.obolibrary.org/obo/MONDO_0010953) (Fanconi anemia complementation group E), [MONDO:0018028](http://purl.obolibrary.org/obo/MONDO_0018028) (tetrasomy 5p), [MONDO:0018029](http://purl.obolibrary.org/obo/MONDO_0018029) (congenital factor XIII deficiency), [MONDO:0019358](http://purl.obolibrary.org/obo/MONDO_0019358) (encephalopathy due to sulfite oxidase deficiency), [MONDO:0019355](http://purl.obolibrary.org/obo/MONDO_0019355) (adult-onset Still disease), [MONDO:0019353](http://purl.obolibrary.org/obo/MONDO_0019353) (Stargardt disease), [MONDO:0020342](http://purl.obolibrary.org/obo/MONDO_0020342) (congenital myopathy with excess of thin filaments), [MONDO:0018022](http://purl.obolibrary.org/obo/MONDO_0018022) (hemoglobin Lepore-beta-thalassemia syndrome), [MONDO:0019354](http://purl.obolibrary.org/obo/MONDO_0019354) (Stickler syndrome), [MONDO:0018023](http://purl.obolibrary.org/obo/MONDO_0018023) (hemoglobin M disease), [MONDO:0020343](http://purl.obolibrary.org/obo/MONDO_0020343) (alpha-crystallinopathy), [MONDO:0019351](http://purl.obolibrary.org/obo/MONDO_0019351) (isolated spina bifida), [MONDO:0020344](http://purl.obolibrary.org/obo/MONDO_0020344) (postsynaptic congenital myasthenic syndrome), [MONDO:0018021](http://purl.obolibrary.org/obo/MONDO_0018021) (hypotrichosis-deafness syndrome), [MONDO:0020345](http://purl.obolibrary.org/obo/MONDO_0020345) (presynaptic congenital myasthenic syndrome), [MONDO:0020346](http://purl.obolibrary.org/obo/MONDO_0020346) (synaptic congenital myasthenic syndrome), [MONDO:0019350](http://purl.obolibrary.org/obo/MONDO_0019350) (hereditary spherocytosis), [MONDO:0006039](http://purl.obolibrary.org/obo/MONDO_0006039) (infectious colitis), [MONDO:0007369](http://purl.obolibrary.org/obo/MONDO_0007369) (hereditary coproporphyria), [MONDO:0006038](http://purl.obolibrary.org/obo/MONDO_0006038) (indeterminate colitis), [MONDO:0006037](http://purl.obolibrary.org/obo/MONDO_0006037) (hydrolethalus syndrome), [MONDO:0007368](http://purl.obolibrary.org/obo/MONDO_0007368) (familial benign copper deficiency), [MONDO:0006036](http://purl.obolibrary.org/obo/MONDO_0006036) (granulosa cell tumor), [MONDO:0006035](http://purl.obolibrary.org/obo/MONDO_0006035) (gastric tubular adenocarcinoma), [MONDO:0020340](http://purl.obolibrary.org/obo/MONDO_0020340) (bilateral perisylvian polymicrogyria), [MONDO:0020341](http://purl.obolibrary.org/obo/MONDO_0020341) (periventricular nodular heterotopia), [MONDO:0006034](http://purl.obolibrary.org/obo/MONDO_0006034) (gastric adenosquamous carcinoma), [MONDO:0007364](http://purl.obolibrary.org/obo/MONDO_0007364) (arthrogryposis, distal, type 2E), [MONDO:0006033](http://purl.obolibrary.org/obo/MONDO_0006033) (diffuse intrinsic pontine glioma), [MONDO:0007363](http://purl.obolibrary.org/obo/MONDO_0007363) (congenital contractural arachnodactyly), [MONDO:0007362](http://purl.obolibrary.org/obo/MONDO_0007362) (cone-rod dystrophy 2), [MONDO:0007360](http://purl.obolibrary.org/obo/MONDO_0007360) (branchiootic syndrome 2), [MONDO:0018017](http://purl.obolibrary.org/obo/MONDO_0018017) (Goblet cell carcinoma), [MONDO:0019348](http://purl.obolibrary.org/obo/MONDO_0019348) (Ehlers-Danlos syndrome with periventricular heterotopia), [MONDO:0008690](http://purl.obolibrary.org/obo/MONDO_0008690) (xeroderma pigmentosum, autosomal dominant, mild), [MONDO:0019349](http://purl.obolibrary.org/obo/MONDO_0019349) (Sotos syndrome), [MONDO:0018018](http://purl.obolibrary.org/obo/MONDO_0018018) (wild type ATTR amyloidosis), [MONDO:0019346](http://purl.obolibrary.org/obo/MONDO_0019346) (sialidosis type 1), [MONDO:0008692](http://purl.obolibrary.org/obo/MONDO_0008692) (abetalipoproteinemia), [MONDO:0008693](http://purl.obolibrary.org/obo/MONDO_0008693) (ablepharon macrostomia syndrome), [MONDO:0018016](http://purl.obolibrary.org/obo/MONDO_0018016) (classic neuroendocrine tumor of appendix), [MONDO:0008694](http://purl.obolibrary.org/obo/MONDO_0008694) (Pseudoprogeria syndrome), [MONDO:0019344](http://purl.obolibrary.org/obo/MONDO_0019344) (Antisynthetase syndrome), [MONDO:0018014](http://purl.obolibrary.org/obo/MONDO_0018014) (transient neonatal multiple acyl-CoA dehydrogenase deficiency), [MONDO:0008696](http://purl.obolibrary.org/obo/MONDO_0008696) (acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome), [MONDO:0019342](http://purl.obolibrary.org/obo/MONDO_0019342) (Seckel syndrome), [MONDO:0021663](http://purl.obolibrary.org/obo/MONDO_0021663) (sarcomatoid squamous cell carcinoma), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0018011](http://purl.obolibrary.org/obo/MONDO_0018011) (juvenile overlap myositis), [MONDO:0021662](http://purl.obolibrary.org/obo/MONDO_0021662) (bile duct neoplasm), [MONDO:0020332](http://purl.obolibrary.org/obo/MONDO_0020332) (systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease), [MONDO:0020333](http://purl.obolibrary.org/obo/MONDO_0020333) (aggressive systemic mastocytosis), [MONDO:0020334](http://purl.obolibrary.org/obo/MONDO_0020334) (mast cell leukemia), [MONDO:0019341](http://purl.obolibrary.org/obo/MONDO_0019341) (tuberous sclerosis complex), [MONDO:0008699](http://purl.obolibrary.org/obo/MONDO_0008699) (achalasia microcephaly syndrome), [MONDO:0018010](http://purl.obolibrary.org/obo/MONDO_0018010) (juvenile idiopathic inflammatory myopathy), [MONDO:0020336](http://purl.obolibrary.org/obo/MONDO_0020336) (autosomal dominant Emery-Dreifuss muscular dystrophy), [MONDO:0020337](http://purl.obolibrary.org/obo/MONDO_0020337) (congenital dyserythropoietic anemia type i), [MONDO:0020338](http://purl.obolibrary.org/obo/MONDO_0020338) (adult pure red cell aplasia), [MONDO:0006049](http://purl.obolibrary.org/obo/MONDO_0006049) (papillary lung adenocarcinoma), [MONDO:0007379](http://purl.obolibrary.org/obo/MONDO_0007379) (Meesmann corneal dystrophy), [MONDO:0006047](http://purl.obolibrary.org/obo/MONDO_0006047) (pancreatic adenocarcinoma), [MONDO:0007378](http://purl.obolibrary.org/obo/MONDO_0007378) (posterior polymorphous corneal dystrophy 1), [MONDO:0006046](http://purl.obolibrary.org/obo/MONDO_0006046) (ovarian serous cystadenocarcinoma), [MONDO:0007377](http://purl.obolibrary.org/obo/MONDO_0007377) (granular corneal dystrophy type i), [MONDO:0020330](http://purl.obolibrary.org/obo/MONDO_0020330) (classic Hodgkin lymphoma, lymphocyte-depleted type), [MONDO:0007376](http://purl.obolibrary.org/obo/MONDO_0007376) (fleck corneal dystrophy), [MONDO:0006045](http://purl.obolibrary.org/obo/MONDO_0006045) (ovarian clear cell adenocarcinoma), [MONDO:0007375](http://purl.obolibrary.org/obo/MONDO_0007375) (epithelial basement membrane dystrophy), [MONDO:0007374](http://purl.obolibrary.org/obo/MONDO_0007374) (Schnyder corneal dystrophy), [MONDO:0006043](http://purl.obolibrary.org/obo/MONDO_0006043) (metaplastic breast carcinoma), [MONDO:0006041](http://purl.obolibrary.org/obo/MONDO_0006041) (lung carcinoid tumor), [MONDO:0007372](http://purl.obolibrary.org/obo/MONDO_0007372) (CNA1), [MONDO:0006040](http://purl.obolibrary.org/obo/MONDO_0006040) (lactic acidosis), [MONDO:0020328](http://purl.obolibrary.org/obo/MONDO_0020328) (classic Hodgkin lymphoma, mixed cellularity type), [MONDO:0021659](http://purl.obolibrary.org/obo/MONDO_0021659) (combined carcinoid and adenocarcinoma), [MONDO:0020329](http://purl.obolibrary.org/obo/MONDO_0020329) (classic Hodgkin lymphoma, lymphocyte-rich type), [MONDO:0019337](http://purl.obolibrary.org/obo/MONDO_0019337) (autoimmune bullous skin disease), [MONDO:0018006](http://purl.obolibrary.org/obo/MONDO_0018006) (adult-onset distal myopathy due to VCP mutation), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0008680](http://purl.obolibrary.org/obo/MONDO_0008680) (wilms tumor 2), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0018004](http://purl.obolibrary.org/obo/MONDO_0018004) (acute megakaryoblastic leukemia without down syndrome), [MONDO:0019335](http://purl.obolibrary.org/obo/MONDO_0019335) (mild hyperphenylalaninemia), [MONDO:0008682](http://purl.obolibrary.org/obo/MONDO_0008682) (Denys-Drash syndrome), [MONDO:0019336](http://purl.obolibrary.org/obo/MONDO_0019336) (Gardner syndrome), [MONDO:0018005](http://purl.obolibrary.org/obo/MONDO_0018005) (spastic paraplegia-Paget disease of bone syndrome), [MONDO:0018002](http://purl.obolibrary.org/obo/MONDO_0018002) (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), [MONDO:0019333](http://purl.obolibrary.org/obo/MONDO_0019333) (autosomal recessive hyperinsulinism due to SUR1 deficiency), [MONDO:0008683](http://purl.obolibrary.org/obo/MONDO_0008683) (WT3), [MONDO:0008684](http://purl.obolibrary.org/obo/MONDO_0008684) (wolf-Hirschhorn syndrome), [MONDO:0019334](http://purl.obolibrary.org/obo/MONDO_0019334) (autosomal recessive hyperinsulinism due to Kir6.2 deficiency), [MONDO:0018000](http://purl.obolibrary.org/obo/MONDO_0018000) (hereditary thrombocytosis with transverse limb defect), [MONDO:0021652](http://purl.obolibrary.org/obo/MONDO_0021652) (diffuse type adenocarcinoma), [MONDO:0008685](http://purl.obolibrary.org/obo/MONDO_0008685) (Wolff-Parkinson-white syndrome (disease)), [MONDO:0020320](http://purl.obolibrary.org/obo/MONDO_0020320) (acute myeloblastic leukemia with maturation), [MONDO:0018001](http://purl.obolibrary.org/obo/MONDO_0018001) (Inverse Klippel-TrC)naunay syndrome), [MONDO:0021651](http://purl.obolibrary.org/obo/MONDO_0021651) (synpolydactyly), [MONDO:0020321](http://purl.obolibrary.org/obo/MONDO_0020321) (acute undifferentiated leukemia), [MONDO:0020322](http://purl.obolibrary.org/obo/MONDO_0020322) (acute biphenotypic leukemia), [MONDO:0020323](http://purl.obolibrary.org/obo/MONDO_0020323) (primary mediastinal large b-cell lymphoma), [MONDO:0008688](http://purl.obolibrary.org/obo/MONDO_0008688) (WT limb-blood syndrome), [MONDO:0021656](http://purl.obolibrary.org/obo/MONDO_0021656) (nongerminomatous germ cell tumor), [MONDO:0020324](http://purl.obolibrary.org/obo/MONDO_0020324) (intravascular large b-cell lymphoma), [MONDO:0008689](http://purl.obolibrary.org/obo/MONDO_0008689) (Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/Or perinatal edema), [MONDO:0020325](http://purl.obolibrary.org/obo/MONDO_0020325) (anaplastic large cell lymphoma), [MONDO:0020326](http://purl.obolibrary.org/obo/MONDO_0020326) (lymphomatoid papulosis), [MONDO:0021657](http://purl.obolibrary.org/obo/MONDO_0021657) (ovarian sex cord-stromal tumor), [MONDO:0020327](http://purl.obolibrary.org/obo/MONDO_0020327) (classic Hodgkin lymphoma, nodular sclerosis type), [MONDO:0006015](http://purl.obolibrary.org/obo/MONDO_0006015) (Waterhouse-Friderichsen syndrome), [MONDO:0007346](http://purl.obolibrary.org/obo/MONDO_0007346) (cochleosaccular degeneration-cataract syndrome), [MONDO:0021650](http://purl.obolibrary.org/obo/MONDO_0021650) (uterine corpus neuroendocrine neoplasm), [MONDO:0007343](http://purl.obolibrary.org/obo/MONDO_0007343) (isolated congenital digital clubbing), [MONDO:0007342](http://purl.obolibrary.org/obo/MONDO_0007342) (clubfoot), [MONDO:0007341](http://purl.obolibrary.org/obo/MONDO_0007341) (cleidorhizomelic syndrome), [MONDO:0007340](http://purl.obolibrary.org/obo/MONDO_0007340) (cleidocranial dysplasia), [MONDO:0020317](http://purl.obolibrary.org/obo/MONDO_0020317) (acute myeloid leukemia with 11q23 abnormalities), [MONDO:0020318](http://purl.obolibrary.org/obo/MONDO_0020318) (acute myeloid leukemia with minimal differentiation), [MONDO:0019326](http://purl.obolibrary.org/obo/MONDO_0019326) (phakomatosis cesiomarmorata), [MONDO:0019327](http://purl.obolibrary.org/obo/MONDO_0019327) (phakomatosis spilorosea), [MONDO:0008670](http://purl.obolibrary.org/obo/MONDO_0008670) (Waardenburg syndrome type 1), [MONDO:0019324](http://purl.obolibrary.org/obo/MONDO_0019324) (pemphigus foliaceus), [MONDO:0008671](http://purl.obolibrary.org/obo/MONDO_0008671) (Waardenburg syndrome type 2A), [MONDO:0019325](http://purl.obolibrary.org/obo/MONDO_0019325) (phakomatosis cesioflammea), [MONDO:0008672](http://purl.obolibrary.org/obo/MONDO_0008672) (Watson syndrome), [MONDO:0019322](http://purl.obolibrary.org/obo/MONDO_0019322) (pemphigus vegetans), [MONDO:0008673](http://purl.obolibrary.org/obo/MONDO_0008673) (acrofacial dysostosis, Weyers type), [MONDO:0019323](http://purl.obolibrary.org/obo/MONDO_0019323) (pemphigus erythematosus), [MONDO:0019320](http://purl.obolibrary.org/obo/MONDO_0019320) (acanthokeratolytic verrucous nevus), [MONDO:0008675](http://purl.obolibrary.org/obo/MONDO_0008675) (Freeman-Sheldon syndrome), [MONDO:0021640](http://purl.obolibrary.org/obo/MONDO_0021640) (grade III glioma), [MONDO:0019321](http://purl.obolibrary.org/obo/MONDO_0019321) (atypical Werner syndrome), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0008676](http://purl.obolibrary.org/obo/MONDO_0008676) (white sponge nevus 1), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0008678](http://purl.obolibrary.org/obo/MONDO_0008678) (Williams syndrome), [MONDO:0020313](http://purl.obolibrary.org/obo/MONDO_0020313) (unclassified myelodysplastic/myeloproliferative disease), [MONDO:0008679](http://purl.obolibrary.org/obo/MONDO_0008679) (Wilms tumor type 1), [MONDO:0020315](http://purl.obolibrary.org/obo/MONDO_0020315) (unclassified myelodysplastic syndrome), [MONDO:0020316](http://purl.obolibrary.org/obo/MONDO_0020316) (acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)), [MONDO:0006029](http://purl.obolibrary.org/obo/MONDO_0006029) (cecum carcinoma), [MONDO:0006028](http://purl.obolibrary.org/obo/MONDO_0006028) (cecum adenocarcinoma), [MONDO:0006027](http://purl.obolibrary.org/obo/MONDO_0006027) (breast synovial sarcoma), [MONDO:0007356](http://purl.obolibrary.org/obo/MONDO_0007356) (Lynch syndrome 1), [MONDO:0007355](http://purl.obolibrary.org/obo/MONDO_0007355) (uveal coloboma-cleft lip and palate-intellectual disability), [MONDO:0006024](http://purl.obolibrary.org/obo/MONDO_0006024) (anaplastic lung carcinoma), [MONDO:0007354](http://purl.obolibrary.org/obo/MONDO_0007354) (coloboma of optic nerve (disease)), [MONDO:0006023](http://purl.obolibrary.org/obo/MONDO_0006023) (aldosterone-producing adenoma), [MONDO:0010994](http://purl.obolibrary.org/obo/MONDO_0010994) (micromelic dwarfism, Fryns type), [MONDO:0007353](http://purl.obolibrary.org/obo/MONDO_0007353) (coloboma of macula-brachydactyly type B syndrome), [MONDO:0007352](http://purl.obolibrary.org/obo/MONDO_0007352) (renal coloboma syndrome), [MONDO:0010995](http://purl.obolibrary.org/obo/MONDO_0010995) (Charcot-Marie-tooth disease type 1C), [MONDO:0010992](http://purl.obolibrary.org/obo/MONDO_0010992) (AymC)-Gripp syndrome), [MONDO:0007351](http://purl.obolibrary.org/obo/MONDO_0007351) (coloboma of macula), [MONDO:0006020](http://purl.obolibrary.org/obo/MONDO_0006020) (Zollinger-Ellison syndrome (disease)), [MONDO:0007350](http://purl.obolibrary.org/obo/MONDO_0007350) (coloboma, ocular, autosomal dominant), [MONDO:0010993](http://purl.obolibrary.org/obo/MONDO_0010993) (Harrod syndrome), [MONDO:0010998](http://purl.obolibrary.org/obo/MONDO_0010998) (ALG3-CDG), [MONDO:0010999](http://purl.obolibrary.org/obo/MONDO_0010999) (fallot complex-intellectual disability-growth delay syndrome), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0010997](http://purl.obolibrary.org/obo/MONDO_0010997) (classic progressive supranuclear palsy syndrome), [MONDO:0018068](http://purl.obolibrary.org/obo/MONDO_0018068) (trisomy 13), [MONDO:0019399](http://purl.obolibrary.org/obo/MONDO_0019399) (Isaac syndrome), [MONDO:0020386](http://purl.obolibrary.org/obo/MONDO_0020386) (double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis), [MONDO:0018067](http://purl.obolibrary.org/obo/MONDO_0018067) (Triploidy), [MONDO:0020387](http://purl.obolibrary.org/obo/MONDO_0020387) (double outlet right ventricle with subpulmonary ventricular septal defect), [MONDO:0019398](http://purl.obolibrary.org/obo/MONDO_0019398) (desmin-related myopathy with Mallory body-like inclusions), [MONDO:0018064](http://purl.obolibrary.org/obo/MONDO_0018064) (trigonocephaly-broad thumbs syndrome), [MONDO:0020388](http://purl.obolibrary.org/obo/MONDO_0020388) (double outlet right ventricle with non-committed subpulmonary ventricular septal defect), [MONDO:0018065](http://purl.obolibrary.org/obo/MONDO_0018065) (isolated trigonocephaly), [MONDO:0019393](http://purl.obolibrary.org/obo/MONDO_0019393) (idiopathic malabsorption due to bile acid synthesis defects), [MONDO:0018062](http://purl.obolibrary.org/obo/MONDO_0018062) (autosomal dominant trichoodontoonychodysplasia-syndactyly), [MONDO:0019391](http://purl.obolibrary.org/obo/MONDO_0019391) (Fanconi anemia), [MONDO:0018060](http://purl.obolibrary.org/obo/MONDO_0018060) (congenital fibrinogen deficiency), [MONDO:0019392](http://purl.obolibrary.org/obo/MONDO_0019392) (syringocystadenoma papilliferum), [MONDO:0018061](http://purl.obolibrary.org/obo/MONDO_0018061) (Trichodermodysplasia-dental alterations syndrome), [MONDO:0018070](http://purl.obolibrary.org/obo/MONDO_0018070) (familial multiple fibrofolliculoma), [MONDO:0020380](http://purl.obolibrary.org/obo/MONDO_0020380) (autosomal dominant cerebellar ataxia), [MONDO:0020381](http://purl.obolibrary.org/obo/MONDO_0020381) (patterned macular dystrophy), [MONDO:0020382](http://purl.obolibrary.org/obo/MONDO_0020382) (multifocal pattern dystrophy simulating fundus flavimaculatus), [MONDO:0020383](http://purl.obolibrary.org/obo/MONDO_0020383) (fundus pulverulentus), [MONDO:0006079](http://purl.obolibrary.org/obo/MONDO_0006079) (ameloblastic carcinoma), [MONDO:0020384](http://purl.obolibrary.org/obo/MONDO_0020384) (Niemann-Pick disease type E), [MONDO:0006078](http://purl.obolibrary.org/obo/MONDO_0006078) (AIDS-related primary central nervous system lymphoma), [MONDO:0020385](http://purl.obolibrary.org/obo/MONDO_0020385) (congenitally uncorrected transposition of the great arteries with coarctation), [MONDO:0006076](http://purl.obolibrary.org/obo/MONDO_0006076) (adrenal gland neuroblastoma), [MONDO:0006075](http://purl.obolibrary.org/obo/MONDO_0006075) (adrenal gland myelolipoma), [MONDO:0006074](http://purl.obolibrary.org/obo/MONDO_0006074) (adenosquamous carcinoma), [MONDO:0006073](http://purl.obolibrary.org/obo/MONDO_0006073) (adenomatoid odontogenic tumor), [MONDO:0006071](http://purl.obolibrary.org/obo/MONDO_0006071) (adenofibroma), [MONDO:0006091](http://purl.obolibrary.org/obo/MONDO_0006091) (appendix neuroendocrine tumor G1), [MONDO:0006090](http://purl.obolibrary.org/obo/MONDO_0006090) (appendix hyperplastic polyp), [MONDO:0019388](http://purl.obolibrary.org/obo/MONDO_0019388) (pelvis syndrome), [MONDO:0018058](http://purl.obolibrary.org/obo/MONDO_0018058) (tracheal agenesis), [MONDO:0020375](http://purl.obolibrary.org/obo/MONDO_0020375) (coralliform cataract), [MONDO:0018055](http://purl.obolibrary.org/obo/MONDO_0018055) (pediatric hepatocellular carcinoma), [MONDO:0019387](http://purl.obolibrary.org/obo/MONDO_0019387) (macrostomia-preauricular tags-external ophthalmoplegia syndrome), [MONDO:0020376](http://purl.obolibrary.org/obo/MONDO_0020376) (early-onset nuclear cataract), [MONDO:0018053](http://purl.obolibrary.org/obo/MONDO_0018053) (trichothiodystrophy), [MONDO:0020377](http://purl.obolibrary.org/obo/MONDO_0020377) (early-onset partial cataract), [MONDO:0018054](http://purl.obolibrary.org/obo/MONDO_0018054) (familial atrial fibrillation), [MONDO:0020378](http://purl.obolibrary.org/obo/MONDO_0020378) (early-onset posterior polar cataract), [MONDO:0020379](http://purl.obolibrary.org/obo/MONDO_0020379) (early-onset zonular cataract), [MONDO:0018052](http://purl.obolibrary.org/obo/MONDO_0018052) (hypoplastic tibiae-postaxial polydactyly syndrome), [MONDO:0018050](http://purl.obolibrary.org/obo/MONDO_0018050) (tibial aplasia-ectrodactyly syndrome), [MONDO:0019390](http://purl.obolibrary.org/obo/MONDO_0019390) (Susac syndrome), [MONDO:0020370](http://purl.obolibrary.org/obo/MONDO_0020370) (Cogan-Reese syndrome), [MONDO:0020371](http://purl.obolibrary.org/obo/MONDO_0020371) (essential iris atrophy), [MONDO:0020372](http://purl.obolibrary.org/obo/MONDO_0020372) (early-onset sutural cataract), [MONDO:0020373](http://purl.obolibrary.org/obo/MONDO_0020373) (early-onset anterior polar cataract), [MONDO:0020374](http://purl.obolibrary.org/obo/MONDO_0020374) (cerulean cataract), [MONDO:0006089](http://purl.obolibrary.org/obo/MONDO_0006089) (appendix goblet cell carcinoid), [MONDO:0006088](http://purl.obolibrary.org/obo/MONDO_0006088) (appendix adenoma), [MONDO:0006087](http://purl.obolibrary.org/obo/MONDO_0006087) (appendix adenocarcinoma), [MONDO:0006086](http://purl.obolibrary.org/obo/MONDO_0006086) (angiomyxoma), [MONDO:0006085](http://purl.obolibrary.org/obo/MONDO_0006085) (angiolipoma), [MONDO:0006082](http://purl.obolibrary.org/obo/MONDO_0006082) (anal squamous cell carcinoma), [MONDO:0006081](http://purl.obolibrary.org/obo/MONDO_0006081) (anal melanoma), [MONDO:0018048](http://purl.obolibrary.org/obo/MONDO_0018048) (Heparin-induced thrombocytopenia (disease)), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0018046](http://purl.obolibrary.org/obo/MONDO_0018046) (thrombocytopenia-robin sequence syndrome), [MONDO:0018047](http://purl.obolibrary.org/obo/MONDO_0018047) (familial thrombomodulin anomalies), [MONDO:0019375](http://purl.obolibrary.org/obo/MONDO_0019375) (megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome), [MONDO:0020364](http://purl.obolibrary.org/obo/MONDO_0020364) (posterior polymorphous corneal dystrophy), [MONDO:0018044](http://purl.obolibrary.org/obo/MONDO_0018044) (idiopathic hypersomnia), [MONDO:0020365](http://purl.obolibrary.org/obo/MONDO_0020365) (congenital hereditary endothelial dystrophy type i), [MONDO:0018045](http://purl.obolibrary.org/obo/MONDO_0018045) (Hoyeraal-Hreidarsson syndrome), [MONDO:0019373](http://purl.obolibrary.org/obo/MONDO_0019373) (desmoplastic small round cell tumor), [MONDO:0020366](http://purl.obolibrary.org/obo/MONDO_0020366) (congenital glaucoma), [MONDO:0018042](http://purl.obolibrary.org/obo/MONDO_0018042) (immunodeficiency syndrome with hypopigmentation), [MONDO:0018043](http://purl.obolibrary.org/obo/MONDO_0018043) (Thomas syndrome), [MONDO:0020367](http://purl.obolibrary.org/obo/MONDO_0020367) (juvenile glaucoma), [MONDO:0019374](http://purl.obolibrary.org/obo/MONDO_0019374) (CAMOS syndrome), [MONDO:0020368](http://purl.obolibrary.org/obo/MONDO_0020368) (Axenfeld anomaly), [MONDO:0019371](http://purl.obolibrary.org/obo/MONDO_0019371) (narcolepsy without cataplexy), [MONDO:0018040](http://purl.obolibrary.org/obo/MONDO_0018040) (immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of b-cells), [MONDO:0020369](http://purl.obolibrary.org/obo/MONDO_0020369) (Chandler syndrome), [MONDO:0019372](http://purl.obolibrary.org/obo/MONDO_0019372) (solitary bone cyst), [MONDO:0018041](http://purl.obolibrary.org/obo/MONDO_0018041) (other immunodeficiency syndrome with predominantly antibody defects), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0020360](http://purl.obolibrary.org/obo/MONDO_0020360) (complete cryptophthalmia), [MONDO:0006058](http://purl.obolibrary.org/obo/MONDO_0006058) (Wilms tumor), [MONDO:0020361](http://purl.obolibrary.org/obo/MONDO_0020361) (partial cryptophthalmia), [MONDO:0007389](http://purl.obolibrary.org/obo/MONDO_0007389) (spondylocostal dysostosis 5), [MONDO:0020362](http://purl.obolibrary.org/obo/MONDO_0020362) (Inverse Marcus-Gunn phenomenon), [MONDO:0006056](http://purl.obolibrary.org/obo/MONDO_0006056) (squamous cell breast carcinoma), [MONDO:0020363](http://purl.obolibrary.org/obo/MONDO_0020363) (Honey-droplet corneal dystrophy), [MONDO:0007387](http://purl.obolibrary.org/obo/MONDO_0007387) (Cornelia de Lange syndrome 1), [MONDO:0006055](http://purl.obolibrary.org/obo/MONDO_0006055) (sex cord-stromal tumor), [MONDO:0006054](http://purl.obolibrary.org/obo/MONDO_0006054) (reproductive system neoplasm), [MONDO:0007384](http://purl.obolibrary.org/obo/MONDO_0007384) (congenital trigeminal anesthesia), [MONDO:0006053](http://purl.obolibrary.org/obo/MONDO_0006053) (renal leiomyoma), [MONDO:0007383](http://purl.obolibrary.org/obo/MONDO_0007383) (Stern-Lubinsky-Durrie syndrome), [MONDO:0007382](http://purl.obolibrary.org/obo/MONDO_0007382) (Ramos-Arroyo syndrome), [MONDO:0007381](http://purl.obolibrary.org/obo/MONDO_0007381) (epithelial recurrent erosion dystrophy), [MONDO:0006050](http://purl.obolibrary.org/obo/MONDO_0006050) (pleomorphic breast carcinoma), [MONDO:0007380](http://purl.obolibrary.org/obo/MONDO_0007380) (lattice corneal dystrophy type i), [MONDO:0018039](http://purl.obolibrary.org/obo/MONDO_0018039) (selective IgM deficiency), [MONDO:0018037](http://purl.obolibrary.org/obo/MONDO_0018037) (hyper-IgE syndrome), [MONDO:0018038](http://purl.obolibrary.org/obo/MONDO_0018038) (immunodeficiency with isotype or light chain deficiencies with normal number of b-cells), [MONDO:0019366](http://purl.obolibrary.org/obo/MONDO_0019366) (Free sialic acid storage disease), [MONDO:0018035](http://purl.obolibrary.org/obo/MONDO_0018035) (syndrome with combined immunodeficiency), [MONDO:0018036](http://purl.obolibrary.org/obo/MONDO_0018036) (immunodeficiency due to absence of thymus), [MONDO:0020353](http://purl.obolibrary.org/obo/MONDO_0020353) (von Hippel anomaly), [MONDO:0018034](http://purl.obolibrary.org/obo/MONDO_0018034) (thalidomide embryopathy), [MONDO:0020354](http://purl.obolibrary.org/obo/MONDO_0020354) (coloboma of choroid and retina), [MONDO:0018031](http://purl.obolibrary.org/obo/MONDO_0018031) (granulomatous slack skin), [MONDO:0020355](http://purl.obolibrary.org/obo/MONDO_0020355) (coloboma of eye lens), [MONDO:0020356](http://purl.obolibrary.org/obo/MONDO_0020356) (coloboma of iris (disease)), [MONDO:0020357](http://purl.obolibrary.org/obo/MONDO_0020357) (coloboma of eyelid), [MONDO:0020358](http://purl.obolibrary.org/obo/MONDO_0020358) (coloboma of optic disc), [MONDO:0020359](http://purl.obolibrary.org/obo/MONDO_0020359) (congenital symblepharon), [MONDO:0006069](http://purl.obolibrary.org/obo/MONDO_0006069) (ACTH-producing pituitary gland carcinoma), [MONDO:0007399](http://purl.obolibrary.org/obo/MONDO_0007399) (craniosynostosis 1), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0006067](http://purl.obolibrary.org/obo/MONDO_0006067) (acinar prostate mucinous adenocarcinoma), [MONDO:0007397](http://purl.obolibrary.org/obo/MONDO_0007397) (craniometaphyseal dysplasia, autosomal dominant), [MONDO:0006066](http://purl.obolibrary.org/obo/MONDO_0006066) (acinar prostate adenocarcinoma, foamy gland variant), [MONDO:0007396](http://purl.obolibrary.org/obo/MONDO_0007396) (dysostosis, Stanescu type), [MONDO:0006065](http://purl.obolibrary.org/obo/MONDO_0006065) (lactose intolerance adult type), [MONDO:0007395](http://purl.obolibrary.org/obo/MONDO_0007395) (craniofacial-deafness-hand syndrome), [MONDO:0006062](http://purl.obolibrary.org/obo/MONDO_0006062) (intestinal disaccharide deficiency and disaccharide malabsorption), [MONDO:0007392](http://purl.obolibrary.org/obo/MONDO_0007392) (Coxoauricular syndrome), [MONDO:0006060](http://purl.obolibrary.org/obo/MONDO_0006060) (nasopharyngeal squamous cell carcinoma), [MONDO:0018098](http://purl.obolibrary.org/obo/MONDO_0018098) (autosomal dominant limb-girdle muscular dystrophy type 1E (DES)), [MONDO:0018095](http://purl.obolibrary.org/obo/MONDO_0018095) (Weaver-Williams syndrome), [MONDO:0018096](http://purl.obolibrary.org/obo/MONDO_0018096) (Weill-Marchesani syndrome), [MONDO:0018094](http://purl.obolibrary.org/obo/MONDO_0018094) (Waardenburg's syndrome), [MONDO:0018088](http://purl.obolibrary.org/obo/MONDO_0018088) (familial Mediterranean fever), [MONDO:0018089](http://purl.obolibrary.org/obo/MONDO_0018089) (double outlet right ventricle), [MONDO:0018085](http://purl.obolibrary.org/obo/MONDO_0018085) (umbilical cord ulceration-intestinal atresia syndrome), [MONDO:0018083](http://purl.obolibrary.org/obo/MONDO_0018083) (transient tyrosinemia of the newborn), [MONDO:0018091](http://purl.obolibrary.org/obo/MONDO_0018091) (microcephaly-brachydactyly-kyphoscoliosis syndrome), [MONDO:0018092](http://purl.obolibrary.org/obo/MONDO_0018092) (Vogt-Koyanagi-Harada disease), [MONDO:0006098](http://purl.obolibrary.org/obo/MONDO_0006098) (atypical lobular breast hyperplasia), [MONDO:0006097](http://purl.obolibrary.org/obo/MONDO_0006097) (atypical lipomatous tumor), [MONDO:0006095](http://purl.obolibrary.org/obo/MONDO_0006095) (atypical carcinoid tumor), [MONDO:0006094](http://purl.obolibrary.org/obo/MONDO_0006094) (Askin tumor), [MONDO:0006093](http://purl.obolibrary.org/obo/MONDO_0006093) (ascending colon neuroendocrine tumor G1), [MONDO:0006092](http://purl.obolibrary.org/obo/MONDO_0006092) (appendix villous adenoma), [MONDO:0018079](http://purl.obolibrary.org/obo/MONDO_0018079) (thymic epithelial neoplasm), [MONDO:0018078](http://purl.obolibrary.org/obo/MONDO_0018078) (soft tissue sarcoma), [MONDO:0018075](http://purl.obolibrary.org/obo/MONDO_0018075) (neural tube defect), [MONDO:0018071](http://purl.obolibrary.org/obo/MONDO_0018071) (trisomy 18), [MONDO:0018080](http://purl.obolibrary.org/obo/MONDO_0018080) (rare germ cell tumor), [MONDO:0008700](http://purl.obolibrary.org/obo/MONDO_0008700) (acheiropody), [MONDO:0008701](http://purl.obolibrary.org/obo/MONDO_0008701) (achondrogenesis type IA), [MONDO:0008702](http://purl.obolibrary.org/obo/MONDO_0008702) (achondrogenesis type II), [MONDO:0008703](http://purl.obolibrary.org/obo/MONDO_0008703) (acromesomelic dysplasia, Grebe type), [MONDO:0008704](http://purl.obolibrary.org/obo/MONDO_0008704) (short-limb skeletal dysplasia with severe combined immunodeficiency), [MONDO:0008705](http://purl.obolibrary.org/obo/MONDO_0008705) (acid phosphatase deficiency), [MONDO:0008706](http://purl.obolibrary.org/obo/MONDO_0008706) (Ackerman syndrome), [MONDO:0008707](http://purl.obolibrary.org/obo/MONDO_0008707) (Acro-renal-mandibular syndrome), [MONDO:0008708](http://purl.obolibrary.org/obo/MONDO_0008708) (acrocallosal syndrome), [MONDO:0008709](http://purl.obolibrary.org/obo/MONDO_0008709) (Acrocephalopolydactyly), [MONDO:0008740](http://purl.obolibrary.org/obo/MONDO_0008740) (agnathia-otocephaly complex), [MONDO:0008741](http://purl.obolibrary.org/obo/MONDO_0008741) (PAGOD syndrome), [MONDO:0008743](http://purl.obolibrary.org/obo/MONDO_0008743) (Stimmler syndrome), [MONDO:0008744](http://purl.obolibrary.org/obo/MONDO_0008744) (alar cartilages hypoplasia-coloboma-telecanthus syndrome), [MONDO:0007409](http://purl.obolibrary.org/obo/MONDO_0007409) (Cryptomicrotia-brachydactyly-excess fingertip arch syndrome), [MONDO:0008745](http://purl.obolibrary.org/obo/MONDO_0008745) (oculocutaneous albinism type 1A), [MONDO:0008746](http://purl.obolibrary.org/obo/MONDO_0008746) (oculocutaneous albinism type 2), [MONDO:0008747](http://purl.obolibrary.org/obo/MONDO_0008747) (oculocutaneous albinism type 3), [MONDO:0007405](http://purl.obolibrary.org/obo/MONDO_0007405) (Crouzon syndrome), [MONDO:0008748](http://purl.obolibrary.org/obo/MONDO_0008748) (Hermansky-Pudlak syndrome 1), [MONDO:0007404](http://purl.obolibrary.org/obo/MONDO_0007404) (Cri-du-chat syndrome), [MONDO:0008749](http://purl.obolibrary.org/obo/MONDO_0008749) (pseudohypoparathyroidism type 2), [MONDO:0007401](http://purl.obolibrary.org/obo/MONDO_0007401) (craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome), [MONDO:0007400](http://purl.obolibrary.org/obo/MONDO_0007400) (Jackson-Weiss syndrome), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0008731](http://purl.obolibrary.org/obo/MONDO_0008731) (familial adrenal hypoplasia with absent pituitary luteinizing hormone), [MONDO:0008732](http://purl.obolibrary.org/obo/MONDO_0008732) (adrenal hypoplasia, Cytomegalic type), [MONDO:0008733](http://purl.obolibrary.org/obo/MONDO_0008733) (familial glucocorticoid deficiency), [MONDO:0008734](http://purl.obolibrary.org/obo/MONDO_0008734) (adrenocortical carcinoma, hereditary), [MONDO:0008735](http://purl.obolibrary.org/obo/MONDO_0008735) (adrenocortical Unresponsiveness to Acth with postreceptor defect), [MONDO:0008736](http://purl.obolibrary.org/obo/MONDO_0008736) (peroxisome biogenesis disorder 2B), [MONDO:0008737](http://purl.obolibrary.org/obo/MONDO_0008737) (congenital afibrinogenemia), [MONDO:0007415](http://purl.obolibrary.org/obo/MONDO_0007415) (mitochondrial complex III deficiency nuclear type 1), [MONDO:0008738](http://purl.obolibrary.org/obo/MONDO_0008738) (aganglionosis, total intestinal), [MONDO:0007413](http://purl.obolibrary.org/obo/MONDO_0007413) (Cyprus facial-neuromusculoskeletal syndrome), [MONDO:0007412](http://purl.obolibrary.org/obo/MONDO_0007412) (Beare-Stevenson cutis gyrata syndrome), [MONDO:0007411](http://purl.obolibrary.org/obo/MONDO_0007411) (cutis laxa, autosomal dominant 1), [MONDO:0007410](http://purl.obolibrary.org/obo/MONDO_0007410) (isolated cryptophthalmia), [MONDO:0008721](http://purl.obolibrary.org/obo/MONDO_0008721) (medium chain acyl-CoA dehydrogenase deficiency), [MONDO:0008722](http://purl.obolibrary.org/obo/MONDO_0008722) (short chain acyl-CoA dehydrogenase deficiency), [MONDO:0008723](http://purl.obolibrary.org/obo/MONDO_0008723) (very long chain acyl-CoA dehydrogenase deficiency), [MONDO:0008724](http://purl.obolibrary.org/obo/MONDO_0008724) (Adducted thumbs-arthrogryposis syndrome, Christian type), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0008726](http://purl.obolibrary.org/obo/MONDO_0008726) (Antley-Bixler syndrome with genital anomalies and Disordered steroidogenesis), [MONDO:0008727](http://purl.obolibrary.org/obo/MONDO_0008727) (congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0008729](http://purl.obolibrary.org/obo/MONDO_0008729) (congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency), [MONDO:0008710](http://purl.obolibrary.org/obo/MONDO_0008710) (Carpenter syndrome 1), [MONDO:0008711](http://purl.obolibrary.org/obo/MONDO_0008711) (Goodman syndrome), [MONDO:0008712](http://purl.obolibrary.org/obo/MONDO_0008712) (Acrocraniofacial dysostosis), [MONDO:0008713](http://purl.obolibrary.org/obo/MONDO_0008713) (acrodermatitis enteropathica), [MONDO:0008714](http://purl.obolibrary.org/obo/MONDO_0008714) (acrofacial dysostosis Rodriguez type), [MONDO:0008715](http://purl.obolibrary.org/obo/MONDO_0008715) (acrofrontofacionasal dysostosis), [MONDO:0008716](http://purl.obolibrary.org/obo/MONDO_0008716) (Acrogeria), [MONDO:0008717](http://purl.obolibrary.org/obo/MONDO_0008717) (acromesomelic dysplasia, Hunter-Thompson type), [MONDO:0008718](http://purl.obolibrary.org/obo/MONDO_0008718) (Morvan syndrome), [MONDO:0008719](http://purl.obolibrary.org/obo/MONDO_0008719) (acrorenal syndrome, autosomal recessive), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0001705](http://purl.obolibrary.org/obo/MONDO_0001705) (pure red-cell aplasia), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0001702](http://purl.obolibrary.org/obo/MONDO_0001702) (labia majora carcinoma), [MONDO:0001704](http://purl.obolibrary.org/obo/MONDO_0001704) (vaginal glandular neoplasm), [MONDO:0001703](http://purl.obolibrary.org/obo/MONDO_0001703) (color vision disorder), [MONDO:0001700](http://purl.obolibrary.org/obo/MONDO_0001700) (megaloblastic anemia (disease)), [MONDO:0001717](http://purl.obolibrary.org/obo/MONDO_0001717) (posterior corneal pigmentation), [MONDO:0001716](http://purl.obolibrary.org/obo/MONDO_0001716) (corneal argyrosis), [MONDO:0001718](http://purl.obolibrary.org/obo/MONDO_0001718) (scleritis (disease)), [MONDO:0001713](http://purl.obolibrary.org/obo/MONDO_0001713) (congenital hypoplastic anemia), [MONDO:0001749](http://purl.obolibrary.org/obo/MONDO_0001749) (cortical senile cataract), [MONDO:0001746](http://purl.obolibrary.org/obo/MONDO_0001746) (optic disk drusen), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0001748](http://purl.obolibrary.org/obo/MONDO_0001748) (maxillary sinus cancer), [MONDO:0001742](http://purl.obolibrary.org/obo/MONDO_0001742) (interval angle-closure glaucoma), [MONDO:0001744](http://purl.obolibrary.org/obo/MONDO_0001744) (angle-closure glaucoma), [MONDO:0001743](http://purl.obolibrary.org/obo/MONDO_0001743) (paranasal sinus lymphoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0012409](http://purl.obolibrary.org/obo/MONDO_0012409) (isolated microphthalmia 2), [MONDO:0012408](http://purl.obolibrary.org/obo/MONDO_0012408) (microphthalmia, isolated, with coloboma 3), [MONDO:0013739](http://purl.obolibrary.org/obo/MONDO_0013739) (Chilblain lupus 2), [MONDO:0013735](http://purl.obolibrary.org/obo/MONDO_0013735) (microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome), [MONDO:0012403](http://purl.obolibrary.org/obo/MONDO_0012403) (SLEB7), [MONDO:0013736](http://purl.obolibrary.org/obo/MONDO_0013736) (myopathy, centronuclear, 3), [MONDO:0012401](http://purl.obolibrary.org/obo/MONDO_0012401) (congenital stromal corneal dystrophy), [MONDO:0013738](http://purl.obolibrary.org/obo/MONDO_0013738) (autosomal recessive nonsyndromic deafness 96), [MONDO:0012407](http://purl.obolibrary.org/obo/MONDO_0012407) (Pyridoxal phosphate-responsive seizures), [MONDO:0013731](http://purl.obolibrary.org/obo/MONDO_0013731) (early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome), [MONDO:0012406](http://purl.obolibrary.org/obo/MONDO_0012406) (HRPT3), [MONDO:0012405](http://purl.obolibrary.org/obo/MONDO_0012405) (polyposis syndrome, hereditary mixed, 2), [MONDO:0013734](http://purl.obolibrary.org/obo/MONDO_0013734) (microphthalmia, syndromic 11), [MONDO:0012404](http://purl.obolibrary.org/obo/MONDO_0012404) (SLEB8), [MONDO:0001757](http://purl.obolibrary.org/obo/MONDO_0001757) (frontal sinus neoplasm), [MONDO:0001756](http://purl.obolibrary.org/obo/MONDO_0001756) (frontal sinus cancer), [MONDO:0001758](http://purl.obolibrary.org/obo/MONDO_0001758) (paranasal sinus sarcoma), [MONDO:0000421](http://purl.obolibrary.org/obo/MONDO_0000421) (inborn serine deficiency), [MONDO:0000422](http://purl.obolibrary.org/obo/MONDO_0000422) (inborn glycogen metabolism disorder), [MONDO:0000424](http://purl.obolibrary.org/obo/MONDO_0000424) (inborn vitamin B12 deficiency (disease)), [MONDO:0000420](http://purl.obolibrary.org/obo/MONDO_0000420) (cerebral folate receptor alpha deficiency), [MONDO:0013728](http://purl.obolibrary.org/obo/MONDO_0013728) (pregnancy loss, recurrent, susceptibility to, 2), [MONDO:0013729](http://purl.obolibrary.org/obo/MONDO_0013729) (pregnancy loss, recurrent, susceptibility to, 3), [MONDO:0013725](http://purl.obolibrary.org/obo/MONDO_0013725) (colorectal cancer, hereditary nonpolyposis, type 7), [MONDO:0013726](http://purl.obolibrary.org/obo/MONDO_0013726) (lethal encephalopathy due to mitochondrial and peroxisomal fission defect), [MONDO:0013727](http://purl.obolibrary.org/obo/MONDO_0013727) (pregnancy loss, recurrent, susceptibility to, 1), [MONDO:0013722](http://purl.obolibrary.org/obo/MONDO_0013722) (hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism), [MONDO:0001724](http://purl.obolibrary.org/obo/MONDO_0001724) (supraglottis cancer), [MONDO:0001723](http://purl.obolibrary.org/obo/MONDO_0001723) (progressive peripheral pterygium), [MONDO:0001722](http://purl.obolibrary.org/obo/MONDO_0001722) (central pterygium), [MONDO:0013717](http://purl.obolibrary.org/obo/MONDO_0013717) (asphyxiating thoracic dystrophy 5), [MONDO:0013719](http://purl.obolibrary.org/obo/MONDO_0013719) (cranioectodermal dysplasia 4), [MONDO:0013715](http://purl.obolibrary.org/obo/MONDO_0013715) (amyotrophic lateral sclerosis type 16), [MONDO:0013710](http://purl.obolibrary.org/obo/MONDO_0013710) (colorectal cancer, hereditary nonpolyposis, type 5), [MONDO:0013711](http://purl.obolibrary.org/obo/MONDO_0013711) (peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome), [MONDO:0013712](http://purl.obolibrary.org/obo/MONDO_0013712) (surfactant metabolism dysfunction, pulmonary, 5), [MONDO:0000407](http://purl.obolibrary.org/obo/MONDO_0000407) (malignant pleural solitary fibrous tumor), [MONDO:0000405](http://purl.obolibrary.org/obo/MONDO_0000405) (anal canal cancer), [MONDO:0001731](http://purl.obolibrary.org/obo/MONDO_0001731) (benign vaginal mixed epithelial and mesenchymal neoplasm), [MONDO:0001733](http://purl.obolibrary.org/obo/MONDO_0001733) (venous tributary occlusion of retina), [MONDO:0000402](http://purl.obolibrary.org/obo/MONDO_0000402) (small cell carcinoma), [MONDO:0013700](http://purl.obolibrary.org/obo/MONDO_0013700) (pancreatic triacylglycerol lipase deficiency), [MONDO:0013772](http://purl.obolibrary.org/obo/MONDO_0013772) (congenital cataract-hearing loss-severe developmental delay syndrome), [MONDO:0013773](http://purl.obolibrary.org/obo/MONDO_0013773) (porencephaly 2), [MONDO:0013774](http://purl.obolibrary.org/obo/MONDO_0013774) (trigonocephaly 2), [MONDO:0011112](http://purl.obolibrary.org/obo/MONDO_0011112) (wilms tumor 5), [MONDO:0012442](http://purl.obolibrary.org/obo/MONDO_0012442) (autosomal recessive nonsyndromic deafness 66), [MONDO:0011110](http://purl.obolibrary.org/obo/MONDO_0011110) (dyssegmental dysplasia-glaucoma syndrome), [MONDO:0013770](http://purl.obolibrary.org/obo/MONDO_0013770) (atrial heart septal defect 9), [MONDO:0000458](http://purl.obolibrary.org/obo/MONDO_0000458) (proneural glioblastoma), [MONDO:0001789](http://purl.obolibrary.org/obo/MONDO_0001789) (neurofibroma of spinal cord), [MONDO:0000459](http://purl.obolibrary.org/obo/MONDO_0000459) (mesenchymal glioblastoma), [MONDO:0000455](http://purl.obolibrary.org/obo/MONDO_0000455) (cone dystrophy), [MONDO:0000456](http://purl.obolibrary.org/obo/MONDO_0000456) (cerebral creatine deficiency syndrome), [MONDO:0000457](http://purl.obolibrary.org/obo/MONDO_0000457) (classical glioblastoma), [MONDO:0001782](http://purl.obolibrary.org/obo/MONDO_0001782) (mature cataract), [MONDO:0000450](http://purl.obolibrary.org/obo/MONDO_0000450) (secondary progressive multiple sclerosis), [MONDO:0001781](http://purl.obolibrary.org/obo/MONDO_0001781) (uterine corpus adenomatoid tumor), [MONDO:0000451](http://purl.obolibrary.org/obo/MONDO_0000451) (primary progressive multiple sclerosis), [MONDO:0000452](http://purl.obolibrary.org/obo/MONDO_0000452) (progressive relapsing multiple sclerosis), [MONDO:0000453](http://purl.obolibrary.org/obo/MONDO_0000453) (short QT syndrome), [MONDO:0001783](http://purl.obolibrary.org/obo/MONDO_0001783) (endometrial stromal nodule), [MONDO:0013779](http://purl.obolibrary.org/obo/MONDO_0013779) (Wiskott-Aldrich syndrome 2), [MONDO:0012447](http://purl.obolibrary.org/obo/MONDO_0012447) (synpolydactyly type 3), [MONDO:0011114](http://purl.obolibrary.org/obo/MONDO_0011114) (familial multiple trichoepithelioma), [MONDO:0012445](http://purl.obolibrary.org/obo/MONDO_0012445) (autosomal recessive nonsyndromic deafness 59), [MONDO:0012444](http://purl.obolibrary.org/obo/MONDO_0012444) (neurodegeneration with brain iron accumulation 2b), [MONDO:0011113](http://purl.obolibrary.org/obo/MONDO_0011113) (Charcot-Marie-tooth disease type 4C), [MONDO:0013775](http://purl.obolibrary.org/obo/MONDO_0013775) (thrombomodulin-related bleeding disorder), [MONDO:0011119](http://purl.obolibrary.org/obo/MONDO_0011119) (iridogoniodysgenesis), [MONDO:0013776](http://purl.obolibrary.org/obo/MONDO_0013776) (spastic ataxia 5), [MONDO:0013777](http://purl.obolibrary.org/obo/MONDO_0013777) (pseudohypoaldosteronism type 2B), [MONDO:0012449](http://purl.obolibrary.org/obo/MONDO_0012449) (spinocerebellar ataxia type 23), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0013778](http://purl.obolibrary.org/obo/MONDO_0013778) (pseudohypoaldosteronism type 2C), [MONDO:0013760](http://purl.obolibrary.org/obo/MONDO_0013760) (congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome), [MONDO:0013761](http://purl.obolibrary.org/obo/MONDO_0013761) (childhood encephalopathy due to thiamine pyrophosphokinase deficiency), [MONDO:0013762](http://purl.obolibrary.org/obo/MONDO_0013762) (Lipoic acid synthetase deficiency), [MONDO:0013763](http://purl.obolibrary.org/obo/MONDO_0013763) (Joubert syndrome 15), [MONDO:0011101](http://purl.obolibrary.org/obo/MONDO_0011101) (peroxisome biogenesis disorder 1B), [MONDO:0012432](http://purl.obolibrary.org/obo/MONDO_0012432) (Joubert syndrome 5), [MONDO:0012430](http://purl.obolibrary.org/obo/MONDO_0012430) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 2), [MONDO:0000469](http://purl.obolibrary.org/obo/MONDO_0000469) (sinoatrial node disease), [MONDO:0000465](http://purl.obolibrary.org/obo/MONDO_0000465) (atrioventricular block (disease)), [MONDO:0000466](http://purl.obolibrary.org/obo/MONDO_0000466) (first-degree atrioventricular block), [MONDO:0001799](http://purl.obolibrary.org/obo/MONDO_0001799) (localized anterior staphyloma), [MONDO:0000467](http://purl.obolibrary.org/obo/MONDO_0000467) (second-degree atrioventricular block), [MONDO:0000468](http://purl.obolibrary.org/obo/MONDO_0000468) (third-degree atrioventricular block), [MONDO:0001793](http://purl.obolibrary.org/obo/MONDO_0001793) (excessive tearing), [MONDO:0000461](http://purl.obolibrary.org/obo/MONDO_0000461) (biotin deficiency), [MONDO:0001792](http://purl.obolibrary.org/obo/MONDO_0001792) (epiphora due to insufficient drainage), [MONDO:0000463](http://purl.obolibrary.org/obo/MONDO_0000463) (urofacial syndrome), [MONDO:0001790](http://purl.obolibrary.org/obo/MONDO_0001790) (spinal cord lipoma), [MONDO:0000460](http://purl.obolibrary.org/obo/MONDO_0000460) (neural glioblastoma), [MONDO:0013768](http://purl.obolibrary.org/obo/MONDO_0013768) (arterial calcification, generalized, of infancy, 2), [MONDO:0012436](http://purl.obolibrary.org/obo/MONDO_0012436) (neonatal diabetes mellitus with congenital hypothyroidism), [MONDO:0011105](http://purl.obolibrary.org/obo/MONDO_0011105) (alacrima, congenital, autosomal recessive), [MONDO:0011104](http://purl.obolibrary.org/obo/MONDO_0011104) (cataract 3 multiple types), [MONDO:0012435](http://purl.obolibrary.org/obo/MONDO_0012435) (3-methylglutaconic aciduria type 5), [MONDO:0011103](http://purl.obolibrary.org/obo/MONDO_0011103) (autosomal dominant nonsyndromic deafness 3A), [MONDO:0011102](http://purl.obolibrary.org/obo/MONDO_0011102) (autosomal dominant nonsyndromic deafness 12), [MONDO:0012433](http://purl.obolibrary.org/obo/MONDO_0012433) (Senior-Loken syndrome 6), [MONDO:0011109](http://purl.obolibrary.org/obo/MONDO_0011109) (multiple epiphyseal dysplasia, Lowry type), [MONDO:0013764](http://purl.obolibrary.org/obo/MONDO_0013764) (Joubert syndrome 16), [MONDO:0012439](http://purl.obolibrary.org/obo/MONDO_0012439) (Alagille syndrome due to a NOTCH2 point mutation), [MONDO:0011108](http://purl.obolibrary.org/obo/MONDO_0011108) (StC<ve-Wiedemann syndrome), [MONDO:0013766](http://purl.obolibrary.org/obo/MONDO_0013766) (familial cold autoinflammatory syndrome 3), [MONDO:0012438](http://purl.obolibrary.org/obo/MONDO_0012438) (pontocerebellar hypoplasia type 5), [MONDO:0011107](http://purl.obolibrary.org/obo/MONDO_0011107) (congenital hypotrichosis with juvenile macular dystrophy), [MONDO:0013767](http://purl.obolibrary.org/obo/MONDO_0013767) (autoimmune lymphoproliferative syndrome type 4), [MONDO:0011106](http://purl.obolibrary.org/obo/MONDO_0011106) (facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome), [MONDO:0012437](http://purl.obolibrary.org/obo/MONDO_0012437) (cataract 21 multiple types), [MONDO:0013750](http://purl.obolibrary.org/obo/MONDO_0013750) (atrial heart septal defect 8), [MONDO:0013751](http://purl.obolibrary.org/obo/MONDO_0013751) (cutis laxa, autosomal dominant 2), [MONDO:0012421](http://purl.obolibrary.org/obo/MONDO_0012421) (autosomal recessive nonsyndromic deafness 44), [MONDO:0012420](http://purl.obolibrary.org/obo/MONDO_0012420) (autosomal recessive nonsyndromic deafness 49), [MONDO:0001768](http://purl.obolibrary.org/obo/MONDO_0001768) (stenosis of lacrimal passage), [MONDO:0001767](http://purl.obolibrary.org/obo/MONDO_0001767) (stenosis of lacrimal punctum), [MONDO:0000438](http://purl.obolibrary.org/obo/MONDO_0000438) (ataxia with oculomotor apraxia type 2), [MONDO:0001769](http://purl.obolibrary.org/obo/MONDO_0001769) (acquired tear duct stenosis), [MONDO:0001764](http://purl.obolibrary.org/obo/MONDO_0001764) (ethmoidal sinus neoplasm), [MONDO:0000432](http://purl.obolibrary.org/obo/MONDO_0000432) (lymphoplasmacytic lymphoma), [MONDO:0001763](http://purl.obolibrary.org/obo/MONDO_0001763) (ethmoid sinus cancer), [MONDO:0000434](http://purl.obolibrary.org/obo/MONDO_0000434) (peripheral T-cell lymphoma), [MONDO:0001766](http://purl.obolibrary.org/obo/MONDO_0001766) (eversion of lacrimal punctum), [MONDO:0001760](http://purl.obolibrary.org/obo/MONDO_0001760) (photokeratitis), [MONDO:0000430](http://purl.obolibrary.org/obo/MONDO_0000430) (mature T-cell and NK-cell lymphoma), [MONDO:0001761](http://purl.obolibrary.org/obo/MONDO_0001761) (favism), [MONDO:0012425](http://purl.obolibrary.org/obo/MONDO_0012425) (FECD2), [MONDO:0013758](http://purl.obolibrary.org/obo/MONDO_0013758) (Charcot-Marie-tooth disease dominant intermediate E), [MONDO:0013759](http://purl.obolibrary.org/obo/MONDO_0013759) (MITF-related melanoma and renal cell carcinoma predisposition syndrome), [MONDO:0012423](http://purl.obolibrary.org/obo/MONDO_0012423) (MORM syndrome), [MONDO:0012422](http://purl.obolibrary.org/obo/MONDO_0012422) (type 1 diabetes mellitus 19), [MONDO:0013753](http://purl.obolibrary.org/obo/MONDO_0013753) (Charcot-Marie-tooth disease axonal type 2P), [MONDO:0012429](http://purl.obolibrary.org/obo/MONDO_0012429) (Aicardi-Goutieres syndrome 2), [MONDO:0013754](http://purl.obolibrary.org/obo/MONDO_0013754) (cutis laxa, autosomal recessive, type 1B), [MONDO:0013755](http://purl.obolibrary.org/obo/MONDO_0013755) (PYCR1-related de Barsy syndrome), [MONDO:0012426](http://purl.obolibrary.org/obo/MONDO_0012426) (immunodeficiency 25), [MONDO:0013756](http://purl.obolibrary.org/obo/MONDO_0013756) (hypertrophic osteoarthropathy, primary, autosomal recessive, 2), [MONDO:0013740](http://purl.obolibrary.org/obo/MONDO_0013740) (lethal occipital encephalocele-skeletal dysplasia syndrome), [MONDO:0012410](http://purl.obolibrary.org/obo/MONDO_0012410) (finnish upper limb-onset distal myopathy), [MONDO:0001779](http://purl.obolibrary.org/obo/MONDO_0001779) (vaginal squamous papilloma), [MONDO:0000448](http://purl.obolibrary.org/obo/MONDO_0000448) (paraganglioma), [MONDO:0001778](http://purl.obolibrary.org/obo/MONDO_0001778) (dermoid cyst of skin), [MONDO:0000443](http://purl.obolibrary.org/obo/MONDO_0000443) (adenylosuccinase lyase deficiency), [MONDO:0001774](http://purl.obolibrary.org/obo/MONDO_0001774) (posterior scleritis), [MONDO:0000440](http://purl.obolibrary.org/obo/MONDO_0000440) (metabolic acidosis), [MONDO:0012419](http://purl.obolibrary.org/obo/MONDO_0012419) (age related macular degeneration 7), [MONDO:0000442](http://purl.obolibrary.org/obo/MONDO_0000442) (paramyloidosis), [MONDO:0012414](http://purl.obolibrary.org/obo/MONDO_0012414) (neuronal ceroid lipofuscinosis 10), [MONDO:0012413](http://purl.obolibrary.org/obo/MONDO_0012413) (syndromic microphthalmia type 5), [MONDO:0012411](http://purl.obolibrary.org/obo/MONDO_0012411) (giant axonal neuropathy 2), [MONDO:0012418](http://purl.obolibrary.org/obo/MONDO_0012418) (autosomal recessive nonsyndromic deafness 62), [MONDO:0013743](http://purl.obolibrary.org/obo/MONDO_0013743) (autosomal systemic lupus erythematosus), [MONDO:0012417](http://purl.obolibrary.org/obo/MONDO_0012417) (heart-hand syndrome, Slovenian type), [MONDO:0013744](http://purl.obolibrary.org/obo/MONDO_0013744) (cataract 37), [MONDO:0013745](http://purl.obolibrary.org/obo/MONDO_0013745) (Joubert syndrome 14), [MONDO:0012415](http://purl.obolibrary.org/obo/MONDO_0012415) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 4), [MONDO:0011152](http://purl.obolibrary.org/obo/MONDO_0011152) (PHGDH deficiency), [MONDO:0012483](http://purl.obolibrary.org/obo/MONDO_0012483) (cone-rod dystrophy 11), [MONDO:0011151](http://purl.obolibrary.org/obo/MONDO_0011151) (exudative vitreoretinopathy 4), [MONDO:0011150](http://purl.obolibrary.org/obo/MONDO_0011150) (acroosteolysis-keloid-like lesions-premature aging syndrome), [MONDO:0012481](http://purl.obolibrary.org/obo/MONDO_0012481) (mevalonic aciduria), [MONDO:0012480](http://purl.obolibrary.org/obo/MONDO_0012480) (diabetes mellitus, transient neonatal, 2), [MONDO:0011156](http://purl.obolibrary.org/obo/MONDO_0011156) (progressive familial intrahepatic cholestasis type 2), [MONDO:0012485](http://purl.obolibrary.org/obo/MONDO_0012485) (autosomal recessive nonsyndromic deafness 68), [MONDO:0011154](http://purl.obolibrary.org/obo/MONDO_0011154) (acrofacial dysostosis, Palagonia type), [MONDO:0011153](http://purl.obolibrary.org/obo/MONDO_0011153) (hyperinsulinemic hypoglycemia, familial, 2), [MONDO:0000498](http://purl.obolibrary.org/obo/MONDO_0000498) (arteritic anterior ischemic optic neuropathy), [MONDO:0000499](http://purl.obolibrary.org/obo/MONDO_0000499) (non-arteritic anterior ischemic optic neuropathy), [MONDO:0011159](http://purl.obolibrary.org/obo/MONDO_0011159) (autosomal dominant nonsyndromic deafness 13), [MONDO:0012489](http://purl.obolibrary.org/obo/MONDO_0012489) (cataract 23), [MONDO:0011158](http://purl.obolibrary.org/obo/MONDO_0011158) (autoimmune lymphoproliferative syndrome type 1), [MONDO:0012472](http://purl.obolibrary.org/obo/MONDO_0012472) (Aicardi-Goutieres syndrome 4), [MONDO:0012471](http://purl.obolibrary.org/obo/MONDO_0012471) (Aicardi-Goutieres syndrome 3), [MONDO:0012470](http://purl.obolibrary.org/obo/MONDO_0012470) (HPC7), [MONDO:0011145](http://purl.obolibrary.org/obo/MONDO_0011145) (colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome), [MONDO:0011144](http://purl.obolibrary.org/obo/MONDO_0011144) (neuronal ceroid lipofuscinosis 6), [MONDO:0012475](http://purl.obolibrary.org/obo/MONDO_0012475) (cone dystrophy with supernormal rod response), [MONDO:0011143](http://purl.obolibrary.org/obo/MONDO_0011143) (cone-rod dystrophy 6), [MONDO:0011142](http://purl.obolibrary.org/obo/MONDO_0011142) (Ehlers-Danlos syndrome, musculocontractural type), [MONDO:0011149](http://purl.obolibrary.org/obo/MONDO_0011149) (premature aging syndrome, Okamoto type), [MONDO:0012479](http://purl.obolibrary.org/obo/MONDO_0012479) (congenital malabsorptive diarrhea 4), [MONDO:0011147](http://purl.obolibrary.org/obo/MONDO_0011147) (chromosome 18q deletion syndrome), [MONDO:0011146](http://purl.obolibrary.org/obo/MONDO_0011146) (tetrasomy 12p), [MONDO:0012477](http://purl.obolibrary.org/obo/MONDO_0012477) (retinitis pigmentosa 33), [MONDO:0012461](http://purl.obolibrary.org/obo/MONDO_0012461) (bulimia nervosa, susceptibility to, 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0012460](http://purl.obolibrary.org/obo/MONDO_0012460) (autosomal recessive nonsyndromic deafness 67), [MONDO:0013795](http://purl.obolibrary.org/obo/MONDO_0013795) (fibrochondrogenesis 2), [MONDO:0011134](http://purl.obolibrary.org/obo/MONDO_0011134) (Curry-Jones syndrome), [MONDO:0012465](http://purl.obolibrary.org/obo/MONDO_0012465) (hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency), [MONDO:0012464](http://purl.obolibrary.org/obo/MONDO_0012464) (cone-rod dystrophy 10), [MONDO:0011133](http://purl.obolibrary.org/obo/MONDO_0011133) (Deaf blind hypopigmentation syndrome, Yemenite type), [MONDO:0012463](http://purl.obolibrary.org/obo/MONDO_0012463) (retinitis pigmentosa 35), [MONDO:0011132](http://purl.obolibrary.org/obo/MONDO_0011132) (T-cell immunodeficiency, congenital alopecia, and nail dystrophy), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0011131](http://purl.obolibrary.org/obo/MONDO_0011131) (Tricho-oculo-dermo-vertebral syndrome), [MONDO:0012462](http://purl.obolibrary.org/obo/MONDO_0012462) (autosomal recessive frontotemporal pachygyria), [MONDO:0012469](http://purl.obolibrary.org/obo/MONDO_0012469) (MYP14), [MONDO:0011138](http://purl.obolibrary.org/obo/MONDO_0011138) (systemic lupus erythematosus, susceptibility to, 1), [MONDO:0011137](http://purl.obolibrary.org/obo/MONDO_0011137) (retinitis pigmentosa 19), [MONDO:0011136](http://purl.obolibrary.org/obo/MONDO_0011136) (Quebec platelet disorder), [MONDO:0011139](http://purl.obolibrary.org/obo/MONDO_0011139) (preaxial Hallucal polydactyly), [MONDO:0013782](http://purl.obolibrary.org/obo/MONDO_0013782) (pseudohypoaldosteronism type 2E), [MONDO:0012450](http://purl.obolibrary.org/obo/MONDO_0012450) (spinocerebellar ataxia type 28), [MONDO:0013783](http://purl.obolibrary.org/obo/MONDO_0013783) (microphthalmia, isolated, with coloboma 7), [MONDO:0011123](http://purl.obolibrary.org/obo/MONDO_0011123) (type 1 diabetes mellitus 15), [MONDO:0011122](http://purl.obolibrary.org/obo/MONDO_0011122) (obesity (disease)), [MONDO:0013780](http://purl.obolibrary.org/obo/MONDO_0013780) (retinitis pigmentosa 63), [MONDO:0011121](http://purl.obolibrary.org/obo/MONDO_0011121) (paragangliomas 2), [MONDO:0012452](http://purl.obolibrary.org/obo/MONDO_0012452) (autosomal recessive nonsyndromic deafness 65), [MONDO:0013781](http://purl.obolibrary.org/obo/MONDO_0013781) (pseudohypoaldosteronism type 2D), [MONDO:0011120](http://purl.obolibrary.org/obo/MONDO_0011120) (neural tube defects, folate-Sensitive), [MONDO:0000488](http://purl.obolibrary.org/obo/MONDO_0000488) (periampullary adenoma), [MONDO:0011127](http://purl.obolibrary.org/obo/MONDO_0011127) (Bartter disease type 1), [MONDO:0012456](http://purl.obolibrary.org/obo/MONDO_0012456) (congenital aphakia), [MONDO:0011125](http://purl.obolibrary.org/obo/MONDO_0011125) (trichothiodystrophy 1, photosensitive), [MONDO:0011124](http://purl.obolibrary.org/obo/MONDO_0011124) (spondyloepimetaphyseal dysplasia-abnormal dentition syndrome), [MONDO:0012455](http://purl.obolibrary.org/obo/MONDO_0012455) (Kleefstra syndrome), [MONDO:0013786](http://purl.obolibrary.org/obo/MONDO_0013786) (cone-rod dystrophy 16), [MONDO:0011129](http://purl.obolibrary.org/obo/MONDO_0011129) (GLC1C), [MONDO:0013788](http://purl.obolibrary.org/obo/MONDO_0013788) (Usher syndrome type 3B), [MONDO:0013789](http://purl.obolibrary.org/obo/MONDO_0013789) (DDOST-CDG), [MONDO:0011128](http://purl.obolibrary.org/obo/MONDO_0011128) (Sheldon-hall syndrome), [MONDO:0011196](http://purl.obolibrary.org/obo/MONDO_0011196) (amyotrophic lateral sclerosis type 5), [MONDO:0011195](http://purl.obolibrary.org/obo/MONDO_0011195) (Usher syndrome type 1E), [MONDO:0011193](http://purl.obolibrary.org/obo/MONDO_0011193) (cone dystrophy 3), [MONDO:0011198](http://purl.obolibrary.org/obo/MONDO_0011198) (spondyloepimetaphyseal dysplasia, Missouri type), [MONDO:0011197](http://purl.obolibrary.org/obo/MONDO_0011197) (hereditary thermosensitive neuropathy), [MONDO:0011192](http://purl.obolibrary.org/obo/MONDO_0011192) (autosomal recessive nonsyndromic deafness 18A), [MONDO:0011191](http://purl.obolibrary.org/obo/MONDO_0011191) (hemangioma, capillary infantile), [MONDO:0011185](http://purl.obolibrary.org/obo/MONDO_0011185) (Thiel-Behnke corneal dystrophy), [MONDO:0011183](http://purl.obolibrary.org/obo/MONDO_0011183) (Paget disease of bone 2, early-onset), [MONDO:0011187](http://purl.obolibrary.org/obo/MONDO_0011187) (polydactyly, postaxial, type A2), [MONDO:0011186](http://purl.obolibrary.org/obo/MONDO_0011186) (Usher syndrome type 1F), [MONDO:0011181](http://purl.obolibrary.org/obo/MONDO_0011181) (fibrosis of extraocular muscles, congenital, 2), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0011171](http://purl.obolibrary.org/obo/MONDO_0011171) (Odonto-tricho-ungual-digito-palmar syndrome), [MONDO:0011177](http://purl.obolibrary.org/obo/MONDO_0011177) (ectodermal dysplasia 4, hair/nail type), [MONDO:0011176](http://purl.obolibrary.org/obo/MONDO_0011176) (intestinal hypomagnesemia 1), [MONDO:0011175](http://purl.obolibrary.org/obo/MONDO_0011175) (FRDA2), [MONDO:0011170](http://purl.obolibrary.org/obo/MONDO_0011170) (autosomal recessive limb-girdle muscular dystrophy type 2G), [MONDO:0011163](http://purl.obolibrary.org/obo/MONDO_0011163) (malignant hyperthermia, susceptibility to, 5), [MONDO:0011162](http://purl.obolibrary.org/obo/MONDO_0011162) (cataract 14 multiple types), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0011160](http://purl.obolibrary.org/obo/MONDO_0011160) (autosomal recessive nonsyndromic deafness 15), [MONDO:0011167](http://purl.obolibrary.org/obo/MONDO_0011167) (type 1 diabetes mellitus 6), [MONDO:0012498](http://purl.obolibrary.org/obo/MONDO_0012498) (congenital stationary night blindness autosomal dominant 1), [MONDO:0012497](http://purl.obolibrary.org/obo/MONDO_0012497) (congenital stationary night blindness autosomal dominant 3), [MONDO:0012496](http://purl.obolibrary.org/obo/MONDO_0012496) (Koolen de Vries syndrome), [MONDO:0012495](http://purl.obolibrary.org/obo/MONDO_0012495) (spondyloepimetaphyseal dysplasia, GeneviC(ve type), [MONDO:0011164](http://purl.obolibrary.org/obo/MONDO_0011164) (malignant hyperthermia, susceptibility to, 6), [MONDO:0012490](http://purl.obolibrary.org/obo/MONDO_0012490) (cone-rod synaptic disorder, congenital nonprogressive), [MONDO:0011168](http://purl.obolibrary.org/obo/MONDO_0011168) (type 1 diabetes mellitus 10), [MONDO:0001828](http://purl.obolibrary.org/obo/MONDO_0001828) (acquired color blindness), [MONDO:0001823](http://purl.obolibrary.org/obo/MONDO_0001823) (sick sinus syndrome), [MONDO:0001822](http://purl.obolibrary.org/obo/MONDO_0001822) (hypolipoproteinemia (disease)), [MONDO:0001825](http://purl.obolibrary.org/obo/MONDO_0001825) (squamous papilloma), [MONDO:0013818](http://purl.obolibrary.org/obo/MONDO_0013818) (Trichohepatoenteric syndrome 2), [MONDO:0013819](http://purl.obolibrary.org/obo/MONDO_0013819) (mental retardation, autosomal dominant 14), [MONDO:0013812](http://purl.obolibrary.org/obo/MONDO_0013812) (Baraitser-winter syndrome 2), [MONDO:0013815](http://purl.obolibrary.org/obo/MONDO_0013815) (FGFR2-related bent bone dysplasia), [MONDO:0013810](http://purl.obolibrary.org/obo/MONDO_0013810) (COG6-CGD), [MONDO:0013811](http://purl.obolibrary.org/obo/MONDO_0013811) (combined oxidative phosphorylation defect type 9), [MONDO:0000507](http://purl.obolibrary.org/obo/MONDO_0000507) (inclusion body myopathy with Paget disease of bone and frontotemporal dementia), [MONDO:0001834](http://purl.obolibrary.org/obo/MONDO_0001834) (visual pathway disease), [MONDO:0000502](http://purl.obolibrary.org/obo/MONDO_0000502) (villous adenoma), [MONDO:0000503](http://purl.obolibrary.org/obo/MONDO_0000503) (in situ pulmonary adenocarcinoma), [MONDO:0001833](http://purl.obolibrary.org/obo/MONDO_0001833) (lacrimal duct obstruction), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0001831](http://purl.obolibrary.org/obo/MONDO_0001831) (irregular astigmatism), [MONDO:0013806](http://purl.obolibrary.org/obo/MONDO_0013806) (familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome), [MONDO:0013807](http://purl.obolibrary.org/obo/MONDO_0013807) (congenital stationary night blindness 1E), [MONDO:0013808](http://purl.obolibrary.org/obo/MONDO_0013808) (Maffucci syndrome), [MONDO:0013802](http://purl.obolibrary.org/obo/MONDO_0013802) (infantile cerebellar-retinal degeneration), [MONDO:0013804](http://purl.obolibrary.org/obo/MONDO_0013804) (mental retardation, autosomal dominant 12), [MONDO:0013800](http://purl.obolibrary.org/obo/MONDO_0013800) (Ehlers-Danlos syndrome, kyphoscoliotic and deafness type), [MONDO:0001805](http://purl.obolibrary.org/obo/MONDO_0001805) (female breast central part cancer), [MONDO:0001804](http://purl.obolibrary.org/obo/MONDO_0001804) (anterior scleritis), [MONDO:0001807](http://purl.obolibrary.org/obo/MONDO_0001807) (familial combined hyperlipidemia), [MONDO:0001806](http://purl.obolibrary.org/obo/MONDO_0001806) (vaginal squamous tumor), [MONDO:0001801](http://purl.obolibrary.org/obo/MONDO_0001801) (staphyloma posticum), [MONDO:0001800](http://purl.obolibrary.org/obo/MONDO_0001800) (equatorial staphyloma), [MONDO:0001816](http://purl.obolibrary.org/obo/MONDO_0001816) (scleroperikeratitis), [MONDO:0001817](http://purl.obolibrary.org/obo/MONDO_0001817) (acute closed-angle glaucoma), [MONDO:0001812](http://purl.obolibrary.org/obo/MONDO_0001812) (parasitic eyelid infestation), [MONDO:0001811](http://purl.obolibrary.org/obo/MONDO_0001811) (tetanic cataract), [MONDO:0001813](http://purl.obolibrary.org/obo/MONDO_0001813) (squamous blepharitis), [MONDO:0013851](http://purl.obolibrary.org/obo/MONDO_0013851) (autosomal dominant aplasia and myelodysplasia), [MONDO:0000539](http://purl.obolibrary.org/obo/MONDO_0000539) (striated muscle rhabdoid tumor), [MONDO:0012520](http://purl.obolibrary.org/obo/MONDO_0012520) (insulin-resistance syndrome type A), [MONDO:0000535](http://purl.obolibrary.org/obo/MONDO_0000535) (tonsil squamous cell carcinoma), [MONDO:0000536](http://purl.obolibrary.org/obo/MONDO_0000536) (pharynx squamous cell carcinoma), [MONDO:0001869](http://purl.obolibrary.org/obo/MONDO_0001869) (paraurethral gland cancer), [MONDO:0001868](http://purl.obolibrary.org/obo/MONDO_0001868) (primary angle-closure glaucoma), [MONDO:0000538](http://purl.obolibrary.org/obo/MONDO_0000538) (spindle epithelial tumor with thymus-like differentiation tumor), [MONDO:0000531](http://purl.obolibrary.org/obo/MONDO_0000531) (bronchus mucoepidermoid carcinoma), [MONDO:0001862](http://purl.obolibrary.org/obo/MONDO_0001862) (malignant visceral pleura tumor), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0001865](http://purl.obolibrary.org/obo/MONDO_0001865) (autoimmune polyendocrinopathy syndrome), [MONDO:0000534](http://purl.obolibrary.org/obo/MONDO_0000534) (trachea mucoepidermoid carcinoma), [MONDO:0001864](http://purl.obolibrary.org/obo/MONDO_0001864) (residual stage angle-closure glaucoma), [MONDO:0001861](http://purl.obolibrary.org/obo/MONDO_0001861) (malignant parietal pleura tumor), [MONDO:0000530](http://purl.obolibrary.org/obo/MONDO_0000530) (rectum adenoma), [MONDO:0012529](http://purl.obolibrary.org/obo/MONDO_0012529) (Diamond-Blackfan anemia 3), [MONDO:0001860](http://purl.obolibrary.org/obo/MONDO_0001860) (folic acid deficiency anemia), [MONDO:0012523](http://purl.obolibrary.org/obo/MONDO_0012523) (retinitis pigmentosa 36), [MONDO:0012522](http://purl.obolibrary.org/obo/MONDO_0012522) (diabetes mellitus, transient neonatal, 3), [MONDO:0013859](http://purl.obolibrary.org/obo/MONDO_0013859) (cataract 38), [MONDO:0012528](http://purl.obolibrary.org/obo/MONDO_0012528) (hypogonadotropic hypogonadism 4 with or without anosmia), [MONDO:0013853](http://purl.obolibrary.org/obo/MONDO_0013853) (pontocerebellar hypoplasia type 1B), [MONDO:0012527](http://purl.obolibrary.org/obo/MONDO_0012527) (cataract 11 multiple types), [MONDO:0013854](http://purl.obolibrary.org/obo/MONDO_0013854) (primary ciliary dyskinesia 17), [MONDO:0012526](http://purl.obolibrary.org/obo/MONDO_0012526) (hereditary angioedema type 3), [MONDO:0012525](http://purl.obolibrary.org/obo/MONDO_0012525) (Leber congenital amaurosis 12), [MONDO:0013840](http://purl.obolibrary.org/obo/MONDO_0013840) (encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome), [MONDO:0000548](http://purl.obolibrary.org/obo/MONDO_0000548) (ovarian clear cell cancer), [MONDO:0001879](http://purl.obolibrary.org/obo/MONDO_0001879) (anus cancer), [MONDO:0000549](http://purl.obolibrary.org/obo/MONDO_0000549) (cervical neuroblastoma), [MONDO:0000543](http://purl.obolibrary.org/obo/MONDO_0000543) (ovarian melanoma), [MONDO:0000544](http://purl.obolibrary.org/obo/MONDO_0000544) (mucosal melanoma), [MONDO:0000545](http://purl.obolibrary.org/obo/MONDO_0000545) (sublingual gland adenoid cystic carcinoma), [MONDO:0000540](http://purl.obolibrary.org/obo/MONDO_0000540) (small intestinal neuroendocrine tumor G1), [MONDO:0012519](http://purl.obolibrary.org/obo/MONDO_0012519) (Rubinstein-Taybi syndrome due to 16p13.3 microdeletion), [MONDO:0001872](http://purl.obolibrary.org/obo/MONDO_0001872) (vestibular nystagmus (disease)), [MONDO:0012518](http://purl.obolibrary.org/obo/MONDO_0012518) (congenital myasthenic syndrome 12), [MONDO:0000541](http://purl.obolibrary.org/obo/MONDO_0000541) (jejunal adenocarcinoma (disease)), [MONDO:0013849](http://purl.obolibrary.org/obo/MONDO_0013849) (microcephaly 8, primary, autosomal recessive), [MONDO:0013845](http://purl.obolibrary.org/obo/MONDO_0013845) (Auriculocondylar syndrome 2), [MONDO:0012513](http://purl.obolibrary.org/obo/MONDO_0012513) (maturity-onset diabetes of the young type 7), [MONDO:0012512](http://purl.obolibrary.org/obo/MONDO_0012512) (fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3), [MONDO:0012510](http://purl.obolibrary.org/obo/MONDO_0012510) (combined oxidative phosphorylation defect type 2), [MONDO:0012517](http://purl.obolibrary.org/obo/MONDO_0012517) (atypical Gaucher's disease due to saposin c deficiency), [MONDO:0012516](http://purl.obolibrary.org/obo/MONDO_0012516) (mandibulofacial dysostosis-microcephaly syndrome), [MONDO:0013843](http://purl.obolibrary.org/obo/MONDO_0013843) (intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency), [MONDO:0012515](http://purl.obolibrary.org/obo/MONDO_0012515) (GLC1M), [MONDO:0012514](http://purl.obolibrary.org/obo/MONDO_0012514) (hypomyelinating leukodystrophy 5), [MONDO:0000517](http://purl.obolibrary.org/obo/MONDO_0000517) (brain stem medulloblastoma), [MONDO:0000518](http://purl.obolibrary.org/obo/MONDO_0000518) (sacrum chordoma), [MONDO:0001848](http://purl.obolibrary.org/obo/MONDO_0001848) (Morgagni cataract), [MONDO:0000519](http://purl.obolibrary.org/obo/MONDO_0000519) (corpus callosum oligodendroglioma), [MONDO:0000513](http://purl.obolibrary.org/obo/MONDO_0000513) (bone ameloblastoma), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0000514](http://purl.obolibrary.org/obo/MONDO_0000514) (bone squamous cell carcinoma), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0000515](http://purl.obolibrary.org/obo/MONDO_0000515) (bone chondrosarcoma), [MONDO:0001847](http://purl.obolibrary.org/obo/MONDO_0001847) (nuclear senile cataract), [MONDO:0000516](http://purl.obolibrary.org/obo/MONDO_0000516) (phalanx chondroma), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0012508](http://purl.obolibrary.org/obo/MONDO_0012508) (agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome), [MONDO:0012507](http://purl.obolibrary.org/obo/MONDO_0012507) (retinal cone dystrophy 4), [MONDO:0013838](http://purl.obolibrary.org/obo/MONDO_0013838) (coenzyme Q10 deficiency, primary, 3), [MONDO:0013834](http://purl.obolibrary.org/obo/MONDO_0013834) (UV-Sensitive syndrome 3), [MONDO:0012502](http://purl.obolibrary.org/obo/MONDO_0012502) (normophosphatemic familial tumoral calcinosis), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0012500](http://purl.obolibrary.org/obo/MONDO_0012500) (Chilblain lupus 1), [MONDO:0013836](http://purl.obolibrary.org/obo/MONDO_0013836) (familial steroid-resistant nephrotic syndrome with sensorineural deafness), [MONDO:0013837](http://purl.obolibrary.org/obo/MONDO_0013837) (deafness-encephaloneuropathy-obesity-valvulopathy syndrome), [MONDO:0013830](http://purl.obolibrary.org/obo/MONDO_0013830) (KTCN5), [MONDO:0013831](http://purl.obolibrary.org/obo/MONDO_0013831) (KTCN6), [MONDO:0012504](http://purl.obolibrary.org/obo/MONDO_0012504) (camptodactyly-tall stature-scoliosis-hearing loss syndrome), [MONDO:0013832](http://purl.obolibrary.org/obo/MONDO_0013832) (KTCN8), [MONDO:0012503](http://purl.obolibrary.org/obo/MONDO_0012503) (thiopurine S-methyltransferase deficiency), [MONDO:0013833](http://purl.obolibrary.org/obo/MONDO_0013833) (KTCN7), [MONDO:0000524](http://purl.obolibrary.org/obo/MONDO_0000524) (mixed extragonadal germ cell cancer), [MONDO:0001855](http://purl.obolibrary.org/obo/MONDO_0001855) (rubeosis iridis), [MONDO:0000525](http://purl.obolibrary.org/obo/MONDO_0000525) (cecum villous adenoma), [MONDO:0000526](http://purl.obolibrary.org/obo/MONDO_0000526) (appendix carcinoid tumor), [MONDO:0000527](http://purl.obolibrary.org/obo/MONDO_0000527) (colon adenoma), [MONDO:0001852](http://purl.obolibrary.org/obo/MONDO_0001852) (small intestine lymphoma), [MONDO:0000520](http://purl.obolibrary.org/obo/MONDO_0000520) (parietal lobe ependymal tumor), [MONDO:0000521](http://purl.obolibrary.org/obo/MONDO_0000521) (salivary gland carcinoma), [MONDO:0001851](http://purl.obolibrary.org/obo/MONDO_0001851) (primary lacrimal atrophy), [MONDO:0001854](http://purl.obolibrary.org/obo/MONDO_0001854) (lacrimal apparatus disease), [MONDO:0001853](http://purl.obolibrary.org/obo/MONDO_0001853) (contact blepharoconjunctivitis), [MONDO:0001850](http://purl.obolibrary.org/obo/MONDO_0001850) (female breast lower-outer quadrant cancer), [MONDO:0013827](http://purl.obolibrary.org/obo/MONDO_0013827) (hyperekplexia 3), [MONDO:0013828](http://purl.obolibrary.org/obo/MONDO_0013828) (hyperekplexia 2), [MONDO:0013829](http://purl.obolibrary.org/obo/MONDO_0013829) (UV-Sensitive syndrome 2), [MONDO:0013823](http://purl.obolibrary.org/obo/MONDO_0013823) (autosomal dominant nonsyndromic deafness 4B), [MONDO:0013824](http://purl.obolibrary.org/obo/MONDO_0013824) (Joubert syndrome 17), [MONDO:0013825](http://purl.obolibrary.org/obo/MONDO_0013825) (congenital diarrhea 6), [MONDO:0013826](http://purl.obolibrary.org/obo/MONDO_0013826) (autosomal recessive nonsyndromic deafness 86), [MONDO:0013820](http://purl.obolibrary.org/obo/MONDO_0013820) (mental retardation, autosomal dominant 15), [MONDO:0013821](http://purl.obolibrary.org/obo/MONDO_0013821) (mental retardation, autosomal dominant 16), [MONDO:0013822](http://purl.obolibrary.org/obo/MONDO_0013822) (acrodysostosis 2 with or without hormone resistance), [MONDO:0013893](http://purl.obolibrary.org/obo/MONDO_0013893) (multiple sclerosis, susceptibility to, 5), [MONDO:0013894](http://purl.obolibrary.org/obo/MONDO_0013894) (short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome), [MONDO:0013895](http://purl.obolibrary.org/obo/MONDO_0013895) (Adams-Oliver syndrome 3), [MONDO:0011233](http://purl.obolibrary.org/obo/MONDO_0011233) (Axenfeld-Rieger syndrome type 3), [MONDO:0012563](http://purl.obolibrary.org/obo/MONDO_0012563) (holoprosencephaly 9), [MONDO:0012562](http://purl.obolibrary.org/obo/MONDO_0012562) (holoprosencephaly 7), [MONDO:0013890](http://purl.obolibrary.org/obo/MONDO_0013890) (congenital myopathy with internal nuclei and atypical cores), [MONDO:0013891](http://purl.obolibrary.org/obo/MONDO_0013891) (amyotrophic lateral sclerosis type 18), [MONDO:0000579](http://purl.obolibrary.org/obo/MONDO_0000579) (coronin-1A deficiency), [MONDO:0000575](http://purl.obolibrary.org/obo/MONDO_0000575) (interleukin-7 receptor alpha deficiency), [MONDO:0000572](http://purl.obolibrary.org/obo/MONDO_0000572) (recombinase activating gene 1 deficiency), [MONDO:0000573](http://purl.obolibrary.org/obo/MONDO_0000573) (recombinase activating gene 2 deficiency), [MONDO:0000570](http://purl.obolibrary.org/obo/MONDO_0000570) (severe combined immunodeficiency due to artemis deficiency), [MONDO:0011237](http://purl.obolibrary.org/obo/MONDO_0011237) (hyperlipidemia, combined, 1), [MONDO:0012568](http://purl.obolibrary.org/obo/MONDO_0012568) (OS4), [MONDO:0011236](http://purl.obolibrary.org/obo/MONDO_0011236) (hyperinsulinism due to glucokinase deficiency), [MONDO:0011235](http://purl.obolibrary.org/obo/MONDO_0011235) (pelvic dysplasia-arthrogryposis of lower limbs syndrome), [MONDO:0012565](http://purl.obolibrary.org/obo/MONDO_0012565) (Fanconi anemia complementation group N), [MONDO:0011234](http://purl.obolibrary.org/obo/MONDO_0011234) (Auriculocondylar syndrome 1), [MONDO:0013896](http://purl.obolibrary.org/obo/MONDO_0013896) (Joubert syndrome 18), [MONDO:0011239](http://purl.obolibrary.org/obo/MONDO_0011239) (colobomatous macrophthalmia-microcornea syndrome), [MONDO:0012569](http://purl.obolibrary.org/obo/MONDO_0012569) (MMVP3), [MONDO:0011238](http://purl.obolibrary.org/obo/MONDO_0011238) (chondrodysplasia punctata, brachytelephalangic, autosomal), [MONDO:0013899](http://purl.obolibrary.org/obo/MONDO_0013899) (Weill-Marchesani syndrome 3), [MONDO:0013881](http://purl.obolibrary.org/obo/MONDO_0013881) (congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndrome), [MONDO:0013882](http://purl.obolibrary.org/obo/MONDO_0013882) (hyperphosphatasia with mental retardation syndrome 2), [MONDO:0013883](http://purl.obolibrary.org/obo/MONDO_0013883) (congenital myasthenic syndrome 13), [MONDO:0013884](http://purl.obolibrary.org/obo/MONDO_0013884) (neuronopathy, distal hereditary motor, type 5B), [MONDO:0012553](http://purl.obolibrary.org/obo/MONDO_0012553) (Cerebrooculofacioskeletal syndrome 2), [MONDO:0011222](http://purl.obolibrary.org/obo/MONDO_0011222) (GLC1D), [MONDO:0012552](http://purl.obolibrary.org/obo/MONDO_0012552) (multiple endocrine neoplasia type 4), [MONDO:0013880](http://purl.obolibrary.org/obo/MONDO_0013880) (facial paresis, hereditary congenital, 3), [MONDO:0000586](http://purl.obolibrary.org/obo/MONDO_0000586) (autoimmune disease of exocrine system), [MONDO:0000587](http://purl.obolibrary.org/obo/MONDO_0000587) (autoimmune disease of eyes, ear, nose and throat), [MONDO:0000588](http://purl.obolibrary.org/obo/MONDO_0000588) (autoimmune disease of gastrointestinal tract), [MONDO:0000589](http://purl.obolibrary.org/obo/MONDO_0000589) (autoimmune disease of musculoskeletal system), [MONDO:0000584](http://purl.obolibrary.org/obo/MONDO_0000584) (B cell linker protein deficiency), [MONDO:0012557](http://purl.obolibrary.org/obo/MONDO_0012557) (cardiomyopathy-hypotonia-lactic acidosis syndrome), [MONDO:0013889](http://purl.obolibrary.org/obo/MONDO_0013889) (short stature-optic atrophy-Pelger-HuC+t anomaly syndrome), [MONDO:0011226](http://purl.obolibrary.org/obo/MONDO_0011226) (autosomal dominant nonsyndromic deafness 15), [MONDO:0011225](http://purl.obolibrary.org/obo/MONDO_0011225) (severe combined immunodeficiency with sensitivity to ionizing radiation), [MONDO:0012556](http://purl.obolibrary.org/obo/MONDO_0012556) (DK1-CDG), [MONDO:0012555](http://purl.obolibrary.org/obo/MONDO_0012555) (Cornelia de Lange syndrome 3), [MONDO:0011224](http://purl.obolibrary.org/obo/MONDO_0011224) (monomelic amyotrophy), [MONDO:0012554](http://purl.obolibrary.org/obo/MONDO_0012554) (Cerebrooculofacioskeletal syndrome 4), [MONDO:0011223](http://purl.obolibrary.org/obo/MONDO_0011223) (amyotrophic lateral sclerosis type 4), [MONDO:0013885](http://purl.obolibrary.org/obo/MONDO_0013885) (Malan overgrowth syndrome), [MONDO:0013886](http://purl.obolibrary.org/obo/MONDO_0013886) (nonprogressive cerebellar atxia with mental retardation), [MONDO:0011229](http://purl.obolibrary.org/obo/MONDO_0011229) (ethylmalonic encephalopathy), [MONDO:0011227](http://purl.obolibrary.org/obo/MONDO_0011227) (short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome), [MONDO:0013870](http://purl.obolibrary.org/obo/MONDO_0013870) (TMEM165-CDG), [MONDO:0013871](http://purl.obolibrary.org/obo/MONDO_0013871) (Seckel syndrome 6), [MONDO:0013872](http://purl.obolibrary.org/obo/MONDO_0013872) (prostate cancer, hereditary, 2), [MONDO:0013873](http://purl.obolibrary.org/obo/MONDO_0013873) (IMAGe syndrome), [MONDO:0011211](http://purl.obolibrary.org/obo/MONDO_0011211) (axial spondylometaphyseal dysplasia), [MONDO:0012541](http://purl.obolibrary.org/obo/MONDO_0012541) (deafness with labyrinthine aplasia, microtia, and microdontia), [MONDO:0012540](http://purl.obolibrary.org/obo/MONDO_0012540) (age related macular degeneration 4), [MONDO:0001888](http://purl.obolibrary.org/obo/MONDO_0001888) (anus lymphoma), [MONDO:0000553](http://purl.obolibrary.org/obo/MONDO_0000553) (uterine corpus endometrial carcinoma), [MONDO:0000554](http://purl.obolibrary.org/obo/MONDO_0000554) (endocervical adenocarcinoma), [MONDO:0001884](http://purl.obolibrary.org/obo/MONDO_0001884) (abducens nerve neoplasm), [MONDO:0000550](http://purl.obolibrary.org/obo/MONDO_0000550) (extra-adrenal sympathetic paraganglioma), [MONDO:0000551](http://purl.obolibrary.org/obo/MONDO_0000551) (retroperitoneal neuroblastoma), [MONDO:0000552](http://purl.obolibrary.org/obo/MONDO_0000552) (breast lobular carcinoma), [MONDO:0011215](http://purl.obolibrary.org/obo/MONDO_0011215) (Osteocraniostenosis), [MONDO:0012545](http://purl.obolibrary.org/obo/MONDO_0012545) (neutral lipid storage myopathy), [MONDO:0011214](http://purl.obolibrary.org/obo/MONDO_0011214) (progressive familial intrahepatic cholestasis type 3), [MONDO:0012544](http://purl.obolibrary.org/obo/MONDO_0012544) (brachydactyly-syndactyly syndrome), [MONDO:0012543](http://purl.obolibrary.org/obo/MONDO_0012543) (OPA5), [MONDO:0011219](http://purl.obolibrary.org/obo/MONDO_0011219) (Fried's tooth and nail syndrome), [MONDO:0013874](http://purl.obolibrary.org/obo/MONDO_0013874) (glucocorticoid deficiency 4), [MONDO:0013875](http://purl.obolibrary.org/obo/MONDO_0013875) (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome), [MONDO:0012549](http://purl.obolibrary.org/obo/MONDO_0012549) (autosomal recessive ataxia, Beauce type), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0011217](http://purl.obolibrary.org/obo/MONDO_0011217) (Desmosterolosis), [MONDO:0012548](http://purl.obolibrary.org/obo/MONDO_0012548) (Kostmann syndrome), [MONDO:0013877](http://purl.obolibrary.org/obo/MONDO_0013877) (mitochondrial pyruvate carrier deficiency), [MONDO:0011216](http://purl.obolibrary.org/obo/MONDO_0011216) (hemochromatosis type 2A), [MONDO:0012547](http://purl.obolibrary.org/obo/MONDO_0012547) (Noonan syndrome 4), [MONDO:0013861](http://purl.obolibrary.org/obo/MONDO_0013861) (amyotrophic lateral sclerosis type 17), [MONDO:0013862](http://purl.obolibrary.org/obo/MONDO_0013862) (immunodeficiency, common variable, 7), [MONDO:0012531](http://purl.obolibrary.org/obo/MONDO_0012531) (xeroderma pigmentosum group B), [MONDO:0012530](http://purl.obolibrary.org/obo/MONDO_0012530) (palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome), [MONDO:0000568](http://purl.obolibrary.org/obo/MONDO_0000568) (autoimmune disease of central nervous system), [MONDO:0000569](http://purl.obolibrary.org/obo/MONDO_0000569) (autoimmune disease of endocrine system), [MONDO:0001899](http://purl.obolibrary.org/obo/MONDO_0001899) (rheumatic congestive heart failure), [MONDO:0001895](http://purl.obolibrary.org/obo/MONDO_0001895) (acute retrobulbar neuritis), [MONDO:0001898](http://purl.obolibrary.org/obo/MONDO_0001898) (choroid disease), [MONDO:0001892](http://purl.obolibrary.org/obo/MONDO_0001892) (spinal cord lymphoma), [MONDO:0000561](http://purl.obolibrary.org/obo/MONDO_0000561) (spinocerebellar ataxia type 16), [MONDO:0001894](http://purl.obolibrary.org/obo/MONDO_0001894) (spinal cord sarcoma), [MONDO:0000563](http://purl.obolibrary.org/obo/MONDO_0000563) (GRID2-related autosomal dominant spinocerebellar ataxia), [MONDO:0001893](http://purl.obolibrary.org/obo/MONDO_0001893) (spinal cord melanoma), [MONDO:0013867](http://purl.obolibrary.org/obo/MONDO_0013867) (brown-Vialetto-van Laere syndrome 2), [MONDO:0011203](http://purl.obolibrary.org/obo/MONDO_0011203) (Pierre robin sequence with pectus excavatum and rib and scapular anomalies), [MONDO:0012534](http://purl.obolibrary.org/obo/MONDO_0012534) (combined oxidative phosphorylation defect type 4), [MONDO:0013869](http://purl.obolibrary.org/obo/MONDO_0013869) (adenine phosphoribosyltransferase deficiency), [MONDO:0011202](http://purl.obolibrary.org/obo/MONDO_0011202) (RHYNS syndrome), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0013863](http://purl.obolibrary.org/obo/MONDO_0013863) (combined immunodeficiency due to LRBA deficiency), [MONDO:0012539](http://purl.obolibrary.org/obo/MONDO_0012539) (Joubert syndrome 6), [MONDO:0013864](http://purl.obolibrary.org/obo/MONDO_0013864) (Cornelia de Lange syndrome 4), [MONDO:0012538](http://purl.obolibrary.org/obo/MONDO_0012538) (nemaline myopathy 7), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), [MONDO:0013865](http://purl.obolibrary.org/obo/MONDO_0013865) (mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency), [MONDO:0012537](http://purl.obolibrary.org/obo/MONDO_0012537) (SHFLD2), [MONDO:0012536](http://purl.obolibrary.org/obo/MONDO_0012536) (osteogenesis imperfecta type 7), [MONDO:0013866](http://purl.obolibrary.org/obo/MONDO_0013866) (neuronal ceroid lipofuscinosis 11), [MONDO:0011273](http://purl.obolibrary.org/obo/MONDO_0011273) (H syndrome), [MONDO:0011272](http://purl.obolibrary.org/obo/MONDO_0011272) (retinitis pigmentosa 25), [MONDO:0011271](http://purl.obolibrary.org/obo/MONDO_0011271) (rigid spine muscular dystrophy 1), [MONDO:0011270](http://purl.obolibrary.org/obo/MONDO_0011270) (prostate cancer, hereditary, 8), [MONDO:0011275](http://purl.obolibrary.org/obo/MONDO_0011275) (acromesomelic dysplasia, Maroteaux type), [MONDO:0011274](http://purl.obolibrary.org/obo/MONDO_0011274) (Muenke syndrome), [MONDO:0011279](http://purl.obolibrary.org/obo/MONDO_0011279) (autosomal recessive nonsyndromic deafness 17), [MONDO:0011261](http://purl.obolibrary.org/obo/MONDO_0011261) (spondyloepiphyseal dysplasia, Nishimura type), [MONDO:0012592](http://purl.obolibrary.org/obo/MONDO_0012592) (osteogenesis imperfecta type 11), [MONDO:0011260](http://purl.obolibrary.org/obo/MONDO_0011260) (pancreatic lymphoma, familial), [MONDO:0012591](http://purl.obolibrary.org/obo/MONDO_0012591) (osteogenesis imperfecta type 5), [MONDO:0011266](http://purl.obolibrary.org/obo/MONDO_0011266) (myotonic dystrophy type 2), [MONDO:0012597](http://purl.obolibrary.org/obo/MONDO_0012597) (prostate cancer, hereditary, 9), [MONDO:0012596](http://purl.obolibrary.org/obo/MONDO_0012596) (PSAT deficiency), [MONDO:0011268](http://purl.obolibrary.org/obo/MONDO_0011268) (renal tubular acidosis, distal, autosomal recessive), [MONDO:0012598](http://purl.obolibrary.org/obo/MONDO_0012598) (GINGF4), [MONDO:0012582](http://purl.obolibrary.org/obo/MONDO_0012582) (interstitial lung disease due to ABCA3 deficiency), [MONDO:0012581](http://purl.obolibrary.org/obo/MONDO_0012581) (osteogenesis imperfecta type 8), [MONDO:0012580](http://purl.obolibrary.org/obo/MONDO_0012580) (hereditary pulmonary alveolar proteinosis), [MONDO:0011255](http://purl.obolibrary.org/obo/MONDO_0011255) (mandibulofacial dysostosis-macroblepharon-macrostomia syndrome), [MONDO:0011253](http://purl.obolibrary.org/obo/MONDO_0011253) (Craniomicromelic syndrome), [MONDO:0012584](http://purl.obolibrary.org/obo/MONDO_0012584) (systemic lupus erythematosus, susceptibility to, 9), [MONDO:0011252](http://purl.obolibrary.org/obo/MONDO_0011252) (spondyloepimetaphyseal dysplasia, Shohat type), [MONDO:0000593](http://purl.obolibrary.org/obo/MONDO_0000593) (autoimmune disease of skin and connective tissue), [MONDO:0000590](http://purl.obolibrary.org/obo/MONDO_0000590) (autoimmune disease of peripheral nervous system), [MONDO:0011259](http://purl.obolibrary.org/obo/MONDO_0011259) (retinitis pigmentosa 22), [MONDO:0011258](http://purl.obolibrary.org/obo/MONDO_0011258) (branchiootic syndrome 1), [MONDO:0011257](http://purl.obolibrary.org/obo/MONDO_0011257) (MPI-CDG), [MONDO:0012588](http://purl.obolibrary.org/obo/MONDO_0012588) (neuronal ceroid lipofuscinosis 7), [MONDO:0011240](http://purl.obolibrary.org/obo/MONDO_0011240) (megalencephaly-capillary malformation-polymicrogyria syndrome), [MONDO:0012571](http://purl.obolibrary.org/obo/MONDO_0012571) (primary ciliary dyskinesia 6), [MONDO:0012575](http://purl.obolibrary.org/obo/MONDO_0012575) (branchiootorenal syndrome 2), [MONDO:0011244](http://purl.obolibrary.org/obo/MONDO_0011244) (Marshall-Smith syndrome), [MONDO:0011243](http://purl.obolibrary.org/obo/MONDO_0011243) (Grange syndrome), [MONDO:0011242](http://purl.obolibrary.org/obo/MONDO_0011242) (Bartter disease type 4a), [MONDO:0011248](http://purl.obolibrary.org/obo/MONDO_0011248) (distal monosomy 13q), [MONDO:0012579](http://purl.obolibrary.org/obo/MONDO_0012579) (autoimmune pulmonary alveolar proteinosis), [MONDO:0011246](http://purl.obolibrary.org/obo/MONDO_0011246) (megaconial type congenital muscular dystrophy), [MONDO:0012576](http://purl.obolibrary.org/obo/MONDO_0012576) (PSNP3), [MONDO:0011245](http://purl.obolibrary.org/obo/MONDO_0011245) (ichthyosis, hystrix-like, with deafness), [MONDO:0011292](http://purl.obolibrary.org/obo/MONDO_0011292) (dermatitis, atopic), [MONDO:0011296](http://purl.obolibrary.org/obo/MONDO_0011296) (Meckel syndrome, type 2), [MONDO:0011291](http://purl.obolibrary.org/obo/MONDO_0011291) (congenital disorder of glycosylation type 1C), [MONDO:0011284](http://purl.obolibrary.org/obo/MONDO_0011284) (astigmatism (disease)), [MONDO:0011283](http://purl.obolibrary.org/obo/MONDO_0011283) (mitochondrial DNA depletion syndrome 1), [MONDO:0011281](http://purl.obolibrary.org/obo/MONDO_0011281) (congenital myasthenic syndrome 5), [MONDO:0011287](http://purl.obolibrary.org/obo/MONDO_0011287) (craniosynostosis-anal anomalies-porokeratosis syndrome), [MONDO:0011286](http://purl.obolibrary.org/obo/MONDO_0011286) (autosomal recessive nonsyndromic deafness 13), [MONDO:0011285](http://purl.obolibrary.org/obo/MONDO_0011285) (age related macular degeneration 1), [MONDO:0002809](http://purl.obolibrary.org/obo/MONDO_0002809) (pancreatic cystadenoma), [MONDO:0002806](http://purl.obolibrary.org/obo/MONDO_0002806) (bronchus carcinoma), [MONDO:0002805](http://purl.obolibrary.org/obo/MONDO_0002805) (hidradenoma), [MONDO:0002808](http://purl.obolibrary.org/obo/MONDO_0002808) (pancreatic serous cystadenoma), [MONDO:0002807](http://purl.obolibrary.org/obo/MONDO_0002807) (bronchial neoplasm (disease)), [MONDO:0002804](http://purl.obolibrary.org/obo/MONDO_0002804) (apocrine adenoma), [MONDO:0002839](http://purl.obolibrary.org/obo/MONDO_0002839) (linitis plastica), [MONDO:0002835](http://purl.obolibrary.org/obo/MONDO_0002835) (papillary transitional carcinoma), [MONDO:0001503](http://purl.obolibrary.org/obo/MONDO_0001503) (primary eye hypotony), [MONDO:0002834](http://purl.obolibrary.org/obo/MONDO_0002834) (primary prostate urothelial carcinoma), [MONDO:0002837](http://purl.obolibrary.org/obo/MONDO_0002837) (sarcomatoid transitional cell carcinoma), [MONDO:0002836](http://purl.obolibrary.org/obo/MONDO_0002836) (urethra transitional cell carcinoma), [MONDO:0002831](http://purl.obolibrary.org/obo/MONDO_0002831) (non-keratinizing sinonasal squamous cell carcinoma), [MONDO:0002830](http://purl.obolibrary.org/obo/MONDO_0002830) (ovary transitional cell carcinoma), [MONDO:0002833](http://purl.obolibrary.org/obo/MONDO_0002833) (fallopian tube transitional cell carcinoma), [MONDO:0001502](http://purl.obolibrary.org/obo/MONDO_0001502) (retroperitoneum carcinoma), [MONDO:0001501](http://purl.obolibrary.org/obo/MONDO_0001501) (retroperitoneal sarcoma), [MONDO:0002832](http://purl.obolibrary.org/obo/MONDO_0002832) (endometrial transitional cell carcinoma), [MONDO:0014828](http://purl.obolibrary.org/obo/MONDO_0014828) (immunodeficiency-centromeric instability-facial anomalies syndrome 3), [MONDO:0014829](http://purl.obolibrary.org/obo/MONDO_0014829) (immunodeficiency-centromeric instability-facial anomalies syndrome 4), [MONDO:0014824](http://purl.obolibrary.org/obo/MONDO_0014824) (craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome), [MONDO:0014826](http://purl.obolibrary.org/obo/MONDO_0014826) (nucleoside diphosphate-linked Moiety X Motif 15 deficiency; NUDT15D), [MONDO:0014820](http://purl.obolibrary.org/obo/MONDO_0014820) (mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type); MTDPS14), [MONDO:0014821](http://purl.obolibrary.org/obo/MONDO_0014821) (complex lethal osteochondrodysplasia), [MONDO:0014823](http://purl.obolibrary.org/obo/MONDO_0014823) (hypotonia, infantile, with psychomotor retardation and characteristic facies 3; IHPRF3), [MONDO:0001519](http://purl.obolibrary.org/obo/MONDO_0001519) (entropion (disease)), [MONDO:0001518](http://purl.obolibrary.org/obo/MONDO_0001518) (spastic entropion), [MONDO:0002849](http://purl.obolibrary.org/obo/MONDO_0002849) (liver rhabdomyosarcoma), [MONDO:0001515](http://purl.obolibrary.org/obo/MONDO_0001515) (corneal degeneration), [MONDO:0002848](http://purl.obolibrary.org/obo/MONDO_0002848) (skeletal muscle neoplasm), [MONDO:0001516](http://purl.obolibrary.org/obo/MONDO_0001516) (spinal muscular atrophy), [MONDO:0002847](http://purl.obolibrary.org/obo/MONDO_0002847) (skeletal muscle cancer), [MONDO:0014819](http://purl.obolibrary.org/obo/MONDO_0014819) (autosomal dominant Robinow syndrome 3), [MONDO:0014814](http://purl.obolibrary.org/obo/MONDO_0014814) (advanced sleep phase syndrome 3), [MONDO:0014810](http://purl.obolibrary.org/obo/MONDO_0014810) (pancytopenia due to IKZF1 mutations), [MONDO:0002817](http://purl.obolibrary.org/obo/MONDO_0002817) (adrenal gland cancer), [MONDO:0002813](http://purl.obolibrary.org/obo/MONDO_0002813) (lipomatous cancer), [MONDO:0002814](http://purl.obolibrary.org/obo/MONDO_0002814) (adrenal carcinoma), [MONDO:0002811](http://purl.obolibrary.org/obo/MONDO_0002811) (main bronchus cancer), [MONDO:0002810](http://purl.obolibrary.org/obo/MONDO_0002810) (pancreatic serous cystic neoplasm), [MONDO:0014806](http://purl.obolibrary.org/obo/MONDO_0014806) (spinal muscular atrophy with congenital bone fractures 1), [MONDO:0014807](http://purl.obolibrary.org/obo/MONDO_0014807) (spinal muscular atrophy with congenital bone fractures 2), [MONDO:0014808](http://purl.obolibrary.org/obo/MONDO_0014808) (congenital secretory sodium diarrhea 8), [MONDO:0014802](http://purl.obolibrary.org/obo/MONDO_0014802) (Cowden syndrome 7), [MONDO:0014803](http://purl.obolibrary.org/obo/MONDO_0014803) (spasticity-ataxia-gait anomalies syndrome), [MONDO:0014804](http://purl.obolibrary.org/obo/MONDO_0014804) (adult-onset autosomal recessive sideroblastic anemia), [MONDO:0014800](http://purl.obolibrary.org/obo/MONDO_0014800) (progressive scapulohumeroperoneal distal myopathy), [MONDO:0002828](http://purl.obolibrary.org/obo/MONDO_0002828) (Bartholin's gland transitional cell carcinoma), [MONDO:0002829](http://purl.obolibrary.org/obo/MONDO_0002829) (Bartholin's gland carcinoma), [MONDO:0002823](http://purl.obolibrary.org/obo/MONDO_0002823) (thyroid medullary carcinoma), [MONDO:0002822](http://purl.obolibrary.org/obo/MONDO_0002822) (trabecular adenocarcinoma), [MONDO:0002821](http://purl.obolibrary.org/obo/MONDO_0002821) (trabecular follicular adenocarcinoma), [MONDO:0013530](http://purl.obolibrary.org/obo/MONDO_0013530) (atrial fibrillation, familial, 10), [MONDO:0014861](http://purl.obolibrary.org/obo/MONDO_0014861) (autoimmune disease, multisystem, infantile-onset, 2; ADMIO2), [MONDO:0013531](http://purl.obolibrary.org/obo/MONDO_0013531) (PSPH deficiency), [MONDO:0012201](http://purl.obolibrary.org/obo/MONDO_0012201) (tibia, bowing of, with Pseudarthrosis and pectus excavatum), [MONDO:0012200](http://purl.obolibrary.org/obo/MONDO_0012200) (posterior polymorphous corneal dystrophy 3), [MONDO:0002879](http://purl.obolibrary.org/obo/MONDO_0002879) (uterine body mixed cancer), [MONDO:0002878](http://purl.obolibrary.org/obo/MONDO_0002878) (uterine corpus adenosarcoma), [MONDO:0001549](http://purl.obolibrary.org/obo/MONDO_0001549) (hemolytic-uremic syndrome), [MONDO:0002874](http://purl.obolibrary.org/obo/MONDO_0002874) (testicular pure germ cell tumor), [MONDO:0000213](http://purl.obolibrary.org/obo/MONDO_0000213) (autoimmune disease, multisystem, infantile-onset), [MONDO:0002877](http://purl.obolibrary.org/obo/MONDO_0002877) (cervical carcinosarcoma), [MONDO:0002876](http://purl.obolibrary.org/obo/MONDO_0002876) (cervical adenosarcoma), [MONDO:0002871](http://purl.obolibrary.org/obo/MONDO_0002871) (testicular trophoblastic tumor), [MONDO:0000210](http://purl.obolibrary.org/obo/MONDO_0000210) (thiopurine metabolic disease), [MONDO:0002872](http://purl.obolibrary.org/obo/MONDO_0002872) (trophoblastic neoplasm), [MONDO:0013537](http://purl.obolibrary.org/obo/MONDO_0013537) (autosomal recessive nonsyndromic deafness 29), [MONDO:0012204](http://purl.obolibrary.org/obo/MONDO_0012204) (familial pseudohyperkalemia), [MONDO:0013539](http://purl.obolibrary.org/obo/MONDO_0013539) (hypotonia-failure to thrive-microcephaly syndrome), [MONDO:0013533](http://purl.obolibrary.org/obo/MONDO_0013533) (hyperlipidemia due to hepatic triglyceride lipase deficiency), [MONDO:0012209](http://purl.obolibrary.org/obo/MONDO_0012209) (Branchiogenic deafness syndrome), [MONDO:0013534](http://purl.obolibrary.org/obo/MONDO_0013534) (apolipoprotein c-Iii deficiency), [MONDO:0014866](http://purl.obolibrary.org/obo/MONDO_0014866) (Charcot-Marie-tooth disease axonal type 2T), [MONDO:0012206](http://purl.obolibrary.org/obo/MONDO_0012206) (Czech dysplasia, metatarsal type), [MONDO:0014867](http://purl.obolibrary.org/obo/MONDO_0014867) (spinocerebellar ataxia 43; SCA43), [MONDO:0013520](http://purl.obolibrary.org/obo/MONDO_0013520) (dyskeratosis congenita, autosomal recessive 3), [MONDO:0013521](http://purl.obolibrary.org/obo/MONDO_0013521) (dyskeratosis congenita, autosomal dominant 2), [MONDO:0002889](http://purl.obolibrary.org/obo/MONDO_0002889) (orbital cancer), [MONDO:0001555](http://purl.obolibrary.org/obo/MONDO_0001555) (neonatal thyrotoxicosis), [MONDO:0000224](http://purl.obolibrary.org/obo/MONDO_0000224) (acquired carbohydrate metabolism disease), [MONDO:0001554](http://purl.obolibrary.org/obo/MONDO_0001554) (phacogenic glaucoma), [MONDO:0002888](http://purl.obolibrary.org/obo/MONDO_0002888) (intraorbital meningioma), [MONDO:0000226](http://purl.obolibrary.org/obo/MONDO_0000226) (mineral metabolism disease), [MONDO:0002882](http://purl.obolibrary.org/obo/MONDO_0002882) (colon neuroendocrine neoplasm), [MONDO:0002881](http://purl.obolibrary.org/obo/MONDO_0002881) (vaginal adenosarcoma), [MONDO:0001553](http://purl.obolibrary.org/obo/MONDO_0001553) (phacolytic glaucoma), [MONDO:0002883](http://purl.obolibrary.org/obo/MONDO_0002883) (intestinal neuroendocrine neoplasm), [MONDO:0002880](http://purl.obolibrary.org/obo/MONDO_0002880) (ovarian mesodermal adenosarcoma), [MONDO:0013527](http://purl.obolibrary.org/obo/MONDO_0013527) (lissencephaly 4), [MONDO:0013529](http://purl.obolibrary.org/obo/MONDO_0013529) (catecholaminergic polymorphic ventricular tachycardia 3), [MONDO:0014853](http://purl.obolibrary.org/obo/MONDO_0014853) (autosomal dominant nonsyndromic deafness 70), [MONDO:0013522](http://purl.obolibrary.org/obo/MONDO_0013522) (dyskeratosis congenita, autosomal dominant 3), [MONDO:0014854](http://purl.obolibrary.org/obo/MONDO_0014854) (autosomal dominant nonsyndromic deafness 66), [MONDO:0013523](http://purl.obolibrary.org/obo/MONDO_0013523) (Nestor-Guillermo progeria syndrome), [MONDO:0013524](http://purl.obolibrary.org/obo/MONDO_0013524) (bleeding diathesis due to thromboxane synthesis deficiency), [MONDO:0013525](http://purl.obolibrary.org/obo/MONDO_0013525) (primary ciliary dyskinesia 16), [MONDO:0014856](http://purl.obolibrary.org/obo/MONDO_0014856) (combined oxidative phosphorylation defect type 30), [MONDO:0014840](http://purl.obolibrary.org/obo/MONDO_0014840) (agammaglobulinemia 8, autosomal dominant; AGM8), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0014841](http://purl.obolibrary.org/obo/MONDO_0014841) (trichothiodystrophy 6, nonphotosensitive; TTD6), [MONDO:0001529](http://purl.obolibrary.org/obo/MONDO_0001529) (pancytopenia), [MONDO:0001526](http://purl.obolibrary.org/obo/MONDO_0001526) (labia minora cancer), [MONDO:0002857](http://purl.obolibrary.org/obo/MONDO_0002857) (gallbladder sarcoma), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0002859](http://purl.obolibrary.org/obo/MONDO_0002859) (breast rhabdomyosarcoma), [MONDO:0001528](http://purl.obolibrary.org/obo/MONDO_0001528) (vulva cancer), [MONDO:0002858](http://purl.obolibrary.org/obo/MONDO_0002858) (ovary rhabdomyosarcoma), [MONDO:0001527](http://purl.obolibrary.org/obo/MONDO_0001527) (conjugate gaze palsy), [MONDO:0002853](http://purl.obolibrary.org/obo/MONDO_0002853) (rectum rhabdomyosarcoma), [MONDO:0002852](http://purl.obolibrary.org/obo/MONDO_0002852) (mediastinum sarcoma), [MONDO:0001524](http://purl.obolibrary.org/obo/MONDO_0001524) (globe disease), [MONDO:0002855](http://purl.obolibrary.org/obo/MONDO_0002855) (ectomesenchymoma), [MONDO:0001523](http://purl.obolibrary.org/obo/MONDO_0001523) (luxation of globe), [MONDO:0002854](http://purl.obolibrary.org/obo/MONDO_0002854) (prostate sarcoma), [MONDO:0002851](http://purl.obolibrary.org/obo/MONDO_0002851) (mediastinum rhabdomyosarcoma), [MONDO:0002850](http://purl.obolibrary.org/obo/MONDO_0002850) (central nervous system rhabdomyosarcoma), [MONDO:0013519](http://purl.obolibrary.org/obo/MONDO_0013519) (dyskeratosis congenita, autosomal recessive 2), [MONDO:0014846](http://purl.obolibrary.org/obo/MONDO_0014846) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency), [MONDO:0013515](http://purl.obolibrary.org/obo/MONDO_0013515) (osteogenesis imperfecta type 6), [MONDO:0013516](http://purl.obolibrary.org/obo/MONDO_0013516) (retinitis pigmentosa 60), [MONDO:0014847](http://purl.obolibrary.org/obo/MONDO_0014847) (spermatogenic failure 15; SPGF15), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia HBB/LCRB), [MONDO:0014849](http://purl.obolibrary.org/obo/MONDO_0014849) (autosomal recessive nonsyndromic deafness 105), [MONDO:0013518](http://purl.obolibrary.org/obo/MONDO_0013518) (pituitary hormone deficiency, combined, 6), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0013513](http://purl.obolibrary.org/obo/MONDO_0013513) (atrial fibrillation, familial, 9), [MONDO:0014845](http://purl.obolibrary.org/obo/MONDO_0014845) (spinocerebellar ataxia, autosomal recessive 22; SCAR22), [MONDO:0014830](http://purl.obolibrary.org/obo/MONDO_0014830) (platelet-type bleeding disorder 20), [MONDO:0000209](http://purl.obolibrary.org/obo/MONDO_0000209) (spinal muscular atrophy with congenital bone fractures), [MONDO:0002868](http://purl.obolibrary.org/obo/MONDO_0002868) (bile duct cystadenocarcinoma), [MONDO:0002867](http://purl.obolibrary.org/obo/MONDO_0002867) (pancreatic cystadenocarcinoma), [MONDO:0001536](http://purl.obolibrary.org/obo/MONDO_0001536) (vaginal leiomyoma), [MONDO:0001539](http://purl.obolibrary.org/obo/MONDO_0001539) (retinal perforation), [MONDO:0001538](http://purl.obolibrary.org/obo/MONDO_0001538) (retinal ischemia), [MONDO:0000208](http://purl.obolibrary.org/obo/MONDO_0000208) (microcephaly, short stature, and impaired glucose metabolism), [MONDO:0002864](http://purl.obolibrary.org/obo/MONDO_0002864) (anus rhabdomyosarcoma), [MONDO:0000201](http://purl.obolibrary.org/obo/MONDO_0000201) (thyroid cancer, nonmedullary), [MONDO:0002863](http://purl.obolibrary.org/obo/MONDO_0002863) (mixed type rhabdomyosarcoma), [MONDO:0002865](http://purl.obolibrary.org/obo/MONDO_0002865) (anus sarcoma), [MONDO:0001534](http://purl.obolibrary.org/obo/MONDO_0001534) (ocular hyperemia), [MONDO:0002860](http://purl.obolibrary.org/obo/MONDO_0002860) (testis rhabdomyosarcoma), [MONDO:0002862](http://purl.obolibrary.org/obo/MONDO_0002862) (bile duct sarcoma), [MONDO:0001531](http://purl.obolibrary.org/obo/MONDO_0001531) (blood coagulation disease), [MONDO:0002861](http://purl.obolibrary.org/obo/MONDO_0002861) (testis sarcoma), [MONDO:0000200](http://purl.obolibrary.org/obo/MONDO_0000200) (Zimmermann-Laband syndrome), [MONDO:0013508](http://purl.obolibrary.org/obo/MONDO_0013508) (MYP19), [MONDO:0013504](http://purl.obolibrary.org/obo/MONDO_0013504) (spermatogenic failure 8), [MONDO:0013505](http://purl.obolibrary.org/obo/MONDO_0013505) (spermatogenic failure 9), [MONDO:0014836](http://purl.obolibrary.org/obo/MONDO_0014836) (Charcot-Marie-tooth disease axonal type 2CC), [MONDO:0014837](http://purl.obolibrary.org/obo/MONDO_0014837) (hereditary thrombocytopenia with early-onset myelofibrosis), [MONDO:0013506](http://purl.obolibrary.org/obo/MONDO_0013506) (schizophrenia 16), [MONDO:0014838](http://purl.obolibrary.org/obo/MONDO_0014838) (Coffin-Siris syndrome 5; CSS5), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0013501](http://purl.obolibrary.org/obo/MONDO_0013501) (amyotrophic lateral sclerosis type 14), [MONDO:0013502](http://purl.obolibrary.org/obo/MONDO_0013502) (amyloidosis, primary localized cutaneous, 2), [MONDO:0012241](http://purl.obolibrary.org/obo/MONDO_0012241) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 3), [MONDO:0013573](http://purl.obolibrary.org/obo/MONDO_0013573) (cranioectodermal dysplasia 3), [MONDO:0012240](http://purl.obolibrary.org/obo/MONDO_0012240) (nemaline myopathy 4), [MONDO:0013574](http://purl.obolibrary.org/obo/MONDO_0013574) (cutis laxa-marfanoid syndrome), [MONDO:0013576](http://purl.obolibrary.org/obo/MONDO_0013576) (recurrent infections associated with rare immunoglobulin isotypes deficiency), [MONDO:0012245](http://purl.obolibrary.org/obo/MONDO_0012245) (epileptic encephalopathy, early infantile, 3), [MONDO:0013570](http://purl.obolibrary.org/obo/MONDO_0013570) (combined oxidative phosphorylation defect type 8), [MONDO:0012244](http://purl.obolibrary.org/obo/MONDO_0012244) (prostate cancer, hereditary, 5), [MONDO:0013571](http://purl.obolibrary.org/obo/MONDO_0013571) (acatalasia), [MONDO:0013572](http://purl.obolibrary.org/obo/MONDO_0013572) (Keppen-Lubinsky syndrome), [MONDO:0001588](http://purl.obolibrary.org/obo/MONDO_0001588) (chronic lacrimal gland enlargement), [MONDO:0001583](http://purl.obolibrary.org/obo/MONDO_0001583) (diabetic polyneuropathy), [MONDO:0001586](http://purl.obolibrary.org/obo/MONDO_0001586) (mucopolysaccharidosis type 1), [MONDO:0001580](http://purl.obolibrary.org/obo/MONDO_0001580) (lacrimal duct cancer), [MONDO:0001582](http://purl.obolibrary.org/obo/MONDO_0001582) (cicatricial ectropion), [MONDO:0012249](http://purl.obolibrary.org/obo/MONDO_0012249) (colorectal cancer, hereditary nonpolyposis, type 2), [MONDO:0012248](http://purl.obolibrary.org/obo/MONDO_0012248) (autosomal recessive limb-girdle muscular dystrophy type 2K), [MONDO:0012247](http://purl.obolibrary.org/obo/MONDO_0012247) (spinocerebellar ataxia type 27), [MONDO:0012246](http://purl.obolibrary.org/obo/MONDO_0012246) (spinocerebellar ataxia type 26), [MONDO:0013578](http://purl.obolibrary.org/obo/MONDO_0013578) (DYRK1A-related intellectual disability syndrome), [MONDO:0013579](http://purl.obolibrary.org/obo/MONDO_0013579) (developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency), [MONDO:0012230](http://purl.obolibrary.org/obo/MONDO_0012230) (MYP10), [MONDO:0013563](http://purl.obolibrary.org/obo/MONDO_0013563) (multiple congenital anomalies-hypotonia-seizures syndrome 1), [MONDO:0014894](http://purl.obolibrary.org/obo/MONDO_0014894) (Meier-Gorlin syndrome 7; MGORS7), [MONDO:0014896](http://purl.obolibrary.org/obo/MONDO_0014896) (muscular dystrophy, congenital, Davignon-Chauveau type; MDCDC), [MONDO:0013565](http://purl.obolibrary.org/obo/MONDO_0013565) (Fanconi anemia complementation group G), [MONDO:0012234](http://purl.obolibrary.org/obo/MONDO_0012234) (LFS3), [MONDO:0012233](http://purl.obolibrary.org/obo/MONDO_0012233) (Li-Fraumeni syndrome 2), [MONDO:0013560](http://purl.obolibrary.org/obo/MONDO_0013560) (Hermansky-Pudlak syndrome 8), [MONDO:0012231](http://purl.obolibrary.org/obo/MONDO_0012231) (Charcot-Marie-tooth disease type 2A2), [MONDO:0014892](http://purl.obolibrary.org/obo/MONDO_0014892) (micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome), [MONDO:0013561](http://purl.obolibrary.org/obo/MONDO_0013561) (chondrodysplasia with joint dislocations, gPAPP type), [MONDO:0001598](http://purl.obolibrary.org/obo/MONDO_0001598) (benign lymphoepithelial lesion of salivary gland), [MONDO:0001591](http://purl.obolibrary.org/obo/MONDO_0001591) (senile entropion), [MONDO:0000260](http://purl.obolibrary.org/obo/MONDO_0000260) (Kartagener syndrome), [MONDO:0012238](http://purl.obolibrary.org/obo/MONDO_0012238) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 2), [MONDO:0012237](http://purl.obolibrary.org/obo/MONDO_0012237) (nemaline myopathy 6), [MONDO:0012236](http://purl.obolibrary.org/obo/MONDO_0012236) (KTCN4), [MONDO:0012235](http://purl.obolibrary.org/obo/MONDO_0012235) (autosomal recessive spinocerebellar ataxia 7), [MONDO:0013566](http://purl.obolibrary.org/obo/MONDO_0013566) (Fanconi anemia complementation group L), [MONDO:0014898](http://purl.obolibrary.org/obo/MONDO_0014898) (progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3; PEOB3), [MONDO:0013567](http://purl.obolibrary.org/obo/MONDO_0013567) (atrial heart septal defect 3), [MONDO:0013568](http://purl.obolibrary.org/obo/MONDO_0013568) (sick sinus syndrome 3, susceptibility to), [MONDO:0014899](http://purl.obolibrary.org/obo/MONDO_0014899) (adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency), [MONDO:0012239](http://purl.obolibrary.org/obo/MONDO_0012239) (nemaline myopathy 1), [MONDO:0013569](http://purl.obolibrary.org/obo/MONDO_0013569) (short-rib thoracic dysplasia 7 with or without polydactyly), [MONDO:0014882](http://purl.obolibrary.org/obo/MONDO_0014882) (hereditary spastic paraplegia 77), [MONDO:0013553](http://purl.obolibrary.org/obo/MONDO_0013553) (immunodeficiency-centromeric instability-facial anomalies syndrome 2), [MONDO:0014884](http://purl.obolibrary.org/obo/MONDO_0014884) (cholestasis, progressive familial intrahepatic, 5; PFIC5), [MONDO:0014885](http://purl.obolibrary.org/obo/MONDO_0014885) (Hermansky-Pudlak syndrome 10; HPS10), [MONDO:0012222](http://purl.obolibrary.org/obo/MONDO_0012222) (alpha-N-acetylgalactosaminidase deficiency type 2), [MONDO:0012221](http://purl.obolibrary.org/obo/MONDO_0012221) (alpha-N-acetylgalactosaminidase deficiency type 1), [MONDO:0014880](http://purl.obolibrary.org/obo/MONDO_0014880) (Duane retraction syndrome 3 with or without deafness; DURS3), [MONDO:0013550](http://purl.obolibrary.org/obo/MONDO_0013550) (distal myopathy with posterior leg and anterior hand involvement), [MONDO:0012220](http://purl.obolibrary.org/obo/MONDO_0012220) (Griscelli syndrome type 3), [MONDO:0001569](http://purl.obolibrary.org/obo/MONDO_0001569) (acoustic neuroma), [MONDO:0001566](http://purl.obolibrary.org/obo/MONDO_0001566) (hypercalcemia (disease)), [MONDO:0001565](http://purl.obolibrary.org/obo/MONDO_0001565) (abnormal retinal correspondence), [MONDO:0002899](http://purl.obolibrary.org/obo/MONDO_0002899) (differentiating neuroblastoma), [MONDO:0002898](http://purl.obolibrary.org/obo/MONDO_0002898) (skin cancer), [MONDO:0001567](http://purl.obolibrary.org/obo/MONDO_0001567) (nephrocalcinosis), [MONDO:0002892](http://purl.obolibrary.org/obo/MONDO_0002892) (skull base chordoma), [MONDO:0001564](http://purl.obolibrary.org/obo/MONDO_0001564) (binocular vision disease), [MONDO:0002894](http://purl.obolibrary.org/obo/MONDO_0002894) (spinal chordoma), [MONDO:0002891](http://purl.obolibrary.org/obo/MONDO_0002891) (gastrointestinal neuroendocrine benign tumor), [MONDO:0002890](http://purl.obolibrary.org/obo/MONDO_0002890) (gastrointestinal adenoma), [MONDO:0012227](http://purl.obolibrary.org/obo/MONDO_0012227) (MYP7), [MONDO:0013559](http://purl.obolibrary.org/obo/MONDO_0013559) (Hermansky-Pudlak syndrome 7), [MONDO:0012225](http://purl.obolibrary.org/obo/MONDO_0012225) (Senior-Loken syndrome 5), [MONDO:0013555](http://purl.obolibrary.org/obo/MONDO_0013555) (Hermansky-Pudlak syndrome 3), [MONDO:0013556](http://purl.obolibrary.org/obo/MONDO_0013556) (Hermansky-Pudlak syndrome 4), [MONDO:0012229](http://purl.obolibrary.org/obo/MONDO_0012229) (MYP9), [MONDO:0013557](http://purl.obolibrary.org/obo/MONDO_0013557) (Hermansky-Pudlak syndrome 5), [MONDO:0012228](http://purl.obolibrary.org/obo/MONDO_0012228) (MYP8), [MONDO:0013558](http://purl.obolibrary.org/obo/MONDO_0013558) (Hermansky-Pudlak syndrome 6), [MONDO:0013540](http://purl.obolibrary.org/obo/MONDO_0013540) (deafness-lymphedema-leukemia syndrome), [MONDO:0014871](http://purl.obolibrary.org/obo/MONDO_0014871) (retinitis pigmentosa 75), [MONDO:0014872](http://purl.obolibrary.org/obo/MONDO_0014872) (congenital stationary night blindness 1H), [MONDO:0013541](http://purl.obolibrary.org/obo/MONDO_0013541) (complex cortical dysplasia with other brain malformations 1), [MONDO:0014873](http://purl.obolibrary.org/obo/MONDO_0014873) (nevus comedonicus syndrome), [MONDO:0014874](http://purl.obolibrary.org/obo/MONDO_0014874) (pontocerebellar hypoplasia, type 2F; PCH2F), [MONDO:0012211](http://purl.obolibrary.org/obo/MONDO_0012211) (MPDU1-CDG), [MONDO:0014870](http://purl.obolibrary.org/obo/MONDO_0014870) (NEK9-related lethal skeletal dysplasia), [MONDO:0001579](http://purl.obolibrary.org/obo/MONDO_0001579) (corneal staphyloma), [MONDO:0000241](http://purl.obolibrary.org/obo/MONDO_0000241) (Keshan disease), [MONDO:0001572](http://purl.obolibrary.org/obo/MONDO_0001572) (leiomyoma), [MONDO:0001571](http://purl.obolibrary.org/obo/MONDO_0001571) (gynecomastia), [MONDO:0014879](http://purl.obolibrary.org/obo/MONDO_0014879) (patent ductus arteriosus 3; PDA3), [MONDO:0012216](http://purl.obolibrary.org/obo/MONDO_0012216) (foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome), [MONDO:0012215](http://purl.obolibrary.org/obo/MONDO_0012215) (myofibrillar myopathy 3), [MONDO:0012214](http://purl.obolibrary.org/obo/MONDO_0012214) (GCCD3), [MONDO:0013544](http://purl.obolibrary.org/obo/MONDO_0013544) (atrial fibrillation, familial, 11), [MONDO:0012219](http://purl.obolibrary.org/obo/MONDO_0012219) (spondyloepiphyseal dysplasia tarda, autosomal recessive, Leroy-Spranger type), [MONDO:0013545](http://purl.obolibrary.org/obo/MONDO_0013545) (atrial fibrillation, familial, 12), [MONDO:0013546](http://purl.obolibrary.org/obo/MONDO_0013546) (mitochondrial complex v (ATP synthase) deficiency nuclear type 2), [MONDO:0014877](http://purl.obolibrary.org/obo/MONDO_0014877) (myopathy, distal, 5; MPD5), [MONDO:0014878](http://purl.obolibrary.org/obo/MONDO_0014878) (patent ductus arteriosus 2; PDA2), [MONDO:0012217](http://purl.obolibrary.org/obo/MONDO_0012217) (Bruck syndrome 2), [MONDO:0013547](http://purl.obolibrary.org/obo/MONDO_0013547) (mitochondrial complex v (ATP synthase) deficiency nuclear type 3), [MONDO:0012289](http://purl.obolibrary.org/obo/MONDO_0012289) (myofibrillar myopathy 5), [MONDO:0012287](http://purl.obolibrary.org/obo/MONDO_0012287) (Stickler syndrome, type i, nonsyndromic ocular), [MONDO:0012286](http://purl.obolibrary.org/obo/MONDO_0012286) (myopathy, Autophagic vacuolar, infantile-onset), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0012280](http://purl.obolibrary.org/obo/MONDO_0012280) (Goldberg-Shprintzen megacolon syndrome), [MONDO:0012274](http://purl.obolibrary.org/obo/MONDO_0012274) (acromesomelic dysplasia, Demirhan type), [MONDO:0012273](http://purl.obolibrary.org/obo/MONDO_0012273) (autosomal recessive nonsyndromic deafness 48), [MONDO:0012271](http://purl.obolibrary.org/obo/MONDO_0012271) (mesoaxial synostotic syndactyly with phalangeal reduction), [MONDO:0012278](http://purl.obolibrary.org/obo/MONDO_0012278) (PSNP2), [MONDO:0012277](http://purl.obolibrary.org/obo/MONDO_0012277) (myofibrillar myopathy 4), [MONDO:0012275](http://purl.obolibrary.org/obo/MONDO_0012275) (fetal valproate syndrome), [MONDO:0012270](http://purl.obolibrary.org/obo/MONDO_0012270) (Tukel syndrome), [MONDO:0012279](http://purl.obolibrary.org/obo/MONDO_0012279) (congenital muscular dystrophy merosin-positive), [MONDO:0012263](http://purl.obolibrary.org/obo/MONDO_0012263) (AIS4), [MONDO:0012262](http://purl.obolibrary.org/obo/MONDO_0012262) (CFEOM3C), [MONDO:0013597](http://purl.obolibrary.org/obo/MONDO_0013597) (platelet-type bleeding disorder 14), [MONDO:0012260](http://purl.obolibrary.org/obo/MONDO_0012260) (cataract 35), [MONDO:0013591](http://purl.obolibrary.org/obo/MONDO_0013591) (epiphyseal dysplasia, multiple, 6), [MONDO:0012267](http://purl.obolibrary.org/obo/MONDO_0012267) (holoprosencephaly 8), [MONDO:0013592](http://purl.obolibrary.org/obo/MONDO_0013592) (nonsyndromic congenital nail disorder 9), [MONDO:0013593](http://purl.obolibrary.org/obo/MONDO_0013593) (autosomal dominant nonsyndromic deafness 64), [MONDO:0013594](http://purl.obolibrary.org/obo/MONDO_0013594) (spinocerebellar ataxia type 36), [MONDO:0013590](http://purl.obolibrary.org/obo/MONDO_0013590) (Stickler syndrome, type 4), [MONDO:0013599](http://purl.obolibrary.org/obo/MONDO_0013599) (autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome), [MONDO:0013584](http://purl.obolibrary.org/obo/MONDO_0013584) (hereditary sensory neuropathy-deafness-dementia syndrome), [MONDO:0012252](http://purl.obolibrary.org/obo/MONDO_0012252) (rhabdoid tumor predisposition syndrome 1), [MONDO:0012251](http://purl.obolibrary.org/obo/MONDO_0012251) (MEDNIK syndrome), [MONDO:0013585](http://purl.obolibrary.org/obo/MONDO_0013585) (hydrolethalus syndrome 2), [MONDO:0012250](http://purl.obolibrary.org/obo/MONDO_0012250) (Charcot-Marie-tooth disease type 4H), [MONDO:0013587](http://purl.obolibrary.org/obo/MONDO_0013587) (glycogen storage disease due to lactate dehydrogenase H-subunit deficiency), [MONDO:0013580](http://purl.obolibrary.org/obo/MONDO_0013580) (pyruvate dehydrogenase E1-beta deficiency), [MONDO:0013582](http://purl.obolibrary.org/obo/MONDO_0013582) (mosaic variegated aneuploidy syndrome 2), [MONDO:0012254](http://purl.obolibrary.org/obo/MONDO_0012254) (multiple epiphyseal dysplasia, with miniepiphyses), [MONDO:0013583](http://purl.obolibrary.org/obo/MONDO_0013583) (occipital pachygyria and polymicrogyria), [MONDO:0012253](http://purl.obolibrary.org/obo/MONDO_0012253) (multiple epiphyseal dysplasia, with severe proximal femoral dysplasia), [MONDO:0012257](http://purl.obolibrary.org/obo/MONDO_0012257) (Cerebrorenodigital syndrome), [MONDO:0013588](http://purl.obolibrary.org/obo/MONDO_0013588) (Perrault syndrome 3), [MONDO:0012296](http://purl.obolibrary.org/obo/MONDO_0012296) (lipomyelomeningocele), [MONDO:0012293](http://purl.obolibrary.org/obo/MONDO_0012293) (autosomal recessive nonsyndromic deafness 23), [MONDO:0012299](http://purl.obolibrary.org/obo/MONDO_0012299) (nanophthalmos 2), [MONDO:0012297](http://purl.obolibrary.org/obo/MONDO_0012297) (SPOAN syndrome), [MONDO:0002919](http://purl.obolibrary.org/obo/MONDO_0002919) (posterior cranial fossa meningioma), [MONDO:0002916](http://purl.obolibrary.org/obo/MONDO_0002916) (brainstem intraparenchymal clear cell meningioma), [MONDO:0002915](http://purl.obolibrary.org/obo/MONDO_0002915) (childhood infratentorial neoplasm), [MONDO:0002918](http://purl.obolibrary.org/obo/MONDO_0002918) (clear cell meningioma), [MONDO:0002912](http://purl.obolibrary.org/obo/MONDO_0002912) (brain stem cancer), [MONDO:0002911](http://purl.obolibrary.org/obo/MONDO_0002911) (brain stem glioma), [MONDO:0002914](http://purl.obolibrary.org/obo/MONDO_0002914) (childhood brain stem neoplasm), [MONDO:0002913](http://purl.obolibrary.org/obo/MONDO_0002913) (cerebellar neoplasm), [MONDO:0014909](http://purl.obolibrary.org/obo/MONDO_0014909) (primary ciliary dyskinesia 34), [MONDO:0014906](http://purl.obolibrary.org/obo/MONDO_0014906) (Charcot-Marie-tooth disease, axonal, autosomal recessive, type 2a2b;), [MONDO:0014907](http://purl.obolibrary.org/obo/MONDO_0014907) (short-rib thoracic dysplasia 15 with polydactyly; SRTD15), [MONDO:0014908](http://purl.obolibrary.org/obo/MONDO_0014908) (microcephaly 17, primary, autosomal recessive; MCPH17), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0014904](http://purl.obolibrary.org/obo/MONDO_0014904) (congenital disorder of glycosylation, type Iaa; CDG1AA), [MONDO:0014900](http://purl.obolibrary.org/obo/MONDO_0014900) (autosomal recessive limb-girdle muscular dystrophy type 2Y), [MONDO:0002927](http://purl.obolibrary.org/obo/MONDO_0002927) (spindle cell sarcoma), [MONDO:0002926](http://purl.obolibrary.org/obo/MONDO_0002926) (clear cell sarcoma), [MONDO:0002928](http://purl.obolibrary.org/obo/MONDO_0002928) (carcinosarcoma), [MONDO:0002923](http://purl.obolibrary.org/obo/MONDO_0002923) (uterine corpus endometrial stromal sarcoma), [MONDO:0002924](http://purl.obolibrary.org/obo/MONDO_0002924) (smooth muscle cancer), [MONDO:0002920](http://purl.obolibrary.org/obo/MONDO_0002920) (malignant ovarian Brenner tumor), [MONDO:0002909](http://purl.obolibrary.org/obo/MONDO_0002909) (hyperglycemia), [MONDO:0002908](http://purl.obolibrary.org/obo/MONDO_0002908) (glucose metabolism disease), [MONDO:0002906](http://purl.obolibrary.org/obo/MONDO_0002906) (scleroderma), [MONDO:0002900](http://purl.obolibrary.org/obo/MONDO_0002900) (cerebral neuroblastoma), [MONDO:0001629](http://purl.obolibrary.org/obo/MONDO_0001629) (Jaccoud's syndrome), [MONDO:0002956](http://purl.obolibrary.org/obo/MONDO_0002956) (skin cystic basal cell carcinoma), [MONDO:0002955](http://purl.obolibrary.org/obo/MONDO_0002955) (vulva basal cell carcinoma), [MONDO:0002958](http://purl.obolibrary.org/obo/MONDO_0002958) (signet ring basal cell carcinoma), [MONDO:0002957](http://purl.obolibrary.org/obo/MONDO_0002957) (sarcomatoid basal cell carcinoma), [MONDO:0001626](http://purl.obolibrary.org/obo/MONDO_0001626) (traumatic glaucoma), [MONDO:0002952](http://purl.obolibrary.org/obo/MONDO_0002952) (follicular basal cell carcinoma), [MONDO:0002951](http://purl.obolibrary.org/obo/MONDO_0002951) (skin adenoid basal cell carcinoma), [MONDO:0001623](http://purl.obolibrary.org/obo/MONDO_0001623) (cicatricial lagophthalmos (disease)), [MONDO:0002954](http://purl.obolibrary.org/obo/MONDO_0002954) (superficial basal cell carcinoma), [MONDO:0001622](http://purl.obolibrary.org/obo/MONDO_0001622) (mechanical lagophthalmos), [MONDO:0002953](http://purl.obolibrary.org/obo/MONDO_0002953) (skin infiltrative basal cell carcinoma), [MONDO:0002950](http://purl.obolibrary.org/obo/MONDO_0002950) (skin clear cell basal cell carcinoma), [MONDO:0013614](http://purl.obolibrary.org/obo/MONDO_0013614) (hypertelorism-preauricular sinus-punctual pits-deafness syndrome), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0013615](http://purl.obolibrary.org/obo/MONDO_0013615) (craniosynostosis and dental anomalies), [MONDO:0013617](http://purl.obolibrary.org/obo/MONDO_0013617) (overgrowth-macrocephaly-facial dysmorphism syndrome), [MONDO:0013610](http://purl.obolibrary.org/obo/MONDO_0013610) (retinitis pigmentosa 61), [MONDO:0013611](http://purl.obolibrary.org/obo/MONDO_0013611) (retinitis pigmentosa 62), [MONDO:0013612](http://purl.obolibrary.org/obo/MONDO_0013612) (Geleophysic dysplasia 2), [MONDO:0014943](http://purl.obolibrary.org/obo/MONDO_0014943) (mitochondrial DNA depletion syndrome 15 (hepatocerebral type);), [MONDO:0014944](http://purl.obolibrary.org/obo/MONDO_0014944) (short stature-brachydactyly-obesity-global developmental delay syndrome), [MONDO:0013613](http://purl.obolibrary.org/obo/MONDO_0013613) (Leber congenital amaurosis 16), [MONDO:0001639](http://purl.obolibrary.org/obo/MONDO_0001639) (deficiency anemia), [MONDO:0000309](http://purl.obolibrary.org/obo/MONDO_0000309) (aniseikonia), [MONDO:0001636](http://purl.obolibrary.org/obo/MONDO_0001636) (mechanical entropion), [MONDO:0002966](http://purl.obolibrary.org/obo/MONDO_0002966) (splenic manifestation of prolymphocytic leukemia), [MONDO:0001635](http://purl.obolibrary.org/obo/MONDO_0001635) (bladder squamous papilloma), [MONDO:0002969](http://purl.obolibrary.org/obo/MONDO_0002969) (ciliary body cancer), [MONDO:0001638](http://purl.obolibrary.org/obo/MONDO_0001638) (protein-deficiency anemia), [MONDO:0001637](http://purl.obolibrary.org/obo/MONDO_0001637) (cicatricial entropion), [MONDO:0002963](http://purl.obolibrary.org/obo/MONDO_0002963) (acantholytic acanthoma), [MONDO:0002962](http://purl.obolibrary.org/obo/MONDO_0002962) (epidermolytic acanthoma), [MONDO:0001634](http://purl.obolibrary.org/obo/MONDO_0001634) (bladder leiomyoma), [MONDO:0001633](http://purl.obolibrary.org/obo/MONDO_0001633) (central retinal artery occlusion), [MONDO:0001630](http://purl.obolibrary.org/obo/MONDO_0001630) (branch retinal artery occlusion), [MONDO:0002961](http://purl.obolibrary.org/obo/MONDO_0002961) (large cell acanthoma), [MONDO:0014938](http://purl.obolibrary.org/obo/MONDO_0014938) (aniridia 3; AN3), [MONDO:0013608](http://purl.obolibrary.org/obo/MONDO_0013608) (Joubert syndrome 13), [MONDO:0014939](http://purl.obolibrary.org/obo/MONDO_0014939) (congenital myasthenic syndrome 20), [MONDO:0013609](http://purl.obolibrary.org/obo/MONDO_0013609) (Meckel syndrome, type 10), [MONDO:0013603](http://purl.obolibrary.org/obo/MONDO_0013603) (MYP20), [MONDO:0014934](http://purl.obolibrary.org/obo/MONDO_0014934) (spinocerebellar ataxia, autosomal recessive 24; SCAR24), [MONDO:0013604](http://purl.obolibrary.org/obo/MONDO_0013604) (myopia 21, autosomal dominant), [MONDO:0014935](http://purl.obolibrary.org/obo/MONDO_0014935) (Frontometaphyseal dysplasia 2; FMD2), [MONDO:0013605](http://purl.obolibrary.org/obo/MONDO_0013605) (brittle cornea syndrome 2), [MONDO:0013606](http://purl.obolibrary.org/obo/MONDO_0013606) (Hermansky-Pudlak syndrome 9), [MONDO:0014937](http://purl.obolibrary.org/obo/MONDO_0014937) (aniridia 2; AN2), [MONDO:0013600](http://purl.obolibrary.org/obo/MONDO_0013600) (insomnia (disease)), [MONDO:0014932](http://purl.obolibrary.org/obo/MONDO_0014932) (orofaciodigital syndrome XV), [MONDO:0013602](http://purl.obolibrary.org/obo/MONDO_0013602) (paragangliomas 5), [MONDO:0001607](http://purl.obolibrary.org/obo/MONDO_0001607) (intrapelvic lymph node leukemic reticuloendotheliosis), [MONDO:0002938](http://purl.obolibrary.org/obo/MONDO_0002938) (metatypical basal cell carcinoma), [MONDO:0001606](http://purl.obolibrary.org/obo/MONDO_0001606) (central nervous system leukemia), [MONDO:0002937](http://purl.obolibrary.org/obo/MONDO_0002937) (nodular basal cell carcinoma), [MONDO:0001608](http://purl.obolibrary.org/obo/MONDO_0001608) (vagus nerve neoplasm), [MONDO:0002939](http://purl.obolibrary.org/obo/MONDO_0002939) (skin pigmented basal cell carcinoma), [MONDO:0002934](http://purl.obolibrary.org/obo/MONDO_0002934) (intravascular angioleiomyoma), [MONDO:0001603](http://purl.obolibrary.org/obo/MONDO_0001603) (paralytic lagophthalmos (disease)), [MONDO:0001602](http://purl.obolibrary.org/obo/MONDO_0001602) (labia minora carcinoma), [MONDO:0002933](http://purl.obolibrary.org/obo/MONDO_0002933) (osteosclerosis), [MONDO:0001605](http://purl.obolibrary.org/obo/MONDO_0001605) (subleukemic leukemia), [MONDO:0002936](http://purl.obolibrary.org/obo/MONDO_0002936) (scrotum basal cell carcinoma), [MONDO:0002935](http://purl.obolibrary.org/obo/MONDO_0002935) (penis basal cell carcinoma), [MONDO:0001604](http://purl.obolibrary.org/obo/MONDO_0001604) (lagophthalmos), [MONDO:0002930](http://purl.obolibrary.org/obo/MONDO_0002930) (kidney sarcoma), [MONDO:0002932](http://purl.obolibrary.org/obo/MONDO_0002932) (conjunctival disease), [MONDO:0002931](http://purl.obolibrary.org/obo/MONDO_0002931) (conjunctivochalasis), [MONDO:0014927](http://purl.obolibrary.org/obo/MONDO_0014927) (Joubert syndrome 27), [MONDO:0014928](http://purl.obolibrary.org/obo/MONDO_0014928) (Joubert syndrome 28), [MONDO:0014929](http://purl.obolibrary.org/obo/MONDO_0014929) (retinitis pigmentosa 76; RP76), [MONDO:0014926](http://purl.obolibrary.org/obo/MONDO_0014926) (Bardet-Biedl syndrome 20; BBS20), [MONDO:0014920](http://purl.obolibrary.org/obo/MONDO_0014920) (patterned macular dystrophy 3), [MONDO:0014922](http://purl.obolibrary.org/obo/MONDO_0014922) (myopathy, myofibrillar, 7; MFM7), [MONDO:0002949](http://purl.obolibrary.org/obo/MONDO_0002949) (morpheaform basal cell carcinoma), [MONDO:0002948](http://purl.obolibrary.org/obo/MONDO_0002948) (skin fibroepithelial basal cell carcinoma), [MONDO:0001617](http://purl.obolibrary.org/obo/MONDO_0001617) (transient global amnesia (disease)), [MONDO:0002945](http://purl.obolibrary.org/obo/MONDO_0002945) (micronodular basal cell carcinoma), [MONDO:0001614](http://purl.obolibrary.org/obo/MONDO_0001614) (intra-abdominal lymph node mast cell malignancy), [MONDO:0002944](http://purl.obolibrary.org/obo/MONDO_0002944) (external ear carcinoma), [MONDO:0002947](http://purl.obolibrary.org/obo/MONDO_0002947) (adamantinoid basal cell epithelioma), [MONDO:0001615](http://purl.obolibrary.org/obo/MONDO_0001615) (shipyard eye), [MONDO:0002941](http://purl.obolibrary.org/obo/MONDO_0002941) (anal margin carcinoma), [MONDO:0001610](http://purl.obolibrary.org/obo/MONDO_0001610) (acute dacryocystitis), [MONDO:0002940](http://purl.obolibrary.org/obo/MONDO_0002940) (anal margin basal cell carcinoma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0002942](http://purl.obolibrary.org/obo/MONDO_0002942) (sebaceous basal cell carcinoma), [MONDO:0001611](http://purl.obolibrary.org/obo/MONDO_0001611) (phlegmonous dacryocystitis), [MONDO:0014916](http://purl.obolibrary.org/obo/MONDO_0014916) (epileptic encephalopathy, early infantile, 41; EIEE41), [MONDO:0014919](http://purl.obolibrary.org/obo/MONDO_0014919) (Sessile Serrated polyposis cancer syndrome; SSPCS), [MONDO:0014913](http://purl.obolibrary.org/obo/MONDO_0014913) (familial adenomatous polyposis 4; FAP4), [MONDO:0014915](http://purl.obolibrary.org/obo/MONDO_0014915) (short-rib thoracic dysplasia 16 with or without polydactyly; SRTD16), [MONDO:0014910](http://purl.obolibrary.org/obo/MONDO_0014910) (primary ciliary dyskinesia 35), [MONDO:0014982](http://purl.obolibrary.org/obo/MONDO_0014982) (myopia 25, autosomal dominant; MYP25), [MONDO:0014983](http://purl.obolibrary.org/obo/MONDO_0014983) (congenital myasthenic syndrome 21), [MONDO:0013652](http://purl.obolibrary.org/obo/MONDO_0013652) (narcolepsy 7), [MONDO:0012322](http://purl.obolibrary.org/obo/MONDO_0012322) (holoprosencephaly 5), [MONDO:0002999](http://purl.obolibrary.org/obo/MONDO_0002999) (central nervous system germinoma), [MONDO:0000339](http://purl.obolibrary.org/obo/MONDO_0000339) (spinal polio), [MONDO:0002996](http://purl.obolibrary.org/obo/MONDO_0002996) (cavernous sinus meningioma), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0002995](http://purl.obolibrary.org/obo/MONDO_0002995) (small intestine neuroendocrine neoplasm), [MONDO:0002998](http://purl.obolibrary.org/obo/MONDO_0002998) (skull base meningioma), [MONDO:0002997](http://purl.obolibrary.org/obo/MONDO_0002997) (anterior cranial fossa meningioma), [MONDO:0001666](http://purl.obolibrary.org/obo/MONDO_0001666) (retinal dystrophies primarily involving bruch's membrane), [MONDO:0001661](http://purl.obolibrary.org/obo/MONDO_0001661) (background diabetic retinopathy), [MONDO:0001660](http://purl.obolibrary.org/obo/MONDO_0001660) (proliferative diabetic retinopathy), [MONDO:0002991](http://purl.obolibrary.org/obo/MONDO_0002991) (adenocarcinofibroma), [MONDO:0002994](http://purl.obolibrary.org/obo/MONDO_0002994) (pancreatic delta cell neuroendocrine tumor), [MONDO:0001663](http://purl.obolibrary.org/obo/MONDO_0001663) (hole retinal cyst), [MONDO:0002993](http://purl.obolibrary.org/obo/MONDO_0002993) (pancreatic somatostatinoma), [MONDO:0001662](http://purl.obolibrary.org/obo/MONDO_0001662) (right bundle branch block (disease)), [MONDO:0002990](http://purl.obolibrary.org/obo/MONDO_0002990) (benign deep fibrous histiocytoma), [MONDO:0012326](http://purl.obolibrary.org/obo/MONDO_0012326) (autosomal recessive nonsyndromic deafness 42), [MONDO:0013659](http://purl.obolibrary.org/obo/MONDO_0013659) (microcephaly-capillary malformation syndrome), [MONDO:0012324](http://purl.obolibrary.org/obo/MONDO_0012324) (14q22q23 microdeletion syndrome), [MONDO:0014985](http://purl.obolibrary.org/obo/MONDO_0014985) (Fanconi anemia complementation group v), [MONDO:0014986](http://purl.obolibrary.org/obo/MONDO_0014986) (Fanconi anemia complementation group r), [MONDO:0014987](http://purl.obolibrary.org/obo/MONDO_0014987) (Fanconi anemia complementation group U), [MONDO:0014988](http://purl.obolibrary.org/obo/MONDO_0014988) (3-methylglutaconic aciduria, type Viii; MGCA8), [MONDO:0012327](http://purl.obolibrary.org/obo/MONDO_0012327) (autosomal recessive nonsyndromic deafness 46), [MONDO:0013640](http://purl.obolibrary.org/obo/MONDO_0013640) (familial retinal arterial macroaneurysm), [MONDO:0013641](http://purl.obolibrary.org/obo/MONDO_0013641) (Warburg micro syndrome 2), [MONDO:0013642](http://purl.obolibrary.org/obo/MONDO_0013642) (holoprosencephaly 11), [MONDO:0012310](http://purl.obolibrary.org/obo/MONDO_0012310) (fibrosis of extraocular muscles, congenital, with Synergistic Divergence), [MONDO:0000348](http://purl.obolibrary.org/obo/MONDO_0000348) (posterior polar cataract (disease)), [MONDO:0001679](http://purl.obolibrary.org/obo/MONDO_0001679) (crater-like holes of optic disc), [MONDO:0001676](http://purl.obolibrary.org/obo/MONDO_0001676) (erythropoietic protoporphyria), [MONDO:0000340](http://purl.obolibrary.org/obo/MONDO_0000340) (bulbospinal polio), [MONDO:0001672](http://purl.obolibrary.org/obo/MONDO_0001672) (bronchus cancer), [MONDO:0000341](http://purl.obolibrary.org/obo/MONDO_0000341) (paralytic poliomyelitis), [MONDO:0013647](http://purl.obolibrary.org/obo/MONDO_0013647) (primary microcephaly-epilepsy-permanent neonatal diabetes syndrome), [MONDO:0012314](http://purl.obolibrary.org/obo/MONDO_0012314) (short Qt syndrome type 3), [MONDO:0013648](http://purl.obolibrary.org/obo/MONDO_0013648) (familial progressive hyperpigmentation), [MONDO:0012313](http://purl.obolibrary.org/obo/MONDO_0012313) (short Qt syndrome type 2), [MONDO:0012312](http://purl.obolibrary.org/obo/MONDO_0012312) (short Qt syndrome type 1), [MONDO:0013644](http://purl.obolibrary.org/obo/MONDO_0013644) (Charcot-Marie-tooth disease axonal type 2O), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0014976](http://purl.obolibrary.org/obo/MONDO_0014976) (lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome), [MONDO:0012317](http://purl.obolibrary.org/obo/MONDO_0012317) (visceral neuropathy, familial, autosomal dominant), [MONDO:0013645](http://purl.obolibrary.org/obo/MONDO_0013645) (autosomal recessive spinocerebellar ataxia 11), [MONDO:0014977](http://purl.obolibrary.org/obo/MONDO_0014977) (muscular dystrophy, limb-girdle, type 2z; LGMD2Z), [MONDO:0012316](http://purl.obolibrary.org/obo/MONDO_0012316) (Majeed syndrome), [MONDO:0013646](http://purl.obolibrary.org/obo/MONDO_0013646) (chromosome 8q21.11 deletion syndrome), [MONDO:0013630](http://purl.obolibrary.org/obo/MONDO_0013630) (Meckel syndrome, type 9), [MONDO:0013631](http://purl.obolibrary.org/obo/MONDO_0013631) (LNCR5), [MONDO:0012300](http://purl.obolibrary.org/obo/MONDO_0012300) (prostate cancer, hereditary, 6), [MONDO:0002978](http://purl.obolibrary.org/obo/MONDO_0002978) (orbit alveolar rhabdomyosarcoma), [MONDO:0002977](http://purl.obolibrary.org/obo/MONDO_0002977) (autoimmune disease of the nervous system), [MONDO:0002979](http://purl.obolibrary.org/obo/MONDO_0002979) (papillary squamous carcinoma), [MONDO:0002974](http://purl.obolibrary.org/obo/MONDO_0002974) (cervical cancer), [MONDO:0002973](http://purl.obolibrary.org/obo/MONDO_0002973) (epithelioid cell melanoma), [MONDO:0001642](http://purl.obolibrary.org/obo/MONDO_0001642) (hordeolum externum), [MONDO:0000313](http://purl.obolibrary.org/obo/MONDO_0000313) (hypophosphatemia (disease)), [MONDO:0002975](http://purl.obolibrary.org/obo/MONDO_0002975) (malignant breast melanoma), [MONDO:0002970](http://purl.obolibrary.org/obo/MONDO_0002970) (ciliary body disease), [MONDO:0002972](http://purl.obolibrary.org/obo/MONDO_0002972) (posterior mediastinum cancer), [MONDO:0002971](http://purl.obolibrary.org/obo/MONDO_0002971) (amelanotic melanoma), [MONDO:0012309](http://purl.obolibrary.org/obo/MONDO_0012309) (parietal foramina 2), [MONDO:0013636](http://purl.obolibrary.org/obo/MONDO_0013636) (primary biliary cholangitis 4), [MONDO:0013637](http://purl.obolibrary.org/obo/MONDO_0013637) (primary biliary cholangitis 5), [MONDO:0013638](http://purl.obolibrary.org/obo/MONDO_0013638) (Warburg micro syndrome 3), [MONDO:0014969](http://purl.obolibrary.org/obo/MONDO_0014969) (isolated sedoheptulokinase deficiency), [MONDO:0012302](http://purl.obolibrary.org/obo/MONDO_0012302) (PFM3), [MONDO:0013639](http://purl.obolibrary.org/obo/MONDO_0013639) (NRCLP6), [MONDO:0012301](http://purl.obolibrary.org/obo/MONDO_0012301) (mitochondrial dna depletion syndrome, myopathic form), [MONDO:0013632](http://purl.obolibrary.org/obo/MONDO_0013632) (autosomal dominant nonsyndromic deafness 33), [MONDO:0012308](http://purl.obolibrary.org/obo/MONDO_0012308) (Joubert syndrome 4), [MONDO:0012307](http://purl.obolibrary.org/obo/MONDO_0012307) (familial scaphocephaly syndrome, McGillivray type), [MONDO:0014965](http://purl.obolibrary.org/obo/MONDO_0014965) (lethal congenital contracture syndrome 11; LCCS11), [MONDO:0014966](http://purl.obolibrary.org/obo/MONDO_0014966) (periventricular nodular heterotopia 7; PVNH7), [MONDO:0013635](http://purl.obolibrary.org/obo/MONDO_0013635) (Adams-Oliver syndrome 2), [MONDO:0013620](http://purl.obolibrary.org/obo/MONDO_0013620) (congenital myasthenic syndrome 16), [MONDO:0014951](http://purl.obolibrary.org/obo/MONDO_0014951) (Sotos syndrome 3; SOTOS3), [MONDO:0002989](http://purl.obolibrary.org/obo/MONDO_0002989) (benign fibrous histiocytoma), [MONDO:0002988](http://purl.obolibrary.org/obo/MONDO_0002988) (cervix melanoma), [MONDO:0001657](http://purl.obolibrary.org/obo/MONDO_0001657) (brain cancer), [MONDO:0000328](http://purl.obolibrary.org/obo/MONDO_0000328) (hyperphosphatemia (disease)), [MONDO:0001654](http://purl.obolibrary.org/obo/MONDO_0001654) (spermatic cord cancer), [MONDO:0001653](http://purl.obolibrary.org/obo/MONDO_0001653) (prepuce cancer), [MONDO:0002981](http://purl.obolibrary.org/obo/MONDO_0002981) (peripheral primitive neuroectodermal tumor of bone), [MONDO:0001652](http://purl.obolibrary.org/obo/MONDO_0001652) (scrotum melanoma), [MONDO:0001651](http://purl.obolibrary.org/obo/MONDO_0001651) (scrotum squamous cell carcinoma), [MONDO:0002982](http://purl.obolibrary.org/obo/MONDO_0002982) (peripheral primitive neuroectodermal tumor of soft tissues), [MONDO:0013627](http://purl.obolibrary.org/obo/MONDO_0013627) (three M syndrome 3), [MONDO:0013628](http://purl.obolibrary.org/obo/MONDO_0013628) (hyperphosphatasia with mental retardation syndrome 3), [MONDO:0014959](http://purl.obolibrary.org/obo/MONDO_0014959) (mitochondrial DNA depletion syndrome 12a (cardiomyopathic type), autosomal dominant; MTDPS12A), [MONDO:0013622](http://purl.obolibrary.org/obo/MONDO_0013622) (platelet-type bleeding disorder 9), [MONDO:0013623](http://purl.obolibrary.org/obo/MONDO_0013623) (platelet-type bleeding disorder 11), [MONDO:0014954](http://purl.obolibrary.org/obo/MONDO_0014954) (Ehlers-Danlos syndrome, periodontal type 2 Edspd2), [MONDO:0014955](http://purl.obolibrary.org/obo/MONDO_0014955) (retinal dystrophy with or without extraocular anomalies; RDEOA), [MONDO:0011031](http://purl.obolibrary.org/obo/MONDO_0011031) (autosomal dominant nonsyndromic deafness 10), [MONDO:0013695](http://purl.obolibrary.org/obo/MONDO_0013695) (colorectal cancer, hereditary nonpolyposis, type 6), [MONDO:0012361](http://purl.obolibrary.org/obo/MONDO_0012361) (SLEB5), [MONDO:0011035](http://purl.obolibrary.org/obo/MONDO_0011035) (neurofibromatosis-Noonan syndrome), [MONDO:0013691](http://purl.obolibrary.org/obo/MONDO_0013691) (Feingold syndrome type 2), [MONDO:0013692](http://purl.obolibrary.org/obo/MONDO_0013692) (BAP1-related tumor predisposition syndrome), [MONDO:0011033](http://purl.obolibrary.org/obo/MONDO_0011033) (type 1 diabetes mellitus 13), [MONDO:0013693](http://purl.obolibrary.org/obo/MONDO_0013693) (inflammatory skin and bowel disease, neonatal, 1), [MONDO:0012363](http://purl.obolibrary.org/obo/MONDO_0012363) (retinitis pigmentosa 32), [MONDO:0011032](http://purl.obolibrary.org/obo/MONDO_0011032) (autosomal dominant nonsyndromic deafness 11), [MONDO:0000377](http://purl.obolibrary.org/obo/MONDO_0000377) (malignant leydig cell tumor), [MONDO:0000378](http://purl.obolibrary.org/obo/MONDO_0000378) (malignant Sertoli cell tumor), [MONDO:0000379](http://purl.obolibrary.org/obo/MONDO_0000379) (malignant Sertoli-leydig cell tumor), [MONDO:0000373](http://purl.obolibrary.org/obo/MONDO_0000373) (gall bladder carcinoma in situ), [MONDO:0000374](http://purl.obolibrary.org/obo/MONDO_0000374) (bile duct carcinoma in situ), [MONDO:0000375](http://purl.obolibrary.org/obo/MONDO_0000375) (bronchus carcinoma in situ), [MONDO:0000376](http://purl.obolibrary.org/obo/MONDO_0000376) (respiratory system cancer), [MONDO:0000371](http://purl.obolibrary.org/obo/MONDO_0000371) (oral cavity carcinoma in situ), [MONDO:0000372](http://purl.obolibrary.org/obo/MONDO_0000372) (pharynx carcinoma in situ), [MONDO:0011038](http://purl.obolibrary.org/obo/MONDO_0011038) (cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome), [MONDO:0012369](http://purl.obolibrary.org/obo/MONDO_0012369) (SLEB6), [MONDO:0012368](http://purl.obolibrary.org/obo/MONDO_0012368) (neurological conditions associated with aminoacylase 1 deficiency), [MONDO:0012367](http://purl.obolibrary.org/obo/MONDO_0012367) (retinitis pigmentosa 31), [MONDO:0013698](http://purl.obolibrary.org/obo/MONDO_0013698) (arthrogryposis, distal, type 1B), [MONDO:0013699](http://purl.obolibrary.org/obo/MONDO_0013699) (colorectal cancer, hereditary nonpolyposis, type 4), [MONDO:0011020](http://purl.obolibrary.org/obo/MONDO_0011020) (osteoporosis-oculocutaneous hypopigmentation syndrome), [MONDO:0012351](http://purl.obolibrary.org/obo/MONDO_0012351) (Zygodactyly type 1), [MONDO:0012350](http://purl.obolibrary.org/obo/MONDO_0012350) (complement factor H deficiency), [MONDO:0013685](http://purl.obolibrary.org/obo/MONDO_0013685) (pancreatic cancer, susceptibility to, 4), [MONDO:0013686](http://purl.obolibrary.org/obo/MONDO_0013686) (myopathy, distal, Tateyama type), [MONDO:0011024](http://purl.obolibrary.org/obo/MONDO_0011024) (dermatitis herpetiformis, familial), [MONDO:0012355](http://purl.obolibrary.org/obo/MONDO_0012355) (autosomal recessive nonsyndromic deafness 28), [MONDO:0011023](http://purl.obolibrary.org/obo/MONDO_0011023) (hereditary mixed polyposis syndrome), [MONDO:0012354](http://purl.obolibrary.org/obo/MONDO_0012354) (platelet-type bleeding disorder 8), [MONDO:0011022](http://purl.obolibrary.org/obo/MONDO_0011022) (Potocki-Shaffer syndrome), [MONDO:0013681](http://purl.obolibrary.org/obo/MONDO_0013681) (alpha-methylacyl-CoA racemase deficiency), [MONDO:0011021](http://purl.obolibrary.org/obo/MONDO_0011021) (neuronal intestinal dysplasia, type b), [MONDO:0000384](http://purl.obolibrary.org/obo/MONDO_0000384) (bladder benign neoplasm), [MONDO:0000385](http://purl.obolibrary.org/obo/MONDO_0000385) (benign digestive system neoplasm), [MONDO:0000386](http://purl.obolibrary.org/obo/MONDO_0000386) (digestive system neuroendocrine tumor), [MONDO:0000387](http://purl.obolibrary.org/obo/MONDO_0000387) (hypochromic microcytic anemia (disease)), [MONDO:0000380](http://purl.obolibrary.org/obo/MONDO_0000380) (paranasal sinus cancer), [MONDO:0000381](http://purl.obolibrary.org/obo/MONDO_0000381) (infiltrating renal pelvis transitional cell carcinoma), [MONDO:0000382](http://purl.obolibrary.org/obo/MONDO_0000382) (respiratory system benign neoplasm), [MONDO:0000383](http://purl.obolibrary.org/obo/MONDO_0000383) (reproductive organ benign neoplasm), [MONDO:0011028](http://purl.obolibrary.org/obo/MONDO_0011028) (autosomal recessive limb-girdle muscular dystrophy type 2F), [MONDO:0012359](http://purl.obolibrary.org/obo/MONDO_0012359) (combined immunodeficiency due to partial RAG1 deficiency), [MONDO:0011027](http://purl.obolibrary.org/obo/MONDO_0011027) (diabetes mellitus, Noninsulin-dependent, 1), [MONDO:0011026](http://purl.obolibrary.org/obo/MONDO_0011026) (autosomal recessive congenital ichthyosis 4A), [MONDO:0012357](http://purl.obolibrary.org/obo/MONDO_0012357) (glaucoma 1, open angle, G), [MONDO:0011025](http://purl.obolibrary.org/obo/MONDO_0011025) (Cayman type cerebellar ataxia), [MONDO:0013687](http://purl.obolibrary.org/obo/MONDO_0013687) (autosomal recessive spinocerebellar ataxia 12), [MONDO:0013688](http://purl.obolibrary.org/obo/MONDO_0013688) (linear and whorled nevoid hypermelanosis), [MONDO:0013689](http://purl.obolibrary.org/obo/MONDO_0013689) (ovarian dysgenesis 3), [MONDO:0012340](http://purl.obolibrary.org/obo/MONDO_0012340) (CELIAC2), [MONDO:0013673](http://purl.obolibrary.org/obo/MONDO_0013673) (Wolfram-like syndrome), [MONDO:0013674](http://purl.obolibrary.org/obo/MONDO_0013674) (neurodegeneration with brain iron accumulation 4), [MONDO:0013675](http://purl.obolibrary.org/obo/MONDO_0013675) (multiple mitochondrial dysfunctions syndrome 2), [MONDO:0011013](http://purl.obolibrary.org/obo/MONDO_0011013) (autosomal dominant hypocalcemia 1), [MONDO:0011012](http://purl.obolibrary.org/obo/MONDO_0011012) (african iron overload), [MONDO:0011011](http://purl.obolibrary.org/obo/MONDO_0011011) (skeletal dysplasia-epilepsy-short stature syndrome), [MONDO:0013670](http://purl.obolibrary.org/obo/MONDO_0013670) (myopia, high, with cataract and vitreoretinal degeneration), [MONDO:0013671](http://purl.obolibrary.org/obo/MONDO_0013671) (hydatidiform mole, recurrent, 2), [MONDO:0011010](http://purl.obolibrary.org/obo/MONDO_0011010) (Matthew-wood syndrome), [MONDO:0012341](http://purl.obolibrary.org/obo/MONDO_0012341) (celiac disease, susceptibility to, 3), [MONDO:0000359](http://purl.obolibrary.org/obo/MONDO_0000359) (spondylocostal dysostosis), [MONDO:0000355](http://purl.obolibrary.org/obo/MONDO_0000355) (Ullrich congenital muscular dystrophy), [MONDO:0001687](http://purl.obolibrary.org/obo/MONDO_0001687) (diabetic cataract), [MONDO:0001686](http://purl.obolibrary.org/obo/MONDO_0001686) (anatomical narrow angle borderline glaucoma), [MONDO:0001688](http://purl.obolibrary.org/obo/MONDO_0001688) (toxic optic neuropathy), [MONDO:0000351](http://purl.obolibrary.org/obo/MONDO_0000351) (hypermethioninemia (disease)), [MONDO:0001685](http://purl.obolibrary.org/obo/MONDO_0001685) (chronic follicular conjunctivitis), [MONDO:0001680](http://purl.obolibrary.org/obo/MONDO_0001680) (vaginal mullerian papilloma), [MONDO:0012348](http://purl.obolibrary.org/obo/MONDO_0012348) (maturity-onset diabetes of the young type 8), [MONDO:0011016](http://purl.obolibrary.org/obo/MONDO_0011016) (type 1 diabetes mellitus 11), [MONDO:0011015](http://purl.obolibrary.org/obo/MONDO_0011015) (cataract 24), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0013676](http://purl.obolibrary.org/obo/MONDO_0013676) (hypermethioninemia due to adenosine kinase deficiency), [MONDO:0013677](http://purl.obolibrary.org/obo/MONDO_0013677) (Emery-Dreifuss muscular dystrophy 7, autosomal dominant), [MONDO:0013678](http://purl.obolibrary.org/obo/MONDO_0013678) (EDICT syndrome), [MONDO:0011018](http://purl.obolibrary.org/obo/MONDO_0011018) (brachyolmia-amelogenesis imperfecta syndrome), [MONDO:0012349](http://purl.obolibrary.org/obo/MONDO_0012349) (spondylocostal dysostosis 3, autosomal recessive), [MONDO:0013679](http://purl.obolibrary.org/obo/MONDO_0013679) (sclerosteosis 2), [MONDO:0013661](http://purl.obolibrary.org/obo/MONDO_0013661) (combined malonic and methylmalonic acidemia), [MONDO:0014992](http://purl.obolibrary.org/obo/MONDO_0014992) (lissencephaly 8; LIS8), [MONDO:0014993](http://purl.obolibrary.org/obo/MONDO_0014993) (myopathy, myofibrillar, 8; MFM8), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0011002](http://purl.obolibrary.org/obo/MONDO_0011002) (neuropathy, hereditary motor and sensory, type 6A), [MONDO:0012333](http://purl.obolibrary.org/obo/MONDO_0012333) (autosomal recessive nonsyndromic deafness 53), [MONDO:0011001](http://purl.obolibrary.org/obo/MONDO_0011001) (Brugada syndrome 1), [MONDO:0014991](http://purl.obolibrary.org/obo/MONDO_0014991) (Seckel syndrome 10; SCKL10), [MONDO:0012330](http://purl.obolibrary.org/obo/MONDO_0012330) (Talo-patello-scaphoid osteolysis), [MONDO:0000366](http://purl.obolibrary.org/obo/MONDO_0000366) (glycogen storage disease IX), [MONDO:0001694](http://purl.obolibrary.org/obo/MONDO_0001694) (diffuse interstitial keratitis), [MONDO:0000365](http://purl.obolibrary.org/obo/MONDO_0000365) (primary congenital glaucoma (disease)), [MONDO:0001695](http://purl.obolibrary.org/obo/MONDO_0001695) (senile ectropion), [MONDO:0001690](http://purl.obolibrary.org/obo/MONDO_0001690) (parasitic conjunctivitis), [MONDO:0001691](http://purl.obolibrary.org/obo/MONDO_0001691) (laryngeal cartilage cancer), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0011006](http://purl.obolibrary.org/obo/MONDO_0011006) (hereditary spastic paraplegia 9A), [MONDO:0012337](http://purl.obolibrary.org/obo/MONDO_0012337) (GLC1I), [MONDO:0012336](http://purl.obolibrary.org/obo/MONDO_0012336) (cataract 22 multiple types), [MONDO:0011004](http://purl.obolibrary.org/obo/MONDO_0011004) (lissencephaly type 3-metacarpal bone dysplasia syndrome), [MONDO:0012335](http://purl.obolibrary.org/obo/MONDO_0012335) (obesity due to pro-opiomelanocortin deficiency), [MONDO:0013666](http://purl.obolibrary.org/obo/MONDO_0013666) (Stickler syndrome, type 5), [MONDO:0011008](http://purl.obolibrary.org/obo/MONDO_0011008) (cleft lip/palate-intestinal malrotation-cardiopathy syndrome), [MONDO:0014998](http://purl.obolibrary.org/obo/MONDO_0014998) (glaucoma 3, primary congenital, E; GLC3E), [MONDO:0012339](http://purl.obolibrary.org/obo/MONDO_0012339) (celiac disease, susceptibility to, 4), [MONDO:0011007](http://purl.obolibrary.org/obo/MONDO_0011007) (diaphragmatic defect-limb deficiency-skull defect syndrome), [MONDO:0011075](http://purl.obolibrary.org/obo/MONDO_0011075) (retinitis pigmentosa 18), [MONDO:0011074](http://purl.obolibrary.org/obo/MONDO_0011074) (autosomal dominant nonsyndromic deafness 7), [MONDO:0011073](http://purl.obolibrary.org/obo/MONDO_0011073) (diabetes mellitus, transient neonatal, 1), [MONDO:0011072](http://purl.obolibrary.org/obo/MONDO_0011072) (NIDDM2), [MONDO:0011079](http://purl.obolibrary.org/obo/MONDO_0011079) (rhizomelic dysplasia, Patterson-Lowry type), [MONDO:0011076](http://purl.obolibrary.org/obo/MONDO_0011076) (myofibrillar myopathy 1), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0011070](http://purl.obolibrary.org/obo/MONDO_0011070) (van Maldergem syndrome 1), [MONDO:0011064](http://purl.obolibrary.org/obo/MONDO_0011064) (lethal chondrodysplasia, Seller type), [MONDO:0012395](http://purl.obolibrary.org/obo/MONDO_0012395) (cataract 18), [MONDO:0011063](http://purl.obolibrary.org/obo/MONDO_0011063) (hidrotic ectodermal dysplasia, Christianson-Fourie type), [MONDO:0012394](http://purl.obolibrary.org/obo/MONDO_0012394) (multiple synostoses syndrome 2), [MONDO:0012393](http://purl.obolibrary.org/obo/MONDO_0012393) (congenital brain dysgenesis due to glutamine synthetase deficiency), [MONDO:0011062](http://purl.obolibrary.org/obo/MONDO_0011062) (aprosencephaly cerebellar dysgenesis), [MONDO:0012392](http://purl.obolibrary.org/obo/MONDO_0012392) (2-methylbutyryl-CoA dehydrogenase deficiency), [MONDO:0012399](http://purl.obolibrary.org/obo/MONDO_0012399) (complex cortical dysplasia with other brain malformations 7), [MONDO:0011068](http://purl.obolibrary.org/obo/MONDO_0011068) (type 1 diabetes mellitus 12), [MONDO:0012398](http://purl.obolibrary.org/obo/MONDO_0012398) (retinal cone dystrophy 3A), [MONDO:0011067](http://purl.obolibrary.org/obo/MONDO_0011067) (autosomal recessive nonsyndromic deafness 12), [MONDO:0011066](http://purl.obolibrary.org/obo/MONDO_0011066) (Charcot-Marie-tooth disease type 4B1), [MONDO:0012396](http://purl.obolibrary.org/obo/MONDO_0012396) (exercise-induced hyperinsulinism), [MONDO:0011065](http://purl.obolibrary.org/obo/MONDO_0011065) (Hunter-McAlpine craniosynostosis), [MONDO:0012391](http://purl.obolibrary.org/obo/MONDO_0012391) (neuronal ceroid lipofuscinosis 8 northern epilepsy variant), [MONDO:0011060](http://purl.obolibrary.org/obo/MONDO_0011060) (early-onset non-syndromic cataract), [MONDO:0011053](http://purl.obolibrary.org/obo/MONDO_0011053) (intellectual disability-sparse hair-brachydactyly syndrome), [MONDO:0012383](http://purl.obolibrary.org/obo/MONDO_0012383) (primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency), [MONDO:0012382](http://purl.obolibrary.org/obo/MONDO_0012382) (hyperinsulinemic hypoglycemia, familial, 4), [MONDO:0011050](http://purl.obolibrary.org/obo/MONDO_0011050) (microcephaly-cardiac defect-lung malsegmentation syndrome), [MONDO:0012381](http://purl.obolibrary.org/obo/MONDO_0012381) (hyperinsulinism due to INSR deficiency), [MONDO:0012388](http://purl.obolibrary.org/obo/MONDO_0012388) (MYP11), [MONDO:0012387](http://purl.obolibrary.org/obo/MONDO_0012387) (osteosclerosis-ichthyosis-premature ovarian failure syndrome), [MONDO:0011056](http://purl.obolibrary.org/obo/MONDO_0011056) (wilms tumor 4), [MONDO:0011054](http://purl.obolibrary.org/obo/MONDO_0011054) (autosomal recessive amelia), [MONDO:0012380](http://purl.obolibrary.org/obo/MONDO_0012380) (autosomal dominant nonsyndromic deafness 53), [MONDO:0000398](http://purl.obolibrary.org/obo/MONDO_0000398) (female breast cancer), [MONDO:0011059](http://purl.obolibrary.org/obo/MONDO_0011059) (holoprosencephaly-craniosynostosis syndrome), [MONDO:0011058](http://purl.obolibrary.org/obo/MONDO_0011058) (autosomal dominant nonsyndromic deafness 9), [MONDO:0000390](http://purl.obolibrary.org/obo/MONDO_0000390) (vitelliform macular dystrophy), [MONDO:0012389](http://purl.obolibrary.org/obo/MONDO_0012389) (MYP12), [MONDO:0011041](http://purl.obolibrary.org/obo/MONDO_0011041) (ectodermal dysplasia with natal teeth, Turnpenny type), [MONDO:0012371](http://purl.obolibrary.org/obo/MONDO_0012371) (Noonan syndrome 3), [MONDO:0012370](http://purl.obolibrary.org/obo/MONDO_0012370) (autosomal recessive nonsyndromic deafness 51), [MONDO:0011046](http://purl.obolibrary.org/obo/MONDO_0011046) (short stature, Brussels type), [MONDO:0012376](http://purl.obolibrary.org/obo/MONDO_0012376) (autosomal recessive nonsyndromic deafness 55), [MONDO:0011045](http://purl.obolibrary.org/obo/MONDO_0011045) (MMEP syndrome), [MONDO:0012375](http://purl.obolibrary.org/obo/MONDO_0012375) (autosomal recessive nonsyndromic deafness 47), [MONDO:0011049](http://purl.obolibrary.org/obo/MONDO_0011049) (Fine-Lubinsky syndrome), [MONDO:0011048](http://purl.obolibrary.org/obo/MONDO_0011048) (epilepsy-microcephaly-skeletal dysplasia syndrome), [MONDO:0011047](http://purl.obolibrary.org/obo/MONDO_0011047) (deafness-epiphyseal dysplasia-short stature syndrome), [MONDO:0012378](http://purl.obolibrary.org/obo/MONDO_0012378) (GINGF3), [MONDO:0011097](http://purl.obolibrary.org/obo/MONDO_0011097) (Axenfeld-Rieger syndrome type 2), [MONDO:0011096](http://purl.obolibrary.org/obo/MONDO_0011096) (autosomal agammaglobulinemia), [MONDO:0011099](http://purl.obolibrary.org/obo/MONDO_0011099) (Athabaskan brainstem dysgenesis syndrome), [MONDO:0011098](http://purl.obolibrary.org/obo/MONDO_0011098) (prostate cancer, hereditary, 1), [MONDO:0011093](http://purl.obolibrary.org/obo/MONDO_0011093) (mucopolysaccharidosis type 9), [MONDO:0011091](http://purl.obolibrary.org/obo/MONDO_0011091) (Charcot-Marie-tooth disease type 2D), [MONDO:0011090](http://purl.obolibrary.org/obo/MONDO_0011090) (isolated hereditary congenital facial paralysis), [MONDO:0011086](http://purl.obolibrary.org/obo/MONDO_0011086) (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-negative, Nk cell-positive), [MONDO:0011085](http://purl.obolibrary.org/obo/MONDO_0011085) (Charcot-Marie-tooth disease type 4D), [MONDO:0011083](http://purl.obolibrary.org/obo/MONDO_0011083) (Trichodental syndrome), [MONDO:0011088](http://purl.obolibrary.org/obo/MONDO_0011088) (congenital myasthenic syndrome 1A), [MONDO:0011087](http://purl.obolibrary.org/obo/MONDO_0011087) (inflammatory bowel disease 2), [MONDO:0011082](http://purl.obolibrary.org/obo/MONDO_0011082) (Oculoauriculofrontonasal syndrome), [MONDO:0011081](http://purl.obolibrary.org/obo/MONDO_0011081) (dislocation of the hip-dysmorphism syndrome), [MONDO:0011080](http://purl.obolibrary.org/obo/MONDO_0011080) (progressive deafness with stapes fixation), [MONDO:0000814](http://purl.obolibrary.org/obo/MONDO_0000814) (b-cell adult acute lymphocytic leukemia), [MONDO:0000816](http://purl.obolibrary.org/obo/MONDO_0000816) (abdominal obesity-metabolic syndrome), [MONDO:0000817](http://purl.obolibrary.org/obo/MONDO_0000817) (corneal opacification and other ocular anomalies), [MONDO:0012806](http://purl.obolibrary.org/obo/MONDO_0012806) (ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant), [MONDO:0012809](http://purl.obolibrary.org/obo/MONDO_0012809) (histiocytoma, Angiomatoid fibrous), [MONDO:0012803](http://purl.obolibrary.org/obo/MONDO_0012803) (diarrhea-vomiting due to trehalase deficiency), [MONDO:0012802](http://purl.obolibrary.org/obo/MONDO_0012802) (oculoauricular syndrome), [MONDO:0012800](http://purl.obolibrary.org/obo/MONDO_0012800) (trichoepithelioma, multiple familial, 2), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0000820](http://purl.obolibrary.org/obo/MONDO_0000820) (cerebral cavernous malformation), [MONDO:0000807](http://purl.obolibrary.org/obo/MONDO_0000807) (latex allergy), [MONDO:0000803](http://purl.obolibrary.org/obo/MONDO_0000803) (tiger prawn allergy), [MONDO:0000804](http://purl.obolibrary.org/obo/MONDO_0000804) (white shrimp allergy), [MONDO:0000805](http://purl.obolibrary.org/obo/MONDO_0000805) (snail allergy), [MONDO:0000806](http://purl.obolibrary.org/obo/MONDO_0000806) (horned turban snail allergy), [MONDO:0000800](http://purl.obolibrary.org/obo/MONDO_0000800) (brown shrimp allergy), [MONDO:0000801](http://purl.obolibrary.org/obo/MONDO_0000801) (green mud crab allergy), [MONDO:0000802](http://purl.obolibrary.org/obo/MONDO_0000802) (indian prawn allergy), [MONDO:0000859](http://purl.obolibrary.org/obo/MONDO_0000859) (spina bifida occulta (disease)), [MONDO:0000857](http://purl.obolibrary.org/obo/MONDO_0000857) (Charcot-Marie-tooth disease type 7), [MONDO:0011519](http://purl.obolibrary.org/obo/MONDO_0011519) (autosomal dominant nonsyndromic deafness 23), [MONDO:0011518](http://purl.obolibrary.org/obo/MONDO_0011518) (Wiedemann-Steiner syndrome), [MONDO:0012849](http://purl.obolibrary.org/obo/MONDO_0012849) (Joubert syndrome 9), [MONDO:0012848](http://purl.obolibrary.org/obo/MONDO_0012848) (Meckel syndrome, type 6), [MONDO:0011512](http://purl.obolibrary.org/obo/MONDO_0011512) (Brooke-Spiegler syndrome), [MONDO:0012842](http://purl.obolibrary.org/obo/MONDO_0012842) (CMM7), [MONDO:0011510](http://purl.obolibrary.org/obo/MONDO_0011510) (Bohring-Opitz syndrome), [MONDO:0012841](http://purl.obolibrary.org/obo/MONDO_0012841) (inflammatory bowel disease 18), [MONDO:0012840](http://purl.obolibrary.org/obo/MONDO_0012840) (inflammatory bowel disease 17), [MONDO:0012847](http://purl.obolibrary.org/obo/MONDO_0012847) (autosomal recessive congenital ichthyosis 6), [MONDO:0012845](http://purl.obolibrary.org/obo/MONDO_0012845) (inflammatory bowel disease 19), [MONDO:0012844](http://purl.obolibrary.org/obo/MONDO_0012844) (primary ciliary dyskinesia 8), [MONDO:0000865](http://purl.obolibrary.org/obo/MONDO_0000865) (congenital fiber-type disproportion), [MONDO:0011508](http://purl.obolibrary.org/obo/MONDO_0011508) (lymphoma, non-Hodgkin, familial), [MONDO:0012838](http://purl.obolibrary.org/obo/MONDO_0012838) (inflammatory bowel disease 16), [MONDO:0011506](http://purl.obolibrary.org/obo/MONDO_0011506) (familial infantile myoclonic epilepsy), [MONDO:0012837](http://purl.obolibrary.org/obo/MONDO_0012837) (inflammatory bowel disease 15), [MONDO:0012832](http://purl.obolibrary.org/obo/MONDO_0012832) (inflammatory bowel disease 14), [MONDO:0011501](http://purl.obolibrary.org/obo/MONDO_0011501) (wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia), [MONDO:0011500](http://purl.obolibrary.org/obo/MONDO_0011500) (Becker nevus syndrome), [MONDO:0012831](http://purl.obolibrary.org/obo/MONDO_0012831) (inflammatory bowel disease 13), [MONDO:0012836](http://purl.obolibrary.org/obo/MONDO_0012836) (SLEB12), [MONDO:0011505](http://purl.obolibrary.org/obo/MONDO_0011505) (familial hypobetalipoproteinemia 2), [MONDO:0011504](http://purl.obolibrary.org/obo/MONDO_0011504) (NDE1-related microhydranencephaly), [MONDO:0012835](http://purl.obolibrary.org/obo/MONDO_0012835) (systemic lupus erythematosus, susceptibility to, 11), [MONDO:0012834](http://purl.obolibrary.org/obo/MONDO_0012834) (systemic lupus erythematosus, susceptibility to, 10), [MONDO:0012833](http://purl.obolibrary.org/obo/MONDO_0012833) (Crouzon syndrome-acanthosis nigricans syndrome), [MONDO:0011502](http://purl.obolibrary.org/obo/MONDO_0011502) (Wolfram syndrome 2), [MONDO:0000837](http://purl.obolibrary.org/obo/MONDO_0000837) (bone resorption disease), [MONDO:0000833](http://purl.obolibrary.org/obo/MONDO_0000833) (bone remodeling disease), [MONDO:0012829](http://purl.obolibrary.org/obo/MONDO_0012829) (inflammatory bowel disease 12), [MONDO:0012828](http://purl.obolibrary.org/obo/MONDO_0012828) (atrial fibrillation, familial, 7), [MONDO:0012821](http://purl.obolibrary.org/obo/MONDO_0012821) (CRCS5), [MONDO:0012820](http://purl.obolibrary.org/obo/MONDO_0012820) (colorectal cancer, susceptibility to, 3), [MONDO:0012825](http://purl.obolibrary.org/obo/MONDO_0012825) (extraskeletal myxoid chondrosarcoma), [MONDO:0012823](http://purl.obolibrary.org/obo/MONDO_0012823) (CRCS7), [MONDO:0012822](http://purl.obolibrary.org/obo/MONDO_0012822) (CRCS6), [MONDO:0000845](http://purl.obolibrary.org/obo/MONDO_0000845) (fibrous dysplasia), [MONDO:0000840](http://purl.obolibrary.org/obo/MONDO_0000840) (dysbaric osteonecrosis), [MONDO:0012818](http://purl.obolibrary.org/obo/MONDO_0012818) (maturity-onset diabetes of the young type 9), [MONDO:0012817](http://purl.obolibrary.org/obo/MONDO_0012817) (Ewing sarcoma), [MONDO:0012816](http://purl.obolibrary.org/obo/MONDO_0012816) (atrial fibrillation, familial, 6), [MONDO:0012815](http://purl.obolibrary.org/obo/MONDO_0012815) (Coats plus syndrome), [MONDO:0012819](http://purl.obolibrary.org/obo/MONDO_0012819) (diabetic ketoacidosis), [MONDO:0012813](http://purl.obolibrary.org/obo/MONDO_0012813) (retinitis pigmentosa 29), [MONDO:0009230](http://purl.obolibrary.org/obo/MONDO_0009230) (fibrosclerosis, multifocal), [MONDO:0009231](http://purl.obolibrary.org/obo/MONDO_0009231) (fibular hypoplasia and complex brachydactyly), [MONDO:0012883](http://purl.obolibrary.org/obo/MONDO_0012883) (acute promyelocytic leukemia), [MONDO:0011551](http://purl.obolibrary.org/obo/MONDO_0011551) (autosomal recessive dopa-responsive dystonia), [MONDO:0009232](http://purl.obolibrary.org/obo/MONDO_0009232) (Fuhrmann syndrome), [MONDO:0010221](http://purl.obolibrary.org/obo/MONDO_0010221) (CHIME syndrome), [MONDO:0009233](http://purl.obolibrary.org/obo/MONDO_0009233) (Fibulo-ulnar hypoplasia-renal anomalies syndrome), [MONDO:0012880](http://purl.obolibrary.org/obo/MONDO_0012880) (hypogonadotropic hypogonadism 5 with or without anosmia), [MONDO:0009234](http://purl.obolibrary.org/obo/MONDO_0009234) (congenital high-molecular-weight kininogen deficiency), [MONDO:0009235](http://purl.obolibrary.org/obo/MONDO_0009235) (familial benign flecked retina), [MONDO:0000898](http://purl.obolibrary.org/obo/MONDO_0000898) (malignant hemangioma), [MONDO:0009236](http://purl.obolibrary.org/obo/MONDO_0009236) (Kandori fleck retina), [MONDO:0009238](http://purl.obolibrary.org/obo/MONDO_0009238) (hereditary folate malabsorption), [MONDO:0009239](http://purl.obolibrary.org/obo/MONDO_0009239) (hypogonadotropic hypogonadism 24 without anosmia), [MONDO:0000894](http://purl.obolibrary.org/obo/MONDO_0000894) (mucinous bronchioloalveolar adenocarcinoma), [MONDO:0000895](http://purl.obolibrary.org/obo/MONDO_0000895) (nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0000891](http://purl.obolibrary.org/obo/MONDO_0000891) (mixed fibrolamellar hepatocellular carcinoma), [MONDO:0000892](http://purl.obolibrary.org/obo/MONDO_0000892) (colon medullary carcinoma), [MONDO:0000893](http://purl.obolibrary.org/obo/MONDO_0000893) (mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0010224](http://purl.obolibrary.org/obo/MONDO_0010224) (corpus callosum agenesis-abnormal genitalia syndrome), [MONDO:0012887](http://purl.obolibrary.org/obo/MONDO_0012887) (inflammatory bowel disease 23), [MONDO:0011555](http://purl.obolibrary.org/obo/MONDO_0011555) (radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome), [MONDO:0012886](http://purl.obolibrary.org/obo/MONDO_0012886) (inflammatory bowel disease 22), [MONDO:0010225](http://purl.obolibrary.org/obo/MONDO_0010225) (Dent disease type 1), [MONDO:0012885](http://purl.obolibrary.org/obo/MONDO_0012885) (SRD5A3-CDG), [MONDO:0010222](http://purl.obolibrary.org/obo/MONDO_0010222) (X-linked Opitz G/BBB syndrome), [MONDO:0012884](http://purl.obolibrary.org/obo/MONDO_0012884) (SLEB13), [MONDO:0011553](http://purl.obolibrary.org/obo/MONDO_0011553) (autosomal recessive nonsyndromic deafness 26), [MONDO:0010228](http://purl.obolibrary.org/obo/MONDO_0010228) (DFNX3), [MONDO:0011559](http://purl.obolibrary.org/obo/MONDO_0011559) (benign recurrent intrahepatic cholestasis type 2), [MONDO:0010226](http://purl.obolibrary.org/obo/MONDO_0010226) (46,XY sex reversal 2), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0011558](http://purl.obolibrary.org/obo/MONDO_0011558) (Usher syndrome type 2C), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0010227](http://purl.obolibrary.org/obo/MONDO_0010227) (retinitis pigmentosa 3), [MONDO:0012872](http://purl.obolibrary.org/obo/MONDO_0012872) (THPH9), [MONDO:0010210](http://purl.obolibrary.org/obo/MONDO_0010210) (xeroderma pigmentosum group A), [MONDO:0009221](http://purl.obolibrary.org/obo/MONDO_0009221) (femur-fibula-ulna complex), [MONDO:0012871](http://purl.obolibrary.org/obo/MONDO_0012871) (Jervell and Lange-Nielsen syndrome 2), [MONDO:0011540](http://purl.obolibrary.org/obo/MONDO_0011540) (spinocerebellar ataxia type 14), [MONDO:0009222](http://purl.obolibrary.org/obo/MONDO_0009222) (Gollop-Wolfgang complex), [MONDO:0009223](http://purl.obolibrary.org/obo/MONDO_0009223) (hypogonadotropic hypogonadism 23 with or without anosmia), [MONDO:0009224](http://purl.obolibrary.org/obo/MONDO_0009224) (fetal iodine syndrome), [MONDO:0009226](http://purl.obolibrary.org/obo/MONDO_0009226) (fibrochondrogenesis 1), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0009228](http://purl.obolibrary.org/obo/MONDO_0009228) (gingival fibromatosis-facial dysmorphism syndrome), [MONDO:0012876](http://purl.obolibrary.org/obo/MONDO_0012876) (heparin cofactor 2 deficiency), [MONDO:0010213](http://purl.obolibrary.org/obo/MONDO_0010213) (xeroderma pigmentosum group E), [MONDO:0011544](http://purl.obolibrary.org/obo/MONDO_0011544) (paragangliomas 3), [MONDO:0010214](http://purl.obolibrary.org/obo/MONDO_0010214) (xeroderma pigmentosum variant type), [MONDO:0012875](http://purl.obolibrary.org/obo/MONDO_0012875) (inflammatory bowel disease 21), [MONDO:0010211](http://purl.obolibrary.org/obo/MONDO_0010211) (xeroderma pigmentosum group C), [MONDO:0011543](http://purl.obolibrary.org/obo/MONDO_0011543) (BRCA3), [MONDO:0012873](http://purl.obolibrary.org/obo/MONDO_0012873) (Ehlers-Danlos syndrome, spondylocheirodysplastic type), [MONDO:0010212](http://purl.obolibrary.org/obo/MONDO_0010212) (xeroderma pigmentosum group D), [MONDO:0010218](http://purl.obolibrary.org/obo/MONDO_0010218) (46,XX sex reversal 2), [MONDO:0010215](http://purl.obolibrary.org/obo/MONDO_0010215) (xeroderma pigmentosum group F), [MONDO:0012878](http://purl.obolibrary.org/obo/MONDO_0012878) (Cowden syndrome 2), [MONDO:0011547](http://purl.obolibrary.org/obo/MONDO_0011547) (cataract 31 multiple types), [MONDO:0010216](http://purl.obolibrary.org/obo/MONDO_0010216) (xeroderma pigmentosum group G), [MONDO:0011530](http://purl.obolibrary.org/obo/MONDO_0011530) (mesomelic dysplasia, Savarirayan type), [MONDO:0009210](http://purl.obolibrary.org/obo/MONDO_0009210) (congenital factor V deficiency), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein C deficiency, autosomal recessive), [MONDO:0009211](http://purl.obolibrary.org/obo/MONDO_0009211) (congenital factor VII deficiency), [MONDO:0009212](http://purl.obolibrary.org/obo/MONDO_0009212) (congenital factor X deficiency), [MONDO:0009213](http://purl.obolibrary.org/obo/MONDO_0009213) (Fanconi anemia complementation group C), [MONDO:0009214](http://purl.obolibrary.org/obo/MONDO_0009214) (Fanconi anemia complementation group D2), [MONDO:0000878](http://purl.obolibrary.org/obo/MONDO_0000878) (cytomegalovirus retinitis), [MONDO:0009215](http://purl.obolibrary.org/obo/MONDO_0009215) (Fanconi anemia complementation group a), [MONDO:0009216](http://purl.obolibrary.org/obo/MONDO_0009216) (glycogen storage disease due to GLUT2 deficiency), [MONDO:0000872](http://purl.obolibrary.org/obo/MONDO_0000872) (b-cell childhood acute lymphoblastic leukemia), [MONDO:0000873](http://purl.obolibrary.org/obo/MONDO_0000873) (lymphoblastic lymphoma), [MONDO:0009218](http://purl.obolibrary.org/obo/MONDO_0009218) (Farber lipogranulomatosis), [MONDO:0000874](http://purl.obolibrary.org/obo/MONDO_0000874) (T-cell childhood lymphoblastic lymphoma), [MONDO:0000875](http://purl.obolibrary.org/obo/MONDO_0000875) (adult acute monocytic leukemia), [MONDO:0010208](http://purl.obolibrary.org/obo/MONDO_0010208) (Wrinkly skin syndrome), [MONDO:0000870](http://purl.obolibrary.org/obo/MONDO_0000870) (childhood acute lymphoblastic leukemia), [MONDO:0000871](http://purl.obolibrary.org/obo/MONDO_0000871) (T-cell childhood acute lymphocytic leukemia), [MONDO:0011539](http://purl.obolibrary.org/obo/MONDO_0011539) (nemaline myopathy 5), [MONDO:0010209](http://purl.obolibrary.org/obo/MONDO_0010209) (xanthinuria type I), [MONDO:0011534](http://purl.obolibrary.org/obo/MONDO_0011534) (Charcot-Marie-tooth disease type 4G), [MONDO:0010203](http://purl.obolibrary.org/obo/MONDO_0010203) (intellectual disability, Wolff type), [MONDO:0011533](http://purl.obolibrary.org/obo/MONDO_0011533) (temtamy preaxial brachydactyly syndrome), [MONDO:0010200](http://purl.obolibrary.org/obo/MONDO_0010200) (Wilson disease), [MONDO:0010201](http://purl.obolibrary.org/obo/MONDO_0010201) (Winchester syndrome), [MONDO:0011531](http://purl.obolibrary.org/obo/MONDO_0011531) (Noonan syndrome 2), [MONDO:0011537](http://purl.obolibrary.org/obo/MONDO_0011537) (macrocephaly-autism syndrome), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (thrombophilia due to protein S deficiency, autosomal dominant), [MONDO:0011536](http://purl.obolibrary.org/obo/MONDO_0011536) (OPA4), [MONDO:0010204](http://purl.obolibrary.org/obo/MONDO_0010204) (lysosomal acid lipase deficiency), [MONDO:0011535](http://purl.obolibrary.org/obo/MONDO_0011535) (split hand-foot malformation 4), [MONDO:0012850](http://purl.obolibrary.org/obo/MONDO_0012850) (hypophosphatemic nephrolithiasis/osteoporosis 1), [MONDO:0009200](http://purl.obolibrary.org/obo/MONDO_0009200) (eyebrow duplication-syndactyly syndrome), [MONDO:0009202](http://purl.obolibrary.org/obo/MONDO_0009202) (Thakker-Donnai syndrome), [MONDO:0009203](http://purl.obolibrary.org/obo/MONDO_0009203) (focal facial dermal dysplasia type III), [MONDO:0009204](http://purl.obolibrary.org/obo/MONDO_0009204) (lethal faciocardiomelic dysplasia), [MONDO:0009205](http://purl.obolibrary.org/obo/MONDO_0009205) (Faciocardiorenal syndrome), [MONDO:0009206](http://purl.obolibrary.org/obo/MONDO_0009206) (factor v and Factor VIII, combined deficiency of, type 1), [MONDO:0000883](http://purl.obolibrary.org/obo/MONDO_0000883) (myeloid neoplasms associated with PDGFRB rearrangement), [MONDO:0009207](http://purl.obolibrary.org/obo/MONDO_0009207) (factor v and Factor VIII, combined deficiency of, with normal protein c and Protein C inhibitor), [MONDO:0000884](http://purl.obolibrary.org/obo/MONDO_0000884) (myeloid and lymphoid neoplasms associated with FGFR1 abnormalities), [MONDO:0009209](http://purl.obolibrary.org/obo/MONDO_0009209) (autosomal recessive faciodigitogenital syndrome), [MONDO:0011529](http://purl.obolibrary.org/obo/MONDO_0011529) (spinocerebellar ataxia type 13), [MONDO:0000881](http://purl.obolibrary.org/obo/MONDO_0000881) (myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1), [MONDO:0011528](http://purl.obolibrary.org/obo/MONDO_0011528) (hyper-IgM syndrome type 2), [MONDO:0012859](http://purl.obolibrary.org/obo/MONDO_0012859) (autosomal recessive osteopetrosis 7), [MONDO:0000882](http://purl.obolibrary.org/obo/MONDO_0000882) (myeloid and lymphoid neoplasms associated with PDGFRA rearrangement), [MONDO:0012854](http://purl.obolibrary.org/obo/MONDO_0012854) (bilateral microtia-deafness-cleft palate syndrome), [MONDO:0011523](http://purl.obolibrary.org/obo/MONDO_0011523) (Bardet-Biedl syndrome 6), [MONDO:0012853](http://purl.obolibrary.org/obo/MONDO_0012853) (progeroid syndrome, Petty type), [MONDO:0011521](http://purl.obolibrary.org/obo/MONDO_0011521) (inflammatory bowel disease 7), [MONDO:0012852](http://purl.obolibrary.org/obo/MONDO_0012852) (inflammatory bowel disease 20), [MONDO:0012851](http://purl.obolibrary.org/obo/MONDO_0012851) (hypophosphatemic nephrolithiasis/osteoporosis 2), [MONDO:0011520](http://purl.obolibrary.org/obo/MONDO_0011520) (systemic lupus erythematosus, susceptibility to, 2), [MONDO:0012858](http://purl.obolibrary.org/obo/MONDO_0012858) (primary CD59 deficiency), [MONDO:0011527](http://purl.obolibrary.org/obo/MONDO_0011527) (Charcot-Marie-tooth disease type 4E), [MONDO:0011526](http://purl.obolibrary.org/obo/MONDO_0011526) (Sebastian syndrome), [MONDO:0011524](http://purl.obolibrary.org/obo/MONDO_0011524) (Dianzani autoimmune lymphoproliferative disease), [MONDO:0012855](http://purl.obolibrary.org/obo/MONDO_0012855) (Joubert syndrome 8), [MONDO:0011592](http://purl.obolibrary.org/obo/MONDO_0011592) (EVR3), [MONDO:0009271](http://purl.obolibrary.org/obo/MONDO_0009271) (geroderma osteodysplastica), [MONDO:0010261](http://purl.obolibrary.org/obo/MONDO_0010261) (microphthalmia, syndromic 2), [MONDO:0011591](http://purl.obolibrary.org/obo/MONDO_0011591) (cataract 26 multiple types), [MONDO:0009272](http://purl.obolibrary.org/obo/MONDO_0009272) (German syndrome), [MONDO:0009273](http://purl.obolibrary.org/obo/MONDO_0009273) (hydatidiform mole, recurrent, 1), [MONDO:0009274](http://purl.obolibrary.org/obo/MONDO_0009274) (Ghosal hematodiaphyseal dysplasia), [MONDO:0010264](http://purl.obolibrary.org/obo/MONDO_0010264) (X-linked adrenal hypoplasia congenita), [MONDO:0009275](http://purl.obolibrary.org/obo/MONDO_0009275) (neonatal hemochromatosis), [MONDO:0011596](http://purl.obolibrary.org/obo/MONDO_0011596) (atopic dermatitis 2), [MONDO:0010265](http://purl.obolibrary.org/obo/MONDO_0010265) (Simpson-Golabi-Behmel syndrome type 2), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0009277](http://purl.obolibrary.org/obo/MONDO_0009277) (glaucoma 3A), [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [MONDO:0010263](http://purl.obolibrary.org/obo/MONDO_0010263) (Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome), [MONDO:0009279](http://purl.obolibrary.org/obo/MONDO_0009279) (triple-a syndrome), [MONDO:0010268](http://purl.obolibrary.org/obo/MONDO_0010268) (X-linked lissencephaly with abnormal genitalia), [MONDO:0011599](http://purl.obolibrary.org/obo/MONDO_0011599) (birdshot chorioretinopathy), [MONDO:0010269](http://purl.obolibrary.org/obo/MONDO_0010269) (Coats disease), [MONDO:0011598](http://purl.obolibrary.org/obo/MONDO_0011598) (atopic dermatitis 4), [MONDO:0011597](http://purl.obolibrary.org/obo/MONDO_0011597) (atopic dermatitis 3), [MONDO:0009281](http://purl.obolibrary.org/obo/MONDO_0009281) (Glutaryl-CoA dehydrogenase deficiency), [MONDO:0011581](http://purl.obolibrary.org/obo/MONDO_0011581) (dilated cardiomyopathy with woolly hair and keratoderma), [MONDO:0009260](http://purl.obolibrary.org/obo/MONDO_0009260) (GM1 gangliosidosis type 1), [MONDO:0011580](http://purl.obolibrary.org/obo/MONDO_0011580) (cerebellar ataxia and hypergonadotropic hypogonadism), [MONDO:0009261](http://purl.obolibrary.org/obo/MONDO_0009261) (GM1 gangliosidosis type 2), [MONDO:0009262](http://purl.obolibrary.org/obo/MONDO_0009262) (GM1 gangliosidosis type 3), [MONDO:0009263](http://purl.obolibrary.org/obo/MONDO_0009263) (GAPO syndrome), [MONDO:0011585](http://purl.obolibrary.org/obo/MONDO_0011585) (autosomal recessive distal spinal muscular atrophy 2), [MONDO:0011584](http://purl.obolibrary.org/obo/MONDO_0011584) (Fanconi anemia complementation group D1), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0009266](http://purl.obolibrary.org/obo/MONDO_0009266) (Gaucher's disease type II), [MONDO:0011583](http://purl.obolibrary.org/obo/MONDO_0011583) (cerebral amyloid angiopathy, App-related), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0011582](http://purl.obolibrary.org/obo/MONDO_0011582) (multiple mitochondrial dysfunctions syndrome 1), [MONDO:0009268](http://purl.obolibrary.org/obo/MONDO_0009268) (Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome), [MONDO:0009269](http://purl.obolibrary.org/obo/MONDO_0009269) (geleophysic dysplasia 1), [MONDO:0011589](http://purl.obolibrary.org/obo/MONDO_0011589) (MCOPCB2), [MONDO:0010257](http://purl.obolibrary.org/obo/MONDO_0010257) (HPCX1), [MONDO:0010258](http://purl.obolibrary.org/obo/MONDO_0010258) (MEHMO syndrome), [MONDO:0011588](http://purl.obolibrary.org/obo/MONDO_0011588) (platelet-type bleeding disorder 12), [MONDO:0010255](http://purl.obolibrary.org/obo/MONDO_0010255) (diabetes mellitus, insulin-dependent, X-linked, susceptibility to), [MONDO:0011587](http://purl.obolibrary.org/obo/MONDO_0011587) (cataract 25), [MONDO:0010259](http://purl.obolibrary.org/obo/MONDO_0010259) (retinitis pigmentosa 24), [MONDO:0009270](http://purl.obolibrary.org/obo/MONDO_0009270) (genito-palato-cardiac syndrome), [MONDO:0011570](http://purl.obolibrary.org/obo/MONDO_0011570) (Charcot-Marie-tooth disease type 2B2), [MONDO:0009251](http://purl.obolibrary.org/obo/MONDO_0009251) (fructose-1,6-bisphosphatase deficiency), [MONDO:0009252](http://purl.obolibrary.org/obo/MONDO_0009252) (essential fructosuria), [MONDO:0009253](http://purl.obolibrary.org/obo/MONDO_0009253) (Fryns syndrome), [MONDO:0010242](http://purl.obolibrary.org/obo/MONDO_0010242) (fetal akinesia syndrome, X-linked), [MONDO:0009254](http://purl.obolibrary.org/obo/MONDO_0009254) (fucosidosis), [MONDO:0010243](http://purl.obolibrary.org/obo/MONDO_0010243) (X-linked immunoneurologic disorder), [MONDO:0011572](http://purl.obolibrary.org/obo/MONDO_0011572) (type 1 diabetes mellitus 18), [MONDO:0009255](http://purl.obolibrary.org/obo/MONDO_0009255) (galactokinase deficiency), [MONDO:0010241](http://purl.obolibrary.org/obo/MONDO_0010241) (congenital stationary night blindness 2A), [MONDO:0009257](http://purl.obolibrary.org/obo/MONDO_0009257) (galactose epimerase deficiency), [MONDO:0009258](http://purl.obolibrary.org/obo/MONDO_0009258) (classic galactosemia), [MONDO:0009259](http://purl.obolibrary.org/obo/MONDO_0009259) (gamma-glutamylcysteine synthetase deficiency), [MONDO:0011578](http://purl.obolibrary.org/obo/MONDO_0011578) (familial papillary thyroid carcinoma with renal papillary neoplasia), [MONDO:0010247](http://purl.obolibrary.org/obo/MONDO_0010247) (X-linked cerebral adrenoleukodystrophy), [MONDO:0011576](http://purl.obolibrary.org/obo/MONDO_0011576) (familial hyperaldosteronism type II), [MONDO:0010245](http://purl.obolibrary.org/obo/MONDO_0010245) (X-linked cone-rod dystrophy 2), [MONDO:0011575](http://purl.obolibrary.org/obo/MONDO_0011575) (Cerebrooculonasal syndrome), [MONDO:0010248](http://purl.obolibrary.org/obo/MONDO_0010248) (X-linked spondyloepimetaphyseal dysplasia), [MONDO:0011579](http://purl.obolibrary.org/obo/MONDO_0011579) (late-onset retinal degenration), [MONDO:0012890](http://purl.obolibrary.org/obo/MONDO_0012890) (pontocerebellar hypoplasia type 2B), [MONDO:0009240](http://purl.obolibrary.org/obo/MONDO_0009240) (Formiminoglutamic aciduria), [MONDO:0009241](http://purl.obolibrary.org/obo/MONDO_0009241) (Fountain syndrome), [MONDO:0009242](http://purl.obolibrary.org/obo/MONDO_0009242) (brittle cornea syndrome), [MONDO:0011563](http://purl.obolibrary.org/obo/MONDO_0011563) (GINGF2), [MONDO:0012894](http://purl.obolibrary.org/obo/MONDO_0012894) (OS6), [MONDO:0012893](http://purl.obolibrary.org/obo/MONDO_0012893) (osteoarthritis susceptibility 5), [MONDO:0010232](http://purl.obolibrary.org/obo/MONDO_0010232) (intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked), [MONDO:0012892](http://purl.obolibrary.org/obo/MONDO_0012892) (connective tissue disorder due to lysyl hydroxylase-3 deficiency), [MONDO:0009245](http://purl.obolibrary.org/obo/MONDO_0009245) (Friedreich ataxia), [MONDO:0012891](http://purl.obolibrary.org/obo/MONDO_0012891) (pontocerebellar hypoplasia type 2C), [MONDO:0011560](http://purl.obolibrary.org/obo/MONDO_0011560) (SLEB3), [MONDO:0009247](http://purl.obolibrary.org/obo/MONDO_0009247) (Frontofacionasal dysplasia), [MONDO:0009249](http://purl.obolibrary.org/obo/MONDO_0009249) (hereditary fructose intolerance), [MONDO:0012898](http://purl.obolibrary.org/obo/MONDO_0012898) (NRCLP4), [MONDO:0012897](http://purl.obolibrary.org/obo/MONDO_0012897) (congenital factor XI deficiency), [MONDO:0011566](http://purl.obolibrary.org/obo/MONDO_0011566) (abdominal obesity-metabolic syndrome quantitative trait locus 2), [MONDO:0010233](http://purl.obolibrary.org/obo/MONDO_0010233) (heterotopia, periventricular, X-linked dominant), [MONDO:0011565](http://purl.obolibrary.org/obo/MONDO_0011565) (metabolic syndrome X), [MONDO:0011564](http://purl.obolibrary.org/obo/MONDO_0011564) (cone-rod dystrophy 8), [MONDO:0010239](http://purl.obolibrary.org/obo/MONDO_0010239) (lissencephaly type 1 due to doublecortin gene mutation), [MONDO:0011569](http://purl.obolibrary.org/obo/MONDO_0011569) (Charcot-Marie-tooth disease type 2B1), [MONDO:0010237](http://purl.obolibrary.org/obo/MONDO_0010237) (X-linked intellectual disability-plagiocephaly syndrome), [MONDO:0011568](http://purl.obolibrary.org/obo/MONDO_0011568) (autosomal dominant nonsyndromic deafness 25), [MONDO:0010238](http://purl.obolibrary.org/obo/MONDO_0010238) (deafness, X-linked 4), [MONDO:0012899](http://purl.obolibrary.org/obo/MONDO_0012899) (AGA3), [MONDO:0010293](http://purl.obolibrary.org/obo/MONDO_0010293) (hypohidrotic ectodermal dysplasia with immunodeficiency), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0010295](http://purl.obolibrary.org/obo/MONDO_0010295) (anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome), [MONDO:0010296](http://purl.obolibrary.org/obo/MONDO_0010296) (AGMX2), [MONDO:0010290](http://purl.obolibrary.org/obo/MONDO_0010290) (MNG2), [MONDO:0010299](http://purl.obolibrary.org/obo/MONDO_0010299) (hypoxanthine guanine phosphoribosyltransferase partial deficiency), [MONDO:0009293](http://purl.obolibrary.org/obo/MONDO_0009293) (glycogen storage disease V), [MONDO:0009294](http://purl.obolibrary.org/obo/MONDO_0009294) (glycogen storage disease VI), [MONDO:0010283](http://purl.obolibrary.org/obo/MONDO_0010283) (syndromic X-linked intellectual disability Lubs type), [MONDO:0009295](http://purl.obolibrary.org/obo/MONDO_0009295) (glycogen storage disease VII), [MONDO:0010280](http://purl.obolibrary.org/obo/MONDO_0010280) (ptosis, hereditary congenital 2), [MONDO:0010281](http://purl.obolibrary.org/obo/MONDO_0010281) (Danon disease), [MONDO:0010286](http://purl.obolibrary.org/obo/MONDO_0010286) (syndromic X-linked intellectual disability Siderius type), [MONDO:0009297](http://purl.obolibrary.org/obo/MONDO_0009297) (renal glycosuria), [MONDO:0010284](http://purl.obolibrary.org/obo/MONDO_0010284) (Armfield syndrome), [MONDO:0009299](http://purl.obolibrary.org/obo/MONDO_0009299) (46 XX gonadal dysgenesis), [MONDO:0010285](http://purl.obolibrary.org/obo/MONDO_0010285) (syndromic X-linked intellectual disability Abidi type), [MONDO:0010288](http://purl.obolibrary.org/obo/MONDO_0010288) (Adrenomyodystrophy), [MONDO:0009282](http://purl.obolibrary.org/obo/MONDO_0009282) (multiple acyl-CoA dehydrogenase deficiency), [MONDO:0010271](http://purl.obolibrary.org/obo/MONDO_0010271) (X-linked myotubular myopathy-abnormal genitalia syndrome), [MONDO:0009283](http://purl.obolibrary.org/obo/MONDO_0009283) (glutaric acidemia type 3), [MONDO:0010272](http://purl.obolibrary.org/obo/MONDO_0010272) (syndromic X-linked intellectual disability type 10), [MONDO:0009284](http://purl.obolibrary.org/obo/MONDO_0009284) (glutathione synthetase deficiency without 5-oxoprolinuria), [MONDO:0010270](http://purl.obolibrary.org/obo/MONDO_0010270) (syndromic X-linked intellectual disability 7), [MONDO:0009285](http://purl.obolibrary.org/obo/MONDO_0009285) (gamma-glutamyl transpeptidase deficiency), [MONDO:0010275](http://purl.obolibrary.org/obo/MONDO_0010275) (spondyloepimetaphyseal dysplasia, Bieganski type), [MONDO:0009287](http://purl.obolibrary.org/obo/MONDO_0009287) (glycogen storage disease due to glucose-6-phosphatase deficiency type Ia), [MONDO:0010273](http://purl.obolibrary.org/obo/MONDO_0010273) (lymphoma, Hodgkin, X-linked pseudoautosomal), [MONDO:0009288](http://purl.obolibrary.org/obo/MONDO_0009288) (glycogen storage disease due to glucose-6-phosphatase deficiency type ib), [MONDO:0009289](http://purl.obolibrary.org/obo/MONDO_0009289) (glycogen storage disease Ic), [MONDO:0010274](http://purl.obolibrary.org/obo/MONDO_0010274) (TGCT1), [MONDO:0010279](http://purl.obolibrary.org/obo/MONDO_0010279) (terminal osseous dysplasia-pigmentary defects syndrome), [MONDO:0010277](http://purl.obolibrary.org/obo/MONDO_0010277) (syndromic X-linked intellectual disability Shashi type), [MONDO:0010278](http://purl.obolibrary.org/obo/MONDO_0010278) (Christianson syndrome), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0009291](http://purl.obolibrary.org/obo/MONDO_0009291) (glycogen storage disease III), [MONDO:0009292](http://purl.obolibrary.org/obo/MONDO_0009292) (glycogen storage disease due to glycogen branching enzyme deficiency), [MONDO:0000909](http://purl.obolibrary.org/obo/MONDO_0000909) (Bartter disease type 4b), [MONDO:0000902](http://purl.obolibrary.org/obo/MONDO_0000902) (agenesis of the corpus callosum with peripheral neuropathy), [MONDO:0000901](http://purl.obolibrary.org/obo/MONDO_0000901) (relapsed/refractory diffuse large B-cell lymphoma), [MONDO:0000935](http://purl.obolibrary.org/obo/MONDO_0000935) (larynx squamous papilloma), [MONDO:0000938](http://purl.obolibrary.org/obo/MONDO_0000938) (gastric leiomyoma), [MONDO:0000933](http://purl.obolibrary.org/obo/MONDO_0000933) (subglottis neoplasm), [MONDO:0000934](http://purl.obolibrary.org/obo/MONDO_0000934) (laryngeal leiomyoma), [MONDO:0000930](http://purl.obolibrary.org/obo/MONDO_0000930) (nodular malignant melanoma), [MONDO:0012927](http://purl.obolibrary.org/obo/MONDO_0012927) (chromosome 1q41-q42 deletion syndrome), [MONDO:0012925](http://purl.obolibrary.org/obo/MONDO_0012925) (Diamond-Blackfan anemia 5), [MONDO:0012929](http://purl.obolibrary.org/obo/MONDO_0012929) (Compton-North congenital myopathy), [MONDO:0012920](http://purl.obolibrary.org/obo/MONDO_0012920) (type 1 diabetes mellitus 21), [MONDO:0012924](http://purl.obolibrary.org/obo/MONDO_0012924) (Diamond-Blackfan anemia 4), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), [MONDO:0012921](http://purl.obolibrary.org/obo/MONDO_0012921) (type 1 diabetes mellitus 22), [MONDO:0000948](http://purl.obolibrary.org/obo/MONDO_0000948) (xerophthalmia), [MONDO:0000949](http://purl.obolibrary.org/obo/MONDO_0000949) (conjunctival degeneration), [MONDO:0000942](http://purl.obolibrary.org/obo/MONDO_0000942) (corneal disease), [MONDO:0000943](http://purl.obolibrary.org/obo/MONDO_0000943) (acute hydrops keratoconus), [MONDO:0000941](http://purl.obolibrary.org/obo/MONDO_0000941) (eyelid degenerative disease), [MONDO:0012919](http://purl.obolibrary.org/obo/MONDO_0012919) (type 1 diabetes mellitus 20), [MONDO:0012918](http://purl.obolibrary.org/obo/MONDO_0012918) (primary ciliary dyskinesia 10), [MONDO:0012913](http://purl.obolibrary.org/obo/MONDO_0012913) (wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome), [MONDO:0012912](http://purl.obolibrary.org/obo/MONDO_0012912) (pseudopseudohypoparathyroidism), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), [MONDO:0012910](http://purl.obolibrary.org/obo/MONDO_0012910) (ARHI1), [MONDO:0000919](http://purl.obolibrary.org/obo/MONDO_0000919) (ampulla of vater cancer), [MONDO:0000913](http://purl.obolibrary.org/obo/MONDO_0000913) (hereditary spherocytosis type 2), [MONDO:0000914](http://purl.obolibrary.org/obo/MONDO_0000914) (CADASIL 1), [MONDO:0000915](http://purl.obolibrary.org/obo/MONDO_0000915) (Bernard-Soulier syndrome type A2), [MONDO:0000910](http://purl.obolibrary.org/obo/MONDO_0000910) (retinitis pigmentosa 6), [MONDO:0000912](http://purl.obolibrary.org/obo/MONDO_0000912) (autosomal recessive nonsyndromic deafness 5), [MONDO:0012906](http://purl.obolibrary.org/obo/MONDO_0012906) (primary ciliary dyskinesia 9), [MONDO:0012903](http://purl.obolibrary.org/obo/MONDO_0012903) (autosomal recessive nonsyndromic deafness 45), [MONDO:0012907](http://purl.obolibrary.org/obo/MONDO_0012907) (blindness-scoliosis-arachnodactyly syndrome), [MONDO:0012902](http://purl.obolibrary.org/obo/MONDO_0012902) (autosomal dominant nonsyndromic deafness 27), [MONDO:0012901](http://purl.obolibrary.org/obo/MONDO_0012901) (congenital prekallikrein deficiency), [MONDO:0000928](http://purl.obolibrary.org/obo/MONDO_0000928) (eyelid melanoma), [MONDO:0000929](http://purl.obolibrary.org/obo/MONDO_0000929) (balloon cell malignant melanoma), [MONDO:0000926](http://purl.obolibrary.org/obo/MONDO_0000926) (eye accommodation disease), [MONDO:0000920](http://purl.obolibrary.org/obo/MONDO_0000920) (duodenum cancer), [MONDO:0000921](http://purl.obolibrary.org/obo/MONDO_0000921) (ampulla of vater neoplasm), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0000975](http://purl.obolibrary.org/obo/MONDO_0000975) (lipoma of spermatic cord), [MONDO:0009312](http://purl.obolibrary.org/obo/MONDO_0009312) (lipodystrophy due to peptidic growth factors deficiency), [MONDO:0000976](http://purl.obolibrary.org/obo/MONDO_0000976) (paratesticular lipoma), [MONDO:0000977](http://purl.obolibrary.org/obo/MONDO_0000977) (chondroid lipoma), [MONDO:0009314](http://purl.obolibrary.org/obo/MONDO_0009314) (GTP cyclohydrolase i deficiency), [MONDO:0009315](http://purl.obolibrary.org/obo/MONDO_0009315) (congenital factor XII deficiency), [MONDO:0000978](http://purl.obolibrary.org/obo/MONDO_0000978) (extrahepatic bile duct lipoma), [MONDO:0000971](http://purl.obolibrary.org/obo/MONDO_0000971) (chest wall lipoma), [MONDO:0009317](http://purl.obolibrary.org/obo/MONDO_0009317) (nonphotosensitive trichothiodystrophy), [MONDO:0000972](http://purl.obolibrary.org/obo/MONDO_0000972) (gallbladder lipoma), [MONDO:0009318](http://purl.obolibrary.org/obo/MONDO_0009318) (Hallermann-Streiff syndrome), [MONDO:0000973](http://purl.obolibrary.org/obo/MONDO_0000973) (external ear lipoma), [MONDO:0000974](http://purl.obolibrary.org/obo/MONDO_0000974) (axillary lipoma), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0011639](http://purl.obolibrary.org/obo/MONDO_0011639) (Diamond-Blackfan anemia 15 with mandibulofacial dysostosis), [MONDO:0012969](http://purl.obolibrary.org/obo/MONDO_0012969) (Microvascular complications of diabetes, susceptibility to, 5), [MONDO:0011638](http://purl.obolibrary.org/obo/MONDO_0011638) (neuroferritinopathy), [MONDO:0000970](http://purl.obolibrary.org/obo/MONDO_0000970) (breast lipoma), [MONDO:0010301](http://purl.obolibrary.org/obo/MONDO_0010301) (THCYTX), [MONDO:0011633](http://purl.obolibrary.org/obo/MONDO_0011633) (Charcot-Marie-tooth disease axonal type 2C), [MONDO:0010302](http://purl.obolibrary.org/obo/MONDO_0010302) (Ito hypomelanosis), [MONDO:0011632](http://purl.obolibrary.org/obo/MONDO_0011632) (amyotrophic lateral sclerosis type 21), [MONDO:0012963](http://purl.obolibrary.org/obo/MONDO_0012963) (Microvascular complications of diabetes, susceptibility to, 3), [MONDO:0012962](http://purl.obolibrary.org/obo/MONDO_0012962) (Microvascular complications of diabetes, susceptibility to, 2), [MONDO:0011631](http://purl.obolibrary.org/obo/MONDO_0011631) (hemochromatosis type 4), [MONDO:0012961](http://purl.obolibrary.org/obo/MONDO_0012961) (type 1 diabetes mellitus 23), [MONDO:0011630](http://purl.obolibrary.org/obo/MONDO_0011630) (retinitis pigmentosa 28), [MONDO:0010305](http://purl.obolibrary.org/obo/MONDO_0010305) (creatine transporter deficiency), [MONDO:0012968](http://purl.obolibrary.org/obo/MONDO_0012968) (Usher syndrome type 1H), [MONDO:0011636](http://purl.obolibrary.org/obo/MONDO_0011636) (DBA2), [MONDO:0012967](http://purl.obolibrary.org/obo/MONDO_0012967) (hemolytic anemia due to adenylate kinase deficiency), [MONDO:0010306](http://purl.obolibrary.org/obo/MONDO_0010306) (X-linked intellectual disability, Cabezas type), [MONDO:0012966](http://purl.obolibrary.org/obo/MONDO_0012966) (Microvascular complications of diabetes, susceptibility to, 4), [MONDO:0010303](http://purl.obolibrary.org/obo/MONDO_0010303) (colobomatous microphthalmia), [MONDO:0011635](http://purl.obolibrary.org/obo/MONDO_0011635) (MNG3), [MONDO:0011634](http://purl.obolibrary.org/obo/MONDO_0011634) (rippling muscle disease), [MONDO:0010304](http://purl.obolibrary.org/obo/MONDO_0010304) (Graves disease, susceptibility to, X-linked 1), [MONDO:0009300](http://purl.obolibrary.org/obo/MONDO_0009300) (Perrault syndrome 1), [MONDO:0009301](http://purl.obolibrary.org/obo/MONDO_0009301) (46,Xy sex reversal 7), [MONDO:0009302](http://purl.obolibrary.org/obo/MONDO_0009302) (XY type gonadal dysgenesis-associated anomalies syndrome), [MONDO:0009303](http://purl.obolibrary.org/obo/MONDO_0009303) (anti-glomerular basement membrane disease), [MONDO:0009304](http://purl.obolibrary.org/obo/MONDO_0009304) (Gorlin-Chaudhry-Moss syndrome), [MONDO:0000982](http://purl.obolibrary.org/obo/MONDO_0000982) (Brown's tendon sheath syndrome), [MONDO:0009306](http://purl.obolibrary.org/obo/MONDO_0009306) (combined immunodeficiency with skin granulomas), [MONDO:0000984](http://purl.obolibrary.org/obo/MONDO_0000984) (thalassemia), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0011629](http://purl.obolibrary.org/obo/MONDO_0011629) (MOGS-CDG), [MONDO:0011628](http://purl.obolibrary.org/obo/MONDO_0011628) (propionic acidemia), [MONDO:0012958](http://purl.obolibrary.org/obo/MONDO_0012958) (MS4), [MONDO:0012953](http://purl.obolibrary.org/obo/MONDO_0012953) (colorectal cancer, susceptibility to, 10), [MONDO:0012952](http://purl.obolibrary.org/obo/MONDO_0012952) (CRCS9), [MONDO:0011621](http://purl.obolibrary.org/obo/MONDO_0011621) (Acropectoral syndrome), [MONDO:0012951](http://purl.obolibrary.org/obo/MONDO_0012951) (CRCS8), [MONDO:0011620](http://purl.obolibrary.org/obo/MONDO_0011620) (metaphyseal dysplasia, Braun-Tinschert type), [MONDO:0012957](http://purl.obolibrary.org/obo/MONDO_0012957) (MS3), [MONDO:0011625](http://purl.obolibrary.org/obo/MONDO_0011625) (autosomal dominant nonsyndromic deafness 18), [MONDO:0012956](http://purl.obolibrary.org/obo/MONDO_0012956) (MS2), [MONDO:0011624](http://purl.obolibrary.org/obo/MONDO_0011624) (transaldolase deficiency), [MONDO:0012955](http://purl.obolibrary.org/obo/MONDO_0012955) (LNCR4), [MONDO:0011623](http://purl.obolibrary.org/obo/MONDO_0011623) (spinocerebellar ataxia, autosomal recessive 1), [MONDO:0012954](http://purl.obolibrary.org/obo/MONDO_0012954) (CRCS11), [MONDO:0000957](http://purl.obolibrary.org/obo/MONDO_0000957) (lacrimal passage granuloma), [MONDO:0000958](http://purl.obolibrary.org/obo/MONDO_0000958) (neuroretinitis), [MONDO:0000953](http://purl.obolibrary.org/obo/MONDO_0000953) (malignant neoplasm of short bones of lower limb), [MONDO:0000954](http://purl.obolibrary.org/obo/MONDO_0000954) (Meckel diverticulum cancer), [MONDO:0000955](http://purl.obolibrary.org/obo/MONDO_0000955) (ileum cancer), [MONDO:0000956](http://purl.obolibrary.org/obo/MONDO_0000956) (small intestine cancer), [MONDO:0000950](http://purl.obolibrary.org/obo/MONDO_0000950) (asthenopia), [MONDO:0000951](http://purl.obolibrary.org/obo/MONDO_0000951) (thymus lymphoma), [MONDO:0000952](http://purl.obolibrary.org/obo/MONDO_0000952) (long bones of lower limb cancer), [MONDO:0012948](http://purl.obolibrary.org/obo/MONDO_0012948) (chromosome 6pter-p24 deletion syndrome), [MONDO:0011616](http://purl.obolibrary.org/obo/MONDO_0011616) (holoprosencephaly 6), [MONDO:0012942](http://purl.obolibrary.org/obo/MONDO_0012942) (LNCR3), [MONDO:0012941](http://purl.obolibrary.org/obo/MONDO_0012941) (inflammatory bowel disease 25), [MONDO:0011610](http://purl.obolibrary.org/obo/MONDO_0011610) (Dimethylglycine dehydrogenase deficiency), [MONDO:0012940](http://purl.obolibrary.org/obo/MONDO_0012940) (inflammatory bowel disease 24), [MONDO:0011615](http://purl.obolibrary.org/obo/MONDO_0011615) (East Texas bleeding disorder), [MONDO:0012945](http://purl.obolibrary.org/obo/MONDO_0012945) (amyotrophic lateral sclerosis type 11), [MONDO:0011614](http://purl.obolibrary.org/obo/MONDO_0011614) (3-hydroxy-3-methylglutaryl-CoA synthase deficiency), [MONDO:0012944](http://purl.obolibrary.org/obo/MONDO_0012944) (chromosome 17P13.3, telomeric, duplication syndrome), [MONDO:0012943](http://purl.obolibrary.org/obo/MONDO_0012943) (retinitis pigmentosa 46), [MONDO:0011612](http://purl.obolibrary.org/obo/MONDO_0011612) (glycine encephalopathy), [MONDO:0000968](http://purl.obolibrary.org/obo/MONDO_0000968) (kidney lipoma), [MONDO:0000969](http://purl.obolibrary.org/obo/MONDO_0000969) (pleural lipoma), [MONDO:0000964](http://purl.obolibrary.org/obo/MONDO_0000964) (skin lipoma), [MONDO:0000965](http://purl.obolibrary.org/obo/MONDO_0000965) (liver lipoma), [MONDO:0000966](http://purl.obolibrary.org/obo/MONDO_0000966) (pleomorphic lipoma), [MONDO:0000967](http://purl.obolibrary.org/obo/MONDO_0000967) (conventional lipoma), [MONDO:0000960](http://purl.obolibrary.org/obo/MONDO_0000960) (diabetic peripheral angiopathy), [MONDO:0000961](http://purl.obolibrary.org/obo/MONDO_0000961) (endobronchial lipoma), [MONDO:0000962](http://purl.obolibrary.org/obo/MONDO_0000962) (spindle cell lipoma), [MONDO:0000963](http://purl.obolibrary.org/obo/MONDO_0000963) (esophageal lipoma), [MONDO:0011608](http://purl.obolibrary.org/obo/MONDO_0011608) (atopic dermatitis 5), [MONDO:0012939](http://purl.obolibrary.org/obo/MONDO_0012939) (Diamond-Blackfan anemia 8), [MONDO:0011607](http://purl.obolibrary.org/obo/MONDO_0011607) (NRCLP2), [MONDO:0012938](http://purl.obolibrary.org/obo/MONDO_0012938) (Diamond-Blackfan anemia 7), [MONDO:0012937](http://purl.obolibrary.org/obo/MONDO_0012937) (Diamond-Blackfan anemia 6), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0011605](http://purl.obolibrary.org/obo/MONDO_0011605) (generalized basaloid follicular hamartoma syndrome), [MONDO:0011609](http://purl.obolibrary.org/obo/MONDO_0011609) (atopic dermatitis 6), [MONDO:0011600](http://purl.obolibrary.org/obo/MONDO_0011600) (congenital myasthenic syndrome 4A), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0011604](http://purl.obolibrary.org/obo/MONDO_0011604) (Spondylo-ocular syndrome), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), [MONDO:0011602](http://purl.obolibrary.org/obo/MONDO_0011602) (autosomal recessive nonsyndromic deafness 27), [MONDO:0012932](http://purl.obolibrary.org/obo/MONDO_0012932) (MYP16), [MONDO:0011601](http://purl.obolibrary.org/obo/MONDO_0011601) (neonatal intrahepatic cholestasis due to citrin deficiency), [MONDO:0009350](http://purl.obolibrary.org/obo/MONDO_0009350) (Holzgreve-Wagner-Rehder syndrome), [MONDO:0009351](http://purl.obolibrary.org/obo/MONDO_0009351) (homocarnosinosis), [MONDO:0009352](http://purl.obolibrary.org/obo/MONDO_0009352) (classic homocystinuria), [MONDO:0011673](http://purl.obolibrary.org/obo/MONDO_0011673) (autosomal dominant nonsyndromic deafness 30), [MONDO:0008021](http://purl.obolibrary.org/obo/MONDO_0008021) (Cowden syndrome 1), [MONDO:0011672](http://purl.obolibrary.org/obo/MONDO_0011672) (persistent polyclonal b-cell lymphocytosis), [MONDO:0009353](http://purl.obolibrary.org/obo/MONDO_0009353) (homocystinuria due to methylene tetrahydrofolate reductase deficiency), [MONDO:0008023](http://purl.obolibrary.org/obo/MONDO_0008023) (muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome), [MONDO:0009354](http://purl.obolibrary.org/obo/MONDO_0009354) (methylcobalamin deficiency type cblE), [MONDO:0011670](http://purl.obolibrary.org/obo/MONDO_0011670) (Ehlers-Danlos syndrome due to tenascin-X deficiency), [MONDO:0008024](http://purl.obolibrary.org/obo/MONDO_0008024) (neuronopathy, distal hereditary motor, type 7A), [MONDO:0009356](http://purl.obolibrary.org/obo/MONDO_0009356) (autosomal recessive humeroradial synostosis), [MONDO:0008025](http://purl.obolibrary.org/obo/MONDO_0008025) (neuronopathy, distal hereditary motor, type 2A), [MONDO:0009357](http://purl.obolibrary.org/obo/MONDO_0009357) (humeroradial synostosis with craniofacial anomalies), [MONDO:0008026](http://purl.obolibrary.org/obo/MONDO_0008026) (autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures), [MONDO:0008028](http://purl.obolibrary.org/obo/MONDO_0008028) (muscular dystrophy, Barnes type), [MONDO:0008029](http://purl.obolibrary.org/obo/MONDO_0008029) (Bethlem myopathy), [MONDO:0011676](http://purl.obolibrary.org/obo/MONDO_0011676) (PHACE syndrome), [MONDO:0011675](http://purl.obolibrary.org/obo/MONDO_0011675) (Charcot-Marie-tooth disease dominant intermediate a), [MONDO:0011674](http://purl.obolibrary.org/obo/MONDO_0011674) (Charcot-Marie-tooth disease dominant intermediate b), [MONDO:0010349](http://purl.obolibrary.org/obo/MONDO_0010349) (ovarian dysgenesis 2), [MONDO:0011679](http://purl.obolibrary.org/obo/MONDO_0011679) (craniosynostosis syndrome, autosomal recessive), [MONDO:0009340](http://purl.obolibrary.org/obo/MONDO_0009340) (non-spherocytic hemolytic anemia due to hexokinase deficiency), [MONDO:0010330](http://purl.obolibrary.org/obo/MONDO_0010330) (primary ciliary dyskinesia-retinitis pigmentosa syndrome), [MONDO:0012993](http://purl.obolibrary.org/obo/MONDO_0012993) (DUH2), [MONDO:0009341](http://purl.obolibrary.org/obo/MONDO_0009341) (Mowat-Wilson syndrome), [MONDO:0012992](http://purl.obolibrary.org/obo/MONDO_0012992) (pancreatic insufficiency-anemia-hyperostosis syndrome), [MONDO:0009342](http://purl.obolibrary.org/obo/MONDO_0009342) (Hirschsprung disease-deafness-polydactyly syndrome), [MONDO:0011661](http://purl.obolibrary.org/obo/MONDO_0011661) (inflammatory bowel disease 5), [MONDO:0011660](http://purl.obolibrary.org/obo/MONDO_0011660) (autosomal dominant nonsyndromic deafness 22), [MONDO:0012990](http://purl.obolibrary.org/obo/MONDO_0012990) (Leber congenital amaurosis 13), [MONDO:0009344](http://purl.obolibrary.org/obo/MONDO_0009344) (Hirschsprung disease-nail hypoplasia-dysmorphism syndrome), [MONDO:0009345](http://purl.obolibrary.org/obo/MONDO_0009345) (histidinemia), [MONDO:0009346](http://purl.obolibrary.org/obo/MONDO_0009346) (histidinuria due to a renal tubular defect), [MONDO:0008016](http://purl.obolibrary.org/obo/MONDO_0008016) (trismus-pseudocamptodactyly syndrome), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0008018](http://purl.obolibrary.org/obo/MONDO_0008018) (Muir-Torre syndrome), [MONDO:0009349](http://purl.obolibrary.org/obo/MONDO_0009349) (holoprosencephaly 1), [MONDO:0008019](http://purl.obolibrary.org/obo/MONDO_0008019) (mullerian aplasia and hyperandrogenism), [MONDO:0010334](http://purl.obolibrary.org/obo/MONDO_0010334) (severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome), [MONDO:0012997](http://purl.obolibrary.org/obo/MONDO_0012997) (cholestasis-pigmentary retinopathy-cleft palate syndrome), [MONDO:0012996](http://purl.obolibrary.org/obo/MONDO_0012996) (AGAT deficiency), [MONDO:0010335](http://purl.obolibrary.org/obo/MONDO_0010335) (X-linked cone-rod dystrophy 3), [MONDO:0011664](http://purl.obolibrary.org/obo/MONDO_0011664) (immunodeficiency due to CD25 deficiency), [MONDO:0012995](http://purl.obolibrary.org/obo/MONDO_0012995) (MYP15), [MONDO:0010332](http://purl.obolibrary.org/obo/MONDO_0010332) (X-linked intellectual disability-cubitus valgus-dysmorphism syndrome), [MONDO:0012994](http://purl.obolibrary.org/obo/MONDO_0012994) (Dopa-responsive dystonia due to sepiapterin reductase deficiency), [MONDO:0010333](http://purl.obolibrary.org/obo/MONDO_0010333) (corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome), [MONDO:0011663](http://purl.obolibrary.org/obo/MONDO_0011663) (juvenile primary lateral sclerosis), [MONDO:0010338](http://purl.obolibrary.org/obo/MONDO_0010338) (X-linked distal spinal muscular atrophy type 3), [MONDO:0011669](http://purl.obolibrary.org/obo/MONDO_0011669) (hypotonia-cystinuria syndrome), [MONDO:0012999](http://purl.obolibrary.org/obo/MONDO_0012999) (guanidinoacetate methyltransferase deficiency), [MONDO:0011668](http://purl.obolibrary.org/obo/MONDO_0011668) (maturity-onset diabetes of the young type 6), [MONDO:0010336](http://purl.obolibrary.org/obo/MONDO_0010336) (orofaciodigital syndrome VIII), [MONDO:0010337](http://purl.obolibrary.org/obo/MONDO_0010337) (X-linked intellectual disability-cerebellar hypoplasia syndrome), [MONDO:0011667](http://purl.obolibrary.org/obo/MONDO_0011667) (maturity-onset diabetes of the young type 4), [MONDO:0009330](http://purl.obolibrary.org/obo/MONDO_0009330) (hemangiopericytoma, malignant), [MONDO:0009331](http://purl.obolibrary.org/obo/MONDO_0009331) (isolated hemihyperplasia), [MONDO:0010320](http://purl.obolibrary.org/obo/MONDO_0010320) (retinitis pigmentosa 23), [MONDO:0012981](http://purl.obolibrary.org/obo/MONDO_0012981) (hereditary spherocytosis type 4), [MONDO:0012980](http://purl.obolibrary.org/obo/MONDO_0012980) (endocrine-cerebro-osteodysplasia syndrome), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0000997](http://purl.obolibrary.org/obo/MONDO_0000997) (monocular esotropia), [MONDO:0009334](http://purl.obolibrary.org/obo/MONDO_0009334) (hemolytic anemia with thermal sensitivity of red cells), [MONDO:0008004](http://purl.obolibrary.org/obo/MONDO_0008004) (familial mitral valve prolapse), [MONDO:0009335](http://purl.obolibrary.org/obo/MONDO_0009335) (hemolytic uremic syndrome, atypical, susceptibility to, 1), [MONDO:0008005](http://purl.obolibrary.org/obo/MONDO_0008005) (Cardiospondylocarpofacial syndrome), [MONDO:0009336](http://purl.obolibrary.org/obo/MONDO_0009336) (hemosiderosis, pulmonary, with deficiency of gamma-a globulin), [MONDO:0008006](http://purl.obolibrary.org/obo/MONDO_0008006) (Mobius syndrome), [MONDO:0009337](http://purl.obolibrary.org/obo/MONDO_0009337) (Hennekam lymphangiectasia-lymphedema syndrome 1), [MONDO:0000993](http://purl.obolibrary.org/obo/MONDO_0000993) (prostate squamous cell carcinoma), [MONDO:0009338](http://purl.obolibrary.org/obo/MONDO_0009338) (hepatic veno-occlusive disease-immunodeficiency syndrome), [MONDO:0000994](http://purl.obolibrary.org/obo/MONDO_0000994) (malignant prostate phyllodes tumor), [MONDO:0008008](http://purl.obolibrary.org/obo/MONDO_0008008) (MOMO syndrome), [MONDO:0009339](http://purl.obolibrary.org/obo/MONDO_0009339) (congenital bile acid synthesis defect 2), [MONDO:0000995](http://purl.obolibrary.org/obo/MONDO_0000995) (familial periodic paralysis), [MONDO:0000996](http://purl.obolibrary.org/obo/MONDO_0000996) (prostate lymphoma), [MONDO:0000991](http://purl.obolibrary.org/obo/MONDO_0000991) (left bundle branch hemiblock), [MONDO:0000992](http://purl.obolibrary.org/obo/MONDO_0000992) (heart conduction disease), [MONDO:0011655](http://purl.obolibrary.org/obo/MONDO_0011655) (alveolar soft part sarcoma (disease)), [MONDO:0010323](http://purl.obolibrary.org/obo/MONDO_0010323) (Atkin-Flaitz syndrome), [MONDO:0012986](http://purl.obolibrary.org/obo/MONDO_0012986) (bilateral parasagittal parieto-occipital polymicrogyria), [MONDO:0012985](http://purl.obolibrary.org/obo/MONDO_0012985) (hereditary spherocytosis type 5), [MONDO:0012984](http://purl.obolibrary.org/obo/MONDO_0012984) (PHARC syndrome), [MONDO:0011653](http://purl.obolibrary.org/obo/MONDO_0011653) (NMTC3), [MONDO:0012983](http://purl.obolibrary.org/obo/MONDO_0012983) (cone-rod dystrophy 12), [MONDO:0010327](http://purl.obolibrary.org/obo/MONDO_0010327) (HSD10 disease), [MONDO:0010328](http://purl.obolibrary.org/obo/MONDO_0010328) (alpha-thalassemia-myelodysplastic syndrome), [MONDO:0012989](http://purl.obolibrary.org/obo/MONDO_0012989) (microcephaly 7, primary, autosomal recessive), [MONDO:0011657](http://purl.obolibrary.org/obo/MONDO_0011657) (autosomal dominant nonsyndromic deafness 24), [MONDO:0012988](http://purl.obolibrary.org/obo/MONDO_0012988) (hypogonadotropic hypogonadism 6 with or without anosmia), [MONDO:0011656](http://purl.obolibrary.org/obo/MONDO_0011656) (PDB4), [MONDO:0012987](http://purl.obolibrary.org/obo/MONDO_0012987) (agammaglobulinemia 6, autosomal recessive), [MONDO:0011640](http://purl.obolibrary.org/obo/MONDO_0011640) (Genitopatellar syndrome), [MONDO:0012971](http://purl.obolibrary.org/obo/MONDO_0012971) (Microvascular complications of diabetes, susceptibility to, 7), [MONDO:0012970](http://purl.obolibrary.org/obo/MONDO_0012970) (Microvascular complications of diabetes, susceptibility to, 6), [MONDO:0009320](http://purl.obolibrary.org/obo/MONDO_0009320) (hall-Riggs syndrome), [MONDO:0009321](http://purl.obolibrary.org/obo/MONDO_0009321) (hallux varus-preaxial polysyndactyly syndrome), [MONDO:0009324](http://purl.obolibrary.org/obo/MONDO_0009324) (Hartnup disease), [MONDO:0009325](http://purl.obolibrary.org/obo/MONDO_0009325) (deafness-enamel hypoplasia-nail defects syndrome), [MONDO:0009326](http://purl.obolibrary.org/obo/MONDO_0009326) (congenital heart block), [MONDO:0011644](http://purl.obolibrary.org/obo/MONDO_0011644) (pars planitis), [MONDO:0012975](http://purl.obolibrary.org/obo/MONDO_0012975) (autosomal dominant nonsyndromic deafness 3B), [MONDO:0012974](http://purl.obolibrary.org/obo/MONDO_0012974) (autosomal dominant nonsyndromic deafness 59), [MONDO:0011643](http://purl.obolibrary.org/obo/MONDO_0011643) (permanent neonatal diabetes mellitus), [MONDO:0012973](http://purl.obolibrary.org/obo/MONDO_0012973) (inflammatory bowel disease 26), [MONDO:0010310](http://purl.obolibrary.org/obo/MONDO_0010310) (osteopathia striata with cranial sclerosis), [MONDO:0010311](http://purl.obolibrary.org/obo/MONDO_0010311) (Becker muscular dystrophy), [MONDO:0012979](http://purl.obolibrary.org/obo/MONDO_0012979) (primary ciliary dyskinesia 12), [MONDO:0011648](http://purl.obolibrary.org/obo/MONDO_0011648) (meningioma, radiation-induced), [MONDO:0012978](http://purl.obolibrary.org/obo/MONDO_0012978) (primary ciliary dyskinesia 11), [MONDO:0010314](http://purl.obolibrary.org/obo/MONDO_0010314) (BPPX), [MONDO:0012977](http://purl.obolibrary.org/obo/MONDO_0012977) (autosomal recessive nonsyndromic deafness 1B), [MONDO:0012976](http://purl.obolibrary.org/obo/MONDO_0012976) (autosomal dominant nonsyndromic deafness 2B), [MONDO:0010315](http://purl.obolibrary.org/obo/MONDO_0010315) (gamma chain deficiency), [MONDO:0008061](http://purl.obolibrary.org/obo/MONDO_0008061) (nail-patella syndrome), [MONDO:0008062](http://purl.obolibrary.org/obo/MONDO_0008062) (narcolepsy 1), [MONDO:0009393](http://purl.obolibrary.org/obo/MONDO_0009393) (ornithine translocase deficiency), [MONDO:0009394](http://purl.obolibrary.org/obo/MONDO_0009394) (juvenile Paget disease), [MONDO:0009395](http://purl.obolibrary.org/obo/MONDO_0009395) (hyperostosis corticalis generalisata), [MONDO:0010385](http://purl.obolibrary.org/obo/MONDO_0010385) (X-linked lymphoproliferative syndrome 2), [MONDO:0009397](http://purl.obolibrary.org/obo/MONDO_0009397) (neonatal severe primary hyperparathyroidism), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0009398](http://purl.obolibrary.org/obo/MONDO_0009398) (hyperphosphatasia with mental retardation syndrome 1), [MONDO:0010383](http://purl.obolibrary.org/obo/MONDO_0010383) (fragile X syndrome), [MONDO:0008069](http://purl.obolibrary.org/obo/MONDO_0008069) (necrotizing encephalomyelopathy, subacute, of Leigh, adult), [MONDO:0021038](http://purl.obolibrary.org/obo/MONDO_0021038) (Ewing sarcoma/peripheral primitive neuroectodermal tumor), [MONDO:0021039](http://purl.obolibrary.org/obo/MONDO_0021039) (extraskeletal Ewing sarcoma/peripheral primitive neuroectodermal tumor), [MONDO:0008070](http://purl.obolibrary.org/obo/MONDO_0008070) (nemaline myopathy 3), [MONDO:0008050](http://purl.obolibrary.org/obo/MONDO_0008050) (Laing early-onset distal myopathy), [MONDO:0010370](http://purl.obolibrary.org/obo/MONDO_0010370) (Cornelia de Lange syndrome 2), [MONDO:0009381](http://purl.obolibrary.org/obo/MONDO_0009381) (hyperbilirubinemia, Conjugated, type 3), [MONDO:0008051](http://purl.obolibrary.org/obo/MONDO_0008051) (tubular aggregate myopathy), [MONDO:0010371](http://purl.obolibrary.org/obo/MONDO_0010371) (Aland island eye disease), [MONDO:0009382](http://purl.obolibrary.org/obo/MONDO_0009382) (PSHB), [MONDO:0009383](http://purl.obolibrary.org/obo/MONDO_0009383) (transient familial neonatal hyperbilirubinemia), [MONDO:0008053](http://purl.obolibrary.org/obo/MONDO_0008053) (MYP2), [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0010374](http://purl.obolibrary.org/obo/MONDO_0010374) (retinitis pigmentosa 34), [MONDO:0008055](http://purl.obolibrary.org/obo/MONDO_0008055) (myotonia congenita, autosomal dominant), [MONDO:0010375](http://purl.obolibrary.org/obo/MONDO_0010375) (hyperekplexia-epilepsy syndrome), [MONDO:0008056](http://purl.obolibrary.org/obo/MONDO_0008056) (myotonic dystrophy type 1), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0009388](http://purl.obolibrary.org/obo/MONDO_0009388) (hyperlysinemia (disease)), [MONDO:0009389](http://purl.obolibrary.org/obo/MONDO_0009389) (hyperlysinemia due to defect 1N lysine transport into mitochondria), [MONDO:0008058](http://purl.obolibrary.org/obo/MONDO_0008058) (cylindrical spirals myopathy), [MONDO:0008059](http://purl.obolibrary.org/obo/MONDO_0008059) (Naegeli-Franceschetti-Jadassohn syndrome), [MONDO:0021021](http://purl.obolibrary.org/obo/MONDO_0021021) (craniodiaphyseal dysplasia, autosomal dominant), [MONDO:0021020](http://purl.obolibrary.org/obo/MONDO_0021020) (Crigler-Najjar syndrome type 1), [MONDO:0021023](http://purl.obolibrary.org/obo/MONDO_0021023) (complete androgen insensitivity syndrome), [MONDO:0021022](http://purl.obolibrary.org/obo/MONDO_0021022) (hereditary hyperekplexia), [MONDO:0010378](http://purl.obolibrary.org/obo/MONDO_0010378) (X-linked hereditary sensory and autonomic neuropathy with deafness), [MONDO:0010379](http://purl.obolibrary.org/obo/MONDO_0010379) (Brunner syndrome), [MONDO:0010377](http://purl.obolibrary.org/obo/MONDO_0010377) (MYP13), [MONDO:0011691](http://purl.obolibrary.org/obo/MONDO_0011691) (amyotrophic lateral sclerosis type 3), [MONDO:0009370](http://purl.obolibrary.org/obo/MONDO_0009370) (L-2-hydroxyglutaric aciduria), [MONDO:0008040](http://purl.obolibrary.org/obo/MONDO_0008040) (transient myeloproliferative syndrome (disease)), [MONDO:0011690](http://purl.obolibrary.org/obo/MONDO_0011690) (Camurati-Engelmann disease, type 2), [MONDO:0009371](http://purl.obolibrary.org/obo/MONDO_0009371) (3-hydroxyisobutyric aciduria), [MONDO:0009372](http://purl.obolibrary.org/obo/MONDO_0009372) (encephalopathy due to hydroxykynureninuria), [MONDO:0008041](http://purl.obolibrary.org/obo/MONDO_0008041) (myoclonic epilepsy, Hartung type), [MONDO:0009373](http://purl.obolibrary.org/obo/MONDO_0009373) (seizures-intellectual disability due to hydroxylysinuria syndrome), [MONDO:0008043](http://purl.obolibrary.org/obo/MONDO_0008043) (myoclonus-cerebellar ataxia-deafness syndrome), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0011694](http://purl.obolibrary.org/obo/MONDO_0011694) (spinocerebellar ataxia type 15/16), [MONDO:0011693](http://purl.obolibrary.org/obo/MONDO_0011693) (glaucoma, normal tension, susceptibility to), [MONDO:0009376](http://purl.obolibrary.org/obo/MONDO_0009376) (carbamoyl phosphate synthetase i deficiency disease), [MONDO:0008045](http://purl.obolibrary.org/obo/MONDO_0008045) (spinal muscular atrophy-progressive myoclonic epilepsy syndrome), [MONDO:0008046](http://purl.obolibrary.org/obo/MONDO_0008046) (autosomal dominant myoglobinuria), [MONDO:0010362](http://purl.obolibrary.org/obo/MONDO_0010362) (glycogen storage disease IXd), [MONDO:0009377](http://purl.obolibrary.org/obo/MONDO_0009377) (hyperammonemia due to N-acetylglutamate synthase deficiency), [MONDO:0009378](http://purl.obolibrary.org/obo/MONDO_0009378) (hyper-beta-alaninemia), [MONDO:0021013](http://purl.obolibrary.org/obo/MONDO_0021013) (trichothiodystrophy 4, nonphotosensitive), [MONDO:0008048](http://purl.obolibrary.org/obo/MONDO_0008048) (autosomal dominant centronuclear myopathy), [MONDO:0009379](http://purl.obolibrary.org/obo/MONDO_0009379) (Rotor syndrome), [MONDO:0021016](http://purl.obolibrary.org/obo/MONDO_0021016) (channelopathy), [MONDO:0008049](http://purl.obolibrary.org/obo/MONDO_0008049) (myopathy, distal, infantile-onset), [MONDO:0021018](http://purl.obolibrary.org/obo/MONDO_0021018) (autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)), [MONDO:0021019](http://purl.obolibrary.org/obo/MONDO_0021019) (X-linked recessive ocular albinism), [MONDO:0021010](http://purl.obolibrary.org/obo/MONDO_0021010) (skin lymphangiosarcoma), [MONDO:0010367](http://purl.obolibrary.org/obo/MONDO_0010367) (SHOX-related short stature), [MONDO:0011699](http://purl.obolibrary.org/obo/MONDO_0011699) (inflammatory bowel disease 8), [MONDO:0011698](http://purl.obolibrary.org/obo/MONDO_0011698) (glycine N-methyltransferase deficiency), [MONDO:0010365](http://purl.obolibrary.org/obo/MONDO_0010365) (CFTDX), [MONDO:0011697](http://purl.obolibrary.org/obo/MONDO_0011697) (Waardenburg syndrome type 2C), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0010369](http://purl.obolibrary.org/obo/MONDO_0010369) (NYS5), [MONDO:0009380](http://purl.obolibrary.org/obo/MONDO_0009380) (Dubin-Johnson syndrome), [MONDO:0011680](http://purl.obolibrary.org/obo/MONDO_0011680) (autosomal recessive congenital ichthyosis 3), [MONDO:0009360](http://purl.obolibrary.org/obo/MONDO_0009360) (hydrocephalus, nonsyndromic, autosomal recessive 1), [MONDO:0008030](http://purl.obolibrary.org/obo/MONDO_0008030) (facioscapulohumeral muscular dystrophy 1), [MONDO:0009361](http://purl.obolibrary.org/obo/MONDO_0009361) (hydrocephalus due to congenital stenosis of aqueduct of sylvius), [MONDO:0008031](http://purl.obolibrary.org/obo/MONDO_0008031) (facioscapulohumeral muscular dystrophy 2), [MONDO:0009363](http://purl.obolibrary.org/obo/MONDO_0009363) (hydrocephaly-tall stature-joint laxity syndrome), [MONDO:0008032](http://purl.obolibrary.org/obo/MONDO_0008032) (autosomal dominant limb-girdle muscular dystrophy type 1A), [MONDO:0011684](http://purl.obolibrary.org/obo/MONDO_0011684) (vitiligo-associated multiple autoimmune disease susceptibility 1), [MONDO:0010353](http://purl.obolibrary.org/obo/MONDO_0010353) (deafness-intellectual disability, Martin-Probst type syndrome), [MONDO:0011683](http://purl.obolibrary.org/obo/MONDO_0011683) (oculocutaneous albinism type 4), [MONDO:0008033](http://purl.obolibrary.org/obo/MONDO_0008033) (autosomal dominant limb-girdle muscular dystrophy type 1B), [MONDO:0009364](http://purl.obolibrary.org/obo/MONDO_0009364) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1), [MONDO:0009365](http://purl.obolibrary.org/obo/MONDO_0009365) (hydrolethalus syndrome 1), [MONDO:0008034](http://purl.obolibrary.org/obo/MONDO_0008034) (muscular dystrophy, pseudohypertrophic, with Internalized capillaries), [MONDO:0010351](http://purl.obolibrary.org/obo/MONDO_0010351) (Fanconi anemia complementation group b), [MONDO:0009367](http://purl.obolibrary.org/obo/MONDO_0009367) (McKusick-Kaufman syndrome), [MONDO:0008036](http://purl.obolibrary.org/obo/MONDO_0008036) (myasthenia, limb-girdle, autoimmune), [MONDO:0009368](http://purl.obolibrary.org/obo/MONDO_0009368) (Urofacial Syndrome type 1), [MONDO:0021009](http://purl.obolibrary.org/obo/MONDO_0021009) (salivary gland mucoepidermoid carcinoma), [MONDO:0021008](http://purl.obolibrary.org/obo/MONDO_0021008) (secondary antiphospholipid syndrome), [MONDO:0021001](http://purl.obolibrary.org/obo/MONDO_0021001) (hemochromatosis type 1), [MONDO:0011688](http://purl.obolibrary.org/obo/MONDO_0011688) (muscular dystrophy-dystroglycanopathy type B5), [MONDO:0011687](http://purl.obolibrary.org/obo/MONDO_0011687) (Charcot-Marie-tooth disease axonal type 2F), [MONDO:0011686](http://purl.obolibrary.org/obo/MONDO_0011686) (DNA ligase IV deficiency), [MONDO:0010355](http://purl.obolibrary.org/obo/MONDO_0010355) (syndromic X-linked intellectual disability Claes-Jensen type), [MONDO:0010358](http://purl.obolibrary.org/obo/MONDO_0010358) (hypophosphatemic rickets, X-linked recessive), [MONDO:0010359](http://purl.obolibrary.org/obo/MONDO_0010359) (Dent disease type 2), [MONDO:0021079](http://purl.obolibrary.org/obo/MONDO_0021079) (childhood neoplasm), [MONDO:0021072](http://purl.obolibrary.org/obo/MONDO_0021072) (sympathetic paraganglioma), [MONDO:0021071](http://purl.obolibrary.org/obo/MONDO_0021071) (laryngeal neoplasm), [MONDO:0021076](http://purl.obolibrary.org/obo/MONDO_0021076) (pancreatic exocrine neoplasm), [MONDO:0021075](http://purl.obolibrary.org/obo/MONDO_0021075) (neoplastic polyp), [MONDO:0021078](http://purl.obolibrary.org/obo/MONDO_0021078) (glandular papilloma), [MONDO:0021077](http://purl.obolibrary.org/obo/MONDO_0021077) (cystic neoplasm), [MONDO:0021070](http://purl.obolibrary.org/obo/MONDO_0021070) (sublingual gland carcinoma), [MONDO:0008094](http://purl.obolibrary.org/obo/MONDO_0008094) (familial multiple nevi flammei), [MONDO:0008097](http://purl.obolibrary.org/obo/MONDO_0008097) (linear nevus sebaceus syndrome), [MONDO:0008098](http://purl.obolibrary.org/obo/MONDO_0008098) (mesomelic dwarfism, Nievergelt type), [MONDO:0008099](http://purl.obolibrary.org/obo/MONDO_0008099) (congenital stationary night blindness autosomal dominant 2), [MONDO:0021069](http://purl.obolibrary.org/obo/MONDO_0021069) (malignant endocrine neoplasm), [MONDO:0021068](http://purl.obolibrary.org/obo/MONDO_0021068) (ovarian neoplasm), [MONDO:0021061](http://purl.obolibrary.org/obo/MONDO_0021061) (neurofibromatosis), [MONDO:0021060](http://purl.obolibrary.org/obo/MONDO_0021060) (RASopathy), [MONDO:0021063](http://purl.obolibrary.org/obo/MONDO_0021063) (malignant colon neoplasm), [MONDO:0021065](http://purl.obolibrary.org/obo/MONDO_0021065) (pleural neoplasm), [MONDO:0021064](http://purl.obolibrary.org/obo/MONDO_0021064) (jugulotympanic paraganglioma), [MONDO:0021067](http://purl.obolibrary.org/obo/MONDO_0021067) (mediastinal germ cell tumor), [MONDO:0021066](http://purl.obolibrary.org/obo/MONDO_0021066) (urinary system neoplasm), [MONDO:0008083](http://purl.obolibrary.org/obo/MONDO_0008083) (neuronal ceroid lipofuscinosis 4B), [MONDO:0008086](http://purl.obolibrary.org/obo/MONDO_0008086) (neuropathy, hereditary sensory and autonomic, type 1A), [MONDO:0008087](http://purl.obolibrary.org/obo/MONDO_0008087) (hereditary neuropathy with liability to pressure palsies), [MONDO:0021058](http://purl.obolibrary.org/obo/MONDO_0021058) (neoplastic syndrome), [MONDO:0021057](http://purl.obolibrary.org/obo/MONDO_0021057) (classic or attenuated familial adenomatous polyposis), [MONDO:0021050](http://purl.obolibrary.org/obo/MONDO_0021050) (vaginal neoplasm), [MONDO:0021052](http://purl.obolibrary.org/obo/MONDO_0021052) (parasympathetic paraganglioma), [MONDO:0021054](http://purl.obolibrary.org/obo/MONDO_0021054) (bone sarcoma), [MONDO:0021053](http://purl.obolibrary.org/obo/MONDO_0021053) (carotid body paraganglioma), [MONDO:0021056](http://purl.obolibrary.org/obo/MONDO_0021056) (familial adenomatous polyposis 1), [MONDO:0021055](http://purl.obolibrary.org/obo/MONDO_0021055) (classic familial adenomatous polyposis), [MONDO:0008093](http://purl.obolibrary.org/obo/MONDO_0008093) (nevus, epidermal), [MONDO:0010392](http://purl.obolibrary.org/obo/MONDO_0010392) (glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [MONDO:0008073](http://purl.obolibrary.org/obo/MONDO_0008073) (familial juvenile hyperuricemic nephropathy type 1), [MONDO:0010390](http://purl.obolibrary.org/obo/MONDO_0010390) (ocular albinism with late-onset sensorineural deafness), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0010391](http://purl.obolibrary.org/obo/MONDO_0010391) (angioma serpiginosum, X-linked), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0010395](http://purl.obolibrary.org/obo/MONDO_0010395) (phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0021047](http://purl.obolibrary.org/obo/MONDO_0021047) (breast phyllodes tumor), [MONDO:0021046](http://purl.obolibrary.org/obo/MONDO_0021046) (breast fibroepithelial neoplasm), [MONDO:0021049](http://purl.obolibrary.org/obo/MONDO_0021049) (vulvar neoplasm), [MONDO:0021048](http://purl.obolibrary.org/obo/MONDO_0021048) (benign mastocytoma), [MONDO:0021041](http://purl.obolibrary.org/obo/MONDO_0021041) (pleural solitary fibrous tumor), [MONDO:0021040](http://purl.obolibrary.org/obo/MONDO_0021040) (pancreatic neoplasm), [MONDO:0021043](http://purl.obolibrary.org/obo/MONDO_0021043) (mixed neoplasm), [MONDO:0021042](http://purl.obolibrary.org/obo/MONDO_0021042) (glioma), [MONDO:0021045](http://purl.obolibrary.org/obo/MONDO_0021045) (fibroepithelial neoplasm), [MONDO:0010398](http://purl.obolibrary.org/obo/MONDO_0010398) (syndromic X-linked intellectual disability 14), [MONDO:0010399](http://purl.obolibrary.org/obo/MONDO_0010399) (chromosome Xp21 deletion syndrome), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type III, mixed central and peripheral), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type IV, of Riccardi), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), [MONDO:0021093](http://purl.obolibrary.org/obo/MONDO_0021093) (cranioectodermal dysplasia 1), [MONDO:0021096](http://purl.obolibrary.org/obo/MONDO_0021096) (papillary epithelial neoplasm), [MONDO:0021098](http://purl.obolibrary.org/obo/MONDO_0021098) (papillomatosis), [MONDO:0021097](http://purl.obolibrary.org/obo/MONDO_0021097) (intraductal breast papilloma), [MONDO:0021099](http://purl.obolibrary.org/obo/MONDO_0021099) (intraductal papillomatosis), [MONDO:0021090](http://purl.obolibrary.org/obo/MONDO_0021090) (lipid-rich breast carcinoma), [MONDO:0021092](http://purl.obolibrary.org/obo/MONDO_0021092) (fallopian tube neoplasm), [MONDO:0021091](http://purl.obolibrary.org/obo/MONDO_0021091) (papillary cystadenoma), [MONDO:0021083](http://purl.obolibrary.org/obo/MONDO_0021083) (congenital fibrosis of extraocular muscles type 1), [MONDO:0021082](http://purl.obolibrary.org/obo/MONDO_0021082) (Meckel diverticulum neoplasm), [MONDO:0021085](http://purl.obolibrary.org/obo/MONDO_0021085) (gastric neoplasm), [MONDO:0021084](http://purl.obolibrary.org/obo/MONDO_0021084) (vision disorder), [MONDO:0021086](http://purl.obolibrary.org/obo/MONDO_0021086) (gingival neoplasm), [MONDO:0021089](http://purl.obolibrary.org/obo/MONDO_0021089) (peripheral nervous system cancer), [MONDO:0021088](http://purl.obolibrary.org/obo/MONDO_0021088) (papillary meningioma), [MONDO:0021081](http://purl.obolibrary.org/obo/MONDO_0021081) (anti-NMDA receptor encephalitis), [MONDO:0021080](http://purl.obolibrary.org/obo/MONDO_0021080) (blood vessel neoplasm), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0001909](http://purl.obolibrary.org/obo/MONDO_0001909) (renal tubular acidosis), [MONDO:0001906](http://purl.obolibrary.org/obo/MONDO_0001906) (posterior dislocation of lens), [MONDO:0001919](http://purl.obolibrary.org/obo/MONDO_0001919) (cystoid macular retinal degeneration), [MONDO:0001918](http://purl.obolibrary.org/obo/MONDO_0001918) (epiphora due to excess lacrimation), [MONDO:0001914](http://purl.obolibrary.org/obo/MONDO_0001914) (scleromalacia perforans), [MONDO:0000616](http://purl.obolibrary.org/obo/MONDO_0000616) (progesterone-receptor negative breast cancer), [MONDO:0000617](http://purl.obolibrary.org/obo/MONDO_0000617) (Her2-receptor positive breast cancer), [MONDO:0000618](http://purl.obolibrary.org/obo/MONDO_0000618) (Her2-receptor negative breast cancer), [MONDO:0000619](http://purl.obolibrary.org/obo/MONDO_0000619) (triple-receptor negative breast cancer), [MONDO:0000612](http://purl.obolibrary.org/obo/MONDO_0000612) (lymphatic system cancer), [MONDO:0000615](http://purl.obolibrary.org/obo/MONDO_0000615) (progesterone-receptor positive breast cancer), [MONDO:0000610](http://purl.obolibrary.org/obo/MONDO_0000610) (marantic endocarditis), [MONDO:0000611](http://purl.obolibrary.org/obo/MONDO_0000611) (pre-malignant neoplasm), [MONDO:0001941](http://purl.obolibrary.org/obo/MONDO_0001941) (blindness), [MONDO:0012608](http://purl.obolibrary.org/obo/MONDO_0012608) (autosomal recessive lower motor neuron disease with childhood onset), [MONDO:0013937](http://purl.obolibrary.org/obo/MONDO_0013937) (peroxisome biogenesis disorder 6B), [MONDO:0013938](http://purl.obolibrary.org/obo/MONDO_0013938) (peroxisome biogenesis disorder 7A (Zellweger)), [MONDO:0013939](http://purl.obolibrary.org/obo/MONDO_0013939) (peroxisome biogenesis disorder 7B), [MONDO:0013933](http://purl.obolibrary.org/obo/MONDO_0013933) (peroxisome biogenesis disorder 5B), [MONDO:0013934](http://purl.obolibrary.org/obo/MONDO_0013934) (combined immunodeficiency due to STK4 deficiency), [MONDO:0013935](http://purl.obolibrary.org/obo/MONDO_0013935) (Usher syndrome type 1J), [MONDO:0013936](http://purl.obolibrary.org/obo/MONDO_0013936) (peroxisome biogenesis disorder 6A (Zellweger)), [MONDO:0012605](http://purl.obolibrary.org/obo/MONDO_0012605) (isolated microphthalmia 5), [MONDO:0012604](http://purl.obolibrary.org/obo/MONDO_0012604) (isolated microphthalmia 3), [MONDO:0013930](http://purl.obolibrary.org/obo/MONDO_0013930) (peroxisome biogenesis disorder 4A (Zellweger)), [MONDO:0013931](http://purl.obolibrary.org/obo/MONDO_0013931) (peroxisome biogenesis disorder 4B), [MONDO:0012602](http://purl.obolibrary.org/obo/MONDO_0012602) (autosomal recessive nonsyndromic deafness 24), [MONDO:0013932](http://purl.obolibrary.org/obo/MONDO_0013932) (peroxisome biogenesis disorder 5A (Zellweger)), [MONDO:0000627](http://purl.obolibrary.org/obo/MONDO_0000627) (benign endocrine neoplasm), [MONDO:0000628](http://purl.obolibrary.org/obo/MONDO_0000628) (central nervous system organ benign neoplasm), [MONDO:0000629](http://purl.obolibrary.org/obo/MONDO_0000629) (cardiovascular organ benign neoplasm), [MONDO:0000624](http://purl.obolibrary.org/obo/MONDO_0000624) (female reproductive organ benign neoplasm), [MONDO:0000625](http://purl.obolibrary.org/obo/MONDO_0000625) (male reproductive organ benign neoplasm), [MONDO:0000626](http://purl.obolibrary.org/obo/MONDO_0000626) (vestibular gland benign neoplasm), [MONDO:0001950](http://purl.obolibrary.org/obo/MONDO_0001950) (corneal ectasia), [MONDO:0000620](http://purl.obolibrary.org/obo/MONDO_0000620) (breast benign neoplasm), [MONDO:0000621](http://purl.obolibrary.org/obo/MONDO_0000621) (immune system cancer), [MONDO:0001952](http://purl.obolibrary.org/obo/MONDO_0001952) (parietal lobe cancer), [MONDO:0013926](http://purl.obolibrary.org/obo/MONDO_0013926) (hypogonadotropic hypogonadism 14 with or without anosmia), [MONDO:0013927](http://purl.obolibrary.org/obo/MONDO_0013927) (peroxisome biogenesis disorder 3A (Zellweger)), [MONDO:0013929](http://purl.obolibrary.org/obo/MONDO_0013929) (autosomal recessive nonsyndromic deafness 98), [MONDO:0013922](http://purl.obolibrary.org/obo/MONDO_0013922) (microcephalic primordial dwarfism, Dauber type), [MONDO:0013923](http://purl.obolibrary.org/obo/MONDO_0013923) (microcephaly 9, primary, autosomal recessive), [MONDO:0013924](http://purl.obolibrary.org/obo/MONDO_0013924) (osteogenesis imperfecta type 13), [MONDO:0013925](http://purl.obolibrary.org/obo/MONDO_0013925) (methylmalonic acidemia with homocystinuria, type cblJ), [MONDO:0001925](http://purl.obolibrary.org/obo/MONDO_0001925) (retinal dystrophy in systemic or cerebroretinal lipidoses), [MONDO:0001924](http://purl.obolibrary.org/obo/MONDO_0001924) (dystrophies primarily involving the retinal pigment epithelium), [MONDO:0001923](http://purl.obolibrary.org/obo/MONDO_0001923) (vitreoretinal dystrophy), [MONDO:0013915](http://purl.obolibrary.org/obo/MONDO_0013915) (hypogonadotropic hypogonadism 13 with or without anosmia), [MONDO:0013917](http://purl.obolibrary.org/obo/MONDO_0013917) (nephronophthisis 15), [MONDO:0013918](http://purl.obolibrary.org/obo/MONDO_0013918) (distal tetrasomy 15q), [MONDO:0013911](http://purl.obolibrary.org/obo/MONDO_0013911) (hypogonadotropic hypogonadism 9 with or without anosmia), [MONDO:0013912](http://purl.obolibrary.org/obo/MONDO_0013912) (hypogonadotropic hypogonadism 10 with or without anosmia), [MONDO:0013913](http://purl.obolibrary.org/obo/MONDO_0013913) (hypogonadotropic hypogonadism 11 with or without anosmia), [MONDO:0013914](http://purl.obolibrary.org/obo/MONDO_0013914) (hypogonadotropic hypogonadism 12 with or without anosmia), [MONDO:0013910](http://purl.obolibrary.org/obo/MONDO_0013910) (hypogonadotropic hypogonadism 8 with or without anosmia), [MONDO:0000605](http://purl.obolibrary.org/obo/MONDO_0000605) (hypersensitivity reaction disease), [MONDO:0001936](http://purl.obolibrary.org/obo/MONDO_0001936) (brawny scleritis), [MONDO:0000606](http://purl.obolibrary.org/obo/MONDO_0000606) (gluten allergy), [MONDO:0000607](http://purl.obolibrary.org/obo/MONDO_0000607) (cutaneous T cell lymphoma), [MONDO:0001939](http://purl.obolibrary.org/obo/MONDO_0001939) (skin epithelioid hemangioma), [MONDO:0000601](http://purl.obolibrary.org/obo/MONDO_0000601) (autoimmune disease of urogenital tract), [MONDO:0000602](http://purl.obolibrary.org/obo/MONDO_0000602) (autoimmune disease of blood), [MONDO:0000603](http://purl.obolibrary.org/obo/MONDO_0000603) (autoimmune disease of cardiovascular system), [MONDO:0013908](http://purl.obolibrary.org/obo/MONDO_0013908) (TTPP3), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0013905](http://purl.obolibrary.org/obo/MONDO_0013905) (autosomal recessive spinocerebellar ataxia 13), [MONDO:0013907](http://purl.obolibrary.org/obo/MONDO_0013907) (bilateral generalized polymicrogyria), [MONDO:0013901](http://purl.obolibrary.org/obo/MONDO_0013901) (spermatogenic failure 10), [MONDO:0013902](http://purl.obolibrary.org/obo/MONDO_0013902) (aortic valve disease 2), [MONDO:0013903](http://purl.obolibrary.org/obo/MONDO_0013903) (NYS7), [MONDO:0013970](http://purl.obolibrary.org/obo/MONDO_0013970) (branched-chain keto acid dehydrogenase kinase deficiency), [MONDO:0013971](http://purl.obolibrary.org/obo/MONDO_0013971) (leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome), [MONDO:0013972](http://purl.obolibrary.org/obo/MONDO_0013972) (Perrault syndrome 2), [MONDO:0012640](http://purl.obolibrary.org/obo/MONDO_0012640) (Charcot-Marie-tooth disease type 4J), [MONDO:0000659](http://purl.obolibrary.org/obo/MONDO_0000659) (delta chain disease), [MONDO:0000652](http://purl.obolibrary.org/obo/MONDO_0000652) (integumentary system benign neoplasm), [MONDO:0000653](http://purl.obolibrary.org/obo/MONDO_0000653) (integumentary system cancer), [MONDO:0001983](http://purl.obolibrary.org/obo/MONDO_0001983) (peripheral degeneration of cornea), [MONDO:0001986](http://purl.obolibrary.org/obo/MONDO_0001986) (Argyll Robertson pupil), [MONDO:0000654](http://purl.obolibrary.org/obo/MONDO_0000654) (connective tissue benign neoplasm), [MONDO:0001985](http://purl.obolibrary.org/obo/MONDO_0001985) (partial arterial retinal occlusion), [MONDO:0001982](http://purl.obolibrary.org/obo/MONDO_0001982) (Niemann-Pick disease), [MONDO:0000650](http://purl.obolibrary.org/obo/MONDO_0000650) (peritoneal benign neoplasm), [MONDO:0013977](http://purl.obolibrary.org/obo/MONDO_0013977) (combined oxidative phosphorylation defect type 13), [MONDO:0011314](http://purl.obolibrary.org/obo/MONDO_0011314) (Graves disease, susceptibility to, 2), [MONDO:0012645](http://purl.obolibrary.org/obo/MONDO_0012645) (GLC1N), [MONDO:0012644](http://purl.obolibrary.org/obo/MONDO_0012644) (asphyxiating thoracic dystrophy 2), [MONDO:0011313](http://purl.obolibrary.org/obo/MONDO_0011313) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1), [MONDO:0013978](http://purl.obolibrary.org/obo/MONDO_0013978) (autosomal recessive nonsyndromic deafness 70), [MONDO:0011312](http://purl.obolibrary.org/obo/MONDO_0011312) (thyroid carcinoma, nonmedullary, with or without cell oxyphilia), [MONDO:0013979](http://purl.obolibrary.org/obo/MONDO_0013979) (primary ciliary dyskinesia 19), [MONDO:0011311](http://purl.obolibrary.org/obo/MONDO_0011311) (glaucoma 1, open angle, f), [MONDO:0013973](http://purl.obolibrary.org/obo/MONDO_0013973) (ECTD5), [MONDO:0013974](http://purl.obolibrary.org/obo/MONDO_0013974) (ECTD6), [MONDO:0012648](http://purl.obolibrary.org/obo/MONDO_0012648) (isobutyryl-CoA dehydrogenase deficiency), [MONDO:0013975](http://purl.obolibrary.org/obo/MONDO_0013975) (ectodermal dysplasia 7, hair/nail type), [MONDO:0012646](http://purl.obolibrary.org/obo/MONDO_0012646) (GLC1H), [MONDO:0013976](http://purl.obolibrary.org/obo/MONDO_0013976) (ectodermal dysplasia 9, hair/nail type), [MONDO:0013960](http://purl.obolibrary.org/obo/MONDO_0013960) (sinoatrial node dysfunction and deafness), [MONDO:0013961](http://purl.obolibrary.org/obo/MONDO_0013961) (hypogonadotropic hypogonadism 16 with or without anosmia), [MONDO:0001999](http://purl.obolibrary.org/obo/MONDO_0001999) (primary pulmonary hypertension), [MONDO:0001998](http://purl.obolibrary.org/obo/MONDO_0001998) (Foster-Kennedy syndrome), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0001994](http://purl.obolibrary.org/obo/MONDO_0001994) (sphenoidal sinus cancer), [MONDO:0001996](http://purl.obolibrary.org/obo/MONDO_0001996) (steroid-induced glaucoma - borderline), [MONDO:0001991](http://purl.obolibrary.org/obo/MONDO_0001991) (malignant cardiac germ cell tumor), [MONDO:0001990](http://purl.obolibrary.org/obo/MONDO_0001990) (malignant cardiac peripheral nerve sheath neoplasm), [MONDO:0001993](http://purl.obolibrary.org/obo/MONDO_0001993) (seminal vesicle adenocarcinoma), [MONDO:0001992](http://purl.obolibrary.org/obo/MONDO_0001992) (rete testis adenocarcinoma), [MONDO:0011308](http://purl.obolibrary.org/obo/MONDO_0011308) (gracile syndrome), [MONDO:0012634](http://purl.obolibrary.org/obo/MONDO_0012634) (craniofacial dysplasia-osteopenia syndrome), [MONDO:0013966](http://purl.obolibrary.org/obo/MONDO_0013966) (catecholaminergic polymorphic ventricular tachycardia 4), [MONDO:0011302](http://purl.obolibrary.org/obo/MONDO_0011302) (type 1 diabetes mellitus 17), [MONDO:0013967](http://purl.obolibrary.org/obo/MONDO_0013967) (peroxisome biogenesis disorder 14B), [MONDO:0013968](http://purl.obolibrary.org/obo/MONDO_0013968) (PGM1-CDG), [MONDO:0011301](http://purl.obolibrary.org/obo/MONDO_0011301) (pseudohypoparathyroidism type 1B), [MONDO:0011300](http://purl.obolibrary.org/obo/MONDO_0011300) (MYP3), [MONDO:0013969](http://purl.obolibrary.org/obo/MONDO_0013969) (combined oxidative phosphorylation defect type 11), [MONDO:0012638](http://purl.obolibrary.org/obo/MONDO_0012638) (microphthalmia-brain atrophy syndrome), [MONDO:0012637](http://purl.obolibrary.org/obo/MONDO_0012637) (COG1-CDG), [MONDO:0013963](http://purl.obolibrary.org/obo/MONDO_0013963) (autosomal recessive nonsyndromic deafness 93), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0013964](http://purl.obolibrary.org/obo/MONDO_0013964) (Diamond-Blackfan anemia 11), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), [MONDO:0013965](http://purl.obolibrary.org/obo/MONDO_0013965) (lethal congenital contracture syndrome 4), [MONDO:0012635](http://purl.obolibrary.org/obo/MONDO_0012635) (COG8-CDG), [MONDO:0013950](http://purl.obolibrary.org/obo/MONDO_0013950) (peroxisome biogenesis disorder 11B), [MONDO:0000638](http://purl.obolibrary.org/obo/MONDO_0000638) (benign glioma), [MONDO:0000639](http://purl.obolibrary.org/obo/MONDO_0000639) (cartilage cancer), [MONDO:0001969](http://purl.obolibrary.org/obo/MONDO_0001969) (mixed gonadal dysgenesis), [MONDO:0001966](http://purl.obolibrary.org/obo/MONDO_0001966) (chronic closed-angle glaucoma), [MONDO:0000634](http://purl.obolibrary.org/obo/MONDO_0000634) (thoracic benign neoplasm), [MONDO:0001965](http://purl.obolibrary.org/obo/MONDO_0001965) (sclerosing keratitis), [MONDO:0000636](http://purl.obolibrary.org/obo/MONDO_0000636) (musculoskeletal system benign neoplasm), [MONDO:0000637](http://purl.obolibrary.org/obo/MONDO_0000637) (musculoskeletal system cancer), [MONDO:0000630](http://purl.obolibrary.org/obo/MONDO_0000630) (immune system organ benign neoplasm), [MONDO:0001962](http://purl.obolibrary.org/obo/MONDO_0001962) (abnormality of glucagon secretion), [MONDO:0000631](http://purl.obolibrary.org/obo/MONDO_0000631) (bone benign neoplasm), [MONDO:0000632](http://purl.obolibrary.org/obo/MONDO_0000632) (uterine benign neoplasm), [MONDO:0000633](http://purl.obolibrary.org/obo/MONDO_0000633) (sensory organ benign neoplasm), [MONDO:0013959](http://purl.obolibrary.org/obo/MONDO_0013959) (Charcot-Marie-tooth disease type 4F), [MONDO:0012622](http://purl.obolibrary.org/obo/MONDO_0012622) (leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome), [MONDO:0012621](http://purl.obolibrary.org/obo/MONDO_0012621) (deafness-infertility syndrome), [MONDO:0012620](http://purl.obolibrary.org/obo/MONDO_0012620) (HPC10), [MONDO:0013951](http://purl.obolibrary.org/obo/MONDO_0013951) (peroxisome biogenesis disorder 12A (Zellweger)), [MONDO:0013952](http://purl.obolibrary.org/obo/MONDO_0013952) (peroxisome biogenesis disorder 13A (Zellweger)), [MONDO:0012626](http://purl.obolibrary.org/obo/MONDO_0012626) (Meckel syndrome, type 4), [MONDO:0012625](http://purl.obolibrary.org/obo/MONDO_0012625) (retinitis pigmentosa 37), [MONDO:0012624](http://purl.obolibrary.org/obo/MONDO_0012624) (acyl-CoA dehydrogenase 9 deficiency), [MONDO:0000649](http://purl.obolibrary.org/obo/MONDO_0000649) (sensory system cancer), [MONDO:0000645](http://purl.obolibrary.org/obo/MONDO_0000645) (fallopian tube benign neoplasm), [MONDO:0001977](http://purl.obolibrary.org/obo/MONDO_0001977) (ureteral lymphoma), [MONDO:0000646](http://purl.obolibrary.org/obo/MONDO_0000646) (ovarian benign neoplasm), [MONDO:0000647](http://purl.obolibrary.org/obo/MONDO_0000647) (benign vaginal neoplasm), [MONDO:0000648](http://purl.obolibrary.org/obo/MONDO_0000648) (nervous system benign neoplasm), [MONDO:0001978](http://purl.obolibrary.org/obo/MONDO_0001978) (regional ureteric cancer), [MONDO:0000641](http://purl.obolibrary.org/obo/MONDO_0000641) (cerebellar medulloblastoma), [MONDO:0000642](http://purl.obolibrary.org/obo/MONDO_0000642) (brain meningioma), [MONDO:0001975](http://purl.obolibrary.org/obo/MONDO_0001975) (cavernous hemangioma of orbit), [MONDO:0000643](http://purl.obolibrary.org/obo/MONDO_0000643) (vulvar benign neoplasm), [MONDO:0000644](http://purl.obolibrary.org/obo/MONDO_0000644) (cervical benign neoplasm), [MONDO:0001974](http://purl.obolibrary.org/obo/MONDO_0001974) (hemangioma of orbit), [MONDO:0001971](http://purl.obolibrary.org/obo/MONDO_0001971) (farmer's lung disease), [MONDO:0000640](http://purl.obolibrary.org/obo/MONDO_0000640) (central nervous system primitive neuroectodermal neoplasm), [MONDO:0013948](http://purl.obolibrary.org/obo/MONDO_0013948) (peroxisome biogenesis disorder 10A (Zellweger)), [MONDO:0013949](http://purl.obolibrary.org/obo/MONDO_0013949) (peroxisome biogenesis disorder 11A (Zellweger)), [MONDO:0013945](http://purl.obolibrary.org/obo/MONDO_0013945) (peroxisome biogenesis disorder 9B), [MONDO:0012610](http://purl.obolibrary.org/obo/MONDO_0012610) (inflammatory bowel disease 10), [MONDO:0013946](http://purl.obolibrary.org/obo/MONDO_0013946) (hypogonadotropic hypogonadism 15 with or without anosmia), [MONDO:0013947](http://purl.obolibrary.org/obo/MONDO_0013947) (young adult-onset distal hereditary motor neuropathy), [MONDO:0013940](http://purl.obolibrary.org/obo/MONDO_0013940) (primary ciliary dyskinesia 18), [MONDO:0013941](http://purl.obolibrary.org/obo/MONDO_0013941) (metaphyseal chondromatosis with d-2-hydroxyglutaric aciduria), [MONDO:0013942](http://purl.obolibrary.org/obo/MONDO_0013942) (peroxisome biogenesis disorder 8A (Zellweger)), [MONDO:0013943](http://purl.obolibrary.org/obo/MONDO_0013943) (peroxisome biogenesis disorder 8B), [MONDO:0011350](http://purl.obolibrary.org/obo/MONDO_0011350) (autosomal dominant nonsyndromic deafness 17), [MONDO:0009031](http://purl.obolibrary.org/obo/MONDO_0009031) (craniodiaphyseal dysplasia), [MONDO:0009032](http://purl.obolibrary.org/obo/MONDO_0009032) (cranioectodermal dysplasia), [MONDO:0009033](http://purl.obolibrary.org/obo/MONDO_0009033) (temtamy syndrome), [MONDO:0011354](http://purl.obolibrary.org/obo/MONDO_0011354) (situs inversus totalis with cystic dysplasia of kidneys and pancreas), [MONDO:0009034](http://purl.obolibrary.org/obo/MONDO_0009034) (craniofacial dyssynostosis), [MONDO:0010023](http://purl.obolibrary.org/obo/MONDO_0010023) (combined immunodeficiency due to ZAP70 deficiency), [MONDO:0009035](http://purl.obolibrary.org/obo/MONDO_0009035) (craniometaphyseal dysplasia, autosomal recessive), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0012683](http://purl.obolibrary.org/obo/MONDO_0012683) (pontocerebellar hypoplasia type 6), [MONDO:0009036](http://purl.obolibrary.org/obo/MONDO_0009036) (cardiocranial syndrome, Pfeiffer type), [MONDO:0011351](http://purl.obolibrary.org/obo/MONDO_0011351) (autosomal recessive nonsyndromic deafness 21), [MONDO:0009038](http://purl.obolibrary.org/obo/MONDO_0009038) (craniosynostosis-fibular aplasia syndrome), [MONDO:0009039](http://purl.obolibrary.org/obo/MONDO_0009039) (Baller-Gerold syndrome), [MONDO:0000698](http://purl.obolibrary.org/obo/MONDO_0000698) (gamma-amino butyric acid metabolism disorder), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0010027](http://purl.obolibrary.org/obo/MONDO_0010027) (Free sialic acid storage disease, infantile form), [MONDO:0012688](http://purl.obolibrary.org/obo/MONDO_0012688) (cataract 17 multiple types), [MONDO:0012687](http://purl.obolibrary.org/obo/MONDO_0012687) (familial cavitary optic disc anomaly), [MONDO:0010024](http://purl.obolibrary.org/obo/MONDO_0010024) (Beemer-Langer syndrome), [MONDO:0011355](http://purl.obolibrary.org/obo/MONDO_0011355) (cone-rod dystrophy 7), [MONDO:0010028](http://purl.obolibrary.org/obo/MONDO_0010028) (sialuria), [MONDO:0011359](http://purl.obolibrary.org/obo/MONDO_0011359) (acromelic frontonasal dysostosis), [MONDO:0010029](http://purl.obolibrary.org/obo/MONDO_0010029) (situs inversus), [MONDO:0012670](http://purl.obolibrary.org/obo/MONDO_0012670) (autosomal recessive nonsyndromic deafness 63), [MONDO:0009020](http://purl.obolibrary.org/obo/MONDO_0009020) (macular corneal dystrophy), [MONDO:0009021](http://purl.obolibrary.org/obo/MONDO_0009021) (Toriello-Carey syndrome), [MONDO:0010011](http://purl.obolibrary.org/obo/MONDO_0010011) (schizencephaly), [MONDO:0012674](http://purl.obolibrary.org/obo/MONDO_0012674) (age related macular degeneration 10), [MONDO:0011342](http://purl.obolibrary.org/obo/MONDO_0011342) (SLC35A1-CDG), [MONDO:0010012](http://purl.obolibrary.org/obo/MONDO_0010012) (autoimmune polyendocrinopathy type 2), [MONDO:0012673](http://purl.obolibrary.org/obo/MONDO_0012673) (CRCS2), [MONDO:0009024](http://purl.obolibrary.org/obo/MONDO_0009024) (cortical blindness-intellectual disability-polydactyly syndrome), [MONDO:0010010](http://purl.obolibrary.org/obo/MONDO_0010010) (Schinzel-Giedion syndrome), [MONDO:0011340](http://purl.obolibrary.org/obo/MONDO_0011340) (congenital tracheal stenosis), [MONDO:0009026](http://purl.obolibrary.org/obo/MONDO_0009026) (Costello syndrome), [MONDO:0009028](http://purl.obolibrary.org/obo/MONDO_0009028) (Crane-Heise syndrome), [MONDO:0010015](http://purl.obolibrary.org/obo/MONDO_0010015) (congenital cataract microcornea with corneal opacity), [MONDO:0011347](http://purl.obolibrary.org/obo/MONDO_0011347) (craniosynostosis with ectopia lentis), [MONDO:0012678](http://purl.obolibrary.org/obo/MONDO_0012678) (ATFB5), [MONDO:0011346](http://purl.obolibrary.org/obo/MONDO_0011346) (xanthinuria type II), [MONDO:0012677](http://purl.obolibrary.org/obo/MONDO_0012677) (atrial fibrillation, familial, 4), [MONDO:0010016](http://purl.obolibrary.org/obo/MONDO_0010016) (sclerosteosis 1), [MONDO:0010013](http://purl.obolibrary.org/obo/MONDO_0010013) (schneckenbecken dysplasia), [MONDO:0012676](http://purl.obolibrary.org/obo/MONDO_0012676) (autosomal recessive osteopetrosis 4), [MONDO:0010014](http://purl.obolibrary.org/obo/MONDO_0010014) (Craniometadiaphyseal dysplasia, wormian bone type), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), [MONDO:0012679](http://purl.obolibrary.org/obo/MONDO_0012679) (autosomal recessive osteopetrosis 6), [MONDO:0011348](http://purl.obolibrary.org/obo/MONDO_0011348) (non-syndromic polydactyly), [MONDO:0013991](http://purl.obolibrary.org/obo/MONDO_0013991) (obesity due to congenital leptin deficiency), [MONDO:0013992](http://purl.obolibrary.org/obo/MONDO_0013992) (obesity due to leptin receptor gene deficiency), [MONDO:0013993](http://purl.obolibrary.org/obo/MONDO_0013993) (pontocerebellar hypoplasia type 7), [MONDO:0013994](http://purl.obolibrary.org/obo/MONDO_0013994) (Joubert syndrome 20), [MONDO:0009011](http://purl.obolibrary.org/obo/MONDO_0009011) (constriction rings syndrome), [MONDO:0009012](http://purl.obolibrary.org/obo/MONDO_0009012) (multiple pterygium-malignant hyperthermia syndrome), [MONDO:0010001](http://purl.obolibrary.org/obo/MONDO_0010001) (ectodermal dysplasia-blindness syndrome), [MONDO:0012662](http://purl.obolibrary.org/obo/MONDO_0012662) (Usher syndrome type 2D), [MONDO:0011330](http://purl.obolibrary.org/obo/MONDO_0011330) (spinocerebellar ataxia type 10), [MONDO:0009014](http://purl.obolibrary.org/obo/MONDO_0009014) (cornea plana 2), [MONDO:0013990](http://purl.obolibrary.org/obo/MONDO_0013990) (pontocerebellar hypoplasia type 8), [MONDO:0009015](http://purl.obolibrary.org/obo/MONDO_0009015) (corneal dystrophy-perceptive deafness syndrome), [MONDO:0009016](http://purl.obolibrary.org/obo/MONDO_0009016) (band keratopathy), [MONDO:0009018](http://purl.obolibrary.org/obo/MONDO_0009018) (central cloudy dystrophy of FranC'ois), [MONDO:0009019](http://purl.obolibrary.org/obo/MONDO_0009019) (congenital hereditary endothelial dystrophy of cornea), [MONDO:0010004](http://purl.obolibrary.org/obo/MONDO_0010004) (EEC syndrome), [MONDO:0013999](http://purl.obolibrary.org/obo/MONDO_0013999) (optic nerve edema-splenomegaly syndrome), [MONDO:0011336](http://purl.obolibrary.org/obo/MONDO_0011336) (familial hemophagocytic lymphohistiocytosis 4), [MONDO:0011335](http://purl.obolibrary.org/obo/MONDO_0011335) (spondyloepimetaphyseal dysplasia with multiple dislocations), [MONDO:0010005](http://purl.obolibrary.org/obo/MONDO_0010005) (Saccharopinuria), [MONDO:0010002](http://purl.obolibrary.org/obo/MONDO_0010002) (Rothmund-Thomson syndrome), [MONDO:0011334](http://purl.obolibrary.org/obo/MONDO_0011334) (limb-mammary syndrome), [MONDO:0012665](http://purl.obolibrary.org/obo/MONDO_0012665) (cataract 33), [MONDO:0012664](http://purl.obolibrary.org/obo/MONDO_0012664) (spastic ataxia 3), [MONDO:0010008](http://purl.obolibrary.org/obo/MONDO_0010008) (Sarcosinemia), [MONDO:0010009](http://purl.obolibrary.org/obo/MONDO_0010009) (SC phocomelia syndrome), [MONDO:0013996](http://purl.obolibrary.org/obo/MONDO_0013996) (focal facial dermal dysplasia type II), [MONDO:0012669](http://purl.obolibrary.org/obo/MONDO_0012669) (Legius syndrome), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0011338](http://purl.obolibrary.org/obo/MONDO_0011338) (Omenn syndrome), [MONDO:0013997](http://purl.obolibrary.org/obo/MONDO_0013997) (focal facial dermal dysplasia type IV), [MONDO:0010007](http://purl.obolibrary.org/obo/MONDO_0010007) (Microbrachycephaly-ptosis-cleft lip syndrome), [MONDO:0011337](http://purl.obolibrary.org/obo/MONDO_0011337) (familial hemophagocytic lymphohistiocytosis 2), [MONDO:0013998](http://purl.obolibrary.org/obo/MONDO_0013998) (Carpenter syndrome 2), [MONDO:0013982](http://purl.obolibrary.org/obo/MONDO_0013982) (ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant), [MONDO:0013983](http://purl.obolibrary.org/obo/MONDO_0013983) (ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0012652](http://purl.obolibrary.org/obo/MONDO_0012652) (autosomal recessive limb-girdle muscular dystrophy type 2L), [MONDO:0011320](http://purl.obolibrary.org/obo/MONDO_0011320) (radioulnar synostosis-microcephaly-scoliosis syndrome), [MONDO:0009001](http://purl.obolibrary.org/obo/MONDO_0009001) (macular coloboma-cleft palate-hallux valgus syndrome), [MONDO:0012650](http://purl.obolibrary.org/obo/MONDO_0012650) (Cernunnos-XLF deficiency), [MONDO:0009002](http://purl.obolibrary.org/obo/MONDO_0009002) (coloboma, ocular, autosomal recessive), [MONDO:0009003](http://purl.obolibrary.org/obo/MONDO_0009003) (achromatopsia 2), [MONDO:0000689](http://purl.obolibrary.org/obo/MONDO_0000689) (survival motor neuron spinal muscular atrophy), [MONDO:0009007](http://purl.obolibrary.org/obo/MONDO_0009007) (Jalili syndrome), [MONDO:0009008](http://purl.obolibrary.org/obo/MONDO_0009008) (heart defect-tongue hamartoma-polysyndactyly syndrome), [MONDO:0009009](http://purl.obolibrary.org/obo/MONDO_0009009) (hypoplasminogenemia), [MONDO:0000687](http://purl.obolibrary.org/obo/MONDO_0000687) (diffuse alopecia areata), [MONDO:0000688](http://purl.obolibrary.org/obo/MONDO_0000688) (organic acidemia), [MONDO:0012656](http://purl.obolibrary.org/obo/MONDO_0012656) (lethal congenital contracture syndrome 3), [MONDO:0011325](http://purl.obolibrary.org/obo/MONDO_0011325) (Fanconi anemia complementation group f), [MONDO:0013989](http://purl.obolibrary.org/obo/MONDO_0013989) (epileptic encephalopathy, early infantile, 14), [MONDO:0012654](http://purl.obolibrary.org/obo/MONDO_0012654) (atrial heart septal defect 4), [MONDO:0012653](http://purl.obolibrary.org/obo/MONDO_0012653) (PHPVAD), [MONDO:0013984](http://purl.obolibrary.org/obo/MONDO_0013984) (autosomal recessive nonsyndromic deafness 84B), [MONDO:0013985](http://purl.obolibrary.org/obo/MONDO_0013985) (autosomal recessive nonsyndromic deafness 18B), [MONDO:0012659](http://purl.obolibrary.org/obo/MONDO_0012659) (age related macular degeneration 9), [MONDO:0013986](http://purl.obolibrary.org/obo/MONDO_0013986) (combined oxidative phosphorylation defect type 14), [MONDO:0012658](http://purl.obolibrary.org/obo/MONDO_0012658) (brachydactyly type B2), [MONDO:0011326](http://purl.obolibrary.org/obo/MONDO_0011326) (citrullinemia, type Ii, adult-onset), [MONDO:0013987](http://purl.obolibrary.org/obo/MONDO_0013987) (combined oxidative phosphorylation defect type 15), [MONDO:0009073](http://purl.obolibrary.org/obo/MONDO_0009073) (Ritscher-Schinzel syndrome 1), [MONDO:0009074](http://purl.obolibrary.org/obo/MONDO_0009074) (facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome), [MONDO:0010063](http://purl.obolibrary.org/obo/MONDO_0010063) (corneal-cerebellar syndrome), [MONDO:0011393](http://purl.obolibrary.org/obo/MONDO_0011393) (apolipoprotein A-I deficiency), [MONDO:0009075](http://purl.obolibrary.org/obo/MONDO_0009075) (Dandy-Walker malformation-postaxial polydactyly syndrome), [MONDO:0010060](http://purl.obolibrary.org/obo/MONDO_0010060) (infantile onset spinocerebellar ataxia), [MONDO:0011392](http://purl.obolibrary.org/obo/MONDO_0011392) (autosomal recessive nonsyndromic deafness 20), [MONDO:0010061](http://purl.obolibrary.org/obo/MONDO_0010061) (autosomal recessive cerebellar ataxia-blindness-deafness syndrome), [MONDO:0009076](http://purl.obolibrary.org/obo/MONDO_0009076) (autosomal recessive nonsyndromic deafness 1A), [MONDO:0011398](http://purl.obolibrary.org/obo/MONDO_0011398) (dystrophic epidermolysis bullosa pruriginosa), [MONDO:0010066](http://purl.obolibrary.org/obo/MONDO_0010066) (familial isolated congenital asplenia), [MONDO:0011397](http://purl.obolibrary.org/obo/MONDO_0011397) (autosomal dominant cerebellar ataxia, deafness and narcolepsy), [MONDO:0009078](http://purl.obolibrary.org/obo/MONDO_0009078) (Jervell and Lange-Nielsen syndrome), [MONDO:0010064](http://purl.obolibrary.org/obo/MONDO_0010064) (spastic ataxia-corneal dystrophy syndrome), [MONDO:0009079](http://purl.obolibrary.org/obo/MONDO_0009079) (DOORS syndrome), [MONDO:0011395](http://purl.obolibrary.org/obo/MONDO_0011395) (cone-rod dystrophy 3), [MONDO:0010065](http://purl.obolibrary.org/obo/MONDO_0010065) (spinocerebellar degeneration with slow eye movements), [MONDO:0010068](http://purl.obolibrary.org/obo/MONDO_0010068) (spondyloepimetaphyseal dysplasia, sponastrime type), [MONDO:0011399](http://purl.obolibrary.org/obo/MONDO_0011399) (alpha thalassemia), [MONDO:0010069](http://purl.obolibrary.org/obo/MONDO_0010069) (spondylocostal dysostosis-anal and genitourinary malformations syndrome), [MONDO:0009080](http://purl.obolibrary.org/obo/MONDO_0009080) (split hand-foot malformation 1 with sensorineural hearing loss), [MONDO:0009082](http://purl.obolibrary.org/obo/MONDO_0009082) (high myopia-sensorineural deafness syndrome), [MONDO:0009083](http://purl.obolibrary.org/obo/MONDO_0009083) (conductive deafness-malformed external ear syndrome), [MONDO:0010051](http://purl.obolibrary.org/obo/MONDO_0010051) (spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome), [MONDO:0011383](http://purl.obolibrary.org/obo/MONDO_0011383) (autoimmune lymphoproliferative syndrome type 2A), [MONDO:0010052](http://purl.obolibrary.org/obo/MONDO_0010052) (spermatogenic failure 4), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0009064](http://purl.obolibrary.org/obo/MONDO_0009064) (ocular cystinosis), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0009065](http://purl.obolibrary.org/obo/MONDO_0009065) (cystinosis, nephropathic), [MONDO:0009066](http://purl.obolibrary.org/obo/MONDO_0009066) (juvenile nephropathic cystinosis), [MONDO:0011386](http://purl.obolibrary.org/obo/MONDO_0011386) (Microvascular complications of diabetes, susceptibility to, 1), [MONDO:0009067](http://purl.obolibrary.org/obo/MONDO_0009067) (cystinuria (disease)), [MONDO:0010056](http://purl.obolibrary.org/obo/MONDO_0010056) (adult spinal muscular atrophy), [MONDO:0009068](http://purl.obolibrary.org/obo/MONDO_0009068) (cytochrome-c oxidase deficiency disease), [MONDO:0010053](http://purl.obolibrary.org/obo/MONDO_0010053) (hereditary spherocytosis type 3), [MONDO:0009069](http://purl.obolibrary.org/obo/MONDO_0009069) (congenital lactic acidosis, Saguenay-Lac-saint-Jean type), [MONDO:0010057](http://purl.obolibrary.org/obo/MONDO_0010057) (spinal muscular atrophy, Ryukyuan type), [MONDO:0011389](http://purl.obolibrary.org/obo/MONDO_0011389) (autosomal dominant nonsyndromic deafness 16), [MONDO:0010058](http://purl.obolibrary.org/obo/MONDO_0010058) (spinal muscular atrophy, scapuloperoneal), [MONDO:0009070](http://purl.obolibrary.org/obo/MONDO_0009070) (d-glyceric aciduria), [MONDO:0009072](http://purl.obolibrary.org/obo/MONDO_0009072) (Dandy-Walker syndrome), [MONDO:0011372](http://purl.obolibrary.org/obo/MONDO_0011372) (microcephaly with simplified Gyral pattern), [MONDO:0009051](http://purl.obolibrary.org/obo/MONDO_0009051) (cutaneous photosensitivity-lethal colitis syndrome), [MONDO:0010041](http://purl.obolibrary.org/obo/MONDO_0010041) (Charlevoix-Saguenay spastic ataxia), [MONDO:0009052](http://purl.obolibrary.org/obo/MONDO_0009052) (cutis laxa, autosomal recessive, type 1A), [MONDO:0011370](http://purl.obolibrary.org/obo/MONDO_0011370) (Stargardt disease 4), [MONDO:0009053](http://purl.obolibrary.org/obo/MONDO_0009053) (ALDH18A1-related de Barsy syndrome), [MONDO:0009054](http://purl.obolibrary.org/obo/MONDO_0009054) (autosomal recessive cutis laxa type 2, classic type), [MONDO:0011376](http://purl.obolibrary.org/obo/MONDO_0011376) (idiopathic ventricular fibrillation, non Brugada type), [MONDO:0011375](http://purl.obolibrary.org/obo/MONDO_0011375) (brittle bone disorder), [MONDO:0010045](http://purl.obolibrary.org/obo/MONDO_0010045) (paraplegia-brachydactyly-cone-shaped epiphysis syndrome), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0009058](http://purl.obolibrary.org/obo/MONDO_0009058) (cystathioninuria (disease)), [MONDO:0010043](http://purl.obolibrary.org/obo/MONDO_0010043) (hereditary spastic paraplegia 17), [MONDO:0011377](http://purl.obolibrary.org/obo/MONDO_0011377) (long QT syndrome 3), [MONDO:0011361](http://purl.obolibrary.org/obo/MONDO_0011361) (prostate cancer/brain Cancer susceptibility), [MONDO:0010030](http://purl.obolibrary.org/obo/MONDO_0010030) (Sjogren syndrome), [MONDO:0011360](http://purl.obolibrary.org/obo/MONDO_0011360) (autosomal recessive nonsyndromic deafness 14), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0009042](http://purl.obolibrary.org/obo/MONDO_0009042) (Craniotelencephalic dysplasia), [MONDO:0012690](http://purl.obolibrary.org/obo/MONDO_0012690) (Noonan syndrome 5), [MONDO:0009043](http://purl.obolibrary.org/obo/MONDO_0009043) (generalized resistance to thyroid hormone), [MONDO:0009044](http://purl.obolibrary.org/obo/MONDO_0009044) (Crigler-Najjar syndrome), [MONDO:0011365](http://purl.obolibrary.org/obo/MONDO_0011365) (blepharophimosis-intellectual disability syndrome, SBBYS type), [MONDO:0011364](http://purl.obolibrary.org/obo/MONDO_0011364) (autosomal recessive nonsyndromic deafness 16), [MONDO:0012695](http://purl.obolibrary.org/obo/MONDO_0012695) (Meckel syndrome, type 5), [MONDO:0009045](http://purl.obolibrary.org/obo/MONDO_0009045) (cataract-nephropathy-encephalopathy syndrome), [MONDO:0009046](http://purl.obolibrary.org/obo/MONDO_0009046) (Fraser syndrome), [MONDO:0010031](http://purl.obolibrary.org/obo/MONDO_0010031) (Sjogren-Larsson syndrome), [MONDO:0012694](http://purl.obolibrary.org/obo/MONDO_0012694) (Joubert syndrome 7), [MONDO:0011363](http://purl.obolibrary.org/obo/MONDO_0011363) (diabetes mellitus, Noninsulin-dependent, 3), [MONDO:0011362](http://purl.obolibrary.org/obo/MONDO_0011362) (hereditary proximal myopathy with early respiratory failure), [MONDO:0012693](http://purl.obolibrary.org/obo/MONDO_0012693) (glycogen storage disease due to muscle and heart glycogen synthase deficiency), [MONDO:0011369](http://purl.obolibrary.org/obo/MONDO_0011369) (hypercholesterolemia, autosomal dominant, 3), [MONDO:0012699](http://purl.obolibrary.org/obo/MONDO_0012699) (autosomal recessive limb-girdle muscular dystrophy type 2M), [MONDO:0011368](http://purl.obolibrary.org/obo/MONDO_0011368) (papillary thyroid Microcarcinoma), [MONDO:0010035](http://purl.obolibrary.org/obo/MONDO_0010035) (Smith-Lemli-Opitz syndrome), [MONDO:0012698](http://purl.obolibrary.org/obo/MONDO_0012698) (Waardenburg syndrome type 2E), [MONDO:0011366](http://purl.obolibrary.org/obo/MONDO_0011366) (ovarian germ cell tumor), [MONDO:0010036](http://purl.obolibrary.org/obo/MONDO_0010036) (congenital secretory sodium diarrhea 3), [MONDO:0010039](http://purl.obolibrary.org/obo/MONDO_0010039) (congenital heart defect-round face-developmental delay syndrome), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0010094](http://purl.obolibrary.org/obo/MONDO_0010094) (spondylocarpotarsal synostosis syndrome), [MONDO:0010099](http://purl.obolibrary.org/obo/MONDO_0010099) (Tay-Sachs disease AB variant), [MONDO:0010097](http://purl.obolibrary.org/obo/MONDO_0010097) (Tatsumi factor deficiency), [MONDO:0010092](http://purl.obolibrary.org/obo/MONDO_0010092) (Filippi syndrome), [MONDO:0010090](http://purl.obolibrary.org/obo/MONDO_0010090) (Summitt syndrome), [MONDO:0009095](http://purl.obolibrary.org/obo/MONDO_0009095) (Dermatoosteolysis, Kirghizian type), [MONDO:0010082](http://purl.obolibrary.org/obo/MONDO_0010082) (subaortic stenosis-short stature syndrome), [MONDO:0009097](http://purl.obolibrary.org/obo/MONDO_0009097) (persistent hyperplastic primary vitreous, autosomal recessive), [MONDO:0010083](http://purl.obolibrary.org/obo/MONDO_0010083) (succinic semialdehyde dehydrogenase deficiency), [MONDO:0010088](http://purl.obolibrary.org/obo/MONDO_0010088) (mucosulfatidosis), [MONDO:0010089](http://purl.obolibrary.org/obo/MONDO_0010089) (isolated sulfite oxidase deficiency), [MONDO:0010087](http://purl.obolibrary.org/obo/MONDO_0010087) (Sugarman brachydactyly), [MONDO:0010073](http://purl.obolibrary.org/obo/MONDO_0010073) (spondyloepiphyseal dysplasia tarda, Kohn type), [MONDO:0009084](http://purl.obolibrary.org/obo/MONDO_0009084) (conductive deafness-ptosis-skeletal anomalies syndrome), [MONDO:0009085](http://purl.obolibrary.org/obo/MONDO_0009085) (deafness-vitiligo-achalasia syndrome), [MONDO:0010074](http://purl.obolibrary.org/obo/MONDO_0010074) (BCYM1B), [MONDO:0009086](http://purl.obolibrary.org/obo/MONDO_0009086) (deafness-small bowel diverticulosis-neuropathy syndrome), [MONDO:0010071](http://purl.obolibrary.org/obo/MONDO_0010071) (Spondyloenchondrodysplasia), [MONDO:0010072](http://purl.obolibrary.org/obo/MONDO_0010072) (spondyloepiphyseal dysplasia tarda, autosomal recessive), [MONDO:0010077](http://purl.obolibrary.org/obo/MONDO_0010077) (spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome), [MONDO:0009089](http://purl.obolibrary.org/obo/MONDO_0009089) (deafness-oligodontia syndrome), [MONDO:0010078](http://purl.obolibrary.org/obo/MONDO_0010078) (Spondyloperipheral dysplasia-short ulna syndrome), [MONDO:0010075](http://purl.obolibrary.org/obo/MONDO_0010075) (spondyloepimetaphyseal dysplasia with joint laxity, type 1, With or without fractures), [MONDO:0010076](http://purl.obolibrary.org/obo/MONDO_0010076) (spondyloepimetaphyseal dysplasia, Irapa type), [MONDO:0010070](http://purl.obolibrary.org/obo/MONDO_0010070) (BCYM1A), [MONDO:0010079](http://purl.obolibrary.org/obo/MONDO_0010079) (Canavan disease), [MONDO:0009090](http://purl.obolibrary.org/obo/MONDO_0009090) (deafness, sensorineural, autosomal-mitochondrial type), [MONDO:0009092](http://purl.obolibrary.org/obo/MONDO_0009092) (Nasu-Hakola disease), [MONDO:0009094](http://purl.obolibrary.org/obo/MONDO_0009094) (Dermochondrocorneal dystrophy), [MONDO:0000708](http://purl.obolibrary.org/obo/MONDO_0000708) (Crohn jejunoileitis), [MONDO:0000709](http://purl.obolibrary.org/obo/MONDO_0000709) (Crohn ileitis), [MONDO:0000704](http://purl.obolibrary.org/obo/MONDO_0000704) (lymphocytic colitis), [MONDO:0000705](http://purl.obolibrary.org/obo/MONDO_0000705) (clostridium difficile colitis), [MONDO:0000706](http://purl.obolibrary.org/obo/MONDO_0000706) (chemical colitis), [MONDO:0000707](http://purl.obolibrary.org/obo/MONDO_0000707) (diversion colitis), [MONDO:0000701](http://purl.obolibrary.org/obo/MONDO_0000701) (ischemic colitis), [MONDO:0000702](http://purl.obolibrary.org/obo/MONDO_0000702) (microscopic colitis), [MONDO:0000703](http://purl.obolibrary.org/obo/MONDO_0000703) (collagenous colitis), [MONDO:0000733](http://purl.obolibrary.org/obo/MONDO_0000733) (cornea plana), [MONDO:0000734](http://purl.obolibrary.org/obo/MONDO_0000734) (Ohdo syndrome and variants), [MONDO:0000736](http://purl.obolibrary.org/obo/MONDO_0000736) (dyschromatosis universalis hereditaria), [MONDO:0000732](http://purl.obolibrary.org/obo/MONDO_0000732) (combined oxidative phosphorylation deficiency), [MONDO:0012728](http://purl.obolibrary.org/obo/MONDO_0012728) (Brugada syndrome 2), [MONDO:0012721](http://purl.obolibrary.org/obo/MONDO_0012721) (progressive myoclonic epilepsy type 3), [MONDO:0012720](http://purl.obolibrary.org/obo/MONDO_0012720) (Krabbe disease, atypical, due to saposin a deficiency), [MONDO:0012725](http://purl.obolibrary.org/obo/MONDO_0012725) (lipoprotein glomerulopathy), [MONDO:0012723](http://purl.obolibrary.org/obo/MONDO_0012723) (Leber congenital amaurosis 10), [MONDO:0000745](http://purl.obolibrary.org/obo/MONDO_0000745) (cardiac arrest), [MONDO:0012719](http://purl.obolibrary.org/obo/MONDO_0012719) (encephalopathy due to prosaposin deficiency), [MONDO:0012718](http://purl.obolibrary.org/obo/MONDO_0012718) (hypotonia with lactic acidemia and hyperammonemia), [MONDO:0012717](http://purl.obolibrary.org/obo/MONDO_0012717) (renal hypomagnesemia 4), [MONDO:0012716](http://purl.obolibrary.org/obo/MONDO_0012716) (spondyloepiphyseal dysplasia, Cantu type), [MONDO:0012710](http://purl.obolibrary.org/obo/MONDO_0012710) (HSCR9), [MONDO:0012714](http://purl.obolibrary.org/obo/MONDO_0012714) (early-onset myopathy with fatal cardiomyopathy), [MONDO:0012713](http://purl.obolibrary.org/obo/MONDO_0012713) (spondylometaphyseal dysplasia, East african type), [MONDO:0000715](http://purl.obolibrary.org/obo/MONDO_0000715) (lymph node adenoid cystic carcinoma), [MONDO:0000711](http://purl.obolibrary.org/obo/MONDO_0000711) (amyotrophic lateral sclerosis type 13), [MONDO:0000712](http://purl.obolibrary.org/obo/MONDO_0000712) (FTDALS1), [MONDO:0000710](http://purl.obolibrary.org/obo/MONDO_0000710) (gastroduodenal Crohn's disease), [MONDO:0012708](http://purl.obolibrary.org/obo/MONDO_0012708) (PLSA1), [MONDO:0012709](http://purl.obolibrary.org/obo/MONDO_0012709) (microphthalmia, isolated, with coloboma 5), [MONDO:0012700](http://purl.obolibrary.org/obo/MONDO_0012700) (distal renal tubular acidosis with anemia), [MONDO:0012703](http://purl.obolibrary.org/obo/MONDO_0012703) (lissencephaly due to TUBA1A mutation), [MONDO:0012702](http://purl.obolibrary.org/obo/MONDO_0012702) (CELIAC6), [MONDO:0012701](http://purl.obolibrary.org/obo/MONDO_0012701) (cataract 12 multiple types), [MONDO:0000727](http://purl.obolibrary.org/obo/MONDO_0000727) (scapuloperoneal myopathy), [MONDO:0000728](http://purl.obolibrary.org/obo/MONDO_0000728) (ptosis (disease)), [MONDO:0000722](http://purl.obolibrary.org/obo/MONDO_0000722) (non-syndromic synpolydactyly), [MONDO:0000721](http://purl.obolibrary.org/obo/MONDO_0000721) (xanthinuria), [MONDO:0011431](http://purl.obolibrary.org/obo/MONDO_0011431) (mass syndrome), [MONDO:0009110](http://purl.obolibrary.org/obo/MONDO_0009110) (dicarboxylic aminoaciduria), [MONDO:0012762](http://purl.obolibrary.org/obo/MONDO_0012762) (catecholaminergic polymorphic ventricular tachycardia 2), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0009111](http://purl.obolibrary.org/obo/MONDO_0009111) (dihydropyrimidinuria), [MONDO:0011430](http://purl.obolibrary.org/obo/MONDO_0011430) (cataract 2 multiple types), [MONDO:0009112](http://purl.obolibrary.org/obo/MONDO_0009112) (rhizomelic chondrodysplasia punctata type 2), [MONDO:0009113](http://purl.obolibrary.org/obo/MONDO_0009113) (hemolytic anemia due to diphosphoglycerate mutase deficiency), [MONDO:0009114](http://purl.obolibrary.org/obo/MONDO_0009114) (congenital sucrase-isomaltase deficiency), [MONDO:0000777](http://purl.obolibrary.org/obo/MONDO_0000777) (gastrointestinal allergy), [MONDO:0009115](http://purl.obolibrary.org/obo/MONDO_0009115) (congenital lactase deficiency), [MONDO:0000778](http://purl.obolibrary.org/obo/MONDO_0000778) (fruit allergy), [MONDO:0000779](http://purl.obolibrary.org/obo/MONDO_0000779) (apple allergy), [MONDO:0009116](http://purl.obolibrary.org/obo/MONDO_0009116) (lactose intolerance (disease)), [MONDO:0000773](http://purl.obolibrary.org/obo/MONDO_0000773) (Timothy grass allergy), [MONDO:0000774](http://purl.obolibrary.org/obo/MONDO_0000774) (autoimmune neuropathy), [MONDO:0000775](http://purl.obolibrary.org/obo/MONDO_0000775) (drug allergy), [MONDO:0000776](http://purl.obolibrary.org/obo/MONDO_0000776) (metal allergy), [MONDO:0000770](http://purl.obolibrary.org/obo/MONDO_0000770) (shellfish allergy), [MONDO:0000771](http://purl.obolibrary.org/obo/MONDO_0000771) (allergic respiratory disease), [MONDO:0000772](http://purl.obolibrary.org/obo/MONDO_0000772) (pollen allergy), [MONDO:0011435](http://purl.obolibrary.org/obo/MONDO_0011435) (microcephaly 2, primary, autosomal recessive, with or without cortical malformations), [MONDO:0010104](http://purl.obolibrary.org/obo/MONDO_0010104) (non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome), [MONDO:0012765](http://purl.obolibrary.org/obo/MONDO_0012765) (LMPH1B), [MONDO:0010101](http://purl.obolibrary.org/obo/MONDO_0010101) (Teebi-Shaltout syndrome), [MONDO:0012764](http://purl.obolibrary.org/obo/MONDO_0012764) (RIDDLE syndrome), [MONDO:0010102](http://purl.obolibrary.org/obo/MONDO_0010102) (taurodontia-absent teeth-sparse hair syndrome), [MONDO:0011432](http://purl.obolibrary.org/obo/MONDO_0011432) (blepharophimosis-intellectual disability syndrome, Verloes type), [MONDO:0011439](http://purl.obolibrary.org/obo/MONDO_0011439) (spinocerebellar ataxia type 12), [MONDO:0010107](http://purl.obolibrary.org/obo/MONDO_0010107) (testicular regression syndrome), [MONDO:0010108](http://purl.obolibrary.org/obo/MONDO_0010108) (testicular germ cell tumor), [MONDO:0012769](http://purl.obolibrary.org/obo/MONDO_0012769) (HPC14), [MONDO:0010105](http://purl.obolibrary.org/obo/MONDO_0010105) (teratoma, pineal), [MONDO:0011437](http://purl.obolibrary.org/obo/MONDO_0011437) (microcephaly 4, primary, autosomal recessive), [MONDO:0012768](http://purl.obolibrary.org/obo/MONDO_0012768) (HPC11), [MONDO:0012767](http://purl.obolibrary.org/obo/MONDO_0012767) (age related macular degeneration 11), [MONDO:0011436](http://purl.obolibrary.org/obo/MONDO_0011436) (autosomal recessive distal spinal muscular atrophy 1), [MONDO:0009100](http://purl.obolibrary.org/obo/MONDO_0009100) (IDDM 1), [MONDO:0012750](http://purl.obolibrary.org/obo/MONDO_0012750) (lethal arthrogryposis-anterior horn cell disease syndrome), [MONDO:0009101](http://purl.obolibrary.org/obo/MONDO_0009101) (Wolfram syndrome 1), [MONDO:0000788](http://purl.obolibrary.org/obo/MONDO_0000788) (fish allergy), [MONDO:0000789](http://purl.obolibrary.org/obo/MONDO_0000789) (Atlantic cod allergy), [MONDO:0009104](http://purl.obolibrary.org/obo/MONDO_0009104) (Donnai-Barrow syndrome), [MONDO:0009105](http://purl.obolibrary.org/obo/MONDO_0009105) (tricho-hepato-enteric syndrome), [MONDO:0009106](http://purl.obolibrary.org/obo/MONDO_0009106) (diastematomyelia), [MONDO:0000784](http://purl.obolibrary.org/obo/MONDO_0000784) (melon allergy), [MONDO:0009107](http://purl.obolibrary.org/obo/MONDO_0009107) (diastrophic dysplasia), [MONDO:0000785](http://purl.obolibrary.org/obo/MONDO_0000785) (peach allergy), [MONDO:0009108](http://purl.obolibrary.org/obo/MONDO_0009108) (hyperdibasic aminoaciduria type 1), [MONDO:0009109](http://purl.obolibrary.org/obo/MONDO_0009109) (lysinuric protein intolerance), [MONDO:0000786](http://purl.obolibrary.org/obo/MONDO_0000786) (plum allergy), [MONDO:0000787](http://purl.obolibrary.org/obo/MONDO_0000787) (tomato allergy), [MONDO:0000780](http://purl.obolibrary.org/obo/MONDO_0000780) (apricot allergy), [MONDO:0000781](http://purl.obolibrary.org/obo/MONDO_0000781) (cherry allergy), [MONDO:0000782](http://purl.obolibrary.org/obo/MONDO_0000782) (indian plum allergy), [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0000783](http://purl.obolibrary.org/obo/MONDO_0000783) (orange allery), [MONDO:0011424](http://purl.obolibrary.org/obo/MONDO_0011424) (Carney triad), [MONDO:0012754](http://purl.obolibrary.org/obo/MONDO_0012754) (NNO3), [MONDO:0011423](http://purl.obolibrary.org/obo/MONDO_0011423) (autosomal recessive limb-girdle muscular dystrophy type 2E), [MONDO:0011422](http://purl.obolibrary.org/obo/MONDO_0011422) (autosomal recessive proximal renal tubular acidosis), [MONDO:0012753](http://purl.obolibrary.org/obo/MONDO_0012753) (amyotrophic lateral sclerosis type 9), [MONDO:0011421](http://purl.obolibrary.org/obo/MONDO_0011421) (mitochondrial complex v (ATP synthase) deficiency, nuclear type 1), [MONDO:0011428](http://purl.obolibrary.org/obo/MONDO_0011428) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3), [MONDO:0012758](http://purl.obolibrary.org/obo/MONDO_0012758) (prostate cancer, hereditary, 13), [MONDO:0011426](http://purl.obolibrary.org/obo/MONDO_0011426) (aceruloplasminemia), [MONDO:0012757](http://purl.obolibrary.org/obo/MONDO_0012757) (lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome), [MONDO:0000756](http://purl.obolibrary.org/obo/MONDO_0000756) (parameningeal embryonal rhabdomyosarcoma), [MONDO:0000757](http://purl.obolibrary.org/obo/MONDO_0000757) (glucocorticoid-induced osteoporosis), [MONDO:0000751](http://purl.obolibrary.org/obo/MONDO_0000751) (cervical polyp (disease)), [MONDO:0011413](http://purl.obolibrary.org/obo/MONDO_0011413) (cataract 9 multiple types), [MONDO:0012743](http://purl.obolibrary.org/obo/MONDO_0012743) (Brugada syndrome 4), [MONDO:0012742](http://purl.obolibrary.org/obo/MONDO_0012742) (Brugada syndrome 3), [MONDO:0011411](http://purl.obolibrary.org/obo/MONDO_0011411) (Chudley-McCullough syndrome), [MONDO:0012741](http://purl.obolibrary.org/obo/MONDO_0012741) (prostate cancer, hereditary, 12), [MONDO:0012748](http://purl.obolibrary.org/obo/MONDO_0012748) (primary ciliary dyskinesia 7), [MONDO:0011417](http://purl.obolibrary.org/obo/MONDO_0011417) (hemochromatosis type 3), [MONDO:0012747](http://purl.obolibrary.org/obo/MONDO_0012747) (glycogen storage disease due to aldolase A deficiency), [MONDO:0011415](http://purl.obolibrary.org/obo/MONDO_0011415) (Leber congenital amaurosis 3), [MONDO:0011414](http://purl.obolibrary.org/obo/MONDO_0011414) (Peters anomaly (disease)), [MONDO:0000766](http://purl.obolibrary.org/obo/MONDO_0000766) (corneal endothelial dystrophy), [MONDO:0000769](http://purl.obolibrary.org/obo/MONDO_0000769) (chicken egg allergy), [MONDO:0000763](http://purl.obolibrary.org/obo/MONDO_0000763) (epithelial and subepithelial dystrophy), [MONDO:0000764](http://purl.obolibrary.org/obo/MONDO_0000764) (epithelial-stromal TGFBI dystrophy), [MONDO:0000765](http://purl.obolibrary.org/obo/MONDO_0000765) (stromal dystrophy), [MONDO:0012739](http://purl.obolibrary.org/obo/MONDO_0012739) (microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome), [MONDO:0012738](http://purl.obolibrary.org/obo/MONDO_0012738) (long QT syndrome 11), [MONDO:0011407](http://purl.obolibrary.org/obo/MONDO_0011407) (HCFP2), [MONDO:0011402](http://purl.obolibrary.org/obo/MONDO_0011402) (congenital cataracts-facial dysmorphism-neuropathy syndrome), [MONDO:0012733](http://purl.obolibrary.org/obo/MONDO_0012733) (bestrophinopathy), [MONDO:0012731](http://purl.obolibrary.org/obo/MONDO_0012731) (elliptocytosis 1), [MONDO:0012737](http://purl.obolibrary.org/obo/MONDO_0012737) (long QT syndrome 10), [MONDO:0012736](http://purl.obolibrary.org/obo/MONDO_0012736) (long QT syndrome 9), [MONDO:0012735](http://purl.obolibrary.org/obo/MONDO_0012735) (Temple-Baraitser syndrome), [MONDO:0012734](http://purl.obolibrary.org/obo/MONDO_0012734) (SERKAL syndrome), [MONDO:0011471](http://purl.obolibrary.org/obo/MONDO_0011471) (inflammatory bowel disease 3), [MONDO:0009150](http://purl.obolibrary.org/obo/MONDO_0009150) (hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome), [MONDO:0009151](http://purl.obolibrary.org/obo/MONDO_0009151) (cleft lip-palate-ectodermal dysplasia syndrome), [MONDO:0011470](http://purl.obolibrary.org/obo/MONDO_0011470) (hyperlipidemia, combined, 2), [MONDO:0009152](http://purl.obolibrary.org/obo/MONDO_0009152) (ectopia lentis 2, isolated, autosomal recessive), [MONDO:0009153](http://purl.obolibrary.org/obo/MONDO_0009153) (ectopia lentis et pupillae), [MONDO:0009154](http://purl.obolibrary.org/obo/MONDO_0009154) (hypothyroidism, congenital, Nongoitrous, 5), [MONDO:0011475](http://purl.obolibrary.org/obo/MONDO_0011475) (Charcot-Marie-tooth disease type 4B2), [MONDO:0010143](http://purl.obolibrary.org/obo/MONDO_0010143) (lethal restrictive dermopathy), [MONDO:0009155](http://purl.obolibrary.org/obo/MONDO_0009155) (EEM syndrome), [MONDO:0011474](http://purl.obolibrary.org/obo/MONDO_0011474) (progressive familial heart block type ib), [MONDO:0010144](http://purl.obolibrary.org/obo/MONDO_0010144) (tibial hemimelia), [MONDO:0009156](http://purl.obolibrary.org/obo/MONDO_0009156) (ectrodactyly-polydactyly syndrome), [MONDO:0011473](http://purl.obolibrary.org/obo/MONDO_0011473) (Leber congenital amaurosis 5), [MONDO:0011472](http://purl.obolibrary.org/obo/MONDO_0011472) (epidermolysis bullosa simplex due to plakophilin deficiency), [MONDO:0010142](http://purl.obolibrary.org/obo/MONDO_0010142) (hypothyroidism due to TSH receptor mutations), [MONDO:0009157](http://purl.obolibrary.org/obo/MONDO_0009157) (split hand-foot malformation 6), [MONDO:0009158](http://purl.obolibrary.org/obo/MONDO_0009158) (Ehlers-Danlos syndrome, fibronectinemic type), [MONDO:0009159](http://purl.obolibrary.org/obo/MONDO_0009159) (Ehlers-Danlos syndrome, cardiac valvular type), [MONDO:0011476](http://purl.obolibrary.org/obo/MONDO_0011476) (MHC class i deficiency), [MONDO:0010149](http://purl.obolibrary.org/obo/MONDO_0010149) (transcobalamin II deficiency), [MONDO:0012791](http://purl.obolibrary.org/obo/MONDO_0012791) (mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria), [MONDO:0012790](http://purl.obolibrary.org/obo/MONDO_0012790) (amyotrophic lateral sclerosis type 10), [MONDO:0009140](http://purl.obolibrary.org/obo/MONDO_0009140) (Silverman-Handmaker type dyssegmental dysplasia), [MONDO:0009143](http://purl.obolibrary.org/obo/MONDO_0009143) (Meier-Gorlin syndrome 1), [MONDO:0010132](http://purl.obolibrary.org/obo/MONDO_0010132) (familial thyroid dyshormonogenesis), [MONDO:0011464](http://purl.obolibrary.org/obo/MONDO_0011464) (spinocerebellar ataxia type 11), [MONDO:0012794](http://purl.obolibrary.org/obo/MONDO_0012794) (ANE syndrome), [MONDO:0010133](http://purl.obolibrary.org/obo/MONDO_0010133) (thyroid dyshormonogenesis 2A), [MONDO:0009145](http://purl.obolibrary.org/obo/MONDO_0009145) (SchC6pf-Schulz-Passarge syndrome), [MONDO:0010130](http://purl.obolibrary.org/obo/MONDO_0010130) (dihydropyrimidine dehydrogenase deficiency), [MONDO:0009146](http://purl.obolibrary.org/obo/MONDO_0009146) (ectodermal dysplasia-sensorineural deafness syndrome), [MONDO:0012792](http://purl.obolibrary.org/obo/MONDO_0012792) (mitochondrial DNA depletion syndrome 8a), [MONDO:0010131](http://purl.obolibrary.org/obo/MONDO_0010131) (thyroid hormone resistance, generalized, autosomal recessive), [MONDO:0009147](http://purl.obolibrary.org/obo/MONDO_0009147) (ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0009148](http://purl.obolibrary.org/obo/MONDO_0009148) (Rosselli-Gulienetti syndrome), [MONDO:0009149](http://purl.obolibrary.org/obo/MONDO_0009149) (ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome), [MONDO:0010136](http://purl.obolibrary.org/obo/MONDO_0010136) (thyroid dyshormonogenesis 4), [MONDO:0011468](http://purl.obolibrary.org/obo/MONDO_0011468) (hereditary motor and sensory neuropathy, Okinawa type), [MONDO:0010137](http://purl.obolibrary.org/obo/MONDO_0010137) (thyroid dyshormonogenesis 5), [MONDO:0010134](http://purl.obolibrary.org/obo/MONDO_0010134) (Pendred syndrome), [MONDO:0011466](http://purl.obolibrary.org/obo/MONDO_0011466) (distal myopathy, Welander type), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0012796](http://purl.obolibrary.org/obo/MONDO_0012796) (retinitis pigmentosa 41), [MONDO:0010135](http://purl.obolibrary.org/obo/MONDO_0010135) (thyroid dyshormonogenesis 3), [MONDO:0010138](http://purl.obolibrary.org/obo/MONDO_0010138) (thyrotoxicosis), [MONDO:0011469](http://purl.obolibrary.org/obo/MONDO_0011469) (congenital amegakaryocytic thrombocytopenia), [MONDO:0012780](http://purl.obolibrary.org/obo/MONDO_0012780) (CELIAC11), [MONDO:0009130](http://purl.obolibrary.org/obo/MONDO_0009130) (Dyggve-Melchior-Clausen disease), [MONDO:0009131](http://purl.obolibrary.org/obo/MONDO_0009131) (Riley-Day syndrome), [MONDO:0012784](http://purl.obolibrary.org/obo/MONDO_0012784) (autosomal recessive ataxia due to ubiquinone deficiency), [MONDO:0010121](http://purl.obolibrary.org/obo/MONDO_0010121) (thrombocytopenia-absent radius syndrome), [MONDO:0012783](http://purl.obolibrary.org/obo/MONDO_0012783) (RFT1-CDG), [MONDO:0010122](http://purl.obolibrary.org/obo/MONDO_0010122) (congenital thrombotic thrombocytopenic purpura), [MONDO:0009133](http://purl.obolibrary.org/obo/MONDO_0009133) (dysequilibrium syndrome), [MONDO:0012782](http://purl.obolibrary.org/obo/MONDO_0012782) (CELIAC13), [MONDO:0009134](http://purl.obolibrary.org/obo/MONDO_0009134) (congenital dyserythropoietic anemia type II), [MONDO:0011451](http://purl.obolibrary.org/obo/MONDO_0011451) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0012781](http://purl.obolibrary.org/obo/MONDO_0012781) (CELIAC12), [MONDO:0010120](http://purl.obolibrary.org/obo/MONDO_0010120) (THC3), [MONDO:0009135](http://purl.obolibrary.org/obo/MONDO_0009135) (anemia, congenital dyserythropoietic, type Ia), [MONDO:0000799](http://purl.obolibrary.org/obo/MONDO_0000799) (crustacean allergy), [MONDO:0009136](http://purl.obolibrary.org/obo/MONDO_0009136) (dyskeratosis congenita, autosomal recessive 1), [MONDO:0009138](http://purl.obolibrary.org/obo/MONDO_0009138) (Dysosteosclerosis), [MONDO:0009139](http://purl.obolibrary.org/obo/MONDO_0009139) (dyssegmental dysplasia, Rolland-Desbuquois type), [MONDO:0000795](http://purl.obolibrary.org/obo/MONDO_0000795) (penicillin allergy), [MONDO:0000796](http://purl.obolibrary.org/obo/MONDO_0000796) (cow milk allergy (disease)), [MONDO:0000797](http://purl.obolibrary.org/obo/MONDO_0000797) (goat milk allergy), [MONDO:0000798](http://purl.obolibrary.org/obo/MONDO_0000798) (mollusc allergy), [MONDO:0000791](http://purl.obolibrary.org/obo/MONDO_0000791) (carp allergy), [MONDO:0000793](http://purl.obolibrary.org/obo/MONDO_0000793) (rainbow trout allergy), [MONDO:0000794](http://purl.obolibrary.org/obo/MONDO_0000794) (beta-lactam allergy), [MONDO:0000790](http://purl.obolibrary.org/obo/MONDO_0000790) (Atlantic salmon allergy), [MONDO:0010125](http://purl.obolibrary.org/obo/MONDO_0010125) (upper limb defect-eye and ear abnormalities syndrome), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0012787](http://purl.obolibrary.org/obo/MONDO_0012787) (hereditary spastic paraplegia 39), [MONDO:0012786](http://purl.obolibrary.org/obo/MONDO_0012786) (juvenile cataract-microcornea-renal glucosuria syndrome), [MONDO:0010123](http://purl.obolibrary.org/obo/MONDO_0010123) (absent thumb-short stature-immunodeficiency syndrome), [MONDO:0011454](http://purl.obolibrary.org/obo/MONDO_0011454) (patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome), [MONDO:0010129](http://purl.obolibrary.org/obo/MONDO_0010129) (thymic-renal-anal-lung dysplasia), [MONDO:0010127](http://purl.obolibrary.org/obo/MONDO_0010127) (thymoma, familial), [MONDO:0011458](http://purl.obolibrary.org/obo/MONDO_0011458) (Leber congenital amaurosis 4), [MONDO:0010128](http://purl.obolibrary.org/obo/MONDO_0010128) (thyrocerebrorenal syndrome), [MONDO:0009120](http://purl.obolibrary.org/obo/MONDO_0009120) (marfanoid syndrome, de Silva type), [MONDO:0010110](http://purl.obolibrary.org/obo/MONDO_0010110) (tetraamelia-multiple malformations syndrome), [MONDO:0009121](http://purl.obolibrary.org/obo/MONDO_0009121) (von Voss-Cherstvoy syndrome), [MONDO:0011442](http://purl.obolibrary.org/obo/MONDO_0011442) (advanced sleep phase syndrome 1), [MONDO:0010111](http://purl.obolibrary.org/obo/MONDO_0010111) (odontotrichomelic syndrome), [MONDO:0009123](http://purl.obolibrary.org/obo/MONDO_0009123) (dopamine beta-hydroxylase deficiency), [MONDO:0009124](http://purl.obolibrary.org/obo/MONDO_0009124) (Dubowitz syndrome), [MONDO:0012770](http://purl.obolibrary.org/obo/MONDO_0012770) (HPC15), [MONDO:0009126](http://purl.obolibrary.org/obo/MONDO_0009126) (duodenal atresia (disease)), [MONDO:0010114](http://purl.obolibrary.org/obo/MONDO_0010114) (thanatophoric dysplasia, glasgow variant), [MONDO:0012777](http://purl.obolibrary.org/obo/MONDO_0012777) (CELIAC8), [MONDO:0012776](http://purl.obolibrary.org/obo/MONDO_0012776) (CELIAC7), [MONDO:0011444](http://purl.obolibrary.org/obo/MONDO_0011444) (Duane retraction syndrome 2), [MONDO:0012775](http://purl.obolibrary.org/obo/MONDO_0012775) (thrombocytopenia 4), [MONDO:0012774](http://purl.obolibrary.org/obo/MONDO_0012774) (chromosome 15q13.3 microdeletion syndrome), [MONDO:0011449](http://purl.obolibrary.org/obo/MONDO_0011449) (Salla disease), [MONDO:0010119](http://purl.obolibrary.org/obo/MONDO_0010119) (Glanzmann's thrombasthenia), [MONDO:0010116](http://purl.obolibrary.org/obo/MONDO_0010116) (Thoracomelic dysplasia), [MONDO:0012779](http://purl.obolibrary.org/obo/MONDO_0012779) (CELIAC10), [MONDO:0011448](http://purl.obolibrary.org/obo/MONDO_0011448) (PPARG-related familial partial lipodystrophy), [MONDO:0012778](http://purl.obolibrary.org/obo/MONDO_0012778) (CELIAC9), [MONDO:0010117](http://purl.obolibrary.org/obo/MONDO_0010117) (three M syndrome 1), [MONDO:0010183](http://purl.obolibrary.org/obo/MONDO_0010183) (methylmalonic aciduria and homocystinuria type cblF), [MONDO:0010184](http://purl.obolibrary.org/obo/MONDO_0010184) (methylmalonic aciduria and homocystinuria type cblC), [MONDO:0010181](http://purl.obolibrary.org/obo/MONDO_0010181) (oculogastrointestinal muscular dystrophy), [MONDO:0009196](http://purl.obolibrary.org/obo/MONDO_0009196) (Ermine phenotype), [MONDO:0009197](http://purl.obolibrary.org/obo/MONDO_0009197) (transient erythroblastopenia of childhood), [MONDO:0010182](http://purl.obolibrary.org/obo/MONDO_0010182) (hypercarotenemia and vitamin a deficiency, autosomal recessive), [MONDO:0010187](http://purl.obolibrary.org/obo/MONDO_0010187) (vitamin K-dependent clotting factors, combined deficiency of, type 1), [MONDO:0010188](http://purl.obolibrary.org/obo/MONDO_0010188) (familial isolated deficiency of vitamin E), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0010186](http://purl.obolibrary.org/obo/MONDO_0010186) (vitamin d-dependent rickets, type 2A), [MONDO:0010180](http://purl.obolibrary.org/obo/MONDO_0010180) (autosomal recessive spondylocostal dysostosis), [MONDO:0010172](http://purl.obolibrary.org/obo/MONDO_0010172) (VACTERL with hydrocephalus), [MONDO:0009183](http://purl.obolibrary.org/obo/MONDO_0009183) (junctional epidermolysis bullosa with pyloric atresia), [MONDO:0010173](http://purl.obolibrary.org/obo/MONDO_0010173) (Mayer-Rokitansky-KC<ster-Hauser syndrome type 1), [MONDO:0009185](http://purl.obolibrary.org/obo/MONDO_0009185) (Amelocerebrohypohidrotic syndrome), [MONDO:0010170](http://purl.obolibrary.org/obo/MONDO_0010170) (Usher syndrome type 3A), [MONDO:0010171](http://purl.obolibrary.org/obo/MONDO_0010171) (Usher syndrome type 1C), [MONDO:0010176](http://purl.obolibrary.org/obo/MONDO_0010176) (Joubert syndrome with orofaciodigital defect), [MONDO:0009188](http://purl.obolibrary.org/obo/MONDO_0009188) (epilepsy-telangiectasia syndrome), [MONDO:0009189](http://purl.obolibrary.org/obo/MONDO_0009189) (multiple epiphyseal dysplasia type 4), [MONDO:0009191](http://purl.obolibrary.org/obo/MONDO_0009191) (Lowry-wood syndrome), [MONDO:0009192](http://purl.obolibrary.org/obo/MONDO_0009192) (Wolcott-Rallison syndrome), [MONDO:0011493](http://purl.obolibrary.org/obo/MONDO_0011493) (Stickler syndrome type 2), [MONDO:0010161](http://purl.obolibrary.org/obo/MONDO_0010161) (tyrosinemia type i), [MONDO:0010162](http://purl.obolibrary.org/obo/MONDO_0010162) (tyrosinemia type III), [MONDO:0010160](http://purl.obolibrary.org/obo/MONDO_0010160) (tyrosinemia type II), [MONDO:0009175](http://purl.obolibrary.org/obo/MONDO_0009175) (eosinophilic fasciitis (disease)), [MONDO:0010165](http://purl.obolibrary.org/obo/MONDO_0010165) (ulna hypoplasia-intellectual disability syndrome), [MONDO:0011497](http://purl.obolibrary.org/obo/MONDO_0011497) (hereditary North american indian childhood cirrhosis), [MONDO:0011496](http://purl.obolibrary.org/obo/MONDO_0011496) (mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis), [MONDO:0009177](http://purl.obolibrary.org/obo/MONDO_0009177) (late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome), [MONDO:0011495](http://purl.obolibrary.org/obo/MONDO_0011495) (Langerhans-cell histiocytosis), [MONDO:0010164](http://purl.obolibrary.org/obo/MONDO_0010164) (phocomelia, Schinzel type), [MONDO:0009179](http://purl.obolibrary.org/obo/MONDO_0009179) (recessive dystrophic epidermolysis bullosa), [MONDO:0010169](http://purl.obolibrary.org/obo/MONDO_0010169) (Usher syndrome type 2A), [MONDO:0010167](http://purl.obolibrary.org/obo/MONDO_0010167) (Urocanic aciduria (disease)), [MONDO:0011499](http://purl.obolibrary.org/obo/MONDO_0011499) (Okamoto syndrome), [MONDO:0010168](http://purl.obolibrary.org/obo/MONDO_0010168) (Usher syndrome type 1), [MONDO:0009180](http://purl.obolibrary.org/obo/MONDO_0009180) (junctional epidermolysis bullosa, non-Herlitz type), [MONDO:0009181](http://purl.obolibrary.org/obo/MONDO_0009181) (epidermolysis bullosa simplex with muscular dystrophy), [MONDO:0009182](http://purl.obolibrary.org/obo/MONDO_0009182) (junctional epidermolysis bullosa Herlitz type), [MONDO:0010150](http://purl.obolibrary.org/obo/MONDO_0010150) (head and neck squamous cell carcinoma), [MONDO:0009161](http://purl.obolibrary.org/obo/MONDO_0009161) (Ehlers-Danlos syndrome, dermatosparaxis type), [MONDO:0009162](http://purl.obolibrary.org/obo/MONDO_0009162) (Ellis-van Creveld syndrome), [MONDO:0010151](http://purl.obolibrary.org/obo/MONDO_0010151) (tricarboxylic acid cycle, defect of), [MONDO:0011481](http://purl.obolibrary.org/obo/MONDO_0011481) (craniosynostosis, Boston type), [MONDO:0011480](http://purl.obolibrary.org/obo/MONDO_0011480) (autosomal dominant nonsyndromic deafness 20), [MONDO:0010154](http://purl.obolibrary.org/obo/MONDO_0010154) (trigonocephaly-bifid nose-acral anomalies syndrome), [MONDO:0009165](http://purl.obolibrary.org/obo/MONDO_0009165) (Aicardi-Goutieres syndrome 1), [MONDO:0011486](http://purl.obolibrary.org/obo/MONDO_0011486) (congenital muscular dystrophy 1B), [MONDO:0011485](http://purl.obolibrary.org/obo/MONDO_0011485) (autosomal recessive congenital ichthyosis 5), [MONDO:0010155](http://purl.obolibrary.org/obo/MONDO_0010155) (Dorfman-Chanarin disease), [MONDO:0009166](http://purl.obolibrary.org/obo/MONDO_0009166) (pontocerebellar hypoplasia type 4), [MONDO:0010152](http://purl.obolibrary.org/obo/MONDO_0010152) (trichomegaly-retina pigmentary degeneration-dwarfism syndrome), [MONDO:0011484](http://purl.obolibrary.org/obo/MONDO_0011484) (catecholaminergic polymorphic ventricular tachycardia 1), [MONDO:0009167](http://purl.obolibrary.org/obo/MONDO_0009167) (Bonnemann-Meinecke-Reich syndrome), [MONDO:0009168](http://purl.obolibrary.org/obo/MONDO_0009168) (Fowler syndrome), [MONDO:0010153](http://purl.obolibrary.org/obo/MONDO_0010153) (trichoodontoonychial dysplasia), [MONDO:0010159](http://purl.obolibrary.org/obo/MONDO_0010159) (constitutional mismatch repair deficiency syndrome), [MONDO:0011488](http://purl.obolibrary.org/obo/MONDO_0011488) (microcephaly 3, primary, autosomal recessive), [MONDO:0010194](http://purl.obolibrary.org/obo/MONDO_0010194) (Weill-Marchesani syndrome 1), [MONDO:0010195](http://purl.obolibrary.org/obo/MONDO_0010195) (Weissenbacher- Zweymuller syndrome), [MONDO:0010192](http://purl.obolibrary.org/obo/MONDO_0010192) (Waardenburg syndrome type 4A), [MONDO:0010193](http://purl.obolibrary.org/obo/MONDO_0010193) (Weaver syndrome), [MONDO:0010198](http://purl.obolibrary.org/obo/MONDO_0010198) (Wernicke-Korsakoff syndrome), [MONDO:0010199](http://purl.obolibrary.org/obo/MONDO_0010199) (white forelock with malformations), [MONDO:0010196](http://purl.obolibrary.org/obo/MONDO_0010196) (Werner syndrome), [MONDO:0010197](http://purl.obolibrary.org/obo/MONDO_0010197) (whistling face syndrome, recessive form), [MONDO:0010190](http://purl.obolibrary.org/obo/MONDO_0010190) (pontocerebellar hypoplasia type 2A), [MONDO:0010191](http://purl.obolibrary.org/obo/MONDO_0010191) (von Willebrand's disease 3), [MONDO:0014196](http://purl.obolibrary.org/obo/MONDO_0014196) (Hartsfield-Bixler-Demyer syndrome), [MONDO:0014197](http://purl.obolibrary.org/obo/MONDO_0014197) (combined immunodeficiency due to MALT1 deficiency), [MONDO:0014198](http://purl.obolibrary.org/obo/MONDO_0014198) (mitochondrial DNA depletion syndrome 13), [MONDO:0014192](http://purl.obolibrary.org/obo/MONDO_0014192) (primary ciliary dyskinesia 22), [MONDO:0014193](http://purl.obolibrary.org/obo/MONDO_0014193) (primary ciliary dyskinesia 23), [MONDO:0014194](http://purl.obolibrary.org/obo/MONDO_0014194) (mitochondrial complex III deficiency nuclear type 6), [MONDO:0014195](http://purl.obolibrary.org/obo/MONDO_0014195) (microcornea-myopic chorioretinal atrophy-telecanthus syndrome), [MONDO:0014190](http://purl.obolibrary.org/obo/MONDO_0014190) (combined oxidative phosphorylation defect type 17), [MONDO:0014191](http://purl.obolibrary.org/obo/MONDO_0014191) (catecholaminergic polymorphic ventricular tachycardia 5), [MONDO:0004818](http://purl.obolibrary.org/obo/MONDO_0004818) (benign neurilemmoma), [MONDO:0004819](http://purl.obolibrary.org/obo/MONDO_0004819) (indolent myeloma), [MONDO:0004816](http://purl.obolibrary.org/obo/MONDO_0004816) (refractory plasma cell neoplasm), [MONDO:0004817](http://purl.obolibrary.org/obo/MONDO_0004817) (non-secretory myeloma), [MONDO:0004815](http://purl.obolibrary.org/obo/MONDO_0004815) (osteosclerotic myeloma), [MONDO:0004812](http://purl.obolibrary.org/obo/MONDO_0004812) (acute dacryoadenitis), [MONDO:0004811](http://purl.obolibrary.org/obo/MONDO_0004811) (simple chronic conjunctivitis), [MONDO:0016809](http://purl.obolibrary.org/obo/MONDO_0016809) (spinocerebellar ataxia with epilepsy), [MONDO:0016808](http://purl.obolibrary.org/obo/MONDO_0016808) (mitochondrial DNA depletion syndrome, hepatocerebral form), [MONDO:0016805](http://purl.obolibrary.org/obo/MONDO_0016805) (isolated oxidative phosphorylation complex disorder), [MONDO:0016804](http://purl.obolibrary.org/obo/MONDO_0016804) (exercise intolerance with lactic acidosis), [MONDO:0016807](http://purl.obolibrary.org/obo/MONDO_0016807) (pure mitochondrial myopathy), [MONDO:0016806](http://purl.obolibrary.org/obo/MONDO_0016806) (maternally-inherited mitochondrial dystonia), [MONDO:0016801](http://purl.obolibrary.org/obo/MONDO_0016801) (mitochondrial substrate carrier disorder), [MONDO:0016800](http://purl.obolibrary.org/obo/MONDO_0016800) (mitochondrial membrane transport disorder), [MONDO:0016803](http://purl.obolibrary.org/obo/MONDO_0016803) (unspecified mitochondrial disorder), [MONDO:0016802](http://purl.obolibrary.org/obo/MONDO_0016802) (mitochondrial protein import disorder), [MONDO:0004829](http://purl.obolibrary.org/obo/MONDO_0004829) (Krukenberg carcinoma), [MONDO:0004827](http://purl.obolibrary.org/obo/MONDO_0004827) (esophagus squamous cell papilloma), [MONDO:0004820](http://purl.obolibrary.org/obo/MONDO_0004820) (peripheral nerve schwannoma), [MONDO:0004808](http://purl.obolibrary.org/obo/MONDO_0004808) (benign mammary dysplasia), [MONDO:0004803](http://purl.obolibrary.org/obo/MONDO_0004803) (disseminated eosinophilic collagen disease), [MONDO:0004804](http://purl.obolibrary.org/obo/MONDO_0004804) (dacryoadenitis), [MONDO:0004802](http://purl.obolibrary.org/obo/MONDO_0004802) (pulmonary eosinophilia), [MONDO:0004800](http://purl.obolibrary.org/obo/MONDO_0004800) (chronic dacryoadenitis), [MONDO:0003527](http://purl.obolibrary.org/obo/MONDO_0003527) (Ferguson-Smith tumor), [MONDO:0003525](http://purl.obolibrary.org/obo/MONDO_0003525) (pancreatic gastrin-producing neuroendocrine tumor), [MONDO:0004856](http://purl.obolibrary.org/obo/MONDO_0004856) (rosacea conjunctivitis), [MONDO:0003523](http://purl.obolibrary.org/obo/MONDO_0003523) (gastrin-producing neuroendocrine tumor), [MONDO:0004854](http://purl.obolibrary.org/obo/MONDO_0004854) (ophthalmia neonatorum), [MONDO:0003524](http://purl.obolibrary.org/obo/MONDO_0003524) (gastric gastrinoma), [MONDO:0004852](http://purl.obolibrary.org/obo/MONDO_0004852) (gonococcal keratitis), [MONDO:0004853](http://purl.obolibrary.org/obo/MONDO_0004853) (gonococcal endophthalmia), [MONDO:0003520](http://purl.obolibrary.org/obo/MONDO_0003520) (malignant acrospiroma), [MONDO:0015517](http://purl.obolibrary.org/obo/MONDO_0015517) (common variable immunodeficiency), [MONDO:0015516](http://purl.obolibrary.org/obo/MONDO_0015516) (Symbrachydactyly of hands and feet), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), [MONDO:0016830](http://purl.obolibrary.org/obo/MONDO_0016830) (Emery-Dreifuss muscular dystrophy), [MONDO:0015501](http://purl.obolibrary.org/obo/MONDO_0015501) (syndrome or malformation associated with head and neck malformations), [MONDO:0016831](http://purl.obolibrary.org/obo/MONDO_0016831) (linear verrucous nevus syndrome), [MONDO:0015500](http://purl.obolibrary.org/obo/MONDO_0015500) (facial arteriovenous malformation), [MONDO:0002208](http://purl.obolibrary.org/obo/MONDO_0002208) (vulva adenocarcinoma), [MONDO:0002207](http://purl.obolibrary.org/obo/MONDO_0002207) (vulval Paget's disease), [MONDO:0003538](http://purl.obolibrary.org/obo/MONDO_0003538) (precursor lymphoblastic lymphoma/leukemia), [MONDO:0003539](http://purl.obolibrary.org/obo/MONDO_0003539) (T-cell adult acute lymphocytic leukemia), [MONDO:0002209](http://purl.obolibrary.org/obo/MONDO_0002209) (heel spur), [MONDO:0003537](http://purl.obolibrary.org/obo/MONDO_0003537) (precursor T-lymphoblastic lymphoma/leukemia), [MONDO:0003534](http://purl.obolibrary.org/obo/MONDO_0003534) (papillary thymic adenocarcinoma), [MONDO:0002206](http://purl.obolibrary.org/obo/MONDO_0002206) (sweat gland cancer), [MONDO:0002205](http://purl.obolibrary.org/obo/MONDO_0002205) (vulvar melanoma (disease)), [MONDO:0003535](http://purl.obolibrary.org/obo/MONDO_0003535) (fallopian tube papillary adenocarcinoma), [MONDO:0003532](http://purl.obolibrary.org/obo/MONDO_0003532) (breast papillary carcinoma), [MONDO:0002200](http://purl.obolibrary.org/obo/MONDO_0002200) (eccrine mixed tumor of skin), [MONDO:0004863](http://purl.obolibrary.org/obo/MONDO_0004863) (purulent endophthalmitis), [MONDO:0003530](http://purl.obolibrary.org/obo/MONDO_0003530) (aggressive digital papillary adenocarcinoma), [MONDO:0004861](http://purl.obolibrary.org/obo/MONDO_0004861) (ophthalmia nodosa), [MONDO:0004862](http://purl.obolibrary.org/obo/MONDO_0004862) (vitreous abscess), [MONDO:0003531](http://purl.obolibrary.org/obo/MONDO_0003531) (eccrine papillary adenocarcinoma), [MONDO:0002201](http://purl.obolibrary.org/obo/MONDO_0002201) (vulvar trichoepithelioma), [MONDO:0004860](http://purl.obolibrary.org/obo/MONDO_0004860) (vitreous disease), [MONDO:0015502](http://purl.obolibrary.org/obo/MONDO_0015502) (Pinnae and external auditory canal anomaly), [MONDO:0003509](http://purl.obolibrary.org/obo/MONDO_0003509) (pineal region choriocarcinoma), [MONDO:0003507](http://purl.obolibrary.org/obo/MONDO_0003507) (choriocarcinoma of ovary), [MONDO:0003508](http://purl.obolibrary.org/obo/MONDO_0003508) (choriocarcinoma of the testis), [MONDO:0004836](http://purl.obolibrary.org/obo/MONDO_0004836) (intravascular fasciitis), [MONDO:0003505](http://purl.obolibrary.org/obo/MONDO_0003505) (femoral cancer), [MONDO:0004837](http://purl.obolibrary.org/obo/MONDO_0004837) (neurofibroma of the esophagus), [MONDO:0003506](http://purl.obolibrary.org/obo/MONDO_0003506) (pulmonary artery choriocarcinoma), [MONDO:0003503](http://purl.obolibrary.org/obo/MONDO_0003503) (fallopian tube squamous cell carcinoma), [MONDO:0003504](http://purl.obolibrary.org/obo/MONDO_0003504) (anal neuroendocrine tumor), [MONDO:0004832](http://purl.obolibrary.org/obo/MONDO_0004832) (esophagus leiomyoma), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0003502](http://purl.obolibrary.org/obo/MONDO_0003502) (ureter squamous cell carcinoma), [MONDO:0003500](http://purl.obolibrary.org/obo/MONDO_0003500) (squamous cell bile duct carcinoma), [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826) (methylmalonic acidemia with homocystinuria), [MONDO:0016829](http://purl.obolibrary.org/obo/MONDO_0016829) (familial visceral myopathy), [MONDO:0016828](http://purl.obolibrary.org/obo/MONDO_0016828) (autosomal recessive sideroblastic anemia), [MONDO:0016825](http://purl.obolibrary.org/obo/MONDO_0016825) (mitochondrial myopathy-lactic acidosis-deafness syndrome), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0003518](http://purl.obolibrary.org/obo/MONDO_0003518) (mediastinum teratoma), [MONDO:0003519](http://purl.obolibrary.org/obo/MONDO_0003519) (malignant syringoma), [MONDO:0003516](http://purl.obolibrary.org/obo/MONDO_0003516) (adult teratoma), [MONDO:0004847](http://purl.obolibrary.org/obo/MONDO_0004847) (senile cataract), [MONDO:0003517](http://purl.obolibrary.org/obo/MONDO_0003517) (mature teratoma), [MONDO:0003514](http://purl.obolibrary.org/obo/MONDO_0003514) (malignant teratoma), [MONDO:0003515](http://purl.obolibrary.org/obo/MONDO_0003515) (fallopian tube teratoma), [MONDO:0003512](http://purl.obolibrary.org/obo/MONDO_0003512) (mediastinal mesenchymal tumor), [MONDO:0003513](http://purl.obolibrary.org/obo/MONDO_0003513) (gastric teratoma), [MONDO:0003510](http://purl.obolibrary.org/obo/MONDO_0003510) (malignant testicular germ cell tumor), [MONDO:0016819](http://purl.obolibrary.org/obo/MONDO_0016819) (Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome), [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0016817](http://purl.obolibrary.org/obo/MONDO_0016817) (Meier-Gorlin syndrome), [MONDO:0016811](http://purl.obolibrary.org/obo/MONDO_0016811) (renal tubulopathy-encephalopathy-liver failure syndrome), [MONDO:0016814](http://purl.obolibrary.org/obo/MONDO_0016814) (maternally-inherited Leigh syndrome), [MONDO:0014222](http://purl.obolibrary.org/obo/MONDO_0014222) (immunodeficiency 14), [MONDO:0015554](http://purl.obolibrary.org/obo/MONDO_0015554) (Typical urticaria pigmentosa), [MONDO:0015553](http://purl.obolibrary.org/obo/MONDO_0015553) (dystrophic epidermolysis bullosa, nails only), [MONDO:0014223](http://purl.obolibrary.org/obo/MONDO_0014223) (amyotrophic lateral sclerosis type 19), [MONDO:0015556](http://purl.obolibrary.org/obo/MONDO_0015556) (nodular urticaria pigmentosa), [MONDO:0015555](http://purl.obolibrary.org/obo/MONDO_0015555) (plaque-form urticaria pigmentosa), [MONDO:0014225](http://purl.obolibrary.org/obo/MONDO_0014225) (hemochromatosis type 5), [MONDO:0015552](http://purl.obolibrary.org/obo/MONDO_0015552) (acral dystrophic epidermolysis bullosa), [MONDO:0014220](http://purl.obolibrary.org/obo/MONDO_0014220) (myopathy due to Myoadenylate deaminase deficiency), [MONDO:0014221](http://purl.obolibrary.org/obo/MONDO_0014221) (triosephosphate isomerase deficiency), [MONDO:0002236](http://purl.obolibrary.org/obo/MONDO_0002236) (ocular cancer), [MONDO:0004898](http://purl.obolibrary.org/obo/MONDO_0004898) (total circumpapillary dystrophy of choroid), [MONDO:0003568](http://purl.obolibrary.org/obo/MONDO_0003568) (chiasmal syndrome), [MONDO:0002238](http://purl.obolibrary.org/obo/MONDO_0002238) (ascending colon cancer), [MONDO:0004899](http://purl.obolibrary.org/obo/MONDO_0004899) (monofixation syndrome), [MONDO:0003565](http://purl.obolibrary.org/obo/MONDO_0003565) (urethral villous adenoma), [MONDO:0004896](http://purl.obolibrary.org/obo/MONDO_0004896) (esotropia), [MONDO:0004897](http://purl.obolibrary.org/obo/MONDO_0004897) (hypotropia), [MONDO:0002235](http://purl.obolibrary.org/obo/MONDO_0002235) (eyelid neoplasm), [MONDO:0004894](http://purl.obolibrary.org/obo/MONDO_0004894) (cyclotropia), [MONDO:0004895](http://purl.obolibrary.org/obo/MONDO_0004895) (accommodative esotropia), [MONDO:0003561](http://purl.obolibrary.org/obo/MONDO_0003561) (malignant giant cell tumor of soft parts), [MONDO:0004892](http://purl.obolibrary.org/obo/MONDO_0004892) (refractive error), [MONDO:0003562](http://purl.obolibrary.org/obo/MONDO_0003562) (rete testis neoplasm), [MONDO:0004893](http://purl.obolibrary.org/obo/MONDO_0004893) (hypertropia), [MONDO:0004890](http://purl.obolibrary.org/obo/MONDO_0004890) (partial central choroid dystrophy), [MONDO:0002230](http://purl.obolibrary.org/obo/MONDO_0002230) (ovarian wilms tumor), [MONDO:0004891](http://purl.obolibrary.org/obo/MONDO_0004891) (hyperopia), [MONDO:0015558](http://purl.obolibrary.org/obo/MONDO_0015558) (isolated bone marrow mastocytosis), [MONDO:0014226](http://purl.obolibrary.org/obo/MONDO_0014226) (idiopathic CD4 lymphocytopenia), [MONDO:0015557](http://purl.obolibrary.org/obo/MONDO_0015557) (Smouldering systemic mastocytosis), [MONDO:0014228](http://purl.obolibrary.org/obo/MONDO_0014228) (corneal dystrophy, Fuchs endothelial, 8), [MONDO:0015559](http://purl.obolibrary.org/obo/MONDO_0015559) (Lymphoadenopathic mastocytosis with eosinophilia), [MONDO:0014229](http://purl.obolibrary.org/obo/MONDO_0014229) (microphthalmia, syndromic 12), [MONDO:0014211](http://purl.obolibrary.org/obo/MONDO_0014211) (primary ciliary dyskinesia 26), [MONDO:0014212](http://purl.obolibrary.org/obo/MONDO_0014212) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type c), [MONDO:0014213](http://purl.obolibrary.org/obo/MONDO_0014213) (intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome), [MONDO:0014214](http://purl.obolibrary.org/obo/MONDO_0014214) (short-rib thoracic dysplasia 8 with or without polydactyly), [MONDO:0015541](http://purl.obolibrary.org/obo/MONDO_0015541) (genetic hemophagocytic lymphohistiocytosis), [MONDO:0002247](http://purl.obolibrary.org/obo/MONDO_0002247) (factor X deficiency), [MONDO:0003578](http://purl.obolibrary.org/obo/MONDO_0003578) (extragonadal nonseminomatous germ cell tumor), [MONDO:0003579](http://purl.obolibrary.org/obo/MONDO_0003579) (nerve fibre bundle defect), [MONDO:0002244](http://purl.obolibrary.org/obo/MONDO_0002244) (factor VII deficiency), [MONDO:0003574](http://purl.obolibrary.org/obo/MONDO_0003574) (external ear cancer), [MONDO:0003575](http://purl.obolibrary.org/obo/MONDO_0003575) (comedocarcinoma), [MONDO:0003572](http://purl.obolibrary.org/obo/MONDO_0003572) (lymphoepithelioma-like carcinoma), [MONDO:0003573](http://purl.obolibrary.org/obo/MONDO_0003573) (pleomorphic carcinoma), [MONDO:0003570](http://purl.obolibrary.org/obo/MONDO_0003570) (lipid-rich carcinoma), [MONDO:0002242](http://purl.obolibrary.org/obo/MONDO_0002242) (coagulation protein disease), [MONDO:0002241](http://purl.obolibrary.org/obo/MONDO_0002241) (factor XIII deficiency), [MONDO:0014219](http://purl.obolibrary.org/obo/MONDO_0014219) (alacrima, achalasia, and mental retardation syndrome), [MONDO:0014215](http://purl.obolibrary.org/obo/MONDO_0014215) (primary ciliary dyskinesia 27), [MONDO:0014216](http://purl.obolibrary.org/obo/MONDO_0014216) (primary ciliary dyskinesia 28), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), [MONDO:0014218](http://purl.obolibrary.org/obo/MONDO_0014218) (severe dermatitis-multiple allergies-metabolic wasting syndrome), [MONDO:0016863](http://purl.obolibrary.org/obo/MONDO_0016863) (Okihiro syndrome due to 20q13 microdeletion), [MONDO:0014200](http://purl.obolibrary.org/obo/MONDO_0014200) (aldosterone-producing adenoma with seizures and neurological abnormalities), [MONDO:0014201](http://purl.obolibrary.org/obo/MONDO_0014201) (early infantile epileptic encephalopathy without suppression burst), [MONDO:0016862](http://purl.obolibrary.org/obo/MONDO_0016862) (Alagille syndrome due to a JAG1 point mutation), [MONDO:0015534](http://purl.obolibrary.org/obo/MONDO_0015534) (juvenile xanthogranuloma), [MONDO:0016865](http://purl.obolibrary.org/obo/MONDO_0016865) (Kleefstra syndrome due to a point mutation), [MONDO:0014202](http://purl.obolibrary.org/obo/MONDO_0014202) (primary ciliary dyskinesia 24), [MONDO:0016864](http://purl.obolibrary.org/obo/MONDO_0016864) (Okihiro syndrome due to a point mutation), [MONDO:0014203](http://purl.obolibrary.org/obo/MONDO_0014203) (primary ciliary dyskinesia 25), [MONDO:0016861](http://purl.obolibrary.org/obo/MONDO_0016861) (Alagille syndrome due to 20p12 microdeletion), [MONDO:0016860](http://purl.obolibrary.org/obo/MONDO_0016860) (familial adenomatous polyposis due to 5q22.2 microdeletion), [MONDO:0002219](http://purl.obolibrary.org/obo/MONDO_0002219) (paraurethral gland neoplasm), [MONDO:0002218](http://purl.obolibrary.org/obo/MONDO_0002218) (temporal lobe cancer), [MONDO:0003549](http://purl.obolibrary.org/obo/MONDO_0003549) (adenosquamous bile duct carcinoma), [MONDO:0003547](http://purl.obolibrary.org/obo/MONDO_0003547) (histiocytic and dendritic cell cancer), [MONDO:0004878](http://purl.obolibrary.org/obo/MONDO_0004878) (female breast upper-outer quadrant cancer), [MONDO:0002214](http://purl.obolibrary.org/obo/MONDO_0002214) (brain germinoma), [MONDO:0003548](http://purl.obolibrary.org/obo/MONDO_0003548) (adenosquamous breast carcinoma), [MONDO:0004879](http://purl.obolibrary.org/obo/MONDO_0004879) (senile atrophy of choroid), [MONDO:0002217](http://purl.obolibrary.org/obo/MONDO_0002217) (central nervous system sarcoma), [MONDO:0003545](http://purl.obolibrary.org/obo/MONDO_0003545) (intradural extramedullary spinal canal neoplasm), [MONDO:0002216](http://purl.obolibrary.org/obo/MONDO_0002216) (brain sarcoma), [MONDO:0002210](http://purl.obolibrary.org/obo/MONDO_0002210) (vulva squamous cell carcinoma), [MONDO:0003544](http://purl.obolibrary.org/obo/MONDO_0003544) (spinal cord cancer), [MONDO:0003541](http://purl.obolibrary.org/obo/MONDO_0003541) (adult acute lymphocytic leukemia), [MONDO:0003540](http://purl.obolibrary.org/obo/MONDO_0003540) (acute T cell leukemia), [MONDO:0014208](http://purl.obolibrary.org/obo/MONDO_0014208) (Charcot-Marie-tooth disease type 2R), [MONDO:0014209](http://purl.obolibrary.org/obo/MONDO_0014209) (early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome), [MONDO:0014205](http://purl.obolibrary.org/obo/MONDO_0014205) (severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome), [MONDO:0014206](http://purl.obolibrary.org/obo/MONDO_0014206) (severe early-onset pulmonary alveolar proteinosis due to MARS deficiency), [MONDO:0014207](http://purl.obolibrary.org/obo/MONDO_0014207) (age related macular degeneration 14), [MONDO:0015523](http://purl.obolibrary.org/obo/MONDO_0015523) (epithelioid hemangioendothelioma), [MONDO:0015522](http://purl.obolibrary.org/obo/MONDO_0015522) (situs ambiguus), [MONDO:0002229](http://purl.obolibrary.org/obo/MONDO_0002229) (ovarian epithelial tumor), [MONDO:0003558](http://purl.obolibrary.org/obo/MONDO_0003558) (adenosquamous prostate carcinoma), [MONDO:0004889](http://purl.obolibrary.org/obo/MONDO_0004889) (central gyrate choroidal dystrophy), [MONDO:0002225](http://purl.obolibrary.org/obo/MONDO_0002225) (ovary sarcoma), [MONDO:0003556](http://purl.obolibrary.org/obo/MONDO_0003556) (endometrial adenosquamous carcinoma), [MONDO:0004888](http://purl.obolibrary.org/obo/MONDO_0004888) (partial circumpapillary choroid dystrophy), [MONDO:0002227](http://purl.obolibrary.org/obo/MONDO_0002227) (ovarian lymphoma), [MONDO:0003557](http://purl.obolibrary.org/obo/MONDO_0003557) (optic nerve sheath meningioma), [MONDO:0003554](http://purl.obolibrary.org/obo/MONDO_0003554) (adenosquamous colon carcinoma), [MONDO:0002222](http://purl.obolibrary.org/obo/MONDO_0002222) (urethra leiomyoma), [MONDO:0004885](http://purl.obolibrary.org/obo/MONDO_0004885) (choroidal sclerosis), [MONDO:0003555](http://purl.obolibrary.org/obo/MONDO_0003555) (Bartholin's gland adenosquamous carcinoma), [MONDO:0002221](http://purl.obolibrary.org/obo/MONDO_0002221) (urethral urothelial papilloma), [MONDO:0004886](http://purl.obolibrary.org/obo/MONDO_0004886) (diffuse secondary choroid atrophy), [MONDO:0002224](http://purl.obolibrary.org/obo/MONDO_0002224) (malignant ovarian cyst), [MONDO:0004883](http://purl.obolibrary.org/obo/MONDO_0004883) (hereditary choroidal atrophy), [MONDO:0004884](http://purl.obolibrary.org/obo/MONDO_0004884) (eye degenerative disease), [MONDO:0002223](http://purl.obolibrary.org/obo/MONDO_0002223) (ovarian malignant mesothelioma), [MONDO:0003553](http://purl.obolibrary.org/obo/MONDO_0003553) (ampulla of vater adenosquamous carcinoma), [MONDO:0003550](http://purl.obolibrary.org/obo/MONDO_0003550) (esophageal adenosquamous carcinoma), [MONDO:0004882](http://purl.obolibrary.org/obo/MONDO_0004882) (angioid streaks of choroid), [MONDO:0003551](http://purl.obolibrary.org/obo/MONDO_0003551) (thymus adenosquamous carcinoma), [MONDO:0015528](http://purl.obolibrary.org/obo/MONDO_0015528) (congenital epulis), [MONDO:0016859](http://purl.obolibrary.org/obo/MONDO_0016859) (blepharophimosis-epicanthus inversus-ptosis due to copy number variations), [MONDO:0016856](http://purl.obolibrary.org/obo/MONDO_0016856) (Mowat-Wilson syndrome due to a ZEB2 point mutation), [MONDO:0015525](http://purl.obolibrary.org/obo/MONDO_0015525) (congenital pseudoarthrosis of the limbs), [MONDO:0016855](http://purl.obolibrary.org/obo/MONDO_0016855) (Mowat-Wilson syndrome due to monosomy 2q22), [MONDO:0015524](http://purl.obolibrary.org/obo/MONDO_0015524) (hyperplastic polyposis syndrome), [MONDO:0016858](http://purl.obolibrary.org/obo/MONDO_0016858) (blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome), [MONDO:0016857](http://purl.obolibrary.org/obo/MONDO_0016857) (blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome), [MONDO:0014266](http://purl.obolibrary.org/obo/MONDO_0014266) (age related macular degeneration 15), [MONDO:0014267](http://purl.obolibrary.org/obo/MONDO_0014267) (severe combined immunodeficiency due to IKK2 deficiency), [MONDO:0014268](http://purl.obolibrary.org/obo/MONDO_0014268) (combined immunodeficiency due to OX40 deficiency), [MONDO:0014269](http://purl.obolibrary.org/obo/MONDO_0014269) (combined oxidative phosphorylation deficiency 19), [MONDO:0015599](http://purl.obolibrary.org/obo/MONDO_0015599) (atopic keratoconjunctivitis), [MONDO:0014260](http://purl.obolibrary.org/obo/MONDO_0014260) (immunodeficiency, common variable, 10), [MONDO:0014261](http://purl.obolibrary.org/obo/MONDO_0014261) (growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome), [MONDO:0002279](http://purl.obolibrary.org/obo/MONDO_0002279) (iron metabolism disease), [MONDO:0002278](http://purl.obolibrary.org/obo/MONDO_0002278) (benign colon neoplasm), [MONDO:0002273](http://purl.obolibrary.org/obo/MONDO_0002273) (plasma protein metabolism disease), [MONDO:0002272](http://purl.obolibrary.org/obo/MONDO_0002272) (polyclonal hypergammaglobulinemia), [MONDO:0002274](http://purl.obolibrary.org/obo/MONDO_0002274) (monoclonal paraproteinemia), [MONDO:0002271](http://purl.obolibrary.org/obo/MONDO_0002271) (colon adenocarcinoma), [MONDO:0014256](http://purl.obolibrary.org/obo/MONDO_0014256) (retinitis pigmentosa 67), [MONDO:0014258](http://purl.obolibrary.org/obo/MONDO_0014258) (congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome), [MONDO:0015583](http://purl.obolibrary.org/obo/MONDO_0015583) (2p21 microdeletion syndrome), [MONDO:0014252](http://purl.obolibrary.org/obo/MONDO_0014252) (familial hypobetalipoproteinemia 1), [MONDO:0014253](http://purl.obolibrary.org/obo/MONDO_0014253) (autoimmune lymphoproliferative syndrome type 3), [MONDO:0014254](http://purl.obolibrary.org/obo/MONDO_0014254) (Otofaciocervical syndrome 2), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0014250](http://purl.obolibrary.org/obo/MONDO_0014250) (familial  hyperprolactinemia), [MONDO:0002289](http://purl.obolibrary.org/obo/MONDO_0002289) (iris disease), [MONDO:0002285](http://purl.obolibrary.org/obo/MONDO_0002285) (pupil disease), [MONDO:0002280](http://purl.obolibrary.org/obo/MONDO_0002280) (anemia (disease)), [MONDO:0002281](http://purl.obolibrary.org/obo/MONDO_0002281) (macrocytic anemia (disease)), [MONDO:0014259](http://purl.obolibrary.org/obo/MONDO_0014259) (neuronopathy, distal hereditary motor, type 2D), [MONDO:0014245](http://purl.obolibrary.org/obo/MONDO_0014245) (Diamond-Blackfan anemia 12), [MONDO:0015572](http://purl.obolibrary.org/obo/MONDO_0015572) (cerebral malformation due to abnormal neuronal migration), [MONDO:0014240](http://purl.obolibrary.org/obo/MONDO_0014240) (periventricular nodular heterotopia 6), [MONDO:0014241](http://purl.obolibrary.org/obo/MONDO_0014241) (leukemia, acute lymphoblastic, susceptibility to, 3), [MONDO:0015574](http://purl.obolibrary.org/obo/MONDO_0015574) (chronic cutaneous lupus erythematosus), [MONDO:0014242](http://purl.obolibrary.org/obo/MONDO_0014242) (van Maldergem syndrome 2), [MONDO:0015573](http://purl.obolibrary.org/obo/MONDO_0015573) (subacute cutaneous lupus erythematosus), [MONDO:0014243](http://purl.obolibrary.org/obo/MONDO_0014243) (Prader-Willi syndrome due to point mutation), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0003587](http://purl.obolibrary.org/obo/MONDO_0003587) (pediatric liposarcoma), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0003585](http://purl.obolibrary.org/obo/MONDO_0003585) (adult liposarcoma), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0003584](http://purl.obolibrary.org/obo/MONDO_0003584) (visual cortex disease), [MONDO:0003581](http://purl.obolibrary.org/obo/MONDO_0003581) (ovarian embryonal carcinoma), [MONDO:0014248](http://purl.obolibrary.org/obo/MONDO_0014248) (autism spectrum disorder-epilepsy-arthrogryposis syndrome), [MONDO:0014249](http://purl.obolibrary.org/obo/MONDO_0014249) (multiple fibroadenoma of the breast), [MONDO:0015579](http://purl.obolibrary.org/obo/MONDO_0015579) (Hb Bart's hydrops fetalis), [MONDO:0015565](http://purl.obolibrary.org/obo/MONDO_0015565) (cap polyposis), [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0014234](http://purl.obolibrary.org/obo/MONDO_0014234) (reticulate acropigmentation of Kitamura), [MONDO:0015567](http://purl.obolibrary.org/obo/MONDO_0015567) (cataract-glaucoma syndrome), [MONDO:0015566](http://purl.obolibrary.org/obo/MONDO_0015566) (2q24 microdeletion syndrome), [MONDO:0014236](http://purl.obolibrary.org/obo/MONDO_0014236) (Ehlers-Danlos syndrome, musculocontractural type 2), [MONDO:0015561](http://purl.obolibrary.org/obo/MONDO_0015561) (aleukemic mast cell leukemia), [MONDO:0015560](http://purl.obolibrary.org/obo/MONDO_0015560) (classic mast cell leukemia), [MONDO:0014232](http://purl.obolibrary.org/obo/MONDO_0014232) (craniosynostosis 5, susceptibility to), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0003596](http://purl.obolibrary.org/obo/MONDO_0003596) (spindle cell liposarcoma), [MONDO:0003597](http://purl.obolibrary.org/obo/MONDO_0003597) (mixed-type liposarcoma), [MONDO:0002262](http://purl.obolibrary.org/obo/MONDO_0002262) (capillary lymphangioma), [MONDO:0003594](http://purl.obolibrary.org/obo/MONDO_0003594) (mixed liposarcoma), [MONDO:0003595](http://purl.obolibrary.org/obo/MONDO_0003595) (sclerosing liposarcoma), [MONDO:0002261](http://purl.obolibrary.org/obo/MONDO_0002261) (keratopathy), [MONDO:0003592](http://purl.obolibrary.org/obo/MONDO_0003592) (gastric liposarcoma), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0003590](http://purl.obolibrary.org/obo/MONDO_0003590) (fibroblastic liposarcoma), [MONDO:0003591](http://purl.obolibrary.org/obo/MONDO_0003591) (kidney liposarcoma), [MONDO:0014237](http://purl.obolibrary.org/obo/MONDO_0014237) (autosomal recessive nonsyndromic deafness 76), [MONDO:0014238](http://purl.obolibrary.org/obo/MONDO_0014238) (severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome), [MONDO:0016899](http://purl.obolibrary.org/obo/MONDO_0016899) (Duchenne and Becker muscular dystrophy), [MONDO:0014239](http://purl.obolibrary.org/obo/MONDO_0014239) (testicular anomalies with or without congenital heart disease), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0014295](http://purl.obolibrary.org/obo/MONDO_0014295) (hereditary spastic paraplegia 57), [MONDO:0014296](http://purl.obolibrary.org/obo/MONDO_0014296) (Warburg micro syndrome 4), [MONDO:0014297](http://purl.obolibrary.org/obo/MONDO_0014297) (Joubert syndrome 22), [MONDO:0014298](http://purl.obolibrary.org/obo/MONDO_0014298) (chromosome 5q12 deletion syndrome), [MONDO:0014291](http://purl.obolibrary.org/obo/MONDO_0014291) (autosomal dominant nonsyndromic deafness 54), [MONDO:0014293](http://purl.obolibrary.org/obo/MONDO_0014293) (autosomal dominant nonsyndromic deafness 58), [MONDO:0014288](http://purl.obolibrary.org/obo/MONDO_0014288) (Joubert syndrome 21), [MONDO:0014289](http://purl.obolibrary.org/obo/MONDO_0014289) (macrocephaly-developmental delay syndrome), [MONDO:0014284](http://purl.obolibrary.org/obo/MONDO_0014284) (short-rib thoracic dysplasia 10 with or without polydactyly), [MONDO:0014285](http://purl.obolibrary.org/obo/MONDO_0014285) (anemia, congenital dyserythropoietic, type ib), [MONDO:0014286](http://purl.obolibrary.org/obo/MONDO_0014286) (neuropathy, hereditary sensory, type 1F), [MONDO:0014287](http://purl.obolibrary.org/obo/MONDO_0014287) (short-rib thoracic dysplasia 11 with or without polydactyly), [MONDO:0014280](http://purl.obolibrary.org/obo/MONDO_0014280) (immunodeficiency 19), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0014283](http://purl.obolibrary.org/obo/MONDO_0014283) (autosomal dominant nonsyndromic deafness 56), [MONDO:0002299](http://purl.obolibrary.org/obo/MONDO_0002299) (glomangioma), [MONDO:0002298](http://purl.obolibrary.org/obo/MONDO_0002298) (skin glomangioma), [MONDO:0002295](http://purl.obolibrary.org/obo/MONDO_0002295) (skin glomus tumor), [MONDO:0002297](http://purl.obolibrary.org/obo/MONDO_0002297) (epidermal appendage tumor), [MONDO:0002291](http://purl.obolibrary.org/obo/MONDO_0002291) (cutaneous granular cell tumor), [MONDO:0002290](http://purl.obolibrary.org/obo/MONDO_0002290) (clitoris cancer), [MONDO:0002293](http://purl.obolibrary.org/obo/MONDO_0002293) (cutaneous ganglioneuroma), [MONDO:0014278](http://purl.obolibrary.org/obo/MONDO_0014278) (immunodeficiency 18), [MONDO:0014273](http://purl.obolibrary.org/obo/MONDO_0014273) (microcephaly-thin corpus callosum-intellectual disability syndrome), [MONDO:0014275](http://purl.obolibrary.org/obo/MONDO_0014275) (Fanconi renotubular syndrome 3), [MONDO:0014276](http://purl.obolibrary.org/obo/MONDO_0014276) (combined immunodeficiency due to CD3gamma deficiency), [MONDO:0014270](http://purl.obolibrary.org/obo/MONDO_0014270) (STT3A-CDG), [MONDO:0014271](http://purl.obolibrary.org/obo/MONDO_0014271) (STT3B-CDG), [MONDO:0004904](http://purl.obolibrary.org/obo/MONDO_0004904) (toxic maculopathy), [MONDO:0004905](http://purl.obolibrary.org/obo/MONDO_0004905) (intestinal disaccharidase deficiency), [MONDO:0004902](http://purl.obolibrary.org/obo/MONDO_0004902) (interstitial keratitis), [MONDO:0004903](http://purl.obolibrary.org/obo/MONDO_0004903) (deep keratitis), [MONDO:0003608](http://purl.obolibrary.org/obo/MONDO_0003608) (optic atrophy), [MONDO:0003609](http://purl.obolibrary.org/obo/MONDO_0003609) (seminal vesicle cystadenoma), [MONDO:0004937](http://purl.obolibrary.org/obo/MONDO_0004937) (hypervitaminosis d), [MONDO:0003606](http://purl.obolibrary.org/obo/MONDO_0003606) (adrenal medulla cancer), [MONDO:0003604](http://purl.obolibrary.org/obo/MONDO_0003604) (functioning pituitary gland neoplasm), [MONDO:0004935](http://purl.obolibrary.org/obo/MONDO_0004935) (acquired carotenemia), [MONDO:0003602](http://purl.obolibrary.org/obo/MONDO_0003602) (intracranial liposarcoma), [MONDO:0003603](http://purl.obolibrary.org/obo/MONDO_0003603) (non-functioning pituitary gland neoplasm), [MONDO:0003600](http://purl.obolibrary.org/obo/MONDO_0003600) (cutaneous liposarcoma), [MONDO:0004931](http://purl.obolibrary.org/obo/MONDO_0004931) (residual stage corticosteroid-induced glaucoma), [MONDO:0003601](http://purl.obolibrary.org/obo/MONDO_0003601) (mediastinum liposarcoma), [MONDO:0004932](http://purl.obolibrary.org/obo/MONDO_0004932) (null-cell leukemia), [MONDO:0004930](http://purl.obolibrary.org/obo/MONDO_0004930) (steroid-induced glaucoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (B-cell chronic lymphocytic leukemia), [MONDO:0004949](http://purl.obolibrary.org/obo/MONDO_0004949) (neoplasm of mature B-cells), [MONDO:0004946](http://purl.obolibrary.org/obo/MONDO_0004946) (hypoglycemia), [MONDO:0004947](http://purl.obolibrary.org/obo/MONDO_0004947) (b-cell acute lymphoblastic leukemia), [MONDO:0003613](http://purl.obolibrary.org/obo/MONDO_0003613) (diffuse peritoneal leiomyomatosis), [MONDO:0003614](http://purl.obolibrary.org/obo/MONDO_0003614) (intravenous leiomyomatosis), [MONDO:0003611](http://purl.obolibrary.org/obo/MONDO_0003611) (uterine ligament papillary cystadenoma associated with von hippel-lindau disease), [MONDO:0004942](http://purl.obolibrary.org/obo/MONDO_0004942) (orbit lymphoma), [MONDO:0003612](http://purl.obolibrary.org/obo/MONDO_0003612) (uterine ligament cancer), [MONDO:0004943](http://purl.obolibrary.org/obo/MONDO_0004943) (orbit sarcoma), [MONDO:0003610](http://purl.obolibrary.org/obo/MONDO_0003610) (rete ovarii cystadenoma), [MONDO:0004941](http://purl.obolibrary.org/obo/MONDO_0004941) (eosinophilia-myalgia syndrome), [MONDO:0004917](http://purl.obolibrary.org/obo/MONDO_0004917) (internal hordeolum), [MONDO:0004918](http://purl.obolibrary.org/obo/MONDO_0004918) (central corneal ulcer), [MONDO:0004913](http://purl.obolibrary.org/obo/MONDO_0004913) (alternating esotropia), [MONDO:0004926](http://purl.obolibrary.org/obo/MONDO_0004926) (dacryocystitis), [MONDO:0004927](http://purl.obolibrary.org/obo/MONDO_0004927) (dacryocystocele), [MONDO:0004924](http://purl.obolibrary.org/obo/MONDO_0004924) (chronic canaliculitis), [MONDO:0004925](http://purl.obolibrary.org/obo/MONDO_0004925) (chronic dacryocystitis), [MONDO:0004923](http://purl.obolibrary.org/obo/MONDO_0004923) (chronic inflammation of lacrimal passage), [MONDO:0015631](http://purl.obolibrary.org/obo/MONDO_0015631) (von willebrand disease type 2N), [MONDO:0014300](http://purl.obolibrary.org/obo/MONDO_0014300) (proximal myopathy with extrapyramidal signs), [MONDO:0015630](http://purl.obolibrary.org/obo/MONDO_0015630) (von willebrand disease type 2M), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0014301](http://purl.obolibrary.org/obo/MONDO_0014301) (DDD3), [MONDO:0015632](http://purl.obolibrary.org/obo/MONDO_0015632) (FASTKD2-related infantile mitochondrial encephalomyopathy), [MONDO:0002318](http://purl.obolibrary.org/obo/MONDO_0002318) (trachea leiomyoma), [MONDO:0003649](http://purl.obolibrary.org/obo/MONDO_0003649) (esophageal neuroendocrine tumor), [MONDO:0002319](http://purl.obolibrary.org/obo/MONDO_0002319) (phosphorus metabolism disease), [MONDO:0002314](http://purl.obolibrary.org/obo/MONDO_0002314) (chronic conjunctivitis), [MONDO:0003646](http://purl.obolibrary.org/obo/MONDO_0003646) (rectum neuroendocrine neoplasm), [MONDO:0004977](http://purl.obolibrary.org/obo/MONDO_0004977) (angioimmunoblastic T-cell lymphoma), [MONDO:0002313](http://purl.obolibrary.org/obo/MONDO_0002313) (vernal conjunctivitis), [MONDO:0003644](http://purl.obolibrary.org/obo/MONDO_0003644) (cavernous hemangioma of colon), [MONDO:0003645](http://purl.obolibrary.org/obo/MONDO_0003645) (cavernous hemangioma of face), [MONDO:0004976](http://purl.obolibrary.org/obo/MONDO_0004976) (amyotrophic lateral sclerosis), [MONDO:0004973](http://purl.obolibrary.org/obo/MONDO_0004973) (adenosquamous lung carcinoma), [MONDO:0002310](http://purl.obolibrary.org/obo/MONDO_0002310) (anterior dislocation of lens), [MONDO:0004974](http://purl.obolibrary.org/obo/MONDO_0004974) (adrenal gland pheochromocytoma), [MONDO:0003643](http://purl.obolibrary.org/obo/MONDO_0003643) (giant hemangioma), [MONDO:0003640](http://purl.obolibrary.org/obo/MONDO_0003640) (verruciform xanthoma of skin), [MONDO:0004971](http://purl.obolibrary.org/obo/MONDO_0004971) (adenoid cystic carcinoma), [MONDO:0003641](http://purl.obolibrary.org/obo/MONDO_0003641) (central nervous system hematopoietic neoplasm), [MONDO:0004972](http://purl.obolibrary.org/obo/MONDO_0004972) (adenoma), [MONDO:0002311](http://purl.obolibrary.org/obo/MONDO_0002311) (retinal vascular disease), [MONDO:0004970](http://purl.obolibrary.org/obo/MONDO_0004970) (adenocarcinoma), [MONDO:0014307](http://purl.obolibrary.org/obo/MONDO_0014307) (Dowling-Degos disease 4), [MONDO:0014309](http://purl.obolibrary.org/obo/MONDO_0014309) (obesity due to CEP19 deficiency), [MONDO:0015635](http://purl.obolibrary.org/obo/MONDO_0015635) (Porokeratotic eccrine ostial and dermal duct nevus), [MONDO:0015634](http://purl.obolibrary.org/obo/MONDO_0015634) (isolated osteopoikilosis), [MONDO:0014306](http://purl.obolibrary.org/obo/MONDO_0014306) (vasculitis due to ADA2 deficiency), [MONDO:0002328](http://purl.obolibrary.org/obo/MONDO_0002328) (intracranial hemangioma), [MONDO:0003659](http://purl.obolibrary.org/obo/MONDO_0003659) (pediatric lymphoma), [MONDO:0004988](http://purl.obolibrary.org/obo/MONDO_0004988) (breast adenocarcinoma), [MONDO:0003657](http://purl.obolibrary.org/obo/MONDO_0003657) (methotrexate-associated lymphoproliferation), [MONDO:0004989](http://purl.obolibrary.org/obo/MONDO_0004989) (breast carcinoma), [MONDO:0003658](http://purl.obolibrary.org/obo/MONDO_0003658) (gray zone lymphoma), [MONDO:0004986](http://purl.obolibrary.org/obo/MONDO_0004986) (bladder carcinoma (disease)), [MONDO:0002327](http://purl.obolibrary.org/obo/MONDO_0002327) (intracranial cavernous angioma), [MONDO:0003655](http://purl.obolibrary.org/obo/MONDO_0003655) (cerebral lymphoma), [MONDO:0004987](http://purl.obolibrary.org/obo/MONDO_0004987) (bladder tumor), [MONDO:0003656](http://purl.obolibrary.org/obo/MONDO_0003656) (hemoglobinuria), [MONDO:0003653](http://purl.obolibrary.org/obo/MONDO_0003653) (stork bite), [MONDO:0004984](http://purl.obolibrary.org/obo/MONDO_0004984) (basal-like breast carcinoma), [MONDO:0003654](http://purl.obolibrary.org/obo/MONDO_0003654) (childhood parosteal osteosarcoma), [MONDO:0003651](http://purl.obolibrary.org/obo/MONDO_0003651) (macrotrabecular hepatoblastoma), [MONDO:0002323](http://purl.obolibrary.org/obo/MONDO_0002323) (senile angioma), [MONDO:0004980](http://purl.obolibrary.org/obo/MONDO_0004980) (atopic eczema), [MONDO:0004981](http://purl.obolibrary.org/obo/MONDO_0004981) (atrial fibrillation (disease)), [MONDO:0003650](http://purl.obolibrary.org/obo/MONDO_0003650) (mixed hepatoblastoma), [MONDO:0015628](http://purl.obolibrary.org/obo/MONDO_0015628) (von willebrand disease type 2A), [MONDO:0015627](http://purl.obolibrary.org/obo/MONDO_0015627) (multiple epiphyseal dysplasia due to collagen 9 anomaly), [MONDO:0015629](http://purl.obolibrary.org/obo/MONDO_0015629) (von willebrand disease type 2B), [MONDO:0015624](http://purl.obolibrary.org/obo/MONDO_0015624) (Diazoxide-sensitive diffuse hyperinsulinism), [MONDO:0015626](http://purl.obolibrary.org/obo/MONDO_0015626) (Charcot-Marie-tooth disease), [MONDO:0015625](http://purl.obolibrary.org/obo/MONDO_0015625) (Diazoxide-resistant diffuse hyperinsulinism), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0015610](http://purl.obolibrary.org/obo/MONDO_0015610) (rare acquired aplastic anemia), [MONDO:0004959](http://purl.obolibrary.org/obo/MONDO_0004959) (plasma cell neoplasm), [MONDO:0003629](http://purl.obolibrary.org/obo/MONDO_0003629) (uterine corpus serous adenocarcinoma), [MONDO:0003626](http://purl.obolibrary.org/obo/MONDO_0003626) (uterine ligament serous adenocarcinoma), [MONDO:0004957](http://purl.obolibrary.org/obo/MONDO_0004957) (mucinous adenocarcinoma), [MONDO:0003627](http://purl.obolibrary.org/obo/MONDO_0003627) (rheumatic pulmonary valve disease), [MONDO:0004958](http://purl.obolibrary.org/obo/MONDO_0004958) (oral squamous cell carcinoma), [MONDO:0004955](http://purl.obolibrary.org/obo/MONDO_0004955) (metabolic syndrome), [MONDO:0003624](http://purl.obolibrary.org/obo/MONDO_0003624) (acinic cell breast carcinoma), [MONDO:0004956](http://purl.obolibrary.org/obo/MONDO_0004956) (metastatic prostate cancer), [MONDO:0003625](http://purl.obolibrary.org/obo/MONDO_0003625) (ovary serous adenocarcinoma), [MONDO:0004953](http://purl.obolibrary.org/obo/MONDO_0004953) (invasive ductal carcinoma), [MONDO:0003622](http://purl.obolibrary.org/obo/MONDO_0003622) (pancreatic vasoactive intestinal peptide producing tumor), [MONDO:0003621](http://purl.obolibrary.org/obo/MONDO_0003621) (small intestinal vasoactive intestinal peptide producing tumor), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0004950](http://purl.obolibrary.org/obo/MONDO_0004950) (gastric carcinoma), [MONDO:0015612](http://purl.obolibrary.org/obo/MONDO_0015612) (Dent disease), [MONDO:0015614](http://purl.obolibrary.org/obo/MONDO_0015614) (dermatitis herpetiformis), [MONDO:0002307](http://purl.obolibrary.org/obo/MONDO_0002307) (blepharoconjunctivitis), [MONDO:0003639](http://purl.obolibrary.org/obo/MONDO_0003639) (lung hilum neoplasm), [MONDO:0002306](http://purl.obolibrary.org/obo/MONDO_0002306) (angular blepharoconjunctivitis), [MONDO:0003637](http://purl.obolibrary.org/obo/MONDO_0003637) (lung clear cell-sugar-tumor), [MONDO:0002309](http://purl.obolibrary.org/obo/MONDO_0002309) (papillary conjunctivitis), [MONDO:0002308](http://purl.obolibrary.org/obo/MONDO_0002308) (giant papillary conjunctivitis), [MONDO:0003638](http://purl.obolibrary.org/obo/MONDO_0003638) (lung meningioma), [MONDO:0003635](http://purl.obolibrary.org/obo/MONDO_0003635) (sebaceous breast carcinoma), [MONDO:0002303](http://purl.obolibrary.org/obo/MONDO_0002303) (central retinal vein occlusion), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0003636](http://purl.obolibrary.org/obo/MONDO_0003636) (vulvar sebaceous carcinoma), [MONDO:0003633](http://purl.obolibrary.org/obo/MONDO_0003633) (malignant mesenchymoma), [MONDO:0004964](http://purl.obolibrary.org/obo/MONDO_0004964) (unspecified peripheral T-cell lymphoma), [MONDO:0002305](http://purl.obolibrary.org/obo/MONDO_0002305) (thrombophilia), [MONDO:0002304](http://purl.obolibrary.org/obo/MONDO_0002304) (protein S deficiency), [MONDO:0004965](http://purl.obolibrary.org/obo/MONDO_0004965) (acinar cell carcinoma), [MONDO:0003631](http://purl.obolibrary.org/obo/MONDO_0003631) (cervical serous adenocarcinoma), [MONDO:0004963](http://purl.obolibrary.org/obo/MONDO_0004963) (T-cell acute lymphoblastic leukemia), [MONDO:0004960](http://purl.obolibrary.org/obo/MONDO_0004960) (monoclonal gammopathy), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0003630](http://purl.obolibrary.org/obo/MONDO_0003630) (pancreatic serous cystadenocarcinoma), [MONDO:0002300](http://purl.obolibrary.org/obo/MONDO_0002300) (dermis tumor), [MONDO:0015609](http://purl.obolibrary.org/obo/MONDO_0015609) (advanced sleep phase syndrome), [MONDO:0015605](http://purl.obolibrary.org/obo/MONDO_0015605) (distal monosomy 9p), [MONDO:0015608](http://purl.obolibrary.org/obo/MONDO_0015608) (acute myeloid leukemia and myelodysplastic syndromes related to radiation), [MONDO:0015607](http://purl.obolibrary.org/obo/MONDO_0015607) (partial chromosome Y deletion), [MONDO:0015602](http://purl.obolibrary.org/obo/MONDO_0015602) (developmental delay-deafness syndrome, Hildebrand type), [MONDO:0013012](http://purl.obolibrary.org/obo/MONDO_0013012) (inflammatory bowel disease 27), [MONDO:0014343](http://purl.obolibrary.org/obo/MONDO_0014343) (Desbuquois dysplasia 2), [MONDO:0013013](http://purl.obolibrary.org/obo/MONDO_0013013) (Question mark ears, isolated), [MONDO:0015674](http://purl.obolibrary.org/obo/MONDO_0015674) (late infantile neuronal ceroid lipofuscinosis), [MONDO:0013014](http://purl.obolibrary.org/obo/MONDO_0013014) (spondyloepimetaphyseal dysplasia, aggrecan type), [MONDO:0014345](http://purl.obolibrary.org/obo/MONDO_0014345) (retinitis pigmentosa 69), [MONDO:0013015](http://purl.obolibrary.org/obo/MONDO_0013015) (Brugada syndrome 5), [MONDO:0014346](http://purl.obolibrary.org/obo/MONDO_0014346) (white sponge nevus 2), [MONDO:0014340](http://purl.obolibrary.org/obo/MONDO_0014340) (atrial fibrillation, familial, 15), [MONDO:0013010](http://purl.obolibrary.org/obo/MONDO_0013010) (autosomal recessive nonsyndromic deafness 71), [MONDO:0015673](http://purl.obolibrary.org/obo/MONDO_0015673) (rare cardiac tumor), [MONDO:0014342](http://purl.obolibrary.org/obo/MONDO_0014342) (female infertility due to zona pellucida defect), [MONDO:0013011](http://purl.obolibrary.org/obo/MONDO_0013011) (atrial heart septal defect 5), [MONDO:0002358](http://purl.obolibrary.org/obo/MONDO_0002358) (laryngeal carcinoma), [MONDO:0002357](http://purl.obolibrary.org/obo/MONDO_0002357) (hepatic flexure cancer), [MONDO:0003688](http://purl.obolibrary.org/obo/MONDO_0003688) (benign intermediate mesothelioma), [MONDO:0001029](http://purl.obolibrary.org/obo/MONDO_0001029) (Klippel-Feil syndrome), [MONDO:0002359](http://purl.obolibrary.org/obo/MONDO_0002359) (juxtacortical chondroma), [MONDO:0003689](http://purl.obolibrary.org/obo/MONDO_0003689) (congenital hemolytic anemia), [MONDO:0003686](http://purl.obolibrary.org/obo/MONDO_0003686) (apocrine sweat gland neoplasm), [MONDO:0001023](http://purl.obolibrary.org/obo/MONDO_0001023) (prolymphocytic leukemia), [MONDO:0002354](http://purl.obolibrary.org/obo/MONDO_0002354) (benign laryngeal neoplasm), [MONDO:0003687](http://purl.obolibrary.org/obo/MONDO_0003687) (endocardium cancer), [MONDO:0002353](http://purl.obolibrary.org/obo/MONDO_0002353) (glottis neoplasm), [MONDO:0001022](http://purl.obolibrary.org/obo/MONDO_0001022) (disuse amblyopia), [MONDO:0003684](http://purl.obolibrary.org/obo/MONDO_0003684) (clear cell chondrosarcoma), [MONDO:0002355](http://purl.obolibrary.org/obo/MONDO_0002355) (glottis carcinoma), [MONDO:0003685](http://purl.obolibrary.org/obo/MONDO_0003685) (retroperitoneal germ cell neoplasm), [MONDO:0003682](http://purl.obolibrary.org/obo/MONDO_0003682) (localized chondrosarcoma), [MONDO:0003683](http://purl.obolibrary.org/obo/MONDO_0003683) (juxtacortical chondrosarcoma), [MONDO:0003680](http://purl.obolibrary.org/obo/MONDO_0003680) (periosteal chondrosarcoma), [MONDO:0002352](http://purl.obolibrary.org/obo/MONDO_0002352) (larynx cancer), [MONDO:0001021](http://purl.obolibrary.org/obo/MONDO_0001021) (ametropic amblyopia), [MONDO:0003681](http://purl.obolibrary.org/obo/MONDO_0003681) (myxoid chondrosarcoma), [MONDO:0001020](http://purl.obolibrary.org/obo/MONDO_0001020) (amblyopia (disease)), [MONDO:0002351](http://purl.obolibrary.org/obo/MONDO_0002351) (glottis cancer), [MONDO:0015679](http://purl.obolibrary.org/obo/MONDO_0015679) (autosomal thrombocytopenia with normal platelets), [MONDO:0013016](http://purl.obolibrary.org/obo/MONDO_0013016) (leukocyte adhesion deficiency 3), [MONDO:0015678](http://purl.obolibrary.org/obo/MONDO_0015678) (dysplasia of head of femur, Meyer type), [MONDO:0013018](http://purl.obolibrary.org/obo/MONDO_0013018) (keratosis follicularis spinulosa decalvans, autosomal dominant), [MONDO:0014349](http://purl.obolibrary.org/obo/MONDO_0014349) (pontocerebellar hypoplasia type 10), [MONDO:0014332](http://purl.obolibrary.org/obo/MONDO_0014332) (Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency), [MONDO:0016995](http://purl.obolibrary.org/obo/MONDO_0016995) (familial multiple meningioma), [MONDO:0016994](http://purl.obolibrary.org/obo/MONDO_0016994) (microcephalic osteodysplastic primordial dwarfism types i and III), [MONDO:0014333](http://purl.obolibrary.org/obo/MONDO_0014333) (polymicrogyria, bilateral perisylvian, autosomal recessive), [MONDO:0013002](http://purl.obolibrary.org/obo/MONDO_0013002) (cone-rod dystrophy 9), [MONDO:0013003](http://purl.obolibrary.org/obo/MONDO_0013003) (isolated congenital hypoglossia/aglossia), [MONDO:0014334](http://purl.obolibrary.org/obo/MONDO_0014334) (severe combined immunodeficiency due to LCK deficiency), [MONDO:0016997](http://purl.obolibrary.org/obo/MONDO_0016997) (hereditary epidermolysis bullosa associated with ocular features), [MONDO:0014335](http://purl.obolibrary.org/obo/MONDO_0014335) (diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome), [MONDO:0016990](http://purl.obolibrary.org/obo/MONDO_0016990) (acquired prothrombin deficiency), [MONDO:0015662](http://purl.obolibrary.org/obo/MONDO_0015662) (rare hemorrhagic disorder due to an acquired coagulation factor defect), [MONDO:0013000](http://purl.obolibrary.org/obo/MONDO_0013000) (porphyria due to ALA dehydratase deficiency), [MONDO:0001038](http://purl.obolibrary.org/obo/MONDO_0001038) (perforated corneal ulcer), [MONDO:0002369](http://purl.obolibrary.org/obo/MONDO_0002369) (cystadenoma), [MONDO:0001037](http://purl.obolibrary.org/obo/MONDO_0001037) (ring corneal ulcer), [MONDO:0002368](http://purl.obolibrary.org/obo/MONDO_0002368) (papillary serous cystadenocarcinoma), [MONDO:0001034](http://purl.obolibrary.org/obo/MONDO_0001034) (marginal corneal ulcer), [MONDO:0002365](http://purl.obolibrary.org/obo/MONDO_0002365) (kidney hemangiopericytoma), [MONDO:0003697](http://purl.obolibrary.org/obo/MONDO_0003697) (non-invasive verrucous carcinoma of the penis), [MONDO:0002364](http://purl.obolibrary.org/obo/MONDO_0002364) (Wolffian duct adenoma), [MONDO:0001033](http://purl.obolibrary.org/obo/MONDO_0001033) (mycotic corneal ulcer), [MONDO:0003698](http://purl.obolibrary.org/obo/MONDO_0003698) (penis verrucous carcinoma), [MONDO:0003695](http://purl.obolibrary.org/obo/MONDO_0003695) (ovarian clear cell adenofibroma), [MONDO:0002367](http://purl.obolibrary.org/obo/MONDO_0002367) (kidney cancer), [MONDO:0001036](http://purl.obolibrary.org/obo/MONDO_0001036) (hypopyon), [MONDO:0002366](http://purl.obolibrary.org/obo/MONDO_0002366) (autonomic nervous system neoplasm), [MONDO:0001035](http://purl.obolibrary.org/obo/MONDO_0001035) (hypopyon ulcer), [MONDO:0003693](http://purl.obolibrary.org/obo/MONDO_0003693) (clear cell cystadenofibroma), [MONDO:0002361](http://purl.obolibrary.org/obo/MONDO_0002361) (transverse colon cancer), [MONDO:0001030](http://purl.obolibrary.org/obo/MONDO_0001030) (keratoconus, stable condition), [MONDO:0003694](http://purl.obolibrary.org/obo/MONDO_0003694) (ovarian clear cell cystadenofibroma), [MONDO:0003691](http://purl.obolibrary.org/obo/MONDO_0003691) (childhood malignant mesenchymoma), [MONDO:0001032](http://purl.obolibrary.org/obo/MONDO_0001032) (Mooren's ulcer), [MONDO:0002363](http://purl.obolibrary.org/obo/MONDO_0002363) (papilloma), [MONDO:0003692](http://purl.obolibrary.org/obo/MONDO_0003692) (adult malignant mesenchymoma), [MONDO:0002362](http://purl.obolibrary.org/obo/MONDO_0002362) (serous surface papilloma), [MONDO:0003690](http://purl.obolibrary.org/obo/MONDO_0003690) (malignant adult ependymoma), [MONDO:0013005](http://purl.obolibrary.org/obo/MONDO_0013005) (EAST syndrome), [MONDO:0014336](http://purl.obolibrary.org/obo/MONDO_0014336) (intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0014338](http://purl.obolibrary.org/obo/MONDO_0014338) (IL21-related infantile inflammatory bowel disease), [MONDO:0013007](http://purl.obolibrary.org/obo/MONDO_0013007) (combined immunodeficiency due to ORAI1 deficiency), [MONDO:0014339](http://purl.obolibrary.org/obo/MONDO_0014339) (autosomal recessive spinocerebellar ataxia 16), [MONDO:0013008](http://purl.obolibrary.org/obo/MONDO_0013008) (combined immunodeficiency due to STIM1 deficiency), [MONDO:0016984](http://purl.obolibrary.org/obo/MONDO_0016984) (nevus of ota), [MONDO:0016983](http://purl.obolibrary.org/obo/MONDO_0016983) (Bartter syndrome with hypocalcemia), [MONDO:0016986](http://purl.obolibrary.org/obo/MONDO_0016986) (congenital smooth muscle hamartoma), [MONDO:0014323](http://purl.obolibrary.org/obo/MONDO_0014323) (retinitis pigmentosa 68), [MONDO:0014324](http://purl.obolibrary.org/obo/MONDO_0014324) (pachyonychia congenita 3), [MONDO:0016985](http://purl.obolibrary.org/obo/MONDO_0016985) (nevus of Ito), [MONDO:0016980](http://purl.obolibrary.org/obo/MONDO_0016980) (ATR-X-related syndrome), [MONDO:0016982](http://purl.obolibrary.org/obo/MONDO_0016982) (angiosarcoma (disease)), [MONDO:0014320](http://purl.obolibrary.org/obo/MONDO_0014320) (optic atrophy-intellectual disability syndrome), [MONDO:0016981](http://purl.obolibrary.org/obo/MONDO_0016981) (infantile spams-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome), [MONDO:0001009](http://purl.obolibrary.org/obo/MONDO_0001009) (solitary cyst of breast), [MONDO:0001008](http://purl.obolibrary.org/obo/MONDO_0001008) (blepharophimosis (disease)), [MONDO:0003668](http://purl.obolibrary.org/obo/MONDO_0003668) (extragonadal seminoma), [MONDO:0003669](http://purl.obolibrary.org/obo/MONDO_0003669) (testicular seminoma), [MONDO:0004997](http://purl.obolibrary.org/obo/MONDO_0004997) (chondroblastoma (disease)), [MONDO:0003666](http://purl.obolibrary.org/obo/MONDO_0003666) (fallopian tube endometrioid adenocarcinoma), [MONDO:0001006](http://purl.obolibrary.org/obo/MONDO_0001006) (glaucomatous atrophy of optic disc), [MONDO:0003667](http://purl.obolibrary.org/obo/MONDO_0003667) (spermatocytoma), [MONDO:0002337](http://purl.obolibrary.org/obo/MONDO_0002337) (intra-abdominal hemangioma), [MONDO:0003664](http://purl.obolibrary.org/obo/MONDO_0003664) (hemolytic anemia), [MONDO:0003665](http://purl.obolibrary.org/obo/MONDO_0003665) (cervical endometrioid adenocarcinoma), [MONDO:0004996](http://purl.obolibrary.org/obo/MONDO_0004996) (childhood acute myeloid leukemia), [MONDO:0002334](http://purl.obolibrary.org/obo/MONDO_0002334) (hematopoietic and lymphoid system neoplasm), [MONDO:0004993](http://purl.obolibrary.org/obo/MONDO_0004993) (carcinoma), [MONDO:0003663](http://purl.obolibrary.org/obo/MONDO_0003663) (uterine ligament endometrioid adenocarcinoma), [MONDO:0004991](http://purl.obolibrary.org/obo/MONDO_0004991) (bronchoalveolar adenocarcinoma), [MONDO:0003660](http://purl.obolibrary.org/obo/MONDO_0003660) (adult lymphoma), [MONDO:0003661](http://purl.obolibrary.org/obo/MONDO_0003661) (breast lymphoma), [MONDO:0004992](http://purl.obolibrary.org/obo/MONDO_0004992) (cancer), [MONDO:0004990](http://purl.obolibrary.org/obo/MONDO_0004990) (breast tumor luminal A or B), [MONDO:0014329](http://purl.obolibrary.org/obo/MONDO_0014329) (atrial standstill 2), [MONDO:0016988](http://purl.obolibrary.org/obo/MONDO_0016988) (hyperinsulinism due to HNF4A deficiency), [MONDO:0014325](http://purl.obolibrary.org/obo/MONDO_0014325) (pachyonychia congenita 4), [MONDO:0014326](http://purl.obolibrary.org/obo/MONDO_0014326) (nemaline myopathy 9), [MONDO:0016989](http://purl.obolibrary.org/obo/MONDO_0016989) (Fuchs heterochromic iridocyclitis), [MONDO:0014311](http://purl.obolibrary.org/obo/MONDO_0014311) (autosomal recessive spinocerebellar ataxia 15), [MONDO:0016975](http://purl.obolibrary.org/obo/MONDO_0016975) (thymoma type AB), [MONDO:0014312](http://purl.obolibrary.org/obo/MONDO_0014312) (Auriculocondylar syndrome 3), [MONDO:0016974](http://purl.obolibrary.org/obo/MONDO_0016974) (thymoma type B), [MONDO:0016971](http://purl.obolibrary.org/obo/MONDO_0016971) (limb-girdle muscular dystrophy), [MONDO:0001019](http://purl.obolibrary.org/obo/MONDO_0001019) (suppression amblyopia), [MONDO:0001016](http://purl.obolibrary.org/obo/MONDO_0001016) (epididymis cancer), [MONDO:0001018](http://purl.obolibrary.org/obo/MONDO_0001018) (lymphoblastic leukemia), [MONDO:0001017](http://purl.obolibrary.org/obo/MONDO_0001017) (epididymis adenocarcinoma), [MONDO:0001012](http://purl.obolibrary.org/obo/MONDO_0001012) (breast fibroadenosis), [MONDO:0002343](http://purl.obolibrary.org/obo/MONDO_0002343) (splenic hemangioma), [MONDO:0001011](http://purl.obolibrary.org/obo/MONDO_0001011) (breast cyst), [MONDO:0001014](http://purl.obolibrary.org/obo/MONDO_0001014) (chronic leukemia), [MONDO:0001013](http://purl.obolibrary.org/obo/MONDO_0001013) (fibrosclerosis of breast), [MONDO:0001010](http://purl.obolibrary.org/obo/MONDO_0001010) (natural killer cell leukemia), [MONDO:0014318](http://purl.obolibrary.org/obo/MONDO_0014318) (hyperphosphatasia with mental retardation syndrome 4), [MONDO:0014319](http://purl.obolibrary.org/obo/MONDO_0014319) (renal Hypodysplasia/aplasia 2), [MONDO:0016977](http://purl.obolibrary.org/obo/MONDO_0016977) (moderately-differentiated thymic neuroendocrine carcinoma), [MONDO:0014314](http://purl.obolibrary.org/obo/MONDO_0014314) (sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome), [MONDO:0016976](http://purl.obolibrary.org/obo/MONDO_0016976) (well-differentiated thymic neuroendocrine carcinoma), [MONDO:0014315](http://purl.obolibrary.org/obo/MONDO_0014315) (Mitchell-Riley syndrome), [MONDO:0016979](http://purl.obolibrary.org/obo/MONDO_0016979) (MRCS syndrome), [MONDO:0014317](http://purl.obolibrary.org/obo/MONDO_0014317) (pancytopenia-developmental delay syndrome), [MONDO:0016978](http://purl.obolibrary.org/obo/MONDO_0016978) (poorly differentiated thymic neuroendocrine carcinoma), [MONDO:0013056](http://purl.obolibrary.org/obo/MONDO_0013056) (epileptic encephalopathy with global cerebral demyelination), [MONDO:0014388](http://purl.obolibrary.org/obo/MONDO_0014388) (familial median cleft of the upper and lower lips), [MONDO:0013059](http://purl.obolibrary.org/obo/MONDO_0013059) (Aicardi-Goutieres syndrome 5), [MONDO:0014383](http://purl.obolibrary.org/obo/MONDO_0014383) (myopathy, tubular aggregate, 2), [MONDO:0013052](http://purl.obolibrary.org/obo/MONDO_0013052) (retinitis pigmentosa 42), [MONDO:0013053](http://purl.obolibrary.org/obo/MONDO_0013053) (microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type), [MONDO:0014386](http://purl.obolibrary.org/obo/MONDO_0014386) (platelet-type bleeding disorder 18), [MONDO:0014380](http://purl.obolibrary.org/obo/MONDO_0014380) (colobomatous microphthalmia-rhizomelic dysplasia syndrome), [MONDO:0014381](http://purl.obolibrary.org/obo/MONDO_0014381) (cholestasis, progressive familial intrahepatic, 4), [MONDO:0013050](http://purl.obolibrary.org/obo/MONDO_0013050) (lethal polymalformative syndrome, Boissel type), [MONDO:0013051](http://purl.obolibrary.org/obo/MONDO_0013051) (autosomal recessive cutis laxa type 2B), [MONDO:0014382](http://purl.obolibrary.org/obo/MONDO_0014382) (tall stature-intellectual disability-facial dysmorphism syndrome), [MONDO:0002398](http://purl.obolibrary.org/obo/MONDO_0002398) (mucinous adenofibroma), [MONDO:0002397](http://purl.obolibrary.org/obo/MONDO_0002397) (liver sarcoma), [MONDO:0002399](http://purl.obolibrary.org/obo/MONDO_0002399) (nodular tenosynovitis), [MONDO:0001068](http://purl.obolibrary.org/obo/MONDO_0001068) (osteomalacia (disease)), [MONDO:0001063](http://purl.obolibrary.org/obo/MONDO_0001063) (cardia cancer), [MONDO:0001062](http://purl.obolibrary.org/obo/MONDO_0001062) (pyloric antrum cancer), [MONDO:0002396](http://purl.obolibrary.org/obo/MONDO_0002396) (nephrogenic adenofibroma), [MONDO:0002395](http://purl.obolibrary.org/obo/MONDO_0002395) (renal adenoma), [MONDO:0001061](http://purl.obolibrary.org/obo/MONDO_0001061) (pylorus cancer), [MONDO:0001060](http://purl.obolibrary.org/obo/MONDO_0001060) (microinvasive gastric cancer), [MONDO:0014376](http://purl.obolibrary.org/obo/MONDO_0014376) (mental retardation, autosomal dominant 27), [MONDO:0013046](http://purl.obolibrary.org/obo/MONDO_0013046) (glycogen storage disease due to muscle beta-enolase deficiency), [MONDO:0014378](http://purl.obolibrary.org/obo/MONDO_0014378) (primary ciliary dyskinesia 29), [MONDO:0013047](http://purl.obolibrary.org/obo/MONDO_0013047) (glycogen storage disease due to lactate dehydrogenase M-subunit deficiency), [MONDO:0014379](http://purl.obolibrary.org/obo/MONDO_0014379) (ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder), [MONDO:0014372](http://purl.obolibrary.org/obo/MONDO_0014372) (cone-rod dystrophy 19), [MONDO:0013041](http://purl.obolibrary.org/obo/MONDO_0013041) (atypical hemolytic-uremic syndrome with i factor anomaly), [MONDO:0013042](http://purl.obolibrary.org/obo/MONDO_0013042) (atypical hemolytic-uremic syndrome with b factor anomaly), [MONDO:0013043](http://purl.obolibrary.org/obo/MONDO_0013043) (atypical hemolytic-uremic syndrome with C3 anomaly), [MONDO:0013044](http://purl.obolibrary.org/obo/MONDO_0013044) (atypical hemolytic-uremic syndrome with thrombomodulin anomaly), [MONDO:0014370](http://purl.obolibrary.org/obo/MONDO_0014370) (pontocerebellar hypoplasia type 2E), [MONDO:0014371](http://purl.obolibrary.org/obo/MONDO_0014371) (early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome), [MONDO:0013040](http://purl.obolibrary.org/obo/MONDO_0013040) (atypical hemolytic-uremic syndrome with MCP/CD46 anomaly), [MONDO:0001076](http://purl.obolibrary.org/obo/MONDO_0001076) (glucose intolerance), [MONDO:0013049](http://purl.obolibrary.org/obo/MONDO_0013049) (DPM3-CDG), [MONDO:0015697](http://purl.obolibrary.org/obo/MONDO_0015697) (immunoglobulin heavy chain deficiency), [MONDO:0014365](http://purl.obolibrary.org/obo/MONDO_0014365) (spermatogenic failure 13), [MONDO:0013035](http://purl.obolibrary.org/obo/MONDO_0013035) (orofaciodigital syndrome XI), [MONDO:0015696](http://purl.obolibrary.org/obo/MONDO_0015696) (Good syndrome), [MONDO:0014366](http://purl.obolibrary.org/obo/MONDO_0014366) (spermatogenic failure 14), [MONDO:0013036](http://purl.obolibrary.org/obo/MONDO_0013036) (Zechi-Ceide syndrome), [MONDO:0014367](http://purl.obolibrary.org/obo/MONDO_0014367) (Aicardi-Goutieres syndrome 7), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0015698](http://purl.obolibrary.org/obo/MONDO_0015698) (transient hypogammaglobulinemia of infancy), [MONDO:0014361](http://purl.obolibrary.org/obo/MONDO_0014361) (autism spectrum disorder due to AUTS2 deficiency), [MONDO:0013031](http://purl.obolibrary.org/obo/MONDO_0013031) (chromosome 5Q14.3 deletion syndrome, distal), [MONDO:0015692](http://purl.obolibrary.org/obo/MONDO_0015692) (refractory anemia with excess blasts in transformation), [MONDO:0014363](http://purl.obolibrary.org/obo/MONDO_0014363) (autosomal recessive nonsyndromic deafness 101), [MONDO:0015695](http://purl.obolibrary.org/obo/MONDO_0015695) (combined immunodeficiency due to CRAC channel dysfunction), [MONDO:0015694](http://purl.obolibrary.org/obo/MONDO_0015694) (malignant melanoma of the mucosa), [MONDO:0014364](http://purl.obolibrary.org/obo/MONDO_0014364) (mitochondrial complex III deficiency nuclear type 8), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0015690](http://purl.obolibrary.org/obo/MONDO_0015690) (myeloid neoplasm associated with PDGFRB rearrangement), [MONDO:0002379](http://purl.obolibrary.org/obo/MONDO_0002379) (cystic teratoma), [MONDO:0002376](http://purl.obolibrary.org/obo/MONDO_0002376) (spleen angiosarcoma), [MONDO:0002375](http://purl.obolibrary.org/obo/MONDO_0002375) (sebaceous adenoma), [MONDO:0002378](http://purl.obolibrary.org/obo/MONDO_0002378) (dermoid cyst), [MONDO:0002377](http://purl.obolibrary.org/obo/MONDO_0002377) (breast intracanalicular fibroadenoma), [MONDO:0002372](http://purl.obolibrary.org/obo/MONDO_0002372) (ovarian monodermal and highly specialized teratoma), [MONDO:0002371](http://purl.obolibrary.org/obo/MONDO_0002371) (breast pericanalicular fibroadenoma), [MONDO:0002373](http://purl.obolibrary.org/obo/MONDO_0002373) (benign mesothelioma), [MONDO:0002370](http://purl.obolibrary.org/obo/MONDO_0002370) (ovarian Brenner tumor), [MONDO:0014369](http://purl.obolibrary.org/obo/MONDO_0014369) (postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome), [MONDO:0013038](http://purl.obolibrary.org/obo/MONDO_0013038) (CLOVES syndrome), [MONDO:0013039](http://purl.obolibrary.org/obo/MONDO_0013039) (three M syndrome 2), [MONDO:0015686](http://purl.obolibrary.org/obo/MONDO_0015686) (primary peritoneal carcinoma (disease)), [MONDO:0015685](http://purl.obolibrary.org/obo/MONDO_0015685) (peritoneal cystic mesothelioma), [MONDO:0014355](http://purl.obolibrary.org/obo/MONDO_0014355) (cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis), [MONDO:0014356](http://purl.obolibrary.org/obo/MONDO_0014356) (mitochondrial complex III deficiency nuclear type 7), [MONDO:0015688](http://purl.obolibrary.org/obo/MONDO_0015688) (myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1), [MONDO:0015687](http://purl.obolibrary.org/obo/MONDO_0015687) (chronic eosinophilic leukemia), [MONDO:0013026](http://purl.obolibrary.org/obo/MONDO_0013026) (subepithelial mucinous corneal dystrophy), [MONDO:0015682](http://purl.obolibrary.org/obo/MONDO_0015682) (primary peritoneal tumor), [MONDO:0014350](http://purl.obolibrary.org/obo/MONDO_0014350) (Seckel syndrome 8), [MONDO:0013020](http://purl.obolibrary.org/obo/MONDO_0013020) (NRCLP5), [MONDO:0014351](http://purl.obolibrary.org/obo/MONDO_0014351) (pontocerebellar hypoplasia type 9), [MONDO:0014352](http://purl.obolibrary.org/obo/MONDO_0014352) (abdominal obesity-metabolic syndrome 3), [MONDO:0014353](http://purl.obolibrary.org/obo/MONDO_0014353) (PGM3-CDG), [MONDO:0015683](http://purl.obolibrary.org/obo/MONDO_0015683) (primary malignant peritoneal tumor), [MONDO:0001059](http://purl.obolibrary.org/obo/MONDO_0001059) (gastric lymphoma), [MONDO:0001056](http://purl.obolibrary.org/obo/MONDO_0001056) (gastric cancer), [MONDO:0002387](http://purl.obolibrary.org/obo/MONDO_0002387) (liver angiosarcoma), [MONDO:0001055](http://purl.obolibrary.org/obo/MONDO_0001055) (conjunctival pterygium), [MONDO:0002386](http://purl.obolibrary.org/obo/MONDO_0002386) (mixed epithelial stromal tumor of the kidney), [MONDO:0001058](http://purl.obolibrary.org/obo/MONDO_0001058) (gastric fundus cancer), [MONDO:0001057](http://purl.obolibrary.org/obo/MONDO_0001057) (malignant gastric granular cell tumor), [MONDO:0002388](http://purl.obolibrary.org/obo/MONDO_0002388) (intracystic papillary adenoma), [MONDO:0002383](http://purl.obolibrary.org/obo/MONDO_0002383) (Pacinian tumor), [MONDO:0002382](http://purl.obolibrary.org/obo/MONDO_0002382) (benign mesenchymoma), [MONDO:0002385](http://purl.obolibrary.org/obo/MONDO_0002385) (cystic nephroma), [MONDO:0001054](http://purl.obolibrary.org/obo/MONDO_0001054) (double pterygium), [MONDO:0002381](http://purl.obolibrary.org/obo/MONDO_0002381) (sweat gland neoplasm), [MONDO:0002380](http://purl.obolibrary.org/obo/MONDO_0002380) (myoepithelial tumor), [MONDO:0013027](http://purl.obolibrary.org/obo/MONDO_0013027) (posterior amorphous corneal dystrophy), [MONDO:0015689](http://purl.obolibrary.org/obo/MONDO_0015689) (myeloid neoplasm associated with PDGFRA rearrangement), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0013029](http://purl.obolibrary.org/obo/MONDO_0013029) (cerebellar ataxia type 9), [MONDO:0013096](http://purl.obolibrary.org/obo/MONDO_0013096) (GLM7), [MONDO:0013097](http://purl.obolibrary.org/obo/MONDO_0013097) (GLM8), [MONDO:0013098](http://purl.obolibrary.org/obo/MONDO_0013098) (noise induced hearing loss), [MONDO:0013099](http://purl.obolibrary.org/obo/MONDO_0013099) (combined pituitary hormone deficiencies, genetic forms), [MONDO:0013092](http://purl.obolibrary.org/obo/MONDO_0013092) (glioma susceptibility 2), [MONDO:0013093](http://purl.obolibrary.org/obo/MONDO_0013093) (glioma susceptibility 3), [MONDO:0013094](http://purl.obolibrary.org/obo/MONDO_0013094) (GLM5), [MONDO:0013095](http://purl.obolibrary.org/obo/MONDO_0013095) (GLM6), [MONDO:0013090](http://purl.obolibrary.org/obo/MONDO_0013090) (chromosome 19q13.11 deletion syndrome), [MONDO:0013091](http://purl.obolibrary.org/obo/MONDO_0013091) (glycogen storage disease IXc), [MONDO:0013085](http://purl.obolibrary.org/obo/MONDO_0013085) (NBLST5), [MONDO:0013086](http://purl.obolibrary.org/obo/MONDO_0013086) (NBLST6), [MONDO:0013088](http://purl.obolibrary.org/obo/MONDO_0013088) (FL1), [MONDO:0013081](http://purl.obolibrary.org/obo/MONDO_0013081) (lymphoproliferative syndrome 1), [MONDO:0013082](http://purl.obolibrary.org/obo/MONDO_0013082) (Hirschsprung disease-ganglioneuroblastoma syndrome), [MONDO:0013083](http://purl.obolibrary.org/obo/MONDO_0013083) (neuroblastoma, susceptibility to, 3), [MONDO:0013084](http://purl.obolibrary.org/obo/MONDO_0013084) (NBLST4), [MONDO:0013080](http://purl.obolibrary.org/obo/MONDO_0013080) (primary biliary cholangitis 3), [MONDO:0013078](http://purl.obolibrary.org/obo/MONDO_0013078) (type 1 diabetes mellitus 24), [MONDO:0013079](http://purl.obolibrary.org/obo/MONDO_0013079) (primary biliary cholangitis 2), [MONDO:0013074](http://purl.obolibrary.org/obo/MONDO_0013074) (Encephalocraniocutaneous lipomatosis), [MONDO:0013070](http://purl.obolibrary.org/obo/MONDO_0013070) (spermatogenic failure 7), [MONDO:0013071](http://purl.obolibrary.org/obo/MONDO_0013071) (Emery-Dreifuss muscular dystrophy 4, autosomal dominant), [MONDO:0013072](http://purl.obolibrary.org/obo/MONDO_0013072) (Emery-Dreifuss muscular dystrophy 5, autosomal dominant), [MONDO:0001084](http://purl.obolibrary.org/obo/MONDO_0001084) (primary optic atrophy), [MONDO:0001086](http://purl.obolibrary.org/obo/MONDO_0001086) (partial optic atrophy), [MONDO:0001083](http://purl.obolibrary.org/obo/MONDO_0001083) (Fanconi syndrome), [MONDO:0001082](http://purl.obolibrary.org/obo/MONDO_0001082) (lymph node cancer), [MONDO:0013067](http://purl.obolibrary.org/obo/MONDO_0013067) (cataract 34 multiple types), [MONDO:0014398](http://purl.obolibrary.org/obo/MONDO_0014398) (combined oxidative phosphorylation defect type 21), [MONDO:0014399](http://purl.obolibrary.org/obo/MONDO_0014399) (PCNA-related progressive neurodegenerative photosensitivy syndrome), [MONDO:0013068](http://purl.obolibrary.org/obo/MONDO_0013068) (ARHI2), [MONDO:0013069](http://purl.obolibrary.org/obo/MONDO_0013069) (autosomal recessive optic atrophy, OPA7 type), [MONDO:0014394](http://purl.obolibrary.org/obo/MONDO_0014394) (Diamond-Blackfan anemia 13), [MONDO:0013063](http://purl.obolibrary.org/obo/MONDO_0013063) (ventricular fibrillation, paroxysmal familial, 2), [MONDO:0013064](http://purl.obolibrary.org/obo/MONDO_0013064) (multiple synostoses syndrome 3), [MONDO:0014395](http://purl.obolibrary.org/obo/MONDO_0014395) (FTDALS2), [MONDO:0014397](http://purl.obolibrary.org/obo/MONDO_0014397) (combined oxidative phosphorylation defect type 20), [MONDO:0013066](http://purl.obolibrary.org/obo/MONDO_0013066) (46,XY sex reversal 3), [MONDO:0013060](http://purl.obolibrary.org/obo/MONDO_0013060) (autosomal recessive Parkinson disease 14), [MONDO:0014391](http://purl.obolibrary.org/obo/MONDO_0014391) (severe combined immunodeficiency due to CTPS1 deficiency), [MONDO:0013061](http://purl.obolibrary.org/obo/MONDO_0013061) (myofibrillar myopathy 6), [MONDO:0013062](http://purl.obolibrary.org/obo/MONDO_0013062) (long QT syndrome 12), [MONDO:0014393](http://purl.obolibrary.org/obo/MONDO_0014393) (lymphedema, hereditary, 1D), [MONDO:0001099](http://purl.obolibrary.org/obo/MONDO_0001099) (lactocele), [MONDO:0001096](http://purl.obolibrary.org/obo/MONDO_0001096) (mediastinum ganglioneuroblastoma), [MONDO:0001095](http://purl.obolibrary.org/obo/MONDO_0001095) (mediastinum neuroblastoma), [MONDO:0001092](http://purl.obolibrary.org/obo/MONDO_0001092) (colon leiomyoma), [MONDO:0001091](http://purl.obolibrary.org/obo/MONDO_0001091) (lipoma of colon), [MONDO:0001094](http://purl.obolibrary.org/obo/MONDO_0001094) (residual stage of open angle glaucoma), [MONDO:0001093](http://purl.obolibrary.org/obo/MONDO_0001093) (colonic lymphangioma), [MONDO:0015297](http://purl.obolibrary.org/obo/MONDO_0015297) (microcephaly-digital anomalies-intellectual disability syndrome), [MONDO:0015298](http://purl.obolibrary.org/obo/MONDO_0015298) (Pellucid marginal degeneration), [MONDO:0015293](http://purl.obolibrary.org/obo/MONDO_0015293) (segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome), [MONDO:0015292](http://purl.obolibrary.org/obo/MONDO_0015292) (endotheliitis), [MONDO:0015295](http://purl.obolibrary.org/obo/MONDO_0015295) (intractable diarrhea-choanal atresia-eye anomalies syndrome), [MONDO:0015291](http://purl.obolibrary.org/obo/MONDO_0015291) (stromal keratitis), [MONDO:0015290](http://purl.obolibrary.org/obo/MONDO_0015290) (neurotrophic keratopathy), [MONDO:0015289](http://purl.obolibrary.org/obo/MONDO_0015289) (infectious epithelial keratitis), [MONDO:0015286](http://purl.obolibrary.org/obo/MONDO_0015286) (congenital disorder of glycosylation), [MONDO:0015288](http://purl.obolibrary.org/obo/MONDO_0015288) (herpes simplex virus keratitis), [MONDO:0015281](http://purl.obolibrary.org/obo/MONDO_0015281) (atrial standstill), [MONDO:0015284](http://purl.obolibrary.org/obo/MONDO_0015284) (heart-hand syndrome type 2), [MONDO:0015283](http://purl.obolibrary.org/obo/MONDO_0015283) (maternally-inherited cardiomyopathy and hearing loss), [MONDO:0015280](http://purl.obolibrary.org/obo/MONDO_0015280) (cardiofaciocutaneous syndrome), [MONDO:0005905](http://purl.obolibrary.org/obo/MONDO_0005905) (periodic limb movement disorder), [MONDO:0005902](http://purl.obolibrary.org/obo/MONDO_0005902) (peanut allergic reaction), [MONDO:0017931](http://purl.obolibrary.org/obo/MONDO_0017931) (hereditary inclusion body myopathy type 4), [MONDO:0017932](http://purl.obolibrary.org/obo/MONDO_0017932) (muscular hypertrophy-hepatomegaly-polyhydramnios syndrome), [MONDO:0016601](http://purl.obolibrary.org/obo/MONDO_0016601) (adult-onset citrullinemia type i), [MONDO:0016600](http://purl.obolibrary.org/obo/MONDO_0016600) (acute neonatal citrullinemia type i), [MONDO:0017930](http://purl.obolibrary.org/obo/MONDO_0017930) (mixed sclerosing bone dystrophy with extra-skeletal manifestations), [MONDO:0004617](http://purl.obolibrary.org/obo/MONDO_0004617) (recurrent hypersomnia), [MONDO:0004614](http://purl.obolibrary.org/obo/MONDO_0004614) (chronic monocytic leukemia), [MONDO:0004615](http://purl.obolibrary.org/obo/MONDO_0004615) (upper gum cancer), [MONDO:0004611](http://purl.obolibrary.org/obo/MONDO_0004611) (soft palate cancer), [MONDO:0005941](http://purl.obolibrary.org/obo/MONDO_0005941) (retroperitoneal cancer), [MONDO:0016607](http://purl.obolibrary.org/obo/MONDO_0016607) (Odontohypophosphatasia), [MONDO:0017939](http://purl.obolibrary.org/obo/MONDO_0017939) (classic multiminicore myopathy), [MONDO:0016606](http://purl.obolibrary.org/obo/MONDO_0016606) (Prenatal benign hypophosphatasia), [MONDO:0017937](http://purl.obolibrary.org/obo/MONDO_0017937) (autosomal dominant intermediate Charcot-Marie-tooth disease with neuropathic pain), [MONDO:0016609](http://purl.obolibrary.org/obo/MONDO_0016609) (inflammatory myopathy with abundant macrophages), [MONDO:0017938](http://purl.obolibrary.org/obo/MONDO_0017938) (X-linked cleft palate with or without ankyloglossia), [MONDO:0016603](http://purl.obolibrary.org/obo/MONDO_0016603) (citrullinemia type II), [MONDO:0017935](http://purl.obolibrary.org/obo/MONDO_0017935) (hyperinsulinism due to HNF1A deficiency), [MONDO:0017936](http://purl.obolibrary.org/obo/MONDO_0017936) (benign Samaritan congenital myopathy), [MONDO:0016602](http://purl.obolibrary.org/obo/MONDO_0016602) (citrin deficiency), [MONDO:0017933](http://purl.obolibrary.org/obo/MONDO_0017933) (hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation), [MONDO:0016605](http://purl.obolibrary.org/obo/MONDO_0016605) (perinatal lethal hypophosphatasia), [MONDO:0017934](http://purl.obolibrary.org/obo/MONDO_0017934) (Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome), [MONDO:0016604](http://purl.obolibrary.org/obo/MONDO_0016604) (dysraphism-cleft lip/palate-limb reduction defects syndrome), [MONDO:0017920](http://purl.obolibrary.org/obo/MONDO_0017920) (deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome), [MONDO:0017921](http://purl.obolibrary.org/obo/MONDO_0017921) (hearing loss-familial salivary gland insensitivity to aldosterone syndrome), [MONDO:0005959](http://purl.obolibrary.org/obo/MONDO_0005959) (sick building syndrome), [MONDO:0004626](http://purl.obolibrary.org/obo/MONDO_0004626) (Hodgkin's paragranuloma), [MONDO:0004623](http://purl.obolibrary.org/obo/MONDO_0004623) (prostate carcinoma in situ), [MONDO:0004624](http://purl.obolibrary.org/obo/MONDO_0004624) (uvula cancer), [MONDO:0005953](http://purl.obolibrary.org/obo/MONDO_0005953) (scirrhous adenocarcinoma), [MONDO:0004621](http://purl.obolibrary.org/obo/MONDO_0004621) (upper lip cancer), [MONDO:0004620](http://purl.obolibrary.org/obo/MONDO_0004620) (Hodgkin's lymphoma, lymphocytic depletion), [MONDO:0017929](http://purl.obolibrary.org/obo/MONDO_0017929) (congenital achiasma), [MONDO:0017926](http://purl.obolibrary.org/obo/MONDO_0017926) (multiple paragangliomas associated with polycythemia), [MONDO:0017927](http://purl.obolibrary.org/obo/MONDO_0017927) (severe lateral tibial bowing with short stature), [MONDO:0017924](http://purl.obolibrary.org/obo/MONDO_0017924) (central nervous system calcification-deafness-tubular acidosis-anemia syndrome), [MONDO:0017922](http://purl.obolibrary.org/obo/MONDO_0017922) (deafness-onychodystrophy syndrome), [MONDO:0017923](http://purl.obolibrary.org/obo/MONDO_0017923) (multiple synostoses syndrome), [MONDO:0017910](http://purl.obolibrary.org/obo/MONDO_0017910) (Dehydrated hereditary stomatocytosis), [MONDO:0017919](http://purl.obolibrary.org/obo/MONDO_0017919) (bladder exstrophy-epispadias-cloacal exstrophy complex), [MONDO:0017911](http://purl.obolibrary.org/obo/MONDO_0017911) (cleft lip/palate-ectodermal dysplasia syndrome), [MONDO:0004607](http://purl.obolibrary.org/obo/MONDO_0004607) (vallecula cancer), [MONDO:0004608](http://purl.obolibrary.org/obo/MONDO_0004608) (oropharynx cancer), [MONDO:0005937](http://purl.obolibrary.org/obo/MONDO_0005937) (REM sleep behavior disorder), [MONDO:0004604](http://purl.obolibrary.org/obo/MONDO_0004604) (Hodgkin's lymphoma, lymphocytic-histiocytic predominance), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0004600](http://purl.obolibrary.org/obo/MONDO_0004600) (monocytic leukemia), [MONDO:0017909](http://purl.obolibrary.org/obo/MONDO_0017909) (glutathione synthetase deficiency), [MONDO:0017906](http://purl.obolibrary.org/obo/MONDO_0017906) (amyloidosis cutis dyschromia), [MONDO:0017907](http://purl.obolibrary.org/obo/MONDO_0017907) (primary lymphoma of the conjunctiva), [MONDO:0017904](http://purl.obolibrary.org/obo/MONDO_0017904) (steroid dehydrogenase deficiency-dental anomalies syndrome), [MONDO:0017975](http://purl.obolibrary.org/obo/MONDO_0017975) (sex chromosome disorder of sex development), [MONDO:0016643](http://purl.obolibrary.org/obo/MONDO_0016643) (frontonasal dysplasia), [MONDO:0016642](http://purl.obolibrary.org/obo/MONDO_0016642) (meningioma (disease)), [MONDO:0017973](http://purl.obolibrary.org/obo/MONDO_0017973) (non-classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0016645](http://purl.obolibrary.org/obo/MONDO_0016645) (rare neoplastic disease), [MONDO:0016644](http://purl.obolibrary.org/obo/MONDO_0016644) (Logopenic progressive aphasia), [MONDO:0017971](http://purl.obolibrary.org/obo/MONDO_0017971) (46,XY disorder of sex development due to a cholesterol synthesis defect), [MONDO:0017972](http://purl.obolibrary.org/obo/MONDO_0017972) (classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0016641](http://purl.obolibrary.org/obo/MONDO_0016641) (limb transversal defect-cardiac anomaly syndrome), [MONDO:0015310](http://purl.obolibrary.org/obo/MONDO_0015310) (syndromic optic nerve hypoplasia), [MONDO:0016640](http://purl.obolibrary.org/obo/MONDO_0016640) (fibrous dysplasia of bone), [MONDO:0017970](http://purl.obolibrary.org/obo/MONDO_0017970) (46,XY disorder of sex development due to impaired androgen production), [MONDO:0004658](http://purl.obolibrary.org/obo/MONDO_0004658) (breast carcinoma in situ), [MONDO:0003327](http://purl.obolibrary.org/obo/MONDO_0003327) (peripheral ganglioneuroblastoma), [MONDO:0003328](http://purl.obolibrary.org/obo/MONDO_0003328) (fallopian tube adenomatoid tumor), [MONDO:0004659](http://purl.obolibrary.org/obo/MONDO_0004659) (eye carcinoma in situ), [MONDO:0003325](http://purl.obolibrary.org/obo/MONDO_0003325) (nodular ganglioneuroblastoma), [MONDO:0004657](http://purl.obolibrary.org/obo/MONDO_0004657) (disseminated chorioretinitis), [MONDO:0003326](http://purl.obolibrary.org/obo/MONDO_0003326) (intermixed schwannian stroma-rich ganglioneuroblastoma), [MONDO:0003323](http://purl.obolibrary.org/obo/MONDO_0003323) (cervical wilms' tumor), [MONDO:0003324](http://purl.obolibrary.org/obo/MONDO_0003324) (stromal predominant kidney wilms' tumor), [MONDO:0003321](http://purl.obolibrary.org/obo/MONDO_0003321) (hereditary wilms' tumor), [MONDO:0004653](http://purl.obolibrary.org/obo/MONDO_0004653) (subacute myeloid leukemia), [MONDO:0003322](http://purl.obolibrary.org/obo/MONDO_0003322) (epithelial predominant wilms' tumor), [MONDO:0004650](http://purl.obolibrary.org/obo/MONDO_0004650) (malignant carotid body paraganglioma), [MONDO:0003320](http://purl.obolibrary.org/obo/MONDO_0003320) (blastema predominant kidney wilms' tumor), [MONDO:0015319](http://purl.obolibrary.org/obo/MONDO_0015319) (rare disease with Pierre robin syndrome), [MONDO:0017979](http://purl.obolibrary.org/obo/MONDO_0017979) (autoimmune lymphoproliferative syndrome), [MONDO:0016647](http://purl.obolibrary.org/obo/MONDO_0016647) (autosomal recessive Stickler syndrome), [MONDO:0016646](http://purl.obolibrary.org/obo/MONDO_0016646) (autosomal dominant optic atrophy and peripheral neuropathy), [MONDO:0016649](http://purl.obolibrary.org/obo/MONDO_0016649) (Warburg micro syndrome), [MONDO:0015318](http://purl.obolibrary.org/obo/MONDO_0015318) (Pierre robin syndrome associated with collagen disease), [MONDO:0016648](http://purl.obolibrary.org/obo/MONDO_0016648) (multiple epiphyseal dysplasia (disease)), [MONDO:0015317](http://purl.obolibrary.org/obo/MONDO_0015317) (Laryngotracheal angioma), [MONDO:0015301](http://purl.obolibrary.org/obo/MONDO_0015301) (primary cutaneous amyloidosis), [MONDO:0016632](http://purl.obolibrary.org/obo/MONDO_0016632) (rare thrombotic disorder due to a coagulation factors defect), [MONDO:0017965](http://purl.obolibrary.org/obo/MONDO_0017965) (syndrome with 46,XX disorder of sex development), [MONDO:0015300](http://purl.obolibrary.org/obo/MONDO_0015300) (cataract-microcornea syndrome), [MONDO:0016631](http://purl.obolibrary.org/obo/MONDO_0016631) (rare hemorrhagic disorder due to an acquired platelet anomaly), [MONDO:0017962](http://purl.obolibrary.org/obo/MONDO_0017962) (46,XX disorder of sex development induced by fetoplacental androgens excess), [MONDO:0015303](http://purl.obolibrary.org/obo/MONDO_0015303) (macular amyloidosis), [MONDO:0016634](http://purl.obolibrary.org/obo/MONDO_0016634) (rare thrombotic disorder due to an acquired coagulation factors defect), [MONDO:0015302](http://purl.obolibrary.org/obo/MONDO_0015302) (nodular cutaneous amyloidosis), [MONDO:0016633](http://purl.obolibrary.org/obo/MONDO_0016633) (rare thrombotic disorder due to a constitutional coagulation factors defect), [MONDO:0017961](http://purl.obolibrary.org/obo/MONDO_0017961) (46,XX disorder of gonadal development), [MONDO:0016630](http://purl.obolibrary.org/obo/MONDO_0016630) (isolated delta-storage pool disease), [MONDO:0004669](http://purl.obolibrary.org/obo/MONDO_0004669) (salivary gland cancer), [MONDO:0004667](http://purl.obolibrary.org/obo/MONDO_0004667) (sublingual gland cancer), [MONDO:0004665](http://purl.obolibrary.org/obo/MONDO_0004665) (Hodgkin's lymphoma, nodular sclerosis), [MONDO:0004663](http://purl.obolibrary.org/obo/MONDO_0004663) (colon carcinoma in situ), [MONDO:0003332](http://purl.obolibrary.org/obo/MONDO_0003332) (malignant struma ovarii), [MONDO:0003333](http://purl.obolibrary.org/obo/MONDO_0003333) (benign struma ovarii), [MONDO:0002003](http://purl.obolibrary.org/obo/MONDO_0002003) (papilledema), [MONDO:0004661](http://purl.obolibrary.org/obo/MONDO_0004661) (trachea carcinoma in situ), [MONDO:0003331](http://purl.obolibrary.org/obo/MONDO_0003331) (ovarian monodermal teratoma), [MONDO:0004660](http://purl.obolibrary.org/obo/MONDO_0004660) (lung carcinoma in situ), [MONDO:0015308](http://purl.obolibrary.org/obo/MONDO_0015308) (laminopathy type Decaudain-Vigouroux), [MONDO:0017968](http://purl.obolibrary.org/obo/MONDO_0017968) (46,XY ovotesticular disorder of sex development), [MONDO:0016636](http://purl.obolibrary.org/obo/MONDO_0016636) (rare thrombotic disorder due to a constitutional platelet anomaly), [MONDO:0016635](http://purl.obolibrary.org/obo/MONDO_0016635) (rare thrombotic disorder due to a platelet anomaly), [MONDO:0017966](http://purl.obolibrary.org/obo/MONDO_0017966) (46,XY disorder of gonadal development), [MONDO:0016638](http://purl.obolibrary.org/obo/MONDO_0016638) (familial hypodysfibrinogenemia), [MONDO:0015307](http://purl.obolibrary.org/obo/MONDO_0015307) (Madras motor neuron disease), [MONDO:0016637](http://purl.obolibrary.org/obo/MONDO_0016637) (rare thrombotic disorder due to an acquired platelet anomaly), [MONDO:0017967](http://purl.obolibrary.org/obo/MONDO_0017967) (testicular agenesis), [MONDO:0016621](http://purl.obolibrary.org/obo/MONDO_0016621) (juvenile Huntington disease), [MONDO:0016620](http://purl.obolibrary.org/obo/MONDO_0016620) (primary hypertrophic osteoarthropathy), [MONDO:0017951](http://purl.obolibrary.org/obo/MONDO_0017951) (trichorhinophalangeal syndrome), [MONDO:0016623](http://purl.obolibrary.org/obo/MONDO_0016623) (rare deficiency anemia), [MONDO:0016622](http://purl.obolibrary.org/obo/MONDO_0016622) (Melhem-Fahl syndrome), [MONDO:0017950](http://purl.obolibrary.org/obo/MONDO_0017950) (microcephalic primordial dwarfism), [MONDO:0004638](http://purl.obolibrary.org/obo/MONDO_0004638) (lymphosarcoma), [MONDO:0003307](http://purl.obolibrary.org/obo/MONDO_0003307) (multiple mucosal neuroma), [MONDO:0003308](http://purl.obolibrary.org/obo/MONDO_0003308) (pleural mesothelioma), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0003305](http://purl.obolibrary.org/obo/MONDO_0003305) (cellular neurofibroma), [MONDO:0004637](http://purl.obolibrary.org/obo/MONDO_0004637) (aryepiglottic fold cancer), [MONDO:0003306](http://purl.obolibrary.org/obo/MONDO_0003306) (atypical neurofibroma), [MONDO:0003303](http://purl.obolibrary.org/obo/MONDO_0003303) (neurofibroma of gallbladder), [MONDO:0005966](http://purl.obolibrary.org/obo/MONDO_0005966) (spleen cancer), [MONDO:0004635](http://purl.obolibrary.org/obo/MONDO_0004635) (postcricoid region cancer), [MONDO:0003304](http://purl.obolibrary.org/obo/MONDO_0003304) (plexiform neurofibroma (disease)), [MONDO:0003301](http://purl.obolibrary.org/obo/MONDO_0003301) (dartoic leiomyoma), [MONDO:0004632](http://purl.obolibrary.org/obo/MONDO_0004632) (Hodgkin's granuloma), [MONDO:0003302](http://purl.obolibrary.org/obo/MONDO_0003302) (epithelioid neurofibroma), [MONDO:0004633](http://purl.obolibrary.org/obo/MONDO_0004633) (Hodgkin's lymphoma, mixed cellularity), [MONDO:0004631](http://purl.obolibrary.org/obo/MONDO_0004631) (tongue cancer), [MONDO:0003300](http://purl.obolibrary.org/obo/MONDO_0003300) (appendix leiomyoma), [MONDO:0016629](http://purl.obolibrary.org/obo/MONDO_0016629) (rare hemorrhagic disorder due to a platelet anomaly), [MONDO:0016628](http://purl.obolibrary.org/obo/MONDO_0016628) (rare hemorrhagic disorder due to a coagulation factors defect), [MONDO:0016625](http://purl.obolibrary.org/obo/MONDO_0016625) (rare acquired deficiency anemia), [MONDO:0016624](http://purl.obolibrary.org/obo/MONDO_0016624) (constitutional deficiency anemia), [MONDO:0016627](http://purl.obolibrary.org/obo/MONDO_0016627) (rare hemorrhagic disorder), [MONDO:0016626](http://purl.obolibrary.org/obo/MONDO_0016626) (hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase deficiency), [MONDO:0016610](http://purl.obolibrary.org/obo/MONDO_0016610) (idiopathic eosinophilic myositis), [MONDO:0017943](http://purl.obolibrary.org/obo/MONDO_0017943) (autoerythrocyte sensitization syndrome), [MONDO:0017940](http://purl.obolibrary.org/obo/MONDO_0017940) (autosomal dominant Charcot-Marie-tooth disease type 2 due to KIF5A mutation), [MONDO:0016611](http://purl.obolibrary.org/obo/MONDO_0016611) (Lipoblastoma), [MONDO:0003318](http://purl.obolibrary.org/obo/MONDO_0003318) (mixed cell type kidney wilms' tumor), [MONDO:0003319](http://purl.obolibrary.org/obo/MONDO_0003319) (scrotum neoplasm), [MONDO:0003316](http://purl.obolibrary.org/obo/MONDO_0003316) (renal wilms' tumor), [MONDO:0004647](http://purl.obolibrary.org/obo/MONDO_0004647) (in situ carcinoma), [MONDO:0003317](http://purl.obolibrary.org/obo/MONDO_0003317) (metachronous kidney wilms' tumor), [MONDO:0004645](http://purl.obolibrary.org/obo/MONDO_0004645) (cheek mucosa cancer), [MONDO:0003314](http://purl.obolibrary.org/obo/MONDO_0003314) (endometrioid stromal and related neoplasms of the vagina), [MONDO:0003315](http://purl.obolibrary.org/obo/MONDO_0003315) (endometrium carcinoma in situ), [MONDO:0004643](http://purl.obolibrary.org/obo/MONDO_0004643) (myeloid leukemia), [MONDO:0003312](http://purl.obolibrary.org/obo/MONDO_0003312) (ovarian endometrioid stromal and related neoplasms), [MONDO:0003313](http://purl.obolibrary.org/obo/MONDO_0003313) (endometrioid stromal sarcoma of the vagina), [MONDO:0004644](http://purl.obolibrary.org/obo/MONDO_0004644) (subacute monocytic leukemia), [MONDO:0004641](http://purl.obolibrary.org/obo/MONDO_0004641) (skin carcinoma in situ), [MONDO:0004642](http://purl.obolibrary.org/obo/MONDO_0004642) (tonsillar pillar cancer), [MONDO:0003311](http://purl.obolibrary.org/obo/MONDO_0003311) (endometrial stromal tumor), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0017948](http://purl.obolibrary.org/obo/MONDO_0017948) (ABetaA21G amyloidosis), [MONDO:0016619](http://purl.obolibrary.org/obo/MONDO_0016619) (autosomal recessive hypohidrotic ectodermal dysplasia), [MONDO:0017949](http://purl.obolibrary.org/obo/MONDO_0017949) (ABeta amyloidosis, Arctic type), [MONDO:0017946](http://purl.obolibrary.org/obo/MONDO_0017946) (ABeta amyloidosis, Iowa type), [MONDO:0016614](http://purl.obolibrary.org/obo/MONDO_0016614) (autosomal recessive ataxia due to PEX10 deficiency), [MONDO:0016613](http://purl.obolibrary.org/obo/MONDO_0016613) (APC-related attenuated familial adenomatous polyposis), [MONDO:0017947](http://purl.obolibrary.org/obo/MONDO_0017947) (ABeta amyloidosis, Italian type), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0017945](http://purl.obolibrary.org/obo/MONDO_0017945) (ABetaL34V amyloidosis), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0016687](http://purl.obolibrary.org/obo/MONDO_0016687) (protoplasmic astrocytoma), [MONDO:0015356](http://purl.obolibrary.org/obo/MONDO_0015356) (hereditary neoplastic syndrome), [MONDO:0016686](http://purl.obolibrary.org/obo/MONDO_0016686) (diffuse astrocytoma), [MONDO:0014025](http://purl.obolibrary.org/obo/MONDO_0014025) (lower motor neuron syndrome with late-adult onset), [MONDO:0015355](http://purl.obolibrary.org/obo/MONDO_0015355) (distal hereditary motor neuropathy type 7), [MONDO:0014026](http://purl.obolibrary.org/obo/MONDO_0014026) (congenital stationary night blindness 1F), [MONDO:0016689](http://purl.obolibrary.org/obo/MONDO_0016689) (gemistocytic astrocytoma), [MONDO:0016688](http://purl.obolibrary.org/obo/MONDO_0016688) (fibrillary astrocytoma), [MONDO:0016683](http://purl.obolibrary.org/obo/MONDO_0016683) (gliomatosis cerebri), [MONDO:0014020](http://purl.obolibrary.org/obo/MONDO_0014020) (hereditary spastic paraplegia 55), [MONDO:0015352](http://purl.obolibrary.org/obo/MONDO_0015352) (distal hereditary motor neuropathy type 2), [MONDO:0015351](http://purl.obolibrary.org/obo/MONDO_0015351) (neuropathy with hearing impairment), [MONDO:0016682](http://purl.obolibrary.org/obo/MONDO_0016682) (giant cell glioblastoma), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0016685](http://purl.obolibrary.org/obo/MONDO_0016685) (low-grade astrocytoma), [MONDO:0015353](http://purl.obolibrary.org/obo/MONDO_0015353) (distal hereditary motor neuropathy type 5), [MONDO:0014023](http://purl.obolibrary.org/obo/MONDO_0014023) (congenital muscular dystrophy with intellectual disability and severe epilepsy), [MONDO:0016684](http://purl.obolibrary.org/obo/MONDO_0016684) (anaplastic astrocytoma), [MONDO:0016681](http://purl.obolibrary.org/obo/MONDO_0016681) (gliosarcoma), [MONDO:0016680](http://purl.obolibrary.org/obo/MONDO_0016680) (high grade astrocytic tumor), [MONDO:0002038](http://purl.obolibrary.org/obo/MONDO_0002038) (head and neck carcinoma), [MONDO:0003369](http://purl.obolibrary.org/obo/MONDO_0003369) (vagina leiomyosarcoma), [MONDO:0002035](http://purl.obolibrary.org/obo/MONDO_0002035) (colon lymphoma), [MONDO:0004698](http://purl.obolibrary.org/obo/MONDO_0004698) (intestine carcinoma in situ), [MONDO:0003367](http://purl.obolibrary.org/obo/MONDO_0003367) (gastric leiomyosarcoma (disease)), [MONDO:0002034](http://purl.obolibrary.org/obo/MONDO_0002034) (cecum lymphoma), [MONDO:0003368](http://purl.obolibrary.org/obo/MONDO_0003368) (prostate leiomyosarcoma), [MONDO:0004699](http://purl.obolibrary.org/obo/MONDO_0004699) (gastrointestinal lymphoma), [MONDO:0003365](http://purl.obolibrary.org/obo/MONDO_0003365) (esophagus leiomyosarcoma), [MONDO:0004696](http://purl.obolibrary.org/obo/MONDO_0004696) (larynx carcinoma in situ), [MONDO:0003363](http://purl.obolibrary.org/obo/MONDO_0003363) (malignant dermis tumor), [MONDO:0004695](http://purl.obolibrary.org/obo/MONDO_0004695) (liver lymphoma), [MONDO:0003364](http://purl.obolibrary.org/obo/MONDO_0003364) (gallbladder leiomyosarcoma), [MONDO:0002033](http://purl.obolibrary.org/obo/MONDO_0002033) (cecum cancer), [MONDO:0003361](http://purl.obolibrary.org/obo/MONDO_0003361) (small intestinal sarcoma), [MONDO:0002032](http://purl.obolibrary.org/obo/MONDO_0002032) (colon carcinoma), [MONDO:0003362](http://purl.obolibrary.org/obo/MONDO_0003362) (cutaneous leiomyosarcoma (disease)), [MONDO:0004693](http://purl.obolibrary.org/obo/MONDO_0004693) (cervix uteri carcinoma in situ), [MONDO:0004690](http://purl.obolibrary.org/obo/MONDO_0004690) (tonsillar fossa cancer), [MONDO:0003360](http://purl.obolibrary.org/obo/MONDO_0003360) (small intestine leiomyosarcoma), [MONDO:0014028](http://purl.obolibrary.org/obo/MONDO_0014028) (distal arthrogryposis type 5D), [MONDO:0015359](http://purl.obolibrary.org/obo/MONDO_0015359) (autosomal dominant hereditary demyelinating motor and sensory neuropathy), [MONDO:0014029](http://purl.obolibrary.org/obo/MONDO_0014029) (osteogenesis imperfecta type 14), [MONDO:0016676](http://purl.obolibrary.org/obo/MONDO_0016676) (recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome), [MONDO:0014013](http://purl.obolibrary.org/obo/MONDO_0014013) (maternal riboflavin deficiency), [MONDO:0016675](http://purl.obolibrary.org/obo/MONDO_0016675) (distal arthrogryposis type 10), [MONDO:0015341](http://purl.obolibrary.org/obo/MONDO_0015341) (congenital panfollicular nevus (disease)), [MONDO:0016672](http://purl.obolibrary.org/obo/MONDO_0016672) (hereditary persistence of fetal hemoglobin-sickle cell disease syndrome), [MONDO:0016671](http://purl.obolibrary.org/obo/MONDO_0016671) (sickle cell-hemoglobin E disease syndrome), [MONDO:0015340](http://purl.obolibrary.org/obo/MONDO_0015340) (drug rash with eosinophilia and systemic symptoms), [MONDO:0016674](http://purl.obolibrary.org/obo/MONDO_0016674) (46,XY partial gonadal dysgenesis), [MONDO:0014012](http://purl.obolibrary.org/obo/MONDO_0014012) (Charcot-Marie-tooth disease axonal type 2Q), [MONDO:0016673](http://purl.obolibrary.org/obo/MONDO_0016673) (localized junctional epidermolysis bullosa, non-Herlitz type), [MONDO:0016670](http://purl.obolibrary.org/obo/MONDO_0016670) (sickle cell-hemoglobin d disease syndrome), [MONDO:0003378](http://purl.obolibrary.org/obo/MONDO_0003378) (liver leiomyosarcoma), [MONDO:0003379](http://purl.obolibrary.org/obo/MONDO_0003379) (rectum leiomyosarcoma), [MONDO:0003376](http://purl.obolibrary.org/obo/MONDO_0003376) (mediastinum leiomyosarcoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0002047](http://purl.obolibrary.org/obo/MONDO_0002047) (pulmonary systemic sclerosis), [MONDO:0002042](http://purl.obolibrary.org/obo/MONDO_0002042) (mechanical ectropion), [MONDO:0003374](http://purl.obolibrary.org/obo/MONDO_0003374) (larynx leiomyosarcoma), [MONDO:0003372](http://purl.obolibrary.org/obo/MONDO_0003372) (vulvar leiomyosarcoma), [MONDO:0002044](http://purl.obolibrary.org/obo/MONDO_0002044) (spastic ectropion), [MONDO:0003373](http://purl.obolibrary.org/obo/MONDO_0003373) (kidney leiomyosarcoma), [MONDO:0002043](http://purl.obolibrary.org/obo/MONDO_0002043) (ectropion (disease)), [MONDO:0003370](http://purl.obolibrary.org/obo/MONDO_0003370) (retroperitoneal leiomyosarcoma), [MONDO:0003371](http://purl.obolibrary.org/obo/MONDO_0003371) (breast leiomyosarcoma), [MONDO:0016679](http://purl.obolibrary.org/obo/MONDO_0016679) (rare tumor of neuroepithelial tissue), [MONDO:0017997](http://purl.obolibrary.org/obo/MONDO_0017997) (telecanthus-hypertelorism-strabismus-pes cavus syndrome), [MONDO:0015333](http://purl.obolibrary.org/obo/MONDO_0015333) (progeroid syndrome), [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0017995](http://purl.obolibrary.org/obo/MONDO_0017995) (spondylocostal dysostosis-hypospadias-intellectual disability syndrome), [MONDO:0016667](http://purl.obolibrary.org/obo/MONDO_0016667) (sickle cell disease associated with an other hemoglobin anomaly), [MONDO:0015335](http://purl.obolibrary.org/obo/MONDO_0015335) (orofacial clefting syndrome), [MONDO:0014005](http://purl.obolibrary.org/obo/MONDO_0014005) (immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0017996](http://purl.obolibrary.org/obo/MONDO_0017996) (blepharophimosis-intellectual disability syndrome due to UBE3B deficiency), [MONDO:0016660](http://purl.obolibrary.org/obo/MONDO_0016660) (autosomal recessive primary microcephaly), [MONDO:0017994](http://purl.obolibrary.org/obo/MONDO_0017994) (severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency), [MONDO:0015332](http://purl.obolibrary.org/obo/MONDO_0015332) (rare developmental defect with connective tissue involvement), [MONDO:0016663](http://purl.obolibrary.org/obo/MONDO_0016663) (overlapping connective tissue disease), [MONDO:0014001](http://purl.obolibrary.org/obo/MONDO_0014001) (Usher syndrome type 1K), [MONDO:0017992](http://purl.obolibrary.org/obo/MONDO_0017992) (autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis), [MONDO:0015331](http://purl.obolibrary.org/obo/MONDO_0015331) (malformation syndrome with skin/mucosae involvement), [MONDO:0017990](http://purl.obolibrary.org/obo/MONDO_0017990) (catecholaminergic polymorphic ventricular tachycardia), [MONDO:0003349](http://purl.obolibrary.org/obo/MONDO_0003349) (central nervous system leiomyosarcoma), [MONDO:0003347](http://purl.obolibrary.org/obo/MONDO_0003347) (inflammatory leiomyosarcoma), [MONDO:0003348](http://purl.obolibrary.org/obo/MONDO_0003348) (conventional leiomyosarcoma), [MONDO:0003345](http://purl.obolibrary.org/obo/MONDO_0003345) (hilar cholangiocarcinoma), [MONDO:0002013](http://purl.obolibrary.org/obo/MONDO_0002013) (lymphangioma), [MONDO:0002012](http://purl.obolibrary.org/obo/MONDO_0002012) (methylmalonic acidemia), [MONDO:0003343](http://purl.obolibrary.org/obo/MONDO_0003343) (retinal hemangioblastoma), [MONDO:0004674](http://purl.obolibrary.org/obo/MONDO_0004674) (chorioretinitis (disease)), [MONDO:0002014](http://purl.obolibrary.org/obo/MONDO_0002014) (autosomal recessive Ehlers-Danlos syndrome, vascular type), [MONDO:0004675](http://purl.obolibrary.org/obo/MONDO_0004675) (mitochondrial encephalomyopathy), [MONDO:0003341](http://purl.obolibrary.org/obo/MONDO_0003341) (subungual glomus tumor), [MONDO:0003342](http://purl.obolibrary.org/obo/MONDO_0003342) (benign perivascular tumor), [MONDO:0004673](http://purl.obolibrary.org/obo/MONDO_0004673) (lower lip cancer), [MONDO:0004670](http://purl.obolibrary.org/obo/MONDO_0004670) (lupus erythematosus), [MONDO:0003340](http://purl.obolibrary.org/obo/MONDO_0003340) (malignant glomus tumor), [MONDO:0004671](http://purl.obolibrary.org/obo/MONDO_0004671) (penis carcinoma in situ), [MONDO:0016669](http://purl.obolibrary.org/obo/MONDO_0016669) (sickle cell-hemoglobin c disease syndrome), [MONDO:0015338](http://purl.obolibrary.org/obo/MONDO_0015338) (syndromic craniosynostosis), [MONDO:0014006](http://purl.obolibrary.org/obo/MONDO_0014006) (intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome), [MONDO:0015337](http://purl.obolibrary.org/obo/MONDO_0015337) (isolated craniosynostosis), [MONDO:0016668](http://purl.obolibrary.org/obo/MONDO_0016668) (sickle cell-beta-thalassemia disease syndrome), [MONDO:0014007](http://purl.obolibrary.org/obo/MONDO_0014007) (Aicardi-Goutieres syndrome 6), [MONDO:0017999](http://purl.obolibrary.org/obo/MONDO_0017999) (fatty acid hydroxylase-associated neurodegeneration), [MONDO:0015339](http://purl.obolibrary.org/obo/MONDO_0015339) (adrenomyeloneuropathy), [MONDO:0015323](http://purl.obolibrary.org/obo/MONDO_0015323) (Teratogenic Pierre robin syndrome), [MONDO:0017986](http://purl.obolibrary.org/obo/MONDO_0017986) (disorder of plasmalogens biosynthesis), [MONDO:0015322](http://purl.obolibrary.org/obo/MONDO_0015322) (Pierre robin syndrome associated with bone disease), [MONDO:0017984](http://purl.obolibrary.org/obo/MONDO_0017984) (familial lambdoid synostosis), [MONDO:0015325](http://purl.obolibrary.org/obo/MONDO_0015325) (cataract-deafness-hypogonadism syndrome), [MONDO:0015324](http://purl.obolibrary.org/obo/MONDO_0015324) (cataract-intellectual disability-anal atresia-urinary defects syndrome), [MONDO:0017985](http://purl.obolibrary.org/obo/MONDO_0017985) (congenital radioulnar synostosis), [MONDO:0017983](http://purl.obolibrary.org/obo/MONDO_0017983) (Humero-radio-ulnar synostosis), [MONDO:0015321](http://purl.obolibrary.org/obo/MONDO_0015321) (Pierre robin syndrome associated with branchial archs anomalies), [MONDO:0017980](http://purl.obolibrary.org/obo/MONDO_0017980) (syngnathia multiple anomalies), [MONDO:0015320](http://purl.obolibrary.org/obo/MONDO_0015320) (Pierre robin syndrome associated with a chromosomal anomaly), [MONDO:0017981](http://purl.obolibrary.org/obo/MONDO_0017981) (syngnathia-cleft palate syndrome), [MONDO:0003358](http://purl.obolibrary.org/obo/MONDO_0003358) (anus leiomyosarcoma), [MONDO:0004689](http://purl.obolibrary.org/obo/MONDO_0004689) (metal metabolism disorder), [MONDO:0003359](http://purl.obolibrary.org/obo/MONDO_0003359) (myxoid leiomyosarcoma), [MONDO:0003356](http://purl.obolibrary.org/obo/MONDO_0003356) (epithelioid leiomyosarcoma), [MONDO:0004687](http://purl.obolibrary.org/obo/MONDO_0004687) (severe nonproliferative diabetic retinopathy), [MONDO:0003357](http://purl.obolibrary.org/obo/MONDO_0003357) (lung leiomyosarcoma), [MONDO:0003354](http://purl.obolibrary.org/obo/MONDO_0003354) (heart sarcoma), [MONDO:0004685](http://purl.obolibrary.org/obo/MONDO_0004685) (Waldeyer's ring cancer), [MONDO:0003355](http://purl.obolibrary.org/obo/MONDO_0003355) (ovary leiomyosarcoma), [MONDO:0004686](http://purl.obolibrary.org/obo/MONDO_0004686) (lattice corneal dystrophy (disease)), [MONDO:0003352](http://purl.obolibrary.org/obo/MONDO_0003352) (colon sarcoma), [MONDO:0004684](http://purl.obolibrary.org/obo/MONDO_0004684) (plantar fibromatosis), [MONDO:0003353](http://purl.obolibrary.org/obo/MONDO_0003353) (heart leiomyosarcoma), [MONDO:0003350](http://purl.obolibrary.org/obo/MONDO_0003350) (granular cell leiomyosarcoma), [MONDO:0003351](http://purl.obolibrary.org/obo/MONDO_0003351) (colon leiomyosarcoma), [MONDO:0004682](http://purl.obolibrary.org/obo/MONDO_0004682) (retromolar area cancer), [MONDO:0004680](http://purl.obolibrary.org/obo/MONDO_0004680) (primary thrombocytopenia), [MONDO:0015327](http://purl.obolibrary.org/obo/MONDO_0015327) (developmental anomaly of metabolic origin), [MONDO:0015326](http://purl.obolibrary.org/obo/MONDO_0015326) (night blindness-skeletal anomalies-dysmorphism syndrome), [MONDO:0017988](http://purl.obolibrary.org/obo/MONDO_0017988) (multifocal atrial tachycardia (disease)), [MONDO:0017989](http://purl.obolibrary.org/obo/MONDO_0017989) (His bundle tachycardia), [MONDO:0014068](http://purl.obolibrary.org/obo/MONDO_0014068) (cone-rod dystrophy 17), [MONDO:0014069](http://purl.obolibrary.org/obo/MONDO_0014069) (syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome), [MONDO:0015399](http://purl.obolibrary.org/obo/MONDO_0015399) (glossopalatine ankylosis), [MONDO:0014064](http://purl.obolibrary.org/obo/MONDO_0014064) (mitochondrial complex III deficiency nuclear type 3), [MONDO:0014065](http://purl.obolibrary.org/obo/MONDO_0014065) (mitochondrial complex III deficiency nuclear type 4), [MONDO:0015398](http://purl.obolibrary.org/obo/MONDO_0015398) (hemifacial microsomia), [MONDO:0014066](http://purl.obolibrary.org/obo/MONDO_0014066) (mitochondrial complex III deficiency nuclear type 5), [MONDO:0015397](http://purl.obolibrary.org/obo/MONDO_0015397) (oculo-auriculo-vertebral spectrum), [MONDO:0014067](http://purl.obolibrary.org/obo/MONDO_0014067) (short ulna-dysmorphism-hypotonia-intellectual disability syndrome), [MONDO:0014060](http://purl.obolibrary.org/obo/MONDO_0014060) (progressive retinal dystrophy due to retinol transport defect), [MONDO:0015392](http://purl.obolibrary.org/obo/MONDO_0015392) (nasal glial heterotopia), [MONDO:0015391](http://purl.obolibrary.org/obo/MONDO_0015391) (nasopharyngeal teratoma), [MONDO:0014061](http://purl.obolibrary.org/obo/MONDO_0014061) (Steel syndrome), [MONDO:0015394](http://purl.obolibrary.org/obo/MONDO_0015394) (nasal encephalocele), [MONDO:0014062](http://purl.obolibrary.org/obo/MONDO_0014062) (mitochondrial DNA deletion syndrome with progressive myopathy), [MONDO:0015393](http://purl.obolibrary.org/obo/MONDO_0015393) (nasal ganglioglioma), [MONDO:0014063](http://purl.obolibrary.org/obo/MONDO_0014063) (mitochondrial complex III deficiency nuclear type 2), [MONDO:0002071](http://purl.obolibrary.org/obo/MONDO_0002071) (supratentorial cancer), [MONDO:0002073](http://purl.obolibrary.org/obo/MONDO_0002073) (malignant pineal area germ cell neoplasm), [MONDO:0002072](http://purl.obolibrary.org/obo/MONDO_0002072) (melanotic neuroectodermal tumor), [MONDO:0014057](http://purl.obolibrary.org/obo/MONDO_0014057) (maple syrup urine disease, mild variant), [MONDO:0014058](http://purl.obolibrary.org/obo/MONDO_0014058) (facial dysmorphism-immunodeficiency-livedo-short stature syndrome), [MONDO:0014059](http://purl.obolibrary.org/obo/MONDO_0014059) (microphthalmia, isolated, with coloboma 9), [MONDO:0015385](http://purl.obolibrary.org/obo/MONDO_0015385) (external auditory canal aplasia/hypoplasia), [MONDO:0014054](http://purl.obolibrary.org/obo/MONDO_0014054) (lymphoproliferative syndrome 2), [MONDO:0015387](http://purl.obolibrary.org/obo/MONDO_0015387) (nasolacrimal duct cyst), [MONDO:0014055](http://purl.obolibrary.org/obo/MONDO_0014055) (FAME4), [MONDO:0015386](http://purl.obolibrary.org/obo/MONDO_0015386) (Epignathus (disease)), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0014050](http://purl.obolibrary.org/obo/MONDO_0014050) (isolated microphthalmia 8), [MONDO:0014051](http://purl.obolibrary.org/obo/MONDO_0014051) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2), [MONDO:0014052](http://purl.obolibrary.org/obo/MONDO_0014052) (congenital myasthenic syndrome 8), [MONDO:0002089](http://purl.obolibrary.org/obo/MONDO_0002089) (retinal vascular occlusion), [MONDO:0002086](http://purl.obolibrary.org/obo/MONDO_0002086) (clear cell acanthoma), [MONDO:0002088](http://purl.obolibrary.org/obo/MONDO_0002088) (partial of retinal vein occlusion), [MONDO:0002087](http://purl.obolibrary.org/obo/MONDO_0002087) (peritoneum cancer), [MONDO:0002082](http://purl.obolibrary.org/obo/MONDO_0002082) (endocrine gland neoplasm), [MONDO:0002084](http://purl.obolibrary.org/obo/MONDO_0002084) (neuroectodermal tumor), [MONDO:0002083](http://purl.obolibrary.org/obo/MONDO_0002083) (Richter's syndrome), [MONDO:0014046](http://purl.obolibrary.org/obo/MONDO_0014046) (Cowden syndrome 4), [MONDO:0014047](http://purl.obolibrary.org/obo/MONDO_0014047) (Cowden syndrome 5), [MONDO:0014048](http://purl.obolibrary.org/obo/MONDO_0014048) (Cowden syndrome 6), [MONDO:0014049](http://purl.obolibrary.org/obo/MONDO_0014049) (urofacial syndrome 2), [MONDO:0014043](http://purl.obolibrary.org/obo/MONDO_0014043) (microcephalic primordial dwarfism due to ZNF335 deficiency), [MONDO:0015373](http://purl.obolibrary.org/obo/MONDO_0015373) (Saldino-Mainzer syndrome), [MONDO:0014044](http://purl.obolibrary.org/obo/MONDO_0014044) (dysmorphism-conductive hearing loss-heart defect syndrome), [MONDO:0015375](http://purl.obolibrary.org/obo/MONDO_0015375) (orofaciodigital syndrome), [MONDO:0014045](http://purl.obolibrary.org/obo/MONDO_0014045) (Cowden syndrome 3), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0014040](http://purl.obolibrary.org/obo/MONDO_0014040) (autosomal recessive osteopetrosis 8), [MONDO:0002057](http://purl.obolibrary.org/obo/MONDO_0002057) (breast leiomyoma), [MONDO:0003389](http://purl.obolibrary.org/obo/MONDO_0003389) (epithelial-myoepithelial carcinoma), [MONDO:0002056](http://purl.obolibrary.org/obo/MONDO_0002056) (breast fibroadenoma), [MONDO:0003387](http://purl.obolibrary.org/obo/MONDO_0003387) (urethra clear cell adenocarcinoma), [MONDO:0002059](http://purl.obolibrary.org/obo/MONDO_0002059) (breast duct papilloma), [MONDO:0002058](http://purl.obolibrary.org/obo/MONDO_0002058) (breast adenoma), [MONDO:0003388](http://purl.obolibrary.org/obo/MONDO_0003388) (ampulla of vater clear cell adenocarcinoma), [MONDO:0003386](http://purl.obolibrary.org/obo/MONDO_0003386) (bladder clear cell adenocarcinoma), [MONDO:0003383](http://purl.obolibrary.org/obo/MONDO_0003383) (fallopian tube clear cell adenocarcinoma), [MONDO:0002055](http://purl.obolibrary.org/obo/MONDO_0002055) (benign eccrine breast spiradenoma), [MONDO:0003384](http://purl.obolibrary.org/obo/MONDO_0003384) (uterine ligament clear cell adenocarcinoma), [MONDO:0003382](http://purl.obolibrary.org/obo/MONDO_0003382) (eyelid disease), [MONDO:0015367](http://purl.obolibrary.org/obo/MONDO_0015367) (Charlie M syndrome), [MONDO:0014035](http://purl.obolibrary.org/obo/MONDO_0014035) (severe intellectual disability-progressive spastic diplegia syndrome), [MONDO:0016698](http://purl.obolibrary.org/obo/MONDO_0016698) (ependymoma), [MONDO:0016697](http://purl.obolibrary.org/obo/MONDO_0016697) (low grade ependymoma), [MONDO:0015369](http://purl.obolibrary.org/obo/MONDO_0015369) (Joubert syndrome and related disorders), [MONDO:0014037](http://purl.obolibrary.org/obo/MONDO_0014037) (spermatogenic failure 11), [MONDO:0014038](http://purl.obolibrary.org/obo/MONDO_0014038) (colorectal cancer, susceptibility to, 12), [MONDO:0016699](http://purl.obolibrary.org/obo/MONDO_0016699) (myxopapillary ependymoma), [MONDO:0015368](http://purl.obolibrary.org/obo/MONDO_0015368) (Neuro-ophthalmological disease), [MONDO:0015363](http://purl.obolibrary.org/obo/MONDO_0015363) (autosomal recessive distal hereditary motor neuropathy), [MONDO:0014031](http://purl.obolibrary.org/obo/MONDO_0014031) (microcephalic primordial dwarfism, Alazami type), [MONDO:0015362](http://purl.obolibrary.org/obo/MONDO_0015362) (autosomal dominant distal hereditary motor neuropathy), [MONDO:0014032](http://purl.obolibrary.org/obo/MONDO_0014032) (brachydactyly type A1C), [MONDO:0016693](http://purl.obolibrary.org/obo/MONDO_0016693) (subependymal giant cell astrocytoma), [MONDO:0016696](http://purl.obolibrary.org/obo/MONDO_0016696) (anaplastic oligodendroglioma), [MONDO:0016695](http://purl.obolibrary.org/obo/MONDO_0016695) (oligodendroglioma), [MONDO:0014034](http://purl.obolibrary.org/obo/MONDO_0014034) (severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome), [MONDO:0016690](http://purl.obolibrary.org/obo/MONDO_0016690) (pleomorphic xanthoastrocytoma), [MONDO:0015361](http://purl.obolibrary.org/obo/MONDO_0015361) (autosomal recessive hereditary demyelinating motor and sensory neuropathy), [MONDO:0016692](http://purl.obolibrary.org/obo/MONDO_0016692) (pilomyxoid astrocytoma), [MONDO:0014030](http://purl.obolibrary.org/obo/MONDO_0014030) (primary ciliary dyskinesia 20), [MONDO:0015360](http://purl.obolibrary.org/obo/MONDO_0015360) (autosomal dominant hereditary axonal motor and sensory neuropathy), [MONDO:0016691](http://purl.obolibrary.org/obo/MONDO_0016691) (pilocytic astrocytoma), [MONDO:0002068](http://purl.obolibrary.org/obo/MONDO_0002068) (female breast lower-inner quadrant cancer), [MONDO:0002067](http://purl.obolibrary.org/obo/MONDO_0002067) (female breast upper-inner quadrant cancer), [MONDO:0003398](http://purl.obolibrary.org/obo/MONDO_0003398) (anterograde amnesia), [MONDO:0003399](http://purl.obolibrary.org/obo/MONDO_0003399) (pineal region yolk sac tumor), [MONDO:0002069](http://purl.obolibrary.org/obo/MONDO_0002069) (female breast axillary tail cancer), [MONDO:0003396](http://purl.obolibrary.org/obo/MONDO_0003396) (epulis), [MONDO:0002063](http://purl.obolibrary.org/obo/MONDO_0002063) (breast papillomatosis), [MONDO:0002066](http://purl.obolibrary.org/obo/MONDO_0002066) (breast adenomyoepithelioma), [MONDO:0003395](http://purl.obolibrary.org/obo/MONDO_0003395) (testicular granulosa cell tumor), [MONDO:0002065](http://purl.obolibrary.org/obo/MONDO_0002065) (benign breast adenomyoepithelioma), [MONDO:0003392](http://purl.obolibrary.org/obo/MONDO_0003392) (fallopian tube germ cell cancer), [MONDO:0002060](http://purl.obolibrary.org/obo/MONDO_0002060) (intraductal papilloma), [MONDO:0002062](http://purl.obolibrary.org/obo/MONDO_0002062) (breast myofibroblastoma), [MONDO:0003390](http://purl.obolibrary.org/obo/MONDO_0003390) (glycogen-rich clear cell breast carcinoma), [MONDO:0003391](http://purl.obolibrary.org/obo/MONDO_0003391) (vulvar alveolar soft part sarcoma), [MONDO:0002061](http://purl.obolibrary.org/obo/MONDO_0002061) (intraductal papillary breast neoplasm), [MONDO:0014039](http://purl.obolibrary.org/obo/MONDO_0014039) (mitochondrial DNA depletion syndrome 11), [MONDO:0014097](http://purl.obolibrary.org/obo/MONDO_0014097) (congenital short bowel syndrome), [MONDO:0014098](http://purl.obolibrary.org/obo/MONDO_0014098) (CIDEC-related familial partial lipodystrophy), [MONDO:0014093](http://purl.obolibrary.org/obo/MONDO_0014093) (retinitis pigmentosa 66), [MONDO:0014094](http://purl.obolibrary.org/obo/MONDO_0014094) (severe congenital hypochromic anemia with ringed sideroblasts), [MONDO:0014096](http://purl.obolibrary.org/obo/MONDO_0014096) (microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome), [MONDO:0014090](http://purl.obolibrary.org/obo/MONDO_0014090) (polydactyly, postaxial, type A6), [MONDO:0014091](http://purl.obolibrary.org/obo/MONDO_0014091) (mitochondrial complex v (ATP synthase) deficiency nuclear type 4), [MONDO:0014086](http://purl.obolibrary.org/obo/MONDO_0014086) (osteogenesis imperfecta type 15), [MONDO:0014087](http://purl.obolibrary.org/obo/MONDO_0014087) (Smith-Mccort dysplasia 2), [MONDO:0014088](http://purl.obolibrary.org/obo/MONDO_0014088) (advanced sleep phase syndrome 2), [MONDO:0014089](http://purl.obolibrary.org/obo/MONDO_0014089) (corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome), [MONDO:0014082](http://purl.obolibrary.org/obo/MONDO_0014082) (cryptosporidiosis-chronic cholangitis-liver disease syndrome), [MONDO:0014083](http://purl.obolibrary.org/obo/MONDO_0014083) (agammaglobulinemia 7, autosomal recessive), [MONDO:0014084](http://purl.obolibrary.org/obo/MONDO_0014084) (ataxia with oculomotor apraxia type 3), [MONDO:0014085](http://purl.obolibrary.org/obo/MONDO_0014085) (hydrocephalus, nonsyndromic, autosomal recessive 2), [MONDO:0014081](http://purl.obolibrary.org/obo/MONDO_0014081) (severe combined immunodeficiency due to CARD11 deficiency), [MONDO:0002096](http://purl.obolibrary.org/obo/MONDO_0002096) (malignant conjunctival melanoma), [MONDO:0002093](http://purl.obolibrary.org/obo/MONDO_0002093) (acanthoma (disease)), [MONDO:0002092](http://purl.obolibrary.org/obo/MONDO_0002092) (small intestine leiomyoma), [MONDO:0002095](http://purl.obolibrary.org/obo/MONDO_0002095) (vascular cancer), [MONDO:0002090](http://purl.obolibrary.org/obo/MONDO_0002090) (eccrine sweat gland neoplasm), [MONDO:0014075](http://purl.obolibrary.org/obo/MONDO_0014075) (cataract 39 multiple types), [MONDO:0014076](http://purl.obolibrary.org/obo/MONDO_0014076) (dyskeratosis congenita, autosomal recessive 5), [MONDO:0014077](http://purl.obolibrary.org/obo/MONDO_0014077) (cobblestone lissencephaly without muscular or ocular involvement), [MONDO:0014078](http://purl.obolibrary.org/obo/MONDO_0014078) (platelet-type bleeding disorder 15), [MONDO:0014071](http://purl.obolibrary.org/obo/MONDO_0014071) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11), [MONDO:0014072](http://purl.obolibrary.org/obo/MONDO_0014072) (d,L-2-hydroxyglutaric aciduria), [MONDO:0014074](http://purl.obolibrary.org/obo/MONDO_0014074) (Charcot-Marie-tooth disease dominant intermediate f), [MONDO:0014070](http://purl.obolibrary.org/obo/MONDO_0014070) (oculocutaneous albinism type 7), [MONDO:0004708](http://purl.obolibrary.org/obo/MONDO_0004708) (esophagus carcinoma in situ), [MONDO:0004709](http://purl.obolibrary.org/obo/MONDO_0004709) (occipital lobe neoplasm), [MONDO:0004706](http://purl.obolibrary.org/obo/MONDO_0004706) (discoid lupus erythematosus of eyelid), [MONDO:0004707](http://purl.obolibrary.org/obo/MONDO_0004707) (anal canal carcinoma in situ), [MONDO:0004705](http://purl.obolibrary.org/obo/MONDO_0004705) (liver fibroma), [MONDO:0004703](http://purl.obolibrary.org/obo/MONDO_0004703) (bladder carcinoma in situ), [MONDO:0004700](http://purl.obolibrary.org/obo/MONDO_0004700) (parotid gland cancer), [MONDO:0004701](http://purl.obolibrary.org/obo/MONDO_0004701) (uterine polyp), [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), [MONDO:0016721](http://purl.obolibrary.org/obo/MONDO_0016721) (pineal tumor of neuroepithelial tissue), [MONDO:0004739](http://purl.obolibrary.org/obo/MONDO_0004739) (urea cycle disorder), [MONDO:0003408](http://purl.obolibrary.org/obo/MONDO_0003408) (ovarian primitive germ cell tumor), [MONDO:0004737](http://purl.obolibrary.org/obo/MONDO_0004737) (homocystinuria (disease)), [MONDO:0003406](http://purl.obolibrary.org/obo/MONDO_0003406) (sleep disorder), [MONDO:0004738](http://purl.obolibrary.org/obo/MONDO_0004738) (histidine metabolism disease), [MONDO:0003404](http://purl.obolibrary.org/obo/MONDO_0003404) (adult yolk sac tumor), [MONDO:0003405](http://purl.obolibrary.org/obo/MONDO_0003405) (adult central nervous system germ cell tumor), [MONDO:0004736](http://purl.obolibrary.org/obo/MONDO_0004736) (amino acid metabolic disorder), [MONDO:0003402](http://purl.obolibrary.org/obo/MONDO_0003402) (testicular yolk sac tumor), [MONDO:0004733](http://purl.obolibrary.org/obo/MONDO_0004733) (pyriform sinus cancer), [MONDO:0003403](http://purl.obolibrary.org/obo/MONDO_0003403) (testicular non-seminomatous germ cell cancer), [MONDO:0004731](http://purl.obolibrary.org/obo/MONDO_0004731) (central sleep apnea), [MONDO:0003400](http://purl.obolibrary.org/obo/MONDO_0003400) (childhood endodermal sinus tumor), [MONDO:0003401](http://purl.obolibrary.org/obo/MONDO_0003401) (central nervous system endodermal sinus tumor), [MONDO:0004732](http://purl.obolibrary.org/obo/MONDO_0004732) (kidney carcinoma in situ), [MONDO:0016727](http://purl.obolibrary.org/obo/MONDO_0016727) (Extraventricular neurocytoma), [MONDO:0016729](http://purl.obolibrary.org/obo/MONDO_0016729) (mixed neuronal-glial tumor), [MONDO:0016724](http://purl.obolibrary.org/obo/MONDO_0016724) (papillary tumor of the pineal region), [MONDO:0016723](http://purl.obolibrary.org/obo/MONDO_0016723) (pineocytoma (disease)), [MONDO:0016726](http://purl.obolibrary.org/obo/MONDO_0016726) (neuronal tumor), [MONDO:0016725](http://purl.obolibrary.org/obo/MONDO_0016725) (pineal parenchymal tumor of intermediate differenciation), [MONDO:0016711](http://purl.obolibrary.org/obo/MONDO_0016711) (desmoplastic/nodular medulloblastoma), [MONDO:0016710](http://purl.obolibrary.org/obo/MONDO_0016710) (medulloblastoma with extensive nodularity), [MONDO:0003419](http://purl.obolibrary.org/obo/MONDO_0003419) (Bartholin's gland adenoma), [MONDO:0003417](http://purl.obolibrary.org/obo/MONDO_0003417) (internuclear ophthalmoplegia), [MONDO:0004749](http://purl.obolibrary.org/obo/MONDO_0004749) (myocardium cancer), [MONDO:0004746](http://purl.obolibrary.org/obo/MONDO_0004746) (myopathy of extraocular muscle), [MONDO:0003413](http://purl.obolibrary.org/obo/MONDO_0003413) (hair follicle neoplasm), [MONDO:0004744](http://purl.obolibrary.org/obo/MONDO_0004744) (borderline glaucoma), [MONDO:0003414](http://purl.obolibrary.org/obo/MONDO_0003414) (skin pilomatrix carcinoma), [MONDO:0003411](http://purl.obolibrary.org/obo/MONDO_0003411) (breast hemangiopericytoma), [MONDO:0003412](http://purl.obolibrary.org/obo/MONDO_0003412) (retroperitoneal hemangiopericytoma), [MONDO:0004743](http://purl.obolibrary.org/obo/MONDO_0004743) (hyperhomocysteinemia), [MONDO:0004741](http://purl.obolibrary.org/obo/MONDO_0004741) (tyrosinemia), [MONDO:0003410](http://purl.obolibrary.org/obo/MONDO_0003410) (Wolffian duct adenocarcinoma), [MONDO:0016717](http://purl.obolibrary.org/obo/MONDO_0016717) (choroid plexus neoplasm), [MONDO:0016719](http://purl.obolibrary.org/obo/MONDO_0016719) (microcephaly-seizures-intellectual disability-heart disease syndrome), [MONDO:0016718](http://purl.obolibrary.org/obo/MONDO_0016718) (choroid plexus carcinoma), [MONDO:0016713](http://purl.obolibrary.org/obo/MONDO_0016713) (central nervous system ewing sarcoma/peripheral primitive neuroectodermal tumor), [MONDO:0016712](http://purl.obolibrary.org/obo/MONDO_0016712) (classic medulloblastoma), [MONDO:0016715](http://purl.obolibrary.org/obo/MONDO_0016715) (ependymoblastoma), [MONDO:0016700](http://purl.obolibrary.org/obo/MONDO_0016700) (anaplastic ependymoma), [MONDO:0004719](http://purl.obolibrary.org/obo/MONDO_0004719) (hard palate cancer), [MONDO:0004718](http://purl.obolibrary.org/obo/MONDO_0004718) (xeroderma of eyelid), [MONDO:0004715](http://purl.obolibrary.org/obo/MONDO_0004715) (liver carcinoma in situ), [MONDO:0004716](http://purl.obolibrary.org/obo/MONDO_0004716) (stomach carcinoma in situ), [MONDO:0004713](http://purl.obolibrary.org/obo/MONDO_0004713) (lower gum cancer), [MONDO:0004714](http://purl.obolibrary.org/obo/MONDO_0004714) (atrophic muscular disease), [MONDO:0004710](http://purl.obolibrary.org/obo/MONDO_0004710) (uterus carcinoma in situ), [MONDO:0016709](http://purl.obolibrary.org/obo/MONDO_0016709) (anaplastic/large cell medulloblastoma), [MONDO:0016706](http://purl.obolibrary.org/obo/MONDO_0016706) (chordoid glioma), [MONDO:0016705](http://purl.obolibrary.org/obo/MONDO_0016705) (angiocentric glioma), [MONDO:0016708](http://purl.obolibrary.org/obo/MONDO_0016708) (embryonal tumor of neuroepithelial tissue), [MONDO:0016707](http://purl.obolibrary.org/obo/MONDO_0016707) (astroblastoma), [MONDO:0016702](http://purl.obolibrary.org/obo/MONDO_0016702) (oligoastrocytoma), [MONDO:0016701](http://purl.obolibrary.org/obo/MONDO_0016701) (oligoastrocytic tumor), [MONDO:0016704](http://purl.obolibrary.org/obo/MONDO_0016704) (glial tumor of neuroepithelial tissue with unknown origin), [MONDO:0016703](http://purl.obolibrary.org/obo/MONDO_0016703) (anaplastic oligoastrocytoma), [MONDO:0004728](http://purl.obolibrary.org/obo/MONDO_0004728) (diabetic macular edema), [MONDO:0004726](http://purl.obolibrary.org/obo/MONDO_0004726) (liver inflammatory myofibroblastic tumor), [MONDO:0004727](http://purl.obolibrary.org/obo/MONDO_0004727) (vestibule of mouth cancer), [MONDO:0004724](http://purl.obolibrary.org/obo/MONDO_0004724) (submandibular gland cancer), [MONDO:0004725](http://purl.obolibrary.org/obo/MONDO_0004725) (rectum carcinoma in situ), [MONDO:0004723](http://purl.obolibrary.org/obo/MONDO_0004723) (liver leiomyoma), [MONDO:0004721](http://purl.obolibrary.org/obo/MONDO_0004721) (liver neoplasm), [MONDO:0016764](http://purl.obolibrary.org/obo/MONDO_0016764) (isolated anophthalmia-microphthalmia syndrome), [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0016763](http://purl.obolibrary.org/obo/MONDO_0016763) (spondylometaphyseal dysplasia), [MONDO:0014102](http://purl.obolibrary.org/obo/MONDO_0014102) (hypogonadotropic hypogonadism 17 with or without anosmia), [MONDO:0014103](http://purl.obolibrary.org/obo/MONDO_0014103) (hypogonadotropic hypogonadism 18 with or without anosmia), [MONDO:0014104](http://purl.obolibrary.org/obo/MONDO_0014104) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 4), [MONDO:0016760](http://purl.obolibrary.org/obo/MONDO_0016760) (microcephaly-microcornea syndrome, Seemanova type), [MONDO:0016762](http://purl.obolibrary.org/obo/MONDO_0016762) (microcornea-corectopia-macular hypoplasia syndrome), [MONDO:0016761](http://purl.obolibrary.org/obo/MONDO_0016761) (spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia), [MONDO:0002119](http://purl.obolibrary.org/obo/MONDO_0002119) (ossifying fibroma (disease)), [MONDO:0002116](http://purl.obolibrary.org/obo/MONDO_0002116) (malignant exocrine pancreas neoplasm), [MONDO:0003448](http://purl.obolibrary.org/obo/MONDO_0003448) (spiradenoma), [MONDO:0003446](http://purl.obolibrary.org/obo/MONDO_0003446) (papillary hidradenoma), [MONDO:0002117](http://purl.obolibrary.org/obo/MONDO_0002117) (pancreas sarcoma), [MONDO:0003447](http://purl.obolibrary.org/obo/MONDO_0003447) (clear cell hidradenoma), [MONDO:0002112](http://purl.obolibrary.org/obo/MONDO_0002112) (benign peritoneal mesothelioma), [MONDO:0003444](http://purl.obolibrary.org/obo/MONDO_0003444) (intrahepatic bile duct adenoma), [MONDO:0004775](http://purl.obolibrary.org/obo/MONDO_0004775) (lens-induced iridocyclitis), [MONDO:0003445](http://purl.obolibrary.org/obo/MONDO_0003445) (extrahepatic bile duct adenoma), [MONDO:0003442](http://purl.obolibrary.org/obo/MONDO_0003442) (bladder papillary urothelial neoplasm), [MONDO:0002114](http://purl.obolibrary.org/obo/MONDO_0002114) (pancreas lymphoma), [MONDO:0004773](http://purl.obolibrary.org/obo/MONDO_0004773) (iridocyclitis (disease)), [MONDO:0003443](http://purl.obolibrary.org/obo/MONDO_0003443) (papillary urothelial neoplasm), [MONDO:0002113](http://purl.obolibrary.org/obo/MONDO_0002113) (peritoneal carcinoma), [MONDO:0004774](http://purl.obolibrary.org/obo/MONDO_0004774) (gonococcal iridocyclitis), [MONDO:0004772](http://purl.obolibrary.org/obo/MONDO_0004772) (glaucomatocyclitic crisis), [MONDO:0002110](http://purl.obolibrary.org/obo/MONDO_0002110) (adrenal rest tumor), [MONDO:0004770](http://purl.obolibrary.org/obo/MONDO_0004770) (exophthalmos (disease)), [MONDO:0014109](http://purl.obolibrary.org/obo/MONDO_0014109) (NGLY1-deficiency), [MONDO:0014105](http://purl.obolibrary.org/obo/MONDO_0014105) (hypogonadotropic hypogonadism 19 with or without anosmia), [MONDO:0014106](http://purl.obolibrary.org/obo/MONDO_0014106) (hypogonadotropic hypogonadism 20 with or without anosmia), [MONDO:0014107](http://purl.obolibrary.org/obo/MONDO_0014107) (hypogonadotropic hypogonadism 21 with or without anosmia), [MONDO:0014108](http://purl.obolibrary.org/obo/MONDO_0014108) (Fanconi anemia complementation group Q), [MONDO:0015422](http://purl.obolibrary.org/obo/MONDO_0015422) (orofaciodigital syndrome type 13), [MONDO:0016752](http://purl.obolibrary.org/obo/MONDO_0016752) (benign peripheral nerve sheath tumor), [MONDO:0015421](http://purl.obolibrary.org/obo/MONDO_0015421) (orofaciodigital syndrome type 12), [MONDO:0016755](http://purl.obolibrary.org/obo/MONDO_0016755) (neurofibroma), [MONDO:0015424](http://purl.obolibrary.org/obo/MONDO_0015424) (lethal chondrodysplasia, Moerman type), [MONDO:0015423](http://purl.obolibrary.org/obo/MONDO_0015423) (anaplastic thyroid carcinoma (disease)), [MONDO:0016754](http://purl.obolibrary.org/obo/MONDO_0016754) (vestibular schwannoma (disease)), [MONDO:0016751](http://purl.obolibrary.org/obo/MONDO_0016751) (malignant perineurioma), [MONDO:0016750](http://purl.obolibrary.org/obo/MONDO_0016750) (microcephaly-cleft palate syndrome), [MONDO:0003459](http://purl.obolibrary.org/obo/MONDO_0003459) (cervical adenofibroma), [MONDO:0002129](http://purl.obolibrary.org/obo/MONDO_0002129) (bone cancer), [MONDO:0004788](http://purl.obolibrary.org/obo/MONDO_0004788) (cervix squamous papilloma), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0002123](http://purl.obolibrary.org/obo/MONDO_0002123) (calcinosis), [MONDO:0003455](http://purl.obolibrary.org/obo/MONDO_0003455) (bile duct papillary neoplasm), [MONDO:0004787](http://purl.obolibrary.org/obo/MONDO_0004787) (cervical mullerian papilloma), [MONDO:0003453](http://purl.obolibrary.org/obo/MONDO_0003453) (conjunctival intraepithelial neoplasm), [MONDO:0004784](http://purl.obolibrary.org/obo/MONDO_0004784) (allergic asthma), [MONDO:0002124](http://purl.obolibrary.org/obo/MONDO_0002124) (secondary lacrimal atrophy), [MONDO:0004785](http://purl.obolibrary.org/obo/MONDO_0004785) (blepharitis), [MONDO:0003454](http://purl.obolibrary.org/obo/MONDO_0003454) (conjunctival cancer), [MONDO:0003450](http://purl.obolibrary.org/obo/MONDO_0003450) (eccrine papillary adenoma), [MONDO:0002120](http://purl.obolibrary.org/obo/MONDO_0002120) (neuroendocrine carcinoma), [MONDO:0015429](http://purl.obolibrary.org/obo/MONDO_0015429) (choroideremia-hypopituitarism syndrome), [MONDO:0015426](http://purl.obolibrary.org/obo/MONDO_0015426) (Desbuquois dysplasia), [MONDO:0016757](http://purl.obolibrary.org/obo/MONDO_0016757) (malignant triton tumor), [MONDO:0015425](http://purl.obolibrary.org/obo/MONDO_0015425) (lethal recessive chondrodysplasia), [MONDO:0016759](http://purl.obolibrary.org/obo/MONDO_0016759) (pontocerebellar hypoplasia type 2), [MONDO:0015428](http://purl.obolibrary.org/obo/MONDO_0015428) (choroidal atrophy-alopecia syndrome), [MONDO:0016758](http://purl.obolibrary.org/obo/MONDO_0016758) (microcephaly-brain defect-spasticity-hypernatremia syndrome), [MONDO:0016742](http://purl.obolibrary.org/obo/MONDO_0016742) (mixed germ cell tumor of central nervous system), [MONDO:0016744](http://purl.obolibrary.org/obo/MONDO_0016744) (primary melanocytic tumor of central nervous system), [MONDO:0016743](http://purl.obolibrary.org/obo/MONDO_0016743) (tumor of meninges), [MONDO:0016740](http://purl.obolibrary.org/obo/MONDO_0016740) (choriocarcinoma of the central nervous system), [MONDO:0003428](http://purl.obolibrary.org/obo/MONDO_0003428) (brain hemangioma), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0003426](http://purl.obolibrary.org/obo/MONDO_0003426) (clear cell adenoma), [MONDO:0004758](http://purl.obolibrary.org/obo/MONDO_0004758) (scotoma (disease)), [MONDO:0003427](http://purl.obolibrary.org/obo/MONDO_0003427) (bronchus adenoma), [MONDO:0003424](http://purl.obolibrary.org/obo/MONDO_0003424) (oncocytic adenoma), [MONDO:0004756](http://purl.obolibrary.org/obo/MONDO_0004756) (nasal cavity neoplasm), [MONDO:0003422](http://purl.obolibrary.org/obo/MONDO_0003422) (lung adenoma), [MONDO:0004753](http://purl.obolibrary.org/obo/MONDO_0004753) (mechanical strabismus), [MONDO:0003423](http://purl.obolibrary.org/obo/MONDO_0003423) (middle ear adenoma), [MONDO:0003420](http://purl.obolibrary.org/obo/MONDO_0003420) (bile duct cystadenoma), [MONDO:0004752](http://purl.obolibrary.org/obo/MONDO_0004752) (neurofibroma of the heart), [MONDO:0003421](http://purl.obolibrary.org/obo/MONDO_0003421) (mixed cell adenoma), [MONDO:0016749](http://purl.obolibrary.org/obo/MONDO_0016749) (tumor of cranial and spinal nerves), [MONDO:0015418](http://purl.obolibrary.org/obo/MONDO_0015418) (lateral facial cleft), [MONDO:0016746](http://purl.obolibrary.org/obo/MONDO_0016746) (meningeal melanocytoma), [MONDO:0015414](http://purl.obolibrary.org/obo/MONDO_0015414) (paramedian nasal cleft), [MONDO:0016745](http://purl.obolibrary.org/obo/MONDO_0016745) (diffuse leptomeningeal melanocytosis), [MONDO:0016748](http://purl.obolibrary.org/obo/MONDO_0016748) (hemangioblastoma), [MONDO:0016747](http://purl.obolibrary.org/obo/MONDO_0016747) (primary melanoma of the central nervous system), [MONDO:0016731](http://purl.obolibrary.org/obo/MONDO_0016731) (desmoplastic infantile astrocytoma/ganglioglioma), [MONDO:0015400](http://purl.obolibrary.org/obo/MONDO_0015400) (frontonasal arteriovenous malformation), [MONDO:0016730](http://purl.obolibrary.org/obo/MONDO_0016730) (gangliocytoma), [MONDO:0016733](http://purl.obolibrary.org/obo/MONDO_0016733) (ganglioglioma), [MONDO:0015402](http://purl.obolibrary.org/obo/MONDO_0015402) (mandibular arteriovenous malformation), [MONDO:0015401](http://purl.obolibrary.org/obo/MONDO_0015401) (maxillary arteriovenous malformation), [MONDO:0002109](http://purl.obolibrary.org/obo/MONDO_0002109) (pituitary cancer), [MONDO:0002108](http://purl.obolibrary.org/obo/MONDO_0002108) (thyroid cancer), [MONDO:0003439](http://purl.obolibrary.org/obo/MONDO_0003439) (urinary bladder villous adenoma), [MONDO:0004768](http://purl.obolibrary.org/obo/MONDO_0004768) (keratoconjunctivitis), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0003435](http://purl.obolibrary.org/obo/MONDO_0003435) (microcystic adenoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0002101](http://purl.obolibrary.org/obo/MONDO_0002101) (facial nerve neoplasm), [MONDO:0003433](http://purl.obolibrary.org/obo/MONDO_0003433) (water-clear cell adenoma), [MONDO:0003434](http://purl.obolibrary.org/obo/MONDO_0003434) (vaginal adenoma), [MONDO:0002100](http://purl.obolibrary.org/obo/MONDO_0002100) (cardiovascular cancer), [MONDO:0003431](http://purl.obolibrary.org/obo/MONDO_0003431) (lipoadenoma), [MONDO:0003432](http://purl.obolibrary.org/obo/MONDO_0003432) (strabismus), [MONDO:0003430](http://purl.obolibrary.org/obo/MONDO_0003430) (prolactin producing pituitary tumor), [MONDO:0016739](http://purl.obolibrary.org/obo/MONDO_0016739) (yolk sac tumor of central nervous system), [MONDO:0016738](http://purl.obolibrary.org/obo/MONDO_0016738) (primary germ cell tumor of central nervous system), [MONDO:0015407](http://purl.obolibrary.org/obo/MONDO_0015407) (cerebrofacial arteriovenous metameric syndrome type 3), [MONDO:0015409](http://purl.obolibrary.org/obo/MONDO_0015409) (isolated congenital syngnathia), [MONDO:0016735](http://purl.obolibrary.org/obo/MONDO_0016735) (papillary glioneuronal tumor), [MONDO:0015404](http://purl.obolibrary.org/obo/MONDO_0015404) (rapidly involuting congenital hemangioma), [MONDO:0016734](http://purl.obolibrary.org/obo/MONDO_0016734) (anaplastic ganglioglioma), [MONDO:0015403](http://purl.obolibrary.org/obo/MONDO_0015403) (non-involuting congenital hemangioma), [MONDO:0015406](http://purl.obolibrary.org/obo/MONDO_0015406) (cerebrofacial arteriovenous metameric syndrome type 1), [MONDO:0015405](http://purl.obolibrary.org/obo/MONDO_0015405) (cerebrofacial arteriovenous metameric syndrome), [MONDO:0016736](http://purl.obolibrary.org/obo/MONDO_0016736) (Rosette-forming glioneuronal tumor of fourth ventricule), [MONDO:0014145](http://purl.obolibrary.org/obo/MONDO_0014145) (Leber congenital amaurosis 17), [MONDO:0014146](http://purl.obolibrary.org/obo/MONDO_0014146) (autosomal dominant hypocalcemia 2), [MONDO:0014147](http://purl.obolibrary.org/obo/MONDO_0014147) (neuronal ceroid lipofuscinosis 13), [MONDO:0014141](http://purl.obolibrary.org/obo/MONDO_0014141) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14), [MONDO:0015473](http://purl.obolibrary.org/obo/MONDO_0015473) (cryptorchidism-arachnodactyly-intellectual disability syndrome), [MONDO:0014142](http://purl.obolibrary.org/obo/MONDO_0014142) (autosomal recessive limb-girdle muscular dystrophy type 2T), [MONDO:0014143](http://purl.obolibrary.org/obo/MONDO_0014143) (Noonan syndrome 8), [MONDO:0014144](http://purl.obolibrary.org/obo/MONDO_0014144) (autosomal recessive limb-girdle muscular dystrophy type 2S), [MONDO:0014140](http://purl.obolibrary.org/obo/MONDO_0014140) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14), [MONDO:0002159](http://purl.obolibrary.org/obo/MONDO_0002159) (fallopian tube leiomyosarcoma), [MONDO:0002158](http://purl.obolibrary.org/obo/MONDO_0002158) (fallopian tube cancer), [MONDO:0003486](http://purl.obolibrary.org/obo/MONDO_0003486) (basaloid squamous cell carcinoma), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0002152](http://purl.obolibrary.org/obo/MONDO_0002152) (intermittent squint), [MONDO:0003480](http://purl.obolibrary.org/obo/MONDO_0003480) (pineal region dysgerminoma), [MONDO:0003481](http://purl.obolibrary.org/obo/MONDO_0003481) (dysgerminoma of ovary), [MONDO:0014149](http://purl.obolibrary.org/obo/MONDO_0014149) (fetal akinesia-cerebral and retinal hemorrhage syndrome), [MONDO:0016797](http://purl.obolibrary.org/obo/MONDO_0016797) (multiple mitochondrial DNA deletion syndrome), [MONDO:0015466](http://purl.obolibrary.org/obo/MONDO_0015466) (cranio-osteoarthropathy), [MONDO:0014134](http://purl.obolibrary.org/obo/MONDO_0014134) (pulmonary hypertension, primary, 2), [MONDO:0016796](http://purl.obolibrary.org/obo/MONDO_0016796) (mitochondrial DNA depletion syndrome, encephalomyopathic form), [MONDO:0015465](http://purl.obolibrary.org/obo/MONDO_0015465) (craniometaphyseal dysplasia), [MONDO:0014135](http://purl.obolibrary.org/obo/MONDO_0014135) (pulmonary hypertension, primary, 3), [MONDO:0014136](http://purl.obolibrary.org/obo/MONDO_0014136) (pulmonary hypertension, primary, 4), [MONDO:0015468](http://purl.obolibrary.org/obo/MONDO_0015468) (craniosynostosis-cataract syndrome), [MONDO:0016799](http://purl.obolibrary.org/obo/MONDO_0016799) (mitochondrial oxidative phosphorylation disorder with no known mechanism), [MONDO:0016798](http://purl.obolibrary.org/obo/MONDO_0016798) (ataxia neuropathy spectrum), [MONDO:0015467](http://purl.obolibrary.org/obo/MONDO_0015467) (craniosynostosis, Philadelphia type), [MONDO:0014130](http://purl.obolibrary.org/obo/MONDO_0014130) (Dowling-Degos disease 2), [MONDO:0015462](http://purl.obolibrary.org/obo/MONDO_0015462) (thin ribs-tubular bones-dysmorphism syndrome), [MONDO:0016793](http://purl.obolibrary.org/obo/MONDO_0016793) (mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA), [MONDO:0015461](http://purl.obolibrary.org/obo/MONDO_0015461) (short rib-polydactyly syndrome), [MONDO:0016792](http://purl.obolibrary.org/obo/MONDO_0016792) (mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA), [MONDO:0015464](http://purl.obolibrary.org/obo/MONDO_0015464) (craniofrontonasal dysplasia-Poland anomaly syndrome), [MONDO:0016795](http://purl.obolibrary.org/obo/MONDO_0016795) (mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA), [MONDO:0014132](http://purl.obolibrary.org/obo/MONDO_0014132) (multiple mitochondrial dysfunctions syndrome 3), [MONDO:0015463](http://purl.obolibrary.org/obo/MONDO_0015463) (craniodigital syndrome-intellectual disability syndrome), [MONDO:0016794](http://purl.obolibrary.org/obo/MONDO_0016794) (maternally-inherited mitochondrial myopathy), [MONDO:0016791](http://purl.obolibrary.org/obo/MONDO_0016791) (mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies), [MONDO:0016790](http://purl.obolibrary.org/obo/MONDO_0016790) (tricarboxylic acid cycle disorder), [MONDO:0003499](http://purl.obolibrary.org/obo/MONDO_0003499) (sarcomatoid squamous cell skin carcinoma), [MONDO:0002167](http://purl.obolibrary.org/obo/MONDO_0002167) (rectum malignant melanoma), [MONDO:0002166](http://purl.obolibrary.org/obo/MONDO_0002166) (rectum lymphoma), [MONDO:0003497](http://purl.obolibrary.org/obo/MONDO_0003497) (renal pelvis squamous cell carcinoma), [MONDO:0002169](http://purl.obolibrary.org/obo/MONDO_0002169) (rectum adenocarcinoma), [MONDO:0002168](http://purl.obolibrary.org/obo/MONDO_0002168) (rectum sarcoma), [MONDO:0003495](http://purl.obolibrary.org/obo/MONDO_0003495) (ovarian squamous cell neoplasm), [MONDO:0002163](http://purl.obolibrary.org/obo/MONDO_0002163) (thymus lipoma), [MONDO:0002162](http://purl.obolibrary.org/obo/MONDO_0002162) (fallopian tube adenosarcoma), [MONDO:0002165](http://purl.obolibrary.org/obo/MONDO_0002165) (rectal neoplasm), [MONDO:0003493](http://purl.obolibrary.org/obo/MONDO_0003493) (thymus squamous cell carcinoma), [MONDO:0003494](http://purl.obolibrary.org/obo/MONDO_0003494) (ovarian squamous cell carcinoma), [MONDO:0002164](http://purl.obolibrary.org/obo/MONDO_0002164) (focal chorioretinitis), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0003490](http://purl.obolibrary.org/obo/MONDO_0003490) (ampulla of vater squamous cell carcinoma), [MONDO:0014138](http://purl.obolibrary.org/obo/MONDO_0014138) (nemaline myopathy 8), [MONDO:0015469](http://purl.obolibrary.org/obo/MONDO_0015469) (craniosynostosis), [MONDO:0014139](http://purl.obolibrary.org/obo/MONDO_0014139) (Ehlers-Danlos syndrome, progeroid type, 2), [MONDO:0016786](http://purl.obolibrary.org/obo/MONDO_0016786) (partial hydatidiform mole), [MONDO:0015455](http://purl.obolibrary.org/obo/MONDO_0015455) (gonococcal conjunctivitis), [MONDO:0014123](http://purl.obolibrary.org/obo/MONDO_0014123) (primary ciliary dyskinesia 21), [MONDO:0016785](http://purl.obolibrary.org/obo/MONDO_0016785) (complete hydatidiform mole), [MONDO:0014124](http://purl.obolibrary.org/obo/MONDO_0014124) (Adams-Oliver syndrome 4), [MONDO:0015454](http://purl.obolibrary.org/obo/MONDO_0015454) (multiple carboxylase deficiency), [MONDO:0014125](http://purl.obolibrary.org/obo/MONDO_0014125) (symphalangism, proximal, 1B), [MONDO:0014126](http://purl.obolibrary.org/obo/MONDO_0014126) (Perrault syndrome 4), [MONDO:0016787](http://purl.obolibrary.org/obo/MONDO_0016787) (epithelioid trophoblastic tumor), [MONDO:0016782](http://purl.obolibrary.org/obo/MONDO_0016782) (paternal 14q32.2 hypomethylation syndrome), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0016781](http://purl.obolibrary.org/obo/MONDO_0016781) (maternal 14q32.2 microdeletion syndrome), [MONDO:0014121](http://purl.obolibrary.org/obo/MONDO_0014121) (autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures), [MONDO:0016784](http://purl.obolibrary.org/obo/MONDO_0016784) (gestational trophoblastic disease), [MONDO:0015453](http://purl.obolibrary.org/obo/MONDO_0015453) (Cogan syndrome), [MONDO:0015452](http://purl.obolibrary.org/obo/MONDO_0015452) (Coffin-Siris syndrome), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0016783](http://purl.obolibrary.org/obo/MONDO_0016783) (maternal 14q32.2 hypermethylation syndrome), [MONDO:0016780](http://purl.obolibrary.org/obo/MONDO_0016780) (paternal 14q32.2 microdeletion syndrome), [MONDO:0002138](http://purl.obolibrary.org/obo/MONDO_0002138) (allergic contact dermatitis of eyelid), [MONDO:0002137](http://purl.obolibrary.org/obo/MONDO_0002137) (noninfectious dermatoses of eyelid), [MONDO:0004799](http://purl.obolibrary.org/obo/MONDO_0004799) (ulcerative blepharitis), [MONDO:0003468](http://purl.obolibrary.org/obo/MONDO_0003468) (biphasic synovial sarcoma), [MONDO:0003469](http://purl.obolibrary.org/obo/MONDO_0003469) (epithelioid cell synovial sarcoma), [MONDO:0003466](http://purl.obolibrary.org/obo/MONDO_0003466) (spindle cell synovial sarcoma), [MONDO:0003467](http://purl.obolibrary.org/obo/MONDO_0003467) (mediastinum synovial sarcoma), [MONDO:0002136](http://purl.obolibrary.org/obo/MONDO_0002136) (eczematous dermatitis of eyelid), [MONDO:0003464](http://purl.obolibrary.org/obo/MONDO_0003464) (cystadenofibroma), [MONDO:0003465](http://purl.obolibrary.org/obo/MONDO_0003465) (fibrous synovial sarcoma), [MONDO:0002135](http://purl.obolibrary.org/obo/MONDO_0002135) (optic nerve disease), [MONDO:0003462](http://purl.obolibrary.org/obo/MONDO_0003462) (papillary adenofibroma), [MONDO:0004794](http://purl.obolibrary.org/obo/MONDO_0004794) (exposure keratitis), [MONDO:0003463](http://purl.obolibrary.org/obo/MONDO_0003463) (ovarian endometrioid adenofibroma), [MONDO:0002132](http://purl.obolibrary.org/obo/MONDO_0002132) (skull cancer), [MONDO:0003460](http://purl.obolibrary.org/obo/MONDO_0003460) (clear cell adenofibroma), [MONDO:0003461](http://purl.obolibrary.org/obo/MONDO_0003461) (fallopian tube adenofibroma), [MONDO:0002131](http://purl.obolibrary.org/obo/MONDO_0002131) (jaw cancer), [MONDO:0004792](http://purl.obolibrary.org/obo/MONDO_0004792) (isthmus cancer), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharyngeal carcinoma), [MONDO:0014127](http://purl.obolibrary.org/obo/MONDO_0014127) (oculocutaneous albinism type 5), [MONDO:0015458](http://purl.obolibrary.org/obo/MONDO_0015458) (intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome), [MONDO:0016789](http://purl.obolibrary.org/obo/MONDO_0016789) (pyruvate metabolism disorder), [MONDO:0014128](http://purl.obolibrary.org/obo/MONDO_0014128) (craniosynostosis 3), [MONDO:0014129](http://purl.obolibrary.org/obo/MONDO_0014129) (autosomal recessive limb-girdle muscular dystrophy type 2R), [MONDO:0014112](http://purl.obolibrary.org/obo/MONDO_0014112) (cardiofaciocutaneous syndrome 2), [MONDO:0014113](http://purl.obolibrary.org/obo/MONDO_0014113) (cardiofaciocutaneous syndrome 3), [MONDO:0016777](http://purl.obolibrary.org/obo/MONDO_0016777) (Inhalational botulism), [MONDO:0014114](http://purl.obolibrary.org/obo/MONDO_0014114) (cardiofaciocutaneous syndrome 4), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0014110](http://purl.obolibrary.org/obo/MONDO_0014110) (cataract 15 multiple types), [MONDO:0014111](http://purl.obolibrary.org/obo/MONDO_0014111) (cataract 19 multiple types), [MONDO:0002149](http://purl.obolibrary.org/obo/MONDO_0002149) (reproductive organ cancer), [MONDO:0003477](http://purl.obolibrary.org/obo/MONDO_0003477) (brain stem ependymoma), [MONDO:0002145](http://purl.obolibrary.org/obo/MONDO_0002145) (sex differentiation disease), [MONDO:0003478](http://purl.obolibrary.org/obo/MONDO_0003478) (childhood ependymoma), [MONDO:0002144](http://purl.obolibrary.org/obo/MONDO_0002144) (hyperuricemia (disease)), [MONDO:0003475](http://purl.obolibrary.org/obo/MONDO_0003475) (papillary ependymoma), [MONDO:0003476](http://purl.obolibrary.org/obo/MONDO_0003476) (clear cell ependymoma), [MONDO:0003473](http://purl.obolibrary.org/obo/MONDO_0003473) (spinal cord ependymoma), [MONDO:0002141](http://purl.obolibrary.org/obo/MONDO_0002141) (cutaneous undifferentiated pleomorphic sarcoma), [MONDO:0002140](http://purl.obolibrary.org/obo/MONDO_0002140) (vagina sarcoma), [MONDO:0003474](http://purl.obolibrary.org/obo/MONDO_0003474) (tanycytic ependymoma), [MONDO:0002143](http://purl.obolibrary.org/obo/MONDO_0002143) (vaginal yolk sac tumor), [MONDO:0002142](http://purl.obolibrary.org/obo/MONDO_0002142) (malignant fibroxanthoma), [MONDO:0003470](http://purl.obolibrary.org/obo/MONDO_0003470) (cellular ependymoma), [MONDO:0016779](http://purl.obolibrary.org/obo/MONDO_0016779) (multiple congenital anomalies due to 14q32.2 maternally expressed gene defect), [MONDO:0015448](http://purl.obolibrary.org/obo/MONDO_0015448) (isolated CoQ-cytochrome c reductase deficiency), [MONDO:0014117](http://purl.obolibrary.org/obo/MONDO_0014117) (Charcot-Marie-tooth disease type 4B3), [MONDO:0015447](http://purl.obolibrary.org/obo/MONDO_0015447) (differentiated thyroid carcinoma), [MONDO:0016778](http://purl.obolibrary.org/obo/MONDO_0016778) (Iatrogenic botulism), [MONDO:0014119](http://purl.obolibrary.org/obo/MONDO_0014119) (intellectual disability-strabismus syndrome), [MONDO:0014189](http://purl.obolibrary.org/obo/MONDO_0014189) (age related macular degeneration 13), [MONDO:0014186](http://purl.obolibrary.org/obo/MONDO_0014186) (retinitis pigmentosa with or without situs inversus), [MONDO:0014181](http://purl.obolibrary.org/obo/MONDO_0014181) (amyotrophic lateral sclerosis type 20), [MONDO:0014182](http://purl.obolibrary.org/obo/MONDO_0014182) (autosomal recessive nonsyndromic deafness 88), [MONDO:0014183](http://purl.obolibrary.org/obo/MONDO_0014183) (myopia 23, autosomal recessive), [MONDO:0002199](http://purl.obolibrary.org/obo/MONDO_0002199) (benign mixed tumor of the vulva), [MONDO:0002195](http://purl.obolibrary.org/obo/MONDO_0002195) (vulvar squamous neoplasm), [MONDO:0002198](http://purl.obolibrary.org/obo/MONDO_0002198) (vulvar glandular tumor), [MONDO:0002197](http://purl.obolibrary.org/obo/MONDO_0002197) (minor vestibular glands adenoma), [MONDO:0002192](http://purl.obolibrary.org/obo/MONDO_0002192) (vulvar angiokeratoma), [MONDO:0002191](http://purl.obolibrary.org/obo/MONDO_0002191) (syringoma), [MONDO:0002194](http://purl.obolibrary.org/obo/MONDO_0002194) (vestibular papilloma), [MONDO:0002193](http://purl.obolibrary.org/obo/MONDO_0002193) (Bartholin's gland benign neoplasm), [MONDO:0002190](http://purl.obolibrary.org/obo/MONDO_0002190) (vulvar syringoma), [MONDO:0014178](http://purl.obolibrary.org/obo/MONDO_0014178) (inclusion body myopathy with early-onset Paget disease With or without frontotemporal dementia 2), [MONDO:0014179](http://purl.obolibrary.org/obo/MONDO_0014179) (inclusion body myopathy with early-onset Paget disease With or without frontotemporal dementia 3), [MONDO:0014174](http://purl.obolibrary.org/obo/MONDO_0014174) (renal-hepatic-pancreatic dysplasia 2), [MONDO:0014175](http://purl.obolibrary.org/obo/MONDO_0014175) (mitochondrial DNA depletion syndrome 12), [MONDO:0014176](http://purl.obolibrary.org/obo/MONDO_0014176) (hypotonia, infantile, with psychomotor retardation and characteristic facies), [MONDO:0014177](http://purl.obolibrary.org/obo/MONDO_0014177) (myopia 22, autosomal dominant), [MONDO:0014172](http://purl.obolibrary.org/obo/MONDO_0014172) (spermatogenic failure 12), [MONDO:0014173](http://purl.obolibrary.org/obo/MONDO_0014173) (microcephaly 11, primary, autosomal recessive), [MONDO:0014167](http://purl.obolibrary.org/obo/MONDO_0014167) (epilepsy, familial adult myoclonic, 5), [MONDO:0015499](http://purl.obolibrary.org/obo/MONDO_0015499) (paralytic facial malformation), [MONDO:0015498](http://purl.obolibrary.org/obo/MONDO_0015498) (oromandibular-limb anomalies syndrome), [MONDO:0014168](http://purl.obolibrary.org/obo/MONDO_0014168) (severe combined immunodeficiency due to CORO1A deficiency), [MONDO:0014169](http://purl.obolibrary.org/obo/MONDO_0014169) (dyschromatosis universalis hereditaria 3), [MONDO:0015495](http://purl.obolibrary.org/obo/MONDO_0015495) (otomandibular dysplasia associated with monogenic syndromes), [MONDO:0014164](http://purl.obolibrary.org/obo/MONDO_0014164) (Meckel syndrome, type 11), [MONDO:0014165](http://purl.obolibrary.org/obo/MONDO_0014165) (multiple congenital anomalies-hypotonia-seizures syndrome 3), [MONDO:0015497](http://purl.obolibrary.org/obo/MONDO_0015497) (Hypoglossia/aglossia), [MONDO:0015496](http://purl.obolibrary.org/obo/MONDO_0015496) (macroglossia), [MONDO:0014166](http://purl.obolibrary.org/obo/MONDO_0014166) (paroxysmal nocturnal hemoglobinuria 2), [MONDO:0014160](http://purl.obolibrary.org/obo/MONDO_0014160) (TCR-alpha-beta-positive T-cell deficiency), [MONDO:0015493](http://purl.obolibrary.org/obo/MONDO_0015493) (lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy), [MONDO:0014162](http://purl.obolibrary.org/obo/MONDO_0014162) (infantile hypertrophic cardiomyopathy due to MRPL44 deficiency), [MONDO:0002178](http://purl.obolibrary.org/obo/MONDO_0002178) (placenta cancer), [MONDO:0002177](http://purl.obolibrary.org/obo/MONDO_0002177) (hyperinsulinism (disease)), [MONDO:0002174](http://purl.obolibrary.org/obo/MONDO_0002174) (preretinal fibrosis), [MONDO:0002173](http://purl.obolibrary.org/obo/MONDO_0002173) (neuroma), [MONDO:0002176](http://purl.obolibrary.org/obo/MONDO_0002176) (connective tissue cancer), [MONDO:0002175](http://purl.obolibrary.org/obo/MONDO_0002175) (degeneration of macula and posterior pole), [MONDO:0002171](http://purl.obolibrary.org/obo/MONDO_0002171) (giant cell tumor), [MONDO:0014156](http://purl.obolibrary.org/obo/MONDO_0014156) (atrial fibrillation, familial, 14), [MONDO:0015487](http://purl.obolibrary.org/obo/MONDO_0015487) (fatal infantile encephalocardiomyopathy), [MONDO:0014157](http://purl.obolibrary.org/obo/MONDO_0014157) (mandibular hypoplasia-deafness-progeroid syndrome), [MONDO:0014159](http://purl.obolibrary.org/obo/MONDO_0014159) (autosomal recessive spinocerebellar ataxia 14), [MONDO:0014153](http://purl.obolibrary.org/obo/MONDO_0014153) (cone-rod dystrophy 18), [MONDO:0015483](http://purl.obolibrary.org/obo/MONDO_0015483) (mandibulofacial dysostosis), [MONDO:0015486](http://purl.obolibrary.org/obo/MONDO_0015486) (keratoconus (disease)), [MONDO:0014154](http://purl.obolibrary.org/obo/MONDO_0014154) (Charcot-Marie-tooth disease recessive intermediate c), [MONDO:0014155](http://purl.obolibrary.org/obo/MONDO_0014155) (atrial fibrillation, familial, 13), [MONDO:0015485](http://purl.obolibrary.org/obo/MONDO_0015485) (primary glaucoma), [MONDO:0015482](http://purl.obolibrary.org/obo/MONDO_0015482) (otomandibular dysplasia), [MONDO:0002189](http://purl.obolibrary.org/obo/MONDO_0002189) (nodular hidradenoma), [MONDO:0002188](http://purl.obolibrary.org/obo/MONDO_0002188) (vulvar nodular hidradenoma), [MONDO:0002185](http://purl.obolibrary.org/obo/MONDO_0002185) (hyperostosis), [MONDO:0002181](http://purl.obolibrary.org/obo/MONDO_0002181) (exostosis), [MONDO:0003929](http://purl.obolibrary.org/obo/MONDO_0003929) (micropapillomatosis labialis), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0003928](http://purl.obolibrary.org/obo/MONDO_0003928) (uterine corpus myxoid leiomyosarcoma), [MONDO:0003925](http://purl.obolibrary.org/obo/MONDO_0003925) (ethmoid sinus inverted papilloma), [MONDO:0003926](http://purl.obolibrary.org/obo/MONDO_0003926) (neurilemmoma of the pleura), [MONDO:0003923](http://purl.obolibrary.org/obo/MONDO_0003923) (ethmoid sinus Schneiderian papilloma), [MONDO:0003924](http://purl.obolibrary.org/obo/MONDO_0003924) (adrenal cortex adenoma), [MONDO:0003921](http://purl.obolibrary.org/obo/MONDO_0003921) (posterior foramen magnum meningioma), [MONDO:0003922](http://purl.obolibrary.org/obo/MONDO_0003922) (ovarian clear cell malignant adenofibroma), [MONDO:0003920](http://purl.obolibrary.org/obo/MONDO_0003920) (gastric small cell carcinoma), [MONDO:0015917](http://purl.obolibrary.org/obo/MONDO_0015917) (malignant glioma), [MONDO:0015913](http://purl.obolibrary.org/obo/MONDO_0015913) (rare thrombotic disease of hematologic origin), [MONDO:0015910](http://purl.obolibrary.org/obo/MONDO_0015910) (rare constitutional hemolytic anemia), [MONDO:0015912](http://purl.obolibrary.org/obo/MONDO_0015912) (MYH-9 related disease), [MONDO:0015911](http://purl.obolibrary.org/obo/MONDO_0015911) (rare acquired hemolytic anemia), [MONDO:0003938](http://purl.obolibrary.org/obo/MONDO_0003938) (bladder colonic type adenocarcinoma), [MONDO:0002604](http://purl.obolibrary.org/obo/MONDO_0002604) (pericytic neoplasm), [MONDO:0003936](http://purl.obolibrary.org/obo/MONDO_0003936) (invasive tubular breast carcinoma), [MONDO:0002603](http://purl.obolibrary.org/obo/MONDO_0002603) (angiomyolipoma), [MONDO:0003934](http://purl.obolibrary.org/obo/MONDO_0003934) (breast apocrine carcinoma), [MONDO:0002606](http://purl.obolibrary.org/obo/MONDO_0002606) (epithelioid type angiomyolipoma), [MONDO:0002605](http://purl.obolibrary.org/obo/MONDO_0002605) (hepatic angiomyolipoma), [MONDO:0003935](http://purl.obolibrary.org/obo/MONDO_0003935) (oncocytic breast carcinoma), [MONDO:0002600](http://purl.obolibrary.org/obo/MONDO_0002600) (mixed germ cell cancer), [MONDO:0003932](http://purl.obolibrary.org/obo/MONDO_0003932) (childhood optic nerve glioma), [MONDO:0003933](http://purl.obolibrary.org/obo/MONDO_0003933) (chest wall bone cancer), [MONDO:0003930](http://purl.obolibrary.org/obo/MONDO_0003930) (non-invasive bladder urothelial carcinoma), [MONDO:0003931](http://purl.obolibrary.org/obo/MONDO_0003931) (childhood optic tract astrocytoma), [MONDO:0002601](http://purl.obolibrary.org/obo/MONDO_0002601) (teratoma), [MONDO:0015907](http://purl.obolibrary.org/obo/MONDO_0015907) (Epimetaphyseal skeletal dysplasia), [MONDO:0015909](http://purl.obolibrary.org/obo/MONDO_0015909) (aplastic anemia), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0015905](http://purl.obolibrary.org/obo/MONDO_0015905) (rare syndromic dyslipidemia), [MONDO:0015904](http://purl.obolibrary.org/obo/MONDO_0015904) (rare hypolipidemia), [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901) (rare hyperlipidemia), [MONDO:0003909](http://purl.obolibrary.org/obo/MONDO_0003909) (Bartholin's gland adenomyoma), [MONDO:0003907](http://purl.obolibrary.org/obo/MONDO_0003907) (ovarian yolk sac tumor, polyvesicular vitelline pattern), [MONDO:0003908](http://purl.obolibrary.org/obo/MONDO_0003908) (clivus meningioma), [MONDO:0003905](http://purl.obolibrary.org/obo/MONDO_0003905) (ovarian yolk sac tumor, glandular pattern), [MONDO:0003906](http://purl.obolibrary.org/obo/MONDO_0003906) (ovarian yolk sac tumor, hepatoid pattern), [MONDO:0003903](http://purl.obolibrary.org/obo/MONDO_0003903) (benign vaginal mixed tumor), [MONDO:0003904](http://purl.obolibrary.org/obo/MONDO_0003904) (lung occult squamous cell carcinoma), [MONDO:0003901](http://purl.obolibrary.org/obo/MONDO_0003901) (cerebellar hemangioblastoma), [MONDO:0003902](http://purl.obolibrary.org/obo/MONDO_0003902) (brain stem hemangioblastoma), [MONDO:0003918](http://purl.obolibrary.org/obo/MONDO_0003918) (angiomatous meningioma), [MONDO:0003916](http://purl.obolibrary.org/obo/MONDO_0003916) (overnutrition), [MONDO:0003917](http://purl.obolibrary.org/obo/MONDO_0003917) (heart lymphoma), [MONDO:0003914](http://purl.obolibrary.org/obo/MONDO_0003914) (inborn purine-pyrimidine metabolic disorder), [MONDO:0003915](http://purl.obolibrary.org/obo/MONDO_0003915) (cortical thymoma), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0015950](http://purl.obolibrary.org/obo/MONDO_0015950) (rare genetic skin tumor), [MONDO:0014621](http://purl.obolibrary.org/obo/MONDO_0014621) (Brugada syndrome 9), [MONDO:0001306](http://purl.obolibrary.org/obo/MONDO_0001306) (recurrent corneal erosion), [MONDO:0001308](http://purl.obolibrary.org/obo/MONDO_0001308) (corneal deposit), [MONDO:0003967](http://purl.obolibrary.org/obo/MONDO_0003967) (synchronous multifocal osteogenic sarcoma), [MONDO:0002638](http://purl.obolibrary.org/obo/MONDO_0002638) (glossopharyngeal nerve neoplasm), [MONDO:0001307](http://purl.obolibrary.org/obo/MONDO_0001307) (corneal abscess), [MONDO:0003968](http://purl.obolibrary.org/obo/MONDO_0003968) (asynchronous multifocal osteogenic sarcoma), [MONDO:0002633](http://purl.obolibrary.org/obo/MONDO_0002633) (cranial nerve neoplasm), [MONDO:0001301](http://purl.obolibrary.org/obo/MONDO_0001301) (rumination disorder), [MONDO:0002632](http://purl.obolibrary.org/obo/MONDO_0002632) (metachronous osteosarcoma of the bone), [MONDO:0003966](http://purl.obolibrary.org/obo/MONDO_0003966) (testicular monophasic choriocarcinoma), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0001303](http://purl.obolibrary.org/obo/MONDO_0001303) (abnormal pupillary function (disease)), [MONDO:0002631](http://purl.obolibrary.org/obo/MONDO_0002631) (conventional osteosarcoma), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0002630](http://purl.obolibrary.org/obo/MONDO_0002630) (small cell osteogenic sarcoma), [MONDO:0014626](http://purl.obolibrary.org/obo/MONDO_0014626) (spinocerebellar ataxia type 41), [MONDO:0014629](http://purl.obolibrary.org/obo/MONDO_0014629) (autoimmune interstitial lung disease-arthritis syndrome), [MONDO:0015959](http://purl.obolibrary.org/obo/MONDO_0015959) (genetic bone tumor), [MONDO:0014623](http://purl.obolibrary.org/obo/MONDO_0014623) (microcephaly 14, primary, autosomal recessive), [MONDO:0015941](http://purl.obolibrary.org/obo/MONDO_0015941) (epiphyseal dysplasia-hearing loss-dysmorphism syndrome), [MONDO:0014610](http://purl.obolibrary.org/obo/MONDO_0014610) (lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome), [MONDO:0002648](http://purl.obolibrary.org/obo/MONDO_0002648) (mammary Paget's disease), [MONDO:0001317](http://purl.obolibrary.org/obo/MONDO_0001317) (phlyctenulosis), [MONDO:0003978](http://purl.obolibrary.org/obo/MONDO_0003978) (colon small cell carcinoma), [MONDO:0001319](http://purl.obolibrary.org/obo/MONDO_0001319) (bladder lateral wall cancer), [MONDO:0003979](http://purl.obolibrary.org/obo/MONDO_0003979) (intrahepatic bile duct cystadenoma), [MONDO:0002649](http://purl.obolibrary.org/obo/MONDO_0002649) (scrotum Paget's disease), [MONDO:0001313](http://purl.obolibrary.org/obo/MONDO_0001313) (acute allergic serous otitis media), [MONDO:0003976](http://purl.obolibrary.org/obo/MONDO_0003976) (malignant type AB thymoma), [MONDO:0003975](http://purl.obolibrary.org/obo/MONDO_0003975) (Littre gland carcinoma), [MONDO:0001314](http://purl.obolibrary.org/obo/MONDO_0001314) (chondrocalcinosis), [MONDO:0002640](http://purl.obolibrary.org/obo/MONDO_0002640) (optic nerve neoplasm), [MONDO:0003972](http://purl.obolibrary.org/obo/MONDO_0003972) (gastric body carcinoma), [MONDO:0003973](http://purl.obolibrary.org/obo/MONDO_0003973) (tubular variant testicular seminoma), [MONDO:0002642](http://purl.obolibrary.org/obo/MONDO_0002642) (trochlear nerve neoplasm), [MONDO:0003970](http://purl.obolibrary.org/obo/MONDO_0003970) (gastric fundus carcinoma), [MONDO:0003971](http://purl.obolibrary.org/obo/MONDO_0003971) (gastric pylorus carcinoma), [MONDO:0001310](http://purl.obolibrary.org/obo/MONDO_0001310) (Bowman's membrane folds or rupture), [MONDO:0014619](http://purl.obolibrary.org/obo/MONDO_0014619) (trichothiodystrophy 3, photosensitive), [MONDO:0014615](http://purl.obolibrary.org/obo/MONDO_0014615) (trichothiodystrophy 2, photosensitive), [MONDO:0014618](http://purl.obolibrary.org/obo/MONDO_0014618) (retinitis pigmentosa 71), [MONDO:0014611](http://purl.obolibrary.org/obo/MONDO_0014611) (multiple mitochondrial dysfunctions syndrome 4), [MONDO:0015942](http://purl.obolibrary.org/obo/MONDO_0015942) (frontometaphyseal dysplasia), [MONDO:0015945](http://purl.obolibrary.org/obo/MONDO_0015945) (polymalformative genetic syndrome with increased risk of developing cancer), [MONDO:0014614](http://purl.obolibrary.org/obo/MONDO_0014614) (congenital stationary night blindness 1G), [MONDO:0015944](http://purl.obolibrary.org/obo/MONDO_0015944) (axial mesodermal dysplasia spectrum), [MONDO:0002619](http://purl.obolibrary.org/obo/MONDO_0002619) (bone fibrosarcoma), [MONDO:0002618](http://purl.obolibrary.org/obo/MONDO_0002618) (malignant fibrous histiocytoma of bone), [MONDO:0002615](http://purl.obolibrary.org/obo/MONDO_0002615) (xanthomatosis (disease)), [MONDO:0003947](http://purl.obolibrary.org/obo/MONDO_0003947) (hyper-IgM syndrome), [MONDO:0003948](http://purl.obolibrary.org/obo/MONDO_0003948) (cerebral hemangioma), [MONDO:0003945](http://purl.obolibrary.org/obo/MONDO_0003945) (bone epithelioid hemangioma), [MONDO:0002617](http://purl.obolibrary.org/obo/MONDO_0002617) (bone angioendothelial sarcoma), [MONDO:0003946](http://purl.obolibrary.org/obo/MONDO_0003946) (vaginal villous adenoma), [MONDO:0002616](http://purl.obolibrary.org/obo/MONDO_0002616) (mesenchymal cell neoplasm), [MONDO:0003943](http://purl.obolibrary.org/obo/MONDO_0003943) (central nervous system hibernoma), [MONDO:0003944](http://purl.obolibrary.org/obo/MONDO_0003944) (endobronchial leiomyoma), [MONDO:0003941](http://purl.obolibrary.org/obo/MONDO_0003941) (classic variant of chromophobe renal cell carcinoma), [MONDO:0003942](http://purl.obolibrary.org/obo/MONDO_0003942) (eosinophilic variant of chromophobe renal cell carcinoma), [MONDO:0014608](http://purl.obolibrary.org/obo/MONDO_0014608) (mandibulofacial dysostosis with alopecia), [MONDO:0015939](http://purl.obolibrary.org/obo/MONDO_0015939) (systemic autoimmune disease), [MONDO:0014609](http://purl.obolibrary.org/obo/MONDO_0014609) (cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome), [MONDO:0015936](http://purl.obolibrary.org/obo/MONDO_0015936) (rare tumor of endocrine glands), [MONDO:0014605](http://purl.obolibrary.org/obo/MONDO_0014605) (microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome), [MONDO:0015935](http://purl.obolibrary.org/obo/MONDO_0015935) (extragonadal germinoma), [MONDO:0014606](http://purl.obolibrary.org/obo/MONDO_0014606) (intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome), [MONDO:0015937](http://purl.obolibrary.org/obo/MONDO_0015937) (rare inflammatory eye disease), [MONDO:0014600](http://purl.obolibrary.org/obo/MONDO_0014600) (dyskeratosis congenita, autosomal recessive 6), [MONDO:0015931](http://purl.obolibrary.org/obo/MONDO_0015931) (rare urogenital tumor), [MONDO:0014601](http://purl.obolibrary.org/obo/MONDO_0014601) (autosomal recessive spinocerebellar ataxia 20), [MONDO:0014602](http://purl.obolibrary.org/obo/MONDO_0014602) (intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome), [MONDO:0014603](http://purl.obolibrary.org/obo/MONDO_0014603) (autosomal dominant nonsyndromic deafness 40), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0002626](http://purl.obolibrary.org/obo/MONDO_0002626) (spinal accessory nerve neoplasm), [MONDO:0003958](http://purl.obolibrary.org/obo/MONDO_0003958) (childhood central nervous system immature teratoma), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0002625](http://purl.obolibrary.org/obo/MONDO_0002625) (Ewing sarcoma of bone), [MONDO:0002628](http://purl.obolibrary.org/obo/MONDO_0002628) (peripheral osteosarcoma), [MONDO:0003957](http://purl.obolibrary.org/obo/MONDO_0003957) (adult pineoblastoma), [MONDO:0002627](http://purl.obolibrary.org/obo/MONDO_0002627) (chondroblastic osteosarcoma), [MONDO:0003954](http://purl.obolibrary.org/obo/MONDO_0003954) (angiokeratoma of Fordyce), [MONDO:0002622](http://purl.obolibrary.org/obo/MONDO_0002622) (multifocal osteogenic sarcoma), [MONDO:0003955](http://purl.obolibrary.org/obo/MONDO_0003955) (juvenile breast papillomatosis), [MONDO:0002621](http://purl.obolibrary.org/obo/MONDO_0002621) (extraosseous osteosarcoma), [MONDO:0003952](http://purl.obolibrary.org/obo/MONDO_0003952) (adult central nervous system choriocarcinoma), [MONDO:0002624](http://purl.obolibrary.org/obo/MONDO_0002624) (bone leiomyosarcoma), [MONDO:0002623](http://purl.obolibrary.org/obo/MONDO_0002623) (pediatric osteosarcoma), [MONDO:0003953](http://purl.obolibrary.org/obo/MONDO_0003953) (pediatric CNS choriocarcinoma), [MONDO:0003950](http://purl.obolibrary.org/obo/MONDO_0003950) (nipple carcinoma), [MONDO:0003951](http://purl.obolibrary.org/obo/MONDO_0003951) (scrotal angioma), [MONDO:0002620](http://purl.obolibrary.org/obo/MONDO_0002620) (localized osteosarcoma), [MONDO:0015994](http://purl.obolibrary.org/obo/MONDO_0015994) (muscular dystrophy-white matter spongiosis syndrome), [MONDO:0013331](http://purl.obolibrary.org/obo/MONDO_0013331) (factor 5 and Factor Viii, combined deficiency of, 2), [MONDO:0014663](http://purl.obolibrary.org/obo/MONDO_0014663) (growth restriction, severe, with distinctive facies), [MONDO:0015993](http://purl.obolibrary.org/obo/MONDO_0015993) (cone-rod dystrophy), [MONDO:0014664](http://purl.obolibrary.org/obo/MONDO_0014664) (Joubert syndrome 23), [MONDO:0013334](http://purl.obolibrary.org/obo/MONDO_0013334) (cocoon syndrome), [MONDO:0015995](http://purl.obolibrary.org/obo/MONDO_0015995) (melorheostosis with osteopoikilosis), [MONDO:0014665](http://purl.obolibrary.org/obo/MONDO_0014665) (Charcot-Marie-tooth disease axonal type 2V), [MONDO:0012003](http://purl.obolibrary.org/obo/MONDO_0012003) (autosomal recessive nonsyndromic deafness 39), [MONDO:0012002](http://purl.obolibrary.org/obo/MONDO_0012002) (autosomal recessive nonsyndromic deafness 40), [MONDO:0014660](http://purl.obolibrary.org/obo/MONDO_0014660) (microcephaly 15, primary, autosomal recessive), [MONDO:0015991](http://purl.obolibrary.org/obo/MONDO_0015991) (citrullinemia), [MONDO:0000014](http://purl.obolibrary.org/obo/MONDO_0000014) (colorblindness, partial), [MONDO:0002677](http://purl.obolibrary.org/obo/MONDO_0002677) (conventional fibrosarcoma), [MONDO:0002676](http://purl.obolibrary.org/obo/MONDO_0002676) (adult fibrosarcoma), [MONDO:0001347](http://purl.obolibrary.org/obo/MONDO_0001347) (facioscapulohumeral muscular dystrophy), [MONDO:0002678](http://purl.obolibrary.org/obo/MONDO_0002678) (pediatric fibrosarcoma), [MONDO:0002672](http://purl.obolibrary.org/obo/MONDO_0002672) (prostate signet ring cell adenocarcinoma), [MONDO:0002675](http://purl.obolibrary.org/obo/MONDO_0002675) (neurofibrosarcoma), [MONDO:0000013](http://purl.obolibrary.org/obo/MONDO_0000013) (choroidal dystrophy), [MONDO:0001340](http://purl.obolibrary.org/obo/MONDO_0001340) (heart cancer), [MONDO:0002671](http://purl.obolibrary.org/obo/MONDO_0002671) (breast signet ring cell adenocarcinoma), [MONDO:0002670](http://purl.obolibrary.org/obo/MONDO_0002670) (ampulla of vater adenocarcinoma), [MONDO:0012006](http://purl.obolibrary.org/obo/MONDO_0012006) (craniosynostosis with ocular abnormalities and Hallucal defects), [MONDO:0012004](http://purl.obolibrary.org/obo/MONDO_0012004) (parathyroid gland carcinoma), [MONDO:0014666](http://purl.obolibrary.org/obo/MONDO_0014666) (hypomyelinating leukodystrophy 11), [MONDO:0015998](http://purl.obolibrary.org/obo/MONDO_0015998) (isolated ectopia lentis), [MONDO:0015997](http://purl.obolibrary.org/obo/MONDO_0015997) (ectopia lentis-chorioretinal dystrophy-myopia syndrome), [MONDO:0014667](http://purl.obolibrary.org/obo/MONDO_0014667) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3), [MONDO:0013336](http://purl.obolibrary.org/obo/MONDO_0013336) (chromosome 19p13.13 deletion syndrome), [MONDO:0014668](http://purl.obolibrary.org/obo/MONDO_0014668) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4), [MONDO:0013337](http://purl.obolibrary.org/obo/MONDO_0013337) (neuropathy, hereditary sensory and autonomic, type 1C), [MONDO:0012008](http://purl.obolibrary.org/obo/MONDO_0012008) (Lelis syndrome), [MONDO:0014669](http://purl.obolibrary.org/obo/MONDO_0014669) (cone-rod dystrophy 21), [MONDO:0013338](http://purl.obolibrary.org/obo/MONDO_0013338) (Charcot-Marie-tooth disease recessive intermediate b), [MONDO:0014651](http://purl.obolibrary.org/obo/MONDO_0014651) (acrofacial dysostosis Cincinnati type), [MONDO:0014652](http://purl.obolibrary.org/obo/MONDO_0014652) (exudative vitreoretinopathy 6), [MONDO:0013322](http://purl.obolibrary.org/obo/MONDO_0013322) (FAME3), [MONDO:0015985](http://purl.obolibrary.org/obo/MONDO_0015985) (bone dysplasia, Azouz type), [MONDO:0014653](http://purl.obolibrary.org/obo/MONDO_0014653) (retinitis pigmentosa 72), [MONDO:0014654](http://purl.obolibrary.org/obo/MONDO_0014654) (Ullrich congenital muscular dystrophy 2), [MONDO:0013323](http://purl.obolibrary.org/obo/MONDO_0013323) (cranioectodermal dysplasia 2), [MONDO:0015981](http://purl.obolibrary.org/obo/MONDO_0015981) (rare genetic gynecological tumor), [MONDO:0001357](http://purl.obolibrary.org/obo/MONDO_0001357) (hypochromic anemia (disease)), [MONDO:0000026](http://purl.obolibrary.org/obo/MONDO_0000026) (Fanconi renotubular syndrome), [MONDO:0001356](http://purl.obolibrary.org/obo/MONDO_0001356) (iron deficiency anemia), [MONDO:0001359](http://purl.obolibrary.org/obo/MONDO_0001359) (Kohler's disease), [MONDO:0002684](http://purl.obolibrary.org/obo/MONDO_0002684) (atypical choroid plexus papilloma), [MONDO:0001352](http://purl.obolibrary.org/obo/MONDO_0001352) (round ligament malignant neoplasm), [MONDO:0002683](http://purl.obolibrary.org/obo/MONDO_0002683) (adult choroid plexus cancer), [MONDO:0001355](http://purl.obolibrary.org/obo/MONDO_0001355) (ocular siderosis), [MONDO:0000024](http://purl.obolibrary.org/obo/MONDO_0000024) (exostoses, multiple), [MONDO:0002685](http://purl.obolibrary.org/obo/MONDO_0002685) (childhood choroid plexus cancer), [MONDO:0002682](http://purl.obolibrary.org/obo/MONDO_0002682) (cerebral ventricle cancer), [MONDO:0001351](http://purl.obolibrary.org/obo/MONDO_0001351) (uterine adnexa cancer), [MONDO:0002681](http://purl.obolibrary.org/obo/MONDO_0002681) (choroid plexus cancer), [MONDO:0001350](http://purl.obolibrary.org/obo/MONDO_0001350) (parametrium malignant neoplasm), [MONDO:0013328](http://purl.obolibrary.org/obo/MONDO_0013328) (retinitis pigmentosa 58), [MONDO:0013329](http://purl.obolibrary.org/obo/MONDO_0013329) (familial clubfoot due to 17q23.1q23.2 microduplication), [MONDO:0013324](http://purl.obolibrary.org/obo/MONDO_0013324) (lymphedema-posterior choanal atresia syndrome), [MONDO:0014655](http://purl.obolibrary.org/obo/MONDO_0014655) (Bethlem myopathy 2), [MONDO:0015986](http://purl.obolibrary.org/obo/MONDO_0015986) (renal agenesis, bilateral), [MONDO:0013325](http://purl.obolibrary.org/obo/MONDO_0013325) (COG5-CDG), [MONDO:0014656](http://purl.obolibrary.org/obo/MONDO_0014656) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 2), [MONDO:0013326](http://purl.obolibrary.org/obo/MONDO_0013326) (Senior-Loken syndrome 7), [MONDO:0015989](http://purl.obolibrary.org/obo/MONDO_0015989) (congenital valvular dysplasia), [MONDO:0014657](http://purl.obolibrary.org/obo/MONDO_0014657) (primary ciliary dyskinesia 32), [MONDO:0014658](http://purl.obolibrary.org/obo/MONDO_0014658) (severe achondroplasia-developmental delay-acanthosis nigricans syndrome), [MONDO:0013327](http://purl.obolibrary.org/obo/MONDO_0013327) (primary hyperoxaluria type 3), [MONDO:0015988](http://purl.obolibrary.org/obo/MONDO_0015988) (multicystic dysplastic kidney), [MONDO:0014640](http://purl.obolibrary.org/obo/MONDO_0014640) (FTDALS3), [MONDO:0015972](http://purl.obolibrary.org/obo/MONDO_0015972) (rare constitutional anemia), [MONDO:0014641](http://purl.obolibrary.org/obo/MONDO_0014641) (FTDALS4), [MONDO:0013310](http://purl.obolibrary.org/obo/MONDO_0013310) (congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency), [MONDO:0013311](http://purl.obolibrary.org/obo/MONDO_0013311) (ectodermal dysplasia-syndactyly syndrome), [MONDO:0015974](http://purl.obolibrary.org/obo/MONDO_0015974) (severe combined immunodeficiency (disease)), [MONDO:0013312](http://purl.obolibrary.org/obo/MONDO_0013312) (retinitis pigmentosa 55), [MONDO:0014643](http://purl.obolibrary.org/obo/MONDO_0014643) (congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome), [MONDO:0015973](http://purl.obolibrary.org/obo/MONDO_0015973) (rare genetic coagulation disorder), [MONDO:0002659](http://purl.obolibrary.org/obo/MONDO_0002659) (uveal cancer), [MONDO:0001328](http://purl.obolibrary.org/obo/MONDO_0001328) (thyroid hormone resistance syndrome), [MONDO:0002658](http://purl.obolibrary.org/obo/MONDO_0002658) (iris cancer), [MONDO:0003989](http://purl.obolibrary.org/obo/MONDO_0003989) (polyembryoma of the ovary), [MONDO:0001329](http://purl.obolibrary.org/obo/MONDO_0001329) (accommodative spasm), [MONDO:0003987](http://purl.obolibrary.org/obo/MONDO_0003987) (lung lymphoma), [MONDO:0002655](http://purl.obolibrary.org/obo/MONDO_0002655) (cutaneous Paget's disease), [MONDO:0001324](http://purl.obolibrary.org/obo/MONDO_0001324) (hyperandrogenism), [MONDO:0003988](http://purl.obolibrary.org/obo/MONDO_0003988) (sternum lymphoma), [MONDO:0003985](http://purl.obolibrary.org/obo/MONDO_0003985) (chest wall lymphoma), [MONDO:0001325](http://purl.obolibrary.org/obo/MONDO_0001325) (penile cancer), [MONDO:0002656](http://purl.obolibrary.org/obo/MONDO_0002656) (skin carcinoma), [MONDO:0003986](http://purl.obolibrary.org/obo/MONDO_0003986) (bone lymphoma), [MONDO:0002651](http://purl.obolibrary.org/obo/MONDO_0002651) (anal Paget's disease), [MONDO:0001320](http://purl.obolibrary.org/obo/MONDO_0001320) (ring staphyloma), [MONDO:0003983](http://purl.obolibrary.org/obo/MONDO_0003983) (synchronous bilateral breast carcinoma), [MONDO:0003984](http://purl.obolibrary.org/obo/MONDO_0003984) (internal auditory canal lipoma), [MONDO:0002650](http://purl.obolibrary.org/obo/MONDO_0002650) (scrotal carcinoma), [MONDO:0002653](http://purl.obolibrary.org/obo/MONDO_0002653) (Paget disease of the penis), [MONDO:0003981](http://purl.obolibrary.org/obo/MONDO_0003981) (cervix small cell carcinoma), [MONDO:0001322](http://purl.obolibrary.org/obo/MONDO_0001322) (pericardium cancer), [MONDO:0002652](http://purl.obolibrary.org/obo/MONDO_0002652) (anus adenocarcinoma), [MONDO:0003982](http://purl.obolibrary.org/obo/MONDO_0003982) (bilateral breast carcinoma), [MONDO:0001321](http://purl.obolibrary.org/obo/MONDO_0001321) (scleral staphyloma (disease)), [MONDO:0003980](http://purl.obolibrary.org/obo/MONDO_0003980) (schwannoma of jugular foramen), [MONDO:0013317](http://purl.obolibrary.org/obo/MONDO_0013317) (Torsade-de-pointes syndrome with short coupling interval), [MONDO:0015976](http://purl.obolibrary.org/obo/MONDO_0015976) (hyper-IgM syndrome without susceptibility to opportunistic infections), [MONDO:0013313](http://purl.obolibrary.org/obo/MONDO_0013313) (ectodermal dysplasia-cutaneous syndactyly syndrome), [MONDO:0014644](http://purl.obolibrary.org/obo/MONDO_0014644) (hereditary spastic paraplegia 74), [MONDO:0015975](http://purl.obolibrary.org/obo/MONDO_0015975) (hyper-IgM syndrome with susceptibility to opportunistic infections), [MONDO:0014645](http://purl.obolibrary.org/obo/MONDO_0014645) (BENTA disease), [MONDO:0013314](http://purl.obolibrary.org/obo/MONDO_0013314) (retinitis pigmentosa 56), [MONDO:0013315](http://purl.obolibrary.org/obo/MONDO_0013315) (retinitis pigmentosa 57), [MONDO:0014646](http://purl.obolibrary.org/obo/MONDO_0014646) (Zimmermann-Laband syndrome 2), [MONDO:0014647](http://purl.obolibrary.org/obo/MONDO_0014647) (CAD-CDG), [MONDO:0013316](http://purl.obolibrary.org/obo/MONDO_0013316) (occult macular dystrophy), [MONDO:0015977](http://purl.obolibrary.org/obo/MONDO_0015977) (agammaglobulinemia), [MONDO:0015961](http://purl.obolibrary.org/obo/MONDO_0015961) (genetic head and neck malformation), [MONDO:0015960](http://purl.obolibrary.org/obo/MONDO_0015960) (rare genetic developmental defect during embryogenesis), [MONDO:0014630](http://purl.obolibrary.org/obo/MONDO_0014630) (NTHL1-related attenuated familial adenomatous polyposis), [MONDO:0013300](http://purl.obolibrary.org/obo/MONDO_0013300) (commissural facial cleft), [MONDO:0014631](http://purl.obolibrary.org/obo/MONDO_0014631) (hypomagnesemia, seizures, and mental retardation), [MONDO:0015963](http://purl.obolibrary.org/obo/MONDO_0015963) (genetic renal tumor), [MONDO:0013301](http://purl.obolibrary.org/obo/MONDO_0013301) (aromatase deficiency), [MONDO:0002669](http://purl.obolibrary.org/obo/MONDO_0002669) (ampullary signet ring cell adenocarcinoma), [MONDO:0002666](http://purl.obolibrary.org/obo/MONDO_0002666) (pancreatic signet ring cell adenocarcinoma), [MONDO:0001335](http://purl.obolibrary.org/obo/MONDO_0001335) (hypotrichosis of eyelid), [MONDO:0003998](http://purl.obolibrary.org/obo/MONDO_0003998) (vaginal tubular adenoma), [MONDO:0000004](http://purl.obolibrary.org/obo/MONDO_0000004) (adrenal hypoplasia), [MONDO:0001334](http://purl.obolibrary.org/obo/MONDO_0001334) (hypertrichosis of eyelid), [MONDO:0002665](http://purl.obolibrary.org/obo/MONDO_0002665) (extrahepatic bile duct adenocarcinoma), [MONDO:0003999](http://purl.obolibrary.org/obo/MONDO_0003999) (juvenile pilocytic astrocytoma), [MONDO:0003997](http://purl.obolibrary.org/obo/MONDO_0003997) (colon Kaposi sarcoma), [MONDO:0001336](http://purl.obolibrary.org/obo/MONDO_0001336) (familial hyperlipidemia), [MONDO:0002667](http://purl.obolibrary.org/obo/MONDO_0002667) (gallbladder signet ring cell adenocarcinoma), [MONDO:0001331](http://purl.obolibrary.org/obo/MONDO_0001331) (conjunctival deposit), [MONDO:0003994](http://purl.obolibrary.org/obo/MONDO_0003994) (vagina botryoid rhabdomyosarcoma), [MONDO:0001330](http://purl.obolibrary.org/obo/MONDO_0001330) (presbyopia), [MONDO:0003995](http://purl.obolibrary.org/obo/MONDO_0003995) (vulvar childhood botryoid-type embryonal rhabdomyosarcoma), [MONDO:0002661](http://purl.obolibrary.org/obo/MONDO_0002661) (uveal disease), [MONDO:0002664](http://purl.obolibrary.org/obo/MONDO_0002664) (bile duct signet ring cell carcinoma), [MONDO:0003992](http://purl.obolibrary.org/obo/MONDO_0003992) (childhood botryoid rhabdomyosarcoma), [MONDO:0003993](http://purl.obolibrary.org/obo/MONDO_0003993) (childhood vagina botryoid rhabdomyosarcoma), [MONDO:0003990](http://purl.obolibrary.org/obo/MONDO_0003990) (malignant breast myoepithelioma), [MONDO:0003991](http://purl.obolibrary.org/obo/MONDO_0003991) (villoglandular endometrial endometrioid adenocarcinoma), [MONDO:0002660](http://purl.obolibrary.org/obo/MONDO_0002660) (blepharochalasis (disease)), [MONDO:0014637](http://purl.obolibrary.org/obo/MONDO_0014637) (DOCK2 deficiency), [MONDO:0013306](http://purl.obolibrary.org/obo/MONDO_0013306) (combined oxidative phosphorylation defect type 7), [MONDO:0014638](http://purl.obolibrary.org/obo/MONDO_0014638) (Fanconi anemia complementation group T), [MONDO:0013307](http://purl.obolibrary.org/obo/MONDO_0013307) (myopathy, lactic acidosis, and sideroblastic anemia 2), [MONDO:0013308](http://purl.obolibrary.org/obo/MONDO_0013308) (Noonan syndrome-like disorder with juvenile myelomonocytic leukemia), [MONDO:0015965](http://purl.obolibrary.org/obo/MONDO_0015965) (rare genetic refraction anomaly), [MONDO:0013303](http://purl.obolibrary.org/obo/MONDO_0013303) (autoimmune disease, susceptibility to, 6), [MONDO:0015964](http://purl.obolibrary.org/obo/MONDO_0015964) (rare genetic palpebral, lacrimal system and conjunctival disease), [MONDO:0014634](http://purl.obolibrary.org/obo/MONDO_0014634) (46,Xy sex reversal 10), [MONDO:0015967](http://purl.obolibrary.org/obo/MONDO_0015967) (rare genetic diabetes mellitus), [MONDO:0013304](http://purl.obolibrary.org/obo/MONDO_0013304) (von willebrand's disease 2), [MONDO:0014635](http://purl.obolibrary.org/obo/MONDO_0014635) (microphthalmia, isolated, with coloboma 10), [MONDO:0014636](http://purl.obolibrary.org/obo/MONDO_0014636) (combined oxidative phosphorylation defect type 25), [MONDO:0015966](http://purl.obolibrary.org/obo/MONDO_0015966) (genetic eye tumor), [MONDO:0013305](http://purl.obolibrary.org/obo/MONDO_0013305) (autosomal dominant nonsyndromic deafness 51), [MONDO:0013375](http://purl.obolibrary.org/obo/MONDO_0013375) (Klippel-Feil syndrome 3, autosomal dominant), [MONDO:0012043](http://purl.obolibrary.org/obo/MONDO_0012043) (Reis-Bucklers corneal dystrophy), [MONDO:0013376](http://purl.obolibrary.org/obo/MONDO_0013376) (microphthalmia, isolated, with coloboma 6), [MONDO:0012042](http://purl.obolibrary.org/obo/MONDO_0012042) (HSCR8), [MONDO:0013377](http://purl.obolibrary.org/obo/MONDO_0013377) (isolated microphthalmia 7), [MONDO:0012041](http://purl.obolibrary.org/obo/MONDO_0012041) (MUTYH-related attenuated familial adenomatous polyposis), [MONDO:0012040](http://purl.obolibrary.org/obo/MONDO_0012040) (inflammatory bowel disease 9), [MONDO:0013372](http://purl.obolibrary.org/obo/MONDO_0013372) (long QT syndrome 5), [MONDO:0012045](http://purl.obolibrary.org/obo/MONDO_0012045) (MYP5), [MONDO:0012044](http://purl.obolibrary.org/obo/MONDO_0012044) (corneal dystrophy, lattice type 3A), [MONDO:0013370](http://purl.obolibrary.org/obo/MONDO_0013370) (long QT syndrome 6), [MONDO:0001386](http://purl.obolibrary.org/obo/MONDO_0001386) (visual epilepsy), [MONDO:0001385](http://purl.obolibrary.org/obo/MONDO_0001385) (cortical blindness), [MONDO:0000056](http://purl.obolibrary.org/obo/MONDO_0000056) (mandibuloacral dysplasia with lipodystrophy), [MONDO:0001388](http://purl.obolibrary.org/obo/MONDO_0001388) (glans penis cancer), [MONDO:0001387](http://purl.obolibrary.org/obo/MONDO_0001387) (penis sarcoma), [MONDO:0001381](http://purl.obolibrary.org/obo/MONDO_0001381) (bladder lymphoma), [MONDO:0001384](http://purl.obolibrary.org/obo/MONDO_0001384) (myopia (disease)), [MONDO:0001383](http://purl.obolibrary.org/obo/MONDO_0001383) (degenerative myopia), [MONDO:0012049](http://purl.obolibrary.org/obo/MONDO_0012049) (orofaciodigital syndrome VII), [MONDO:0001380](http://purl.obolibrary.org/obo/MONDO_0001380) (bladder dome cancer), [MONDO:0013379](http://purl.obolibrary.org/obo/MONDO_0013379) (Noonan syndrome 7), [MONDO:0013364](http://purl.obolibrary.org/obo/MONDO_0013364) (Rubinstein-Taybi syndrome due to EP300 haploinsufficiency), [MONDO:0014695](http://purl.obolibrary.org/obo/MONDO_0014695) (glioma susceptibility 9), [MONDO:0012032](http://purl.obolibrary.org/obo/MONDO_0012032) (Braddock syndrome), [MONDO:0014696](http://purl.obolibrary.org/obo/MONDO_0014696) (Cerebrooculofacioskeletal syndrome 3), [MONDO:0012031](http://purl.obolibrary.org/obo/MONDO_0012031) (platelet-type bleeding disorder 10), [MONDO:0013365](http://purl.obolibrary.org/obo/MONDO_0013365) (autosomal recessive nonsyndromic deafness 83), [MONDO:0014697](http://purl.obolibrary.org/obo/MONDO_0014697) (immunodeficiency, common variable, 12), [MONDO:0013366](http://purl.obolibrary.org/obo/MONDO_0013366) (spondylocostal dysostosis 4, autosomal recessive), [MONDO:0012030](http://purl.obolibrary.org/obo/MONDO_0012030) (autosomal dominant nonsyndromic deafness 43), [MONDO:0013367](http://purl.obolibrary.org/obo/MONDO_0013367) (long QT syndrome 2), [MONDO:0014698](http://purl.obolibrary.org/obo/MONDO_0014698) (microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome), [MONDO:0013360](http://purl.obolibrary.org/obo/MONDO_0013360) (brachyolmia, Maroteaux type), [MONDO:0012036](http://purl.obolibrary.org/obo/MONDO_0012036) (SLEB4), [MONDO:0014691](http://purl.obolibrary.org/obo/MONDO_0014691) (Noonan syndrome 9), [MONDO:0013361](http://purl.obolibrary.org/obo/MONDO_0013361) (prothrombin deficiency), [MONDO:0014692](http://purl.obolibrary.org/obo/MONDO_0014692) (retinitis pigmentosa 74), [MONDO:0012035](http://purl.obolibrary.org/obo/MONDO_0012035) (craniosynostosis-intracranial calcifications syndrome), [MONDO:0012034](http://purl.obolibrary.org/obo/MONDO_0012034) (autosomal dominant limb-girdle muscular dystrophy type 1F), [MONDO:0013362](http://purl.obolibrary.org/obo/MONDO_0013362) (THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome), [MONDO:0014693](http://purl.obolibrary.org/obo/MONDO_0014693) (Noonan syndrome 10), [MONDO:0013363](http://purl.obolibrary.org/obo/MONDO_0013363) (chromosome 2q31.1 duplication syndrome), [MONDO:0014694](http://purl.obolibrary.org/obo/MONDO_0014694) (spondylocostal dysostosis 6, autosomal recessive), [MONDO:0012033](http://purl.obolibrary.org/obo/MONDO_0012033) (bradyopsia), [MONDO:0014690](http://purl.obolibrary.org/obo/MONDO_0014690) (dyskeratosis congenita, autosomal dominant 6), [MONDO:0000066](http://purl.obolibrary.org/obo/MONDO_0000066) (mitochondrial complex deficiency), [MONDO:0001396](http://purl.obolibrary.org/obo/MONDO_0001396) (abnormal threshold of rods), [MONDO:0001399](http://purl.obolibrary.org/obo/MONDO_0001399) (ureter leiomyoma), [MONDO:0001398](http://purl.obolibrary.org/obo/MONDO_0001398) (ureter benign neoplasm), [MONDO:0001393](http://purl.obolibrary.org/obo/MONDO_0001393) (peripheral focal chorioretinitis), [MONDO:0001392](http://purl.obolibrary.org/obo/MONDO_0001392) (monocular exotropia), [MONDO:0000062](http://purl.obolibrary.org/obo/MONDO_0000062) (isolated microphthalmia), [MONDO:0001395](http://purl.obolibrary.org/obo/MONDO_0001395) (macular keratitis), [MONDO:0001394](http://purl.obolibrary.org/obo/MONDO_0001394) (chronic erythremia), [MONDO:0001390](http://purl.obolibrary.org/obo/MONDO_0001390) (transient refractive change), [MONDO:0013368](http://purl.obolibrary.org/obo/MONDO_0013368) (mammary-digital-nail syndrome), [MONDO:0012021](http://purl.obolibrary.org/obo/MONDO_0012021) (MYP17), [MONDO:0014684](http://purl.obolibrary.org/obo/MONDO_0014684) (combined oxidative phosphorylation defect type 26), [MONDO:0013354](http://purl.obolibrary.org/obo/MONDO_0013354) (spastic ataxia 4), [MONDO:0014686](http://purl.obolibrary.org/obo/MONDO_0014686) (short stature, microcephaly, and endocrine dysfunction), [MONDO:0013355](http://purl.obolibrary.org/obo/MONDO_0013355) (congenital dyserythropoietic anemia type IV), [MONDO:0014687](http://purl.obolibrary.org/obo/MONDO_0014687) (retinitis pigmentosa 73), [MONDO:0012025](http://purl.obolibrary.org/obo/MONDO_0012025) (branchiootic syndrome 3), [MONDO:0014681](http://purl.obolibrary.org/obo/MONDO_0014681) (thyroid cancer, nonmedullary, 4), [MONDO:0013350](http://purl.obolibrary.org/obo/MONDO_0013350) (mitochondrial DNA depletion syndrome 4b), [MONDO:0012024](http://purl.obolibrary.org/obo/MONDO_0012024) (retinitis pigmentosa 26), [MONDO:0012023](http://purl.obolibrary.org/obo/MONDO_0012023) (autosomal dominant nonsyndromic deafness 49), [MONDO:0014682](http://purl.obolibrary.org/obo/MONDO_0014682) (thyroid cancer, nonmedullary, 5), [MONDO:0013351](http://purl.obolibrary.org/obo/MONDO_0013351) (infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0001368](http://purl.obolibrary.org/obo/MONDO_0001368) (phthisical cornea), [MONDO:0002698](http://purl.obolibrary.org/obo/MONDO_0002698) (testicular gonadoblastoma (disease)), [MONDO:0001364](http://purl.obolibrary.org/obo/MONDO_0001364) (regular astigmatism), [MONDO:0001363](http://purl.obolibrary.org/obo/MONDO_0001363) (blind hypertensive eye), [MONDO:0002697](http://purl.obolibrary.org/obo/MONDO_0002697) (ovarian gonadoblastoma (disease)), [MONDO:0002696](http://purl.obolibrary.org/obo/MONDO_0002696) (Sertoli cell tumor), [MONDO:0002691](http://purl.obolibrary.org/obo/MONDO_0002691) (liver cancer), [MONDO:0001360](http://purl.obolibrary.org/obo/MONDO_0001360) (blind hypotensive eye), [MONDO:0001362](http://purl.obolibrary.org/obo/MONDO_0001362) (leukocoria), [MONDO:0012029](http://purl.obolibrary.org/obo/MONDO_0012029) (microcephaly 6, primary, autosomal recessive), [MONDO:0012028](http://purl.obolibrary.org/obo/MONDO_0012028) (AIS3), [MONDO:0012027](http://purl.obolibrary.org/obo/MONDO_0012027) (AIS2), [MONDO:0012026](http://purl.obolibrary.org/obo/MONDO_0012026) (myotonia, potassium-aggravated), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0014688](http://purl.obolibrary.org/obo/MONDO_0014688) (short-rib thoracic dysplasia 14 with polydactyly), [MONDO:0013358](http://purl.obolibrary.org/obo/MONDO_0013358) (Seckel syndrome 4), [MONDO:0014689](http://purl.obolibrary.org/obo/MONDO_0014689) (Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome), [MONDO:0013359](http://purl.obolibrary.org/obo/MONDO_0013359) (familial hyperaldosteronism type III), [MONDO:0014673](http://purl.obolibrary.org/obo/MONDO_0014673) (cataract 44), [MONDO:0013342](http://purl.obolibrary.org/obo/MONDO_0013342) (hereditary spastic paraplegia 48), [MONDO:0014674](http://purl.obolibrary.org/obo/MONDO_0014674) (maturity-onset diabetes of the young type 14), [MONDO:0014675](http://purl.obolibrary.org/obo/MONDO_0014675) (autosomal recessive nonsyndromic deafness 104), [MONDO:0014676](http://purl.obolibrary.org/obo/MONDO_0014676) (Emery-Dreifuss muscular dystrophy 3, autosomal recessive), [MONDO:0013345](http://purl.obolibrary.org/obo/MONDO_0013345) (d-2-Hydroxyglutaric aciduria 2), [MONDO:0012014](http://purl.obolibrary.org/obo/MONDO_0012014) (Charcot-Marie-tooth disease recessive intermediate a), [MONDO:0014670](http://purl.obolibrary.org/obo/MONDO_0014670) (lethal congenital contracture syndrome 9), [MONDO:0012013](http://purl.obolibrary.org/obo/MONDO_0012013) (glaucoma-ectopia-microspherophakia-stiff joints-short stature syndrome), [MONDO:0014671](http://purl.obolibrary.org/obo/MONDO_0014671) (neuropathy, hereditary motor and sensory, type 6B), [MONDO:0012012](http://purl.obolibrary.org/obo/MONDO_0012012) (Charcot-Marie-tooth disease dominant intermediate c), [MONDO:0013341](http://purl.obolibrary.org/obo/MONDO_0013341) (methylmalonic acidemia due to transcobalamin receptor defect), [MONDO:0014672](http://purl.obolibrary.org/obo/MONDO_0014672) (osteogenesis imperfecta type 17), [MONDO:0001379](http://purl.obolibrary.org/obo/MONDO_0001379) (ureteric orifice cancer), [MONDO:0001378](http://purl.obolibrary.org/obo/MONDO_0001378) (urachus cancer), [MONDO:0001375](http://purl.obolibrary.org/obo/MONDO_0001375) (bladder trigone cancer), [MONDO:0000044](http://purl.obolibrary.org/obo/MONDO_0000044) (hypophosphatemic rickets), [MONDO:0001374](http://purl.obolibrary.org/obo/MONDO_0001374) (bladder sarcoma), [MONDO:0001377](http://purl.obolibrary.org/obo/MONDO_0001377) (vitreous syneresis), [MONDO:0001376](http://purl.obolibrary.org/obo/MONDO_0001376) (urinary bladder anterior wall cancer), [MONDO:0001371](http://purl.obolibrary.org/obo/MONDO_0001371) (protein-energy malnutrition), [MONDO:0001373](http://purl.obolibrary.org/obo/MONDO_0001373) (urinary bladder posterior wall cancer), [MONDO:0001372](http://purl.obolibrary.org/obo/MONDO_0001372) (bladder neck cancer), [MONDO:0012018](http://purl.obolibrary.org/obo/MONDO_0012018) (myopathy, Myosin storage, autosomal dominant), [MONDO:0012017](http://purl.obolibrary.org/obo/MONDO_0012017) (Parkes Weber syndrome), [MONDO:0012016](http://purl.obolibrary.org/obo/MONDO_0012016) (capillary malformation-arteriovenous malformation syndrome), [MONDO:0012015](http://purl.obolibrary.org/obo/MONDO_0012015) (NYS3), [MONDO:0014677](http://purl.obolibrary.org/obo/MONDO_0014677) (achromatopsia 7), [MONDO:0013348](http://purl.obolibrary.org/obo/MONDO_0013348) (cone-rod dystrophy 15), [MONDO:0014679](http://purl.obolibrary.org/obo/MONDO_0014679) (polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis), [MONDO:0012019](http://purl.obolibrary.org/obo/MONDO_0012019) (spondyloepiphyseal dysplasia, Kimberley type), [MONDO:0013349](http://purl.obolibrary.org/obo/MONDO_0013349) (ALG11-CDG), [MONDO:0012087](http://purl.obolibrary.org/obo/MONDO_0012087) (primary ciliary dyskinesia 4), [MONDO:0012086](http://purl.obolibrary.org/obo/MONDO_0012086) (autosomal dominant nonsyndromic deafness 31), [MONDO:0012085](http://purl.obolibrary.org/obo/MONDO_0012085) (primary ciliary dyskinesia 3), [MONDO:0012084](http://purl.obolibrary.org/obo/MONDO_0012084) (aromatic L-amino acid decarboxylase deficiency), [MONDO:0012088](http://purl.obolibrary.org/obo/MONDO_0012088) (primary ciliary dyskinesia 5), [MONDO:0012083](http://purl.obolibrary.org/obo/MONDO_0012083) (autosomal dominant nonsyndromic deafness 28), [MONDO:0012080](http://purl.obolibrary.org/obo/MONDO_0012080) (neuronopathy, distal hereditary motor, type 2B), [MONDO:0000090](http://purl.obolibrary.org/obo/MONDO_0000090) (progressive external ophthalmoplegia with mitochondrial DNA deletions), [MONDO:0012075](http://purl.obolibrary.org/obo/MONDO_0012075) (oligodontia-cancer predisposition syndrome), [MONDO:0012074](http://purl.obolibrary.org/obo/MONDO_0012074) (mandibuloacral dysplasia with type B lipodystrophy), [MONDO:0012073](http://purl.obolibrary.org/obo/MONDO_0012073) (Ribose-5-P isomerase deficiency), [MONDO:0012078](http://purl.obolibrary.org/obo/MONDO_0012078) (Joubert syndrome 3), [MONDO:0012077](http://purl.obolibrary.org/obo/MONDO_0012077) (amyotrophic lateral sclerosis type 8), [MONDO:0012072](http://purl.obolibrary.org/obo/MONDO_0012072) (familial partial lipodystrophy, KC6bberling type), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0012070](http://purl.obolibrary.org/obo/MONDO_0012070) (autosomal dominant Charcot-Marie-tooth disease type 2G), [MONDO:0012064](http://purl.obolibrary.org/obo/MONDO_0012064) (choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome), [MONDO:0012063](http://purl.obolibrary.org/obo/MONDO_0012063) (ulnar/fibula ray defect-brachydactyly syndrome), [MONDO:0012069](http://purl.obolibrary.org/obo/MONDO_0012069) (KTCN3), [MONDO:0013394](http://purl.obolibrary.org/obo/MONDO_0013394) (porencephaly-microcephaly-bilateral congenital cataract syndrome), [MONDO:0013395](http://purl.obolibrary.org/obo/MONDO_0013395) (retinitis pigmentosa 4), [MONDO:0013396](http://purl.obolibrary.org/obo/MONDO_0013396) (chromosome 1p32-p31 deletion syndrome), [MONDO:0012066](http://purl.obolibrary.org/obo/MONDO_0012066) (ATFB1), [MONDO:0013390](http://purl.obolibrary.org/obo/MONDO_0013390) (autosomal recessive limb-girdle muscular dystrophy type 2Q), [MONDO:0013391](http://purl.obolibrary.org/obo/MONDO_0013391) (leukoencephalopathy-dystonia-motor neuropathy syndrome), [MONDO:0013392](http://purl.obolibrary.org/obo/MONDO_0013392) (autosomal recessive spinocerebellar ataxia 10), [MONDO:0012061](http://purl.obolibrary.org/obo/MONDO_0012061) (familial sick sinus syndrome), [MONDO:0012060](http://purl.obolibrary.org/obo/MONDO_0012060) (autosomal recessive nonsyndromic deafness 35), [MONDO:0000078](http://purl.obolibrary.org/obo/MONDO_0000078) (acrocephalopolysyndactyly), [MONDO:0000079](http://purl.obolibrary.org/obo/MONDO_0000079) (nephrolithiasis/osteoporosis, hypophosphatemic), [MONDO:0000075](http://purl.obolibrary.org/obo/MONDO_0000075) (neuronopathy, distal hereditary motor), [MONDO:0013386](http://purl.obolibrary.org/obo/MONDO_0013386) (autosomal recessive nonsyndromic deafness 74), [MONDO:0012052](http://purl.obolibrary.org/obo/MONDO_0012052) (ALG1-CDG), [MONDO:0013382](http://purl.obolibrary.org/obo/MONDO_0013382) (progressive demyelinating neuropathy with bilateral striatal necrosis), [MONDO:0013383](http://purl.obolibrary.org/obo/MONDO_0013383) (Hirschsprung disease, susceptibility to, 3), [MONDO:0012056](http://purl.obolibrary.org/obo/MONDO_0012056) (Leber congenital amaurosis 9), [MONDO:0013384](http://purl.obolibrary.org/obo/MONDO_0013384) (Hirschsprung disease, susceptibility to, 4), [MONDO:0012055](http://purl.obolibrary.org/obo/MONDO_0012055) (larsen-like osseous dysplasia-short stature syndrome), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0013381](http://purl.obolibrary.org/obo/MONDO_0013381) (neuropathy, hereditary sensory, type 1D), [MONDO:0000087](http://purl.obolibrary.org/obo/MONDO_0000087) (polymicrogyria), [MONDO:0012059](http://purl.obolibrary.org/obo/MONDO_0012059) (polydactyly, postaxial, type A4), [MONDO:0012098](http://purl.obolibrary.org/obo/MONDO_0012098) (spinocerebellar ataxia type 20), [MONDO:0012097](http://purl.obolibrary.org/obo/MONDO_0012097) (spondylocostal dysostosis 2, autosomal recessive), [MONDO:0012096](http://purl.obolibrary.org/obo/MONDO_0012096) (Charcot-Marie-tooth disease axonal type 2L), [MONDO:0012095](http://purl.obolibrary.org/obo/MONDO_0012095) (intellectual disability-brachydactyly-Pierre robin syndrome), [MONDO:0012099](http://purl.obolibrary.org/obo/MONDO_0012099) (AICA-ribosiduria), [MONDO:0012090](http://purl.obolibrary.org/obo/MONDO_0012090) (autosomal dominant nonsyndromic deafness 47), [MONDO:0012094](http://purl.obolibrary.org/obo/MONDO_0012094) (prostate cancer, hereditary, 4), [MONDO:0012093](http://purl.obolibrary.org/obo/MONDO_0012093) (prostate cancer, hereditary, 3), [MONDO:0012091](http://purl.obolibrary.org/obo/MONDO_0012091) (autosomal recessive nonsyndromic deafness 32), [MONDO:0002718](http://purl.obolibrary.org/obo/MONDO_0002718) (central nervous system teratoma), [MONDO:0002717](http://purl.obolibrary.org/obo/MONDO_0002717) (spinal cord intramedullary teratoma), [MONDO:0002719](http://purl.obolibrary.org/obo/MONDO_0002719) (conus medullaris neoplasm), [MONDO:0002714](http://purl.obolibrary.org/obo/MONDO_0002714) (central nervous system cancer), [MONDO:0002713](http://purl.obolibrary.org/obo/MONDO_0002713) (epidural spinal canal neoplasm), [MONDO:0002716](http://purl.obolibrary.org/obo/MONDO_0002716) (childhood spinal cord tumor), [MONDO:0002715](http://purl.obolibrary.org/obo/MONDO_0002715) (uterine cancer), [MONDO:0002710](http://purl.obolibrary.org/obo/MONDO_0002710) (infiltrating angiolipoma), [MONDO:0002712](http://purl.obolibrary.org/obo/MONDO_0002712) (epidural spinal canal angiolipoma), [MONDO:0014709](http://purl.obolibrary.org/obo/MONDO_0014709) (Heimler syndrome 2), [MONDO:0014703](http://purl.obolibrary.org/obo/MONDO_0014703) (Adams-Oliver syndrome 6), [MONDO:0014704](http://purl.obolibrary.org/obo/MONDO_0014704) (skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome), [MONDO:0014705](http://purl.obolibrary.org/obo/MONDO_0014705) (craniosynostosis 6), [MONDO:0014706](http://purl.obolibrary.org/obo/MONDO_0014706) (cutis laxa, autosomal dominant 3), [MONDO:0014700](http://purl.obolibrary.org/obo/MONDO_0014700) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation), [MONDO:0014701](http://purl.obolibrary.org/obo/MONDO_0014701) (spondyloepiphyseal dysplasia, Stanescu type), [MONDO:0002729](http://purl.obolibrary.org/obo/MONDO_0002729) (kidney rhabdoid cancer), [MONDO:0002728](http://purl.obolibrary.org/obo/MONDO_0002728) (rhabdoid tumor), [MONDO:0002724](http://purl.obolibrary.org/obo/MONDO_0002724) (mast cell neoplasm), [MONDO:0002726](http://purl.obolibrary.org/obo/MONDO_0002726) (cutaneous solitary mastocytoma), [MONDO:0002720](http://purl.obolibrary.org/obo/MONDO_0002720) (sella turcica neoplasm), [MONDO:0002722](http://purl.obolibrary.org/obo/MONDO_0002722) (olfactory nerve neoplasm), [MONDO:0002707](http://purl.obolibrary.org/obo/MONDO_0002707) (breast mucinous carcinoma), [MONDO:0002708](http://purl.obolibrary.org/obo/MONDO_0002708) (retinitis), [MONDO:0002703](http://purl.obolibrary.org/obo/MONDO_0002703) (appendix mucinous cystadenocarcinoma), [MONDO:0002702](http://purl.obolibrary.org/obo/MONDO_0002702) (ovarian cystadenocarcinoma), [MONDO:0002705](http://purl.obolibrary.org/obo/MONDO_0002705) (breast mucinous cystadenocarcinoma), [MONDO:0002701](http://purl.obolibrary.org/obo/MONDO_0002701) (ovarian mucinous cystadenocarcinoma), [MONDO:0014740](http://purl.obolibrary.org/obo/MONDO_0014740) (autosomal dominant nonsyndromic deafness 68), [MONDO:0013410](http://purl.obolibrary.org/obo/MONDO_0013410) (46,Xy sex reversal 6), [MONDO:0014741](http://purl.obolibrary.org/obo/MONDO_0014741) (facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation), [MONDO:0013411](http://purl.obolibrary.org/obo/MONDO_0013411) (cataract 16 multiple types), [MONDO:0002758](http://purl.obolibrary.org/obo/MONDO_0002758) (vulva verrucous carcinoma), [MONDO:0001426](http://purl.obolibrary.org/obo/MONDO_0001426) (mediastinum neurofibroma), [MONDO:0002759](http://purl.obolibrary.org/obo/MONDO_0002759) (bladder verrucous carcinoma), [MONDO:0002754](http://purl.obolibrary.org/obo/MONDO_0002754) (extramedullary plasmacytoma), [MONDO:0002753](http://purl.obolibrary.org/obo/MONDO_0002753) (mucinous stomach adenocarcinoma), [MONDO:0001422](http://purl.obolibrary.org/obo/MONDO_0001422) (Conn's syndrome), [MONDO:0002756](http://purl.obolibrary.org/obo/MONDO_0002756) (solitary plasmacytoma of chest wall), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0002755](http://purl.obolibrary.org/obo/MONDO_0002755) (solitary osseous plasmacytoma), [MONDO:0002750](http://purl.obolibrary.org/obo/MONDO_0002750) (bladder colloid adenocarcinoma), [MONDO:0002752](http://purl.obolibrary.org/obo/MONDO_0002752) (ovary adenocarcinoma), [MONDO:0001421](http://purl.obolibrary.org/obo/MONDO_0001421) (frontal lobe neoplasm), [MONDO:0002751](http://purl.obolibrary.org/obo/MONDO_0002751) (bladder adenocarcinoma), [MONDO:0001420](http://purl.obolibrary.org/obo/MONDO_0001420) (trigeminal nerve neoplasm), [MONDO:0013416](http://purl.obolibrary.org/obo/MONDO_0013416) (age related macular degeneration 8), [MONDO:0014748](http://purl.obolibrary.org/obo/MONDO_0014748) (progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome), [MONDO:0014743](http://purl.obolibrary.org/obo/MONDO_0014743) (rhizomelic chondrodysplasia punctata type 5), [MONDO:0014744](http://purl.obolibrary.org/obo/MONDO_0014744) (acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome), [MONDO:0013413](http://purl.obolibrary.org/obo/MONDO_0013413) (retinitis pigmentosa 45), [MONDO:0014745](http://purl.obolibrary.org/obo/MONDO_0014745) (congenital myasthenic syndrome 19), [MONDO:0013414](http://purl.obolibrary.org/obo/MONDO_0013414) (retinitis pigmentosa 44), [MONDO:0014746](http://purl.obolibrary.org/obo/MONDO_0014746) (SLC39A8-CDG), [MONDO:0014730](http://purl.obolibrary.org/obo/MONDO_0014730) (microcephaly 16, primary, autosomal recessive; MCPH16), [MONDO:0014731](http://purl.obolibrary.org/obo/MONDO_0014731) (seizures-scoliosis-macrocephaly syndrome), [MONDO:0013400](http://purl.obolibrary.org/obo/MONDO_0013400) (congenital adrenal insufficiency), [MONDO:0001437](http://purl.obolibrary.org/obo/MONDO_0001437) (pulmonary alveolar proteinosis), [MONDO:0002768](http://purl.obolibrary.org/obo/MONDO_0002768) (hermaphroditism), [MONDO:0000107](http://purl.obolibrary.org/obo/MONDO_0000107) (auriculocondylar syndrome), [MONDO:0001439](http://purl.obolibrary.org/obo/MONDO_0001439) (episcleritis periodica fugax), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0002764](http://purl.obolibrary.org/obo/MONDO_0002764) (urethra squamous cell carcinoma), [MONDO:0000104](http://purl.obolibrary.org/obo/MONDO_0000104) (anemia, hypochromic microcytic with iron overload), [MONDO:0001436](http://purl.obolibrary.org/obo/MONDO_0001436) (hemosiderosis), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0000105](http://purl.obolibrary.org/obo/MONDO_0000105) (anemia, nonspherocytic hemolytic), [MONDO:0001435](http://purl.obolibrary.org/obo/MONDO_0001435) (bullous retinoschisis), [MONDO:0001430](http://purl.obolibrary.org/obo/MONDO_0001430) (deep corneal vascularisation), [MONDO:0002761](http://purl.obolibrary.org/obo/MONDO_0002761) (cervical verrucous carcinoma), [MONDO:0002760](http://purl.obolibrary.org/obo/MONDO_0002760) (bladder squamous cell carcinoma), [MONDO:0002763](http://purl.obolibrary.org/obo/MONDO_0002763) (urethral verrucous carcinoma), [MONDO:0002762](http://purl.obolibrary.org/obo/MONDO_0002762) (esophagus verrucous carcinoma), [MONDO:0001431](http://purl.obolibrary.org/obo/MONDO_0001431) (nutritional optic neuropathy), [MONDO:0013409](http://purl.obolibrary.org/obo/MONDO_0013409) (age related macular degeneration 5), [MONDO:0013405](http://purl.obolibrary.org/obo/MONDO_0013405) (retinitis pigmentosa 49), [MONDO:0014736](http://purl.obolibrary.org/obo/MONDO_0014736) (Charcot-Marie-tooth disease axonal type 2Z), [MONDO:0014737](http://purl.obolibrary.org/obo/MONDO_0014737) (Dehydrated hereditary stomatocytosis 2; DHS2), [MONDO:0013406](http://purl.obolibrary.org/obo/MONDO_0013406) (age related macular degeneration 6), [MONDO:0013407](http://purl.obolibrary.org/obo/MONDO_0013407) (retinitis pigmentosa 47), [MONDO:0014738](http://purl.obolibrary.org/obo/MONDO_0014738) (autosomal dominant nonsyndromic deafness 69), [MONDO:0013408](http://purl.obolibrary.org/obo/MONDO_0013408) (FADD-related immunodeficiency), [MONDO:0014739](http://purl.obolibrary.org/obo/MONDO_0014739) (autosomal recessive nonsyndromic deafness 97), [MONDO:0014733](http://purl.obolibrary.org/obo/MONDO_0014733) (Charcot-Marie-tooth disease type 4K), [MONDO:0013402](http://purl.obolibrary.org/obo/MONDO_0013402) (retinitis pigmentosa 27), [MONDO:0013404](http://purl.obolibrary.org/obo/MONDO_0013404) (hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase), [MONDO:0014735](http://purl.obolibrary.org/obo/MONDO_0014735) (Charcot-Marie-tooth disease type 2Y), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0002739](http://purl.obolibrary.org/obo/MONDO_0002739) (bile duct mucinous adenocarcinoma), [MONDO:0002736](http://purl.obolibrary.org/obo/MONDO_0002736) (ampulla of vater mucinous adenocarcinoma), [MONDO:0002735](http://purl.obolibrary.org/obo/MONDO_0002735) (anal canal adenocarcinoma (disease)), [MONDO:0001407](http://purl.obolibrary.org/obo/MONDO_0001407) (tracheal cancer), [MONDO:0001406](http://purl.obolibrary.org/obo/MONDO_0001406) (peripheral nervous system neoplasm), [MONDO:0001401](http://purl.obolibrary.org/obo/MONDO_0001401) (female breast nipple and areola cancer), [MONDO:0002732](http://purl.obolibrary.org/obo/MONDO_0002732) (lung benign neoplasm), [MONDO:0001400](http://purl.obolibrary.org/obo/MONDO_0001400) (schwannoma of ureter), [MONDO:0002731](http://purl.obolibrary.org/obo/MONDO_0002731) (cerebrum cancer), [MONDO:0001403](http://purl.obolibrary.org/obo/MONDO_0001403) (labium majus cancer), [MONDO:0002734](http://purl.obolibrary.org/obo/MONDO_0002734) (anal colloid adenocarcinoma), [MONDO:0001402](http://purl.obolibrary.org/obo/MONDO_0001402) (vaginal cancer), [MONDO:0002730](http://purl.obolibrary.org/obo/MONDO_0002730) (childhood kidney neoplasm), [MONDO:0014725](http://purl.obolibrary.org/obo/MONDO_0014725) (spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome), [MONDO:0014726](http://purl.obolibrary.org/obo/MONDO_0014726) (Charcot-Marie-tooth disease axonal type 2X), [MONDO:0014728](http://purl.obolibrary.org/obo/MONDO_0014728) (combined oxidative phosphorylation defect type 27), [MONDO:0014722](http://purl.obolibrary.org/obo/MONDO_0014722) (Roifman syndrome), [MONDO:0014723](http://purl.obolibrary.org/obo/MONDO_0014723) (PMP22-RAI1 contiguous gene duplication syndrome), [MONDO:0014724](http://purl.obolibrary.org/obo/MONDO_0014724) (Joubert syndrome 24), [MONDO:0001419](http://purl.obolibrary.org/obo/MONDO_0001419) (trachea squamous cell carcinoma), [MONDO:0001416](http://purl.obolibrary.org/obo/MONDO_0001416) (female reproductive organ cancer), [MONDO:0002747](http://purl.obolibrary.org/obo/MONDO_0002747) (endometrial mucinous adenocarcinoma), [MONDO:0002746](http://purl.obolibrary.org/obo/MONDO_0002746) (fallopian tube adenocarcinoma), [MONDO:0001418](http://purl.obolibrary.org/obo/MONDO_0001418) (trachea sarcoma), [MONDO:0002749](http://purl.obolibrary.org/obo/MONDO_0002749) (extracranial neuroblastoma), [MONDO:0002748](http://purl.obolibrary.org/obo/MONDO_0002748) (rectum mucinous adenocarcinoma), [MONDO:0001417](http://purl.obolibrary.org/obo/MONDO_0001417) (tracheal lymphoma), [MONDO:0002743](http://purl.obolibrary.org/obo/MONDO_0002743) (prostate colloid adenocarcinoma), [MONDO:0001412](http://purl.obolibrary.org/obo/MONDO_0001412) (conjunctival concretion), [MONDO:0001411](http://purl.obolibrary.org/obo/MONDO_0001411) (synostosis), [MONDO:0002742](http://purl.obolibrary.org/obo/MONDO_0002742) (cervical mucinous adenocarcinoma), [MONDO:0001414](http://purl.obolibrary.org/obo/MONDO_0001414) (osteopoikilosis (disease)), [MONDO:0002745](http://purl.obolibrary.org/obo/MONDO_0002745) (fallopian tube mucinous tumor), [MONDO:0002744](http://purl.obolibrary.org/obo/MONDO_0002744) (fallopian tube mucinous adenocarcinoma), [MONDO:0002741](http://purl.obolibrary.org/obo/MONDO_0002741) (uterine ligament adenocarcinoma), [MONDO:0002740](http://purl.obolibrary.org/obo/MONDO_0002740) (uterine ligament mucinous adenocarcinoma), [MONDO:0014719](http://purl.obolibrary.org/obo/MONDO_0014719) (ITPA-related encephalopathy), [MONDO:0014714](http://purl.obolibrary.org/obo/MONDO_0014714) (progressive microcephaly-seizures-cortical blindness-developmental delay syndrome), [MONDO:0014716](http://purl.obolibrary.org/obo/MONDO_0014716) (macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome), [MONDO:0014711](http://purl.obolibrary.org/obo/MONDO_0014711) (Charcot-Marie-tooth disease, axonal type 2W), [MONDO:0014712](http://purl.obolibrary.org/obo/MONDO_0014712) (Senior-Loken syndrome 9; SLSN9), [MONDO:0013452](http://purl.obolibrary.org/obo/MONDO_0013452) (multisystemic smooth muscle dysfunction syndrome), [MONDO:0012120](http://purl.obolibrary.org/obo/MONDO_0012120) (pyruvate dehydrogenase phosphatase deficiency), [MONDO:0014784](http://purl.obolibrary.org/obo/MONDO_0014784) (severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome), [MONDO:0013453](http://purl.obolibrary.org/obo/MONDO_0013453) (Leber congenital amaurosis 8), [MONDO:0013454](http://purl.obolibrary.org/obo/MONDO_0013454) (Leber congenital amaurosis 11), [MONDO:0014785](http://purl.obolibrary.org/obo/MONDO_0014785) (microcephaly, short stature, and impaired glucose metabolism 2; MSSGM2), [MONDO:0012124](http://purl.obolibrary.org/obo/MONDO_0012124) (sudden infant death-dysgenesis of the testes syndrome), [MONDO:0012123](http://purl.obolibrary.org/obo/MONDO_0012123) (congenital disorder of glycosylation type 1E), [MONDO:0014780](http://purl.obolibrary.org/obo/MONDO_0014780) (hyperphosphatasia with mental retardation syndrome 6; HPMRS6), [MONDO:0014781](http://purl.obolibrary.org/obo/MONDO_0014781) (combined oxidative phosphorylation deficiency 29; COXPD29), [MONDO:0013450](http://purl.obolibrary.org/obo/MONDO_0013450) (congenital stationary night blindness 1D), [MONDO:0014782](http://purl.obolibrary.org/obo/MONDO_0014782) (autosomal recessive limb-girdle muscular dystrophy type 2X), [MONDO:0002798](http://purl.obolibrary.org/obo/MONDO_0002798) (childhood central nervous system primitive neuroectodermal neoplasm), [MONDO:0000136](http://purl.obolibrary.org/obo/MONDO_0000136) (keratosis follicularis spinulosa decalvans), [MONDO:0001466](http://purl.obolibrary.org/obo/MONDO_0001466) (punctate epithelial keratoconjunctivitis), [MONDO:0002797](http://purl.obolibrary.org/obo/MONDO_0002797) (childhood medulloblastoma), [MONDO:0002799](http://purl.obolibrary.org/obo/MONDO_0002799) (nodular medulloblastoma), [MONDO:0001463](http://purl.obolibrary.org/obo/MONDO_0001463) (splenic flexure cancer), [MONDO:0002794](http://purl.obolibrary.org/obo/MONDO_0002794) (adult medulloblastoma), [MONDO:0001462](http://purl.obolibrary.org/obo/MONDO_0001462) (descending colon cancer), [MONDO:0002793](http://purl.obolibrary.org/obo/MONDO_0002793) (medullomyoblastoma), [MONDO:0000133](http://purl.obolibrary.org/obo/MONDO_0000133) (immunodeficiency-centromeric instability-facial anomalies syndrome), [MONDO:0001465](http://purl.obolibrary.org/obo/MONDO_0001465) (superficial keratitis), [MONDO:0002796](http://purl.obolibrary.org/obo/MONDO_0002796) (melanotic medulloblastoma), [MONDO:0001464](http://purl.obolibrary.org/obo/MONDO_0001464) (sigmoid colon cancer), [MONDO:0002795](http://purl.obolibrary.org/obo/MONDO_0002795) (adult central nervous system primitive neuroectodermal neoplasm), [MONDO:0002790](http://purl.obolibrary.org/obo/MONDO_0002790) (seminal vesicle tumor), [MONDO:0002792](http://purl.obolibrary.org/obo/MONDO_0002792) (cerebellar vermis medulloblastoma), [MONDO:0002791](http://purl.obolibrary.org/obo/MONDO_0002791) (large cell medulloblastoma), [MONDO:0012128](http://purl.obolibrary.org/obo/MONDO_0012128) (dextro-looped transposition of the great arteries 1), [MONDO:0012127](http://purl.obolibrary.org/obo/MONDO_0012127) (autosomal recessive limb-girdle muscular dystrophy type 2J), [MONDO:0012126](http://purl.obolibrary.org/obo/MONDO_0012126) (familial avascular necrosis of femoral head), [MONDO:0013456](http://purl.obolibrary.org/obo/MONDO_0013456) (constitutional megaloblastic anemia with severe neurologic disease), [MONDO:0014787](http://purl.obolibrary.org/obo/MONDO_0014787) (severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome), [MONDO:0014788](http://purl.obolibrary.org/obo/MONDO_0014788) (autosomal recessive limb-girdle muscular dystrophy type 2W), [MONDO:0013457](http://purl.obolibrary.org/obo/MONDO_0013457) (Leber congenital amaurosis 15), [MONDO:0013458](http://purl.obolibrary.org/obo/MONDO_0013458) (hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome), [MONDO:0014789](http://purl.obolibrary.org/obo/MONDO_0014789) (CCDC115-CDG), [MONDO:0013459](http://purl.obolibrary.org/obo/MONDO_0013459) (osteogenesis imperfecta type 10), [MONDO:0013441](http://purl.obolibrary.org/obo/MONDO_0013441) (asphyxiating thoracic dystrophy 4), [MONDO:0014773](http://purl.obolibrary.org/obo/MONDO_0014773) (cardiac anomalies-developmental delay-facial dysmorphism syndrome), [MONDO:0014774](http://purl.obolibrary.org/obo/MONDO_0014774) (neuroblastoma, susceptibility to, 7; NBLST7), [MONDO:0013443](http://purl.obolibrary.org/obo/MONDO_0013443) (Seckel syndrome 5), [MONDO:0014775](http://purl.obolibrary.org/obo/MONDO_0014775) (neonatal severe cardiopulmonary failure due to mitochondrial methylation defect), [MONDO:0014770](http://purl.obolibrary.org/obo/MONDO_0014770) (Joubert syndrome 25), [MONDO:0013440](http://purl.obolibrary.org/obo/MONDO_0013440) (autosomal recessive limb-girdle muscular dystrophy type 2P), [MONDO:0014771](http://purl.obolibrary.org/obo/MONDO_0014771) (Joubert syndrome 26), [MONDO:0001478](http://purl.obolibrary.org/obo/MONDO_0001478) (anisometropia (disease)), [MONDO:0000147](http://purl.obolibrary.org/obo/MONDO_0000147) (polyposis), [MONDO:0001476](http://purl.obolibrary.org/obo/MONDO_0001476) (coloboma), [MONDO:0000144](http://purl.obolibrary.org/obo/MONDO_0000144) (pregnancy loss, recurrent, susceptibility), [MONDO:0001470](http://purl.obolibrary.org/obo/MONDO_0001470) (anal margin squamous cell carcinoma), [MONDO:0001472](http://purl.obolibrary.org/obo/MONDO_0001472) (testicular lymphoma), [MONDO:0000141](http://purl.obolibrary.org/obo/MONDO_0000141) (mosaic variegated aneuploidy syndrome), [MONDO:0012117](http://purl.obolibrary.org/obo/MONDO_0012117) (ALG9-CDG), [MONDO:0013449](http://purl.obolibrary.org/obo/MONDO_0013449) (Leber congenital amaurosis 7), [MONDO:0012116](http://purl.obolibrary.org/obo/MONDO_0012116) (spinocerebellar ataxia type 8), [MONDO:0012114](http://purl.obolibrary.org/obo/MONDO_0012114) (Ehlers-Danlos syndrome, Beasley-Cohen type), [MONDO:0014776](http://purl.obolibrary.org/obo/MONDO_0014776) (spinocerebellar ataxia type 42), [MONDO:0014777](http://purl.obolibrary.org/obo/MONDO_0014777) (hypotonia, infantile, with psychomotor retardation and characteristic facies 2; IHPRF2), [MONDO:0013446](http://purl.obolibrary.org/obo/MONDO_0013446) (Leber congenital amaurosis 6), [MONDO:0013447](http://purl.obolibrary.org/obo/MONDO_0013447) (retinitis pigmentosa 48), [MONDO:0012118](http://purl.obolibrary.org/obo/MONDO_0012118) (COG7-CDG), [MONDO:0014779](http://purl.obolibrary.org/obo/MONDO_0014779) (wilms tumor 6; WT6), [MONDO:0013430](http://purl.obolibrary.org/obo/MONDO_0013430) (Meier-Gorlin syndrome 3), [MONDO:0013431](http://purl.obolibrary.org/obo/MONDO_0013431) (Meier-Gorlin syndrome 4), [MONDO:0013432](http://purl.obolibrary.org/obo/MONDO_0013432) (Meier-Gorlin syndrome 5), [MONDO:0014764](http://purl.obolibrary.org/obo/MONDO_0014764) (spastic paraplegia-severe developmental delay-epilepsy syndrome), [MONDO:0012102](http://purl.obolibrary.org/obo/MONDO_0012102) (GLC1K), [MONDO:0012101](http://purl.obolibrary.org/obo/MONDO_0012101) (GLC1J), [MONDO:0014760](http://purl.obolibrary.org/obo/MONDO_0014760) (TFRC-related combined immunodeficiency), [MONDO:0000118](http://purl.obolibrary.org/obo/MONDO_0000118) (reticulate pigment disorder), [MONDO:0002779](http://purl.obolibrary.org/obo/MONDO_0002779) (central nervous system chondroma), [MONDO:0002778](http://purl.obolibrary.org/obo/MONDO_0002778) (epidural spinal canal meningioma), [MONDO:0002772](http://purl.obolibrary.org/obo/MONDO_0002772) (intraventricular meningioma), [MONDO:0001441](http://purl.obolibrary.org/obo/MONDO_0001441) (pica disease), [MONDO:0000110](http://purl.obolibrary.org/obo/MONDO_0000110) (bifid nose), [MONDO:0001440](http://purl.obolibrary.org/obo/MONDO_0001440) (neurotrophic keratoconjunctivitis), [MONDO:0002773](http://purl.obolibrary.org/obo/MONDO_0002773) (third ventricle chordoid glioma), [MONDO:0013438](http://purl.obolibrary.org/obo/MONDO_0013438) (pontocerebellar hypoplasia type 2D), [MONDO:0012106](http://purl.obolibrary.org/obo/MONDO_0012106) (microcephaly 5, primary, autosomal recessive), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0013439](http://purl.obolibrary.org/obo/MONDO_0013439) (congenital bile acid synthesis defect 3), [MONDO:0012104](http://purl.obolibrary.org/obo/MONDO_0012104) (partial acquired lipodystrophy), [MONDO:0012103](http://purl.obolibrary.org/obo/MONDO_0012103) (spinocerebellar ataxia type 25), [MONDO:0013434](http://purl.obolibrary.org/obo/MONDO_0013434) (primary ciliary dyskinesia 14), [MONDO:0013435](http://purl.obolibrary.org/obo/MONDO_0013435) (primary ciliary dyskinesia 15), [MONDO:0014767](http://purl.obolibrary.org/obo/MONDO_0014767) (Seckel syndrome 9; SCKL9), [MONDO:0012108](http://purl.obolibrary.org/obo/MONDO_0012108) (spondyloepimetaphyseal dysplasia, matrilin-3 type), [MONDO:0013436](http://purl.obolibrary.org/obo/MONDO_0013436) (retinitis pigmentosa 39), [MONDO:0014768](http://purl.obolibrary.org/obo/MONDO_0014768) (CADASIL 2), [MONDO:0013437](http://purl.obolibrary.org/obo/MONDO_0013437) (retinitis pigmentosa 43), [MONDO:0014750](http://purl.obolibrary.org/obo/MONDO_0014750) (primary ciliary dyskinesia 33), [MONDO:0013420](http://purl.obolibrary.org/obo/MONDO_0013420) (age related macular degeneration 12), [MONDO:0014751](http://purl.obolibrary.org/obo/MONDO_0014751) (palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome), [MONDO:0014753](http://purl.obolibrary.org/obo/MONDO_0014753) (autosomal recessive isolated optic atrophy), [MONDO:0000129](http://purl.obolibrary.org/obo/MONDO_0000129) (glutaric aciduria (disease)), [MONDO:0001456](http://purl.obolibrary.org/obo/MONDO_0001456) (cobblestone retinal degeneration), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0002786](http://purl.obolibrary.org/obo/MONDO_0002786) (diencephalic cancer), [MONDO:0001455](http://purl.obolibrary.org/obo/MONDO_0001455) (retinal lattice degeneration), [MONDO:0002789](http://purl.obolibrary.org/obo/MONDO_0002789) (hemangiopericytic tumor), [MONDO:0001457](http://purl.obolibrary.org/obo/MONDO_0001457) (secondary vitreoretinal degeneration), [MONDO:0000127](http://purl.obolibrary.org/obo/MONDO_0000127) (geleophysic dysplasia), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0001452](http://purl.obolibrary.org/obo/MONDO_0001452) (pseudoretinitis pigmentosa), [MONDO:0001451](http://purl.obolibrary.org/obo/MONDO_0001451) (peripheral retinal degeneration), [MONDO:0001454](http://purl.obolibrary.org/obo/MONDO_0001454) (Blessig's cysts), [MONDO:0002785](http://purl.obolibrary.org/obo/MONDO_0002785) (skull base neoplasm), [MONDO:0001453](http://purl.obolibrary.org/obo/MONDO_0001453) (senile reticular retinal degeneration), [MONDO:0002780](http://purl.obolibrary.org/obo/MONDO_0002780) (extraskeletal chondroma), [MONDO:0014758](http://purl.obolibrary.org/obo/MONDO_0014758) (radioulnar synostosis with amegakaryocytic thrombocytopenia 2; RUSAT2), [MONDO:0013428](http://purl.obolibrary.org/obo/MONDO_0013428) (Meier-Gorlin syndrome 2), [MONDO:0013429](http://purl.obolibrary.org/obo/MONDO_0013429) (retinitis pigmentosa 40), [MONDO:0014754](http://purl.obolibrary.org/obo/MONDO_0014754) (coenzyme Q10 deficiency, primary, 8; COQ10D8), [MONDO:0013424](http://purl.obolibrary.org/obo/MONDO_0013424) (3p- syndrome), [MONDO:0013425](http://purl.obolibrary.org/obo/MONDO_0013425) (retinitis pigmentosa 20), [MONDO:0012164](http://purl.obolibrary.org/obo/MONDO_0012164) (Meacham syndrome), [MONDO:0012163](http://purl.obolibrary.org/obo/MONDO_0012163) (severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive), [MONDO:0012162](http://purl.obolibrary.org/obo/MONDO_0012162) (patterned macular dystrophy 2), [MONDO:0013499](http://purl.obolibrary.org/obo/MONDO_0013499) (Fanconi anemia complementation group P), [MONDO:0012161](http://purl.obolibrary.org/obo/MONDO_0012161) (susceptibility to respiratory infections associated with CD8alpha chain mutation), [MONDO:0012167](http://purl.obolibrary.org/obo/MONDO_0012167) (ATFB2), [MONDO:0012165](http://purl.obolibrary.org/obo/MONDO_0012165) (BNAR syndrome), [MONDO:0013495](http://purl.obolibrary.org/obo/MONDO_0013495) (autosomal recessive congenital ichthyosis 8), [MONDO:0000179](http://purl.obolibrary.org/obo/MONDO_0000179) (Neu-Laxova syndrome), [MONDO:0012160](http://purl.obolibrary.org/obo/MONDO_0012160) (spondylometaphyseal dysplasia-cone-rod dystrophy syndrome), [MONDO:0000171](http://purl.obolibrary.org/obo/MONDO_0000171) (muscular dystrophy-dystroglycanopathy, type A), [MONDO:0000172](http://purl.obolibrary.org/obo/MONDO_0000172) (muscular dystrophy-dystroglycanopathy, type B), [MONDO:0000173](http://purl.obolibrary.org/obo/MONDO_0000173) (muscular dystrophy-dystroglycanopathy, type C), [MONDO:0000170](http://purl.obolibrary.org/obo/MONDO_0000170) (microphthalmia, isolated, with coloboma), [MONDO:0013485](http://purl.obolibrary.org/obo/MONDO_0013485) (spinocerebellar ataxia type 35), [MONDO:0013486](http://purl.obolibrary.org/obo/MONDO_0013486) (spinocerebellar ataxia type 32), [MONDO:0012157](http://purl.obolibrary.org/obo/MONDO_0012157) (congenital myasthenic syndrome 4C), [MONDO:0013481](http://purl.obolibrary.org/obo/MONDO_0013481) (chromosome 13q14 deletion syndrome), [MONDO:0012156](http://purl.obolibrary.org/obo/MONDO_0012156) (myasthenic syndrome, congenital, 1B, fast-channel), [MONDO:0013482](http://purl.obolibrary.org/obo/MONDO_0013482) (Meckel syndrome, type 8), [MONDO:0012154](http://purl.obolibrary.org/obo/MONDO_0012154) (myopia 6), [MONDO:0013484](http://purl.obolibrary.org/obo/MONDO_0013484) (cataract 36), [MONDO:0013480](http://purl.obolibrary.org/obo/MONDO_0013480) (renal hypomagnesemia 6), [MONDO:0000182](http://purl.obolibrary.org/obo/MONDO_0000182) (congenital myasthenic syndrome with tubular aggregates), [MONDO:0000184](http://purl.obolibrary.org/obo/MONDO_0000184) (congenital vitamin K-dependent coagulation factors combined deficiency), [MONDO:0012159](http://purl.obolibrary.org/obo/MONDO_0012159) (LNCR1), [MONDO:0000181](http://purl.obolibrary.org/obo/MONDO_0000181) (microcephaly and chorioretinopathy), [MONDO:0012158](http://purl.obolibrary.org/obo/MONDO_0012158) (KTCN2), [MONDO:0013489](http://purl.obolibrary.org/obo/MONDO_0013489) (autosomal recessive nonsyndromic deafness 89), [MONDO:0012146](http://purl.obolibrary.org/obo/MONDO_0012146) (familial hemophagocytic lymphohistiocytosis 3), [MONDO:0012145](http://purl.obolibrary.org/obo/MONDO_0012145) (macular degeneration, age-related, 3), [MONDO:0013471](http://purl.obolibrary.org/obo/MONDO_0013471) (autosomal recessive nonsyndromic deafness 61), [MONDO:0013472](http://purl.obolibrary.org/obo/MONDO_0013472) (myofibrillar myopathy 7), [MONDO:0012144](http://purl.obolibrary.org/obo/MONDO_0012144) (Waardenburg syndrome type 2D), [MONDO:0012143](http://purl.obolibrary.org/obo/MONDO_0012143) (hereditary cryohydrocytosis with reduced stomatin), [MONDO:0001488](http://purl.obolibrary.org/obo/MONDO_0001488) (anterior corneal pigmentation), [MONDO:0000155](http://purl.obolibrary.org/obo/MONDO_0000155) (triglyceride storage disease), [MONDO:0001487](http://purl.obolibrary.org/obo/MONDO_0001487) (intrahepatic gall duct cancer), [MONDO:0000156](http://purl.obolibrary.org/obo/MONDO_0000156) (trigonocephaly), [MONDO:0001480](http://purl.obolibrary.org/obo/MONDO_0001480) (malignant tumor of undescended testis), [MONDO:0001482](http://purl.obolibrary.org/obo/MONDO_0001482) (testicular leukemia), [MONDO:0000152](http://purl.obolibrary.org/obo/MONDO_0000152) (thiamine-responsive dysfunction syndrome), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0013463](http://purl.obolibrary.org/obo/MONDO_0013463) (dextro-looped transposition of the great arteries 3), [MONDO:0014794](http://purl.obolibrary.org/obo/MONDO_0014794) (Meier-Gorlin syndrome 6; MGORS6), [MONDO:0012130](http://purl.obolibrary.org/obo/MONDO_0012130) (myofibrillar myopathy 2), [MONDO:0013465](http://purl.obolibrary.org/obo/MONDO_0013465) (achromatopsia 4), [MONDO:0014790](http://purl.obolibrary.org/obo/MONDO_0014790) (TMEM199-CDG), [MONDO:0013460](http://purl.obolibrary.org/obo/MONDO_0013460) (osteogenesis imperfecta type 12), [MONDO:0014792](http://purl.obolibrary.org/obo/MONDO_0014792) (Paget disease of bone 6; PDB6), [MONDO:0012132](http://purl.obolibrary.org/obo/MONDO_0012132) (colorectal cancer, susceptibility to, 1), [MONDO:0001499](http://purl.obolibrary.org/obo/MONDO_0001499) (retroperitoneal lymphoma), [MONDO:0000169](http://purl.obolibrary.org/obo/MONDO_0000169) (microphthalmia, isolated, with cataract), [MONDO:0001492](http://purl.obolibrary.org/obo/MONDO_0001492) (kyphoscoliotic heart disease), [MONDO:0000160](http://purl.obolibrary.org/obo/MONDO_0000160) (epilepsy, familial adult myoclonic), [MONDO:0000162](http://purl.obolibrary.org/obo/MONDO_0000162) (autoimmune thyroid disease, susceptibility to), [MONDO:0001493](http://purl.obolibrary.org/obo/MONDO_0001493) (chronic pulmonary heart disease), [MONDO:0012139](http://purl.obolibrary.org/obo/MONDO_0012139) (macular dystrophy, retinal, 3), [MONDO:0012138](http://purl.obolibrary.org/obo/MONDO_0012138) (muscular dystrophy-dystroglycanopathy type B6), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0001490](http://purl.obolibrary.org/obo/MONDO_0001490) (corneal granular dystrophy), [MONDO:0012136](http://purl.obolibrary.org/obo/MONDO_0012136) (carnitine palmitoyl transferase II deficiency, neonatal form), [MONDO:0014798](http://purl.obolibrary.org/obo/MONDO_0014798) (brachydactyly type A1D), [MONDO:0013468](http://purl.obolibrary.org/obo/MONDO_0013468) (retinitis pigmentosa 59), [MONDO:0014799](http://purl.obolibrary.org/obo/MONDO_0014799) (cataract 45), [MONDO:0013469](http://purl.obolibrary.org/obo/MONDO_0013469) (retinitis pigmentosa 38), [MONDO:0012197](http://purl.obolibrary.org/obo/MONDO_0012197) (idiopathic aplastic anemia), [MONDO:0012196](http://purl.obolibrary.org/obo/MONDO_0012196) (autosomal dominant auditory neuropathy 1), [MONDO:0012195](http://purl.obolibrary.org/obo/MONDO_0012195) (arthrogryposis-severe scoliosis syndrome), [MONDO:0012199](http://purl.obolibrary.org/obo/MONDO_0012199) (posterior polymorphous corneal dystrophy 2), [MONDO:0012198](http://purl.obolibrary.org/obo/MONDO_0012198) (PCWH syndrome), [MONDO:0012193](http://purl.obolibrary.org/obo/MONDO_0012193) (autosomal dominant limb-girdle muscular dystrophy type 1G), [MONDO:0012192](http://purl.obolibrary.org/obo/MONDO_0012192) (permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome), [MONDO:0012191](http://purl.obolibrary.org/obo/MONDO_0012191) (Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1), [MONDO:0012190](http://purl.obolibrary.org/obo/MONDO_0012190) (nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome), [MONDO:0012186](http://purl.obolibrary.org/obo/MONDO_0012186) (Fanconi anemia complementation group i), [MONDO:0012185](http://purl.obolibrary.org/obo/MONDO_0012185) (spondylometaphyseal dysplasia, A4 type), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0012189](http://purl.obolibrary.org/obo/MONDO_0012189) (Amish infantile epilepsy syndrome), [MONDO:0012188](http://purl.obolibrary.org/obo/MONDO_0012188) (neuronal ceroid lipofuscinosis 9), [MONDO:0012187](http://purl.obolibrary.org/obo/MONDO_0012187) (Fanconi anemia complementation group j), [MONDO:0000190](http://purl.obolibrary.org/obo/MONDO_0000190) (ventricular fibrillation (disease)), [MONDO:0012175](http://purl.obolibrary.org/obo/MONDO_0012175) (cataract 28), [MONDO:0012173](http://purl.obolibrary.org/obo/MONDO_0012173) (long chain 3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0012172](http://purl.obolibrary.org/obo/MONDO_0012172) (mitochondrial trifunctional protein deficiency), [MONDO:0012179](http://purl.obolibrary.org/obo/MONDO_0012179) (NRCLP3), [MONDO:0012177](http://purl.obolibrary.org/obo/MONDO_0012177) (posterior column ataxia-retinitis pigmentosa syndrome), [MONDO:0012170](http://purl.obolibrary.org/obo/MONDO_0012170) (autosomal recessive nonsyndromic deafness 36), [MONDO:0015710](http://purl.obolibrary.org/obo/MONDO_0015710) (immune dysregulation disease with immunodeficiency), [MONDO:0003729](http://purl.obolibrary.org/obo/MONDO_0003729) (aleukemic leukemia cutis), [MONDO:0003728](http://purl.obolibrary.org/obo/MONDO_0003728) (breast fibrosarcoma), [MONDO:0003726](http://purl.obolibrary.org/obo/MONDO_0003726) (apocrine adenosis of breast), [MONDO:0003723](http://purl.obolibrary.org/obo/MONDO_0003723) (blunt duct adenosis of breast), [MONDO:0003724](http://purl.obolibrary.org/obo/MONDO_0003724) (non-proliferative fibrocystic change of the breast), [MONDO:0003721](http://purl.obolibrary.org/obo/MONDO_0003721) (kidney osteogenic sarcoma), [MONDO:0003722](http://purl.obolibrary.org/obo/MONDO_0003722) (internal auditory canal meningioma), [MONDO:0003720](http://purl.obolibrary.org/obo/MONDO_0003720) (kidney fibrosarcoma), [MONDO:0015719](http://purl.obolibrary.org/obo/MONDO_0015719) (severe hemophilia A), [MONDO:0015716](http://purl.obolibrary.org/obo/MONDO_0015716) (Moderately severe hemophilia b), [MONDO:0015715](http://purl.obolibrary.org/obo/MONDO_0015715) (severe hemophilia b), [MONDO:0015717](http://purl.obolibrary.org/obo/MONDO_0015717) (mild hemophilia b), [MONDO:0015712](http://purl.obolibrary.org/obo/MONDO_0015712) (non-distal trisomy 10q), [MONDO:0015711](http://purl.obolibrary.org/obo/MONDO_0015711) (specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of b cells), [MONDO:0002408](http://purl.obolibrary.org/obo/MONDO_0002408) (bilirubin metabolic disorder), [MONDO:0003737](http://purl.obolibrary.org/obo/MONDO_0003737) (malignant testicular leydig cell tumor), [MONDO:0002407](http://purl.obolibrary.org/obo/MONDO_0002407) (capillary hemangioma), [MONDO:0003734](http://purl.obolibrary.org/obo/MONDO_0003734) (adult central nervous system immature teratoma), [MONDO:0002402](http://purl.obolibrary.org/obo/MONDO_0002402) (malignant giant cell tumor), [MONDO:0002401](http://purl.obolibrary.org/obo/MONDO_0002401) (malignant giant cell tumor of the tendon sheath), [MONDO:0003735](http://purl.obolibrary.org/obo/MONDO_0003735) (central nervous system immature teratoma), [MONDO:0002404](http://purl.obolibrary.org/obo/MONDO_0002404) (liver hemangioma), [MONDO:0003732](http://purl.obolibrary.org/obo/MONDO_0003732) (adult central nervous system mature teratoma), [MONDO:0002403](http://purl.obolibrary.org/obo/MONDO_0002403) (synovium cancer), [MONDO:0003733](http://purl.obolibrary.org/obo/MONDO_0003733) (central nervous system mature teratoma), [MONDO:0003730](http://purl.obolibrary.org/obo/MONDO_0003730) (aleukemic leukemia), [MONDO:0003731](http://purl.obolibrary.org/obo/MONDO_0003731) (adult central nervous system teratoma), [MONDO:0015709](http://purl.obolibrary.org/obo/MONDO_0015709) (immunodeficiency syndrome with autoimmunity), [MONDO:0015708](http://purl.obolibrary.org/obo/MONDO_0015708) (Immuno-osseous dysplasia), [MONDO:0015705](http://purl.obolibrary.org/obo/MONDO_0015705) (autosomal recessive centronuclear myopathy), [MONDO:0015704](http://purl.obolibrary.org/obo/MONDO_0015704) (familial scaphocephaly syndrome), [MONDO:0015707](http://purl.obolibrary.org/obo/MONDO_0015707) (DNA repair defect other than combined T-cell and B-cell immunodeficiencies), [MONDO:0015701](http://purl.obolibrary.org/obo/MONDO_0015701) (T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency), [MONDO:0015703](http://purl.obolibrary.org/obo/MONDO_0015703) (T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta), [MONDO:0015702](http://purl.obolibrary.org/obo/MONDO_0015702) (T-B+ severe combined immunodeficiency due to CD45 deficiency), [MONDO:0003707](http://purl.obolibrary.org/obo/MONDO_0003707) (distal biliary tract carcinoma), [MONDO:0003708](http://purl.obolibrary.org/obo/MONDO_0003708) (extrahepatic bile duct small cell adenocarcinoma), [MONDO:0003705](http://purl.obolibrary.org/obo/MONDO_0003705) (adult brainstem mixed glioma), [MONDO:0003706](http://purl.obolibrary.org/obo/MONDO_0003706) (adult brainstem astrocytoma), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0003701](http://purl.obolibrary.org/obo/MONDO_0003701) (nonencapsulated sclerosing carcinoma), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0003700](http://purl.obolibrary.org/obo/MONDO_0003700) (brachial plexus neoplasm), [MONDO:0003719](http://purl.obolibrary.org/obo/MONDO_0003719) (renal pelvis neoplasm), [MONDO:0003716](http://purl.obolibrary.org/obo/MONDO_0003716) (kidney pelvis papillary carcinoma), [MONDO:0003717](http://purl.obolibrary.org/obo/MONDO_0003717) (renal pelvis papillary tumor), [MONDO:0003714](http://purl.obolibrary.org/obo/MONDO_0003714) (bladder urachal squamous cell carcinoma), [MONDO:0003715](http://purl.obolibrary.org/obo/MONDO_0003715) (bladder urachal carcinoma), [MONDO:0003712](http://purl.obolibrary.org/obo/MONDO_0003712) (angiokeratoma of mibelli), [MONDO:0003713](http://purl.obolibrary.org/obo/MONDO_0003713) (angiokeratoma circumscriptum), [MONDO:0003710](http://purl.obolibrary.org/obo/MONDO_0003710) (ovarian mixed germ cell neoplasm), [MONDO:0015752](http://purl.obolibrary.org/obo/MONDO_0015752) (intellectual disability-cataracts-kyphosis syndrome), [MONDO:0014421](http://purl.obolibrary.org/obo/MONDO_0014421) (glucocorticoid resistance), [MONDO:0015751](http://purl.obolibrary.org/obo/MONDO_0015751) (craniosynostosis-hydrocephalus-Arnold-Chiari malformation type i-radioulnar synostosis syndrome), [MONDO:0015753](http://purl.obolibrary.org/obo/MONDO_0015753) (cap myopathy), [MONDO:0014423](http://purl.obolibrary.org/obo/MONDO_0014423) (severe combined immunodeficiency due to DNA-PKcs deficiency), [MONDO:0001108](http://purl.obolibrary.org/obo/MONDO_0001108) (broad ligament malignant neoplasm), [MONDO:0002435](http://purl.obolibrary.org/obo/MONDO_0002435) (cranial nerve III tumor), [MONDO:0002434](http://purl.obolibrary.org/obo/MONDO_0002434) (malignant oculomotor nerve tumor), [MONDO:0003768](http://purl.obolibrary.org/obo/MONDO_0003768) (signet ring cell variant cervical mucinous adenocarcinoma), [MONDO:0003765](http://purl.obolibrary.org/obo/MONDO_0003765) (adult leptomeningeal melanoma), [MONDO:0003766](http://purl.obolibrary.org/obo/MONDO_0003766) (thalamic cancer), [MONDO:0003764](http://purl.obolibrary.org/obo/MONDO_0003764) (pediatric leptomeningeal melanoma), [MONDO:0003761](http://purl.obolibrary.org/obo/MONDO_0003761) (meningeal melanoma), [MONDO:0002433](http://purl.obolibrary.org/obo/MONDO_0002433) (cranial nerve malignant neoplasm), [MONDO:0002432](http://purl.obolibrary.org/obo/MONDO_0002432) (malignant neoplasm of acoustic nerve), [MONDO:0003762](http://purl.obolibrary.org/obo/MONDO_0003762) (malignant leptomeningeal tumor), [MONDO:0003760](http://purl.obolibrary.org/obo/MONDO_0003760) (pediatric ovarian germ cell tumor), [MONDO:0014428](http://purl.obolibrary.org/obo/MONDO_0014428) (autosomal recessive nonsyndromic deafness 102), [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759) (B-cell non-Hodgkin lymphoma), [MONDO:0015756](http://purl.obolibrary.org/obo/MONDO_0015756) (myeloid hemopathy), [MONDO:0015755](http://purl.obolibrary.org/obo/MONDO_0015755) (myopathy with hexagonally cross-linked tubular arrays), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0014426](http://purl.obolibrary.org/obo/MONDO_0014426) (nanophthalmos 4), [MONDO:0015757](http://purl.obolibrary.org/obo/MONDO_0015757) (lymphoid hemopathy), [MONDO:0014427](http://purl.obolibrary.org/obo/MONDO_0014427) (cone-rod dystrophy 20), [MONDO:0014410](http://purl.obolibrary.org/obo/MONDO_0014410) (spinocerebellar ataxia type 37), [MONDO:0014411](http://purl.obolibrary.org/obo/MONDO_0014411) (myopia 24, autosomal dominant), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0002449](http://purl.obolibrary.org/obo/MONDO_0002449) (nodular degeneration of cornea), [MONDO:0001117](http://purl.obolibrary.org/obo/MONDO_0001117) (methemoglobinemia), [MONDO:0002448](http://purl.obolibrary.org/obo/MONDO_0002448) (larynx sarcoma), [MONDO:0003776](http://purl.obolibrary.org/obo/MONDO_0003776) (renal pelvis inverted papilloma), [MONDO:0002447](http://purl.obolibrary.org/obo/MONDO_0002447) (endometrial carcinoma (disease)), [MONDO:0003777](http://purl.obolibrary.org/obo/MONDO_0003777) (renal pelvis urothelial papilloma), [MONDO:0003774](http://purl.obolibrary.org/obo/MONDO_0003774) (cerebral convexity meningioma), [MONDO:0003775](http://purl.obolibrary.org/obo/MONDO_0003775) (lateral ventricle meningioma), [MONDO:0003772](http://purl.obolibrary.org/obo/MONDO_0003772) (cerebral meningioma), [MONDO:0002443](http://purl.obolibrary.org/obo/MONDO_0002443) (bruxism (disease)), [MONDO:0003773](http://purl.obolibrary.org/obo/MONDO_0003773) (intracerebral cystic meningioma), [MONDO:0003770](http://purl.obolibrary.org/obo/MONDO_0003770) (thoracic spinal canal and spinal cord meningioma), [MONDO:0003771](http://purl.obolibrary.org/obo/MONDO_0003771) (jugular foramen meningioma), [MONDO:0014417](http://purl.obolibrary.org/obo/MONDO_0014417) (spinocerebellar ataxia type 38), [MONDO:0015749](http://purl.obolibrary.org/obo/MONDO_0015749) (6q16 deletion syndrome), [MONDO:0015748](http://purl.obolibrary.org/obo/MONDO_0015748) (hereditary mucosal leukokeratosis), [MONDO:0014418](http://purl.obolibrary.org/obo/MONDO_0014418) (myopathy, centronuclear, 5), [MONDO:0014419](http://purl.obolibrary.org/obo/MONDO_0014419) (ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome), [MONDO:0015745](http://purl.obolibrary.org/obo/MONDO_0015745) (microcephaly-polymicrogyria-corpus callosum agenesis syndrome), [MONDO:0014413](http://purl.obolibrary.org/obo/MONDO_0014413) (orofaciodigital syndrome type 14), [MONDO:0014414](http://purl.obolibrary.org/obo/MONDO_0014414) (STAT3-related early-onset multisystem autoimmune disease), [MONDO:0015746](http://purl.obolibrary.org/obo/MONDO_0015746) (male infertility due to globozoospermia), [MONDO:0015732](http://purl.obolibrary.org/obo/MONDO_0015732) (intermediate anorectal malformation), [MONDO:0014400](http://purl.obolibrary.org/obo/MONDO_0014400) (retinitis pigmentosa 70), [MONDO:0014401](http://purl.obolibrary.org/obo/MONDO_0014401) (tall stature-scoliosis-macrodactyly of the great toes syndrome), [MONDO:0015731](http://purl.obolibrary.org/obo/MONDO_0015731) (high anorectal malformation), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0003747](http://purl.obolibrary.org/obo/MONDO_0003747) (telangiectatic glomangioma), [MONDO:0002418](http://purl.obolibrary.org/obo/MONDO_0002418) (ethmoid sinus adenocarcinoma), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0002413](http://purl.obolibrary.org/obo/MONDO_0002413) (glycogen storage disease I), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0002412](http://purl.obolibrary.org/obo/MONDO_0002412) (glycogen storage disease), [MONDO:0003743](http://purl.obolibrary.org/obo/MONDO_0003743) (heart malignant hemangiopericytoma), [MONDO:0002415](http://purl.obolibrary.org/obo/MONDO_0002415) (bone carcinoma), [MONDO:0002414](http://purl.obolibrary.org/obo/MONDO_0002414) (gastric hemangioma), [MONDO:0003744](http://purl.obolibrary.org/obo/MONDO_0003744) (spindle cell intraocular melanoma), [MONDO:0003741](http://purl.obolibrary.org/obo/MONDO_0003741) (juvenile type testicular granulosa cell tumor), [MONDO:0003742](http://purl.obolibrary.org/obo/MONDO_0003742) (heart fibrosarcoma), [MONDO:0015738](http://purl.obolibrary.org/obo/MONDO_0015738) (childhood-onset nemaline myopathy), [MONDO:0014406](http://purl.obolibrary.org/obo/MONDO_0014406) (pancreatic agenesis 2), [MONDO:0015737](http://purl.obolibrary.org/obo/MONDO_0015737) (Typical nemaline myopathy), [MONDO:0014407](http://purl.obolibrary.org/obo/MONDO_0014407) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2), [MONDO:0014408](http://purl.obolibrary.org/obo/MONDO_0014408) (megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3), [MONDO:0015739](http://purl.obolibrary.org/obo/MONDO_0015739) (adult-onset nemaline myopathy), [MONDO:0015734](http://purl.obolibrary.org/obo/MONDO_0015734) (rectal duplication), [MONDO:0014402](http://purl.obolibrary.org/obo/MONDO_0014402) (severe neurodegenerative syndrome with lipodystrophy), [MONDO:0015733](http://purl.obolibrary.org/obo/MONDO_0015733) (low anorectal malformation), [MONDO:0015736](http://purl.obolibrary.org/obo/MONDO_0015736) (intermediate nemaline myopathy), [MONDO:0014405](http://purl.obolibrary.org/obo/MONDO_0014405) (STING-associated vasculopathy with onset in infancy), [MONDO:0015735](http://purl.obolibrary.org/obo/MONDO_0015735) (severe congenital nemaline myopathy), [MONDO:0015721](http://purl.obolibrary.org/obo/MONDO_0015721) (mild hemophilia A), [MONDO:0015720](http://purl.obolibrary.org/obo/MONDO_0015720) (moderately severe hemophilia A), [MONDO:0003758](http://purl.obolibrary.org/obo/MONDO_0003758) (childhood testicular germ cell tumor), [MONDO:0003759](http://purl.obolibrary.org/obo/MONDO_0003759) (childhood ovarian yolk sac tumor), [MONDO:0002424](http://purl.obolibrary.org/obo/MONDO_0002424) (rectosigmoid carcinoma), [MONDO:0003756](http://purl.obolibrary.org/obo/MONDO_0003756) (ovarian mucinous neoplasm), [MONDO:0002423](http://purl.obolibrary.org/obo/MONDO_0002423) (rectosigmoid junction neoplasm), [MONDO:0002426](http://purl.obolibrary.org/obo/MONDO_0002426) (lung sarcoma), [MONDO:0002425](http://purl.obolibrary.org/obo/MONDO_0002425) (rectosigmoid junction cancer), [MONDO:0003755](http://purl.obolibrary.org/obo/MONDO_0003755) (urinary tract non-invasive transitional cell neoplasm), [MONDO:0003752](http://purl.obolibrary.org/obo/MONDO_0003752) (frontal sinus Schneiderian papilloma), [MONDO:0003753](http://purl.obolibrary.org/obo/MONDO_0003753) (nasal vestibule squamous papilloma), [MONDO:0003750](http://purl.obolibrary.org/obo/MONDO_0003750) (central nervous system childhood germ cell tumor), [MONDO:0002422](http://purl.obolibrary.org/obo/MONDO_0002422) (adamantinoma), [MONDO:0003751](http://purl.obolibrary.org/obo/MONDO_0003751) (pediatric germ cell cancer), [MONDO:0015726](http://purl.obolibrary.org/obo/MONDO_0015726) (distal trisomy 14q), [MONDO:0015728](http://purl.obolibrary.org/obo/MONDO_0015728) (distal trisomy 15q), [MONDO:0015722](http://purl.obolibrary.org/obo/MONDO_0015722) (congenital vitamin K-dependent coagulation factors deficiency), [MONDO:0014464](http://purl.obolibrary.org/obo/MONDO_0014464) (progressive encephalopathy with leukodystrophy due to DECR deficiency), [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0015795](http://purl.obolibrary.org/obo/MONDO_0015795) (undifferentiated embryonal sarcoma of the liver), [MONDO:0013134](http://purl.obolibrary.org/obo/MONDO_0013134) (glaucoma 1, open angle, O), [MONDO:0014465](http://purl.obolibrary.org/obo/MONDO_0014465) (primary ciliary dyskinesia 30), [MONDO:0014466](http://purl.obolibrary.org/obo/MONDO_0014466) (Neu-Laxova syndrome 2), [MONDO:0013135](http://purl.obolibrary.org/obo/MONDO_0013135) (familial hemophagocytic lymphohistiocytosis 5), [MONDO:0015798](http://purl.obolibrary.org/obo/MONDO_0015798) (inflammatory myofibroblastic tumor), [MONDO:0015797](http://purl.obolibrary.org/obo/MONDO_0015797) (UV-sensitive syndrome), [MONDO:0014467](http://purl.obolibrary.org/obo/MONDO_0014467) (Charcot-Marie-tooth disease recessive intermediate d), [MONDO:0014460](http://purl.obolibrary.org/obo/MONDO_0014460) (nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome), [MONDO:0014461](http://purl.obolibrary.org/obo/MONDO_0014461) (hypogonadotropic hypogonadism 22 with or without anosmia), [MONDO:0013130](http://purl.obolibrary.org/obo/MONDO_0013130) (isolated microphthalmia 4), [MONDO:0015794](http://purl.obolibrary.org/obo/MONDO_0015794) (antenatal multiminicore disease with arthrogryposis multiplex congenita), [MONDO:0015793](http://purl.obolibrary.org/obo/MONDO_0015793) (moderate multiminicore disease with hand involvement), [MONDO:0002479](http://purl.obolibrary.org/obo/MONDO_0002479) (Sertoli-leydig cell tumor), [MONDO:0002478](http://purl.obolibrary.org/obo/MONDO_0002478) (mixed germ cell-sex cord-stromal tumor), [MONDO:0001147](http://purl.obolibrary.org/obo/MONDO_0001147) (meningocele (disease)), [MONDO:0001144](http://purl.obolibrary.org/obo/MONDO_0001144) (partial third-nerve palsy), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0002474](http://purl.obolibrary.org/obo/MONDO_0002474) (primary hyperoxaluria), [MONDO:0001143](http://purl.obolibrary.org/obo/MONDO_0001143) (paralytic squint), [MONDO:0001146](http://purl.obolibrary.org/obo/MONDO_0001146) (fourth cranial nerve palsy), [MONDO:0002477](http://purl.obolibrary.org/obo/MONDO_0002477) (prostate neuroendocrine neoplasm), [MONDO:0001145](http://purl.obolibrary.org/obo/MONDO_0001145) (total third-nerve palsy), [MONDO:0002470](http://purl.obolibrary.org/obo/MONDO_0002470) (photosensitive trichothiodystrophy), [MONDO:0002472](http://purl.obolibrary.org/obo/MONDO_0002472) (carcinoma ex pleomorphic adenoma), [MONDO:0013137](http://purl.obolibrary.org/obo/MONDO_0013137) (choroidal dystrophy, central areolar 2), [MONDO:0014468](http://purl.obolibrary.org/obo/MONDO_0014468) (congenital myasthenic syndrome 7), [MONDO:0015799](http://purl.obolibrary.org/obo/MONDO_0015799) (Smith-McCort dysplasia), [MONDO:0014469](http://purl.obolibrary.org/obo/MONDO_0014469) (autosomal recessive nonsyndromic deafness 103), [MONDO:0013122](http://purl.obolibrary.org/obo/MONDO_0013122) (glaucoma 3, primary congenital, d), [MONDO:0014453](http://purl.obolibrary.org/obo/MONDO_0014453) (immunodeficiency 36), [MONDO:0015785](http://purl.obolibrary.org/obo/MONDO_0015785) (Prader-Willi syndrome due to translocation), [MONDO:0015784](http://purl.obolibrary.org/obo/MONDO_0015784) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2), [MONDO:0013123](http://purl.obolibrary.org/obo/MONDO_0013123) (atrial heart septal defect 6), [MONDO:0014454](http://purl.obolibrary.org/obo/MONDO_0014454) (Hennekam lymphangiectasia-lymphedema syndrome 2), [MONDO:0014455](http://purl.obolibrary.org/obo/MONDO_0014455) (cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome), [MONDO:0015787](http://purl.obolibrary.org/obo/MONDO_0015787) (symptomatic form of hemophilia a in female carriers), [MONDO:0015786](http://purl.obolibrary.org/obo/MONDO_0015786) (Prader-Willi syndrome due to imprinting mutation), [MONDO:0013125](http://purl.obolibrary.org/obo/MONDO_0013125) (CLAPO syndrome), [MONDO:0015781](http://purl.obolibrary.org/obo/MONDO_0015781) (facial dysmorphism-shawl scrotum-joint laxity syndrome), [MONDO:0015780](http://purl.obolibrary.org/obo/MONDO_0015780) (dyskeratosis congenita), [MONDO:0013120](http://purl.obolibrary.org/obo/MONDO_0013120) (46,Xy sex reversal 5), [MONDO:0015783](http://purl.obolibrary.org/obo/MONDO_0015783) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1), [MONDO:0014452](http://purl.obolibrary.org/obo/MONDO_0014452) (familial dysfibrinogenemia), [MONDO:0015782](http://purl.obolibrary.org/obo/MONDO_0015782) (dysmorphism-cleft palate-loose skin syndrome), [MONDO:0013121](http://purl.obolibrary.org/obo/MONDO_0013121) (GLC3C), [MONDO:0002489](http://purl.obolibrary.org/obo/MONDO_0002489) (malignant breast phyllodes tumor), [MONDO:0002486](http://purl.obolibrary.org/obo/MONDO_0002486) (lobular neoplasia), [MONDO:0002485](http://purl.obolibrary.org/obo/MONDO_0002485) (breast neuroendocrine neoplasm), [MONDO:0002488](http://purl.obolibrary.org/obo/MONDO_0002488) (intraductal breast neoplasm), [MONDO:0002487](http://purl.obolibrary.org/obo/MONDO_0002487) (breast granular cell tumor), [MONDO:0002482](http://purl.obolibrary.org/obo/MONDO_0002482) (nipple neoplasm), [MONDO:0002481](http://purl.obolibrary.org/obo/MONDO_0002481) (ovary neuroendocrine neoplasm), [MONDO:0002484](http://purl.obolibrary.org/obo/MONDO_0002484) (breast ductal carcinoma), [MONDO:0001152](http://purl.obolibrary.org/obo/MONDO_0001152) (amnestic disorder), [MONDO:0002483](http://purl.obolibrary.org/obo/MONDO_0002483) (breast myoepithelial tumor), [MONDO:0002480](http://purl.obolibrary.org/obo/MONDO_0002480) (female reproductive endometrioid cancer), [MONDO:0014457](http://purl.obolibrary.org/obo/MONDO_0014457) (hyperphosphatasia with mental retardation syndrome 5), [MONDO:0014458](http://purl.obolibrary.org/obo/MONDO_0014458) (Fanconi renotubular syndrome 4 with Maturity-onset diabetes of the young), [MONDO:0013127](http://purl.obolibrary.org/obo/MONDO_0013127) (asphyxiating thoracic dystrophy 3), [MONDO:0015788](http://purl.obolibrary.org/obo/MONDO_0015788) (symptomatic form of hemophilia b in female carriers), [MONDO:0014459](http://purl.obolibrary.org/obo/MONDO_0014459) (Adams-Oliver syndrome 5), [MONDO:0013129](http://purl.obolibrary.org/obo/MONDO_0013129) (cone dystrophy 4), [MONDO:0013111](http://purl.obolibrary.org/obo/MONDO_0013111) (acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins), [MONDO:0014442](http://purl.obolibrary.org/obo/MONDO_0014442) (Bardet-Biedl syndrome 14), [MONDO:0015774](http://purl.obolibrary.org/obo/MONDO_0015774) (thoraco-abdominal enteric duplication), [MONDO:0015773](http://purl.obolibrary.org/obo/MONDO_0015773) (fibular dimelia-diplopodia syndrome), [MONDO:0014443](http://purl.obolibrary.org/obo/MONDO_0014443) (Bardet-Biedl syndrome 15), [MONDO:0015776](http://purl.obolibrary.org/obo/MONDO_0015776) (rhizomelic chondrodysplasia punctata), [MONDO:0013113](http://purl.obolibrary.org/obo/MONDO_0013113) (metaphyseal anadysplasia 2), [MONDO:0014444](http://purl.obolibrary.org/obo/MONDO_0014444) (Bardet-Biedl syndrome 16), [MONDO:0015775](http://purl.obolibrary.org/obo/MONDO_0015775) (non-rhizomelic chondrodysplasia punctata), [MONDO:0013114](http://purl.obolibrary.org/obo/MONDO_0013114) (autosomal dominant nonsyndromic deafness 50), [MONDO:0014445](http://purl.obolibrary.org/obo/MONDO_0014445) (Bardet-Biedl syndrome 17), [MONDO:0015770](http://purl.obolibrary.org/obo/MONDO_0015770) (congenital hypogonadotropic hypogonadism), [MONDO:0014440](http://purl.obolibrary.org/obo/MONDO_0014440) (Bardet-Biedl syndrome 12), [MONDO:0013110](http://purl.obolibrary.org/obo/MONDO_0013110) (neurodegenerative syndrome due to cerebral folate transport deficiency), [MONDO:0014441](http://purl.obolibrary.org/obo/MONDO_0014441) (Bardet-Biedl syndrome 13), [MONDO:0001129](http://purl.obolibrary.org/obo/MONDO_0001129) (nasal cavity olfactory neuroblastoma), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0003789](http://purl.obolibrary.org/obo/MONDO_0003789) (hereditary papillary renal cell carcinoma), [MONDO:0002459](http://purl.obolibrary.org/obo/MONDO_0002459) (hypersensitivity reaction type IV disease), [MONDO:0001128](http://purl.obolibrary.org/obo/MONDO_0001128) (nasal cavity cancer), [MONDO:0003787](http://purl.obolibrary.org/obo/MONDO_0003787) (childhood testicular mixed germ cell tumor), [MONDO:0003788](http://purl.obolibrary.org/obo/MONDO_0003788) (childhood embryonal testis carcinoma), [MONDO:0003786](http://purl.obolibrary.org/obo/MONDO_0003786) (childhood testicular choriocarcinoma), [MONDO:0002452](http://purl.obolibrary.org/obo/MONDO_0002452) (prostate leiomyoma), [MONDO:0002455](http://purl.obolibrary.org/obo/MONDO_0002455) (exocervical carcinoma), [MONDO:0003784](http://purl.obolibrary.org/obo/MONDO_0003784) (nasal cavity carcinoma in situ), [MONDO:0002454](http://purl.obolibrary.org/obo/MONDO_0002454) (thyroid adenoma (disease)), [MONDO:0003782](http://purl.obolibrary.org/obo/MONDO_0003782) (uterine corpus epithelioid leiomyosarcoma), [MONDO:0002451](http://purl.obolibrary.org/obo/MONDO_0002451) (benign prostate phyllodes tumor), [MONDO:0002450](http://purl.obolibrary.org/obo/MONDO_0002450) (prostatic adenoma), [MONDO:0013119](http://purl.obolibrary.org/obo/MONDO_0013119) (autosomal recessive nonsyndromic deafness 77), [MONDO:0013115](http://purl.obolibrary.org/obo/MONDO_0013115) (RIN2 syndrome), [MONDO:0014446](http://purl.obolibrary.org/obo/MONDO_0014446) (Bardet-Biedl syndrome 18), [MONDO:0013116](http://purl.obolibrary.org/obo/MONDO_0013116) (congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome), [MONDO:0014447](http://purl.obolibrary.org/obo/MONDO_0014447) (Bardet-Biedl syndrome 19), [MONDO:0013117](http://purl.obolibrary.org/obo/MONDO_0013117) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 5), [MONDO:0015779](http://purl.obolibrary.org/obo/MONDO_0015779) (45,X/46,XY mixed gonadal dysgenesis), [MONDO:0013118](http://purl.obolibrary.org/obo/MONDO_0013118) (Nijmegen breakage syndrome-like disorder), [MONDO:0013100](http://purl.obolibrary.org/obo/MONDO_0013100) (ATFB8), [MONDO:0014431](http://purl.obolibrary.org/obo/MONDO_0014431) (LIPE-related familial partial lipodystrophy), [MONDO:0015762](http://purl.obolibrary.org/obo/MONDO_0015762) (progressive familial intrahepatic cholestasis), [MONDO:0014432](http://purl.obolibrary.org/obo/MONDO_0014432) (Bardet-Biedl syndrome 2), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0014433](http://purl.obolibrary.org/obo/MONDO_0014433) (Bardet-Biedl syndrome 4), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0015765](http://purl.obolibrary.org/obo/MONDO_0015765) (congenital myopathy with cores), [MONDO:0014434](http://purl.obolibrary.org/obo/MONDO_0014434) (Bardet-Biedl syndrome 5), [MONDO:0015760](http://purl.obolibrary.org/obo/MONDO_0015760) (T-cell non-Hodgkin lymphoma), [MONDO:0003799](http://purl.obolibrary.org/obo/MONDO_0003799) (conjunctivitis (disease)), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0003796](http://purl.obolibrary.org/obo/MONDO_0003796) (rectum Kaposi sarcoma), [MONDO:0002464](http://purl.obolibrary.org/obo/MONDO_0002464) (lacrimal gland cancer), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0003797](http://purl.obolibrary.org/obo/MONDO_0003797) (inflammatory MFH), [MONDO:0002466](http://purl.obolibrary.org/obo/MONDO_0002466) (eye carcinoma), [MONDO:0003795](http://purl.obolibrary.org/obo/MONDO_0003795) (ovarian small cell carcinoma), [MONDO:0003792](http://purl.obolibrary.org/obo/MONDO_0003792) (ovarian carcinosarcoma), [MONDO:0002460](http://purl.obolibrary.org/obo/MONDO_0002460) (lacrimal system cancer), [MONDO:0003790](http://purl.obolibrary.org/obo/MONDO_0003790) (prostatic urethra urothelial carcinoma), [MONDO:0001130](http://purl.obolibrary.org/obo/MONDO_0001130) (nasal cavity lymphoma), [MONDO:0003791](http://purl.obolibrary.org/obo/MONDO_0003791) (prostatic urethral cancer), [MONDO:0014439](http://purl.obolibrary.org/obo/MONDO_0014439) (Bardet-Biedl syndrome 11), [MONDO:0013108](http://purl.obolibrary.org/obo/MONDO_0013108) (leukemia, acute lymphocytic, susceptibility to, 1), [MONDO:0013109](http://purl.obolibrary.org/obo/MONDO_0013109) (leukemia, acute lymphocytic, susceptibility to, 2), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0014435](http://purl.obolibrary.org/obo/MONDO_0014435) (Bardet-Biedl syndrome 7), [MONDO:0014436](http://purl.obolibrary.org/obo/MONDO_0014436) (Bardet-Biedl syndrome 8), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), [MONDO:0014437](http://purl.obolibrary.org/obo/MONDO_0014437) (Bardet-Biedl syndrome 9), [MONDO:0014438](http://purl.obolibrary.org/obo/MONDO_0014438) (Bardet-Biedl syndrome 10), [MONDO:0013107](http://purl.obolibrary.org/obo/MONDO_0013107) (atopic dermatitis 7), [MONDO:0015768](http://purl.obolibrary.org/obo/MONDO_0015768) (trisomy 5p), [MONDO:0013177](http://purl.obolibrary.org/obo/MONDO_0013177) (congenital muscular dystrophy due to integrin alpha-7 deficiency), [MONDO:0013178](http://purl.obolibrary.org/obo/MONDO_0013178) (congenital muscular dystrophy due to LMNA mutation), [MONDO:0013174](http://purl.obolibrary.org/obo/MONDO_0013174) (primary ciliary dyskinesia 13), [MONDO:0013175](http://purl.obolibrary.org/obo/MONDO_0013175) (retinitis pigmentosa 50), [MONDO:0013176](http://purl.obolibrary.org/obo/MONDO_0013176) (ichthyosis-short stature-brachydactyly-microspherophakia syndrome), [MONDO:0013170](http://purl.obolibrary.org/obo/MONDO_0013170) (cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies), [MONDO:0013171](http://purl.obolibrary.org/obo/MONDO_0013171) (purine nucleoside phosphorylase deficiency), [MONDO:0013172](http://purl.obolibrary.org/obo/MONDO_0013172) (polymicrogyria with optic nerve hypoplasia), [MONDO:0001188](http://purl.obolibrary.org/obo/MONDO_0001188) (esophagus lymphoma), [MONDO:0001187](http://purl.obolibrary.org/obo/MONDO_0001187) (urinary bladder cancer), [MONDO:0001183](http://purl.obolibrary.org/obo/MONDO_0001183) (contact lens corneal edema), [MONDO:0001185](http://purl.obolibrary.org/obo/MONDO_0001185) (dissociative amnesia), [MONDO:0001180](http://purl.obolibrary.org/obo/MONDO_0001180) (bullous keratopathy), [MONDO:0001182](http://purl.obolibrary.org/obo/MONDO_0001182) (idiopathic corneal edema), [MONDO:0001181](http://purl.obolibrary.org/obo/MONDO_0001181) (secondary corneal edema), [MONDO:0014497](http://purl.obolibrary.org/obo/MONDO_0014497) (polyendocrine-polyneuropathy syndrome), [MONDO:0013166](http://purl.obolibrary.org/obo/MONDO_0013166) (GABA aminotransferase deficiency), [MONDO:0013169](http://purl.obolibrary.org/obo/MONDO_0013169) (chromosome 5p13 duplication syndrome), [MONDO:0013162](http://purl.obolibrary.org/obo/MONDO_0013162) (autosomal recessive limb-girdle muscular dystrophy type 2N), [MONDO:0014493](http://purl.obolibrary.org/obo/MONDO_0014493) (autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency), [MONDO:0013164](http://purl.obolibrary.org/obo/MONDO_0013164) (beta-ureidopropionase deficiency), [MONDO:0014495](http://purl.obolibrary.org/obo/MONDO_0014495) (retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome), [MONDO:0014496](http://purl.obolibrary.org/obo/MONDO_0014496) (mitochondrial complex III deficiency nuclear type 9), [MONDO:0014490](http://purl.obolibrary.org/obo/MONDO_0014490) (ketoacidosis due to monocarboxylate transporter-1 deficiency), [MONDO:0013160](http://purl.obolibrary.org/obo/MONDO_0013160) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2), [MONDO:0013161](http://purl.obolibrary.org/obo/MONDO_0013161) (autosomal recessive limb-girdle muscular dystrophy type 2O), [MONDO:0001193](http://purl.obolibrary.org/obo/MONDO_0001193) (chorioretinal scar), [MONDO:0001192](http://purl.obolibrary.org/obo/MONDO_0001192) (esophagus melanoma), [MONDO:0013155](http://purl.obolibrary.org/obo/MONDO_0013155) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3), [MONDO:0014487](http://purl.obolibrary.org/obo/MONDO_0014487) (congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome), [MONDO:0013156](http://purl.obolibrary.org/obo/MONDO_0013156) (muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4), [MONDO:0014488](http://purl.obolibrary.org/obo/MONDO_0014488) (diabetes mellitus, Noninsulin-dependent, 5), [MONDO:0013157](http://purl.obolibrary.org/obo/MONDO_0013157) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5), [MONDO:0014489](http://purl.obolibrary.org/obo/MONDO_0014489) (limb-girdle muscular dystrophy due to POMK deficiency), [MONDO:0013158](http://purl.obolibrary.org/obo/MONDO_0013158) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6), [MONDO:0013151](http://purl.obolibrary.org/obo/MONDO_0013151) (CACD3), [MONDO:0014483](http://purl.obolibrary.org/obo/MONDO_0014483) (retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies), [MONDO:0013152](http://purl.obolibrary.org/obo/MONDO_0013152) (SLEB14), [MONDO:0014484](http://purl.obolibrary.org/obo/MONDO_0014484) (microcephaly 12, primary, autosomal recessive), [MONDO:0013153](http://purl.obolibrary.org/obo/MONDO_0013153) (inflammatory bowel disease 28), [MONDO:0013154](http://purl.obolibrary.org/obo/MONDO_0013154) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2), [MONDO:0014485](http://purl.obolibrary.org/obo/MONDO_0014485) (pontocerebellar hypoplasia, type 1C), [MONDO:0014480](http://purl.obolibrary.org/obo/MONDO_0014480) (46,Xy sex reversal 9), [MONDO:0014481](http://purl.obolibrary.org/obo/MONDO_0014481) (inflammatory skin and bowel disease, neonatal, 2), [MONDO:0002497](http://purl.obolibrary.org/obo/MONDO_0002497) (food allergy), [MONDO:0002496](http://purl.obolibrary.org/obo/MONDO_0002496) (submucosal invasive colon adenocarcinoma), [MONDO:0002493](http://purl.obolibrary.org/obo/MONDO_0002493) (prostatic acinar adenocarcinoma), [MONDO:0002495](http://purl.obolibrary.org/obo/MONDO_0002495) (colon signet ring adenocarcinoma), [MONDO:0002490](http://purl.obolibrary.org/obo/MONDO_0002490) (breast sarcoma), [MONDO:0013159](http://purl.obolibrary.org/obo/MONDO_0013159) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1), [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0014475](http://purl.obolibrary.org/obo/MONDO_0014475) (spinocerebellar ataxia type 40), [MONDO:0013145](http://purl.obolibrary.org/obo/MONDO_0013145) (Brugada syndrome 6), [MONDO:0013146](http://purl.obolibrary.org/obo/MONDO_0013146) (Brugada syndrome 7), [MONDO:0014471](http://purl.obolibrary.org/obo/MONDO_0014471) (isolated ATP synthase deficiency), [MONDO:0013141](http://purl.obolibrary.org/obo/MONDO_0013141) (autosomal dominant macrothrombocytopenia TUBB1-related), [MONDO:0014473](http://purl.obolibrary.org/obo/MONDO_0014473) (microcephaly 13, primary, autosomal recessive), [MONDO:0014474](http://purl.obolibrary.org/obo/MONDO_0014474) (autosomal recessive limb-girdle muscular dystrophy type 2U), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0014470](http://purl.obolibrary.org/obo/MONDO_0014470) (autosomal dominant nonsyndromic deafness 65), [MONDO:0001176](http://purl.obolibrary.org/obo/MONDO_0001176) (lens disease), [MONDO:0001179](http://purl.obolibrary.org/obo/MONDO_0001179) (pinguecula), [MONDO:0001178](http://purl.obolibrary.org/obo/MONDO_0001178) (pseudopterygium), [MONDO:0001175](http://purl.obolibrary.org/obo/MONDO_0001175) (immature cataract), [MONDO:0001174](http://purl.obolibrary.org/obo/MONDO_0001174) (conjunctival vascular disease), [MONDO:0013148](http://purl.obolibrary.org/obo/MONDO_0013148) (Brugada syndrome 8), [MONDO:0013199](http://purl.obolibrary.org/obo/MONDO_0013199) (tuberous sclerosis 2), [MONDO:0013196](http://purl.obolibrary.org/obo/MONDO_0013196) (colorectal cancer, hereditary nonpolyposis, type 8), [MONDO:0013193](http://purl.obolibrary.org/obo/MONDO_0013193) (thyrotoxic periodic paralysis, susceptibility to, 2), [MONDO:0013190](http://purl.obolibrary.org/obo/MONDO_0013190) (factor Xiii, b subunit, deficiency of), [MONDO:0013188](http://purl.obolibrary.org/obo/MONDO_0013188) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 3), [MONDO:0013184](http://purl.obolibrary.org/obo/MONDO_0013184) (congenital diarrhea 5 with tufting enteropathy), [MONDO:0013186](http://purl.obolibrary.org/obo/MONDO_0013186) (Noonan syndrome 6), [MONDO:0013187](http://purl.obolibrary.org/obo/MONDO_0013187) (factor Xiii, a subunit, deficiency of), [MONDO:0013182](http://purl.obolibrary.org/obo/MONDO_0013182) (chromosome 17p13.3 duplication syndrome), [MONDO:0013183](http://purl.obolibrary.org/obo/MONDO_0013183) (congenital stationary night blindness 1C), [MONDO:0003808](http://purl.obolibrary.org/obo/MONDO_0003808) (mediastinal osteogenic sarcoma), [MONDO:0003809](http://purl.obolibrary.org/obo/MONDO_0003809) (malignant mediastinum hemangiopericytoma), [MONDO:0003806](http://purl.obolibrary.org/obo/MONDO_0003806) (thyroid hyalinizing trabecular adenoma), [MONDO:0003805](http://purl.obolibrary.org/obo/MONDO_0003805) (malignant pericardial mesothelioma), [MONDO:0003802](http://purl.obolibrary.org/obo/MONDO_0003802) (cornea cancer), [MONDO:0003800](http://purl.obolibrary.org/obo/MONDO_0003800) (conventional malignant hemangiopericytoma), [MONDO:0003801](http://purl.obolibrary.org/obo/MONDO_0003801) (corneal intraepithelial neoplasm), [MONDO:0003819](http://purl.obolibrary.org/obo/MONDO_0003819) (childhood teratoma of the ovary), [MONDO:0003817](http://purl.obolibrary.org/obo/MONDO_0003817) (peritoneal serous papillary adenocarcinoma), [MONDO:0003818](http://purl.obolibrary.org/obo/MONDO_0003818) (childhood mature teratoma of the ovary), [MONDO:0003813](http://purl.obolibrary.org/obo/MONDO_0003813) (ovarian papillary tumor), [MONDO:0003811](http://purl.obolibrary.org/obo/MONDO_0003811) (mixed epithelial tumor of ovary), [MONDO:0003812](http://purl.obolibrary.org/obo/MONDO_0003812) (ovarian endometrial cancer), [MONDO:0003810](http://purl.obolibrary.org/obo/MONDO_0003810) (bladder diffuse clear cell adenocarcinoma), [MONDO:0014500](http://purl.obolibrary.org/obo/MONDO_0014500) (atrial conduction disease), [MONDO:0002516](http://purl.obolibrary.org/obo/MONDO_0002516) (digestive system cancer), [MONDO:0003849](http://purl.obolibrary.org/obo/MONDO_0003849) (clivus chordoma), [MONDO:0002518](http://purl.obolibrary.org/obo/MONDO_0002518) (gallbladder papillary neoplasm), [MONDO:0003844](http://purl.obolibrary.org/obo/MONDO_0003844) (central nervous system lipoma), [MONDO:0002512](http://purl.obolibrary.org/obo/MONDO_0002512) (papillary adenocarcinoma), [MONDO:0003845](http://purl.obolibrary.org/obo/MONDO_0003845) (corpus callosum lipoma), [MONDO:0002511](http://purl.obolibrary.org/obo/MONDO_0002511) (stenosis of lacrimal sac), [MONDO:0003842](http://purl.obolibrary.org/obo/MONDO_0003842) (childhood cerebellar astrocytic neoplasm), [MONDO:0002514](http://purl.obolibrary.org/obo/MONDO_0002514) (hepatobiliary neoplasm), [MONDO:0002513](http://purl.obolibrary.org/obo/MONDO_0002513) (kidney benign neoplasm), [MONDO:0003843](http://purl.obolibrary.org/obo/MONDO_0003843) (cerebral hemisphere lipoma), [MONDO:0003840](http://purl.obolibrary.org/obo/MONDO_0003840) (epicardium lipoma), [MONDO:0003841](http://purl.obolibrary.org/obo/MONDO_0003841) (heart lipoma), [MONDO:0002510](http://purl.obolibrary.org/obo/MONDO_0002510) (germ cell and embryonal cancer), [MONDO:0014509](http://purl.obolibrary.org/obo/MONDO_0014509) (macular dystrophy, vitelliform, 5), [MONDO:0015839](http://purl.obolibrary.org/obo/MONDO_0015839) (septate uterus), [MONDO:0014507](http://purl.obolibrary.org/obo/MONDO_0014507) (Catel-Manzke syndrome), [MONDO:0014508](http://purl.obolibrary.org/obo/MONDO_0014508) (macular dystrophy, vitelliform, 4), [MONDO:0014501](http://purl.obolibrary.org/obo/MONDO_0014501) (macular degeneration, early-onset), [MONDO:0014503](http://purl.obolibrary.org/obo/MONDO_0014503) (autosomal recessive spinocerebellar ataxia 17), [MONDO:0014504](http://purl.obolibrary.org/obo/MONDO_0014504) (Perrault syndrome 5), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0002527](http://purl.obolibrary.org/obo/MONDO_0002527) (keratoacanthoma), [MONDO:0003859](http://purl.obolibrary.org/obo/MONDO_0003859) (bilateral meningioma of optic nerve), [MONDO:0002526](http://purl.obolibrary.org/obo/MONDO_0002526) (dermal unilateral segmental cavernous angioma), [MONDO:0002529](http://purl.obolibrary.org/obo/MONDO_0002529) (skin squamous cell carcinoma), [MONDO:0003857](http://purl.obolibrary.org/obo/MONDO_0003857) (adult intracranial malignant hemangiopericytoma), [MONDO:0002528](http://purl.obolibrary.org/obo/MONDO_0002528) (synovium neoplasm), [MONDO:0003858](http://purl.obolibrary.org/obo/MONDO_0003858) (anterior optic tract meningioma), [MONDO:0003855](http://purl.obolibrary.org/obo/MONDO_0003855) (immature teratoma of ovary), [MONDO:0002522](http://purl.obolibrary.org/obo/MONDO_0002522) (tenosynovial giant cell tumor), [MONDO:0003856](http://purl.obolibrary.org/obo/MONDO_0003856) (adult malignant hemangiopericytoma), [MONDO:0002525](http://purl.obolibrary.org/obo/MONDO_0002525) (inherited lipid metabolism disorder), [MONDO:0003853](http://purl.obolibrary.org/obo/MONDO_0003853) (Bartholin's gland adenocarcinoma), [MONDO:0003851](http://purl.obolibrary.org/obo/MONDO_0003851) (ovarian fetiform teratoma), [MONDO:0003852](http://purl.obolibrary.org/obo/MONDO_0003852) (ovarian solid teratoma), [MONDO:0002520](http://purl.obolibrary.org/obo/MONDO_0002520) (acute porphyria), [MONDO:0003850](http://purl.obolibrary.org/obo/MONDO_0003850) (clivus chondroid chordoma), [MONDO:0015826](http://purl.obolibrary.org/obo/MONDO_0015826) (autosomal dominant spondylocostal dysostosis), [MONDO:0015825](http://purl.obolibrary.org/obo/MONDO_0015825) (obesity due to congenital leptin resistance), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), [MONDO:0015824](http://purl.obolibrary.org/obo/MONDO_0015824) (oculomaxillofacial dysostosis), [MONDO:0015823](http://purl.obolibrary.org/obo/MONDO_0015823) (primary immunodeficiency due to a defect in adaptive immunity), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0003829](http://purl.obolibrary.org/obo/MONDO_0003829) (chromophil adenoma of the kidney), [MONDO:0003826](http://purl.obolibrary.org/obo/MONDO_0003826) (mediastinum seminoma), [MONDO:0003827](http://purl.obolibrary.org/obo/MONDO_0003827) (transient hypogammaglobulinemia), [MONDO:0003824](http://purl.obolibrary.org/obo/MONDO_0003824) (hereditary kidney oncocytoma), [MONDO:0003825](http://purl.obolibrary.org/obo/MONDO_0003825) (kidney oncocytoma), [MONDO:0003822](http://purl.obolibrary.org/obo/MONDO_0003822) (non-invasive bladder papillary urothelial neoplasm), [MONDO:0003820](http://purl.obolibrary.org/obo/MONDO_0003820) (mature ovarian teratoma), [MONDO:0003821](http://purl.obolibrary.org/obo/MONDO_0003821) (ovarian biphasic or triphasic teratoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0015811](http://purl.obolibrary.org/obo/MONDO_0015811) (primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma), [MONDO:0015810](http://purl.obolibrary.org/obo/MONDO_0015810) (primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0015812](http://purl.obolibrary.org/obo/MONDO_0015812) (primary cutaneous gamma/delta-positive T-cell lymphoma), [MONDO:0003839](http://purl.obolibrary.org/obo/MONDO_0003839) (ovarian mucinous malignant adenofibroma), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0002505](http://purl.obolibrary.org/obo/MONDO_0002505) (juvenile astrocytoma), [MONDO:0003838](http://purl.obolibrary.org/obo/MONDO_0003838) (malignant ACTH producing neoplasm of pituitary gland), [MONDO:0003835](http://purl.obolibrary.org/obo/MONDO_0003835) (gastric cardia adenocarcinoma), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0002501](http://purl.obolibrary.org/obo/MONDO_0002501) (brain glioblastoma), [MONDO:0003834](http://purl.obolibrary.org/obo/MONDO_0003834) (gastric cardia carcinoma), [MONDO:0002503](http://purl.obolibrary.org/obo/MONDO_0002503) (adult astrocytic tumour), [MONDO:0003831](http://purl.obolibrary.org/obo/MONDO_0003831) (type 2 papillary adenoma of the kidney), [MONDO:0003830](http://purl.obolibrary.org/obo/MONDO_0003830) (type 1 papillary adenoma of the kidney), [MONDO:0015808](http://purl.obolibrary.org/obo/MONDO_0015808) (folliculotropic mycosis fungoides), [MONDO:0015807](http://purl.obolibrary.org/obo/MONDO_0015807) (myopic macular degeneration), [MONDO:0015809](http://purl.obolibrary.org/obo/MONDO_0015809) (localized pagetoid reticulosis), [MONDO:0015804](http://purl.obolibrary.org/obo/MONDO_0015804) (infant botulism), [MONDO:0015803](http://purl.obolibrary.org/obo/MONDO_0015803) (wound botulism), [MONDO:0015806](http://purl.obolibrary.org/obo/MONDO_0015806) (adult intestinal botulism), [MONDO:0015805](http://purl.obolibrary.org/obo/MONDO_0015805) (intestinal botulism), [MONDO:0015800](http://purl.obolibrary.org/obo/MONDO_0015800) (osteosclerosis-developmental delay-craniosynostosis syndrome), [MONDO:0015801](http://purl.obolibrary.org/obo/MONDO_0015801) (hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation), [MONDO:0015873](http://purl.obolibrary.org/obo/MONDO_0015873) (Paget disease of the nipple), [MONDO:0014541](http://purl.obolibrary.org/obo/MONDO_0014541) (motor developmental delay due to 14q32.2 paternally expressed gene defect), [MONDO:0013210](http://purl.obolibrary.org/obo/MONDO_0013210) (autosomal recessive nonsyndromic deafness 25), [MONDO:0015872](http://purl.obolibrary.org/obo/MONDO_0015872) (giant adenofibroma of the breast), [MONDO:0014542](http://purl.obolibrary.org/obo/MONDO_0014542) (congenital myasthenic syndrome 15), [MONDO:0014543](http://purl.obolibrary.org/obo/MONDO_0014543) (congenital myasthenic syndrome 14), [MONDO:0013212](http://purl.obolibrary.org/obo/MONDO_0013212) (Charcot-Marie-tooth disease axonal type 2N), [MONDO:0014544](http://purl.obolibrary.org/obo/MONDO_0014544) (osteogenesis imperfecta type 16), [MONDO:0015874](http://purl.obolibrary.org/obo/MONDO_0015874) (benign ductal tumor of breast), [MONDO:0015871](http://purl.obolibrary.org/obo/MONDO_0015871) (benign breast phyllodes tumor), [MONDO:0015870](http://purl.obolibrary.org/obo/MONDO_0015870) (rare malignant breast tumor), [MONDO:0002559](http://purl.obolibrary.org/obo/MONDO_0002559) (plexiform schwannoma), [MONDO:0001228](http://purl.obolibrary.org/obo/MONDO_0001228) (conjunctival folliculosis), [MONDO:0002556](http://purl.obolibrary.org/obo/MONDO_0002556) (macrocystic neurilemmoma), [MONDO:0003888](http://purl.obolibrary.org/obo/MONDO_0003888) (childhood testicular mixed embryonal carcinoma and teratoma), [MONDO:0002555](http://purl.obolibrary.org/obo/MONDO_0002555) (neurilemmoma of the fifth cranial nerve), [MONDO:0003889](http://purl.obolibrary.org/obo/MONDO_0003889) (infiltrating bladder urothelial carcinoma, clear cell variant), [MONDO:0001224](http://purl.obolibrary.org/obo/MONDO_0001224) (Angelucci's syndrome), [MONDO:0003886](http://purl.obolibrary.org/obo/MONDO_0003886) (mucinous cystadenofibroma), [MONDO:0002558](http://purl.obolibrary.org/obo/MONDO_0002558) (melanotic neurilemmoma), [MONDO:0003887](http://purl.obolibrary.org/obo/MONDO_0003887) (ovarian mucinous adenofibroma), [MONDO:0001226](http://purl.obolibrary.org/obo/MONDO_0001226) (acute contagious conjunctivitis), [MONDO:0003884](http://purl.obolibrary.org/obo/MONDO_0003884) (lipoma of the rectum), [MONDO:0003885](http://purl.obolibrary.org/obo/MONDO_0003885) (large intestine lipoma), [MONDO:0002551](http://purl.obolibrary.org/obo/MONDO_0002551) (c-P angle neurinoma), [MONDO:0003882](http://purl.obolibrary.org/obo/MONDO_0003882) (central nervous system fibrosarcoma), [MONDO:0002554](http://purl.obolibrary.org/obo/MONDO_0002554) (sympathetic neurilemmoma), [MONDO:0002553](http://purl.obolibrary.org/obo/MONDO_0002553) (cerebellopontine angle tumor), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0003881](http://purl.obolibrary.org/obo/MONDO_0003881) (vulvar apocrine adenocarcinoma), [MONDO:0002550](http://purl.obolibrary.org/obo/MONDO_0002550) (hypoglossal nerve neoplasm), [MONDO:0014549](http://purl.obolibrary.org/obo/MONDO_0014549) (lethal congenital contracture syndrome 6), [MONDO:0013218](http://purl.obolibrary.org/obo/MONDO_0013218) (exudative vitreoretinopathy 5), [MONDO:0013219](http://purl.obolibrary.org/obo/MONDO_0013219) (hypophosphatemic rickets, autosomal recessive, 2), [MONDO:0014545](http://purl.obolibrary.org/obo/MONDO_0014545) (progressive myoclonic epilepsy type 8), [MONDO:0014546](http://purl.obolibrary.org/obo/MONDO_0014546) (myopathy due to calsequestrin and SERCA1 protein overload), [MONDO:0013215](http://purl.obolibrary.org/obo/MONDO_0013215) (autosomal recessive nonsyndromic deafness 79), [MONDO:0015876](http://purl.obolibrary.org/obo/MONDO_0015876) (rare vulvovaginal tumor), [MONDO:0014547](http://purl.obolibrary.org/obo/MONDO_0014547) (combined oxidative phosphorylation defect type 24), [MONDO:0013216](http://purl.obolibrary.org/obo/MONDO_0013216) (Diamond-Blackfan anemia 9), [MONDO:0013217](http://purl.obolibrary.org/obo/MONDO_0013217) (Diamond-Blackfan anemia 10), [MONDO:0014548](http://purl.obolibrary.org/obo/MONDO_0014548) (long QT syndrome 14), [MONDO:0014530](http://purl.obolibrary.org/obo/MONDO_0014530) (autosomal recessive spinocerebellar ataxia 18), [MONDO:0015861](http://purl.obolibrary.org/obo/MONDO_0015861) (rare uterine adnexal tumor), [MONDO:0014531](http://purl.obolibrary.org/obo/MONDO_0014531) (amyotrohpic lateral sclerosis type 22), [MONDO:0013201](http://purl.obolibrary.org/obo/MONDO_0013201) (Waardenburg syndrome type 4B), [MONDO:0014532](http://purl.obolibrary.org/obo/MONDO_0014532) (autosomal dominant mitochondrial myopathy with exercise intolerance), [MONDO:0015864](http://purl.obolibrary.org/obo/MONDO_0015864) (mixed germ cell tumor), [MONDO:0013202](http://purl.obolibrary.org/obo/MONDO_0013202) (Waardenburg syndrome type 4C), [MONDO:0015863](http://purl.obolibrary.org/obo/MONDO_0015863) (polyembryoma), [MONDO:0001239](http://purl.obolibrary.org/obo/MONDO_0001239) (anemia of prematurity), [MONDO:0001236](http://purl.obolibrary.org/obo/MONDO_0001236) (appendiceal neoplasm), [MONDO:0003899](http://purl.obolibrary.org/obo/MONDO_0003899) (adult myxoid chondrosarcoma), [MONDO:0001235](http://purl.obolibrary.org/obo/MONDO_0001235) (appendix cancer), [MONDO:0003897](http://purl.obolibrary.org/obo/MONDO_0003897) (breast epithelioid hemangioma), [MONDO:0003898](http://purl.obolibrary.org/obo/MONDO_0003898) (pediatric myxoid chondrosarcoma), [MONDO:0001237](http://purl.obolibrary.org/obo/MONDO_0001237) (appendix lymphoma), [MONDO:0003895](http://purl.obolibrary.org/obo/MONDO_0003895) (periosteal osteogenic sarcoma), [MONDO:0002563](http://purl.obolibrary.org/obo/MONDO_0002563) (jejunal somatostatinoma), [MONDO:0003896](http://purl.obolibrary.org/obo/MONDO_0003896) (breast capillary hemangioma), [MONDO:0003893](http://purl.obolibrary.org/obo/MONDO_0003893) (rete testis adenoma), [MONDO:0003894](http://purl.obolibrary.org/obo/MONDO_0003894) (mediastinal melanocytic neurilemmoma), [MONDO:0002564](http://purl.obolibrary.org/obo/MONDO_0002564) (jejunal neoplasm), [MONDO:0003891](http://purl.obolibrary.org/obo/MONDO_0003891) (bladder signet ring cell adenocarcinoma), [MONDO:0003892](http://purl.obolibrary.org/obo/MONDO_0003892) (acinar lung adenocarcinoma), [MONDO:0002561](http://purl.obolibrary.org/obo/MONDO_0002561) (lysosomal storage disease), [MONDO:0003890](http://purl.obolibrary.org/obo/MONDO_0003890) (infiltrating bladder urothelial carcinoma), [MONDO:0014538](http://purl.obolibrary.org/obo/MONDO_0014538) (fibrosis of extraocular muscles, congenital, 5), [MONDO:0013207](http://purl.obolibrary.org/obo/MONDO_0013207) (FECD7), [MONDO:0013208](http://purl.obolibrary.org/obo/MONDO_0013208) (cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome), [MONDO:0015869](http://purl.obolibrary.org/obo/MONDO_0015869) (rare benign breast tumor), [MONDO:0014534](http://purl.obolibrary.org/obo/MONDO_0014534) (lissencephaly 6 with microcephaly), [MONDO:0013203](http://purl.obolibrary.org/obo/MONDO_0013203) (corneal dystrophy, Fuchs endothelial, 3), [MONDO:0013204](http://purl.obolibrary.org/obo/MONDO_0013204) (corneal dystrophy, Fuchs endothelial, 4), [MONDO:0015868](http://purl.obolibrary.org/obo/MONDO_0015868) (rare breast tumor), [MONDO:0013205](http://purl.obolibrary.org/obo/MONDO_0013205) (FECD5), [MONDO:0014536](http://purl.obolibrary.org/obo/MONDO_0014536) (thrombocytopenia 5), [MONDO:0015867](http://purl.obolibrary.org/obo/MONDO_0015867) (vaginal carcinoma), [MONDO:0013206](http://purl.obolibrary.org/obo/MONDO_0013206) (corneal dystrophy, Fuchs endothelial, 6), [MONDO:0014520](http://purl.obolibrary.org/obo/MONDO_0014520) (46,XX ovarian dysgenesis-short stature syndrome), [MONDO:0014522](http://purl.obolibrary.org/obo/MONDO_0014522) (retinal dystrophy and obesity), [MONDO:0001207](http://purl.obolibrary.org/obo/MONDO_0001207) (neonatal respiratory failure), [MONDO:0001206](http://purl.obolibrary.org/obo/MONDO_0001206) (aqueous misdirection), [MONDO:0002537](http://purl.obolibrary.org/obo/MONDO_0002537) (inverted papilloma), [MONDO:0003868](http://purl.obolibrary.org/obo/MONDO_0003868) (anterior foramen magnum meningioma), [MONDO:0001208](http://purl.obolibrary.org/obo/MONDO_0001208) (acute respiratory failure), [MONDO:0003869](http://purl.obolibrary.org/obo/MONDO_0003869) (childhood brain stem glioma), [MONDO:0001203](http://purl.obolibrary.org/obo/MONDO_0001203) (prolapse of lacrimal gland), [MONDO:0002534](http://purl.obolibrary.org/obo/MONDO_0002534) (fallopian tube papilloma), [MONDO:0003866](http://purl.obolibrary.org/obo/MONDO_0003866) (hepatic osteogenic sarcoma), [MONDO:0002533](http://purl.obolibrary.org/obo/MONDO_0002533) (papillary adenoma), [MONDO:0003867](http://purl.obolibrary.org/obo/MONDO_0003867) (diffuse meningeal melanocytosis), [MONDO:0002536](http://purl.obolibrary.org/obo/MONDO_0002536) (skin papilloma), [MONDO:0003864](http://purl.obolibrary.org/obo/MONDO_0003864) (CLL/SLL), [MONDO:0001205](http://purl.obolibrary.org/obo/MONDO_0001205) (hypersecretion glaucoma), [MONDO:0001204](http://purl.obolibrary.org/obo/MONDO_0001204) (esophagus sarcoma), [MONDO:0002535](http://purl.obolibrary.org/obo/MONDO_0002535) (verrucous papilloma), [MONDO:0003865](http://purl.obolibrary.org/obo/MONDO_0003865) (acral lentiginous melanoma (disease)), [MONDO:0003862](http://purl.obolibrary.org/obo/MONDO_0003862) (melanocytic psammomatous MPNST), [MONDO:0003863](http://purl.obolibrary.org/obo/MONDO_0003863) (malignant melanocytic neoplasm of the peripheral nerve sheath), [MONDO:0002532](http://purl.obolibrary.org/obo/MONDO_0002532) (squamous cell neoplasm), [MONDO:0003860](http://purl.obolibrary.org/obo/MONDO_0003860) (cerebellopontine angle meningioma), [MONDO:0002531](http://purl.obolibrary.org/obo/MONDO_0002531) (skin neoplasm), [MONDO:0003861](http://purl.obolibrary.org/obo/MONDO_0003861) (vulvar eccrine adenocarcinoma), [MONDO:0014527](http://purl.obolibrary.org/obo/MONDO_0014527) (progeroid features-hepatocellular carcinoma predisposition syndrome), [MONDO:0014528](http://purl.obolibrary.org/obo/MONDO_0014528) (chronic atrial and intestinal dysrhythmia), [MONDO:0014529](http://purl.obolibrary.org/obo/MONDO_0014529) (cerebellar-facial-dental syndrome), [MONDO:0014523](http://purl.obolibrary.org/obo/MONDO_0014523) (juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome), [MONDO:0014525](http://purl.obolibrary.org/obo/MONDO_0014525) (combined oxidative phosphorylation defect type 23), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), [MONDO:0015840](http://purl.obolibrary.org/obo/MONDO_0015840) (complete septate uterus), [MONDO:0014510](http://purl.obolibrary.org/obo/MONDO_0014510) (severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-CoA reductase 1 deficiency), [MONDO:0014511](http://purl.obolibrary.org/obo/MONDO_0014511) (Charcot-Marie-tooth disease axonal type 2S), [MONDO:0015841](http://purl.obolibrary.org/obo/MONDO_0015841) (partial septate uterus), [MONDO:0002549](http://purl.obolibrary.org/obo/MONDO_0002549) (schwannoma of twelfth cranial nerve), [MONDO:0001217](http://purl.obolibrary.org/obo/MONDO_0001217) (pseudomembranous conjunctivitis), [MONDO:0002548](http://purl.obolibrary.org/obo/MONDO_0002548) (cellular schwannoma), [MONDO:0003879](http://purl.obolibrary.org/obo/MONDO_0003879) (ovarian endometrioid malignant adenofibroma), [MONDO:0001219](http://purl.obolibrary.org/obo/MONDO_0001219) (serous conjunctivitis except viral), [MONDO:0001214](http://purl.obolibrary.org/obo/MONDO_0001214) (acute conjunctivitis), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0002544](http://purl.obolibrary.org/obo/MONDO_0002544) (brain oligodendroglioma), [MONDO:0003875](http://purl.obolibrary.org/obo/MONDO_0003875) (childhood central nervous system mature teratoma), [MONDO:0002547](http://purl.obolibrary.org/obo/MONDO_0002547) (nerve sheath neoplasm), [MONDO:0002546](http://purl.obolibrary.org/obo/MONDO_0002546) (schwannoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0002541](http://purl.obolibrary.org/obo/MONDO_0002541) (spinal cord oligodendroglioma), [MONDO:0003873](http://purl.obolibrary.org/obo/MONDO_0003873) (ovarian surface papilloma), [MONDO:0003874](http://purl.obolibrary.org/obo/MONDO_0003874) (ovary papillary carcinoma), [MONDO:0002540](http://purl.obolibrary.org/obo/MONDO_0002540) (childhood oligodendroglioma), [MONDO:0002543](http://purl.obolibrary.org/obo/MONDO_0002543) (adult oligodendroglioma), [MONDO:0001211](http://purl.obolibrary.org/obo/MONDO_0001211) (total internal ophthalmoplegia), [MONDO:0002542](http://purl.obolibrary.org/obo/MONDO_0002542) (spinal cord glioma), [MONDO:0003872](http://purl.obolibrary.org/obo/MONDO_0003872) (ovarian papillary cystadenoma), [MONDO:0003870](http://purl.obolibrary.org/obo/MONDO_0003870) (childhood brainstem astrocytoma), [MONDO:0014516](http://purl.obolibrary.org/obo/MONDO_0014516) (microcephaly and chorioretinopathy 2), [MONDO:0014518](http://purl.obolibrary.org/obo/MONDO_0014518) (platelet-type bleeding disorder 19), [MONDO:0015844](http://purl.obolibrary.org/obo/MONDO_0015844) (agenesis and aplasia of uterine body), [MONDO:0014512](http://purl.obolibrary.org/obo/MONDO_0014512) (PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation), [MONDO:0014513](http://purl.obolibrary.org/obo/MONDO_0014513) (nemaline myopathy 10), [MONDO:0014515](http://purl.obolibrary.org/obo/MONDO_0014515) (macular dystrophy with central cone involvement), [MONDO:0015845](http://purl.obolibrary.org/obo/MONDO_0015845) (uterine cervical aplasia and agenesis), [MONDO:0014585](http://purl.obolibrary.org/obo/MONDO_0014585) (congenital myasthenic syndrome 3C), [MONDO:0013255](http://purl.obolibrary.org/obo/MONDO_0013255) (arthrogryposis, renal dysfunction, and cholestasis 2), [MONDO:0014586](http://purl.obolibrary.org/obo/MONDO_0014586) (congenital myasthenic syndrome 4B), [MONDO:0013256](http://purl.obolibrary.org/obo/MONDO_0013256) (chromosome 15q24 deletion syndrome), [MONDO:0014587](http://purl.obolibrary.org/obo/MONDO_0014587) (congenital myasthenic syndrome 9), [MONDO:0014588](http://purl.obolibrary.org/obo/MONDO_0014588) (congenital myasthenic syndrome 11), [MONDO:0014581](http://purl.obolibrary.org/obo/MONDO_0014581) (congenital myasthenic syndrome 2A), [MONDO:0013250](http://purl.obolibrary.org/obo/MONDO_0013250) (autosomal recessive nonsyndromic deafness 85), [MONDO:0014582](http://purl.obolibrary.org/obo/MONDO_0014582) (congenital myasthenic syndrome 2C), [MONDO:0013252](http://purl.obolibrary.org/obo/MONDO_0013252) (Warsaw breakage syndrome), [MONDO:0014583](http://purl.obolibrary.org/obo/MONDO_0014583) (congenital myasthenic syndrome 3A), [MONDO:0014584](http://purl.obolibrary.org/obo/MONDO_0014584) (congenital myasthenic syndrome 3B), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0014580](http://purl.obolibrary.org/obo/MONDO_0014580) (mental retardation, autosomal dominant 33), [MONDO:0001269](http://purl.obolibrary.org/obo/MONDO_0001269) (scleral disease), [MONDO:0002599](http://purl.obolibrary.org/obo/MONDO_0002599) (teratocarcinoma), [MONDO:0002598](http://purl.obolibrary.org/obo/MONDO_0002598) (germinoma (disease)), [MONDO:0002597](http://purl.obolibrary.org/obo/MONDO_0002597) (notochordal cancer), [MONDO:0002592](http://purl.obolibrary.org/obo/MONDO_0002592) (invasive malignant thymoma), [MONDO:0001261](http://purl.obolibrary.org/obo/MONDO_0001261) (Mobitz type II atrioventricular block), [MONDO:0001263](http://purl.obolibrary.org/obo/MONDO_0001263) (histoplasmosis retinitis), [MONDO:0002590](http://purl.obolibrary.org/obo/MONDO_0002590) (combined thymoma), [MONDO:0014589](http://purl.obolibrary.org/obo/MONDO_0014589) (maturity-onset diabetes of the young type 13), [MONDO:0013259](http://purl.obolibrary.org/obo/MONDO_0013259) (Oguchi disease-2), [MONDO:0013243](http://purl.obolibrary.org/obo/MONDO_0013243) (neuronopathy, distal hereditary motor, type 2C), [MONDO:0013244](http://purl.obolibrary.org/obo/MONDO_0013244) (brachydactyly type E2), [MONDO:0014575](http://purl.obolibrary.org/obo/MONDO_0014575) (Singleton-Merten syndrome 2), [MONDO:0013245](http://purl.obolibrary.org/obo/MONDO_0013245) (syndromic multisystem autoimmune disease due to itch deficiency), [MONDO:0014576](http://purl.obolibrary.org/obo/MONDO_0014576) (Lipoyl transferase 1 deficiency), [MONDO:0014577](http://purl.obolibrary.org/obo/MONDO_0014577) (short-rib thoracic dysplasia 13 with or without polydactyly), [MONDO:0014570](http://purl.obolibrary.org/obo/MONDO_0014570) (lethal congenital contracture syndrome 8), [MONDO:0014571](http://purl.obolibrary.org/obo/MONDO_0014571) (optic atrophy 8), [MONDO:0013240](http://purl.obolibrary.org/obo/MONDO_0013240) (maturity-onset diabetes of the young type 10), [MONDO:0014572](http://purl.obolibrary.org/obo/MONDO_0014572) (autosomal recessive spinocerebellar ataxia 19), [MONDO:0013241](http://purl.obolibrary.org/obo/MONDO_0013241) (spinocerebellar ataxia type 30), [MONDO:0014573](http://purl.obolibrary.org/obo/MONDO_0014573) (Cole-Carpenter syndrome 2), [MONDO:0013242](http://purl.obolibrary.org/obo/MONDO_0013242) (maturity-onset diabetes of the young type 11), [MONDO:0001279](http://purl.obolibrary.org/obo/MONDO_0001279) (spinal canal and spinal cord meningioma), [MONDO:0001275](http://purl.obolibrary.org/obo/MONDO_0001275) (spinal meningioma), [MONDO:0001278](http://purl.obolibrary.org/obo/MONDO_0001278) (adult respiratory distress syndrome), [MONDO:0001271](http://purl.obolibrary.org/obo/MONDO_0001271) (lens subluxation (disease)), [MONDO:0014578](http://purl.obolibrary.org/obo/MONDO_0014578) (congenital myasthenic syndrome 17), [MONDO:0013247](http://purl.obolibrary.org/obo/MONDO_0013247) (Fanconi renotubular syndrome 2), [MONDO:0014579](http://purl.obolibrary.org/obo/MONDO_0014579) (Senior-Loken syndrome 8), [MONDO:0013248](http://purl.obolibrary.org/obo/MONDO_0013248) (Fanconi anemia complementation group O), [MONDO:0013249](http://purl.obolibrary.org/obo/MONDO_0013249) (autosomal recessive nonsyndromic deafness 84A), [MONDO:0013232](http://purl.obolibrary.org/obo/MONDO_0013232) (Brachydactylous dwarfism, Mseleni type), [MONDO:0014563](http://purl.obolibrary.org/obo/MONDO_0014563) (mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency), [MONDO:0013233](http://purl.obolibrary.org/obo/MONDO_0013233) (spondyloepimetaphyseal dysplasia, Handigodu type), [MONDO:0014564](http://purl.obolibrary.org/obo/MONDO_0014564) (congenital bile acid synthesis defect 5), [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0014565](http://purl.obolibrary.org/obo/MONDO_0014565) (cataract 43), [MONDO:0014566](http://purl.obolibrary.org/obo/MONDO_0014566) (Charcot-Marie-tooth disease axonal type 2U), [MONDO:0013235](http://purl.obolibrary.org/obo/MONDO_0013235) (pancreatic cancer, susceptibility to, 2), [MONDO:0015891](http://purl.obolibrary.org/obo/MONDO_0015891) (hypogonadotropic hypogonadism associated with other endocrinopathies), [MONDO:0015890](http://purl.obolibrary.org/obo/MONDO_0015890) (rare disorder with hypogonadotropic hypogonadism), [MONDO:0014561](http://purl.obolibrary.org/obo/MONDO_0014561) (3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia), [MONDO:0013231](http://purl.obolibrary.org/obo/MONDO_0013231) (Leber congenital amaurosis 14), [MONDO:0014562](http://purl.obolibrary.org/obo/MONDO_0014562) (neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome), [MONDO:0001247](http://purl.obolibrary.org/obo/MONDO_0001247) (social phobia), [MONDO:0002578](http://purl.obolibrary.org/obo/MONDO_0002578) (botryoid rhabdomyosarcoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0002579](http://purl.obolibrary.org/obo/MONDO_0002579) (orbit embryonal rhabdomyosarcoma), [MONDO:0002574](http://purl.obolibrary.org/obo/MONDO_0002574) (prostate embryonal rhabdomyosarcoma), [MONDO:0001243](http://purl.obolibrary.org/obo/MONDO_0001243) (disseminated intravascular coagulation), [MONDO:0001242](http://purl.obolibrary.org/obo/MONDO_0001242) (DIC in newborn), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0001245](http://purl.obolibrary.org/obo/MONDO_0001245) (microcytic anemia), [MONDO:0001244](http://purl.obolibrary.org/obo/MONDO_0001244) (vitamin K deficiency hemorrhagic disease), [MONDO:0002571](http://purl.obolibrary.org/obo/MONDO_0002571) (central nervous system lymphoma), [MONDO:0001240](http://purl.obolibrary.org/obo/MONDO_0001240) (neonatal anemia), [MONDO:0013236](http://purl.obolibrary.org/obo/MONDO_0013236) (pancreatic cancer, susceptibility to, 3), [MONDO:0015899](http://purl.obolibrary.org/obo/MONDO_0015899) (rare primary hyperaldosteronism), [MONDO:0014569](http://purl.obolibrary.org/obo/MONDO_0014569) (lethal congenital contracture syndrome 7), [MONDO:0014552](http://purl.obolibrary.org/obo/MONDO_0014552) (lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome), [MONDO:0015884](http://purl.obolibrary.org/obo/MONDO_0015884) (autosomal dominant hypohidrotic ectodermal dysplasia), [MONDO:0013221](http://purl.obolibrary.org/obo/MONDO_0013221) (MMD2), [MONDO:0013222](http://purl.obolibrary.org/obo/MONDO_0013222) (distal anoctaminopathy), [MONDO:0015883](http://purl.obolibrary.org/obo/MONDO_0015883) (hidrotic ectodermal dysplasia, Halal type), [MONDO:0014554](http://purl.obolibrary.org/obo/MONDO_0014554) (infantile multisystem neurologic-endocrine-pancreatic disease), [MONDO:0015886](http://purl.obolibrary.org/obo/MONDO_0015886) (rare diabetes mellitus type 1), [MONDO:0013223](http://purl.obolibrary.org/obo/MONDO_0013223) (autosomal recessive spondylometaphyseal dysplasia, MC)garbanC) type), [MONDO:0013224](http://purl.obolibrary.org/obo/MONDO_0013224) (rhabdoid tumor predisposition syndrome 2), [MONDO:0015885](http://purl.obolibrary.org/obo/MONDO_0015885) (rare insulin-resistance syndrome), [MONDO:0015882](http://purl.obolibrary.org/obo/MONDO_0015882) (rare tumor of pancreas), [MONDO:0014550](http://purl.obolibrary.org/obo/MONDO_0014550) (long QT syndrome 15), [MONDO:0015881](http://purl.obolibrary.org/obo/MONDO_0015881) (rare gastroesophageal tumor), [MONDO:0013220](http://purl.obolibrary.org/obo/MONDO_0013220) (hemochromatosis type 2B), [MONDO:0001257](http://purl.obolibrary.org/obo/MONDO_0001257) (retinal microaneurysm), [MONDO:0002588](http://purl.obolibrary.org/obo/MONDO_0002588) (thymoma type A), [MONDO:0001254](http://purl.obolibrary.org/obo/MONDO_0001254) (peripheral scars of retina), [MONDO:0002585](http://purl.obolibrary.org/obo/MONDO_0002585) (proliferative type fibrocystic change of breast), [MONDO:0001253](http://purl.obolibrary.org/obo/MONDO_0001253) (solar retinopathy), [MONDO:0001256](http://purl.obolibrary.org/obo/MONDO_0001256) (arteriovenous malformation), [MONDO:0002587](http://purl.obolibrary.org/obo/MONDO_0002587) (encapsulated thymoma), [MONDO:0002586](http://purl.obolibrary.org/obo/MONDO_0002586) (thymus cancer), [MONDO:0002581](http://purl.obolibrary.org/obo/MONDO_0002581) (spindle cell rhabdomyosarcoma), [MONDO:0001250](http://purl.obolibrary.org/obo/MONDO_0001250) (keratomalacia), [MONDO:0002580](http://purl.obolibrary.org/obo/MONDO_0002580) (orbit rhabdomyosarcoma), [MONDO:0002583](http://purl.obolibrary.org/obo/MONDO_0002583) (mucinous ovarian cystadenoma), [MONDO:0002582](http://purl.obolibrary.org/obo/MONDO_0002582) (subacute leukemia), [MONDO:0015888](http://purl.obolibrary.org/obo/MONDO_0015888) (other rare diabetes mellitus), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0014556](http://purl.obolibrary.org/obo/MONDO_0014556) (congenital contractures of the limbs and face, hypotonia, and developmental delay), [MONDO:0014557](http://purl.obolibrary.org/obo/MONDO_0014557) (ataxia-oculomotor apraxia type 4), [MONDO:0015887](http://purl.obolibrary.org/obo/MONDO_0015887) (rare diabetes mellitus type 2), [MONDO:0013226](http://purl.obolibrary.org/obo/MONDO_0013226) (combined immunodeficiency with faciooculoskeletal anomalies), [MONDO:0014558](http://purl.obolibrary.org/obo/MONDO_0014558) (autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome), [MONDO:0013227](http://purl.obolibrary.org/obo/MONDO_0013227) (congenital plasminogen activator inhibitor type 1 deficiency), [MONDO:0013228](http://purl.obolibrary.org/obo/MONDO_0013228) (spondylo-megaepiphyseal-metaphyseal dysplasia), [MONDO:0013298](http://purl.obolibrary.org/obo/MONDO_0013298) (chromosome 17q21.31 duplication syndrome), [MONDO:0013294](http://purl.obolibrary.org/obo/MONDO_0013294) (atopic dermatitis 8), [MONDO:0013295](http://purl.obolibrary.org/obo/MONDO_0013295) (atopic dermatitis 9), [MONDO:0013296](http://purl.obolibrary.org/obo/MONDO_0013296) (myeloid neoplasm associated with FGFR1 rearrangement), [MONDO:0013297](http://purl.obolibrary.org/obo/MONDO_0013297) (autosomal dominant limb-girdle muscular dystrophy type 1H), [MONDO:0013290](http://purl.obolibrary.org/obo/MONDO_0013290) (agammaglobulinemia 5, autosomal dominant), [MONDO:0013291](http://purl.obolibrary.org/obo/MONDO_0013291) (glycogen storage disease XV), [MONDO:0013293](http://purl.obolibrary.org/obo/MONDO_0013293) (isolated microphthalmia 6), [MONDO:0013287](http://purl.obolibrary.org/obo/MONDO_0013287) (agammaglobulinemia 2, autosomal recessive), [MONDO:0013288](http://purl.obolibrary.org/obo/MONDO_0013288) (agammaglobulinemia 3, autosomal recessive), [MONDO:0013289](http://purl.obolibrary.org/obo/MONDO_0013289) (agammaglobulinemia 4, autosomal recessive), [MONDO:0013283](http://purl.obolibrary.org/obo/MONDO_0013283) (immunodeficiency, common variable, 3), [MONDO:0013284](http://purl.obolibrary.org/obo/MONDO_0013284) (immunodeficiency, common variable, 4), [MONDO:0013285](http://purl.obolibrary.org/obo/MONDO_0013285) (immunodeficiency, common variable, 5), [MONDO:0013286](http://purl.obolibrary.org/obo/MONDO_0013286) (immunodeficiency, common variable, 6), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0013281](http://purl.obolibrary.org/obo/MONDO_0013281) (COG4-CDG), [MONDO:0013282](http://purl.obolibrary.org/obo/MONDO_0013282) (alpha 1-antitrypsin deficiency), [MONDO:0013276](http://purl.obolibrary.org/obo/MONDO_0013276) (Reynolds syndrome), [MONDO:0013278](http://purl.obolibrary.org/obo/MONDO_0013278) (lymphedema, hereditary, 1C), [MONDO:0013279](http://purl.obolibrary.org/obo/MONDO_0013279) (long QT syndrome 13), [MONDO:0013274](http://purl.obolibrary.org/obo/MONDO_0013274) (retinitis pigmentosa 51), [MONDO:0013275](http://purl.obolibrary.org/obo/MONDO_0013275) (hemolytic anemia due to glucophosphate isomerase deficiency), [MONDO:0013271](http://purl.obolibrary.org/obo/MONDO_0013271) (frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome), [MONDO:0001286](http://purl.obolibrary.org/obo/MONDO_0001286) (exotropia), [MONDO:0001281](http://purl.obolibrary.org/obo/MONDO_0001281) (alternating exotropia), [MONDO:0001280](http://purl.obolibrary.org/obo/MONDO_0001280) (choroiditis), [MONDO:0014596](http://purl.obolibrary.org/obo/MONDO_0014596) (lissencephaly 7 with cerebellar hypoplasia), [MONDO:0013267](http://purl.obolibrary.org/obo/MONDO_0013267) (chromosome 16p11.2 deletion syndrome, 220kb), [MONDO:0013268](http://purl.obolibrary.org/obo/MONDO_0013268) (frontonasal dysplasia with alopecia and genital anomaly), [MONDO:0014592](http://purl.obolibrary.org/obo/MONDO_0014592) (microcephaly and chorioretinopathy 3), [MONDO:0014594](http://purl.obolibrary.org/obo/MONDO_0014594) (autosomal dominant nonsyndromic deafness 67), [MONDO:0013263](http://purl.obolibrary.org/obo/MONDO_0013263) (retinitis pigmentosa 54), [MONDO:0014595](http://purl.obolibrary.org/obo/MONDO_0014595) (epileptic encephalopathy, early infantile, 30), [MONDO:0013264](http://purl.obolibrary.org/obo/MONDO_0013264) (amyotrophic lateral sclerosis type 12), [MONDO:0014590](http://purl.obolibrary.org/obo/MONDO_0014590) (congenital myasthenic syndrome 18), [MONDO:0014591](http://purl.obolibrary.org/obo/MONDO_0014591) (autosomal dominant Robinow syndrome 2), [MONDO:0001299](http://purl.obolibrary.org/obo/MONDO_0001299) (diabetic autonomic neuropathy), [MONDO:0001293](http://purl.obolibrary.org/obo/MONDO_0001293) (subglottis cancer), [MONDO:0001296](http://purl.obolibrary.org/obo/MONDO_0001296) (acquired night blindness), [MONDO:0001290](http://purl.obolibrary.org/obo/MONDO_0001290) (allergic cutaneous vasculitis), [MONDO:0013269](http://purl.obolibrary.org/obo/MONDO_0013269) (autosomal recessive nonsyndromic deafness 91), 

**Mapped go classes:** [GO:0061452](http://purl.obolibrary.org/obo/GO_0061452) (retrotrapezoid nucleus neuron differentiation), [GO:0060121](http://purl.obolibrary.org/obo/GO_0060121) (vestibular receptor cell stereocilium organization), [GO:0035166](http://purl.obolibrary.org/obo/GO_0035166) (post-embryonic hemopoiesis), [GO:0060122](http://purl.obolibrary.org/obo/GO_0060122) (inner ear receptor cell stereocilium organization), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0060124](http://purl.obolibrary.org/obo/GO_0060124) (positive regulation of growth hormone secretion), [GO:0036499](http://purl.obolibrary.org/obo/GO_0036499) (PERK-mediated unfolded protein response), [GO:2000120](http://purl.obolibrary.org/obo/GO_2000120) (positive regulation of sodium-dependent phosphate transport), [GO:0036492](http://purl.obolibrary.org/obo/GO_0036492) (eiF2alpha phosphorylation in response to endoplasmic reticulum stress), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:1901222](http://purl.obolibrary.org/obo/GO_1901222) (regulation of NIK/NF-kappaB signaling), [GO:0019918](http://purl.obolibrary.org/obo/GO_0019918) (peptidyl-arginine methylation, to symmetrical-dimethyl arginine), [GO:1901224](http://purl.obolibrary.org/obo/GO_1901224) (positive regulation of NIK/NF-kappaB signaling), [GO:0060129](http://purl.obolibrary.org/obo/GO_0060129) (thyroid-stimulating hormone-secreting cell differentiation), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0006600](http://purl.obolibrary.org/obo/GO_0006600) (creatine metabolic process), [GO:0060126](http://purl.obolibrary.org/obo/GO_0060126) (somatotropin secreting cell differentiation), [GO:0006601](http://purl.obolibrary.org/obo/GO_0006601) (creatine biosynthetic process), [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development), [GO:0060128](http://purl.obolibrary.org/obo/GO_0060128) (corticotropin hormone secreting cell differentiation), [GO:0061459](http://purl.obolibrary.org/obo/GO_0061459) (L-arginine transmembrane transporter activity), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0050795](http://purl.obolibrary.org/obo/GO_0050795) (regulation of behavior), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0048483](http://purl.obolibrary.org/obo/GO_0048483) (autonomic nervous system development), [GO:2000119](http://purl.obolibrary.org/obo/GO_2000119) (negative regulation of sodium-dependent phosphate transport), [GO:0050794](http://purl.obolibrary.org/obo/GO_0050794) (regulation of cellular process), [GO:0048489](http://purl.obolibrary.org/obo/GO_0048489) (synaptic vesicle transport), [GO:0048488](http://purl.obolibrary.org/obo/GO_0048488) (synaptic vesicle endocytosis), [GO:0050792](http://purl.obolibrary.org/obo/GO_0050792) (regulation of viral process), [GO:0072101](http://purl.obolibrary.org/obo/GO_0072101) (specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway), [GO:0048487](http://purl.obolibrary.org/obo/GO_0048487) (beta-tubulin binding), [GO:0097402](http://purl.obolibrary.org/obo/GO_0097402) (neuroblast migration), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0048486](http://purl.obolibrary.org/obo/GO_0048486) (parasympathetic nervous system development), [GO:0072107](http://purl.obolibrary.org/obo/GO_0072107) (positive regulation of ureteric bud formation), [GO:0072106](http://purl.obolibrary.org/obo/GO_0072106) (regulation of ureteric bud formation), [GO:0098735](http://purl.obolibrary.org/obo/GO_0098735) (positive regulation of the force of heart contraction), [GO:0072104](http://purl.obolibrary.org/obo/GO_0072104) (glomerular capillary formation), [GO:2000110](http://purl.obolibrary.org/obo/GO_2000110) (negative regulation of macrophage apoptotic process), [GO:2000117](http://purl.obolibrary.org/obo/GO_2000117) (negative regulation of cysteine-type endopeptidase activity), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0072108](http://purl.obolibrary.org/obo/GO_0072108) (positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0050798](http://purl.obolibrary.org/obo/GO_0050798) (activated T cell proliferation), [GO:0019902](http://purl.obolibrary.org/obo/GO_0019902) (phosphatase binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0036486](http://purl.obolibrary.org/obo/GO_0036486) (ventral trunk neural crest cell migration), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0060112](http://purl.obolibrary.org/obo/GO_0060112) (generation of ovulation cycle rhythm), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0019905](http://purl.obolibrary.org/obo/GO_0019905) (syntaxin binding), [GO:0019907](http://purl.obolibrary.org/obo/GO_0019907) (cyclin-dependent protein kinase activating kinase holoenzyme complex), [GO:0060118](http://purl.obolibrary.org/obo/GO_0060118) (vestibular receptor cell development), [GO:0060119](http://purl.obolibrary.org/obo/GO_0060119) (inner ear receptor cell development), [GO:0006611](http://purl.obolibrary.org/obo/GO_0006611) (protein export from nucleus), [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane), [GO:1902569](http://purl.obolibrary.org/obo/GO_1902569) (negative regulation of activation of Janus kinase activity), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0061448](http://purl.obolibrary.org/obo/GO_0061448) (connective tissue development), [GO:0048496](http://purl.obolibrary.org/obo/GO_0048496) (maintenance of animal organ identity), [GO:0006605](http://purl.obolibrary.org/obo/GO_0006605) (protein targeting), [GO:0048495](http://purl.obolibrary.org/obo/GO_0048495) (Roundabout binding), [GO:0048499](http://purl.obolibrary.org/obo/GO_0048499) (synaptic vesicle membrane organization), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0098742](http://purl.obolibrary.org/obo/GO_0098742) (cell-cell adhesion via plasma-membrane adhesion molecules), [GO:0006607](http://purl.obolibrary.org/obo/GO_0006607) (NLS-bearing protein import into nucleus), [GO:0098743](http://purl.obolibrary.org/obo/GO_0098743) (cell aggregation), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0098749](http://purl.obolibrary.org/obo/GO_0098749) (cerebellar neuron development), [GO:0097418](http://purl.obolibrary.org/obo/GO_0097418) (neurofibrillary tangle), [GO:2000121](http://purl.obolibrary.org/obo/GO_2000121) (regulation of removal of superoxide radicals), [GO:0035148](http://purl.obolibrary.org/obo/GO_0035148) (tube formation), [GO:0048490](http://purl.obolibrary.org/obo/GO_0048490) (anterograde synaptic vesicle transport), [GO:0019911](http://purl.obolibrary.org/obo/GO_0019911) (structural constituent of myelin sheath), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0061474](http://purl.obolibrary.org/obo/GO_0061474) (phagolysosome membrane), [GO:0035145](http://purl.obolibrary.org/obo/GO_0035145) (exon-exon junction complex), [GO:0036477](http://purl.obolibrary.org/obo/GO_0036477) (somatodendritic compartment), [GO:1902572](http://purl.obolibrary.org/obo/GO_1902572) (negative regulation of serine-type peptidase activity), [GO:0035141](http://purl.obolibrary.org/obo/GO_0035141) (medial fin morphogenesis), [GO:0047173](http://purl.obolibrary.org/obo/GO_0047173) (phosphatidylcholine-retinol O-acyltransferase activity), [GO:0072125](http://purl.obolibrary.org/obo/GO_0072125) (negative regulation of glomerular mesangial cell proliferation), [GO:0098711](http://purl.obolibrary.org/obo/GO_0098711) (iron ion import across plasma membrane), [GO:0098712](http://purl.obolibrary.org/obo/GO_0098712) (L-glutamate import across plasma membrane), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0072126](http://purl.obolibrary.org/obo/GO_0072126) (positive regulation of glomerular mesangial cell proliferation), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0098719](http://purl.obolibrary.org/obo/GO_0098719) (sodium ion import across plasma membrane), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:2000138](http://purl.obolibrary.org/obo/GO_2000138) (positive regulation of cell proliferation involved in heart morphogenesis), [GO:0036468](http://purl.obolibrary.org/obo/GO_0036468) (L-dopa decarboxylase activity), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis), [GO:2000137](http://purl.obolibrary.org/obo/GO_2000137) (negative regulation of cell proliferation involved in heart morphogenesis), [GO:0036464](http://purl.obolibrary.org/obo/GO_0036464) (cytoplasmic ribonucleoprotein granule), [GO:0060133](http://purl.obolibrary.org/obo/GO_0060133) (somatotropin secreting cell development), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0036466](http://purl.obolibrary.org/obo/GO_0036466) (synaptic vesicle recycling via endosome), [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy), [GO:1901255](http://purl.obolibrary.org/obo/GO_1901255) (nucleotide-excision repair involved in interstrand cross-link repair), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:0061462](http://purl.obolibrary.org/obo/GO_0061462) (protein localization to lysosome), [GO:0060136](http://purl.obolibrary.org/obo/GO_0060136) (embryonic process involved in female pregnancy), [GO:0060137](http://purl.obolibrary.org/obo/GO_0060137) (maternal process involved in parturition), [GO:0061469](http://purl.obolibrary.org/obo/GO_0061469) (regulation of type B pancreatic cell proliferation), [GO:0060139](http://purl.obolibrary.org/obo/GO_0060139) (positive regulation of apoptotic process by virus), [GO:0047184](http://purl.obolibrary.org/obo/GO_0047184) (1-acylglycerophosphocholine O-acyltransferase activity), [GO:0072114](http://purl.obolibrary.org/obo/GO_0072114) (pronephros morphogenesis), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0072111](http://purl.obolibrary.org/obo/GO_0072111) (cell proliferation involved in kidney development), [GO:2000146](http://purl.obolibrary.org/obo/GO_2000146) (negative regulation of cell motility), [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number), [GO:2000145](http://purl.obolibrary.org/obo/GO_2000145) (regulation of cell motility), [GO:2000144](http://purl.obolibrary.org/obo/GO_2000144) (positive regulation of DNA-templated transcription, initiation), [GO:0072116](http://purl.obolibrary.org/obo/GO_0072116) (pronephros formation), [GO:0035125](http://purl.obolibrary.org/obo/GO_0035125) (embryonic anal fin morphogenesis), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:2000147](http://purl.obolibrary.org/obo/GO_2000147) (positive regulation of cell motility), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0019957](http://purl.obolibrary.org/obo/GO_0019957) (C-C chemokine binding), [GO:0061410](http://purl.obolibrary.org/obo/GO_0061410) (positive regulation of transcription from RNA polymerase II promoter in response to ethanol), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:1902513](http://purl.obolibrary.org/obo/GO_1902513) (regulation of organelle transport along microtubule), [GO:1902510](http://purl.obolibrary.org/obo/GO_1902510) (regulation of apoptotic DNA fragmentation), [GO:0061419](http://purl.obolibrary.org/obo/GO_0061419) (positive regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0005314](http://purl.obolibrary.org/obo/GO_0005314) (high-affinity glutamate transmembrane transporter activity), [GO:1902514](http://purl.obolibrary.org/obo/GO_1902514) (regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0005313](http://purl.obolibrary.org/obo/GO_0005313) (L-glutamate transmembrane transporter activity), [GO:0006637](http://purl.obolibrary.org/obo/GO_0006637) (acyl-CoA metabolic process), [GO:0032924](http://purl.obolibrary.org/obo/GO_0032924) (activin receptor signaling pathway), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0006635](http://purl.obolibrary.org/obo/GO_0006635) (fatty acid beta-oxidation), [GO:0005307](http://purl.obolibrary.org/obo/GO_0005307) (choline:sodium symporter activity), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0006636](http://purl.obolibrary.org/obo/GO_0006636) (unsaturated fatty acid biosynthetic process), [GO:0005309](http://purl.obolibrary.org/obo/GO_0005309) (creatine:sodium symporter activity), [GO:0005308](http://purl.obolibrary.org/obo/GO_0005308) (creatine transmembrane transporter activity), [GO:0032926](http://purl.obolibrary.org/obo/GO_0032926) (negative regulation of activin receptor signaling pathway), [GO:0032927](http://purl.obolibrary.org/obo/GO_0032927) (positive regulation of activin receptor signaling pathway), [GO:0106019](http://purl.obolibrary.org/obo/GO_0106019) (phosphatidylinositol-4,5-bisphosphate phosphatase activity), [GO:0019960](http://purl.obolibrary.org/obo/GO_0019960) (C-X3-C chemokine binding), [GO:2000156](http://purl.obolibrary.org/obo/GO_2000156) (regulation of retrograde vesicle-mediated transport, Golgi to ER), [GO:0019966](http://purl.obolibrary.org/obo/GO_0019966) (interleukin-1 binding), [GO:0035198](http://purl.obolibrary.org/obo/GO_0035198) (miRNA binding), [GO:2000170](http://purl.obolibrary.org/obo/GO_2000170) (positive regulation of peptidyl-cysteine S-nitrosylation), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:2000173](http://purl.obolibrary.org/obo/GO_2000173) (negative regulation of branching morphogenesis of a nerve), [GO:1902523](http://purl.obolibrary.org/obo/GO_1902523) (positive regulation of protein K63-linked ubiquitination), [GO:0006651](http://purl.obolibrary.org/obo/GO_0006651) (diacylglycerol biosynthetic process), [GO:0006650](http://purl.obolibrary.org/obo/GO_0006650) (glycerophospholipid metabolic process), [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress), [GO:0006656](http://purl.obolibrary.org/obo/GO_0006656) (phosphatidylcholine biosynthetic process), [GO:0061402](http://purl.obolibrary.org/obo/GO_0061402) (positive regulation of transcription from RNA polymerase II promoter in response to acidic pH), [GO:0006653](http://purl.obolibrary.org/obo/GO_0006653) (1,2-diacyl-sn-glycero-3-phosphocholine metabolic process), [GO:0005324](http://purl.obolibrary.org/obo/GO_0005324) (long-chain fatty acid transporter activity), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0005316](http://purl.obolibrary.org/obo/GO_0005316) (high-affinity inorganic phosphate:sodium symporter activity), [GO:0006649](http://purl.obolibrary.org/obo/GO_0006649) (phospholipid transfer to membrane), [GO:0032914](http://purl.obolibrary.org/obo/GO_0032914) (positive regulation of transforming growth factor beta1 production), [GO:0005315](http://purl.obolibrary.org/obo/GO_0005315) (inorganic phosphate transmembrane transporter activity), [GO:0032911](http://purl.obolibrary.org/obo/GO_0032911) (negative regulation of transforming growth factor beta1 production), [GO:0006646](http://purl.obolibrary.org/obo/GO_0006646) (phosphatidylethanolamine biosynthetic process), [GO:0032912](http://purl.obolibrary.org/obo/GO_0032912) (negative regulation of transforming growth factor beta2 production), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0032918](http://purl.obolibrary.org/obo/GO_0032918) (spermidine acetylation), [GO:0032916](http://purl.obolibrary.org/obo/GO_0032916) (positive regulation of transforming growth factor beta3 production), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0106028](http://purl.obolibrary.org/obo/GO_0106028) (neuron projection retraction), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0019953](http://purl.obolibrary.org/obo/GO_0019953) (sexual reproduction), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0050764](http://purl.obolibrary.org/obo/GO_0050764) (regulation of phagocytosis), [GO:0098706](http://purl.obolibrary.org/obo/GO_0098706) (ferric iron import across plasma membrane), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0098707](http://purl.obolibrary.org/obo/GO_0098707) (ferrous iron import across plasma membrane), [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis), [GO:0019934](http://purl.obolibrary.org/obo/GO_0019934) (cGMP-mediated signaling), [GO:0060100](http://purl.obolibrary.org/obo/GO_0060100) (positive regulation of phagocytosis, engulfment), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:1902530](http://purl.obolibrary.org/obo/GO_1902530) (positive regulation of protein linear polyubiquitination), [GO:1903861](http://purl.obolibrary.org/obo/GO_1903861) (positive regulation of dendrite extension), [GO:1902531](http://purl.obolibrary.org/obo/GO_1902531) (regulation of intracellular signal transduction), [GO:1903862](http://purl.obolibrary.org/obo/GO_1903862) (positive regulation of oxidative phosphorylation), [GO:1901202](http://purl.obolibrary.org/obo/GO_1901202) (negative regulation of extracellular matrix assembly), [GO:1901201](http://purl.obolibrary.org/obo/GO_1901201) (regulation of extracellular matrix assembly), [GO:0047127](http://purl.obolibrary.org/obo/GO_0047127) (thiomorpholine-carboxylate dehydrogenase activity), [GO:1902533](http://purl.obolibrary.org/obo/GO_1902533) (positive regulation of intracellular signal transduction), [GO:1901203](http://purl.obolibrary.org/obo/GO_1901203) (positive regulation of extracellular matrix assembly), [GO:0006622](http://purl.obolibrary.org/obo/GO_0006622) (protein targeting to lysosome), [GO:0006623](http://purl.obolibrary.org/obo/GO_0006623) (protein targeting to vacuole), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0006620](http://purl.obolibrary.org/obo/GO_0006620) (posttranslational protein targeting to endoplasmic reticulum membrane), [GO:1901207](http://purl.obolibrary.org/obo/GO_1901207) (regulation of heart looping), [GO:0050773](http://purl.obolibrary.org/obo/GO_0050773) (regulation of dendrite development), [GO:0006616](http://purl.obolibrary.org/obo/GO_0006616) (SRP-dependent cotranslational protein targeting to membrane, translocation), [GO:0050774](http://purl.obolibrary.org/obo/GO_0050774) (negative regulation of dendrite morphogenesis), [GO:0047131](http://purl.obolibrary.org/obo/GO_0047131) (saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0047130](http://purl.obolibrary.org/obo/GO_0047130) (saccharopine dehydrogenase (NADP+, L-lysine-forming) activity), [GO:0032901](http://purl.obolibrary.org/obo/GO_0032901) (positive regulation of neurotrophin production), [GO:0006614](http://purl.obolibrary.org/obo/GO_0006614) (SRP-dependent cotranslational protein targeting to membrane), [GO:0050772](http://purl.obolibrary.org/obo/GO_0050772) (positive regulation of axonogenesis), [GO:0050770](http://purl.obolibrary.org/obo/GO_0050770) (regulation of axonogenesis), [GO:0047134](http://purl.obolibrary.org/obo/GO_0047134) (protein-disulfide reductase activity), [GO:2000179](http://purl.obolibrary.org/obo/GO_2000179) (positive regulation of neural precursor cell proliferation), [GO:2000178](http://purl.obolibrary.org/obo/GO_2000178) (negative regulation of neural precursor cell proliferation), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0050778](http://purl.obolibrary.org/obo/GO_0050778) (positive regulation of immune response), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0035173](http://purl.obolibrary.org/obo/GO_0035173) (histone kinase activity), [GO:0035174](http://purl.obolibrary.org/obo/GO_0035174) (histone serine kinase activity), [GO:2000195](http://purl.obolibrary.org/obo/GO_2000195) (negative regulation of female gonad development), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0035175](http://purl.obolibrary.org/obo/GO_0035175) (histone kinase activity (H3-S10 specific)), [GO:0061428](http://purl.obolibrary.org/obo/GO_0061428) (negative regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0047138](http://purl.obolibrary.org/obo/GO_0047138) (aquacobalamin reductase activity), [GO:0061429](http://purl.obolibrary.org/obo/GO_0061429) (positive regulation of transcription from RNA polymerase II promoter by oleic acid), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:1901214](http://purl.obolibrary.org/obo/GO_1901214) (regulation of neuron death), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0061424](http://purl.obolibrary.org/obo/GO_0061424) (positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0061425](http://purl.obolibrary.org/obo/GO_0061425) (positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter), [GO:0005302](http://purl.obolibrary.org/obo/GO_0005302) (L-tyrosine transmembrane transporter activity), [GO:0006626](http://purl.obolibrary.org/obo/GO_0006626) (protein targeting to mitochondrion), [GO:0006627](http://purl.obolibrary.org/obo/GO_0006627) (protein processing involved in protein targeting to mitochondrion), [GO:0006624](http://purl.obolibrary.org/obo/GO_0006624) (vacuolar protein processing), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0006625](http://purl.obolibrary.org/obo/GO_0006625) (protein targeting to peroxisome), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0050780](http://purl.obolibrary.org/obo/GO_0050780) (dopamine receptor binding), [GO:0048477](http://purl.obolibrary.org/obo/GO_0048477) (oogenesis), [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:2000189](http://purl.obolibrary.org/obo/GO_2000189) (positive regulation of cholesterol homeostasis), [GO:2000187](http://purl.obolibrary.org/obo/GO_2000187) (positive regulation of phosphate transmembrane transport), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0050787](http://purl.obolibrary.org/obo/GO_0050787) (detoxification of mercury ion), [GO:0019932](http://purl.obolibrary.org/obo/GO_0019932) (second-messenger-mediated signaling), [GO:0043626](http://purl.obolibrary.org/obo/GO_0043626) (PCNA complex), [GO:0043625](http://purl.obolibrary.org/obo/GO_0043625) (delta DNA polymerase complex), [GO:0043628](http://purl.obolibrary.org/obo/GO_0043628) (ncRNA 3'-end processing), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0006681](http://purl.obolibrary.org/obo/GO_0006681) (galactosylceramide metabolic process), [GO:0072190](http://purl.obolibrary.org/obo/GO_0072190) (ureter urothelium development), [GO:0006685](http://purl.obolibrary.org/obo/GO_0006685) (sphingomyelin catabolic process), [GO:0005351](http://purl.obolibrary.org/obo/GO_0005351) (sugar:proton symporter activity), [GO:0097490](http://purl.obolibrary.org/obo/GO_0097490) (sympathetic neuron projection extension), [GO:0006683](http://purl.obolibrary.org/obo/GO_0006683) (galactosylceramide catabolic process), [GO:0006688](http://purl.obolibrary.org/obo/GO_0006688) (glycosphingolipid biosynthetic process), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0072193](http://purl.obolibrary.org/obo/GO_0072193) (ureter smooth muscle cell differentiation), [GO:0006689](http://purl.obolibrary.org/obo/GO_0006689) (ganglioside catabolic process), [GO:0005355](http://purl.obolibrary.org/obo/GO_0005355) (glucose transmembrane transporter activity), [GO:0097491](http://purl.obolibrary.org/obo/GO_0097491) (sympathetic neuron projection guidance), [GO:0072192](http://purl.obolibrary.org/obo/GO_0072192) (ureter epithelial cell differentiation), [GO:0006687](http://purl.obolibrary.org/obo/GO_0006687) (glycosphingolipid metabolic process), [GO:0043623](http://purl.obolibrary.org/obo/GO_0043623) (cellular protein complex assembly), [GO:0097493](http://purl.obolibrary.org/obo/GO_0097493) (structural molecule activity conferring elasticity), [GO:0004018](http://purl.obolibrary.org/obo/GO_0004018) (N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0097484](http://purl.obolibrary.org/obo/GO_0097484) (dendrite extension), [GO:0004017](http://purl.obolibrary.org/obo/GO_0004017) (adenylate kinase activity), [GO:0031638](http://purl.obolibrary.org/obo/GO_0031638) (zymogen activation), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0004019](http://purl.obolibrary.org/obo/GO_0004019) (adenylosuccinate synthase activity), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0072189](http://purl.obolibrary.org/obo/GO_0072189) (ureter development), [GO:0031639](http://purl.obolibrary.org/obo/GO_0031639) (plasminogen activation), [GO:0016010](http://purl.obolibrary.org/obo/GO_0016010) (dystrophin-associated glycoprotein complex), [GO:0016011](http://purl.obolibrary.org/obo/GO_0016011) (dystroglycan complex), [GO:0016012](http://purl.obolibrary.org/obo/GO_0016012) (sarcoglycan complex), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0032964](http://purl.obolibrary.org/obo/GO_0032964) (collagen biosynthetic process), [GO:0030300](http://purl.obolibrary.org/obo/GO_0030300) (regulation of intestinal cholesterol absorption), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0032963](http://purl.obolibrary.org/obo/GO_0032963) (collagen metabolic process), [GO:0042306](http://purl.obolibrary.org/obo/GO_0042306) (regulation of protein import into nucleus), [GO:0042307](http://purl.obolibrary.org/obo/GO_0042307) (positive regulation of protein import into nucleus), [GO:0006691](http://purl.obolibrary.org/obo/GO_0006691) (leukotriene metabolic process), [GO:0042309](http://purl.obolibrary.org/obo/GO_0042309) (homoiothermy), [GO:0060196](http://purl.obolibrary.org/obo/GO_0060196) (positive regulation of antisense RNA transcription), [GO:0004030](http://purl.obolibrary.org/obo/GO_0004030) (aldehyde dehydrogenase [NAD(P)+] activity), [GO:0060197](http://purl.obolibrary.org/obo/GO_0060197) (cloacal septation), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0004034](http://purl.obolibrary.org/obo/GO_0004034) (aldose 1-epimerase activity), [GO:0043631](http://purl.obolibrary.org/obo/GO_0043631) (RNA polyadenylation), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0042301](http://purl.obolibrary.org/obo/GO_0042301) (phosphate ion binding), [GO:0004035](http://purl.obolibrary.org/obo/GO_0004035) (alkaline phosphatase activity), [GO:0072182](http://purl.obolibrary.org/obo/GO_0072182) (regulation of nephron tubule epithelial cell differentiation), [GO:0072181](http://purl.obolibrary.org/obo/GO_0072181) (mesonephric duct formation), [GO:0072180](http://purl.obolibrary.org/obo/GO_0072180) (mesonephric duct morphogenesis), [GO:0072176](http://purl.obolibrary.org/obo/GO_0072176) (nephric duct development), [GO:0032957](http://purl.obolibrary.org/obo/GO_0032957) (inositol trisphosphate metabolic process), [GO:0004029](http://purl.obolibrary.org/obo/GO_0004029) (aldehyde dehydrogenase (NAD) activity), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0004028](http://purl.obolibrary.org/obo/GO_0004028) (3-chloroallyl aldehyde dehydrogenase activity), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0072174](http://purl.obolibrary.org/obo/GO_0072174) (metanephric tubule formation), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0072179](http://purl.obolibrary.org/obo/GO_0072179) (nephric duct formation), [GO:0097499](http://purl.obolibrary.org/obo/GO_0097499) (protein localization to non-motile cilium), [GO:0072178](http://purl.obolibrary.org/obo/GO_0072178) (nephric duct morphogenesis), [GO:0031628](http://purl.obolibrary.org/obo/GO_0031628) (opioid receptor binding), [GO:0032959](http://purl.obolibrary.org/obo/GO_0032959) (inositol trisphosphate biosynthetic process), [GO:0072177](http://purl.obolibrary.org/obo/GO_0072177) (mesonephric duct development), [GO:0031629](http://purl.obolibrary.org/obo/GO_0031629) (synaptic vesicle fusion to presynaptic active zone membrane), [GO:0031622](http://purl.obolibrary.org/obo/GO_0031622) (positive regulation of fever generation), [GO:0016004](http://purl.obolibrary.org/obo/GO_0016004) (phospholipase activator activity), [GO:0031623](http://purl.obolibrary.org/obo/GO_0031623) (receptor internalization), [GO:0031620](http://purl.obolibrary.org/obo/GO_0031620) (regulation of fever generation), [GO:0019979](http://purl.obolibrary.org/obo/GO_0019979) (interleukin-4 binding), [GO:0043648](http://purl.obolibrary.org/obo/GO_0043648) (dicarboxylic acid metabolic process), [GO:0006662](http://purl.obolibrary.org/obo/GO_0006662) (glycerol ether metabolic process), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0004001](http://purl.obolibrary.org/obo/GO_0004001) (adenosine kinase activity), [GO:0006660](http://purl.obolibrary.org/obo/GO_0006660) (phosphatidylserine catabolic process), [GO:0042311](http://purl.obolibrary.org/obo/GO_0042311) (vasodilation), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0006661](http://purl.obolibrary.org/obo/GO_0006661) (phosphatidylinositol biosynthetic process), [GO:0004003](http://purl.obolibrary.org/obo/GO_0004003) (ATP-dependent DNA helicase activity), [GO:0097470](http://purl.obolibrary.org/obo/GO_0097470) (ribbon synapse), [GO:0042313](http://purl.obolibrary.org/obo/GO_0042313) (protein kinase C deactivation), [GO:0006664](http://purl.obolibrary.org/obo/GO_0006664) (glycolipid metabolic process), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0004004](http://purl.obolibrary.org/obo/GO_0004004) (ATP-dependent RNA helicase activity), [GO:0006659](http://purl.obolibrary.org/obo/GO_0006659) (phosphatidylserine biosynthetic process), [GO:0032947](http://purl.obolibrary.org/obo/GO_0032947) (protein complex scaffold activity), [GO:0031616](http://purl.obolibrary.org/obo/GO_0031616) (spindle pole centrosome), [GO:0005326](http://purl.obolibrary.org/obo/GO_0005326) (neurotransmitter transporter activity), [GO:0098793](http://purl.obolibrary.org/obo/GO_0098793) (presynapse), [GO:0006657](http://purl.obolibrary.org/obo/GO_0006657) (CDP-choline pathway), [GO:0098794](http://purl.obolibrary.org/obo/GO_0098794) (postsynapse), [GO:0005328](http://purl.obolibrary.org/obo/GO_0005328) (neurotransmitter:sodium symporter activity), [GO:0006658](http://purl.obolibrary.org/obo/GO_0006658) (phosphatidylserine metabolic process), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:0097466](http://purl.obolibrary.org/obo/GO_0097466) (ubiquitin-dependent glycoprotein ERAD pathway), [GO:0098797](http://purl.obolibrary.org/obo/GO_0098797) (plasma membrane protein complex), [GO:0031618](http://purl.obolibrary.org/obo/GO_0031618) (nuclear pericentric heterochromatin), [GO:0019985](http://purl.obolibrary.org/obo/GO_0019985) (translesion synthesis), [GO:0032940](http://purl.obolibrary.org/obo/GO_0032940) (secretion by cell), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0043651](http://purl.obolibrary.org/obo/GO_0043651) (linoleic acid metabolic process), [GO:0006673](http://purl.obolibrary.org/obo/GO_0006673) (inositol phosphoceramide metabolic process), [GO:0004012](http://purl.obolibrary.org/obo/GO_0004012) (phospholipid-translocating ATPase activity), [GO:0043653](http://purl.obolibrary.org/obo/GO_0043653) (mitochondrial fragmentation involved in apoptotic process), [GO:0043652](http://purl.obolibrary.org/obo/GO_0043652) (engulfment of apoptotic cell), [GO:0006672](http://purl.obolibrary.org/obo/GO_0006672) (ceramide metabolic process), [GO:0042322](http://purl.obolibrary.org/obo/GO_0042322) (negative regulation of circadian sleep/wake cycle, REM sleep), [GO:0042323](http://purl.obolibrary.org/obo/GO_0042323) (negative regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0043654](http://purl.obolibrary.org/obo/GO_0043654) (recognition of apoptotic cell), [GO:0042324](http://purl.obolibrary.org/obo/GO_0042324) (hypocretin receptor binding), [GO:0006678](http://purl.obolibrary.org/obo/GO_0006678) (glucosylceramide metabolic process), [GO:0004013](http://purl.obolibrary.org/obo/GO_0004013) (adenosylhomocysteinase activity), [GO:0004016](http://purl.obolibrary.org/obo/GO_0004016) (adenylate cyclase activity), [GO:0006675](http://purl.obolibrary.org/obo/GO_0006675) (mannosyl-inositol phosphorylceramide metabolic process), [GO:0042325](http://purl.obolibrary.org/obo/GO_0042325) (regulation of phosphorylation), [GO:0042326](http://purl.obolibrary.org/obo/GO_0042326) (negative regulation of phosphorylation), [GO:0072198](http://purl.obolibrary.org/obo/GO_0072198) (mesenchymal cell proliferation involved in ureter development), [GO:0005338](http://purl.obolibrary.org/obo/GO_0005338) (nucleotide-sugar transmembrane transporter activity), [GO:0072197](http://purl.obolibrary.org/obo/GO_0072197) (ureter morphogenesis), [GO:0097473](http://purl.obolibrary.org/obo/GO_0097473) (retinal rod cell apoptotic process), [GO:0005337](http://purl.obolibrary.org/obo/GO_0005337) (nucleoside transmembrane transporter activity), [GO:0032933](http://purl.obolibrary.org/obo/GO_0032933) (SREBP signaling pathway), [GO:0072196](http://purl.obolibrary.org/obo/GO_0072196) (proximal/distal pattern formation involved in pronephric nephron development), [GO:0004008](http://purl.obolibrary.org/obo/GO_0004008) (copper-exporting ATPase activity), [GO:0097475](http://purl.obolibrary.org/obo/GO_0097475) (motor neuron migration), [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding), [GO:0097477](http://purl.obolibrary.org/obo/GO_0097477) (lateral motor column neuron migration), [GO:0019970](http://purl.obolibrary.org/obo/GO_0019970) (interleukin-11 binding), [GO:0019976](http://purl.obolibrary.org/obo/GO_0019976) (interleukin-2 binding), [GO:0032930](http://purl.obolibrary.org/obo/GO_0032930) (positive regulation of superoxide anion generation), [GO:0060165](http://purl.obolibrary.org/obo/GO_0060165) (regulation of timing of subpallium neuron differentiation), [GO:0060166](http://purl.obolibrary.org/obo/GO_0060166) (olfactory pit development), [GO:0005391](http://purl.obolibrary.org/obo/GO_0005391) (sodium:potassium-exchanging ATPase activity), [GO:0004060](http://purl.obolibrary.org/obo/GO_0004060) (arylamine N-acetyltransferase activity), [GO:0030350](http://purl.obolibrary.org/obo/GO_0030350) (iron-responsive element binding), [GO:0060163](http://purl.obolibrary.org/obo/GO_0060163) (subpallium neuron fate commitment), [GO:0004063](http://purl.obolibrary.org/obo/GO_0004063) (aryldialkylphosphatase activity), [GO:0004065](http://purl.obolibrary.org/obo/GO_0004065) (arylsulfatase activity), [GO:0004064](http://purl.obolibrary.org/obo/GO_0004064) (arylesterase activity), [GO:1902598](http://purl.obolibrary.org/obo/GO_1902598) (creatine transmembrane transport), [GO:0004066](http://purl.obolibrary.org/obo/GO_0004066) (asparagine synthase (glutamine-hydrolyzing) activity), [GO:0060169](http://purl.obolibrary.org/obo/GO_0060169) (negative regulation of adenosine receptor signaling pathway), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0097450](http://purl.obolibrary.org/obo/GO_0097450) (astrocyte end-foot), [GO:0098773](http://purl.obolibrary.org/obo/GO_0098773) (skin epidermis development), [GO:0097441](http://purl.obolibrary.org/obo/GO_0097441) (basal dendrite), [GO:0097440](http://purl.obolibrary.org/obo/GO_0097440) (apical dendrite), [GO:0097443](http://purl.obolibrary.org/obo/GO_0097443) (sorting endosome), [GO:0016050](http://purl.obolibrary.org/obo/GO_0016050) (vesicle organization), [GO:0016051](http://purl.obolibrary.org/obo/GO_0016051) (carbohydrate biosynthetic process), [GO:0016052](http://purl.obolibrary.org/obo/GO_0016052) (carbohydrate catabolic process), [GO:0097447](http://purl.obolibrary.org/obo/GO_0097447) (dendritic tree), [GO:0072144](http://purl.obolibrary.org/obo/GO_0072144) (glomerular mesangial cell development), [GO:0097449](http://purl.obolibrary.org/obo/GO_0097449) (astrocyte projection), [GO:0031673](http://purl.obolibrary.org/obo/GO_0031673) (H zone), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0031674](http://purl.obolibrary.org/obo/GO_0031674) (I band), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0060170](http://purl.obolibrary.org/obo/GO_0060170) (ciliary membrane), [GO:0016056](http://purl.obolibrary.org/obo/GO_0016056) (rhodopsin mediated signaling pathway), [GO:0072148](http://purl.obolibrary.org/obo/GO_0072148) (epithelial cell fate commitment), [GO:0031672](http://purl.obolibrary.org/obo/GO_0031672) (A band), [GO:0060171](http://purl.obolibrary.org/obo/GO_0060171) (stereocilium membrane), [GO:0030346](http://purl.obolibrary.org/obo/GO_0030346) (protein phosphatase 2B binding), [GO:0061485](http://purl.obolibrary.org/obo/GO_0061485) (memory T cell proliferation), [GO:0060155](http://purl.obolibrary.org/obo/GO_0060155) (platelet dense granule organization), [GO:0004070](http://purl.obolibrary.org/obo/GO_0004070) (aspartate carbamoyltransferase activity), [GO:0060157](http://purl.obolibrary.org/obo/GO_0060157) (urinary bladder development), [GO:0031670](http://purl.obolibrary.org/obo/GO_0031670) (cellular response to nutrient), [GO:0060152](http://purl.obolibrary.org/obo/GO_0060152) (microtubule-based peroxisome localization), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0004075](http://purl.obolibrary.org/obo/GO_0004075) (biotin carboxylase activity), [GO:0004078](http://purl.obolibrary.org/obo/GO_0004078) (biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity), [GO:0004077](http://purl.obolibrary.org/obo/GO_0004077) (biotin-[acetyl-CoA-carboxylase] ligase activity), [GO:0060158](http://purl.obolibrary.org/obo/GO_0060158) (phospholipase C-activating dopamine receptor signaling pathway), [GO:0004079](http://purl.obolibrary.org/obo/GO_0004079) (biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity), [GO:0060159](http://purl.obolibrary.org/obo/GO_0060159) (regulation of dopamine receptor signaling pathway), [GO:0098792](http://purl.obolibrary.org/obo/GO_0098792) (xenophagy), [GO:0097451](http://purl.obolibrary.org/obo/GO_0097451) (glial limiting end-foot), [GO:0030337](http://purl.obolibrary.org/obo/GO_0030337) (DNA polymerase processivity factor activity), [GO:0031668](http://purl.obolibrary.org/obo/GO_0031668) (cellular response to extracellular stimulus), [GO:0097453](http://purl.obolibrary.org/obo/GO_0097453) (mesaxon), [GO:0072136](http://purl.obolibrary.org/obo/GO_0072136) (metanephric mesenchymal cell proliferation involved in metanephros development), [GO:0097458](http://purl.obolibrary.org/obo/GO_0097458) (neuron part), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0016043](http://purl.obolibrary.org/obo/GO_0016043) (cellular component organization), [GO:0030330](http://purl.obolibrary.org/obo/GO_0030330) (DNA damage response, signal transduction by p53 class mediator), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0072139](http://purl.obolibrary.org/obo/GO_0072139) (glomerular parietal epithelial cell differentiation), [GO:0032994](http://purl.obolibrary.org/obo/GO_0032994) (protein-lipid complex), [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex), [GO:0072138](http://purl.obolibrary.org/obo/GO_0072138) (mesenchymal cell proliferation involved in ureteric bud development), [GO:0030332](http://purl.obolibrary.org/obo/GO_0030332) (cyclin binding), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0072137](http://purl.obolibrary.org/obo/GO_0072137) (condensed mesenchymal cell proliferation), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0031666](http://purl.obolibrary.org/obo/GO_0031666) (positive regulation of lipopolysaccharide-mediated signaling pathway), [GO:0031667](http://purl.obolibrary.org/obo/GO_0031667) (response to nutrient levels), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0016049](http://purl.obolibrary.org/obo/GO_0016049) (cell growth), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0031665](http://purl.obolibrary.org/obo/GO_0031665) (negative regulation of lipopolysaccharide-mediated signaling pathway), [GO:0060187](http://purl.obolibrary.org/obo/GO_0060187) (cell pole), [GO:0005372](http://purl.obolibrary.org/obo/GO_0005372) (water transmembrane transporter activity), [GO:0005371](http://purl.obolibrary.org/obo/GO_0005371) (tricarboxylate secondary active transmembrane transporter activity), [GO:0004043](http://purl.obolibrary.org/obo/GO_0004043) (L-aminoadipate-semialdehyde dehydrogenase activity), [GO:0004042](http://purl.obolibrary.org/obo/GO_0004042) (acetyl-CoA:L-glutamate N-acetyltransferase activity), [GO:0004045](http://purl.obolibrary.org/obo/GO_0004045) (aminoacyl-tRNA hydrolase activity), [GO:0005375](http://purl.obolibrary.org/obo/GO_0005375) (copper ion transmembrane transporter activity), [GO:0072172](http://purl.obolibrary.org/obo/GO_0072172) (mesonephric tubule formation), [GO:0004047](http://purl.obolibrary.org/obo/GO_0004047) (aminomethyltransferase activity), [GO:0004046](http://purl.obolibrary.org/obo/GO_0004046) (aminoacylase activity), [GO:0043602](http://purl.obolibrary.org/obo/GO_0043602) (nitrate catabolic process), [GO:0072170](http://purl.obolibrary.org/obo/GO_0072170) (metanephric tubule development), [GO:0031659](http://purl.obolibrary.org/obo/GO_0031659) (positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0030327](http://purl.obolibrary.org/obo/GO_0030327) (prenylated protein catabolic process), [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0097421](http://purl.obolibrary.org/obo/GO_0097421) (liver regeneration), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0072162](http://purl.obolibrary.org/obo/GO_0072162) (metanephric mesenchymal cell differentiation), [GO:0098754](http://purl.obolibrary.org/obo/GO_0098754) (detoxification), [GO:0016031](http://purl.obolibrary.org/obo/GO_0016031) (tRNA import into mitochondrion), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0032982](http://purl.obolibrary.org/obo/GO_0032982) (myosin filament), [GO:0030321](http://purl.obolibrary.org/obo/GO_0030321) (transepithelial chloride transport), [GO:0060192](http://purl.obolibrary.org/obo/GO_0060192) (negative regulation of lipase activity), [GO:0032981](http://purl.obolibrary.org/obo/GO_0032981) (mitochondrial respiratory chain complex I assembly), [GO:0097428](http://purl.obolibrary.org/obo/GO_0097428) (protein maturation by iron-sulfur cluster transfer), [GO:0030323](http://purl.obolibrary.org/obo/GO_0030323) (respiratory tube development), [GO:0016036](http://purl.obolibrary.org/obo/GO_0016036) (cellular response to phosphate starvation), [GO:0032986](http://purl.obolibrary.org/obo/GO_0032986) (protein-DNA complex disassembly), [GO:0030322](http://purl.obolibrary.org/obo/GO_0030322) (stabilization of membrane potential), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0016038](http://purl.obolibrary.org/obo/GO_0016038) (absorption of visible light), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0043615](http://purl.obolibrary.org/obo/GO_0043615) (astrocyte cell migration), [GO:0060177](http://purl.obolibrary.org/obo/GO_0060177) (regulation of angiotensin metabolic process), [GO:1901292](http://purl.obolibrary.org/obo/GO_1901292) (nucleoside phosphate catabolic process), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation), [GO:0043619](http://purl.obolibrary.org/obo/GO_0043619) (regulation of transcription from RNA polymerase II promoter in response to oxidative stress), [GO:0005381](http://purl.obolibrary.org/obo/GO_0005381) (iron ion transmembrane transporter activity), [GO:1901297](http://purl.obolibrary.org/obo/GO_1901297) (positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:1901299](http://purl.obolibrary.org/obo/GO_1901299) (negative regulation of hydrogen peroxide-mediated programmed cell death), [GO:0005385](http://purl.obolibrary.org/obo/GO_0005385) (zinc ion transmembrane transporter activity), [GO:0004053](http://purl.obolibrary.org/obo/GO_0004053) (arginase activity), [GO:0004056](http://purl.obolibrary.org/obo/GO_0004056) (argininosuccinate lyase activity), [GO:0004055](http://purl.obolibrary.org/obo/GO_0004055) (argininosuccinate synthase activity), [GO:0072161](http://purl.obolibrary.org/obo/GO_0072161) (mesenchymal cell differentiation involved in kidney development), [GO:0004058](http://purl.obolibrary.org/obo/GO_0004058) (aromatic-L-amino-acid decarboxylase activity), [GO:0005388](http://purl.obolibrary.org/obo/GO_0005388) (calcium-transporting ATPase activity), [GO:0098770](http://purl.obolibrary.org/obo/GO_0098770) (FBXO family protein binding), [GO:0004059](http://purl.obolibrary.org/obo/GO_0004059) (aralkylamine N-acetyltransferase activity), [GO:0031648](http://purl.obolibrary.org/obo/GO_0031648) (protein destabilization), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0032979](http://purl.obolibrary.org/obo/GO_0032979) (protein insertion into mitochondrial membrane from inner side), [GO:0030315](http://purl.obolibrary.org/obo/GO_0030315) (T-tubule), [GO:0031649](http://purl.obolibrary.org/obo/GO_0031649) (heat generation), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0097431](http://purl.obolibrary.org/obo/GO_0097431) (mitotic spindle pole), [GO:0098761](http://purl.obolibrary.org/obo/GO_0098761) (cellular response to interleukin-7), [GO:0032978](http://purl.obolibrary.org/obo/GO_0032978) (protein insertion into membrane from inner side), [GO:0097433](http://purl.obolibrary.org/obo/GO_0097433) (dense body), [GO:0072156](http://purl.obolibrary.org/obo/GO_0072156) (distal tubule morphogenesis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0097435](http://purl.obolibrary.org/obo/GO_0097435) (supramolecular fiber organization), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031640](http://purl.obolibrary.org/obo/GO_0031640) (killing of cells of other organism), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0016024](http://purl.obolibrary.org/obo/GO_0016024) (CDP-diacylglycerol biosynthetic process), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:1901291](http://purl.obolibrary.org/obo/GO_1901291) (negative regulation of double-strand break repair via single-strand annealing), [GO:0030314](http://purl.obolibrary.org/obo/GO_0030314) (junctional membrane complex), [GO:0032973](http://purl.obolibrary.org/obo/GO_0032973) (amino acid export), [GO:0032974](http://purl.obolibrary.org/obo/GO_0032974) (amino acid transmembrane export from vacuole), [GO:0031643](http://purl.obolibrary.org/obo/GO_0031643) (positive regulation of myelination), [GO:0016028](http://purl.obolibrary.org/obo/GO_0016028) (rhabdomere), [GO:0043585](http://purl.obolibrary.org/obo/GO_0043585) (nose morphogenesis), [GO:0042254](http://purl.obolibrary.org/obo/GO_0042254) (ribosome biogenesis), [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development), [GO:0043587](http://purl.obolibrary.org/obo/GO_0043587) (tongue morphogenesis), [GO:0042255](http://purl.obolibrary.org/obo/GO_0042255) (ribosome assembly), [GO:0043586](http://purl.obolibrary.org/obo/GO_0043586) (tongue development), [GO:0042256](http://purl.obolibrary.org/obo/GO_0042256) (mature ribosome assembly), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001702](http://purl.obolibrary.org/obo/GO_0001702) (gastrulation with mouth forming second), [GO:0031594](http://purl.obolibrary.org/obo/GO_0031594) (neuromuscular junction), [GO:0001706](http://purl.obolibrary.org/obo/GO_0001706) (endoderm formation), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0030267](http://purl.obolibrary.org/obo/GO_0030267) (glyoxylate reductase (NADP) activity), [GO:0031593](http://purl.obolibrary.org/obo/GO_0031593) (polyubiquitin modification-dependent protein binding), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0043596](http://purl.obolibrary.org/obo/GO_0043596) (nuclear replication fork), [GO:0042264](http://purl.obolibrary.org/obo/GO_0042264) (peptidyl-aspartic acid hydroxylation), [GO:0042267](http://purl.obolibrary.org/obo/GO_0042267) (natural killer cell mediated cytotoxicity), [GO:0042269](http://purl.obolibrary.org/obo/GO_0042269) (regulation of natural killer cell mediated cytotoxicity), [GO:0001710](http://purl.obolibrary.org/obo/GO_0001710) (mesodermal cell fate commitment), [GO:0001711](http://purl.obolibrary.org/obo/GO_0001711) (endodermal cell fate commitment), [GO:0042272](http://purl.obolibrary.org/obo/GO_0042272) (nuclear RNA export factor complex), [GO:0042273](http://purl.obolibrary.org/obo/GO_0042273) (ribosomal large subunit biogenesis), [GO:0001714](http://purl.obolibrary.org/obo/GO_0001714) (endodermal cell fate specification), [GO:0042274](http://purl.obolibrary.org/obo/GO_0042274) (ribosomal small subunit biogenesis), [GO:0031585](http://purl.obolibrary.org/obo/GO_0031585) (regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0031583](http://purl.obolibrary.org/obo/GO_0031583) (phospholipase D-activating G-protein coupled receptor signaling pathway), [GO:0031589](http://purl.obolibrary.org/obo/GO_0031589) (cell-substrate adhesion), [GO:0031588](http://purl.obolibrary.org/obo/GO_0031588) (nucleotide-activated protein kinase complex), [GO:0005290](http://purl.obolibrary.org/obo/GO_0005290) (L-histidine transmembrane transporter activity), [GO:0031581](http://purl.obolibrary.org/obo/GO_0031581) (hemidesmosome assembly), [GO:0030250](http://purl.obolibrary.org/obo/GO_0030250) (guanylate cyclase activator activity), [GO:0042276](http://purl.obolibrary.org/obo/GO_0042276) (error-prone translesion synthesis), [GO:0042277](http://purl.obolibrary.org/obo/GO_0042277) (peptide binding), [GO:0042278](http://purl.obolibrary.org/obo/GO_0042278) (purine nucleoside metabolic process), [GO:0030249](http://purl.obolibrary.org/obo/GO_0030249) (guanylate cyclase regulator activity), [GO:0042281](http://purl.obolibrary.org/obo/GO_0042281) (dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042283](http://purl.obolibrary.org/obo/GO_0042283) (dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042285](http://purl.obolibrary.org/obo/GO_0042285) (xylosyltransferase activity), [GO:0030242](http://purl.obolibrary.org/obo/GO_0030242) (autophagy of peroxisome), [GO:0030241](http://purl.obolibrary.org/obo/GO_0030241) (skeletal muscle myosin thick filament assembly), [GO:0031572](http://purl.obolibrary.org/obo/GO_0031572) (G2 DNA damage checkpoint), [GO:0031573](http://purl.obolibrary.org/obo/GO_0031573) (intra-S DNA damage checkpoint), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0031579](http://purl.obolibrary.org/obo/GO_0031579) (membrane raft organization), [GO:0030247](http://purl.obolibrary.org/obo/GO_0030247) (polysaccharide binding), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0030240](http://purl.obolibrary.org/obo/GO_0030240) (skeletal muscle thin filament assembly), [GO:0042287](http://purl.obolibrary.org/obo/GO_0042287) (MHC protein binding), [GO:0042288](http://purl.obolibrary.org/obo/GO_0042288) (MHC class I protein binding), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0030238](http://purl.obolibrary.org/obo/GO_0030238) (male sex determination), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0030234](http://purl.obolibrary.org/obo/GO_0030234) (enzyme regulator activity), [GO:0030237](http://purl.obolibrary.org/obo/GO_0030237) (female sex determination), [GO:0043549](http://purl.obolibrary.org/obo/GO_0043549) (regulation of kinase activity), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0043541](http://purl.obolibrary.org/obo/GO_0043541) (UDP-N-acetylglucosamine transferase complex), [GO:0000414](http://purl.obolibrary.org/obo/GO_0000414) (regulation of histone H3-K36 methylation), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0000413](http://purl.obolibrary.org/obo/GO_0000413) (protein peptidyl-prolyl isomerization), [GO:0000412](http://purl.obolibrary.org/obo/GO_0000412) (histone peptidyl-prolyl isomerization), [GO:0043545](http://purl.obolibrary.org/obo/GO_0043545) (molybdopterin cofactor metabolic process), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0044878](http://purl.obolibrary.org/obo/GO_0044878) (mitotic cytokinesis checkpoint), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0043546](http://purl.obolibrary.org/obo/GO_0043546) (molybdopterin cofactor binding), [GO:0001740](http://purl.obolibrary.org/obo/GO_0001740) (Barr body), [GO:0001741](http://purl.obolibrary.org/obo/GO_0001741) (XY body), [GO:0001743](http://purl.obolibrary.org/obo/GO_0001743) (optic placode formation), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0042220](http://purl.obolibrary.org/obo/GO_0042220) (response to cocaine), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0043553](http://purl.obolibrary.org/obo/GO_0043553) (negative regulation of phosphatidylinositol 3-kinase activity), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0000422](http://purl.obolibrary.org/obo/GO_0000422) (autophagy of mitochondrion), [GO:0000421](http://purl.obolibrary.org/obo/GO_0000421) (autophagosome membrane), [GO:0072097](http://purl.obolibrary.org/obo/GO_0072097) (negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway), [GO:0001754](http://purl.obolibrary.org/obo/GO_0001754) (eye photoreceptor cell differentiation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0001757](http://purl.obolibrary.org/obo/GO_0001757) (somite specification), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0001759](http://purl.obolibrary.org/obo/GO_0001759) (organ induction), [GO:0030296](http://purl.obolibrary.org/obo/GO_0030296) (protein tyrosine kinase activator activity), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0030291](http://purl.obolibrary.org/obo/GO_0030291) (protein serine/threonine kinase inhibitor activity), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0043567](http://purl.obolibrary.org/obo/GO_0043567) (regulation of insulin-like growth factor receptor signaling pathway), [GO:0043569](http://purl.obolibrary.org/obo/GO_0043569) (negative regulation of insulin-like growth factor receptor signaling pathway), [GO:0043568](http://purl.obolibrary.org/obo/GO_0043568) (positive regulation of insulin-like growth factor receptor signaling pathway), [GO:0097386](http://purl.obolibrary.org/obo/GO_0097386) (glial cell projection), [GO:0043570](http://purl.obolibrary.org/obo/GO_0043570) (maintenance of DNA repeat elements), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0030286](http://purl.obolibrary.org/obo/GO_0030286) (dynein complex), [GO:0001727](http://purl.obolibrary.org/obo/GO_0001727) (lipid kinase activity), [GO:0001729](http://purl.obolibrary.org/obo/GO_0001729) (ceramide kinase activity), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0030284](http://purl.obolibrary.org/obo/GO_0030284) (estrogen receptor activity), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:0000406](http://purl.obolibrary.org/obo/GO_0000406) (double-strand/single-strand DNA junction binding), [GO:0030283](http://purl.obolibrary.org/obo/GO_0030283) (testosterone dehydrogenase [NAD(P)] activity), [GO:0000405](http://purl.obolibrary.org/obo/GO_0000405) (bubble DNA binding), [GO:0000404](http://purl.obolibrary.org/obo/GO_0000404) (heteroduplex DNA loop binding), [GO:0043576](http://purl.obolibrary.org/obo/GO_0043576) (regulation of respiratory gaseous exchange), [GO:0000403](http://purl.obolibrary.org/obo/GO_0000403) (Y-form DNA binding), [GO:0042245](http://purl.obolibrary.org/obo/GO_0042245) (RNA repair), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0043577](http://purl.obolibrary.org/obo/GO_0043577) (chemotropism), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0001738](http://purl.obolibrary.org/obo/GO_0001738) (morphogenesis of a polarized epithelium), [GO:0030277](http://purl.obolibrary.org/obo/GO_0030277) (maintenance of gastrointestinal epithelium), [GO:0001739](http://purl.obolibrary.org/obo/GO_0001739) (sex chromatin), [GO:0030276](http://purl.obolibrary.org/obo/GO_0030276) (clathrin binding), [GO:0030279](http://purl.obolibrary.org/obo/GO_0030279) (negative regulation of ossification), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:1903800](http://purl.obolibrary.org/obo/GO_1903800) (positive regulation of production of miRNAs involved in gene silencing by miRNA), [GO:0000454](http://purl.obolibrary.org/obo/GO_0000454) (snoRNA guided rRNA pseudouridine synthesis), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0000463](http://purl.obolibrary.org/obo/GO_0000463) (maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000462](http://purl.obolibrary.org/obo/GO_0000462) (maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0000461](http://purl.obolibrary.org/obo/GO_0000461) (endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000460](http://purl.obolibrary.org/obo/GO_0000460) (maturation of 5.8S rRNA), [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0050713](http://purl.obolibrary.org/obo/GO_0050713) (negative regulation of interleukin-1 beta secretion), [GO:0050714](http://purl.obolibrary.org/obo/GO_0050714) (positive regulation of protein secretion), [GO:0050710](http://purl.obolibrary.org/obo/GO_0050710) (negative regulation of cytokine secretion), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0000469](http://purl.obolibrary.org/obo/GO_0000469) (cleavage involved in rRNA processing), [GO:0000467](http://purl.obolibrary.org/obo/GO_0000467) (exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:1903815](http://purl.obolibrary.org/obo/GO_1903815) (negative regulation of collecting lymphatic vessel constriction), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0048406](http://purl.obolibrary.org/obo/GO_0048406) (nerve growth factor binding), [GO:0000472](http://purl.obolibrary.org/obo/GO_0000472) (endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0000470](http://purl.obolibrary.org/obo/GO_0000470) (maturation of LSU-rRNA), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0000439](http://purl.obolibrary.org/obo/GO_0000439) (core TFIIH complex), [GO:0000435](http://purl.obolibrary.org/obo/GO_0000435) (positive regulation of transcription from RNA polymerase II promoter by galactose), [GO:0000433](http://purl.obolibrary.org/obo/GO_0000433) (negative regulation of transcription from RNA polymerase II promoter by glucose), [GO:0001771](http://purl.obolibrary.org/obo/GO_0001771) (immunological synapse formation), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0001763](http://purl.obolibrary.org/obo/GO_0001763) (morphogenesis of a branching structure), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0001766](http://purl.obolibrary.org/obo/GO_0001766) (membrane raft polarization), [GO:0001768](http://purl.obolibrary.org/obo/GO_0001768) (establishment of T cell polarity), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0050732](http://purl.obolibrary.org/obo/GO_0050732) (negative regulation of peptidyl-tyrosine phosphorylation), [GO:0000448](http://purl.obolibrary.org/obo/GO_0000448) (cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000447](http://purl.obolibrary.org/obo/GO_0000447) (endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000446](http://purl.obolibrary.org/obo/GO_0000446) (nucleoplasmic THO complex), [GO:0001780](http://purl.obolibrary.org/obo/GO_0001780) (neutrophil homeostasis), [GO:0000445](http://purl.obolibrary.org/obo/GO_0000445) (THO complex part of transcription export complex), [GO:0001781](http://purl.obolibrary.org/obo/GO_0001781) (neutrophil apoptotic process), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0001773](http://purl.obolibrary.org/obo/GO_0001773) (myeloid dendritic cell activation), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:1903827](http://purl.obolibrary.org/obo/GO_1903827) (regulation of cellular protein localization), [GO:0001775](http://purl.obolibrary.org/obo/GO_0001775) (cell activation), [GO:1903828](http://purl.obolibrary.org/obo/GO_1903828) (negative regulation of cellular protein localization), [GO:0001776](http://purl.obolibrary.org/obo/GO_0001776) (leukocyte homeostasis), [GO:0001778](http://purl.obolibrary.org/obo/GO_0001778) (plasma membrane repair), [GO:0001779](http://purl.obolibrary.org/obo/GO_0001779) (natural killer cell differentiation), [GO:0035122](http://purl.obolibrary.org/obo/GO_0035122) (embryonic medial fin morphogenesis), [GO:0036455](http://purl.obolibrary.org/obo/GO_0036455) (iron-sulfur transferase activity), [GO:0035124](http://purl.obolibrary.org/obo/GO_0035124) (embryonic caudal fin morphogenesis), [GO:0042297](http://purl.obolibrary.org/obo/GO_0042297) (vocal learning), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0036449](http://purl.obolibrary.org/obo/GO_0036449) (microtubule minus-end), [GO:0035119](http://purl.obolibrary.org/obo/GO_0035119) (embryonic pelvic fin morphogenesis), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0036444](http://purl.obolibrary.org/obo/GO_0036444) (mitochondrial calcium uptake), [GO:0036438](http://purl.obolibrary.org/obo/GO_0036438) (maintenance of lens transparency), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0036435](http://purl.obolibrary.org/obo/GO_0036435) (K48-linked polyubiquitin modification-dependent protein binding), [GO:2000203](http://purl.obolibrary.org/obo/GO_2000203) (regulation of ribosomal large subunit export from nucleus), [GO:0035102](http://purl.obolibrary.org/obo/GO_0035102) (PRC1 complex), [GO:0000478](http://purl.obolibrary.org/obo/GO_0000478) (endonucleolytic cleavage involved in rRNA processing), [GO:2000219](http://purl.obolibrary.org/obo/GO_2000219) (positive regulation of invasive growth in response to glucose limitation), [GO:0000480](http://purl.obolibrary.org/obo/GO_0000480) (endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:2000212](http://purl.obolibrary.org/obo/GO_2000212) (negative regulation of glutamate metabolic process), [GO:2000210](http://purl.obolibrary.org/obo/GO_2000210) (positive regulation of anoikis), [GO:0050708](http://purl.obolibrary.org/obo/GO_0050708) (regulation of protein secretion), [GO:0000495](http://purl.obolibrary.org/obo/GO_0000495) (box H/ACA snoRNA 3'-end processing), [GO:2000228](http://purl.obolibrary.org/obo/GO_2000228) (positive regulation of pancreatic A cell differentiation), [GO:0000492](http://purl.obolibrary.org/obo/GO_0000492) (box C/D snoRNP assembly), [GO:2000223](http://purl.obolibrary.org/obo/GO_2000223) (regulation of BMP signaling pathway involved in heart jogging), [GO:2000222](http://purl.obolibrary.org/obo/GO_2000222) (positive regulation of pseudohyphal growth), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:0050702](http://purl.obolibrary.org/obo/GO_0050702) (interleukin-1 beta secretion), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0036413](http://purl.obolibrary.org/obo/GO_0036413) (histone H3-R26 citrullination), [GO:0050701](http://purl.obolibrary.org/obo/GO_0050701) (interleukin-1 secretion), [GO:0036414](http://purl.obolibrary.org/obo/GO_0036414) (histone citrullination), [GO:2000225](http://purl.obolibrary.org/obo/GO_2000225) (negative regulation of testosterone biosynthetic process), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), [GO:0060242](http://purl.obolibrary.org/obo/GO_0060242) (contact inhibition), [GO:0061576](http://purl.obolibrary.org/obo/GO_0061576) (acyl-CoA ceramide synthase complex), [GO:0035282](http://purl.obolibrary.org/obo/GO_0035282) (segmentation), [GO:1903763](http://purl.obolibrary.org/obo/GO_1903763) (gap junction channel activity involved in cell communication by electrical coupling), [GO:0035284](http://purl.obolibrary.org/obo/GO_0035284) (brain segmentation), [GO:1902430](http://purl.obolibrary.org/obo/GO_1902430) (negative regulation of amyloid-beta formation), [GO:1903766](http://purl.obolibrary.org/obo/GO_1903766) (positive regulation of potassium ion export across plasma membrane), [GO:0035280](http://purl.obolibrary.org/obo/GO_0035280) (miRNA loading onto RISC involved in gene silencing by miRNA), [GO:0061578](http://purl.obolibrary.org/obo/GO_0061578) (Lys63-specific deubiquitinase activity), [GO:0060249](http://purl.obolibrary.org/obo/GO_0060249) (anatomical structure homeostasis), [GO:0006720](http://purl.obolibrary.org/obo/GO_0006720) (isoprenoid metabolic process), [GO:0098850](http://purl.obolibrary.org/obo/GO_0098850) (extrinsic component of synaptic vesicle membrane), [GO:0006714](http://purl.obolibrary.org/obo/GO_0006714) (sesquiterpenoid metabolic process), [GO:0098855](http://purl.obolibrary.org/obo/GO_0098855) (HCN channel complex), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0072221](http://purl.obolibrary.org/obo/GO_0072221) (metanephric distal convoluted tubule development), [GO:0097526](http://purl.obolibrary.org/obo/GO_0097526) (spliceosomal tri-snRNP complex), [GO:0097525](http://purl.obolibrary.org/obo/GO_0097525) (spliceosomal snRNP complex), [GO:0098856](http://purl.obolibrary.org/obo/GO_0098856) (intestinal lipid absorption), [GO:0097527](http://purl.obolibrary.org/obo/GO_0097527) (necroptotic signaling pathway), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0060231](http://purl.obolibrary.org/obo/GO_0060231) (mesenchymal to epithelial transition), [GO:0061564](http://purl.obolibrary.org/obo/GO_0061564) (axon development), [GO:0035278](http://purl.obolibrary.org/obo/GO_0035278) (miRNA mediated inhibition of translation), [GO:0060234](http://purl.obolibrary.org/obo/GO_0060234) (neuroblast delamination), [GO:2000010](http://purl.obolibrary.org/obo/GO_2000010) (positive regulation of protein localization to cell surface), [GO:1903774](http://purl.obolibrary.org/obo/GO_1903774) (positive regulation of viral budding via host ESCRT complex), [GO:1902443](http://purl.obolibrary.org/obo/GO_1902443) (negative regulation of ripoptosome assembly involved in necroptotic process), [GO:0060230](http://purl.obolibrary.org/obo/GO_0060230) (lipoprotein lipase activator activity), [GO:1903772](http://purl.obolibrary.org/obo/GO_1903772) (regulation of viral budding via host ESCRT complex), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0060235](http://purl.obolibrary.org/obo/GO_0060235) (lens induction in camera-type eye), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:1903779](http://purl.obolibrary.org/obo/GO_1903779) (regulation of cardiac conduction), [GO:0060237](http://purl.obolibrary.org/obo/GO_0060237) (regulation of fungal-type cell wall organization), [GO:0006725](http://purl.obolibrary.org/obo/GO_0006725) (cellular aromatic compound metabolic process), [GO:0097531](http://purl.obolibrary.org/obo/GO_0097531) (mast cell migration), [GO:2000008](http://purl.obolibrary.org/obo/GO_2000008) (regulation of protein localization to cell surface), [GO:0006729](http://purl.obolibrary.org/obo/GO_0006729) (tetrahydrobiopterin biosynthetic process), [GO:0097535](http://purl.obolibrary.org/obo/GO_0097535) (lymphoid lineage cell migration into thymus), [GO:0072210](http://purl.obolibrary.org/obo/GO_0072210) (metanephric nephron development), [GO:0098869](http://purl.obolibrary.org/obo/GO_0098869) (cellular oxidant detoxification), [GO:0097536](http://purl.obolibrary.org/obo/GO_0097536) (thymus epithelium morphogenesis), [GO:0097539](http://purl.obolibrary.org/obo/GO_0097539) (ciliary transition fiber), [GO:2000001](http://purl.obolibrary.org/obo/GO_2000001) (regulation of DNA damage checkpoint), [GO:0098868](http://purl.obolibrary.org/obo/GO_0098868) (bone growth), [GO:2000007](http://purl.obolibrary.org/obo/GO_2000007) (negative regulation of metanephric comma-shaped body morphogenesis), [GO:0035268](http://purl.obolibrary.org/obo/GO_0035268) (protein mannosylation), [GO:0035269](http://purl.obolibrary.org/obo/GO_0035269) (protein O-linked mannosylation), [GO:2000005](http://purl.obolibrary.org/obo/GO_2000005) (negative regulation of metanephric S-shaped body morphogenesis), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0060265](http://purl.obolibrary.org/obo/GO_0060265) (positive regulation of respiratory burst involved in inflammatory response), [GO:0060266](http://purl.obolibrary.org/obo/GO_0060266) (negative regulation of respiratory burst involved in inflammatory response), [GO:0061598](http://purl.obolibrary.org/obo/GO_0061598) (molybdopterin adenylyltransferase activity), [GO:0035267](http://purl.obolibrary.org/obo/GO_0035267) (NuA4 histone acetyltransferase complex), [GO:0061591](http://purl.obolibrary.org/obo/GO_0061591) (calcium activated galactosylceramide scrambling), [GO:2000021](http://purl.obolibrary.org/obo/GO_2000021) (regulation of ion homeostasis), [GO:0060261](http://purl.obolibrary.org/obo/GO_0060261) (positive regulation of transcription initiation from RNA polymerase II promoter), [GO:2000020](http://purl.obolibrary.org/obo/GO_2000020) (positive regulation of male gonad development), [GO:0035261](http://purl.obolibrary.org/obo/GO_0035261) (external genitalia morphogenesis), [GO:1903788](http://purl.obolibrary.org/obo/GO_1903788) (positive regulation of glutathione biosynthetic process), [GO:0061599](http://purl.obolibrary.org/obo/GO_0061599) (molybdopterin molybdotransferase activity), [GO:0060268](http://purl.obolibrary.org/obo/GO_0060268) (negative regulation of respiratory burst), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:1902459](http://purl.obolibrary.org/obo/GO_1902459) (positive regulation of stem cell population maintenance), [GO:2000019](http://purl.obolibrary.org/obo/GO_2000019) (negative regulation of male gonad development), [GO:0097500](http://purl.obolibrary.org/obo/GO_0097500) (receptor localization to non-motile cilium), [GO:0097502](http://purl.obolibrary.org/obo/GO_0097502) (mannosylation), [GO:0098830](http://purl.obolibrary.org/obo/GO_0098830) (presynaptic endosome), [GO:0098831](http://purl.obolibrary.org/obo/GO_0098831) (presynaptic active zone cytoplasmic component), [GO:0097504](http://purl.obolibrary.org/obo/GO_0097504) (Gemini of coiled bodies), [GO:0047293](http://purl.obolibrary.org/obo/GO_0047293) (4-hydroxybenzoate nonaprenyltransferase activity), [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding), [GO:0035258](http://purl.obolibrary.org/obo/GO_0035258) (steroid hormone receptor binding), [GO:0035259](http://purl.obolibrary.org/obo/GO_0035259) (glucocorticoid receptor binding), [GO:0047291](http://purl.obolibrary.org/obo/GO_0047291) (lactosylceramide alpha-2,3-sialyltransferase activity), [GO:0098839](http://purl.obolibrary.org/obo/GO_0098839) (postsynaptic density membrane), [GO:0060253](http://purl.obolibrary.org/obo/GO_0060253) (negative regulation of glial cell proliferation), [GO:0035253](http://purl.obolibrary.org/obo/GO_0035253) (ciliary rootlet), [GO:0035254](http://purl.obolibrary.org/obo/GO_0035254) (glutamate receptor binding), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0035256](http://purl.obolibrary.org/obo/GO_0035256) (G-protein coupled glutamate receptor binding), [GO:0061580](http://purl.obolibrary.org/obo/GO_0061580) (colon epithelial cell migration), [GO:0035250](http://purl.obolibrary.org/obo/GO_0035250) (UDP-galactosyltransferase activity), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:0060251](http://purl.obolibrary.org/obo/GO_0060251) (regulation of glial cell proliferation), [GO:1902462](http://purl.obolibrary.org/obo/GO_1902462) (positive regulation of mesenchymal stem cell proliferation), [GO:0035251](http://purl.obolibrary.org/obo/GO_0035251) (UDP-glucosyltransferase activity), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:0035252](http://purl.obolibrary.org/obo/GO_0035252) (UDP-xylosyltransferase activity), [GO:1903799](http://purl.obolibrary.org/obo/GO_1903799) (negative regulation of production of miRNAs involved in gene silencing by miRNA), [GO:1901135](http://purl.obolibrary.org/obo/GO_1901135) (carbohydrate derivative metabolic process), [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process), [GO:0061588](http://purl.obolibrary.org/obo/GO_0061588) (calcium activated phospholipid scrambling), [GO:0006710](http://purl.obolibrary.org/obo/GO_0006710) (androgen catabolic process), [GO:0061589](http://purl.obolibrary.org/obo/GO_0061589) (calcium activated phosphatidylserine scrambling), [GO:0060259](http://purl.obolibrary.org/obo/GO_0060259) (regulation of feeding behavior), [GO:0006703](http://purl.obolibrary.org/obo/GO_0006703) (estrogen biosynthetic process), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0098840](http://purl.obolibrary.org/obo/GO_0098840) (protein transport along microtubule), [GO:0006701](http://purl.obolibrary.org/obo/GO_0006701) (progesterone biosynthetic process), [GO:0006702](http://purl.obolibrary.org/obo/GO_0006702) (androgen biosynthetic process), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0097510](http://purl.obolibrary.org/obo/GO_0097510) (base-excision repair, AP site formation via deaminated base removal), [GO:0006705](http://purl.obolibrary.org/obo/GO_0006705) (mineralocorticoid biosynthetic process), [GO:0006706](http://purl.obolibrary.org/obo/GO_0006706) (steroid catabolic process), [GO:0097512](http://purl.obolibrary.org/obo/GO_0097512) (cardiac myofibril), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0061590](http://purl.obolibrary.org/obo/GO_0061590) (calcium activated phosphatidylcholine scrambling), [GO:0035246](http://purl.obolibrary.org/obo/GO_0035246) (peptidyl-arginine N-methylation), [GO:0097519](http://purl.obolibrary.org/obo/GO_0097519) (DNA recombinase complex), [GO:2000027](http://purl.obolibrary.org/obo/GO_2000027) (regulation of organ morphogenesis), [GO:0035249](http://purl.obolibrary.org/obo/GO_0035249) (synaptic transmission, glutamatergic), [GO:2000042](http://purl.obolibrary.org/obo/GO_2000042) (negative regulation of double-strand break repair via homologous recombination), [GO:0061537](http://purl.obolibrary.org/obo/GO_0061537) (glycine secretion, neurotransmission), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0090096](http://purl.obolibrary.org/obo/GO_0090096) (positive regulation of metanephric cap mesenchymal cell proliferation), [GO:1903721](http://purl.obolibrary.org/obo/GO_1903721) (positive regulation of I-kappaB phosphorylation), [GO:0006760](http://purl.obolibrary.org/obo/GO_0006760) (folic acid-containing compound metabolic process), [GO:0004102](http://purl.obolibrary.org/obo/GO_0004102) (choline O-acetyltransferase activity), [GO:0061534](http://purl.obolibrary.org/obo/GO_0061534) (gamma-aminobutyric acid secretion, neurotransmission), [GO:0061535](http://purl.obolibrary.org/obo/GO_0061535) (glutamate secretion, neurotransmission), [GO:0004104](http://purl.obolibrary.org/obo/GO_0004104) (cholinesterase activity), [GO:0060205](http://purl.obolibrary.org/obo/GO_0060205) (cytoplasmic vesicle lumen), [GO:0004103](http://purl.obolibrary.org/obo/GO_0004103) (choline kinase activity), [GO:0048562](http://purl.obolibrary.org/obo/GO_0048562) (embryonic organ morphogenesis), [GO:0050872](http://purl.obolibrary.org/obo/GO_0050872) (white fat cell differentiation), [GO:0050873](http://purl.obolibrary.org/obo/GO_0050873) (brown fat cell differentiation), [GO:0031715](http://purl.obolibrary.org/obo/GO_0031715) (C5L2 anaphylatoxin chemotactic receptor binding), [GO:0050870](http://purl.obolibrary.org/obo/GO_0050870) (positive regulation of T cell activation), [GO:0048560](http://purl.obolibrary.org/obo/GO_0048560) (establishment of anatomical structure orientation), [GO:0031713](http://purl.obolibrary.org/obo/GO_0031713) (B2 bradykinin receptor binding), [GO:0050871](http://purl.obolibrary.org/obo/GO_0050871) (positive regulation of B cell activation), [GO:1903718](http://purl.obolibrary.org/obo/GO_1903718) (cellular response to ammonia), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0048563](http://purl.obolibrary.org/obo/GO_0048563) (post-embryonic animal organ morphogenesis), [GO:2000035](http://purl.obolibrary.org/obo/GO_2000035) (regulation of stem cell division), [GO:0098815](http://purl.obolibrary.org/obo/GO_0098815) (modulation of excitatory postsynaptic potential), [GO:0050878](http://purl.obolibrary.org/obo/GO_0050878) (regulation of body fluid levels), [GO:0050877](http://purl.obolibrary.org/obo/GO_0050877) (nervous system process), [GO:0031711](http://purl.obolibrary.org/obo/GO_0031711) (bradykinin receptor binding), [GO:2000050](http://purl.obolibrary.org/obo/GO_2000050) (regulation of non-canonical Wnt signaling pathway), [GO:2000054](http://purl.obolibrary.org/obo/GO_2000054) (negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:2000052](http://purl.obolibrary.org/obo/GO_2000052) (positive regulation of non-canonical Wnt signaling pathway), [GO:2000051](http://purl.obolibrary.org/obo/GO_2000051) (negative regulation of non-canonical Wnt signaling pathway), [GO:0006772](http://purl.obolibrary.org/obo/GO_0006772) (thiamine metabolic process), [GO:0047238](http://purl.obolibrary.org/obo/GO_0047238) (glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0006776](http://purl.obolibrary.org/obo/GO_0006776) (vitamin A metabolic process), [GO:0006777](http://purl.obolibrary.org/obo/GO_0006777) (Mo-molybdopterin cofactor biosynthetic process), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0061525](http://purl.obolibrary.org/obo/GO_0061525) (hindgut development), [GO:0050883](http://purl.obolibrary.org/obo/GO_0050883) (musculoskeletal movement, spinal reflex action), [GO:0031703](http://purl.obolibrary.org/obo/GO_0031703) (type 2 angiotensin receptor binding), [GO:0005436](http://purl.obolibrary.org/obo/GO_0005436) (sodium:phosphate symporter activity), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0004105](http://purl.obolibrary.org/obo/GO_0004105) (choline-phosphate cytidylyltransferase activity), [GO:0050881](http://purl.obolibrary.org/obo/GO_0050881) (musculoskeletal movement), [GO:0031701](http://purl.obolibrary.org/obo/GO_0031701) (angiotensin receptor binding), [GO:0048570](http://purl.obolibrary.org/obo/GO_0048570) (notochord morphogenesis), [GO:0006768](http://purl.obolibrary.org/obo/GO_0006768) (biotin metabolic process), [GO:0031702](http://purl.obolibrary.org/obo/GO_0031702) (type 1 angiotensin receptor binding), [GO:0050882](http://purl.obolibrary.org/obo/GO_0050882) (voluntary musculoskeletal movement), [GO:0098821](http://purl.obolibrary.org/obo/GO_0098821) (BMP receptor activity), [GO:0031707](http://purl.obolibrary.org/obo/GO_0031707) (endothelin A receptor binding), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0031708](http://purl.obolibrary.org/obo/GO_0031708) (endothelin B receptor binding), [GO:0004109](http://purl.obolibrary.org/obo/GO_0004109) (coproporphyrinogen oxidase activity), [GO:2000047](http://purl.obolibrary.org/obo/GO_2000047) (regulation of cell-cell adhesion mediated by cadherin), [GO:0098826](http://purl.obolibrary.org/obo/GO_0098826) (endoplasmic reticulum tubular network membrane), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:2000049](http://purl.obolibrary.org/obo/GO_2000049) (positive regulation of cell-cell adhesion mediated by cadherin), [GO:2000048](http://purl.obolibrary.org/obo/GO_2000048) (negative regulation of cell-cell adhesion mediated by cadherin), [GO:0060220](http://purl.obolibrary.org/obo/GO_0060220) (camera-type eye photoreceptor cell fate commitment), [GO:0061551](http://purl.obolibrary.org/obo/GO_0061551) (trigeminal ganglion development), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation), [GO:2000065](http://purl.obolibrary.org/obo/GO_2000065) (negative regulation of cortisol biosynthetic process), [GO:2000063](http://purl.obolibrary.org/obo/GO_2000063) (positive regulation of ureter smooth muscle cell differentiation), [GO:2000062](http://purl.obolibrary.org/obo/GO_2000062) (negative regulation of ureter smooth muscle cell differentiation), [GO:0061550](http://purl.obolibrary.org/obo/GO_0061550) (cranial ganglion development), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0090076](http://purl.obolibrary.org/obo/GO_0090076) (relaxation of skeletal muscle), [GO:0060229](http://purl.obolibrary.org/obo/GO_0060229) (lipase activator activity), [GO:0006740](http://purl.obolibrary.org/obo/GO_0006740) (NADPH regeneration), [GO:0090074](http://purl.obolibrary.org/obo/GO_0090074) (negative regulation of protein homodimerization activity), [GO:0006744](http://purl.obolibrary.org/obo/GO_0006744) (ubiquinone biosynthetic process), [GO:0006741](http://purl.obolibrary.org/obo/GO_0006741) (NADP biosynthetic process), [GO:1902415](http://purl.obolibrary.org/obo/GO_1902415) (regulation of mRNA binding), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0005412](http://purl.obolibrary.org/obo/GO_0005412) (glucose:sodium symporter activity), [GO:0090080](http://purl.obolibrary.org/obo/GO_0090080) (positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway), [GO:0050892](http://purl.obolibrary.org/obo/GO_0050892) (intestinal absorption), [GO:0006734](http://purl.obolibrary.org/obo/GO_0006734) (NADH metabolic process), [GO:0050893](http://purl.obolibrary.org/obo/GO_0050893) (sensory processing), [GO:0050890](http://purl.obolibrary.org/obo/GO_0050890) (cognition), [GO:0072201](http://purl.obolibrary.org/obo/GO_0072201) (negative regulation of mesenchymal cell proliferation), [GO:0050891](http://purl.obolibrary.org/obo/GO_0050891) (multicellular organismal water homeostasis), [GO:0072200](http://purl.obolibrary.org/obo/GO_0072200) (negative regulation of mesenchymal cell proliferation involved in ureter development), [GO:0006739](http://purl.obolibrary.org/obo/GO_0006739) (NADP metabolic process), [GO:2000058](http://purl.obolibrary.org/obo/GO_2000058) (regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072205](http://purl.obolibrary.org/obo/GO_0072205) (metanephric collecting duct development), [GO:0072203](http://purl.obolibrary.org/obo/GO_0072203) (cell proliferation involved in metanephros development), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072207](http://purl.obolibrary.org/obo/GO_0072207) (metanephric epithelium development), [GO:0050897](http://purl.obolibrary.org/obo/GO_0050897) (cobalt ion binding), [GO:0060211](http://purl.obolibrary.org/obo/GO_0060211) (regulation of nuclear-transcribed mRNA poly(A) tail shortening), [GO:0035295](http://purl.obolibrary.org/obo/GO_0035295) (tube development), [GO:0006750](http://purl.obolibrary.org/obo/GO_0006750) (glutathione biosynthetic process), [GO:0060217](http://purl.obolibrary.org/obo/GO_0060217) (hemangioblast cell differentiation), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0061549](http://purl.obolibrary.org/obo/GO_0061549) (sympathetic ganglion development), [GO:0006751](http://purl.obolibrary.org/obo/GO_0006751) (glutathione catabolic process), [GO:1903753](http://purl.obolibrary.org/obo/GO_1903753) (negative regulation of p38MAPK cascade), [GO:0060219](http://purl.obolibrary.org/obo/GO_0060219) (camera-type eye photoreceptor cell differentiation), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0090086](http://purl.obolibrary.org/obo/GO_0090086) (negative regulation of protein deubiquitination), [GO:0006754](http://purl.obolibrary.org/obo/GO_0006754) (ATP biosynthetic process), [GO:0060214](http://purl.obolibrary.org/obo/GO_0060214) (endocardium formation), [GO:0090084](http://purl.obolibrary.org/obo/GO_0090084) (negative regulation of inclusion body assembly), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:1903758](http://purl.obolibrary.org/obo/GO_1903758) (negative regulation of transcription from RNA polymerase II promoter by histone modification), [GO:0061547](http://purl.obolibrary.org/obo/GO_0061547) (glycogen synthase activity, transferring glucose-1-phosphate), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0006747](http://purl.obolibrary.org/obo/GO_0006747) (FAD biosynthetic process), [GO:0090091](http://purl.obolibrary.org/obo/GO_0090091) (positive regulation of extracellular matrix disassembly), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0048599](http://purl.obolibrary.org/obo/GO_0048599) (oocyte development), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0048597](http://purl.obolibrary.org/obo/GO_0048597) (post-embryonic camera-type eye morphogenesis), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:2000066](http://purl.obolibrary.org/obo/GO_2000066) (positive regulation of cortisol biosynthetic process), [GO:0042415](http://purl.obolibrary.org/obo/GO_0042415) (norepinephrine metabolic process), [GO:0042416](http://purl.obolibrary.org/obo/GO_0042416) (dopamine biosynthetic process), [GO:0042417](http://purl.obolibrary.org/obo/GO_0042417) (dopamine metabolic process), [GO:1901184](http://purl.obolibrary.org/obo/GO_1901184) (regulation of ERBB signaling pathway), [GO:0042418](http://purl.obolibrary.org/obo/GO_0042418) (epinephrine biosynthetic process), [GO:1901186](http://purl.obolibrary.org/obo/GO_1901186) (positive regulation of ERBB signaling pathway), [GO:1901189](http://purl.obolibrary.org/obo/GO_1901189) (positive regulation of ephrin receptor signaling pathway), [GO:0005471](http://purl.obolibrary.org/obo/GO_0005471) (ATP:ADP antiporter activity), [GO:0004143](http://purl.obolibrary.org/obo/GO_0004143) (diacylglycerol kinase activity), [GO:0004146](http://purl.obolibrary.org/obo/GO_0004146) (dihydrofolate reductase activity), [GO:0004145](http://purl.obolibrary.org/obo/GO_0004145) (diamine N-acetyltransferase activity), [GO:0005476](http://purl.obolibrary.org/obo/GO_0005476) (carnitine:acyl carnitine antiporter activity), [GO:0004148](http://purl.obolibrary.org/obo/GO_0004148) (dihydrolipoyl dehydrogenase activity), [GO:0042414](http://purl.obolibrary.org/obo/GO_0042414) (epinephrine metabolic process), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0004138](http://purl.obolibrary.org/obo/GO_0004138) (deoxyguanosine kinase activity), [GO:0030427](http://purl.obolibrary.org/obo/GO_0030427) (site of polarized growth), [GO:0030429](http://purl.obolibrary.org/obo/GO_0030429) (kynureninase activity), [GO:0016132](http://purl.obolibrary.org/obo/GO_0016132) (brassinosteroid biosynthetic process), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0042426](http://purl.obolibrary.org/obo/GO_0042426) (choline catabolic process), [GO:0042427](http://purl.obolibrary.org/obo/GO_0042427) (serotonin biosynthetic process), [GO:0042428](http://purl.obolibrary.org/obo/GO_0042428) (serotonin metabolic process), [GO:2000098](http://purl.obolibrary.org/obo/GO_2000098) (negative regulation of smooth muscle cell-matrix adhesion), [GO:2000097](http://purl.obolibrary.org/obo/GO_2000097) (regulation of smooth muscle cell-matrix adhesion), [GO:2000096](http://purl.obolibrary.org/obo/GO_2000096) (positive regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0004151](http://purl.obolibrary.org/obo/GO_0004151) (dihydroorotase activity), [GO:2000095](http://purl.obolibrary.org/obo/GO_2000095) (regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0005484](http://purl.obolibrary.org/obo/GO_0005484) (SNAP receptor activity), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0004155](http://purl.obolibrary.org/obo/GO_0004155) (6,7-dihydropteridine reductase activity), [GO:0042420](http://purl.obolibrary.org/obo/GO_0042420) (dopamine catabolic process), [GO:0042421](http://purl.obolibrary.org/obo/GO_0042421) (norepinephrine biosynthetic process), [GO:0043754](http://purl.obolibrary.org/obo/GO_0043754) (dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity), [GO:0004157](http://purl.obolibrary.org/obo/GO_0004157) (dihydropyrimidinase activity), [GO:0005487](http://purl.obolibrary.org/obo/GO_0005487) (nuclear pore activity), [GO:0042423](http://purl.obolibrary.org/obo/GO_0042423) (catecholamine biosynthetic process), [GO:0042424](http://purl.obolibrary.org/obo/GO_0042424) (catecholamine catabolic process), [GO:0004159](http://purl.obolibrary.org/obo/GO_0004159) (dihydrouracil dehydrogenase (NAD+) activity), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0030412](http://purl.obolibrary.org/obo/GO_0030412) (formimidoyltetrahydrofolate cyclodeaminase activity), [GO:0042438](http://purl.obolibrary.org/obo/GO_0042438) (melanin biosynthetic process), [GO:0006780](http://purl.obolibrary.org/obo/GO_0006780) (uroporphyrinogen III biosynthetic process), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0006784](http://purl.obolibrary.org/obo/GO_0006784) (heme a biosynthetic process), [GO:0004122](http://purl.obolibrary.org/obo/GO_0004122) (cystathionine beta-synthase activity), [GO:0005452](http://purl.obolibrary.org/obo/GO_0005452) (inorganic anion exchanger activity), [GO:0006782](http://purl.obolibrary.org/obo/GO_0006782) (protoporphyrinogen IX biosynthetic process), [GO:0004121](http://purl.obolibrary.org/obo/GO_0004121) (cystathionine beta-lyase activity), [GO:0004123](http://purl.obolibrary.org/obo/GO_0004123) (cystathionine gamma-lyase activity), [GO:0004126](http://purl.obolibrary.org/obo/GO_0004126) (cytidine deaminase activity), [GO:0097584](http://purl.obolibrary.org/obo/GO_0097584) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt2p dimer complex), [GO:0097583](http://purl.obolibrary.org/obo/GO_0097583) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt3p dimer complex), [GO:0006778](http://purl.obolibrary.org/obo/GO_0006778) (porphyrin-containing compound metabolic process), [GO:0004119](http://purl.obolibrary.org/obo/GO_0004119) (cGMP-inhibited cyclic-nucleotide phosphodiesterase activity), [GO:0097586](http://purl.obolibrary.org/obo/GO_0097586) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt4p homodimer complex), [GO:0006779](http://purl.obolibrary.org/obo/GO_0006779) (porphyrin-containing compound biosynthetic process), [GO:0097585](http://purl.obolibrary.org/obo/GO_0097585) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt3p dimer complex), [GO:0097587](http://purl.obolibrary.org/obo/GO_0097587) (MutLgamma complex), [GO:0030407](http://purl.obolibrary.org/obo/GO_0030407) (formimidoyltransferase activity), [GO:0030409](http://purl.obolibrary.org/obo/GO_0030409) (glutamate formimidoyltransferase activity), [GO:0031730](http://purl.obolibrary.org/obo/GO_0031730) (CCR5 chemokine receptor binding), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0006790](http://purl.obolibrary.org/obo/GO_0006790) (sulfur compound metabolic process), [GO:0004133](http://purl.obolibrary.org/obo/GO_0004133) (glycogen debranching enzyme activity), [GO:0042443](http://purl.obolibrary.org/obo/GO_0042443) (phenylethylamine metabolic process), [GO:0006798](http://purl.obolibrary.org/obo/GO_0006798) (polyphosphate catabolic process), [GO:0004135](http://purl.obolibrary.org/obo/GO_0004135) (amylo-alpha-1,6-glucosidase activity), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0004134](http://purl.obolibrary.org/obo/GO_0004134) (4-alpha-glucanotransferase activity), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0006796](http://purl.obolibrary.org/obo/GO_0006796) (phosphate-containing compound metabolic process), [GO:0004137](http://purl.obolibrary.org/obo/GO_0004137) (deoxycytidine kinase activity), [GO:0006797](http://purl.obolibrary.org/obo/GO_0006797) (polyphosphate metabolic process), [GO:0042447](http://purl.obolibrary.org/obo/GO_0042447) (hormone catabolic process), [GO:0004128](http://purl.obolibrary.org/obo/GO_0004128) (cytochrome-b5 reductase activity, acting on NAD(P)H), [GO:0005459](http://purl.obolibrary.org/obo/GO_0005459) (UDP-galactose transmembrane transporter activity), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0097598](http://purl.obolibrary.org/obo/GO_0097598) (sperm cytoplasmic droplet), [GO:0031727](http://purl.obolibrary.org/obo/GO_0031727) (CCR2 chemokine receptor binding), [GO:0042450](http://purl.obolibrary.org/obo/GO_0042450) (arginine biosynthetic process via ornithine), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), [GO:0060287](http://purl.obolibrary.org/obo/GO_0060287) (epithelial cilium movement involved in determination of left/right asymmetry), [GO:0004180](http://purl.obolibrary.org/obo/GO_0004180) (carboxypeptidase activity), [GO:0043704](http://purl.obolibrary.org/obo/GO_0043704) (photoreceptor cell fate specification), [GO:1902475](http://purl.obolibrary.org/obo/GO_1902475) (L-alpha-amino acid transmembrane transport), [GO:0060282](http://purl.obolibrary.org/obo/GO_0060282) (positive regulation of oocyte development), [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport), [GO:1901142](http://purl.obolibrary.org/obo/GO_1901142) (insulin metabolic process), [GO:0004181](http://purl.obolibrary.org/obo/GO_0004181) (metallocarboxypeptidase activity), [GO:0060283](http://purl.obolibrary.org/obo/GO_0060283) (negative regulation of oocyte development), [GO:0060285](http://purl.obolibrary.org/obo/GO_0060285) (cilium-dependent cell motility), [GO:0004185](http://purl.obolibrary.org/obo/GO_0004185) (serine-type carboxypeptidase activity), [GO:0072264](http://purl.obolibrary.org/obo/GO_0072264) (metanephric glomerular endothelium development), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0016174](http://purl.obolibrary.org/obo/GO_0016174) (NAD(P)H oxidase activity), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0060290](http://purl.obolibrary.org/obo/GO_0060290) (transdifferentiation), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0031798](http://purl.obolibrary.org/obo/GO_0031798) (type 1 metabotropic glutamate receptor binding), [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette), [GO:0001906](http://purl.obolibrary.org/obo/GO_0001906) (cell killing), [GO:0004190](http://purl.obolibrary.org/obo/GO_0004190) (aspartic-type endopeptidase activity), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0004197](http://purl.obolibrary.org/obo/GO_0004197) (cysteine-type endopeptidase activity), [GO:0004198](http://purl.obolibrary.org/obo/GO_0004198) (calcium-dependent cysteine-type endopeptidase activity), [GO:0060279](http://purl.obolibrary.org/obo/GO_0060279) (positive regulation of ovulation), [GO:0097582](http://purl.obolibrary.org/obo/GO_0097582) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex), [GO:0072255](http://purl.obolibrary.org/obo/GO_0072255) (metanephric glomerular mesangial cell development), [GO:0001913](http://purl.obolibrary.org/obo/GO_0001913) (T cell mediated cytotoxicity), [GO:0031783](http://purl.obolibrary.org/obo/GO_0031783) (type 5 melanocortin receptor binding), [GO:0016165](http://purl.obolibrary.org/obo/GO_0016165) (linoleate 13S-lipoxygenase activity), [GO:0031781](http://purl.obolibrary.org/obo/GO_0031781) (type 3 melanocortin receptor binding), [GO:0001915](http://purl.obolibrary.org/obo/GO_0001915) (negative regulation of T cell mediated cytotoxicity), [GO:0001916](http://purl.obolibrary.org/obo/GO_0001916) (positive regulation of T cell mediated cytotoxicity), [GO:0031782](http://purl.obolibrary.org/obo/GO_0031782) (type 4 melanocortin receptor binding), [GO:0001917](http://purl.obolibrary.org/obo/GO_0001917) (photoreceptor inner segment), [GO:0001918](http://purl.obolibrary.org/obo/GO_0001918) (farnesylated protein binding), [GO:0001919](http://purl.obolibrary.org/obo/GO_0001919) (regulation of receptor recycling), [GO:1901164](http://purl.obolibrary.org/obo/GO_1901164) (negative regulation of trophoblast cell migration), [GO:0031780](http://purl.obolibrary.org/obo/GO_0031780) (corticotropin hormone receptor binding), [GO:1902495](http://purl.obolibrary.org/obo/GO_1902495) (transmembrane transporter complex), [GO:1901166](http://purl.obolibrary.org/obo/GO_1901166) (neural crest cell migration involved in autonomic nervous system development), [GO:0005497](http://purl.obolibrary.org/obo/GO_0005497) (androgen binding), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0004165](http://purl.obolibrary.org/obo/GO_0004165) (dodecenoyl-CoA delta-isomerase activity), [GO:0004168](http://purl.obolibrary.org/obo/GO_0004168) (dolichol kinase activity), [GO:0004167](http://purl.obolibrary.org/obo/GO_0004167) (dopachrome isomerase activity), [GO:0004169](http://purl.obolibrary.org/obo/GO_0004169) (dolichyl-phosphate-mannose-protein mannosyltransferase activity), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0097542](http://purl.obolibrary.org/obo/GO_0097542) (ciliary tip), [GO:0030449](http://purl.obolibrary.org/obo/GO_0030449) (regulation of complement activation), [GO:0097541](http://purl.obolibrary.org/obo/GO_0097541) (axonemal basal plate), [GO:0097544](http://purl.obolibrary.org/obo/GO_0097544) (ciliary shaft), [GO:0072289](http://purl.obolibrary.org/obo/GO_0072289) (metanephric nephron tubule formation), [GO:0097543](http://purl.obolibrary.org/obo/GO_0097543) (ciliary inversin compartment), [GO:0016150](http://purl.obolibrary.org/obo/GO_0016150) (translation release factor activity, codon nonspecific), [GO:0016151](http://purl.obolibrary.org/obo/GO_0016151) (nickel cation binding), [GO:0097546](http://purl.obolibrary.org/obo/GO_0097546) (ciliary base), [GO:0031772](http://purl.obolibrary.org/obo/GO_0031772) (type 2 hypocretin receptor binding), [GO:0016153](http://purl.obolibrary.org/obo/GO_0016153) (urocanate hydratase activity), [GO:0016154](http://purl.obolibrary.org/obo/GO_0016154) (pyrimidine-nucleoside phosphorylase activity), [GO:0031773](http://purl.obolibrary.org/obo/GO_0031773) (kisspeptin receptor binding), [GO:0031771](http://purl.obolibrary.org/obo/GO_0031771) (type 1 hypocretin receptor binding), [GO:0016139](http://purl.obolibrary.org/obo/GO_0016139) (glycoside catabolic process), [GO:0060298](http://purl.obolibrary.org/obo/GO_0060298) (positive regulation of sarcomere organization), [GO:0042406](http://purl.obolibrary.org/obo/GO_0042406) (extrinsic component of endoplasmic reticulum membrane), [GO:0042407](http://purl.obolibrary.org/obo/GO_0042407) (cristae formation), [GO:0060293](http://purl.obolibrary.org/obo/GO_0060293) (germ plasm), [GO:0043739](http://purl.obolibrary.org/obo/GO_0043739) (G/U mismatch-specific uracil-DNA glycosylase activity), [GO:0060294](http://purl.obolibrary.org/obo/GO_0060294) (cilium movement involved in cell motility), [GO:0004170](http://purl.obolibrary.org/obo/GO_0004170) (dUTP diphosphatase activity), [GO:0060296](http://purl.obolibrary.org/obo/GO_0060296) (regulation of cilium beat frequency involved in ciliary motility), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0004174](http://purl.obolibrary.org/obo/GO_0004174) (electron-transferring-flavoprotein dehydrogenase activity), [GO:0004177](http://purl.obolibrary.org/obo/GO_0004177) (aminopeptidase activity), [GO:0004176](http://purl.obolibrary.org/obo/GO_0004176) (ATP-dependent peptidase activity), [GO:0042402](http://purl.obolibrary.org/obo/GO_0042402) (cellular biogenic amine catabolic process), [GO:0043734](http://purl.obolibrary.org/obo/GO_0043734) (DNA-N1-methyladenine dioxygenase activity), [GO:0042403](http://purl.obolibrary.org/obo/GO_0042403) (thyroid hormone metabolic process), [GO:0030437](http://purl.obolibrary.org/obo/GO_0030437) (ascospore formation), [GO:0097550](http://purl.obolibrary.org/obo/GO_0097550) (transcriptional preinitiation complex), [GO:0097553](http://purl.obolibrary.org/obo/GO_0097553) (calcium ion transmembrane import into cytosol), [GO:0072273](http://purl.obolibrary.org/obo/GO_0072273) (metanephric nephron morphogenesis), [GO:0031768](http://purl.obolibrary.org/obo/GO_0031768) (ghrelin receptor binding), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0030431](http://purl.obolibrary.org/obo/GO_0030431) (sleep), [GO:0030433](http://purl.obolibrary.org/obo/GO_0030433) (ubiquitin-dependent ERAD pathway), [GO:0030432](http://purl.obolibrary.org/obo/GO_0030432) (peristalsis), [GO:0030435](http://purl.obolibrary.org/obo/GO_0030435) (sporulation resulting in formation of a cellular spore), [GO:0001820](http://purl.obolibrary.org/obo/GO_0001820) (serotonin secretion), [GO:0001821](http://purl.obolibrary.org/obo/GO_0001821) (histamine secretion), [GO:0016094](http://purl.obolibrary.org/obo/GO_0016094) (polyprenol biosynthetic process), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0042382](http://purl.obolibrary.org/obo/GO_0042382) (paraspeckles), [GO:0016095](http://purl.obolibrary.org/obo/GO_0016095) (polyprenol catabolic process), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0001823](http://purl.obolibrary.org/obo/GO_0001823) (mesonephros development), [GO:0001824](http://purl.obolibrary.org/obo/GO_0001824) (blastocyst development), [GO:0001825](http://purl.obolibrary.org/obo/GO_0001825) (blastocyst formation), [GO:0001826](http://purl.obolibrary.org/obo/GO_0001826) (inner cell mass cell differentiation), [GO:0001829](http://purl.obolibrary.org/obo/GO_0001829) (trophectodermal cell differentiation), [GO:0030388](http://purl.obolibrary.org/obo/GO_0030388) (fructose 1,6-bisphosphate metabolic process), [GO:0065004](http://purl.obolibrary.org/obo/GO_0065004) (protein-DNA complex assembly), [GO:0000506](http://purl.obolibrary.org/obo/GO_0000506) (glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex), [GO:0065001](http://purl.obolibrary.org/obo/GO_0065001) (specification of axis polarity), [GO:0065002](http://purl.obolibrary.org/obo/GO_0065002) (intracellular protein transmembrane transport), [GO:0000502](http://purl.obolibrary.org/obo/GO_0000502) (proteasome complex), [GO:0000500](http://purl.obolibrary.org/obo/GO_0000500) (RNA polymerase I upstream activating factor complex), [GO:0016080](http://purl.obolibrary.org/obo/GO_0016080) (synaptic vesicle targeting), [GO:0042391](http://purl.obolibrary.org/obo/GO_0042391) (regulation of membrane potential), [GO:0016082](http://purl.obolibrary.org/obo/GO_0016082) (synaptic vesicle priming), [GO:0001831](http://purl.obolibrary.org/obo/GO_0001831) (trophectodermal cellular morphogenesis), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0042393](http://purl.obolibrary.org/obo/GO_0042393) (histone binding), [GO:0001835](http://purl.obolibrary.org/obo/GO_0001835) (blastocyst hatching), [GO:0065010](http://purl.obolibrary.org/obo/GO_0065010) (extracellular membrane-bounded organelle), [GO:0030374](http://purl.obolibrary.org/obo/GO_0030374) (ligand-dependent nuclear receptor transcription coactivator activity), [GO:0001836](http://purl.obolibrary.org/obo/GO_0001836) (release of cytochrome c from mitochondria), [GO:0001837](http://purl.obolibrary.org/obo/GO_0001837) (epithelial to mesenchymal transition), [GO:0001838](http://purl.obolibrary.org/obo/GO_0001838) (embryonic epithelial tube formation), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0004081](http://purl.obolibrary.org/obo/GO_0004081) (bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity), [GO:0004080](http://purl.obolibrary.org/obo/GO_0004080) (biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity), [GO:0004082](http://purl.obolibrary.org/obo/GO_0004082) (bisphosphoglycerate mutase activity), [GO:0004085](http://purl.obolibrary.org/obo/GO_0004085) (butyryl-CoA dehydrogenase activity), [GO:0030371](http://purl.obolibrary.org/obo/GO_0030371) (translation repressor activity), [GO:0004087](http://purl.obolibrary.org/obo/GO_0004087) (carbamoyl-phosphate synthase (ammonia) activity), [GO:0004089](http://purl.obolibrary.org/obo/GO_0004089) (carbonate dehydratase activity), [GO:0004088](http://purl.obolibrary.org/obo/GO_0004088) (carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity), [GO:0016070](http://purl.obolibrary.org/obo/GO_0016070) (RNA metabolic process), [GO:0016075](http://purl.obolibrary.org/obo/GO_0016075) (rRNA catabolic process), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0016079](http://purl.obolibrary.org/obo/GO_0016079) (synaptic vesicle exocytosis), [GO:0030366](http://purl.obolibrary.org/obo/GO_0030366) (molybdopterin synthase activity), [GO:0030368](http://purl.obolibrary.org/obo/GO_0030368) (interleukin-17 receptor activity), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0004096](http://purl.obolibrary.org/obo/GO_0004096) (catalase activity), [GO:0004095](http://purl.obolibrary.org/obo/GO_0004095) (carnitine O-palmitoyltransferase activity), [GO:0004098](http://purl.obolibrary.org/obo/GO_0004098) (cerebroside-sulfatase activity), [GO:0004097](http://purl.obolibrary.org/obo/GO_0004097) (catechol oxidase activity), [GO:0001811](http://purl.obolibrary.org/obo/GO_0001811) (negative regulation of type I hypersensitivity), [GO:0016062](http://purl.obolibrary.org/obo/GO_0016062) (adaptation of rhodopsin mediated signaling), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0030352](http://purl.obolibrary.org/obo/GO_0030352) (inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity), [GO:0031685](http://purl.obolibrary.org/obo/GO_0031685) (adenosine receptor binding), [GO:0030351](http://purl.obolibrary.org/obo/GO_0030351) (inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001817](http://purl.obolibrary.org/obo/GO_0001817) (regulation of cytokine production), [GO:0001818](http://purl.obolibrary.org/obo/GO_0001818) (negative regulation of cytokine production), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:0001865](http://purl.obolibrary.org/obo/GO_0001865) (NK T cell differentiation), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0001869](http://purl.obolibrary.org/obo/GO_0001869) (negative regulation of complement activation, lectin pathway), [GO:0012510](http://purl.obolibrary.org/obo/GO_0012510) (trans-Golgi network transport vesicle membrane), [GO:0042346](http://purl.obolibrary.org/obo/GO_0042346) (positive regulation of NF-kappaB import into nucleus), [GO:0001880](http://purl.obolibrary.org/obo/GO_0001880) (Mullerian duct regression), [GO:0043679](http://purl.obolibrary.org/obo/GO_0043679) (axon terminus), [GO:0001881](http://purl.obolibrary.org/obo/GO_0001881) (receptor recycling), [GO:0042347](http://purl.obolibrary.org/obo/GO_0042347) (negative regulation of NF-kappaB import into nucleus), [GO:0001882](http://purl.obolibrary.org/obo/GO_0001882) (nucleoside binding), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0043686](http://purl.obolibrary.org/obo/GO_0043686) (co-translational protein modification), [GO:0043687](http://purl.obolibrary.org/obo/GO_0043687) (post-translational protein modification), [GO:0042359](http://purl.obolibrary.org/obo/GO_0042359) (vitamin D metabolic process), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001842](http://purl.obolibrary.org/obo/GO_0001842) (neural fold formation), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0042360](http://purl.obolibrary.org/obo/GO_0042360) (vitamin E metabolic process), [GO:0001845](http://purl.obolibrary.org/obo/GO_0001845) (phagolysosome assembly), [GO:0001846](http://purl.obolibrary.org/obo/GO_0001846) (opsonin binding), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0001849](http://purl.obolibrary.org/obo/GO_0001849) (complement component C1q binding), [GO:0043697](http://purl.obolibrary.org/obo/GO_0043697) (cell dedifferentiation), [GO:0042369](http://purl.obolibrary.org/obo/GO_0042369) (vitamin D catabolic process), [GO:0001851](http://purl.obolibrary.org/obo/GO_0001851) (complement component C3b binding), [GO:0042371](http://purl.obolibrary.org/obo/GO_0042371) (vitamin K biosynthetic process), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0012505](http://purl.obolibrary.org/obo/GO_0012505) (endomembrane system), [GO:0012501](http://purl.obolibrary.org/obo/GO_0012501) (programmed cell death), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0048513](http://purl.obolibrary.org/obo/GO_0048513) (animal organ development), [GO:0000578](http://purl.obolibrary.org/obo/GO_0000578) (embryonic axis specification), [GO:0048512](http://purl.obolibrary.org/obo/GO_0048512) (circadian behavior), [GO:0090050](http://purl.obolibrary.org/obo/GO_0090050) (positive regulation of cell migration involved in sprouting angiogenesis), [GO:0090051](http://purl.obolibrary.org/obo/GO_0090051) (negative regulation of cell migration involved in sprouting angiogenesis), [GO:0048520](http://purl.obolibrary.org/obo/GO_0048520) (positive regulation of behavior), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0050833](http://purl.obolibrary.org/obo/GO_0050833) (pyruvate transmembrane transporter activity), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0036520](http://purl.obolibrary.org/obo/GO_0036520) (astrocyte-dopaminergic neuron signaling), [GO:0050849](http://purl.obolibrary.org/obo/GO_0050849) (negative regulation of calcium-mediated signaling), [GO:0048524](http://purl.obolibrary.org/obo/GO_0048524) (positive regulation of viral process), [GO:0050840](http://purl.obolibrary.org/obo/GO_0050840) (extracellular matrix binding), [GO:1990931](http://purl.obolibrary.org/obo/GO_1990931) (RNA N6-methyladenosine dioxygenase activity), [GO:0050847](http://purl.obolibrary.org/obo/GO_0050847) (progesterone receptor signaling pathway), [GO:0036515](http://purl.obolibrary.org/obo/GO_0036515) (serotonergic neuron axon guidance), [GO:0050848](http://purl.obolibrary.org/obo/GO_0050848) (regulation of calcium-mediated signaling), [GO:0036517](http://purl.obolibrary.org/obo/GO_0036517) (chemoattraction of serotonergic neuron axon), [GO:0036518](http://purl.obolibrary.org/obo/GO_0036518) (chemorepulsion of dopaminergic neuron axon), [GO:1990938](http://purl.obolibrary.org/obo/GO_1990938) (peptidyl-aspartic acid autophosphorylation), [GO:1990939](http://purl.obolibrary.org/obo/GO_1990939) (ATP-dependent microtubule motor activity), [GO:0036513](http://purl.obolibrary.org/obo/GO_0036513) (Derlin-1 retrotranslocation complex), [GO:0036514](http://purl.obolibrary.org/obo/GO_0036514) (dopaminergic neuron axon guidance), [GO:0090038](http://purl.obolibrary.org/obo/GO_0090038) (negative regulation of protein kinase C signaling), [GO:0090037](http://purl.obolibrary.org/obo/GO_0090037) (positive regulation of protein kinase C signaling), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0090030](http://purl.obolibrary.org/obo/GO_0090030) (regulation of steroid hormone biosynthetic process), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0048534](http://purl.obolibrary.org/obo/GO_0048534) (hematopoietic or lymphoid organ development), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0061511](http://purl.obolibrary.org/obo/GO_0061511) (centriole elongation), [GO:0061512](http://purl.obolibrary.org/obo/GO_0061512) (protein localization to cilium), [GO:0001891](http://purl.obolibrary.org/obo/GO_0001891) (phagocytic cup), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0048539](http://purl.obolibrary.org/obo/GO_0048539) (bone marrow development), [GO:0061513](http://purl.obolibrary.org/obo/GO_0061513) (glucose 6-phosphate:inorganic phosphate antiporter activity), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0048538](http://purl.obolibrary.org/obo/GO_0048538) (thymus development), [GO:0001883](http://purl.obolibrary.org/obo/GO_0001883) (purine nucleoside binding), [GO:0050850](http://purl.obolibrary.org/obo/GO_0050850) (positive regulation of calcium-mediated signaling), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0001887](http://purl.obolibrary.org/obo/GO_0001887) (selenium compound metabolic process), [GO:0061519](http://purl.obolibrary.org/obo/GO_0061519) (macrophage homeostasis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0048541](http://purl.obolibrary.org/obo/GO_0048541) (Peyer's patch development), [GO:0050856](http://purl.obolibrary.org/obo/GO_0050856) (regulation of T cell receptor signaling pathway), [GO:0050857](http://purl.obolibrary.org/obo/GO_0050857) (positive regulation of antigen receptor-mediated signaling pathway), [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response), [GO:1990948](http://purl.obolibrary.org/obo/GO_1990948) (ubiquitin ligase inhibitor activity), [GO:0050855](http://purl.obolibrary.org/obo/GO_0050855) (regulation of B cell receptor signaling pathway), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0036503](http://purl.obolibrary.org/obo/GO_0036503) (ERAD pathway), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0048545](http://purl.obolibrary.org/obo/GO_0048545) (response to steroid hormone), [GO:0061507](http://purl.obolibrary.org/obo/GO_0061507) (cyclic-GMP-AMP binding), [GO:1903715](http://purl.obolibrary.org/obo/GO_1903715) (regulation of aerobic respiration), [GO:0048549](http://purl.obolibrary.org/obo/GO_0048549) (positive regulation of pinocytosis), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0047220](http://purl.obolibrary.org/obo/GO_0047220) (galactosylxylosylprotein 3-beta-galactosyltransferase activity), [GO:0050862](http://purl.obolibrary.org/obo/GO_0050862) (positive regulation of T cell receptor signaling pathway), [GO:0001895](http://purl.obolibrary.org/obo/GO_0001895) (retina homeostasis), [GO:1903706](http://purl.obolibrary.org/obo/GO_1903706) (regulation of hemopoiesis), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:1903707](http://purl.obolibrary.org/obo/GO_1903707) (negative regulation of hemopoiesis), [GO:0047223](http://purl.obolibrary.org/obo/GO_0047223) (beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity), [GO:0050869](http://purl.obolibrary.org/obo/GO_0050869) (negative regulation of B cell activation), [GO:1990955](http://purl.obolibrary.org/obo/GO_1990955) (G-rich single-stranded DNA binding), [GO:0050867](http://purl.obolibrary.org/obo/GO_0050867) (positive regulation of cell activation), [GO:0050868](http://purl.obolibrary.org/obo/GO_0050868) (negative regulation of T cell activation), [GO:1990959](http://purl.obolibrary.org/obo/GO_1990959) (eosinophil homeostasis), [GO:0035242](http://purl.obolibrary.org/obo/GO_0035242) (protein-arginine omega-N asymmetric methyltransferase activity), [GO:0035243](http://purl.obolibrary.org/obo/GO_0035243) (protein-arginine omega-N symmetric methyltransferase activity), [GO:0090017](http://purl.obolibrary.org/obo/GO_0090017) (anterior neural plate formation), [GO:0035240](http://purl.obolibrary.org/obo/GO_0035240) (dopamine binding), [GO:0035241](http://purl.obolibrary.org/obo/GO_0035241) (protein-arginine omega-N monomethyltransferase activity), [GO:0090010](http://purl.obolibrary.org/obo/GO_0090010) (transforming growth factor beta receptor signaling pathway involved in primitive streak formation), [GO:1990960](http://purl.obolibrary.org/obo/GO_1990960) (basophil homeostasis), [GO:1990962](http://purl.obolibrary.org/obo/GO_1990962) (drug transport across blood-brain barrier), [GO:1990963](http://purl.obolibrary.org/obo/GO_1990963) (establishment of blood-retinal barrier), [GO:0035239](http://purl.obolibrary.org/obo/GO_0035239) (tube morphogenesis), [GO:1990966](http://purl.obolibrary.org/obo/GO_1990966) (ATP generation from poly-ADP-D-ribose), [GO:0035235](http://purl.obolibrary.org/obo/GO_0035235) (ionotropic glutamate receptor signaling pathway), [GO:0035238](http://purl.obolibrary.org/obo/GO_0035238) (vitamin A biosynthetic process), [GO:0035234](http://purl.obolibrary.org/obo/GO_0035234) (ectopic germ cell programmed cell death), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0090026](http://purl.obolibrary.org/obo/GO_0090026) (positive regulation of monocyte chemotaxis), [GO:0050805](http://purl.obolibrary.org/obo/GO_0050805) (negative regulation of synaptic transmission), [GO:0090023](http://purl.obolibrary.org/obo/GO_0090023) (positive regulation of neutrophil chemotaxis), [GO:0090024](http://purl.obolibrary.org/obo/GO_0090024) (negative regulation of neutrophil chemotaxis), [GO:0050806](http://purl.obolibrary.org/obo/GO_0050806) (positive regulation of synaptic transmission), [GO:0090022](http://purl.obolibrary.org/obo/GO_0090022) (regulation of neutrophil chemotaxis), [GO:0050803](http://purl.obolibrary.org/obo/GO_0050803) (regulation of synapse structure or activity), [GO:0050804](http://purl.obolibrary.org/obo/GO_0050804) (modulation of chemical synaptic transmission), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0048500](http://purl.obolibrary.org/obo/GO_0048500) (signal recognition particle), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0050811](http://purl.obolibrary.org/obo/GO_0050811) (GABA receptor binding), [GO:0090008](http://purl.obolibrary.org/obo/GO_0090008) (hypoblast development), [GO:0050829](http://purl.obolibrary.org/obo/GO_0050829) (defense response to Gram-negative bacterium), [GO:0048505](http://purl.obolibrary.org/obo/GO_0048505) (regulation of timing of cell differentiation), [GO:2000108](http://purl.obolibrary.org/obo/GO_2000108) (positive regulation of leukocyte apoptotic process), [GO:2000107](http://purl.obolibrary.org/obo/GO_2000107) (negative regulation of leukocyte apoptotic process), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:2000105](http://purl.obolibrary.org/obo/GO_2000105) (positive regulation of DNA-dependent DNA replication), [GO:0090009](http://purl.obolibrary.org/obo/GO_0090009) (primitive streak formation), [GO:0050820](http://purl.obolibrary.org/obo/GO_0050820) (positive regulation of coagulation), [GO:0036257](http://purl.obolibrary.org/obo/GO_0036257) (multivesicular body organization), [GO:0036250](http://purl.obolibrary.org/obo/GO_0036250) (peroxisome transport along microtubule), [GO:1904970](http://purl.obolibrary.org/obo/GO_1904970) (brush border assembly), [GO:0048239](http://purl.obolibrary.org/obo/GO_0048239) (negative regulation of DNA recombination at telomere), [GO:0048237](http://purl.obolibrary.org/obo/GO_0048237) (rough endoplasmic reticulum lumen), [GO:1903644](http://purl.obolibrary.org/obo/GO_1903644) (regulation of chaperone-mediated protein folding), [GO:0051885](http://purl.obolibrary.org/obo/GO_0051885) (positive regulation of timing of anagen), [GO:0048240](http://purl.obolibrary.org/obo/GO_0048240) (sperm capacitation), [GO:0051880](http://purl.obolibrary.org/obo/GO_0051880) (G-quadruplex DNA binding), [GO:0048247](http://purl.obolibrary.org/obo/GO_0048247) (lymphocyte chemotaxis), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0051881](http://purl.obolibrary.org/obo/GO_0051881) (regulation of mitochondrial membrane potential), [GO:0048244](http://purl.obolibrary.org/obo/GO_0048244) (phytanoyl-CoA dioxygenase activity), [GO:2000355](http://purl.obolibrary.org/obo/GO_2000355) (negative regulation of ovarian follicle development), [GO:2000354](http://purl.obolibrary.org/obo/GO_2000354) (regulation of ovarian follicle development), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:2000358](http://purl.obolibrary.org/obo/GO_2000358) (positive regulation of kidney smooth muscle cell differentiation), [GO:2000357](http://purl.obolibrary.org/obo/GO_2000357) (negative regulation of kidney smooth muscle cell differentiation), [GO:1904983](http://purl.obolibrary.org/obo/GO_1904983) (glycine import into mitochondrion), [GO:0061205](http://purl.obolibrary.org/obo/GO_0061205) (paramesonephric duct development), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0051893](http://purl.obolibrary.org/obo/GO_0051893) (regulation of focal adhesion assembly), [GO:0051894](http://purl.obolibrary.org/obo/GO_0051894) (positive regulation of focal adhesion assembly), [GO:0048251](http://purl.obolibrary.org/obo/GO_0048251) (elastic fiber assembly), [GO:0051891](http://purl.obolibrary.org/obo/GO_0051891) (positive regulation of cardioblast differentiation), [GO:0050560](http://purl.obolibrary.org/obo/GO_0050560) (aspartate-tRNA(Asn) ligase activity), [GO:0048257](http://purl.obolibrary.org/obo/GO_0048257) (3'-flap endonuclease activity), [GO:0050561](http://purl.obolibrary.org/obo/GO_0050561) (glutamate-tRNA(Gln) ligase activity), [GO:0048255](http://purl.obolibrary.org/obo/GO_0048255) (mRNA stabilization), [GO:2000366](http://purl.obolibrary.org/obo/GO_2000366) (positive regulation of STAT protein import into nucleus), [GO:0098506](http://purl.obolibrary.org/obo/GO_0098506) (polynucleotide 3' dephosphorylation), [GO:0098504](http://purl.obolibrary.org/obo/GO_0098504) (DNA 3' dephosphorylation involved in DNA repair), [GO:2000363](http://purl.obolibrary.org/obo/GO_2000363) (positive regulation of prostaglandin-E synthase activity), [GO:0098505](http://purl.obolibrary.org/obo/GO_0098505) (G-rich strand telomeric DNA binding), [GO:0051899](http://purl.obolibrary.org/obo/GO_0051899) (membrane depolarization), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0098508](http://purl.obolibrary.org/obo/GO_0098508) (endothelial to hematopoietic transition), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0036233](http://purl.obolibrary.org/obo/GO_0036233) (glycine import), [GO:2000381](http://purl.obolibrary.org/obo/GO_2000381) (negative regulation of mesoderm development), [GO:1902336](http://purl.obolibrary.org/obo/GO_1902336) (positive regulation of retinal ganglion cell axon guidance), [GO:1901006](http://purl.obolibrary.org/obo/GO_1901006) (ubiquinone-6 biosynthetic process), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:0000278](http://purl.obolibrary.org/obo/GO_0000278) (mitotic cell cycle), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0048265](http://purl.obolibrary.org/obo/GO_0048265) (response to pain), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0048263](http://purl.obolibrary.org/obo/GO_0048263) (determination of dorsal identity), [GO:0000285](http://purl.obolibrary.org/obo/GO_0000285) (1-phosphatidylinositol-3-phosphate 5-kinase activity), [GO:0048262](http://purl.obolibrary.org/obo/GO_0048262) (determination of dorsal/ventral asymmetry), [GO:0048268](http://purl.obolibrary.org/obo/GO_0048268) (clathrin coat assembly), [GO:0000282](http://purl.obolibrary.org/obo/GO_0000282) (cellular bud site selection), [GO:0000281](http://purl.obolibrary.org/obo/GO_0000281) (mitotic cytokinesis), [GO:0048266](http://purl.obolibrary.org/obo/GO_0048266) (behavioral response to pain), [GO:0000280](http://purl.obolibrary.org/obo/GO_0000280) (nuclear division), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0048261](http://purl.obolibrary.org/obo/GO_0048261) (negative regulation of receptor-mediated endocytosis), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0036228](http://purl.obolibrary.org/obo/GO_0036228) (protein localization to nuclear inner membrane), [GO:1903670](http://purl.obolibrary.org/obo/GO_1903670) (regulation of sprouting angiogenesis), [GO:2000391](http://purl.obolibrary.org/obo/GO_2000391) (positive regulation of neutrophil extravasation), [GO:0036221](http://purl.obolibrary.org/obo/GO_0036221) (UTP diphosphatase activity), [GO:0036222](http://purl.obolibrary.org/obo/GO_0036222) (XTP diphosphatase activity), [GO:2000394](http://purl.obolibrary.org/obo/GO_2000394) (positive regulation of lamellipodium morphogenesis), [GO:1903672](http://purl.obolibrary.org/obo/GO_1903672) (positive regulation of sprouting angiogenesis), [GO:0036220](http://purl.obolibrary.org/obo/GO_0036220) (ITP diphosphatase activity), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:1901016](http://purl.obolibrary.org/obo/GO_1901016) (regulation of potassium ion transmembrane transporter activity), [GO:0000289](http://purl.obolibrary.org/obo/GO_0000289) (nuclear-transcribed mRNA poly(A) tail shortening), [GO:0000288](http://purl.obolibrary.org/obo/GO_0000288) (nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0000294](http://purl.obolibrary.org/obo/GO_0000294) (nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay), [GO:0000293](http://purl.obolibrary.org/obo/GO_0000293) (ferric-chelate reductase activity), [GO:0048278](http://purl.obolibrary.org/obo/GO_0048278) (vesicle docking), [GO:0000291](http://purl.obolibrary.org/obo/GO_0000291) (nuclear-transcribed mRNA catabolic process, exonucleolytic), [GO:0036218](http://purl.obolibrary.org/obo/GO_0036218) (dTTP diphosphatase activity), [GO:0036219](http://purl.obolibrary.org/obo/GO_0036219) (GTP diphosphatase activity), [GO:2000386](http://purl.obolibrary.org/obo/GO_2000386) (positive regulation of ovarian follicle development), [GO:0036217](http://purl.obolibrary.org/obo/GO_0036217) (dGTP diphosphatase activity), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0036295](http://purl.obolibrary.org/obo/GO_0036295) (cellular response to increased oxygen levels), [GO:0036297](http://purl.obolibrary.org/obo/GO_0036297) (interstrand cross-link repair), [GO:1904937](http://purl.obolibrary.org/obo/GO_1904937) (sensory neuron migration), [GO:0006402](http://purl.obolibrary.org/obo/GO_0006402) (mRNA catabolic process), [GO:0006403](http://purl.obolibrary.org/obo/GO_0006403) (RNA localization), [GO:1904935](http://purl.obolibrary.org/obo/GO_1904935) (positive regulation of cell proliferation in midbrain), [GO:0006400](http://purl.obolibrary.org/obo/GO_0006400) (tRNA modification), [GO:1904934](http://purl.obolibrary.org/obo/GO_1904934) (negative regulation of cell proliferation in midbrain), [GO:0006401](http://purl.obolibrary.org/obo/GO_0006401) (RNA catabolic process), [GO:0050510](http://purl.obolibrary.org/obo/GO_0050510) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity), [GO:0050518](http://purl.obolibrary.org/obo/GO_0050518) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity), [GO:2000397](http://purl.obolibrary.org/obo/GO_2000397) (positive regulation of ubiquitin-dependent endocytosis), [GO:0019722](http://purl.obolibrary.org/obo/GO_0019722) (calcium-mediated signaling), [GO:0019724](http://purl.obolibrary.org/obo/GO_0019724) (B cell mediated immunity), [GO:0019706](http://purl.obolibrary.org/obo/GO_0019706) (protein-cysteine S-palmitoyltransferase activity), [GO:0036289](http://purl.obolibrary.org/obo/GO_0036289) (peptidyl-serine autophosphorylation), [GO:1904948](http://purl.obolibrary.org/obo/GO_1904948) (midbrain dopaminergic neuron differentiation), [GO:0006413](http://purl.obolibrary.org/obo/GO_0006413) (translational initiation), [GO:0006414](http://purl.obolibrary.org/obo/GO_0006414) (translational elongation), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0048208](http://purl.obolibrary.org/obo/GO_0048208) (COPII vesicle coating), [GO:0006406](http://purl.obolibrary.org/obo/GO_0006406) (mRNA export from nucleus), [GO:0006407](http://purl.obolibrary.org/obo/GO_0006407) (rRNA export from nucleus), [GO:0006405](http://purl.obolibrary.org/obo/GO_0006405) (RNA export from nucleus), [GO:1904938](http://purl.obolibrary.org/obo/GO_1904938) (planar cell polarity pathway involved in axon guidance), [GO:0048213](http://purl.obolibrary.org/obo/GO_0048213) (Golgi vesicle prefusion complex stabilization), [GO:1990909](http://purl.obolibrary.org/obo/GO_1990909) (Wnt signalosome), [GO:0036275](http://purl.obolibrary.org/obo/GO_0036275) (response to 5-fluorouracil), [GO:1904954](http://purl.obolibrary.org/obo/GO_1904954) (canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation), [GO:1904953](http://purl.obolibrary.org/obo/GO_1904953) (Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation), [GO:1903621](http://purl.obolibrary.org/obo/GO_1903621) (protein localization to photoreceptor connecting cilium), [GO:1904959](http://purl.obolibrary.org/obo/GO_1904959) (regulation of cytochrome-c oxidase activity), [GO:0048219](http://purl.obolibrary.org/obo/GO_0048219) (inter-Golgi cisterna vesicle-mediated transport), [GO:1904949](http://purl.obolibrary.org/obo/GO_1904949) (ATPase complex), [GO:0036269](http://purl.obolibrary.org/obo/GO_0036269) (swimming behavior), [GO:1990904](http://purl.obolibrary.org/obo/GO_1990904) (ribonucleoprotein complex), [GO:0051864](http://purl.obolibrary.org/obo/GO_0051864) (histone demethylase activity (H3-K36 specific)), [GO:0019702](http://purl.obolibrary.org/obo/GO_0019702) (protein-arginine N5-methyltransferase activity), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:1990907](http://purl.obolibrary.org/obo/GO_1990907) (beta-catenin-TCF complex), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:1902303](http://purl.obolibrary.org/obo/GO_1902303) (negative regulation of potassium ion export), [GO:1902304](http://purl.obolibrary.org/obo/GO_1902304) (positive regulation of potassium ion export), [GO:1902305](http://purl.obolibrary.org/obo/GO_1902305) (regulation of sodium ion transmembrane transport), [GO:0051871](http://purl.obolibrary.org/obo/GO_0051871) (dihydrofolic acid binding), [GO:0051870](http://purl.obolibrary.org/obo/GO_0051870) (methotrexate binding), [GO:0051879](http://purl.obolibrary.org/obo/GO_0051879) (Hsp90 protein binding), [GO:0051877](http://purl.obolibrary.org/obo/GO_0051877) (pigment granule aggregation in cell center), [GO:0051878](http://purl.obolibrary.org/obo/GO_0051878) (lateral element assembly), [GO:0051875](http://purl.obolibrary.org/obo/GO_0051875) (pigment granule localization), [GO:0050544](http://purl.obolibrary.org/obo/GO_0050544) (arachidonic acid binding), [GO:1990918](http://purl.obolibrary.org/obo/GO_1990918) (double-strand break repair involved in meiotic recombination), [GO:0051876](http://purl.obolibrary.org/obo/GO_0051876) (pigment granule dispersal), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:1902394](http://purl.obolibrary.org/obo/GO_1902394) (positive regulation of exodeoxyribonuclease activity), [GO:0061299](http://purl.obolibrary.org/obo/GO_0061299) (retina vasculature morphogenesis in camera-type eye), [GO:0061296](http://purl.obolibrary.org/obo/GO_0061296) (negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis), [GO:0005110](http://purl.obolibrary.org/obo/GO_0005110) (frizzled-2 binding), [GO:0005112](http://purl.obolibrary.org/obo/GO_0005112) (Notch binding), [GO:0005111](http://purl.obolibrary.org/obo/GO_0005111) (type 2 fibroblast growth factor receptor binding), [GO:0006446](http://purl.obolibrary.org/obo/GO_0006446) (regulation of translational initiation), [GO:0097250](http://purl.obolibrary.org/obo/GO_0097250) (mitochondrial respiratory chain supercomplex assembly), [GO:0005114](http://purl.obolibrary.org/obo/GO_0005114) (type II transforming growth factor beta receptor binding), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0005115](http://purl.obolibrary.org/obo/GO_0005115) (receptor tyrosine kinase-like orphan receptor binding), [GO:0032727](http://purl.obolibrary.org/obo/GO_0032727) (positive regulation of interferon-alpha production), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0005109](http://purl.obolibrary.org/obo/GO_0005109) (frizzled binding), [GO:0006437](http://purl.obolibrary.org/obo/GO_0006437) (tyrosyl-tRNA aminoacylation), [GO:0098574](http://purl.obolibrary.org/obo/GO_0098574) (cytoplasmic side of lysosomal membrane), [GO:0006438](http://purl.obolibrary.org/obo/GO_0006438) (valyl-tRNA aminoacylation), [GO:0032725](http://purl.obolibrary.org/obo/GO_0032725) (positive regulation of granulocyte macrophage colony-stimulating factor production), [GO:0032728](http://purl.obolibrary.org/obo/GO_0032728) (positive regulation of interferon-beta production), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0017101](http://purl.obolibrary.org/obo/GO_0017101) (aminoacyl-tRNA synthetase multienzyme complex), [GO:0017102](http://purl.obolibrary.org/obo/GO_0017102) (methionyl glutamyl tRNA synthetase complex), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019767](http://purl.obolibrary.org/obo/GO_0019767) (IgE receptor activity), [GO:0006450](http://purl.obolibrary.org/obo/GO_0006450) (regulation of translational fidelity), [GO:0005121](http://purl.obolibrary.org/obo/GO_0005121) (Toll binding), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0006457](http://purl.obolibrary.org/obo/GO_0006457) (protein folding), [GO:0006458](http://purl.obolibrary.org/obo/GO_0006458) ('de novo' protein folding), [GO:0044721](http://purl.obolibrary.org/obo/GO_0044721) (protein import into peroxisome matrix, substrate release), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0098586](http://purl.obolibrary.org/obo/GO_0098586) (cellular response to virus), [GO:0032713](http://purl.obolibrary.org/obo/GO_0032713) (negative regulation of interleukin-4 production), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0006449](http://purl.obolibrary.org/obo/GO_0006449) (regulation of translational termination), [GO:0032714](http://purl.obolibrary.org/obo/GO_0032714) (negative regulation of interleukin-5 production), [GO:0061290](http://purl.obolibrary.org/obo/GO_0061290) (canonical Wnt signaling pathway involved in metanephric kidney development), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0018406](http://purl.obolibrary.org/obo/GO_0018406) (protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan), [GO:0043405](http://purl.obolibrary.org/obo/GO_0043405) (regulation of MAP kinase activity), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:1901086](http://purl.obolibrary.org/obo/GO_1901086) (benzylpenicillin metabolic process), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0043409](http://purl.obolibrary.org/obo/GO_0043409) (negative regulation of MAPK cascade), [GO:0006420](http://purl.obolibrary.org/obo/GO_0006420) (arginyl-tRNA aminoacylation), [GO:0006421](http://purl.obolibrary.org/obo/GO_0006421) (asparaginyl-tRNA aminoacylation), [GO:0098560](http://purl.obolibrary.org/obo/GO_0098560) (cytoplasmic side of late endosome membrane), [GO:0006424](http://purl.obolibrary.org/obo/GO_0006424) (glutamyl-tRNA aminoacylation), [GO:0043402](http://purl.obolibrary.org/obo/GO_0043402) (glucocorticoid mediated signaling pathway), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0006425](http://purl.obolibrary.org/obo/GO_0006425) (glutaminyl-tRNA aminoacylation), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0006423](http://purl.obolibrary.org/obo/GO_0006423) (cysteinyl-tRNA aminoacylation), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0006418](http://purl.obolibrary.org/obo/GO_0006418) (tRNA aminoacylation for protein translation), [GO:0006415](http://purl.obolibrary.org/obo/GO_0006415) (translational termination), [GO:0032703](http://purl.obolibrary.org/obo/GO_0032703) (negative regulation of interleukin-2 production), [GO:0097222](http://purl.obolibrary.org/obo/GO_0097222) (mitochondrial mRNA polyadenylation), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0006419](http://purl.obolibrary.org/obo/GO_0006419) (alanyl-tRNA aminoacylation), [GO:0097227](http://purl.obolibrary.org/obo/GO_0097227) (sperm annulus), [GO:0098556](http://purl.obolibrary.org/obo/GO_0098556) (cytoplasmic side of rough endoplasmic reticulum membrane), [GO:0097228](http://purl.obolibrary.org/obo/GO_0097228) (sperm principal piece), [GO:0098559](http://purl.obolibrary.org/obo/GO_0098559) (cytoplasmic side of early endosome membrane), [GO:0032700](http://purl.obolibrary.org/obo/GO_0032700) (negative regulation of interleukin-17 production), [GO:1901094](http://purl.obolibrary.org/obo/GO_1901094) (negative regulation of protein homotetramerization), [GO:0019725](http://purl.obolibrary.org/obo/GO_0019725) (cellular homeostasis), [GO:1901097](http://purl.obolibrary.org/obo/GO_1901097) (negative regulation of autophagosome maturation), [GO:0043418](http://purl.obolibrary.org/obo/GO_0043418) (homocysteine catabolic process), [GO:1901098](http://purl.obolibrary.org/obo/GO_1901098) (positive regulation of autophagosome maturation), [GO:0006431](http://purl.obolibrary.org/obo/GO_0006431) (methionyl-tRNA aminoacylation), [GO:0006432](http://purl.obolibrary.org/obo/GO_0006432) (phenylalanyl-tRNA aminoacylation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0006430](http://purl.obolibrary.org/obo/GO_0006430) (lysyl-tRNA aminoacylation), [GO:0006435](http://purl.obolibrary.org/obo/GO_0006435) (threonyl-tRNA aminoacylation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0005105](http://purl.obolibrary.org/obo/GO_0005105) (type 1 fibroblast growth factor receptor binding), [GO:0097241](http://purl.obolibrary.org/obo/GO_0097241) (hematopoietic stem cell migration to bone marrow), [GO:0005104](http://purl.obolibrary.org/obo/GO_0005104) (fibroblast growth factor receptor binding), [GO:0006434](http://purl.obolibrary.org/obo/GO_0006434) (seryl-tRNA aminoacylation), [GO:0006428](http://purl.obolibrary.org/obo/GO_0006428) (isoleucyl-tRNA aminoacylation), [GO:0006429](http://purl.obolibrary.org/obo/GO_0006429) (leucyl-tRNA aminoacylation), [GO:0006426](http://purl.obolibrary.org/obo/GO_0006426) (glycyl-tRNA aminoacylation), [GO:0006427](http://purl.obolibrary.org/obo/GO_0006427) (histidyl-tRNA aminoacylation), [GO:0097233](http://purl.obolibrary.org/obo/GO_0097233) (alveolar lamellar body membrane), [GO:0097236](http://purl.obolibrary.org/obo/GO_0097236) (positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0097235](http://purl.obolibrary.org/obo/GO_0097235) (positive regulation of fatty acid beta-oxidation by positive regulation of transcription from RNA polymerase II promoter), [GO:0019731](http://purl.obolibrary.org/obo/GO_0019731) (antibacterial humoral response), [GO:0018400](http://purl.obolibrary.org/obo/GO_0018400) (peptidyl-proline hydroxylation to 3-hydroxy-L-proline), [GO:0018401](http://purl.obolibrary.org/obo/GO_0018401) (peptidyl-proline hydroxylation to 4-hydroxy-L-proline), [GO:0006482](http://purl.obolibrary.org/obo/GO_0006482) (protein demethylation), [GO:0032770](http://purl.obolibrary.org/obo/GO_0032770) (positive regulation of monooxygenase activity), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:1902358](http://purl.obolibrary.org/obo/GO_1902358) (sulfate transmembrane transport), [GO:0005154](http://purl.obolibrary.org/obo/GO_0005154) (epidermal growth factor receptor binding), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0006488](http://purl.obolibrary.org/obo/GO_0006488) (dolichol-linked oligosaccharide biosynthetic process), [GO:0006489](http://purl.obolibrary.org/obo/GO_0006489) (dolichyl diphosphate biosynthetic process), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0097201](http://purl.obolibrary.org/obo/GO_0097201) (negative regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0097200](http://purl.obolibrary.org/obo/GO_0097200) (cysteine-type endopeptidase activity involved in execution phase of apoptosis), [GO:0048284](http://purl.obolibrary.org/obo/GO_0048284) (organelle fusion), [GO:0098535](http://purl.obolibrary.org/obo/GO_0098535) (de novo centriole assembly involved in multi-ciliated epithelial cell differentiation), [GO:0097202](http://purl.obolibrary.org/obo/GO_0097202) (activation of cysteine-type endopeptidase activity), [GO:0098536](http://purl.obolibrary.org/obo/GO_0098536) (deuterosome), [GO:0097205](http://purl.obolibrary.org/obo/GO_0097205) (renal filtration), [GO:0098534](http://purl.obolibrary.org/obo/GO_0098534) (centriole assembly), [GO:0032762](http://purl.obolibrary.org/obo/GO_0032762) (mast cell cytokine production), [GO:0031432](http://purl.obolibrary.org/obo/GO_0031432) (titin binding), [GO:0017144](http://purl.obolibrary.org/obo/GO_0017144) (drug metabolic process), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0097209](http://purl.obolibrary.org/obo/GO_0097209) (epidermal lamellar body), [GO:0030100](http://purl.obolibrary.org/obo/GO_0030100) (regulation of endocytosis), [GO:0031430](http://purl.obolibrary.org/obo/GO_0031430) (M band), [GO:0097208](http://purl.obolibrary.org/obo/GO_0097208) (alveolar lamellar body), [GO:0017146](http://purl.obolibrary.org/obo/GO_0017146) (NMDA selective glutamate receptor complex), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0031435](http://purl.obolibrary.org/obo/GO_0031435) (mitogen-activated protein kinase kinase kinase binding), [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex), [GO:0032767](http://purl.obolibrary.org/obo/GO_0032767) (copper-dependent protein binding), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0018478](http://purl.obolibrary.org/obo/GO_0018478) (malonate-semialdehyde dehydrogenase (acetylating) activity), [GO:0031433](http://purl.obolibrary.org/obo/GO_0031433) (telethonin binding), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0030104](http://purl.obolibrary.org/obo/GO_0030104) (water homeostasis), [GO:0032765](http://purl.obolibrary.org/obo/GO_0032765) (positive regulation of mast cell cytokine production), [GO:0017129](http://purl.obolibrary.org/obo/GO_0017129) (triglyceride binding), [GO:1902362](http://purl.obolibrary.org/obo/GO_1902362) (melanocyte apoptotic process), [GO:0006490](http://purl.obolibrary.org/obo/GO_0006490) (oligosaccharide-lipid intermediate biosynthetic process), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0006493](http://purl.obolibrary.org/obo/GO_0006493) (protein O-linked glycosylation), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:1902366](http://purl.obolibrary.org/obo/GO_1902366) (regulation of Notch signaling pathway involved in somitogenesis), [GO:0006497](http://purl.obolibrary.org/obo/GO_0006497) (protein lipidation), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:1902367](http://purl.obolibrary.org/obo/GO_1902367) (negative regulation of Notch signaling pathway involved in somitogenesis), [GO:0005166](http://purl.obolibrary.org/obo/GO_0005166) (neurotrophin p75 receptor binding), [GO:0005169](http://purl.obolibrary.org/obo/GO_0005169) (neurotrophin TRKB receptor binding), [GO:0048298](http://purl.obolibrary.org/obo/GO_0048298) (positive regulation of isotype switching to IgA isotypes), [GO:0098542](http://purl.obolibrary.org/obo/GO_0098542) (defense response to other organism), [GO:0031428](http://purl.obolibrary.org/obo/GO_0031428) (box C/D snoRNP complex), [GO:0031429](http://purl.obolibrary.org/obo/GO_0031429) (box H/ACA snoRNP complex), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0097211](http://purl.obolibrary.org/obo/GO_0097211) (cellular response to gonadotropin-releasing hormone), [GO:0031427](http://purl.obolibrary.org/obo/GO_0031427) (response to methotrexate), [GO:0017133](http://purl.obolibrary.org/obo/GO_0017133) (mitochondrial electron transfer flavoprotein complex), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0019797](http://purl.obolibrary.org/obo/GO_0019797) (procollagen-proline 3-dioxygenase activity), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0048294](http://purl.obolibrary.org/obo/GO_0048294) (negative regulation of isotype switching to IgE isotypes), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0031422](http://purl.obolibrary.org/obo/GO_0031422) (RecQ helicase-Topo III complex), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0017119](http://purl.obolibrary.org/obo/GO_0017119) (Golgi transport complex), [GO:1902373](http://purl.obolibrary.org/obo/GO_1902373) (negative regulation of mRNA catabolic process), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0006464](http://purl.obolibrary.org/obo/GO_0006464) (cellular protein modification process), [GO:0005131](http://purl.obolibrary.org/obo/GO_0005131) (growth hormone receptor binding), [GO:0006465](http://purl.obolibrary.org/obo/GO_0006465) (signal peptide processing), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:1902379](http://purl.obolibrary.org/obo/GO_1902379) (chemoattractant activity involved in axon guidance), [GO:0005133](http://purl.obolibrary.org/obo/GO_0005133) (interferon-gamma receptor binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0031418](http://purl.obolibrary.org/obo/GO_0031418) (L-ascorbic acid binding), [GO:0005128](http://purl.obolibrary.org/obo/GO_0005128) (erythropoietin receptor binding), [GO:0031415](http://purl.obolibrary.org/obo/GO_0031415) (NatA complex), [GO:0032747](http://purl.obolibrary.org/obo/GO_0032747) (positive regulation of interleukin-23 production), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0017121](http://purl.obolibrary.org/obo/GO_0017121) (phospholipid scrambling), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0018454](http://purl.obolibrary.org/obo/GO_0018454) (acetoacetyl-CoA reductase activity), [GO:0031413](http://purl.obolibrary.org/obo/GO_0031413) (regulation of buoyancy), [GO:0017126](http://purl.obolibrary.org/obo/GO_0017126) (nucleologenesis), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0017128](http://purl.obolibrary.org/obo/GO_0017128) (phospholipid scramblase activity), [GO:0019789](http://purl.obolibrary.org/obo/GO_0019789) (SUMO transferase activity), [GO:0032743](http://purl.obolibrary.org/obo/GO_0032743) (positive regulation of interleukin-2 production), [GO:0017108](http://purl.obolibrary.org/obo/GO_0017108) (5'-flap endonuclease activity), [GO:0017109](http://purl.obolibrary.org/obo/GO_0017109) (glutamate-cysteine ligase complex), [GO:0006471](http://purl.obolibrary.org/obo/GO_0006471) (protein ADP-ribosylation), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0005143](http://purl.obolibrary.org/obo/GO_0005143) (interleukin-12 receptor binding), [GO:0006475](http://purl.obolibrary.org/obo/GO_0006475) (internal protein amino acid acetylation), [GO:0006473](http://purl.obolibrary.org/obo/GO_0006473) (protein acetylation), [GO:0006474](http://purl.obolibrary.org/obo/GO_0006474) (N-terminal protein amino acid acetylation), [GO:0006479](http://purl.obolibrary.org/obo/GO_0006479) (protein methylation), [GO:0005149](http://purl.obolibrary.org/obo/GO_0005149) (interleukin-1 receptor binding), [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding), [GO:0031404](http://purl.obolibrary.org/obo/GO_0031404) (chloride ion binding), [GO:0032735](http://purl.obolibrary.org/obo/GO_0032735) (positive regulation of interleukin-12 production), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0019770](http://purl.obolibrary.org/obo/GO_0019770) (IgG receptor activity), [GO:0017110](http://purl.obolibrary.org/obo/GO_0017110) (nucleoside-diphosphatase activity), [GO:0098528](http://purl.obolibrary.org/obo/GO_0098528) (skeletal muscle fiber differentiation), [GO:0019772](http://purl.obolibrary.org/obo/GO_0019772) (low-affinity IgG receptor activity), [GO:0017111](http://purl.obolibrary.org/obo/GO_0017111) (nucleoside-triphosphatase activity), [GO:0017112](http://purl.obolibrary.org/obo/GO_0017112) (Rab guanyl-nucleotide exchange factor activity), [GO:0017113](http://purl.obolibrary.org/obo/GO_0017113) (dihydropyrimidine dehydrogenase (NADP+) activity), [GO:0032733](http://purl.obolibrary.org/obo/GO_0032733) (positive regulation of interleukin-10 production), [GO:0031402](http://purl.obolibrary.org/obo/GO_0031402) (sodium ion binding), [GO:0032731](http://purl.obolibrary.org/obo/GO_0032731) (positive regulation of interleukin-1 beta production), [GO:0017116](http://purl.obolibrary.org/obo/GO_0017116) (single-stranded DNA-dependent ATP-dependent DNA helicase activity), [GO:0031401](http://purl.obolibrary.org/obo/GO_0031401) (positive regulation of protein modification process), [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding), [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0032693](http://purl.obolibrary.org/obo/GO_0032693) (negative regulation of interleukin-10 production), [GO:0031362](http://purl.obolibrary.org/obo/GO_0031362) (anchored component of external side of plasma membrane), [GO:0030031](http://purl.obolibrary.org/obo/GO_0030031) (cell projection assembly), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0032691](http://purl.obolibrary.org/obo/GO_0032691) (negative regulation of interleukin-1 beta production), [GO:0005078](http://purl.obolibrary.org/obo/GO_0005078) (MAP-kinase scaffold activity), [GO:0018394](http://purl.obolibrary.org/obo/GO_0018394) (peptidyl-lysine acetylation), [GO:0018393](http://purl.obolibrary.org/obo/GO_0018393) (internal peptidyl-lysine acetylation), [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity), [GO:0017069](http://purl.obolibrary.org/obo/GO_0017069) (snRNA binding), [GO:0032689](http://purl.obolibrary.org/obo/GO_0032689) (negative regulation of interferon-gamma production), [GO:0030026](http://purl.obolibrary.org/obo/GO_0030026) (cellular manganese ion homeostasis), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0070965](http://purl.obolibrary.org/obo/GO_0070965) (positive regulation of neutrophil mediated killing of fungus), [GO:0032688](http://purl.obolibrary.org/obo/GO_0032688) (negative regulation of interferon-beta production), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0032682](http://purl.obolibrary.org/obo/GO_0032682) (negative regulation of chemokine production), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0005088](http://purl.obolibrary.org/obo/GO_0005088) (Ras guanyl-nucleotide exchange factor activity), [GO:0005089](http://purl.obolibrary.org/obo/GO_0005089) (Rho guanyl-nucleotide exchange factor activity), [GO:0042026](http://purl.obolibrary.org/obo/GO_0042026) (protein refolding), [GO:0030018](http://purl.obolibrary.org/obo/GO_0030018) (Z disc), [GO:0044690](http://purl.obolibrary.org/obo/GO_0044690) (methionine import), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0043362](http://purl.obolibrary.org/obo/GO_0043362) (nucleate erythrocyte maturation), [GO:0030011](http://purl.obolibrary.org/obo/GO_0030011) (maintenance of cell polarity), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity), [GO:0017056](http://purl.obolibrary.org/obo/GO_0017056) (structural constituent of nuclear pore), [GO:0017059](http://purl.obolibrary.org/obo/GO_0017059) (serine C-palmitoyltransferase complex), [GO:0030017](http://purl.obolibrary.org/obo/GO_0030017) (sarcomere), [GO:0031345](http://purl.obolibrary.org/obo/GO_0031345) (negative regulation of cell projection organization), [GO:0030016](http://purl.obolibrary.org/obo/GO_0030016) (myofibril), [GO:0031346](http://purl.obolibrary.org/obo/GO_0031346) (positive regulation of cell projection organization), [GO:0006383](http://purl.obolibrary.org/obo/GO_0006383) (transcription by RNA polymerase III), [GO:0031340](http://purl.obolibrary.org/obo/GO_0031340) (positive regulation of vesicle fusion), [GO:0005053](http://purl.obolibrary.org/obo/GO_0005053) (peroxisome matrix targeting signal-2 binding), [GO:0006382](http://purl.obolibrary.org/obo/GO_0006382) (adenosine to inosine editing), [GO:0005052](http://purl.obolibrary.org/obo/GO_0005052) (peroxisome matrix targeting signal-1 binding), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0005055](http://purl.obolibrary.org/obo/GO_0005055) (laminin receptor activity), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0006388](http://purl.obolibrary.org/obo/GO_0006388) (tRNA splicing, via endonucleolytic cleavage and ligation), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0042035](http://purl.obolibrary.org/obo/GO_0042035) (regulation of cytokine biosynthetic process), [GO:0043367](http://purl.obolibrary.org/obo/GO_0043367) (CD4-positive, alpha-beta T cell differentiation), [GO:0097192](http://purl.obolibrary.org/obo/GO_0097192) (extrinsic apoptotic signaling pathway in absence of ligand), [GO:0042036](http://purl.obolibrary.org/obo/GO_0042036) (negative regulation of cytokine biosynthetic process), [GO:0043369](http://purl.obolibrary.org/obo/GO_0043369) (CD4-positive or CD8-positive, alpha-beta T cell lineage commitment), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0097197](http://purl.obolibrary.org/obo/GO_0097197) (tetraspanin-enriched microdomain), [GO:0030008](http://purl.obolibrary.org/obo/GO_0030008) (TRAPP complex), [GO:0097187](http://purl.obolibrary.org/obo/GO_0097187) (dentinogenesis), [GO:0030007](http://purl.obolibrary.org/obo/GO_0030007) (cellular potassium ion homeostasis), [GO:0043370](http://purl.obolibrary.org/obo/GO_0043370) (regulation of CD4-positive, alpha-beta T cell differentiation), [GO:0031338](http://purl.obolibrary.org/obo/GO_0031338) (regulation of vesicle fusion), [GO:0031339](http://purl.obolibrary.org/obo/GO_0031339) (negative regulation of vesicle fusion), [GO:0017040](http://purl.obolibrary.org/obo/GO_0017040) (ceramidase activity), [GO:0070981](http://purl.obolibrary.org/obo/GO_0070981) (L-asparagine biosynthetic process), [GO:0043374](http://purl.obolibrary.org/obo/GO_0043374) (CD8-positive, alpha-beta T cell differentiation), [GO:0031333](http://purl.obolibrary.org/obo/GO_0031333) (negative regulation of protein complex assembly), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0033993](http://purl.obolibrary.org/obo/GO_0033993) (response to lipid), [GO:0030001](http://purl.obolibrary.org/obo/GO_0030001) (metal ion transport), [GO:0017048](http://purl.obolibrary.org/obo/GO_0017048) (Rho GTPase binding), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:0030004](http://purl.obolibrary.org/obo/GO_0030004) (cellular monovalent inorganic cation homeostasis), [GO:0030003](http://purl.obolibrary.org/obo/GO_0030003) (cellular cation homeostasis), [GO:0070989](http://purl.obolibrary.org/obo/GO_0070989) (oxidative demethylation), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:0031334](http://purl.obolibrary.org/obo/GO_0031334) (positive regulation of protein complex assembly), [GO:0070987](http://purl.obolibrary.org/obo/GO_0070987) (error-free translesion synthesis), [GO:0031335](http://purl.obolibrary.org/obo/GO_0031335) (regulation of sulfur amino acid metabolic process), [GO:0006390](http://purl.obolibrary.org/obo/GO_0006390) (mitochondrial transcription), [GO:0006391](http://purl.obolibrary.org/obo/GO_0006391) (transcription initiation from mitochondrial promoter), [GO:0042044](http://purl.obolibrary.org/obo/GO_0042044) (fluid transport), [GO:0042045](http://purl.obolibrary.org/obo/GO_0042045) (epithelial fluid transport), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0005068](http://purl.obolibrary.org/obo/GO_0005068) (transmembrane receptor protein tyrosine kinase adaptor activity), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0042048](http://purl.obolibrary.org/obo/GO_0042048) (olfactory behavior), [GO:0097199](http://purl.obolibrary.org/obo/GO_0097199) (cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0033989](http://purl.obolibrary.org/obo/GO_0033989) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity), [GO:0042051](http://purl.obolibrary.org/obo/GO_0042051) (compound eye photoreceptor development), [GO:0042053](http://purl.obolibrary.org/obo/GO_0042053) (regulation of dopamine metabolic process), [GO:0019693](http://purl.obolibrary.org/obo/GO_0019693) (ribose phosphate metabolic process), [GO:0042054](http://purl.obolibrary.org/obo/GO_0042054) (histone methyltransferase activity), [GO:0070973](http://purl.obolibrary.org/obo/GO_0070973) (protein localization to endoplasmic reticulum exit site), [GO:0031321](http://purl.obolibrary.org/obo/GO_0031321) (ascospore-type prospore assembly), [GO:0070974](http://purl.obolibrary.org/obo/GO_0070974) (POU domain binding), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0070972](http://purl.obolibrary.org/obo/GO_0070972) (protein localization to endoplasmic reticulum), [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation), [GO:0017038](http://purl.obolibrary.org/obo/GO_0017038) (protein import), [GO:0031323](http://purl.obolibrary.org/obo/GO_0031323) (regulation of cellular metabolic process), [GO:0070976](http://purl.obolibrary.org/obo/GO_0070976) (TIR domain binding), [GO:0043306](http://purl.obolibrary.org/obo/GO_0043306) (positive regulation of mast cell degranulation), [GO:0030071](http://purl.obolibrary.org/obo/GO_0030071) (regulation of mitotic metaphase/anaphase transition), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0030072](http://purl.obolibrary.org/obo/GO_0030072) (peptide hormone secretion), [GO:0045963](http://purl.obolibrary.org/obo/GO_0045963) (negative regulation of dopamine metabolic process), [GO:0043303](http://purl.obolibrary.org/obo/GO_0043303) (mast cell degranulation), [GO:0045964](http://purl.obolibrary.org/obo/GO_0045964) (positive regulation of dopamine metabolic process), [GO:0043304](http://purl.obolibrary.org/obo/GO_0043304) (regulation of mast cell degranulation), [GO:0002830](http://purl.obolibrary.org/obo/GO_0002830) (positive regulation of type 2 immune response), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0097167](http://purl.obolibrary.org/obo/GO_0097167) (circadian regulation of translation), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0014819](http://purl.obolibrary.org/obo/GO_0014819) (regulation of skeletal muscle contraction), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0014816](http://purl.obolibrary.org/obo/GO_0014816) (skeletal muscle satellite cell differentiation), [GO:0001505](http://purl.obolibrary.org/obo/GO_0001505) (regulation of neurotransmitter levels), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0002839](http://purl.obolibrary.org/obo/GO_0002839) (positive regulation of immune response to tumor cell), [GO:0001508](http://purl.obolibrary.org/obo/GO_0001508) (action potential), [GO:0014813](http://purl.obolibrary.org/obo/GO_0014813) (skeletal muscle satellite cell commitment), [GO:0031396](http://purl.obolibrary.org/obo/GO_0031396) (regulation of protein ubiquitination), [GO:0014812](http://purl.obolibrary.org/obo/GO_0014812) (muscle cell migration), [GO:0031397](http://purl.obolibrary.org/obo/GO_0031397) (negative regulation of protein ubiquitination), [GO:0031390](http://purl.obolibrary.org/obo/GO_0031390) (Ctf18 RFC-like complex), [GO:0044648](http://purl.obolibrary.org/obo/GO_0044648) (histone H3-K4 dimethylation), [GO:0070914](http://purl.obolibrary.org/obo/GO_0070914) (UV-damage excision repair), [GO:0102336](http://purl.obolibrary.org/obo/GO_0102336) (3-oxo-arachidoyl-CoA synthase activity), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0102338](http://purl.obolibrary.org/obo/GO_0102338) (3-oxo-lignoceronyl-CoA synthase activity), [GO:0102337](http://purl.obolibrary.org/obo/GO_0102337) (3-oxo-cerotoyl-CoA synthase activity), [GO:0043310](http://purl.obolibrary.org/obo/GO_0043310) (negative regulation of eosinophil degranulation), [GO:0043312](http://purl.obolibrary.org/obo/GO_0043312) (neutrophil degranulation), [GO:0045977](http://purl.obolibrary.org/obo/GO_0045977) (positive regulation of mitotic cell cycle, embryonic), [GO:0043314](http://purl.obolibrary.org/obo/GO_0043314) (negative regulation of neutrophil degranulation), [GO:0043316](http://purl.obolibrary.org/obo/GO_0043316) (cytotoxic T cell degranulation), [GO:0043315](http://purl.obolibrary.org/obo/GO_0043315) (positive regulation of neutrophil degranulation), [GO:0017091](http://purl.obolibrary.org/obo/GO_0017091) (AU-rich element binding), [GO:0097176](http://purl.obolibrary.org/obo/GO_0097176) (epoxide metabolic process), [GO:0001512](http://purl.obolibrary.org/obo/GO_0001512) (dihydronicotinamide riboside quinone reductase activity), [GO:0097178](http://purl.obolibrary.org/obo/GO_0097178) (ruffle assembly), [GO:0017095](http://purl.obolibrary.org/obo/GO_0017095) (heparan sulfate 6-O-sulfotransferase activity), [GO:0014829](http://purl.obolibrary.org/obo/GO_0014829) (vascular smooth muscle contraction), [GO:0001514](http://purl.obolibrary.org/obo/GO_0001514) (selenocysteine incorporation), [GO:0001515](http://purl.obolibrary.org/obo/GO_0001515) (opioid peptide activity), [GO:0001516](http://purl.obolibrary.org/obo/GO_0001516) (prostaglandin biosynthetic process), [GO:0001517](http://purl.obolibrary.org/obo/GO_0001517) (N-acetylglucosamine 6-O-sulfotransferase activity), [GO:0014826](http://purl.obolibrary.org/obo/GO_0014826) (vein smooth muscle contraction), [GO:0017099](http://purl.obolibrary.org/obo/GO_0017099) (very-long-chain-acyl-CoA dehydrogenase activity), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0001518](http://purl.obolibrary.org/obo/GO_0001518) (voltage-gated sodium channel complex), [GO:0030057](http://purl.obolibrary.org/obo/GO_0030057) (desmosome), [GO:0014824](http://purl.obolibrary.org/obo/GO_0014824) (artery smooth muscle contraction), [GO:0014823](http://purl.obolibrary.org/obo/GO_0014823) (response to activity), [GO:0031386](http://purl.obolibrary.org/obo/GO_0031386) (protein tag), [GO:0043328](http://purl.obolibrary.org/obo/GO_0043328) (protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:0005092](http://purl.obolibrary.org/obo/GO_0005092) (GDP-dissociation inhibitor activity), [GO:0005095](http://purl.obolibrary.org/obo/GO_0005095) (GTPase inhibitor activity), [GO:0030050](http://purl.obolibrary.org/obo/GO_0030050) (vesicle transport along actin filament), [GO:0031384](http://purl.obolibrary.org/obo/GO_0031384) (regulation of initiation of mating projection growth), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0045984](http://purl.obolibrary.org/obo/GO_0045984) (negative regulation of pyrimidine nucleobase metabolic process), [GO:0043320](http://purl.obolibrary.org/obo/GO_0043320) (natural killer cell degranulation), [GO:0043325](http://purl.obolibrary.org/obo/GO_0043325) (phosphatidylinositol-3,4-bisphosphate binding), [GO:0045988](http://purl.obolibrary.org/obo/GO_0045988) (negative regulation of striated muscle contraction), [GO:0097151](http://purl.obolibrary.org/obo/GO_0097151) (positive regulation of inhibitory postsynaptic potential), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0097153](http://purl.obolibrary.org/obo/GO_0097153) (cysteine-type endopeptidase activity involved in apoptotic process), [GO:0045986](http://purl.obolibrary.org/obo/GO_0045986) (negative regulation of smooth muscle contraction), [GO:0045987](http://purl.obolibrary.org/obo/GO_0045987) (positive regulation of smooth muscle contraction), [GO:0097152](http://purl.obolibrary.org/obo/GO_0097152) (mesenchymal cell apoptotic process), [GO:0017080](http://purl.obolibrary.org/obo/GO_0017080) (sodium channel regulator activity), [GO:0017081](http://purl.obolibrary.org/obo/GO_0017081) (chloride channel regulator activity), [GO:0017082](http://purl.obolibrary.org/obo/GO_0017082) (mineralocorticoid receptor activity), [GO:0017084](http://purl.obolibrary.org/obo/GO_0017084) (delta1-pyrroline-5-carboxylate synthetase activity), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0070940](http://purl.obolibrary.org/obo/GO_0070940) (dephosphorylation of RNA polymerase II C-terminal domain), [GO:0030043](http://purl.obolibrary.org/obo/GO_0030043) (actin filament fragmentation), [GO:0030046](http://purl.obolibrary.org/obo/GO_0030046) (parallel actin filament bundle assembly), [GO:0030048](http://purl.obolibrary.org/obo/GO_0030048) (actin filament-based movement), [GO:0002819](http://purl.obolibrary.org/obo/GO_0002819) (regulation of adaptive immune response), [GO:0030049](http://purl.obolibrary.org/obo/GO_0030049) (muscle filament sliding), [GO:0070935](http://purl.obolibrary.org/obo/GO_0070935) (3'-UTR-mediated mRNA stabilization), [GO:0070936](http://purl.obolibrary.org/obo/GO_0070936) (protein K48-linked ubiquitination), [GO:0070939](http://purl.obolibrary.org/obo/GO_0070939) (Dsl1/NZR complex), [GO:0030042](http://purl.obolibrary.org/obo/GO_0030042) (actin filament depolymerization), [GO:0030041](http://purl.obolibrary.org/obo/GO_0030041) (actin filament polymerization), [GO:0045995](http://purl.obolibrary.org/obo/GO_0045995) (regulation of embryonic development), [GO:0043332](http://purl.obolibrary.org/obo/GO_0043332) (mating projection tip), [GO:0044666](http://purl.obolibrary.org/obo/GO_0044666) (MLL3/4 complex), [GO:0043335](http://purl.obolibrary.org/obo/GO_0043335) (protein unfolding), [GO:0097155](http://purl.obolibrary.org/obo/GO_0097155) (fasciculation of sensory neuron axon), [GO:0097154](http://purl.obolibrary.org/obo/GO_0097154) (GABAergic neuron differentiation), [GO:0017070](http://purl.obolibrary.org/obo/GO_0017070) (U6 snRNA binding), [GO:0097157](http://purl.obolibrary.org/obo/GO_0097157) (pre-mRNA intronic binding), [GO:0017071](http://purl.obolibrary.org/obo/GO_0017071) (intracellular cyclic nucleotide activated cation channel complex), [GO:0002821](http://purl.obolibrary.org/obo/GO_0002821) (positive regulation of adaptive immune response), [GO:0014808](http://purl.obolibrary.org/obo/GO_0014808) (release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0097159](http://purl.obolibrary.org/obo/GO_0097159) (organic cyclic compound binding), [GO:0014807](http://purl.obolibrary.org/obo/GO_0014807) (regulation of somitogenesis), [GO:0014806](http://purl.obolibrary.org/obo/GO_0014806) (smooth muscle hyperplasia), [GO:0017075](http://purl.obolibrary.org/obo/GO_0017075) (syntaxin-1 binding), [GO:0017076](http://purl.obolibrary.org/obo/GO_0017076) (purine nucleotide binding), [GO:0030033](http://purl.obolibrary.org/obo/GO_0030033) (microvillus assembly), [GO:0017077](http://purl.obolibrary.org/obo/GO_0017077) (oxidative phosphorylation uncoupler activity), [GO:0030032](http://purl.obolibrary.org/obo/GO_0030032) (lamellipodium assembly), [GO:0002827](http://purl.obolibrary.org/obo/GO_0002827) (positive regulation of T-helper 1 type immune response), [GO:0014802](http://purl.obolibrary.org/obo/GO_0014802) (terminal cisterna), [GO:0002828](http://purl.obolibrary.org/obo/GO_0002828) (regulation of type 2 immune response), [GO:0030035](http://purl.obolibrary.org/obo/GO_0030035) (microspike assembly), [GO:0032695](http://purl.obolibrary.org/obo/GO_0032695) (negative regulation of interleukin-12 production), [GO:0002829](http://purl.obolibrary.org/obo/GO_0002829) (negative regulation of type 2 immune response), [GO:0031369](http://purl.obolibrary.org/obo/GO_0031369) (translation initiation factor binding), [GO:0030037](http://purl.obolibrary.org/obo/GO_0030037) (actin filament reorganization involved in cell cycle), [GO:0070933](http://purl.obolibrary.org/obo/GO_0070933) (histone H4 deacetylation), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0070932](http://purl.obolibrary.org/obo/GO_0070932) (histone H3 deacetylation), [GO:1990809](http://purl.obolibrary.org/obo/GO_1990809) (endoplasmic reticulum tubular network membrane organization), [GO:0014861](http://purl.obolibrary.org/obo/GO_0014861) (regulation of skeletal muscle contraction via regulation of action potential), [GO:0000217](http://purl.obolibrary.org/obo/GO_0000217) (DNA secondary structure binding), [GO:0000214](http://purl.obolibrary.org/obo/GO_0000214) (tRNA-intron endonuclease complex), [GO:0001550](http://purl.obolibrary.org/obo/GO_0001550) (ovarian cumulus expansion), [GO:0000213](http://purl.obolibrary.org/obo/GO_0000213) (tRNA-intron endonuclease activity), [GO:0002881](http://purl.obolibrary.org/obo/GO_0002881) (negative regulation of chronic inflammatory response to non-antigenic stimulus), [GO:0000212](http://purl.obolibrary.org/obo/GO_0000212) (meiotic spindle organization), [GO:0001552](http://purl.obolibrary.org/obo/GO_0001552) (ovarian follicle atresia), [GO:0000221](http://purl.obolibrary.org/obo/GO_0000221) (vacuolar proton-transporting V-type ATPase, V1 domain), [GO:0001542](http://purl.obolibrary.org/obo/GO_0001542) (ovulation from ovarian follicle), [GO:0000220](http://purl.obolibrary.org/obo/GO_0000220) (vacuolar proton-transporting V-type ATPase, V0 domain), [GO:0001543](http://purl.obolibrary.org/obo/GO_0001543) (ovarian follicle rupture), [GO:0001545](http://purl.obolibrary.org/obo/GO_0001545) (primary ovarian follicle growth), [GO:0002876](http://purl.obolibrary.org/obo/GO_0002876) (positive regulation of chronic inflammatory response to antigenic stimulus), [GO:0001546](http://purl.obolibrary.org/obo/GO_0001546) (preantral ovarian follicle growth), [GO:0001547](http://purl.obolibrary.org/obo/GO_0001547) (antral ovarian follicle growth), [GO:0014858](http://purl.obolibrary.org/obo/GO_0014858) (positive regulation of skeletal muscle cell proliferation), [GO:0014857](http://purl.obolibrary.org/obo/GO_0014857) (regulation of skeletal muscle cell proliferation), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0014853](http://purl.obolibrary.org/obo/GO_0014853) (regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction), [GO:0014873](http://purl.obolibrary.org/obo/GO_0014873) (response to muscle activity involved in regulation of muscle adaptation), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0000226](http://purl.obolibrary.org/obo/GO_0000226) (microtubule cytoskeleton organization), [GO:0000225](http://purl.obolibrary.org/obo/GO_0000225) (N-acetylglucosaminylphosphatidylinositol deacetylase activity), [GO:0001561](http://purl.obolibrary.org/obo/GO_0001561) (fatty acid alpha-oxidation), [GO:0000224](http://purl.obolibrary.org/obo/GO_0000224) (peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity), [GO:0001553](http://purl.obolibrary.org/obo/GO_0001553) (luteinization), [GO:2000406](http://purl.obolibrary.org/obo/GO_2000406) (positive regulation of T cell migration), [GO:0001555](http://purl.obolibrary.org/obo/GO_0001555) (oocyte growth), [GO:2000405](http://purl.obolibrary.org/obo/GO_2000405) (negative regulation of T cell migration), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:2000404](http://purl.obolibrary.org/obo/GO_2000404) (regulation of T cell migration), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:1990812](http://purl.obolibrary.org/obo/GO_1990812) (growth cone filopodium), [GO:0030098](http://purl.obolibrary.org/obo/GO_0030098) (lymphocyte differentiation), [GO:1990816](http://purl.obolibrary.org/obo/GO_1990816) (vacuole-mitochondrion membrane contact site), [GO:0014866](http://purl.obolibrary.org/obo/GO_0014866) (skeletal myofibril assembly), [GO:0030091](http://purl.obolibrary.org/obo/GO_0030091) (protein repair), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0001530](http://purl.obolibrary.org/obo/GO_0001530) (lipopolysaccharide binding), [GO:0002851](http://purl.obolibrary.org/obo/GO_0002851) (positive regulation of peripheral T cell tolerance induction), [GO:0001520](http://purl.obolibrary.org/obo/GO_0001520) (outer dense fiber), [GO:0001522](http://purl.obolibrary.org/obo/GO_0001522) (pseudouridine synthesis), [GO:0001523](http://purl.obolibrary.org/obo/GO_0001523) (retinoid metabolic process), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001527](http://purl.obolibrary.org/obo/GO_0001527) (microfibril), [GO:2000410](http://purl.obolibrary.org/obo/GO_2000410) (regulation of thymocyte migration), [GO:1990825](http://purl.obolibrary.org/obo/GO_1990825) (sequence-specific mRNA binding), [GO:0014835](http://purl.obolibrary.org/obo/GO_0014835) (myoblast differentiation involved in skeletal muscle regeneration), [GO:0014834](http://purl.obolibrary.org/obo/GO_0014834) (skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration), [GO:0014832](http://purl.obolibrary.org/obo/GO_0014832) (urinary bladder smooth muscle contraction), [GO:0051823](http://purl.obolibrary.org/obo/GO_0051823) (regulation of synapse structural plasticity), [GO:0014831](http://purl.obolibrary.org/obo/GO_0014831) (gastro-intestinal system smooth muscle contraction), [GO:1990829](http://purl.obolibrary.org/obo/GO_1990829) (C-rich single-stranded DNA binding), [GO:0014850](http://purl.obolibrary.org/obo/GO_0014850) (response to muscle activity), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0050508](http://purl.obolibrary.org/obo/GO_0050508) (glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity), [GO:0000208](http://purl.obolibrary.org/obo/GO_0000208) (MAPK import into nucleus involved in osmosensory signaling pathway), [GO:0050509](http://purl.obolibrary.org/obo/GO_0050509) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:1904924](http://purl.obolibrary.org/obo/GO_1904924) (negative regulation of mitophagy in response to mitochondrial depolarization), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0002862](http://purl.obolibrary.org/obo/GO_0002862) (negative regulation of inflammatory response to antigenic stimulus), [GO:2000427](http://purl.obolibrary.org/obo/GO_2000427) (positive regulation of apoptotic cell clearance), [GO:0002865](http://purl.obolibrary.org/obo/GO_0002865) (negative regulation of acute inflammatory response to antigenic stimulus), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0001537](http://purl.obolibrary.org/obo/GO_0001537) (N-acetylgalactosamine 4-O-sulfotransferase activity), [GO:1990837](http://purl.obolibrary.org/obo/GO_1990837) (sequence-specific double-stranded DNA binding), [GO:2000425](http://purl.obolibrary.org/obo/GO_2000425) (regulation of apoptotic cell clearance), [GO:0014842](http://purl.obolibrary.org/obo/GO_0014842) (regulation of skeletal muscle satellite cell proliferation), [GO:0014841](http://purl.obolibrary.org/obo/GO_0014841) (skeletal muscle satellite cell proliferation), [GO:0050501](http://purl.obolibrary.org/obo/GO_0050501) (hyaluronan synthase activity), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0042059](http://purl.obolibrary.org/obo/GO_0042059) (negative regulation of epidermal growth factor receptor signaling pathway), [GO:0000255](http://purl.obolibrary.org/obo/GO_0000255) (allantoin metabolic process), [GO:0001596](http://purl.obolibrary.org/obo/GO_0001596) (angiotensin type I receptor activity), [GO:2000439](http://purl.obolibrary.org/obo/GO_2000439) (positive regulation of monocyte extravasation), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0000262](http://purl.obolibrary.org/obo/GO_0000262) (mitochondrial chromosome), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0042063](http://purl.obolibrary.org/obo/GO_0042063) (gliogenesis), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:1990845](http://purl.obolibrary.org/obo/GO_1990845) (adaptive thermogenesis), [GO:0014898](http://purl.obolibrary.org/obo/GO_0014898) (cardiac muscle hypertrophy in response to stress), [GO:2000435](http://purl.obolibrary.org/obo/GO_2000435) (negative regulation of protein neddylation), [GO:0042069](http://purl.obolibrary.org/obo/GO_0042069) (regulation of catecholamine metabolic process), [GO:0000268](http://purl.obolibrary.org/obo/GO_0000268) (peroxisome targeting sequence binding), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0042073](http://purl.obolibrary.org/obo/GO_0042073) (intraciliary transport), [GO:0070991](http://purl.obolibrary.org/obo/GO_0070991) (medium-chain-acyl-CoA dehydrogenase activity), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:1990854](http://purl.obolibrary.org/obo/GO_1990854) (vacuole-ER tethering), [GO:0070990](http://purl.obolibrary.org/obo/GO_0070990) (snRNP binding), [GO:0070996](http://purl.obolibrary.org/obo/GO_0070996) (type 1 melanocortin receptor binding), [GO:0070997](http://purl.obolibrary.org/obo/GO_0070997) (neuron death), [GO:0014883](http://purl.obolibrary.org/obo/GO_0014883) (transition between fast and slow fiber), [GO:0014881](http://purl.obolibrary.org/obo/GO_0014881) (regulation of myofibril size), [GO:0042078](http://purl.obolibrary.org/obo/GO_0042078) (germ-line stem cell division), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0001571](http://purl.obolibrary.org/obo/GO_0001571) (non-tyrosine kinase fibroblast growth factor receptor activity), [GO:0000235](http://purl.obolibrary.org/obo/GO_0000235) (astral microtubule), [GO:0001573](http://purl.obolibrary.org/obo/GO_0001573) (ganglioside metabolic process), [GO:0000242](http://purl.obolibrary.org/obo/GO_0000242) (pericentriolar material), [GO:0001565](http://purl.obolibrary.org/obo/GO_0001565) (phorbol ester receptor activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:2000454](http://purl.obolibrary.org/obo/GO_2000454) (positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation), [GO:1990869](http://purl.obolibrary.org/obo/GO_1990869) (cellular response to chemokine), [GO:2000451](http://purl.obolibrary.org/obo/GO_2000451) (positive regulation of CD8-positive, alpha-beta T cell extravasation), [GO:0014894](http://purl.obolibrary.org/obo/GO_0014894) (response to denervation involved in regulation of muscle adaptation), [GO:0042088](http://purl.obolibrary.org/obo/GO_0042088) (T-helper 1 type immune response), [GO:0001580](http://purl.obolibrary.org/obo/GO_0001580) (detection of chemical stimulus involved in sensory perception of bitter taste), [GO:0000248](http://purl.obolibrary.org/obo/GO_0000248) (C-5 sterol desaturase activity), [GO:0000247](http://purl.obolibrary.org/obo/GO_0000247) (C-8 sterol isomerase activity), [GO:0000246](http://purl.obolibrary.org/obo/GO_0000246) (delta24(24-1) sterol reductase activity), [GO:0000245](http://purl.obolibrary.org/obo/GO_0000245) (spliceosomal complex assembly), [GO:0000244](http://purl.obolibrary.org/obo/GO_0000244) (spliceosomal tri-snRNP complex assembly), [GO:1990871](http://purl.obolibrary.org/obo/GO_1990871) (Vma12-Vma22 assembly complex), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0042093](http://purl.obolibrary.org/obo/GO_0042093) (T-helper cell differentiation), [GO:0001578](http://purl.obolibrary.org/obo/GO_0001578) (microtubule bundle formation), [GO:0001579](http://purl.obolibrary.org/obo/GO_0001579) (medium-chain fatty acid transport), [GO:0000250](http://purl.obolibrary.org/obo/GO_0000250) (lanosterol synthase activity), [GO:1990876](http://purl.obolibrary.org/obo/GO_1990876) (cytoplasmic side of nuclear pore), [GO:0042098](http://purl.obolibrary.org/obo/GO_0042098) (T cell proliferation), [GO:1990879](http://purl.obolibrary.org/obo/GO_1990879) (CST complex), [GO:2000464](http://purl.obolibrary.org/obo/GO_2000464) (positive regulation of astrocyte chemotaxis), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0014889](http://purl.obolibrary.org/obo/GO_0014889) (muscle atrophy), [GO:2000467](http://purl.obolibrary.org/obo/GO_2000467) (positive regulation of glycogen (starch) synthase activity), [GO:0036376](http://purl.obolibrary.org/obo/GO_0036376) (sodium ion export across plasma membrane), [GO:0060002](http://purl.obolibrary.org/obo/GO_0060002) (plus-end directed microfilament motor activity), [GO:0061333](http://purl.obolibrary.org/obo/GO_0061333) (renal tubule morphogenesis), [GO:0060003](http://purl.obolibrary.org/obo/GO_0060003) (copper ion export), [GO:0036378](http://purl.obolibrary.org/obo/GO_0036378) (calcitriol biosynthetic process from calciol), [GO:1904851](http://purl.obolibrary.org/obo/GO_1904851) (positive regulation of establishment of protein localization to telomere), [GO:0036372](http://purl.obolibrary.org/obo/GO_0036372) (opsin transport), [GO:0036374](http://purl.obolibrary.org/obo/GO_0036374) (glutathione hydrolase activity), [GO:0060008](http://purl.obolibrary.org/obo/GO_0060008) (Sertoli cell differentiation), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:1904854](http://purl.obolibrary.org/obo/GO_1904854) (proteasome core complex binding), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0061337](http://purl.obolibrary.org/obo/GO_0061337) (cardiac conduction), [GO:0060007](http://purl.obolibrary.org/obo/GO_0060007) (linear vestibuloocular reflex), [GO:0050672](http://purl.obolibrary.org/obo/GO_0050672) (negative regulation of lymphocyte proliferation), [GO:0050673](http://purl.obolibrary.org/obo/GO_0050673) (epithelial cell proliferation), [GO:0048368](http://purl.obolibrary.org/obo/GO_0048368) (lateral mesoderm development), [GO:0050671](http://purl.obolibrary.org/obo/GO_0050671) (positive regulation of lymphocyte proliferation), [GO:0047035](http://purl.obolibrary.org/obo/GO_0047035) (testosterone dehydrogenase (NAD+) activity), [GO:0048365](http://purl.obolibrary.org/obo/GO_0048365) (Rac GTPase binding), [GO:2000232](http://purl.obolibrary.org/obo/GO_2000232) (regulation of rRNA processing), [GO:0050678](http://purl.obolibrary.org/obo/GO_0050678) (regulation of epithelial cell proliferation), [GO:0036368](http://purl.obolibrary.org/obo/GO_0036368) (cone photoresponse recovery), [GO:2000238](http://purl.obolibrary.org/obo/GO_2000238) (regulation of tRNA export from nucleus), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000235](http://purl.obolibrary.org/obo/GO_2000235) (regulation of tRNA processing), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:0036367](http://purl.obolibrary.org/obo/GO_0036367) (light adaption), [GO:2000252](http://purl.obolibrary.org/obo/GO_2000252) (negative regulation of feeding behavior), [GO:2000251](http://purl.obolibrary.org/obo/GO_2000251) (positive regulation of actin cytoskeleton reorganization), [GO:1904861](http://purl.obolibrary.org/obo/GO_1904861) (excitatory synapse assembly), [GO:0036363](http://purl.obolibrary.org/obo/GO_0036363) (transforming growth factor beta activation), [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis), [GO:0061326](http://purl.obolibrary.org/obo/GO_0061326) (renal tubule development), [GO:1903538](http://purl.obolibrary.org/obo/GO_1903538) (regulation of meiotic cell cycle process involved in oocyte maturation), [GO:0023051](http://purl.obolibrary.org/obo/GO_0023051) (regulation of signaling), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0048378](http://purl.obolibrary.org/obo/GO_0048378) (regulation of lateral mesodermal cell fate specification), [GO:0050682](http://purl.obolibrary.org/obo/GO_0050682) (AF-2 domain binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:2000249](http://purl.obolibrary.org/obo/GO_2000249) (regulation of actin cytoskeleton reorganization), [GO:0050687](http://purl.obolibrary.org/obo/GO_0050687) (negative regulation of defense response to virus), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0060022](http://purl.obolibrary.org/obo/GO_0060022) (hard palate development), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0061354](http://purl.obolibrary.org/obo/GO_0061354) (planar cell polarity pathway involved in pericardium morphogenesis), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0035024](http://purl.obolibrary.org/obo/GO_0035024) (negative regulation of Rho protein signal transduction), [GO:0061355](http://purl.obolibrary.org/obo/GO_0061355) (Wnt protein secretion), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:1904874](http://purl.obolibrary.org/obo/GO_1904874) (positive regulation of telomerase RNA localization to Cajal body), [GO:1903543](http://purl.obolibrary.org/obo/GO_1903543) (positive regulation of exosomal secretion), [GO:0061350](http://purl.obolibrary.org/obo/GO_0061350) (planar cell polarity pathway involved in cardiac muscle tissue morphogenesis), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:0061351](http://purl.obolibrary.org/obo/GO_0061351) (neural precursor cell proliferation), [GO:0036351](http://purl.obolibrary.org/obo/GO_0036351) (histone H2A-K13 ubiquitination), [GO:1904872](http://purl.obolibrary.org/obo/GO_1904872) (regulation of telomerase RNA localization to Cajal body), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0035021](http://purl.obolibrary.org/obo/GO_0035021) (negative regulation of Rac protein signal transduction), [GO:0036352](http://purl.obolibrary.org/obo/GO_0036352) (histone H2A-K15 ubiquitination), [GO:1903546](http://purl.obolibrary.org/obo/GO_1903546) (protein localization to photoreceptor outer segment), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:1902219](http://purl.obolibrary.org/obo/GO_1902219) (negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0000398](http://purl.obolibrary.org/obo/GO_0000398) (mRNA splicing, via spliceosome), [GO:0060029](http://purl.obolibrary.org/obo/GO_0060029) (convergent extension involved in organogenesis), [GO:1904879](http://purl.obolibrary.org/obo/GO_1904879) (positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0048386](http://purl.obolibrary.org/obo/GO_0048386) (positive regulation of retinoic acid receptor signaling pathway), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0050692](http://purl.obolibrary.org/obo/GO_0050692) (DBD domain binding), [GO:0050693](http://purl.obolibrary.org/obo/GO_0050693) (LBD domain binding), [GO:0047057](http://purl.obolibrary.org/obo/GO_0047057) (vitamin-K-epoxide reductase (warfarin-sensitive) activity), [GO:0048388](http://purl.obolibrary.org/obo/GO_0048388) (endosomal lumen acidification), [GO:0048387](http://purl.obolibrary.org/obo/GO_0048387) (negative regulation of retinoic acid receptor signaling pathway), [GO:0072001](http://purl.obolibrary.org/obo/GO_0072001) (renal system development), [GO:0050691](http://purl.obolibrary.org/obo/GO_0050691) (regulation of defense response to virus by host), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0072006](http://purl.obolibrary.org/obo/GO_0072006) (nephron development), [GO:2000254](http://purl.obolibrary.org/obo/GO_2000254) (regulation of male germ cell proliferation), [GO:2000253](http://purl.obolibrary.org/obo/GO_2000253) (positive regulation of feeding behavior), [GO:0048382](http://purl.obolibrary.org/obo/GO_0048382) (mesendoderm development), [GO:0050698](http://purl.obolibrary.org/obo/GO_0050698) (proteoglycan sulfotransferase activity), [GO:0050699](http://purl.obolibrary.org/obo/GO_0050699) (WW domain binding), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:2000270](http://purl.obolibrary.org/obo/GO_2000270) (negative regulation of fibroblast apoptotic process), [GO:0060011](http://purl.obolibrary.org/obo/GO_0060011) (Sertoli cell proliferation), [GO:1904881](http://purl.obolibrary.org/obo/GO_1904881) (cellular response to hydrogen sulfide), [GO:0060012](http://purl.obolibrary.org/obo/GO_0060012) (synaptic transmission, glycinergic), [GO:0036343](http://purl.obolibrary.org/obo/GO_0036343) (psychomotor behavior), [GO:0060013](http://purl.obolibrary.org/obo/GO_0060013) (righting reflex), [GO:0061344](http://purl.obolibrary.org/obo/GO_0061344) (regulation of cell adhesion involved in heart morphogenesis), [GO:0060014](http://purl.obolibrary.org/obo/GO_0060014) (granulosa cell differentiation), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0036345](http://purl.obolibrary.org/obo/GO_0036345) (platelet maturation), [GO:2000273](http://purl.obolibrary.org/obo/GO_2000273) (positive regulation of receptor activity), [GO:1904884](http://purl.obolibrary.org/obo/GO_1904884) (positive regulation of telomerase catalytic core complex assembly), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:1903551](http://purl.obolibrary.org/obo/GO_1903551) (regulation of extracellular exosome assembly), [GO:2000271](http://purl.obolibrary.org/obo/GO_2000271) (positive regulation of fibroblast apoptotic process), [GO:0060010](http://purl.obolibrary.org/obo/GO_0060010) (Sertoli cell fate commitment), [GO:0060019](http://purl.obolibrary.org/obo/GO_0060019) (radial glial cell differentiation), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0061346](http://purl.obolibrary.org/obo/GO_0061346) (planar cell polarity pathway involved in heart morphogenesis), [GO:0023026](http://purl.obolibrary.org/obo/GO_0023026) (MHC class II protein complex binding), [GO:0061347](http://purl.obolibrary.org/obo/GO_0061347) (planar cell polarity pathway involved in outflow tract morphogenesis), [GO:0060016](http://purl.obolibrary.org/obo/GO_0060016) (granulosa cell development), [GO:0060017](http://purl.obolibrary.org/obo/GO_0060017) (parathyroid gland development), [GO:0061348](http://purl.obolibrary.org/obo/GO_0061348) (planar cell polarity pathway involved in ventricular septum morphogenesis), [GO:0061349](http://purl.obolibrary.org/obo/GO_0061349) (planar cell polarity pathway involved in cardiac right atrium morphogenesis), [GO:0060018](http://purl.obolibrary.org/obo/GO_0060018) (astrocyte fate commitment), [GO:0047066](http://purl.obolibrary.org/obo/GO_0047066) (phospholipid-hydroperoxide glutathione peroxidase activity), [GO:2000266](http://purl.obolibrary.org/obo/GO_2000266) (regulation of blood coagulation, intrinsic pathway), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0035005](http://purl.obolibrary.org/obo/GO_0035005) (1-phosphatidylinositol-4-phosphate 3-kinase activity), [GO:0048392](http://purl.obolibrary.org/obo/GO_0048392) (intermediate mesodermal cell differentiation), [GO:0036336](http://purl.obolibrary.org/obo/GO_0036336) (dendritic cell migration), [GO:0036337](http://purl.obolibrary.org/obo/GO_0036337) (Fas signaling pathway), [GO:2000269](http://purl.obolibrary.org/obo/GO_2000269) (regulation of fibroblast apoptotic process), [GO:0035088](http://purl.obolibrary.org/obo/GO_0035088) (establishment or maintenance of apical/basal cell polarity), [GO:0019835](http://purl.obolibrary.org/obo/GO_0019835) (cytolysis), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0035087](http://purl.obolibrary.org/obo/GO_0035087) (siRNA loading onto RISC involved in RNA interference), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0035082](http://purl.obolibrary.org/obo/GO_0035082) (axoneme assembly), [GO:0032809](http://purl.obolibrary.org/obo/GO_0032809) (neuronal cell body membrane), [GO:0048318](http://purl.obolibrary.org/obo/GO_0048318) (axial mesoderm development), [GO:0048320](http://purl.obolibrary.org/obo/GO_0048320) (axial mesoderm formation), [GO:0006516](http://purl.obolibrary.org/obo/GO_0006516) (glycoprotein catabolic process), [GO:0032803](http://purl.obolibrary.org/obo/GO_0032803) (regulation of low-density lipoprotein particle receptor catabolic process), [GO:0006517](http://purl.obolibrary.org/obo/GO_0006517) (protein deglycosylation), [GO:0006515](http://purl.obolibrary.org/obo/GO_0006515) (protein quality control for misfolded or incompletely synthesized proteins), [GO:0032802](http://purl.obolibrary.org/obo/GO_0032802) (low-density lipoprotein particle receptor catabolic process), [GO:0032807](http://purl.obolibrary.org/obo/GO_0032807) (DNA ligase IV complex), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0006518](http://purl.obolibrary.org/obo/GO_0006518) (peptide metabolic process), [GO:0032805](http://purl.obolibrary.org/obo/GO_0032805) (positive regulation of low-density lipoprotein particle receptor catabolic process), [GO:0051969](http://purl.obolibrary.org/obo/GO_0051969) (regulation of transmission of nerve impulse), [GO:2000277](http://purl.obolibrary.org/obo/GO_2000277) (positive regulation of oxidative phosphorylation uncoupler activity), [GO:2000276](http://purl.obolibrary.org/obo/GO_2000276) (negative regulation of oxidative phosphorylation uncoupler activity), [GO:0051967](http://purl.obolibrary.org/obo/GO_0051967) (negative regulation of synaptic transmission, glutamatergic), [GO:0019841](http://purl.obolibrary.org/obo/GO_0019841) (retinol binding), [GO:0051968](http://purl.obolibrary.org/obo/GO_0051968) (positive regulation of synaptic transmission, glutamatergic), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0051966](http://purl.obolibrary.org/obo/GO_0051966) (regulation of synaptic transmission, glutamatergic), [GO:0019842](http://purl.obolibrary.org/obo/GO_0019842) (vitamin binding), [GO:0051963](http://purl.obolibrary.org/obo/GO_0051963) (regulation of synapse assembly), [GO:0050632](http://purl.obolibrary.org/obo/GO_0050632) (propionyl-CoA C2-trimethyltridecanoyltransferase activity), [GO:0051964](http://purl.obolibrary.org/obo/GO_0051964) (negative regulation of synapse assembly), [GO:2000279](http://purl.obolibrary.org/obo/GO_2000279) (negative regulation of DNA biosynthetic process), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:2000291](http://purl.obolibrary.org/obo/GO_2000291) (regulation of myoblast proliferation), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0019829](http://purl.obolibrary.org/obo/GO_0019829) (cation-transporting ATPase activity), [GO:0006531](http://purl.obolibrary.org/obo/GO_0006531) (aspartate metabolic process), [GO:0048327](http://purl.obolibrary.org/obo/GO_0048327) (axial mesodermal cell fate specification), [GO:0005200](http://purl.obolibrary.org/obo/GO_0005200) (structural constituent of cytoskeleton), [GO:0006534](http://purl.obolibrary.org/obo/GO_0006534) (cysteine metabolic process), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0006535](http://purl.obolibrary.org/obo/GO_0006535) (cysteine biosynthetic process from serine), [GO:0048329](http://purl.obolibrary.org/obo/GO_0048329) (negative regulation of axial mesodermal cell fate specification), [GO:0006527](http://purl.obolibrary.org/obo/GO_0006527) (arginine catabolic process), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0006525](http://purl.obolibrary.org/obo/GO_0006525) (arginine metabolic process), [GO:0051970](http://purl.obolibrary.org/obo/GO_0051970) (negative regulation of transmission of nerve impulse), [GO:0006526](http://purl.obolibrary.org/obo/GO_0006526) (arginine biosynthetic process), [GO:0051971](http://purl.obolibrary.org/obo/GO_0051971) (positive regulation of transmission of nerve impulse), [GO:0048333](http://purl.obolibrary.org/obo/GO_0048333) (mesodermal cell differentiation), [GO:0006529](http://purl.obolibrary.org/obo/GO_0006529) (asparagine biosynthetic process), [GO:0048332](http://purl.obolibrary.org/obo/GO_0048332) (mesoderm morphogenesis), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0051978](http://purl.obolibrary.org/obo/GO_0051978) (lysophospholipid transporter activity), [GO:0051977](http://purl.obolibrary.org/obo/GO_0051977) (lysophospholipid transport), [GO:0051974](http://purl.obolibrary.org/obo/GO_0051974) (negative regulation of telomerase activity), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0061312](http://purl.obolibrary.org/obo/GO_0061312) (BMP signaling pathway involved in heart development), [GO:0019815](http://purl.obolibrary.org/obo/GO_0019815) (B cell receptor complex), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:0035065](http://purl.obolibrary.org/obo/GO_0035065) (regulation of histone acetylation), [GO:0048339](http://purl.obolibrary.org/obo/GO_0048339) (paraxial mesoderm development), [GO:0048337](http://purl.obolibrary.org/obo/GO_0048337) (positive regulation of mesodermal cell fate specification), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:1904831](http://purl.obolibrary.org/obo/GO_1904831) (positive regulation of aortic smooth muscle cell differentiation), [GO:0061314](http://purl.obolibrary.org/obo/GO_0061314) (Notch signaling involved in heart development), [GO:1903507](http://purl.obolibrary.org/obo/GO_1903507) (negative regulation of nucleic acid-templated transcription), [GO:0061316](http://purl.obolibrary.org/obo/GO_0061316) (canonical Wnt signaling pathway involved in heart development), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0051984](http://purl.obolibrary.org/obo/GO_0051984) (positive regulation of chromosome segregation), [GO:0050650](http://purl.obolibrary.org/obo/GO_0050650) (chondroitin sulfate proteoglycan biosynthetic process), [GO:0050651](http://purl.obolibrary.org/obo/GO_0050651) (dermatan sulfate proteoglycan biosynthetic process), [GO:0047015](http://purl.obolibrary.org/obo/GO_0047015) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity), [GO:0048343](http://purl.obolibrary.org/obo/GO_0048343) (paraxial mesodermal cell fate commitment), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:2000298](http://purl.obolibrary.org/obo/GO_2000298) (regulation of Rho-dependent protein serine/threonine kinase activity), [GO:0051987](http://purl.obolibrary.org/obo/GO_0051987) (positive regulation of attachment of spindle microtubules to kinetochore), [GO:0050654](http://purl.obolibrary.org/obo/GO_0050654) (chondroitin sulfate proteoglycan metabolic process), [GO:0050655](http://purl.obolibrary.org/obo/GO_0050655) (dermatan sulfate proteoglycan metabolic process), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0019805](http://purl.obolibrary.org/obo/GO_0019805) (quinolinate biosynthetic process), [GO:0035051](http://purl.obolibrary.org/obo/GO_0035051) (cardiocyte differentiation), [GO:0019807](http://purl.obolibrary.org/obo/GO_0019807) (aspartoacylase activity), [GO:0019809](http://purl.obolibrary.org/obo/GO_0019809) (spermidine binding), [GO:0019808](http://purl.obolibrary.org/obo/GO_0019808) (polyamine binding), [GO:0035054](http://purl.obolibrary.org/obo/GO_0035054) (embryonic heart tube anterior/posterior pattern specification), [GO:1903514](http://purl.obolibrary.org/obo/GO_1903514) (release of sequestered calcium ion into cytosol by endoplasmic reticulum), [GO:0048348](http://purl.obolibrary.org/obo/GO_0048348) (paraxial mesodermal cell fate specification), [GO:0061308](http://purl.obolibrary.org/obo/GO_0061308) (cardiac neural crest cell development involved in heart development), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0061309](http://purl.obolibrary.org/obo/GO_0061309) (cardiac neural crest cell development involved in outflow tract morphogenesis), [GO:0047016](http://purl.obolibrary.org/obo/GO_0047016) (cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006513](http://purl.obolibrary.org/obo/GO_0006513) (protein monoubiquitination), [GO:0061304](http://purl.obolibrary.org/obo/GO_0061304) (retinal blood vessel morphogenesis), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0050663](http://purl.obolibrary.org/obo/GO_0050663) (cytokine secretion), [GO:0006505](http://purl.obolibrary.org/obo/GO_0006505) (GPI anchor metabolic process), [GO:0006506](http://purl.obolibrary.org/obo/GO_0006506) (GPI anchor biosynthetic process), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0050662](http://purl.obolibrary.org/obo/GO_0050662) (coenzyme binding), [GO:0051990](http://purl.obolibrary.org/obo/GO_0051990) ((R)-2-hydroxyglutarate dehydrogenase activity), [GO:0006509](http://purl.obolibrary.org/obo/GO_0006509) (membrane protein ectodomain proteolysis), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0050665](http://purl.obolibrary.org/obo/GO_0050665) (hydrogen peroxide biosynthetic process), [GO:0060088](http://purl.obolibrary.org/obo/GO_0060088) (auditory receptor cell stereocilium organization), [GO:0043504](http://purl.obolibrary.org/obo/GO_0043504) (mitochondrial DNA repair), [GO:0043507](http://purl.obolibrary.org/obo/GO_0043507) (positive regulation of JUN kinase activity), [GO:0044838](http://purl.obolibrary.org/obo/GO_0044838) (cell quiescence), [GO:0043506](http://purl.obolibrary.org/obo/GO_0043506) (regulation of JUN kinase activity), [GO:0043508](http://purl.obolibrary.org/obo/GO_0043508) (negative regulation of JUN kinase activity), [GO:0006560](http://purl.obolibrary.org/obo/GO_0006560) (proline metabolic process), [GO:1902275](http://purl.obolibrary.org/obo/GO_1902275) (regulation of chromatin organization), [GO:0060086](http://purl.obolibrary.org/obo/GO_0060086) (circadian temperature homeostasis), [GO:0006563](http://purl.obolibrary.org/obo/GO_0006563) (L-serine metabolic process), [GO:0005230](http://purl.obolibrary.org/obo/GO_0005230) (extracellular ligand-gated ion channel activity), [GO:0006564](http://purl.obolibrary.org/obo/GO_0006564) (L-serine biosynthetic process), [GO:0044830](http://purl.obolibrary.org/obo/GO_0044830) (modulation by host of viral RNA genome replication), [GO:0006561](http://purl.obolibrary.org/obo/GO_0006561) (proline biosynthetic process), [GO:0006562](http://purl.obolibrary.org/obo/GO_0006562) (proline catabolic process), [GO:0097371](http://purl.obolibrary.org/obo/GO_0097371) (MDM2/MDM4 family protein binding), [GO:0043501](http://purl.obolibrary.org/obo/GO_0043501) (skeletal muscle adaptation), [GO:0072073](http://purl.obolibrary.org/obo/GO_0072073) (kidney epithelium development), [GO:0006568](http://purl.obolibrary.org/obo/GO_0006568) (tryptophan metabolic process), [GO:0005234](http://purl.obolibrary.org/obo/GO_0005234) (extracellularly glutamate-gated ion channel activity), [GO:0006566](http://purl.obolibrary.org/obo/GO_0006566) (threonine metabolic process), [GO:0005227](http://purl.obolibrary.org/obo/GO_0005227) (calcium activated cation channel activity), [GO:0097363](http://purl.obolibrary.org/obo/GO_0097363) (protein O-GlcNAc transferase activity), [GO:0031514](http://purl.obolibrary.org/obo/GO_0031514) (motile cilium), [GO:0006558](http://purl.obolibrary.org/obo/GO_0006558) (L-phenylalanine metabolic process), [GO:0006559](http://purl.obolibrary.org/obo/GO_0006559) (L-phenylalanine catabolic process), [GO:0005229](http://purl.obolibrary.org/obo/GO_0005229) (intracellular calcium activated chloride channel activity), [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding), [GO:0031518](http://purl.obolibrary.org/obo/GO_0031518) (CBF3 complex), [GO:0072068](http://purl.obolibrary.org/obo/GO_0072068) (late distal convoluted tubule development), [GO:0032849](http://purl.obolibrary.org/obo/GO_0032849) (positive regulation of cellular pH reduction), [GO:0031519](http://purl.obolibrary.org/obo/GO_0031519) (PcG protein complex), [GO:0097369](http://purl.obolibrary.org/obo/GO_0097369) (sodium ion import), [GO:0060091](http://purl.obolibrary.org/obo/GO_0060091) (kinocilium), [GO:0060092](http://purl.obolibrary.org/obo/GO_0060092) (regulation of synaptic transmission, glycinergic), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0019885](http://purl.obolibrary.org/obo/GO_0019885) (antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0019887](http://purl.obolibrary.org/obo/GO_0019887) (protein kinase regulator activity), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0019889](http://purl.obolibrary.org/obo/GO_0019889) (pteridine metabolic process), [GO:0019888](http://purl.obolibrary.org/obo/GO_0019888) (protein phosphatase regulator activity), [GO:0060077](http://purl.obolibrary.org/obo/GO_0060077) (inhibitory synapse), [GO:0019869](http://purl.obolibrary.org/obo/GO_0019869) (chloride channel inhibitor activity), [GO:0060078](http://purl.obolibrary.org/obo/GO_0060078) (regulation of postsynaptic membrane potential), [GO:1902285](http://purl.obolibrary.org/obo/GO_1902285) (semaphorin-plexin signaling pathway involved in neuron projection guidance), [GO:0043515](http://purl.obolibrary.org/obo/GO_0043515) (kinetochore binding), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:0043518](http://purl.obolibrary.org/obo/GO_0043518) (negative regulation of DNA damage response, signal transduction by p53 class mediator), [GO:1902282](http://purl.obolibrary.org/obo/GO_1902282) (voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization), [GO:0043517](http://purl.obolibrary.org/obo/GO_0043517) (positive regulation of DNA damage response, signal transduction by p53 class mediator), [GO:0006570](http://purl.obolibrary.org/obo/GO_0006570) (tyrosine metabolic process), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:0006571](http://purl.obolibrary.org/obo/GO_0006571) (tyrosine biosynthetic process), [GO:0060075](http://purl.obolibrary.org/obo/GO_0060075) (regulation of resting membrane potential), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:1902287](http://purl.obolibrary.org/obo/GO_1902287) (semaphorin-plexin signaling pathway involved in axon guidance), [GO:0006574](http://purl.obolibrary.org/obo/GO_0006574) (valine catabolic process), [GO:0005242](http://purl.obolibrary.org/obo/GO_0005242) (inward rectifier potassium channel activity), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0006572](http://purl.obolibrary.org/obo/GO_0006572) (tyrosine catabolic process), [GO:0006573](http://purl.obolibrary.org/obo/GO_0006573) (valine metabolic process), [GO:0005243](http://purl.obolibrary.org/obo/GO_0005243) (gap junction channel activity), [GO:0005246](http://purl.obolibrary.org/obo/GO_0005246) (calcium channel regulator activity), [GO:0005245](http://purl.obolibrary.org/obo/GO_0005245) (voltage-gated calcium channel activity), [GO:0005248](http://purl.obolibrary.org/obo/GO_0005248) (voltage-gated sodium channel activity), [GO:0005247](http://purl.obolibrary.org/obo/GO_0005247) (voltage-gated chloride channel activity), [GO:0032836](http://purl.obolibrary.org/obo/GO_0032836) (glomerular basement membrane development), [GO:0031505](http://purl.obolibrary.org/obo/GO_0031505) (fungal-type cell wall organization), [GO:0032837](http://purl.obolibrary.org/obo/GO_0032837) (distributive segregation), [GO:0097374](http://purl.obolibrary.org/obo/GO_0097374) (sensory neuron axon guidance), [GO:0031503](http://purl.obolibrary.org/obo/GO_0031503) (protein complex localization), [GO:0072053](http://purl.obolibrary.org/obo/GO_0072053) (renal inner medulla development), [GO:0006569](http://purl.obolibrary.org/obo/GO_0006569) (tryptophan catabolic process), [GO:0032834](http://purl.obolibrary.org/obo/GO_0032834) (positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0097376](http://purl.obolibrary.org/obo/GO_0097376) (interneuron axon guidance), [GO:0019870](http://purl.obolibrary.org/obo/GO_0019870) (potassium channel inhibitor activity), [GO:0031507](http://purl.obolibrary.org/obo/GO_0031507) (heterochromatin assembly), [GO:0032839](http://purl.obolibrary.org/obo/GO_0032839) (dendrite cytoplasm), [GO:0031508](http://purl.obolibrary.org/obo/GO_0031508) (pericentric heterochromatin assembly), [GO:0060080](http://purl.obolibrary.org/obo/GO_0060080) (inhibitory postsynaptic potential), [GO:0060081](http://purl.obolibrary.org/obo/GO_0060081) (membrane hyperpolarization), [GO:0019871](http://purl.obolibrary.org/obo/GO_0019871) (sodium channel inhibitor activity), [GO:0031501](http://purl.obolibrary.org/obo/GO_0031501) (mannosyltransferase complex), [GO:0019878](http://purl.obolibrary.org/obo/GO_0019878) (lysine biosynthetic process via aminoadipic acid), [GO:0032831](http://purl.obolibrary.org/obo/GO_0032831) (positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation), [GO:0120013](http://purl.obolibrary.org/obo/GO_0120013) (intermembrane lipid transfer activity), [GO:0019859](http://purl.obolibrary.org/obo/GO_0019859) (thymine metabolic process), [GO:0072091](http://purl.obolibrary.org/obo/GO_0072091) (regulation of stem cell proliferation), [GO:0006541](http://purl.obolibrary.org/obo/GO_0006541) (glutamine metabolic process), [GO:0006542](http://purl.obolibrary.org/obo/GO_0006542) (glutamine biosynthetic process), [GO:0006540](http://purl.obolibrary.org/obo/GO_0006540) (glutamate decarboxylation to succinate), [GO:0072095](http://purl.obolibrary.org/obo/GO_0072095) (regulation of branch elongation involved in ureteric bud branching), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0006545](http://purl.obolibrary.org/obo/GO_0006545) (glycine biosynthetic process), [GO:0044853](http://purl.obolibrary.org/obo/GO_0044853) (plasma membrane raft), [GO:0006546](http://purl.obolibrary.org/obo/GO_0006546) (glycine catabolic process), [GO:0043522](http://purl.obolibrary.org/obo/GO_0043522) (leucine zipper domain binding), [GO:0005212](http://purl.obolibrary.org/obo/GO_0005212) (structural constituent of eye lens), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0097350](http://purl.obolibrary.org/obo/GO_0097350) (neutrophil clearance), [GO:0006544](http://purl.obolibrary.org/obo/GO_0006544) (glycine metabolic process), [GO:0032825](http://purl.obolibrary.org/obo/GO_0032825) (positive regulation of natural killer cell differentiation), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0006538](http://purl.obolibrary.org/obo/GO_0006538) (glutamate catabolic process), [GO:0006536](http://purl.obolibrary.org/obo/GO_0006536) (glutamate metabolic process), [GO:0006537](http://purl.obolibrary.org/obo/GO_0006537) (glutamate biosynthetic process), [GO:0072089](http://purl.obolibrary.org/obo/GO_0072089) (stem cell proliferation), [GO:0019860](http://purl.obolibrary.org/obo/GO_0019860) (uracil metabolic process), [GO:0019863](http://purl.obolibrary.org/obo/GO_0019863) (IgE binding), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0019864](http://purl.obolibrary.org/obo/GO_0019864) (IgG binding), [GO:0043537](http://purl.obolibrary.org/obo/GO_0043537) (negative regulation of blood vessel endothelial cell migration), [GO:0043539](http://purl.obolibrary.org/obo/GO_0043539) (protein serine/threonine kinase activator activity), [GO:0035095](http://purl.obolibrary.org/obo/GO_0035095) (behavioral response to nicotine), [GO:0060097](http://purl.obolibrary.org/obo/GO_0060097) (cytoskeletal rearrangement involved in phagocytosis, engulfment), [GO:0035097](http://purl.obolibrary.org/obo/GO_0035097) (histone methyltransferase complex), [GO:0120008](http://purl.obolibrary.org/obo/GO_0120008) (positive regulation of glutamatergic neuron differentiation), [GO:0035098](http://purl.obolibrary.org/obo/GO_0035098) (ESC/E(Z) complex), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0006552](http://purl.obolibrary.org/obo/GO_0006552) (leucine catabolic process), [GO:0005220](http://purl.obolibrary.org/obo/GO_0005220) (inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0120009](http://purl.obolibrary.org/obo/GO_0120009) (intermembrane lipid transfer), [GO:0035092](http://purl.obolibrary.org/obo/GO_0035092) (sperm chromatin condensation), [GO:0005222](http://purl.obolibrary.org/obo/GO_0005222) (intracellular cAMP activated cation channel activity), [GO:0006550](http://purl.obolibrary.org/obo/GO_0006550) (isoleucine catabolic process), [GO:0035093](http://purl.obolibrary.org/obo/GO_0035093) (spermatogenesis, exchange of chromosomal proteins), [GO:0035094](http://purl.obolibrary.org/obo/GO_0035094) (response to nicotine), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0005221](http://purl.obolibrary.org/obo/GO_0005221) (intracellular cyclic nucleotide activated cation channel activity), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0006556](http://purl.obolibrary.org/obo/GO_0006556) (S-adenosylmethionine biosynthetic process), [GO:0005223](http://purl.obolibrary.org/obo/GO_0005223) (intracellular cGMP activated cation channel activity), [GO:0043533](http://purl.obolibrary.org/obo/GO_0043533) (inositol 1,3,4,5 tetrakisphosphate binding), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0097362](http://purl.obolibrary.org/obo/GO_0097362) (MCM8-MCM9 complex), [GO:0043535](http://purl.obolibrary.org/obo/GO_0043535) (regulation of blood vessel endothelial cell migration), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0005225](http://purl.obolibrary.org/obo/GO_0005225) (volume-sensitive anion channel activity), [GO:0006549](http://purl.obolibrary.org/obo/GO_0006549) (isoleucine metabolic process), [GO:0032814](http://purl.obolibrary.org/obo/GO_0032814) (regulation of natural killer cell activation), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0097352](http://purl.obolibrary.org/obo/GO_0097352) (autophagosome maturation), [GO:0005219](http://purl.obolibrary.org/obo/GO_0005219) (ryanodine-sensitive calcium-release channel activity), [GO:0072075](http://purl.obolibrary.org/obo/GO_0072075) (metanephric mesenchyme development), [GO:0032812](http://purl.obolibrary.org/obo/GO_0032812) (positive regulation of epinephrine secretion), [GO:0006547](http://purl.obolibrary.org/obo/GO_0006547) (histidine metabolic process), [GO:0032813](http://purl.obolibrary.org/obo/GO_0032813) (tumor necrosis factor receptor superfamily binding), [GO:0006548](http://purl.obolibrary.org/obo/GO_0006548) (histidine catabolic process), [GO:0032819](http://purl.obolibrary.org/obo/GO_0032819) (positive regulation of natural killer cell proliferation), [GO:0032816](http://purl.obolibrary.org/obo/GO_0032816) (positive regulation of natural killer cell activation), [GO:0032817](http://purl.obolibrary.org/obo/GO_0032817) (regulation of natural killer cell proliferation), [GO:0019852](http://purl.obolibrary.org/obo/GO_0019852) (L-ascorbic acid metabolic process), [GO:0019856](http://purl.obolibrary.org/obo/GO_0019856) (pyrimidine nucleobase biosynthetic process), [GO:0019855](http://purl.obolibrary.org/obo/GO_0019855) (calcium channel inhibitor activity), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:1902230](http://purl.obolibrary.org/obo/GO_1902230) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle), [GO:1904891](http://purl.obolibrary.org/obo/GO_1904891) (positive regulation of excitatory synapse assembly), [GO:0060046](http://purl.obolibrary.org/obo/GO_0060046) (regulation of acrosome reaction), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0060040](http://purl.obolibrary.org/obo/GO_0060040) (retinal bipolar neuron differentiation), [GO:0061371](http://purl.obolibrary.org/obo/GO_0061371) (determination of heart left/right asymmetry), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1903565](http://purl.obolibrary.org/obo/GO_1903565) (negative regulation of protein localization to cilium), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0061373](http://purl.obolibrary.org/obo/GO_0061373) (mammillary axonal complex development), [GO:1904894](http://purl.obolibrary.org/obo/GO_1904894) (positive regulation of STAT cascade), [GO:0005272](http://purl.obolibrary.org/obo/GO_0005272) (sodium channel activity), [GO:1902232](http://purl.obolibrary.org/obo/GO_1902232) (regulation of positive thymic T cell selection), [GO:0060043](http://purl.obolibrary.org/obo/GO_0060043) (regulation of cardiac muscle cell proliferation), [GO:1902237](http://purl.obolibrary.org/obo/GO_1902237) (positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:1903568](http://purl.obolibrary.org/obo/GO_1903568) (negative regulation of protein localization to ciliary membrane), [GO:1904899](http://purl.obolibrary.org/obo/GO_1904899) (positive regulation of hepatic stellate cell proliferation), [GO:1903566](http://purl.obolibrary.org/obo/GO_1903566) (positive regulation of protein localization to cilium), [GO:0005277](http://purl.obolibrary.org/obo/GO_0005277) (acetylcholine transmembrane transporter activity), [GO:1902235](http://purl.obolibrary.org/obo/GO_1902235) (regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0060049](http://purl.obolibrary.org/obo/GO_0060049) (regulation of protein glycosylation), [GO:0032889](http://purl.obolibrary.org/obo/GO_0032889) (regulation of vacuole fusion, non-autophagic), [GO:0030229](http://purl.obolibrary.org/obo/GO_0030229) (very-low-density lipoprotein particle receptor activity), [GO:0097324](http://purl.obolibrary.org/obo/GO_0097324) (melanocyte migration), [GO:0098656](http://purl.obolibrary.org/obo/GO_0098656) (anion transmembrane transport), [GO:0097326](http://purl.obolibrary.org/obo/GO_0097326) (melanocyte adhesion), [GO:0098655](http://purl.obolibrary.org/obo/GO_0098655) (cation transmembrane transport), [GO:0097325](http://purl.obolibrary.org/obo/GO_0097325) (melanocyte proliferation), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0061380](http://purl.obolibrary.org/obo/GO_0061380) (superior colliculus development), [GO:0031550](http://purl.obolibrary.org/obo/GO_0031550) (positive regulation of brain-derived neurotrophic factor receptor signaling pathway), [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation), [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0032886](http://purl.obolibrary.org/obo/GO_0032886) (regulation of microtubule-based process), [GO:0044803](http://purl.obolibrary.org/obo/GO_0044803) (multi-organism membrane organization), [GO:0060034](http://purl.obolibrary.org/obo/GO_0060034) (notochord cell differentiation), [GO:0061365](http://purl.obolibrary.org/obo/GO_0061365) (positive regulation of triglyceride lipase activity), [GO:1903572](http://purl.obolibrary.org/obo/GO_1903572) (positive regulation of protein kinase D signaling), [GO:0060035](http://purl.obolibrary.org/obo/GO_0060035) (notochord cell development), [GO:0005280](http://purl.obolibrary.org/obo/GO_0005280) (amino acid:proton symporter activity), [GO:0060036](http://purl.obolibrary.org/obo/GO_0060036) (notochord cell vacuolation), [GO:0061360](http://purl.obolibrary.org/obo/GO_0061360) (optic chiasma development), [GO:0032880](http://purl.obolibrary.org/obo/GO_0032880) (regulation of protein localization), [GO:0060030](http://purl.obolibrary.org/obo/GO_0060030) (dorsal convergence), [GO:1903573](http://purl.obolibrary.org/obo/GO_1903573) (negative regulation of response to endoplasmic reticulum stress), [GO:0120029](http://purl.obolibrary.org/obo/GO_0120029) (hydrogen ion export across plasma membrane), [GO:0005283](http://purl.obolibrary.org/obo/GO_0005283) (sodium:amino acid symporter activity), [GO:0060032](http://purl.obolibrary.org/obo/GO_0060032) (notochord regression), [GO:0061368](http://purl.obolibrary.org/obo/GO_0061368) (behavioral response to formalin induced pain), [GO:0060037](http://purl.obolibrary.org/obo/GO_0060037) (pharyngeal system development), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0061369](http://purl.obolibrary.org/obo/GO_0061369) (negative regulation of testicular blood vessel morphogenesis), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0072011](http://purl.obolibrary.org/obo/GO_0072011) (glomerular endothelium development), [GO:0030217](http://purl.obolibrary.org/obo/GO_0030217) (T cell differentiation), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0072010](http://purl.obolibrary.org/obo/GO_0072010) (glomerular epithelium development), [GO:0098664](http://purl.obolibrary.org/obo/GO_0098664) (G-protein coupled serotonin receptor signaling pathway), [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0031547](http://purl.obolibrary.org/obo/GO_0031547) (brain-derived neurotrophic factor receptor signaling pathway), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0072019](http://purl.obolibrary.org/obo/GO_0072019) (proximal convoluted tubule development), [GO:0032872](http://purl.obolibrary.org/obo/GO_0032872) (regulation of stress-activated MAPK cascade), [GO:0032873](http://purl.obolibrary.org/obo/GO_0032873) (negative regulation of stress-activated MAPK cascade), [GO:0032870](http://purl.obolibrary.org/obo/GO_0032870) (cellular response to hormone stimulus), [GO:0072017](http://purl.obolibrary.org/obo/GO_0072017) (distal tubule development), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0030210](http://purl.obolibrary.org/obo/GO_0030210) (heparin biosynthetic process), [GO:0031545](http://purl.obolibrary.org/obo/GO_0031545) (peptidyl-proline 4-dioxygenase activity), [GO:0032876](http://purl.obolibrary.org/obo/GO_0032876) (negative regulation of DNA endoreduplication), [GO:0030213](http://purl.obolibrary.org/obo/GO_0030213) (hyaluronan biosynthetic process), [GO:0030212](http://purl.obolibrary.org/obo/GO_0030212) (hyaluronan metabolic process), [GO:0030215](http://purl.obolibrary.org/obo/GO_0030215) (semaphorin receptor binding), [GO:0032874](http://purl.obolibrary.org/obo/GO_0032874) (positive regulation of stress-activated MAPK cascade), [GO:0030214](http://purl.obolibrary.org/obo/GO_0030214) (hyaluronan catabolic process), [GO:0060066](http://purl.obolibrary.org/obo/GO_0060066) (oviduct development), [GO:1902251](http://purl.obolibrary.org/obo/GO_1902251) (negative regulation of erythrocyte apoptotic process), [GO:0060067](http://purl.obolibrary.org/obo/GO_0060067) (cervix development), [GO:0060068](http://purl.obolibrary.org/obo/GO_0060068) (vagina development), [GO:0120058](http://purl.obolibrary.org/obo/GO_0120058) (positive regulation of small intestinal transit), [GO:0044818](http://purl.obolibrary.org/obo/GO_0044818) (mitotic G2/M transition checkpoint), [GO:1902255](http://purl.obolibrary.org/obo/GO_1902255) (positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0006582](http://purl.obolibrary.org/obo/GO_0006582) (melanin metabolic process), [GO:0005251](http://purl.obolibrary.org/obo/GO_0005251) (delayed rectifier potassium channel activity), [GO:0060064](http://purl.obolibrary.org/obo/GO_0060064) (Spemann organizer formation at the anterior end of the primitive streak), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:1902254](http://purl.obolibrary.org/obo/GO_1902254) (negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0005250](http://purl.obolibrary.org/obo/GO_0005250) (A-type (transient outward) potassium channel activity), [GO:0006585](http://purl.obolibrary.org/obo/GO_0006585) (dopamine biosynthetic process from tyrosine), [GO:0005252](http://purl.obolibrary.org/obo/GO_0005252) (open rectifier potassium channel activity), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:0006583](http://purl.obolibrary.org/obo/GO_0006583) (melanin biosynthetic process from tyrosine), [GO:1903588](http://purl.obolibrary.org/obo/GO_1903588) (negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis), [GO:0005254](http://purl.obolibrary.org/obo/GO_0005254) (chloride channel activity), [GO:0006584](http://purl.obolibrary.org/obo/GO_0006584) (catecholamine metabolic process), [GO:0006589](http://purl.obolibrary.org/obo/GO_0006589) (octopamine biosynthetic process), [GO:0072050](http://purl.obolibrary.org/obo/GO_0072050) (S-shaped body morphogenesis), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0030206](http://purl.obolibrary.org/obo/GO_0030206) (chondroitin sulfate biosynthetic process), [GO:0072044](http://purl.obolibrary.org/obo/GO_0072044) (collecting duct development), [GO:0005249](http://purl.obolibrary.org/obo/GO_0005249) (voltage-gated potassium channel activity), [GO:0030208](http://purl.obolibrary.org/obo/GO_0030208) (dermatan sulfate biosynthetic process), [GO:0097300](http://purl.obolibrary.org/obo/GO_0097300) (programmed necrotic cell death), [GO:0032868](http://purl.obolibrary.org/obo/GO_0032868) (response to insulin), [GO:0030209](http://purl.obolibrary.org/obo/GO_0030209) (dermatan sulfate catabolic process), [GO:0072045](http://purl.obolibrary.org/obo/GO_0072045) (convergent extension involved in nephron morphogenesis), [GO:0097306](http://purl.obolibrary.org/obo/GO_0097306) (cellular response to alcohol), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0098639](http://purl.obolibrary.org/obo/GO_0098639) (collagen binding involved in cell-matrix adhesion), [GO:0098636](http://purl.obolibrary.org/obo/GO_0098636) (protein complex involved in cell adhesion), [GO:0030200](http://purl.obolibrary.org/obo/GO_0030200) (heparan sulfate proteoglycan catabolic process), [GO:0060071](http://purl.obolibrary.org/obo/GO_0060071) (Wnt signaling pathway, planar cell polarity pathway), [GO:0030201](http://purl.obolibrary.org/obo/GO_0030201) (heparan sulfate proteoglycan metabolic process), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0031532](http://purl.obolibrary.org/obo/GO_0031532) (actin cytoskeleton reorganization), [GO:0030204](http://purl.obolibrary.org/obo/GO_0030204) (chondroitin sulfate metabolic process), [GO:0030203](http://purl.obolibrary.org/obo/GO_0030203) (glycosaminoglycan metabolic process), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:0060055](http://purl.obolibrary.org/obo/GO_0060055) (angiogenesis involved in wound healing), [GO:0060058](http://purl.obolibrary.org/obo/GO_0060058) (positive regulation of apoptotic process involved in mammary gland involution), [GO:1902261](http://purl.obolibrary.org/obo/GO_1902261) (positive regulation of delayed rectifier potassium channel activity), [GO:0044829](http://purl.obolibrary.org/obo/GO_0044829) (positive regulation by host of viral genome replication), [GO:0005260](http://purl.obolibrary.org/obo/GO_0005260) (intracellularly ATP-gated chloride channel activity), [GO:1903597](http://purl.obolibrary.org/obo/GO_1903597) (negative regulation of gap junction assembly), [GO:0006592](http://purl.obolibrary.org/obo/GO_0006592) (ornithine biosynthetic process), [GO:0006593](http://purl.obolibrary.org/obo/GO_0006593) (ornithine catabolic process), [GO:0044828](http://purl.obolibrary.org/obo/GO_0044828) (negative regulation by host of viral genome replication), [GO:0060052](http://purl.obolibrary.org/obo/GO_0060052) (neurofilament cytoskeleton organization), [GO:1903598](http://purl.obolibrary.org/obo/GO_1903598) (positive regulation of gap junction assembly), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0006590](http://purl.obolibrary.org/obo/GO_0006590) (thyroid hormone generation), [GO:0061384](http://purl.obolibrary.org/obo/GO_0061384) (heart trabecula morphogenesis), [GO:1903595](http://purl.obolibrary.org/obo/GO_1903595) (positive regulation of histamine secretion by mast cell), [GO:0005261](http://purl.obolibrary.org/obo/GO_0005261) (cation channel activity), [GO:0006591](http://purl.obolibrary.org/obo/GO_0006591) (ornithine metabolic process), [GO:0060054](http://purl.obolibrary.org/obo/GO_0060054) (positive regulation of epithelial cell proliferation involved in wound healing), [GO:0006595](http://purl.obolibrary.org/obo/GO_0006595) (polyamine metabolic process), [GO:0060059](http://purl.obolibrary.org/obo/GO_0060059) (embryonic retina morphogenesis in camera-type eye), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0006598](http://purl.obolibrary.org/obo/GO_0006598) (polyamine catabolic process), [GO:0031527](http://purl.obolibrary.org/obo/GO_0031527) (filopodium membrane), [GO:0072033](http://purl.obolibrary.org/obo/GO_0072033) (renal vesicle formation), [GO:0098641](http://purl.obolibrary.org/obo/GO_0098641) (cadherin binding involved in cell-cell adhesion), [GO:0031528](http://purl.obolibrary.org/obo/GO_0031528) (microvillus membrane), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0031529](http://purl.obolibrary.org/obo/GO_0031529) (ruffle organization), [GO:0072034](http://purl.obolibrary.org/obo/GO_0072034) (renal vesicle induction), [GO:0019894](http://purl.obolibrary.org/obo/GO_0019894) (kinesin binding), [GO:0019896](http://purl.obolibrary.org/obo/GO_0019896) (axonal transport of mitochondrion), [GO:0060060](http://purl.obolibrary.org/obo/GO_0060060) (post-embryonic retina morphogenesis in camera-type eye), [GO:0060061](http://purl.obolibrary.org/obo/GO_0060061) (Spemann organizer formation), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0019897](http://purl.obolibrary.org/obo/GO_0019897) (extrinsic component of plasma membrane), [GO:0120053](http://purl.obolibrary.org/obo/GO_0120053) (ribitol beta-1,4-xylosyltransferase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0030150](http://purl.obolibrary.org/obo/GO_0030150) (protein import into mitochondrial matrix), [GO:0030151](http://purl.obolibrary.org/obo/GO_0030151) (molybdenum ion binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0042132](http://purl.obolibrary.org/obo/GO_0042132) (fructose 1,6-bisphosphate 1-phosphatase activity), [GO:0044794](http://purl.obolibrary.org/obo/GO_0044794) (positive regulation by host of viral process), [GO:0042134](http://purl.obolibrary.org/obo/GO_0042134) (rRNA primary transcript binding), [GO:0042135](http://purl.obolibrary.org/obo/GO_0042135) (neurotransmitter catabolic process), [GO:0042136](http://purl.obolibrary.org/obo/GO_0042136) (neurotransmitter biosynthetic process), [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex), [GO:1990761](http://purl.obolibrary.org/obo/GO_1990761) (growth cone lamellipodium), [GO:1990763](http://purl.obolibrary.org/obo/GO_1990763) (arrestin family protein binding), [GO:0017183](http://purl.obolibrary.org/obo/GO_0017183) (peptidyl-diphthamide biosynthetic process from peptidyl-histidine), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0017185](http://purl.obolibrary.org/obo/GO_0017185) (peptidyl-lysine hydroxylation), [GO:0017187](http://purl.obolibrary.org/obo/GO_0017187) (peptidyl-glutamic acid carboxylation), [GO:1990769](http://purl.obolibrary.org/obo/GO_1990769) (proximal neuron projection), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0031477](http://purl.obolibrary.org/obo/GO_0031477) (myosin VII complex), [GO:0030148](http://purl.obolibrary.org/obo/GO_0030148) (sphingolipid biosynthetic process), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0030140](http://purl.obolibrary.org/obo/GO_0030140) (trans-Golgi network transport vesicle), [GO:0042144](http://purl.obolibrary.org/obo/GO_0042144) (vacuole fusion, non-autophagic), [GO:0042147](http://purl.obolibrary.org/obo/GO_0042147) (retrograde transport, endosome to Golgi), [GO:0042149](http://purl.obolibrary.org/obo/GO_0042149) (cellular response to glucose starvation), [GO:0030139](http://purl.obolibrary.org/obo/GO_0030139) (endocytic vesicle), [GO:0014909](http://purl.obolibrary.org/obo/GO_0014909) (smooth muscle cell migration), [GO:0017171](http://purl.obolibrary.org/obo/GO_0017171) (serine hydrolase activity), [GO:0043484](http://purl.obolibrary.org/obo/GO_0043484) (regulation of RNA splicing), [GO:0014905](http://purl.obolibrary.org/obo/GO_0014905) (myoblast fusion involved in skeletal muscle regeneration), [GO:0017174](http://purl.obolibrary.org/obo/GO_0017174) (glycine N-methyltransferase activity), [GO:0002923](http://purl.obolibrary.org/obo/GO_0002923) (regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0002924](http://purl.obolibrary.org/obo/GO_0002924) (negative regulation of humoral immune response mediated by circulating immunoglobulin), [GO:1990778](http://purl.obolibrary.org/obo/GO_1990778) (protein localization to cell periphery), [GO:0031464](http://purl.obolibrary.org/obo/GO_0031464) (Cul4A-RING E3 ubiquitin ligase complex), [GO:0017176](http://purl.obolibrary.org/obo/GO_0017176) (phosphatidylinositol N-acetylglucosaminyltransferase activity), [GO:0002925](http://purl.obolibrary.org/obo/GO_0002925) (positive regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex), [GO:0031465](http://purl.obolibrary.org/obo/GO_0031465) (Cul4B-RING E3 ubiquitin ligase complex), [GO:0120072](http://purl.obolibrary.org/obo/GO_0120072) (positive regulation of pyloric antrum smooth muscle contraction), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0032793](http://purl.obolibrary.org/obo/GO_0032793) (positive regulation of CREB transcription factor activity), [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0031463](http://purl.obolibrary.org/obo/GO_0031463) (Cul3-RING ubiquitin ligase complex), [GO:0030136](http://purl.obolibrary.org/obo/GO_0030136) (clathrin-coated vesicle), [GO:0031468](http://purl.obolibrary.org/obo/GO_0031468) (nuclear envelope reassembly), [GO:0032799](http://purl.obolibrary.org/obo/GO_0032799) (low-density lipoprotein receptor particle metabolic process), [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle), [GO:0032797](http://purl.obolibrary.org/obo/GO_0032797) (SMN complex), [GO:0031467](http://purl.obolibrary.org/obo/GO_0031467) (Cul7-RING ubiquitin ligase complex), [GO:0030137](http://purl.obolibrary.org/obo/GO_0030137) (COPI-coated vesicle), [GO:0005172](http://purl.obolibrary.org/obo/GO_0005172) (vascular endothelial growth factor receptor binding), [GO:0005171](http://purl.obolibrary.org/obo/GO_0005171) (hepatocyte growth factor receptor binding), [GO:0031461](http://purl.obolibrary.org/obo/GO_0031461) (cullin-RING ubiquitin ligase complex), [GO:0032792](http://purl.obolibrary.org/obo/GO_0032792) (negative regulation of CREB transcription factor activity), [GO:0005174](http://purl.obolibrary.org/obo/GO_0005174) (CD40 receptor binding), [GO:0005173](http://purl.obolibrary.org/obo/GO_0005173) (stem cell factor receptor binding), [GO:0043486](http://purl.obolibrary.org/obo/GO_0043486) (histone exchange), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0043488](http://purl.obolibrary.org/obo/GO_0043488) (regulation of mRNA stability), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0043490](http://purl.obolibrary.org/obo/GO_0043490) (malate-aspartate shuttle), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0043495](http://purl.obolibrary.org/obo/GO_0043495) (protein membrane anchor), [GO:0032784](http://purl.obolibrary.org/obo/GO_0032784) (regulation of DNA-templated transcription, elongation), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0017166](http://purl.obolibrary.org/obo/GO_0017166) (vinculin binding), [GO:0030120](http://purl.obolibrary.org/obo/GO_0030120) (vesicle coat), [GO:0030123](http://purl.obolibrary.org/obo/GO_0030123) (AP-3 adaptor complex), [GO:0032782](http://purl.obolibrary.org/obo/GO_0032782) (bile acid secretion), [GO:0030122](http://purl.obolibrary.org/obo/GO_0030122) (AP-2 adaptor complex), [GO:0017168](http://purl.obolibrary.org/obo/GO_0017168) (5-oxoprolinase (ATP-hydrolyzing) activity), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:0032786](http://purl.obolibrary.org/obo/GO_0032786) (positive regulation of DNA-templated transcription, elongation), [GO:0030126](http://purl.obolibrary.org/obo/GO_0030126) (COPI vesicle coat), [GO:0005183](http://purl.obolibrary.org/obo/GO_0005183) (gonadotropin hormone-releasing hormone activity), [GO:0032780](http://purl.obolibrary.org/obo/GO_0032780) (negative regulation of ATPase activity), [GO:0032781](http://purl.obolibrary.org/obo/GO_0032781) (positive regulation of ATPase activity), [GO:0005184](http://purl.obolibrary.org/obo/GO_0005184) (neuropeptide hormone activity), [GO:0043497](http://purl.obolibrary.org/obo/GO_0043497) (regulation of protein heterodimerization activity), [GO:0042166](http://purl.obolibrary.org/obo/GO_0042166) (acetylcholine binding), [GO:0043496](http://purl.obolibrary.org/obo/GO_0043496) (regulation of protein homodimerization activity), [GO:0042168](http://purl.obolibrary.org/obo/GO_0042168) (heme metabolic process), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0031448](http://purl.obolibrary.org/obo/GO_0031448) (positive regulation of fast-twitch skeletal muscle fiber contraction), [GO:0031449](http://purl.obolibrary.org/obo/GO_0031449) (regulation of slow-twitch skeletal muscle fiber contraction), [GO:0042171](http://purl.obolibrary.org/obo/GO_0042171) (lysophosphatidic acid acyltransferase activity), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0017151](http://purl.obolibrary.org/obo/GO_0017151) (DEAD/H-box RNA helicase binding), [GO:1990799](http://purl.obolibrary.org/obo/GO_1990799) (mitochondrial tRNA wobble position uridine thiolation), [GO:0018484](http://purl.obolibrary.org/obo/GO_0018484) (4-hydroxybenzaldehyde dehydrogenase activity), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:0042175](http://purl.obolibrary.org/obo/GO_0042175) (nuclear outer membrane-endoplasmic reticulum membrane network), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0120092](http://purl.obolibrary.org/obo/GO_0120092) (crotonyl-CoA hydratase activity), [GO:0002903](http://purl.obolibrary.org/obo/GO_0002903) (negative regulation of B cell apoptotic process), [GO:0032773](http://purl.obolibrary.org/obo/GO_0032773) (positive regulation of monophenol monooxygenase activity), [GO:0031442](http://purl.obolibrary.org/obo/GO_0031442) (positive regulation of mRNA 3'-end processing), [GO:0031443](http://purl.obolibrary.org/obo/GO_0031443) (fast-twitch skeletal muscle fiber contraction), [GO:0002904](http://purl.obolibrary.org/obo/GO_0002904) (positive regulation of B cell apoptotic process), [GO:0017156](http://purl.obolibrary.org/obo/GO_0017156) (calcium ion regulated exocytosis), [GO:0120094](http://purl.obolibrary.org/obo/GO_0120094) (negative regulation of peptidyl-lysine crotonylation), [GO:0030111](http://purl.obolibrary.org/obo/GO_0030111) (regulation of Wnt signaling pathway), [GO:0017157](http://purl.obolibrary.org/obo/GO_0017157) (regulation of exocytosis), [GO:0002906](http://purl.obolibrary.org/obo/GO_0002906) (negative regulation of mature B cell apoptotic process), [GO:0017158](http://purl.obolibrary.org/obo/GO_0017158) (regulation of calcium ion-dependent exocytosis), [GO:0032777](http://purl.obolibrary.org/obo/GO_0032777) (Piccolo NuA4 histone acetyltransferase complex), [GO:0031444](http://purl.obolibrary.org/obo/GO_0031444) (slow-twitch skeletal muscle fiber contraction), [GO:0030116](http://purl.obolibrary.org/obo/GO_0030116) (glial cell-derived neurotrophic factor receptor binding), [GO:0032776](http://purl.obolibrary.org/obo/GO_0032776) (DNA methylation on cytosine), [GO:0030194](http://purl.obolibrary.org/obo/GO_0030194) (positive regulation of blood coagulation), [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0043420](http://purl.obolibrary.org/obo/GO_0043420) (anthranilate metabolic process), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0097291](http://purl.obolibrary.org/obo/GO_0097291) (renal phosphate ion absorption), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0097296](http://purl.obolibrary.org/obo/GO_0097296) (activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0043426](http://purl.obolibrary.org/obo/GO_0043426) (MRF binding), [GO:0043425](http://purl.obolibrary.org/obo/GO_0043425) (bHLH transcription factor binding), [GO:0097286](http://purl.obolibrary.org/obo/GO_0097286) (iron ion import), [GO:0002951](http://purl.obolibrary.org/obo/GO_0002951) (leukotriene-C(4) hydrolase), [GO:0030187](http://purl.obolibrary.org/obo/GO_0030187) (melatonin biosynthetic process), [GO:0043438](http://purl.obolibrary.org/obo/GO_0043438) (acetoacetic acid metabolic process), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0000309](http://purl.obolibrary.org/obo/GO_0000309) (nicotinamide-nucleotide adenylyltransferase activity), [GO:0030185](http://purl.obolibrary.org/obo/GO_0030185) (nitric oxide transport), [GO:0000307](http://purl.obolibrary.org/obo/GO_0000307) (cyclin-dependent protein kinase holoenzyme complex), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0000304](http://purl.obolibrary.org/obo/GO_0000304) (response to singlet oxygen), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000303](http://purl.obolibrary.org/obo/GO_0000303) (response to superoxide), [GO:0000302](http://purl.obolibrary.org/obo/GO_0000302) (response to reactive oxygen species), [GO:0042104](http://purl.obolibrary.org/obo/GO_0042104) (positive regulation of activated T cell proliferation), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0000301](http://purl.obolibrary.org/obo/GO_0000301) (retrograde transport, vesicle recycling within Golgi), [GO:0042105](http://purl.obolibrary.org/obo/GO_0042105) (alpha-beta T cell receptor complex), [GO:0001640](http://purl.obolibrary.org/obo/GO_0001640) (adenylate cyclase inhibiting G-protein coupled glutamate receptor activity), [GO:0044770](http://purl.obolibrary.org/obo/GO_0044770) (cell cycle phase transition), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0030175](http://purl.obolibrary.org/obo/GO_0030175) (filopodium), [GO:0001639](http://purl.obolibrary.org/obo/GO_0001639) (PLC activating G-protein coupled glutamate receptor activity), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030177](http://purl.obolibrary.org/obo/GO_0030177) (positive regulation of Wnt signaling pathway), [GO:0042118](http://purl.obolibrary.org/obo/GO_0042118) (endothelial cell activation), [GO:0042119](http://purl.obolibrary.org/obo/GO_0042119) (neutrophil activation), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0030174](http://purl.obolibrary.org/obo/GO_0030174) (regulation of DNA-dependent DNA replication initiation), [GO:0030173](http://purl.obolibrary.org/obo/GO_0030173) (integral component of Golgi membrane), [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint), [GO:0042110](http://purl.obolibrary.org/obo/GO_0042110) (T cell activation), [GO:0044772](http://purl.obolibrary.org/obo/GO_0044772) (mitotic cell cycle phase transition), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0044774](http://purl.obolibrary.org/obo/GO_0044774) (mitotic DNA integrity checkpoint), [GO:0097272](http://purl.obolibrary.org/obo/GO_0097272) (ammonia homeostasis), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0042117](http://purl.obolibrary.org/obo/GO_0042117) (monocyte activation), [GO:0098597](http://purl.obolibrary.org/obo/GO_0098597) (observational learning), [GO:0098598](http://purl.obolibrary.org/obo/GO_0098598) (learned vocalization behavior or vocal learning), [GO:0097264](http://purl.obolibrary.org/obo/GO_0097264) (self proteolysis), [GO:0002930](http://purl.obolibrary.org/obo/GO_0002930) (trabecular meshwork development), [GO:0002931](http://purl.obolibrary.org/obo/GO_0002931) (response to ischemia), [GO:0097268](http://purl.obolibrary.org/obo/GO_0097268) (cytoophidium), [GO:0044782](http://purl.obolibrary.org/obo/GO_0044782) (cilium organization), [GO:0098599](http://purl.obolibrary.org/obo/GO_0098599) (palmitoyl hydrolase activity), [GO:0014916](http://purl.obolibrary.org/obo/GO_0014916) (regulation of lung blood pressure), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0031497](http://purl.obolibrary.org/obo/GO_0031497) (chromatin assembly), [GO:0014912](http://purl.obolibrary.org/obo/GO_0014912) (negative regulation of smooth muscle cell migration), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0030166](http://purl.obolibrary.org/obo/GO_0030166) (proteoglycan biosynthetic process), [GO:0031496](http://purl.obolibrary.org/obo/GO_0031496) (positive regulation of mating type switching), [GO:0002939](http://purl.obolibrary.org/obo/GO_0002939) (tRNA N1-guanine methylation), [GO:0030169](http://purl.obolibrary.org/obo/GO_0030169) (low-density lipoprotein particle binding), [GO:0014910](http://purl.obolibrary.org/obo/GO_0014910) (regulation of smooth muscle cell migration), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0042129](http://purl.obolibrary.org/obo/GO_0042129) (regulation of T cell proliferation), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0031493](http://purl.obolibrary.org/obo/GO_0031493) (nucleosomal histone binding), [GO:0030160](http://purl.obolibrary.org/obo/GO_0030160) (GKAP/Homer scaffold activity), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0031491](http://purl.obolibrary.org/obo/GO_0031491) (nucleosome binding), [GO:0030162](http://purl.obolibrary.org/obo/GO_0030162) (regulation of proteolysis), [GO:0031492](http://purl.obolibrary.org/obo/GO_0031492) (nucleosomal DNA binding), [GO:0044783](http://purl.obolibrary.org/obo/GO_0044783) (G1 DNA damage checkpoint), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0043456](http://purl.obolibrary.org/obo/GO_0043456) (regulation of pentose-phosphate shunt), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0097284](http://purl.obolibrary.org/obo/GO_0097284) (hepatocyte apoptotic process), [GO:0042128](http://purl.obolibrary.org/obo/GO_0042128) (nitrate assimilation), [GO:0097276](http://purl.obolibrary.org/obo/GO_0097276) (cellular creatinine homeostasis), [GO:0097275](http://purl.obolibrary.org/obo/GO_0097275) (cellular ammonia homeostasis), [GO:0097278](http://purl.obolibrary.org/obo/GO_0097278) (complement-dependent cytotoxicity), [GO:0097277](http://purl.obolibrary.org/obo/GO_0097277) (cellular urea homeostasis), [GO:0044791](http://purl.obolibrary.org/obo/GO_0044791) (positive regulation by host of viral release from host cell), [GO:0044790](http://purl.obolibrary.org/obo/GO_0044790) (negative regulation by host of viral release from host cell), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0001614](http://purl.obolibrary.org/obo/GO_0001614) (purinergic nucleotide receptor activity), [GO:0043462](http://purl.obolibrary.org/obo/GO_0043462) (regulation of ATPase activity), [GO:0043461](http://purl.obolibrary.org/obo/GO_0043461) (proton-transporting ATP synthase complex assembly), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0017198](http://purl.obolibrary.org/obo/GO_0017198) (N-terminal peptidyl-serine acetylation), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0030158](http://purl.obolibrary.org/obo/GO_0030158) (protein xylosyltransferase activity), [GO:0030157](http://purl.obolibrary.org/obo/GO_0030157) (pancreatic juice secretion), [GO:0031489](http://purl.obolibrary.org/obo/GO_0031489) (myosin V binding), [GO:0030159](http://purl.obolibrary.org/obo/GO_0030159) (receptor signaling complex scaffold activity), [GO:0051928](http://purl.obolibrary.org/obo/GO_0051928) (positive regulation of calcium ion transport), [GO:0001671](http://purl.obolibrary.org/obo/GO_0001671) (ATPase activator activity), [GO:0000333](http://purl.obolibrary.org/obo/GO_0000333) (telomerase catalytic core complex), [GO:0001673](http://purl.obolibrary.org/obo/GO_0001673) (male germ cell nucleus), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0001667](http://purl.obolibrary.org/obo/GO_0001667) (ameboidal-type cell migration), [GO:0001669](http://purl.obolibrary.org/obo/GO_0001669) (acrosomal vesicle), [GO:0051926](http://purl.obolibrary.org/obo/GO_0051926) (negative regulation of calcium ion transport), [GO:0051923](http://purl.obolibrary.org/obo/GO_0051923) (sulfation), [GO:0051924](http://purl.obolibrary.org/obo/GO_0051924) (regulation of calcium ion transport), [GO:0051938](http://purl.obolibrary.org/obo/GO_0051938) (L-glutamate import), [GO:0000349](http://purl.obolibrary.org/obo/GO_0000349) (generation of catalytic spliceosome for first transesterification step), [GO:0001680](http://purl.obolibrary.org/obo/GO_0001680) (tRNA 3'-terminal CCA addition), [GO:0001681](http://purl.obolibrary.org/obo/GO_0001681) (sialate O-acetylesterase activity), [GO:0001675](http://purl.obolibrary.org/obo/GO_0001675) (acrosome assembly), [GO:0001676](http://purl.obolibrary.org/obo/GO_0001676) (long-chain fatty acid metabolic process), [GO:0001678](http://purl.obolibrary.org/obo/GO_0001678) (cellular glucose homeostasis), [GO:0051935](http://purl.obolibrary.org/obo/GO_0051935) (glutamate reuptake), [GO:0051930](http://purl.obolibrary.org/obo/GO_0051930) (regulation of sensory perception of pain), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0000320](http://purl.obolibrary.org/obo/GO_0000320) (re-entry into mitotic cell cycle), [GO:0001642](http://purl.obolibrary.org/obo/GO_0001642) (group III metabotropic glutamate receptor activity), [GO:0048302](http://purl.obolibrary.org/obo/GO_0048302) (regulation of isotype switching to IgG isotypes), [GO:1990700](http://purl.obolibrary.org/obo/GO_1990700) (nucleolar chromatin organization), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0102279](http://purl.obolibrary.org/obo/GO_0102279) (lecithin:11-cis retinol acyltransferase activity), [GO:0050614](http://purl.obolibrary.org/obo/GO_0050614) (delta24-sterol reductase activity), [GO:0051946](http://purl.obolibrary.org/obo/GO_0051946) (regulation of glutamate uptake involved in transmission of nerve impulse), [GO:0050613](http://purl.obolibrary.org/obo/GO_0050613) (delta14-sterol reductase activity), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0048306](http://purl.obolibrary.org/obo/GO_0048306) (calcium-dependent protein binding), [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen), [GO:0048305](http://purl.obolibrary.org/obo/GO_0048305) (immunoglobulin secretion), [GO:0048304](http://purl.obolibrary.org/obo/GO_0048304) (positive regulation of isotype switching to IgG isotypes), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:0048309](http://purl.obolibrary.org/obo/GO_0048309) (endoplasmic reticulum inheritance), [GO:1904803](http://purl.obolibrary.org/obo/GO_1904803) (regulation of translation involved in cellular response to UV), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0048313](http://purl.obolibrary.org/obo/GO_0048313) (Golgi inheritance), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:0048311](http://purl.obolibrary.org/obo/GO_0048311) (mitochondrion distribution), [GO:0001659](http://purl.obolibrary.org/obo/GO_0001659) (temperature homeostasis), [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex), [GO:0048310](http://purl.obolibrary.org/obo/GO_0048310) (nucleus inheritance), [GO:2000309](http://purl.obolibrary.org/obo/GO_2000309) (positive regulation of tumor necrosis factor (ligand) superfamily member 11 production), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0051958](http://purl.obolibrary.org/obo/GO_0051958) (methotrexate transport), [GO:2000300](http://purl.obolibrary.org/obo/GO_2000300) (regulation of synaptic vesicle exocytosis), [GO:0051959](http://purl.obolibrary.org/obo/GO_0051959) (dynein light intermediate chain binding), [GO:1990715](http://purl.obolibrary.org/obo/GO_1990715) (mRNA CDS binding), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:2000304](http://purl.obolibrary.org/obo/GO_2000304) (positive regulation of ceramide biosynthetic process), [GO:1990718](http://purl.obolibrary.org/obo/GO_1990718) (axonemal central pair projection), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0042177](http://purl.obolibrary.org/obo/GO_0042177) (negative regulation of protein catabolic process), [GO:0000379](http://purl.obolibrary.org/obo/GO_0000379) (tRNA-type intron splice site recognition and cleavage), [GO:0023014](http://purl.obolibrary.org/obo/GO_0023014) (signal transduction by protein phosphorylation), [GO:0023016](http://purl.obolibrary.org/obo/GO_0023016) (signal transduction by trans-phosphorylation), [GO:0000386](http://purl.obolibrary.org/obo/GO_0000386) (second spliceosomal transesterification activity), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0042182](http://purl.obolibrary.org/obo/GO_0042182) (ketone catabolic process), [GO:0000381](http://purl.obolibrary.org/obo/GO_0000381) (regulation of alternative mRNA splicing, via spliceosome), [GO:0000380](http://purl.obolibrary.org/obo/GO_0000380) (alternative mRNA splicing, via spliceosome), [GO:0036328](http://purl.obolibrary.org/obo/GO_0036328) (VEGF-C-activated receptor activity), [GO:2000310](http://purl.obolibrary.org/obo/GO_2000310) (regulation of NMDA receptor activity), [GO:2000314](http://purl.obolibrary.org/obo/GO_2000314) (negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:2000313](http://purl.obolibrary.org/obo/GO_2000313) (regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0000388](http://purl.obolibrary.org/obo/GO_0000388) (spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)), [GO:0000387](http://purl.obolibrary.org/obo/GO_0000387) (spliceosomal snRNP assembly), [GO:2000329](http://purl.obolibrary.org/obo/GO_2000329) (negative regulation of T-helper 17 cell lineage commitment), [GO:1990730](http://purl.obolibrary.org/obo/GO_1990730) (VCP-NSFL1C complex), [GO:0000390](http://purl.obolibrary.org/obo/GO_0000390) (spliceosomal complex disassembly), [GO:0036317](http://purl.obolibrary.org/obo/GO_0036317) (tyrosyl-RNA phosphodiesterase activity), [GO:2000321](http://purl.obolibrary.org/obo/GO_2000321) (positive regulation of T-helper 17 cell differentiation), [GO:2000320](http://purl.obolibrary.org/obo/GO_2000320) (negative regulation of T-helper 17 cell differentiation), [GO:2000324](http://purl.obolibrary.org/obo/GO_2000324) (positive regulation of glucocorticoid receptor signaling pathway), [GO:2000323](http://purl.obolibrary.org/obo/GO_2000323) (negative regulation of glucocorticoid receptor signaling pathway), [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity), [GO:0036312](http://purl.obolibrary.org/obo/GO_0036312) (phosphatidylinositol 3-kinase regulatory subunit binding), [GO:0001691](http://purl.obolibrary.org/obo/GO_0001691) (pseudophosphatase activity), [GO:2000338](http://purl.obolibrary.org/obo/GO_2000338) (regulation of chemokine (C-X-C motif) ligand 1 production), [GO:1990745](http://purl.obolibrary.org/obo/GO_1990745) (EARP complex), [GO:0036306](http://purl.obolibrary.org/obo/GO_0036306) (embryonic heart tube elongation), [GO:0051904](http://purl.obolibrary.org/obo/GO_0051904) (pigment granule transport), [GO:0051901](http://purl.obolibrary.org/obo/GO_0051901) (positive regulation of mitochondrial depolarization), [GO:0051902](http://purl.obolibrary.org/obo/GO_0051902) (negative regulation of mitochondrial depolarization), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:0036303](http://purl.obolibrary.org/obo/GO_0036303) (lymph vessel morphogenesis), [GO:0051900](http://purl.obolibrary.org/obo/GO_0051900) (regulation of mitochondrial depolarization), [GO:2000334](http://purl.obolibrary.org/obo/GO_2000334) (positive regulation of blood microparticle formation), [GO:0051918](http://purl.obolibrary.org/obo/GO_0051918) (negative regulation of fibrinolysis), [GO:0051919](http://purl.obolibrary.org/obo/GO_0051919) (positive regulation of fibrinolysis), [GO:2000350](http://purl.obolibrary.org/obo/GO_2000350) (positive regulation of CD40 signaling pathway), [GO:0001696](http://purl.obolibrary.org/obo/GO_0001696) (gastric acid secretion), [GO:0000372](http://purl.obolibrary.org/obo/GO_0000372) (Group I intron splicing), [GO:2000343](http://purl.obolibrary.org/obo/GO_2000343) (positive regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000341](http://purl.obolibrary.org/obo/GO_2000341) (regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000348](http://purl.obolibrary.org/obo/GO_2000348) (regulation of CD40 signaling pathway), [GO:2000346](http://purl.obolibrary.org/obo/GO_2000346) (negative regulation of hepatocyte proliferation), [GO:2000345](http://purl.obolibrary.org/obo/GO_2000345) (regulation of hepatocyte proliferation), [GO:0016404](http://purl.obolibrary.org/obo/GO_0016404) (15-hydroxyprostaglandin dehydrogenase (NAD+) activity), [GO:0016407](http://purl.obolibrary.org/obo/GO_0016407) (acetyltransferase activity), [GO:0016409](http://purl.obolibrary.org/obo/GO_0016409) (palmitoyltransferase activity), [GO:0005750](http://purl.obolibrary.org/obo/GO_0005750) (mitochondrial respiratory chain complex III), [GO:0004421](http://purl.obolibrary.org/obo/GO_0004421) (hydroxymethylglutaryl-CoA synthase activity), [GO:0005751](http://purl.obolibrary.org/obo/GO_0005751) (mitochondrial respiratory chain complex IV), [GO:0004423](http://purl.obolibrary.org/obo/GO_0004423) (iduronate-2-sulfatase activity), [GO:0004422](http://purl.obolibrary.org/obo/GO_0004422) (hypoxanthine phosphoribosyltransferase activity), [GO:0072583](http://purl.obolibrary.org/obo/GO_0072583) (clathrin-dependent endocytosis), [GO:0005745](http://purl.obolibrary.org/obo/GO_0005745) (m-AAA complex), [GO:0005744](http://purl.obolibrary.org/obo/GO_0005744) (mitochondrial inner membrane presequence translocase complex), [GO:0005747](http://purl.obolibrary.org/obo/GO_0005747) (mitochondrial respiratory chain complex I), [GO:0005746](http://purl.obolibrary.org/obo/GO_0005746) (mitochondrial respiratory chain), [GO:0004415](http://purl.obolibrary.org/obo/GO_0004415) (hyalurononglucosaminidase activity), [GO:0005749](http://purl.obolibrary.org/obo/GO_0005749) (mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)), [GO:0030705](http://purl.obolibrary.org/obo/GO_0030705) (cytoskeleton-dependent intracellular transport), [GO:0004418](http://purl.obolibrary.org/obo/GO_0004418) (hydroxymethylbilane synthase activity), [GO:0030704](http://purl.obolibrary.org/obo/GO_0030704) (vitelline membrane formation), [GO:0071253](http://purl.obolibrary.org/obo/GO_0071253) (connexin binding), [GO:0004419](http://purl.obolibrary.org/obo/GO_0004419) (hydroxymethylglutaryl-CoA lyase activity), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0072589](http://purl.obolibrary.org/obo/GO_0072589) (box H/ACA scaRNP complex), [GO:0016410](http://purl.obolibrary.org/obo/GO_0016410) (N-acyltransferase activity), [GO:0016411](http://purl.obolibrary.org/obo/GO_0016411) (acylglycerol O-acyltransferase activity), [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification), [GO:0060596](http://purl.obolibrary.org/obo/GO_0060596) (mammary placode formation), [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0042706](http://purl.obolibrary.org/obo/GO_0042706) (eye photoreceptor cell fate commitment), [GO:0060592](http://purl.obolibrary.org/obo/GO_0060592) (mammary gland formation), [GO:0004430](http://purl.obolibrary.org/obo/GO_0004430) (1-phosphatidylinositol 4-kinase activity), [GO:0005760](http://purl.obolibrary.org/obo/GO_0005760) (gamma DNA polymerase complex), [GO:0003100](http://purl.obolibrary.org/obo/GO_0003100) (regulation of systemic arterial blood pressure by endothelin), [GO:0005763](http://purl.obolibrary.org/obo/GO_0005763) (mitochondrial small ribosomal subunit), [GO:0060599](http://purl.obolibrary.org/obo/GO_0060599) (lateral sprouting involved in mammary gland duct morphogenesis), [GO:0005762](http://purl.obolibrary.org/obo/GO_0005762) (mitochondrial large ribosomal subunit), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0042700](http://purl.obolibrary.org/obo/GO_0042700) (luteinizing hormone signaling pathway), [GO:0072572](http://purl.obolibrary.org/obo/GO_0072572) (poly-ADP-D-ribose binding), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0005757](http://purl.obolibrary.org/obo/GO_0005757) (mitochondrial permeability transition pore complex), [GO:0072576](http://purl.obolibrary.org/obo/GO_0072576) (liver morphogenesis), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0072574](http://purl.obolibrary.org/obo/GO_0072574) (hepatocyte proliferation), [GO:0072579](http://purl.obolibrary.org/obo/GO_0072579) (glycine receptor clustering), [GO:0016401](http://purl.obolibrary.org/obo/GO_0016401) (palmitoyl-CoA oxidase activity), [GO:0042719](http://purl.obolibrary.org/obo/GO_0042719) (mitochondrial intermembrane space protein transporter complex), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0071280](http://purl.obolibrary.org/obo/GO_0071280) (cellular response to copper ion), [GO:0071281](http://purl.obolibrary.org/obo/GO_0071281) (cellular response to iron ion), [GO:0005732](http://purl.obolibrary.org/obo/GO_0005732) (small nucleolar ribonucleoprotein complex), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0005724](http://purl.obolibrary.org/obo/GO_0005724) (nuclear telomeric heterochromatin), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0005729](http://purl.obolibrary.org/obo/GO_0005729) (2-micrometer circle DNA), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0042721](http://purl.obolibrary.org/obo/GO_0042721) (mitochondrial inner membrane protein insertion complex), [GO:0004411](http://purl.obolibrary.org/obo/GO_0004411) (homogentisate 1,2-dioxygenase activity), [GO:0072594](http://purl.obolibrary.org/obo/GO_0072594) (establishment of protein localization to organelle), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0071266](http://purl.obolibrary.org/obo/GO_0071266) ('de novo' L-methionine biosynthetic process), [GO:0004407](http://purl.obolibrary.org/obo/GO_0004407) (histone deacetylase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0004408](http://purl.obolibrary.org/obo/GO_0004408) (holocytochrome-c synthase activity), [GO:0071268](http://purl.obolibrary.org/obo/GO_0071268) (homocysteine biosynthetic process), [GO:0016447](http://purl.obolibrary.org/obo/GO_0016447) (somatic recombination of immunoglobulin gene segments), [GO:0060561](http://purl.obolibrary.org/obo/GO_0060561) (apoptotic process involved in morphogenesis), [GO:0015114](http://purl.obolibrary.org/obo/GO_0015114) (phosphate ion transmembrane transporter activity), [GO:0060563](http://purl.obolibrary.org/obo/GO_0060563) (neuroepithelial cell differentiation), [GO:0015111](http://purl.obolibrary.org/obo/GO_0015111) (iodide transmembrane transporter activity), [GO:1901660](http://purl.obolibrary.org/obo/GO_1901660) (calcium ion export), [GO:0005790](http://purl.obolibrary.org/obo/GO_0005790) (smooth endoplasmic reticulum), [GO:0061890](http://purl.obolibrary.org/obo/GO_0061890) (positive regulation of astrocyte activation), [GO:1902990](http://purl.obolibrary.org/obo/GO_1902990) (mitotic telomere maintenance via semi-conservative replication), [GO:1902991](http://purl.obolibrary.org/obo/GO_1902991) (regulation of amyloid precursor protein catabolic process), [GO:0004461](http://purl.obolibrary.org/obo/GO_0004461) (lactose synthase activity), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0003130](http://purl.obolibrary.org/obo/GO_0003130) (BMP signaling pathway involved in heart induction), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0004465](http://purl.obolibrary.org/obo/GO_0004465) (lipoprotein lipase activity), [GO:0005796](http://purl.obolibrary.org/obo/GO_0005796) (Golgi lumen), [GO:0005795](http://purl.obolibrary.org/obo/GO_0005795) (Golgi stack), [GO:0060566](http://purl.obolibrary.org/obo/GO_0060566) (positive regulation of DNA-templated transcription, termination), [GO:0004464](http://purl.obolibrary.org/obo/GO_0004464) (leukotriene-C4 synthase activity), [GO:0005798](http://purl.obolibrary.org/obo/GO_0005798) (Golgi-associated vesicle), [GO:0060567](http://purl.obolibrary.org/obo/GO_0060567) (negative regulation of DNA-templated transcription, termination), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0004466](http://purl.obolibrary.org/obo/GO_0004466) (long-chain-acyl-CoA dehydrogenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0004458](http://purl.obolibrary.org/obo/GO_0004458) (D-lactate dehydrogenase (cytochrome) activity), [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen), [GO:0004457](http://purl.obolibrary.org/obo/GO_0004457) (lactate dehydrogenase activity), [GO:0003128](http://purl.obolibrary.org/obo/GO_0003128) (heart field specification), [GO:0004459](http://purl.obolibrary.org/obo/GO_0004459) (L-lactate dehydrogenase activity), [GO:0047598](http://purl.obolibrary.org/obo/GO_0047598) (7-dehydrocholesterol reductase activity), [GO:0072542](http://purl.obolibrary.org/obo/GO_0072542) (protein phosphatase activator activity), [GO:0072540](http://purl.obolibrary.org/obo/GO_0072540) (T-helper 17 cell lineage commitment), [GO:0071216](http://purl.obolibrary.org/obo/GO_0071216) (cellular response to biotic stimulus), [GO:0072545](http://purl.obolibrary.org/obo/GO_0072545) (tyrosine binding), [GO:0072544](http://purl.obolibrary.org/obo/GO_0072544) (L-DOPA binding), [GO:0071219](http://purl.obolibrary.org/obo/GO_0071219) (cellular response to molecule of bacterial origin), [GO:0015108](http://purl.obolibrary.org/obo/GO_0015108) (chloride transmembrane transporter activity), [GO:0015106](http://purl.obolibrary.org/obo/GO_0015106) (bicarbonate transmembrane transporter activity), [GO:0030742](http://purl.obolibrary.org/obo/GO_0030742) (GTP-dependent protein binding), [GO:0015126](http://purl.obolibrary.org/obo/GO_0015126) (canalicular bile acid transmembrane transporter activity), [GO:0060550](http://purl.obolibrary.org/obo/GO_0060550) (positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity), [GO:0015125](http://purl.obolibrary.org/obo/GO_0015125) (bile acid transmembrane transporter activity), [GO:0060552](http://purl.obolibrary.org/obo/GO_0060552) (positive regulation of fructose 1,6-bisphosphate metabolic process), [GO:2001022](http://purl.obolibrary.org/obo/GO_2001022) (positive regulation of response to DNA damage stimulus), [GO:1901673](http://purl.obolibrary.org/obo/GO_1901673) (regulation of mitotic spindle assembly), [GO:0003140](http://purl.obolibrary.org/obo/GO_0003140) (determination of left/right asymmetry in lateral mesoderm), [GO:1901674](http://purl.obolibrary.org/obo/GO_1901674) (regulation of histone H3-K27 acetylation), [GO:0060559](http://purl.obolibrary.org/obo/GO_0060559) (positive regulation of calcidiol 1-monooxygenase activity), [GO:0003143](http://purl.obolibrary.org/obo/GO_0003143) (embryonic heart tube morphogenesis), [GO:0061885](http://purl.obolibrary.org/obo/GO_0061885) (positive regulation of mini excitatory postsynaptic potential), [GO:0004476](http://purl.obolibrary.org/obo/GO_0004476) (mannose-6-phosphate isomerase activity), [GO:0004475](http://purl.obolibrary.org/obo/GO_0004475) (mannose-1-phosphate guanylyltransferase activity), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0004478](http://purl.obolibrary.org/obo/GO_0004478) (methionine adenosyltransferase activity), [GO:0004477](http://purl.obolibrary.org/obo/GO_0004477) (methenyltetrahydrofolate cyclohydrolase activity), [GO:0060557](http://purl.obolibrary.org/obo/GO_0060557) (positive regulation of vitamin D biosynthetic process), [GO:0003147](http://purl.obolibrary.org/obo/GO_0003147) (neural crest cell migration involved in heart formation), [GO:0004468](http://purl.obolibrary.org/obo/GO_0004468) (lysine N-acetyltransferase activity, acting on acetyl phosphate as donor), [GO:0003139](http://purl.obolibrary.org/obo/GO_0003139) (secondary heart field specification), [GO:0046272](http://purl.obolibrary.org/obo/GO_0046272) (stilbene catabolic process), [GO:0072534](http://purl.obolibrary.org/obo/GO_0072534) (perineuronal net), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0071203](http://purl.obolibrary.org/obo/GO_0071203) (WASH complex), [GO:2001012](http://purl.obolibrary.org/obo/GO_2001012) (mesenchymal cell differentiation involved in renal system development), [GO:0030730](http://purl.obolibrary.org/obo/GO_0030730) (sequestering of triglyceride), [GO:0016444](http://purl.obolibrary.org/obo/GO_0016444) (somatic cell DNA recombination), [GO:2001014](http://purl.obolibrary.org/obo/GO_2001014) (regulation of skeletal muscle cell differentiation), [GO:0016445](http://purl.obolibrary.org/obo/GO_0016445) (somatic diversification of immunoglobulins), [GO:2001015](http://purl.obolibrary.org/obo/GO_2001015) (negative regulation of skeletal muscle cell differentiation), [GO:0016446](http://purl.obolibrary.org/obo/GO_0016446) (somatic hypermutation of immunoglobulin genes), [GO:0015116](http://purl.obolibrary.org/obo/GO_0015116) (sulfate transmembrane transporter activity), [GO:0030731](http://purl.obolibrary.org/obo/GO_0030731) (guanidinoacetate N-methyltransferase activity), [GO:2001032](http://purl.obolibrary.org/obo/GO_2001032) (regulation of double-strand break repair via nonhomologous end joining), [GO:0060585](http://purl.obolibrary.org/obo/GO_0060585) (positive regulation of prostaglandin-endoperoxide synthase activity), [GO:0060586](http://purl.obolibrary.org/obo/GO_0060586) (multicellular organismal iron ion homeostasis), [GO:0016429](http://purl.obolibrary.org/obo/GO_0016429) (tRNA (adenine-N1-)-methyltransferase activity), [GO:1901684](http://purl.obolibrary.org/obo/GO_1901684) (arsenate ion transmembrane transport), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0060587](http://purl.obolibrary.org/obo/GO_0060587) (regulation of lipoprotein lipid oxidation), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0004445](http://purl.obolibrary.org/obo/GO_0004445) (inositol-polyphosphate 5-phosphatase activity), [GO:0005775](http://purl.obolibrary.org/obo/GO_0005775) (vacuolar lumen), [GO:0003104](http://purl.obolibrary.org/obo/GO_0003104) (positive regulation of glomerular filtration), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0003105](http://purl.obolibrary.org/obo/GO_0003105) (negative regulation of glomerular filtration), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0071233](http://purl.obolibrary.org/obo/GO_0071233) (cellular response to leucine), [GO:0004439](http://purl.obolibrary.org/obo/GO_0004439) (phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity), [GO:0072563](http://purl.obolibrary.org/obo/GO_0072563) (endothelial microparticle), [GO:0071231](http://purl.obolibrary.org/obo/GO_0071231) (cellular response to folic acid), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0030728](http://purl.obolibrary.org/obo/GO_0030728) (ovulation), [GO:2001028](http://purl.obolibrary.org/obo/GO_2001028) (positive regulation of endothelial cell chemotaxis), [GO:0071236](http://purl.obolibrary.org/obo/GO_0071236) (cellular response to antibiotic), [GO:2001025](http://purl.obolibrary.org/obo/GO_2001025) (positive regulation of response to drug), [GO:2001043](http://purl.obolibrary.org/obo/GO_2001043) (positive regulation of cell separation after cytokinesis), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:0015101](http://purl.obolibrary.org/obo/GO_0015101) (organic cation transmembrane transporter activity), [GO:1900364](http://purl.obolibrary.org/obo/GO_1900364) (negative regulation of mRNA polyadenylation), [GO:0060571](http://purl.obolibrary.org/obo/GO_0060571) (morphogenesis of an epithelial fold), [GO:2001040](http://purl.obolibrary.org/obo/GO_2001040) (positive regulation of cellular response to drug), [GO:0004450](http://purl.obolibrary.org/obo/GO_0004450) (isocitrate dehydrogenase (NADP+) activity), [GO:0030719](http://purl.obolibrary.org/obo/GO_0030719) (P granule organization), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005782](http://purl.obolibrary.org/obo/GO_0005782) (peroxisomal matrix), [GO:0005785](http://purl.obolibrary.org/obo/GO_0005785) (signal recognition particle receptor complex), [GO:0060576](http://purl.obolibrary.org/obo/GO_0060576) (intestinal epithelial cell development), [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis), [GO:0005784](http://purl.obolibrary.org/obo/GO_0005784) (Sec61 translocon complex), [GO:1900369](http://purl.obolibrary.org/obo/GO_1900369) (negative regulation of RNA interference), [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis), [GO:0060579](http://purl.obolibrary.org/obo/GO_0060579) (ventral spinal cord interneuron fate commitment), [GO:0005786](http://purl.obolibrary.org/obo/GO_0005786) (signal recognition particle, endoplasmic reticulum targeting), [GO:0005778](http://purl.obolibrary.org/obo/GO_0005778) (peroxisomal membrane), [GO:0004447](http://purl.obolibrary.org/obo/GO_0004447) (iodide peroxidase activity), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0004446](http://purl.obolibrary.org/obo/GO_0004446) (inositol-hexakisphosphate phosphatase activity), [GO:0004449](http://purl.obolibrary.org/obo/GO_0004449) (isocitrate dehydrogenase (NAD+) activity), [GO:0004448](http://purl.obolibrary.org/obo/GO_0004448) (isocitrate dehydrogenase activity), [GO:0005779](http://purl.obolibrary.org/obo/GO_0005779) (integral component of peroxisomal membrane), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0071223](http://purl.obolibrary.org/obo/GO_0071223) (cellular response to lipoteichoic acid), [GO:0071221](http://purl.obolibrary.org/obo/GO_0071221) (cellular response to bacterial lipopeptide), [GO:0071226](http://purl.obolibrary.org/obo/GO_0071226) (cellular response to molecule of fungal origin), [GO:0072558](http://purl.obolibrary.org/obo/GO_0072558) (NLRP1 inflammasome complex), [GO:0071224](http://purl.obolibrary.org/obo/GO_0071224) (cellular response to peptidoglycan), [GO:0071225](http://purl.obolibrary.org/obo/GO_0071225) (cellular response to muramyl dipeptide), [GO:0016421](http://purl.obolibrary.org/obo/GO_0016421) (CoA carboxylase activity), [GO:0046292](http://purl.obolibrary.org/obo/GO_0046292) (formaldehyde metabolic process), [GO:0016423](http://purl.obolibrary.org/obo/GO_0016423) (tRNA (guanine) methyltransferase activity), [GO:0072559](http://purl.obolibrary.org/obo/GO_0072559) (NLRP3 inflammasome complex), [GO:0071229](http://purl.obolibrary.org/obo/GO_0071229) (cellular response to acid chemical), [GO:2001037](http://purl.obolibrary.org/obo/GO_2001037) (positive regulation of tongue muscle cell differentiation), [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:2001055](http://purl.obolibrary.org/obo/GO_2001055) (positive regulation of mesenchymal cell apoptotic process), [GO:0003170](http://purl.obolibrary.org/obo/GO_0003170) (heart valve development), [GO:0003171](http://purl.obolibrary.org/obo/GO_0003171) (atrioventricular valve development), [GO:0015152](http://purl.obolibrary.org/obo/GO_0015152) (glucose-6-phosphate transmembrane transporter activity), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0003174](http://purl.obolibrary.org/obo/GO_0003174) (mitral valve development), [GO:0003175](http://purl.obolibrary.org/obo/GO_0003175) (tricuspid valve development), [GO:0042773](http://purl.obolibrary.org/obo/GO_0042773) (ATP synthesis coupled electron transport), [GO:0003176](http://purl.obolibrary.org/obo/GO_0003176) (aortic valve development), [GO:0042775](http://purl.obolibrary.org/obo/GO_0042775) (mitochondrial ATP synthesis coupled electron transport), [GO:0003179](http://purl.obolibrary.org/obo/GO_0003179) (heart valve morphogenesis), [GO:0042776](http://purl.obolibrary.org/obo/GO_0042776) (mitochondrial ATP synthesis coupled proton transport), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0042780](http://purl.obolibrary.org/obo/GO_0042780) (tRNA 3'-end processing), [GO:0016493](http://purl.obolibrary.org/obo/GO_0016493) (C-C chemokine receptor activity), [GO:0016495](http://purl.obolibrary.org/obo/GO_0016495) (C-X3-C chemokine receptor activity), [GO:2001045](http://purl.obolibrary.org/obo/GO_2001045) (negative regulation of integrin-mediated signaling pathway), [GO:2001046](http://purl.obolibrary.org/obo/GO_2001046) (positive regulation of integrin-mediated signaling pathway), [GO:0042789](http://purl.obolibrary.org/obo/GO_0042789) (mRNA transcription by RNA polymerase II), [GO:0003180](http://purl.obolibrary.org/obo/GO_0003180) (aortic valve morphogenesis), [GO:0000904](http://purl.obolibrary.org/obo/GO_0000904) (cell morphogenesis involved in differentiation), [GO:0003181](http://purl.obolibrary.org/obo/GO_0003181) (atrioventricular valve morphogenesis), [GO:0015165](http://purl.obolibrary.org/obo/GO_0015165) (pyrimidine nucleotide-sugar transmembrane transporter activity), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0003183](http://purl.obolibrary.org/obo/GO_0003183) (mitral valve morphogenesis), [GO:0003184](http://purl.obolibrary.org/obo/GO_0003184) (pulmonary valve morphogenesis), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0042781](http://purl.obolibrary.org/obo/GO_0042781) (3'-tRNA processing endoribonuclease activity), [GO:0003187](http://purl.obolibrary.org/obo/GO_0003187) (ventriculo bulbo valve morphogenesis), [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0042788](http://purl.obolibrary.org/obo/GO_0042788) (polysomal ribosome), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0042791](http://purl.obolibrary.org/obo/GO_0042791) (5S class rRNA transcription from RNA polymerase III type 1 promoter), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0016486](http://purl.obolibrary.org/obo/GO_0016486) (peptide hormone processing), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0052106](http://purl.obolibrary.org/obo/GO_0052106) (quorum sensing involved in interaction with host), [GO:0015137](http://purl.obolibrary.org/obo/GO_0015137) (citrate transmembrane transporter activity), [GO:0015136](http://purl.obolibrary.org/obo/GO_0015136) (sialic acid transmembrane transporter activity), [GO:0015132](http://purl.obolibrary.org/obo/GO_0015132) (prostaglandin transmembrane transporter activity), [GO:0003150](http://purl.obolibrary.org/obo/GO_0003150) (muscular septum morphogenesis), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:0004485](http://purl.obolibrary.org/obo/GO_0004485) (methylcrotonoyl-CoA carboxylase activity), [GO:0004487](http://purl.obolibrary.org/obo/GO_0004487) (methylenetetrahydrofolate dehydrogenase (NAD+) activity), [GO:0003156](http://purl.obolibrary.org/obo/GO_0003156) (regulation of animal organ formation), [GO:0003157](http://purl.obolibrary.org/obo/GO_0003157) (endocardium development), [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity), [GO:0042799](http://purl.obolibrary.org/obo/GO_0042799) (histone methyltransferase activity (H4-K20 specific)), [GO:0004488](http://purl.obolibrary.org/obo/GO_0004488) (methylenetetrahydrofolate dehydrogenase (NADP+) activity), [GO:0003158](http://purl.obolibrary.org/obo/GO_0003158) (endothelium development), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0003149](http://purl.obolibrary.org/obo/GO_0003149) (membranous septum morphogenesis), [GO:0004479](http://purl.obolibrary.org/obo/GO_0004479) (methionyl-tRNA formyltransferase activity), [GO:0016471](http://purl.obolibrary.org/obo/GO_0016471) (vacuolar proton-transporting V-type ATPase complex), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0015129](http://purl.obolibrary.org/obo/GO_0015129) (lactate transmembrane transporter activity), [GO:0015127](http://purl.obolibrary.org/obo/GO_0015127) (bilirubin transmembrane transporter activity), [GO:0016479](http://purl.obolibrary.org/obo/GO_0016479) (negative regulation of transcription by RNA polymerase I), [GO:0016458](http://purl.obolibrary.org/obo/GO_0016458) (gene silencing), [GO:0016459](http://purl.obolibrary.org/obo/GO_0016459) (myosin complex), [GO:0004490](http://purl.obolibrary.org/obo/GO_0004490) (methylglutaconyl-CoA hydratase activity), [GO:0003160](http://purl.obolibrary.org/obo/GO_0003160) (endocardium morphogenesis), [GO:0003161](http://purl.obolibrary.org/obo/GO_0003161) (cardiac conduction system development), [GO:0004491](http://purl.obolibrary.org/obo/GO_0004491) (methylmalonate-semialdehyde dehydrogenase (acylating) activity), [GO:0004494](http://purl.obolibrary.org/obo/GO_0004494) (methylmalonyl-CoA mutase activity), [GO:0004493](http://purl.obolibrary.org/obo/GO_0004493) (methylmalonyl-CoA epimerase activity), [GO:0004496](http://purl.obolibrary.org/obo/GO_0004496) (mevalonate kinase activity), [GO:0003166](http://purl.obolibrary.org/obo/GO_0003166) (bundle of His development), [GO:0004498](http://purl.obolibrary.org/obo/GO_0004498) (calcidiol 1-monooxygenase activity), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0003167](http://purl.obolibrary.org/obo/GO_0003167) (atrioventricular bundle cell differentiation), [GO:0003169](http://purl.obolibrary.org/obo/GO_0003169) (coronary vein morphogenesis), [GO:0016460](http://purl.obolibrary.org/obo/GO_0016460) (myosin II complex), [GO:0016461](http://purl.obolibrary.org/obo/GO_0016461) (unconventional myosin complex), [GO:0016462](http://purl.obolibrary.org/obo/GO_0016462) (pyrophosphatase activity), [GO:0042734](http://purl.obolibrary.org/obo/GO_0042734) (presynaptic membrane), [GO:0000938](http://purl.obolibrary.org/obo/GO_0000938) (GARP complex), [GO:0015199](http://purl.obolibrary.org/obo/GO_0015199) (amino-acid betaine transmembrane transporter activity), [GO:0042738](http://purl.obolibrary.org/obo/GO_0042738) (exogenous drug catabolic process), [GO:0015197](http://purl.obolibrary.org/obo/GO_0015197) (peptide transporter activity), [GO:0015195](http://purl.obolibrary.org/obo/GO_0015195) (L-threonine transmembrane transporter activity), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0015194](http://purl.obolibrary.org/obo/GO_0015194) (L-serine transmembrane transporter activity), [GO:0015193](http://purl.obolibrary.org/obo/GO_0015193) (L-proline transmembrane transporter activity), [GO:0000930](http://purl.obolibrary.org/obo/GO_0000930) (gamma-tubulin complex), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0015191](http://purl.obolibrary.org/obo/GO_0015191) (L-methionine transmembrane transporter activity), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0071294](http://purl.obolibrary.org/obo/GO_0071294) (cellular response to zinc ion), [GO:0042745](http://purl.obolibrary.org/obo/GO_0042745) (circadian sleep/wake cycle), [GO:0042746](http://purl.obolibrary.org/obo/GO_0042746) (circadian sleep/wake cycle, wakefulness), [GO:0000940](http://purl.obolibrary.org/obo/GO_0000940) (condensed chromosome outer kinetochore), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0042743](http://purl.obolibrary.org/obo/GO_0042743) (hydrogen peroxide metabolic process), [GO:0042744](http://purl.obolibrary.org/obo/GO_0042744) (hydrogen peroxide catabolic process), [GO:0071285](http://purl.obolibrary.org/obo/GO_0071285) (cellular response to lithium ion), [GO:0071283](http://purl.obolibrary.org/obo/GO_0071283) (cellular response to iron(III) ion), [GO:0071286](http://purl.obolibrary.org/obo/GO_0071286) (cellular response to magnesium ion), [GO:0071287](http://purl.obolibrary.org/obo/GO_0071287) (cellular response to manganese ion), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0042758](http://purl.obolibrary.org/obo/GO_0042758) (long-chain fatty acid catabolic process), [GO:0015179](http://purl.obolibrary.org/obo/GO_0015179) (L-amino acid transmembrane transporter activity), [GO:0003190](http://purl.obolibrary.org/obo/GO_0003190) (atrioventricular valve formation), [GO:0042759](http://purl.obolibrary.org/obo/GO_0042759) (long-chain fatty acid biosynthetic process), [GO:0000915](http://purl.obolibrary.org/obo/GO_0000915) (actomyosin contractile ring assembly), [GO:0003192](http://purl.obolibrary.org/obo/GO_0003192) (mitral valve formation), [GO:0003193](http://purl.obolibrary.org/obo/GO_0003193) (pulmonary valve formation), [GO:0015175](http://purl.obolibrary.org/obo/GO_0015175) (neutral amino acid transmembrane transporter activity), [GO:0015174](http://purl.obolibrary.org/obo/GO_0015174) (basic amino acid transmembrane transporter activity), [GO:0003195](http://purl.obolibrary.org/obo/GO_0003195) (tricuspid valve formation), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0003197](http://purl.obolibrary.org/obo/GO_0003197) (endocardial cushion development), [GO:0015171](http://purl.obolibrary.org/obo/GO_0015171) (amino acid transmembrane transporter activity), [GO:0003198](http://purl.obolibrary.org/obo/GO_0003198) (epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0042752](http://purl.obolibrary.org/obo/GO_0042752) (regulation of circadian rhythm), [GO:0042753](http://purl.obolibrary.org/obo/GO_0042753) (positive regulation of circadian rhythm), [GO:0042754](http://purl.obolibrary.org/obo/GO_0042754) (negative regulation of circadian rhythm), [GO:0042755](http://purl.obolibrary.org/obo/GO_0042755) (eating behavior), [GO:0102991](http://purl.obolibrary.org/obo/GO_0102991) (myristoyl-CoA hydrolase activity), [GO:0042769](http://purl.obolibrary.org/obo/GO_0042769) (DNA damage response, detection of DNA damage), [GO:0015189](http://purl.obolibrary.org/obo/GO_0015189) (L-lysine transmembrane transporter activity), [GO:0015188](http://purl.obolibrary.org/obo/GO_0015188) (L-isoleucine transmembrane transporter activity), [GO:0015187](http://purl.obolibrary.org/obo/GO_0015187) (glycine transmembrane transporter activity), [GO:0015186](http://purl.obolibrary.org/obo/GO_0015186) (L-glutamine transmembrane transporter activity), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0015184](http://purl.obolibrary.org/obo/GO_0015184) (L-cystine transmembrane transporter activity), [GO:0042760](http://purl.obolibrary.org/obo/GO_0042760) (very long-chain fatty acid catabolic process), [GO:0015183](http://purl.obolibrary.org/obo/GO_0015183) (L-aspartate transmembrane transporter activity), [GO:0000921](http://purl.obolibrary.org/obo/GO_0000921) (septin ring assembly), [GO:0042761](http://purl.obolibrary.org/obo/GO_0042761) (very long-chain fatty acid biosynthetic process), [GO:0000920](http://purl.obolibrary.org/obo/GO_0000920) (cell separation after cytokinesis), [GO:0015180](http://purl.obolibrary.org/obo/GO_0015180) (L-alanine transmembrane transporter activity), [GO:0042764](http://purl.obolibrary.org/obo/GO_0042764) (ascospore-type prospore), [GO:0042765](http://purl.obolibrary.org/obo/GO_0042765) (GPI-anchor transamidase complex), [GO:0042766](http://purl.obolibrary.org/obo/GO_0042766) (nucleosome mobilization), [GO:1905144](http://purl.obolibrary.org/obo/GO_1905144) (response to acetylcholine), [GO:0090335](http://purl.obolibrary.org/obo/GO_0090335) (regulation of brown fat cell differentiation), [GO:0090336](http://purl.obolibrary.org/obo/GO_0090336) (positive regulation of brown fat cell differentiation), [GO:0090331](http://purl.obolibrary.org/obo/GO_0090331) (negative regulation of platelet aggregation), [GO:1905146](http://purl.obolibrary.org/obo/GO_1905146) (lysosomal protein catabolic process), [GO:0048808](http://purl.obolibrary.org/obo/GO_0048808) (male genitalia morphogenesis), [GO:0048807](http://purl.obolibrary.org/obo/GO_0048807) (female genitalia morphogenesis), [GO:0090346](http://purl.obolibrary.org/obo/GO_0090346) (cellular organofluorine metabolic process), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0009200](http://purl.obolibrary.org/obo/GO_0009200) (deoxyribonucleoside triphosphate metabolic process), [GO:0090342](http://purl.obolibrary.org/obo/GO_0090342) (regulation of cell aging), [GO:0009202](http://purl.obolibrary.org/obo/GO_0009202) (deoxyribonucleoside triphosphate biosynthetic process), [GO:0090316](http://purl.obolibrary.org/obo/GO_0090316) (positive regulation of intracellular protein transport), [GO:1905165](http://purl.obolibrary.org/obo/GO_1905165) (regulation of lysosomal protein catabolic process), [GO:0090314](http://purl.obolibrary.org/obo/GO_0090314) (positive regulation of protein targeting to membrane), [GO:0090312](http://purl.obolibrary.org/obo/GO_0090312) (positive regulation of protein deacetylation), [GO:1905168](http://purl.obolibrary.org/obo/GO_1905168) (positive regulation of double-strand break repair via homologous recombination), [GO:0090310](http://purl.obolibrary.org/obo/GO_0090310) (negative regulation of methylation-dependent chromatin silencing), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0015095](http://purl.obolibrary.org/obo/GO_0015095) (magnesium ion transmembrane transporter activity), [GO:0015093](http://purl.obolibrary.org/obo/GO_0015093) (ferrous iron transmembrane transporter activity), [GO:0015091](http://purl.obolibrary.org/obo/GO_0015091) (ferric iron transmembrane transporter activity), [GO:0048814](http://purl.obolibrary.org/obo/GO_0048814) (regulation of dendrite morphogenesis), [GO:0048813](http://purl.obolibrary.org/obo/GO_0048813) (dendrite morphogenesis), [GO:0090319](http://purl.obolibrary.org/obo/GO_0090319) (positive regulation of chylomicron remodeling), [GO:1905176](http://purl.obolibrary.org/obo/GO_1905176) (positive regulation of vascular smooth muscle cell dedifferentiation), [GO:0090324](http://purl.obolibrary.org/obo/GO_0090324) (negative regulation of oxidative phosphorylation), [GO:0090321](http://purl.obolibrary.org/obo/GO_0090321) (positive regulation of chylomicron remnant clearance), [GO:0048823](http://purl.obolibrary.org/obo/GO_0048823) (nucleate erythrocyte development), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0048820](http://purl.obolibrary.org/obo/GO_0048820) (hair follicle maturation), [GO:1902902](http://purl.obolibrary.org/obo/GO_1902902) (negative regulation of autophagosome assembly), [GO:0040038](http://purl.obolibrary.org/obo/GO_0040038) (polar body extrusion after meiotic divisions), [GO:0040037](http://purl.obolibrary.org/obo/GO_0040037) (negative regulation of fibroblast growth factor receptor signaling pathway), [GO:0040036](http://purl.obolibrary.org/obo/GO_0040036) (regulation of fibroblast growth factor receptor signaling pathway), [GO:0035520](http://purl.obolibrary.org/obo/GO_0035520) (monoubiquitinated protein deubiquitination), [GO:1905103](http://purl.obolibrary.org/obo/GO_1905103) (integral component of lysosomal membrane), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0042694](http://purl.obolibrary.org/obo/GO_0042694) (muscle cell fate specification), [GO:0009236](http://purl.obolibrary.org/obo/GO_0009236) (cobalamin biosynthetic process), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0042696](http://purl.obolibrary.org/obo/GO_0042696) (menarche), [GO:0009234](http://purl.obolibrary.org/obo/GO_0009234) (menaquinone biosynthetic process), [GO:0042698](http://purl.obolibrary.org/obo/GO_0042698) (ovulation cycle), [GO:0042699](http://purl.obolibrary.org/obo/GO_0042699) (follicle-stimulating hormone signaling pathway), [GO:0035518](http://purl.obolibrary.org/obo/GO_0035518) (histone H2A monoubiquitination), [GO:0035515](http://purl.obolibrary.org/obo/GO_0035515) (oxidative RNA demethylase activity), [GO:0035516](http://purl.obolibrary.org/obo/GO_0035516) (oxidative DNA demethylase activity), [GO:0010216](http://purl.obolibrary.org/obo/GO_0010216) (maintenance of DNA methylation), [GO:0035517](http://purl.obolibrary.org/obo/GO_0035517) (PR-DUB complex), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0035513](http://purl.obolibrary.org/obo/GO_0035513) (oxidative RNA demethylation), [GO:0090305](http://purl.obolibrary.org/obo/GO_0090305) (nucleic acid phosphodiester bond hydrolysis), [GO:0090303](http://purl.obolibrary.org/obo/GO_0090303) (positive regulation of wound healing), [GO:0090301](http://purl.obolibrary.org/obo/GO_0090301) (negative regulation of neural crest formation), [GO:0009249](http://purl.obolibrary.org/obo/GO_0009249) (protein lipoylation), [GO:0035509](http://purl.obolibrary.org/obo/GO_0035509) (negative regulation of myosin-light-chain-phosphatase activity), [GO:0010226](http://purl.obolibrary.org/obo/GO_0010226) (response to lithium ion), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0090309](http://purl.obolibrary.org/obo/GO_0090309) (positive regulation of methylation-dependent chromatin silencing), [GO:0010224](http://purl.obolibrary.org/obo/GO_0010224) (response to UV-B), [GO:0090306](http://purl.obolibrary.org/obo/GO_0090306) (spindle assembly involved in meiosis), [GO:0090307](http://purl.obolibrary.org/obo/GO_0090307) (mitotic spindle assembly), [GO:1905123](http://purl.obolibrary.org/obo/GO_1905123) (regulation of glucosylceramidase activity), [GO:1905122](http://purl.obolibrary.org/obo/GO_1905122) (polyamine import), [GO:0009213](http://purl.obolibrary.org/obo/GO_0009213) (pyrimidine deoxyribonucleoside triphosphate catabolic process), [GO:0009217](http://purl.obolibrary.org/obo/GO_0009217) (purine deoxyribonucleoside triphosphate catabolic process), [GO:0009229](http://purl.obolibrary.org/obo/GO_0009229) (thiamine diphosphate biosynthetic process), [GO:0009272](http://purl.obolibrary.org/obo/GO_0009272) (fungal-type cell wall biogenesis), [GO:0035562](http://purl.obolibrary.org/obo/GO_0035562) (negative regulation of chromatin binding), [GO:0035563](http://purl.obolibrary.org/obo/GO_0035563) (positive regulation of chromatin binding), [GO:0060520](http://purl.obolibrary.org/obo/GO_0060520) (activation of prostate induction by androgen receptor signaling pathway), [GO:0009277](http://purl.obolibrary.org/obo/GO_0009277) (fungal-type cell wall), [GO:0048878](http://purl.obolibrary.org/obo/GO_0048878) (chemical homeostasis), [GO:1901620](http://purl.obolibrary.org/obo/GO_1901620) (regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0048877](http://purl.obolibrary.org/obo/GO_0048877) (homeostasis of number of retina cells), [GO:0061857](http://purl.obolibrary.org/obo/GO_0061857) (endoplasmic reticulum stress-induced pre-emptive quality control), [GO:1902953](http://purl.obolibrary.org/obo/GO_1902953) (positive regulation of ER to Golgi vesicle-mediated transport), [GO:1902950](http://purl.obolibrary.org/obo/GO_1902950) (regulation of dendritic spine maintenance), [GO:0060527](http://purl.obolibrary.org/obo/GO_0060527) (prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis), [GO:1901622](http://purl.obolibrary.org/obo/GO_1901622) (positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0047545](http://purl.obolibrary.org/obo/GO_0047545) (2-hydroxyglutarate dehydrogenase activity), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0048875](http://purl.obolibrary.org/obo/GO_0048875) (chemical homeostasis within a tissue), [GO:0060523](http://purl.obolibrary.org/obo/GO_0060523) (prostate epithelial cord elongation), [GO:1901626](http://purl.obolibrary.org/obo/GO_1901626) (regulation of postsynaptic membrane organization), [GO:0060529](http://purl.obolibrary.org/obo/GO_0060529) (squamous basal epithelial stem cell differentiation involved in prostate gland acinus development), [GO:0048884](http://purl.obolibrary.org/obo/GO_0048884) (neuromast development), [GO:0048882](http://purl.obolibrary.org/obo/GO_0048882) (lateral line development), [GO:0010259](http://purl.obolibrary.org/obo/GO_0010259) (multicellular organism aging), [GO:0034225](http://purl.obolibrary.org/obo/GO_0034225) (regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0034224](http://purl.obolibrary.org/obo/GO_0034224) (cellular response to zinc ion starvation), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0010257](http://purl.obolibrary.org/obo/GO_0010257) (NADH dehydrogenase complex assembly), [GO:0010256](http://purl.obolibrary.org/obo/GO_0010256) (endomembrane system organization), [GO:0010273](http://purl.obolibrary.org/obo/GO_0010273) (detoxification of copper ion), [GO:0035552](http://purl.obolibrary.org/obo/GO_0035552) (oxidative single-stranded DNA demethylation), [GO:0035553](http://purl.obolibrary.org/obo/GO_0035553) (oxidative single-stranded RNA demethylation), [GO:0034221](http://purl.obolibrary.org/obo/GO_0034221) (fungal-type cell wall chitin biosynthetic process), [GO:0034220](http://purl.obolibrary.org/obo/GO_0034220) (ion transmembrane transport), [GO:0060516](http://purl.obolibrary.org/obo/GO_0060516) (primary prostatic bud elongation), [GO:0060517](http://purl.obolibrary.org/obo/GO_0060517) (epithelial cell proliferation involved in prostatic bud elongation), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0060512](http://purl.obolibrary.org/obo/GO_0060512) (prostate gland morphogenesis), [GO:0060513](http://purl.obolibrary.org/obo/GO_0060513) (prostatic bud formation), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:1902966](http://purl.obolibrary.org/obo/GO_1902966) (positive regulation of protein localization to early endosome), [GO:0048890](http://purl.obolibrary.org/obo/GO_0048890) (lateral line ganglion development), [GO:0048894](http://purl.obolibrary.org/obo/GO_0048894) (efferent axon development in a lateral line nerve), [GO:0034214](http://purl.obolibrary.org/obo/GO_0034214) (protein hexamerization), [GO:0035549](http://purl.obolibrary.org/obo/GO_0035549) (positive regulation of interferon-beta secretion), [GO:0034212](http://purl.obolibrary.org/obo/GO_0034212) (peptide N-acetyltransferase activity), [GO:0034219](http://purl.obolibrary.org/obo/GO_0034219) (carbohydrate transmembrane transport), [GO:0035545](http://purl.obolibrary.org/obo/GO_0035545) (determination of left/right asymmetry in nervous system), [GO:0061870](http://purl.obolibrary.org/obo/GO_0061870) (positive regulation of hepatic stellate cell migration), [GO:0060541](http://purl.obolibrary.org/obo/GO_0060541) (respiratory system development), [GO:0090399](http://purl.obolibrary.org/obo/GO_0090399) (replicative senescence), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0009259](http://purl.obolibrary.org/obo/GO_0009259) (ribonucleotide metabolic process), [GO:1901642](http://purl.obolibrary.org/obo/GO_1901642) (nucleoside transmembrane transport), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0047568](http://purl.obolibrary.org/obo/GO_0047568) (3-oxo-5-beta-steroid 4-dehydrogenase activity), [GO:0048899](http://purl.obolibrary.org/obo/GO_0048899) (anterior lateral line development), [GO:0009257](http://purl.obolibrary.org/obo/GO_0009257) (10-formyltetrahydrofolate biosynthetic process), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0061874](http://purl.obolibrary.org/obo/GO_0061874) (positive regulation of hepatic stellate cell contraction), [GO:0060544](http://purl.obolibrary.org/obo/GO_0060544) (regulation of necroptotic process), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:1902977](http://purl.obolibrary.org/obo/GO_1902977) (mitotic DNA replication preinitiation complex assembly), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:0034203](http://purl.obolibrary.org/obo/GO_0034203) (glycolipid translocation), [GO:0035539](http://purl.obolibrary.org/obo/GO_0035539) (8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity), [GO:0034205](http://purl.obolibrary.org/obo/GO_0034205) (amyloid-beta formation), [GO:0009262](http://purl.obolibrary.org/obo/GO_0009262) (deoxyribonucleotide metabolic process), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0009263](http://purl.obolibrary.org/obo/GO_0009263) (deoxyribonucleotide biosynthetic process), [GO:1901653](http://purl.obolibrary.org/obo/GO_1901653) (cellular response to peptide), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:0060537](http://purl.obolibrary.org/obo/GO_0060537) (muscle tissue development), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0060539](http://purl.obolibrary.org/obo/GO_0060539) (diaphragm development), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0060532](http://purl.obolibrary.org/obo/GO_0060532) (bronchus cartilage development), [GO:1901657](http://purl.obolibrary.org/obo/GO_1901657) (glycosyl compound metabolic process), [GO:0060534](http://purl.obolibrary.org/obo/GO_0060534) (trachea cartilage development), [GO:0035529](http://purl.obolibrary.org/obo/GO_0035529) (NADH pyrophosphatase activity), [GO:0072513](http://purl.obolibrary.org/obo/GO_0072513) (positive regulation of secondary heart field cardioblast proliferation), [GO:0035522](http://purl.obolibrary.org/obo/GO_0035522) (monoubiquitinated histone H2A deubiquitination), [GO:0035524](http://purl.obolibrary.org/obo/GO_0035524) (proline transmembrane transport), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0090370](http://purl.obolibrary.org/obo/GO_0090370) (negative regulation of cholesterol efflux), [GO:1902910](http://purl.obolibrary.org/obo/GO_1902910) (positive regulation of melanosome transport), [GO:1902906](http://purl.obolibrary.org/obo/GO_1902906) (proteasome storage granule assembly), [GO:0048841](http://purl.obolibrary.org/obo/GO_0048841) (regulation of axon extension involved in axon guidance), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:1902908](http://purl.obolibrary.org/obo/GO_1902908) (regulation of melanosome transport), [GO:0035598](http://purl.obolibrary.org/obo/GO_0035598) (N6-threonylcarbomyladenosine methylthiotransferase activity), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0035590](http://purl.obolibrary.org/obo/GO_0035590) (purinergic nucleotide receptor signaling pathway), [GO:0035591](http://purl.obolibrary.org/obo/GO_0035591) (signaling adaptor activity), [GO:0090389](http://purl.obolibrary.org/obo/GO_0090389) (phagosome-lysosome fusion involved in apoptotic cell clearance), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0048843](http://purl.obolibrary.org/obo/GO_0048843) (negative regulation of axon extension involved in axon guidance), [GO:0048842](http://purl.obolibrary.org/obo/GO_0048842) (positive regulation of axon extension involved in axon guidance), [GO:0005721](http://purl.obolibrary.org/obo/GO_0005721) (pericentric heterochromatin), [GO:0048846](http://purl.obolibrary.org/obo/GO_0048846) (axon extension involved in axon guidance), [GO:0005720](http://purl.obolibrary.org/obo/GO_0005720) (nuclear heterochromatin), [GO:0005712](http://purl.obolibrary.org/obo/GO_0005712) (chiasma), [GO:1902915](http://purl.obolibrary.org/obo/GO_1902915) (negative regulation of protein polyubiquitination), [GO:0048852](http://purl.obolibrary.org/obo/GO_0048852) (diencephalon morphogenesis), [GO:0048850](http://purl.obolibrary.org/obo/GO_0048850) (hypophysis morphogenesis), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:0034258](http://purl.obolibrary.org/obo/GO_0034258) (nicotinamide riboside transport), [GO:0034257](http://purl.obolibrary.org/obo/GO_0034257) (nicotinamide riboside transmembrane transporter activity), [GO:0035583](http://purl.obolibrary.org/obo/GO_0035583) (sequestering of TGFbeta in extracellular matrix), [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source), [GO:0009298](http://purl.obolibrary.org/obo/GO_0009298) (GDP-mannose biosynthetic process), [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development), [GO:0060503](http://purl.obolibrary.org/obo/GO_0060503) (bud dilation involved in lung branching), [GO:0048855](http://purl.obolibrary.org/obo/GO_0048855) (adenohypophysis morphogenesis), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0048859](http://purl.obolibrary.org/obo/GO_0048859) (formation of anatomical boundary), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0048858](http://purl.obolibrary.org/obo/GO_0048858) (cell projection morphogenesis), [GO:0060502](http://purl.obolibrary.org/obo/GO_0060502) (epithelial cell proliferation involved in lung morphogenesis), [GO:0048863](http://purl.obolibrary.org/obo/GO_0048863) (stem cell differentiation), [GO:0060509](http://purl.obolibrary.org/obo/GO_0060509) (Type I pneumocyte differentiation), [GO:0034247](http://purl.obolibrary.org/obo/GO_0034247) (snoRNA splicing), [GO:0090368](http://purl.obolibrary.org/obo/GO_0090368) (regulation of ornithine metabolic process), [GO:0035574](http://purl.obolibrary.org/obo/GO_0035574) (histone H4-K20 demethylation), [GO:0090369](http://purl.obolibrary.org/obo/GO_0090369) (ornithine carbamoyltransferase inhibitor activity), [GO:0035575](http://purl.obolibrary.org/obo/GO_0035575) (histone demethylase activity (H4-K20 specific)), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0034243](http://purl.obolibrary.org/obo/GO_0034243) (regulation of transcription elongation from RNA polymerase II promoter), [GO:0090365](http://purl.obolibrary.org/obo/GO_0090365) (regulation of mRNA modification), [GO:0034241](http://purl.obolibrary.org/obo/GO_0034241) (positive regulation of macrophage fusion), [GO:0048866](http://purl.obolibrary.org/obo/GO_0048866) (stem cell fate specification), [GO:0048865](http://purl.obolibrary.org/obo/GO_0048865) (stem cell fate commitment), [GO:0048864](http://purl.obolibrary.org/obo/GO_0048864) (stem cell development), [GO:0046208](http://purl.obolibrary.org/obo/GO_0046208) (spermine catabolic process), [GO:1901612](http://purl.obolibrary.org/obo/GO_1901612) (cardiolipin binding), [GO:0061820](http://purl.obolibrary.org/obo/GO_0061820) (telomeric D-loop disassembly), [GO:0046209](http://purl.obolibrary.org/obo/GO_0046209) (nitric oxide metabolic process), [GO:0061821](http://purl.obolibrary.org/obo/GO_0061821) (telomeric D-loop binding), [GO:0048870](http://purl.obolibrary.org/obo/GO_0048870) (cell motility), [GO:1902936](http://purl.obolibrary.org/obo/GO_1902936) (phosphatidylinositol bisphosphate binding), [GO:1902937](http://purl.obolibrary.org/obo/GO_1902937) (inward rectifier potassium channel complex), [GO:0061827](http://purl.obolibrary.org/obo/GO_0061827) (sperm head), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0048872](http://purl.obolibrary.org/obo/GO_0048872) (homeostasis of number of cells), [GO:0048871](http://purl.obolibrary.org/obo/GO_0048871) (multicellular organismal homeostasis), [GO:0046210](http://purl.obolibrary.org/obo/GO_0046210) (nitric oxide catabolic process), [GO:0034237](http://purl.obolibrary.org/obo/GO_0034237) (protein kinase A regulatory subunit binding), [GO:0034236](http://purl.obolibrary.org/obo/GO_0034236) (protein kinase A catalytic subunit binding), [GO:0035565](http://purl.obolibrary.org/obo/GO_0035565) (regulation of pronephros size), [GO:0010288](http://purl.obolibrary.org/obo/GO_0010288) (response to lead ion), [GO:0035566](http://purl.obolibrary.org/obo/GO_0035566) (regulation of metanephros size), [GO:0035567](http://purl.obolibrary.org/obo/GO_0035567) (non-canonical Wnt signaling pathway), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0016528](http://purl.obolibrary.org/obo/GO_0016528) (sarcoplasm), [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum), [GO:1901585](http://purl.obolibrary.org/obo/GO_1901585) (regulation of acid-sensing ion channel activity), [GO:0005871](http://purl.obolibrary.org/obo/GO_0005871) (kinesin complex), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0071380](http://purl.obolibrary.org/obo/GO_0071380) (cellular response to prostaglandin E stimulus), [GO:0003211](http://purl.obolibrary.org/obo/GO_0003211) (cardiac ventricle formation), [GO:0005875](http://purl.obolibrary.org/obo/GO_0005875) (microtubule associated complex), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0003203](http://purl.obolibrary.org/obo/GO_0003203) (endocardial cushion morphogenesis), [GO:0071372](http://purl.obolibrary.org/obo/GO_0071372) (cellular response to follicle-stimulating hormone stimulus), [GO:0004535](http://purl.obolibrary.org/obo/GO_0004535) (poly(A)-specific ribonuclease activity), [GO:0005865](http://purl.obolibrary.org/obo/GO_0005865) (striated muscle thin filament), [GO:0071373](http://purl.obolibrary.org/obo/GO_0071373) (cellular response to luteinizing hormone stimulus), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0005868](http://purl.obolibrary.org/obo/GO_0005868) (cytoplasmic dynein complex), [GO:0004536](http://purl.obolibrary.org/obo/GO_0004536) (deoxyribonuclease activity), [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0003206](http://purl.obolibrary.org/obo/GO_0003206) (cardiac chamber morphogenesis), [GO:0030823](http://purl.obolibrary.org/obo/GO_0030823) (regulation of cGMP metabolic process), [GO:0071376](http://purl.obolibrary.org/obo/GO_0071376) (cellular response to corticotropin-releasing hormone stimulus), [GO:0003207](http://purl.obolibrary.org/obo/GO_0003207) (cardiac chamber formation), [GO:0030825](http://purl.obolibrary.org/obo/GO_0030825) (positive regulation of cGMP metabolic process), [GO:0005869](http://purl.obolibrary.org/obo/GO_0005869) (dynactin complex), [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis), [GO:0071377](http://purl.obolibrary.org/obo/GO_0071377) (cellular response to glucagon stimulus), [GO:0045098](http://purl.obolibrary.org/obo/GO_0045098) (type III intermediate filament), [GO:0003209](http://purl.obolibrary.org/obo/GO_0003209) (cardiac atrium morphogenesis), [GO:0030828](http://purl.obolibrary.org/obo/GO_0030828) (positive regulation of cGMP biosynthetic process), [GO:0071374](http://purl.obolibrary.org/obo/GO_0071374) (cellular response to parathyroid hormone stimulus), [GO:0071375](http://purl.obolibrary.org/obo/GO_0071375) (cellular response to peptide hormone stimulus), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0016532](http://purl.obolibrary.org/obo/GO_0016532) (superoxide dismutase copper chaperone activity), [GO:0016514](http://purl.obolibrary.org/obo/GO_0016514) (SWI/SNF complex), [GO:0042823](http://purl.obolibrary.org/obo/GO_0042823) (pyridoxal phosphate biosynthetic process), [GO:0042824](http://purl.obolibrary.org/obo/GO_0042824) (MHC class I peptide loading complex), [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body), [GO:0042825](http://purl.obolibrary.org/obo/GO_0042825) (TAP complex), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0042827](http://purl.obolibrary.org/obo/GO_0042827) (platelet dense granule), [GO:0016519](http://purl.obolibrary.org/obo/GO_0016519) (gastric inhibitory peptide receptor activity), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0005880](http://purl.obolibrary.org/obo/GO_0005880) (nuclear microtubule), [GO:0030818](http://purl.obolibrary.org/obo/GO_0030818) (negative regulation of cAMP biosynthetic process), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0004551](http://purl.obolibrary.org/obo/GO_0004551) (nucleotide diphosphatase activity), [GO:0005881](http://purl.obolibrary.org/obo/GO_0005881) (cytoplasmic microtubule), [GO:0004550](http://purl.obolibrary.org/obo/GO_0004550) (nucleoside diphosphate kinase activity), [GO:0005884](http://purl.obolibrary.org/obo/GO_0005884) (actin filament), [GO:0033092](http://purl.obolibrary.org/obo/GO_0033092) (positive regulation of immature T cell proliferation in thymus), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0003221](http://purl.obolibrary.org/obo/GO_0003221) (right ventricular cardiac muscle tissue morphogenesis), [GO:0005883](http://purl.obolibrary.org/obo/GO_0005883) (neurofilament), [GO:0003222](http://purl.obolibrary.org/obo/GO_0003222) (ventricular trabecula myocardium morphogenesis), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0003223](http://purl.obolibrary.org/obo/GO_0003223) (ventricular compact myocardium morphogenesis), [GO:0004555](http://purl.obolibrary.org/obo/GO_0004555) (alpha,alpha-trehalase activity), [GO:0005885](http://purl.obolibrary.org/obo/GO_0005885) (Arp2/3 protein complex), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0003214](http://purl.obolibrary.org/obo/GO_0003214) (cardiac left ventricle morphogenesis), [GO:0005876](http://purl.obolibrary.org/obo/GO_0005876) (spindle microtubule), [GO:0003215](http://purl.obolibrary.org/obo/GO_0003215) (cardiac right ventricle morphogenesis), [GO:0005879](http://purl.obolibrary.org/obo/GO_0005879) (axonemal microtubule), [GO:0071360](http://purl.obolibrary.org/obo/GO_0071360) (cellular response to exogenous dsRNA), [GO:0003218](http://purl.obolibrary.org/obo/GO_0003218) (cardiac left ventricle formation), [GO:0070034](http://purl.obolibrary.org/obo/GO_0070034) (telomerase RNA binding), [GO:0030814](http://purl.obolibrary.org/obo/GO_0030814) (regulation of cAMP metabolic process), [GO:0004549](http://purl.obolibrary.org/obo/GO_0004549) (tRNA-specific ribonuclease activity), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0070032](http://purl.obolibrary.org/obo/GO_0070032) (synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0070037](http://purl.obolibrary.org/obo/GO_0070037) (rRNA (pseudouridine) methyltransferase activity), [GO:0016520](http://purl.obolibrary.org/obo/GO_0016520) (growth hormone-releasing hormone receptor activity), [GO:0033085](http://purl.obolibrary.org/obo/GO_0033085) (negative regulation of T cell differentiation in thymus), [GO:0042834](http://purl.obolibrary.org/obo/GO_0042834) (peptidoglycan binding), [GO:0016504](http://purl.obolibrary.org/obo/GO_0016504) (peptidase activator activity), [GO:1900272](http://purl.obolibrary.org/obo/GO_1900272) (negative regulation of long-term synaptic potentiation), [GO:1900271](http://purl.obolibrary.org/obo/GO_1900271) (regulation of long-term synaptic potentiation), [GO:0016505](http://purl.obolibrary.org/obo/GO_0016505) (peptidase activator activity involved in apoptotic process), [GO:0033089](http://purl.obolibrary.org/obo/GO_0033089) (positive regulation of T cell differentiation in thymus), [GO:0033088](http://purl.obolibrary.org/obo/GO_0033088) (negative regulation of immature T cell proliferation in thymus), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0016507](http://purl.obolibrary.org/obo/GO_0016507) (mitochondrial fatty acid beta-oxidation multienzyme complex), [GO:0033087](http://purl.obolibrary.org/obo/GO_0033087) (negative regulation of immature T cell proliferation), [GO:0016508](http://purl.obolibrary.org/obo/GO_0016508) (long-chain-enoyl-CoA hydratase activity), [GO:0016509](http://purl.obolibrary.org/obo/GO_0016509) (long-chain-3-hydroxyacyl-CoA dehydrogenase activity), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0033081](http://purl.obolibrary.org/obo/GO_0033081) (regulation of T cell differentiation in thymus), [GO:0033080](http://purl.obolibrary.org/obo/GO_0033080) (immature T cell proliferation in thymus), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0005852](http://purl.obolibrary.org/obo/GO_0005852) (eukaryotic translation initiation factor 3 complex), [GO:0004521](http://purl.obolibrary.org/obo/GO_0004521) (endoribonuclease activity), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0005844](http://purl.obolibrary.org/obo/GO_0005844) (polysome), [GO:0071394](http://purl.obolibrary.org/obo/GO_0071394) (cellular response to testosterone stimulus), [GO:0070064](http://purl.obolibrary.org/obo/GO_0070064) (proline-rich region binding), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0071392](http://purl.obolibrary.org/obo/GO_0071392) (cellular response to estradiol stimulus), [GO:0070061](http://purl.obolibrary.org/obo/GO_0070061) (fructose binding), [GO:0004515](http://purl.obolibrary.org/obo/GO_0004515) (nicotinate-nucleotide adenylyltransferase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071393](http://purl.obolibrary.org/obo/GO_0071393) (cellular response to progesterone stimulus), [GO:0004517](http://purl.obolibrary.org/obo/GO_0004517) (nitric-oxide synthase activity), [GO:0071398](http://purl.obolibrary.org/obo/GO_0071398) (cellular response to fatty acid), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0005849](http://purl.obolibrary.org/obo/GO_0005849) (mRNA cleavage factor complex), [GO:0070069](http://purl.obolibrary.org/obo/GO_0070069) (cytochrome complex), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0005862](http://purl.obolibrary.org/obo/GO_0005862) (muscle thin filament tropomyosin), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0005861](http://purl.obolibrary.org/obo/GO_0005861) (troponin complex), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0004523](http://purl.obolibrary.org/obo/GO_0004523) (RNA-DNA hybrid ribonuclease activity), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0070053](http://purl.obolibrary.org/obo/GO_0070053) (thrombospondin receptor activity), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0070051](http://purl.obolibrary.org/obo/GO_0070051) (fibrinogen binding), [GO:0005859](http://purl.obolibrary.org/obo/GO_0005859) (muscle myosin complex), [GO:0004528](http://purl.obolibrary.org/obo/GO_0004528) (phosphodiesterase I activity), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0005858](http://purl.obolibrary.org/obo/GO_0005858) (axonemal dynein complex), [GO:0070058](http://purl.obolibrary.org/obo/GO_0070058) (tRNA gene clustering), [GO:0034399](http://purl.obolibrary.org/obo/GO_0034399) (nuclear periphery), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0060684](http://purl.obolibrary.org/obo/GO_0060684) (epithelial-mesenchymal cell signaling), [GO:0015234](http://purl.obolibrary.org/obo/GO_0015234) (thiamine transmembrane transporter activity), [GO:0060685](http://purl.obolibrary.org/obo/GO_0060685) (regulation of prostatic bud formation), [GO:0015232](http://purl.obolibrary.org/obo/GO_0015232) (heme transporter activity), [GO:1900210](http://purl.obolibrary.org/obo/GO_1900210) (positive regulation of cardiolipin metabolic process), [GO:0003250](http://purl.obolibrary.org/obo/GO_0003250) (regulation of cell proliferation involved in heart valve morphogenesis), [GO:1900212](http://purl.obolibrary.org/obo/GO_1900212) (negative regulation of mesenchymal cell apoptotic process involved in metanephros development), [GO:0004582](http://purl.obolibrary.org/obo/GO_0004582) (dolichyl-phosphate beta-D-mannosyltransferase activity), [GO:0045047](http://purl.obolibrary.org/obo/GO_0045047) (protein targeting to ER), [GO:0004584](http://purl.obolibrary.org/obo/GO_0004584) (dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity), [GO:0003253](http://purl.obolibrary.org/obo/GO_0003253) (cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0004583](http://purl.obolibrary.org/obo/GO_0004583) (dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity), [GO:0060686](http://purl.obolibrary.org/obo/GO_0060686) (negative regulation of prostatic bud formation), [GO:0003254](http://purl.obolibrary.org/obo/GO_0003254) (regulation of membrane depolarization), [GO:1900215](http://purl.obolibrary.org/obo/GO_1900215) (negative regulation of apoptotic process involved in metanephric collecting duct development), [GO:0060687](http://purl.obolibrary.org/obo/GO_0060687) (regulation of branching involved in prostate gland morphogenesis), [GO:0004585](http://purl.obolibrary.org/obo/GO_0004585) (ornithine carbamoyltransferase activity), [GO:1901546](http://purl.obolibrary.org/obo/GO_1901546) (regulation of synaptic vesicle lumen acidification), [GO:1900218](http://purl.obolibrary.org/obo/GO_1900218) (negative regulation of apoptotic process involved in metanephric nephron tubule development), [GO:0060688](http://purl.obolibrary.org/obo/GO_0060688) (regulation of morphogenesis of a branching structure), [GO:0004588](http://purl.obolibrary.org/obo/GO_0004588) (orotate phosphoribosyltransferase activity), [GO:0003256](http://purl.obolibrary.org/obo/GO_0003256) (regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation), [GO:0004587](http://purl.obolibrary.org/obo/GO_0004587) (ornithine-oxo-acid transaminase activity), [GO:0030866](http://purl.obolibrary.org/obo/GO_0030866) (cortical actin cytoskeleton organization), [GO:0004579](http://purl.obolibrary.org/obo/GO_0004579) (dolichyl-diphosphooligosaccharide-protein glycotransferase activity), [GO:0045053](http://purl.obolibrary.org/obo/GO_0045053) (protein retention in Golgi apparatus), [GO:0004578](http://purl.obolibrary.org/obo/GO_0004578) (chitobiosyldiphosphodolichol beta-mannosyltransferase activity), [GO:0030868](http://purl.obolibrary.org/obo/GO_0030868) (smooth endoplasmic reticulum membrane), [GO:0030867](http://purl.obolibrary.org/obo/GO_0030867) (rough endoplasmic reticulum membrane), [GO:0045056](http://purl.obolibrary.org/obo/GO_0045056) (transcytosis), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0030869](http://purl.obolibrary.org/obo/GO_0030869) (RENT complex), [GO:0072663](http://purl.obolibrary.org/obo/GO_0072663) (establishment of protein localization to peroxisome), [GO:0016570](http://purl.obolibrary.org/obo/GO_0016570) (histone modification), [GO:0045055](http://purl.obolibrary.org/obo/GO_0045055) (regulated exocytosis), [GO:0016571](http://purl.obolibrary.org/obo/GO_0016571) (histone methylation), [GO:0071336](http://purl.obolibrary.org/obo/GO_0071336) (regulation of hair follicle cell proliferation), [GO:0070006](http://purl.obolibrary.org/obo/GO_0070006) (metalloaminopeptidase activity), [GO:0016572](http://purl.obolibrary.org/obo/GO_0016572) (histone phosphorylation), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0016574](http://purl.obolibrary.org/obo/GO_0016574) (histone ubiquitination), [GO:0016575](http://purl.obolibrary.org/obo/GO_0016575) (histone deacetylation), [GO:0030862](http://purl.obolibrary.org/obo/GO_0030862) (positive regulation of polarized epithelial cell differentiation), [GO:0016576](http://purl.obolibrary.org/obo/GO_0016576) (histone dephosphorylation), [GO:0030864](http://purl.obolibrary.org/obo/GO_0030864) (cortical actin cytoskeleton), [GO:0016577](http://purl.obolibrary.org/obo/GO_0016577) (histone demethylation), [GO:0015227](http://purl.obolibrary.org/obo/GO_0015227) (acyl carnitine transmembrane transporter activity), [GO:0071339](http://purl.obolibrary.org/obo/GO_0071339) (MLL1 complex), [GO:0015226](http://purl.obolibrary.org/obo/GO_0015226) (carnitine transmembrane transporter activity), [GO:0030863](http://purl.obolibrary.org/obo/GO_0030863) (cortical cytoskeleton), [GO:0016578](http://purl.obolibrary.org/obo/GO_0016578) (histone deubiquitination), [GO:0015247](http://purl.obolibrary.org/obo/GO_0015247) (aminophospholipid transmembrane transporter activity), [GO:0016557](http://purl.obolibrary.org/obo/GO_0016557) (peroxisome membrane biogenesis), [GO:0016558](http://purl.obolibrary.org/obo/GO_0016558) (protein import into peroxisome matrix), [GO:0060672](http://purl.obolibrary.org/obo/GO_0060672) (epithelial cell morphogenesis involved in placental branching), [GO:0016559](http://purl.obolibrary.org/obo/GO_0016559) (peroxisome fission), [GO:0015245](http://purl.obolibrary.org/obo/GO_0015245) (fatty acid transmembrane transporter activity), [GO:0004591](http://purl.obolibrary.org/obo/GO_0004591) (oxoglutarate dehydrogenase (succinyl-transferring) activity), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0004590](http://purl.obolibrary.org/obo/GO_0004590) (orotidine-5'-phosphate decarboxylase activity), [GO:0003261](http://purl.obolibrary.org/obo/GO_0003261) (cardiac muscle progenitor cell migration to the midline involved in heart field formation), [GO:0003262](http://purl.obolibrary.org/obo/GO_0003262) (endocardial progenitor cell migration to the midline involved in heart field formation), [GO:1900222](http://purl.obolibrary.org/obo/GO_1900222) (negative regulation of amyloid-beta clearance), [GO:1902884](http://purl.obolibrary.org/obo/GO_1902884) (positive regulation of response to oxidative stress), [GO:0045059](http://purl.obolibrary.org/obo/GO_0045059) (positive thymic T cell selection), [GO:1900224](http://purl.obolibrary.org/obo/GO_1900224) (positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry), [GO:0004594](http://purl.obolibrary.org/obo/GO_0004594) (pantothenate kinase activity), [GO:0060675](http://purl.obolibrary.org/obo/GO_0060675) (ureteric bud morphogenesis), [GO:0004597](http://purl.obolibrary.org/obo/GO_0004597) (peptide-aspartate beta-dioxygenase activity), [GO:1900227](http://purl.obolibrary.org/obo/GO_1900227) (positive regulation of NLRP3 inflammasome complex assembly), [GO:0060676](http://purl.obolibrary.org/obo/GO_0060676) (ureteric bud formation), [GO:0004596](http://purl.obolibrary.org/obo/GO_0004596) (peptide alpha-N-acetyltransferase activity), [GO:1901557](http://purl.obolibrary.org/obo/GO_1901557) (response to fenofibrate), [GO:0060677](http://purl.obolibrary.org/obo/GO_0060677) (ureteric bud elongation), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0045063](http://purl.obolibrary.org/obo/GO_0045063) (T-helper 1 cell differentiation), [GO:0045064](http://purl.obolibrary.org/obo/GO_0045064) (T-helper 2 cell differentiation), [GO:0030854](http://purl.obolibrary.org/obo/GO_0030854) (positive regulation of granulocyte differentiation), [GO:0046395](http://purl.obolibrary.org/obo/GO_0046395) (carboxylic acid catabolic process), [GO:0045061](http://purl.obolibrary.org/obo/GO_0045061) (thymic T cell selection), [GO:0030857](http://purl.obolibrary.org/obo/GO_0030857) (negative regulation of epithelial cell differentiation), [GO:0030856](http://purl.obolibrary.org/obo/GO_0030856) (regulation of epithelial cell differentiation), [GO:0030859](http://purl.obolibrary.org/obo/GO_0030859) (polarized epithelial cell differentiation), [GO:0071321](http://purl.obolibrary.org/obo/GO_0071321) (cellular response to cGMP), [GO:0030858](http://purl.obolibrary.org/obo/GO_0030858) (positive regulation of epithelial cell differentiation), [GO:0071322](http://purl.obolibrary.org/obo/GO_0071322) (cellular response to carbohydrate stimulus), [GO:0045065](http://purl.obolibrary.org/obo/GO_0045065) (cytotoxic T cell differentiation), [GO:0071320](http://purl.obolibrary.org/obo/GO_0071320) (cellular response to cAMP), [GO:0045066](http://purl.obolibrary.org/obo/GO_0045066) (regulatory T cell differentiation), [GO:0072657](http://purl.obolibrary.org/obo/GO_0072657) (protein localization to membrane), [GO:0016560](http://purl.obolibrary.org/obo/GO_0016560) (protein import into peroxisome matrix, docking), [GO:0072656](http://purl.obolibrary.org/obo/GO_0072656) (maintenance of protein location in mitochondrion), [GO:0016561](http://purl.obolibrary.org/obo/GO_0016561) (protein import into peroxisome matrix, translocation), [GO:0072655](http://purl.obolibrary.org/obo/GO_0072655) (establishment of protein localization to mitochondrion), [GO:0016562](http://purl.obolibrary.org/obo/GO_0016562) (protein import into peroxisome matrix, receptor recycling), [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation), [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process), [GO:0030850](http://purl.obolibrary.org/obo/GO_0030850) (prostate gland development), [GO:0045060](http://purl.obolibrary.org/obo/GO_0045060) (negative thymic T cell selection), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0030853](http://purl.obolibrary.org/obo/GO_0030853) (negative regulation of granulocyte differentiation), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0030852](http://purl.obolibrary.org/obo/GO_0030852) (regulation of granulocyte differentiation), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:0004560](http://purl.obolibrary.org/obo/GO_0004560) (alpha-L-fucosidase activity), [GO:0005890](http://purl.obolibrary.org/obo/GO_0005890) (sodium:potassium-exchanging ATPase complex), [GO:1902895](http://purl.obolibrary.org/obo/GO_1902895) (positive regulation of pri-miRNA transcription by RNA polymerase II), [GO:0003230](http://purl.obolibrary.org/obo/GO_0003230) (cardiac atrium development), [GO:0004561](http://purl.obolibrary.org/obo/GO_0004561) (alpha-N-acetylglucosaminidase activity), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0005892](http://purl.obolibrary.org/obo/GO_0005892) (acetylcholine-gated channel complex), [GO:0004564](http://purl.obolibrary.org/obo/GO_0004564) (beta-fructofuranosidase activity), [GO:0003232](http://purl.obolibrary.org/obo/GO_0003232) (bulbus arteriosus development), [GO:0004563](http://purl.obolibrary.org/obo/GO_0004563) (beta-N-acetylhexosaminidase activity), [GO:0004566](http://purl.obolibrary.org/obo/GO_0004566) (beta-glucuronidase activity), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0003226](http://purl.obolibrary.org/obo/GO_0003226) (right ventricular compact myocardium morphogenesis), [GO:0004556](http://purl.obolibrary.org/obo/GO_0004556) (alpha-amylase activity), [GO:0071351](http://purl.obolibrary.org/obo/GO_0071351) (cellular response to interleukin-18), [GO:0004559](http://purl.obolibrary.org/obo/GO_0004559) (alpha-mannosidase activity), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0003229](http://purl.obolibrary.org/obo/GO_0003229) (ventricular cardiac muscle tissue development), [GO:0071354](http://purl.obolibrary.org/obo/GO_0071354) (cellular response to interleukin-6), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0045078](http://purl.obolibrary.org/obo/GO_0045078) (positive regulation of interferon-gamma biosynthetic process), [GO:0030847](http://purl.obolibrary.org/obo/GO_0030847) (termination of RNA polymerase II transcription, exosome-dependent), [GO:0072684](http://purl.obolibrary.org/obo/GO_0072684) (mitochondrial tRNA 3'-trailer cleavage, endonucleolytic), [GO:0071353](http://purl.obolibrary.org/obo/GO_0071353) (cellular response to interleukin-4), [GO:0045077](http://purl.obolibrary.org/obo/GO_0045077) (negative regulation of interferon-gamma biosynthetic process), [GO:0071359](http://purl.obolibrary.org/obo/GO_0071359) (cellular response to dsRNA), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0070025](http://purl.obolibrary.org/obo/GO_0070025) (carbon monoxide binding), [GO:0070026](http://purl.obolibrary.org/obo/GO_0070026) (nitric oxide binding), [GO:0072687](http://purl.obolibrary.org/obo/GO_0072687) (meiotic spindle), [GO:0045070](http://purl.obolibrary.org/obo/GO_0045070) (positive regulation of viral genome replication), [GO:0016553](http://purl.obolibrary.org/obo/GO_0016553) (base conversion or substitution editing), [GO:0045071](http://purl.obolibrary.org/obo/GO_0045071) (negative regulation of viral genome replication), [GO:0015205](http://purl.obolibrary.org/obo/GO_0015205) (nucleobase transmembrane transporter activity), [GO:0042800](http://purl.obolibrary.org/obo/GO_0042800) (histone methyltransferase activity (H3-K4 specific)), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060696](http://purl.obolibrary.org/obo/GO_0060696) (regulation of phospholipid catabolic process), [GO:0016538](http://purl.obolibrary.org/obo/GO_0016538) (cyclin-dependent protein serine/threonine kinase regulator activity), [GO:0016539](http://purl.obolibrary.org/obo/GO_0016539) (intein-mediated protein splicing), [GO:0042805](http://purl.obolibrary.org/obo/GO_0042805) (actinin binding), [GO:0015220](http://purl.obolibrary.org/obo/GO_0015220) (choline transmembrane transporter activity), [GO:0042806](http://purl.obolibrary.org/obo/GO_0042806) (fucose binding), [GO:0004573](http://purl.obolibrary.org/obo/GO_0004573) (mannosyl-oligosaccharide glucosidase activity), [GO:0060697](http://purl.obolibrary.org/obo/GO_0060697) (positive regulation of phospholipid catabolic process), [GO:0004575](http://purl.obolibrary.org/obo/GO_0004575) (sucrose alpha-glucosidase activity), [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity), [GO:0004577](http://purl.obolibrary.org/obo/GO_0004577) (N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity), [GO:0004576](http://purl.obolibrary.org/obo/GO_0004576) (oligosaccharyl transferase activity), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0045085](http://purl.obolibrary.org/obo/GO_0045085) (negative regulation of interleukin-2 biosynthetic process), [GO:0005899](http://purl.obolibrary.org/obo/GO_0005899) (insulin receptor complex), [GO:0072671](http://purl.obolibrary.org/obo/GO_0072671) (mitochondria-associated ubiquitin-dependent protein catabolic process), [GO:0045086](http://purl.obolibrary.org/obo/GO_0045086) (positive regulation of interleukin-2 biosynthetic process), [GO:0030832](http://purl.obolibrary.org/obo/GO_0030832) (regulation of actin filament length), [GO:0004567](http://purl.obolibrary.org/obo/GO_0004567) (beta-mannosidase activity), [GO:0071340](http://purl.obolibrary.org/obo/GO_0071340) (skeletal muscle acetylcholine-gated channel clustering), [GO:0030835](http://purl.obolibrary.org/obo/GO_0030835) (negative regulation of actin filament depolymerization), [GO:0045083](http://purl.obolibrary.org/obo/GO_0045083) (negative regulation of interleukin-12 biosynthetic process), [GO:0045084](http://purl.obolibrary.org/obo/GO_0045084) (positive regulation of interleukin-12 biosynthetic process), [GO:0045089](http://purl.obolibrary.org/obo/GO_0045089) (positive regulation of innate immune response), [GO:0070012](http://purl.obolibrary.org/obo/GO_0070012) (oligopeptidase activity), [GO:0030837](http://purl.obolibrary.org/obo/GO_0030837) (negative regulation of actin filament polymerization), [GO:0030836](http://purl.obolibrary.org/obo/GO_0030836) (positive regulation of actin filament depolymerization), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0072673](http://purl.obolibrary.org/obo/GO_0072673) (lamellipodium morphogenesis), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0030838](http://purl.obolibrary.org/obo/GO_0030838) (positive regulation of actin filament polymerization), [GO:0070016](http://purl.obolibrary.org/obo/GO_0070016) (armadillo repeat domain binding), [GO:0071347](http://purl.obolibrary.org/obo/GO_0071347) (cellular response to interleukin-1), [GO:0072679](http://purl.obolibrary.org/obo/GO_0072679) (thymocyte migration), [GO:0042809](http://purl.obolibrary.org/obo/GO_0042809) (vitamin D receptor binding), [GO:0071345](http://purl.obolibrary.org/obo/GO_0071345) (cellular response to cytokine stimulus), [GO:0016540](http://purl.obolibrary.org/obo/GO_0016540) (protein autoprocessing), [GO:0072676](http://purl.obolibrary.org/obo/GO_0072676) (lymphocyte migration), [GO:0071346](http://purl.obolibrary.org/obo/GO_0071346) (cellular response to interferon-gamma), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), [GO:0015279](http://purl.obolibrary.org/obo/GO_0015279) (store-operated calcium channel activity), [GO:0015278](http://purl.obolibrary.org/obo/GO_0015278) (calcium-release channel activity), [GO:0015276](http://purl.obolibrary.org/obo/GO_0015276) (ligand-gated ion channel activity), [GO:0003290](http://purl.obolibrary.org/obo/GO_0003290) (atrial septum secundum morphogenesis), [GO:0003294](http://purl.obolibrary.org/obo/GO_0003294) (atrial ventricular junction remodeling), [GO:0015272](http://purl.obolibrary.org/obo/GO_0015272) (ATP-activated inward rectifier potassium channel activity), [GO:0042891](http://purl.obolibrary.org/obo/GO_0042891) (antibiotic transport), [GO:0015271](http://purl.obolibrary.org/obo/GO_0015271) (outward rectifier potassium channel activity), [GO:0042895](http://purl.obolibrary.org/obo/GO_0042895) (antibiotic transmembrane transporter activity), [GO:0052213](http://purl.obolibrary.org/obo/GO_0052213) (interaction with symbiont via secreted substance involved in symbiotic interaction), [GO:0090502](http://purl.obolibrary.org/obo/GO_0090502) (RNA phosphodiester bond hydrolysis, endonucleolytic), [GO:0090503](http://purl.obolibrary.org/obo/GO_0090503) (RNA phosphodiester bond hydrolysis, exonucleolytic), [GO:0090501](http://purl.obolibrary.org/obo/GO_0090501) (RNA phosphodiester bond hydrolysis), [GO:0015280](http://purl.obolibrary.org/obo/GO_0015280) (ligand-gated sodium channel activity), [GO:0030899](http://purl.obolibrary.org/obo/GO_0030899) (calcium-dependent ATPase activity), [GO:0030898](http://purl.obolibrary.org/obo/GO_0030898) (actin-dependent ATPase activity), [GO:0030891](http://purl.obolibrary.org/obo/GO_0030891) (VCB complex), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0030893](http://purl.obolibrary.org/obo/GO_0030893) (meiotic cohesin complex), [GO:0030897](http://purl.obolibrary.org/obo/GO_0030897) (HOPS complex), [GO:0090504](http://purl.obolibrary.org/obo/GO_0090504) (epiboly), [GO:0015252](http://purl.obolibrary.org/obo/GO_0015252) (proton channel activity), [GO:0003272](http://purl.obolibrary.org/obo/GO_0003272) (endocardial cushion formation), [GO:0015250](http://purl.obolibrary.org/obo/GO_0015250) (water channel activity), [GO:0003279](http://purl.obolibrary.org/obo/GO_0003279) (cardiac septum development), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0016591](http://purl.obolibrary.org/obo/GO_0016591) (DNA-directed RNA polymerase II, holoenzyme), [GO:0016592](http://purl.obolibrary.org/obo/GO_0016592) (mediator complex), [GO:0016593](http://purl.obolibrary.org/obo/GO_0016593) (Cdc73/Paf1 complex), [GO:0016594](http://purl.obolibrary.org/obo/GO_0016594) (glycine binding), [GO:0016595](http://purl.obolibrary.org/obo/GO_0016595) (glutamate binding), [GO:0030881](http://purl.obolibrary.org/obo/GO_0030881) (beta-2-microglobulin binding), [GO:0016596](http://purl.obolibrary.org/obo/GO_0016596) (thienylcyclohexylpiperidine binding), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0015248](http://purl.obolibrary.org/obo/GO_0015248) (sterol transporter activity), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0015269](http://purl.obolibrary.org/obo/GO_0015269) (calcium-activated potassium channel activity), [GO:0015267](http://purl.obolibrary.org/obo/GO_0015267) (channel activity), [GO:0015266](http://purl.obolibrary.org/obo/GO_0015266), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0003283](http://purl.obolibrary.org/obo/GO_0003283) (atrial septum development), [GO:0003284](http://purl.obolibrary.org/obo/GO_0003284) (septum primum development), [GO:0003289](http://purl.obolibrary.org/obo/GO_0003289) (atrial septum primum morphogenesis), [GO:0030877](http://purl.obolibrary.org/obo/GO_0030877) (beta-catenin destruction complex), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0016581](http://purl.obolibrary.org/obo/GO_0016581) (NuRD complex), [GO:0016584](http://purl.obolibrary.org/obo/GO_0016584) (nucleosome positioning), [GO:0030870](http://purl.obolibrary.org/obo/GO_0030870) (Mre11 complex), [GO:0016589](http://purl.obolibrary.org/obo/GO_0016589) (NURF complex), [GO:0070093](http://purl.obolibrary.org/obo/GO_0070093) (negative regulation of glucagon secretion), [GO:0042853](http://purl.obolibrary.org/obo/GO_0042853) (L-alanine catabolic process), [GO:0070085](http://purl.obolibrary.org/obo/GO_0070085) (glycosylation), [GO:0070086](http://purl.obolibrary.org/obo/GO_0070086) (ubiquitin-dependent endocytosis), [GO:0070087](http://purl.obolibrary.org/obo/GO_0070087) (chromo shadow domain binding), [GO:0042866](http://purl.obolibrary.org/obo/GO_0042866) (pyruvate biosynthetic process), [GO:0009405](http://purl.obolibrary.org/obo/GO_0009405) (pathogenesis), [GO:0009404](http://purl.obolibrary.org/obo/GO_0009404) (toxin metabolic process), [GO:0070080](http://purl.obolibrary.org/obo/GO_0070080) (titin Z domain binding), [GO:0070072](http://purl.obolibrary.org/obo/GO_0070072) (vacuolar proton-transporting V-type ATPase complex assembly), [GO:0102867](http://purl.obolibrary.org/obo/GO_0102867) (molybdenum cofactor sulfurtransferase activity), [GO:0015299](http://purl.obolibrary.org/obo/GO_0015299) (solute:proton antiporter activity), [GO:0015297](http://purl.obolibrary.org/obo/GO_0015297) (antiporter activity), [GO:0015295](http://purl.obolibrary.org/obo/GO_0015295) (solute:proton symporter activity), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0015292](http://purl.obolibrary.org/obo/GO_0015292) (uniporter activity), [GO:0042883](http://purl.obolibrary.org/obo/GO_0042883) (cysteine transport), [GO:0070094](http://purl.obolibrary.org/obo/GO_0070094) (positive regulation of glucagon secretion), [GO:0070095](http://purl.obolibrary.org/obo/GO_0070095) (fructose-6-phosphate binding), [GO:0070098](http://purl.obolibrary.org/obo/GO_0070098) (chemokine-mediated signaling pathway), [GO:0048919](http://purl.obolibrary.org/obo/GO_0048919) (posterior lateral line neuromast development), [GO:0048918](http://purl.obolibrary.org/obo/GO_0048918) (posterior lateral line nerve development), [GO:1905023](http://purl.obolibrary.org/obo/GO_1905023) (positive regulation of threonine-tRNA ligase activity), [GO:0048917](http://purl.obolibrary.org/obo/GO_0048917) (posterior lateral line ganglion development), [GO:0048916](http://purl.obolibrary.org/obo/GO_0048916) (posterior lateral line development), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0009313](http://purl.obolibrary.org/obo/GO_0009313) (oligosaccharide catabolic process), [GO:0009312](http://purl.obolibrary.org/obo/GO_0009312) (oligosaccharide biosynthetic process), [GO:0052182](http://purl.obolibrary.org/obo/GO_0052182) (modification by host of symbiont morphology or physiology via secreted substance), [GO:0009311](http://purl.obolibrary.org/obo/GO_0009311) (oligosaccharide metabolic process), [GO:0000973](http://purl.obolibrary.org/obo/GO_0000973) (posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery), [GO:0048914](http://purl.obolibrary.org/obo/GO_0048914) (myelination of anterior lateral line nerve axons), [GO:0000972](http://purl.obolibrary.org/obo/GO_0000972) (transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0009308](http://purl.obolibrary.org/obo/GO_0009308) (amine metabolic process), [GO:1905020](http://purl.obolibrary.org/obo/GO_1905020) (positive regulation of methionine-tRNA ligase activity), [GO:0048929](http://purl.obolibrary.org/obo/GO_0048929) (efferent axon development in posterior lateral line nerve), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0000988](http://purl.obolibrary.org/obo/GO_0000988) (transcription factor activity, protein binding), [GO:0048922](http://purl.obolibrary.org/obo/GO_0048922) (posterior lateral line neuromast deposition), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0048920](http://purl.obolibrary.org/obo/GO_0048920) (posterior lateral line neuromast primordium migration), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0048925](http://purl.obolibrary.org/obo/GO_0048925) (lateral line system development), [GO:0000982](http://purl.obolibrary.org/obo/GO_0000982) (transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0048923](http://purl.obolibrary.org/obo/GO_0048923) (posterior lateral line neuromast hair cell differentiation), [GO:0000990](http://purl.obolibrary.org/obo/GO_0000990) (transcription factor activity, core RNA polymerase binding), [GO:0000958](http://purl.obolibrary.org/obo/GO_0000958) (mitochondrial mRNA catabolic process), [GO:0000957](http://purl.obolibrary.org/obo/GO_0000957) (mitochondrial RNA catabolic process), [GO:0000956](http://purl.obolibrary.org/obo/GO_0000956) (nuclear-transcribed mRNA catabolic process), [GO:0048932](http://purl.obolibrary.org/obo/GO_0048932) (myelination of posterior lateral line nerve axons), [GO:0048937](http://purl.obolibrary.org/obo/GO_0048937) (lateral line nerve glial cell development), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0048935](http://purl.obolibrary.org/obo/GO_0048935) (peripheral nervous system neuron development), [GO:0009303](http://purl.obolibrary.org/obo/GO_0009303) (rRNA transcription), [GO:0000965](http://purl.obolibrary.org/obo/GO_0000965) (mitochondrial RNA 3'-end processing), [GO:0000964](http://purl.obolibrary.org/obo/GO_0000964) (mitochondrial RNA 5'-end processing), [GO:0047617](http://purl.obolibrary.org/obo/GO_0047617) (acyl-CoA hydrolase activity), [GO:0000962](http://purl.obolibrary.org/obo/GO_0000962) (positive regulation of mitochondrial RNA catabolic process), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0009305](http://purl.obolibrary.org/obo/GO_0009305) (protein biotinylation), [GO:0047620](http://purl.obolibrary.org/obo/GO_0047620) (acylglycerol kinase activity), [GO:1905050](http://purl.obolibrary.org/obo/GO_1905050) (positive regulation of metallopeptidase activity), [GO:0035640](http://purl.obolibrary.org/obo/GO_0035640) (exploration behavior), [GO:0008023](http://purl.obolibrary.org/obo/GO_0008023) (transcription elongation factor complex), [GO:0090410](http://purl.obolibrary.org/obo/GO_0090410) (malonate catabolic process), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0009353](http://purl.obolibrary.org/obo/GO_0009353) (mitochondrial oxoglutarate dehydrogenase complex), [GO:0008021](http://purl.obolibrary.org/obo/GO_0008021) (synaptic vesicle), [GO:0008020](http://purl.obolibrary.org/obo/GO_0008020) (G-protein coupled photoreceptor activity), [GO:0008026](http://purl.obolibrary.org/obo/GO_0008026) (ATP-dependent helicase activity), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0008028](http://purl.obolibrary.org/obo/GO_0008028) (monocarboxylic acid transmembrane transporter activity), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0035631](http://purl.obolibrary.org/obo/GO_0035631) (CD40 receptor complex), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0035634](http://purl.obolibrary.org/obo/GO_0035634) (response to stilbenoid), [GO:0035630](http://purl.obolibrary.org/obo/GO_0035630) (bone mineralization involved in bone maturation), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:0008038](http://purl.obolibrary.org/obo/GO_0008038) (neuron recognition), [GO:0009368](http://purl.obolibrary.org/obo/GO_0009368) (endopeptidase Clp complex), [GO:0008037](http://purl.obolibrary.org/obo/GO_0008037) (cell recognition), [GO:0008035](http://purl.obolibrary.org/obo/GO_0008035) (high-density lipoprotein particle binding), [GO:0035625](http://purl.obolibrary.org/obo/GO_0035625) (epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway), [GO:0035627](http://purl.obolibrary.org/obo/GO_0035627) (ceramide transport), [GO:0035621](http://purl.obolibrary.org/obo/GO_0035621) (ER to Golgi ceramide transport), [GO:0035622](http://purl.obolibrary.org/obo/GO_0035622) (intrahepatic bile duct development), [GO:0090427](http://purl.obolibrary.org/obo/GO_0090427) (activation of meiosis), [GO:0035623](http://purl.obolibrary.org/obo/GO_0035623) (renal glucose absorption), [GO:1905006](http://purl.obolibrary.org/obo/GO_1905006) (negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0009331](http://purl.obolibrary.org/obo/GO_0009331) (glycerol-3-phosphate dehydrogenase complex), [GO:0000999](http://purl.obolibrary.org/obo/GO_0000999) (RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly), [GO:0008009](http://purl.obolibrary.org/obo/GO_0008009) (chemokine activity), [GO:0000994](http://purl.obolibrary.org/obo/GO_0000994) (RNA polymerase III core binding), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0010314](http://purl.obolibrary.org/obo/GO_0010314) (phosphatidylinositol-5-phosphate binding), [GO:0035613](http://purl.obolibrary.org/obo/GO_0035613) (RNA stem-loop binding), [GO:0035610](http://purl.obolibrary.org/obo/GO_0035610) (protein side chain deglutamylation), [GO:0035611](http://purl.obolibrary.org/obo/GO_0035611) (protein branching point deglutamylation), [GO:0035612](http://purl.obolibrary.org/obo/GO_0035612) (AP-2 adaptor complex binding), [GO:1905010](http://purl.obolibrary.org/obo/GO_1905010) (positive regulation of L-lysine import across plasma membrane), [GO:1905017](http://purl.obolibrary.org/obo/GO_1905017) (positive regulation of isoleucine-tRNA ligase activity), [GO:0048909](http://purl.obolibrary.org/obo/GO_0048909) (anterior lateral line nerve development), [GO:0008016](http://purl.obolibrary.org/obo/GO_0008016) (regulation of heart contraction), [GO:0008015](http://purl.obolibrary.org/obo/GO_0008015) (blood circulation), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0048901](http://purl.obolibrary.org/obo/GO_0048901) (anterior lateral line neuromast development), [GO:0035607](http://purl.obolibrary.org/obo/GO_0035607) (fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development), [GO:0035608](http://purl.obolibrary.org/obo/GO_0035608) (protein deglutamylation), [GO:0035609](http://purl.obolibrary.org/obo/GO_0035609) (C-terminal protein deglutamylation), [GO:0090409](http://purl.obolibrary.org/obo/GO_0090409) (malonyl-CoA synthetase activity), [GO:0035600](http://purl.obolibrary.org/obo/GO_0035600) (tRNA methylthiolation), [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0010385](http://purl.obolibrary.org/obo/GO_0010385) (double-stranded methylated DNA binding), [GO:0034354](http://purl.obolibrary.org/obo/GO_0034354) ('de novo' NAD biosynthetic process from tryptophan), [GO:0008066](http://purl.obolibrary.org/obo/GO_0008066) (glutamate receptor activity), [GO:0009396](http://purl.obolibrary.org/obo/GO_0009396) (folic acid-containing compound biosynthetic process), [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier), [GO:0008064](http://purl.obolibrary.org/obo/GO_0008064) (regulation of actin polymerization or depolymerization), [GO:0034351](http://purl.obolibrary.org/obo/GO_0034351) (negative regulation of glial cell apoptotic process), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0045005](http://purl.obolibrary.org/obo/GO_0045005) (DNA-dependent DNA replication maintenance of fidelity), [GO:0046337](http://purl.obolibrary.org/obo/GO_0046337) (phosphatidylethanolamine metabolic process), [GO:0045006](http://purl.obolibrary.org/obo/GO_0045006) (DNA deamination), [GO:0045003](http://purl.obolibrary.org/obo/GO_0045003) (double-strand break repair via synthesis-dependent strand annealing), [GO:0045004](http://purl.obolibrary.org/obo/GO_0045004) (DNA replication proofreading), [GO:0060649](http://purl.obolibrary.org/obo/GO_0060649) (mammary gland bud elongation), [GO:0046338](http://purl.obolibrary.org/obo/GO_0046338) (phosphatidylethanolamine catabolic process), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0046340](http://purl.obolibrary.org/obo/GO_0046340) (diacylglycerol catabolic process), [GO:0045010](http://purl.obolibrary.org/obo/GO_0045010) (actin nucleation), [GO:0033014](http://purl.obolibrary.org/obo/GO_0033014) (tetrapyrrole biosynthetic process), [GO:0035676](http://purl.obolibrary.org/obo/GO_0035676) (anterior lateral line neuromast hair cell development), [GO:0035677](http://purl.obolibrary.org/obo/GO_0035677) (posterior lateral line neuromast hair cell development), [GO:0033018](http://purl.obolibrary.org/obo/GO_0033018) (sarcoplasmic reticulum lumen), [GO:0033017](http://purl.obolibrary.org/obo/GO_0033017) (sarcoplasmic reticulum membrane), [GO:0035678](http://purl.obolibrary.org/obo/GO_0035678) (neuromast hair cell morphogenesis), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0035673](http://purl.obolibrary.org/obo/GO_0035673) (oligopeptide transmembrane transporter activity), [GO:0035674](http://purl.obolibrary.org/obo/GO_0035674) (tricarboxylic acid transmembrane transport), [GO:0008078](http://purl.obolibrary.org/obo/GO_0008078) (mesodermal cell migration), [GO:0010390](http://purl.obolibrary.org/obo/GO_0010390) (histone monoubiquitination), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0008076](http://purl.obolibrary.org/obo/GO_0008076) (voltage-gated potassium channel complex), [GO:0033010](http://purl.obolibrary.org/obo/GO_0033010) (paranodal junction), [GO:0045014](http://purl.obolibrary.org/obo/GO_0045014) (negative regulation of transcription by glucose), [GO:0060638](http://purl.obolibrary.org/obo/GO_0060638) (mesenchymal-epithelial cell signaling), [GO:0045019](http://purl.obolibrary.org/obo/GO_0045019) (negative regulation of nitric oxide biosynthetic process), [GO:0046352](http://purl.obolibrary.org/obo/GO_0046352) (disaccharide catabolic process), [GO:0045022](http://purl.obolibrary.org/obo/GO_0045022) (early endosome to late endosome transport), [GO:0033005](http://purl.obolibrary.org/obo/GO_0033005) (positive regulation of mast cell activation), [GO:0034334](http://purl.obolibrary.org/obo/GO_0034334) (adherens junction maintenance), [GO:0034333](http://purl.obolibrary.org/obo/GO_0034333) (adherens junction assembly), [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0035666](http://purl.obolibrary.org/obo/GO_0035666) (TRIF-dependent toll-like receptor signaling pathway), [GO:0060662](http://purl.obolibrary.org/obo/GO_0060662) (salivary gland cavitation), [GO:0008045](http://purl.obolibrary.org/obo/GO_0008045) (motor neuron axon guidance), [GO:0034332](http://purl.obolibrary.org/obo/GO_0034332) (adherens junction organization), [GO:0009374](http://purl.obolibrary.org/obo/GO_0009374) (biotin binding), [GO:0008043](http://purl.obolibrary.org/obo/GO_0008043) (intracellular ferritin complex), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0045027](http://purl.obolibrary.org/obo/GO_0045027) (DNA end binding), [GO:0060669](http://purl.obolibrary.org/obo/GO_0060669) (embryonic placenta morphogenesis), [GO:0046359](http://purl.obolibrary.org/obo/GO_0046359) (butyrate catabolic process), [GO:0008048](http://purl.obolibrary.org/obo/GO_0008048) (calcium sensitive guanylate cyclase activator activity), [GO:0045028](http://purl.obolibrary.org/obo/GO_0045028) (G-protein coupled purinergic nucleotide receptor activity), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0046356](http://purl.obolibrary.org/obo/GO_0046356) (acetyl-CoA catabolic process), [GO:0009378](http://purl.obolibrary.org/obo/GO_0009378) (four-way junction helicase activity), [GO:0045025](http://purl.obolibrary.org/obo/GO_0045025) (mitochondrial degradosome), [GO:1901522](http://purl.obolibrary.org/obo/GO_1901522) (positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus), [GO:0045026](http://purl.obolibrary.org/obo/GO_0045026) (plasma membrane fusion), [GO:0008046](http://purl.obolibrary.org/obo/GO_0008046) (axon guidance receptor activity), [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis), [GO:1902857](http://purl.obolibrary.org/obo/GO_1902857) (positive regulation of non-motile cilium assembly), [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling), [GO:1902855](http://purl.obolibrary.org/obo/GO_1902855) (regulation of non-motile cilium assembly), [GO:0060666](http://purl.obolibrary.org/obo/GO_0060666) (dichotomous subdivision of terminal units involved in salivary gland branching), [GO:1902856](http://purl.obolibrary.org/obo/GO_1902856) (negative regulation of non-motile cilium assembly), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0045033](http://purl.obolibrary.org/obo/GO_0045033) (peroxisome inheritance), [GO:0035659](http://purl.obolibrary.org/obo/GO_0035659) (Wnt signaling pathway involved in wound healing, spreading of epidermal cells), [GO:0071313](http://purl.obolibrary.org/obo/GO_0071313) (cellular response to caffeine), [GO:0072643](http://purl.obolibrary.org/obo/GO_0072643) (interferon-gamma secretion), [GO:0010359](http://purl.obolibrary.org/obo/GO_0010359) (regulation of anion channel activity), [GO:0071318](http://purl.obolibrary.org/obo/GO_0071318) (cellular response to ATP), [GO:0034329](http://purl.obolibrary.org/obo/GO_0034329) (cell junction assembly), [GO:0071316](http://purl.obolibrary.org/obo/GO_0071316) (cellular response to nicotine), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0008052](http://purl.obolibrary.org/obo/GO_0008052) (sensory organ boundary specification), [GO:1902860](http://purl.obolibrary.org/obo/GO_1902860) (propionyl-CoA biosynthetic process), [GO:0010370](http://purl.obolibrary.org/obo/GO_0010370) (perinucleolar chromocenter), [GO:0008053](http://purl.obolibrary.org/obo/GO_0008053) (mitochondrial fusion), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:0045039](http://purl.obolibrary.org/obo/GO_0045039) (protein import into mitochondrial inner membrane), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0060659](http://purl.obolibrary.org/obo/GO_0060659) (nipple sheath formation), [GO:1901533](http://purl.obolibrary.org/obo/GO_1901533) (negative regulation of hematopoietic progenitor cell differentiation), [GO:1901536](http://purl.obolibrary.org/obo/GO_1901536) (negative regulation of DNA demethylation), [GO:0045041](http://purl.obolibrary.org/obo/GO_0045041) (protein import into mitochondrial intermembrane space), [GO:1901529](http://purl.obolibrary.org/obo/GO_1901529) (positive regulation of anion channel activity), [GO:0046373](http://purl.obolibrary.org/obo/GO_0046373) (L-arabinose metabolic process), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0045046](http://purl.obolibrary.org/obo/GO_0045046) (protein import into peroxisome membrane), [GO:0010369](http://purl.obolibrary.org/obo/GO_0010369) (chromocenter), [GO:0035646](http://purl.obolibrary.org/obo/GO_0035646) (endosome to melanosome transport), [GO:0034312](http://purl.obolibrary.org/obo/GO_0034312) (diol biosynthetic process), [GO:0035649](http://purl.obolibrary.org/obo/GO_0035649) (Nrd1 complex), [GO:0035643](http://purl.obolibrary.org/obo/GO_0035643) (L-DOPA receptor activity), [GO:0035644](http://purl.obolibrary.org/obo/GO_0035644) (phosphoanandamide dephosphorylation), [GO:0035645](http://purl.obolibrary.org/obo/GO_0035645) (enteric smooth muscle cell differentiation), [GO:0034394](http://purl.obolibrary.org/obo/GO_0034394) (protein localization to cell surface), [GO:0033063](http://purl.obolibrary.org/obo/GO_0033063) (Rad51B-Rad51C-Rad51D-XRCC2 complex), [GO:0034393](http://purl.obolibrary.org/obo/GO_0034393) (positive regulation of smooth muscle cell apoptotic process), [GO:0034392](http://purl.obolibrary.org/obo/GO_0034392) (negative regulation of smooth muscle cell apoptotic process), [GO:1905065](http://purl.obolibrary.org/obo/GO_1905065) (positive regulation of vascular smooth muscle cell differentiation), [GO:0034391](http://purl.obolibrary.org/obo/GO_0034391) (regulation of smooth muscle cell apoptotic process), [GO:0034398](http://purl.obolibrary.org/obo/GO_0034398) (telomere tethering at nuclear periphery), [GO:0034396](http://purl.obolibrary.org/obo/GO_0034396) (negative regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0090497](http://purl.obolibrary.org/obo/GO_0090497) (mesenchymal cell migration), [GO:0034395](http://purl.obolibrary.org/obo/GO_0034395) (regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0060602](http://purl.obolibrary.org/obo/GO_0060602) (branch elongation of an epithelium), [GO:0060603](http://purl.obolibrary.org/obo/GO_0060603) (mammary gland duct morphogenesis), [GO:0004500](http://purl.obolibrary.org/obo/GO_0004500) (dopamine beta-monooxygenase activity), [GO:0060606](http://purl.obolibrary.org/obo/GO_0060606) (tube closure), [GO:0005828](http://purl.obolibrary.org/obo/GO_0005828) (kinetochore microtubule), [GO:0005827](http://purl.obolibrary.org/obo/GO_0005827) (polar microtubule), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033059](http://purl.obolibrary.org/obo/GO_0033059) (cellular pigmentation), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0034388](http://purl.obolibrary.org/obo/GO_0034388) (Pwp2p-containing subcomplex of 90S preribosome), [GO:1905064](http://purl.obolibrary.org/obo/GO_1905064) (negative regulation of vascular smooth muscle cell differentiation), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0034382](http://purl.obolibrary.org/obo/GO_0034382) (chylomicron remnant clearance), [GO:0034381](http://purl.obolibrary.org/obo/GO_0034381) (plasma lipoprotein particle clearance), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0034386](http://purl.obolibrary.org/obo/GO_0034386) (4-aminobutyrate:2-oxoglutarate transaminase activity), [GO:0034384](http://purl.obolibrary.org/obo/GO_0034384) (high-density lipoprotein particle clearance), [GO:0005840](http://purl.obolibrary.org/obo/GO_0005840) (ribosome), [GO:0004511](http://purl.obolibrary.org/obo/GO_0004511) (tyrosine 3-monooxygenase activity), [GO:0004510](http://purl.obolibrary.org/obo/GO_0004510) (tryptophan 5-monooxygenase activity), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0005832](http://purl.obolibrary.org/obo/GO_0005832) (chaperonin-containing T-complex), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0004503](http://purl.obolibrary.org/obo/GO_0004503) (monophenol monooxygenase activity), [GO:0004505](http://purl.obolibrary.org/obo/GO_0004505) (phenylalanine 4-monooxygenase activity), [GO:0004508](http://purl.obolibrary.org/obo/GO_0004508) (steroid 17-alpha-monooxygenase activity), [GO:0005839](http://purl.obolibrary.org/obo/GO_0005839) (proteasome core complex), [GO:0004507](http://purl.obolibrary.org/obo/GO_0004507) (steroid 11-beta-monooxygenase activity), [GO:0034379](http://purl.obolibrary.org/obo/GO_0034379) (very-low-density lipoprotein particle assembly), [GO:0004509](http://purl.obolibrary.org/obo/GO_0004509) (steroid 21-monooxygenase activity), [GO:0034377](http://purl.obolibrary.org/obo/GO_0034377) (plasma lipoprotein particle assembly), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0034371](http://purl.obolibrary.org/obo/GO_0034371) (chylomicron remodeling), [GO:0034370](http://purl.obolibrary.org/obo/GO_0034370) (triglyceride-rich lipoprotein particle remodeling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0008089](http://purl.obolibrary.org/obo/GO_0008089) (anterograde axonal transport), [GO:0034375](http://purl.obolibrary.org/obo/GO_0034375) (high-density lipoprotein particle remodeling), [GO:0008088](http://purl.obolibrary.org/obo/GO_0008088) (axo-dendritic transport), [GO:0033044](http://purl.obolibrary.org/obo/GO_0033044) (regulation of chromosome organization), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0060627](http://purl.obolibrary.org/obo/GO_0060627) (regulation of vesicle-mediated transport), [GO:0061953](http://purl.obolibrary.org/obo/GO_0061953) (mRNA (adenine-N1-)-methyltransferase activity), [GO:0060623](http://purl.obolibrary.org/obo/GO_0060623) (regulation of chromosome condensation), [GO:1902807](http://purl.obolibrary.org/obo/GO_1902807) (negative regulation of cell cycle G1/S phase transition), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network), [GO:0046321](http://purl.obolibrary.org/obo/GO_0046321) (positive regulation of fatty acid oxidation), [GO:0046322](http://purl.obolibrary.org/obo/GO_0046322) (negative regulation of fatty acid oxidation), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:0046320](http://purl.obolibrary.org/obo/GO_0046320) (regulation of fatty acid oxidation), [GO:0072602](http://purl.obolibrary.org/obo/GO_0072602) (interleukin-4 secretion), [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0072606](http://purl.obolibrary.org/obo/GO_0072606) (interleukin-8 secretion), [GO:0008080](http://purl.obolibrary.org/obo/GO_0008080) (N-acetyltransferase activity), [GO:0072604](http://purl.obolibrary.org/obo/GO_0072604) (interleukin-6 secretion), [GO:0033030](http://purl.obolibrary.org/obo/GO_0033030) (negative regulation of neutrophil apoptotic process), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0035694](http://purl.obolibrary.org/obo/GO_0035694) (mitochondrial protein catabolic process), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:1905098](http://purl.obolibrary.org/obo/GO_1905098) (negative regulation of guanyl-nucleotide exchange factor activity), [GO:0008093](http://purl.obolibrary.org/obo/GO_0008093) (cytoskeletal adaptor activity), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0033033](http://purl.obolibrary.org/obo/GO_0033033) (negative regulation of myeloid cell apoptotic process), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0008097](http://purl.obolibrary.org/obo/GO_0008097) (5S rRNA binding), [GO:0033031](http://purl.obolibrary.org/obo/GO_0033031) (positive regulation of neutrophil apoptotic process), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0046323](http://purl.obolibrary.org/obo/GO_0046323) (glucose import), [GO:0046324](http://purl.obolibrary.org/obo/GO_0046324) (regulation of glucose import), [GO:0046329](http://purl.obolibrary.org/obo/GO_0046329) (negative regulation of JNK cascade), [GO:0046327](http://purl.obolibrary.org/obo/GO_0046327) (glycerol biosynthetic process from pyruvate), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0046328](http://purl.obolibrary.org/obo/GO_0046328) (regulation of JNK cascade), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:1902817](http://purl.obolibrary.org/obo/GO_1902817) (negative regulation of protein localization to microtubule), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0005815](http://purl.obolibrary.org/obo/GO_0005815) (microtubule organizing center), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole), [GO:0045002](http://purl.obolibrary.org/obo/GO_0045002) (double-strand break repair via single-strand annealing), [GO:0046333](http://purl.obolibrary.org/obo/GO_0046333) (octopamine metabolic process), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0005816](http://purl.obolibrary.org/obo/GO_0005816) (spindle pole body), [GO:0046331](http://purl.obolibrary.org/obo/GO_0046331) (lateral inhibition), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0033026](http://purl.obolibrary.org/obo/GO_0033026) (negative regulation of mast cell apoptotic process), [GO:0034356](http://purl.obolibrary.org/obo/GO_0034356) (NAD biosynthesis via nicotinamide riboside salvage pathway), [GO:0008092](http://purl.obolibrary.org/obo/GO_0008092) (cytoskeletal protein binding), [GO:0035686](http://purl.obolibrary.org/obo/GO_0035686) (sperm fibrous sheath), [GO:0008091](http://purl.obolibrary.org/obo/GO_0008091) (spectrin), [GO:0008090](http://purl.obolibrary.org/obo/GO_0008090) (retrograde axonal transport), [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron), [GO:0060363](http://purl.obolibrary.org/obo/GO_0060363) (cranial suture morphogenesis), [GO:0060364](http://purl.obolibrary.org/obo/GO_0060364) (frontal suture morphogenesis), [GO:0060365](http://purl.obolibrary.org/obo/GO_0060365) (coronal suture morphogenesis), [GO:1900131](http://purl.obolibrary.org/obo/GO_1900131) (negative regulation of lipid binding), [GO:1900133](http://purl.obolibrary.org/obo/GO_1900133) (regulation of renin secretion into blood stream), [GO:0006843](http://purl.obolibrary.org/obo/GO_0006843) (mitochondrial citrate transport), [GO:0072341](http://purl.obolibrary.org/obo/GO_0072341) (modified amino acid binding), [GO:0006836](http://purl.obolibrary.org/obo/GO_0006836) (neurotransmitter transport), [GO:0005502](http://purl.obolibrary.org/obo/GO_0005502) (11-cis retinal binding), [GO:0006833](http://purl.obolibrary.org/obo/GO_0006833) (water transport), [GO:0098970](http://purl.obolibrary.org/obo/GO_0098970) (postsynaptic neurotransmitter receptor diffusion trapping), [GO:0005504](http://purl.obolibrary.org/obo/GO_0005504) (fatty acid binding), [GO:0097643](http://purl.obolibrary.org/obo/GO_0097643) (amylin receptor activity), [GO:0071013](http://purl.obolibrary.org/obo/GO_0071013) (catalytic step 2 spliceosome), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0072345](http://purl.obolibrary.org/obo/GO_0072345) (NAADP-sensitive calcium-release channel activity), [GO:0006839](http://purl.obolibrary.org/obo/GO_0006839) (mitochondrial transport), [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process), [GO:0098976](http://purl.obolibrary.org/obo/GO_0098976) (excitatory chemical synaptic transmission), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0072344](http://purl.obolibrary.org/obo/GO_0072344) (rescue of stalled ribosome), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0071011](http://purl.obolibrary.org/obo/GO_0071011) (precatalytic spliceosome), [GO:2001209](http://purl.obolibrary.org/obo/GO_2001209) (positive regulation of transcription elongation from RNA polymerase I promoter), [GO:2001204](http://purl.obolibrary.org/obo/GO_2001204) (regulation of osteoclast development), [GO:2001205](http://purl.obolibrary.org/obo/GO_2001205) (negative regulation of osteoclast development), [GO:2001206](http://purl.obolibrary.org/obo/GO_2001206) (positive regulation of osteoclast development), [GO:2001200](http://purl.obolibrary.org/obo/GO_2001200) (positive regulation of dendritic cell differentiation), [GO:0046061](http://purl.obolibrary.org/obo/GO_0046061) (dATP catabolic process), [GO:0047391](http://purl.obolibrary.org/obo/GO_0047391) (alkylglycerophosphoethanolamine phosphodiesterase activity), [GO:0034063](http://purl.obolibrary.org/obo/GO_0034063) (stress granule assembly), [GO:0018812](http://purl.obolibrary.org/obo/GO_0018812) (3-hydroxyacyl-CoA dehydratase activity), [GO:0034067](http://purl.obolibrary.org/obo/GO_0034067) (protein localization to Golgi apparatus), [GO:0060350](http://purl.obolibrary.org/obo/GO_0060350) (endochondral bone morphogenesis), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:1900145](http://purl.obolibrary.org/obo/GO_1900145) (regulation of nodal signaling pathway involved in determination of left/right asymmetry), [GO:0006850](http://purl.obolibrary.org/obo/GO_0006850) (mitochondrial pyruvate transmembrane transport), [GO:0005521](http://purl.obolibrary.org/obo/GO_0005521) (lamin binding), [GO:0005520](http://purl.obolibrary.org/obo/GO_0005520) (insulin-like growth factor binding), [GO:0006851](http://purl.obolibrary.org/obo/GO_0006851) (mitochondrial calcium ion transmembrane transport), [GO:0061689](http://purl.obolibrary.org/obo/GO_0061689) (tricellular tight junction), [GO:0005523](http://purl.obolibrary.org/obo/GO_0005523) (tropomyosin binding), [GO:0005522](http://purl.obolibrary.org/obo/GO_0005522) (profilin binding), [GO:0005513](http://purl.obolibrary.org/obo/GO_0005513) (detection of calcium ion), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0072334](http://purl.obolibrary.org/obo/GO_0072334) (UDP-galactose transmembrane transport), [GO:0072332](http://purl.obolibrary.org/obo/GO_0072332) (intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0006848](http://purl.obolibrary.org/obo/GO_0006848) (pyruvate transport), [GO:0071001](http://purl.obolibrary.org/obo/GO_0071001) (U4/U6 snRNP), [GO:2001214](http://purl.obolibrary.org/obo/GO_2001214) (positive regulation of vasculogenesis), [GO:0071004](http://purl.obolibrary.org/obo/GO_0071004) (U2-type prespliceosome), [GO:0046070](http://purl.obolibrary.org/obo/GO_0046070) (dGTP metabolic process), [GO:2001213](http://purl.obolibrary.org/obo/GO_2001213) (negative regulation of vasculogenesis), [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation), [GO:0035385](http://purl.obolibrary.org/obo/GO_0035385) (Roundabout signaling pathway), [GO:0010085](http://purl.obolibrary.org/obo/GO_0010085) (polarity specification of proximal/distal axis), [GO:0034050](http://purl.obolibrary.org/obo/GO_0034050) (host programmed cell death induced by symbiont), [GO:1900153](http://purl.obolibrary.org/obo/GO_1900153) (positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0060381](http://purl.obolibrary.org/obo/GO_0060381) (positive regulation of single-stranded telomeric DNA binding), [GO:0034056](http://purl.obolibrary.org/obo/GO_0034056) (estrogen response element binding), [GO:0060383](http://purl.obolibrary.org/obo/GO_0060383) (positive regulation of DNA strand elongation), [GO:0060384](http://purl.obolibrary.org/obo/GO_0060384) (innervation), [GO:1900158](http://purl.obolibrary.org/obo/GO_1900158) (negative regulation of bone mineralization involved in bone maturation), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0060389](http://purl.obolibrary.org/obo/GO_0060389) (pathway-restricted SMAD protein phosphorylation), [GO:0006821](http://purl.obolibrary.org/obo/GO_0006821) (chloride transport), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0006814](http://purl.obolibrary.org/obo/GO_0006814) (sodium ion transport), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0006812](http://purl.obolibrary.org/obo/GO_0006812) (cation transport), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0006817](http://purl.obolibrary.org/obo/GO_0006817) (phosphate ion transport), [GO:0071035](http://purl.obolibrary.org/obo/GO_0071035) (nuclear polyadenylation-dependent rRNA catabolic process), [GO:2001229](http://purl.obolibrary.org/obo/GO_2001229) (negative regulation of response to gamma radiation), [GO:0097623](http://purl.obolibrary.org/obo/GO_0097623) (potassium ion export across plasma membrane), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0071034](http://purl.obolibrary.org/obo/GO_0071034) (CUT catabolic process), [GO:2001225](http://purl.obolibrary.org/obo/GO_2001225) (regulation of chloride transport), [GO:0072369](http://purl.obolibrary.org/obo/GO_0072369) (regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter), [GO:0060391](http://purl.obolibrary.org/obo/GO_0060391) (positive regulation of SMAD protein import into nucleus), [GO:0071038](http://purl.obolibrary.org/obo/GO_0071038) (nuclear polyadenylation-dependent tRNA catabolic process), [GO:0046083](http://purl.obolibrary.org/obo/GO_0046083) (adenine metabolic process), [GO:2001222](http://purl.obolibrary.org/obo/GO_2001222) (regulation of neuron migration), [GO:2001223](http://purl.obolibrary.org/obo/GO_2001223) (negative regulation of neuron migration), [GO:2001224](http://purl.obolibrary.org/obo/GO_2001224) (positive regulation of neuron migration), [GO:0060374](http://purl.obolibrary.org/obo/GO_0060374) (mast cell differentiation), [GO:0043813](http://purl.obolibrary.org/obo/GO_0043813) (phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity), [GO:1901491](http://purl.obolibrary.org/obo/GO_1901491) (negative regulation of lymphangiogenesis), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:2001241](http://purl.obolibrary.org/obo/GO_2001241) (positive regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0060376](http://purl.obolibrary.org/obo/GO_0060376) (positive regulation of mast cell differentiation), [GO:0035377](http://purl.obolibrary.org/obo/GO_0035377) (transepithelial water transport), [GO:2001242](http://purl.obolibrary.org/obo/GO_2001242) (regulation of intrinsic apoptotic signaling pathway), [GO:1901492](http://purl.obolibrary.org/obo/GO_1901492) (positive regulation of lymphangiogenesis), [GO:1900164](http://purl.obolibrary.org/obo/GO_1900164) (nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry), [GO:0034046](http://purl.obolibrary.org/obo/GO_0034046) (poly(G) binding), [GO:0035371](http://purl.obolibrary.org/obo/GO_0035371) (microtubule plus-end), [GO:0034045](http://purl.obolibrary.org/obo/GO_0034045) (phagophore assembly site membrane), [GO:0060371](http://purl.obolibrary.org/obo/GO_0060371) (regulation of atrial cardiac muscle cell membrane depolarization), [GO:1900163](http://purl.obolibrary.org/obo/GO_1900163) (positive regulation of phospholipid scramblase activity), [GO:0035372](http://purl.obolibrary.org/obo/GO_0035372) (protein localization to microtubule), [GO:0060372](http://purl.obolibrary.org/obo/GO_0060372) (regulation of atrial cardiac muscle cell membrane repolarization), [GO:1900165](http://purl.obolibrary.org/obo/GO_1900165) (negative regulation of interleukin-6 secretion), [GO:0060373](http://purl.obolibrary.org/obo/GO_0060373) (regulation of ventricular cardiac muscle cell membrane depolarization), [GO:0060378](http://purl.obolibrary.org/obo/GO_0060378) (regulation of brood size), [GO:0005501](http://purl.obolibrary.org/obo/GO_0005501) (retinoid binding), [GO:0006824](http://purl.obolibrary.org/obo/GO_0006824) (cobalt ion transport), [GO:0006825](http://purl.obolibrary.org/obo/GO_0006825) (copper ion transport), [GO:0046098](http://purl.obolibrary.org/obo/GO_0046098) (guanine metabolic process), [GO:0072350](http://purl.obolibrary.org/obo/GO_0072350) (tricarboxylic acid metabolic process), [GO:0006828](http://purl.obolibrary.org/obo/GO_0006828) (manganese ion transport), [GO:0006829](http://purl.obolibrary.org/obo/GO_0006829) (zinc II ion transport), [GO:0072355](http://purl.obolibrary.org/obo/GO_0072355) (histone H3-T3 phosphorylation), [GO:0006826](http://purl.obolibrary.org/obo/GO_0006826) (iron ion transport), [GO:0072354](http://purl.obolibrary.org/obo/GO_0072354) (histone kinase activity (H3-T3 specific)), [GO:0034039](http://purl.obolibrary.org/obo/GO_0034039) (8-oxo-7,8-dihydroguanine DNA N-glycosylase activity), [GO:0071028](http://purl.obolibrary.org/obo/GO_0071028) (nuclear mRNA surveillance), [GO:2001236](http://purl.obolibrary.org/obo/GO_2001236) (regulation of extrinsic apoptotic signaling pathway), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:0072359](http://purl.obolibrary.org/obo/GO_0072359) (circulatory system development), [GO:0072358](http://purl.obolibrary.org/obo/GO_0072358) (cardiovascular system development), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:2001239](http://purl.obolibrary.org/obo/GO_2001239) (regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:2001233](http://purl.obolibrary.org/obo/GO_2001233) (regulation of apoptotic signaling pathway), [GO:0035368](http://purl.obolibrary.org/obo/GO_0035368) (selenocysteine insertion sequence binding), [GO:2001234](http://purl.obolibrary.org/obo/GO_2001234) (negative regulation of apoptotic signaling pathway), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0046092](http://purl.obolibrary.org/obo/GO_0046092) (deoxycytidine metabolic process), [GO:0016206](http://purl.obolibrary.org/obo/GO_0016206) (catechol O-methyltransferase activity), [GO:2001252](http://purl.obolibrary.org/obo/GO_2001252) (positive regulation of chromosome organization), [GO:0060322](http://purl.obolibrary.org/obo/GO_0060322) (head development), [GO:0016208](http://purl.obolibrary.org/obo/GO_0016208) (AMP binding), [GO:0016209](http://purl.obolibrary.org/obo/GO_0016209) (antioxidant activity), [GO:0006882](http://purl.obolibrary.org/obo/GO_0006882) (cellular zinc ion homeostasis), [GO:0047349](http://purl.obolibrary.org/obo/GO_0047349) (D-ribitol-5-phosphate cytidylyltransferase activity), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0006883](http://purl.obolibrary.org/obo/GO_0006883) (cellular sodium ion homeostasis), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0006880](http://purl.obolibrary.org/obo/GO_0006880) (intracellular sequestering of iron ion), [GO:0046015](http://purl.obolibrary.org/obo/GO_0046015) (regulation of transcription by glucose), [GO:0048677](http://purl.obolibrary.org/obo/GO_0048677) (axon extension involved in regeneration), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0060323](http://purl.obolibrary.org/obo/GO_0060323) (head morphogenesis), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0006887](http://purl.obolibrary.org/obo/GO_0006887) (exocytosis), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0006884](http://purl.obolibrary.org/obo/GO_0006884) (cell volume homeostasis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0006885](http://purl.obolibrary.org/obo/GO_0006885) (regulation of pH), [GO:0005547](http://purl.obolibrary.org/obo/GO_0005547) (phosphatidylinositol-3,4,5-trisphosphate binding), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0046020](http://purl.obolibrary.org/obo/GO_0046020) (negative regulation of transcription from RNA polymerase II promoter by pheromones), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0030505](http://purl.obolibrary.org/obo/GO_0030505) (inorganic diphosphate transport), [GO:0005548](http://purl.obolibrary.org/obo/GO_0005548) (phospholipid transporter activity), [GO:0006878](http://purl.obolibrary.org/obo/GO_0006878) (cellular copper ion homeostasis), [GO:0030504](http://purl.obolibrary.org/obo/GO_0030504) (inorganic diphosphate transmembrane transporter activity), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0030507](http://purl.obolibrary.org/obo/GO_0030507) (spectrin binding), [GO:0072300](http://purl.obolibrary.org/obo/GO_0072300) (positive regulation of metanephric glomerulus development), [GO:0030506](http://purl.obolibrary.org/obo/GO_0030506) (ankyrin binding), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0072305](http://purl.obolibrary.org/obo/GO_0072305) (negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis), [GO:0097602](http://purl.obolibrary.org/obo/GO_0097602) (cullin family protein binding), [GO:0050999](http://purl.obolibrary.org/obo/GO_0050999) (regulation of nitric-oxide synthase activity), [GO:2001243](http://purl.obolibrary.org/obo/GO_2001243) (negative regulation of intrinsic apoptotic signaling pathway), [GO:0050998](http://purl.obolibrary.org/obo/GO_0050998) (nitric-oxide synthase binding), [GO:2001244](http://purl.obolibrary.org/obo/GO_2001244) (positive regulation of intrinsic apoptotic signaling pathway), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0072307](http://purl.obolibrary.org/obo/GO_0072307) (regulation of metanephric nephron tubule epithelial cell differentiation), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0060311](http://purl.obolibrary.org/obo/GO_0060311) (negative regulation of elastin catabolic process), [GO:0006890](http://purl.obolibrary.org/obo/GO_0006890) (retrograde vesicle-mediated transport, Golgi to ER), [GO:0006893](http://purl.obolibrary.org/obo/GO_0006893) (Golgi to plasma membrane transport), [GO:0060316](http://purl.obolibrary.org/obo/GO_0060316) (positive regulation of ryanodine-sensitive calcium-release channel activity), [GO:1900101](http://purl.obolibrary.org/obo/GO_1900101) (regulation of endoplasmic reticulum unfolded protein response), [GO:0060317](http://purl.obolibrary.org/obo/GO_0060317) (cardiac epithelial to mesenchymal transition), [GO:0006891](http://purl.obolibrary.org/obo/GO_0006891) (intra-Golgi vesicle-mediated transport), [GO:0006892](http://purl.obolibrary.org/obo/GO_0006892) (post-Golgi vesicle-mediated transport), [GO:0060319](http://purl.obolibrary.org/obo/GO_0060319) (primitive erythrocyte differentiation), [GO:0060312](http://purl.obolibrary.org/obo/GO_0060312) (regulation of blood vessel remodeling), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:1900106](http://purl.obolibrary.org/obo/GO_1900106) (positive regulation of hyaluranon cable assembly), [GO:0006898](http://purl.obolibrary.org/obo/GO_0006898) (receptor-mediated endocytosis), [GO:0060313](http://purl.obolibrary.org/obo/GO_0060313) (negative regulation of blood vessel remodeling), [GO:0060314](http://purl.obolibrary.org/obo/GO_0060314) (regulation of ryanodine-sensitive calcium-release channel activity), [GO:0006895](http://purl.obolibrary.org/obo/GO_0006895) (Golgi to endosome transport), [GO:0006896](http://purl.obolibrary.org/obo/GO_0006896) (Golgi to vacuole transport), [GO:0060315](http://purl.obolibrary.org/obo/GO_0060315) (negative regulation of ryanodine-sensitive calcium-release channel activity), [GO:0061646](http://purl.obolibrary.org/obo/GO_0061646) (positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0098943](http://purl.obolibrary.org/obo/GO_0098943) (neurotransmitter receptor transport, postsynaptic endosome to lysosome), [GO:0048697](http://purl.obolibrary.org/obo/GO_0048697) (positive regulation of collateral sprouting in absence of injury), [GO:0048696](http://purl.obolibrary.org/obo/GO_0048696) (regulation of collateral sprouting in absence of injury), [GO:0031826](http://purl.obolibrary.org/obo/GO_0031826) (type 2A serotonin receptor binding), [GO:0046033](http://purl.obolibrary.org/obo/GO_0046033) (AMP metabolic process), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity), [GO:2001259](http://purl.obolibrary.org/obo/GO_2001259) (positive regulation of cation channel activity), [GO:0016202](http://purl.obolibrary.org/obo/GO_0016202) (regulation of striated muscle tissue development), [GO:0031821](http://purl.obolibrary.org/obo/GO_0031821) (G-protein coupled serotonin receptor binding), [GO:2001255](http://purl.obolibrary.org/obo/GO_2001255) (positive regulation of histone H3-K36 trimethylation), [GO:0016203](http://purl.obolibrary.org/obo/GO_0016203) (muscle attachment), [GO:2001256](http://purl.obolibrary.org/obo/GO_2001256) (regulation of store-operated calcium entry), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0060342](http://purl.obolibrary.org/obo/GO_0060342) (photoreceptor inner segment membrane), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:0060340](http://purl.obolibrary.org/obo/GO_0060340) (positive regulation of type I interferon-mediated signaling pathway), [GO:0034098](http://purl.obolibrary.org/obo/GO_0034098) (VCP-NPL4-UFD1 AAA ATPase complex), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0046039](http://purl.obolibrary.org/obo/GO_0046039) (GTP metabolic process), [GO:0046037](http://purl.obolibrary.org/obo/GO_0046037) (GMP metabolic process), [GO:0048699](http://purl.obolibrary.org/obo/GO_0048699) (generation of neurons), [GO:0046038](http://purl.obolibrary.org/obo/GO_0046038) (GMP catabolic process), [GO:1902775](http://purl.obolibrary.org/obo/GO_1902775) (mitochondrial large ribosomal subunit assembly), [GO:0090193](http://purl.obolibrary.org/obo/GO_0090193) (positive regulation of glomerulus development), [GO:0060345](http://purl.obolibrary.org/obo/GO_0060345) (spleen trabecula formation), [GO:0006865](http://purl.obolibrary.org/obo/GO_0006865) (amino acid transport), [GO:0090194](http://purl.obolibrary.org/obo/GO_0090194) (negative regulation of glomerulus development), [GO:0060346](http://purl.obolibrary.org/obo/GO_0060346) (bone trabecula formation), [GO:1900119](http://purl.obolibrary.org/obo/GO_1900119) (positive regulation of execution phase of apoptosis), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0090191](http://purl.obolibrary.org/obo/GO_0090191) (negative regulation of branching involved in ureteric bud morphogenesis), [GO:0005534](http://purl.obolibrary.org/obo/GO_0005534) (galactose binding), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0006857](http://purl.obolibrary.org/obo/GO_0006857) (oligopeptide transport), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006858](http://purl.obolibrary.org/obo/GO_0006858) (extracellular transport), [GO:0006855](http://purl.obolibrary.org/obo/GO_0006855) (drug transmembrane transport), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0046040](http://purl.obolibrary.org/obo/GO_0046040) (IMP metabolic process), [GO:0098910](http://purl.obolibrary.org/obo/GO_0098910) (regulation of atrial cardiac muscle cell action potential), [GO:0005528](http://purl.obolibrary.org/obo/GO_0005528) (FK506 binding), [GO:0072321](http://purl.obolibrary.org/obo/GO_0072321) (chaperone-mediated protein transport), [GO:2001269](http://purl.obolibrary.org/obo/GO_2001269) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0098914](http://purl.obolibrary.org/obo/GO_0098914) (membrane repolarization during atrial cardiac muscle cell action potential), [GO:0098911](http://purl.obolibrary.org/obo/GO_0098911) (regulation of ventricular cardiac muscle cell action potential), [GO:0098912](http://purl.obolibrary.org/obo/GO_0098912) (membrane depolarization during atrial cardiac muscle cell action potential), [GO:0098915](http://purl.obolibrary.org/obo/GO_0098915) (membrane repolarization during ventricular cardiac muscle cell action potential), [GO:2001268](http://purl.obolibrary.org/obo/GO_2001268) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0034085](http://purl.obolibrary.org/obo/GO_0034085) (establishment of sister chromatid cohesion), [GO:2001286](http://purl.obolibrary.org/obo/GO_2001286) (regulation of caveolin-mediated endocytosis), [GO:0060333](http://purl.obolibrary.org/obo/GO_0060333) (interferon-gamma-mediated signaling pathway), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:0034088](http://purl.obolibrary.org/obo/GO_0034088) (maintenance of mitotic sister chromatid cohesion), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0034087](http://purl.obolibrary.org/obo/GO_0034087) (establishment of mitotic sister chromatid cohesion), [GO:0060338](http://purl.obolibrary.org/obo/GO_0060338) (regulation of type I interferon-mediated signaling pathway), [GO:0061669](http://purl.obolibrary.org/obo/GO_0061669) (spontaneous neurotransmitter secretion), [GO:0060339](http://purl.obolibrary.org/obo/GO_0060339) (negative regulation of type I interferon-mediated signaling pathway), [GO:0005540](http://purl.obolibrary.org/obo/GO_0005540) (hyaluronic acid binding), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:1900128](http://purl.obolibrary.org/obo/GO_1900128) (regulation of G-protein activated inward rectifier potassium channel activity), [GO:0006875](http://purl.obolibrary.org/obo/GO_0006875) (cellular metal ion homeostasis), [GO:1900127](http://purl.obolibrary.org/obo/GO_1900127) (positive regulation of hyaluronan biosynthetic process), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:0060335](http://purl.obolibrary.org/obo/GO_0060335) (positive regulation of interferon-gamma-mediated signaling pathway), [GO:0006873](http://purl.obolibrary.org/obo/GO_0006873) (cellular ion homeostasis), [GO:0060336](http://purl.obolibrary.org/obo/GO_0060336) (negative regulation of interferon-gamma-mediated signaling pathway), [GO:0005545](http://purl.obolibrary.org/obo/GO_0005545) (1-phosphatidylinositol binding), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0006868](http://purl.obolibrary.org/obo/GO_0006868) (glutamine transport), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005537](http://purl.obolibrary.org/obo/GO_0005537) (mannose binding), [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding), [GO:0046058](http://purl.obolibrary.org/obo/GO_0046058) (cAMP metabolic process), [GO:2001294](http://purl.obolibrary.org/obo/GO_2001294) (malonyl-CoA catabolic process), [GO:0042536](http://purl.obolibrary.org/obo/GO_0042536) (negative regulation of tumor necrosis factor biosynthetic process), [GO:0042537](http://purl.obolibrary.org/obo/GO_0042537) (benzene-containing compound metabolic process), [GO:0042538](http://purl.obolibrary.org/obo/GO_0042538) (hyperosmotic salinity response), [GO:0042539](http://purl.obolibrary.org/obo/GO_0042539) (hypotonic salinity response), [GO:0005592](http://purl.obolibrary.org/obo/GO_0005592) (collagen type XI trimer), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0042532](http://purl.obolibrary.org/obo/GO_0042532) (negative regulation of tyrosine phosphorylation of STAT protein), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0030547](http://purl.obolibrary.org/obo/GO_0030547) (receptor inhibitor activity), [GO:0016250](http://purl.obolibrary.org/obo/GO_0016250) (N-sulfoglucosamine sulfohydrolase activity), [GO:0031870](http://purl.obolibrary.org/obo/GO_0031870) (thromboxane A2 receptor binding), [GO:0030540](http://purl.obolibrary.org/obo/GO_0030540) (female genitalia development), [GO:0016255](http://purl.obolibrary.org/obo/GO_0016255) (attachment of GPI anchor to protein), [GO:0030543](http://purl.obolibrary.org/obo/GO_0030543) (2-micrometer plasmid partitioning), [GO:0016256](http://purl.obolibrary.org/obo/GO_0016256) (N-glycan processing to lysosome), [GO:2001287](http://purl.obolibrary.org/obo/GO_2001287) (negative regulation of caveolin-mediated endocytosis), [GO:0030544](http://purl.obolibrary.org/obo/GO_0030544) (Hsp70 protein binding), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0042541](http://purl.obolibrary.org/obo/GO_0042541) (hemoglobin biosynthetic process), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0030538](http://purl.obolibrary.org/obo/GO_0030538) (embryonic genitalia morphogenesis), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0016241](http://purl.obolibrary.org/obo/GO_0016241) (regulation of macroautophagy), [GO:0031860](http://purl.obolibrary.org/obo/GO_0031860) (telomeric 3' overhang formation), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0016243](http://purl.obolibrary.org/obo/GO_0016243) (regulation of autophagosome size), [GO:0030532](http://purl.obolibrary.org/obo/GO_0030532) (small nuclear ribonucleoprotein complex), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0042558](http://purl.obolibrary.org/obo/GO_0042558) (pteridine-containing compound metabolic process), [GO:0042559](http://purl.obolibrary.org/obo/GO_0042559) (pteridine-containing compound biosynthetic process), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0102704](http://purl.obolibrary.org/obo/GO_0102704) (GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity), [GO:0042551](http://purl.obolibrary.org/obo/GO_0042551) (neuron maturation), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042555](http://purl.obolibrary.org/obo/GO_0042555) (MCM complex), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0005577](http://purl.obolibrary.org/obo/GO_0005577) (fibrinogen complex), [GO:0031857](http://purl.obolibrary.org/obo/GO_0031857) (type 1 parathyroid hormone receptor binding), [GO:0031856](http://purl.obolibrary.org/obo/GO_0031856) (parathyroid hormone receptor binding), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0043890](http://purl.obolibrary.org/obo/GO_0043890) (N-acetylgalactosamine-6-sulfatase activity), [GO:0016231](http://purl.obolibrary.org/obo/GO_0016231) (beta-N-acetylglucosaminidase activity), [GO:0016233](http://purl.obolibrary.org/obo/GO_0016233) (telomere capping), [GO:0030521](http://purl.obolibrary.org/obo/GO_0030521) (androgen receptor signaling pathway), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0030520](http://purl.obolibrary.org/obo/GO_0030520) (intracellular estrogen receptor signaling pathway), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0030522](http://purl.obolibrary.org/obo/GO_0030522) (intracellular receptor signaling pathway), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0016237](http://purl.obolibrary.org/obo/GO_0016237) (lysosomal microautophagy), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0005587](http://purl.obolibrary.org/obo/GO_0005587) (collagen type IV trimer), [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer), [GO:0005588](http://purl.obolibrary.org/obo/GO_0005588) (collagen type V trimer), [GO:0030514](http://purl.obolibrary.org/obo/GO_0030514) (negative regulation of BMP signaling pathway), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0005579](http://purl.obolibrary.org/obo/GO_0005579) (membrane attack complex), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0030515](http://purl.obolibrary.org/obo/GO_0030515) (snoRNA binding), [GO:0030518](http://purl.obolibrary.org/obo/GO_0030518) (intracellular steroid hormone receptor signaling pathway), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0031848](http://purl.obolibrary.org/obo/GO_0031848) (protection from non-homologous end joining at telomere), [GO:0031849](http://purl.obolibrary.org/obo/GO_0031849) (olfactory receptor binding), [GO:0042571](http://purl.obolibrary.org/obo/GO_0042571) (immunoglobulin complex, circulating), [GO:0016222](http://purl.obolibrary.org/obo/GO_0016222) (procollagen-proline 4-dioxygenase complex), [GO:0030510](http://purl.obolibrary.org/obo/GO_0030510) (regulation of BMP signaling pathway), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0030511](http://purl.obolibrary.org/obo/GO_0030511) (positive regulation of transforming growth factor beta receptor signaling pathway), [GO:0016226](http://purl.obolibrary.org/obo/GO_0016226) (iron-sulfur cluster assembly), [GO:0072385](http://purl.obolibrary.org/obo/GO_0072385) (minus-end-directed organelle transport along microtubule), [GO:0097682](http://purl.obolibrary.org/obo/GO_0097682) (intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity), [GO:0016290](http://purl.obolibrary.org/obo/GO_0016290) (palmitoyl-CoA hydrolase activity), [GO:0071051](http://purl.obolibrary.org/obo/GO_0071051) (polyadenylation-dependent snoRNA 3'-end processing), [GO:0072383](http://purl.obolibrary.org/obo/GO_0072383) (plus-end-directed vesicle transport along microtubule), [GO:0072382](http://purl.obolibrary.org/obo/GO_0072382) (minus-end-directed vesicle transport along microtubule), [GO:0072389](http://purl.obolibrary.org/obo/GO_0072389) (flavin adenine dinucleotide catabolic process), [GO:0097689](http://purl.obolibrary.org/obo/GO_0097689) (iron channel activity), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0030586](http://purl.obolibrary.org/obo/GO_0030586) ([methionine synthase] reductase activity), [GO:1900182](http://purl.obolibrary.org/obo/GO_1900182) (positive regulation of protein localization to nucleus), [GO:0060396](http://purl.obolibrary.org/obo/GO_0060396) (growth hormone receptor signaling pathway), [GO:0060397](http://purl.obolibrary.org/obo/GO_0060397) (JAK-STAT cascade involved in growth hormone signaling pathway), [GO:0060399](http://purl.obolibrary.org/obo/GO_0060399) (positive regulation of growth hormone receptor signaling pathway), [GO:1900186](http://purl.obolibrary.org/obo/GO_1900186) (negative regulation of clathrin-dependent endocytosis), [GO:0000706](http://purl.obolibrary.org/obo/GO_0000706) (meiotic DNA double-strand break processing), [GO:0060393](http://purl.obolibrary.org/obo/GO_0060393) (regulation of pathway-restricted SMAD protein phosphorylation), [GO:0060394](http://purl.obolibrary.org/obo/GO_0060394) (negative regulation of pathway-restricted SMAD protein phosphorylation), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0000703](http://purl.obolibrary.org/obo/GO_0000703) (oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity), [GO:0000702](http://purl.obolibrary.org/obo/GO_0000702) (oxidized base lesion DNA N-glycosylase activity), [GO:0000701](http://purl.obolibrary.org/obo/GO_0000701) (purine-specific mismatch base pair DNA N-glycosylase activity), [GO:0097694](http://purl.obolibrary.org/obo/GO_0097694) (establishment of RNA localization to telomere), [GO:0071042](http://purl.obolibrary.org/obo/GO_0071042) (nuclear polyadenylation-dependent mRNA catabolic process), [GO:0030579](http://purl.obolibrary.org/obo/GO_0030579) (ubiquitin-dependent SMAD protein catabolic process), [GO:0071041](http://purl.obolibrary.org/obo/GO_0071041) (antisense RNA transcript catabolic process), [GO:0097695](http://purl.obolibrary.org/obo/GO_0097695) (establishment of macromolecular complex localization to telomere), [GO:0072378](http://purl.obolibrary.org/obo/GO_0072378) (blood coagulation, fibrin clot formation), [GO:0071044](http://purl.obolibrary.org/obo/GO_0071044) (histone mRNA catabolic process), [GO:0016286](http://purl.obolibrary.org/obo/GO_0016286) (small conductance calcium-activated potassium channel activity), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0016287](http://purl.obolibrary.org/obo/GO_0016287) (glycerone-phosphate O-acyltransferase activity), [GO:0071049](http://purl.obolibrary.org/obo/GO_0071049) (nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription), [GO:0030573](http://purl.obolibrary.org/obo/GO_0030573) (bile acid catabolic process), [GO:1900180](http://purl.obolibrary.org/obo/GO_1900180) (regulation of protein localization to nucleus), [GO:1900194](http://purl.obolibrary.org/obo/GO_1900194) (negative regulation of oocyte maturation), [GO:0071073](http://purl.obolibrary.org/obo/GO_0071073) (positive regulation of phospholipid biosynthetic process), [GO:0071074](http://purl.obolibrary.org/obo/GO_0071074) (eukaryotic initiation factor eIF2 binding), [GO:0016274](http://purl.obolibrary.org/obo/GO_0016274) (protein-arginine N-methyltransferase activity), [GO:0016277](http://purl.obolibrary.org/obo/GO_0016277) ([myelin basic protein]-arginine N-methyltransferase activity), [GO:0016279](http://purl.obolibrary.org/obo/GO_0016279) (protein-lysine N-methyltransferase activity), [GO:0071071](http://purl.obolibrary.org/obo/GO_0071071) (regulation of phospholipid biosynthetic process), [GO:0043855](http://purl.obolibrary.org/obo/GO_0043855) (cyclic nucleotide-gated ion channel activity), [GO:0097680](http://purl.obolibrary.org/obo/GO_0097680) (double-strand break repair via classical nonhomologous end joining), [GO:0072393](http://purl.obolibrary.org/obo/GO_0072393) (microtubule anchoring at microtubule organizing center), [GO:0016262](http://purl.obolibrary.org/obo/GO_0016262) (protein N-acetylglucosaminyltransferase activity), [GO:0016264](http://purl.obolibrary.org/obo/GO_0016264) (gap junction assembly), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:0001941](http://purl.obolibrary.org/obo/GO_0001941) (postsynaptic membrane organization), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0090107](http://purl.obolibrary.org/obo/GO_0090107) (regulation of high-density lipoprotein particle assembly), [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation), [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0001951](http://purl.obolibrary.org/obo/GO_0001951) (intestinal D-glucose absorption), [GO:0001952](http://purl.obolibrary.org/obo/GO_0001952) (regulation of cell-matrix adhesion), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0001954](http://purl.obolibrary.org/obo/GO_0001954) (positive regulation of cell-matrix adhesion), [GO:0001955](http://purl.obolibrary.org/obo/GO_0001955) (blood vessel maturation), [GO:0001956](http://purl.obolibrary.org/obo/GO_0001956) (positive regulation of neurotransmitter secretion), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0030497](http://purl.obolibrary.org/obo/GO_0030497) (fatty acid elongation), [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody), [GO:0030491](http://purl.obolibrary.org/obo/GO_0030491) (heteroduplex formation), [GO:0030490](http://purl.obolibrary.org/obo/GO_0030490) (maturation of SSU-rRNA), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0001920](http://purl.obolibrary.org/obo/GO_0001920) (negative regulation of receptor recycling), [GO:0001921](http://purl.obolibrary.org/obo/GO_0001921) (positive regulation of receptor recycling), [GO:0016197](http://purl.obolibrary.org/obo/GO_0016197) (endosomal transport), [GO:0016199](http://purl.obolibrary.org/obo/GO_0016199) (axon midline choice point recognition), [GO:0030485](http://purl.obolibrary.org/obo/GO_0030485) (smooth muscle contractile fiber), [GO:0030488](http://purl.obolibrary.org/obo/GO_0030488) (tRNA methylation), [GO:0050908](http://purl.obolibrary.org/obo/GO_0050908) (detection of light stimulus involved in visual perception), [GO:0050909](http://purl.obolibrary.org/obo/GO_0050909) (sensory perception of taste), [GO:0050905](http://purl.obolibrary.org/obo/GO_0050905) (neuromuscular process), [GO:0016182](http://purl.obolibrary.org/obo/GO_0016182) (synaptic vesicle budding from endosome), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0001935](http://purl.obolibrary.org/obo/GO_0001935) (endothelial cell proliferation), [GO:0030473](http://purl.obolibrary.org/obo/GO_0030473) (nuclear migration along microtubule), [GO:0001936](http://purl.obolibrary.org/obo/GO_0001936) (regulation of endothelial cell proliferation), [GO:0050900](http://purl.obolibrary.org/obo/GO_0050900) (leukocyte migration), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0050901](http://purl.obolibrary.org/obo/GO_0050901) (leukocyte tethering or rolling), [GO:0030474](http://purl.obolibrary.org/obo/GO_0030474) (spindle pole body duplication), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:0030479](http://purl.obolibrary.org/obo/GO_0030479) (actin cortical patch), [GO:0043783](http://purl.obolibrary.org/obo/GO_0043783) (oxidoreductase activity, oxidizing metal ions with flavin as acceptor), [GO:0001991](http://purl.obolibrary.org/obo/GO_0001991) (regulation of systemic arterial blood pressure by circulatory renin-angiotensin), [GO:0001988](http://purl.obolibrary.org/obo/GO_0001988) (positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure), [GO:0042461](http://purl.obolibrary.org/obo/GO_0042461) (photoreceptor cell development), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0009008](http://purl.obolibrary.org/obo/GO_0009008) (DNA-methyltransferase activity), [GO:0001993](http://purl.obolibrary.org/obo/GO_0001993) (regulation of systemic arterial blood pressure by norepinephrine-epinephrine), [GO:0042470](http://purl.obolibrary.org/obo/GO_0042470) (melanosome), [GO:0001998](http://purl.obolibrary.org/obo/GO_0001998) (angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure), [GO:0042471](http://purl.obolibrary.org/obo/GO_0042471) (ear morphogenesis), [GO:0001999](http://purl.obolibrary.org/obo/GO_0001999) (renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0042473](http://purl.obolibrary.org/obo/GO_0042473) (outer ear morphogenesis), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0001970](http://purl.obolibrary.org/obo/GO_0001970) (positive regulation of activation of membrane attack complex), [GO:0001960](http://purl.obolibrary.org/obo/GO_0001960) (negative regulation of cytokine-mediated signaling pathway), [GO:0001961](http://purl.obolibrary.org/obo/GO_0001961) (positive regulation of cytokine-mediated signaling pathway), [GO:0001963](http://purl.obolibrary.org/obo/GO_0001963) (synaptic transmission, dopaminergic), [GO:0001964](http://purl.obolibrary.org/obo/GO_0001964) (startle response), [GO:0042481](http://purl.obolibrary.org/obo/GO_0042481) (regulation of odontogenesis), [GO:0001965](http://purl.obolibrary.org/obo/GO_0001965) (G-protein alpha-subunit binding), [GO:0001966](http://purl.obolibrary.org/obo/GO_0001966) (thigmotaxis), [GO:0042482](http://purl.obolibrary.org/obo/GO_0042482) (positive regulation of odontogenesis), [GO:0001967](http://purl.obolibrary.org/obo/GO_0001967) (suckling behavior), [GO:0001968](http://purl.obolibrary.org/obo/GO_0001968) (fibronectin binding), [GO:0042487](http://purl.obolibrary.org/obo/GO_0042487) (regulation of odontogenesis of dentin-containing tooth), [GO:0042489](http://purl.obolibrary.org/obo/GO_0042489) (negative regulation of odontogenesis of dentin-containing tooth), [GO:0001971](http://purl.obolibrary.org/obo/GO_0001971) (negative regulation of activation of membrane attack complex), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0001973](http://purl.obolibrary.org/obo/GO_0001973) (adenosine receptor signaling pathway), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0042490](http://purl.obolibrary.org/obo/GO_0042490) (mechanoreceptor differentiation), [GO:0042491](http://purl.obolibrary.org/obo/GO_0042491) (inner ear auditory receptor cell differentiation), [GO:0001975](http://purl.obolibrary.org/obo/GO_0001975) (response to amphetamine), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0090179](http://purl.obolibrary.org/obo/GO_0090179) (planar cell polarity pathway involved in neural tube closure), [GO:0090177](http://purl.obolibrary.org/obo/GO_0090177) (establishment of planar polarity involved in neural tube closure), [GO:0009032](http://purl.obolibrary.org/obo/GO_0009032) (thymidine phosphorylase activity), [GO:0022006](http://purl.obolibrary.org/obo/GO_0022006) (zona limitans intrathalamica formation), [GO:0090175](http://purl.obolibrary.org/obo/GO_0090175) (regulation of establishment of planar polarity), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0022007](http://purl.obolibrary.org/obo/GO_0022007) (convergent extension involved in neural plate elongation), [GO:0061615](http://purl.obolibrary.org/obo/GO_0061615) (glycolytic process through fructose-6-phosphate), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0048633](http://purl.obolibrary.org/obo/GO_0048633) (positive regulation of skeletal muscle tissue growth), [GO:0022009](http://purl.obolibrary.org/obo/GO_0022009) (central nervous system vasculogenesis), [GO:0090171](http://purl.obolibrary.org/obo/GO_0090171) (chondrocyte morphogenesis), [GO:1902715](http://purl.obolibrary.org/obo/GO_1902715) (positive regulation of interferon-gamma secretion), [GO:0061611](http://purl.obolibrary.org/obo/GO_0061611) (mannose to fructose-6-phosphate metabolic process), [GO:0048639](http://purl.obolibrary.org/obo/GO_0048639) (positive regulation of developmental growth), [GO:0048638](http://purl.obolibrary.org/obo/GO_0048638) (regulation of developmental growth), [GO:0022004](http://purl.obolibrary.org/obo/GO_0022004) (midbrain-hindbrain boundary maturation during brain development), [GO:0090170](http://purl.obolibrary.org/obo/GO_0090170) (regulation of Golgi inheritance), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:0048643](http://purl.obolibrary.org/obo/GO_0048643) (positive regulation of skeletal muscle tissue development), [GO:0061618](http://purl.obolibrary.org/obo/GO_0061618) (sublamina densa), [GO:0048642](http://purl.obolibrary.org/obo/GO_0048642) (negative regulation of skeletal muscle tissue development), [GO:0061619](http://purl.obolibrary.org/obo/GO_0061619) (glycolytic process from mannose through fructose-6-phosphate), [GO:0048641](http://purl.obolibrary.org/obo/GO_0048641) (regulation of skeletal muscle tissue development), [GO:0048640](http://purl.obolibrary.org/obo/GO_0048640) (negative regulation of developmental growth), [GO:0050957](http://purl.obolibrary.org/obo/GO_0050957) (equilibrioception), [GO:0050953](http://purl.obolibrary.org/obo/GO_0050953) (sensory perception of light stimulus), [GO:0035312](http://purl.obolibrary.org/obo/GO_0035312) (5'-3' exodeoxyribonuclease activity), [GO:0035313](http://purl.obolibrary.org/obo/GO_0035313) (wound healing, spreading of epidermal cells), [GO:0050954](http://purl.obolibrary.org/obo/GO_0050954) (sensory perception of mechanical stimulus), [GO:0035315](http://purl.obolibrary.org/obo/GO_0035315) (hair cell differentiation), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0098908](http://purl.obolibrary.org/obo/GO_0098908) (regulation of neuronal action potential), [GO:0098909](http://purl.obolibrary.org/obo/GO_0098909) (regulation of cardiac muscle cell action potential involved in regulation of contraction), [GO:0090188](http://purl.obolibrary.org/obo/GO_0090188) (negative regulation of pancreatic juice secretion), [GO:1902721](http://purl.obolibrary.org/obo/GO_1902721) (negative regulation of prolactin secretion), [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0090184](http://purl.obolibrary.org/obo/GO_0090184) (positive regulation of kidney development), [GO:0048644](http://purl.obolibrary.org/obo/GO_0048644) (muscle organ morphogenesis), [GO:1902723](http://purl.obolibrary.org/obo/GO_1902723) (negative regulation of skeletal muscle satellite cell proliferation), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0090190](http://purl.obolibrary.org/obo/GO_0090190) (positive regulation of branching involved in ureteric bud morphogenesis), [GO:0047323](http://purl.obolibrary.org/obo/GO_0047323) ([3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity), [GO:0061609](http://purl.obolibrary.org/obo/GO_0061609) (fructose-1-phosphate aldolase activity), [GO:0050966](http://purl.obolibrary.org/obo/GO_0050966) (detection of mechanical stimulus involved in sensory perception of pain), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0098906](http://purl.obolibrary.org/obo/GO_0098906) (regulation of Purkinje myocyte action potential), [GO:0050965](http://purl.obolibrary.org/obo/GO_0050965) (detection of temperature stimulus involved in sensory perception of pain), [GO:0098904](http://purl.obolibrary.org/obo/GO_0098904) (regulation of AV node cell action potential), [GO:0035303](http://purl.obolibrary.org/obo/GO_0035303) (regulation of dephosphorylation), [GO:0098905](http://purl.obolibrary.org/obo/GO_0098905) (regulation of bundle of His cell action potential), [GO:0010025](http://purl.obolibrary.org/obo/GO_0010025) (wax biosynthetic process), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0009013](http://purl.obolibrary.org/obo/GO_0009013) (succinate-semialdehyde dehydrogenase [NAD(P)+] activity), [GO:0090158](http://purl.obolibrary.org/obo/GO_0090158) (endoplasmic reticulum membrane organization), [GO:0090156](http://purl.obolibrary.org/obo/GO_0090156) (cellular sphingolipid homeostasis), [GO:0090153](http://purl.obolibrary.org/obo/GO_0090153) (regulation of sphingolipid biosynthetic process), [GO:0060306](http://purl.obolibrary.org/obo/GO_0060306) (regulation of membrane repolarization), [GO:0060307](http://purl.obolibrary.org/obo/GO_0060307) (regulation of ventricular cardiac muscle cell membrane repolarization), [GO:0061632](http://purl.obolibrary.org/obo/GO_0061632) (RNA lariat debranching enzyme activator activity), [GO:0090150](http://purl.obolibrary.org/obo/GO_0090150) (establishment of protein localization to membrane), [GO:0060302](http://purl.obolibrary.org/obo/GO_0060302) (negative regulation of cytokine activity), [GO:0009019](http://purl.obolibrary.org/obo/GO_0009019) (tRNA (guanine-N1-)-methyltransferase activity), [GO:0060304](http://purl.obolibrary.org/obo/GO_0060304) (regulation of phosphatidylinositol dephosphorylation), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0048659](http://purl.obolibrary.org/obo/GO_0048659) (smooth muscle cell proliferation), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0048660](http://purl.obolibrary.org/obo/GO_0048660) (regulation of smooth muscle cell proliferation), [GO:1902728](http://purl.obolibrary.org/obo/GO_1902728) (positive regulation of growth factor dependent skeletal muscle satellite cell proliferation), [GO:0048665](http://purl.obolibrary.org/obo/GO_0048665) (neuron fate specification), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0048662](http://purl.obolibrary.org/obo/GO_0048662) (negative regulation of smooth muscle cell proliferation), [GO:0050973](http://purl.obolibrary.org/obo/GO_0050973) (detection of mechanical stimulus involved in equilibrioception), [GO:0050974](http://purl.obolibrary.org/obo/GO_0050974) (detection of mechanical stimulus involved in sensory perception), [GO:0061620](http://purl.obolibrary.org/obo/GO_0061620) (glycolytic process through glucose-6-phosphate), [GO:0090166](http://purl.obolibrary.org/obo/GO_0090166) (Golgi disassembly), [GO:0009022](http://purl.obolibrary.org/obo/GO_0009022) (tRNA nucleotidyltransferase activity), [GO:0048669](http://purl.obolibrary.org/obo/GO_0048669) (collateral sprouting in absence of injury), [GO:0061625](http://purl.obolibrary.org/obo/GO_0061625) (glycolytic process through fructose-1-phosphate), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0048668](http://purl.obolibrary.org/obo/GO_0048668) (collateral sprouting), [GO:0046007](http://purl.obolibrary.org/obo/GO_0046007) (negative regulation of activated T cell proliferation), [GO:1902741](http://purl.obolibrary.org/obo/GO_1902741) (positive regulation of interferon-alpha secretion), [GO:0048667](http://purl.obolibrary.org/obo/GO_0048667) (cell morphogenesis involved in neuron differentiation), [GO:0090162](http://purl.obolibrary.org/obo/GO_0090162) (establishment of epithelial cell polarity), [GO:1902742](http://purl.obolibrary.org/obo/GO_1902742) (apoptotic process involved in development), [GO:0048666](http://purl.obolibrary.org/obo/GO_0048666) (neuron development), [GO:1902747](http://purl.obolibrary.org/obo/GO_1902747) (negative regulation of lens fiber cell differentiation), [GO:0061621](http://purl.obolibrary.org/obo/GO_0061621) (canonical glycolysis), [GO:0090161](http://purl.obolibrary.org/obo/GO_0090161) (Golgi ribbon formation), [GO:1902748](http://purl.obolibrary.org/obo/GO_1902748) (positive regulation of lens fiber cell differentiation), [GO:0061623](http://purl.obolibrary.org/obo/GO_0061623) (glycolytic process from galactose), [GO:1902746](http://purl.obolibrary.org/obo/GO_1902746) (regulation of lens fiber cell differentiation), [GO:0061624](http://purl.obolibrary.org/obo/GO_0061624) (fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate), [GO:0050982](http://purl.obolibrary.org/obo/GO_0050982) (detection of mechanical stimulus), [GO:0048672](http://purl.obolibrary.org/obo/GO_0048672) (positive regulation of collateral sprouting), [GO:0046010](http://purl.obolibrary.org/obo/GO_0046010) (positive regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0048670](http://purl.obolibrary.org/obo/GO_0048670) (regulation of collateral sprouting), [GO:1901409](http://purl.obolibrary.org/obo/GO_1901409) (positive regulation of phosphorylation of RNA polymerase II C-terminal domain), [GO:0046013](http://purl.obolibrary.org/obo/GO_0046013) (regulation of T cell homeostatic proliferation), [GO:0048675](http://purl.obolibrary.org/obo/GO_0048675) (axon extension), [GO:0010008](http://purl.obolibrary.org/obo/GO_0010008) (endosome membrane), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0010001](http://purl.obolibrary.org/obo/GO_0010001) (glial cell differentiation), [GO:0090139](http://purl.obolibrary.org/obo/GO_0090139) (mitochondrial DNA packaging), [GO:0009074](http://purl.obolibrary.org/obo/GO_0009074) (aromatic amino acid family catabolic process), [GO:0050919](http://purl.obolibrary.org/obo/GO_0050919) (negative chemotaxis), [GO:0009072](http://purl.obolibrary.org/obo/GO_0009072) (aromatic amino acid family metabolic process), [GO:0090138](http://purl.obolibrary.org/obo/GO_0090138) (regulation of actin cytoskeleton organization by cell-cell adhesion), [GO:0050917](http://purl.obolibrary.org/obo/GO_0050917) (sensory perception of umami taste), [GO:0050918](http://purl.obolibrary.org/obo/GO_0050918) (positive chemotaxis), [GO:0090136](http://purl.obolibrary.org/obo/GO_0090136) (epithelial cell-cell adhesion), [GO:0035360](http://purl.obolibrary.org/obo/GO_0035360) (positive regulation of peroxisome proliferator activated receptor signaling pathway), [GO:0090134](http://purl.obolibrary.org/obo/GO_0090134) (cell migration involved in mesendoderm migration), [GO:0050916](http://purl.obolibrary.org/obo/GO_0050916) (sensory perception of sweet taste), [GO:0090131](http://purl.obolibrary.org/obo/GO_0090131) (mesenchyme migration), [GO:0090132](http://purl.obolibrary.org/obo/GO_0090132) (epithelium migration), [GO:0050913](http://purl.obolibrary.org/obo/GO_0050913) (sensory perception of bitter taste), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0009070](http://purl.obolibrary.org/obo/GO_0009070) (serine family amino acid biosynthetic process), [GO:0035357](http://purl.obolibrary.org/obo/GO_0035357) (peroxisome proliferator activated receptor signaling pathway), [GO:0035359](http://purl.obolibrary.org/obo/GO_0035359) (negative regulation of peroxisome proliferator activated receptor signaling pathway), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0009085](http://purl.obolibrary.org/obo/GO_0009085) (lysine biosynthetic process), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0090148](http://purl.obolibrary.org/obo/GO_0090148) (membrane fission), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0009083](http://purl.obolibrary.org/obo/GO_0009083) (branched-chain amino acid catabolic process), [GO:0090149](http://purl.obolibrary.org/obo/GO_0090149) (mitochondrial membrane fission), [GO:0009088](http://purl.obolibrary.org/obo/GO_0009088) (threonine biosynthetic process), [GO:0050927](http://purl.obolibrary.org/obo/GO_0050927) (positive regulation of positive chemotaxis), [GO:0009087](http://purl.obolibrary.org/obo/GO_0009087) (methionine catabolic process), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0090141](http://purl.obolibrary.org/obo/GO_0090141) (positive regulation of mitochondrial fission), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0022037](http://purl.obolibrary.org/obo/GO_0022037) (metencephalon development), [GO:0022038](http://purl.obolibrary.org/obo/GO_0022038) (corpus callosum development), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0006808](http://purl.obolibrary.org/obo/GO_0006808) (regulation of nitrogen utilization), [GO:0006809](http://purl.obolibrary.org/obo/GO_0006809) (nitric oxide biosynthetic process), [GO:0050920](http://purl.obolibrary.org/obo/GO_0050920) (regulation of chemotaxis), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0009081](http://purl.obolibrary.org/obo/GO_0009081) (branched-chain amino acid metabolic process), [GO:0010042](http://purl.obolibrary.org/obo/GO_0010042) (response to manganese ion), [GO:0090118](http://purl.obolibrary.org/obo/GO_0090118) (receptor-mediated endocytosis involved in cholesterol transport), [GO:0009052](http://purl.obolibrary.org/obo/GO_0009052) (pentose-phosphate shunt, non-oxidative branch), [GO:0010044](http://purl.obolibrary.org/obo/GO_0010044) (response to aluminum ion), [GO:0009051](http://purl.obolibrary.org/obo/GO_0009051) (pentose-phosphate shunt, oxidative branch), [GO:0090116](http://purl.obolibrary.org/obo/GO_0090116) (C-5 methylation of cytosine), [GO:0048619](http://purl.obolibrary.org/obo/GO_0048619) (embryonic hindgut morphogenesis), [GO:0010043](http://purl.obolibrary.org/obo/GO_0010043) (response to zinc ion), [GO:0090114](http://purl.obolibrary.org/obo/GO_0090114) (COPII-coated vesicle budding), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0010040](http://purl.obolibrary.org/obo/GO_0010040) (response to iron(II) ion), [GO:0050938](http://purl.obolibrary.org/obo/GO_0050938) (regulation of xanthophore differentiation), [GO:0022028](http://purl.obolibrary.org/obo/GO_0022028) (tangential migration from the subventricular zone to the olfactory bulb), [GO:0090110](http://purl.obolibrary.org/obo/GO_0090110) (cargo loading into COPII-coated vesicle), [GO:0022029](http://purl.obolibrary.org/obo/GO_0022029) (telencephalon cell migration), [GO:0009058](http://purl.obolibrary.org/obo/GO_0009058) (biosynthetic process), [GO:0048618](http://purl.obolibrary.org/obo/GO_0048618) (post-embryonic foregut morphogenesis), [GO:0048617](http://purl.obolibrary.org/obo/GO_0048617) (embryonic foregut morphogenesis), [GO:0022027](http://purl.obolibrary.org/obo/GO_0022027) (interkinetic nuclear migration), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0010039](http://purl.obolibrary.org/obo/GO_0010039) (response to iron ion), [GO:0035338](http://purl.obolibrary.org/obo/GO_0035338) (long-chain fatty-acyl-CoA biosynthetic process), [GO:0010038](http://purl.obolibrary.org/obo/GO_0010038) (response to metal ion), [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation), [GO:0035339](http://purl.obolibrary.org/obo/GO_0035339) (SPOTS complex), [GO:0050931](http://purl.obolibrary.org/obo/GO_0050931) (pigment cell differentiation), [GO:0010035](http://purl.obolibrary.org/obo/GO_0010035) (response to inorganic substance), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0010037](http://purl.obolibrary.org/obo/GO_0010037) (response to carbon dioxide), [GO:0035336](http://purl.obolibrary.org/obo/GO_0035336) (long-chain fatty-acyl-CoA metabolic process), [GO:0050930](http://purl.obolibrary.org/obo/GO_0050930) (induction of positive chemotaxis), [GO:0035330](http://purl.obolibrary.org/obo/GO_0035330) (regulation of hippo signaling), [GO:0090129](http://purl.obolibrary.org/obo/GO_0090129) (positive regulation of synapse maturation), [GO:0009063](http://purl.obolibrary.org/obo/GO_0009063) (cellular amino acid catabolic process), [GO:0009062](http://purl.obolibrary.org/obo/GO_0009062) (fatty acid catabolic process), [GO:0035332](http://purl.obolibrary.org/obo/GO_0035332) (positive regulation of hippo signaling), [GO:0009061](http://purl.obolibrary.org/obo/GO_0009061) (anaerobic respiration), [GO:0048625](http://purl.obolibrary.org/obo/GO_0048625) (myoblast fate commitment), [GO:0009069](http://purl.obolibrary.org/obo/GO_0009069) (serine family amino acid metabolic process), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0035329](http://purl.obolibrary.org/obo/GO_0035329) (hippo signaling), [GO:0009060](http://purl.obolibrary.org/obo/GO_0009060) (aerobic respiration), [GO:0010046](http://purl.obolibrary.org/obo/GO_0010046) (response to mycotoxin), [GO:0010045](http://purl.obolibrary.org/obo/GO_0010045) (response to nickel cation), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), [GO:0035326](http://purl.obolibrary.org/obo/GO_0035326) (enhancer binding), [GO:0060484](http://purl.obolibrary.org/obo/GO_0060484) (lung-associated mesenchyme development), [GO:0060485](http://purl.obolibrary.org/obo/GO_0060485) (mesenchyme development), [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0060487](http://purl.obolibrary.org/obo/GO_0060487) (lung epithelial cell differentiation), [GO:1901341](http://purl.obolibrary.org/obo/GO_1901341) (positive regulation of store-operated calcium channel activity), [GO:0060481](http://purl.obolibrary.org/obo/GO_0060481) (lobar bronchus epithelium development), [GO:0034198](http://purl.obolibrary.org/obo/GO_0034198) (cellular response to amino acid starvation), [GO:0034197](http://purl.obolibrary.org/obo/GO_0034197) (triglyceride transport), [GO:1901342](http://purl.obolibrary.org/obo/GO_1901342) (regulation of vasculature development), [GO:1900015](http://purl.obolibrary.org/obo/GO_1900015) (regulation of cytokine production involved in inflammatory response), [GO:0004300](http://purl.obolibrary.org/obo/GO_0004300) (enoyl-CoA hydratase activity), [GO:0060488](http://purl.obolibrary.org/obo/GO_0060488) (orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0060489](http://purl.obolibrary.org/obo/GO_0060489) (planar dichotomous subdivision of terminal units involved in lung branching morphogenesis), [GO:0034191](http://purl.obolibrary.org/obo/GO_0034191) (apolipoprotein A-I receptor binding), [GO:0034190](http://purl.obolibrary.org/obo/GO_0034190) (apolipoprotein receptor binding), [GO:0004301](http://purl.obolibrary.org/obo/GO_0004301) (epoxide hydrolase activity), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0046185](http://purl.obolibrary.org/obo/GO_0046185) (aldehyde catabolic process), [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell), [GO:0006957](http://purl.obolibrary.org/obo/GO_0006957) (complement activation, alternative pathway), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0031915](http://purl.obolibrary.org/obo/GO_0031915) (positive regulation of synaptic plasticity), [GO:0060490](http://purl.obolibrary.org/obo/GO_0060490) (lateral sprouting involved in lung morphogenesis), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0034184](http://purl.obolibrary.org/obo/GO_0034184) (positive regulation of maintenance of mitotic sister chromatid cohesion), [GO:0034189](http://purl.obolibrary.org/obo/GO_0034189) (very-low-density lipoprotein particle binding), [GO:1900020](http://purl.obolibrary.org/obo/GO_1900020) (positive regulation of protein kinase C activity), [GO:0060471](http://purl.obolibrary.org/obo/GO_0060471) (cortical granule exocytosis), [GO:0034186](http://purl.obolibrary.org/obo/GO_0034186) (apolipoprotein A-I binding), [GO:0006970](http://purl.obolibrary.org/obo/GO_0006970) (response to osmotic stress), [GO:1900025](http://purl.obolibrary.org/obo/GO_1900025) (negative regulation of substrate adhesion-dependent cell spreading), [GO:0006971](http://purl.obolibrary.org/obo/GO_0006971) (hypotonic response), [GO:1902686](http://purl.obolibrary.org/obo/GO_1902686) (mitochondrial outer membrane permeabilization involved in programmed cell death), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:1900027](http://purl.obolibrary.org/obo/GO_1900027) (regulation of ruffle assembly), [GO:1900026](http://purl.obolibrary.org/obo/GO_1900026) (positive regulation of substrate adhesion-dependent cell spreading), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004311](http://purl.obolibrary.org/obo/GO_0004311) (farnesyltranstransferase activity), [GO:1900029](http://purl.obolibrary.org/obo/GO_1900029) (positive regulation of ruffle assembly), [GO:0005642](http://purl.obolibrary.org/obo/GO_0005642) (annulate lamellae), [GO:0006975](http://purl.obolibrary.org/obo/GO_0006975) (DNA damage induced protein phosphorylation), [GO:1900028](http://purl.obolibrary.org/obo/GO_1900028) (negative regulation of ruffle assembly), [GO:0005641](http://purl.obolibrary.org/obo/GO_0005641) (nuclear envelope lumen), [GO:0006972](http://purl.obolibrary.org/obo/GO_0006972) (hyperosmotic response), [GO:0005643](http://purl.obolibrary.org/obo/GO_0005643) (nuclear pore), [GO:0006973](http://purl.obolibrary.org/obo/GO_0006973) (intracellular accumulation of glycerol), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0031901](http://purl.obolibrary.org/obo/GO_0031901) (early endosome membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0006968](http://purl.obolibrary.org/obo/GO_0006968) (cellular defense response), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0004305](http://purl.obolibrary.org/obo/GO_0004305) (ethanolamine kinase activity), [GO:0031905](http://purl.obolibrary.org/obo/GO_0031905) (early endosome lumen), [GO:0005639](http://purl.obolibrary.org/obo/GO_0005639) (integral component of nuclear inner membrane), [GO:0004308](http://purl.obolibrary.org/obo/GO_0004308) (exo-alpha-sialidase activity), [GO:0005638](http://purl.obolibrary.org/obo/GO_0005638) (lamin filament), [GO:0004309](http://purl.obolibrary.org/obo/GO_0004309) (exopolyphosphatase activity), [GO:0043923](http://purl.obolibrary.org/obo/GO_0043923) (positive regulation by host of viral transcription), [GO:1902692](http://purl.obolibrary.org/obo/GO_1902692) (regulation of neuroblast proliferation), [GO:0043928](http://purl.obolibrary.org/obo/GO_0043928) (exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay), [GO:0006941](http://purl.obolibrary.org/obo/GO_0006941) (striated muscle contraction), [GO:0006942](http://purl.obolibrary.org/obo/GO_0006942) (regulation of striated muscle contraction), [GO:0006940](http://purl.obolibrary.org/obo/GO_0006940) (regulation of smooth muscle contraction), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0006933](http://purl.obolibrary.org/obo/GO_0006933) (negative regulation of cell adhesion involved in substrate-bound cell migration), [GO:0072488](http://purl.obolibrary.org/obo/GO_0072488) (ammonium transmembrane transport), [GO:2001108](http://purl.obolibrary.org/obo/GO_2001108) (positive regulation of Rho guanyl-nucleotide exchange factor activity), [GO:0005605](http://purl.obolibrary.org/obo/GO_0005605) (basal lamina), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0006936](http://purl.obolibrary.org/obo/GO_0006936) (muscle contraction), [GO:0006937](http://purl.obolibrary.org/obo/GO_0006937) (regulation of muscle contraction), [GO:0097746](http://purl.obolibrary.org/obo/GO_0097746) (regulation of blood vessel diameter), [GO:0097745](http://purl.obolibrary.org/obo/GO_0097745) (mitochondrial tRNA 5'-end processing), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:2001107](http://purl.obolibrary.org/obo/GO_2001107) (negative regulation of Rho guanyl-nucleotide exchange factor activity), [GO:0097749](http://purl.obolibrary.org/obo/GO_0097749) (membrane tubulation), [GO:0043934](http://purl.obolibrary.org/obo/GO_0043934) (sporulation), [GO:0035497](http://purl.obolibrary.org/obo/GO_0035497) (cAMP response element binding), [GO:0042605](http://purl.obolibrary.org/obo/GO_0042605) (peptide antigen binding), [GO:0060491](http://purl.obolibrary.org/obo/GO_0060491) (regulation of cell projection assembly), [GO:0035491](http://purl.obolibrary.org/obo/GO_0035491) (positive regulation of leukotriene production involved in inflammatory response), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:1901373](http://purl.obolibrary.org/obo/GO_1901373) (lipid hydroperoxide transport), [GO:0034165](http://purl.obolibrary.org/obo/GO_0034165) (positive regulation of toll-like receptor 9 signaling pathway), [GO:0042608](http://purl.obolibrary.org/obo/GO_0042608) (T cell receptor binding), [GO:1901379](http://purl.obolibrary.org/obo/GO_1901379) (regulation of potassium ion transmembrane transport), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0006953](http://purl.obolibrary.org/obo/GO_0006953) (acute-phase response), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0006950](http://purl.obolibrary.org/obo/GO_0006950) (response to stress), [GO:0043931](http://purl.obolibrary.org/obo/GO_0043931) (ossification involved in bone maturation), [GO:0071141](http://purl.obolibrary.org/obo/GO_0071141) (SMAD protein complex), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005614](http://purl.obolibrary.org/obo/GO_0005614) (interstitial matrix), [GO:0097752](http://purl.obolibrary.org/obo/GO_0097752) (regulation of DNA stability), [GO:0097755](http://purl.obolibrary.org/obo/GO_0097755) (positive regulation of blood vessel diameter), [GO:0071149](http://purl.obolibrary.org/obo/GO_0071149) (TEAD-2-YAP complex), [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter), [GO:0034157](http://purl.obolibrary.org/obo/GO_0034157) (positive regulation of toll-like receptor 7 signaling pathway), [GO:0071148](http://purl.obolibrary.org/obo/GO_0071148) (TEAD-1-YAP complex), [GO:2001111](http://purl.obolibrary.org/obo/GO_2001111) (positive regulation of lens epithelial cell proliferation), [GO:0060440](http://purl.obolibrary.org/obo/GO_0060440) (trachea formation), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0060442](http://purl.obolibrary.org/obo/GO_0060442) (branching involved in prostate gland morphogenesis), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0004340](http://purl.obolibrary.org/obo/GO_0004340) (glucokinase activity), [GO:0060449](http://purl.obolibrary.org/obo/GO_0060449) (bud elongation involved in lung branching), [GO:0005673](http://purl.obolibrary.org/obo/GO_0005673) (transcription factor TFIIE complex), [GO:0048798](http://purl.obolibrary.org/obo/GO_0048798) (swim bladder inflation), [GO:0003011](http://purl.obolibrary.org/obo/GO_0003011) (involuntary skeletal muscle contraction), [GO:0060444](http://purl.obolibrary.org/obo/GO_0060444) (branching involved in mammary gland duct morphogenesis), [GO:0003012](http://purl.obolibrary.org/obo/GO_0003012) (muscle system process), [GO:0005675](http://purl.obolibrary.org/obo/GO_0005675) (holo TFIIH complex), [GO:0060445](http://purl.obolibrary.org/obo/GO_0060445) (branching involved in salivary gland morphogenesis), [GO:0003014](http://purl.obolibrary.org/obo/GO_0003014) (renal system process), [GO:0004346](http://purl.obolibrary.org/obo/GO_0004346) (glucose-6-phosphatase activity), [GO:0005677](http://purl.obolibrary.org/obo/GO_0005677) (chromatin silencing complex), [GO:0060447](http://purl.obolibrary.org/obo/GO_0060447) (bud outgrowth involved in lung branching), [GO:0004345](http://purl.obolibrary.org/obo/GO_0004345) (glucose-6-phosphate dehydrogenase activity), [GO:1902636](http://purl.obolibrary.org/obo/GO_1902636) (kinociliary basal body), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003006](http://purl.obolibrary.org/obo/GO_0003006) (developmental process involved in reproduction), [GO:0030623](http://purl.obolibrary.org/obo/GO_0030623) (U5 snRNA binding), [GO:0004336](http://purl.obolibrary.org/obo/GO_0004336) (galactosylceramidase activity), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0006998](http://purl.obolibrary.org/obo/GO_0006998) (nuclear envelope organization), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:1903959](http://purl.obolibrary.org/obo/GO_1903959) (regulation of anion transmembrane transport), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0006999](http://purl.obolibrary.org/obo/GO_0006999) (nuclear pore organization), [GO:0003009](http://purl.obolibrary.org/obo/GO_0003009) (skeletal muscle contraction), [GO:0097720](http://purl.obolibrary.org/obo/GO_0097720) (calcineurin-mediated signaling), [GO:0030628](http://purl.obolibrary.org/obo/GO_0030628) (pre-mRNA 3'-splice site binding), [GO:0046146](http://purl.obolibrary.org/obo/GO_0046146) (tetrahydrobiopterin metabolic process), [GO:0097722](http://purl.obolibrary.org/obo/GO_0097722) (sperm motility), [GO:0031959](http://purl.obolibrary.org/obo/GO_0031959) (mineralocorticoid receptor signaling pathway), [GO:0072425](http://purl.obolibrary.org/obo/GO_0072425) (signal transduction involved in G2 DNA damage checkpoint), [GO:0016331](http://purl.obolibrary.org/obo/GO_0016331) (morphogenesis of embryonic epithelium), [GO:0097726](http://purl.obolibrary.org/obo/GO_0097726) (LEM domain binding), [GO:0072423](http://purl.obolibrary.org/obo/GO_0072423) (response to DNA damage checkpoint signaling), [GO:0030620](http://purl.obolibrary.org/obo/GO_0030620) (U2 snRNA binding), [GO:0031952](http://purl.obolibrary.org/obo/GO_0031952) (regulation of protein autophosphorylation), [GO:0031953](http://purl.obolibrary.org/obo/GO_0031953) (negative regulation of protein autophosphorylation), [GO:0030622](http://purl.obolibrary.org/obo/GO_0030622) (U4atac snRNA binding), [GO:0030621](http://purl.obolibrary.org/obo/GO_0030621) (U4 snRNA binding), [GO:0097729](http://purl.obolibrary.org/obo/GO_0097729) (9+2 motile cilium), [GO:2001140](http://purl.obolibrary.org/obo/GO_2001140) (positive regulation of phospholipid transport), [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0061762](http://purl.obolibrary.org/obo/GO_0061762) (CAMKK-AMPK signaling cascade), [GO:0015002](http://purl.obolibrary.org/obo/GO_0015002) (heme-copper terminal oxidase activity), [GO:0005680](http://purl.obolibrary.org/obo/GO_0005680) (anaphase-promoting complex), [GO:0005682](http://purl.obolibrary.org/obo/GO_0005682) (U5 snRNP), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0004351](http://purl.obolibrary.org/obo/GO_0004351) (glutamate decarboxylase activity), [GO:0060438](http://purl.obolibrary.org/obo/GO_0060438) (trachea development), [GO:0005681](http://purl.obolibrary.org/obo/GO_0005681) (spliceosomal complex), [GO:0004350](http://purl.obolibrary.org/obo/GO_0004350) (glutamate-5-semialdehyde dehydrogenase activity), [GO:1903976](http://purl.obolibrary.org/obo/GO_1903976) (negative regulation of glial cell migration), [GO:0060439](http://purl.obolibrary.org/obo/GO_0060439) (trachea morphogenesis), [GO:0004353](http://purl.obolibrary.org/obo/GO_0004353) (glutamate dehydrogenase [NAD(P)+] activity), [GO:0005684](http://purl.obolibrary.org/obo/GO_0005684) (U2-type spliceosomal complex), [GO:0004352](http://purl.obolibrary.org/obo/GO_0004352) (glutamate dehydrogenase (NAD+) activity), [GO:0005686](http://purl.obolibrary.org/obo/GO_0005686) (U2 snRNP), [GO:0060433](http://purl.obolibrary.org/obo/GO_0060433) (bronchus development), [GO:0005685](http://purl.obolibrary.org/obo/GO_0005685) (U1 snRNP), [GO:0004357](http://purl.obolibrary.org/obo/GO_0004357) (glutamate-cysteine ligase activity), [GO:0005687](http://purl.obolibrary.org/obo/GO_0005687) (U4 snRNP), [GO:1901317](http://purl.obolibrary.org/obo/GO_1901317) (regulation of flagellated sperm motility), [GO:0004356](http://purl.obolibrary.org/obo/GO_0004356) (glutamate-ammonia ligase activity), [GO:0003016](http://purl.obolibrary.org/obo/GO_0003016) (respiratory system process), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0047484](http://purl.obolibrary.org/obo/GO_0047484) (regulation of response to osmotic stress), [GO:0004347](http://purl.obolibrary.org/obo/GO_0004347) (glucose-6-phosphate isomerase activity), [GO:0031943](http://purl.obolibrary.org/obo/GO_0031943) (regulation of glucocorticoid metabolic process), [GO:0004349](http://purl.obolibrary.org/obo/GO_0004349) (glutamate 5-kinase activity), [GO:0097731](http://purl.obolibrary.org/obo/GO_0097731) (9+0 non-motile cilium), [GO:0030617](http://purl.obolibrary.org/obo/GO_0030617) (transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity), [GO:0097730](http://purl.obolibrary.org/obo/GO_0097730) (non-motile cilium), [GO:0030619](http://purl.obolibrary.org/obo/GO_0030619) (U1 snRNA binding), [GO:0046154](http://purl.obolibrary.org/obo/GO_0046154) (rhodopsin metabolic process), [GO:0097733](http://purl.obolibrary.org/obo/GO_0097733) (photoreceptor cell cilium), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0016321](http://purl.obolibrary.org/obo/GO_0016321) (female meiosis chromosome segregation), [GO:0031941](http://purl.obolibrary.org/obo/GO_0031941) (filamentous actin), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0031942](http://purl.obolibrary.org/obo/GO_0031942) (i-AAA complex), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:2001135](http://purl.obolibrary.org/obo/GO_2001135) (regulation of endocytic recycling), [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis), [GO:0016307](http://purl.obolibrary.org/obo/GO_0016307) (phosphatidylinositol phosphate kinase activity), [GO:0016308](http://purl.obolibrary.org/obo/GO_0016308) (1-phosphatidylinositol-4-phosphate 5-kinase activity), [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis), [GO:1903980](http://purl.obolibrary.org/obo/GO_1903980) (positive regulation of microglial cell activation), [GO:2001150](http://purl.obolibrary.org/obo/GO_2001150) (positive regulation of dipeptide transmembrane transport), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0004322](http://purl.obolibrary.org/obo/GO_0004322) (ferroxidase activity), [GO:0005652](http://purl.obolibrary.org/obo/GO_0005652) (nuclear lamina), [GO:0006986](http://purl.obolibrary.org/obo/GO_0006986) (response to unfolded protein), [GO:0061798](http://purl.obolibrary.org/obo/GO_0061798) (GTP 3',8'-cyclase activity), [GO:0061799](http://purl.obolibrary.org/obo/GO_0061799) (cyclic pyranopterin monophosphate synthase activity), [GO:1903988](http://purl.obolibrary.org/obo/GO_1903988) (ferrous iron export across plasma membrane), [GO:0006983](http://purl.obolibrary.org/obo/GO_0006983) (ER overload response), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0031934](http://purl.obolibrary.org/obo/GO_0031934) (mating-type region heterochromatin), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0031932](http://purl.obolibrary.org/obo/GO_0031932) (TORC2 complex), [GO:0006977](http://purl.obolibrary.org/obo/GO_0006977) (DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest), [GO:0047499](http://purl.obolibrary.org/obo/GO_0047499) (calcium-independent phospholipase A2 activity), [GO:0046167](http://purl.obolibrary.org/obo/GO_0046167) (glycerol-3-phosphate biosynthetic process), [GO:0031938](http://purl.obolibrary.org/obo/GO_0031938) (regulation of chromatin silencing at telomere), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0046168](http://purl.obolibrary.org/obo/GO_0046168) (glycerol-3-phosphate catabolic process), [GO:0071110](http://purl.obolibrary.org/obo/GO_0071110) (histone biotinylation), [GO:0047497](http://purl.obolibrary.org/obo/GO_0047497) (mitochondrion transport along microtubule), [GO:0031936](http://purl.obolibrary.org/obo/GO_0031936) (negative regulation of chromatin silencing), [GO:0047496](http://purl.obolibrary.org/obo/GO_0047496) (vesicle transport along microtubule), [GO:0046166](http://purl.obolibrary.org/obo/GO_0046166) (glyceraldehyde-3-phosphate biosynthetic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0031930](http://purl.obolibrary.org/obo/GO_0031930) (mitochondria-nucleus signaling pathway), [GO:0031931](http://purl.obolibrary.org/obo/GO_0031931) (TORC1 complex), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:0060452](http://purl.obolibrary.org/obo/GO_0060452) (positive regulation of cardiac muscle contraction), [GO:2001165](http://purl.obolibrary.org/obo/GO_2001165) (positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues), [GO:0060459](http://purl.obolibrary.org/obo/GO_0060459) (left lung development), [GO:0031929](http://purl.obolibrary.org/obo/GO_0031929) (TOR signaling), [GO:0005662](http://purl.obolibrary.org/obo/GO_0005662) (DNA replication factor A complex), [GO:1900004](http://purl.obolibrary.org/obo/GO_1900004) (negative regulation of serine-type endopeptidase activity), [GO:0004333](http://purl.obolibrary.org/obo/GO_0004333) (fumarate hydratase activity), [GO:0006996](http://purl.obolibrary.org/obo/GO_0006996) (organelle organization), [GO:0005664](http://purl.obolibrary.org/obo/GO_0005664) (nuclear origin of replication recognition complex), [GO:0006997](http://purl.obolibrary.org/obo/GO_0006997) (nucleus organization), [GO:0003002](http://purl.obolibrary.org/obo/GO_0003002) (regionalization), [GO:0004332](http://purl.obolibrary.org/obo/GO_0004332) (fructose-bisphosphate aldolase activity), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0004335](http://purl.obolibrary.org/obo/GO_0004335) (galactokinase activity), [GO:1903999](http://purl.obolibrary.org/obo/GO_1903999) (negative regulation of eating behavior), [GO:0060458](http://purl.obolibrary.org/obo/GO_0060458) (right lung development), [GO:1901339](http://purl.obolibrary.org/obo/GO_1901339) (regulation of store-operated calcium channel activity), [GO:0006995](http://purl.obolibrary.org/obo/GO_0006995) (cellular response to nitrogen starvation), [GO:1902669](http://purl.obolibrary.org/obo/GO_1902669) (positive regulation of axon guidance), [GO:0004334](http://purl.obolibrary.org/obo/GO_0004334) (fumarylacetoacetase activity), [GO:0061789](http://purl.obolibrary.org/obo/GO_0061789) (dense core granule priming), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0004325](http://purl.obolibrary.org/obo/GO_0004325) (ferrochelatase activity), [GO:0005656](http://purl.obolibrary.org/obo/GO_0005656) (nuclear pre-replicative complex), [GO:0006987](http://purl.obolibrary.org/obo/GO_0006987) (activation of signaling protein activity involved in unfolded protein response), [GO:0005658](http://purl.obolibrary.org/obo/GO_0005658) (alpha DNA polymerase:primase complex), [GO:0004329](http://purl.obolibrary.org/obo/GO_0004329) (formate-tetrahydrofolate ligase activity), [GO:0072431](http://purl.obolibrary.org/obo/GO_0072431) (signal transduction involved in mitotic G1 DNA damage checkpoint), [GO:2001159](http://purl.obolibrary.org/obo/GO_2001159) (regulation of protein localization by the Cvt pathway), [GO:0097712](http://purl.obolibrary.org/obo/GO_0097712) (vesicle targeting, trans-Golgi to periciliary membrane compartment), [GO:0071104](http://purl.obolibrary.org/obo/GO_0071104) (response to interleukin-9), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0097718](http://purl.obolibrary.org/obo/GO_0097718) (disordered domain specific binding), [GO:0071108](http://purl.obolibrary.org/obo/GO_0071108) (protein K48-linked deubiquitination), [GO:2001173](http://purl.obolibrary.org/obo/GO_2001173) (regulation of histone H2B conserved C-terminal lysine ubiquitination), [GO:0015036](http://purl.obolibrary.org/obo/GO_0015036) (disulfide oxidoreductase activity), [GO:0015035](http://purl.obolibrary.org/obo/GO_0015035) (protein disulfide oxidoreductase activity), [GO:0039003](http://purl.obolibrary.org/obo/GO_0039003) (pronephric field specification), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0004382](http://purl.obolibrary.org/obo/GO_0004382) (guanosine-diphosphatase activity), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0003051](http://purl.obolibrary.org/obo/GO_0003051) (angiotensin-mediated drinking behavior), [GO:0015030](http://purl.obolibrary.org/obo/GO_0015030) (Cajal body), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0003056](http://purl.obolibrary.org/obo/GO_0003056) (regulation of vascular smooth muscle contraction), [GO:0043985](http://purl.obolibrary.org/obo/GO_0043985) (histone H4-R3 methylation), [GO:0003057](http://purl.obolibrary.org/obo/GO_0003057) (regulation of the force of heart contraction by chemical signal), [GO:0043984](http://purl.obolibrary.org/obo/GO_0043984) (histone H4-K16 acetylation), [GO:0043987](http://purl.obolibrary.org/obo/GO_0043987) (histone H3-S10 phosphorylation), [GO:0003059](http://purl.obolibrary.org/obo/GO_0003059) (positive regulation of the force of heart contraction by epinephrine), [GO:0030667](http://purl.obolibrary.org/obo/GO_0030667) (secretory granule membrane), [GO:0031998](http://purl.obolibrary.org/obo/GO_0031998) (regulation of fatty acid beta-oxidation), [GO:0031999](http://purl.obolibrary.org/obo/GO_0031999) (negative regulation of fatty acid beta-oxidation), [GO:0030669](http://purl.obolibrary.org/obo/GO_0030669) (clathrin-coated endocytic vesicle membrane), [GO:0030660](http://purl.obolibrary.org/obo/GO_0030660) (Golgi-associated vesicle membrane), [GO:0030663](http://purl.obolibrary.org/obo/GO_0030663) (COPI-coated vesicle membrane), [GO:0031994](http://purl.obolibrary.org/obo/GO_0031994) (insulin-like growth factor I binding), [GO:0030665](http://purl.obolibrary.org/obo/GO_0030665) (clathrin-coated vesicle membrane), [GO:2001184](http://purl.obolibrary.org/obo/GO_2001184) (positive regulation of interleukin-12 secretion), [GO:2001186](http://purl.obolibrary.org/obo/GO_2001186) (negative regulation of CD8-positive, alpha-beta T cell activation), [GO:0040001](http://purl.obolibrary.org/obo/GO_0040001) (establishment of mitotic spindle localization), [GO:0042660](http://purl.obolibrary.org/obo/GO_0042660) (positive regulation of cell fate specification), [GO:0042661](http://purl.obolibrary.org/obo/GO_0042661) (regulation of mesodermal cell fate specification), [GO:0042663](http://purl.obolibrary.org/obo/GO_0042663) (regulation of endodermal cell fate specification), [GO:0004396](http://purl.obolibrary.org/obo/GO_0004396) (hexokinase activity), [GO:0042664](http://purl.obolibrary.org/obo/GO_0042664) (negative regulation of endodermal cell fate specification), [GO:0043996](http://purl.obolibrary.org/obo/GO_0043996) (histone acetyltransferase activity (H4-K8 specific)), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0043995](http://purl.obolibrary.org/obo/GO_0043995) (histone acetyltransferase activity (H4-K5 specific)), [GO:0040007](http://purl.obolibrary.org/obo/GO_0040007) (growth), [GO:0003069](http://purl.obolibrary.org/obo/GO_0003069) (acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0042667](http://purl.obolibrary.org/obo/GO_0042667) (auditory receptor cell fate specification), [GO:0030659](http://purl.obolibrary.org/obo/GO_0030659) (cytoplasmic vesicle membrane), [GO:0031987](http://purl.obolibrary.org/obo/GO_0031987) (locomotion involved in locomotory behavior), [GO:0030658](http://purl.obolibrary.org/obo/GO_0030658) (transport vesicle membrane), [GO:0042670](http://purl.obolibrary.org/obo/GO_0042670) (retinal cone cell differentiation), [GO:0016361](http://purl.obolibrary.org/obo/GO_0016361) (activin receptor activity, type I), [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031985](http://purl.obolibrary.org/obo/GO_0031985) (Golgi cisterna), [GO:2001178](http://purl.obolibrary.org/obo/GO_2001178) (positive regulation of mediator complex assembly), [GO:0031983](http://purl.obolibrary.org/obo/GO_0031983) (vesicle lumen), [GO:0040016](http://purl.obolibrary.org/obo/GO_0040016) (embryonic cleavage), [GO:0040015](http://purl.obolibrary.org/obo/GO_0040015) (negative regulation of multicellular organism growth), [GO:0015015](http://purl.obolibrary.org/obo/GO_0015015) (heparan sulfate proteoglycan biosynthetic process, enzymatic modification), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0015014](http://purl.obolibrary.org/obo/GO_0015014) (heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process), [GO:0040013](http://purl.obolibrary.org/obo/GO_0040013) (negative regulation of locomotion), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0040012](http://purl.obolibrary.org/obo/GO_0040012) (regulation of locomotion), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0040010](http://purl.obolibrary.org/obo/GO_0040010) (positive regulation of growth rate), [GO:0004360](http://purl.obolibrary.org/obo/GO_0004360) (glutamine-fructose-6-phosphate transaminase (isomerizing) activity), [GO:0005690](http://purl.obolibrary.org/obo/GO_0005690) (U4atac snRNP), [GO:0004361](http://purl.obolibrary.org/obo/GO_0004361) (glutaryl-CoA dehydrogenase activity), [GO:0004364](http://purl.obolibrary.org/obo/GO_0004364) (glutathione transferase activity), [GO:0003032](http://purl.obolibrary.org/obo/GO_0003032) (detection of oxygen), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0004363](http://purl.obolibrary.org/obo/GO_0004363) (glutathione synthase activity), [GO:0005697](http://purl.obolibrary.org/obo/GO_0005697) (telomerase holoenzyme complex), [GO:0040019](http://purl.obolibrary.org/obo/GO_0040019) (positive regulation of embryonic development), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0004368](http://purl.obolibrary.org/obo/GO_0004368) (glycerol-3-phosphate dehydrogenase activity), [GO:0004367](http://purl.obolibrary.org/obo/GO_0004367) (glycerol-3-phosphate dehydrogenase [NAD+] activity), [GO:0040017](http://purl.obolibrary.org/obo/GO_0040017) (positive regulation of locomotion), [GO:0003029](http://purl.obolibrary.org/obo/GO_0003029) (detection of hypoxic conditions in blood by carotid body chemoreceptor signaling), [GO:0030644](http://purl.obolibrary.org/obo/GO_0030644) (cellular chloride ion homeostasis), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0030643](http://purl.obolibrary.org/obo/GO_0030643) (cellular phosphate ion homeostasis), [GO:0015026](http://purl.obolibrary.org/obo/GO_0015026) (coreceptor activity), [GO:0016339](http://purl.obolibrary.org/obo/GO_0016339) (calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules), [GO:0004370](http://purl.obolibrary.org/obo/GO_0004370) (glycerol kinase activity), [GO:0040020](http://purl.obolibrary.org/obo/GO_0040020) (regulation of meiotic nuclear division), [GO:0015020](http://purl.obolibrary.org/obo/GO_0015020) (glucuronosyltransferase activity), [GO:0004373](http://purl.obolibrary.org/obo/GO_0004373) (glycogen (starch) synthase activity), [GO:0004375](http://purl.obolibrary.org/obo/GO_0004375) (glycine dehydrogenase (decarboxylating) activity), [GO:0004377](http://purl.obolibrary.org/obo/GO_0004377) (GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0004376](http://purl.obolibrary.org/obo/GO_0004376) (glycolipid mannosyltransferase activity), [GO:0040029](http://purl.obolibrary.org/obo/GO_0040029) (regulation of gene expression, epigenetic), [GO:0004378](http://purl.obolibrary.org/obo/GO_0004378) (GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0042692](http://purl.obolibrary.org/obo/GO_0042692) (muscle cell differentiation), [GO:0016342](http://purl.obolibrary.org/obo/GO_0016342) (catenin complex), [GO:0015019](http://purl.obolibrary.org/obo/GO_0015019) (heparan-alpha-glucosaminide N-acetyltransferase activity), [GO:0015018](http://purl.obolibrary.org/obo/GO_0015018) (galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:1901381](http://purl.obolibrary.org/obo/GO_1901381) (positive regulation of potassium ion transmembrane transport), [GO:1901380](http://purl.obolibrary.org/obo/GO_1901380) (negative regulation of potassium ion transmembrane transport), [GO:1900052](http://purl.obolibrary.org/obo/GO_1900052) (regulation of retinoic acid biosynthetic process), [GO:0042615](http://purl.obolibrary.org/obo/GO_0042615) (CD154 receptor binding), [GO:1901383](http://purl.obolibrary.org/obo/GO_1901383) (negative regulation of chorionic trophoblast cell proliferation), [GO:0003091](http://purl.obolibrary.org/obo/GO_0003091) (renal water homeostasis), [GO:0015079](http://purl.obolibrary.org/obo/GO_0015079) (potassium ion transmembrane transporter activity), [GO:0015078](http://purl.obolibrary.org/obo/GO_0015078) (hydrogen ion transmembrane transporter activity), [GO:1901385](http://purl.obolibrary.org/obo/GO_1901385) (regulation of voltage-gated calcium channel activity), [GO:0003093](http://purl.obolibrary.org/obo/GO_0003093) (regulation of glomerular filtration), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0000815](http://purl.obolibrary.org/obo/GO_0000815) (ESCRT III complex), [GO:0003094](http://purl.obolibrary.org/obo/GO_0003094) (glomerular filtration), [GO:0000813](http://purl.obolibrary.org/obo/GO_0000813) (ESCRT I complex), [GO:1901386](http://purl.obolibrary.org/obo/GO_1901386) (negative regulation of voltage-gated calcium channel activity), [GO:0015075](http://purl.obolibrary.org/obo/GO_0015075) (ion transmembrane transporter activity), [GO:0000812](http://purl.obolibrary.org/obo/GO_0000812) (Swr1 complex), [GO:0015074](http://purl.obolibrary.org/obo/GO_0015074) (DNA integration), [GO:0003096](http://purl.obolibrary.org/obo/GO_0003096) (renal sodium ion transport), [GO:0042612](http://purl.obolibrary.org/obo/GO_0042612) (MHC class I protein complex), [GO:0071174](http://purl.obolibrary.org/obo/GO_0071174) (mitotic spindle checkpoint), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0042629](http://purl.obolibrary.org/obo/GO_0042629) (mast cell granule), [GO:0015087](http://purl.obolibrary.org/obo/GO_0015087) (cobalt ion transmembrane transporter activity), [GO:0015086](http://purl.obolibrary.org/obo/GO_0015086) (cadmium ion transmembrane transporter activity), [GO:0015085](http://purl.obolibrary.org/obo/GO_0015085) (calcium ion transmembrane transporter activity), [GO:0000822](http://purl.obolibrary.org/obo/GO_0000822) (inositol hexakisphosphate binding), [GO:0043950](http://purl.obolibrary.org/obo/GO_0043950) (positive regulation of cAMP-mediated signaling), [GO:0000821](http://purl.obolibrary.org/obo/GO_0000821) (regulation of arginine metabolic process), [GO:0015081](http://purl.obolibrary.org/obo/GO_0015081) (sodium ion transmembrane transporter activity), [GO:0042622](http://purl.obolibrary.org/obo/GO_0042622) (photoreceptor outer segment membrane), [GO:0042623](http://purl.obolibrary.org/obo/GO_0042623) (ATPase activity, coupled), [GO:0071162](http://purl.obolibrary.org/obo/GO_0071162) (CMG complex), [GO:0072492](http://purl.obolibrary.org/obo/GO_0072492) (host cell mitochondrial intermembrane space), [GO:0071168](http://purl.obolibrary.org/obo/GO_0071168) (protein localization to chromatin), [GO:0072498](http://purl.obolibrary.org/obo/GO_0072498) (embryonic skeletal joint development), [GO:0071166](http://purl.obolibrary.org/obo/GO_0071166) (ribonucleoprotein complex localization), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0071169](http://purl.obolibrary.org/obo/GO_0071169) (establishment of protein localization to chromatin), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0039023](http://purl.obolibrary.org/obo/GO_0039023) (pronephric duct morphogenesis), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0003071](http://purl.obolibrary.org/obo/GO_0003071) (renal system process involved in regulation of systemic arterial blood pressure), [GO:1900075](http://purl.obolibrary.org/obo/GO_1900075) (positive regulation of neuromuscular synaptic transmission), [GO:0030690](http://purl.obolibrary.org/obo/GO_0030690) (Noc1p-Noc2p complex), [GO:0003073](http://purl.obolibrary.org/obo/GO_0003073) (regulation of systemic arterial blood pressure), [GO:0015052](http://purl.obolibrary.org/obo/GO_0015052) (beta3-adrenergic receptor activity), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0039020](http://purl.obolibrary.org/obo/GO_0039020) (pronephric nephron tubule development), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0042634](http://purl.obolibrary.org/obo/GO_0042634) (regulation of hair cycle), [GO:0030686](http://purl.obolibrary.org/obo/GO_0030686) (90S preribosome), [GO:0030687](http://purl.obolibrary.org/obo/GO_0030687) (preribosome, large subunit precursor), [GO:0000808](http://purl.obolibrary.org/obo/GO_0000808) (origin recognition complex), [GO:0015068](http://purl.obolibrary.org/obo/GO_0015068) (glycine amidinotransferase activity), [GO:0003081](http://purl.obolibrary.org/obo/GO_0003081) (regulation of systemic arterial blood pressure by renin-angiotensin), [GO:1900087](http://purl.obolibrary.org/obo/GO_1900087) (positive regulation of G1/S transition of mitotic cell cycle), [GO:0015067](http://purl.obolibrary.org/obo/GO_0015067) (amidinotransferase activity), [GO:1900086](http://purl.obolibrary.org/obo/GO_1900086) (positive regulation of peptidyl-tyrosine autophosphorylation), [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure), [GO:0000802](http://purl.obolibrary.org/obo/GO_0000802) (transverse filament), [GO:0003085](http://purl.obolibrary.org/obo/GO_0003085) (negative regulation of systemic arterial blood pressure), [GO:0000801](http://purl.obolibrary.org/obo/GO_0000801) (central element), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0042640](http://purl.obolibrary.org/obo/GO_0042640) (anagen), [GO:0042643](http://purl.obolibrary.org/obo/GO_0042643) (actomyosin, actin portion), [GO:0042645](http://purl.obolibrary.org/obo/GO_0042645) (mitochondrial nucleoid), [GO:0030678](http://purl.obolibrary.org/obo/GO_0030678) (mitochondrial ribonuclease P complex), [GO:0030673](http://purl.obolibrary.org/obo/GO_0030673) (axolemma), [GO:0030672](http://purl.obolibrary.org/obo/GO_0030672) (synaptic vesicle membrane), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0039008](http://purl.obolibrary.org/obo/GO_0039008) (pronephric nephron tubule morphogenesis), [GO:0030676](http://purl.obolibrary.org/obo/GO_0030676) (Rac guanyl-nucleotide exchange factor activity), [GO:0090212](http://purl.obolibrary.org/obo/GO_0090212) (negative regulation of establishment of blood-brain barrier), [GO:0000735](http://purl.obolibrary.org/obo/GO_0000735) (removal of nonhomologous ends), [GO:0000733](http://purl.obolibrary.org/obo/GO_0000733) (DNA strand renaturation), [GO:0000732](http://purl.obolibrary.org/obo/GO_0000732) (strand displacement), [GO:0000731](http://purl.obolibrary.org/obo/GO_0000731) (DNA synthesis involved in DNA repair), [GO:0000749](http://purl.obolibrary.org/obo/GO_0000749) (response to pheromone involved in conjugation with cellular fusion), [GO:0090222](http://purl.obolibrary.org/obo/GO_0090222) (centrosome-templated microtubule nucleation), [GO:0000742](http://purl.obolibrary.org/obo/GO_0000742) (karyogamy involved in conjugation with cellular fusion), [GO:0000741](http://purl.obolibrary.org/obo/GO_0000741) (karyogamy), [GO:0000715](http://purl.obolibrary.org/obo/GO_0000715) (nucleotide-excision repair, DNA damage recognition), [GO:0000712](http://purl.obolibrary.org/obo/GO_0000712) (resolution of meiotic recombination intermediates), [GO:0000711](http://purl.obolibrary.org/obo/GO_0000711) (meiotic DNA repair synthesis), [GO:0000710](http://purl.obolibrary.org/obo/GO_0000710) (meiotic mismatch repair), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:0000729](http://purl.obolibrary.org/obo/GO_0000729) (DNA double-strand break processing), [GO:0090201](http://purl.obolibrary.org/obo/GO_0090201) (negative regulation of release of cytochrome c from mitochondria), [GO:0000727](http://purl.obolibrary.org/obo/GO_0000727) (double-strand break repair via break-induced replication), [GO:0090200](http://purl.obolibrary.org/obo/GO_0090200) (positive regulation of release of cytochrome c from mitochondria), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis), [GO:0090209](http://purl.obolibrary.org/obo/GO_0090209) (negative regulation of triglyceride metabolic process), [GO:0090207](http://purl.obolibrary.org/obo/GO_0090207) (regulation of triglyceride metabolic process), [GO:0090208](http://purl.obolibrary.org/obo/GO_0090208) (positive regulation of triglyceride metabolic process), [GO:0042572](http://purl.obolibrary.org/obo/GO_0042572) (retinol metabolic process), [GO:0009116](http://purl.obolibrary.org/obo/GO_0009116) (nucleoside metabolic process), [GO:0000779](http://purl.obolibrary.org/obo/GO_0000779) (condensed chromosome, centromeric region), [GO:0000778](http://purl.obolibrary.org/obo/GO_0000778) (condensed nuclear chromosome kinetochore), [GO:0042573](http://purl.obolibrary.org/obo/GO_0042573) (retinoic acid metabolic process), [GO:0009115](http://purl.obolibrary.org/obo/GO_0009115) (xanthine catabolic process), [GO:0000777](http://purl.obolibrary.org/obo/GO_0000777) (condensed chromosome kinetochore), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0000776](http://purl.obolibrary.org/obo/GO_0000776) (kinetochore), [GO:0009113](http://purl.obolibrary.org/obo/GO_0009113) (purine nucleobase biosynthetic process), [GO:0000775](http://purl.obolibrary.org/obo/GO_0000775) (chromosome, centromeric region), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0000774](http://purl.obolibrary.org/obo/GO_0000774) (adenyl-nucleotide exchange factor activity), [GO:0042578](http://purl.obolibrary.org/obo/GO_0042578) (phosphoric ester hydrolase activity), [GO:0009117](http://purl.obolibrary.org/obo/GO_0009117) (nucleotide metabolic process), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0000780](http://purl.obolibrary.org/obo/GO_0000780) (condensed nuclear chromosome, centromeric region), [GO:0042582](http://purl.obolibrary.org/obo/GO_0042582) (azurophil granule), [GO:0042583](http://purl.obolibrary.org/obo/GO_0042583) (chromaffin granule), [GO:0000786](http://purl.obolibrary.org/obo/GO_0000786) (nucleosome), [GO:0042587](http://purl.obolibrary.org/obo/GO_0042587) (glycogen granule), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0042588](http://purl.obolibrary.org/obo/GO_0042588) (zymogen granule), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000783](http://purl.obolibrary.org/obo/GO_0000783) (nuclear telomere cap complex), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0000792](http://purl.obolibrary.org/obo/GO_0000792) (heterochromatin), [GO:0000791](http://purl.obolibrary.org/obo/GO_0000791) (euchromatin), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0042590](http://purl.obolibrary.org/obo/GO_0042590) (antigen processing and presentation of exogenous peptide antigen via MHC class I), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0042594](http://purl.obolibrary.org/obo/GO_0042594) (response to starvation), [GO:0042596](http://purl.obolibrary.org/obo/GO_0042596) (fear response), [GO:0042597](http://purl.obolibrary.org/obo/GO_0042597) (periplasmic space), [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body), [GO:0000750](http://purl.obolibrary.org/obo/GO_0000750) (pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0009101](http://purl.obolibrary.org/obo/GO_0009101) (glycoprotein biosynthetic process), [GO:0009100](http://purl.obolibrary.org/obo/GO_0009100) (glycoprotein metabolic process), [GO:0009102](http://purl.obolibrary.org/obo/GO_0009102) (biotin biosynthetic process), [GO:0009108](http://purl.obolibrary.org/obo/GO_0009108) (coenzyme biosynthetic process), [GO:0009107](http://purl.obolibrary.org/obo/GO_0009107) (lipoate biosynthetic process), [GO:0009152](http://purl.obolibrary.org/obo/GO_0009152) (purine ribonucleotide biosynthetic process), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0010142](http://purl.obolibrary.org/obo/GO_0010142) (farnesyl diphosphate biosynthetic process, mevalonate pathway), [GO:0009156](http://purl.obolibrary.org/obo/GO_0009156) (ribonucleoside monophosphate biosynthetic process), [GO:0034112](http://purl.obolibrary.org/obo/GO_0034112) (positive regulation of homotypic cell-cell adhesion), [GO:0009154](http://purl.obolibrary.org/obo/GO_0009154) (purine ribonucleotide catabolic process), [GO:0090296](http://purl.obolibrary.org/obo/GO_0090296) (regulation of mitochondrial DNA replication), [GO:0090297](http://purl.obolibrary.org/obo/GO_0090297) (positive regulation of mitochondrial DNA replication), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0048755](http://purl.obolibrary.org/obo/GO_0048755) (branching morphogenesis of a nerve), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:0060407](http://purl.obolibrary.org/obo/GO_0060407) (negative regulation of penile erection), [GO:0061732](http://purl.obolibrary.org/obo/GO_0061732) (mitochondrial acetyl-CoA biosynthetic process from pyruvate), [GO:0047429](http://purl.obolibrary.org/obo/GO_0047429) (nucleoside-triphosphate diphosphatase activity), [GO:0090290](http://purl.obolibrary.org/obo/GO_0090290) (positive regulation of osteoclast proliferation), [GO:0060402](http://purl.obolibrary.org/obo/GO_0060402) (calcium ion transport into cytosol), [GO:0061734](http://purl.obolibrary.org/obo/GO_0061734) (parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization), [GO:0046101](http://purl.obolibrary.org/obo/GO_0046101) (hypoxanthine biosynthetic process), [GO:0061739](http://purl.obolibrary.org/obo/GO_0061739) (protein lipidation involved in autophagosome assembly), [GO:0060408](http://purl.obolibrary.org/obo/GO_0060408) (regulation of acetylcholine metabolic process), [GO:0048763](http://purl.obolibrary.org/obo/GO_0048763) (calcium-induced calcium release activity), [GO:0048762](http://purl.obolibrary.org/obo/GO_0048762) (mesenchymal cell differentiation), [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process), [GO:0034104](http://purl.obolibrary.org/obo/GO_0034104) (negative regulation of tissue remodeling), [GO:0035438](http://purl.obolibrary.org/obo/GO_0035438) (cyclic-di-GMP binding), [GO:0034109](http://purl.obolibrary.org/obo/GO_0034109) (homotypic cell-cell adhesion), [GO:0010133](http://purl.obolibrary.org/obo/GO_0010133) (proline catabolic process to glutamate), [GO:0035434](http://purl.obolibrary.org/obo/GO_0035434) (copper ion transmembrane transport), [GO:0035435](http://purl.obolibrary.org/obo/GO_0035435) (phosphate ion transmembrane transport), [GO:0034101](http://purl.obolibrary.org/obo/GO_0034101) (erythrocyte homeostasis), [GO:0009165](http://purl.obolibrary.org/obo/GO_0009165) (nucleotide biosynthetic process), [GO:1902600](http://purl.obolibrary.org/obo/GO_1902600) (hydrogen ion transmembrane transport), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0009168](http://purl.obolibrary.org/obo/GO_0009168) (purine ribonucleoside monophosphate biosynthetic process), [GO:0046104](http://purl.obolibrary.org/obo/GO_0046104) (thymidine metabolic process), [GO:1903935](http://purl.obolibrary.org/obo/GO_1903935) (response to sodium arsenite), [GO:0061723](http://purl.obolibrary.org/obo/GO_0061723) (glycophagy), [GO:1902603](http://purl.obolibrary.org/obo/GO_1902603) (carnitine transmembrane transport), [GO:0048769](http://purl.obolibrary.org/obo/GO_0048769) (sarcomerogenesis), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0047444](http://purl.obolibrary.org/obo/GO_0047444) (N-acylneuraminate-9-phosphate synthase activity), [GO:0047442](http://purl.obolibrary.org/obo/GO_0047442) (17-alpha-hydroxyprogesterone aldolase activity), [GO:0048773](http://purl.obolibrary.org/obo/GO_0048773) (erythrophore differentiation), [GO:0046111](http://purl.obolibrary.org/obo/GO_0046111) (xanthine biosynthetic process), [GO:0035426](http://purl.obolibrary.org/obo/GO_0035426) (extracellular matrix-cell signaling), [GO:0035428](http://purl.obolibrary.org/obo/GO_0035428) (hexose transmembrane transport), [GO:0061750](http://purl.obolibrary.org/obo/GO_0061750) (acid sphingomyelin phosphodiesterase activity), [GO:0060420](http://purl.obolibrary.org/obo/GO_0060420) (regulation of heart growth), [GO:0061752](http://purl.obolibrary.org/obo/GO_0061752) (telomeric repeat-containing RNA binding), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0090277](http://purl.obolibrary.org/obo/GO_0090277) (positive regulation of peptide hormone secretion), [GO:0060426](http://purl.obolibrary.org/obo/GO_0060426) (lung vasculature development), [GO:0090275](http://purl.obolibrary.org/obo/GO_0090275) (negative regulation of somatostatin secretion), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0090272](http://purl.obolibrary.org/obo/GO_0090272) (negative regulation of fibroblast growth factor production), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0000798](http://purl.obolibrary.org/obo/GO_0000798) (nuclear cohesin complex), [GO:0046115](http://purl.obolibrary.org/obo/GO_0046115) (guanosine catabolic process), [GO:0060422](http://purl.obolibrary.org/obo/GO_0060422) (peptidyl-dipeptidase inhibitor activity), [GO:0000795](http://purl.obolibrary.org/obo/GO_0000795) (synaptonemal complex), [GO:1902613](http://purl.obolibrary.org/obo/GO_1902613) (negative regulation of anti-Mullerian hormone signaling pathway), [GO:0060425](http://purl.obolibrary.org/obo/GO_0060425) (lung morphogenesis), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:0061756](http://purl.obolibrary.org/obo/GO_0061756) (leukocyte adhesion to vascular endothelial cell), [GO:0048786](http://purl.obolibrary.org/obo/GO_0048786) (presynaptic active zone), [GO:0046122](http://purl.obolibrary.org/obo/GO_0046122) (purine deoxyribonucleoside metabolic process), [GO:0035418](http://purl.obolibrary.org/obo/GO_0035418) (protein localization to synapse), [GO:0035411](http://purl.obolibrary.org/obo/GO_0035411) (catenin import into nucleus), [GO:0035412](http://purl.obolibrary.org/obo/GO_0035412) (regulation of catenin import into nucleus), [GO:0035414](http://purl.obolibrary.org/obo/GO_0035414) (negative regulation of catenin import into nucleus), [GO:0009141](http://purl.obolibrary.org/obo/GO_0009141) (nucleoside triphosphate metabolic process), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:0090287](http://purl.obolibrary.org/obo/GO_0090287) (regulation of cellular response to growth factor stimulus), [GO:0009143](http://purl.obolibrary.org/obo/GO_0009143) (nucleoside triphosphate catabolic process), [GO:0009142](http://purl.obolibrary.org/obo/GO_0009142) (nucleoside triphosphate biosynthetic process), [GO:1902622](http://purl.obolibrary.org/obo/GO_1902622) (regulation of neutrophil migration), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:0060416](http://purl.obolibrary.org/obo/GO_0060416) (response to growth hormone), [GO:0090286](http://purl.obolibrary.org/obo/GO_0090286) (cytoskeletal anchoring at nuclear membrane), [GO:0048788](http://purl.obolibrary.org/obo/GO_0048788) (cytoskeleton of presynaptic active zone), [GO:0048787](http://purl.obolibrary.org/obo/GO_0048787) (presynaptic active zone membrane), [GO:0090281](http://purl.obolibrary.org/obo/GO_0090281) (negative regulation of calcium ion import), [GO:0060411](http://purl.obolibrary.org/obo/GO_0060411) (cardiac septum morphogenesis), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0060413](http://purl.obolibrary.org/obo/GO_0060413) (atrial septum morphogenesis), [GO:1903955](http://purl.obolibrary.org/obo/GO_1903955) (positive regulation of protein targeting to mitochondrion), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0060414](http://purl.obolibrary.org/obo/GO_0060414) (aorta smooth muscle tissue morphogenesis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0048791](http://purl.obolibrary.org/obo/GO_0048791) (calcium ion-regulated exocytosis of neurotransmitter), [GO:1902617](http://purl.obolibrary.org/obo/GO_1902617) (response to fluoride), [GO:1903949](http://purl.obolibrary.org/obo/GO_1903949) (positive regulation of atrial cardiac muscle cell action potential), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0060419](http://purl.obolibrary.org/obo/GO_0060419) (heart growth), [GO:0035409](http://purl.obolibrary.org/obo/GO_0035409) (histone H3-Y41 phosphorylation), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0035404](http://purl.obolibrary.org/obo/GO_0035404) (histone-serine phosphorylation), [GO:0035401](http://purl.obolibrary.org/obo/GO_0035401) (histone kinase activity (H3-Y41 specific)), [GO:0035403](http://purl.obolibrary.org/obo/GO_0035403) (histone kinase activity (H3-T6 specific)), [GO:0090259](http://purl.obolibrary.org/obo/GO_0090259) (regulation of retinal ganglion cell axon guidance), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0035481](http://purl.obolibrary.org/obo/GO_0035481) (positive regulation of Notch signaling pathway involved in heart induction), [GO:0035483](http://purl.obolibrary.org/obo/GO_0035483) (gastric emptying), [GO:0048713](http://purl.obolibrary.org/obo/GO_0048713) (regulation of oligodendrocyte differentiation), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0048711](http://purl.obolibrary.org/obo/GO_0048711) (positive regulation of astrocyte differentiation), [GO:0048715](http://purl.obolibrary.org/obo/GO_0048715) (negative regulation of oligodendrocyte differentiation), [GO:0048714](http://purl.obolibrary.org/obo/GO_0048714) (positive regulation of oligodendrocyte differentiation), [GO:0006913](http://purl.obolibrary.org/obo/GO_0006913) (nucleocytoplasmic transport), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0035477](http://purl.obolibrary.org/obo/GO_0035477) (regulation of angioblast cell migration involved in selective angioblast sprouting), [GO:0009191](http://purl.obolibrary.org/obo/GO_0009191) (ribonucleoside diphosphate catabolic process), [GO:0035478](http://purl.obolibrary.org/obo/GO_0035478) (chylomicron binding), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0034141](http://purl.obolibrary.org/obo/GO_0034141) (positive regulation of toll-like receptor 3 signaling pathway), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0035474](http://purl.obolibrary.org/obo/GO_0035474) (selective angioblast sprouting), [GO:0048729](http://purl.obolibrary.org/obo/GO_0048729) (tissue morphogenesis), [GO:0034145](http://purl.obolibrary.org/obo/GO_0034145) (positive regulation of toll-like receptor 4 signaling pathway), [GO:0035470](http://purl.obolibrary.org/obo/GO_0035470) (positive regulation of vascular wound healing), [GO:0090265](http://purl.obolibrary.org/obo/GO_0090265) (positive regulation of immune complex clearance by monocytes and macrophages), [GO:0090266](http://purl.obolibrary.org/obo/GO_0090266) (regulation of mitotic cell cycle spindle assembly checkpoint), [GO:0034142](http://purl.obolibrary.org/obo/GO_0034142) (toll-like receptor 4 signaling pathway), [GO:0035472](http://purl.obolibrary.org/obo/GO_0035472) (choriogonadotropin hormone receptor activity), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0090262](http://purl.obolibrary.org/obo/GO_0090262) (regulation of transcription-coupled nucleotide-excision repair), [GO:0006924](http://purl.obolibrary.org/obo/GO_0006924) (activation-induced cell death of T cells), [GO:0048731](http://purl.obolibrary.org/obo/GO_0048731) (system development), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0006925](http://purl.obolibrary.org/obo/GO_0006925) (inflammatory cell apoptotic process), [GO:0006929](http://purl.obolibrary.org/obo/GO_0006929) (substrate-dependent cell migration), [GO:0035469](http://purl.obolibrary.org/obo/GO_0035469) (determination of pancreatic left/right asymmetry), [GO:0035462](http://purl.obolibrary.org/obo/GO_0035462) (determination of left/right asymmetry in diencephalon), [GO:0090238](http://purl.obolibrary.org/obo/GO_0090238) (positive regulation of arachidonic acid secretion), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0090232](http://purl.obolibrary.org/obo/GO_0090232) (positive regulation of spindle checkpoint), [GO:0061713](http://purl.obolibrary.org/obo/GO_0061713) (anterior neural tube closure), [GO:0090231](http://purl.obolibrary.org/obo/GO_0090231) (regulation of spindle checkpoint), [GO:0061714](http://purl.obolibrary.org/obo/GO_0061714) (folic acid receptor activity), [GO:0048733](http://purl.obolibrary.org/obo/GO_0048733) (sebaceous gland development), [GO:0048732](http://purl.obolibrary.org/obo/GO_0048732) (gland development), [GO:0048739](http://purl.obolibrary.org/obo/GO_0048739) (cardiac muscle fiber development), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0061712](http://purl.obolibrary.org/obo/GO_0061712) (tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0010159](http://purl.obolibrary.org/obo/GO_0010159) (specification of animal organ position), [GO:0034124](http://purl.obolibrary.org/obo/GO_0034124) (regulation of MyD88-dependent toll-like receptor signaling pathway), [GO:0035455](http://purl.obolibrary.org/obo/GO_0035455) (response to interferon-alpha), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0090245](http://purl.obolibrary.org/obo/GO_0090245) (axis elongation involved in somitogenesis), [GO:0034122](http://purl.obolibrary.org/obo/GO_0034122) (negative regulation of toll-like receptor signaling pathway), [GO:0034121](http://purl.obolibrary.org/obo/GO_0034121) (regulation of toll-like receptor signaling pathway), [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis), [GO:0009187](http://purl.obolibrary.org/obo/GO_0009187) (cyclic nucleotide metabolic process), [GO:0090243](http://purl.obolibrary.org/obo/GO_0090243) (fibroblast growth factor receptor signaling pathway involved in somitogenesis), [GO:0090244](http://purl.obolibrary.org/obo/GO_0090244) (Wnt signaling pathway involved in somitogenesis), [GO:0010171](http://purl.obolibrary.org/obo/GO_0010171) (body morphogenesis), [GO:0061702](http://purl.obolibrary.org/obo/GO_0061702) (inflammasome complex), [GO:0090241](http://purl.obolibrary.org/obo/GO_0090241) (negative regulation of histone H4 acetylation), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0048743](http://purl.obolibrary.org/obo/GO_0048743) (positive regulation of skeletal muscle fiber development), [GO:0048749](http://purl.obolibrary.org/obo/GO_0048749) (compound eye development), [GO:0061700](http://purl.obolibrary.org/obo/GO_0061700) (GATOR2 complex), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:1903912](http://purl.obolibrary.org/obo/GO_1903912) (negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation), [GO:1903904](http://purl.obolibrary.org/obo/GO_1903904) (negative regulation of establishment of T cell polarity), [GO:1903905](http://purl.obolibrary.org/obo/GO_1903905) (positive regulation of establishment of T cell polarity), [GO:0048753](http://purl.obolibrary.org/obo/GO_0048753) (pigment granule organization), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0006906](http://purl.obolibrary.org/obo/GO_0006906) (vesicle fusion), [GO:0006903](http://purl.obolibrary.org/obo/GO_0006903) (vesicle targeting), [GO:0061708](http://purl.obolibrary.org/obo/GO_0061708) (tRNA-5-taurinomethyluridine 2-sulfurtransferase), [GO:0061709](http://purl.obolibrary.org/obo/GO_0061709) (reticulophagy), [GO:0006904](http://purl.obolibrary.org/obo/GO_0006904) (vesicle docking involved in exocytosis), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0034116](http://purl.obolibrary.org/obo/GO_0034116) (positive regulation of heterotypic cell-cell adhesion), [GO:0006907](http://purl.obolibrary.org/obo/GO_0006907) (pinocytosis), [GO:0034113](http://purl.obolibrary.org/obo/GO_0034113) (heterotypic cell-cell adhesion), [GO:0035445](http://purl.obolibrary.org/obo/GO_0035445) (borate transmembrane transport), [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0004897](http://purl.obolibrary.org/obo/GO_0004897) (ciliary neurotrophic factor receptor activity), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002238](http://purl.obolibrary.org/obo/GO_0002238) (response to molecule of fungal origin), [GO:0016890](http://purl.obolibrary.org/obo/GO_0016890) (site-specific endodeoxyribonuclease activity, specific for altered base), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:0016878](http://purl.obolibrary.org/obo/GO_0016878) (acid-thiol ligase activity), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0002246](http://purl.obolibrary.org/obo/GO_0002246) (wound healing involved in inflammatory response), [GO:0070392](http://purl.obolibrary.org/obo/GO_0070392) (detection of lipoteichoic acid), [GO:0016881](http://purl.obolibrary.org/obo/GO_0016881) (acid-amino acid ligase activity), [GO:0016885](http://purl.obolibrary.org/obo/GO_0016885) (ligase activity, forming carbon-carbon bonds), [GO:0016866](http://purl.obolibrary.org/obo/GO_0016866) (intramolecular transferase activity), [GO:0016868](http://purl.obolibrary.org/obo/GO_0016868) (intramolecular transferase activity, phosphotransferases), [GO:1905601](http://purl.obolibrary.org/obo/GO_1905601) (negative regulation of receptor-mediated endocytosis involved in cholesterol transport), [GO:0004883](http://purl.obolibrary.org/obo/GO_0004883) (glucocorticoid receptor activity), [GO:0004882](http://purl.obolibrary.org/obo/GO_0004882) (androgen receptor activity), [GO:0004875](http://purl.obolibrary.org/obo/GO_0004875) (complement receptor activity), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0016857](http://purl.obolibrary.org/obo/GO_0016857) (racemase and epimerase activity, acting on carbohydrates and derivatives), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0002281](http://purl.obolibrary.org/obo/GO_0002281) (macrophage activation involved in immune response), [GO:0002282](http://purl.obolibrary.org/obo/GO_0002282) (microglial cell activation involved in immune response), [GO:0002283](http://purl.obolibrary.org/obo/GO_0002283) (neutrophil activation involved in immune response), [GO:0093001](http://purl.obolibrary.org/obo/GO_0093001) (glycolysis from storage polysaccharide through glucose-1-phosphate), [GO:0070365](http://purl.obolibrary.org/obo/GO_0070365) (hepatocyte differentiation), [GO:0071696](http://purl.obolibrary.org/obo/GO_0071696) (ectodermal placode development), [GO:0044088](http://purl.obolibrary.org/obo/GO_0044088) (regulation of vacuole organization), [GO:0071699](http://purl.obolibrary.org/obo/GO_0071699) (olfactory placode morphogenesis), [GO:0070368](http://purl.obolibrary.org/obo/GO_0070368) (positive regulation of hepatocyte differentiation), [GO:0070369](http://purl.obolibrary.org/obo/GO_0070369) (beta-catenin-TCF7L2 complex), [GO:0071698](http://purl.obolibrary.org/obo/GO_0071698) (olfactory placode development), [GO:0070367](http://purl.obolibrary.org/obo/GO_0070367) (negative regulation of hepatocyte differentiation), [GO:0002292](http://purl.obolibrary.org/obo/GO_0002292) (T cell differentiation involved in immune response), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0070350](http://purl.obolibrary.org/obo/GO_0070350) (regulation of white fat cell proliferation), [GO:0071688](http://purl.obolibrary.org/obo/GO_0071688) (striated muscle myosin thick filament assembly), [GO:0070358](http://purl.obolibrary.org/obo/GO_0070358) (actin polymerization-dependent cell motility), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0002260](http://purl.obolibrary.org/obo/GO_0002260) (lymphocyte homeostasis), [GO:0002262](http://purl.obolibrary.org/obo/GO_0002262) (myeloid cell homeostasis), [GO:0002265](http://purl.obolibrary.org/obo/GO_0002265) (astrocyte activation involved in immune response), [GO:0070382](http://purl.obolibrary.org/obo/GO_0070382) (exocytic vesicle), [GO:0070384](http://purl.obolibrary.org/obo/GO_0070384) (Harderian gland development), [GO:0039530](http://purl.obolibrary.org/obo/GO_0039530) (MDA-5 signaling pathway), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0002276](http://purl.obolibrary.org/obo/GO_0002276) (basophil activation involved in immune response), [GO:0002277](http://purl.obolibrary.org/obo/GO_0002277) (myeloid dendritic cell activation involved in immune response), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0002268](http://purl.obolibrary.org/obo/GO_0002268) (follicular dendritic cell differentiation), [GO:0070372](http://purl.obolibrary.org/obo/GO_0070372) (regulation of ERK1 and ERK2 cascade), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0039529](http://purl.obolibrary.org/obo/GO_0039529) (RIG-I signaling pathway), [GO:0039528](http://purl.obolibrary.org/obo/GO_0039528) (cytoplasmic pattern recognition receptor signaling pathway in response to virus), [GO:1904339](http://purl.obolibrary.org/obo/GO_1904339) (negative regulation of dopaminergic neuron differentiation), [GO:1903007](http://purl.obolibrary.org/obo/GO_1903007) (positive regulation of Lys63-specific deubiquitinase activity), [GO:0051250](http://purl.obolibrary.org/obo/GO_0051250) (negative regulation of lymphocyte activation), [GO:1903006](http://purl.obolibrary.org/obo/GO_1903006) (positive regulation of protein K63-linked deubiquitination), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:1990246](http://purl.obolibrary.org/obo/GO_1990246) (uniplex complex), [GO:1903010](http://purl.obolibrary.org/obo/GO_1903010) (regulation of bone development), [GO:1904346](http://purl.obolibrary.org/obo/GO_1904346) (positive regulation of gastric mucosal blood circulation), [GO:1903012](http://purl.obolibrary.org/obo/GO_1903012) (positive regulation of bone development), [GO:1904343](http://purl.obolibrary.org/obo/GO_1904343) (positive regulation of colon smooth muscle contraction), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0052591](http://purl.obolibrary.org/obo/GO_0052591) (sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity), [GO:1904349](http://purl.obolibrary.org/obo/GO_1904349) (positive regulation of small intestine smooth muscle contraction), [GO:0052590](http://purl.obolibrary.org/obo/GO_0052590) (sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:1990262](http://purl.obolibrary.org/obo/GO_1990262) (anti-Mullerian hormone signaling pathway), [GO:1990254](http://purl.obolibrary.org/obo/GO_1990254) (keratin filament binding), [GO:0051258](http://purl.obolibrary.org/obo/GO_0051258) (protein polymerization), [GO:0051255](http://purl.obolibrary.org/obo/GO_0051255) (spindle midzone assembly), [GO:0051256](http://purl.obolibrary.org/obo/GO_0051256) (mitotic spindle midzone assembly), [GO:0010705](http://purl.obolibrary.org/obo/GO_0010705) (meiotic DNA double-strand break processing involved in reciprocal meiotic recombination), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:1903022](http://purl.obolibrary.org/obo/GO_1903022) (positive regulation of phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands), [GO:1904352](http://purl.obolibrary.org/obo/GO_1904352) (positive regulation of protein catabolic process in the vacuole), [GO:1903025](http://purl.obolibrary.org/obo/GO_1903025) (regulation of RNA polymerase II regulatory region sequence-specific DNA binding), [GO:1904356](http://purl.obolibrary.org/obo/GO_1904356) (regulation of telomere maintenance via telomere lengthening), [GO:1904355](http://purl.obolibrary.org/obo/GO_1904355) (positive regulation of telomere capping), [GO:0051271](http://purl.obolibrary.org/obo/GO_0051271) (negative regulation of cellular component movement), [GO:0051272](http://purl.obolibrary.org/obo/GO_0051272) (positive regulation of cellular component movement), [GO:0051270](http://purl.obolibrary.org/obo/GO_0051270) (regulation of cellular component movement), [GO:1904358](http://purl.obolibrary.org/obo/GO_1904358) (positive regulation of telomere maintenance via telomere lengthening), [GO:1990272](http://purl.obolibrary.org/obo/GO_1990272) (anti-Mullerian hormone receptor activity), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:1990269](http://purl.obolibrary.org/obo/GO_1990269) (RNA polymerase II C-terminal domain phosphoserine binding), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:1903033](http://purl.obolibrary.org/obo/GO_1903033) (positive regulation of microtubule plus-end binding), [GO:1903036](http://purl.obolibrary.org/obo/GO_1903036) (positive regulation of response to wounding), [GO:1903038](http://purl.obolibrary.org/obo/GO_1903038) (negative regulation of leukocyte cell-cell adhesion), [GO:0051281](http://purl.obolibrary.org/obo/GO_0051281) (positive regulation of release of sequestered calcium ion into cytosol), [GO:0051279](http://purl.obolibrary.org/obo/GO_0051279) (regulation of release of sequestered calcium ion into cytosol), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0008422](http://purl.obolibrary.org/obo/GO_0008422) (beta-glucosidase activity), [GO:0008420](http://purl.obolibrary.org/obo/GO_0008420) (CTD phosphatase activity), [GO:0009758](http://purl.obolibrary.org/obo/GO_0009758) (carbohydrate utilization), [GO:0008426](http://purl.obolibrary.org/obo/GO_0008426) (protein kinase C inhibitor activity), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:1905627](http://purl.obolibrary.org/obo/GO_1905627) (regulation of serotonin biosynthetic process), [GO:0034707](http://purl.obolibrary.org/obo/GO_0034707) (chloride channel complex), [GO:0034706](http://purl.obolibrary.org/obo/GO_0034706) (sodium channel complex), [GO:0010739](http://purl.obolibrary.org/obo/GO_0010739) (positive regulation of protein kinase A signaling), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0034705](http://purl.obolibrary.org/obo/GO_0034705) (potassium channel complex), [GO:0034704](http://purl.obolibrary.org/obo/GO_0034704) (calcium channel complex), [GO:0008417](http://purl.obolibrary.org/obo/GO_0008417) (fucosyltransferase activity), [GO:0010738](http://purl.obolibrary.org/obo/GO_0010738) (regulation of protein kinase A signaling), [GO:0010737](http://purl.obolibrary.org/obo/GO_0010737) (protein kinase A signaling), [GO:0010734](http://purl.obolibrary.org/obo/GO_0010734) (negative regulation of protein glutathionylation), [GO:0051208](http://purl.obolibrary.org/obo/GO_0051208) (sequestering of calcium ion), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0034702](http://purl.obolibrary.org/obo/GO_0034702) (ion channel complex), [GO:0010730](http://purl.obolibrary.org/obo/GO_0010730) (negative regulation of hydrogen peroxide biosynthetic process), [GO:0051204](http://purl.obolibrary.org/obo/GO_0051204) (protein insertion into mitochondrial membrane), [GO:0051205](http://purl.obolibrary.org/obo/GO_0051205) (protein insertion into membrane), [GO:0008430](http://purl.obolibrary.org/obo/GO_0008430) (selenium binding), [GO:1904306](http://purl.obolibrary.org/obo/GO_1904306) (positive regulation of gastro-intestinal system smooth muscle contraction), [GO:0008432](http://purl.obolibrary.org/obo/GO_0008432) (JUN kinase binding), [GO:0007100](http://purl.obolibrary.org/obo/GO_0007100) (mitotic centrosome separation), [GO:0008431](http://purl.obolibrary.org/obo/GO_0008431) (vitamin E binding), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0008429](http://purl.obolibrary.org/obo/GO_0008429) (phosphatidylethanolamine binding), [GO:0010748](http://purl.obolibrary.org/obo/GO_0010748) (negative regulation of plasma membrane long-chain fatty acid transport), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0010745](http://purl.obolibrary.org/obo/GO_0010745) (negative regulation of macrophage derived foam cell differentiation), [GO:0010744](http://purl.obolibrary.org/obo/GO_0010744) (positive regulation of macrophage derived foam cell differentiation), [GO:0052548](http://purl.obolibrary.org/obo/GO_0052548) (regulation of endopeptidase activity), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0008401](http://purl.obolibrary.org/obo/GO_0008401) (retinoic acid 4-hydroxylase activity), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0010717](http://purl.obolibrary.org/obo/GO_0010717) (regulation of epithelial to mesenchymal transition), [GO:0051225](http://purl.obolibrary.org/obo/GO_0051225) (spindle assembly), [GO:0051222](http://purl.obolibrary.org/obo/GO_0051222) (positive regulation of protein transport), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0010714](http://purl.obolibrary.org/obo/GO_0010714) (positive regulation of collagen metabolic process), [GO:0010712](http://purl.obolibrary.org/obo/GO_0010712) (regulation of collagen metabolic process), [GO:0051228](http://purl.obolibrary.org/obo/GO_0051228) (mitotic spindle disassembly), [GO:0051229](http://purl.obolibrary.org/obo/GO_0051229) (meiotic spindle disassembly), [GO:1904322](http://purl.obolibrary.org/obo/GO_1904322) (cellular response to forskolin), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0008412](http://purl.obolibrary.org/obo/GO_0008412) (4-hydroxybenzoate octaprenyltransferase activity), [GO:0008410](http://purl.obolibrary.org/obo/GO_0008410) (CoA-transferase activity), [GO:0008413](http://purl.obolibrary.org/obo/GO_0008413) (8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity), [GO:0008409](http://purl.obolibrary.org/obo/GO_0008409) (5'-3' exonuclease activity), [GO:0008408](http://purl.obolibrary.org/obo/GO_0008408) (3'-5' exonuclease activity), [GO:0051233](http://purl.obolibrary.org/obo/GO_0051233) (spindle midzone), [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development), [GO:0010725](http://purl.obolibrary.org/obo/GO_0010725) (regulation of primitive erythrocyte differentiation), [GO:0010724](http://purl.obolibrary.org/obo/GO_0010724) (regulation of definitive erythrocyte differentiation), [GO:0051232](http://purl.obolibrary.org/obo/GO_0051232) (meiotic spindle elongation), [GO:0010721](http://purl.obolibrary.org/obo/GO_0010721) (negative regulation of cell development), [GO:0010720](http://purl.obolibrary.org/obo/GO_0010720) (positive regulation of cell development), [GO:0010722](http://purl.obolibrary.org/obo/GO_0010722) (regulation of ferrochelatase activity), [GO:0046619](http://purl.obolibrary.org/obo/GO_0046619) (optic placode formation involved in camera-type eye formation), [GO:0046618](http://purl.obolibrary.org/obo/GO_0046618) (drug export), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0008340](http://purl.obolibrary.org/obo/GO_0008340) (determination of adult lifespan), [GO:0007014](http://purl.obolibrary.org/obo/GO_0007014) (actin ubiquitination), [GO:0007015](http://purl.obolibrary.org/obo/GO_0007015) (actin filament organization), [GO:0008345](http://purl.obolibrary.org/obo/GO_0008345) (larval locomotory behavior), [GO:0060923](http://purl.obolibrary.org/obo/GO_0060923) (cardiac muscle cell fate commitment), [GO:0008344](http://purl.obolibrary.org/obo/GO_0008344) (adult locomotory behavior), [GO:0008343](http://purl.obolibrary.org/obo/GO_0008343) (adult feeding behavior), [GO:0007018](http://purl.obolibrary.org/obo/GO_0007018) (microtubule-based movement), [GO:0007019](http://purl.obolibrary.org/obo/GO_0007019) (microtubule depolymerization), [GO:0007016](http://purl.obolibrary.org/obo/GO_0007016) (cytoskeletal anchoring at plasma membrane), [GO:0008347](http://purl.obolibrary.org/obo/GO_0008347) (glial cell migration), [GO:0007017](http://purl.obolibrary.org/obo/GO_0007017) (microtubule-based process), [GO:0007009](http://purl.obolibrary.org/obo/GO_0007009) (plasma membrane organization), [GO:0034628](http://purl.obolibrary.org/obo/GO_0034628) ('de novo' NAD biosynthetic process from aspartate), [GO:0010659](http://purl.obolibrary.org/obo/GO_0010659) (cardiac muscle cell apoptotic process), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0035955](http://purl.obolibrary.org/obo/GO_0035955) (negative regulation of dipeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0010657](http://purl.obolibrary.org/obo/GO_0010657) (muscle cell apoptotic process), [GO:0010656](http://purl.obolibrary.org/obo/GO_0010656) (negative regulation of muscle cell apoptotic process), [GO:0034626](http://purl.obolibrary.org/obo/GO_0034626) (fatty acid elongation, polyunsaturated fatty acid), [GO:0034625](http://purl.obolibrary.org/obo/GO_0034625) (fatty acid elongation, monounsaturated fatty acid), [GO:0035952](http://purl.obolibrary.org/obo/GO_0035952) (negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019008](http://purl.obolibrary.org/obo/GO_0019008) (molybdopterin synthase complex), [GO:0010652](http://purl.obolibrary.org/obo/GO_0010652) (positive regulation of cell communication by chemical coupling), [GO:0046628](http://purl.obolibrary.org/obo/GO_0046628) (positive regulation of insulin receptor signaling pathway), [GO:0007021](http://purl.obolibrary.org/obo/GO_0007021) (tubulin complex assembly), [GO:0008353](http://purl.obolibrary.org/obo/GO_0008353) (RNA polymerase II carboxy-terminal domain kinase activity), [GO:0008352](http://purl.obolibrary.org/obo/GO_0008352) (katanin complex), [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance), [GO:0007020](http://purl.obolibrary.org/obo/GO_0007020) (microtubule nucleation), [GO:0046622](http://purl.obolibrary.org/obo/GO_0046622) (positive regulation of organ growth), [GO:0007026](http://purl.obolibrary.org/obo/GO_0007026) (negative regulation of microtubule depolymerization), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0007023](http://purl.obolibrary.org/obo/GO_0007023) (post-chaperonin tubulin folding pathway), [GO:0060912](http://purl.obolibrary.org/obo/GO_0060912) (cardiac cell fate specification), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:0008354](http://purl.obolibrary.org/obo/GO_0008354) (germ cell migration), [GO:0007029](http://purl.obolibrary.org/obo/GO_0007029) (endoplasmic reticulum organization), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0046624](http://purl.obolibrary.org/obo/GO_0046624) (sphingolipid transporter activity), [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding), [GO:0034618](http://purl.obolibrary.org/obo/GO_0034618) (arginine binding), [GO:0034617](http://purl.obolibrary.org/obo/GO_0034617) (tetrahydrobiopterin binding), [GO:0035947](http://purl.obolibrary.org/obo/GO_0035947) (regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter), [GO:0060914](http://purl.obolibrary.org/obo/GO_0060914) (heart formation), [GO:0010669](http://purl.obolibrary.org/obo/GO_0010669) (epithelial structure maintenance), [GO:0060916](http://purl.obolibrary.org/obo/GO_0060916) (mesenchymal cell proliferation involved in lung development), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0010668](http://purl.obolibrary.org/obo/GO_0010668) (ectodermal cell differentiation), [GO:0010667](http://purl.obolibrary.org/obo/GO_0010667) (negative regulation of cardiac muscle cell apoptotic process), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0034613](http://purl.obolibrary.org/obo/GO_0034613) (cellular protein localization), [GO:0010664](http://purl.obolibrary.org/obo/GO_0010664) (negative regulation of striated muscle cell apoptotic process), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0046639](http://purl.obolibrary.org/obo/GO_0046639) (negative regulation of alpha-beta T cell differentiation), [GO:0009651](http://purl.obolibrary.org/obo/GO_0009651) (response to salt stress), [GO:0022626](http://purl.obolibrary.org/obo/GO_0022626) (cytosolic ribosome), [GO:0008320](http://purl.obolibrary.org/obo/GO_0008320) (protein transmembrane transporter activity), [GO:0022627](http://purl.obolibrary.org/obo/GO_0022627) (cytosolic small ribosomal subunit), [GO:0009650](http://purl.obolibrary.org/obo/GO_0009650) (UV protection), [GO:0008324](http://purl.obolibrary.org/obo/GO_0008324) (cation transmembrane transporter activity), [GO:0046633](http://purl.obolibrary.org/obo/GO_0046633) (alpha-beta T cell proliferation), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0047963](http://purl.obolibrary.org/obo/GO_0047963) (glycine N-choloyltransferase activity), [GO:0046631](http://purl.obolibrary.org/obo/GO_0046631) (alpha-beta T cell activation), [GO:0009652](http://purl.obolibrary.org/obo/GO_0009652) (thigmotropism), [GO:0022625](http://purl.obolibrary.org/obo/GO_0022625) (cytosolic large ribosomal subunit), [GO:0099132](http://purl.obolibrary.org/obo/GO_0099132) (ATP hydrolysis coupled cation transmembrane transport), [GO:0008328](http://purl.obolibrary.org/obo/GO_0008328) (ionotropic glutamate receptor complex), [GO:0046638](http://purl.obolibrary.org/obo/GO_0046638) (positive regulation of alpha-beta T cell differentiation), [GO:0099133](http://purl.obolibrary.org/obo/GO_0099133) (ATP hydrolysis coupled anion transmembrane transport), [GO:0008327](http://purl.obolibrary.org/obo/GO_0008327) (methyl-CpG binding), [GO:0046635](http://purl.obolibrary.org/obo/GO_0046635) (positive regulation of alpha-beta T cell activation), [GO:0099131](http://purl.obolibrary.org/obo/GO_0099131) (ATP hydrolysis coupled ion transmembrane transport), [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0046641](http://purl.obolibrary.org/obo/GO_0046641) (positive regulation of alpha-beta T cell proliferation), [GO:0060948](http://purl.obolibrary.org/obo/GO_0060948) (cardiac vascular smooth muscle cell development), [GO:0010638](http://purl.obolibrary.org/obo/GO_0010638) (positive regulation of organelle organization), [GO:0010633](http://purl.obolibrary.org/obo/GO_0010633) (negative regulation of epithelial cell migration), [GO:0010632](http://purl.obolibrary.org/obo/GO_0010632) (regulation of epithelial cell migration), [GO:0010634](http://purl.obolibrary.org/obo/GO_0010634) (positive regulation of epithelial cell migration), [GO:0034604](http://purl.obolibrary.org/obo/GO_0034604) (pyruvate dehydrogenase (NAD+) activity), [GO:0034602](http://purl.obolibrary.org/obo/GO_0034602) (oxoglutarate dehydrogenase (NAD+) activity), [GO:0010631](http://purl.obolibrary.org/obo/GO_0010631) (epithelial cell migration), [GO:0008331](http://purl.obolibrary.org/obo/GO_0008331) (high voltage-gated calcium channel activity), [GO:0022615](http://purl.obolibrary.org/obo/GO_0022615) (protein to membrane docking), [GO:0007000](http://purl.obolibrary.org/obo/GO_0007000) (nucleolus organization), [GO:0022617](http://purl.obolibrary.org/obo/GO_0022617) (extracellular matrix disassembly), [GO:0007004](http://purl.obolibrary.org/obo/GO_0007004) (telomere maintenance via telomerase), [GO:0022612](http://purl.obolibrary.org/obo/GO_0022612) (gland morphogenesis), [GO:0008333](http://purl.obolibrary.org/obo/GO_0008333) (endosome to lysosome transport), [GO:0008332](http://purl.obolibrary.org/obo/GO_0008332) (low voltage-gated calcium channel activity), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0046649](http://purl.obolibrary.org/obo/GO_0046649) (lymphocyte activation), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0060931](http://purl.obolibrary.org/obo/GO_0060931) (sinoatrial node cell development), [GO:0007006](http://purl.obolibrary.org/obo/GO_0007006) (mitochondrial membrane organization), [GO:0046651](http://purl.obolibrary.org/obo/GO_0046651) (lymphocyte proliferation), [GO:0035927](http://purl.obolibrary.org/obo/GO_0035927) (RNA import into mitochondrion), [GO:0035928](http://purl.obolibrary.org/obo/GO_0035928) (rRNA import into mitochondrion), [GO:0010649](http://purl.obolibrary.org/obo/GO_0010649) (regulation of cell communication by electrical coupling), [GO:0010644](http://purl.obolibrary.org/obo/GO_0010644) (cell communication by electrical coupling), [GO:0035922](http://purl.obolibrary.org/obo/GO_0035922) (foramen ovale closure), [GO:0010643](http://purl.obolibrary.org/obo/GO_0010643) (cell communication by chemical coupling), [GO:0035924](http://purl.obolibrary.org/obo/GO_0035924) (cellular response to vascular endothelial growth factor stimulus), [GO:0010640](http://purl.obolibrary.org/obo/GO_0010640) (regulation of platelet-derived growth factor receptor signaling pathway), [GO:0010642](http://purl.obolibrary.org/obo/GO_0010642) (negative regulation of platelet-derived growth factor receptor signaling pathway), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0007051](http://purl.obolibrary.org/obo/GO_0007051) (spindle organization), [GO:0008381](http://purl.obolibrary.org/obo/GO_0008381) (mechanosensitive ion channel activity), [GO:0008380](http://purl.obolibrary.org/obo/GO_0008380) (RNA splicing), [GO:1904251](http://purl.obolibrary.org/obo/GO_1904251) (regulation of bile acid metabolic process), [GO:1905589](http://purl.obolibrary.org/obo/GO_1905589) (positive regulation of L-arginine import across plasma membrane), [GO:0008386](http://purl.obolibrary.org/obo/GO_0008386) (cholesterol monooxygenase (side-chain-cleaving) activity), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:0033340](http://purl.obolibrary.org/obo/GO_0033340) (pelvic fin development), [GO:0007052](http://purl.obolibrary.org/obo/GO_0007052) (mitotic spindle organization), [GO:0008384](http://purl.obolibrary.org/obo/GO_0008384) (IkappaB kinase activity), [GO:0034670](http://purl.obolibrary.org/obo/GO_0034670) (chemotaxis to arachidonic acid), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0051170](http://purl.obolibrary.org/obo/GO_0051170) (nuclear import), [GO:0051171](http://purl.obolibrary.org/obo/GO_0051171) (regulation of nitrogen compound metabolic process), [GO:0020027](http://purl.obolibrary.org/obo/GO_0020027) (hemoglobin metabolic process), [GO:0051169](http://purl.obolibrary.org/obo/GO_0051169) (nuclear transport), [GO:0035998](http://purl.obolibrary.org/obo/GO_0035998) (7,8-dihydroneopterin 3'-triphosphate biosynthetic process), [GO:0033335](http://purl.obolibrary.org/obo/GO_0033335) (anal fin development), [GO:0034666](http://purl.obolibrary.org/obo/GO_0034666) (integrin alpha2-beta1 complex), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0035999](http://purl.obolibrary.org/obo/GO_0035999) (tetrahydrofolate interconversion), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0019048](http://purl.obolibrary.org/obo/GO_0019048) (modulation by virus of host morphology or physiology), [GO:0034663](http://purl.obolibrary.org/obo/GO_0034663) (endoplasmic reticulum chaperone complex), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0032007](http://purl.obolibrary.org/obo/GO_0032007) (negative regulation of TOR signaling), [GO:0035994](http://purl.obolibrary.org/obo/GO_0035994) (response to muscle stretch), [GO:0032008](http://purl.obolibrary.org/obo/GO_0032008) (positive regulation of TOR signaling), [GO:0033338](http://purl.obolibrary.org/obo/GO_0033338) (medial fin development), [GO:0035995](http://purl.obolibrary.org/obo/GO_0035995) (detection of muscle stretch), [GO:0010694](http://purl.obolibrary.org/obo/GO_0010694) (positive regulation of alkaline phosphatase activity), [GO:0033337](http://purl.obolibrary.org/obo/GO_0033337) (dorsal fin development), [GO:0032006](http://purl.obolibrary.org/obo/GO_0032006) (regulation of TOR signaling), [GO:0033336](http://purl.obolibrary.org/obo/GO_0033336) (caudal fin development), [GO:0034667](http://purl.obolibrary.org/obo/GO_0034667) (integrin alpha3-beta1 complex), [GO:0035990](http://purl.obolibrary.org/obo/GO_0035990) (tendon cell differentiation), [GO:1905596](http://purl.obolibrary.org/obo/GO_1905596) (negative regulation of low-density lipoprotein particle receptor binding), [GO:0007062](http://purl.obolibrary.org/obo/GO_0007062) (sister chromatid cohesion), [GO:1905594](http://purl.obolibrary.org/obo/GO_1905594) (resveratrol binding), [GO:0035993](http://purl.obolibrary.org/obo/GO_0035993) (deltoid tuberosity development), [GO:0032000](http://purl.obolibrary.org/obo/GO_0032000) (positive regulation of fatty acid beta-oxidation), [GO:0007066](http://purl.obolibrary.org/obo/GO_0007066) (female meiosis sister chromatid cohesion), [GO:0008396](http://purl.obolibrary.org/obo/GO_0008396) (oxysterol 7-alpha-hydroxylase activity), [GO:0008395](http://purl.obolibrary.org/obo/GO_0008395) (steroid hydroxylase activity), [GO:1905598](http://purl.obolibrary.org/obo/GO_1905598) (negative regulation of low-density lipoprotein receptor activity), [GO:0007064](http://purl.obolibrary.org/obo/GO_0007064) (mitotic sister chromatid cohesion), [GO:0051181](http://purl.obolibrary.org/obo/GO_0051181) (cofactor transport), [GO:0051180](http://purl.obolibrary.org/obo/GO_0051180) (vitamin transport), [GO:0051177](http://purl.obolibrary.org/obo/GO_0051177) (meiotic sister chromatid cohesion), [GO:0019031](http://purl.obolibrary.org/obo/GO_0019031) (viral envelope), [GO:0051174](http://purl.obolibrary.org/obo/GO_0051174) (regulation of phosphorus metabolic process), [GO:0019034](http://purl.obolibrary.org/obo/GO_0019034) (viral replication complex), [GO:0035987](http://purl.obolibrary.org/obo/GO_0035987) (endodermal cell differentiation), [GO:0035988](http://purl.obolibrary.org/obo/GO_0035988) (chondrocyte proliferation), [GO:0035989](http://purl.obolibrary.org/obo/GO_0035989) (tendon development), [GO:0034653](http://purl.obolibrary.org/obo/GO_0034653) (retinoic acid catabolic process), [GO:0033328](http://purl.obolibrary.org/obo/GO_0033328) (peroxisome membrane targeting sequence binding), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:1905590](http://purl.obolibrary.org/obo/GO_1905590) (fibronectin fibril organization), [GO:0035985](http://purl.obolibrary.org/obo/GO_0035985) (senescence-associated heterochromatin focus), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0034651](http://purl.obolibrary.org/obo/GO_0034651) (cortisol biosynthetic process), [GO:0034650](http://purl.obolibrary.org/obo/GO_0034650) (cortisol metabolic process), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0008361](http://purl.obolibrary.org/obo/GO_0008361) (regulation of cell size), [GO:0007031](http://purl.obolibrary.org/obo/GO_0007031) (peroxisome organization), [GO:0020003](http://purl.obolibrary.org/obo/GO_0020003) (symbiont-containing vacuole), [GO:0007037](http://purl.obolibrary.org/obo/GO_0007037), [GO:0060900](http://purl.obolibrary.org/obo/GO_0060900) (embryonic camera-type eye formation), [GO:0008366](http://purl.obolibrary.org/obo/GO_0008366) (axon ensheathment), [GO:0007034](http://purl.obolibrary.org/obo/GO_0007034) (vacuolar transport), [GO:0060901](http://purl.obolibrary.org/obo/GO_0060901) (regulation of hair cycle by canonical Wnt signaling pathway), [GO:0007035](http://purl.obolibrary.org/obo/GO_0007035) (vacuolar acidification), [GO:0007039](http://purl.obolibrary.org/obo/GO_0007039) (protein catabolic process in the vacuole), [GO:0060907](http://purl.obolibrary.org/obo/GO_0060907) (positive regulation of macrophage cytokine production), [GO:0034649](http://purl.obolibrary.org/obo/GO_0034649) (histone demethylase activity (H3-monomethyl-K4 specific)), [GO:1990226](http://purl.obolibrary.org/obo/GO_1990226) (histone methyltransferase binding), [GO:0051186](http://purl.obolibrary.org/obo/GO_0051186) (cofactor metabolic process), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:0034648](http://purl.obolibrary.org/obo/GO_0034648) (histone demethylase activity (H3-dimethyl-K4 specific)), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0034645](http://purl.obolibrary.org/obo/GO_0034645) (cellular macromolecule biosynthetic process), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0035970](http://purl.obolibrary.org/obo/GO_0035970) (peptidyl-threonine dephosphorylation), [GO:0008375](http://purl.obolibrary.org/obo/GO_0008375) (acetylglucosaminyltransferase activity), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0008374](http://purl.obolibrary.org/obo/GO_0008374) (O-acyltransferase activity), [GO:0007044](http://purl.obolibrary.org/obo/GO_0007044) (cell-substrate junction assembly), [GO:0007041](http://purl.obolibrary.org/obo/GO_0007041) (lysosomal transport), [GO:0008373](http://purl.obolibrary.org/obo/GO_0008373) (sialyltransferase activity), [GO:0007042](http://purl.obolibrary.org/obo/GO_0007042) (lysosomal lumen acidification), [GO:1904288](http://purl.obolibrary.org/obo/GO_1904288) (BAT3 complex binding), [GO:0008379](http://purl.obolibrary.org/obo/GO_0008379) (thioredoxin peroxidase activity), [GO:0046600](http://purl.obolibrary.org/obo/GO_0046600) (negative regulation of centriole replication), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0046601](http://purl.obolibrary.org/obo/GO_0046601) (positive regulation of centriole replication), [GO:0008376](http://purl.obolibrary.org/obo/GO_0008376) (acetylgalactosaminyltransferase activity), [GO:0046605](http://purl.obolibrary.org/obo/GO_0046605) (regulation of centrosome cycle), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:1990234](http://purl.obolibrary.org/obo/GO_1990234) (transferase complex), [GO:0034638](http://purl.obolibrary.org/obo/GO_0034638) (phosphatidylcholine catabolic process), [GO:0019012](http://purl.obolibrary.org/obo/GO_0019012) (virion), [GO:1990239](http://purl.obolibrary.org/obo/GO_1990239) (steroid hormone binding), [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling), [GO:0034633](http://purl.obolibrary.org/obo/GO_0034633) (retinol transport), [GO:0019013](http://purl.obolibrary.org/obo/GO_0019013) (viral nucleocapsid), [GO:0034632](http://purl.obolibrary.org/obo/GO_0034632) (retinol transmembrane transporter activity), [GO:0033300](http://purl.obolibrary.org/obo/GO_0033300) (dehydroascorbic acid transmembrane transporter activity), [GO:1904283](http://purl.obolibrary.org/obo/GO_1904283) (negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0033306](http://purl.obolibrary.org/obo/GO_0033306) (phytol metabolic process), [GO:0034635](http://purl.obolibrary.org/obo/GO_0034635) (glutathione transport), [GO:0007094](http://purl.obolibrary.org/obo/GO_0007094) (mitotic spindle assembly checkpoint), [GO:0007095](http://purl.obolibrary.org/obo/GO_0007095) (mitotic G2 DNA damage checkpoint), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0007099](http://purl.obolibrary.org/obo/GO_0007099) (centriole replication), [GO:0032055](http://purl.obolibrary.org/obo/GO_0032055) (negative regulation of translation in response to stress), [GO:0016805](http://purl.obolibrary.org/obo/GO_0016805) (dipeptidase activity), [GO:0007096](http://purl.obolibrary.org/obo/GO_0007096) (regulation of exit from mitosis), [GO:0032052](http://purl.obolibrary.org/obo/GO_0032052) (bile acid binding), [GO:0007097](http://purl.obolibrary.org/obo/GO_0007097) (nuclear migration), [GO:0046697](http://purl.obolibrary.org/obo/GO_0046697) (decidualization), [GO:0004812](http://purl.obolibrary.org/obo/GO_0004812) (aminoacyl-tRNA ligase activity), [GO:0019087](http://purl.obolibrary.org/obo/GO_0019087) (transformation of host cell by virus), [GO:0004814](http://purl.obolibrary.org/obo/GO_0004814) (arginine-tRNA ligase activity), [GO:0004813](http://purl.obolibrary.org/obo/GO_0004813) (alanine-tRNA ligase activity), [GO:0004816](http://purl.obolibrary.org/obo/GO_0004816) (asparagine-tRNA ligase activity), [GO:0004815](http://purl.obolibrary.org/obo/GO_0004815) (aspartate-tRNA ligase activity), [GO:0070324](http://purl.obolibrary.org/obo/GO_0070324) (thyroid hormone binding), [GO:0004818](http://purl.obolibrary.org/obo/GO_0004818) (glutamate-tRNA ligase activity), [GO:0070325](http://purl.obolibrary.org/obo/GO_0070325) (lipoprotein particle receptor binding), [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process), [GO:0004817](http://purl.obolibrary.org/obo/GO_0004817) (cysteine-tRNA ligase activity), [GO:0004819](http://purl.obolibrary.org/obo/GO_0004819) (glutamine-tRNA ligase activity), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0007091](http://purl.obolibrary.org/obo/GO_0007091) (metaphase/anaphase transition of mitotic cell cycle), [GO:0032049](http://purl.obolibrary.org/obo/GO_0032049) (cardiolipin biosynthetic process), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0070327](http://purl.obolibrary.org/obo/GO_0070327) (thyroid hormone transport), [GO:0032040](http://purl.obolibrary.org/obo/GO_0032040) (small-subunit processome), [GO:0060993](http://purl.obolibrary.org/obo/GO_0060993) (kidney morphogenesis), [GO:0032042](http://purl.obolibrary.org/obo/GO_0032042) (mitochondrial DNA metabolic process), [GO:0060999](http://purl.obolibrary.org/obo/GO_0060999) (positive regulation of dendritic spine development), [GO:0060996](http://purl.obolibrary.org/obo/GO_0060996) (dendritic spine development), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0004821](http://purl.obolibrary.org/obo/GO_0004821) (histidine-tRNA ligase activity), [GO:0004820](http://purl.obolibrary.org/obo/GO_0004820) (glycine-tRNA ligase activity), [GO:0019074](http://purl.obolibrary.org/obo/GO_0019074) (viral RNA genome packaging), [GO:0004823](http://purl.obolibrary.org/obo/GO_0004823) (leucine-tRNA ligase activity), [GO:0004822](http://purl.obolibrary.org/obo/GO_0004822) (isoleucine-tRNA ligase activity), [GO:0004825](http://purl.obolibrary.org/obo/GO_0004825) (methionine-tRNA ligase activity), [GO:0004824](http://purl.obolibrary.org/obo/GO_0004824) (lysine-tRNA ligase activity), [GO:0004826](http://purl.obolibrary.org/obo/GO_0004826) (phenylalanine-tRNA ligase activity), [GO:0032036](http://purl.obolibrary.org/obo/GO_0032036) (myosin heavy chain binding), [GO:0034699](http://purl.obolibrary.org/obo/GO_0034699) (response to luteinizing hormone), [GO:0004829](http://purl.obolibrary.org/obo/GO_0004829) (threonine-tRNA ligase activity), [GO:0070314](http://purl.obolibrary.org/obo/GO_0070314) (G1 to G0 transition), [GO:0019079](http://purl.obolibrary.org/obo/GO_0019079) (viral genome replication), [GO:0004828](http://purl.obolibrary.org/obo/GO_0004828) (serine-tRNA ligase activity), [GO:0033365](http://purl.obolibrary.org/obo/GO_0033365) (protein localization to organelle), [GO:0032038](http://purl.obolibrary.org/obo/GO_0032038) (myosin II heavy chain binding), [GO:0070315](http://purl.obolibrary.org/obo/GO_0070315) (G1 to G0 transition involved in cell differentiation), [GO:0032039](http://purl.obolibrary.org/obo/GO_0032039) (integrator complex), [GO:0033364](http://purl.obolibrary.org/obo/GO_0033364) (mast cell secretory granule organization), [GO:0034695](http://purl.obolibrary.org/obo/GO_0034695) (response to prostaglandin E), [GO:0007076](http://purl.obolibrary.org/obo/GO_0007076) (mitotic chromosome condensation), [GO:0033363](http://purl.obolibrary.org/obo/GO_0033363) (secretory granule organization), [GO:0034694](http://purl.obolibrary.org/obo/GO_0034694) (response to prostaglandin), [GO:0007074](http://purl.obolibrary.org/obo/GO_0007074) (positive regulation of transcription involved in exit from mitosis, from RNA polymerase II promoter), [GO:0007079](http://purl.obolibrary.org/obo/GO_0007079) (mitotic chromosome movement towards spindle pole), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0044062](http://purl.obolibrary.org/obo/GO_0044062) (regulation of excretion), [GO:0044065](http://purl.obolibrary.org/obo/GO_0044065) (regulation of respiratory system process), [GO:0071674](http://purl.obolibrary.org/obo/GO_0071674) (mononuclear cell migration), [GO:0032025](http://purl.obolibrary.org/obo/GO_0032025) (response to cobalt ion), [GO:0071678](http://purl.obolibrary.org/obo/GO_0071678) (olfactory bulb axon guidance), [GO:0032026](http://purl.obolibrary.org/obo/GO_0032026) (response to magnesium ion), [GO:0019068](http://purl.obolibrary.org/obo/GO_0019068) (virion assembly), [GO:0032024](http://purl.obolibrary.org/obo/GO_0032024) (positive regulation of insulin secretion), [GO:0070345](http://purl.obolibrary.org/obo/GO_0070345) (negative regulation of fat cell proliferation), [GO:0032029](http://purl.obolibrary.org/obo/GO_0032029) (myosin tail binding), [GO:0032027](http://purl.obolibrary.org/obo/GO_0032027) (myosin light chain binding), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0007084](http://purl.obolibrary.org/obo/GO_0007084) (mitotic nuclear envelope reassembly), [GO:0033353](http://purl.obolibrary.org/obo/GO_0033353) (S-adenosylmethionine cycle), [GO:0007088](http://purl.obolibrary.org/obo/GO_0007088) (regulation of mitotic nuclear division), [GO:0007089](http://purl.obolibrary.org/obo/GO_0007089) (traversing start control point of mitotic cell cycle), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0004801](http://purl.obolibrary.org/obo/GO_0004801) (sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity), [GO:0019051](http://purl.obolibrary.org/obo/GO_0019051) (induction by virus of host apoptotic process), [GO:0071663](http://purl.obolibrary.org/obo/GO_0071663) (positive regulation of granzyme B production), [GO:0070330](http://purl.obolibrary.org/obo/GO_0070330) (aromatase activity), [GO:0004807](http://purl.obolibrary.org/obo/GO_0004807) (triose-phosphate isomerase activity), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0032012](http://purl.obolibrary.org/obo/GO_0032012) (regulation of ARF protein signal transduction), [GO:0071664](http://purl.obolibrary.org/obo/GO_0071664) (catenin-TCF7L2 complex), [GO:0033343](http://purl.obolibrary.org/obo/GO_0033343) (positive regulation of collagen binding), [GO:0007080](http://purl.obolibrary.org/obo/GO_0007080) (mitotic metaphase plate congression), [GO:0044070](http://purl.obolibrary.org/obo/GO_0044070) (regulation of anion transport), [GO:0032094](http://purl.obolibrary.org/obo/GO_0032094) (response to food), [GO:0032095](http://purl.obolibrary.org/obo/GO_0032095) (regulation of response to food), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0032098](http://purl.obolibrary.org/obo/GO_0032098) (regulation of appetite), [GO:0032099](http://purl.obolibrary.org/obo/GO_0032099) (negative regulation of appetite), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0032097](http://purl.obolibrary.org/obo/GO_0032097) (positive regulation of response to food), [GO:0045324](http://purl.obolibrary.org/obo/GO_0045324) (late endosome to vacuole transport), [GO:0060965](http://purl.obolibrary.org/obo/GO_0060965) (negative regulation of gene silencing by miRNA), [GO:0046655](http://purl.obolibrary.org/obo/GO_0046655) (folic acid metabolic process), [GO:0046656](http://purl.obolibrary.org/obo/GO_0046656) (folic acid biosynthetic process), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0045322](http://purl.obolibrary.org/obo/GO_0045322) (unmethylated CpG binding), [GO:0046654](http://purl.obolibrary.org/obo/GO_0046654) (tetrahydrofolate biosynthetic process), [GO:0060968](http://purl.obolibrary.org/obo/GO_0060968) (regulation of gene silencing), [GO:0004861](http://purl.obolibrary.org/obo/GO_0004861) (cyclin-dependent protein serine/threonine kinase inhibitor activity), [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding), [GO:0004860](http://purl.obolibrary.org/obo/GO_0004860) (protein kinase inhibitor activity), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0045329](http://purl.obolibrary.org/obo/GO_0045329) (carnitine biosynthetic process), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0046658](http://purl.obolibrary.org/obo/GO_0046658) (anchored component of plasma membrane), [GO:0004854](http://purl.obolibrary.org/obo/GO_0004854) (xanthine dehydrogenase activity), [GO:0004853](http://purl.obolibrary.org/obo/GO_0004853) (uroporphyrinogen decarboxylase activity), [GO:0004855](http://purl.obolibrary.org/obo/GO_0004855) (xanthine oxidase activity), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0046660](http://purl.obolibrary.org/obo/GO_0046660) (female sex differentiation), [GO:0046661](http://purl.obolibrary.org/obo/GO_0046661) (male sex differentiation), [GO:0004859](http://purl.obolibrary.org/obo/GO_0004859) (phospholipase inhibitor activity), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0015501](http://purl.obolibrary.org/obo/GO_0015501) (glutamate:sodium symporter activity), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0045335](http://purl.obolibrary.org/obo/GO_0045335) (phagocytic vesicle), [GO:0046666](http://purl.obolibrary.org/obo/GO_0046666) (retinal cell programmed cell death), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0045333](http://purl.obolibrary.org/obo/GO_0045333) (cellular respiration), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046668](http://purl.obolibrary.org/obo/GO_0046668) (regulation of retinal cell programmed cell death), [GO:1900746](http://purl.obolibrary.org/obo/GO_1900746) (regulation of vascular endothelial growth factor signaling pathway), [GO:1900745](http://purl.obolibrary.org/obo/GO_1900745) (positive regulation of p38MAPK cascade), [GO:0004865](http://purl.obolibrary.org/obo/GO_0004865) (protein serine/threonine phosphatase inhibitor activity), [GO:0004864](http://purl.obolibrary.org/obo/GO_0004864) (protein phosphatase inhibitor activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0060958](http://purl.obolibrary.org/obo/GO_0060958) (endocardial cell development), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0045340](http://purl.obolibrary.org/obo/GO_0045340) (mercury ion binding), [GO:0046671](http://purl.obolibrary.org/obo/GO_0046671) (negative regulation of retinal cell programmed cell death), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0032079](http://purl.obolibrary.org/obo/GO_0032079) (positive regulation of endodeoxyribonuclease activity), [GO:0071603](http://purl.obolibrary.org/obo/GO_0071603) (endothelial cell-cell adhesion), [GO:0071639](http://purl.obolibrary.org/obo/GO_0071639) (positive regulation of monocyte chemotactic protein-1 production), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0060982](http://purl.obolibrary.org/obo/GO_0060982) (coronary artery morphogenesis), [GO:0070309](http://purl.obolibrary.org/obo/GO_0070309) (lens fiber cell morphogenesis), [GO:0032077](http://purl.obolibrary.org/obo/GO_0032077) (positive regulation of deoxyribonuclease activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0046677](http://purl.obolibrary.org/obo/GO_0046677) (response to antibiotic), [GO:0060988](http://purl.obolibrary.org/obo/GO_0060988) (lipid tube assembly), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0045345](http://purl.obolibrary.org/obo/GO_0045345) (positive regulation of MHC class I biosynthetic process), [GO:0060983](http://purl.obolibrary.org/obo/GO_0060983) (epicardium-derived cardiac vascular smooth muscle cell differentiation), [GO:0045348](http://purl.obolibrary.org/obo/GO_0045348) (positive regulation of MHC class II biosynthetic process), [GO:1900748](http://purl.obolibrary.org/obo/GO_1900748) (positive regulation of vascular endothelial growth factor signaling pathway), [GO:0004832](http://purl.obolibrary.org/obo/GO_0004832) (valine-tRNA ligase activity), [GO:1900747](http://purl.obolibrary.org/obo/GO_1900747) (negative regulation of vascular endothelial growth factor signaling pathway), [GO:0004831](http://purl.obolibrary.org/obo/GO_0004831) (tyrosine-tRNA ligase activity), [GO:0004833](http://purl.obolibrary.org/obo/GO_0004833) (tryptophan 2,3-dioxygenase activity), [GO:0046684](http://purl.obolibrary.org/obo/GO_0046684) (response to pyrethroid), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0044020](http://purl.obolibrary.org/obo/GO_0044020) (histone methyltransferase activity (H4-R3 specific)), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0004838](http://purl.obolibrary.org/obo/GO_0004838) (L-tyrosine:2-oxoglutarate aminotransferase activity), [GO:0004839](http://purl.obolibrary.org/obo/GO_0004839) (ubiquitin activating enzyme activity), [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding), [GO:0070301](http://purl.obolibrary.org/obo/GO_0070301) (cellular response to hydrogen peroxide), [GO:0071632](http://purl.obolibrary.org/obo/GO_0071632) (optomotor response), [GO:0070306](http://purl.obolibrary.org/obo/GO_0070306) (lens fiber cell differentiation), [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development), [GO:0071635](http://purl.obolibrary.org/obo/GO_0071635) (negative regulation of transforming growth factor beta production), [GO:0016830](http://purl.obolibrary.org/obo/GO_0016830) (carbon-carbon lyase activity), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:0071636](http://purl.obolibrary.org/obo/GO_0071636) (positive regulation of transforming growth factor beta production), [GO:0070305](http://purl.obolibrary.org/obo/GO_0070305) (response to cGMP), [GO:0016810](http://purl.obolibrary.org/obo/GO_0016810) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds), [GO:0016811](http://purl.obolibrary.org/obo/GO_0016811) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides), [GO:0016812](http://purl.obolibrary.org/obo/GO_0016812) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides), [GO:0033391](http://purl.obolibrary.org/obo/GO_0033391) (chromatoid body), [GO:0032060](http://purl.obolibrary.org/obo/GO_0032060) (bleb assembly), [GO:0060971](http://purl.obolibrary.org/obo/GO_0060971) (embryonic heart tube left/right pattern formation), [GO:0071629](http://purl.obolibrary.org/obo/GO_0071629) (cytoplasm protein quality control by the ubiquitin-proteasome system), [GO:0016813](http://purl.obolibrary.org/obo/GO_0016813) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines), [GO:0016814](http://purl.obolibrary.org/obo/GO_0016814) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines), [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0016818](http://purl.obolibrary.org/obo/GO_0016818) (hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides), [GO:0046688](http://purl.obolibrary.org/obo/GO_0046688) (response to copper ion), [GO:0046689](http://purl.obolibrary.org/obo/GO_0046689) (response to mercury ion), [GO:0060977](http://purl.obolibrary.org/obo/GO_0060977) (coronary vasculature morphogenesis), [GO:0060978](http://purl.obolibrary.org/obo/GO_0060978) (angiogenesis involved in coronary vascular morphogenesis), [GO:0046686](http://purl.obolibrary.org/obo/GO_0046686) (response to cadmium ion), [GO:0044027](http://purl.obolibrary.org/obo/GO_0044027) (hypermethylation of CpG island), [GO:0060979](http://purl.obolibrary.org/obo/GO_0060979) (vasculogenesis involved in coronary vascular morphogenesis), [GO:0044026](http://purl.obolibrary.org/obo/GO_0044026) (DNA hypermethylation), [GO:0044029](http://purl.obolibrary.org/obo/GO_0044029) (hypomethylation of CpG island), [GO:0060972](http://purl.obolibrary.org/obo/GO_0060972) (left/right pattern formation), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0004852](http://purl.obolibrary.org/obo/GO_0004852) (uroporphyrinogen-III synthase activity), [GO:0045359](http://purl.obolibrary.org/obo/GO_0045359) (positive regulation of interferon-beta biosynthetic process), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0004843](http://purl.obolibrary.org/obo/GO_0004843) (thiol-dependent ubiquitin-specific protease activity), [GO:0046691](http://purl.obolibrary.org/obo/GO_0046691) (intracellular canaliculus), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0004844](http://purl.obolibrary.org/obo/GO_0004844) (uracil DNA N-glycosylase activity), [GO:0019098](http://purl.obolibrary.org/obo/GO_0019098) (reproductive behavior), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0071627](http://purl.obolibrary.org/obo/GO_0071627) (integral component of fungal-type vacuolar membrane), [GO:0015672](http://purl.obolibrary.org/obo/GO_0015672) (monovalent inorganic cation transport), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0015670](http://purl.obolibrary.org/obo/GO_0015670) (carbon dioxide transport), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0002360](http://purl.obolibrary.org/obo/GO_0002360) (T cell lineage commitment), [GO:0003691](http://purl.obolibrary.org/obo/GO_0003691) (double-stranded telomeric DNA binding), [GO:0002361](http://purl.obolibrary.org/obo/GO_0002361) (CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation), [GO:0003692](http://purl.obolibrary.org/obo/GO_0003692) (left-handed Z-DNA binding), [GO:0002362](http://purl.obolibrary.org/obo/GO_0002362) (CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment), [GO:0001026](http://purl.obolibrary.org/obo/GO_0001026) (TFIIIB-type transcription factor activity), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0001034](http://purl.obolibrary.org/obo/GO_0001034) (RNA polymerase III transcription factor activity, sequence-specific DNA binding), [GO:0002357](http://purl.obolibrary.org/obo/GO_0002357) (defense response to tumor cell), [GO:0002358](http://purl.obolibrary.org/obo/GO_0002358) (B cell homeostatic proliferation), [GO:0016997](http://purl.obolibrary.org/obo/GO_0016997) (alpha-sialidase activity), [GO:0016998](http://purl.obolibrary.org/obo/GO_0016998) (cell wall macromolecule catabolic process), [GO:0016999](http://purl.obolibrary.org/obo/GO_0016999) (antibiotic metabolic process), [GO:0015682](http://purl.obolibrary.org/obo/GO_0015682) (ferric iron transport), [GO:0002371](http://purl.obolibrary.org/obo/GO_0002371) (dendritic cell cytokine production), [GO:0002374](http://purl.obolibrary.org/obo/GO_0002374) (cytokine secretion involved in immune response), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0002377](http://purl.obolibrary.org/obo/GO_0002377) (immunoglobulin production), [GO:0001046](http://purl.obolibrary.org/obo/GO_0001046) (core promoter sequence-specific DNA binding), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0052629](http://purl.obolibrary.org/obo/GO_0052629) (phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity), [GO:0015679](http://purl.obolibrary.org/obo/GO_0015679) (plasma membrane copper ion transport), [GO:0015677](http://purl.obolibrary.org/obo/GO_0015677) (copper ion import), [GO:0015651](http://purl.obolibrary.org/obo/GO_0015651) (quaternary ammonium group transmembrane transporter activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0002344](http://purl.obolibrary.org/obo/GO_0002344) (B cell affinity maturation), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0004996](http://purl.obolibrary.org/obo/GO_0004996) (thyroid-stimulating hormone receptor activity), [GO:0001011](http://purl.obolibrary.org/obo/GO_0001011) (transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0004998](http://purl.obolibrary.org/obo/GO_0004998) (transferrin receptor activity), [GO:0051309](http://purl.obolibrary.org/obo/GO_0051309) (female meiosis chromosome separation), [GO:0016990](http://purl.obolibrary.org/obo/GO_0016990) (arginine deiminase activity), [GO:0016992](http://purl.obolibrary.org/obo/GO_0016992) (lipoate synthase activity), [GO:0051306](http://purl.obolibrary.org/obo/GO_0051306) (mitotic sister chromatid separation), [GO:0051303](http://purl.obolibrary.org/obo/GO_0051303) (establishment of chromosome localization), [GO:0051304](http://purl.obolibrary.org/obo/GO_0051304) (chromosome separation), [GO:0015662](http://purl.obolibrary.org/obo/GO_0015662) (ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism), [GO:0016979](http://purl.obolibrary.org/obo/GO_0016979) (lipoate-protein ligase activity), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0001018](http://purl.obolibrary.org/obo/GO_0001018) (mitochondrial promoter sequence-specific DNA binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003678](http://purl.obolibrary.org/obo/GO_0003678) (DNA helicase activity), [GO:0051310](http://purl.obolibrary.org/obo/GO_0051310) (metaphase plate congression), [GO:0051315](http://purl.obolibrary.org/obo/GO_0051315) (attachment of mitotic spindle microtubules to kinetochore), [GO:0039689](http://purl.obolibrary.org/obo/GO_0039689) (negative stranded viral RNA replication), [GO:0070481](http://purl.obolibrary.org/obo/GO_0070481) (nuclear-transcribed mRNA catabolic process, non-stop decay), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0001075](http://purl.obolibrary.org/obo/GO_0001075) (transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly), [GO:0070471](http://purl.obolibrary.org/obo/GO_0070471) (uterine smooth muscle contraction), [GO:0001089](http://purl.obolibrary.org/obo/GO_0001089) (transcription factor activity, TFIIF-class transcription factor binding), [GO:0001087](http://purl.obolibrary.org/obo/GO_0001087) (transcription factor activity, TFIIB-class binding), [GO:0070474](http://purl.obolibrary.org/obo/GO_0070474) (positive regulation of uterine smooth muscle contraction), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0070475](http://purl.obolibrary.org/obo/GO_0070475) (rRNA base methylation), [GO:0070478](http://purl.obolibrary.org/obo/GO_0070478) (nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay), [GO:0015698](http://purl.obolibrary.org/obo/GO_0015698) (inorganic anion transport), [GO:0015697](http://purl.obolibrary.org/obo/GO_0015697) (quaternary ammonium group transport), [GO:0015696](http://purl.obolibrary.org/obo/GO_0015696) (ammonium transport), [GO:0015695](http://purl.obolibrary.org/obo/GO_0015695) (organic cation transport), [GO:0015694](http://purl.obolibrary.org/obo/GO_0015694) (mercury ion transport), [GO:0015693](http://purl.obolibrary.org/obo/GO_0015693) (magnesium ion transport), [GO:0015691](http://purl.obolibrary.org/obo/GO_0015691) (cadmium ion transport), [GO:0002381](http://purl.obolibrary.org/obo/GO_0002381) (immunoglobulin production involved in immunoglobulin mediated immune response), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0002378](http://purl.obolibrary.org/obo/GO_0002378) (immunoglobulin biosynthetic process), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0070492](http://purl.obolibrary.org/obo/GO_0070492) (oligosaccharide binding), [GO:0001068](http://purl.obolibrary.org/obo/GO_0001068) (transcription regulatory region RNA binding), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0070495](http://purl.obolibrary.org/obo/GO_0070495) (negative regulation of thrombin-activated receptor signaling pathway), [GO:0070498](http://purl.obolibrary.org/obo/GO_0070498) (interleukin-1-mediated signaling pathway), [GO:0051371](http://purl.obolibrary.org/obo/GO_0051371) (muscle alpha-actinin binding), [GO:0008504](http://purl.obolibrary.org/obo/GO_0008504) (monoamine transmembrane transporter activity), [GO:1990130](http://purl.obolibrary.org/obo/GO_1990130) (GATOR1 complex), [GO:0008502](http://purl.obolibrary.org/obo/GO_0008502) (melatonin receptor activity), [GO:0010817](http://purl.obolibrary.org/obo/GO_0010817) (regulation of hormone levels), [GO:0009826](http://purl.obolibrary.org/obo/GO_0009826) (unidimensional cell growth), [GO:0052696](http://purl.obolibrary.org/obo/GO_0052696) (flavonoid glucuronidation), [GO:0051365](http://purl.obolibrary.org/obo/GO_0051365) (cellular response to potassium ion starvation), [GO:1990124](http://purl.obolibrary.org/obo/GO_1990124) (messenger ribonucleoprotein complex), [GO:0052697](http://purl.obolibrary.org/obo/GO_0052697) (xenobiotic glucuronidation), [GO:0010812](http://purl.obolibrary.org/obo/GO_0010812) (negative regulation of cell-substrate adhesion), [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity), [GO:0010815](http://purl.obolibrary.org/obo/GO_0010815) (bradykinin catabolic process), [GO:0010811](http://purl.obolibrary.org/obo/GO_0010811) (positive regulation of cell-substrate adhesion), [GO:0086002](http://purl.obolibrary.org/obo/GO_0086002) (cardiac muscle cell action potential involved in contraction), [GO:0086001](http://purl.obolibrary.org/obo/GO_0086001) (cardiac muscle cell action potential), [GO:0086006](http://purl.obolibrary.org/obo/GO_0086006) (voltage-gated sodium channel activity involved in cardiac muscle cell action potential), [GO:0086007](http://purl.obolibrary.org/obo/GO_0086007) (voltage-gated calcium channel activity involved in cardiac muscle cell action potential), [GO:0086004](http://purl.obolibrary.org/obo/GO_0086004) (regulation of cardiac muscle cell contraction), [GO:0086005](http://purl.obolibrary.org/obo/GO_0086005) (ventricular cardiac muscle cell action potential), [GO:0008511](http://purl.obolibrary.org/obo/GO_0008511) (sodium:potassium:chloride symporter activity), [GO:0008510](http://purl.obolibrary.org/obo/GO_0008510) (sodium:bicarbonate symporter activity), [GO:0086008](http://purl.obolibrary.org/obo/GO_0086008) (voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization), [GO:0051380](http://purl.obolibrary.org/obo/GO_0051380) (norepinephrine binding), [GO:0086009](http://purl.obolibrary.org/obo/GO_0086009) (membrane repolarization), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0050046](http://purl.obolibrary.org/obo/GO_0050046) (lathosterol oxidase activity), [GO:0051378](http://purl.obolibrary.org/obo/GO_0051378) (serotonin binding), [GO:0051379](http://purl.obolibrary.org/obo/GO_0051379) (epinephrine binding), [GO:0009838](http://purl.obolibrary.org/obo/GO_0009838) (abscission), [GO:0008507](http://purl.obolibrary.org/obo/GO_0008507) (sodium:iodide symporter activity), [GO:0008506](http://purl.obolibrary.org/obo/GO_0008506) (sucrose:proton symporter activity), [GO:0051377](http://purl.obolibrary.org/obo/GO_0051377) (mannose-ethanolamine phosphotransferase activity), [GO:0010824](http://purl.obolibrary.org/obo/GO_0010824) (regulation of centrosome duplication), [GO:1990138](http://purl.obolibrary.org/obo/GO_1990138) (neuron projection extension), [GO:0010826](http://purl.obolibrary.org/obo/GO_0010826) (negative regulation of centrosome duplication), [GO:0008509](http://purl.obolibrary.org/obo/GO_0008509) (anion transmembrane transporter activity), [GO:0051373](http://purl.obolibrary.org/obo/GO_0051373) (FATZ binding), [GO:0010825](http://purl.obolibrary.org/obo/GO_0010825) (positive regulation of centrosome duplication), [GO:0010820](http://purl.obolibrary.org/obo/GO_0010820) (positive regulation of T cell chemotaxis), [GO:0010822](http://purl.obolibrary.org/obo/GO_0010822) (positive regulation of mitochondrion organization), [GO:0010821](http://purl.obolibrary.org/obo/GO_0010821) (regulation of mitochondrion organization), [GO:0086010](http://purl.obolibrary.org/obo/GO_0086010) (membrane depolarization during action potential), [GO:1904231](http://purl.obolibrary.org/obo/GO_1904231) (positive regulation of succinate dehydrogenase activity), [GO:1904234](http://purl.obolibrary.org/obo/GO_1904234) (positive regulation of aconitate hydratase activity), [GO:1905564](http://purl.obolibrary.org/obo/GO_1905564) (positive regulation of vascular endothelial cell proliferation), [GO:0051393](http://purl.obolibrary.org/obo/GO_0051393) (alpha-actinin binding), [GO:1904238](http://purl.obolibrary.org/obo/GO_1904238) (pericyte cell differentiation), [GO:0050061](http://purl.obolibrary.org/obo/GO_0050061) (long-chain-aldehyde dehydrogenase activity), [GO:0051389](http://purl.obolibrary.org/obo/GO_0051389) (inactivation of MAPKK activity), [GO:1990145](http://purl.obolibrary.org/obo/GO_1990145) (maintenance of translational fidelity), [GO:0051387](http://purl.obolibrary.org/obo/GO_0051387) (negative regulation of neurotrophin TRK receptor signaling pathway), [GO:1990147](http://purl.obolibrary.org/obo/GO_1990147) (talin binding), [GO:0051388](http://purl.obolibrary.org/obo/GO_0051388) (positive regulation of neurotrophin TRK receptor signaling pathway), [GO:0001097](http://purl.obolibrary.org/obo/GO_0001097) (TFIIH-class transcription factor binding), [GO:0051386](http://purl.obolibrary.org/obo/GO_0051386) (regulation of neurotrophin TRK receptor signaling pathway), [GO:0001096](http://purl.obolibrary.org/obo/GO_0001096) (TFIIF-class transcription factor binding), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0001094](http://purl.obolibrary.org/obo/GO_0001094) (TFIID-class transcription factor binding), [GO:0001093](http://purl.obolibrary.org/obo/GO_0001093) (TFIIB-class transcription factor binding), [GO:1905574](http://purl.obolibrary.org/obo/GO_1905574) (ganglioside GM2 binding), [GO:1905573](http://purl.obolibrary.org/obo/GO_1905573) (ganglioside GM1 binding), [GO:1905572](http://purl.obolibrary.org/obo/GO_1905572) (ganglioside GM1 transport to membrane), [GO:1904247](http://purl.obolibrary.org/obo/GO_1904247) (positive regulation of polynucleotide adenylyltransferase activity), [GO:0039694](http://purl.obolibrary.org/obo/GO_0039694) (viral RNA genome replication), [GO:1905577](http://purl.obolibrary.org/obo/GO_1905577) (ganglioside GP1c binding), [GO:1905576](http://purl.obolibrary.org/obo/GO_1905576) (ganglioside GT1b binding), [GO:1905575](http://purl.obolibrary.org/obo/GO_1905575) (ganglioside GM3 binding), [GO:1904244](http://purl.obolibrary.org/obo/GO_1904244) (positive regulation of pancreatic trypsinogen secretion), [GO:1990163](http://purl.obolibrary.org/obo/GO_1990163) (ATP-dependent four-way junction helicase activity), [GO:1990165](http://purl.obolibrary.org/obo/GO_1990165) (single-strand break-containing DNA binding), [GO:0010808](http://purl.obolibrary.org/obo/GO_0010808) (positive regulation of synaptic vesicle priming), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0010804](http://purl.obolibrary.org/obo/GO_0010804) (negative regulation of tumor necrosis factor-mediated signaling pathway), [GO:0010800](http://purl.obolibrary.org/obo/GO_0010800) (positive regulation of peptidyl-threonine phosphorylation), [GO:0008540](http://purl.obolibrary.org/obo/GO_0008540) (proteasome regulatory particle, base subcomplex), [GO:0021516](http://purl.obolibrary.org/obo/GO_0021516) (dorsal spinal cord development), [GO:0022848](http://purl.obolibrary.org/obo/GO_0022848) (acetylcholine-gated cation-selective channel activity), [GO:0021517](http://purl.obolibrary.org/obo/GO_0021517) (ventral spinal cord development), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0021511](http://purl.obolibrary.org/obo/GO_0021511) (spinal cord patterning), [GO:0007212](http://purl.obolibrary.org/obo/GO_0007212) (dopamine receptor signaling pathway), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0007213](http://purl.obolibrary.org/obo/GO_0007213) (G-protein coupled acetylcholine receptor signaling pathway), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0007216](http://purl.obolibrary.org/obo/GO_0007216) (G-protein coupled glutamate receptor signaling pathway), [GO:0007217](http://purl.obolibrary.org/obo/GO_0007217) (tachykinin receptor signaling pathway), [GO:0022840](http://purl.obolibrary.org/obo/GO_0022840) (leak channel activity), [GO:0007214](http://purl.obolibrary.org/obo/GO_0007214) (gamma-aminobutyric acid signaling pathway), [GO:0021510](http://purl.obolibrary.org/obo/GO_0021510) (spinal cord development), [GO:0007215](http://purl.obolibrary.org/obo/GO_0007215) (glutamate receptor signaling pathway), [GO:0022841](http://purl.obolibrary.org/obo/GO_0022841) (potassium ion leak channel activity), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0007207](http://purl.obolibrary.org/obo/GO_0007207) (phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway), [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process), [GO:0052650](http://purl.obolibrary.org/obo/GO_0052650) (NADP-retinol dehydrogenase activity), [GO:0052651](http://purl.obolibrary.org/obo/GO_0052651) (monoacylglycerol catabolic process), [GO:0019201](http://purl.obolibrary.org/obo/GO_0019201) (nucleotide kinase activity), [GO:0019200](http://purl.obolibrary.org/obo/GO_0019200) (carbohydrate kinase activity), [GO:0019205](http://purl.obolibrary.org/obo/GO_0019205) (nucleobase-containing compound kinase activity), [GO:0019206](http://purl.obolibrary.org/obo/GO_0019206) (nucleoside kinase activity), [GO:0052657](http://purl.obolibrary.org/obo/GO_0052657) (guanine phosphoribosyltransferase activity), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0009881](http://purl.obolibrary.org/obo/GO_0009881) (photoreceptor activity), [GO:0007220](http://purl.obolibrary.org/obo/GO_0007220) (Notch receptor processing), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0021506](http://purl.obolibrary.org/obo/GO_0021506) (anterior neuropore closure), [GO:0007223](http://purl.obolibrary.org/obo/GO_0007223) (Wnt signaling pathway, calcium modulating pathway), [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021501](http://purl.obolibrary.org/obo/GO_0021501) (prechordal plate formation), [GO:1905515](http://purl.obolibrary.org/obo/GO_1905515) (non-motile cilium assembly), [GO:0022832](http://purl.obolibrary.org/obo/GO_0022832) (voltage-gated channel activity), [GO:1990182](http://purl.obolibrary.org/obo/GO_1990182) (exosomal secretion), [GO:0007221](http://purl.obolibrary.org/obo/GO_0007221) (positive regulation of transcription of Notch receptor target), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0007227](http://purl.obolibrary.org/obo/GO_0007227) (signal transduction downstream of smoothened), [GO:0007228](http://purl.obolibrary.org/obo/GO_0007228) (positive regulation of hh target transcription factor activity), [GO:0009889](http://purl.obolibrary.org/obo/GO_0009889) (regulation of biosynthetic process), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:1905517](http://purl.obolibrary.org/obo/GO_1905517) (macrophage migration), [GO:0007218](http://purl.obolibrary.org/obo/GO_0007218) (neuropeptide signaling pathway), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0010868](http://purl.obolibrary.org/obo/GO_0010868) (negative regulation of triglyceride biosynthetic process), [GO:0010867](http://purl.obolibrary.org/obo/GO_0010867) (positive regulation of triglyceride biosynthetic process), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0010866](http://purl.obolibrary.org/obo/GO_0010866) (regulation of triglyceride biosynthetic process), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0022829](http://purl.obolibrary.org/obo/GO_0022829) (wide pore channel activity), [GO:0022824](http://purl.obolibrary.org/obo/GO_0022824) (transmitter-gated ion channel activity), [GO:1990190](http://purl.obolibrary.org/obo/GO_1990190) (peptide-glutamate-N-acetyltransferase activity), [GO:0022820](http://purl.obolibrary.org/obo/GO_0022820) (potassium ion symporter activity), [GO:0008521](http://purl.obolibrary.org/obo/GO_0008521) (acetyl-CoA transmembrane transporter activity), [GO:0008526](http://purl.obolibrary.org/obo/GO_0008526) (phosphatidylinositol transporter activity), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0010839](http://purl.obolibrary.org/obo/GO_0010839) (negative regulation of keratinocyte proliferation), [GO:0008519](http://purl.obolibrary.org/obo/GO_0008519) (ammonium transmembrane transporter activity), [GO:1990189](http://purl.obolibrary.org/obo/GO_1990189) (peptide-serine-N-acetyltransferase activity), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0051346](http://purl.obolibrary.org/obo/GO_0051346) (negative regulation of hydrolase activity), [GO:0051343](http://purl.obolibrary.org/obo/GO_0051343) (positive regulation of cyclic-nucleotide phosphodiesterase activity), [GO:0008517](http://purl.obolibrary.org/obo/GO_0008517) (folic acid transmembrane transporter activity), [GO:0010835](http://purl.obolibrary.org/obo/GO_0010835) (regulation of protein ADP-ribosylation), [GO:0110008](http://purl.obolibrary.org/obo/GO_0110008) (ncRNA deadenylation), [GO:0010837](http://purl.obolibrary.org/obo/GO_0010837) (regulation of keratinocyte proliferation), [GO:0010836](http://purl.obolibrary.org/obo/GO_0010836) (negative regulation of protein ADP-ribosylation), [GO:0010830](http://purl.obolibrary.org/obo/GO_0010830) (regulation of myotube differentiation), [GO:0010833](http://purl.obolibrary.org/obo/GO_0010833) (telomere maintenance via telomere lengthening), [GO:0010832](http://purl.obolibrary.org/obo/GO_0010832) (negative regulation of myotube differentiation), [GO:0051349](http://purl.obolibrary.org/obo/GO_0051349) (positive regulation of lyase activity), [GO:0051348](http://purl.obolibrary.org/obo/GO_0051348) (negative regulation of transferase activity), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0007205](http://purl.obolibrary.org/obo/GO_0007205) (protein kinase C-activating G-protein coupled receptor signaling pathway), [GO:0008535](http://purl.obolibrary.org/obo/GO_0008535) (respiratory chain complex IV assembly), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0008534](http://purl.obolibrary.org/obo/GO_0008534) (oxidized purine nucleobase lesion DNA N-glycosylase activity), [GO:0008528](http://purl.obolibrary.org/obo/GO_0008528) (G-protein coupled peptide receptor activity), [GO:0051353](http://purl.obolibrary.org/obo/GO_0051353) (positive regulation of oxidoreductase activity), [GO:0051351](http://purl.obolibrary.org/obo/GO_0051351) (positive regulation of ligase activity), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0045409](http://purl.obolibrary.org/obo/GO_0045409) (negative regulation of interleukin-6 biosynthetic process), [GO:0007131](http://purl.obolibrary.org/obo/GO_0007131) (reciprocal meiotic recombination), [GO:1904179](http://purl.obolibrary.org/obo/GO_1904179) (positive regulation of adipose tissue development), [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0007130](http://purl.obolibrary.org/obo/GO_0007130) (synaptonemal complex assembly), [GO:0008460](http://purl.obolibrary.org/obo/GO_0008460) (dTDP-glucose 4,6-dehydratase activity), [GO:0009798](http://purl.obolibrary.org/obo/GO_0009798) (axis specification), [GO:0008466](http://purl.obolibrary.org/obo/GO_0008466) (glycogenin glucosyltransferase activity), [GO:0008465](http://purl.obolibrary.org/obo/GO_0008465) (glycerate dehydrogenase activity), [GO:0008469](http://purl.obolibrary.org/obo/GO_0008469) (histone-arginine N-methyltransferase activity), [GO:0110024](http://purl.obolibrary.org/obo/GO_0110024) (positive regulation of cardiac muscle myoblast proliferation), [GO:0008470](http://purl.obolibrary.org/obo/GO_0008470) (isovaleryl-CoA dehydrogenase activity), [GO:0010792](http://purl.obolibrary.org/obo/GO_0010792) (DNA double-strand break processing involved in repair via single-strand annealing), [GO:0008474](http://purl.obolibrary.org/obo/GO_0008474) (palmitoyl-(protein) hydrolase activity), [GO:0007143](http://purl.obolibrary.org/obo/GO_0007143) (female meiotic nuclear division), [GO:0007140](http://purl.obolibrary.org/obo/GO_0007140) (male meiotic nuclear division), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0007147](http://purl.obolibrary.org/obo/GO_0007147) (female meiosis II), [GO:0007144](http://purl.obolibrary.org/obo/GO_0007144) (female meiosis I), [GO:0045410](http://purl.obolibrary.org/obo/GO_0045410) (positive regulation of interleukin-6 biosynthetic process), [GO:0008475](http://purl.obolibrary.org/obo/GO_0008475) (procollagen-lysine 5-dioxygenase activity), [GO:1904184](http://purl.obolibrary.org/obo/GO_1904184) (positive regulation of pyruvate dehydrogenase activity), [GO:1904183](http://purl.obolibrary.org/obo/GO_1904183) (negative regulation of pyruvate dehydrogenase activity), [GO:1904199](http://purl.obolibrary.org/obo/GO_1904199) (positive regulation of regulation of vascular smooth muscle cell membrane depolarization), [GO:0045429](http://purl.obolibrary.org/obo/GO_0045429) (positive regulation of nitric oxide biosynthetic process), [GO:0008441](http://purl.obolibrary.org/obo/GO_0008441) (3'(2'),5'-bisphosphate nucleotidase activity), [GO:0046755](http://purl.obolibrary.org/obo/GO_0046755) (viral budding), [GO:0008443](http://purl.obolibrary.org/obo/GO_0008443) (phosphofructokinase activity), [GO:0008449](http://purl.obolibrary.org/obo/GO_0008449) (N-acetylglucosamine-6-sulfatase activity), [GO:0007117](http://purl.obolibrary.org/obo/GO_0007117) (budding cell bud growth), [GO:0007118](http://purl.obolibrary.org/obo/GO_0007118) (budding cell apical bud growth), [GO:0034728](http://purl.obolibrary.org/obo/GO_0034728) (nucleosome organization), [GO:0034727](http://purl.obolibrary.org/obo/GO_0034727) (piecemeal microautophagy of the nucleus), [GO:0010757](http://purl.obolibrary.org/obo/GO_0010757) (negative regulation of plasminogen activation), [GO:0019100](http://purl.obolibrary.org/obo/GO_0019100) (male germ-line sex determination), [GO:0010759](http://purl.obolibrary.org/obo/GO_0010759) (positive regulation of macrophage chemotaxis), [GO:0019102](http://purl.obolibrary.org/obo/GO_0019102) (male somatic sex determination), [GO:0034720](http://purl.obolibrary.org/obo/GO_0034720) (histone H3-K4 demethylation), [GO:0071711](http://purl.obolibrary.org/obo/GO_0071711) (basement membrane organization), [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination), [GO:0019104](http://purl.obolibrary.org/obo/GO_0019104) (DNA N-glycosylase activity), [GO:0071712](http://purl.obolibrary.org/obo/GO_0071712) (ER-associated misfolded protein catabolic process), [GO:0010751](http://purl.obolibrary.org/obo/GO_0010751) (negative regulation of nitric oxide mediated signal transduction), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0007124](http://purl.obolibrary.org/obo/GO_0007124) (pseudohyphal growth), [GO:0008456](http://purl.obolibrary.org/obo/GO_0008456) (alpha-N-acetylgalactosaminidase activity), [GO:0009786](http://purl.obolibrary.org/obo/GO_0009786) (regulation of asymmetric cell division), [GO:0008455](http://purl.obolibrary.org/obo/GO_0008455) (alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity), [GO:0008453](http://purl.obolibrary.org/obo/GO_0008453) (alanine-glyoxylate transaminase activity), [GO:0007128](http://purl.obolibrary.org/obo/GO_0007128) (meiotic prophase I), [GO:0008459](http://purl.obolibrary.org/obo/GO_0008459) (chondroitin 6-sulfotransferase activity), [GO:0007129](http://purl.obolibrary.org/obo/GO_0007129) (synapsis), [GO:0045437](http://purl.obolibrary.org/obo/GO_0045437) (uridine nucleosidase activity), [GO:1901925](http://purl.obolibrary.org/obo/GO_1901925) (negative regulation of protein import into nucleus during spindle assembly checkpoint), [GO:0007119](http://purl.obolibrary.org/obo/GO_0007119) (budding cell isotropic bud growth), [GO:0034719](http://purl.obolibrary.org/obo/GO_0034719) (SMN-Sm protein complex), [GO:0010765](http://purl.obolibrary.org/obo/GO_0010765) (positive regulation of sodium ion transport), [GO:0010766](http://purl.obolibrary.org/obo/GO_0010766) (negative regulation of sodium ion transport), [GO:0034713](http://purl.obolibrary.org/obo/GO_0034713) (type I transforming growth factor beta receptor binding), [GO:0010760](http://purl.obolibrary.org/obo/GO_0010760) (negative regulation of macrophage chemotaxis), [GO:0071704](http://purl.obolibrary.org/obo/GO_0071704) (organic substance metabolic process), [GO:0010763](http://purl.obolibrary.org/obo/GO_0010763) (positive regulation of fibroblast migration), [GO:0010762](http://purl.obolibrary.org/obo/GO_0010762) (regulation of fibroblast migration), [GO:0007171](http://purl.obolibrary.org/obo/GO_0007171) (activation of transmembrane receptor protein tyrosine kinase activity), [GO:0007175](http://purl.obolibrary.org/obo/GO_0007175) (negative regulation of epidermal growth factor-activated receptor activity), [GO:0007176](http://purl.obolibrary.org/obo/GO_0007176) (regulation of epidermal growth factor-activated receptor activity), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0051292](http://purl.obolibrary.org/obo/GO_0051292) (nuclear pore complex assembly), [GO:0051290](http://purl.obolibrary.org/obo/GO_0051290) (protein heterotetramerization), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0051286](http://purl.obolibrary.org/obo/GO_0051286) (cell tip), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0007182](http://purl.obolibrary.org/obo/GO_0007182) (common-partner SMAD protein phosphorylation), [GO:1905474](http://purl.obolibrary.org/obo/GO_1905474) (canonical Wnt signaling pathway involved in stem cell proliferation), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0007187](http://purl.obolibrary.org/obo/GO_0007187) (G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger), [GO:0007184](http://purl.obolibrary.org/obo/GO_0007184) (SMAD protein import into nucleus), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:2000969](http://purl.obolibrary.org/obo/GO_2000969) (positive regulation of AMPA receptor activity), [GO:0032119](http://purl.obolibrary.org/obo/GO_0032119) (sequestering of zinc ion), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0004904](http://purl.obolibrary.org/obo/GO_0004904) (interferon receptor activity), [GO:0004903](http://purl.obolibrary.org/obo/GO_0004903) (growth hormone receptor activity), [GO:0034774](http://purl.obolibrary.org/obo/GO_0034774) (secretory granule lumen), [GO:0019158](http://purl.obolibrary.org/obo/GO_0019158) (mannokinase activity), [GO:0034777](http://purl.obolibrary.org/obo/GO_0034777) (recycling endosome lumen), [GO:0032116](http://purl.obolibrary.org/obo/GO_0032116) (SMC loading complex), [GO:0046718](http://purl.obolibrary.org/obo/GO_0046718) (viral entry into host cell), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:0008484](http://purl.obolibrary.org/obo/GO_0008484) (sulfuric ester hydrolase activity), [GO:1904158](http://purl.obolibrary.org/obo/GO_1904158) (axonemal central apparatus assembly), [GO:0008483](http://purl.obolibrary.org/obo/GO_0008483) (transaminase activity), [GO:0034770](http://purl.obolibrary.org/obo/GO_0034770) (histone H4-K20 methylation), [GO:0008482](http://purl.obolibrary.org/obo/GO_0008482) (sulfite oxidase activity), [GO:0007157](http://purl.obolibrary.org/obo/GO_0007157) (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), [GO:0007158](http://purl.obolibrary.org/obo/GO_0007158) (neuron cell-cell adhesion), [GO:0008488](http://purl.obolibrary.org/obo/GO_0008488) (gamma-glutamyl carboxylase activity), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0046715](http://purl.obolibrary.org/obo/GO_0046715) (active borate transmembrane transporter activity), [GO:0007159](http://purl.obolibrary.org/obo/GO_0007159) (leukocyte cell-cell adhesion), [GO:0046713](http://purl.obolibrary.org/obo/GO_0046713) (borate transport), [GO:2000977](http://purl.obolibrary.org/obo/GO_2000977) (regulation of forebrain neuron differentiation), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:1990108](http://purl.obolibrary.org/obo/GO_1990108) (protein linear deubiquitination), [GO:2000973](http://purl.obolibrary.org/obo/GO_2000973) (regulation of pro-B cell differentiation), [GO:0032100](http://purl.obolibrary.org/obo/GO_0032100) (positive regulation of appetite), [GO:0010794](http://purl.obolibrary.org/obo/GO_0010794) (regulation of dolichol biosynthetic process), [GO:0010793](http://purl.obolibrary.org/obo/GO_0010793) (regulation of mRNA export from nucleus), [GO:0034767](http://purl.obolibrary.org/obo/GO_0034767) (positive regulation of ion transmembrane transport), [GO:1905480](http://purl.obolibrary.org/obo/GO_1905480) (positive regulation of glutamate-ammonia ligase activity), [GO:0010796](http://purl.obolibrary.org/obo/GO_0010796) (regulation of multivesicular body size), [GO:0010795](http://purl.obolibrary.org/obo/GO_0010795) (regulation of ubiquinone biosynthetic process), [GO:0034766](http://purl.obolibrary.org/obo/GO_0034766) (negative regulation of ion transmembrane transport), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0007164](http://purl.obolibrary.org/obo/GO_0007164) (establishment of tissue polarity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034760](http://purl.obolibrary.org/obo/GO_0034760) (negative regulation of iron ion transmembrane transport), [GO:0008495](http://purl.obolibrary.org/obo/GO_0008495) (protoheme IX farnesyltransferase activity), [GO:0008494](http://purl.obolibrary.org/obo/GO_0008494) (translation activator activity), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007168](http://purl.obolibrary.org/obo/GO_0007168) (receptor guanylyl cyclase signaling pathway), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0046722](http://purl.obolibrary.org/obo/GO_0046722) (lactic acid secretion), [GO:0008499](http://purl.obolibrary.org/obo/GO_0008499) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0007167](http://purl.obolibrary.org/obo/GO_0007167) (enzyme linked receptor protein signaling pathway), [GO:0046725](http://purl.obolibrary.org/obo/GO_0046725) (negative regulation by virus of viral protein levels in host cell), [GO:0046726](http://purl.obolibrary.org/obo/GO_0046726) (positive regulation by virus of viral protein levels in host cell), [GO:0046724](http://purl.obolibrary.org/obo/GO_0046724) (oxalic acid secretion), [GO:2000984](http://purl.obolibrary.org/obo/GO_2000984) (negative regulation of ATP citrate synthase activity), [GO:2000980](http://purl.obolibrary.org/obo/GO_2000980) (regulation of inner ear receptor cell differentiation), [GO:0034755](http://purl.obolibrary.org/obo/GO_0034755) (iron ion transmembrane transport), [GO:0016925](http://purl.obolibrary.org/obo/GO_0016925) (protein sumoylation), [GO:1901987](http://purl.obolibrary.org/obo/GO_1901987) (regulation of cell cycle phase transition), [GO:0004931](http://purl.obolibrary.org/obo/GO_0004931) (extracellularly ATP-gated cation channel activity), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0045494](http://purl.obolibrary.org/obo/GO_0045494) (photoreceptor cell maintenance), [GO:0004936](http://purl.obolibrary.org/obo/GO_0004936) (alpha-adrenergic receptor activity), [GO:0070445](http://purl.obolibrary.org/obo/GO_0070445) (regulation of oligodendrocyte progenitor proliferation), [GO:0004938](http://purl.obolibrary.org/obo/GO_0004938) (alpha2-adrenergic receptor activity), [GO:0033499](http://purl.obolibrary.org/obo/GO_0033499) (galactose catabolic process via UDP-galactose), [GO:0070444](http://purl.obolibrary.org/obo/GO_0070444) (oligodendrocyte progenitor proliferation), [GO:0070447](http://purl.obolibrary.org/obo/GO_0070447) (positive regulation of oligodendrocyte progenitor proliferation), [GO:0032160](http://purl.obolibrary.org/obo/GO_0032160) (septin filament array), [GO:0033490](http://purl.obolibrary.org/obo/GO_0033490) (cholesterol biosynthetic process via lathosterol), [GO:0016913](http://purl.obolibrary.org/obo/GO_0016913) (follicle-stimulating hormone activity), [GO:1901990](http://purl.obolibrary.org/obo/GO_1901990) (regulation of mitotic cell cycle phase transition), [GO:0032165](http://purl.obolibrary.org/obo/GO_0032165) (prospore septin filament array), [GO:1901992](http://purl.obolibrary.org/obo/GO_1901992) (positive regulation of mitotic cell cycle phase transition), [GO:0016918](http://purl.obolibrary.org/obo/GO_0016918) (retinal binding), [GO:0045499](http://purl.obolibrary.org/obo/GO_0045499) (chemorepellent activity), [GO:1901998](http://purl.obolibrary.org/obo/GO_1901998) (toxin transport), [GO:0004950](http://purl.obolibrary.org/obo/GO_0004950) (chemokine receptor activity), [GO:0004941](http://purl.obolibrary.org/obo/GO_0004941) (beta2-adrenergic receptor activity), [GO:0004945](http://purl.obolibrary.org/obo/GO_0004945) (angiotensin type II receptor activity), [GO:0070431](http://purl.obolibrary.org/obo/GO_0070431) (nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0004948](http://purl.obolibrary.org/obo/GO_0004948) (calcitonin receptor activity), [GO:0071763](http://purl.obolibrary.org/obo/GO_0071763) (nuclear membrane organization), [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0007194](http://purl.obolibrary.org/obo/GO_0007194) (negative regulation of adenylate cyclase activity), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0007197](http://purl.obolibrary.org/obo/GO_0007197) (adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway), [GO:0032154](http://purl.obolibrary.org/obo/GO_0032154) (cleavage furrow), [GO:0016903](http://purl.obolibrary.org/obo/GO_0016903) (oxidoreductase activity, acting on the aldehyde or oxo group of donors), [GO:0033484](http://purl.obolibrary.org/obo/GO_0033484) (nitric oxide homeostasis), [GO:0007196](http://purl.obolibrary.org/obo/GO_0007196) (adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway), [GO:0016907](http://purl.obolibrary.org/obo/GO_0016907) (G-protein coupled acetylcholine receptor activity), [GO:0007199](http://purl.obolibrary.org/obo/GO_0007199) (G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger), [GO:0071791](http://purl.obolibrary.org/obo/GO_0071791) (chemokine (C-C motif) ligand 5 binding), [GO:0004911](http://purl.obolibrary.org/obo/GO_0004911) (interleukin-2 receptor activity), [GO:0044183](http://purl.obolibrary.org/obo/GO_0044183) (protein binding involved in protein folding), [GO:0019187](http://purl.obolibrary.org/obo/GO_0019187) (beta-1,4-mannosyltransferase activity), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0070469](http://purl.obolibrary.org/obo/GO_0070469) (respiratory chain), [GO:0032142](http://purl.obolibrary.org/obo/GO_0032142) (single guanine insertion binding), [GO:0032143](http://purl.obolibrary.org/obo/GO_0032143) (single thymine insertion binding), [GO:0004920](http://purl.obolibrary.org/obo/GO_0004920) (interleukin-10 receptor activity), [GO:0044195](http://purl.obolibrary.org/obo/GO_0044195) (nucleoplasmic reticulum), [GO:0004921](http://purl.obolibrary.org/obo/GO_0004921) (interleukin-11 receptor activity), [GO:0044194](http://purl.obolibrary.org/obo/GO_0044194) (cytolytic granule), [GO:0004924](http://purl.obolibrary.org/obo/GO_0004924) (oncostatin-M receptor activity), [GO:0071782](http://purl.obolibrary.org/obo/GO_0071782) (endoplasmic reticulum tubular network), [GO:0004925](http://purl.obolibrary.org/obo/GO_0004925) (prolactin receptor activity), [GO:0032135](http://purl.obolibrary.org/obo/GO_0032135) (DNA insertion or deletion binding), [GO:0032133](http://purl.obolibrary.org/obo/GO_0032133) (chromosome passenger complex), [GO:0071786](http://purl.obolibrary.org/obo/GO_0071786) (endoplasmic reticulum tubular network organization), [GO:0032139](http://purl.obolibrary.org/obo/GO_0032139) (dinucleotide insertion or deletion binding), [GO:0070458](http://purl.obolibrary.org/obo/GO_0070458) (cellular detoxification of nitrogen compound), [GO:0032137](http://purl.obolibrary.org/obo/GO_0032137) (guanine/thymine mispair binding), [GO:0032138](http://purl.obolibrary.org/obo/GO_0032138) (single base insertion or deletion binding), [GO:0070409](http://purl.obolibrary.org/obo/GO_0070409) (carbamoyl phosphate biosynthetic process), [GO:0015631](http://purl.obolibrary.org/obo/GO_0015631) (tubulin binding), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0070407](http://purl.obolibrary.org/obo/GO_0070407) (oxidation-dependent protein catabolic process), [GO:0045445](http://purl.obolibrary.org/obo/GO_0045445) (myoblast differentiation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0045446](http://purl.obolibrary.org/obo/GO_0045446) (endothelial cell differentiation), [GO:0004980](http://purl.obolibrary.org/obo/GO_0004980) (melanocyte-stimulating hormone receptor activity), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0002320](http://purl.obolibrary.org/obo/GO_0002320) (lymphoid progenitor cell differentiation), [GO:0002314](http://purl.obolibrary.org/obo/GO_0002314) (germinal center B cell differentiation), [GO:0004977](http://purl.obolibrary.org/obo/GO_0004977) (melanocortin receptor activity), [GO:0002315](http://purl.obolibrary.org/obo/GO_0002315) (marginal zone B cell differentiation), [GO:0002316](http://purl.obolibrary.org/obo/GO_0002316) (follicular B cell differentiation), [GO:0045453](http://purl.obolibrary.org/obo/GO_0045453) (bone resorption), [GO:0004978](http://purl.obolibrary.org/obo/GO_0004978) (corticotropin receptor activity), [GO:0002318](http://purl.obolibrary.org/obo/GO_0002318) (myeloid progenitor cell differentiation), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding), [GO:0016971](http://purl.obolibrary.org/obo/GO_0016971) (flavin-linked sulfhydryl oxidase activity), [GO:0016972](http://purl.obolibrary.org/obo/GO_0016972) (thiol oxidase activity), [GO:0016973](http://purl.obolibrary.org/obo/GO_0016973) (poly(A)+ mRNA export from nucleus), [GO:0071734](http://purl.obolibrary.org/obo/GO_0071734) (biotin-[pyruvate-carboxylase] ligase activity), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0070404](http://purl.obolibrary.org/obo/GO_0070404) (NADH binding), [GO:0015643](http://purl.obolibrary.org/obo/GO_0015643) (toxic substance binding), [GO:0004991](http://purl.obolibrary.org/obo/GO_0004991) (parathyroid hormone receptor activity), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0046785](http://purl.obolibrary.org/obo/GO_0046785) (microtubule polymerization), [GO:0046786](http://purl.obolibrary.org/obo/GO_0046786) (viral replication complex formation and maintenance), [GO:0002331](http://purl.obolibrary.org/obo/GO_0002331) (pre-B cell allelic exclusion), [GO:1900625](http://purl.obolibrary.org/obo/GO_1900625) (positive regulation of monocyte aggregation), [GO:0004995](http://purl.obolibrary.org/obo/GO_0004995) (tachykinin receptor activity), [GO:0046790](http://purl.obolibrary.org/obo/GO_0046790) (virion binding), [GO:0002323](http://purl.obolibrary.org/obo/GO_0002323) (natural killer cell activation involved in immune response), [GO:0001002](http://purl.obolibrary.org/obo/GO_0001002) (RNA polymerase III type 1 promoter sequence-specific DNA binding), [GO:0004985](http://purl.obolibrary.org/obo/GO_0004985) (opioid receptor activity), [GO:0002326](http://purl.obolibrary.org/obo/GO_0002326) (B cell lineage commitment), [GO:0002327](http://purl.obolibrary.org/obo/GO_0002327) (immature B cell differentiation), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0002328](http://purl.obolibrary.org/obo/GO_0002328) (pro-B cell differentiation), [GO:0071726](http://purl.obolibrary.org/obo/GO_0071726) (cellular response to diacyl bacterial lipopeptide), [GO:0032194](http://purl.obolibrary.org/obo/GO_0032194) (ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate), [GO:1901962](http://purl.obolibrary.org/obo/GO_1901962) (S-adenosyl-L-methionine transmembrane transport), [GO:0004960](http://purl.obolibrary.org/obo/GO_0004960) (thromboxane receptor activity), [GO:1901964](http://purl.obolibrary.org/obo/GO_1901964) (positive regulation of cell proliferation involved in outflow tract morphogenesis), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0004961](http://purl.obolibrary.org/obo/GO_0004961) (thromboxane A2 receptor activity), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0044140](http://purl.obolibrary.org/obo/GO_0044140) (negative regulation of growth of symbiont on or near host surface), [GO:0004957](http://purl.obolibrary.org/obo/GO_0004957) (prostaglandin E receptor activity), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:0070427](http://purl.obolibrary.org/obo/GO_0070427) (nucleotide-binding oligomerization domain containing 1 signaling pathway), [GO:0032183](http://purl.obolibrary.org/obo/GO_0032183) (SUMO binding), [GO:0032180](http://purl.obolibrary.org/obo/GO_0032180) (ubiquinone biosynthetic process from tyrosine), [GO:0016934](http://purl.obolibrary.org/obo/GO_0016934) (extracellularly glycine-gated chloride channel activity), [GO:0032181](http://purl.obolibrary.org/obo/GO_0032181) (dinucleotide repeat insertion binding), [GO:0070419](http://purl.obolibrary.org/obo/GO_0070419) (nonhomologous end joining complex), [GO:0032186](http://purl.obolibrary.org/obo/GO_0032186) (cellular bud neck septin ring organization), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0016937](http://purl.obolibrary.org/obo/GO_0016937) (short-branched-chain-acyl-CoA dehydrogenase activity), [GO:0044146](http://purl.obolibrary.org/obo/GO_0044146) (negative regulation of growth of symbiont involved in interaction with host), [GO:0004971](http://purl.obolibrary.org/obo/GO_0004971) (AMPA glutamate receptor activity), [GO:0004970](http://purl.obolibrary.org/obo/GO_0004970) (ionotropic glutamate receptor activity), [GO:0004964](http://purl.obolibrary.org/obo/GO_0004964) (luteinizing hormone receptor activity), [GO:0004963](http://purl.obolibrary.org/obo/GO_0004963) (follicle-stimulating hormone receptor activity), [GO:0002302](http://purl.obolibrary.org/obo/GO_0002302) (CD8-positive, alpha-beta T cell differentiation involved in immune response), [GO:0004968](http://purl.obolibrary.org/obo/GO_0004968) (gonadotropin-releasing hormone receptor activity), [GO:0004967](http://purl.obolibrary.org/obo/GO_0004967) (glucagon receptor activity), [GO:0070412](http://purl.obolibrary.org/obo/GO_0070412) (R-SMAD binding), [GO:0070410](http://purl.obolibrary.org/obo/GO_0070410) (co-SMAD binding), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), [GO:0070411](http://purl.obolibrary.org/obo/GO_0070411) (I-SMAD binding), [GO:0070417](http://purl.obolibrary.org/obo/GO_0070417) (cellular response to cold), [GO:0016941](http://purl.obolibrary.org/obo/GO_0016941) (natriuretic peptide receptor activity), [GO:1990090](http://purl.obolibrary.org/obo/GO_1990090) (cellular response to nerve growth factor stimulus), [GO:1990091](http://purl.obolibrary.org/obo/GO_1990091) (sodium-dependent self proteolysis), [GO:0005991](http://purl.obolibrary.org/obo/GO_0005991) (trehalose metabolic process), [GO:0004663](http://purl.obolibrary.org/obo/GO_0004663) (Rab geranylgeranyltransferase activity), [GO:0003331](http://purl.obolibrary.org/obo/GO_0003331) (positive regulation of extracellular matrix constituent secretion), [GO:0002001](http://purl.obolibrary.org/obo/GO_0002001) (renin secretion into blood stream), [GO:0005993](http://purl.obolibrary.org/obo/GO_0005993) (trehalose catabolic process), [GO:0003333](http://purl.obolibrary.org/obo/GO_0003333) (amino acid transmembrane transport), [GO:0003334](http://purl.obolibrary.org/obo/GO_0003334) (keratinocyte development), [GO:0002003](http://purl.obolibrary.org/obo/GO_0002003) (angiotensin maturation), [GO:0004656](http://purl.obolibrary.org/obo/GO_0004656) (procollagen-proline 4-dioxygenase activity), [GO:0071493](http://purl.obolibrary.org/obo/GO_0071493) (cellular response to UV-B), [GO:0005987](http://purl.obolibrary.org/obo/GO_0005987) (sucrose catabolic process), [GO:0071494](http://purl.obolibrary.org/obo/GO_0071494) (cellular response to UV-C), [GO:0005986](http://purl.obolibrary.org/obo/GO_0005986) (sucrose biosynthetic process), [GO:0004655](http://purl.obolibrary.org/obo/GO_0004655) (porphobilinogen synthase activity), [GO:0005989](http://purl.obolibrary.org/obo/GO_0005989) (lactose biosynthetic process), [GO:0070160](http://purl.obolibrary.org/obo/GO_0070160) (occluding junction), [GO:0004658](http://purl.obolibrary.org/obo/GO_0004658) (propionyl-CoA carboxylase activity), [GO:0004657](http://purl.obolibrary.org/obo/GO_0004657) (proline dehydrogenase activity), [GO:0071492](http://purl.obolibrary.org/obo/GO_0071492) (cellular response to UV-A), [GO:0030947](http://purl.obolibrary.org/obo/GO_0030947) (regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0070166](http://purl.obolibrary.org/obo/GO_0070166) (enamel mineralization), [GO:0071498](http://purl.obolibrary.org/obo/GO_0071498) (cellular response to fluid shear stress), [GO:0004659](http://purl.obolibrary.org/obo/GO_0004659) (prenyltransferase activity), [GO:0030949](http://purl.obolibrary.org/obo/GO_0030949) (positive regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0030948](http://purl.obolibrary.org/obo/GO_0030948) (negative regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0071499](http://purl.obolibrary.org/obo/GO_0071499) (cellular response to laminar fluid shear stress), [GO:0070168](http://purl.obolibrary.org/obo/GO_0070168) (negative regulation of biomineral tissue development), [GO:0016651](http://purl.obolibrary.org/obo/GO_0016651) (oxidoreductase activity, acting on NAD(P)H), [GO:0016653](http://purl.obolibrary.org/obo/GO_0016653) (oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0015321](http://purl.obolibrary.org/obo/GO_0015321) (sodium-dependent phosphate transmembrane transporter activity), [GO:0016638](http://purl.obolibrary.org/obo/GO_0016638) (oxidoreductase activity, acting on the CH-NH2 group of donors), [GO:0016639](http://purl.obolibrary.org/obo/GO_0016639) (oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0003341](http://purl.obolibrary.org/obo/GO_0003341) (cilium movement), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0003342](http://purl.obolibrary.org/obo/GO_0003342) (proepicardium development), [GO:0003344](http://purl.obolibrary.org/obo/GO_0003344) (pericardium morphogenesis), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0071482](http://purl.obolibrary.org/obo/GO_0071482) (cellular response to light stimulus), [GO:0070152](http://purl.obolibrary.org/obo/GO_0070152) (mitochondrial isoleucyl-tRNA aminoacylation), [GO:0003337](http://purl.obolibrary.org/obo/GO_0003337) (mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0071480](http://purl.obolibrary.org/obo/GO_0071480) (cellular response to gamma radiation), [GO:0004668](http://purl.obolibrary.org/obo/GO_0004668) (protein-arginine deiminase activity), [GO:0070150](http://purl.obolibrary.org/obo/GO_0070150) (mitochondrial glycyl-tRNA aminoacylation), [GO:0071481](http://purl.obolibrary.org/obo/GO_0071481) (cellular response to X-ray), [GO:0003338](http://purl.obolibrary.org/obo/GO_0003338) (metanephros morphogenesis), [GO:0071486](http://purl.obolibrary.org/obo/GO_0071486) (cellular response to high light intensity), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0070156](http://purl.obolibrary.org/obo/GO_0070156) (mitochondrial phenylalanyl-tRNA aminoacylation), [GO:0070154](http://purl.obolibrary.org/obo/GO_0070154) (mitochondrial lysyl-tRNA aminoacylation), [GO:0070159](http://purl.obolibrary.org/obo/GO_0070159) (mitochondrial threonyl-tRNA aminoacylation), [GO:0015319](http://purl.obolibrary.org/obo/GO_0015319) (sodium:inorganic phosphate symporter activity), [GO:0070158](http://purl.obolibrary.org/obo/GO_0070158) (mitochondrial seryl-tRNA aminoacylation), [GO:0016641](http://purl.obolibrary.org/obo/GO_0016641) (oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor), [GO:0016624](http://purl.obolibrary.org/obo/GO_0016624) (oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0005971](http://purl.obolibrary.org/obo/GO_0005971) (ribonucleoside-diphosphate reductase complex), [GO:0003311](http://purl.obolibrary.org/obo/GO_0003311) (pancreatic D cell differentiation), [GO:0004643](http://purl.obolibrary.org/obo/GO_0004643) (phosphoribosylaminoimidazolecarboxamide formyltransferase activity), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0004634](http://purl.obolibrary.org/obo/GO_0004634) (phosphopyruvate hydratase activity), [GO:0070184](http://purl.obolibrary.org/obo/GO_0070184) (mitochondrial tyrosyl-tRNA aminoacylation), [GO:0003303](http://purl.obolibrary.org/obo/GO_0003303) (BMP signaling pathway involved in heart jogging), [GO:0005964](http://purl.obolibrary.org/obo/GO_0005964) (phosphorylase kinase complex), [GO:0005967](http://purl.obolibrary.org/obo/GO_0005967) (mitochondrial pyruvate dehydrogenase complex), [GO:0070182](http://purl.obolibrary.org/obo/GO_0070182) (DNA polymerase binding), [GO:0003305](http://purl.obolibrary.org/obo/GO_0003305) (cell migration involved in heart jogging), [GO:0003306](http://purl.obolibrary.org/obo/GO_0003306) (Wnt signaling pathway involved in heart development), [GO:0005968](http://purl.obolibrary.org/obo/GO_0005968) (Rab-protein geranylgeranyltransferase complex), [GO:0003308](http://purl.obolibrary.org/obo/GO_0003308) (negative regulation of Wnt signaling pathway involved in heart development), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0070187](http://purl.obolibrary.org/obo/GO_0070187) (shelterin complex), [GO:0033194](http://purl.obolibrary.org/obo/GO_0033194) (response to hydroperoxide), [GO:0015301](http://purl.obolibrary.org/obo/GO_0015301) (anion:anion antiporter activity), [GO:0016614](http://purl.obolibrary.org/obo/GO_0016614) (oxidoreductase activity, acting on CH-OH group of donors), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0033198](http://purl.obolibrary.org/obo/GO_0033198) (response to ATP), [GO:0033197](http://purl.obolibrary.org/obo/GO_0033197) (response to vitamin E), [GO:0016618](http://purl.obolibrary.org/obo/GO_0016618) (hydroxypyruvate reductase activity), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0005980](http://purl.obolibrary.org/obo/GO_0005980) (glycogen catabolic process), [GO:0004652](http://purl.obolibrary.org/obo/GO_0004652) (polynucleotide adenylyltransferase activity), [GO:0070181](http://purl.obolibrary.org/obo/GO_0070181) (small ribosomal subunit rRNA binding), [GO:0003322](http://purl.obolibrary.org/obo/GO_0003322) (pancreatic A cell development), [GO:0004654](http://purl.obolibrary.org/obo/GO_0004654) (polyribonucleotide nucleotidyltransferase activity), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0004653](http://purl.obolibrary.org/obo/GO_0004653) (polypeptide N-acetylgalactosaminyltransferase activity), [GO:0003313](http://purl.obolibrary.org/obo/GO_0003313) (heart rudiment development), [GO:0030910](http://purl.obolibrary.org/obo/GO_0030910) (olfactory placode formation), [GO:0070173](http://purl.obolibrary.org/obo/GO_0070173) (regulation of enamel mineralization), [GO:0004645](http://purl.obolibrary.org/obo/GO_0004645) (phosphorylase activity), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003314](http://purl.obolibrary.org/obo/GO_0003314) (heart rudiment morphogenesis), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0003315](http://purl.obolibrary.org/obo/GO_0003315) (heart rudiment formation), [GO:0004647](http://purl.obolibrary.org/obo/GO_0004647) (phosphoserine phosphatase activity), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0070172](http://purl.obolibrary.org/obo/GO_0070172) (positive regulation of tooth mineralization), [GO:0030911](http://purl.obolibrary.org/obo/GO_0030911) (TPR domain binding), [GO:0005979](http://purl.obolibrary.org/obo/GO_0005979) (regulation of glycogen biosynthetic process), [GO:0003318](http://purl.obolibrary.org/obo/GO_0003318) (cell migration to the midline involved in heart development), [GO:0004648](http://purl.obolibrary.org/obo/GO_0004648) (O-phospho-L-serine:2-oxoglutarate aminotransferase activity), [GO:0030913](http://purl.obolibrary.org/obo/GO_0030913) (paranodal junction assembly), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0030915](http://purl.obolibrary.org/obo/GO_0030915) (Smc5-Smc6 complex), [GO:0016620](http://purl.obolibrary.org/obo/GO_0016620) (oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor), [GO:0014025](http://purl.obolibrary.org/obo/GO_0014025) (neural keel formation), [GO:0003370](http://purl.obolibrary.org/obo/GO_0003370) (cell-cell adhesion involved in mesendodermal cell migration), [GO:0015350](http://purl.obolibrary.org/obo/GO_0015350) (methotrexate transmembrane transporter activity), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0045168](http://purl.obolibrary.org/obo/GO_0045168) (cell-cell signaling involved in cell fate commitment), [GO:0002042](http://purl.obolibrary.org/obo/GO_0002042) (cell migration involved in sprouting angiogenesis), [GO:0002043](http://purl.obolibrary.org/obo/GO_0002043) (blood vessel endothelial cell proliferation involved in sprouting angiogenesis), [GO:0003374](http://purl.obolibrary.org/obo/GO_0003374) (dynamin family protein polymerization involved in mitochondrial fission), [GO:0002044](http://purl.obolibrary.org/obo/GO_0002044) (blood vessel endothelial cell migration involved in intussusceptive angiogenesis), [GO:0003376](http://purl.obolibrary.org/obo/GO_0003376) (sphingosine-1-phosphate signaling pathway), [GO:0002046](http://purl.obolibrary.org/obo/GO_0002046) (opsin binding), [GO:0004699](http://purl.obolibrary.org/obo/GO_0004699) (calcium-independent protein kinase C activity), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0045178](http://purl.obolibrary.org/obo/GO_0045178) (basal part of cell), [GO:0071454](http://purl.obolibrary.org/obo/GO_0071454) (cellular response to anoxia), [GO:0070121](http://purl.obolibrary.org/obo/GO_0070121) (Kupffer's vesicle development), [GO:0045176](http://purl.obolibrary.org/obo/GO_0045176) (apical protein localization), [GO:0070126](http://purl.obolibrary.org/obo/GO_0070126) (mitochondrial translational termination), [GO:0070127](http://purl.obolibrary.org/obo/GO_0070127) (tRNA aminoacylation for mitochondrial protein translation), [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0070125](http://purl.obolibrary.org/obo/GO_0070125) (mitochondrial translational elongation), [GO:0030983](http://purl.obolibrary.org/obo/GO_0030983) (mismatched DNA binding), [GO:0015349](http://purl.obolibrary.org/obo/GO_0015349) (thyroid hormone transmembrane transporter activity), [GO:0071459](http://purl.obolibrary.org/obo/GO_0071459) (protein localization to chromosome, centromeric region), [GO:0014016](http://purl.obolibrary.org/obo/GO_0014016) (neuroblast differentiation), [GO:0015347](http://purl.obolibrary.org/obo/GO_0015347) (sodium-independent organic anion transmembrane transporter activity), [GO:0070129](http://purl.obolibrary.org/obo/GO_0070129) (regulation of mitochondrial translation), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0014036](http://purl.obolibrary.org/obo/GO_0014036) (neural crest cell fate specification), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0002051](http://purl.obolibrary.org/obo/GO_0002051) (osteoblast fate commitment), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0002055](http://purl.obolibrary.org/obo/GO_0002055) (adenine binding), [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding), [GO:0045184](http://purl.obolibrary.org/obo/GO_0045184) (establishment of protein localization), [GO:0003379](http://purl.obolibrary.org/obo/GO_0003379) (establishment of cell polarity involved in gastrulation cell migration), [GO:0030976](http://purl.obolibrary.org/obo/GO_0030976) (thiamine pyrophosphate binding), [GO:0030975](http://purl.obolibrary.org/obo/GO_0030975) (thiamine binding), [GO:0045182](http://purl.obolibrary.org/obo/GO_0045182) (translation regulator activity), [GO:0071442](http://purl.obolibrary.org/obo/GO_0071442) (positive regulation of histone H3-K14 acetylation), [GO:0071440](http://purl.obolibrary.org/obo/GO_0071440) (regulation of histone H3-K14 acetylation), [GO:0045187](http://purl.obolibrary.org/obo/GO_0045187) (regulation of circadian sleep/wake cycle, sleep), [GO:0042908](http://purl.obolibrary.org/obo/GO_0042908) (xenobiotic transport), [GO:0071447](http://purl.obolibrary.org/obo/GO_0071447) (cellular response to hydroperoxide), [GO:0030970](http://purl.obolibrary.org/obo/GO_0030970) (retrograde protein transport, ER to cytosol), [GO:0016684](http://purl.obolibrary.org/obo/GO_0016684) (oxidoreductase activity, acting on peroxide as acceptor), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0030974](http://purl.obolibrary.org/obo/GO_0030974) (thiamine pyrophosphate transmembrane transport), [GO:0014028](http://purl.obolibrary.org/obo/GO_0014028) (notochord formation), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0016668](http://purl.obolibrary.org/obo/GO_0016668) (oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor), [GO:0014002](http://purl.obolibrary.org/obo/GO_0014002) (astrocyte development), [GO:0003350](http://purl.obolibrary.org/obo/GO_0003350) (pulmonary myocardium development), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0004683](http://purl.obolibrary.org/obo/GO_0004683) (calmodulin-dependent protein kinase activity), [GO:0003351](http://purl.obolibrary.org/obo/GO_0003351) (epithelial cilium movement), [GO:0002021](http://purl.obolibrary.org/obo/GO_0002021) (response to dietary excess), [GO:0003352](http://purl.obolibrary.org/obo/GO_0003352) (regulation of cilium movement), [GO:0002024](http://purl.obolibrary.org/obo/GO_0002024) (diet induced thermogenesis), [GO:0002025](http://purl.obolibrary.org/obo/GO_0002025) (norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0003356](http://purl.obolibrary.org/obo/GO_0003356) (regulation of cilium beat frequency), [GO:0070141](http://purl.obolibrary.org/obo/GO_0070141) (response to UV-A), [GO:0003347](http://purl.obolibrary.org/obo/GO_0003347) (epicardial cell to mesenchymal cell transition), [GO:0071472](http://purl.obolibrary.org/obo/GO_0071472) (cellular response to salt stress), [GO:0002016](http://purl.obolibrary.org/obo/GO_0002016) (regulation of blood volume by renin-angiotensin), [GO:0004677](http://purl.obolibrary.org/obo/GO_0004677) (DNA-dependent protein kinase activity), [GO:0002017](http://purl.obolibrary.org/obo/GO_0002017) (regulation of blood volume by renal aldosterone), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0004679](http://purl.obolibrary.org/obo/GO_0004679) (AMP-activated protein kinase activity), [GO:0002018](http://purl.obolibrary.org/obo/GO_0002018) (renin-angiotensin regulation of aldosterone production), [GO:0003349](http://purl.obolibrary.org/obo/GO_0003349) (epicardium-derived cardiac endothelial cell differentiation), [GO:0002019](http://purl.obolibrary.org/obo/GO_0002019) (regulation of renal output by angiotensin), [GO:0071475](http://purl.obolibrary.org/obo/GO_0071475) (cellular hyperosmotic salinity response), [GO:0070144](http://purl.obolibrary.org/obo/GO_0070144) (mitochondrial arginyl-tRNA aminoacylation), [GO:0071476](http://purl.obolibrary.org/obo/GO_0071476) (cellular hypotonic response), [GO:0030968](http://purl.obolibrary.org/obo/GO_0030968) (endoplasmic reticulum unfolded protein response), [GO:0070145](http://purl.obolibrary.org/obo/GO_0070145) (mitochondrial asparaginyl-tRNA aminoacylation), [GO:0045197](http://purl.obolibrary.org/obo/GO_0045197) (establishment or maintenance of epithelial cell apical/basal polarity), [GO:0045198](http://purl.obolibrary.org/obo/GO_0045198) (establishment of epithelial cell apical/basal polarity), [GO:0070143](http://purl.obolibrary.org/obo/GO_0070143) (mitochondrial alanyl-tRNA aminoacylation), [GO:0071474](http://purl.obolibrary.org/obo/GO_0071474) (cellular hyperosmotic response), [GO:0071479](http://purl.obolibrary.org/obo/GO_0071479) (cellular response to ionizing radiation), [GO:0070149](http://purl.obolibrary.org/obo/GO_0070149) (mitochondrial glutamyl-tRNA aminoacylation), [GO:0016671](http://purl.obolibrary.org/obo/GO_0016671) (oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor), [GO:0071477](http://purl.obolibrary.org/obo/GO_0071477) (cellular hypotonic salinity response), [GO:0070146](http://purl.obolibrary.org/obo/GO_0070146) (mitochondrial aspartyl-tRNA aminoacylation), [GO:0030961](http://purl.obolibrary.org/obo/GO_0030961) (peptidyl-arginine hydroxylation), [GO:0045190](http://purl.obolibrary.org/obo/GO_0045190) (isotype switching), [GO:0014015](http://purl.obolibrary.org/obo/GO_0014015) (positive regulation of gliogenesis), [GO:0042921](http://purl.obolibrary.org/obo/GO_0042921) (glucocorticoid receptor signaling pathway), [GO:0014014](http://purl.obolibrary.org/obo/GO_0014014) (negative regulation of gliogenesis), [GO:0014013](http://purl.obolibrary.org/obo/GO_0014013) (regulation of gliogenesis), [GO:0042923](http://purl.obolibrary.org/obo/GO_0042923) (neuropeptide binding), [GO:0014012](http://purl.obolibrary.org/obo/GO_0014012) (peripheral nervous system axon regeneration), [GO:0014010](http://purl.obolibrary.org/obo/GO_0014010) (Schwann cell proliferation), [GO:0004691](http://purl.obolibrary.org/obo/GO_0004691) (cAMP-dependent protein kinase activity), [GO:0004694](http://purl.obolibrary.org/obo/GO_0004694) (eukaryotic translation initiation factor 2alpha kinase activity), [GO:0002032](http://purl.obolibrary.org/obo/GO_0002032) (desensitization of G-protein coupled receptor protein signaling pathway by arrestin), [GO:0004693](http://purl.obolibrary.org/obo/GO_0004693) (cyclin-dependent protein serine/threonine kinase activity), [GO:0002033](http://purl.obolibrary.org/obo/GO_0002033) (angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0002034](http://purl.obolibrary.org/obo/GO_0002034) (regulation of blood vessel diameter by renin-angiotensin), [GO:0002035](http://purl.obolibrary.org/obo/GO_0002035) (brain renin-angiotensin system), [GO:0004698](http://purl.obolibrary.org/obo/GO_0004698) (calcium-dependent protein kinase C activity), [GO:0004697](http://purl.obolibrary.org/obo/GO_0004697) (protein kinase C activity), [GO:0002026](http://purl.obolibrary.org/obo/GO_0002026) (regulation of the force of heart contraction), [GO:0004689](http://purl.obolibrary.org/obo/GO_0004689) (phosphorylase kinase activity), [GO:0003357](http://purl.obolibrary.org/obo/GO_0003357) (noradrenergic neuron differentiation), [GO:0030954](http://purl.obolibrary.org/obo/GO_0030954) (astral microtubule nucleation), [GO:0071460](http://purl.obolibrary.org/obo/GO_0071460) (cellular response to cell-matrix adhesion), [GO:0002027](http://purl.obolibrary.org/obo/GO_0002027) (regulation of heart rate), [GO:0003358](http://purl.obolibrary.org/obo/GO_0003358) (noradrenergic neuron development), [GO:0030953](http://purl.obolibrary.org/obo/GO_0030953) (astral microtubule organization), [GO:0003359](http://purl.obolibrary.org/obo/GO_0003359) (noradrenergic neuron fate commitment), [GO:0002028](http://purl.obolibrary.org/obo/GO_0002028) (regulation of sodium ion transport), [GO:0030955](http://purl.obolibrary.org/obo/GO_0030955) (potassium ion binding), [GO:0071465](http://purl.obolibrary.org/obo/GO_0071465) (cellular response to desiccation), [GO:0030957](http://purl.obolibrary.org/obo/GO_0030957) (Tat protein binding), [GO:0070131](http://purl.obolibrary.org/obo/GO_0070131) (positive regulation of mitochondrial translation), [GO:0071468](http://purl.obolibrary.org/obo/GO_0071468) (cellular response to acidic pH), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016661](http://purl.obolibrary.org/obo/GO_0016661) (oxidoreductase activity, acting on other nitrogenous compounds as donors), [GO:0071467](http://purl.obolibrary.org/obo/GO_0071467) (cellular response to pH), [GO:0014009](http://purl.obolibrary.org/obo/GO_0014009) (glial cell proliferation), [GO:0030950](http://purl.obolibrary.org/obo/GO_0030950) (establishment or maintenance of actin cytoskeleton polarity), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), [GO:0038037](http://purl.obolibrary.org/obo/GO_0038037) (G-protein coupled receptor dimeric complex), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0038036](http://purl.obolibrary.org/obo/GO_0038036) (sphingosine-1-phosphate receptor activity), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0014067](http://purl.obolibrary.org/obo/GO_0014067) (negative regulation of phosphatidylinositol 3-kinase signaling), [GO:0090611](http://purl.obolibrary.org/obo/GO_0090611) (ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway), [GO:0038038](http://purl.obolibrary.org/obo/GO_0038038) (G-protein coupled receptor homodimeric complex), [GO:0038033](http://purl.obolibrary.org/obo/GO_0038033) (positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway), [GO:0002080](http://purl.obolibrary.org/obo/GO_0002080) (acrosomal membrane), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0002081](http://purl.obolibrary.org/obo/GO_0002081) (outer acrosomal membrane), [GO:0002082](http://purl.obolibrary.org/obo/GO_0002082) (regulation of oxidative phosphorylation), [GO:0002083](http://purl.obolibrary.org/obo/GO_0002083) (4-hydroxybenzoate decaprenyltransferase activity), [GO:0002084](http://purl.obolibrary.org/obo/GO_0002084) (protein depalmitoylation), [GO:0014061](http://purl.obolibrary.org/obo/GO_0014061) (regulation of norepinephrine secretion), [GO:0002085](http://purl.obolibrary.org/obo/GO_0002085) (inhibition of neuroepithelial cell differentiation), [GO:0038031](http://purl.obolibrary.org/obo/GO_0038031) (non-canonical Wnt signaling pathway via JNK cascade), [GO:0002086](http://purl.obolibrary.org/obo/GO_0002086) (diaphragm contraction), [GO:1905426](http://purl.obolibrary.org/obo/GO_1905426) (positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation), [GO:0002087](http://purl.obolibrary.org/obo/GO_0002087) (regulation of respiratory gaseous exchange by neurological system process), [GO:0038030](http://purl.obolibrary.org/obo/GO_0038030) (non-canonical Wnt signaling pathway via MAPK cascade), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:1990001](http://purl.obolibrary.org/obo/GO_1990001) (inhibition of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0051005](http://purl.obolibrary.org/obo/GO_0051005) (negative regulation of lipoprotein lipase activity), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0051001](http://purl.obolibrary.org/obo/GO_0051001) (negative regulation of nitric-oxide synthase activity), [GO:1990008](http://purl.obolibrary.org/obo/GO_1990008) (neurosecretory vesicle), [GO:1990009](http://purl.obolibrary.org/obo/GO_1990009) (retinal cell apoptotic process), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:0038026](http://purl.obolibrary.org/obo/GO_0038026) (reelin-mediated signaling pathway), [GO:1904100](http://purl.obolibrary.org/obo/GO_1904100) (positive regulation of protein O-linked glycosylation), [GO:1905431](http://purl.obolibrary.org/obo/GO_1905431) (microcystin transport), [GO:0038028](http://purl.obolibrary.org/obo/GO_0038028) (insulin receptor signaling pathway via phosphatidylinositol 3-kinase), [GO:0002090](http://purl.obolibrary.org/obo/GO_0002090) (regulation of receptor internalization), [GO:0002091](http://purl.obolibrary.org/obo/GO_0002091) (negative regulation of receptor internalization), [GO:0002092](http://purl.obolibrary.org/obo/GO_0002092) (positive regulation of receptor internalization), [GO:0038021](http://purl.obolibrary.org/obo/GO_0038021) (leptin receptor activity), [GO:0002093](http://purl.obolibrary.org/obo/GO_0002093) (auditory receptor cell morphogenesis), [GO:0002094](http://purl.obolibrary.org/obo/GO_0002094) (polyprenyltransferase activity), [GO:1904106](http://purl.obolibrary.org/obo/GO_1904106) (protein localization to microvillus), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0002098](http://purl.obolibrary.org/obo/GO_0002098) (tRNA wobble uridine modification), [GO:1904109](http://purl.obolibrary.org/obo/GO_1904109) (positive regulation of cholesterol import), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0051016](http://purl.obolibrary.org/obo/GO_0051016) (barbed-end actin filament capping), [GO:0051013](http://purl.obolibrary.org/obo/GO_0051013) (microtubule severing), [GO:0051014](http://purl.obolibrary.org/obo/GO_0051014) (actin filament severing), [GO:0051011](http://purl.obolibrary.org/obo/GO_0051011) (microtubule minus-end binding), [GO:0051010](http://purl.obolibrary.org/obo/GO_0051010) (microtubule plus-end binding), [GO:0051019](http://purl.obolibrary.org/obo/GO_0051019) (mitogen-activated protein kinase binding), [GO:0038018](http://purl.obolibrary.org/obo/GO_0038018) (Wnt receptor catabolic process), [GO:0051017](http://purl.obolibrary.org/obo/GO_0051017) (actin filament bundle assembly), [GO:0051018](http://purl.obolibrary.org/obo/GO_0051018) (protein kinase A binding), [GO:0015379](http://purl.obolibrary.org/obo/GO_0015379) (potassium:chloride symporter activity), [GO:0014047](http://purl.obolibrary.org/obo/GO_0014047) (glutamate secretion), [GO:0015378](http://purl.obolibrary.org/obo/GO_0015378) (sodium:chloride symporter activity), [GO:0015377](http://purl.obolibrary.org/obo/GO_0015377) (cation:chloride symporter activity), [GO:0014045](http://purl.obolibrary.org/obo/GO_0014045) (establishment of endothelial blood-brain barrier), [GO:0038016](http://purl.obolibrary.org/obo/GO_0038016) (insulin receptor internalization), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0015375](http://purl.obolibrary.org/obo/GO_0015375) (glycine:sodium symporter activity), [GO:0014043](http://purl.obolibrary.org/obo/GO_0014043) (negative regulation of neuron maturation), [GO:0014042](http://purl.obolibrary.org/obo/GO_0014042) (positive regulation of neuron maturation), [GO:0002060](http://purl.obolibrary.org/obo/GO_0002060) (purine nucleobase binding), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0002063](http://purl.obolibrary.org/obo/GO_0002063) (chondrocyte development), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:1990030](http://purl.obolibrary.org/obo/GO_1990030) (pericellular basket), [GO:0002067](http://purl.obolibrary.org/obo/GO_0002067) (glandular epithelial cell differentiation), [GO:0002068](http://purl.obolibrary.org/obo/GO_0002068) (glandular epithelial cell development), [GO:0051026](http://purl.obolibrary.org/obo/GO_0051026) (chiasma assembly), [GO:1990023](http://purl.obolibrary.org/obo/GO_1990023) (mitotic spindle midzone), [GO:0002059](http://purl.obolibrary.org/obo/GO_0002059) (thymine binding), [GO:0051024](http://purl.obolibrary.org/obo/GO_0051024) (positive regulation of immunoglobulin secretion), [GO:0051023](http://purl.obolibrary.org/obo/GO_0051023) (regulation of immunoglobulin secretion), [GO:1990029](http://purl.obolibrary.org/obo/GO_1990029) (vasomotion), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0051028](http://purl.obolibrary.org/obo/GO_0051028) (mRNA transport), [GO:0015369](http://purl.obolibrary.org/obo/GO_0015369) (calcium:proton antiporter activity), [GO:0014059](http://purl.obolibrary.org/obo/GO_0014059) (regulation of dopamine secretion), [GO:1904121](http://purl.obolibrary.org/obo/GO_1904121) (phosphatidylethanolamine transporter activity), [GO:0038006](http://purl.obolibrary.org/obo/GO_0038006) (netrin receptor activity involved in chemoattraction), [GO:0014056](http://purl.obolibrary.org/obo/GO_0014056) (regulation of acetylcholine secretion, neurotransmission), [GO:0015386](http://purl.obolibrary.org/obo/GO_0015386) (potassium:proton antiporter activity), [GO:0002070](http://purl.obolibrary.org/obo/GO_0002070) (epithelial cell maturation), [GO:0015385](http://purl.obolibrary.org/obo/GO_0015385) (sodium:proton antiporter activity), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0002072](http://purl.obolibrary.org/obo/GO_0002072) (optic cup morphogenesis involved in camera-type eye development), [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling), [GO:0014051](http://purl.obolibrary.org/obo/GO_0014051) (gamma-aminobutyric acid secretion), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0002076](http://purl.obolibrary.org/obo/GO_0002076) (osteoblast development), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0002079](http://purl.obolibrary.org/obo/GO_0002079) (inner acrosomal membrane), [GO:0030990](http://purl.obolibrary.org/obo/GO_0030990) (intraciliary transport particle), [GO:0030992](http://purl.obolibrary.org/obo/GO_0030992) (intraciliary transport particle B), [GO:0030991](http://purl.obolibrary.org/obo/GO_0030991) (intraciliary transport particle A), [GO:0090606](http://purl.obolibrary.org/obo/GO_0090606) (single-species surface biofilm formation), [GO:0051039](http://purl.obolibrary.org/obo/GO_0051039) (positive regulation of transcription involved in meiotic cell cycle), [GO:0042976](http://purl.obolibrary.org/obo/GO_0042976) (activation of Janus kinase activity), [GO:1990051](http://purl.obolibrary.org/obo/GO_1990051) (activation of protein kinase C activity), [GO:0042974](http://purl.obolibrary.org/obo/GO_0042974) (retinoic acid receptor binding), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0042987](http://purl.obolibrary.org/obo/GO_0042987) (amyloid precursor protein catabolic process), [GO:0042989](http://purl.obolibrary.org/obo/GO_0042989) (sequestering of actin monomers), [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade), [GO:0038065](http://purl.obolibrary.org/obo/GO_0038065) (collagen-activated signaling pathway), [GO:0038062](http://purl.obolibrary.org/obo/GO_0038062) (protein tyrosine kinase collagen receptor activity), [GO:0038061](http://purl.obolibrary.org/obo/GO_0038061) (NIK/NF-kappaB signaling), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0038064](http://purl.obolibrary.org/obo/GO_0038064) (collagen receptor activity), [GO:0038063](http://purl.obolibrary.org/obo/GO_0038063) (collagen-activated tyrosine kinase receptor signaling pathway), [GO:0042985](http://purl.obolibrary.org/obo/GO_0042985) (negative regulation of amyloid precursor protein biosynthetic process), [GO:0070195](http://purl.obolibrary.org/obo/GO_0070195) (growth hormone receptor complex), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0070193](http://purl.obolibrary.org/obo/GO_0070193) (synaptonemal complex organization), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0070197](http://purl.obolibrary.org/obo/GO_0070197) (meiotic attachment of telomere to nuclear envelope), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0070198](http://purl.obolibrary.org/obo/GO_0070198) (protein localization to chromosome, telomeric region), [GO:0010501](http://purl.obolibrary.org/obo/GO_0010501) (RNA secondary structure unwinding), [GO:1990070](http://purl.obolibrary.org/obo/GO_1990070) (TRAPPI protein complex), [GO:1990071](http://purl.obolibrary.org/obo/GO_1990071) (TRAPPII protein complex), [GO:0042992](http://purl.obolibrary.org/obo/GO_0042992) (negative regulation of transcription factor import into nucleus), [GO:1990072](http://purl.obolibrary.org/obo/GO_1990072) (TRAPPIII protein complex), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0038052](http://purl.obolibrary.org/obo/GO_0038052) (RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:1990074](http://purl.obolibrary.org/obo/GO_1990074) (polyuridylation-dependent mRNA catabolic process), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:1990075](http://purl.obolibrary.org/obo/GO_1990075) (periciliary membrane compartment), [GO:0038042](http://purl.obolibrary.org/obo/GO_0038042) (dimeric G-protein coupled receptor signaling pathway), [GO:1990086](http://purl.obolibrary.org/obo/GO_1990086) (lens fiber cell apoptotic process), [GO:0047708](http://purl.obolibrary.org/obo/GO_0047708) (biotinidase activity), [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex), [GO:0022407](http://purl.obolibrary.org/obo/GO_0022407) (regulation of cell-cell adhesion), [GO:1904059](http://purl.obolibrary.org/obo/GO_1904059) (regulation of locomotor rhythm), [GO:0022408](http://purl.obolibrary.org/obo/GO_0022408) (negative regulation of cell-cell adhesion), [GO:0022409](http://purl.obolibrary.org/obo/GO_0022409) (positive regulation of cell-cell adhesion), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0009435](http://purl.obolibrary.org/obo/GO_0009435) (NAD biosynthetic process), [GO:0022405](http://purl.obolibrary.org/obo/GO_0022405) (hair cycle process), [GO:0008108](http://purl.obolibrary.org/obo/GO_0008108) (UDP-glucose:hexose-1-phosphate uridylyltransferase activity), [GO:0009437](http://purl.obolibrary.org/obo/GO_0009437) (carnitine metabolic process), [GO:0022400](http://purl.obolibrary.org/obo/GO_0022400) (regulation of rhodopsin mediated signaling pathway), [GO:0009436](http://purl.obolibrary.org/obo/GO_0009436) (glyoxylate catabolic process), [GO:0035716](http://purl.obolibrary.org/obo/GO_0035716) (chemokine (C-C motif) ligand 12 binding), [GO:0035717](http://purl.obolibrary.org/obo/GO_0035717) (chemokine (C-C motif) ligand 7 binding), [GO:0035715](http://purl.obolibrary.org/obo/GO_0035715) (chemokine (C-C motif) ligand 2 binding), [GO:0009444](http://purl.obolibrary.org/obo/GO_0009444) (pyruvate oxidation), [GO:0008113](http://purl.obolibrary.org/obo/GO_0008113) (peptide-methionine (S)-S-oxide reductase activity), [GO:0009443](http://purl.obolibrary.org/obo/GO_0009443) (pyridoxal 5'-phosphate salvage), [GO:0008119](http://purl.obolibrary.org/obo/GO_0008119) (thiopurine S-methyltransferase activity), [GO:0009448](http://purl.obolibrary.org/obo/GO_0009448) (gamma-aminobutyric acid metabolic process), [GO:0035705](http://purl.obolibrary.org/obo/GO_0035705) (T-helper 17 cell chemotaxis), [GO:0035701](http://purl.obolibrary.org/obo/GO_0035701) (hematopoietic stem cell migration), [GO:0010424](http://purl.obolibrary.org/obo/GO_0010424) (DNA methylation on cytosine within a CG sequence), [GO:0035702](http://purl.obolibrary.org/obo/GO_0035702) (monocyte homeostasis), [GO:1904060](http://purl.obolibrary.org/obo/GO_1904060) (negative regulation of locomotor rhythm), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0090555](http://purl.obolibrary.org/obo/GO_0090555) (phosphatidylethanolamine-translocating ATPase activity), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0009410](http://purl.obolibrary.org/obo/GO_0009410) (response to xenobiotic stimulus), [GO:1901800](http://purl.obolibrary.org/obo/GO_1901800) (positive regulation of proteasomal protein catabolic process), [GO:0009416](http://purl.obolibrary.org/obo/GO_0009416) (response to light stimulus), [GO:0047726](http://purl.obolibrary.org/obo/GO_0047726) (iron-cytochrome-c reductase activity), [GO:0047724](http://purl.obolibrary.org/obo/GO_0047724) (inosine nucleosidase activity), [GO:0060709](http://purl.obolibrary.org/obo/GO_0060709) (glycogen cell differentiation involved in embryonic placenta development), [GO:0009409](http://purl.obolibrary.org/obo/GO_0009409) (response to cold), [GO:0009408](http://purl.obolibrary.org/obo/GO_0009408) (response to heat), [GO:0060706](http://purl.obolibrary.org/obo/GO_0060706) (cell differentiation involved in embryonic placenta development), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0090559](http://purl.obolibrary.org/obo/GO_0090559) (regulation of membrane permeability), [GO:1904086](http://purl.obolibrary.org/obo/GO_1904086) (regulation of epiboly involved in gastrulation with mouth forming second), [GO:0046403](http://purl.obolibrary.org/obo/GO_0046403) (polynucleotide 3'-phosphatase activity), [GO:1901810](http://purl.obolibrary.org/obo/GO_1901810) (beta-carotene metabolic process), [GO:0046404](http://purl.obolibrary.org/obo/GO_0046404) (ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0010460](http://purl.obolibrary.org/obo/GO_0010460) (positive regulation of heart rate), [GO:0008140](http://purl.obolibrary.org/obo/GO_0008140) (cAMP response element binding protein binding), [GO:0090533](http://purl.obolibrary.org/obo/GO_0090533) (cation-transporting ATPase complex), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0033100](http://purl.obolibrary.org/obo/GO_0033100) (NuA3 histone acetyltransferase complex), [GO:0008143](http://purl.obolibrary.org/obo/GO_0008143) (poly(A) binding), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0008146](http://purl.obolibrary.org/obo/GO_0008146) (sulfotransferase activity), [GO:0010457](http://purl.obolibrary.org/obo/GO_0010457) (centriole-centriole cohesion), [GO:0034421](http://purl.obolibrary.org/obo/GO_0034421) (post-translational protein acetylation), [GO:0010458](http://purl.obolibrary.org/obo/GO_0010458) (exit from mitosis), [GO:0010453](http://purl.obolibrary.org/obo/GO_0010453) (regulation of cell fate commitment), [GO:0034427](http://purl.obolibrary.org/obo/GO_0034427) (nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'), [GO:0010452](http://purl.obolibrary.org/obo/GO_0010452) (histone H3-K36 methylation), [GO:0035753](http://purl.obolibrary.org/obo/GO_0035753) (maintenance of DNA trinucleotide repeats), [GO:0035754](http://purl.obolibrary.org/obo/GO_0035754) (B cell chemotaxis), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0010470](http://purl.obolibrary.org/obo/GO_0010470) (regulation of gastrulation), [GO:1904021](http://purl.obolibrary.org/obo/GO_1904021) (negative regulation of G-protein coupled receptor internalization), [GO:0035751](http://purl.obolibrary.org/obo/GO_0035751) (regulation of lysosomal lumen pH), [GO:0008154](http://purl.obolibrary.org/obo/GO_0008154) (actin polymerization or depolymerization), [GO:1905356](http://purl.obolibrary.org/obo/GO_1905356) (regulation of snRNA pseudouridine synthesis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0008156](http://purl.obolibrary.org/obo/GO_0008156) (negative regulation of DNA replication), [GO:0034418](http://purl.obolibrary.org/obo/GO_0034418) (urate biosynthetic process), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0035745](http://purl.obolibrary.org/obo/GO_0035745) (T-helper 2 cell cytokine production), [GO:0010467](http://purl.obolibrary.org/obo/GO_0010467) (gene expression), [GO:0035748](http://purl.obolibrary.org/obo/GO_0035748) (myelin sheath abaxonal region), [GO:0010469](http://purl.obolibrary.org/obo/GO_0010469) (regulation of receptor activity), [GO:0034417](http://purl.obolibrary.org/obo/GO_0034417) (bisphosphoglycerate 3-phosphatase activity), [GO:0010464](http://purl.obolibrary.org/obo/GO_0010464) (regulation of mesenchymal cell proliferation), [GO:0010463](http://purl.obolibrary.org/obo/GO_0010463) (mesenchymal cell proliferation), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0010465](http://purl.obolibrary.org/obo/GO_0010465) (nerve growth factor receptor activity), [GO:0034414](http://purl.obolibrary.org/obo/GO_0034414) (tRNA 3'-trailer cleavage, endonucleolytic), [GO:1904037](http://purl.obolibrary.org/obo/GO_1904037) (positive regulation of epithelial cell apoptotic process), [GO:0008121](http://purl.obolibrary.org/obo/GO_0008121) (ubiquinol-cytochrome-c reductase activity), [GO:0009451](http://purl.obolibrary.org/obo/GO_0009451) (RNA modification), [GO:0009450](http://purl.obolibrary.org/obo/GO_0009450) (gamma-aminobutyric acid catabolic process), [GO:0008124](http://purl.obolibrary.org/obo/GO_0008124) (4-alpha-hydroxytetrahydrobiopterin dehydratase activity), [GO:0008127](http://purl.obolibrary.org/obo/GO_0008127) (quercetin 2,3-dioxygenase activity), [GO:0034402](http://purl.obolibrary.org/obo/GO_0034402) (recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex), [GO:0035735](http://purl.obolibrary.org/obo/GO_0035735) (intraciliary transport involved in cilium assembly), [GO:0035736](http://purl.obolibrary.org/obo/GO_0035736) (cell proliferation involved in compound eye morphogenesis), [GO:1904030](http://purl.obolibrary.org/obo/GO_1904030) (negative regulation of cyclin-dependent protein kinase activity), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:0010430](http://purl.obolibrary.org/obo/GO_0010430) (fatty acid omega-oxidation), [GO:1904042](http://purl.obolibrary.org/obo/GO_1904042) (negative regulation of cystathionine beta-synthase activity), [GO:0090521](http://purl.obolibrary.org/obo/GO_0090521) (glomerular visceral epithelial cell migration), [GO:0008131](http://purl.obolibrary.org/obo/GO_0008131) (primary amine oxidase activity), [GO:1904047](http://purl.obolibrary.org/obo/GO_1904047) (S-adenosyl-L-methionine binding), [GO:0008137](http://purl.obolibrary.org/obo/GO_0008137) (NADH dehydrogenase (ubiquinone) activity), [GO:0022414](http://purl.obolibrary.org/obo/GO_0022414) (reproductive process), [GO:0008135](http://purl.obolibrary.org/obo/GO_0008135) (translation factor activity, RNA binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:1990000](http://purl.obolibrary.org/obo/GO_1990000) (amyloid fibril formation), [GO:0035729](http://purl.obolibrary.org/obo/GO_0035729) (cellular response to hepatocyte growth factor stimulus), [GO:0035725](http://purl.obolibrary.org/obo/GO_0035725) (sodium ion transmembrane transport), [GO:0035726](http://purl.obolibrary.org/obo/GO_0035726) (common myeloid progenitor cell proliferation), [GO:0010447](http://purl.obolibrary.org/obo/GO_0010447) (response to acidic pH), [GO:0035720](http://purl.obolibrary.org/obo/GO_0035720) (intraciliary anterograde transport), [GO:0035721](http://purl.obolibrary.org/obo/GO_0035721) (intraciliary retrograde transport), [GO:1905370](http://purl.obolibrary.org/obo/GO_1905370) (serine-type endopeptidase complex), [GO:0035722](http://purl.obolibrary.org/obo/GO_0035722) (interleukin-12-mediated signaling pathway), [GO:0008184](http://purl.obolibrary.org/obo/GO_0008184) (glycogen phosphorylase activity), [GO:0060760](http://purl.obolibrary.org/obo/GO_0060760) (positive regulation of response to cytokine stimulus), [GO:0060762](http://purl.obolibrary.org/obo/GO_0060762) (regulation of branching involved in mammary gland duct morphogenesis), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0034475](http://purl.obolibrary.org/obo/GO_0034475) (U4 snRNA 3'-end processing), [GO:0008188](http://purl.obolibrary.org/obo/GO_0008188) (neuropeptide receptor activity), [GO:0008187](http://purl.obolibrary.org/obo/GO_0008187) (poly-pyrimidine tract binding), [GO:0008186](http://purl.obolibrary.org/obo/GO_0008186) (RNA-dependent ATPase activity), [GO:0034473](http://purl.obolibrary.org/obo/GO_0034473) (U1 snRNA 3'-end processing), [GO:0033141](http://purl.obolibrary.org/obo/GO_0033141) (positive regulation of peptidyl-serine phosphorylation of STAT protein), [GO:0034472](http://purl.obolibrary.org/obo/GO_0034472) (snRNA 3'-end processing), [GO:0060768](http://purl.obolibrary.org/obo/GO_0060768) (regulation of epithelial cell proliferation involved in prostate gland development), [GO:0060769](http://purl.obolibrary.org/obo/GO_0060769) (positive regulation of epithelial cell proliferation involved in prostate gland development), [GO:0045124](http://purl.obolibrary.org/obo/GO_0045124) (regulation of bone resorption), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0060765](http://purl.obolibrary.org/obo/GO_0060765) (regulation of androgen receptor signaling pathway), [GO:0045128](http://purl.obolibrary.org/obo/GO_0045128) (negative regulation of reciprocal meiotic recombination), [GO:0046459](http://purl.obolibrary.org/obo/GO_0046459) (short-chain fatty acid metabolic process), [GO:0060766](http://purl.obolibrary.org/obo/GO_0060766) (negative regulation of androgen receptor signaling pathway), [GO:0046461](http://purl.obolibrary.org/obo/GO_0046461) (neutral lipid catabolic process), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0005903](http://purl.obolibrary.org/obo/GO_0005903) (brush border), [GO:0046464](http://purl.obolibrary.org/obo/GO_0046464) (acylglycerol catabolic process), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0045134](http://purl.obolibrary.org/obo/GO_0045134) (uridine-diphosphatase activity), [GO:0005905](http://purl.obolibrary.org/obo/GO_0005905) (clathrin-coated pit), [GO:0045132](http://purl.obolibrary.org/obo/GO_0045132) (meiotic chromosome segregation), [GO:0033137](http://purl.obolibrary.org/obo/GO_0033137) (negative regulation of peptidyl-serine phosphorylation), [GO:0033135](http://purl.obolibrary.org/obo/GO_0033135) (regulation of peptidyl-serine phosphorylation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0035799](http://purl.obolibrary.org/obo/GO_0035799) (ureter maturation), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0010498](http://purl.obolibrary.org/obo/GO_0010498) (proteasomal protein catabolic process), [GO:0008195](http://purl.obolibrary.org/obo/GO_0008195) (phosphatidate phosphatase activity), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0060750](http://purl.obolibrary.org/obo/GO_0060750) (epithelial cell proliferation involved in mammary gland duct elongation), [GO:0035794](http://purl.obolibrary.org/obo/GO_0035794) (positive regulation of mitochondrial membrane permeability), [GO:0008199](http://purl.obolibrary.org/obo/GO_0008199) (ferric iron binding), [GO:0034464](http://purl.obolibrary.org/obo/GO_0034464) (BBSome), [GO:0008198](http://purl.obolibrary.org/obo/GO_0008198) (ferrous iron binding), [GO:0035790](http://purl.obolibrary.org/obo/GO_0035790) (platelet-derived growth factor receptor-alpha signaling pathway), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0033130](http://purl.obolibrary.org/obo/GO_0033130) (acetylcholine receptor binding), [GO:0045137](http://purl.obolibrary.org/obo/GO_0045137) (development of primary sexual characteristics), [GO:0046469](http://purl.obolibrary.org/obo/GO_0046469) (platelet activating factor metabolic process), [GO:0046466](http://purl.obolibrary.org/obo/GO_0046466) (membrane lipid catabolic process), [GO:0045136](http://purl.obolibrary.org/obo/GO_0045136) (development of secondary sexual characteristics), [GO:1901874](http://purl.obolibrary.org/obo/GO_1901874) (negative regulation of post-translational protein modification), [GO:1901879](http://purl.obolibrary.org/obo/GO_1901879) (regulation of protein depolymerization), [GO:0060754](http://purl.obolibrary.org/obo/GO_0060754) (positive regulation of mast cell chemotaxis), [GO:0046471](http://purl.obolibrary.org/obo/GO_0046471) (phosphatidylglycerol metabolic process), [GO:0045141](http://purl.obolibrary.org/obo/GO_0045141) (meiotic telomere clustering), [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:0045144](http://purl.obolibrary.org/obo/GO_0045144) (meiotic sister chromatid segregation), [GO:0046475](http://purl.obolibrary.org/obo/GO_0046475) (glycerophospholipid catabolic process), [GO:0005913](http://purl.obolibrary.org/obo/GO_0005913) (cell-cell adherens junction), [GO:0046473](http://purl.obolibrary.org/obo/GO_0046473) (phosphatidic acid metabolic process), [GO:0005915](http://purl.obolibrary.org/obo/GO_0005915) (zonula adherens), [GO:0045143](http://purl.obolibrary.org/obo/GO_0045143) (homologous chromosome segregation), [GO:0046474](http://purl.obolibrary.org/obo/GO_0046474) (glycerophospholipid biosynthetic process), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0034455](http://purl.obolibrary.org/obo/GO_0034455) (t-UTP complex), [GO:0071400](http://purl.obolibrary.org/obo/GO_0071400) (cellular response to oleic acid), [GO:0034454](http://purl.obolibrary.org/obo/GO_0034454) (microtubule anchoring at centrosome), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0033128](http://purl.obolibrary.org/obo/GO_0033128) (negative regulation of histone phosphorylation), [GO:0071404](http://purl.obolibrary.org/obo/GO_0071404) (cellular response to low-density lipoprotein particle stimulus), [GO:0035787](http://purl.obolibrary.org/obo/GO_0035787) (cell migration involved in kidney development), [GO:0010482](http://purl.obolibrary.org/obo/GO_0010482) (regulation of epidermal cell division), [GO:0060782](http://purl.obolibrary.org/obo/GO_0060782) (regulation of mesenchymal cell proliferation involved in prostate gland development), [GO:0010481](http://purl.obolibrary.org/obo/GO_0010481) (epidermal cell division), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0060783](http://purl.obolibrary.org/obo/GO_0060783) (mesenchymal smoothened signaling pathway involved in prostate gland development), [GO:0060784](http://purl.obolibrary.org/obo/GO_0060784) (regulation of cell proliferation involved in tissue homeostasis), [GO:0034453](http://purl.obolibrary.org/obo/GO_0034453) (microtubule anchoring), [GO:0034452](http://purl.obolibrary.org/obo/GO_0034452) (dynactin binding), [GO:0034451](http://purl.obolibrary.org/obo/GO_0034451) (centriolar satellite), [GO:0033120](http://purl.obolibrary.org/obo/GO_0033120) (positive regulation of RNA splicing), [GO:0034450](http://purl.obolibrary.org/obo/GO_0034450) (ubiquitin-ubiquitin ligase activity), [GO:0060789](http://purl.obolibrary.org/obo/GO_0060789) (hair follicle placode formation), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0046477](http://purl.obolibrary.org/obo/GO_0046477) (glycosylceramide catabolic process), [GO:0060788](http://purl.obolibrary.org/obo/GO_0060788) (ectodermal placode formation), [GO:0046486](http://purl.obolibrary.org/obo/GO_0046486) (glycerolipid metabolic process), [GO:0045155](http://purl.obolibrary.org/obo/GO_0045155) (electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity), [GO:0046487](http://purl.obolibrary.org/obo/GO_0046487) (glyoxylate metabolic process), [GO:0071432](http://purl.obolibrary.org/obo/GO_0071432) (peptide mating pheromone maturation involved in conjugation with cellular fusion), [GO:0045153](http://purl.obolibrary.org/obo/GO_0045153) (electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity), [GO:0034446](http://purl.obolibrary.org/obo/GO_0034446) (substrate adhesion-dependent cell spreading), [GO:0071435](http://purl.obolibrary.org/obo/GO_0071435) (potassium ion export), [GO:0070102](http://purl.obolibrary.org/obo/GO_0070102) (interleukin-6-mediated signaling pathway), [GO:0071433](http://purl.obolibrary.org/obo/GO_0071433) (cell wall repair), [GO:0071439](http://purl.obolibrary.org/obo/GO_0071439) (clathrin complex), [GO:0035774](http://purl.obolibrary.org/obo/GO_0035774) (positive regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0033119](http://purl.obolibrary.org/obo/GO_0033119) (negative regulation of RNA splicing), [GO:0035775](http://purl.obolibrary.org/obo/GO_0035775) (pronephric glomerulus morphogenesis), [GO:0035776](http://purl.obolibrary.org/obo/GO_0035776) (pronephric proximal tubule development), [GO:0033116](http://purl.obolibrary.org/obo/GO_0033116) (endoplasmic reticulum-Golgi intermediate compartment membrane), [GO:0071438](http://purl.obolibrary.org/obo/GO_0071438) (invadopodium membrane), [GO:0035777](http://purl.obolibrary.org/obo/GO_0035777) (pronephric distal tubule development), [GO:0060770](http://purl.obolibrary.org/obo/GO_0060770) (negative regulation of epithelial cell proliferation involved in prostate gland development), [GO:0035770](http://purl.obolibrary.org/obo/GO_0035770) (ribonucleoprotein granule), [GO:0035771](http://purl.obolibrary.org/obo/GO_0035771) (interleukin-4-mediated signaling pathway), [GO:0008171](http://purl.obolibrary.org/obo/GO_0008171) (O-methyltransferase activity), [GO:0010494](http://purl.obolibrary.org/obo/GO_0010494) (cytoplasmic stress granule), [GO:0008177](http://purl.obolibrary.org/obo/GO_0008177) (succinate dehydrogenase (ubiquinone) activity), [GO:0034441](http://purl.obolibrary.org/obo/GO_0034441) (plasma lipoprotein particle oxidation), [GO:0034440](http://purl.obolibrary.org/obo/GO_0034440) (lipid oxidation), [GO:0045159](http://purl.obolibrary.org/obo/GO_0045159) (myosin II binding), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:1901897](http://purl.obolibrary.org/obo/GO_1901897) (regulation of relaxation of cardiac muscle), [GO:0008179](http://purl.obolibrary.org/obo/GO_0008179) (adenylate cyclase binding), [GO:0060775](http://purl.obolibrary.org/obo/GO_0060775) (planar cell polarity pathway involved in gastrula mediolateral intercalation), [GO:0045162](http://purl.obolibrary.org/obo/GO_0045162) (clustering of voltage-gated sodium channels), [GO:0046491](http://purl.obolibrary.org/obo/GO_0046491) (L-methylmalonyl-CoA metabolic process), [GO:0071420](http://purl.obolibrary.org/obo/GO_0071420) (cellular response to histamine), [GO:0071421](http://purl.obolibrary.org/obo/GO_0071421) (manganese ion transmembrane transport), [GO:0045167](http://purl.obolibrary.org/obo/GO_0045167) (asymmetric protein localization involved in cell fate determination), [GO:0046498](http://purl.obolibrary.org/obo/GO_0046498) (S-adenosylhomocysteine metabolic process), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0034435](http://purl.obolibrary.org/obo/GO_0034435) (cholesterol esterification), [GO:0035767](http://purl.obolibrary.org/obo/GO_0035767) (endothelial cell chemotaxis), [GO:0071425](http://purl.obolibrary.org/obo/GO_0071425) (hematopoietic stem cell proliferation), [GO:0033101](http://purl.obolibrary.org/obo/GO_0033101) (cellular bud membrane), [GO:0033108](http://purl.obolibrary.org/obo/GO_0033108) (mitochondrial respiratory chain complex assembly), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0072757](http://purl.obolibrary.org/obo/GO_0072757) (cellular response to camptothecin), [GO:0033184](http://purl.obolibrary.org/obo/GO_0033184) (positive regulation of histone ubiquitination), [GO:0016601](http://purl.obolibrary.org/obo/GO_0016601) (Rac protein signal transduction), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0016608](http://purl.obolibrary.org/obo/GO_0016608) (growth hormone-releasing hormone activity), [GO:0033185](http://purl.obolibrary.org/obo/GO_0033185) (dolichol-phosphate-mannose synthase complex), [GO:0030906](http://purl.obolibrary.org/obo/GO_0030906) (retromer, cargo-selective complex), [GO:0033180](http://purl.obolibrary.org/obo/GO_0033180) (proton-transporting V-type ATPase, V1 domain), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0046415](http://purl.obolibrary.org/obo/GO_0046415) (urate metabolic process), [GO:0004620](http://purl.obolibrary.org/obo/GO_0004620) (phospholipase activity), [GO:0046416](http://purl.obolibrary.org/obo/GO_0046416) (D-amino acid metabolic process), [GO:0005943](http://purl.obolibrary.org/obo/GO_0005943) (phosphatidylinositol 3-kinase complex, class IA), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0004611](http://purl.obolibrary.org/obo/GO_0004611) (phosphoenolpyruvate carboxykinase activity), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0005945](http://purl.obolibrary.org/obo/GO_0005945) (6-phosphofructokinase complex), [GO:0004614](http://purl.obolibrary.org/obo/GO_0004614) (phosphoglucomutase activity), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0004613](http://purl.obolibrary.org/obo/GO_0004613) (phosphoenolpyruvate carboxykinase (GTP) activity), [GO:0005944](http://purl.obolibrary.org/obo/GO_0005944) (phosphatidylinositol 3-kinase complex, class IB), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0005947](http://purl.obolibrary.org/obo/GO_0005947) (mitochondrial alpha-ketoglutarate dehydrogenase complex), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0004615](http://purl.obolibrary.org/obo/GO_0004615) (phosphomannomutase activity), [GO:0047751](http://purl.obolibrary.org/obo/GO_0047751) (cholestenone 5-alpha-reductase activity), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0047750](http://purl.obolibrary.org/obo/GO_0047750) (cholestenol delta-isomerase activity), [GO:0004618](http://purl.obolibrary.org/obo/GO_0004618) (phosphoglycerate kinase activity), [GO:0030904](http://purl.obolibrary.org/obo/GO_0030904) (retromer complex), [GO:0004617](http://purl.obolibrary.org/obo/GO_0004617) (phosphoglycerate dehydrogenase activity), [GO:0004619](http://purl.obolibrary.org/obo/GO_0004619) (phosphoglycerate mutase activity), [GO:0033179](http://purl.obolibrary.org/obo/GO_0033179) (proton-transporting V-type ATPase, V0 domain), [GO:0060715](http://purl.obolibrary.org/obo/GO_0060715) (syncytiotrophoblast cell differentiation involved in labyrinthine layer development), [GO:0005960](http://purl.obolibrary.org/obo/GO_0005960) (glycine cleavage complex), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0003300](http://purl.obolibrary.org/obo/GO_0003300) (cardiac muscle hypertrophy), [GO:0060710](http://purl.obolibrary.org/obo/GO_0060710) (chorio-allantoic fusion), [GO:0046427](http://purl.obolibrary.org/obo/GO_0046427) (positive regulation of JAK-STAT cascade), [GO:0003301](http://purl.obolibrary.org/obo/GO_0003301) (physiological cardiac muscle hypertrophy), [GO:0047757](http://purl.obolibrary.org/obo/GO_0047757) (chondroitin-glucuronate 5-epimerase activity), [GO:0004623](http://purl.obolibrary.org/obo/GO_0004623) (phospholipase A2 activity), [GO:0004622](http://purl.obolibrary.org/obo/GO_0004622) (lysophospholipase activity), [GO:1901827](http://purl.obolibrary.org/obo/GO_1901827) (zeaxanthin biosynthetic process), [GO:0005955](http://purl.obolibrary.org/obo/GO_0005955) (calcineurin complex), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0005958](http://purl.obolibrary.org/obo/GO_0005958) (DNA-dependent protein kinase-DNA ligase 4 complex), [GO:0060717](http://purl.obolibrary.org/obo/GO_0060717) (chorion development), [GO:0004629](http://purl.obolibrary.org/obo/GO_0004629) (phospholipase C activity), [GO:0033169](http://purl.obolibrary.org/obo/GO_0033169) (histone H3-K9 demethylation), [GO:0016600](http://purl.obolibrary.org/obo/GO_0016600) (flotillin complex), [GO:0033162](http://purl.obolibrary.org/obo/GO_0033162) (melanosome membrane), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0034497](http://purl.obolibrary.org/obo/GO_0034497) (protein localization to phagophore assembly site), [GO:0033165](http://purl.obolibrary.org/obo/GO_0033165) (interphotoreceptor matrix), [GO:0033164](http://purl.obolibrary.org/obo/GO_0033164) (glycolipid 6-alpha-mannosyltransferase activity), [GO:0060745](http://purl.obolibrary.org/obo/GO_0060745) (mammary gland branching involved in pregnancy), [GO:0045104](http://purl.obolibrary.org/obo/GO_0045104) (intermediate filament cytoskeleton organization), [GO:0090594](http://purl.obolibrary.org/obo/GO_0090594) (inflammatory response to wounding), [GO:0060748](http://purl.obolibrary.org/obo/GO_0060748) (tertiary branching involved in mammary gland duct morphogenesis), [GO:0045103](http://purl.obolibrary.org/obo/GO_0045103) (intermediate filament-based process), [GO:1901841](http://purl.obolibrary.org/obo/GO_1901841) (regulation of high voltage-gated calcium channel activity), [GO:0046434](http://purl.obolibrary.org/obo/GO_0046434) (organophosphate catabolic process), [GO:0045109](http://purl.obolibrary.org/obo/GO_0045109) (intermediate filament organization), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:1901843](http://purl.obolibrary.org/obo/GO_1901843) (positive regulation of high voltage-gated calcium channel activity), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0060744](http://purl.obolibrary.org/obo/GO_0060744) (mammary gland branching involved in thelarche), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0047770](http://purl.obolibrary.org/obo/GO_0047770) (carboxylate reductase activity), [GO:1901836](http://purl.obolibrary.org/obo/GO_1901836) (regulation of transcription of nucleolar large rRNA by RNA polymerase I), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0005922](http://purl.obolibrary.org/obo/GO_0005922) (connexin complex), [GO:1901838](http://purl.obolibrary.org/obo/GO_1901838) (positive regulation of transcription of nucleolar large rRNA by RNA polymerase I), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0005927](http://purl.obolibrary.org/obo/GO_0005927) (muscle tendon junction), [GO:0045110](http://purl.obolibrary.org/obo/GO_0045110) (intermediate filament bundle assembly), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0033159](http://purl.obolibrary.org/obo/GO_0033159) (negative regulation of protein import into nucleus, translocation), [GO:0033158](http://purl.obolibrary.org/obo/GO_0033158) (regulation of protein import into nucleus, translocation), [GO:0033157](http://purl.obolibrary.org/obo/GO_0033157) (regulation of intracellular protein transport), [GO:0072721](http://purl.obolibrary.org/obo/GO_0072721) (cellular response to dithiothreitol), [GO:0033151](http://purl.obolibrary.org/obo/GO_0033151) (V(D)J recombination), [GO:0033153](http://purl.obolibrary.org/obo/GO_0033153) (T cell receptor V(D)J recombination), [GO:0033152](http://purl.obolibrary.org/obo/GO_0033152) (immunoglobulin V(D)J recombination), [GO:0060734](http://purl.obolibrary.org/obo/GO_0060734) (regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0060731](http://purl.obolibrary.org/obo/GO_0060731) (positive regulation of intestinal epithelial structure maintenance), [GO:0060732](http://purl.obolibrary.org/obo/GO_0060732) (positive regulation of inositol phosphate biosynthetic process), [GO:1901857](http://purl.obolibrary.org/obo/GO_1901857) (positive regulation of cellular respiration), [GO:0004610](http://purl.obolibrary.org/obo/GO_0004610) (phosphoacetylglucosamine mutase activity), [GO:0046449](http://purl.obolibrary.org/obo/GO_0046449) (creatinine metabolic process), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0005934](http://purl.obolibrary.org/obo/GO_0005934) (cellular bud tip), [GO:0005933](http://purl.obolibrary.org/obo/GO_0005933) (cellular bud), [GO:0004602](http://purl.obolibrary.org/obo/GO_0004602) (glutathione peroxidase activity), [GO:0060738](http://purl.obolibrary.org/obo/GO_0060738) (epithelial-mesenchymal signaling involved in prostate gland development), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0045123](http://purl.obolibrary.org/obo/GO_0045123) (cellular extravasation), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0045120](http://purl.obolibrary.org/obo/GO_0045120) (pronucleus), [GO:0047783](http://purl.obolibrary.org/obo/GO_0047783) (corticosterone 18-monooxygenase activity), [GO:0004607](http://purl.obolibrary.org/obo/GO_0004607) (phosphatidylcholine-sterol O-acyltransferase activity), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0005937](http://purl.obolibrary.org/obo/GO_0005937) (mating projection), [GO:0046452](http://purl.obolibrary.org/obo/GO_0046452) (dihydrofolate metabolic process), [GO:0033148](http://purl.obolibrary.org/obo/GO_0033148) (positive regulation of intracellular estrogen receptor signaling pathway), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0033146](http://purl.obolibrary.org/obo/GO_0033146) (regulation of intracellular estrogen receptor signaling pathway), [GO:0034476](http://purl.obolibrary.org/obo/GO_0034476) (U5 snRNA 3'-end processing), [GO:0033149](http://purl.obolibrary.org/obo/GO_0033149) (FFAT motif binding), [GO:0015432](http://purl.obolibrary.org/obo/GO_0015432) (bile acid-exporting ATPase activity), [GO:0015431](http://purl.obolibrary.org/obo/GO_0015431) (glutathione S-conjugate-exporting ATPase activity), [GO:0004784](http://purl.obolibrary.org/obo/GO_0004784) (superoxide dismutase activity), [GO:0004777](http://purl.obolibrary.org/obo/GO_0004777) (succinate-semialdehyde dehydrogenase (NAD+) activity), [GO:0004776](http://purl.obolibrary.org/obo/GO_0004776) (succinate-CoA ligase (GDP-forming) activity), [GO:0002115](http://purl.obolibrary.org/obo/GO_0002115) (store-operated calcium entry), [GO:0070287](http://purl.obolibrary.org/obo/GO_0070287) (ferritin receptor activity), [GO:0070285](http://purl.obolibrary.org/obo/GO_0070285) (pigment cell development), [GO:0070286](http://purl.obolibrary.org/obo/GO_0070286) (axonemal dynein complex assembly), [GO:0016772](http://purl.obolibrary.org/obo/GO_0016772) (transferase activity, transferring phosphorus-containing groups), [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor), [GO:0016776](http://purl.obolibrary.org/obo/GO_0016776) (phosphotransferase activity, phosphate group as acceptor), [GO:0016755](http://purl.obolibrary.org/obo/GO_0016755) (transferase activity, transferring amino-acyl groups), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0016758](http://purl.obolibrary.org/obo/GO_0016758) (transferase activity, transferring hexosyl groups), [GO:0015440](http://purl.obolibrary.org/obo/GO_0015440) (peptide-transporting ATPase activity), [GO:0004797](http://purl.obolibrary.org/obo/GO_0004797) (thymidine kinase activity), [GO:0002134](http://purl.obolibrary.org/obo/GO_0002134) (UTP binding), [GO:0004796](http://purl.obolibrary.org/obo/GO_0004796) (thromboxane-A synthase activity), [GO:0004788](http://purl.obolibrary.org/obo/GO_0004788) (thiamine diphosphokinase activity), [GO:0070273](http://purl.obolibrary.org/obo/GO_0070273) (phosphatidylinositol-4-phosphate binding), [GO:0070278](http://purl.obolibrary.org/obo/GO_0070278) (extracellular matrix constituent secretion), [GO:0015439](http://purl.obolibrary.org/obo/GO_0015439) (heme-transporting ATPase activity), [GO:0016763](http://purl.obolibrary.org/obo/GO_0016763) (transferase activity, transferring pentosyl groups), [GO:0016765](http://purl.obolibrary.org/obo/GO_0016765) (transferase activity, transferring alkyl or aryl (other than methyl) groups), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0015410](http://purl.obolibrary.org/obo/GO_0015410) (manganese-transporting ATPase activity), [GO:0016747](http://purl.obolibrary.org/obo/GO_0016747) (transferase activity, transferring acyl groups other than amino-acyl groups), [GO:0004760](http://purl.obolibrary.org/obo/GO_0004760) (serine-pyruvate transaminase activity), [GO:0003431](http://purl.obolibrary.org/obo/GO_0003431) (growth plate cartilage chondrocyte development), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0003433](http://purl.obolibrary.org/obo/GO_0003433) (chondrocyte development involved in endochondral bone morphogenesis), [GO:0004755](http://purl.obolibrary.org/obo/GO_0004755) (saccharopine dehydrogenase (NADP+, L-glutamate-forming) activity), [GO:0004757](http://purl.obolibrary.org/obo/GO_0004757) (sepiapterin reductase activity), [GO:0003428](http://purl.obolibrary.org/obo/GO_0003428) (chondrocyte intercalation involved in growth plate cartilage morphogenesis), [GO:0004758](http://purl.obolibrary.org/obo/GO_0004758) (serine C-palmitoyltransferase activity), [GO:0004771](http://purl.obolibrary.org/obo/GO_0004771) (sterol esterase activity), [GO:0004775](http://purl.obolibrary.org/obo/GO_0004775) (succinate-CoA ligase (ADP-forming) activity), [GO:0004774](http://purl.obolibrary.org/obo/GO_0004774) (succinate-CoA ligase activity), [GO:0070294](http://purl.obolibrary.org/obo/GO_0070294) (renal sodium ion absorption), [GO:0004768](http://purl.obolibrary.org/obo/GO_0004768) (stearoyl-CoA 9-desaturase activity), [GO:0004767](http://purl.obolibrary.org/obo/GO_0004767) (sphingomyelin phosphodiesterase activity), [GO:0070293](http://purl.obolibrary.org/obo/GO_0070293) (renal absorption), [GO:0004769](http://purl.obolibrary.org/obo/GO_0004769) (steroid delta-isomerase activity), [GO:0070296](http://purl.obolibrary.org/obo/GO_0070296) (sarcoplasmic reticulum calcium ion transport), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016742](http://purl.obolibrary.org/obo/GO_0016742) (hydroxymethyl-, formyl- and related transferase activity), [GO:0016743](http://purl.obolibrary.org/obo/GO_0016743) (carboxyl- or carbamoyltransferase activity), [GO:0002161](http://purl.obolibrary.org/obo/GO_0002161) (aminoacyl-tRNA editing activity), [GO:1900454](http://purl.obolibrary.org/obo/GO_1900454) (positive regulation of long term synaptic depression), [GO:0002162](http://purl.obolibrary.org/obo/GO_0002162) (dystroglycan binding), [GO:0045294](http://purl.obolibrary.org/obo/GO_0045294) (alpha-catenin binding), [GO:0002158](http://purl.obolibrary.org/obo/GO_0002158) (osteoclast proliferation), [GO:0045295](http://purl.obolibrary.org/obo/GO_0045295) (gamma-catenin binding), [GO:0045292](http://purl.obolibrary.org/obo/GO_0045292) (mRNA cis splicing, via spliceosome), [GO:0070243](http://purl.obolibrary.org/obo/GO_0070243) (regulation of thymocyte apoptotic process), [GO:0045298](http://purl.obolibrary.org/obo/GO_0045298) (tubulin complex), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0045299](http://purl.obolibrary.org/obo/GO_0045299) (otolith mineralization), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0071578](http://purl.obolibrary.org/obo/GO_0071578) (zinc II ion transmembrane import), [GO:0071579](http://purl.obolibrary.org/obo/GO_0071579) (regulation of zinc ion transport), [GO:0070245](http://purl.obolibrary.org/obo/GO_0070245) (positive regulation of thymocyte apoptotic process), [GO:0071577](http://purl.obolibrary.org/obo/GO_0071577) (zinc II ion transmembrane transport), [GO:0038106](http://purl.obolibrary.org/obo/GO_0038106) (choriogonadotropin hormone binding), [GO:0038109](http://purl.obolibrary.org/obo/GO_0038109) (Kit signaling pathway), [GO:0038108](http://purl.obolibrary.org/obo/GO_0038108) (negative regulation of appetite by leptin-mediated signaling pathway), [GO:0016799](http://purl.obolibrary.org/obo/GO_0016799) (hydrolase activity, hydrolyzing N-glycosyl compounds), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1900460](http://purl.obolibrary.org/obo/GO_1900460) (negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter), [GO:1900462](http://purl.obolibrary.org/obo/GO_1900462) (negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter), [GO:1901796](http://purl.obolibrary.org/obo/GO_1901796) (regulation of signal transduction by p53 class mediator), [GO:1901798](http://purl.obolibrary.org/obo/GO_1901798) (positive regulation of signal transduction by p53 class mediator), [GO:1901799](http://purl.obolibrary.org/obo/GO_1901799) (negative regulation of proteasomal protein catabolic process), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0070232](http://purl.obolibrary.org/obo/GO_0070232) (regulation of T cell apoptotic process), [GO:0070233](http://purl.obolibrary.org/obo/GO_0070233) (negative regulation of T cell apoptotic process), [GO:0071564](http://purl.obolibrary.org/obo/GO_0071564) (npBAF complex), [GO:0070230](http://purl.obolibrary.org/obo/GO_0070230) (positive regulation of lymphocyte apoptotic process), [GO:0071561](http://purl.obolibrary.org/obo/GO_0071561) (nucleus-vacuole junction), [GO:0070231](http://purl.obolibrary.org/obo/GO_0070231) (T cell apoptotic process), [GO:0071567](http://purl.obolibrary.org/obo/GO_0071567) (UFM1 hydrolase activity), [GO:0070236](http://purl.obolibrary.org/obo/GO_0070236) (negative regulation of activation-induced cell death of T cells), [GO:0071565](http://purl.obolibrary.org/obo/GO_0071565) (nBAF complex), [GO:0071566](http://purl.obolibrary.org/obo/GO_0071566) (UFM1 activating enzyme activity), [GO:0071569](http://purl.obolibrary.org/obo/GO_0071569) (protein ufmylation), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0002141](http://purl.obolibrary.org/obo/GO_0002141) (stereocilia ankle link), [GO:0002142](http://purl.obolibrary.org/obo/GO_0002142) (stereocilia ankle link complex), [GO:0002143](http://purl.obolibrary.org/obo/GO_0002143) (tRNA wobble position uridine thiolation), [GO:0070262](http://purl.obolibrary.org/obo/GO_0070262) (peptidyl-serine dephosphorylation), [GO:0002138](http://purl.obolibrary.org/obo/GO_0002138) (retinoic acid biosynthetic process), [GO:0070260](http://purl.obolibrary.org/obo/GO_0070260) (5'-tyrosyl-DNA phosphodiesterase activity), [GO:0071596](http://purl.obolibrary.org/obo/GO_0071596) (ubiquitin-dependent protein catabolic process via the N-end rule pathway), [GO:0070265](http://purl.obolibrary.org/obo/GO_0070265) (necrotic cell death), [GO:0070266](http://purl.obolibrary.org/obo/GO_0070266) (necroptotic process), [GO:0016790](http://purl.obolibrary.org/obo/GO_0016790) (thiolester hydrolase activity), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0070269](http://purl.obolibrary.org/obo/GO_0070269) (pyroptosis), [GO:0071598](http://purl.obolibrary.org/obo/GO_0071598) (neuronal ribonucleoprotein granule), [GO:0016793](http://purl.obolibrary.org/obo/GO_0016793) (triphosphoric monoester hydrolase activity), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0070268](http://purl.obolibrary.org/obo/GO_0070268) (cornification), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0015467](http://purl.obolibrary.org/obo/GO_0015467) (G-protein activated inward rectifier potassium channel activity), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0015464](http://purl.obolibrary.org/obo/GO_0015464) (acetylcholine receptor activity), [GO:0015462](http://purl.obolibrary.org/obo/GO_0015462) (ATPase-coupled protein transmembrane transporter activity), [GO:0002152](http://purl.obolibrary.org/obo/GO_0002152) (bile acid conjugation), [GO:0002154](http://purl.obolibrary.org/obo/GO_0002154) (thyroid hormone mediated signaling pathway), [GO:0071585](http://purl.obolibrary.org/obo/GO_0071585) (detoxification of cadmium ion), [GO:0071586](http://purl.obolibrary.org/obo/GO_0071586) (CAAX-box protein processing), [GO:0070252](http://purl.obolibrary.org/obo/GO_0070252) (actin-mediated cell contraction), [GO:0070253](http://purl.obolibrary.org/obo/GO_0070253) (somatostatin secretion), [GO:0016780](http://purl.obolibrary.org/obo/GO_0016780) (phosphotransferase activity, for other substituted phosphate groups), [GO:0070256](http://purl.obolibrary.org/obo/GO_0070256) (negative regulation of mucus secretion), [GO:0016783](http://purl.obolibrary.org/obo/GO_0016783) (sulfurtransferase activity), [GO:0015459](http://purl.obolibrary.org/obo/GO_0015459) (potassium channel regulator activity), [GO:0016785](http://purl.obolibrary.org/obo/GO_0016785) (transferase activity, transferring selenium-containing groups), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0051123](http://purl.obolibrary.org/obo/GO_0051123) (RNA polymerase II transcriptional preinitiation complex assembly), [GO:0051124](http://purl.obolibrary.org/obo/GO_0051124) (synaptic growth at neuromuscular junction), [GO:0051122](http://purl.obolibrary.org/obo/GO_0051122) (hepoxilin biosynthetic process), [GO:0051120](http://purl.obolibrary.org/obo/GO_0051120) (hepoxilin A3 synthase activity), [GO:1905312](http://purl.obolibrary.org/obo/GO_1905312) (positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0051131](http://purl.obolibrary.org/obo/GO_0051131) (chaperone-mediated protein complex assembly), [GO:0051138](http://purl.obolibrary.org/obo/GO_0051138) (positive regulation of NK T cell differentiation), [GO:0038132](http://purl.obolibrary.org/obo/GO_0038132) (neuregulin binding), [GO:0038131](http://purl.obolibrary.org/obo/GO_0038131) (neuregulin receptor activity), [GO:0002181](http://purl.obolibrary.org/obo/GO_0002181) (cytoplasmic translation), [GO:0089720](http://purl.obolibrary.org/obo/GO_0089720) (caspase binding), [GO:0038133](http://purl.obolibrary.org/obo/GO_0038133) (ERBB2-ERBB3 signaling pathway), [GO:0051150](http://purl.obolibrary.org/obo/GO_0051150) (regulation of smooth muscle cell differentiation), [GO:0015491](http://purl.obolibrary.org/obo/GO_0015491) (cation:cation antiporter activity), [GO:1905327](http://purl.obolibrary.org/obo/GO_1905327) (tracheoesophageal septum formation), [GO:0002189](http://purl.obolibrary.org/obo/GO_0002189) (ribose phosphate diphosphokinase complex), [GO:0051147](http://purl.obolibrary.org/obo/GO_0051147) (regulation of muscle cell differentiation), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0090722](http://purl.obolibrary.org/obo/GO_0090722) (receptor-receptor interaction), [GO:1904000](http://purl.obolibrary.org/obo/GO_1904000) (positive regulation of eating behavior), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:1905333](http://purl.obolibrary.org/obo/GO_1905333) (regulation of gastric motility), [GO:0002193](http://purl.obolibrary.org/obo/GO_0002193) (MAML1-RBP-Jkappa- ICN1 complex), [GO:0002196](http://purl.obolibrary.org/obo/GO_0002196) (Ser-tRNA(Ala) hydrolase activity), [GO:0051156](http://purl.obolibrary.org/obo/GO_0051156) (glucose 6-phosphate metabolic process), [GO:0051154](http://purl.obolibrary.org/obo/GO_0051154) (negative regulation of striated muscle cell differentiation), [GO:0051155](http://purl.obolibrary.org/obo/GO_0051155) (positive regulation of striated muscle cell differentiation), [GO:0090729](http://purl.obolibrary.org/obo/GO_0090729) (toxin activity), [GO:0022604](http://purl.obolibrary.org/obo/GO_0022604) (regulation of cell morphogenesis), [GO:0038194](http://purl.obolibrary.org/obo/GO_0038194) (thyroid-stimulating hormone signaling pathway), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0089709](http://purl.obolibrary.org/obo/GO_0089709) (L-histidine transmembrane transport), [GO:0022602](http://purl.obolibrary.org/obo/GO_0022602) (ovulation cycle process), [GO:0008306](http://purl.obolibrary.org/obo/GO_0008306) (associative learning), [GO:0038190](http://purl.obolibrary.org/obo/GO_0038190) (VEGF-activated neuropilin signaling pathway), [GO:0008305](http://purl.obolibrary.org/obo/GO_0008305) (integrin complex), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0038191](http://purl.obolibrary.org/obo/GO_0038191) (neuropilin binding), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0010613](http://purl.obolibrary.org/obo/GO_0010613) (positive regulation of cardiac muscle hypertrophy), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:0089711](http://purl.obolibrary.org/obo/GO_0089711) (L-glutamate transmembrane transport), [GO:0089712](http://purl.obolibrary.org/obo/GO_0089712) (L-aspartate transmembrane transport), [GO:0008312](http://purl.obolibrary.org/obo/GO_0008312) (7S RNA binding), [GO:0009642](http://purl.obolibrary.org/obo/GO_0009642) (response to light intensity), [GO:0008310](http://purl.obolibrary.org/obo/GO_0008310) (single-stranded DNA 3'-5' exodeoxyribonuclease activity), [GO:0009648](http://purl.obolibrary.org/obo/GO_0009648) (photoperiodism), [GO:0038180](http://purl.obolibrary.org/obo/GO_0038180) (nerve growth factor signaling pathway), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0008307](http://purl.obolibrary.org/obo/GO_0008307) (structural constituent of muscle), [GO:0010626](http://purl.obolibrary.org/obo/GO_0010626) (negative regulation of Schwann cell proliferation), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0010625](http://purl.obolibrary.org/obo/GO_0010625) (positive regulation of Schwann cell proliferation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0035902](http://purl.obolibrary.org/obo/GO_0035902) (response to immobilization stress), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0051103](http://purl.obolibrary.org/obo/GO_0051103) (DNA ligation involved in DNA repair), [GO:0009607](http://purl.obolibrary.org/obo/GO_0009607) (response to biotic stimulus), [GO:0051101](http://purl.obolibrary.org/obo/GO_0051101) (regulation of DNA binding), [GO:0051102](http://purl.obolibrary.org/obo/GO_0051102) (DNA ligation involved in DNA recombination), [GO:0038164](http://purl.obolibrary.org/obo/GO_0038164) (thrombopoietin receptor activity), [GO:0038166](http://purl.obolibrary.org/obo/GO_0038166) (angiotensin-activated signaling pathway), [GO:0038161](http://purl.obolibrary.org/obo/GO_0038161) (prolactin signaling pathway), [GO:0038163](http://purl.obolibrary.org/obo/GO_0038163) (thrombopoietin-mediated signaling pathway), [GO:0038162](http://purl.obolibrary.org/obo/GO_0038162) (erythropoietin-mediated signaling pathway), [GO:0010608](http://purl.obolibrary.org/obo/GO_0010608) (posttranscriptional regulation of gene expression), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0010603](http://purl.obolibrary.org/obo/GO_0010603) (regulation of cytoplasmic mRNA processing body assembly), [GO:0010606](http://purl.obolibrary.org/obo/GO_0010606) (positive regulation of cytoplasmic mRNA processing body assembly), [GO:0051119](http://purl.obolibrary.org/obo/GO_0051119) (sugar transmembrane transporter activity), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:0090694](http://purl.obolibrary.org/obo/GO_0090694) (Scc2-Scc4 cohesin loading complex), [GO:0060800](http://purl.obolibrary.org/obo/GO_0060800) (regulation of cell differentiation involved in embryonic placenta development), [GO:0051096](http://purl.obolibrary.org/obo/GO_0051096) (positive regulation of helicase activity), [GO:0060802](http://purl.obolibrary.org/obo/GO_0060802) (epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification), [GO:0060803](http://purl.obolibrary.org/obo/GO_0060803) (BMP signaling pathway involved in mesodermal cell fate specification), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0051090](http://purl.obolibrary.org/obo/GO_0051090) (regulation of DNA binding transcription factor activity), [GO:0034508](http://purl.obolibrary.org/obo/GO_0034508) (centromere complex assembly), [GO:0060809](http://purl.obolibrary.org/obo/GO_0060809) (mesodermal to mesenchymal transition involved in gastrulation), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0060804](http://purl.obolibrary.org/obo/GO_0060804) (positive regulation of Wnt signaling pathway by BMP signaling pathway), [GO:0051088](http://purl.obolibrary.org/obo/GO_0051088) (PMA-inducible membrane protein ectodomain proteolysis), [GO:0051089](http://purl.obolibrary.org/obo/GO_0051089) (constitutive protein ectodomain proteolysis), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0034501](http://purl.obolibrary.org/obo/GO_0034501) (protein localization to kinetochore), [GO:0010536](http://purl.obolibrary.org/obo/GO_0010536) (positive regulation of activation of Janus kinase activity), [GO:0034504](http://purl.obolibrary.org/obo/GO_0034504) (protein localization to nucleus), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0046501](http://purl.obolibrary.org/obo/GO_0046501) (protoporphyrinogen IX metabolic process), [GO:0099040](http://purl.obolibrary.org/obo/GO_0099040) (ceramide translocation), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0046502](http://purl.obolibrary.org/obo/GO_0046502) (uroporphyrinogen III metabolic process), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0046500](http://purl.obolibrary.org/obo/GO_0046500) (S-adenosylmethionine metabolic process), [GO:0008239](http://purl.obolibrary.org/obo/GO_0008239) (dipeptidyl-peptidase activity), [GO:0008238](http://purl.obolibrary.org/obo/GO_0008238) (exopeptidase activity), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0099038](http://purl.obolibrary.org/obo/GO_0099038) (ceramide-translocating ATPase activity), [GO:0075044](http://purl.obolibrary.org/obo/GO_0075044) (autophagy of host cells involved in interaction with symbiont), [GO:0051099](http://purl.obolibrary.org/obo/GO_0051099) (positive regulation of binding), [GO:0035826](http://purl.obolibrary.org/obo/GO_0035826) (rubidium ion transport), [GO:0047840](http://purl.obolibrary.org/obo/GO_0047840) (dCTP diphosphatase activity), [GO:0035827](http://purl.obolibrary.org/obo/GO_0035827) (rubidium ion transmembrane transporter activity), [GO:0035829](http://purl.obolibrary.org/obo/GO_0035829) (renal rubidium ion absorption), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0010543](http://purl.obolibrary.org/obo/GO_0010543) (regulation of platelet activation), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0060823](http://purl.obolibrary.org/obo/GO_0060823) (canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0090671](http://purl.obolibrary.org/obo/GO_0090671) (telomerase RNA localization to Cajal body), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0038097](http://purl.obolibrary.org/obo/GO_0038097) (positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway), [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis), [GO:0060825](http://purl.obolibrary.org/obo/GO_0060825) (fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0008207](http://purl.obolibrary.org/obo/GO_0008207) (C21-steroid hormone metabolic process), [GO:0008206](http://purl.obolibrary.org/obo/GO_0008206) (bile acid metabolic process), [GO:0038093](http://purl.obolibrary.org/obo/GO_0038093) (Fc receptor signaling pathway), [GO:0046514](http://purl.obolibrary.org/obo/GO_0046514) (ceramide catabolic process), [GO:0038092](http://purl.obolibrary.org/obo/GO_0038092) (nodal signaling pathway), [GO:0060821](http://purl.obolibrary.org/obo/GO_0060821) (inactivation of X chromosome by DNA methylation), [GO:0010519](http://purl.obolibrary.org/obo/GO_0010519) (negative regulation of phospholipase activity), [GO:0035815](http://purl.obolibrary.org/obo/GO_0035815) (positive regulation of renal sodium excretion), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0010512](http://purl.obolibrary.org/obo/GO_0010512) (negative regulation of phosphatidylinositol biosynthetic process), [GO:0035811](http://purl.obolibrary.org/obo/GO_0035811) (negative regulation of urine volume), [GO:0035813](http://purl.obolibrary.org/obo/GO_0035813) (regulation of renal sodium excretion), [GO:0035814](http://purl.obolibrary.org/obo/GO_0035814) (negative regulation of renal sodium excretion), [GO:0035810](http://purl.obolibrary.org/obo/GO_0035810) (positive regulation of urine volume), [GO:0008210](http://purl.obolibrary.org/obo/GO_0008210) (estrogen metabolic process), [GO:0038084](http://purl.obolibrary.org/obo/GO_0038084) (vascular endothelial growth factor signaling pathway), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0008211](http://purl.obolibrary.org/obo/GO_0008211) (glucocorticoid metabolic process), [GO:0046527](http://purl.obolibrary.org/obo/GO_0046527) (glucosyltransferase activity), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0046525](http://purl.obolibrary.org/obo/GO_0046525) (xylosylprotein 4-beta-galactosyltransferase activity), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0010527](http://purl.obolibrary.org/obo/GO_0010527) (positive regulation of transposition, RNA-mediated), [GO:0046530](http://purl.obolibrary.org/obo/GO_0046530) (photoreceptor cell differentiation), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0060816](http://purl.obolibrary.org/obo/GO_0060816) (random inactivation of X chromosome), [GO:0035800](http://purl.obolibrary.org/obo/GO_0035800) (deubiquitinase activator activity), [GO:0010523](http://purl.obolibrary.org/obo/GO_0010523) (negative regulation of calcium ion transport into cytosol), [GO:0010525](http://purl.obolibrary.org/obo/GO_0010525) (regulation of transposition, RNA-mediated), [GO:0035802](http://purl.obolibrary.org/obo/GO_0035802) (adrenal cortex formation), [GO:0010524](http://purl.obolibrary.org/obo/GO_0010524) (positive regulation of calcium ion transport into cytosol), [GO:0010521](http://purl.obolibrary.org/obo/GO_0010521) (telomerase inhibitor activity), [GO:0010520](http://purl.obolibrary.org/obo/GO_0010520) (regulation of reciprocal meiotic recombination), [GO:0035880](http://purl.obolibrary.org/obo/GO_0035880) (embryonic nail plate morphogenesis), [GO:1905221](http://purl.obolibrary.org/obo/GO_1905221) (positive regulation of platelet formation), [GO:0008260](http://purl.obolibrary.org/obo/GO_0008260) (3-oxoacid CoA-transferase activity), [GO:0035881](http://purl.obolibrary.org/obo/GO_0035881) (amacrine cell differentiation), [GO:0090657](http://purl.obolibrary.org/obo/GO_0090657) (telomeric loop disassembly), [GO:0008265](http://purl.obolibrary.org/obo/GO_0008265) (Mo-molybdopterin cofactor sulfurase activity), [GO:0034551](http://purl.obolibrary.org/obo/GO_0034551) (mitochondrial respiratory chain complex III assembly), [GO:1905229](http://purl.obolibrary.org/obo/GO_1905229) (cellular response to thyrotropin-releasing hormone), [GO:0008266](http://purl.obolibrary.org/obo/GO_0008266) (poly(U) RNA binding), [GO:0009597](http://purl.obolibrary.org/obo/GO_0009597) (detection of virus), [GO:0051048](http://purl.obolibrary.org/obo/GO_0051048) (negative regulation of secretion), [GO:0051044](http://purl.obolibrary.org/obo/GO_0051044) (positive regulation of membrane protein ectodomain proteolysis), [GO:0051042](http://purl.obolibrary.org/obo/GO_0051042) (negative regulation of calcium-independent cell-cell adhesion), [GO:0035877](http://purl.obolibrary.org/obo/GO_0035877) (death effector domain binding), [GO:0035878](http://purl.obolibrary.org/obo/GO_0035878) (nail development), [GO:0035879](http://purl.obolibrary.org/obo/GO_0035879) (plasma membrane lactate transport), [GO:0035873](http://purl.obolibrary.org/obo/GO_0035873) (lactate transmembrane transport), [GO:0033218](http://purl.obolibrary.org/obo/GO_0033218) (amide binding), [GO:0010574](http://purl.obolibrary.org/obo/GO_0010574) (regulation of vascular endothelial growth factor production), [GO:0010573](http://purl.obolibrary.org/obo/GO_0010573) (vascular endothelial growth factor production), [GO:0033216](http://purl.obolibrary.org/obo/GO_0033216) (ferric iron import), [GO:0090658](http://purl.obolibrary.org/obo/GO_0090658) (cone matrix sheath), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0090659](http://purl.obolibrary.org/obo/GO_0090659) (walking behavior), [GO:0010592](http://purl.obolibrary.org/obo/GO_0010592) (positive regulation of lamellipodium assembly), [GO:0008272](http://purl.obolibrary.org/obo/GO_0008272) (sulfate transport), [GO:0010591](http://purl.obolibrary.org/obo/GO_0010591) (regulation of lamellipodium assembly), [GO:0008271](http://purl.obolibrary.org/obo/GO_0008271) (secondary active sulfate transmembrane transporter activity), [GO:0035870](http://purl.obolibrary.org/obo/GO_0035870) (dITP diphosphatase activity), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0010594](http://purl.obolibrary.org/obo/GO_0010594) (regulation of endothelial cell migration), [GO:0090666](http://purl.obolibrary.org/obo/GO_0090666) (scaRNA localization to Cajal body), [GO:0033210](http://purl.obolibrary.org/obo/GO_0033210) (leptin-mediated signaling pathway), [GO:0090661](http://purl.obolibrary.org/obo/GO_0090661) (box H/ACA telomerase RNP complex), [GO:0008273](http://purl.obolibrary.org/obo/GO_0008273) (calcium, potassium:sodium antiporter activity), [GO:0090660](http://purl.obolibrary.org/obo/GO_0090660) (cerebrospinal fluid circulation), [GO:0008278](http://purl.obolibrary.org/obo/GO_0008278) (cohesin complex), [GO:0008277](http://purl.obolibrary.org/obo/GO_0008277) (regulation of G-protein coupled receptor protein signaling pathway), [GO:0051059](http://purl.obolibrary.org/obo/GO_0051059) (NF-kappaB binding), [GO:0051057](http://purl.obolibrary.org/obo/GO_0051057) (positive regulation of small GTPase mediated signal transduction), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0051056](http://purl.obolibrary.org/obo/GO_0051056) (regulation of small GTPase mediated signal transduction), [GO:0051054](http://purl.obolibrary.org/obo/GO_0051054) (positive regulation of DNA metabolic process), [GO:0035869](http://purl.obolibrary.org/obo/GO_0035869) (ciliary transition zone), [GO:0010587](http://purl.obolibrary.org/obo/GO_0010587) (miRNA catabolic process), [GO:0090669](http://purl.obolibrary.org/obo/GO_0090669) (telomerase RNA stabilization), [GO:1905243](http://purl.obolibrary.org/obo/GO_1905243) (cellular response to 3,3',5-triiodo-L-thyronine), [GO:0035861](http://purl.obolibrary.org/obo/GO_0035861) (site of double-strand break), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0008241](http://purl.obolibrary.org/obo/GO_0008241) (peptidyl-dipeptidase activity), [GO:0008240](http://purl.obolibrary.org/obo/GO_0008240) (tripeptidyl-peptidase activity), [GO:0051066](http://purl.obolibrary.org/obo/GO_0051066) (dihydrobiopterin metabolic process), [GO:0010559](http://purl.obolibrary.org/obo/GO_0010559) (regulation of glycoprotein biosynthetic process), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0035854](http://purl.obolibrary.org/obo/GO_0035854) (eosinophil fate commitment), [GO:0008250](http://purl.obolibrary.org/obo/GO_0008250) (oligosaccharyltransferase complex), [GO:0090646](http://purl.obolibrary.org/obo/GO_0090646) (mitochondrial tRNA processing), [GO:0010572](http://purl.obolibrary.org/obo/GO_0010572) (positive regulation of platelet activation), [GO:0035850](http://purl.obolibrary.org/obo/GO_0035850) (epithelial cell differentiation involved in kidney development), [GO:0009585](http://purl.obolibrary.org/obo/GO_0009585) (red, far-red light phototransduction), [GO:0008254](http://purl.obolibrary.org/obo/GO_0008254) (3'-nucleotidase activity), [GO:0008253](http://purl.obolibrary.org/obo/GO_0008253) (5'-nucleotidase activity), [GO:0009583](http://purl.obolibrary.org/obo/GO_0009583) (detection of light stimulus), [GO:0009589](http://purl.obolibrary.org/obo/GO_0009589) (detection of UV), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0047812](http://purl.obolibrary.org/obo/GO_0047812) (D-amino-acid N-acetyltransferase activity), [GO:0034517](http://purl.obolibrary.org/obo/GO_0034517) (ribophagy), [GO:0035844](http://purl.obolibrary.org/obo/GO_0035844) (cloaca development), [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization), [GO:0010569](http://purl.obolibrary.org/obo/GO_0010569) (regulation of double-strand break repair via homologous recombination), [GO:0034516](http://purl.obolibrary.org/obo/GO_0034516) (response to vitamin B6), [GO:0035841](http://purl.obolibrary.org/obo/GO_0035841) (new growing cell tip), [GO:0090647](http://purl.obolibrary.org/obo/GO_0090647) (modulation of age-related behavioral decline), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), [GO:0034513](http://purl.obolibrary.org/obo/GO_0034513) (box H/ACA snoRNA binding), [GO:0090648](http://purl.obolibrary.org/obo/GO_0090648) (response to environmental enrichment), [GO:0034590](http://purl.obolibrary.org/obo/GO_0034590) (L-hydroxyproline transmembrane transporter activity), [GO:0033265](http://purl.obolibrary.org/obo/GO_0033265) (choline binding), [GO:1901741](http://purl.obolibrary.org/obo/GO_1901741) (positive regulation of myoblast fusion), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0046577](http://purl.obolibrary.org/obo/GO_0046577) (long-chain-alcohol oxidase activity), [GO:0060887](http://purl.obolibrary.org/obo/GO_0060887) (limb epidermis development), [GO:1900407](http://purl.obolibrary.org/obo/GO_1900407) (regulation of cellular response to oxidative stress), [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0045254](http://purl.obolibrary.org/obo/GO_0045254) (pyruvate dehydrogenase complex), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:0045252](http://purl.obolibrary.org/obo/GO_0045252) (oxoglutarate dehydrogenase complex), [GO:0095500](http://purl.obolibrary.org/obo/GO_0095500) (acetylcholine receptor signaling pathway), [GO:0034589](http://purl.obolibrary.org/obo/GO_0034589) (hydroxyproline transport), [GO:0033257](http://purl.obolibrary.org/obo/GO_0033257) (Bcl3/NF-kappaB2 complex), [GO:0070201](http://purl.obolibrary.org/obo/GO_0070201) (regulation of establishment of protein localization), [GO:0033256](http://purl.obolibrary.org/obo/GO_0033256) (I-kappaB/NF-kappaB complex), [GO:0070202](http://purl.obolibrary.org/obo/GO_0070202) (regulation of establishment of protein localization to chromosome), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0071539](http://purl.obolibrary.org/obo/GO_0071539) (protein localization to centrosome), [GO:0070208](http://purl.obolibrary.org/obo/GO_0070208) (protein heterotrimerization), [GO:0070206](http://purl.obolibrary.org/obo/GO_0070206) (protein trimerization), [GO:0060872](http://purl.obolibrary.org/obo/GO_0060872) (semicircular canal development), [GO:1901750](http://purl.obolibrary.org/obo/GO_1901750) (leukotriene D4 biosynthetic process), [GO:0060879](http://purl.obolibrary.org/obo/GO_0060879) (semicircular canal fusion), [GO:0046588](http://purl.obolibrary.org/obo/GO_0046588) (negative regulation of calcium-dependent cell-cell adhesion), [GO:0060876](http://purl.obolibrary.org/obo/GO_0060876) (semicircular canal formation), [GO:0045261](http://purl.obolibrary.org/obo/GO_0045261) (proton-transporting ATP synthase complex, catalytic core F(1)), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0004703](http://purl.obolibrary.org/obo/GO_0004703) (G-protein coupled receptor kinase activity), [GO:0045263](http://purl.obolibrary.org/obo/GO_0045263) (proton-transporting ATP synthase complex, coupling factor F(o)), [GO:0004708](http://purl.obolibrary.org/obo/GO_0004708) (MAP kinase kinase activity), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008282](http://purl.obolibrary.org/obo/GO_0008282) (inward rectifying potassium channel), [GO:0008281](http://purl.obolibrary.org/obo/GO_0008281) (sulfonylurea receptor activity), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0099093](http://purl.obolibrary.org/obo/GO_0099093) (mitochondrial calcium release), [GO:0046599](http://purl.obolibrary.org/obo/GO_0046599) (regulation of centriole replication), [GO:1900436](http://purl.obolibrary.org/obo/GO_1900436) (positive regulation of filamentous growth of a population of unicellular organisms in response to starvation), [GO:0045273](http://purl.obolibrary.org/obo/GO_0045273) (respiratory chain complex II), [GO:0045277](http://purl.obolibrary.org/obo/GO_0045277) (respiratory chain complex IV), [GO:0045275](http://purl.obolibrary.org/obo/GO_0045275) (respiratory chain complex III), [GO:0071557](http://purl.obolibrary.org/obo/GO_0071557) (histone H3-K27 demethylation), [GO:0033234](http://purl.obolibrary.org/obo/GO_0033234) (negative regulation of protein sumoylation), [GO:0071555](http://purl.obolibrary.org/obo/GO_0071555) (cell wall organization), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0071558](http://purl.obolibrary.org/obo/GO_0071558) (histone demethylase activity (H3-K27 specific)), [GO:0035898](http://purl.obolibrary.org/obo/GO_0035898) (parathyroid hormone secretion), [GO:0071559](http://purl.obolibrary.org/obo/GO_0071559) (response to transforming growth factor beta), [GO:0070228](http://purl.obolibrary.org/obo/GO_0070228) (regulation of lymphocyte apoptotic process), [GO:0008294](http://purl.obolibrary.org/obo/GO_0008294) (calcium- and calmodulin-responsive adenylate cyclase activity), [GO:0008292](http://purl.obolibrary.org/obo/GO_0008292) (acetylcholine biosynthetic process), [GO:0008298](http://purl.obolibrary.org/obo/GO_0008298) (intracellular mRNA localization), [GO:0033231](http://purl.obolibrary.org/obo/GO_0033231) (carbohydrate export), [GO:0008297](http://purl.obolibrary.org/obo/GO_0008297) (single-stranded DNA exodeoxyribonuclease activity), [GO:0008296](http://purl.obolibrary.org/obo/GO_0008296) (3'-5'-exodeoxyribonuclease activity), [GO:0008299](http://purl.obolibrary.org/obo/GO_0008299) (isoprenoid biosynthetic process), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:0060898](http://purl.obolibrary.org/obo/GO_0060898) (eye field cell fate commitment involved in camera-type eye formation), [GO:0045281](http://purl.obolibrary.org/obo/GO_0045281) (succinate dehydrogenase complex), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0070211](http://purl.obolibrary.org/obo/GO_0070211) (Snt2C complex), [GO:0035889](http://purl.obolibrary.org/obo/GO_0035889) (otolith tethering), [GO:0034553](http://purl.obolibrary.org/obo/GO_0034553) (mitochondrial respiratory chain complex II assembly), [GO:0071549](http://purl.obolibrary.org/obo/GO_0071549) (cellular response to dexamethasone stimulus), [GO:0035886](http://purl.obolibrary.org/obo/GO_0035886) (vascular smooth muscle cell differentiation), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), [GO:0035887](http://purl.obolibrary.org/obo/GO_0035887) (aortic smooth muscle cell differentiation), [GO:0016723](http://purl.obolibrary.org/obo/GO_0016723) (oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor), [GO:0016726](http://purl.obolibrary.org/obo/GO_0016726) (oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor), [GO:0046534](http://purl.obolibrary.org/obo/GO_0046534) (positive regulation of photoreceptor cell differentiation), [GO:0045203](http://purl.obolibrary.org/obo/GO_0045203) (integral component of cell outer membrane), [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0047865](http://purl.obolibrary.org/obo/GO_0047865) (dimethylglycine dehydrogenase activity), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060847](http://purl.obolibrary.org/obo/GO_0060847) (endothelial cell fate specification), [GO:0046533](http://purl.obolibrary.org/obo/GO_0046533) (negative regulation of photoreceptor cell differentiation), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0046538](http://purl.obolibrary.org/obo/GO_0046538) (2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity), [GO:0004740](http://purl.obolibrary.org/obo/GO_0004740) (pyruvate dehydrogenase (acetyl-transferring) kinase activity), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0004742](http://purl.obolibrary.org/obo/GO_0004742) (dihydrolipoyllysine-residue acetyltransferase activity), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0004741](http://purl.obolibrary.org/obo/GO_0004741) ([pyruvate dehydrogenase (lipoamide)] phosphatase activity), [GO:0003401](http://purl.obolibrary.org/obo/GO_0003401) (axis elongation), [GO:0004733](http://purl.obolibrary.org/obo/GO_0004733) (pyridoxamine-phosphate oxidase activity), [GO:0003402](http://purl.obolibrary.org/obo/GO_0003402) (planar cell polarity pathway involved in axis elongation), [GO:0004735](http://purl.obolibrary.org/obo/GO_0004735) (pyrroline-5-carboxylate reductase activity), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0046541](http://purl.obolibrary.org/obo/GO_0046541) (saliva secretion), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0004736](http://purl.obolibrary.org/obo/GO_0004736) (pyruvate carboxylase activity), [GO:0004739](http://purl.obolibrary.org/obo/GO_0004739) (pyruvate dehydrogenase (acetyl-transferring) activity), [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development), [GO:0046540](http://purl.obolibrary.org/obo/GO_0046540) (U4/U6 x U5 tri-snRNP complex), [GO:0004738](http://purl.obolibrary.org/obo/GO_0004738) (pyruvate dehydrogenase activity), [GO:0003409](http://purl.obolibrary.org/obo/GO_0003409) (optic cup structural organization), [GO:0033299](http://purl.obolibrary.org/obo/GO_0033299) (secretion of lysosomal enzymes), [GO:0016712](http://purl.obolibrary.org/obo/GO_0016712) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen), [GO:0033292](http://purl.obolibrary.org/obo/GO_0033292) (T-tubule organization), [GO:0016714](http://purl.obolibrary.org/obo/GO_0016714) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen), [GO:0016715](http://purl.obolibrary.org/obo/GO_0016715) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen), [GO:0016716](http://purl.obolibrary.org/obo/GO_0016716) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen), [GO:0045214](http://purl.obolibrary.org/obo/GO_0045214) (sarcomere organization), [GO:0046546](http://purl.obolibrary.org/obo/GO_0046546) (development of primary male sexual characteristics), [GO:0046543](http://purl.obolibrary.org/obo/GO_0046543) (development of secondary female sexual characteristics), [GO:0060836](http://purl.obolibrary.org/obo/GO_0060836) (lymphatic endothelial cell differentiation), [GO:0046544](http://purl.obolibrary.org/obo/GO_0046544) (development of secondary male sexual characteristics), [GO:0099083](http://purl.obolibrary.org/obo/GO_0099083) (retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission), [GO:0046549](http://purl.obolibrary.org/obo/GO_0046549) (retinal cone cell development), [GO:0004751](http://purl.obolibrary.org/obo/GO_0004751) (ribose-5-phosphate isomerase activity), [GO:0003420](http://purl.obolibrary.org/obo/GO_0003420) (regulation of growth plate cartilage chondrocyte proliferation), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060831](http://purl.obolibrary.org/obo/GO_0060831) (smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0004753](http://purl.obolibrary.org/obo/GO_0004753) (saccharopine dehydrogenase activity), [GO:0045217](http://purl.obolibrary.org/obo/GO_0045217) (cell-cell junction maintenance), [GO:0046548](http://purl.obolibrary.org/obo/GO_0046548) (retinal rod cell development), [GO:0004744](http://purl.obolibrary.org/obo/GO_0004744) (retinal isomerase activity), [GO:0003412](http://purl.obolibrary.org/obo/GO_0003412) (establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis), [GO:0003413](http://purl.obolibrary.org/obo/GO_0003413) (chondrocyte differentiation involved in endochondral bone morphogenesis), [GO:0004743](http://purl.obolibrary.org/obo/GO_0004743) (pyruvate kinase activity), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0003415](http://purl.obolibrary.org/obo/GO_0003415) (chondrocyte hypertrophy), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0003416](http://purl.obolibrary.org/obo/GO_0003416) (endochondral bone growth), [GO:0045221](http://purl.obolibrary.org/obo/GO_0045221) (negative regulation of FasL biosynthetic process), [GO:0046552](http://purl.obolibrary.org/obo/GO_0046552) (photoreceptor cell fate commitment), [GO:0004748](http://purl.obolibrary.org/obo/GO_0004748) (ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor), [GO:0003417](http://purl.obolibrary.org/obo/GO_0003417) (growth plate cartilage development), [GO:0004749](http://purl.obolibrary.org/obo/GO_0004749) (ribose phosphate diphosphokinase activity), [GO:0046551](http://purl.obolibrary.org/obo/GO_0046551) (retinal cone cell fate commitment), [GO:0003419](http://purl.obolibrary.org/obo/GO_0003419) (growth plate cartilage chondrocyte proliferation), [GO:0016701](http://purl.obolibrary.org/obo/GO_0016701) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen), [GO:0016702](http://purl.obolibrary.org/obo/GO_0016702) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen), [GO:0033280](http://purl.obolibrary.org/obo/GO_0033280) (response to vitamin D), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0016706](http://purl.obolibrary.org/obo/GO_0016706) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors), [GO:0046556](http://purl.obolibrary.org/obo/GO_0046556) (alpha-L-arabinofuranosidase activity), [GO:0016709](http://purl.obolibrary.org/obo/GO_0016709) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen), [GO:0004720](http://purl.obolibrary.org/obo/GO_0004720) (protein-lysine 6-oxidase activity), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004712](http://purl.obolibrary.org/obo/GO_0004712) (protein serine/threonine/tyrosine kinase activity), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0071514](http://purl.obolibrary.org/obo/GO_0071514) (genetic imprinting), [GO:0071507](http://purl.obolibrary.org/obo/GO_0071507) (MAPK cascade involved in conjugation with cellular fusion), [GO:0033270](http://purl.obolibrary.org/obo/GO_0033270) (paranode region of axon), [GO:0071508](http://purl.obolibrary.org/obo/GO_0071508) (activation of MAPK activity involved in conjugation with cellular fusion), [GO:0033275](http://purl.obolibrary.org/obo/GO_0033275) (actin-myosin filament sliding), [GO:0060855](http://purl.obolibrary.org/obo/GO_0060855) (venous endothelial cell migration involved in lymph vessel development), [GO:0060856](http://purl.obolibrary.org/obo/GO_0060856) (establishment of blood-brain barrier), [GO:0045234](http://purl.obolibrary.org/obo/GO_0045234) (protein palmitoleylation), [GO:0060853](http://purl.obolibrary.org/obo/GO_0060853) (Notch signaling pathway involved in arterial endothelial cell fate commitment), [GO:0004731](http://purl.obolibrary.org/obo/GO_0004731) (purine-nucleoside phosphorylase activity), [GO:0045239](http://purl.obolibrary.org/obo/GO_0045239) (tricarboxylic acid cycle enzyme complex), [GO:0003400](http://purl.obolibrary.org/obo/GO_0003400) (regulation of COPII vesicle coating), [GO:0060854](http://purl.obolibrary.org/obo/GO_0060854) (branching involved in lymph vessel morphogenesis), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:1901727](http://purl.obolibrary.org/obo/GO_1901727) (positive regulation of histone deacetylase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004724](http://purl.obolibrary.org/obo/GO_0004724) (magnesium-dependent protein serine/threonine phosphatase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0045244](http://purl.obolibrary.org/obo/GO_0045244) (succinate-CoA ligase complex (GDP-forming)), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0033268](http://purl.obolibrary.org/obo/GO_0033268) (node of Ranvier), [GO:0004729](http://purl.obolibrary.org/obo/GO_0004729) (oxygen-dependent protoporphyrinogen oxidase activity), [GO:0071506](http://purl.obolibrary.org/obo/GO_0071506) (cellular response to mycophenolic acid), [GO:0071504](http://purl.obolibrary.org/obo/GO_0071504) (cellular response to heparin), [GO:1903400](http://purl.obolibrary.org/obo/GO_1903400) (L-arginine transmembrane transport), [GO:0036010](http://purl.obolibrary.org/obo/GO_0036010) (protein localization to endosome), [GO:1903401](http://purl.obolibrary.org/obo/GO_1903401) (L-lysine transmembrane transport), [GO:0051642](http://purl.obolibrary.org/obo/GO_0051642) (centrosome localization), [GO:0000066](http://purl.obolibrary.org/obo/GO_0000066) (mitochondrial ornithine transport), [GO:0051641](http://purl.obolibrary.org/obo/GO_0051641) (cellular localization), [GO:0000064](http://purl.obolibrary.org/obo/GO_0000064) (L-ornithine transmembrane transporter activity), [GO:0000062](http://purl.obolibrary.org/obo/GO_0000062) (fatty-acyl-CoA binding), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen), [GO:0051648](http://purl.obolibrary.org/obo/GO_0051648) (vesicle localization), [GO:2000594](http://purl.obolibrary.org/obo/GO_2000594) (positive regulation of metanephric DCT cell differentiation), [GO:0051646](http://purl.obolibrary.org/obo/GO_0051646) (mitochondrion localization), [GO:0050313](http://purl.obolibrary.org/obo/GO_0050313) (sulfur dioxygenase activity), [GO:2000597](http://purl.obolibrary.org/obo/GO_2000597) (positive regulation of optic nerve formation), [GO:0051645](http://purl.obolibrary.org/obo/GO_0051645) (Golgi localization), [GO:0036002](http://purl.obolibrary.org/obo/GO_0036002) (pre-mRNA binding), [GO:0036003](http://purl.obolibrary.org/obo/GO_0036003) (positive regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0048009](http://purl.obolibrary.org/obo/GO_0048009) (insulin-like growth factor receptor signaling pathway), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0048007](http://purl.obolibrary.org/obo/GO_0048007) (antigen processing and presentation, exogenous lipid antigen via MHC class Ib), [GO:1903413](http://purl.obolibrary.org/obo/GO_1903413) (cellular response to bile acid), [GO:0048012](http://purl.obolibrary.org/obo/GO_0048012) (hepatocyte growth factor receptor signaling pathway), [GO:0050321](http://purl.obolibrary.org/obo/GO_0050321) (tau-protein kinase activity), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0000076](http://purl.obolibrary.org/obo/GO_0000076) (DNA replication checkpoint), [GO:0048016](http://purl.obolibrary.org/obo/GO_0048016) (inositol phosphate-mediated signaling), [GO:0000073](http://purl.obolibrary.org/obo/GO_0000073) (spindle pole body separation), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0000070](http://purl.obolibrary.org/obo/GO_0000070) (mitotic sister chromatid segregation), [GO:0051659](http://purl.obolibrary.org/obo/GO_0051659) (maintenance of mitochondrion location), [GO:1903421](http://purl.obolibrary.org/obo/GO_1903421) (regulation of synaptic vesicle recycling), [GO:1903426](http://purl.obolibrary.org/obo/GO_1903426) (regulation of reactive oxygen species biosynthetic process), [GO:0048019](http://purl.obolibrary.org/obo/GO_0048019) (receptor antagonist activity), [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity), [GO:1904754](http://purl.obolibrary.org/obo/GO_1904754) (positive regulation of vascular associated smooth muscle cell migration), [GO:0048017](http://purl.obolibrary.org/obo/GO_0048017) (inositol lipid-mediated signaling), [GO:0000038](http://purl.obolibrary.org/obo/GO_0000038) (very long-chain fatty acid metabolic process), [GO:1903427](http://purl.obolibrary.org/obo/GO_1903427) (negative regulation of reactive oxygen species biosynthetic process), [GO:1903428](http://purl.obolibrary.org/obo/GO_1903428) (positive regulation of reactive oxygen species biosynthetic process), [GO:0000045](http://purl.obolibrary.org/obo/GO_0000045) (autophagosome assembly), [GO:0048023](http://purl.obolibrary.org/obo/GO_0048023) (positive regulation of melanin biosynthetic process), [GO:0048022](http://purl.obolibrary.org/obo/GO_0048022) (negative regulation of melanin biosynthetic process), [GO:0000042](http://purl.obolibrary.org/obo/GO_0000042) (protein targeting to Golgi), [GO:0048020](http://purl.obolibrary.org/obo/GO_0048020) (CCR chemokine receptor binding), [GO:0048027](http://purl.obolibrary.org/obo/GO_0048027) (mRNA 5'-UTR binding), [GO:0048026](http://purl.obolibrary.org/obo/GO_0048026) (positive regulation of mRNA splicing, via spliceosome), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0048024](http://purl.obolibrary.org/obo/GO_0048024) (regulation of mRNA splicing, via spliceosome), [GO:0051666](http://purl.obolibrary.org/obo/GO_0051666) (actin cortical patch localization), [GO:1903431](http://purl.obolibrary.org/obo/GO_1903431) (positive regulation of cell maturation), [GO:1904768](http://purl.obolibrary.org/obo/GO_1904768) (all-trans-retinol binding), [GO:0048029](http://purl.obolibrary.org/obo/GO_0048029) (monosaccharide binding), [GO:1903434](http://purl.obolibrary.org/obo/GO_1903434) (negative regulation of constitutive secretory pathway), [GO:1903435](http://purl.obolibrary.org/obo/GO_1903435) (positive regulation of constitutive secretory pathway), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:1902109](http://purl.obolibrary.org/obo/GO_1902109) (negative regulation of mitochondrial membrane permeability involved in apoptotic process), [GO:0000048](http://purl.obolibrary.org/obo/GO_0000048) (peptidyltransferase activity), [GO:0048034](http://purl.obolibrary.org/obo/GO_0048034) (heme O biosynthetic process), [GO:0000055](http://purl.obolibrary.org/obo/GO_0000055) (ribosomal large subunit export from nucleus), [GO:0000053](http://purl.obolibrary.org/obo/GO_0000053) (argininosuccinate metabolic process), [GO:0048038](http://purl.obolibrary.org/obo/GO_0048038) (quinone binding), [GO:0000052](http://purl.obolibrary.org/obo/GO_0000052) (citrulline metabolic process), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0000050](http://purl.obolibrary.org/obo/GO_0000050) (urea cycle), [GO:0008823](http://purl.obolibrary.org/obo/GO_0008823) (cupric reductase activity), [GO:0008821](http://purl.obolibrary.org/obo/GO_0008821) (crossover junction endodeoxyribonuclease activity), [GO:0008817](http://purl.obolibrary.org/obo/GO_0008817) (cob(I)yrinic acid a,c-diamide adenosyltransferase activity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0051604](http://purl.obolibrary.org/obo/GO_0051604) (protein maturation), [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0080182](http://purl.obolibrary.org/obo/GO_0080182) (histone H3-K4 trimethylation), [GO:0036041](http://purl.obolibrary.org/obo/GO_0036041) (long-chain fatty acid binding), [GO:0036042](http://purl.obolibrary.org/obo/GO_0036042) (long-chain fatty acyl-CoA binding), [GO:0007502](http://purl.obolibrary.org/obo/GO_0007502) (digestive tract mesoderm development), [GO:1904706](http://purl.obolibrary.org/obo/GO_1904706) (negative regulation of vascular smooth muscle cell proliferation), [GO:0007500](http://purl.obolibrary.org/obo/GO_0007500) (mesodermal cell fate determination), [GO:0008832](http://purl.obolibrary.org/obo/GO_0008832) (dGTPase activity), [GO:0007501](http://purl.obolibrary.org/obo/GO_0007501) (mesodermal cell fate specification), [GO:0008828](http://purl.obolibrary.org/obo/GO_0008828) (dATP pyrophosphohydrolase activity), [GO:0036038](http://purl.obolibrary.org/obo/GO_0036038) (MKS complex), [GO:0036035](http://purl.obolibrary.org/obo/GO_0036035) (osteoclast development), [GO:0036033](http://purl.obolibrary.org/obo/GO_0036033) (mediator complex binding), [GO:1904713](http://purl.obolibrary.org/obo/GO_1904713) (beta-catenin destruction complex binding), [GO:1904715](http://purl.obolibrary.org/obo/GO_1904715) (negative regulation of chaperone-mediated autophagy), [GO:0000079](http://purl.obolibrary.org/obo/GO_0000079) (regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:1904714](http://purl.obolibrary.org/obo/GO_1904714) (regulation of chaperone-mediated autophagy), [GO:0000086](http://purl.obolibrary.org/obo/GO_0000086) (G2/M transition of mitotic cell cycle), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0000083](http://purl.obolibrary.org/obo/GO_0000083) (regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0000082](http://purl.obolibrary.org/obo/GO_0000082) (G1/S transition of mitotic cell cycle), [GO:0008802](http://purl.obolibrary.org/obo/GO_0008802) (betaine-aldehyde dehydrogenase activity), [GO:0000095](http://purl.obolibrary.org/obo/GO_0000095) (S-adenosyl-L-methionine transmembrane transporter activity), [GO:0036016](http://purl.obolibrary.org/obo/GO_0036016) (cellular response to interleukin-3), [GO:0036019](http://purl.obolibrary.org/obo/GO_0036019) (endolysosome), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0019516](http://purl.obolibrary.org/obo/GO_0019516) (lactate oxidation), [GO:0045806](http://purl.obolibrary.org/obo/GO_0045806) (negative regulation of endocytosis), [GO:0061052](http://purl.obolibrary.org/obo/GO_0061052) (negative regulation of cell growth involved in cardiac muscle cell development), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0045807](http://purl.obolibrary.org/obo/GO_0045807) (positive regulation of endocytosis), [GO:0021837](http://purl.obolibrary.org/obo/GO_0021837) (motogenic signaling involved in postnatal olfactory bulb interneuron migration), [GO:0061055](http://purl.obolibrary.org/obo/GO_0061055) (myotome development), [GO:0036092](http://purl.obolibrary.org/obo/GO_0036092) (phosphatidylinositol-3-phosphate biosynthetic process), [GO:0021830](http://purl.obolibrary.org/obo/GO_0021830) (interneuron migration from the subpallium to the cortex), [GO:0021831](http://purl.obolibrary.org/obo/GO_0021831) (embryonic olfactory bulb interneuron precursor migration), [GO:0036093](http://purl.obolibrary.org/obo/GO_0036093) (germ cell proliferation), [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0007533](http://purl.obolibrary.org/obo/GO_0007533) (mating type switching), [GO:0008865](http://purl.obolibrary.org/obo/GO_0008865) (fructokinase activity), [GO:0006203](http://purl.obolibrary.org/obo/GO_0006203) (dGTP catabolic process), [GO:0007528](http://purl.obolibrary.org/obo/GO_0007528) (neuromuscular junction development), [GO:0007529](http://purl.obolibrary.org/obo/GO_0007529) (establishment of synaptic specificity at neuromuscular junction), [GO:0033814](http://purl.obolibrary.org/obo/GO_0033814) (propanoyl-CoA C-acyltransferase activity), [GO:0097002](http://purl.obolibrary.org/obo/GO_0097002) (mitochondrial inner boundary membrane), [GO:0097006](http://purl.obolibrary.org/obo/GO_0097006) (regulation of plasma lipoprotein particle levels), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0061061](http://purl.obolibrary.org/obo/GO_0061061) (muscle structure development), [GO:0061045](http://purl.obolibrary.org/obo/GO_0061045) (negative regulation of wound healing), [GO:0061046](http://purl.obolibrary.org/obo/GO_0061046) (regulation of branching involved in lung morphogenesis), [GO:0021828](http://purl.obolibrary.org/obo/GO_0021828) (gonadotrophin-releasing hormone neuronal migration to the hypothalamus), [GO:1902164](http://purl.obolibrary.org/obo/GO_1902164) (positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0061047](http://purl.obolibrary.org/obo/GO_0061047) (positive regulation of branching involved in lung morphogenesis), [GO:0045814](http://purl.obolibrary.org/obo/GO_0045814) (negative regulation of gene expression, epigenetic), [GO:1902167](http://purl.obolibrary.org/obo/GO_1902167) (positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0061041](http://purl.obolibrary.org/obo/GO_0061041) (regulation of wound healing), [GO:1902165](http://purl.obolibrary.org/obo/GO_1902165) (regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:1902166](http://purl.obolibrary.org/obo/GO_1902166) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0061044](http://purl.obolibrary.org/obo/GO_0061044) (negative regulation of vascular wound healing), [GO:0006212](http://purl.obolibrary.org/obo/GO_0006212) (uracil catabolic process), [GO:0006210](http://purl.obolibrary.org/obo/GO_0006210) (thymine catabolic process), [GO:0061049](http://purl.obolibrary.org/obo/GO_0061049) (cell growth involved in cardiac muscle cell development), [GO:0045813](http://purl.obolibrary.org/obo/GO_0045813) (positive regulation of Wnt signaling pathway, calcium modulating pathway), [GO:0006213](http://purl.obolibrary.org/obo/GO_0006213) (pyrimidine nucleoside metabolic process), [GO:0006214](http://purl.obolibrary.org/obo/GO_0006214) (thymidine catabolic process), [GO:0097012](http://purl.obolibrary.org/obo/GO_0097012) (response to granulocyte macrophage colony-stimulating factor), [GO:0006208](http://purl.obolibrary.org/obo/GO_0006208) (pyrimidine nucleobase catabolic process), [GO:0097011](http://purl.obolibrary.org/obo/GO_0097011) (cellular response to granulocyte macrophage colony-stimulating factor stimulus), [GO:0006206](http://purl.obolibrary.org/obo/GO_0006206) (pyrimidine nucleobase metabolic process), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0019511](http://purl.obolibrary.org/obo/GO_0019511) (peptidyl-proline hydroxylation), [GO:0061051](http://purl.obolibrary.org/obo/GO_0061051) (positive regulation of cell growth involved in cardiac muscle cell development), [GO:0019510](http://purl.obolibrary.org/obo/GO_0019510) (S-adenosylhomocysteine catabolic process), [GO:1902174](http://purl.obolibrary.org/obo/GO_1902174) (positive regulation of keratinocyte apoptotic process), [GO:0061078](http://purl.obolibrary.org/obo/GO_0061078) (positive regulation of prostaglandin secretion involved in immune response), [GO:0021819](http://purl.obolibrary.org/obo/GO_0021819) (layer formation in cerebral cortex), [GO:0061074](http://purl.obolibrary.org/obo/GO_0061074) (regulation of neural retina development), [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway), [GO:1902176](http://purl.obolibrary.org/obo/GO_1902176) (negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0045820](http://purl.obolibrary.org/obo/GO_0045820) (negative regulation of glycolytic process), [GO:0045823](http://purl.obolibrary.org/obo/GO_0045823) (positive regulation of heart contraction), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0045822](http://purl.obolibrary.org/obo/GO_0045822) (negative regulation of heart contraction), [GO:0007512](http://purl.obolibrary.org/obo/GO_0007512) (adult heart development), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0099641](http://purl.obolibrary.org/obo/GO_0099641) (anterograde axonal protein transport), [GO:0061081](http://purl.obolibrary.org/obo/GO_0061081) (positive regulation of myeloid leukocyte cytokine production involved in immune response), [GO:0045838](http://purl.obolibrary.org/obo/GO_0045838) (positive regulation of membrane potential), [GO:0045839](http://purl.obolibrary.org/obo/GO_0045839) (negative regulation of mitotic nuclear division), [GO:0045836](http://purl.obolibrary.org/obo/GO_0045836) (positive regulation of meiotic nuclear division), [GO:0021801](http://purl.obolibrary.org/obo/GO_0021801) (cerebral cortex radial glia guided migration), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:1902188](http://purl.obolibrary.org/obo/GO_1902188) (positive regulation of viral release from host cell), [GO:0036066](http://purl.obolibrary.org/obo/GO_0036066) (protein O-linked fucosylation), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0045830](http://purl.obolibrary.org/obo/GO_0045830) (positive regulation of isotype switching), [GO:0036060](http://purl.obolibrary.org/obo/GO_0036060) (slit diaphragm assembly), [GO:0021800](http://purl.obolibrary.org/obo/GO_0021800) (cerebral cortex tangential migration), [GO:0045834](http://purl.obolibrary.org/obo/GO_0045834) (positive regulation of lipid metabolic process), [GO:0007525](http://purl.obolibrary.org/obo/GO_0007525) (somatic muscle development), [GO:0045835](http://purl.obolibrary.org/obo/GO_0045835) (negative regulation of meiotic nuclear division), [GO:0007522](http://purl.obolibrary.org/obo/GO_0007522) (visceral muscle development), [GO:0008853](http://purl.obolibrary.org/obo/GO_0008853) (exodeoxyribonuclease III activity), [GO:0045833](http://purl.obolibrary.org/obo/GO_0045833) (negative regulation of lipid metabolic process), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0061073](http://purl.obolibrary.org/obo/GO_0061073) (ciliary body morphogenesis), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), [GO:0061014](http://purl.obolibrary.org/obo/GO_0061014) (positive regulation of mRNA catabolic process), [GO:0007571](http://purl.obolibrary.org/obo/GO_0007571) (age-dependent general metabolic decline), [GO:0006241](http://purl.obolibrary.org/obo/GO_0006241) (CTP biosynthetic process), [GO:0021879](http://purl.obolibrary.org/obo/GO_0021879) (forebrain neuron differentiation), [GO:1903441](http://purl.obolibrary.org/obo/GO_1903441) (protein localization to ciliary membrane), [GO:0061010](http://purl.obolibrary.org/obo/GO_0061010) (gall bladder development), [GO:1904778](http://purl.obolibrary.org/obo/GO_1904778) (positive regulation of protein localization to cell cortex), [GO:1903445](http://purl.obolibrary.org/obo/GO_1903445) (protein transport from ciliary membrane to plasma membrane), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0021877](http://purl.obolibrary.org/obo/GO_0021877) (forebrain neuron fate commitment), [GO:0061017](http://purl.obolibrary.org/obo/GO_0061017) (hepatoblast differentiation), [GO:0021871](http://purl.obolibrary.org/obo/GO_0021871) (forebrain regionalization), [GO:1903449](http://purl.obolibrary.org/obo/GO_1903449) (androst-4-ene-3,17-dione biosynthetic process), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0032526](http://purl.obolibrary.org/obo/GO_0032526) (response to retinoic acid), [GO:0032527](http://purl.obolibrary.org/obo/GO_0032527) (protein exit from endoplasmic reticulum), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0051683](http://purl.obolibrary.org/obo/GO_0051683) (establishment of Golgi localization), [GO:0019563](http://purl.obolibrary.org/obo/GO_0019563) (glycerol catabolic process), [GO:0048041](http://purl.obolibrary.org/obo/GO_0048041) (focal adhesion assembly), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification), [GO:1904782](http://purl.obolibrary.org/obo/GO_1904782) (negative regulation of NMDA glutamate receptor activity), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:0061003](http://purl.obolibrary.org/obo/GO_0061003) (positive regulation of dendritic spine morphogenesis), [GO:1903452](http://purl.obolibrary.org/obo/GO_1903452) (positive regulation of G1 to G0 transition), [GO:1904784](http://purl.obolibrary.org/obo/GO_1904784) (NLRP1 inflammasome complex assembly), [GO:1904783](http://purl.obolibrary.org/obo/GO_1904783) (positive regulation of NMDA glutamate receptor activity), [GO:0061009](http://purl.obolibrary.org/obo/GO_0061009) (common bile duct development), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0007585](http://purl.obolibrary.org/obo/GO_0007585) (respiratory gaseous exchange), [GO:1903457](http://purl.obolibrary.org/obo/GO_1903457) (lactate catabolic process), [GO:0006259](http://purl.obolibrary.org/obo/GO_0006259) (DNA metabolic process), [GO:0021860](http://purl.obolibrary.org/obo/GO_0021860) (pyramidal neuron development), [GO:0007588](http://purl.obolibrary.org/obo/GO_0007588) (excretion), [GO:0061007](http://purl.obolibrary.org/obo/GO_0061007) (hepaticobiliary system process), [GO:0061008](http://purl.obolibrary.org/obo/GO_0061008) (hepaticobiliary system development), [GO:0006258](http://purl.obolibrary.org/obo/GO_0006258) (UDP-glucose catabolic process), [GO:0007589](http://purl.obolibrary.org/obo/GO_0007589) (body fluid secretion), [GO:0032515](http://purl.obolibrary.org/obo/GO_0032515) (negative regulation of phosphoprotein phosphatase activity), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0051693](http://purl.obolibrary.org/obo/GO_0051693) (actin filament capping), [GO:0051694](http://purl.obolibrary.org/obo/GO_0051694) (pointed-end actin filament capping), [GO:0099634](http://purl.obolibrary.org/obo/GO_0099634) (postsynaptic specialization membrane), [GO:0032510](http://purl.obolibrary.org/obo/GO_0032510) (endosome to lysosome transport via multivesicular body sorting pathway), [GO:0048050](http://purl.obolibrary.org/obo/GO_0048050) (post-embryonic eye morphogenesis), [GO:0032511](http://purl.obolibrary.org/obo/GO_0032511) (late endosome to vacuole transport via multivesicular body sorting pathway), [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development), [GO:0018208](http://purl.obolibrary.org/obo/GO_0018208) (peptidyl-proline modification), [GO:0061035](http://purl.obolibrary.org/obo/GO_0061035) (regulation of cartilage development), [GO:0061036](http://purl.obolibrary.org/obo/GO_0061036) (positive regulation of cartilage development), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:1903465](http://purl.obolibrary.org/obo/GO_1903465) (positive regulation of mitotic cell cycle DNA replication), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0006222](http://purl.obolibrary.org/obo/GO_0006222) (UMP biosynthetic process), [GO:0021853](http://purl.obolibrary.org/obo/GO_0021853) (cerebral cortex GABAergic interneuron migration), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0021855](http://purl.obolibrary.org/obo/GO_0021855) (hypothalamus cell migration), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:1904798](http://purl.obolibrary.org/obo/GO_1904798) (positive regulation of core promoter binding), [GO:0061038](http://purl.obolibrary.org/obo/GO_0061038) (uterus morphogenesis), [GO:0008887](http://purl.obolibrary.org/obo/GO_0008887) (glycerate kinase activity), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0007548](http://purl.obolibrary.org/obo/GO_0007548) (sex differentiation), [GO:0048069](http://purl.obolibrary.org/obo/GO_0048069) (eye pigmentation), [GO:0032508](http://purl.obolibrary.org/obo/GO_0032508) (DNA duplex unwinding), [GO:0099606](http://purl.obolibrary.org/obo/GO_0099606) (microtubule plus-end directed mitotic chromosome migration), [GO:0099607](http://purl.obolibrary.org/obo/GO_0099607) (lateral attachment of mitotic spindle microtubules to kinetochore), [GO:0099604](http://purl.obolibrary.org/obo/GO_0099604) (ligand-gated calcium channel activity), [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process), [GO:0019546](http://purl.obolibrary.org/obo/GO_0019546) (arginine deiminase pathway), [GO:0019547](http://purl.obolibrary.org/obo/GO_0019547) (arginine catabolic process to ornithine), [GO:0018216](http://purl.obolibrary.org/obo/GO_0018216) (peptidyl-arginine methylation), [GO:0061024](http://purl.obolibrary.org/obo/GO_0061024) (membrane organization), [GO:0061025](http://purl.obolibrary.org/obo/GO_0061025) (membrane fusion), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0021847](http://purl.obolibrary.org/obo/GO_0021847) (ventricular zone neuroblast division), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier), [GO:0061029](http://purl.obolibrary.org/obo/GO_0061029) (eyelid development in camera-type eye), [GO:0007566](http://purl.obolibrary.org/obo/GO_0007566) (embryo implantation), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0006228](http://purl.obolibrary.org/obo/GO_0006228) (UTP biosynthetic process), [GO:0048076](http://purl.obolibrary.org/obo/GO_0048076) (regulation of compound eye pigmentation), [GO:0033829](http://purl.obolibrary.org/obo/GO_0033829) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity), [GO:0048070](http://purl.obolibrary.org/obo/GO_0048070) (regulation of developmental pigmentation), [GO:0019531](http://purl.obolibrary.org/obo/GO_0019531) (oxalate transmembrane transporter activity), [GO:0019530](http://purl.obolibrary.org/obo/GO_0019530) (taurine metabolic process), [GO:0099615](http://purl.obolibrary.org/obo/GO_0099615) ((D)-2-hydroxyglutarate-pyruvate transhydrogenase activity), [GO:0019532](http://purl.obolibrary.org/obo/GO_0019532) (oxalate transport), [GO:0048074](http://purl.obolibrary.org/obo/GO_0048074) (negative regulation of eye pigmentation), [GO:0033823](http://purl.obolibrary.org/obo/GO_0033823) (procollagen glucosyltransferase activity), [GO:0019534](http://purl.obolibrary.org/obo/GO_0019534) (toxin transmembrane transporter activity), [GO:0018205](http://purl.obolibrary.org/obo/GO_0018205) (peptidyl-lysine modification), [GO:0070728](http://purl.obolibrary.org/obo/GO_0070728) (leucine binding), [GO:0007494](http://purl.obolibrary.org/obo/GO_0007494) (midgut development), [GO:0006163](http://purl.obolibrary.org/obo/GO_0006163) (purine nucleotide metabolic process), [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity), [GO:0006164](http://purl.obolibrary.org/obo/GO_0006164) (purine nucleotide biosynthetic process), [GO:0031120](http://purl.obolibrary.org/obo/GO_0031120) (snRNA pseudouridine synthesis), [GO:0032451](http://purl.obolibrary.org/obo/GO_0032451) (demethylase activity), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0006161](http://purl.obolibrary.org/obo/GO_0006161) (deoxyguanosine catabolic process), [GO:0007493](http://purl.obolibrary.org/obo/GO_0007493) (endodermal cell fate determination), [GO:0021797](http://purl.obolibrary.org/obo/GO_0021797) (forebrain anterior/posterior pattern specification), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0006167](http://purl.obolibrary.org/obo/GO_0006167) (AMP biosynthetic process), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0045765](http://purl.obolibrary.org/obo/GO_0045765) (regulation of angiogenesis), [GO:0007499](http://purl.obolibrary.org/obo/GO_0007499) (ectoderm and mesoderm interaction), [GO:0006168](http://purl.obolibrary.org/obo/GO_0006168) (adenine salvage), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0006165](http://purl.obolibrary.org/obo/GO_0006165) (nucleoside diphosphate phosphorylation), [GO:0007497](http://purl.obolibrary.org/obo/GO_0007497) (posterior midgut development), [GO:0006166](http://purl.obolibrary.org/obo/GO_0006166) (purine ribonucleoside salvage), [GO:0021794](http://purl.obolibrary.org/obo/GO_0021794) (thalamus development), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0021795](http://purl.obolibrary.org/obo/GO_0021795) (cerebral cortex cell migration), [GO:0006169](http://purl.obolibrary.org/obo/GO_0006169) (adenosine salvage), [GO:0021796](http://purl.obolibrary.org/obo/GO_0021796) (cerebral cortex regionalization), [GO:0031118](http://purl.obolibrary.org/obo/GO_0031118) (rRNA pseudouridine synthesis), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0031119](http://purl.obolibrary.org/obo/GO_0031119) (tRNA pseudouridine synthesis), [GO:0019483](http://purl.obolibrary.org/obo/GO_0019483) (beta-alanine biosynthetic process), [GO:0019482](http://purl.obolibrary.org/obo/GO_0019482) (beta-alanine metabolic process), [GO:0019484](http://purl.obolibrary.org/obo/GO_0019484) (beta-alanine catabolic process), [GO:0032443](http://purl.obolibrary.org/obo/GO_0032443) (regulation of ergosterol biosynthetic process), [GO:0031113](http://purl.obolibrary.org/obo/GO_0031113) (regulation of microtubule polymerization), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0070724](http://purl.obolibrary.org/obo/GO_0070724) (BMP receptor complex), [GO:0032448](http://purl.obolibrary.org/obo/GO_0032448) (DNA hairpin binding), [GO:0070722](http://purl.obolibrary.org/obo/GO_0070722) (Tle3-Aes complex), [GO:0032445](http://purl.obolibrary.org/obo/GO_0032445) (fructose import), [GO:0070723](http://purl.obolibrary.org/obo/GO_0070723) (response to cholesterol), [GO:0006171](http://purl.obolibrary.org/obo/GO_0006171) (cAMP biosynthetic process), [GO:0070715](http://purl.obolibrary.org/obo/GO_0070715) (sodium-dependent organic cation transport), [GO:0006175](http://purl.obolibrary.org/obo/GO_0006175) (dATP biosynthetic process), [GO:0006172](http://purl.obolibrary.org/obo/GO_0006172) (ADP biosynthetic process), [GO:0006178](http://purl.obolibrary.org/obo/GO_0006178) (guanine salvage), [GO:0045776](http://purl.obolibrary.org/obo/GO_0045776) (negative regulation of blood pressure), [GO:0043111](http://purl.obolibrary.org/obo/GO_0043111) (replication fork arrest), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0045773](http://purl.obolibrary.org/obo/GO_0045773) (positive regulation of axon extension), [GO:0043113](http://purl.obolibrary.org/obo/GO_0043113) (receptor clustering), [GO:0006177](http://purl.obolibrary.org/obo/GO_0006177) (GMP biosynthetic process), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0043116](http://purl.obolibrary.org/obo/GO_0043116) (negative regulation of vascular permeability), [GO:0045779](http://purl.obolibrary.org/obo/GO_0045779) (negative regulation of bone resorption), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0021784](http://purl.obolibrary.org/obo/GO_0021784) (postganglionic parasympathetic fiber development), [GO:0045778](http://purl.obolibrary.org/obo/GO_0045778) (positive regulation of ossification), [GO:0043117](http://purl.obolibrary.org/obo/GO_0043117) (positive regulation of vascular permeability), [GO:0021785](http://purl.obolibrary.org/obo/GO_0021785) (branchiomotor neuron axon guidance), [GO:0031109](http://purl.obolibrary.org/obo/GO_0031109) (microtubule polymerization or depolymerization), [GO:0032438](http://purl.obolibrary.org/obo/GO_0032438) (melanosome organization), [GO:0019470](http://purl.obolibrary.org/obo/GO_0019470) (4-hydroxyproline catabolic process), [GO:0045780](http://purl.obolibrary.org/obo/GO_0045780) (positive regulation of bone resorption), [GO:0043120](http://purl.obolibrary.org/obo/GO_0043120) (tumor necrosis factor binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0032432](http://purl.obolibrary.org/obo/GO_0032432) (actin filament bundle), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0032433](http://purl.obolibrary.org/obo/GO_0032433) (filopodium tip), [GO:0032430](http://purl.obolibrary.org/obo/GO_0032430) (positive regulation of phospholipase A2 activity), [GO:0033762](http://purl.obolibrary.org/obo/GO_0033762) (response to glucagon), [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration), [GO:0019477](http://purl.obolibrary.org/obo/GO_0019477) (L-lysine catabolic process), [GO:0018146](http://purl.obolibrary.org/obo/GO_0018146) (keratan sulfate biosynthetic process), [GO:0032431](http://purl.obolibrary.org/obo/GO_0032431) (activation of phospholipase A2 activity), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0031105](http://purl.obolibrary.org/obo/GO_0031105) (septin complex), [GO:0032437](http://purl.obolibrary.org/obo/GO_0032437) (cuticular plate), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0032434](http://purl.obolibrary.org/obo/GO_0032434) (regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0032435](http://purl.obolibrary.org/obo/GO_0032435) (negative regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0031104](http://purl.obolibrary.org/obo/GO_0031104) (dendrite regeneration), [GO:0021779](http://purl.obolibrary.org/obo/GO_0021779) (oligodendrocyte cell fate commitment), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0006145](http://purl.obolibrary.org/obo/GO_0006145) (purine nucleobase catabolic process), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045785](http://purl.obolibrary.org/obo/GO_0045785) (positive regulation of cell adhesion), [GO:0021778](http://purl.obolibrary.org/obo/GO_0021778) (oligodendrocyte cell fate specification), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0006144](http://purl.obolibrary.org/obo/GO_0006144) (purine nucleobase metabolic process), [GO:0044458](http://purl.obolibrary.org/obo/GO_0044458) (motile cilium assembly), [GO:0006149](http://purl.obolibrary.org/obo/GO_0006149) (deoxyinosine catabolic process), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0043129](http://purl.obolibrary.org/obo/GO_0043129) (surfactant homeostasis), [GO:0006148](http://purl.obolibrary.org/obo/GO_0006148) (inosine catabolic process), [GO:0043128](http://purl.obolibrary.org/obo/GO_0043128) (positive regulation of 1-phosphatidylinositol 4-kinase activity), [GO:0032429](http://purl.obolibrary.org/obo/GO_0032429) (regulation of phospholipase A2 activity), [GO:0045793](http://purl.obolibrary.org/obo/GO_0045793) (positive regulation of cell size), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0045794](http://purl.obolibrary.org/obo/GO_0045794) (negative regulation of cell volume), [GO:1990666](http://purl.obolibrary.org/obo/GO_1990666) (PCSK9-LDLR complex), [GO:1990667](http://purl.obolibrary.org/obo/GO_1990667) (PCSK9-AnxA2 complex), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0070742](http://purl.obolibrary.org/obo/GO_0070742) (C2H2 zinc finger domain binding), [GO:0032421](http://purl.obolibrary.org/obo/GO_0032421) (stereocilium bundle), [GO:0055102](http://purl.obolibrary.org/obo/GO_0055102) (lipase inhibitor activity), [GO:0019464](http://purl.obolibrary.org/obo/GO_0019464) (glycine decarboxylation via glycine cleavage system), [GO:0032422](http://purl.obolibrary.org/obo/GO_0032422) (purine-rich negative regulatory element binding), [GO:0055103](http://purl.obolibrary.org/obo/GO_0055103) (ligase regulator activity), [GO:0070740](http://purl.obolibrary.org/obo/GO_0070740) (tubulin-glutamic acid ligase activity), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:0055105](http://purl.obolibrary.org/obo/GO_0055105) (ubiquitin-protein transferase inhibitor activity), [GO:0032425](http://purl.obolibrary.org/obo/GO_0032425) (positive regulation of mismatch repair), [GO:0032426](http://purl.obolibrary.org/obo/GO_0032426) (stereocilium tip), [GO:0032423](http://purl.obolibrary.org/obo/GO_0032423) (regulation of mismatch repair), [GO:0021768](http://purl.obolibrary.org/obo/GO_0021768) (nucleus accumbens development), [GO:0021769](http://purl.obolibrary.org/obo/GO_0021769) (orbitofrontal cortex development), [GO:0055120](http://purl.obolibrary.org/obo/GO_0055120) (striated muscle dense body), [GO:0006150](http://purl.obolibrary.org/obo/GO_0006150) (hypoxanthine oxidation), [GO:0021764](http://purl.obolibrary.org/obo/GO_0021764) (amygdala development), [GO:0006157](http://purl.obolibrary.org/obo/GO_0006157) (deoxyadenosine catabolic process), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0043138](http://purl.obolibrary.org/obo/GO_0043138) (3'-5' DNA helicase activity), [GO:0021761](http://purl.obolibrary.org/obo/GO_0021761) (limbic system development), [GO:0043137](http://purl.obolibrary.org/obo/GO_0043137) (DNA replication, removal of RNA primer), [GO:0021762](http://purl.obolibrary.org/obo/GO_0021762) (substantia nigra development), [GO:0021763](http://purl.obolibrary.org/obo/GO_0021763) (subthalamic nucleus development), [GO:0043139](http://purl.obolibrary.org/obo/GO_0043139) (5'-3' DNA helicase activity), [GO:0032418](http://purl.obolibrary.org/obo/GO_0032418) (lysosome localization), [GO:0032416](http://purl.obolibrary.org/obo/GO_0032416) (negative regulation of sodium:proton antiporter activity), [GO:0043141](http://purl.obolibrary.org/obo/GO_0043141) (ATP-dependent 5'-3' DNA helicase activity), [GO:0043140](http://purl.obolibrary.org/obo/GO_0043140) (ATP-dependent 3'-5' DNA helicase activity), [GO:0043142](http://purl.obolibrary.org/obo/GO_0043142) (single-stranded DNA-dependent ATPase activity), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:0032411](http://purl.obolibrary.org/obo/GO_0032411) (positive regulation of transporter activity), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0055117](http://purl.obolibrary.org/obo/GO_0055117) (regulation of cardiac muscle contraction), [GO:0018126](http://purl.obolibrary.org/obo/GO_0018126) (protein hydroxylation), [GO:0033745](http://purl.obolibrary.org/obo/GO_0033745) (L-methionine-(R)-S-oxide reductase activity), [GO:0070734](http://purl.obolibrary.org/obo/GO_0070734) (histone H3-K27 methylation), [GO:0055119](http://purl.obolibrary.org/obo/GO_0055119) (relaxation of cardiac muscle), [GO:0033743](http://purl.obolibrary.org/obo/GO_0033743) (peptide-methionine (R)-S-oxide reductase activity), [GO:0045726](http://purl.obolibrary.org/obo/GO_0045726) (positive regulation of integrin biosynthetic process), [GO:0045727](http://purl.obolibrary.org/obo/GO_0045727) (positive regulation of translation), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:1902078](http://purl.obolibrary.org/obo/GO_1902078) (positive regulation of lateral motor column neuron migration), [GO:0045720](http://purl.obolibrary.org/obo/GO_0045720) (negative regulation of integrin biosynthetic process), [GO:0045721](http://purl.obolibrary.org/obo/GO_0045721) (negative regulation of gluconeogenesis), [GO:0045724](http://purl.obolibrary.org/obo/GO_0045724) (positive regulation of cilium assembly), [GO:0045725](http://purl.obolibrary.org/obo/GO_0045725) (positive regulation of glycogen biosynthetic process), [GO:0045722](http://purl.obolibrary.org/obo/GO_0045722) (positive regulation of gluconeogenesis), [GO:0045723](http://purl.obolibrary.org/obo/GO_0045723) (positive regulation of fatty acid biosynthetic process), [GO:1990683](http://purl.obolibrary.org/obo/GO_1990683) (DNA double-strand break attachment to nuclear envelope), [GO:0015909](http://purl.obolibrary.org/obo/GO_0015909) (long-chain fatty acid transport), [GO:0018193](http://purl.obolibrary.org/obo/GO_0018193) (peptidyl-amino acid modification), [GO:0015908](http://purl.obolibrary.org/obo/GO_0015908) (fatty acid transport), [GO:0003923](http://purl.obolibrary.org/obo/GO_0003923) (GPI-anchor transamidase activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0032488](http://purl.obolibrary.org/obo/GO_0032488) (Cdc42 protein signal transduction), [GO:1902072](http://purl.obolibrary.org/obo/GO_1902072) (negative regulation of hypoxia-inducible factor-1alpha signaling pathway), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0032480](http://purl.obolibrary.org/obo/GO_0032480) (negative regulation of type I interferon production), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:2000607](http://purl.obolibrary.org/obo/GO_2000607) (negative regulation of cell proliferation involved in mesonephros development), [GO:1990696](http://purl.obolibrary.org/obo/GO_1990696) (USH2 complex), [GO:2000609](http://purl.obolibrary.org/obo/GO_2000609) (regulation of thyroid hormone generation), [GO:1990698](http://purl.obolibrary.org/obo/GO_1990698) (palmitoleoyltransferase activity), [GO:0003934](http://purl.obolibrary.org/obo/GO_0003934) (GTP cyclohydrolase I activity), [GO:0015918](http://purl.obolibrary.org/obo/GO_0015918) (sterol transport), [GO:0015917](http://purl.obolibrary.org/obo/GO_0015917) (aminophospholipid transport), [GO:0003937](http://purl.obolibrary.org/obo/GO_0003937) (IMP cyclohydrolase activity), [GO:0003938](http://purl.obolibrary.org/obo/GO_0003938) (IMP dehydrogenase activity), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0031143](http://purl.obolibrary.org/obo/GO_0031143) (pseudopodium), [GO:2000601](http://purl.obolibrary.org/obo/GO_2000601) (positive regulation of Arp2/3 complex-mediated actin nucleation), [GO:0032475](http://purl.obolibrary.org/obo/GO_0032475) (otolith formation), [GO:0015910](http://purl.obolibrary.org/obo/GO_0015910) (peroxisomal long-chain fatty acid import), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0032472](http://purl.obolibrary.org/obo/GO_0032472) (Golgi calcium ion transport), [GO:0006183](http://purl.obolibrary.org/obo/GO_0006183) (GTP biosynthetic process), [GO:0032470](http://purl.obolibrary.org/obo/GO_0032470) (positive regulation of endoplasmic reticulum calcium ion concentration), [GO:0032471](http://purl.obolibrary.org/obo/GO_0032471) (negative regulation of endoplasmic reticulum calcium ion concentration), [GO:0045742](http://purl.obolibrary.org/obo/GO_0045742) (positive regulation of epidermal growth factor receptor signaling pathway), [GO:0006189](http://purl.obolibrary.org/obo/GO_0006189) ('de novo' IMP biosynthetic process), [GO:0045743](http://purl.obolibrary.org/obo/GO_0045743) (positive regulation of fibroblast growth factor receptor signaling pathway), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0006188](http://purl.obolibrary.org/obo/GO_0006188) (IMP biosynthetic process), [GO:0099572](http://purl.obolibrary.org/obo/GO_0099572) (postsynaptic specialization), [GO:0045746](http://purl.obolibrary.org/obo/GO_0045746) (negative regulation of Notch signaling pathway), [GO:0045747](http://purl.obolibrary.org/obo/GO_0045747) (positive regulation of Notch signaling pathway), [GO:0045744](http://purl.obolibrary.org/obo/GO_0045744) (negative regulation of G-protein coupled receptor protein signaling pathway), [GO:0045745](http://purl.obolibrary.org/obo/GO_0045745) (positive regulation of G-protein coupled receptor protein signaling pathway), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0099565](http://purl.obolibrary.org/obo/GO_0099565) (chemical synaptic transmission, postsynaptic), [GO:0099566](http://purl.obolibrary.org/obo/GO_0099566) (regulation of postsynaptic cytosolic calcium ion concentration), [GO:2000615](http://purl.obolibrary.org/obo/GO_2000615) (regulation of histone H3-K9 acetylation), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0031134](http://purl.obolibrary.org/obo/GO_0031134) (sister chromatid biorientation), [GO:0032466](http://purl.obolibrary.org/obo/GO_0032466) (negative regulation of cytokinesis), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:2000611](http://purl.obolibrary.org/obo/GO_2000611) (positive regulation of thyroid hormone generation), [GO:0031133](http://purl.obolibrary.org/obo/GO_0031133) (regulation of axon diameter), [GO:0032464](http://purl.obolibrary.org/obo/GO_0032464) (positive regulation of protein homooligomerization), [GO:2000612](http://purl.obolibrary.org/obo/GO_2000612) (regulation of thyroid-stimulating hormone secretion), [GO:0032469](http://purl.obolibrary.org/obo/GO_0032469) (endoplasmic reticulum calcium ion homeostasis), [GO:1902093](http://purl.obolibrary.org/obo/GO_1902093) (positive regulation of flagellated sperm motility), [GO:0031138](http://purl.obolibrary.org/obo/GO_0031138) (negative regulation of conjugation with cellular fusion), [GO:0003909](http://purl.obolibrary.org/obo/GO_0003909) (DNA ligase activity), [GO:0070700](http://purl.obolibrary.org/obo/GO_0070700) (BMP receptor binding), [GO:0032467](http://purl.obolibrary.org/obo/GO_0032467) (positive regulation of cytokinesis), [GO:0032468](http://purl.obolibrary.org/obo/GO_0032468) (Golgi calcium ion homeostasis), [GO:0006193](http://purl.obolibrary.org/obo/GO_0006193) (ITP catabolic process), [GO:0032461](http://purl.obolibrary.org/obo/GO_0032461) (positive regulation of protein oligomerization), [GO:0033791](http://purl.obolibrary.org/obo/GO_0033791) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity), [GO:0006195](http://purl.obolibrary.org/obo/GO_0006195) (purine nucleotide catabolic process), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0099583](http://purl.obolibrary.org/obo/GO_0099583) (neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration), [GO:0003910](http://purl.obolibrary.org/obo/GO_0003910) (DNA ligase (ATP) activity), [GO:0018160](http://purl.obolibrary.org/obo/GO_0018160) (peptidyl-pyrromethane cofactor linkage), [GO:0045760](http://purl.obolibrary.org/obo/GO_0045760) (positive regulation of action potential), [GO:2000627](http://purl.obolibrary.org/obo/GO_2000627) (positive regulation of miRNA catabolic process), [GO:2000620](http://purl.obolibrary.org/obo/GO_2000620) (positive regulation of histone H4-K16 acetylation), [GO:0032454](http://purl.obolibrary.org/obo/GO_0032454) (histone demethylase activity (H3-K9 specific)), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0003916](http://purl.obolibrary.org/obo/GO_0003916) (DNA topoisomerase activity), [GO:0003917](http://purl.obolibrary.org/obo/GO_0003917) (DNA topoisomerase type I activity), [GO:0032452](http://purl.obolibrary.org/obo/GO_0032452) (histone demethylase activity), [GO:0031122](http://purl.obolibrary.org/obo/GO_0031122) (cytoplasmic microtubule organization), [GO:0032453](http://purl.obolibrary.org/obo/GO_0032453) (histone demethylase activity (H3-K4 specific)), [GO:2000623](http://purl.obolibrary.org/obo/GO_2000623) (negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), [GO:0003919](http://purl.obolibrary.org/obo/GO_0003919) (FMN adenylyltransferase activity), [GO:0031128](http://purl.obolibrary.org/obo/GO_0031128) (developmental induction), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:0031126](http://purl.obolibrary.org/obo/GO_0031126) (snoRNA 3'-end processing), [GO:0033787](http://purl.obolibrary.org/obo/GO_0033787) (cyanocobalamin reductase (cyanide-eliminating) activity), [GO:0080130](http://purl.obolibrary.org/obo/GO_0080130) (L-phenylalanine:2-oxoglutarate aminotransferase activity), [GO:0001308](http://purl.obolibrary.org/obo/GO_0001308) (negative regulation of chromatin silencing involved in replicative cell aging), [GO:0001306](http://purl.obolibrary.org/obo/GO_0001306) (age-dependent response to oxidative stress), [GO:0001302](http://purl.obolibrary.org/obo/GO_0001302) (replicative cell aging), [GO:0001300](http://purl.obolibrary.org/obo/GO_0001300) (chronological cell aging), [GO:0002631](http://purl.obolibrary.org/obo/GO_0002631) (regulation of granuloma formation), [GO:0003962](http://purl.obolibrary.org/obo/GO_0003962) (cystathionine gamma-synthase activity), [GO:0003964](http://purl.obolibrary.org/obo/GO_0003964) (RNA-directed DNA polymerase activity), [GO:0002633](http://purl.obolibrary.org/obo/GO_0002633) (positive regulation of granuloma formation), [GO:0043196](http://purl.obolibrary.org/obo/GO_0043196) (varicosity), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0002636](http://purl.obolibrary.org/obo/GO_0002636) (positive regulation of germinal center formation), [GO:2000637](http://purl.obolibrary.org/obo/GO_2000637) (positive regulation of gene silencing by miRNA), [GO:0043198](http://purl.obolibrary.org/obo/GO_0043198) (dendritic shaft), [GO:0002637](http://purl.obolibrary.org/obo/GO_0002637) (regulation of immunoglobulin production), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0002638](http://purl.obolibrary.org/obo/GO_0002638) (negative regulation of immunoglobulin production), [GO:0002639](http://purl.obolibrary.org/obo/GO_0002639) (positive regulation of immunoglobulin production), [GO:2000630](http://purl.obolibrary.org/obo/GO_2000630) (positive regulation of miRNA metabolic process), [GO:0052906](http://purl.obolibrary.org/obo/GO_0052906) (tRNA (guanine(37)-N(1))-methyltransferase activity), [GO:0043199](http://purl.obolibrary.org/obo/GO_0043199) (sulfate binding), [GO:0080146](http://purl.obolibrary.org/obo/GO_0080146) (L-cysteine desulfhydrase activity), [GO:0001315](http://purl.obolibrary.org/obo/GO_0001315) (age-dependent response to reactive oxygen species), [GO:0003974](http://purl.obolibrary.org/obo/GO_0003974) (UDP-N-acetylglucosamine 4-epimerase activity), [GO:0001320](http://purl.obolibrary.org/obo/GO_0001320) (age-dependent response to reactive oxygen species involved in chronological cell aging), [GO:0003975](http://purl.obolibrary.org/obo/GO_0003975) (UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity), [GO:0003976](http://purl.obolibrary.org/obo/GO_0003976) (UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity), [GO:2000647](http://purl.obolibrary.org/obo/GO_2000647) (negative regulation of stem cell proliferation), [GO:0003978](http://purl.obolibrary.org/obo/GO_0003978) (UDP-glucose 4-epimerase activity), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:2000649](http://purl.obolibrary.org/obo/GO_2000649) (regulation of sodium ion transmembrane transporter activity), [GO:0052905](http://purl.obolibrary.org/obo/GO_0052905) (tRNA (guanine(9)-N(1))-methyltransferase activity), [GO:2000643](http://purl.obolibrary.org/obo/GO_2000643) (positive regulation of early endosome to late endosome transport), [GO:2000645](http://purl.obolibrary.org/obo/GO_2000645) (negative regulation of receptor catabolic process), [GO:2000641](http://purl.obolibrary.org/obo/GO_2000641) (regulation of early endosome to late endosome transport), [GO:0052917](http://purl.obolibrary.org/obo/GO_0052917) (dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity), [GO:0052918](http://purl.obolibrary.org/obo/GO_0052918) (dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0080111](http://purl.obolibrary.org/obo/GO_0080111) (DNA demethylation), [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity), [GO:0003942](http://purl.obolibrary.org/obo/GO_0003942) (N-acetyl-gamma-glutamyl-phosphate reductase activity), [GO:0003943](http://purl.obolibrary.org/obo/GO_0003943) (N-acetylgalactosamine-4-sulfatase activity), [GO:0003945](http://purl.obolibrary.org/obo/GO_0003945) (N-acetyllactosamine synthase activity), [GO:0015929](http://purl.obolibrary.org/obo/GO_0015929) (hexosaminidase activity), [GO:0015928](http://purl.obolibrary.org/obo/GO_0015928) (fucosidase activity), [GO:2000653](http://purl.obolibrary.org/obo/GO_2000653) (regulation of genetic imprinting), [GO:0003948](http://purl.obolibrary.org/obo/GO_0003948) (N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity), [GO:0031179](http://purl.obolibrary.org/obo/GO_0031179) (peptide modification), [GO:2000650](http://purl.obolibrary.org/obo/GO_2000650) (negative regulation of sodium ion transmembrane transporter activity), [GO:2000670](http://purl.obolibrary.org/obo/GO_2000670) (positive regulation of dendritic cell apoptotic process), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:0052928](http://purl.obolibrary.org/obo/GO_0052928) (CTP:3'-cytidine-tRNA cytidylyltransferase activity), [GO:0052929](http://purl.obolibrary.org/obo/GO_0052929) (ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity), [GO:0003951](http://purl.obolibrary.org/obo/GO_0003951) (NAD+ kinase activity), [GO:0003954](http://purl.obolibrary.org/obo/GO_0003954) (NADH dehydrogenase activity), [GO:2000669](http://purl.obolibrary.org/obo/GO_2000669) (negative regulation of dendritic cell apoptotic process), [GO:0002625](http://purl.obolibrary.org/obo/GO_0002625) (regulation of T cell antigen processing and presentation), [GO:0002626](http://purl.obolibrary.org/obo/GO_0002626) (negative regulation of T cell antigen processing and presentation), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:2000664](http://purl.obolibrary.org/obo/GO_2000664) (positive regulation of interleukin-5 secretion), [GO:0015937](http://purl.obolibrary.org/obo/GO_0015937) (coenzyme A biosynthetic process), [GO:0052926](http://purl.obolibrary.org/obo/GO_0052926) (dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0015936](http://purl.obolibrary.org/obo/GO_0015936) (coenzyme A metabolic process), [GO:0032499](http://purl.obolibrary.org/obo/GO_0032499) (detection of peptidoglycan), [GO:0052927](http://purl.obolibrary.org/obo/GO_0052927) (CTP:tRNA cytidylyltransferase activity), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0015935](http://purl.obolibrary.org/obo/GO_0015935) (small ribosomal subunit), [GO:2000667](http://purl.obolibrary.org/obo/GO_2000667) (positive regulation of interleukin-13 secretion), [GO:0052925](http://purl.obolibrary.org/obo/GO_0052925) (dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0015934](http://purl.obolibrary.org/obo/GO_0015934) (large ribosomal subunit), [GO:0032497](http://purl.obolibrary.org/obo/GO_0032497) (detection of lipopolysaccharide), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0015991](http://purl.obolibrary.org/obo/GO_0015991) (ATP hydrolysis coupled proton transport), [GO:0015990](http://purl.obolibrary.org/obo/GO_0015990) (electron transport coupled proton transport), [GO:0055131](http://purl.obolibrary.org/obo/GO_0055131) (C3HC4-type RING finger domain binding), [GO:0000018](http://purl.obolibrary.org/obo/GO_0000018) (regulation of DNA recombination), [GO:0043149](http://purl.obolibrary.org/obo/GO_0043149) (stress fiber assembly), [GO:0002682](http://purl.obolibrary.org/obo/GO_0002682) (regulation of immune system process), [GO:0000016](http://purl.obolibrary.org/obo/GO_0000016) (lactase activity), [GO:0002683](http://purl.obolibrary.org/obo/GO_0002683) (negative regulation of immune system process), [GO:0000015](http://purl.obolibrary.org/obo/GO_0000015) (phosphopyruvate hydratase complex), [GO:0000014](http://purl.obolibrary.org/obo/GO_0000014) (single-stranded DNA endodeoxyribonuclease activity), [GO:0002684](http://purl.obolibrary.org/obo/GO_0002684) (positive regulation of immune system process), [GO:0002685](http://purl.obolibrary.org/obo/GO_0002685) (regulation of leukocyte migration), [GO:0000023](http://purl.obolibrary.org/obo/GO_0000023) (maltose metabolic process), [GO:0002675](http://purl.obolibrary.org/obo/GO_0002675) (positive regulation of acute inflammatory response), [GO:0000022](http://purl.obolibrary.org/obo/GO_0000022) (mitotic spindle elongation), [GO:0002677](http://purl.obolibrary.org/obo/GO_0002677) (negative regulation of chronic inflammatory response), [GO:2000679](http://purl.obolibrary.org/obo/GO_2000679) (positive regulation of transcription regulatory region DNA binding), [GO:0002679](http://purl.obolibrary.org/obo/GO_0002679) (respiratory burst involved in defense response), [GO:0070761](http://purl.obolibrary.org/obo/GO_0070761) (pre-snoRNP complex), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0043153](http://purl.obolibrary.org/obo/GO_0043153) (entrainment of circadian clock by photoperiod), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:2000676](http://purl.obolibrary.org/obo/GO_2000676) (positive regulation of type B pancreatic cell apoptotic process), [GO:2000678](http://purl.obolibrary.org/obo/GO_2000678) (negative regulation of transcription regulatory region DNA binding), [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process), [GO:0015986](http://purl.obolibrary.org/obo/GO_0015986) (ATP synthesis coupled proton transport), [GO:0002690](http://purl.obolibrary.org/obo/GO_0002690) (positive regulation of leukocyte chemotaxis), [GO:0002691](http://purl.obolibrary.org/obo/GO_0002691) (regulation of cellular extravasation), [GO:0000028](http://purl.obolibrary.org/obo/GO_0000028) (ribosomal small subunit assembly), [GO:0002692](http://purl.obolibrary.org/obo/GO_0002692) (negative regulation of cellular extravasation), [GO:0000027](http://purl.obolibrary.org/obo/GO_0000027) (ribosomal large subunit assembly), [GO:0000026](http://purl.obolibrary.org/obo/GO_0000026) (alpha-1,2-mannosyltransferase activity), [GO:0000025](http://purl.obolibrary.org/obo/GO_0000025) (maltose catabolic process), [GO:0002686](http://purl.obolibrary.org/obo/GO_0002686) (negative regulation of leukocyte migration), [GO:0002687](http://purl.obolibrary.org/obo/GO_0002687) (positive regulation of leukocyte migration), [GO:0000033](http://purl.obolibrary.org/obo/GO_0000033) (alpha-1,3-mannosyltransferase activity), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:0000032](http://purl.obolibrary.org/obo/GO_0000032) (cell wall mannoprotein biosynthetic process), [GO:0000030](http://purl.obolibrary.org/obo/GO_0000030) (mannosyltransferase activity), [GO:0043162](http://purl.obolibrary.org/obo/GO_0043162) (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:1990616](http://purl.obolibrary.org/obo/GO_1990616) (magnesium ion export from mitochondrion), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:2000683](http://purl.obolibrary.org/obo/GO_2000683) (regulation of cellular response to X-ray), [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding), [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding), [GO:0003991](http://purl.obolibrary.org/obo/GO_0003991) (acetylglutamate kinase activity), [GO:0001324](http://purl.obolibrary.org/obo/GO_0001324) (age-dependent response to oxidative stress involved in chronological cell aging), [GO:0003993](http://purl.obolibrary.org/obo/GO_0003993) (acid phosphatase activity), [GO:0003994](http://purl.obolibrary.org/obo/GO_0003994) (aconitate hydratase activity), [GO:0000001](http://purl.obolibrary.org/obo/GO_0000001) (mitochondrion inheritance), [GO:0003985](http://purl.obolibrary.org/obo/GO_0003985) (acetyl-CoA C-acetyltransferase activity), [GO:0043171](http://purl.obolibrary.org/obo/GO_0043171) (peptide catabolic process), [GO:0003988](http://purl.obolibrary.org/obo/GO_0003988) (acetyl-CoA C-acyltransferase activity), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0043176](http://purl.obolibrary.org/obo/GO_0043176) (amine binding), [GO:0070781](http://purl.obolibrary.org/obo/GO_0070781) (response to biotin), [GO:0015966](http://purl.obolibrary.org/obo/GO_0015966) (diadenosine tetraphosphate biosynthetic process), [GO:0000009](http://purl.obolibrary.org/obo/GO_0000009) (alpha-1,6-mannosyltransferase activity), [GO:0043178](http://purl.obolibrary.org/obo/GO_0043178) (alcohol binding), [GO:0043179](http://purl.obolibrary.org/obo/GO_0043179) (rhythmic excitation), [GO:0002674](http://purl.obolibrary.org/obo/GO_0002674) (negative regulation of acute inflammatory response), [GO:0000002](http://purl.obolibrary.org/obo/GO_0000002) (mitochondrial genome maintenance), [GO:0003995](http://purl.obolibrary.org/obo/GO_0003995) (acyl-CoA dehydrogenase activity), [GO:0000012](http://purl.obolibrary.org/obo/GO_0000012) (single strand break repair), [GO:0002664](http://purl.obolibrary.org/obo/GO_0002664) (regulation of T cell tolerance induction), [GO:0043181](http://purl.obolibrary.org/obo/GO_0043181) (vacuolar sequestering), [GO:0000011](http://purl.obolibrary.org/obo/GO_0000011) (vacuole inheritance), [GO:0003997](http://purl.obolibrary.org/obo/GO_0003997) (acyl-CoA oxidase activity), [GO:0002666](http://purl.obolibrary.org/obo/GO_0002666) (positive regulation of T cell tolerance induction), [GO:0000010](http://purl.obolibrary.org/obo/GO_0000010) (trans-hexaprenyltranstransferase activity), [GO:0043183](http://purl.obolibrary.org/obo/GO_0043183) (vascular endothelial growth factor receptor 1 binding), [GO:0002667](http://purl.obolibrary.org/obo/GO_0002667) (regulation of T cell anergy), [GO:0003999](http://purl.obolibrary.org/obo/GO_0003999) (adenine phosphoribosyltransferase activity), [GO:0043185](http://purl.obolibrary.org/obo/GO_0043185) (vascular endothelial growth factor receptor 3 binding), [GO:0070772](http://purl.obolibrary.org/obo/GO_0070772) (PAS complex), [GO:0002669](http://purl.obolibrary.org/obo/GO_0002669) (positive regulation of T cell anergy), [GO:0043184](http://purl.obolibrary.org/obo/GO_0043184) (vascular endothelial growth factor receptor 2 binding), [GO:0043186](http://purl.obolibrary.org/obo/GO_0043186) (P granule), [GO:0070776](http://purl.obolibrary.org/obo/GO_0070776) (MOZ/MORF histone acetyltransferase complex), [GO:0070779](http://purl.obolibrary.org/obo/GO_0070779) (D-aspartate import), [GO:0015976](http://purl.obolibrary.org/obo/GO_0015976) (carbon utilization), [GO:2000483](http://purl.obolibrary.org/obo/GO_2000483) (negative regulation of interleukin-8 secretion), [GO:0000178](http://purl.obolibrary.org/obo/GO_0000178) (exosome (RNase complex)), [GO:0000188](http://purl.obolibrary.org/obo/GO_0000188) (inactivation of MAPK activity), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0051764](http://purl.obolibrary.org/obo/GO_0051764) (actin crosslink formation), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0000185](http://purl.obolibrary.org/obo/GO_0000185) (activation of MAPKKK activity), [GO:0000184](http://purl.obolibrary.org/obo/GO_0000184) (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), [GO:0000183](http://purl.obolibrary.org/obo/GO_0000183) (chromatin silencing at rDNA), [GO:0000182](http://purl.obolibrary.org/obo/GO_0000182) (rDNA binding), [GO:0036126](http://purl.obolibrary.org/obo/GO_0036126) (sperm flagellum), [GO:0050435](http://purl.obolibrary.org/obo/GO_0050435) (amyloid-beta metabolic process), [GO:2000473](http://purl.obolibrary.org/obo/GO_2000473) (positive regulation of hematopoietic stem cell migration), [GO:0050434](http://purl.obolibrary.org/obo/GO_0050434) (positive regulation of viral transcription), [GO:0036128](http://purl.obolibrary.org/obo/GO_0036128) (CatSper complex), [GO:0050436](http://purl.obolibrary.org/obo/GO_0050436) (microfibril binding), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:2000490](http://purl.obolibrary.org/obo/GO_2000490) (negative regulation of hepatic stellate cell activation), [GO:1904628](http://purl.obolibrary.org/obo/GO_1904628) (cellular response to phorbol 13-acetate 12-myristate), [GO:0051775](http://purl.obolibrary.org/obo/GO_0051775) (response to redox state), [GO:0050444](http://purl.obolibrary.org/obo/GO_0050444) (aquacobalamin reductase (NADPH) activity), [GO:0000196](http://purl.obolibrary.org/obo/GO_0000196) (MAPK cascade involved in cell wall organization or biogenesis), [GO:0051770](http://purl.obolibrary.org/obo/GO_0051770) (positive regulation of nitric-oxide synthase biosynthetic process), [GO:0051771](http://purl.obolibrary.org/obo/GO_0051771) (negative regulation of nitric-oxide synthase biosynthetic process), [GO:2000484](http://purl.obolibrary.org/obo/GO_2000484) (positive regulation of interleukin-8 secretion), [GO:0036117](http://purl.obolibrary.org/obo/GO_0036117) (hyaluranon cable), [GO:2000486](http://purl.obolibrary.org/obo/GO_2000486) (negative regulation of glutamine transport), [GO:0036111](http://purl.obolibrary.org/obo/GO_0036111) (very long-chain fatty-acyl-CoA metabolic process), [GO:0036112](http://purl.obolibrary.org/obo/GO_0036112) (medium-chain fatty-acyl-CoA metabolic process), [GO:1904632](http://purl.obolibrary.org/obo/GO_1904632) (cellular response to glucoside), [GO:1905962](http://purl.obolibrary.org/obo/GO_1905962) (glutamatergic neuron differentiation), [GO:1904630](http://purl.obolibrary.org/obo/GO_1904630) (cellular response to diterpene), [GO:0000159](http://purl.obolibrary.org/obo/GO_0000159) (protein phosphatase type 2A complex), [GO:0000156](http://purl.obolibrary.org/obo/GO_0000156) (phosphorelay response regulator activity), [GO:1903307](http://purl.obolibrary.org/obo/GO_1903307) (positive regulation of regulated secretory pathway), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0048144](http://purl.obolibrary.org/obo/GO_0048144) (fibroblast proliferation), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0048143](http://purl.obolibrary.org/obo/GO_0048143) (astrocyte activation), [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0048148](http://purl.obolibrary.org/obo/GO_0048148) (behavioral response to cocaine), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0000160](http://purl.obolibrary.org/obo/GO_0000160) (phosphorelay signal transduction system), [GO:0051780](http://purl.obolibrary.org/obo/GO_0051780) (behavioral response to nutrient), [GO:0048145](http://purl.obolibrary.org/obo/GO_0048145) (regulation of fibroblast proliferation), [GO:0036105](http://purl.obolibrary.org/obo/GO_0036105) (peroxisome membrane class-1 targeting sequence binding), [GO:0051787](http://purl.obolibrary.org/obo/GO_0051787) (misfolded protein binding), [GO:0061100](http://purl.obolibrary.org/obo/GO_0061100) (lung neuroendocrine cell differentiation), [GO:0061102](http://purl.obolibrary.org/obo/GO_0061102) (stomach neuroendocrine cell differentiation), [GO:0061103](http://purl.obolibrary.org/obo/GO_0061103) (carotid body glomus cell differentiation), [GO:1904646](http://purl.obolibrary.org/obo/GO_1904646) (cellular response to amyloid-beta), [GO:1904645](http://purl.obolibrary.org/obo/GO_1904645) (response to amyloid-beta), [GO:0048149](http://purl.obolibrary.org/obo/GO_0048149) (behavioral response to ethanol), [GO:0061104](http://purl.obolibrary.org/obo/GO_0061104) (adrenal chromaffin cell differentiation), [GO:1903319](http://purl.obolibrary.org/obo/GO_1903319) (positive regulation of protein maturation), [GO:0000169](http://purl.obolibrary.org/obo/GO_0000169) (activation of MAPK activity involved in osmosensory signaling pathway), [GO:0051796](http://purl.obolibrary.org/obo/GO_0051796) (negative regulation of timing of catagen), [GO:0000177](http://purl.obolibrary.org/obo/GO_0000177) (cytoplasmic exosome (RNase complex)), [GO:0000176](http://purl.obolibrary.org/obo/GO_0000176) (nuclear exosome (RNase complex)), [GO:0000175](http://purl.obolibrary.org/obo/GO_0000175) (3'-5'-exoribonuclease activity), [GO:0051795](http://purl.obolibrary.org/obo/GO_0051795) (positive regulation of timing of catagen), [GO:0051793](http://purl.obolibrary.org/obo/GO_0051793) (medium-chain fatty acid catabolic process), [GO:0051791](http://purl.obolibrary.org/obo/GO_0051791) (medium-chain fatty acid metabolic process), [GO:0048156](http://purl.obolibrary.org/obo/GO_0048156) (tau protein binding), [GO:0051798](http://purl.obolibrary.org/obo/GO_0051798) (positive regulation of hair follicle development), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0036179](http://purl.obolibrary.org/obo/GO_0036179) (osteoclast maturation), [GO:0021918](http://purl.obolibrary.org/obo/GO_0021918) (regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment), [GO:0021912](http://purl.obolibrary.org/obo/GO_0021912) (regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification), [GO:0021913](http://purl.obolibrary.org/obo/GO_0021913) (regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification), [GO:0021914](http://purl.obolibrary.org/obo/GO_0021914) (negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning), [GO:0008940](http://purl.obolibrary.org/obo/GO_0008940) (nitrate reductase activity), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0007610](http://purl.obolibrary.org/obo/GO_0007610) (behavior), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0008941](http://purl.obolibrary.org/obo/GO_0008941) (nitric oxide dioxygenase activity), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0007603](http://purl.obolibrary.org/obo/GO_0007603) (phototransduction, visible light), [GO:0008934](http://purl.obolibrary.org/obo/GO_0008934) (inositol monophosphate 1-phosphatase activity), [GO:0007608](http://purl.obolibrary.org/obo/GO_0007608) (sensory perception of smell), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning), [GO:0021905](http://purl.obolibrary.org/obo/GO_0021905) (forebrain-midbrain boundary formation), [GO:0021902](http://purl.obolibrary.org/obo/GO_0021902) (commitment of neuronal cell to specific neuron type in forebrain), [GO:0007620](http://purl.obolibrary.org/obo/GO_0007620) (copulation), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0007622](http://purl.obolibrary.org/obo/GO_0007622) (rhythmic behavior), [GO:0007616](http://purl.obolibrary.org/obo/GO_0007616) (long-term memory), [GO:0007617](http://purl.obolibrary.org/obo/GO_0007617) (mating behavior), [GO:1905908](http://purl.obolibrary.org/obo/GO_1905908) (positive regulation of amyloid fibril formation), [GO:0051731](http://purl.obolibrary.org/obo/GO_0051731) (polynucleotide 5'-hydroxyl-kinase activity), [GO:0007614](http://purl.obolibrary.org/obo/GO_0007614) (short-term memory), [GO:1905907](http://purl.obolibrary.org/obo/GO_1905907) (negative regulation of amyloid fibril formation), [GO:1905906](http://purl.obolibrary.org/obo/GO_1905906) (regulation of amyloid fibril formation), [GO:0051736](http://purl.obolibrary.org/obo/GO_0051736) (ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity), [GO:0036159](http://purl.obolibrary.org/obo/GO_0036159) (inner dynein arm assembly), [GO:0051733](http://purl.obolibrary.org/obo/GO_0051733) (polydeoxyribonucleotide kinase activity), [GO:0036157](http://purl.obolibrary.org/obo/GO_0036157) (outer dynein arm), [GO:0036158](http://purl.obolibrary.org/obo/GO_0036158) (outer dynein arm assembly), [GO:1905923](http://purl.obolibrary.org/obo/GO_1905923) (positive regulation of acetylcholine biosynthetic process), [GO:1905920](http://purl.obolibrary.org/obo/GO_1905920) (positive regulation of CoA-transferase activity), [GO:0048103](http://purl.obolibrary.org/obo/GO_0048103) (somatic stem cell division), [GO:0048102](http://purl.obolibrary.org/obo/GO_0048102) (autophagic cell death), [GO:0075713](http://purl.obolibrary.org/obo/GO_0075713) (establishment of integrated proviral latency), [GO:0036145](http://purl.obolibrary.org/obo/GO_0036145) (dendritic cell homeostasis), [GO:0036146](http://purl.obolibrary.org/obo/GO_0036146) (cellular response to mycotoxin), [GO:0048105](http://purl.obolibrary.org/obo/GO_0048105) (establishment of body hair planar orientation), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0007602](http://purl.obolibrary.org/obo/GO_0007602) (phototransduction), [GO:0007600](http://purl.obolibrary.org/obo/GO_0007600) (sensory perception), [GO:0050421](http://purl.obolibrary.org/obo/GO_0050421) (nitrite reductase (NO-forming) activity), [GO:0050427](http://purl.obolibrary.org/obo/GO_0050427) (3'-phosphoadenosine 5'-phosphosulfate metabolic process), [GO:0051754](http://purl.obolibrary.org/obo/GO_0051754) (meiotic sister chromatid cohesion, centromeric), [GO:0045926](http://purl.obolibrary.org/obo/GO_0045926) (negative regulation of growth), [GO:0019637](http://purl.obolibrary.org/obo/GO_0019637) (organophosphate metabolic process), [GO:0061178](http://purl.obolibrary.org/obo/GO_0061178) (regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:1904693](http://purl.obolibrary.org/obo/GO_1904693) (midbrain morphogenesis), [GO:0045927](http://purl.obolibrary.org/obo/GO_0045927) (positive regulation of growth), [GO:0061179](http://purl.obolibrary.org/obo/GO_0061179) (negative regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:1902035](http://purl.obolibrary.org/obo/GO_1902035) (positive regulation of hematopoietic stem cell proliferation), [GO:1902036](http://purl.obolibrary.org/obo/GO_1902036) (regulation of hematopoietic stem cell differentiation), [GO:0021956](http://purl.obolibrary.org/obo/GO_0021956) (central nervous system interneuron axonogenesis), [GO:1902033](http://purl.obolibrary.org/obo/GO_1902033) (regulation of hematopoietic stem cell proliferation), [GO:0021957](http://purl.obolibrary.org/obo/GO_0021957) (corticospinal tract morphogenesis), [GO:1903364](http://purl.obolibrary.org/obo/GO_1903364) (positive regulation of cellular protein catabolic process), [GO:1903365](http://purl.obolibrary.org/obo/GO_1903365) (regulation of fear response), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:1902037](http://purl.obolibrary.org/obo/GO_1902037) (negative regulation of hematopoietic stem cell differentiation), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:1902038](http://purl.obolibrary.org/obo/GO_1902038) (positive regulation of hematopoietic stem cell differentiation), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0045921](http://purl.obolibrary.org/obo/GO_0045921) (positive regulation of exocytosis), [GO:0032606](http://purl.obolibrary.org/obo/GO_0032606) (type I interferon production), [GO:0033934](http://purl.obolibrary.org/obo/GO_0033934) (glucan 1,4-alpha-maltotriohydrolase activity), [GO:0032609](http://purl.obolibrary.org/obo/GO_0032609) (interferon-gamma production), [GO:0032608](http://purl.obolibrary.org/obo/GO_0032608) (interferon-beta production), [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development), [GO:0097129](http://purl.obolibrary.org/obo/GO_0097129) (cyclin D2-CDK4 complex), [GO:0061181](http://purl.obolibrary.org/obo/GO_0061181) (regulation of chondrocyte development), [GO:0032602](http://purl.obolibrary.org/obo/GO_0032602) (chemokine production), [GO:0018315](http://purl.obolibrary.org/obo/GO_0018315) (molybdenum incorporation into molybdenum-molybdopterin complex), [GO:0019646](http://purl.obolibrary.org/obo/GO_0019646) (aerobic electron transport chain), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:1903373](http://purl.obolibrary.org/obo/GO_1903373) (positive regulation of endoplasmic reticulum tubular network organization), [GO:0045937](http://purl.obolibrary.org/obo/GO_0045937) (positive regulation of phosphate metabolic process), [GO:1902043](http://purl.obolibrary.org/obo/GO_1902043) (positive regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0045938](http://purl.obolibrary.org/obo/GO_0045938) (positive regulation of circadian sleep/wake cycle, sleep), [GO:1903377](http://purl.obolibrary.org/obo/GO_1903377) (negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway), [GO:1903375](http://purl.obolibrary.org/obo/GO_1903375) (facioacoustic ganglion development), [GO:0021940](http://purl.obolibrary.org/obo/GO_0021940) (positive regulation of cerebellar granule cell precursor proliferation), [GO:0045930](http://purl.obolibrary.org/obo/GO_0045930) (negative regulation of mitotic cell cycle), [GO:0006333](http://purl.obolibrary.org/obo/GO_0006333) (chromatin assembly or disassembly), [GO:0021943](http://purl.obolibrary.org/obo/GO_0021943) (formation of radial glial scaffolds), [GO:0005004](http://purl.obolibrary.org/obo/GO_0005004) (GPI-linked ephrin receptor activity), [GO:0005003](http://purl.obolibrary.org/obo/GO_0005003) (ephrin receptor activity), [GO:0006337](http://purl.obolibrary.org/obo/GO_0006337) (nucleosome disassembly), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0006334](http://purl.obolibrary.org/obo/GO_0006334) (nucleosome assembly), [GO:0045932](http://purl.obolibrary.org/obo/GO_0045932) (negative regulation of muscle contraction), [GO:0005005](http://purl.obolibrary.org/obo/GO_0005005) (transmembrane-ephrin receptor activity), [GO:0097132](http://purl.obolibrary.org/obo/GO_0097132) (cyclin D2-CDK6 complex), [GO:0045948](http://purl.obolibrary.org/obo/GO_0045948) (positive regulation of translational initiation), [GO:0021938](http://purl.obolibrary.org/obo/GO_0021938) (smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation), [GO:0044615](http://purl.obolibrary.org/obo/GO_0044615) (nuclear pore nuclear basket), [GO:0045947](http://purl.obolibrary.org/obo/GO_0045947) (negative regulation of translational initiation), [GO:0070903](http://purl.obolibrary.org/obo/GO_0070903) (mitochondrial tRNA thio-modification), [GO:0061195](http://purl.obolibrary.org/obo/GO_0061195) (taste bud formation), [GO:0061196](http://purl.obolibrary.org/obo/GO_0061196) (fungiform papilla development), [GO:0021934](http://purl.obolibrary.org/obo/GO_0021934) (hindbrain tangential cell migration), [GO:0061197](http://purl.obolibrary.org/obo/GO_0061197) (fungiform papilla morphogenesis), [GO:0021935](http://purl.obolibrary.org/obo/GO_0021935) (cerebellar granule cell precursor tangential migration), [GO:0061198](http://purl.obolibrary.org/obo/GO_0061198) (fungiform papilla formation), [GO:0045940](http://purl.obolibrary.org/obo/GO_0045940) (positive regulation of steroid metabolic process), [GO:0021930](http://purl.obolibrary.org/obo/GO_0021930) (cerebellar granule cell precursor proliferation), [GO:0007631](http://purl.obolibrary.org/obo/GO_0007631) (feeding behavior), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0007634](http://purl.obolibrary.org/obo/GO_0007634) (optokinetic behavior), [GO:0006303](http://purl.obolibrary.org/obo/GO_0006303) (double-strand break repair via nonhomologous end joining), [GO:0006304](http://purl.obolibrary.org/obo/GO_0006304) (DNA modification), [GO:0045945](http://purl.obolibrary.org/obo/GO_0045945) (positive regulation of transcription by RNA polymerase III), [GO:0007635](http://purl.obolibrary.org/obo/GO_0007635) (chemosensory behavior), [GO:0044611](http://purl.obolibrary.org/obo/GO_0044611) (nuclear pore inner ring), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0044614](http://purl.obolibrary.org/obo/GO_0044614) (nuclear pore cytoplasmic filaments), [GO:0007632](http://purl.obolibrary.org/obo/GO_0007632) (visual behavior), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0044613](http://purl.obolibrary.org/obo/GO_0044613) (nuclear pore central transport channel), [GO:0008963](http://purl.obolibrary.org/obo/GO_0008963) (phospho-N-acetylmuramoyl-pentapeptide-transferase activity), [GO:0045943](http://purl.obolibrary.org/obo/GO_0045943) (positive regulation of transcription by RNA polymerase I), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0007625](http://purl.obolibrary.org/obo/GO_0007625) (grooming behavior), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0097101](http://purl.obolibrary.org/obo/GO_0097101) (blood vessel endothelial cell fate specification), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:0070901](http://purl.obolibrary.org/obo/GO_0070901) (mitochondrial tRNA methylation), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0061189](http://purl.obolibrary.org/obo/GO_0061189) (positive regulation of sclerotome development), [GO:0061184](http://purl.obolibrary.org/obo/GO_0061184) (positive regulation of dermatome development), [GO:0021924](http://purl.obolibrary.org/obo/GO_0021924) (cell proliferation in external granule layer), [GO:0061186](http://purl.obolibrary.org/obo/GO_0061186) (negative regulation of chromatin silencing at silent mating-type cassette), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0006311](http://purl.obolibrary.org/obo/GO_0006311) (meiotic gene conversion), [GO:0008970](http://purl.obolibrary.org/obo/GO_0008970) (phosphatidylcholine 1-acylhydrolase activity), [GO:0045950](http://purl.obolibrary.org/obo/GO_0045950) (negative regulation of mitotic recombination), [GO:0045956](http://purl.obolibrary.org/obo/GO_0045956) (positive regulation of calcium ion-dependent exocytosis), [GO:0045953](http://purl.obolibrary.org/obo/GO_0045953) (negative regulation of natural killer cell mediated cytotoxicity), [GO:0097120](http://purl.obolibrary.org/obo/GO_0097120) (receptor localization to synapse), [GO:0006312](http://purl.obolibrary.org/obo/GO_0006312) (mitotic recombination), [GO:0045954](http://purl.obolibrary.org/obo/GO_0045954) (positive regulation of natural killer cell mediated cytotoxicity), [GO:0007638](http://purl.obolibrary.org/obo/GO_0007638) (mechanosensory behavior), [GO:0006307](http://purl.obolibrary.org/obo/GO_0006307) (DNA dealkylation involved in DNA repair), [GO:0006308](http://purl.obolibrary.org/obo/GO_0006308) (DNA catabolic process), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0097112](http://purl.obolibrary.org/obo/GO_0097112) (gamma-aminobutyric acid receptor clustering), [GO:0006306](http://purl.obolibrary.org/obo/GO_0006306) (DNA methylation), [GO:0097114](http://purl.obolibrary.org/obo/GO_0097114) (NMDA glutamate receptor clustering), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0097119](http://purl.obolibrary.org/obo/GO_0097119) (postsynaptic density protein 95 clustering), [GO:0061193](http://purl.obolibrary.org/obo/GO_0061193) (taste bud development), [GO:1903392](http://purl.obolibrary.org/obo/GO_1903392) (negative regulation of adherens junction organization), [GO:0061136](http://purl.obolibrary.org/obo/GO_0061136) (regulation of proteasomal protein catabolic process), [GO:0021999](http://purl.obolibrary.org/obo/GO_0021999) (neural plate anterior/posterior regionalization), [GO:0006361](http://purl.obolibrary.org/obo/GO_0006361) (transcription initiation from RNA polymerase I promoter), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0061131](http://purl.obolibrary.org/obo/GO_0061131) (pancreas field specification), [GO:0005030](http://purl.obolibrary.org/obo/GO_0005030) (neurotrophin receptor activity), [GO:1904651](http://purl.obolibrary.org/obo/GO_1904651) (positive regulation of fat cell apoptotic process), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0021997](http://purl.obolibrary.org/obo/GO_0021997) (neural plate axis specification), [GO:0006363](http://purl.obolibrary.org/obo/GO_0006363) (termination of RNA polymerase I transcription), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0061138](http://purl.obolibrary.org/obo/GO_0061138) (morphogenesis of a branching epithelium), [GO:0006367](http://purl.obolibrary.org/obo/GO_0006367) (transcription initiation from RNA polymerase II promoter), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:1904659](http://purl.obolibrary.org/obo/GO_1904659) (glucose transmembrane transport), [GO:1903329](http://purl.obolibrary.org/obo/GO_1903329) (regulation of iron-sulfur cluster assembly), [GO:0032648](http://purl.obolibrary.org/obo/GO_0032648) (regulation of interferon-beta production), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0017020](http://purl.obolibrary.org/obo/GO_0017020) (myosin phosphatase regulator activity), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0019682](http://purl.obolibrary.org/obo/GO_0019682) (glyceraldehyde-3-phosphate metabolic process), [GO:0017022](http://purl.obolibrary.org/obo/GO_0017022) (myosin binding), [GO:0032642](http://purl.obolibrary.org/obo/GO_0032642) (regulation of chemokine production), [GO:0017025](http://purl.obolibrary.org/obo/GO_0017025) (TBP-class protein binding), [GO:0032640](http://purl.obolibrary.org/obo/GO_0032640) (tumor necrosis factor production), [GO:0031314](http://purl.obolibrary.org/obo/GO_0031314) (extrinsic component of mitochondrial inner membrane), [GO:0031315](http://purl.obolibrary.org/obo/GO_0031315) (extrinsic component of mitochondrial outer membrane), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0005042](http://purl.obolibrary.org/obo/GO_0005042) (netrin receptor activity), [GO:0005041](http://purl.obolibrary.org/obo/GO_0005041) (low-density lipoprotein receptor activity), [GO:1902001](http://purl.obolibrary.org/obo/GO_1902001) (fatty acid transmembrane transport), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:1904669](http://purl.obolibrary.org/obo/GO_1904669) (ATP export), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0006376](http://purl.obolibrary.org/obo/GO_0006376) (mRNA splice site selection), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0021985](http://purl.obolibrary.org/obo/GO_0021985) (neurohypophysis development), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:1902004](http://purl.obolibrary.org/obo/GO_1902004) (positive regulation of amyloid-beta formation), [GO:1904667](http://purl.obolibrary.org/obo/GO_1904667) (negative regulation of ubiquitin protein ligase activity), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0005048](http://purl.obolibrary.org/obo/GO_0005048) (signal sequence binding), [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development), [GO:0006378](http://purl.obolibrary.org/obo/GO_0006378) (mRNA polyadenylation), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0006379](http://purl.obolibrary.org/obo/GO_0006379) (mRNA cleavage), [GO:0005049](http://purl.obolibrary.org/obo/GO_0005049) (nuclear export signal receptor activity), [GO:0031307](http://purl.obolibrary.org/obo/GO_0031307) (integral component of mitochondrial outer membrane), [GO:0031305](http://purl.obolibrary.org/obo/GO_0031305) (integral component of mitochondrial inner membrane), [GO:0031306](http://purl.obolibrary.org/obo/GO_0031306) (intrinsic component of mitochondrial outer membrane), [GO:0050482](http://purl.obolibrary.org/obo/GO_0050482) (arachidonic acid secretion), [GO:0031309](http://purl.obolibrary.org/obo/GO_0031309) (integral component of nuclear outer membrane), [GO:0033962](http://purl.obolibrary.org/obo/GO_0033962) (cytoplasmic mRNA processing body assembly), [GO:0018343](http://purl.obolibrary.org/obo/GO_0018343) (protein farnesylation), [GO:0019674](http://purl.obolibrary.org/obo/GO_0019674) (NAD metabolic process), [GO:0033961](http://purl.obolibrary.org/obo/GO_0033961) (cis-stilbene-oxide hydrolase activity), [GO:0019673](http://purl.obolibrary.org/obo/GO_0019673) (GDP-mannose metabolic process), [GO:0018345](http://purl.obolibrary.org/obo/GO_0018345) (protein palmitoylation), [GO:0019676](http://purl.obolibrary.org/obo/GO_0019676) (ammonia assimilation cycle), [GO:0018344](http://purl.obolibrary.org/obo/GO_0018344) (protein geranylgeranylation), [GO:0017015](http://purl.obolibrary.org/obo/GO_0017015) (regulation of transforming growth factor beta receptor signaling pathway), [GO:0031303](http://purl.obolibrary.org/obo/GO_0031303) (integral component of endosome membrane), [GO:0048172](http://purl.obolibrary.org/obo/GO_0048172) (regulation of short-term neuronal synaptic plasticity), [GO:0031304](http://purl.obolibrary.org/obo/GO_0031304) (intrinsic component of mitochondrial inner membrane), [GO:0017016](http://purl.obolibrary.org/obo/GO_0017016) (Ras GTPase binding), [GO:0032635](http://purl.obolibrary.org/obo/GO_0032635) (interleukin-6 production), [GO:0017017](http://purl.obolibrary.org/obo/GO_0017017) (MAP kinase tyrosine/serine/threonine phosphatase activity), [GO:0031301](http://purl.obolibrary.org/obo/GO_0031301) (integral component of organelle membrane), [GO:0048170](http://purl.obolibrary.org/obo/GO_0048170) (positive regulation of long-term neuronal synaptic plasticity), [GO:0032633](http://purl.obolibrary.org/obo/GO_0032633) (interleukin-4 production), [GO:0061155](http://purl.obolibrary.org/obo/GO_0061155) (pulmonary artery endothelial tube morphogenesis), [GO:0061156](http://purl.obolibrary.org/obo/GO_0061156) (pulmonary artery morphogenesis), [GO:1902010](http://purl.obolibrary.org/obo/GO_1902010) (negative regulation of translation in response to endoplasmic reticulum stress), [GO:0061151](http://purl.obolibrary.org/obo/GO_0061151) (BMP signaling pathway involved in renal system segmentation), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:1904674](http://purl.obolibrary.org/obo/GO_1904674) (positive regulation of somatic stem cell population maintenance), [GO:0045906](http://purl.obolibrary.org/obo/GO_0045906) (negative regulation of vasoconstriction), [GO:0061153](http://purl.obolibrary.org/obo/GO_0061153) (trachea gland development), [GO:0021979](http://purl.obolibrary.org/obo/GO_0021979) (hypothalamus cell differentiation), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:1902017](http://purl.obolibrary.org/obo/GO_1902017) (regulation of cilium assembly), [GO:0006342](http://purl.obolibrary.org/obo/GO_0006342) (chromatin silencing), [GO:1903347](http://purl.obolibrary.org/obo/GO_1903347) (negative regulation of bicellular tight junction assembly), [GO:0006348](http://purl.obolibrary.org/obo/GO_0006348) (chromatin silencing at telomere), [GO:0045901](http://purl.obolibrary.org/obo/GO_0045901) (positive regulation of translational elongation), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0006346](http://purl.obolibrary.org/obo/GO_0006346) (methylation-dependent chromatin silencing), [GO:0005008](http://purl.obolibrary.org/obo/GO_0005008) (hepatocyte growth factor-activated receptor activity), [GO:0048188](http://purl.obolibrary.org/obo/GO_0048188) (Set1C/COMPASS complex), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0019661](http://purl.obolibrary.org/obo/GO_0019661) (glucose catabolic process to lactate via pyruvate), [GO:0017005](http://purl.obolibrary.org/obo/GO_0017005) (3'-tyrosyl-DNA phosphodiesterase activity), [GO:0032621](http://purl.obolibrary.org/obo/GO_0032621) (interleukin-18 production), [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development), [GO:0045916](http://purl.obolibrary.org/obo/GO_0045916) (negative regulation of complement activation), [GO:0061145](http://purl.obolibrary.org/obo/GO_0061145) (lung smooth muscle development), [GO:1903352](http://purl.obolibrary.org/obo/GO_1903352) (L-ornithine transmembrane transport), [GO:0061146](http://purl.obolibrary.org/obo/GO_0061146) (Peyer's patch morphogenesis), [GO:0045919](http://purl.obolibrary.org/obo/GO_0045919) (positive regulation of cytolysis), [GO:0021966](http://purl.obolibrary.org/obo/GO_0021966) (corticospinal neuron axon guidance), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005020](http://purl.obolibrary.org/obo/GO_0005020) (stem cell factor receptor activity), [GO:1904685](http://purl.obolibrary.org/obo/GO_1904685) (positive regulation of metalloendopeptidase activity), [GO:0045918](http://purl.obolibrary.org/obo/GO_0045918) (negative regulation of cytolysis), [GO:0061143](http://purl.obolibrary.org/obo/GO_0061143) (alveolar primary septum development), [GO:0006354](http://purl.obolibrary.org/obo/GO_0006354) (DNA-templated transcription, elongation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005021](http://purl.obolibrary.org/obo/GO_0005021) (vascular endothelial growth factor-activated receptor activity), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0006352](http://purl.obolibrary.org/obo/GO_0006352) (DNA-templated transcription, initiation), [GO:0006353](http://purl.obolibrary.org/obo/GO_0006353) (DNA-templated transcription, termination), [GO:0021965](http://purl.obolibrary.org/obo/GO_0021965) (spinal cord ventral commissure morphogenesis), [GO:1903358](http://purl.obolibrary.org/obo/GO_1903358) (regulation of Golgi organization), [GO:0005026](http://purl.obolibrary.org/obo/GO_0005026) (transforming growth factor beta receptor activity, type II), [GO:0061149](http://purl.obolibrary.org/obo/GO_0061149) (BMP signaling pathway involved in ureter morphogenesis), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0006359](http://purl.obolibrary.org/obo/GO_0006359) (regulation of transcription by RNA polymerase III), [GO:0021960](http://purl.obolibrary.org/obo/GO_0021960) (anterior commissure morphogenesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0045910](http://purl.obolibrary.org/obo/GO_0045910) (negative regulation of DNA recombination), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0005018](http://purl.obolibrary.org/obo/GO_0005018) (platelet-derived growth factor alpha-receptor activity), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0032615](http://purl.obolibrary.org/obo/GO_0032615) (interleukin-12 production), [GO:0099738](http://purl.obolibrary.org/obo/GO_0099738) (cell cortex region), [GO:0048194](http://purl.obolibrary.org/obo/GO_0048194) (Golgi vesicle budding), [GO:0032613](http://purl.obolibrary.org/obo/GO_0032613) (interleukin-10 production), [GO:0048193](http://purl.obolibrary.org/obo/GO_0048193) (Golgi vesicle transport), [GO:0032610](http://purl.obolibrary.org/obo/GO_0032610) (interleukin-1 alpha production), [GO:0032611](http://purl.obolibrary.org/obo/GO_0032611) (interleukin-1 beta production), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0070847](http://purl.obolibrary.org/obo/GO_0070847) (core mediator complex), [GO:0070848](http://purl.obolibrary.org/obo/GO_0070848) (response to growth factor), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0006285](http://purl.obolibrary.org/obo/GO_0006285) (base-excision repair, AP site formation), [GO:0006283](http://purl.obolibrary.org/obo/GO_0006283) (transcription-coupled nucleotide-excision repair), [GO:0032570](http://purl.obolibrary.org/obo/GO_0032570) (response to progesterone), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0097094](http://purl.obolibrary.org/obo/GO_0097094) (craniofacial suture morphogenesis), [GO:0006287](http://purl.obolibrary.org/obo/GO_0006287) (base-excision repair, gap-filling), [GO:0097095](http://purl.obolibrary.org/obo/GO_0097095) (frontonasal suture morphogenesis), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0097089](http://purl.obolibrary.org/obo/GO_0097089) (methyl-branched fatty acid metabolic process), [GO:0018271](http://purl.obolibrary.org/obo/GO_0018271) (biotin-protein ligase activity), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:1990523](http://purl.obolibrary.org/obo/GO_1990523) (bone regeneration), [GO:0018272](http://purl.obolibrary.org/obo/GO_0018272) (protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031233](http://purl.obolibrary.org/obo/GO_0031233) (intrinsic component of external side of plasma membrane), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:1990527](http://purl.obolibrary.org/obo/GO_1990527) (Tec1p-Ste12p-Dig1p complex), [GO:0070842](http://purl.obolibrary.org/obo/GO_0070842) (aggresome assembly), [GO:0018279](http://purl.obolibrary.org/obo/GO_0018279) (protein N-linked glycosylation via asparagine), [GO:0031231](http://purl.obolibrary.org/obo/GO_0031231) (intrinsic component of peroxisomal membrane), [GO:0070840](http://purl.obolibrary.org/obo/GO_0070840) (dynein complex binding), [GO:0031232](http://purl.obolibrary.org/obo/GO_0031232) (extrinsic component of external side of plasma membrane), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0032567](http://purl.obolibrary.org/obo/GO_0032567) (dGTP binding), [GO:0070836](http://purl.obolibrary.org/obo/GO_0070836) (caveola assembly), [GO:0070837](http://purl.obolibrary.org/obo/GO_0070837) (dehydroascorbic acid transport), [GO:0006290](http://purl.obolibrary.org/obo/GO_0006290) (pyrimidine dimer repair), [GO:0006295](http://purl.obolibrary.org/obo/GO_0006295) (nucleotide-excision repair, DNA incision, 3'-to lesion), [GO:0006296](http://purl.obolibrary.org/obo/GO_0006296) (nucleotide-excision repair, DNA incision, 5'-to lesion), [GO:0006294](http://purl.obolibrary.org/obo/GO_0006294) (nucleotide-excision repair, preincision complex assembly), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0006297](http://purl.obolibrary.org/obo/GO_0006297) (nucleotide-excision repair, DNA gap filling), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006298](http://purl.obolibrary.org/obo/GO_0006298) (mismatch repair), [GO:0044565](http://purl.obolibrary.org/obo/GO_0044565) (dendritic cell proliferation), [GO:0043237](http://purl.obolibrary.org/obo/GO_0043237) (laminin-1 binding), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0045899](http://purl.obolibrary.org/obo/GO_0045899) (positive regulation of RNA polymerase II transcriptional preinitiation complex assembly), [GO:1990531](http://purl.obolibrary.org/obo/GO_1990531) (Lem3p-Dnf1p complex), [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding), [GO:0043240](http://purl.obolibrary.org/obo/GO_0043240) (Fanconi anaemia nuclear complex), [GO:1990535](http://purl.obolibrary.org/obo/GO_1990535) (neuron projection maintenance), [GO:0033885](http://purl.obolibrary.org/obo/GO_0033885) (10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity), [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0070831](http://purl.obolibrary.org/obo/GO_0070831) (basement membrane assembly), [GO:0031223](http://purl.obolibrary.org/obo/GO_0031223) (auditory behavior), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0032558](http://purl.obolibrary.org/obo/GO_0032558) (adenyl deoxyribonucleotide binding), [GO:0031227](http://purl.obolibrary.org/obo/GO_0031227) (intrinsic component of endoplasmic reticulum membrane), [GO:0031224](http://purl.obolibrary.org/obo/GO_0031224) (intrinsic component of membrane), [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding), [GO:0031225](http://purl.obolibrary.org/obo/GO_0031225) (anchored component of membrane), [GO:0070869](http://purl.obolibrary.org/obo/GO_0070869) (heterochromatin assembly involved in chromatin silencing), [GO:0006260](http://purl.obolibrary.org/obo/GO_0006260) (DNA replication), [GO:0006261](http://purl.obolibrary.org/obo/GO_0006261) (DNA-dependent DNA replication), [GO:0006266](http://purl.obolibrary.org/obo/GO_0006266) (DNA ligation), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0006267](http://purl.obolibrary.org/obo/GO_0006267) (pre-replicative complex assembly involved in nuclear cell cycle DNA replication), [GO:0006264](http://purl.obolibrary.org/obo/GO_0006264) (mitochondrial DNA replication), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0006265](http://purl.obolibrary.org/obo/GO_0006265) (DNA topological change), [GO:0021892](http://purl.obolibrary.org/obo/GO_0021892) (cerebral cortex GABAergic interneuron differentiation), [GO:0043247](http://purl.obolibrary.org/obo/GO_0043247) (telomere maintenance in response to DNA damage), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0006268](http://purl.obolibrary.org/obo/GO_0006268) (DNA unwinding involved in DNA replication), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0021895](http://purl.obolibrary.org/obo/GO_0021895) (cerebral cortex neuron differentiation), [GO:0097067](http://purl.obolibrary.org/obo/GO_0097067) (cellular response to thyroid hormone stimulus), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:1990542](http://purl.obolibrary.org/obo/GO_1990542) (mitochondrial transmembrane transport), [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding), [GO:0070860](http://purl.obolibrary.org/obo/GO_0070860) (RNA polymerase I core factor complex), [GO:0043252](http://purl.obolibrary.org/obo/GO_0043252) (sodium-independent organic anion transport), [GO:0032543](http://purl.obolibrary.org/obo/GO_0032543) (mitochondrial translation), [GO:0031210](http://purl.obolibrary.org/obo/GO_0031210) (phosphatidylcholine binding), [GO:0032541](http://purl.obolibrary.org/obo/GO_0032541) (cortical endoplasmic reticulum), [GO:0070867](http://purl.obolibrary.org/obo/GO_0070867) (mating projection tip membrane), [GO:0033878](http://purl.obolibrary.org/obo/GO_0033878) (hormone-sensitive lipase activity), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0006270](http://purl.obolibrary.org/obo/GO_0006270) (DNA replication initiation), [GO:0070859](http://purl.obolibrary.org/obo/GO_0070859) (positive regulation of bile acid biosynthetic process), [GO:0006273](http://purl.obolibrary.org/obo/GO_0006273) (lagging strand elongation), [GO:0021889](http://purl.obolibrary.org/obo/GO_0021889) (olfactory bulb interneuron differentiation), [GO:0006272](http://purl.obolibrary.org/obo/GO_0006272) (leading strand elongation), [GO:0021885](http://purl.obolibrary.org/obo/GO_0021885) (forebrain cell migration), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0006278](http://purl.obolibrary.org/obo/GO_0006278) (RNA-dependent DNA biosynthetic process), [GO:0006275](http://purl.obolibrary.org/obo/GO_0006275) (regulation of DNA replication), [GO:0006276](http://purl.obolibrary.org/obo/GO_0006276) (plasmid maintenance), [GO:0021881](http://purl.obolibrary.org/obo/GO_0021881) (Wnt-activated signaling pathway involved in forebrain neuron fate commitment), [GO:0097084](http://purl.obolibrary.org/obo/GO_0097084) (vascular smooth muscle cell development), [GO:0006279](http://purl.obolibrary.org/obo/GO_0006279) (premeiotic DNA replication), [GO:0021884](http://purl.obolibrary.org/obo/GO_0021884) (forebrain neuron development), [GO:0097078](http://purl.obolibrary.org/obo/GO_0097078) (FAL1-SGD1 complex), [GO:0021891](http://purl.obolibrary.org/obo/GO_0021891) (olfactory bulb interneuron development), [GO:0043262](http://purl.obolibrary.org/obo/GO_0043262) (adenosine-diphosphatase activity), [GO:0018242](http://purl.obolibrary.org/obo/GO_0018242) (protein O-linked glycosylation via serine), [GO:0044594](http://purl.obolibrary.org/obo/GO_0044594) (17-beta-hydroxysteroid dehydrogenase (NAD+) activity), [GO:0070852](http://purl.obolibrary.org/obo/GO_0070852) (cell body fiber), [GO:0031201](http://purl.obolibrary.org/obo/GO_0031201) (SNARE complex), [GO:0032532](http://purl.obolibrary.org/obo/GO_0032532) (regulation of microvillus length), [GO:0070851](http://purl.obolibrary.org/obo/GO_0070851) (growth factor receptor binding), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0031205](http://purl.obolibrary.org/obo/GO_0031205) (endoplasmic reticulum Sec complex), [GO:0032536](http://purl.obolibrary.org/obo/GO_0032536) (regulation of cell projection size), [GO:0032534](http://purl.obolibrary.org/obo/GO_0032534) (regulation of microvillus assembly), [GO:0031284](http://purl.obolibrary.org/obo/GO_0031284) (positive regulation of guanylate cyclase activity), [GO:0061098](http://purl.obolibrary.org/obo/GO_0061098) (positive regulation of protein tyrosine kinase activity), [GO:0031282](http://purl.obolibrary.org/obo/GO_0031282) (regulation of guanylate cyclase activity), [GO:0045841](http://purl.obolibrary.org/obo/GO_0045841) (negative regulation of mitotic metaphase/anaphase transition), [GO:0045842](http://purl.obolibrary.org/obo/GO_0045842) (positive regulation of mitotic metaphase/anaphase transition), [GO:0097050](http://purl.obolibrary.org/obo/GO_0097050) (type B pancreatic cell apoptotic process), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0045843](http://purl.obolibrary.org/obo/GO_0045843) (negative regulation of striated muscle tissue development), [GO:0097053](http://purl.obolibrary.org/obo/GO_0097053) (L-kynurenine catabolic process), [GO:0097045](http://purl.obolibrary.org/obo/GO_0097045) (phosphatidylserine exposure on blood platelet), [GO:0002711](http://purl.obolibrary.org/obo/GO_0002711) (positive regulation of T cell mediated immunity), [GO:0097049](http://purl.obolibrary.org/obo/GO_0097049) (motor neuron apoptotic process), [GO:1990569](http://purl.obolibrary.org/obo/GO_1990569) (UDP-N-acetylglucosamine transmembrane transport), [GO:0031275](http://purl.obolibrary.org/obo/GO_0031275) (regulation of lateral pseudopodium assembly), [GO:1903281](http://purl.obolibrary.org/obo/GO_1903281) (positive regulation of calcium:sodium antiporter activity), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0061085](http://purl.obolibrary.org/obo/GO_0061085) (regulation of histone H3-K27 methylation), [GO:0031274](http://purl.obolibrary.org/obo/GO_0031274) (positive regulation of pseudopodium assembly), [GO:0061088](http://purl.obolibrary.org/obo/GO_0061088) (regulation of sequestering of zinc ion), [GO:0097061](http://purl.obolibrary.org/obo/GO_0097061) (dendritic spine organization), [GO:0097060](http://purl.obolibrary.org/obo/GO_0097060) (synaptic membrane), [GO:0045851](http://purl.obolibrary.org/obo/GO_0045851) (pH reduction), [GO:0044524](http://purl.obolibrary.org/obo/GO_0044524) (protein sulfhydration), [GO:0097062](http://purl.obolibrary.org/obo/GO_0097062) (dendritic spine maintenance), [GO:1990573](http://purl.obolibrary.org/obo/GO_1990573) (potassium ion import across plasma membrane), [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process), [GO:0014709](http://purl.obolibrary.org/obo/GO_0014709) (positive regulation of somitomeric trunk muscle development), [GO:0045860](http://purl.obolibrary.org/obo/GO_0045860) (positive regulation of protein kinase activity), [GO:0002724](http://purl.obolibrary.org/obo/GO_0002724) (regulation of T cell cytokine production), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0002725](http://purl.obolibrary.org/obo/GO_0002725) (negative regulation of T cell cytokine production), [GO:0014706](http://purl.obolibrary.org/obo/GO_0014706) (striated muscle tissue development), [GO:0002726](http://purl.obolibrary.org/obo/GO_0002726) (positive regulation of T cell cytokine production), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0031267](http://purl.obolibrary.org/obo/GO_0031267) (small GTPase binding), [GO:0002728](http://purl.obolibrary.org/obo/GO_0002728) (negative regulation of natural killer cell cytokine production), [GO:0031264](http://purl.obolibrary.org/obo/GO_0031264) (death-inducing signaling complex), [GO:0002729](http://purl.obolibrary.org/obo/GO_0002729) (positive regulation of natural killer cell cytokine production), [GO:0031265](http://purl.obolibrary.org/obo/GO_0031265) (CD95 death-inducing signaling complex), [GO:0014701](http://purl.obolibrary.org/obo/GO_0014701) (junctional sarcoplasmic reticulum membrane), [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding), [GO:0044539](http://purl.obolibrary.org/obo/GO_0044539) (long-chain fatty acid import), [GO:0032590](http://purl.obolibrary.org/obo/GO_0032590) (dendrite membrane), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0032593](http://purl.obolibrary.org/obo/GO_0032593) (insulin-responsive compartment), [GO:0032591](http://purl.obolibrary.org/obo/GO_0032591) (dendritic spine membrane), [GO:0070829](http://purl.obolibrary.org/obo/GO_0070829) (heterochromatin maintenance), [GO:0032592](http://purl.obolibrary.org/obo/GO_0032592) (integral component of mitochondrial membrane), [GO:0031261](http://purl.obolibrary.org/obo/GO_0031261) (DNA replication preinitiation complex), [GO:0043200](http://purl.obolibrary.org/obo/GO_0043200) (response to amino acid), [GO:0044530](http://purl.obolibrary.org/obo/GO_0044530) (supraspliceosomal complex), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0045862](http://purl.obolibrary.org/obo/GO_0045862) (positive regulation of proteolysis), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:1990592](http://purl.obolibrary.org/obo/GO_1990592) (protein K69-linked ufmylation), [GO:0044537](http://purl.obolibrary.org/obo/GO_0044537) (regulation of circulating fibrinogen levels), [GO:0018293](http://purl.obolibrary.org/obo/GO_0018293) (protein-FAD linkage), [GO:0097026](http://purl.obolibrary.org/obo/GO_0097026) (dendritic cell dendrite assembly), [GO:1990589](http://purl.obolibrary.org/obo/GO_1990589) (ATF4-CREB1 transcription factor complex), [GO:0044540](http://purl.obolibrary.org/obo/GO_0044540) (L-cystine L-cysteine-lyase (deaminating)), [GO:0097028](http://purl.obolibrary.org/obo/GO_0097028) (dendritic cell differentiation), [GO:0032587](http://purl.obolibrary.org/obo/GO_0032587) (ruffle membrane), [GO:0031256](http://purl.obolibrary.org/obo/GO_0031256) (leading edge membrane), [GO:0018298](http://purl.obolibrary.org/obo/GO_0018298) (protein-chromophore linkage), [GO:0031253](http://purl.obolibrary.org/obo/GO_0031253) (cell projection membrane), [GO:0032585](http://purl.obolibrary.org/obo/GO_0032585) (multivesicular body membrane), [GO:0032588](http://purl.obolibrary.org/obo/GO_0032588) (trans-Golgi network membrane), [GO:0031258](http://purl.obolibrary.org/obo/GO_0031258) (lamellipodium membrane), [GO:0070816](http://purl.obolibrary.org/obo/GO_0070816) (phosphorylation of RNA polymerase II C-terminal domain), [GO:0043218](http://purl.obolibrary.org/obo/GO_0043218) (compact myelin), [GO:0070814](http://purl.obolibrary.org/obo/GO_0070814) (hydrogen sulfide biosynthetic process), [GO:0031252](http://purl.obolibrary.org/obo/GO_0031252) (cell leading edge), [GO:0032580](http://purl.obolibrary.org/obo/GO_0032580) (Golgi cisterna membrane), [GO:0032581](http://purl.obolibrary.org/obo/GO_0032581) (ER-dependent peroxisome organization), [GO:0045875](http://purl.obolibrary.org/obo/GO_0045875) (negative regulation of sister chromatid cohesion), [GO:0045872](http://purl.obolibrary.org/obo/GO_0045872) (positive regulation of rhodopsin gene expression), [GO:0044546](http://purl.obolibrary.org/obo/GO_0044546) (NLRP3 inflammasome complex assembly), [GO:0043215](http://purl.obolibrary.org/obo/GO_0043215) (daunorubicin transport), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0045876](http://purl.obolibrary.org/obo/GO_0045876) (positive regulation of sister chromatid cohesion), [GO:0044548](http://purl.obolibrary.org/obo/GO_0044548) (S100 protein binding), [GO:0097034](http://purl.obolibrary.org/obo/GO_0097034) (mitochondrial respiratory chain complex IV biogenesis), [GO:2000507](http://purl.obolibrary.org/obo/GO_2000507) (positive regulation of energy homeostasis), [GO:0097033](http://purl.obolibrary.org/obo/GO_0097033) (mitochondrial respiratory chain complex III biogenesis), [GO:1990599](http://purl.obolibrary.org/obo/GO_1990599) (3' overhang single-stranded DNA endodeoxyribonuclease activity), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:0018283](http://purl.obolibrary.org/obo/GO_0018283) (iron incorporation into metallo-sulfur cluster), [GO:0097037](http://purl.obolibrary.org/obo/GO_0097037) (heme export), [GO:2000504](http://purl.obolibrary.org/obo/GO_2000504) (positive regulation of blood vessel remodeling), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:2000505](http://purl.obolibrary.org/obo/GO_2000505) (regulation of energy homeostasis), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:2000506](http://purl.obolibrary.org/obo/GO_2000506) (negative regulation of energy homeostasis), [GO:0032575](http://purl.obolibrary.org/obo/GO_0032575) (ATP-dependent 5'-3' RNA helicase activity), [GO:2000502](http://purl.obolibrary.org/obo/GO_2000502) (negative regulation of natural killer cell chemotaxis), [GO:0070813](http://purl.obolibrary.org/obo/GO_0070813) (hydrogen sulfide metabolic process), [GO:0102009](http://purl.obolibrary.org/obo/GO_0102009) (proline dipeptidase activity), [GO:0014740](http://purl.obolibrary.org/obo/GO_0014740) (negative regulation of muscle hyperplasia), [GO:0102007](http://purl.obolibrary.org/obo/GO_0102007) (acyl-L-homoserine-lactone lactonohydrolase activity), [GO:0002761](http://purl.obolibrary.org/obo/GO_0002761) (regulation of myeloid leukocyte differentiation), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0002757](http://purl.obolibrary.org/obo/GO_0002757) (immune response-activating signal transduction), [GO:2000510](http://purl.obolibrary.org/obo/GO_2000510) (positive regulation of dendritic cell chemotaxis), [GO:0014734](http://purl.obolibrary.org/obo/GO_0014734) (skeletal muscle hypertrophy), [GO:0014731](http://purl.obolibrary.org/obo/GO_0014731) (spectrin-associated cytoskeleton), [GO:0000105](http://purl.obolibrary.org/obo/GO_0000105) (histidine biosynthetic process), [GO:0000104](http://purl.obolibrary.org/obo/GO_0000104) (succinate dehydrogenase activity), [GO:0000102](http://purl.obolibrary.org/obo/GO_0000102) (L-methionine secondary active transmembrane transporter activity), [GO:0000101](http://purl.obolibrary.org/obo/GO_0000101) (sulfur amino acid transport), [GO:0002763](http://purl.obolibrary.org/obo/GO_0002763) (positive regulation of myeloid leukocyte differentiation), [GO:0000111](http://purl.obolibrary.org/obo/GO_0000111) (nucleotide-excision repair factor 2 complex), [GO:0000110](http://purl.obolibrary.org/obo/GO_0000110) (nucleotide-excision repair factor 1 complex), [GO:0002768](http://purl.obolibrary.org/obo/GO_0002768) (immune response-regulating cell surface receptor signaling pathway), [GO:0051707](http://purl.obolibrary.org/obo/GO_0051707) (response to other organism), [GO:0001405](http://purl.obolibrary.org/obo/GO_0001405) (presequence translocase-associated import motor), [GO:0001403](http://purl.obolibrary.org/obo/GO_0001403) (invasive growth in response to glucose limitation), [GO:0001402](http://purl.obolibrary.org/obo/GO_0001402) (signal transduction involved in filamentous growth), [GO:0001400](http://purl.obolibrary.org/obo/GO_0001400) (mating projection base), [GO:0002731](http://purl.obolibrary.org/obo/GO_0002731) (negative regulation of dendritic cell cytokine production), [GO:0014719](http://purl.obolibrary.org/obo/GO_0014719) (skeletal muscle satellite cell activation), [GO:0014718](http://purl.obolibrary.org/obo/GO_0014718) (positive regulation of satellite cell activation involved in skeletal muscle regeneration), [GO:0031297](http://purl.obolibrary.org/obo/GO_0031297) (replication fork processing), [GO:0031298](http://purl.obolibrary.org/obo/GO_0031298) (replication fork protection complex), [GO:0051702](http://purl.obolibrary.org/obo/GO_0051702) (interaction with symbiont), [GO:0031292](http://purl.obolibrary.org/obo/GO_0031292) (gene conversion at mating-type locus, DNA double-strand break processing), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0031296](http://purl.obolibrary.org/obo/GO_0031296) (B cell costimulation), [GO:0031293](http://purl.obolibrary.org/obo/GO_0031293) (membrane protein intracellular domain proteolysis), [GO:0051718](http://purl.obolibrary.org/obo/GO_0051718) (DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates), [GO:0002741](http://purl.obolibrary.org/obo/GO_0002741) (positive regulation of cytokine secretion involved in immune response), [GO:0014728](http://purl.obolibrary.org/obo/GO_0014728) (regulation of the force of skeletal muscle contraction), [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:2000546](http://purl.obolibrary.org/obo/GO_2000546) (positive regulation of endothelial cell chemotaxis to fibroblast growth factor), [GO:0051712](http://purl.obolibrary.org/obo/GO_0051712) (positive regulation of killing of cells of other organism), [GO:0014722](http://purl.obolibrary.org/obo/GO_0014722) (regulation of skeletal muscle contraction by calcium ion signaling), [GO:2000541](http://purl.obolibrary.org/obo/GO_2000541) (positive regulation of protein geranylgeranylation), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0043266](http://purl.obolibrary.org/obo/GO_0043266) (regulation of potassium ion transport), [GO:0043265](http://purl.obolibrary.org/obo/GO_0043265) (ectoplasm), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043268](http://purl.obolibrary.org/obo/GO_0043268) (positive regulation of potassium ion transport), [GO:0044599](http://purl.obolibrary.org/obo/GO_0044599) (AP-5 adaptor complex), [GO:0043267](http://purl.obolibrary.org/obo/GO_0043267) (negative regulation of potassium ion transport), [GO:0000138](http://purl.obolibrary.org/obo/GO_0000138) (Golgi trans cisterna), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0000137](http://purl.obolibrary.org/obo/GO_0000137) (Golgi cis cisterna), [GO:0000144](http://purl.obolibrary.org/obo/GO_0000144) (cellular bud neck septin ring), [GO:0000142](http://purl.obolibrary.org/obo/GO_0000142) (cellular bud neck contractile ring), [GO:0043270](http://purl.obolibrary.org/obo/GO_0043270) (positive regulation of ion transport), [GO:0070881](http://purl.obolibrary.org/obo/GO_0070881) (regulation of proline transport), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0070880](http://purl.obolibrary.org/obo/GO_0070880) (fungal-type cell wall beta-glucan biosynthetic process), [GO:0070886](http://purl.obolibrary.org/obo/GO_0070886) (positive regulation of calcineurin-NFAT signaling cascade), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0070889](http://purl.obolibrary.org/obo/GO_0070889) (platelet alpha granule organization), [GO:2000552](http://purl.obolibrary.org/obo/GO_2000552) (negative regulation of T-helper 2 cell cytokine production), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:2000553](http://purl.obolibrary.org/obo/GO_2000553) (positive regulation of T-helper 2 cell cytokine production), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0043279](http://purl.obolibrary.org/obo/GO_0043279) (response to alkaloid), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0043278](http://purl.obolibrary.org/obo/GO_0043278) (response to morphine), [GO:0000147](http://purl.obolibrary.org/obo/GO_0000147) (actin cortical patch assembly), [GO:0000146](http://purl.obolibrary.org/obo/GO_0000146) (microfilament motor activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000155](http://purl.obolibrary.org/obo/GO_0000155) (phosphorelay sensor kinase activity), [GO:0000154](http://purl.obolibrary.org/obo/GO_0000154) (rRNA modification), [GO:0043282](http://purl.obolibrary.org/obo/GO_0043282) (pharyngeal muscle development), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0070870](http://purl.obolibrary.org/obo/GO_0070870) (heterochromatin maintenance involved in chromatin silencing), [GO:2000566](http://purl.obolibrary.org/obo/GO_2000566) (positive regulation of CD8-positive, alpha-beta T cell proliferation), [GO:0070873](http://purl.obolibrary.org/obo/GO_0070873) (regulation of glycogen metabolic process), [GO:2000564](http://purl.obolibrary.org/obo/GO_2000564) (regulation of CD8-positive, alpha-beta T cell proliferation), [GO:2000582](http://purl.obolibrary.org/obo/GO_2000582) (positive regulation of ATP-dependent microtubule motor activity, plus-end-directed), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0000112](http://purl.obolibrary.org/obo/GO_0000112) (nucleotide-excision repair factor 3 complex), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0043291](http://purl.obolibrary.org/obo/GO_0043291) (RAVE complex), [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber), [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding), [GO:0043297](http://purl.obolibrary.org/obo/GO_0043297) (apical junction assembly), [GO:0043296](http://purl.obolibrary.org/obo/GO_0043296) (apical junction complex), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:2000574](http://purl.obolibrary.org/obo/GO_2000574) (regulation of microtubule motor activity), [GO:2000591](http://purl.obolibrary.org/obo/GO_2000591) (positive regulation of metanephric mesenchymal cell migration), [GO:0000126](http://purl.obolibrary.org/obo/GO_0000126) (transcription factor TFIIIB complex), [GO:0000123](http://purl.obolibrary.org/obo/GO_0000123) (histone acetyltransferase complex), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0002787](http://purl.obolibrary.org/obo/GO_0002787) (negative regulation of antibacterial peptide production), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0102084](http://purl.obolibrary.org/obo/GO_0102084) (L-dopa O-methyltransferase activity), [GO:0070892](http://purl.obolibrary.org/obo/GO_0070892) (lipoteichoic acid receptor activity), [GO:0070893](http://purl.obolibrary.org/obo/GO_0070893) (transposon integration), [GO:0070891](http://purl.obolibrary.org/obo/GO_0070891) (lipoteichoic acid binding), [GO:0070897](http://purl.obolibrary.org/obo/GO_0070897) (DNA-templated transcriptional preinitiation complex assembly), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), [GO:0070898](http://purl.obolibrary.org/obo/GO_0070898) (RNA polymerase III transcriptional preinitiation complex assembly), [GO:0070899](http://purl.obolibrary.org/obo/GO_0070899) (mitochondrial tRNA wobble uridine modification), [GO:0002481](http://purl.obolibrary.org/obo/GO_0002481) (antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent), [GO:0001147](http://purl.obolibrary.org/obo/GO_0001147) (transcription termination site sequence-specific DNA binding), [GO:0001156](http://purl.obolibrary.org/obo/GO_0001156) (TFIIIC-class transcription factor binding), [GO:0001152](http://purl.obolibrary.org/obo/GO_0001152) (transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIC recruiting), [GO:0051409](http://purl.obolibrary.org/obo/GO_0051409) (response to nitrosative stress), [GO:0051402](http://purl.obolibrary.org/obo/GO_0051402) (neuron apoptotic process), [GO:0051403](http://purl.obolibrary.org/obo/GO_0051403) (stress-activated MAPK cascade), [GO:1904504](http://purl.obolibrary.org/obo/GO_1904504) (positive regulation of lipophagy), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:1904506](http://purl.obolibrary.org/obo/GO_1904506) (negative regulation of telomere maintenance in response to DNA damage), [GO:0001162](http://purl.obolibrary.org/obo/GO_0001162) (RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding), [GO:0001161](http://purl.obolibrary.org/obo/GO_0001161) (intronic transcription regulatory region sequence-specific DNA binding), [GO:0052745](http://purl.obolibrary.org/obo/GO_0052745) (inositol phosphate phosphatase activity), [GO:0051414](http://purl.obolibrary.org/obo/GO_0051414) (response to cortisol), [GO:0015770](http://purl.obolibrary.org/obo/GO_0015770) (sucrose transport), [GO:0003796](http://purl.obolibrary.org/obo/GO_0003796) (lysozyme activity), [GO:0003786](http://purl.obolibrary.org/obo/GO_0003786) (actin lateral binding), [GO:0001134](http://purl.obolibrary.org/obo/GO_0001134) (transcription factor activity, transcription factor recruiting), [GO:0002455](http://purl.obolibrary.org/obo/GO_0002455) (humoral immune response mediated by circulating immunoglobulin), [GO:0001133](http://purl.obolibrary.org/obo/GO_0001133) (RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding), [GO:0002456](http://purl.obolibrary.org/obo/GO_0002456) (T cell mediated immunity), [GO:0002457](http://purl.obolibrary.org/obo/GO_0002457) (T cell antigen processing and presentation), [GO:0002458](http://purl.obolibrary.org/obo/GO_0002458) (peripheral T cell tolerance induction), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:0051427](http://purl.obolibrary.org/obo/GO_0051427) (hormone receptor binding), [GO:0051425](http://purl.obolibrary.org/obo/GO_0051425) (PTB domain binding), [GO:1904526](http://purl.obolibrary.org/obo/GO_1904526) (regulation of microtubule binding), [GO:0001139](http://purl.obolibrary.org/obo/GO_0001139) (transcription factor activity, core RNA polymerase II recruiting), [GO:0002474](http://purl.obolibrary.org/obo/GO_0002474) (antigen processing and presentation of peptide antigen via MHC class I), [GO:0001135](http://purl.obolibrary.org/obo/GO_0001135) (transcription factor activity, RNA polymerase II transcription factor recruiting), [GO:1904527](http://purl.obolibrary.org/obo/GO_1904527) (negative regulation of microtubule binding), [GO:0051434](http://purl.obolibrary.org/obo/GO_0051434) (BH3 domain binding), [GO:0002467](http://purl.obolibrary.org/obo/GO_0002467) (germinal center formation), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0009912](http://purl.obolibrary.org/obo/GO_0009912) (auditory receptor cell fate commitment), [GO:0001198](http://purl.obolibrary.org/obo/GO_0001198) (negative regulation of mating-type specific transcription from RNA polymerase II promoter), [GO:0001195](http://purl.obolibrary.org/obo/GO_0001195) (maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase III promoter), [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0010909](http://purl.obolibrary.org/obo/GO_0010909) (positive regulation of heparan sulfate proteoglycan biosynthetic process), [GO:0009922](http://purl.obolibrary.org/obo/GO_0009922) (fatty acid elongase activity), [GO:0010907](http://purl.obolibrary.org/obo/GO_0010907) (positive regulation of glucose metabolic process), [GO:0009914](http://purl.obolibrary.org/obo/GO_0009914) (hormone transport), [GO:0009913](http://purl.obolibrary.org/obo/GO_0009913) (epidermal cell differentiation), [GO:0010906](http://purl.obolibrary.org/obo/GO_0010906) (regulation of glucose metabolic process), [GO:0009918](http://purl.obolibrary.org/obo/GO_0009918) (sterol delta7 reductase activity), [GO:0010902](http://purl.obolibrary.org/obo/GO_0010902) (positive regulation of very-low-density lipoprotein particle remodeling), [GO:0009917](http://purl.obolibrary.org/obo/GO_0009917) (sterol 5-alpha reductase activity), [GO:1905802](http://purl.obolibrary.org/obo/GO_1905802) (regulation of cellular response to manganese ion), [GO:1904570](http://purl.obolibrary.org/obo/GO_1904570) (negative regulation of selenocysteine incorporation), [GO:1903243](http://purl.obolibrary.org/obo/GO_1903243) (negative regulation of cardiac muscle hypertrophy in response to stress), [GO:1904574](http://purl.obolibrary.org/obo/GO_1904574) (negative regulation of selenocysteine insertion sequence binding), [GO:1903244](http://purl.obolibrary.org/obo/GO_1903244) (positive regulation of cardiac muscle hypertrophy in response to stress), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0051491](http://purl.obolibrary.org/obo/GO_0051491) (positive regulation of filopodium assembly), [GO:0051492](http://purl.obolibrary.org/obo/GO_0051492) (regulation of stress fiber assembly), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0051490](http://purl.obolibrary.org/obo/GO_0051490) (negative regulation of filopodium assembly), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0008622](http://purl.obolibrary.org/obo/GO_0008622) (epsilon DNA polymerase complex), [GO:0009949](http://purl.obolibrary.org/obo/GO_0009949) (polarity specification of anterior/posterior axis), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0009946](http://purl.obolibrary.org/obo/GO_0009946) (proximal/distal axis specification), [GO:0008615](http://purl.obolibrary.org/obo/GO_0008615) (pyridoxine biosynthetic process), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:0046906](http://purl.obolibrary.org/obo/GO_0046906) (tetrapyrrole binding), [GO:0046903](http://purl.obolibrary.org/obo/GO_0046903) (secretion), [GO:1903251](http://purl.obolibrary.org/obo/GO_1903251) (multi-ciliated epithelial cell differentiation), [GO:1904588](http://purl.obolibrary.org/obo/GO_1904588) (cellular response to glycoprotein), [GO:0046907](http://purl.obolibrary.org/obo/GO_0046907) (intracellular transport), [GO:0008631](http://purl.obolibrary.org/obo/GO_0008631) (intrinsic apoptotic signaling pathway in response to oxidative stress), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0009966](http://purl.obolibrary.org/obo/GO_0009966) (regulation of signal transduction), [GO:0046902](http://purl.obolibrary.org/obo/GO_0046902) (regulation of mitochondrial membrane permeability), [GO:0008635](http://purl.obolibrary.org/obo/GO_0008635) (activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0010944](http://purl.obolibrary.org/obo/GO_0010944) (negative regulation of transcription by competitive promoter binding), [GO:0051493](http://purl.obolibrary.org/obo/GO_0051493) (regulation of cytoskeleton organization), [GO:0010947](http://purl.obolibrary.org/obo/GO_0010947) (negative regulation of meiotic joint molecule formation), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0046914](http://purl.obolibrary.org/obo/GO_0046914) (transition metal ion binding), [GO:0022904](http://purl.obolibrary.org/obo/GO_0022904) (respiratory electron transport chain), [GO:0022900](http://purl.obolibrary.org/obo/GO_0022900) (electron transport chain), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0046912](http://purl.obolibrary.org/obo/GO_0046912) (transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer), [GO:0009931](http://purl.obolibrary.org/obo/GO_0009931) (calcium-dependent protein serine/threonine kinase activity), [GO:0010916](http://purl.obolibrary.org/obo/GO_0010916) (negative regulation of very-low-density lipoprotein particle clearance), [GO:0050178](http://purl.obolibrary.org/obo/GO_0050178) (phenylpyruvate tautomerase activity), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0046928](http://purl.obolibrary.org/obo/GO_0046928) (regulation of neurotransmitter secretion), [GO:0086100](http://purl.obolibrary.org/obo/GO_0086100) (endothelin receptor signaling pathway), [GO:0046929](http://purl.obolibrary.org/obo/GO_0046929) (negative regulation of neurotransmitter secretion), [GO:0008610](http://purl.obolibrary.org/obo/GO_0008610) (lipid biosynthetic process), [GO:0008611](http://purl.obolibrary.org/obo/GO_0008611) (ether lipid biosynthetic process), [GO:0046922](http://purl.obolibrary.org/obo/GO_0046922) (peptide-O-fucosyltransferase activity), [GO:0010923](http://purl.obolibrary.org/obo/GO_0010923) (negative regulation of phosphatase activity), [GO:0010922](http://purl.obolibrary.org/obo/GO_0010922) (positive regulation of phosphatase activity), [GO:0008609](http://purl.obolibrary.org/obo/GO_0008609) (alkylglycerone-phosphate synthase activity), [GO:0008608](http://purl.obolibrary.org/obo/GO_0008608) (attachment of spindle microtubules to kinetochore), [GO:0010921](http://purl.obolibrary.org/obo/GO_0010921) (regulation of phosphatase activity), [GO:0019318](http://purl.obolibrary.org/obo/GO_0019318) (hexose metabolic process), [GO:0009992](http://purl.obolibrary.org/obo/GO_0009992) (cellular water homeostasis), [GO:0021636](http://purl.obolibrary.org/obo/GO_0021636) (trigeminal nerve morphogenesis), [GO:1903202](http://purl.obolibrary.org/obo/GO_1903202) (negative regulation of oxidative stress-induced cell death), [GO:0021637](http://purl.obolibrary.org/obo/GO_0021637) (trigeminal nerve structural organization), [GO:0006002](http://purl.obolibrary.org/obo/GO_0006002) (fructose 6-phosphate metabolic process), [GO:0021633](http://purl.obolibrary.org/obo/GO_0021633) (optic nerve structural organization), [GO:1903206](http://purl.obolibrary.org/obo/GO_1903206) (negative regulation of hydrogen peroxide-induced cell death), [GO:0021634](http://purl.obolibrary.org/obo/GO_0021634) (optic nerve formation), [GO:0006000](http://purl.obolibrary.org/obo/GO_0006000) (fructose metabolic process), [GO:1904535](http://purl.obolibrary.org/obo/GO_1904535) (positive regulation of telomeric loop disassembly), [GO:1903204](http://purl.obolibrary.org/obo/GO_1903204) (negative regulation of oxidative stress-induced neuron death), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0006004](http://purl.obolibrary.org/obo/GO_0006004) (fucose metabolic process), [GO:0021631](http://purl.obolibrary.org/obo/GO_0021631) (optic nerve morphogenesis), [GO:1903208](http://purl.obolibrary.org/obo/GO_1903208) (negative regulation of hydrogen peroxide-induced neuron death), [GO:0033617](http://purl.obolibrary.org/obo/GO_0033617) (mitochondrial respiratory chain complex IV assembly), [GO:0033615](http://purl.obolibrary.org/obo/GO_0033615) (mitochondrial proton-transporting ATP synthase complex assembly), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0051441](http://purl.obolibrary.org/obo/GO_0051441) (positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle), [GO:0033619](http://purl.obolibrary.org/obo/GO_0033619) (membrane protein proteolysis), [GO:0019322](http://purl.obolibrary.org/obo/GO_0019322) (pentose biosynthetic process), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0010970](http://purl.obolibrary.org/obo/GO_0010970) (transport along microtubule), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0010972](http://purl.obolibrary.org/obo/GO_0010972) (negative regulation of G2/M transition of mitotic cell cycle), [GO:0051446](http://purl.obolibrary.org/obo/GO_0051446) (positive regulation of meiotic cell cycle), [GO:0033612](http://purl.obolibrary.org/obo/GO_0033612) (receptor serine/threonine kinase binding), [GO:0010971](http://purl.obolibrary.org/obo/GO_0010971) (positive regulation of G2/M transition of mitotic cell cycle), [GO:0051447](http://purl.obolibrary.org/obo/GO_0051447) (negative regulation of meiotic cell cycle), [GO:0007341](http://purl.obolibrary.org/obo/GO_0007341) (penetration of zona pellucida), [GO:0021628](http://purl.obolibrary.org/obo/GO_0021628) (olfactory nerve formation), [GO:1905872](http://purl.obolibrary.org/obo/GO_1905872) (negative regulation of protein localization to cell leading edge), [GO:0006013](http://purl.obolibrary.org/obo/GO_0006013) (mannose metabolic process), [GO:0006014](http://purl.obolibrary.org/obo/GO_0006014) (D-ribose metabolic process), [GO:0021623](http://purl.obolibrary.org/obo/GO_0021623) (oculomotor nerve formation), [GO:0006011](http://purl.obolibrary.org/obo/GO_0006011) (UDP-glucose metabolic process), [GO:0007342](http://purl.obolibrary.org/obo/GO_0007342) (fusion of sperm to egg plasma membrane involved in single fertilization), [GO:0006012](http://purl.obolibrary.org/obo/GO_0006012) (galactose metabolic process), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:0006015](http://purl.obolibrary.org/obo/GO_0006015) (5-phosphoribose 1-diphosphate biosynthetic process), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0051453](http://purl.obolibrary.org/obo/GO_0051453) (regulation of intracellular pH), [GO:0007339](http://purl.obolibrary.org/obo/GO_0007339) (binding of sperm to zona pellucida), [GO:0051454](http://purl.obolibrary.org/obo/GO_0051454) (intracellular pH elevation), [GO:0051451](http://purl.obolibrary.org/obo/GO_0051451) (myoblast migration), [GO:0010989](http://purl.obolibrary.org/obo/GO_0010989) (negative regulation of low-density lipoprotein particle clearance), [GO:0051452](http://purl.obolibrary.org/obo/GO_0051452) (intracellular pH reduction), [GO:0010988](http://purl.obolibrary.org/obo/GO_0010988) (regulation of low-density lipoprotein particle clearance), [GO:0033609](http://purl.obolibrary.org/obo/GO_0033609) (oxalate metabolic process), [GO:0051450](http://purl.obolibrary.org/obo/GO_0051450) (myoblast proliferation), [GO:0010987](http://purl.obolibrary.org/obo/GO_0010987) (negative regulation of high-density lipoprotein particle clearance), [GO:0010980](http://purl.obolibrary.org/obo/GO_0010980) (positive regulation of vitamin D 24-hydroxylase activity), [GO:0051457](http://purl.obolibrary.org/obo/GO_0051457) (maintenance of protein location in nucleus), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0021615](http://purl.obolibrary.org/obo/GO_0021615) (glossopharyngeal nerve morphogenesis), [GO:0008643](http://purl.obolibrary.org/obo/GO_0008643) (carbohydrate transport), [GO:0021610](http://purl.obolibrary.org/obo/GO_0021610) (facial nerve morphogenesis), [GO:0008641](http://purl.obolibrary.org/obo/GO_0008641) (ubiquitin-like modifier activating enzyme activity), [GO:1903225](http://purl.obolibrary.org/obo/GO_1903225) (negative regulation of endodermal cell differentiation), [GO:0021612](http://purl.obolibrary.org/obo/GO_0021612) (facial nerve structural organization), [GO:0009972](http://purl.obolibrary.org/obo/GO_0009972) (cytidine deamination), [GO:0008645](http://purl.obolibrary.org/obo/GO_0008645) (hexose transport), [GO:0051466](http://purl.obolibrary.org/obo/GO_0051466) (positive regulation of corticotropin-releasing hormone secretion), [GO:0052795](http://purl.obolibrary.org/obo/GO_0052795) (exo-alpha-(2->6)-sialidase activity), [GO:0051464](http://purl.obolibrary.org/obo/GO_0051464) (positive regulation of cortisol secretion), [GO:0008637](http://purl.obolibrary.org/obo/GO_0008637) (apoptotic mitochondrial changes), [GO:0052796](http://purl.obolibrary.org/obo/GO_0052796) (exo-alpha-(2->8)-sialidase activity), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0010956](http://purl.obolibrary.org/obo/GO_0010956) (negative regulation of calcidiol 1-monooxygenase activity), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0052794](http://purl.obolibrary.org/obo/GO_0052794) (exo-alpha-(2->3)-sialidase activity), [GO:0051461](http://purl.obolibrary.org/obo/GO_0051461) (positive regulation of corticotropin secretion), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:0010954](http://purl.obolibrary.org/obo/GO_0010954) (positive regulation of protein processing), [GO:1903232](http://purl.obolibrary.org/obo/GO_1903232) (melanosome assembly), [GO:0051480](http://purl.obolibrary.org/obo/GO_0051480) (regulation of cytosolic calcium ion concentration), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:1903238](http://purl.obolibrary.org/obo/GO_1903238) (positive regulation of leukocyte tethering or rolling), [GO:0007323](http://purl.obolibrary.org/obo/GO_0007323) (peptide pheromone maturation), [GO:0051481](http://purl.obolibrary.org/obo/GO_0051481) (negative regulation of cytosolic calcium ion concentration), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:0007320](http://purl.obolibrary.org/obo/GO_0007320) (insemination), [GO:1905899](http://purl.obolibrary.org/obo/GO_1905899) (regulation of smooth muscle tissue development), [GO:1905898](http://purl.obolibrary.org/obo/GO_1905898) (positive regulation of response to endoplasmic reticulum stress), [GO:0009982](http://purl.obolibrary.org/obo/GO_0009982) (pseudouridine synthase activity), [GO:0021602](http://purl.obolibrary.org/obo/GO_0021602) (cranial nerve morphogenesis), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0008656](http://purl.obolibrary.org/obo/GO_0008656) (cysteine-type endopeptidase activator activity involved in apoptotic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0010966](http://purl.obolibrary.org/obo/GO_0010966) (regulation of phosphate transport), [GO:0010969](http://purl.obolibrary.org/obo/GO_0010969) (regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0010963](http://purl.obolibrary.org/obo/GO_0010963) (regulation of L-arginine import), [GO:0010961](http://purl.obolibrary.org/obo/GO_0010961) (cellular magnesium ion homeostasis), [GO:0010960](http://purl.obolibrary.org/obo/GO_0010960) (magnesium ion homeostasis), [GO:0086077](http://purl.obolibrary.org/obo/GO_0086077) (gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling), [GO:0086078](http://purl.obolibrary.org/obo/GO_0086078) (gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0033540](http://purl.obolibrary.org/obo/GO_0033540) (fatty acid beta-oxidation using acyl-CoA oxidase), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0021559](http://purl.obolibrary.org/obo/GO_0021559) (trigeminal nerve development), [GO:0007253](http://purl.obolibrary.org/obo/GO_0007253) (cytoplasmic sequestering of NF-kappaB), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0008582](http://purl.obolibrary.org/obo/GO_0008582) (regulation of synaptic growth at neuromuscular junction), [GO:0021555](http://purl.obolibrary.org/obo/GO_0021555) (midbrain-hindbrain boundary morphogenesis), [GO:0007256](http://purl.obolibrary.org/obo/GO_0007256) (activation of JNKK activity), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0007257](http://purl.obolibrary.org/obo/GO_0007257) (activation of JUN kinase activity), [GO:0021556](http://purl.obolibrary.org/obo/GO_0021556) (central nervous system formation), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0021551](http://purl.obolibrary.org/obo/GO_0021551) (central nervous system morphogenesis), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0007258](http://purl.obolibrary.org/obo/GO_0007258) (JUN phosphorylation), [GO:0021553](http://purl.obolibrary.org/obo/GO_0021553) (olfactory nerve development), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0008589](http://purl.obolibrary.org/obo/GO_0008589) (regulation of smoothened signaling pathway), [GO:0007259](http://purl.obolibrary.org/obo/GO_0007259) (JAK-STAT cascade), [GO:0033539](http://purl.obolibrary.org/obo/GO_0033539) (fatty acid beta-oxidation using acyl-CoA dehydrogenase), [GO:1900925](http://purl.obolibrary.org/obo/GO_1900925) (positive regulation of glycine import), [GO:0021561](http://purl.obolibrary.org/obo/GO_0021561) (facial nerve development), [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:1990403](http://purl.obolibrary.org/obo/GO_1990403) (embryonic brain development), [GO:0019242](http://purl.obolibrary.org/obo/GO_0019242) (methylglyoxal biosynthetic process), [GO:1990405](http://purl.obolibrary.org/obo/GO_1990405) (protein antigen binding), [GO:0010897](http://purl.obolibrary.org/obo/GO_0010897) (negative regulation of triglyceride catabolic process), [GO:0032202](http://purl.obolibrary.org/obo/GO_0032202) (telomere assembly), [GO:0019244](http://purl.obolibrary.org/obo/GO_0019244) (lactate biosynthetic process from pyruvate), [GO:0086080](http://purl.obolibrary.org/obo/GO_0086080) (protein binding involved in heterotypic cell-cell adhesion), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0032205](http://purl.obolibrary.org/obo/GO_0032205) (negative regulation of telomere maintenance), [GO:0019249](http://purl.obolibrary.org/obo/GO_0019249) (lactate biosynthetic process), [GO:0071813](http://purl.obolibrary.org/obo/GO_0071813) (lipoprotein particle binding), [GO:0010893](http://purl.obolibrary.org/obo/GO_0010893) (positive regulation of steroid biosynthetic process), [GO:0086087](http://purl.obolibrary.org/obo/GO_0086087) (voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization), [GO:0032206](http://purl.obolibrary.org/obo/GO_0032206) (positive regulation of telomere maintenance), [GO:0032203](http://purl.obolibrary.org/obo/GO_0032203) (telomere formation via telomerase), [GO:0071812](http://purl.obolibrary.org/obo/GO_0071812) (positive regulation of fever generation by positive regulation of prostaglandin secretion), [GO:0010894](http://purl.obolibrary.org/obo/GO_0010894) (negative regulation of steroid biosynthetic process), [GO:0032204](http://purl.obolibrary.org/obo/GO_0032204) (regulation of telomere maintenance), [GO:0071806](http://purl.obolibrary.org/obo/GO_0071806) (protein transmembrane transport), [GO:0044209](http://purl.obolibrary.org/obo/GO_0044209) (AMP salvage), [GO:0007260](http://purl.obolibrary.org/obo/GO_0007260) (tyrosine phosphorylation of STAT protein), [GO:0044208](http://purl.obolibrary.org/obo/GO_0044208) ('de novo' AMP biosynthetic process), [GO:0071805](http://purl.obolibrary.org/obo/GO_0071805) (potassium ion transmembrane transport), [GO:0086089](http://purl.obolibrary.org/obo/GO_0086089) (voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization), [GO:0008595](http://purl.obolibrary.org/obo/GO_0008595) (anterior/posterior axis specification, embryo), [GO:0007263](http://purl.obolibrary.org/obo/GO_0007263) (nitric oxide mediated signal transduction), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0008594](http://purl.obolibrary.org/obo/GO_0008594) (photoreceptor cell morphogenesis), [GO:0008593](http://purl.obolibrary.org/obo/GO_0008593) (regulation of Notch signaling pathway), [GO:0007262](http://purl.obolibrary.org/obo/GO_0007262) (STAT protein import into nucleus), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0021544](http://purl.obolibrary.org/obo/GO_0021544) (subpallium development), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0021545](http://purl.obolibrary.org/obo/GO_0021545) (cranial nerve development), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0007266](http://purl.obolibrary.org/obo/GO_0007266) (Rho protein signal transduction), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0021540](http://purl.obolibrary.org/obo/GO_0021540) (corpus callosum morphogenesis), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0007269](http://purl.obolibrary.org/obo/GO_0007269) (neurotransmitter secretion), [GO:0021543](http://purl.obolibrary.org/obo/GO_0021543) (pallium development), [GO:2000806](http://purl.obolibrary.org/obo/GO_2000806) (positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0019230](http://purl.obolibrary.org/obo/GO_0019230) (proprioception), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0086090](http://purl.obolibrary.org/obo/GO_0086090) (voltage-gated potassium channel activity involved in SA node cell action potential repolarization), [GO:2000802](http://purl.obolibrary.org/obo/GO_2000802) (positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation), [GO:1990414](http://purl.obolibrary.org/obo/GO_1990414) (replication-born double-strand break repair via sister chromatid exchange), [GO:0044210](http://purl.obolibrary.org/obo/GO_0044210) ('de novo' CTP biosynthetic process), [GO:0046870](http://purl.obolibrary.org/obo/GO_0046870) (cadmium ion binding), [GO:1990415](http://purl.obolibrary.org/obo/GO_1990415) (Pex17p-Pex14p docking complex), [GO:0033522](http://purl.obolibrary.org/obo/GO_0033522) (histone H2A ubiquitination), [GO:1990416](http://purl.obolibrary.org/obo/GO_1990416) (cellular response to brain-derived neurotrophic factor stimulus), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0086091](http://purl.obolibrary.org/obo/GO_0086091) (regulation of heart rate by cardiac conduction), [GO:0019236](http://purl.obolibrary.org/obo/GO_0019236) (response to pheromone), [GO:0086092](http://purl.obolibrary.org/obo/GO_0086092) (regulation of the force of heart contraction by cardiac conduction), [GO:0086097](http://purl.obolibrary.org/obo/GO_0086097) (phospholipase C-activating angiotensin-activated signaling pathway), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0086098](http://purl.obolibrary.org/obo/GO_0086098) (angiotensin-activated signaling pathway involved in heart process), [GO:0071803](http://purl.obolibrary.org/obo/GO_0071803) (positive regulation of podosome assembly), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0071801](http://purl.obolibrary.org/obo/GO_0071801) (regulation of podosome assembly), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0033523](http://purl.obolibrary.org/obo/GO_0033523) (histone H2B ubiquitination), [GO:0070508](http://purl.obolibrary.org/obo/GO_0070508) (cholesterol import), [GO:0070509](http://purl.obolibrary.org/obo/GO_0070509) (calcium ion import), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0010880](http://purl.obolibrary.org/obo/GO_0010880) (regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0070506](http://purl.obolibrary.org/obo/GO_0070506) (high-density lipoprotein particle receptor activity), [GO:0070507](http://purl.obolibrary.org/obo/GO_0070507) (regulation of microtubule cytoskeleton organization), [GO:0071838](http://purl.obolibrary.org/obo/GO_0071838) (cell proliferation in bone marrow), [GO:0086056](http://purl.obolibrary.org/obo/GO_0086056) (voltage-gated calcium channel activity involved in AV node cell action potential), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0007231](http://purl.obolibrary.org/obo/GO_0007231) (osmosensory signaling pathway), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0009892](http://purl.obolibrary.org/obo/GO_0009892) (negative regulation of metabolic process), [GO:0021539](http://purl.obolibrary.org/obo/GO_0021539) (subthalamus development), [GO:0086059](http://purl.obolibrary.org/obo/GO_0086059) (voltage-gated calcium channel activity involved SA node cell action potential), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0021533](http://purl.obolibrary.org/obo/GO_0021533) (cell differentiation in hindbrain), [GO:0045545](http://purl.obolibrary.org/obo/GO_0045545) (syndecan binding), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0021534](http://purl.obolibrary.org/obo/GO_0021534) (cell proliferation in hindbrain), [GO:0046873](http://purl.obolibrary.org/obo/GO_0046873) (metal ion transmembrane transporter activity), [GO:0045542](http://purl.obolibrary.org/obo/GO_0045542) (positive regulation of cholesterol biosynthetic process), [GO:0021535](http://purl.obolibrary.org/obo/GO_0021535) (cell migration in hindbrain), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0044213](http://purl.obolibrary.org/obo/GO_0044213) (intronic transcription regulatory region DNA binding), [GO:0008569](http://purl.obolibrary.org/obo/GO_0008569) (ATP-dependent microtubule motor activity, minus-end-directed), [GO:0021530](http://purl.obolibrary.org/obo/GO_0021530) (spinal cord oligodendrocyte cell fate specification), [GO:0021531](http://purl.obolibrary.org/obo/GO_0021531) (spinal cord radial glial cell differentiation), [GO:0044218](http://purl.obolibrary.org/obo/GO_0044218) (other organism cell membrane), [GO:0008568](http://purl.obolibrary.org/obo/GO_0008568) (microtubule-severing ATPase activity), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0021532](http://purl.obolibrary.org/obo/GO_0021532) (neural tube patterning), [GO:0045547](http://purl.obolibrary.org/obo/GO_0045547) (dehydrodolichyl diphosphate synthase activity), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0046883](http://purl.obolibrary.org/obo/GO_0046883) (regulation of hormone secretion), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0046881](http://purl.obolibrary.org/obo/GO_0046881) (positive regulation of follicle-stimulating hormone secretion), [GO:0019220](http://purl.obolibrary.org/obo/GO_0019220) (regulation of phosphate metabolic process), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:0044220](http://purl.obolibrary.org/obo/GO_0044220) (host cell perinuclear region of cytoplasm), [GO:0086060](http://purl.obolibrary.org/obo/GO_0086060) (voltage-gated sodium channel activity involved in AV node cell action potential), [GO:0010875](http://purl.obolibrary.org/obo/GO_0010875) (positive regulation of cholesterol efflux), [GO:0010874](http://purl.obolibrary.org/obo/GO_0010874) (regulation of cholesterol efflux), [GO:0019222](http://purl.obolibrary.org/obo/GO_0019222) (regulation of metabolic process), [GO:0086061](http://purl.obolibrary.org/obo/GO_0086061) (voltage-gated sodium channel activity involved in bundle of His cell action potential), [GO:1990429](http://purl.obolibrary.org/obo/GO_1990429) (peroxisomal importomer complex), [GO:0019227](http://purl.obolibrary.org/obo/GO_0019227) (neuronal action potential propagation), [GO:0086064](http://purl.obolibrary.org/obo/GO_0086064) (cell communication by electrical coupling involved in cardiac conduction), [GO:0019226](http://purl.obolibrary.org/obo/GO_0019226) (transmission of nerve impulse), [GO:0086065](http://purl.obolibrary.org/obo/GO_0086065) (cell communication involved in cardiac conduction), [GO:0010870](http://purl.obolibrary.org/obo/GO_0010870) (positive regulation of receptor biosynthetic process), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0019229](http://purl.obolibrary.org/obo/GO_0019229) (regulation of vasoconstriction), [GO:0086062](http://purl.obolibrary.org/obo/GO_0086062) (voltage-gated sodium channel activity involved in Purkinje myocyte action potential), [GO:0019228](http://purl.obolibrary.org/obo/GO_0019228) (neuronal action potential), [GO:0086063](http://purl.obolibrary.org/obo/GO_0086063) (voltage-gated sodium channel activity involved in SA node cell action potential), [GO:0019209](http://purl.obolibrary.org/obo/GO_0019209) (kinase activator activity), [GO:0019208](http://purl.obolibrary.org/obo/GO_0019208) (phosphatase regulator activity), [GO:0010891](http://purl.obolibrary.org/obo/GO_0010891) (negative regulation of sequestering of triglyceride), [GO:0010890](http://purl.obolibrary.org/obo/GO_0010890) (positive regulation of sequestering of triglyceride), [GO:0086067](http://purl.obolibrary.org/obo/GO_0086067) (AV node cell to bundle of His cell communication), [GO:0022857](http://purl.obolibrary.org/obo/GO_0022857) (transmembrane transporter activity), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0021529](http://purl.obolibrary.org/obo/GO_0021529) (spinal cord oligodendrocyte cell differentiation), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0046886](http://purl.obolibrary.org/obo/GO_0046886) (positive regulation of hormone biosynthetic process), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0046884](http://purl.obolibrary.org/obo/GO_0046884) (follicle-stimulating hormone secretion), [GO:0021524](http://purl.obolibrary.org/obo/GO_0021524) (visceral motor neuron differentiation), [GO:0008574](http://purl.obolibrary.org/obo/GO_0008574) (ATP-dependent microtubule motor activity, plus-end-directed), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0022850](http://purl.obolibrary.org/obo/GO_0022850) (serotonin-gated cation-selective channel activity), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0021521](http://purl.obolibrary.org/obo/GO_0021521) (ventral spinal cord interneuron specification), [GO:0044228](http://purl.obolibrary.org/obo/GO_0044228) (host cell surface), [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0033505](http://purl.obolibrary.org/obo/GO_0033505) (floor plate morphogenesis), [GO:2000822](http://purl.obolibrary.org/obo/GO_2000822) (regulation of behavioral fear response), [GO:1990435](http://purl.obolibrary.org/obo/GO_1990435) (upper tip-link density), [GO:0010886](http://purl.obolibrary.org/obo/GO_0010886) (positive regulation of cholesterol storage), [GO:0019212](http://purl.obolibrary.org/obo/GO_0019212) (phosphatase inhibitor activity), [GO:0019211](http://purl.obolibrary.org/obo/GO_0019211) (phosphatase activator activity), [GO:0071821](http://purl.obolibrary.org/obo/GO_0071821) (FANCM-MHF complex), [GO:0010888](http://purl.obolibrary.org/obo/GO_0010888) (negative regulation of lipid storage), [GO:2000821](http://purl.obolibrary.org/obo/GO_2000821) (regulation of grooming behavior), [GO:0033504](http://purl.obolibrary.org/obo/GO_0033504) (floor plate development), [GO:0010882](http://purl.obolibrary.org/obo/GO_0010882) (regulation of cardiac muscle contraction by calcium ion signaling), [GO:0019216](http://purl.obolibrary.org/obo/GO_0019216) (regulation of lipid metabolic process), [GO:0086075](http://purl.obolibrary.org/obo/GO_0086075) (gap junction channel activity involved in cardiac conduction electrical coupling), [GO:0019215](http://purl.obolibrary.org/obo/GO_0019215) (intermediate filament binding), [GO:0086076](http://purl.obolibrary.org/obo/GO_0086076) (gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling), [GO:0010881](http://purl.obolibrary.org/obo/GO_0010881) (regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0019218](http://purl.obolibrary.org/obo/GO_0019218) (regulation of steroid metabolic process), [GO:0019217](http://purl.obolibrary.org/obo/GO_0019217) (regulation of fatty acid metabolic process), [GO:0010883](http://purl.obolibrary.org/obo/GO_0010883) (regulation of lipid storage), [GO:0007292](http://purl.obolibrary.org/obo/GO_0007292) (female gamete generation), [GO:0086036](http://purl.obolibrary.org/obo/GO_0086036) (regulation of cardiac muscle cell membrane potential), [GO:0032252](http://purl.obolibrary.org/obo/GO_0032252) (secretory granule localization), [GO:0007296](http://purl.obolibrary.org/obo/GO_0007296) (vitellogenesis), [GO:1903169](http://purl.obolibrary.org/obo/GO_1903169) (regulation of calcium ion transmembrane transport), [GO:0086037](http://purl.obolibrary.org/obo/GO_0086037) (sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential), [GO:0021599](http://purl.obolibrary.org/obo/GO_0021599) (abducens nerve formation), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0046811](http://purl.obolibrary.org/obo/GO_0046811) (histone deacetylase inhibitor activity), [GO:0050080](http://purl.obolibrary.org/obo/GO_0050080) (malonyl-CoA decarboxylase activity), [GO:2000835](http://purl.obolibrary.org/obo/GO_2000835) (negative regulation of androgen secretion), [GO:0019287](http://purl.obolibrary.org/obo/GO_0019287) (isopentenyl diphosphate biosynthetic process, mevalonate pathway), [GO:0033577](http://purl.obolibrary.org/obo/GO_0033577) (protein glycosylation in endoplasmic reticulum), [GO:2000830](http://purl.obolibrary.org/obo/GO_2000830) (positive regulation of parathyroid hormone secretion), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:1904491](http://purl.obolibrary.org/obo/GO_1904491) (protein localization to ciliary transition zone), [GO:0086043](http://purl.obolibrary.org/obo/GO_0086043) (bundle of His cell action potential), [GO:0086041](http://purl.obolibrary.org/obo/GO_0086041) (voltage-gated potassium channel activity involved in SA node cell action potential depolarization), [GO:0086046](http://purl.obolibrary.org/obo/GO_0086046) (membrane depolarization during SA node cell action potential), [GO:0086047](http://purl.obolibrary.org/obo/GO_0086047) (membrane depolarization during Purkinje myocyte cell action potential), [GO:0086044](http://purl.obolibrary.org/obo/GO_0086044) (atrial cardiac muscle cell to AV node cell communication by electrical coupling), [GO:0046827](http://purl.obolibrary.org/obo/GO_0046827) (positive regulation of protein export from nucleus), [GO:0086045](http://purl.obolibrary.org/obo/GO_0086045) (membrane depolarization during AV node cell action potential), [GO:0033572](http://purl.obolibrary.org/obo/GO_0033572) (transferrin transport), [GO:0086048](http://purl.obolibrary.org/obo/GO_0086048) (membrane depolarization during bundle of His cell action potential), [GO:0033570](http://purl.obolibrary.org/obo/GO_0033570) (transferrin transmembrane transporter activity), [GO:0021588](http://purl.obolibrary.org/obo/GO_0021588) (cerebellum formation), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0046822](http://purl.obolibrary.org/obo/GO_0046822) (regulation of nucleocytoplasmic transport), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0021593](http://purl.obolibrary.org/obo/GO_0021593) (rhombomere morphogenesis), [GO:0021594](http://purl.obolibrary.org/obo/GO_0021594) (rhombomere formation), [GO:0019276](http://purl.obolibrary.org/obo/GO_0019276) (UDP-N-acetylgalactosamine metabolic process), [GO:0021590](http://purl.obolibrary.org/obo/GO_0021590) (cerebellum maturation), [GO:1990459](http://purl.obolibrary.org/obo/GO_1990459) (transferrin receptor binding), [GO:0086050](http://purl.obolibrary.org/obo/GO_0086050) (membrane repolarization during bundle of His cell action potential), [GO:0033564](http://purl.obolibrary.org/obo/GO_0033564) (anterior/posterior axon guidance), [GO:0032232](http://purl.obolibrary.org/obo/GO_0032232) (negative regulation of actin filament bundle assembly), [GO:0032233](http://purl.obolibrary.org/obo/GO_0032233) (positive regulation of actin filament bundle assembly), [GO:0033563](http://purl.obolibrary.org/obo/GO_0033563) (dorsal/ventral axon guidance), [GO:0086053](http://purl.obolibrary.org/obo/GO_0086053) (AV node cell to bundle of His cell communication by electrical coupling), [GO:0086054](http://purl.obolibrary.org/obo/GO_0086054) (bundle of His cell to Purkinje myocyte communication by electrical coupling), [GO:0032237](http://purl.obolibrary.org/obo/GO_0032237) (activation of store-operated calcium channel activity), [GO:0086052](http://purl.obolibrary.org/obo/GO_0086052) (membrane repolarization during SA node cell action potential), [GO:0033567](http://purl.obolibrary.org/obo/GO_0033567) (DNA replication, Okazaki fragment processing), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:0046839](http://purl.obolibrary.org/obo/GO_0046839) (phospholipid dephosphorylation), [GO:0086013](http://purl.obolibrary.org/obo/GO_0086013) (membrane repolarization during cardiac muscle cell action potential), [GO:0007271](http://purl.obolibrary.org/obo/GO_0007271) (synaptic transmission, cholinergic), [GO:0086014](http://purl.obolibrary.org/obo/GO_0086014) (atrial cardiac muscle cell action potential), [GO:0086011](http://purl.obolibrary.org/obo/GO_0086011) (membrane repolarization during action potential), [GO:0086012](http://purl.obolibrary.org/obo/GO_0086012) (membrane depolarization during cardiac muscle cell action potential), [GO:0046838](http://purl.obolibrary.org/obo/GO_0046838) (phosphorylated carbohydrate dephosphorylation), [GO:0007274](http://purl.obolibrary.org/obo/GO_0007274) (neuromuscular synaptic transmission), [GO:0032230](http://purl.obolibrary.org/obo/GO_0032230) (positive regulation of synaptic transmission, GABAergic), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0086018](http://purl.obolibrary.org/obo/GO_0086018) (SA node cell to atrial cardiac muscle cell signaling), [GO:0086015](http://purl.obolibrary.org/obo/GO_0086015) (SA node cell action potential), [GO:0086016](http://purl.obolibrary.org/obo/GO_0086016) (AV node cell action potential), [GO:0021578](http://purl.obolibrary.org/obo/GO_0021578) (hindbrain maturation), [GO:0007276](http://purl.obolibrary.org/obo/GO_0007276) (gamete generation), [GO:0046835](http://purl.obolibrary.org/obo/GO_0046835) (carbohydrate phosphorylation), [GO:0045504](http://purl.obolibrary.org/obo/GO_0045504) (dynein heavy chain binding), [GO:0045505](http://purl.obolibrary.org/obo/GO_0045505) (dynein intermediate chain binding), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0046834](http://purl.obolibrary.org/obo/GO_0046834) (lipid phosphorylation), [GO:0021576](http://purl.obolibrary.org/obo/GO_0021576) (hindbrain formation), [GO:0045503](http://purl.obolibrary.org/obo/GO_0045503) (dynein light chain binding), [GO:0032229](http://purl.obolibrary.org/obo/GO_0032229) (negative regulation of synaptic transmission, GABAergic), [GO:1990467](http://purl.obolibrary.org/obo/GO_1990467) (NuA3a histone acetyltransferase complex), [GO:1990468](http://purl.obolibrary.org/obo/GO_1990468) (NuA3b histone acetyltransferase complex), [GO:0019265](http://purl.obolibrary.org/obo/GO_0019265) (glycine biosynthetic process, by transamination of glyoxylate), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0032224](http://purl.obolibrary.org/obo/GO_0032224) (positive regulation of synaptic transmission, cholinergic), [GO:2000852](http://purl.obolibrary.org/obo/GO_2000852) (regulation of corticosterone secretion), [GO:0032222](http://purl.obolibrary.org/obo/GO_0032222) (regulation of synaptic transmission, cholinergic), [GO:0033552](http://purl.obolibrary.org/obo/GO_0033552) (response to vitamin B3), [GO:0032227](http://purl.obolibrary.org/obo/GO_0032227) (negative regulation of synaptic transmission, dopaminergic), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0032225](http://purl.obolibrary.org/obo/GO_0032225) (regulation of synaptic transmission, dopaminergic), [GO:2000850](http://purl.obolibrary.org/obo/GO_2000850) (negative regulation of glucocorticoid secretion), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0007286](http://purl.obolibrary.org/obo/GO_0007286) (spermatid development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007284](http://purl.obolibrary.org/obo/GO_0007284) (spermatogonial cell division), [GO:0086027](http://purl.obolibrary.org/obo/GO_0086027) (AV node cell to bundle of His cell signaling), [GO:0022898](http://purl.obolibrary.org/obo/GO_0022898) (regulation of transmembrane transporter activity), [GO:0021568](http://purl.obolibrary.org/obo/GO_0021568) (rhombomere 2 development), [GO:0021569](http://purl.obolibrary.org/obo/GO_0021569) (rhombomere 3 development), [GO:0007288](http://purl.obolibrary.org/obo/GO_0007288) (sperm axoneme assembly), [GO:1990481](http://purl.obolibrary.org/obo/GO_1990481) (mRNA pseudouridine synthesis), [GO:0021562](http://purl.obolibrary.org/obo/GO_0021562) (vestibulocochlear nerve development), [GO:0046847](http://purl.obolibrary.org/obo/GO_0046847) (filopodium assembly), [GO:0022894](http://purl.obolibrary.org/obo/GO_0022894) (Intermediate conductance calcium-activated potassium channel activity), [GO:0021570](http://purl.obolibrary.org/obo/GO_0021570) (rhombomere 4 development), [GO:0021571](http://purl.obolibrary.org/obo/GO_0021571) (rhombomere 5 development), [GO:0032218](http://purl.obolibrary.org/obo/GO_0032218) (riboflavin transport), [GO:0021572](http://purl.obolibrary.org/obo/GO_0021572) (rhombomere 6 development), [GO:2000866](http://purl.obolibrary.org/obo/GO_2000866) (positive regulation of estradiol secretion), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0019254](http://purl.obolibrary.org/obo/GO_0019254) (carnitine metabolic process, CoA-linked), [GO:0032212](http://purl.obolibrary.org/obo/GO_0032212) (positive regulation of telomere maintenance via telomerase), [GO:0019255](http://purl.obolibrary.org/obo/GO_0019255) (glucose 1-phosphate metabolic process), [GO:0032210](http://purl.obolibrary.org/obo/GO_0032210) (regulation of telomere maintenance via telomerase), [GO:0032211](http://purl.obolibrary.org/obo/GO_0032211) (negative regulation of telomere maintenance via telomerase), [GO:0032216](http://purl.obolibrary.org/obo/GO_0032216) (glucosaminyl-phosphotidylinositol O-acyltransferase activity), [GO:0032217](http://purl.obolibrary.org/obo/GO_0032217) (riboflavin transmembrane transporter activity), [GO:0032290](http://purl.obolibrary.org/obo/GO_0032290) (peripheral nervous system myelin formation), [GO:0044279](http://purl.obolibrary.org/obo/GO_0044279) (other organism membrane), [GO:0003730](http://purl.obolibrary.org/obo/GO_0003730) (mRNA 3'-UTR binding), [GO:0003720](http://purl.obolibrary.org/obo/GO_0003720) (telomerase activity), [GO:0003721](http://purl.obolibrary.org/obo/GO_0003721) (telomerase RNA reverse transcriptase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0071893](http://purl.obolibrary.org/obo/GO_0071893) (BMP signaling pathway involved in nephric duct formation), [GO:0003724](http://purl.obolibrary.org/obo/GO_0003724) (RNA helicase activity), [GO:0003725](http://purl.obolibrary.org/obo/GO_0003725) (double-stranded RNA binding), [GO:0071894](http://purl.obolibrary.org/obo/GO_0071894) (histone H2B conserved C-terminal lysine ubiquitination), [GO:0003726](http://purl.obolibrary.org/obo/GO_0003726) (double-stranded RNA adenosine deaminase activity), [GO:0003727](http://purl.obolibrary.org/obo/GO_0003727) (single-stranded RNA binding), [GO:0071897](http://purl.obolibrary.org/obo/GO_0071897) (DNA biosynthetic process), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0015705](http://purl.obolibrary.org/obo/GO_0015705) (iodide transport), [GO:0070567](http://purl.obolibrary.org/obo/GO_0070567) (cytidylyltransferase activity), [GO:0032287](http://purl.obolibrary.org/obo/GO_0032287) (peripheral nervous system myelin maintenance), [GO:0071895](http://purl.obolibrary.org/obo/GO_0071895) (odontoblast differentiation), [GO:0070564](http://purl.obolibrary.org/obo/GO_0070564) (positive regulation of vitamin D receptor signaling pathway), [GO:0032288](http://purl.obolibrary.org/obo/GO_0032288) (myelin assembly), [GO:0015701](http://purl.obolibrary.org/obo/GO_0015701) (bicarbonate transport), [GO:2000872](http://purl.obolibrary.org/obo/GO_2000872) (positive regulation of progesterone secretion), [GO:0032281](http://purl.obolibrary.org/obo/GO_0032281) (AMPA glutamate receptor complex), [GO:0032280](http://purl.obolibrary.org/obo/GO_0032280) (symmetric synapse), [GO:0032285](http://purl.obolibrary.org/obo/GO_0032285) (non-myelinated axon ensheathment), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0044292](http://purl.obolibrary.org/obo/GO_0044292) (dendrite terminus), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0044294](http://purl.obolibrary.org/obo/GO_0044294) (dendritic growth cone), [GO:0003735](http://purl.obolibrary.org/obo/GO_0003735) (structural constituent of ribosome), [GO:0044295](http://purl.obolibrary.org/obo/GO_0044295) (axonal growth cone), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0015718](http://purl.obolibrary.org/obo/GO_0015718) (monocarboxylic acid transport), [GO:0002407](http://purl.obolibrary.org/obo/GO_0002407) (dendritic cell chemotaxis), [GO:0070550](http://purl.obolibrary.org/obo/GO_0070550) (rDNA condensation), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0032279](http://purl.obolibrary.org/obo/GO_0032279) (asymmetric synapse), [GO:0015712](http://purl.obolibrary.org/obo/GO_0015712) (hexose phosphate transport), [GO:0015711](http://purl.obolibrary.org/obo/GO_0015711) (organic anion transport), [GO:0070557](http://purl.obolibrary.org/obo/GO_0070557) (PCNA-p21 complex), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), [GO:0032270](http://purl.obolibrary.org/obo/GO_0032270) (positive regulation of cellular protein metabolic process), [GO:0032275](http://purl.obolibrary.org/obo/GO_0032275) (luteinizing hormone secretion), [GO:0044299](http://purl.obolibrary.org/obo/GO_0044299) (C-fiber), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070584](http://purl.obolibrary.org/obo/GO_0070584) (mitochondrion morphogenesis), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0033598](http://purl.obolibrary.org/obo/GO_0033598) (mammary gland epithelial cell proliferation), [GO:0033597](http://purl.obolibrary.org/obo/GO_0033597) (mitotic checkpoint complex), [GO:0070586](http://purl.obolibrary.org/obo/GO_0070586) (cell-cell adhesion involved in gastrulation), [GO:0003708](http://purl.obolibrary.org/obo/GO_0003708) (retinoic acid receptor activity), [GO:0032266](http://purl.obolibrary.org/obo/GO_0032266) (phosphatidylinositol-3-phosphate binding), [GO:0033596](http://purl.obolibrary.org/obo/GO_0033596) (TSC1-TSC2 complex), [GO:0070587](http://purl.obolibrary.org/obo/GO_0070587) (regulation of cell-cell adhesion involved in gastrulation), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0032264](http://purl.obolibrary.org/obo/GO_0032264) (IMP salvage), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0032261](http://purl.obolibrary.org/obo/GO_0032261) (purine nucleotide salvage), [GO:0033592](http://purl.obolibrary.org/obo/GO_0033592) (RNA strand annealing activity), [GO:0070570](http://purl.obolibrary.org/obo/GO_0070570) (regulation of neuron projection regeneration), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0070573](http://purl.obolibrary.org/obo/GO_0070573) (metallodipeptidase activity), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0070574](http://purl.obolibrary.org/obo/GO_0070574) (cadmium ion transmembrane transport), [GO:0070577](http://purl.obolibrary.org/obo/GO_0070577) (lysine-acetylated histone binding), [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0032258](http://purl.obolibrary.org/obo/GO_0032258) (protein localization by the Cvt pathway), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0070528](http://purl.obolibrary.org/obo/GO_0070528) (protein kinase C signaling), [GO:0044233](http://purl.obolibrary.org/obo/GO_0044233) (ER-mitochondrion membrane contact site), [GO:0044236](http://purl.obolibrary.org/obo/GO_0044236) (multicellular organism metabolic process), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity), [GO:0001103](http://purl.obolibrary.org/obo/GO_0001103) (RNA polymerase II repressing transcription factor binding), [GO:0003774](http://purl.obolibrary.org/obo/GO_0003774) (motor activity), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0002443](http://purl.obolibrary.org/obo/GO_0002443) (leukocyte mediated immunity), [GO:0045569](http://purl.obolibrary.org/obo/GO_0045569) (TRAIL binding), [GO:0001112](http://purl.obolibrary.org/obo/GO_0001112) (DNA-templated transcriptional open complex formation), [GO:0002434](http://purl.obolibrary.org/obo/GO_0002434) (immune complex clearance), [GO:0044241](http://purl.obolibrary.org/obo/GO_0044241) (lipid digestion), [GO:0002437](http://purl.obolibrary.org/obo/GO_0002437) (inflammatory response to antigenic stimulus), [GO:0071850](http://purl.obolibrary.org/obo/GO_0071850) (mitotic cell cycle arrest), [GO:0002438](http://purl.obolibrary.org/obo/GO_0002438) (acute inflammatory response to antigenic stimulus), [GO:0002439](http://purl.obolibrary.org/obo/GO_0002439) (chronic inflammatory response to antigenic stimulus), [GO:0044242](http://purl.obolibrary.org/obo/GO_0044242) (cellular lipid catabolic process), [GO:0070522](http://purl.obolibrary.org/obo/GO_0070522) (ERCC4-ERCC1 complex), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0071855](http://purl.obolibrary.org/obo/GO_0071855) (neuropeptide receptor binding), [GO:0071848](http://purl.obolibrary.org/obo/GO_0071848) (positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling), [GO:0015760](http://purl.obolibrary.org/obo/GO_0015760) (glucose-6-phosphate transport), [GO:0045577](http://purl.obolibrary.org/obo/GO_0045577) (regulation of B cell differentiation), [GO:0045578](http://purl.obolibrary.org/obo/GO_0045578) (negative regulation of B cell differentiation), [GO:0045576](http://purl.obolibrary.org/obo/GO_0045576) (mast cell activation), [GO:0044249](http://purl.obolibrary.org/obo/GO_0044249) (cellular biosynthetic process), [GO:0045579](http://purl.obolibrary.org/obo/GO_0045579) (positive regulation of B cell differentiation), [GO:0003785](http://purl.obolibrary.org/obo/GO_0003785) (actin monomer binding), [GO:0045580](http://purl.obolibrary.org/obo/GO_0045580) (regulation of T cell differentiation), [GO:0003777](http://purl.obolibrary.org/obo/GO_0003777) (microtubule motor activity), [GO:0002446](http://purl.obolibrary.org/obo/GO_0002446) (neutrophil mediated immunity), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0045582](http://purl.obolibrary.org/obo/GO_0045582) (positive regulation of T cell differentiation), [GO:0039706](http://purl.obolibrary.org/obo/GO_0039706) (co-receptor binding), [GO:0070512](http://purl.obolibrary.org/obo/GO_0070512) (positive regulation of histone H4-K20 methylation), [GO:0015758](http://purl.obolibrary.org/obo/GO_0015758) (glucose transport), [GO:0039702](http://purl.obolibrary.org/obo/GO_0039702) (viral budding via host ESCRT complex), [GO:0071847](http://purl.obolibrary.org/obo/GO_0071847) (TNFSF11-mediated signaling pathway), [GO:0015755](http://purl.obolibrary.org/obo/GO_0015755) (fructose transport), [GO:0045588](http://purl.obolibrary.org/obo/GO_0045588) (positive regulation of gamma-delta T cell differentiation), [GO:0044255](http://purl.obolibrary.org/obo/GO_0044255) (cellular lipid metabolic process), [GO:0045589](http://purl.obolibrary.org/obo/GO_0045589) (regulation of regulatory T cell differentiation), [GO:0044257](http://purl.obolibrary.org/obo/GO_0044257) (cellular protein catabolic process), [GO:0045591](http://purl.obolibrary.org/obo/GO_0045591) (positive regulation of regulatory T cell differentiation), [GO:0003743](http://purl.obolibrary.org/obo/GO_0003743) (translation initiation factor activity), [GO:0045590](http://purl.obolibrary.org/obo/GO_0045590) (negative regulation of regulatory T cell differentiation), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0071871](http://purl.obolibrary.org/obo/GO_0071871) (response to epinephrine), [GO:0070540](http://purl.obolibrary.org/obo/GO_0070540) (stearic acid binding), [GO:0003746](http://purl.obolibrary.org/obo/GO_0003746) (translation elongation factor activity), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0044262](http://purl.obolibrary.org/obo/GO_0044262) (cellular carbohydrate metabolic process), [GO:0003747](http://purl.obolibrary.org/obo/GO_0003747) (translation release factor activity), [GO:0071872](http://purl.obolibrary.org/obo/GO_0071872) (cellular response to epinephrine stimulus), [GO:0044265](http://purl.obolibrary.org/obo/GO_0044265) (cellular macromolecule catabolic process), [GO:0002418](http://purl.obolibrary.org/obo/GO_0002418) (immune response to tumor cell), [GO:0071870](http://purl.obolibrary.org/obo/GO_0071870) (cellular response to catecholamine stimulus), [GO:0071875](http://purl.obolibrary.org/obo/GO_0071875) (adrenergic receptor signaling pathway), [GO:0070544](http://purl.obolibrary.org/obo/GO_0070544) (histone H3-K36 demethylation), [GO:0070542](http://purl.obolibrary.org/obo/GO_0070542) (response to fatty acid), [GO:0071874](http://purl.obolibrary.org/obo/GO_0071874) (cellular response to norepinephrine stimulus), [GO:0070543](http://purl.obolibrary.org/obo/GO_0070543) (response to linoleic acid), [GO:0015723](http://purl.obolibrary.org/obo/GO_0015723) (bilirubin transport), [GO:0015722](http://purl.obolibrary.org/obo/GO_0015722) (canalicular bile acid transport), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0044267](http://purl.obolibrary.org/obo/GO_0044267) (cellular protein metabolic process), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0002432](http://purl.obolibrary.org/obo/GO_0002432) (granuloma formation), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0044271](http://purl.obolibrary.org/obo/GO_0044271) (cellular nitrogen compound biosynthetic process), [GO:0003756](http://purl.obolibrary.org/obo/GO_0003756) (protein disulfide isomerase activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0015739](http://purl.obolibrary.org/obo/GO_0015739) (sialic acid transport), [GO:0070534](http://purl.obolibrary.org/obo/GO_0070534) (protein K63-linked ubiquitination), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex), [GO:0032299](http://purl.obolibrary.org/obo/GO_0032299) (ribonuclease H2 complex), [GO:0070538](http://purl.obolibrary.org/obo/GO_0070538) (oleic acid binding), [GO:0071866](http://purl.obolibrary.org/obo/GO_0071866) (negative regulation of apoptotic process in bone marrow), [GO:0070535](http://purl.obolibrary.org/obo/GO_0070535) (histone H2A K63-linked ubiquitination), [GO:0015732](http://purl.obolibrary.org/obo/GO_0015732) (prostaglandin transport), [GO:0052851](http://purl.obolibrary.org/obo/GO_0052851) (ferric-chelate reductase (NADPH) activity), [GO:0051525](http://purl.obolibrary.org/obo/GO_0051525) (NFAT protein binding), [GO:0051538](http://purl.obolibrary.org/obo/GO_0051538) (3 iron, 4 sulfur cluster binding), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding), [GO:0052866](http://purl.obolibrary.org/obo/GO_0052866) (phosphatidylinositol phosphate phosphatase activity), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0051542](http://purl.obolibrary.org/obo/GO_0051542) (elastin biosynthetic process), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0002579](http://purl.obolibrary.org/obo/GO_0002579) (positive regulation of antigen processing and presentation), [GO:0140018](http://purl.obolibrary.org/obo/GO_0140018) (regulation of cytoplasmic translational fidelity), [GO:0051549](http://purl.obolibrary.org/obo/GO_0051549) (positive regulation of keratinocyte migration), [GO:0015889](http://purl.obolibrary.org/obo/GO_0015889) (cobalamin transport), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0015888](http://purl.obolibrary.org/obo/GO_0015888) (thiamine transport), [GO:0051546](http://purl.obolibrary.org/obo/GO_0051546) (keratinocyte migration), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:1904408](http://purl.obolibrary.org/obo/GO_1904408) (melatonin binding), [GO:0052885](http://purl.obolibrary.org/obo/GO_0052885) (all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity), [GO:0002588](http://purl.obolibrary.org/obo/GO_0002588) (positive regulation of antigen processing and presentation of peptide antigen via MHC class II), [GO:0052884](http://purl.obolibrary.org/obo/GO_0052884) (all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity), [GO:0055093](http://purl.obolibrary.org/obo/GO_0055093) (response to hyperoxia), [GO:0055096](http://purl.obolibrary.org/obo/GO_0055096) (low-density lipoprotein particle mediated signaling), [GO:0055090](http://purl.obolibrary.org/obo/GO_0055090) (acylglycerol homeostasis), [GO:0055091](http://purl.obolibrary.org/obo/GO_0055091) (phospholipid homeostasis), [GO:0008700](http://purl.obolibrary.org/obo/GO_0008700) (4-hydroxy-2-oxoglutarate aldolase activity), [GO:0052816](http://purl.obolibrary.org/obo/GO_0052816) (long-chain acyl-CoA hydrolase activity), [GO:0052817](http://purl.obolibrary.org/obo/GO_0052817) (very long chain acyl-CoA hydrolase activity), [GO:0052814](http://purl.obolibrary.org/obo/GO_0052814) (medium-chain-aldehyde dehydrogenase activity), [GO:0052815](http://purl.obolibrary.org/obo/GO_0052815) (medium-chain acyl-CoA hydrolase activity), [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity), [GO:0052826](http://purl.obolibrary.org/obo/GO_0052826) (inositol hexakisphosphate 2-phosphatase activity), [GO:0140059](http://purl.obolibrary.org/obo/GO_0140059) (dendrite arborization), [GO:0052834](http://purl.obolibrary.org/obo/GO_0052834) (inositol monophosphate phosphatase activity), [GO:0052832](http://purl.obolibrary.org/obo/GO_0052832) (inositol monophosphate 3-phosphatase activity), [GO:0052833](http://purl.obolibrary.org/obo/GO_0052833) (inositol monophosphate 4-phosphatase activity), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0008746](http://purl.obolibrary.org/obo/GO_0008746) (NAD(P)+ transhydrogenase activity), [GO:0007412](http://purl.obolibrary.org/obo/GO_0007412) (axon target recognition), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0007405](http://purl.obolibrary.org/obo/GO_0007405) (neuroblast proliferation), [GO:0007406](http://purl.obolibrary.org/obo/GO_0007406) (negative regulation of neuroblast proliferation), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0019402](http://purl.obolibrary.org/obo/GO_0019402) (galactitol metabolic process), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0021702](http://purl.obolibrary.org/obo/GO_0021702) (cerebellar Purkinje cell differentiation), [GO:0021703](http://purl.obolibrary.org/obo/GO_0021703) (locus ceruleus development), [GO:1903136](http://purl.obolibrary.org/obo/GO_1903136) (cuprous ion binding), [GO:1904465](http://purl.obolibrary.org/obo/GO_1904465) (negative regulation of matrix metallopeptidase secretion), [GO:0050291](http://purl.obolibrary.org/obo/GO_0050291) (sphingosine N-acyltransferase activity), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:1904469](http://purl.obolibrary.org/obo/GO_1904469) (positive regulation of tumor necrosis factor secretion), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:1904468](http://purl.obolibrary.org/obo/GO_1904468) (negative regulation of tumor necrosis factor secretion), [GO:0008750](http://purl.obolibrary.org/obo/GO_0008750) (NAD(P)+ transhydrogenase (AB-specific) activity), [GO:0008757](http://purl.obolibrary.org/obo/GO_0008757) (S-adenosylmethionine-dependent methyltransferase activity), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:1990385](http://purl.obolibrary.org/obo/GO_1990385) (meiotic spindle midzone), [GO:0007418](http://purl.obolibrary.org/obo/GO_0007418) (ventral midline development), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:1990379](http://purl.obolibrary.org/obo/GO_1990379) (lipid transport across blood brain barrier), [GO:0099557](http://purl.obolibrary.org/obo/GO_0099557) (trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission), [GO:1903142](http://purl.obolibrary.org/obo/GO_1903142) (positive regulation of establishment of endothelial barrier), [GO:1903140](http://purl.obolibrary.org/obo/GO_1903140) (regulation of establishment of endothelial barrier), [GO:1903146](http://purl.obolibrary.org/obo/GO_1903146) (regulation of autophagy of mitochondrion), [GO:1904478](http://purl.obolibrary.org/obo/GO_1904478) (regulation of intestinal absorption), [GO:1990391](http://purl.obolibrary.org/obo/GO_1990391) (DNA repair complex), [GO:1990393](http://purl.obolibrary.org/obo/GO_1990393) (3M complex), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:0099526](http://purl.obolibrary.org/obo/GO_0099526) (presynapse to nucleus signaling pathway), [GO:0099527](http://purl.obolibrary.org/obo/GO_0099527) (postsynapse to nucleus signaling pathway), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0045716](http://purl.obolibrary.org/obo/GO_0045716) (positive regulation of low-density lipoprotein particle receptor biosynthetic process), [GO:0045719](http://purl.obolibrary.org/obo/GO_0045719) (negative regulation of glycogen biosynthetic process), [GO:0007400](http://purl.obolibrary.org/obo/GO_0007400) (neuroblast fate determination), [GO:0007402](http://purl.obolibrary.org/obo/GO_0007402) (ganglion mother cell fate determination), [GO:0099530](http://purl.obolibrary.org/obo/GO_0099530) (G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential), [GO:0099536](http://purl.obolibrary.org/obo/GO_0099536) (synaptic signaling), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0019439](http://purl.obolibrary.org/obo/GO_0019439) (aromatic compound catabolic process), [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0021759](http://purl.obolibrary.org/obo/GO_0021759) (globus pallidus development), [GO:0006123](http://purl.obolibrary.org/obo/GO_0006123) (mitochondrial electron transport, cytochrome c to oxygen), [GO:0021754](http://purl.obolibrary.org/obo/GO_0021754) (facial nucleus development), [GO:0006121](http://purl.obolibrary.org/obo/GO_0006121) (mitochondrial electron transport, succinate to ubiquinone), [GO:0006122](http://purl.obolibrary.org/obo/GO_0006122) (mitochondrial electron transport, ubiquinol to cytochrome c), [GO:0021756](http://purl.obolibrary.org/obo/GO_0021756) (striatum development), [GO:0021750](http://purl.obolibrary.org/obo/GO_0021750) (vestibular nucleus development), [GO:1904417](http://purl.obolibrary.org/obo/GO_1904417) (positive regulation of xenophagy), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0051563](http://purl.obolibrary.org/obo/GO_0051563) (smooth endoplasmic reticulum calcium ion homeostasis), [GO:0006119](http://purl.obolibrary.org/obo/GO_0006119) (oxidative phosphorylation), [GO:0051561](http://purl.obolibrary.org/obo/GO_0051561) (positive regulation of mitochondrial calcium ion concentration), [GO:0019441](http://purl.obolibrary.org/obo/GO_0019441) (tryptophan catabolic process to kynurenine), [GO:0051560](http://purl.obolibrary.org/obo/GO_0051560) (mitochondrial calcium ion homeostasis), [GO:0032400](http://purl.obolibrary.org/obo/GO_0032400) (melanosome localization), [GO:0019442](http://purl.obolibrary.org/obo/GO_0019442) (tryptophan catabolic process to acetyl-CoA), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0051569](http://purl.obolibrary.org/obo/GO_0051569) (regulation of histone H3-K4 methylation), [GO:0051567](http://purl.obolibrary.org/obo/GO_0051567) (histone H3-K9 methylation), [GO:0051568](http://purl.obolibrary.org/obo/GO_0051568) (histone H3-K4 methylation), [GO:0032402](http://purl.obolibrary.org/obo/GO_0032402) (melanosome transport), [GO:0019448](http://purl.obolibrary.org/obo/GO_0019448) (L-cysteine catabolic process), [GO:1904427](http://purl.obolibrary.org/obo/GO_1904427) (positive regulation of calcium ion transmembrane transport), [GO:1904426](http://purl.obolibrary.org/obo/GO_1904426) (positive regulation of GTP binding), [GO:0051580](http://purl.obolibrary.org/obo/GO_0051580) (regulation of neurotransmitter uptake), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0007468](http://purl.obolibrary.org/obo/GO_0007468) (regulation of rhodopsin gene expression), [GO:0051574](http://purl.obolibrary.org/obo/GO_0051574) (positive regulation of histone H3-K9 methylation), [GO:0051575](http://purl.obolibrary.org/obo/GO_0051575) (5'-deoxyribose-5-phosphate lyase activity), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0019430](http://purl.obolibrary.org/obo/GO_0019430) (removal of superoxide radicals), [GO:0051570](http://purl.obolibrary.org/obo/GO_0051570) (regulation of histone H3-K9 methylation), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0019432](http://purl.obolibrary.org/obo/GO_0019432) (triglyceride biosynthetic process), [GO:0018101](http://purl.obolibrary.org/obo/GO_0018101) (protein citrullination), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:1904430](http://purl.obolibrary.org/obo/GO_1904430) (negative regulation of t-circle formation), [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding), [GO:0006101](http://purl.obolibrary.org/obo/GO_0006101) (citrate metabolic process), [GO:0006102](http://purl.obolibrary.org/obo/GO_0006102) (isocitrate metabolic process), [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding), [GO:0051591](http://purl.obolibrary.org/obo/GO_0051591) (response to cAMP), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0006105](http://purl.obolibrary.org/obo/GO_0006105) (succinate metabolic process), [GO:0006106](http://purl.obolibrary.org/obo/GO_0006106) (fumarate metabolic process), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0007435](http://purl.obolibrary.org/obo/GO_0007435) (salivary gland morphogenesis), [GO:0006104](http://purl.obolibrary.org/obo/GO_0006104) (succinyl-CoA metabolic process), [GO:0050254](http://purl.obolibrary.org/obo/GO_0050254) (rhodopsin kinase activity), [GO:0050251](http://purl.obolibrary.org/obo/GO_0050251) (retinol isomerase activity), [GO:0051584](http://purl.obolibrary.org/obo/GO_0051584) (regulation of dopamine uptake involved in synaptic transmission), [GO:0050253](http://purl.obolibrary.org/obo/GO_0050253) (retinyl-palmitate esterase activity), [GO:1904440](http://purl.obolibrary.org/obo/GO_1904440) (positive regulation of ferrous iron import across plasma membrane), [GO:0019408](http://purl.obolibrary.org/obo/GO_0019408) (dolichol biosynthetic process), [GO:1905776](http://purl.obolibrary.org/obo/GO_1905776) (positive regulation of DNA helicase activity), [GO:1905774](http://purl.obolibrary.org/obo/GO_1905774) (regulation of DNA helicase activity), [GO:1905773](http://purl.obolibrary.org/obo/GO_1905773) (8-hydroxy-2'-deoxyguanosine DNA binding), [GO:0006112](http://purl.obolibrary.org/obo/GO_0006112) (energy reserve metabolic process), [GO:0006110](http://purl.obolibrary.org/obo/GO_0006110) (regulation of glycolytic process), [GO:1904447](http://purl.obolibrary.org/obo/GO_1904447) (folic acid import across plasma membrane), [GO:0007442](http://purl.obolibrary.org/obo/GO_0007442) (hindgut morphogenesis), [GO:0021723](http://purl.obolibrary.org/obo/GO_0021723) (medullary reticular formation development), [GO:0006111](http://purl.obolibrary.org/obo/GO_0006111) (regulation of gluconeogenesis), [GO:0006116](http://purl.obolibrary.org/obo/GO_0006116) (NADH oxidation), [GO:0006114](http://purl.obolibrary.org/obo/GO_0006114) (glycerol biosynthetic process), [GO:0006107](http://purl.obolibrary.org/obo/GO_0006107) (oxaloacetate metabolic process), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0006108](http://purl.obolibrary.org/obo/GO_0006108) (malate metabolic process), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0051593](http://purl.obolibrary.org/obo/GO_0051593) (response to folic acid), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:1903087](http://purl.obolibrary.org/obo/GO_1903087) (mitotic spindle pole body duplication), [GO:0071939](http://purl.obolibrary.org/obo/GO_0071939) (vitamin A import), [GO:0006042](http://purl.obolibrary.org/obo/GO_0006042) (glucosamine biosynthetic process), [GO:0032330](http://purl.obolibrary.org/obo/GO_0032330) (regulation of chondrocyte differentiation), [GO:0034991](http://purl.obolibrary.org/obo/GO_0034991) (nuclear meiotic cohesin complex), [GO:0034990](http://purl.obolibrary.org/obo/GO_0034990) (nuclear mitotic cohesin complex), [GO:0046974](http://purl.obolibrary.org/obo/GO_0046974) (histone methyltransferase activity (H3-K9 specific)), [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0046975](http://purl.obolibrary.org/obo/GO_0046975) (histone methyltransferase activity (H3-K36 specific)), [GO:0046972](http://purl.obolibrary.org/obo/GO_0046972) (histone acetyltransferase activity (H4-K16 specific)), [GO:0021678](http://purl.obolibrary.org/obo/GO_0021678) (third ventricle development), [GO:0006044](http://purl.obolibrary.org/obo/GO_0006044) (N-acetylglucosamine metabolic process), [GO:0021679](http://purl.obolibrary.org/obo/GO_0021679) (cerebellar molecular layer development), [GO:0045647](http://purl.obolibrary.org/obo/GO_0045647) (negative regulation of erythrocyte differentiation), [GO:0045648](http://purl.obolibrary.org/obo/GO_0045648) (positive regulation of erythrocyte differentiation), [GO:0044314](http://purl.obolibrary.org/obo/GO_0044314) (protein K27-linked ubiquitination), [GO:0046979](http://purl.obolibrary.org/obo/GO_0046979) (TAP2 binding), [GO:0044317](http://purl.obolibrary.org/obo/GO_0044317) (rod spherule), [GO:0007379](http://purl.obolibrary.org/obo/GO_0007379) (segment specification), [GO:0046976](http://purl.obolibrary.org/obo/GO_0046976) (histone methyltransferase activity (H3-K27 specific)), [GO:0006048](http://purl.obolibrary.org/obo/GO_0006048) (UDP-N-acetylglucosamine biosynthetic process), [GO:0021675](http://purl.obolibrary.org/obo/GO_0021675) (nerve development), [GO:0044316](http://purl.obolibrary.org/obo/GO_0044316) (cone cell pedicle), [GO:0045646](http://purl.obolibrary.org/obo/GO_0045646) (regulation of erythrocyte differentiation), [GO:0021680](http://purl.obolibrary.org/obo/GO_0021680) (cerebellar Purkinje cell layer development), [GO:0021681](http://purl.obolibrary.org/obo/GO_0021681) (cerebellar granular layer development), [GO:0045650](http://purl.obolibrary.org/obo/GO_0045650) (negative regulation of macrophage differentiation), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0045651](http://purl.obolibrary.org/obo/GO_0045651) (positive regulation of macrophage differentiation), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0019363](http://purl.obolibrary.org/obo/GO_0019363) (pyridine nucleotide biosynthetic process), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0019368](http://purl.obolibrary.org/obo/GO_0019368) (fatty acid elongation, unsaturated fatty acid), [GO:0034982](http://purl.obolibrary.org/obo/GO_0034982) (mitochondrial protein processing), [GO:0019367](http://purl.obolibrary.org/obo/GO_0019367) (fatty acid elongation, saturated fatty acid), [GO:0071934](http://purl.obolibrary.org/obo/GO_0071934) (thiamine transmembrane transport), [GO:0070603](http://purl.obolibrary.org/obo/GO_0070603) (SWI/SNF superfamily-type complex), [GO:0019369](http://purl.obolibrary.org/obo/GO_0019369) (arachidonic acid metabolic process), [GO:0034987](http://purl.obolibrary.org/obo/GO_0034987) (immunoglobulin receptor binding), [GO:0032324](http://purl.obolibrary.org/obo/GO_0032324) (molybdopterin cofactor biosynthetic process), [GO:0070602](http://purl.obolibrary.org/obo/GO_0070602) (regulation of centromeric sister chromatid cohesion), [GO:0034986](http://purl.obolibrary.org/obo/GO_0034986) (iron chaperone activity), [GO:1903082](http://purl.obolibrary.org/obo/GO_1903082) (positive regulation of C-C chemokine receptor CCR7 signaling pathway), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0045654](http://purl.obolibrary.org/obo/GO_0045654) (positive regulation of megakaryocyte differentiation), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0044321](http://purl.obolibrary.org/obo/GO_0044321) (response to leptin), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0021667](http://purl.obolibrary.org/obo/GO_0021667) (rhombomere 6 morphogenesis), [GO:0007386](http://purl.obolibrary.org/obo/GO_0007386) (compartment pattern specification), [GO:0046984](http://purl.obolibrary.org/obo/GO_0046984) (regulation of hemoglobin biosynthetic process), [GO:0044323](http://purl.obolibrary.org/obo/GO_0044323) (retinoic acid-responsive element binding), [GO:0021661](http://purl.obolibrary.org/obo/GO_0021661) (rhombomere 4 morphogenesis), [GO:0044326](http://purl.obolibrary.org/obo/GO_0044326) (dendritic spine neck), [GO:0045658](http://purl.obolibrary.org/obo/GO_0045658) (regulation of neutrophil differentiation), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0045656](http://purl.obolibrary.org/obo/GO_0045656) (negative regulation of monocyte differentiation), [GO:0021663](http://purl.obolibrary.org/obo/GO_0021663) (rhombomere 4 formation), [GO:0021664](http://purl.obolibrary.org/obo/GO_0021664) (rhombomere 5 morphogenesis), [GO:0044327](http://purl.obolibrary.org/obo/GO_0044327) (dendritic spine head), [GO:0021670](http://purl.obolibrary.org/obo/GO_0021670) (lateral ventricle development), [GO:0045661](http://purl.obolibrary.org/obo/GO_0045661) (regulation of myoblast differentiation), [GO:0045662](http://purl.obolibrary.org/obo/GO_0045662) (negative regulation of myoblast differentiation), [GO:0044330](http://purl.obolibrary.org/obo/GO_0044330) (canonical Wnt signaling pathway involved in positive regulation of wound healing), [GO:0045660](http://purl.obolibrary.org/obo/GO_0045660) (positive regulation of neutrophil differentiation), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0032311](http://purl.obolibrary.org/obo/GO_0032311) (angiogenin-PRI complex), [GO:0018026](http://purl.obolibrary.org/obo/GO_0018026) (peptidyl-lysine monomethylation), [GO:0032310](http://purl.obolibrary.org/obo/GO_0032310) (prostaglandin secretion), [GO:0018027](http://purl.obolibrary.org/obo/GO_0018027) (peptidyl-lysine dimethylation), [GO:0019358](http://purl.obolibrary.org/obo/GO_0019358) (nicotinate nucleotide salvage), [GO:0034976](http://purl.obolibrary.org/obo/GO_0034976) (response to endoplasmic reticulum stress), [GO:0071921](http://purl.obolibrary.org/obo/GO_0071921) (cohesin loading), [GO:0034975](http://purl.obolibrary.org/obo/GO_0034975) (protein folding in endoplasmic reticulum), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0070628](http://purl.obolibrary.org/obo/GO_0070628) (proteasome binding), [GO:0021658](http://purl.obolibrary.org/obo/GO_0021658) (rhombomere 3 morphogenesis), [GO:0006021](http://purl.obolibrary.org/obo/GO_0006021) (inositol biosynthetic process), [GO:0007352](http://purl.obolibrary.org/obo/GO_0007352) (zygotic specification of dorsal/ventral axis), [GO:0008681](http://purl.obolibrary.org/obo/GO_0008681) (2-octaprenyl-6-methoxyphenol hydroxylase activity), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0044333](http://purl.obolibrary.org/obo/GO_0044333) (Wnt signaling pathway involved in digestive tract morphogenesis), [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0043001](http://purl.obolibrary.org/obo/GO_0043001) (Golgi to plasma membrane protein transport), [GO:0045663](http://purl.obolibrary.org/obo/GO_0045663) (positive regulation of myoblast differentiation), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0044334](http://purl.obolibrary.org/obo/GO_0044334) (canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0021650](http://purl.obolibrary.org/obo/GO_0021650) (vestibulocochlear nerve formation), [GO:0044337](http://purl.obolibrary.org/obo/GO_0044337) (canonical Wnt signaling pathway involved in positive regulation of apoptotic process), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation), [GO:0043008](http://purl.obolibrary.org/obo/GO_0043008) (ATP-dependent protein binding), [GO:0044339](http://purl.obolibrary.org/obo/GO_0044339) (canonical Wnt signaling pathway involved in osteoblast differentiation), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0006027](http://purl.obolibrary.org/obo/GO_0006027) (glycosaminoglycan catabolic process), [GO:0043007](http://purl.obolibrary.org/obo/GO_0043007) (maintenance of rDNA), [GO:0044338](http://purl.obolibrary.org/obo/GO_0044338) (canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation), [GO:1900825](http://purl.obolibrary.org/obo/GO_1900825) (regulation of membrane depolarization during cardiac muscle cell action potential), [GO:0032308](http://purl.obolibrary.org/obo/GO_0032308) (positive regulation of prostaglandin secretion), [GO:0034969](http://purl.obolibrary.org/obo/GO_0034969) (histone arginine methylation), [GO:0034968](http://purl.obolibrary.org/obo/GO_0034968) (histone lysine methylation), [GO:0045672](http://purl.obolibrary.org/obo/GO_0045672) (positive regulation of osteoclast differentiation), [GO:0010999](http://purl.obolibrary.org/obo/GO_0010999) (regulation of eIF2 alpha phosphorylation by heme), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:1990304](http://purl.obolibrary.org/obo/GO_1990304) (MUB1-RAD6-UBR2 ubiquitin ligase complex), [GO:0044342](http://purl.obolibrary.org/obo/GO_0044342) (type B pancreatic cell proliferation), [GO:0043011](http://purl.obolibrary.org/obo/GO_0043011) (myeloid dendritic cell differentiation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0045671](http://purl.obolibrary.org/obo/GO_0045671) (negative regulation of osteoclast differentiation), [GO:0044341](http://purl.obolibrary.org/obo/GO_0044341) (sodium-dependent phosphate transport), [GO:0032300](http://purl.obolibrary.org/obo/GO_0032300) (mismatch repair complex), [GO:0033632](http://purl.obolibrary.org/obo/GO_0033632) (regulation of cell-cell adhesion mediated by integrin), [GO:0010996](http://purl.obolibrary.org/obo/GO_0010996) (response to auditory stimulus), [GO:0019344](http://purl.obolibrary.org/obo/GO_0019344) (cysteine biosynthetic process), [GO:0034963](http://purl.obolibrary.org/obo/GO_0034963) (box C/D snoRNA processing), [GO:0032301](http://purl.obolibrary.org/obo/GO_0032301) (MutSalpha complex), [GO:0071953](http://purl.obolibrary.org/obo/GO_0071953) (elastic fiber), [GO:0019343](http://purl.obolibrary.org/obo/GO_0019343) (cysteine biosynthetic process via cystathionine), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0019346](http://purl.obolibrary.org/obo/GO_0019346) (transsulfuration), [GO:0010998](http://purl.obolibrary.org/obo/GO_0010998) (regulation of translational initiation by eIF2 alpha phosphorylation), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0071951](http://purl.obolibrary.org/obo/GO_0071951) (conversion of methionyl-tRNA to N-formyl-methionyl-tRNA), [GO:0019348](http://purl.obolibrary.org/obo/GO_0019348) (dolichol metabolic process), [GO:0010992](http://purl.obolibrary.org/obo/GO_0010992) (ubiquitin recycling), [GO:0034967](http://purl.obolibrary.org/obo/GO_0034967) (Set3 complex), [GO:0070626](http://purl.obolibrary.org/obo/GO_0070626) ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity), [GO:0010991](http://purl.obolibrary.org/obo/GO_0010991) (negative regulation of SMAD protein complex assembly), [GO:0032302](http://purl.obolibrary.org/obo/GO_0032302) (MutSbeta complex), [GO:0010994](http://purl.obolibrary.org/obo/GO_0010994) (free ubiquitin chain polymerization), [GO:0033634](http://purl.obolibrary.org/obo/GO_0033634) (positive regulation of cell-cell adhesion mediated by integrin), [GO:0034964](http://purl.obolibrary.org/obo/GO_0034964) (box H/ACA snoRNA processing), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0055001](http://purl.obolibrary.org/obo/GO_0055001) (muscle cell development), [GO:0044344](http://purl.obolibrary.org/obo/GO_0044344) (cellular response to fibroblast growth factor stimulus), [GO:0021644](http://purl.obolibrary.org/obo/GO_0021644) (vagus nerve morphogenesis), [GO:0007367](http://purl.obolibrary.org/obo/GO_0007367) (segment polarity determination), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0043014](http://purl.obolibrary.org/obo/GO_0043014) (alpha-tubulin binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0007369](http://purl.obolibrary.org/obo/GO_0007369) (gastrulation), [GO:0021642](http://purl.obolibrary.org/obo/GO_0021642) (trochlear nerve formation), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0033627](http://purl.obolibrary.org/obo/GO_0033627) (cell adhesion mediated by integrin), [GO:0043020](http://purl.obolibrary.org/obo/GO_0043020) (NADPH oxidase complex), [GO:0044351](http://purl.obolibrary.org/obo/GO_0044351) (macropinocytosis), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:2000703](http://purl.obolibrary.org/obo/GO_2000703) (negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation), [GO:0043022](http://purl.obolibrary.org/obo/GO_0043022) (ribosome binding), [GO:1990316](http://purl.obolibrary.org/obo/GO_1990316) (Atg1/ULK1 kinase complex), [GO:0043021](http://purl.obolibrary.org/obo/GO_0043021) (ribonucleoprotein complex binding), [GO:0018002](http://purl.obolibrary.org/obo/GO_0018002) (N-terminal peptidyl-glutamic acid acetylation), [GO:0071942](http://purl.obolibrary.org/obo/GO_0071942) (XPC complex), [GO:0071940](http://purl.obolibrary.org/obo/GO_0071940) (fungal-type cell wall assembly), [GO:0033625](http://purl.obolibrary.org/obo/GO_0033625) (positive regulation of integrin activation), [GO:0033623](http://purl.obolibrary.org/obo/GO_0033623) (regulation of integrin activation), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0070613](http://purl.obolibrary.org/obo/GO_0070613) (regulation of protein processing), [GO:0033622](http://purl.obolibrary.org/obo/GO_0033622) (integrin activation), [GO:0045607](http://purl.obolibrary.org/obo/GO_0045607) (regulation of inner ear auditory receptor cell differentiation), [GO:0006082](http://purl.obolibrary.org/obo/GO_0006082) (organic acid metabolic process), [GO:0032370](http://purl.obolibrary.org/obo/GO_0032370) (positive regulation of lipid transport), [GO:0046939](http://purl.obolibrary.org/obo/GO_0046939) (nucleotide phosphorylation), [GO:0006083](http://purl.obolibrary.org/obo/GO_0006083) (acetate metabolic process), [GO:1903041](http://purl.obolibrary.org/obo/GO_1903041) (regulation of chondrocyte hypertrophy), [GO:0045605](http://purl.obolibrary.org/obo/GO_0045605) (negative regulation of epidermal cell differentiation), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0006081](http://purl.obolibrary.org/obo/GO_0006081) (cellular aldehyde metabolic process), [GO:0006086](http://purl.obolibrary.org/obo/GO_0006086) (acetyl-CoA biosynthetic process from pyruvate), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:1903045](http://purl.obolibrary.org/obo/GO_1903045) (neural crest cell migration involved in sympathetic nervous system development), [GO:0006085](http://purl.obolibrary.org/obo/GO_0006085) (acetyl-CoA biosynthetic process), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0046931](http://purl.obolibrary.org/obo/GO_0046931) (pore complex assembly), [GO:0006089](http://purl.obolibrary.org/obo/GO_0006089) (lactate metabolic process), [GO:0046934](http://purl.obolibrary.org/obo/GO_0046934) (phosphatidylinositol-4,5-bisphosphate 3-kinase activity), [GO:0045603](http://purl.obolibrary.org/obo/GO_0045603) (positive regulation of endothelial cell differentiation), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:0045601](http://purl.obolibrary.org/obo/GO_0045601) (regulation of endothelial cell differentiation), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0046933](http://purl.obolibrary.org/obo/GO_0046933) (proton-transporting ATP synthase activity, rotational mechanism), [GO:2000719](http://purl.obolibrary.org/obo/GO_2000719) (negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric), [GO:0032366](http://purl.obolibrary.org/obo/GO_0032366) (intracellular sterol transport), [GO:0033698](http://purl.obolibrary.org/obo/GO_0033698) (Rpd3L complex), [GO:0032367](http://purl.obolibrary.org/obo/GO_0032367) (intracellular cholesterol transport), [GO:0032364](http://purl.obolibrary.org/obo/GO_0032364) (oxygen homeostasis), [GO:0033699](http://purl.obolibrary.org/obo/GO_0033699) (DNA 5'-adenosine monophosphate hydrolase activity), [GO:0033690](http://purl.obolibrary.org/obo/GO_0033690) (positive regulation of osteoblast proliferation), [GO:0045618](http://purl.obolibrary.org/obo/GO_0045618) (positive regulation of keratinocyte differentiation), [GO:0046949](http://purl.obolibrary.org/obo/GO_0046949) (fatty-acyl-CoA biosynthetic process), [GO:1904385](http://purl.obolibrary.org/obo/GO_1904385) (cellular response to angiotensin), [GO:0006094](http://purl.obolibrary.org/obo/GO_0006094) (gluconeogenesis), [GO:0045619](http://purl.obolibrary.org/obo/GO_0045619) (regulation of lymphocyte differentiation), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:0006091](http://purl.obolibrary.org/obo/GO_0006091) (generation of precursor metabolites and energy), [GO:0046947](http://purl.obolibrary.org/obo/GO_0046947) (hydroxylysine biosynthetic process), [GO:1903053](http://purl.obolibrary.org/obo/GO_1903053) (regulation of extracellular matrix organization), [GO:0045617](http://purl.obolibrary.org/obo/GO_0045617) (negative regulation of keratinocyte differentiation), [GO:0006097](http://purl.obolibrary.org/obo/GO_0006097) (glyoxylate cycle), [GO:0033693](http://purl.obolibrary.org/obo/GO_0033693) (neurofilament bundle assembly), [GO:0006098](http://purl.obolibrary.org/obo/GO_0006098) (pentose-phosphate shunt), [GO:0031032](http://purl.obolibrary.org/obo/GO_0031032) (actomyosin structure organization), [GO:1904388](http://purl.obolibrary.org/obo/GO_1904388) (negative regulation of ncRNA transcription associated with protein coding gene TSS/TES), [GO:1903056](http://purl.obolibrary.org/obo/GO_1903056) (regulation of melanosome organization), [GO:0033692](http://purl.obolibrary.org/obo/GO_0033692) (cellular polysaccharide biosynthetic process), [GO:0033691](http://purl.obolibrary.org/obo/GO_0033691) (sialic acid binding), [GO:0006096](http://purl.obolibrary.org/obo/GO_0006096) (glycolytic process), [GO:0006099](http://purl.obolibrary.org/obo/GO_0006099) (tricarboxylic acid cycle), [GO:2000729](http://purl.obolibrary.org/obo/GO_2000729) (positive regulation of mesenchymal cell proliferation involved in ureter development), [GO:0003810](http://purl.obolibrary.org/obo/GO_0003810) (protein-glutamine gamma-glutamyltransferase activity), [GO:0019395](http://purl.obolibrary.org/obo/GO_0019395) (fatty acid oxidation), [GO:0018063](http://purl.obolibrary.org/obo/GO_0018063) (cytochrome c-heme linkage), [GO:2000726](http://purl.obolibrary.org/obo/GO_2000726) (negative regulation of cardiac muscle cell differentiation), [GO:0032355](http://purl.obolibrary.org/obo/GO_0032355) (response to estradiol), [GO:0033686](http://purl.obolibrary.org/obo/GO_0033686) (positive regulation of luteinizing hormone secretion), [GO:2000721](http://purl.obolibrary.org/obo/GO_2000721) (positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation), [GO:0032353](http://purl.obolibrary.org/obo/GO_0032353) (negative regulation of hormone biosynthetic process), [GO:0031023](http://purl.obolibrary.org/obo/GO_0031023) (microtubule organizing center organization), [GO:0006090](http://purl.obolibrary.org/obo/GO_0006090) (pyruvate metabolic process), [GO:0032357](http://purl.obolibrary.org/obo/GO_0032357) (oxidized purine DNA binding), [GO:0033688](http://purl.obolibrary.org/obo/GO_0033688) (regulation of osteoblast proliferation), [GO:0045629](http://purl.obolibrary.org/obo/GO_0045629) (negative regulation of T-helper 2 cell differentiation), [GO:1904396](http://purl.obolibrary.org/obo/GO_1904396) (regulation of neuromuscular junction development), [GO:0071914](http://purl.obolibrary.org/obo/GO_0071914) (prominosome), [GO:1904395](http://purl.obolibrary.org/obo/GO_1904395) (positive regulation of skeletal muscle acetylcholine-gated channel clustering), [GO:0045627](http://purl.obolibrary.org/obo/GO_0045627) (positive regulation of T-helper 1 cell differentiation), [GO:0046959](http://purl.obolibrary.org/obo/GO_0046959) (habituation), [GO:0033683](http://purl.obolibrary.org/obo/GO_0033683) (nucleotide-excision repair, DNA incision), [GO:0032350](http://purl.obolibrary.org/obo/GO_0032350) (regulation of hormone metabolic process), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0045621](http://purl.obolibrary.org/obo/GO_0045621) (positive regulation of lymphocyte differentiation), [GO:0046952](http://purl.obolibrary.org/obo/GO_0046952) (ketone body catabolic process), [GO:0046950](http://purl.obolibrary.org/obo/GO_0046950) (cellular ketone body metabolic process), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0006067](http://purl.obolibrary.org/obo/GO_0006067) (ethanol metabolic process), [GO:0046951](http://purl.obolibrary.org/obo/GO_0046951) (ketone body biosynthetic process), [GO:0045626](http://purl.obolibrary.org/obo/GO_0045626) (negative regulation of T-helper 1 cell differentiation), [GO:0021695](http://purl.obolibrary.org/obo/GO_0021695) (cerebellar cortex development), [GO:0021696](http://purl.obolibrary.org/obo/GO_0021696) (cerebellar cortex morphogenesis), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:2000738](http://purl.obolibrary.org/obo/GO_2000738) (positive regulation of stem cell differentiation), [GO:2000739](http://purl.obolibrary.org/obo/GO_2000739) (regulation of mesenchymal stem cell differentiation), [GO:2000734](http://purl.obolibrary.org/obo/GO_2000734) (negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation), [GO:2000737](http://purl.obolibrary.org/obo/GO_2000737) (negative regulation of stem cell differentiation), [GO:1990349](http://purl.obolibrary.org/obo/GO_1990349) (gap junction-mediated intercellular transport), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0018057](http://purl.obolibrary.org/obo/GO_0018057) (peptidyl-lysine oxidation), [GO:0031014](http://purl.obolibrary.org/obo/GO_0031014) (troponin T binding), [GO:0032342](http://purl.obolibrary.org/obo/GO_0032342) (aldosterone biosynthetic process), [GO:0031011](http://purl.obolibrary.org/obo/GO_0031011) (Ino80 complex), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0033673](http://purl.obolibrary.org/obo/GO_0033673) (negative regulation of kinase activity), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0032348](http://purl.obolibrary.org/obo/GO_0032348) (negative regulation of aldosterone biosynthetic process), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0032349](http://purl.obolibrary.org/obo/GO_0032349) (positive regulation of aldosterone biosynthetic process), [GO:0071910](http://purl.obolibrary.org/obo/GO_0071910) (determination of liver left/right asymmetry), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0071911](http://purl.obolibrary.org/obo/GO_0071911) (synchronous neurotransmitter secretion), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:1903076](http://purl.obolibrary.org/obo/GO_1903076) (regulation of protein localization to plasma membrane), [GO:0044308](http://purl.obolibrary.org/obo/GO_0044308) (axonal spine), [GO:0006072](http://purl.obolibrary.org/obo/GO_0006072) (glycerol-3-phosphate metabolic process), [GO:0044307](http://purl.obolibrary.org/obo/GO_0044307) (dendritic branch), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0045639](http://purl.obolibrary.org/obo/GO_0045639) (positive regulation of myeloid cell differentiation), [GO:0071909](http://purl.obolibrary.org/obo/GO_0071909) (determination of stomach left/right asymmetry), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0071907](http://purl.obolibrary.org/obo/GO_0071907) (determination of digestive tract left/right asymmetry), [GO:0071908](http://purl.obolibrary.org/obo/GO_0071908) (determination of intestine left/right asymmetry), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0046961](http://purl.obolibrary.org/obo/GO_0046961) (proton-transporting ATPase activity, rotational mechanism), [GO:0044302](http://purl.obolibrary.org/obo/GO_0044302) (dentate gyrus mossy fiber), [GO:0045636](http://purl.obolibrary.org/obo/GO_0045636) (positive regulation of melanocyte differentiation), [GO:0044304](http://purl.obolibrary.org/obo/GO_0044304) (main axon), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0046965](http://purl.obolibrary.org/obo/GO_0046965) (retinoid X receptor binding), [GO:0045634](http://purl.obolibrary.org/obo/GO_0045634) (regulation of melanocyte differentiation), [GO:0044306](http://purl.obolibrary.org/obo/GO_0044306) (neuron projection terminus), [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding), [GO:0021692](http://purl.obolibrary.org/obo/GO_0021692) (cerebellar Purkinje cell layer morphogenesis), [GO:0021693](http://purl.obolibrary.org/obo/GO_0021693) (cerebellar Purkinje cell layer structural organization), [GO:0019370](http://purl.obolibrary.org/obo/GO_0019370) (leukotriene biosynthetic process), [GO:1990357](http://purl.obolibrary.org/obo/GO_1990357) (terminal web), [GO:0019372](http://purl.obolibrary.org/obo/GO_0019372) (lipoxygenase pathway), [GO:2000741](http://purl.obolibrary.org/obo/GO_2000741) (positive regulation of mesenchymal stem cell differentiation), [GO:0019377](http://purl.obolibrary.org/obo/GO_0019377) (glycolipid catabolic process), [GO:0031000](http://purl.obolibrary.org/obo/GO_0031000) (response to caffeine), [GO:0032331](http://purl.obolibrary.org/obo/GO_0032331) (negative regulation of chondrocyte differentiation), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0034993](http://purl.obolibrary.org/obo/GO_0034993) (LINC complex), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0071902](http://purl.obolibrary.org/obo/GO_0071902) (positive regulation of protein serine/threonine kinase activity), [GO:1903071](http://purl.obolibrary.org/obo/GO_1903071) (positive regulation of ER-associated ubiquitin-dependent protein catabolic process), [GO:0031083](http://purl.obolibrary.org/obo/GO_0031083) (BLOC-1 complex), [GO:0031084](http://purl.obolibrary.org/obo/GO_0031084) (BLOC-2 complex), [GO:0055056](http://purl.obolibrary.org/obo/GO_0055056) (D-glucose transmembrane transporter activity), [GO:0031085](http://purl.obolibrary.org/obo/GO_0031085) (BLOC-3 complex), [GO:0043068](http://purl.obolibrary.org/obo/GO_0043068) (positive regulation of programmed cell death), [GO:0043067](http://purl.obolibrary.org/obo/GO_0043067) (regulation of programmed cell death), [GO:0043069](http://purl.obolibrary.org/obo/GO_0043069) (negative regulation of programmed cell death), [GO:0080019](http://purl.obolibrary.org/obo/GO_0080019) (fatty-acyl-CoA reductase (alcohol-forming) activity), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0003842](http://purl.obolibrary.org/obo/GO_0003842) (1-pyrroline-5-carboxylate dehydrogenase activity), [GO:0002513](http://purl.obolibrary.org/obo/GO_0002513) (tolerance induction to self antigen), [GO:0003844](http://purl.obolibrary.org/obo/GO_0003844) (1,4-alpha-glucan branching enzyme activity), [GO:0003847](http://purl.obolibrary.org/obo/GO_0003847) (1-alkyl-2-acetylglycerophosphocholine esterase activity), [GO:0002517](http://purl.obolibrary.org/obo/GO_0002517) (T cell tolerance induction), [GO:0015828](http://purl.obolibrary.org/obo/GO_0015828) (tyrosine transport), [GO:2000753](http://purl.obolibrary.org/obo/GO_2000753) (positive regulation of glucosylceramide catabolic process), [GO:0015826](http://purl.obolibrary.org/obo/GO_0015826) (threonine transport), [GO:0015825](http://purl.obolibrary.org/obo/GO_0015825) (L-serine transport), [GO:0031077](http://purl.obolibrary.org/obo/GO_0031077) (post-embryonic camera-type eye development), [GO:0015824](http://purl.obolibrary.org/obo/GO_0015824) (proline transport), [GO:2000755](http://purl.obolibrary.org/obo/GO_2000755) (positive regulation of sphingomyelin catabolic process), [GO:0015821](http://purl.obolibrary.org/obo/GO_0015821) (methionine transport), [GO:0031071](http://purl.obolibrary.org/obo/GO_0031071) (cysteine desulfurase activity), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0015840](http://purl.obolibrary.org/obo/GO_0015840) (urea transport), [GO:0055062](http://purl.obolibrary.org/obo/GO_0055062) (phosphate ion homeostasis), [GO:0055064](http://purl.obolibrary.org/obo/GO_0055064) (chloride ion homeostasis), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0055065](http://purl.obolibrary.org/obo/GO_0055065) (metal ion homeostasis), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:0080025](http://purl.obolibrary.org/obo/GO_0080025) (phosphatidylinositol-3,5-bisphosphate binding), [GO:0003860](http://purl.obolibrary.org/obo/GO_0003860) (3-hydroxyisobutyryl-CoA hydrolase activity), [GO:0002521](http://purl.obolibrary.org/obo/GO_0002521) (leukocyte differentiation), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0002523](http://purl.obolibrary.org/obo/GO_0002523) (leukocyte migration involved in inflammatory response), [GO:0043083](http://purl.obolibrary.org/obo/GO_0043083) (synaptic cleft), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:0070672](http://purl.obolibrary.org/obo/GO_0070672) (response to interleukin-15), [GO:2000767](http://purl.obolibrary.org/obo/GO_2000767) (positive regulation of cytoplasmic translation), [GO:2000768](http://purl.obolibrary.org/obo/GO_2000768) (positive regulation of nephron tubule epithelial cell differentiation), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0002526](http://purl.obolibrary.org/obo/GO_0002526) (acute inflammatory response), [GO:0003857](http://purl.obolibrary.org/obo/GO_0003857) (3-hydroxyacyl-CoA dehydrogenase activity), [GO:0070670](http://purl.obolibrary.org/obo/GO_0070670) (response to interleukin-4), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0070671](http://purl.obolibrary.org/obo/GO_0070671) (response to interleukin-12), [GO:0015838](http://purl.obolibrary.org/obo/GO_0015838) (amino-acid betaine transport), [GO:0070676](http://purl.obolibrary.org/obo/GO_0070676) (intralumenal vesicle formation), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0032391](http://purl.obolibrary.org/obo/GO_0032391) (photoreceptor connecting cilium), [GO:0031060](http://purl.obolibrary.org/obo/GO_0031060) (regulation of histone methylation), [GO:0032392](http://purl.obolibrary.org/obo/GO_0032392) (DNA geometric change), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:2000780](http://purl.obolibrary.org/obo/GO_2000780) (negative regulation of double-strand break repair), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0032395](http://purl.obolibrary.org/obo/GO_0032395) (MHC class II receptor activity), [GO:0031064](http://purl.obolibrary.org/obo/GO_0031064) (negative regulation of histone deacetylation), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0055077](http://purl.obolibrary.org/obo/GO_0055077) (gap junction hemi-channel activity), [GO:0031062](http://purl.obolibrary.org/obo/GO_0031062) (positive regulation of histone methylation), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0055070](http://purl.obolibrary.org/obo/GO_0055070) (copper ion homeostasis), [GO:0018095](http://purl.obolibrary.org/obo/GO_0018095) (protein polyglutamylation), [GO:2000778](http://purl.obolibrary.org/obo/GO_2000778) (positive regulation of interleukin-6 secretion), [GO:0003823](http://purl.obolibrary.org/obo/GO_0003823) (antigen binding), [GO:0015809](http://purl.obolibrary.org/obo/GO_0015809) (arginine transport), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0015808](http://purl.obolibrary.org/obo/GO_0015808) (L-alanine transport), [GO:0015807](http://purl.obolibrary.org/obo/GO_0015807) (L-amino acid transport), [GO:0003826](http://purl.obolibrary.org/obo/GO_0003826) (alpha-ketoacid dehydrogenase activity), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0032388](http://purl.obolibrary.org/obo/GO_0032388) (positive regulation of intracellular transport), [GO:0015805](http://purl.obolibrary.org/obo/GO_0015805) (S-adenosyl-L-methionine transport), [GO:0055069](http://purl.obolibrary.org/obo/GO_0055069) (zinc ion homeostasis), [GO:0015804](http://purl.obolibrary.org/obo/GO_0015804) (neutral amino acid transport), [GO:0032389](http://purl.obolibrary.org/obo/GO_0032389) (MutLalpha complex), [GO:0032386](http://purl.obolibrary.org/obo/GO_0032386) (regulation of intracellular transport), [GO:0015803](http://purl.obolibrary.org/obo/GO_0015803) (branched-chain amino acid transport), [GO:0031056](http://purl.obolibrary.org/obo/GO_0031056) (regulation of histone modification), [GO:0032387](http://purl.obolibrary.org/obo/GO_0032387) (negative regulation of intracellular transport), [GO:2000772](http://purl.obolibrary.org/obo/GO_2000772) (regulation of cellular senescence), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0031053](http://purl.obolibrary.org/obo/GO_0031053) (primary miRNA processing), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0055087](http://purl.obolibrary.org/obo/GO_0055087) (Ski complex), [GO:0032385](http://purl.obolibrary.org/obo/GO_0032385) (positive regulation of intracellular cholesterol transport), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0080008](http://purl.obolibrary.org/obo/GO_0080008) (Cul4-RING E3 ubiquitin ligase complex), [GO:0055081](http://purl.obolibrary.org/obo/GO_0055081) (anion homeostasis), [GO:0080009](http://purl.obolibrary.org/obo/GO_0080009) (mRNA methylation), [GO:0003831](http://purl.obolibrary.org/obo/GO_0003831) (beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity), [GO:0002502](http://purl.obolibrary.org/obo/GO_0002502) (peptide antigen assembly with MHC class I protein complex), [GO:0003834](http://purl.obolibrary.org/obo/GO_0003834) (beta-carotene 15,15'-monooxygenase activity), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0015819](http://purl.obolibrary.org/obo/GO_0015819) (lysine transport), [GO:0003837](http://purl.obolibrary.org/obo/GO_0003837) (beta-ureidopropionase activity), [GO:0015816](http://purl.obolibrary.org/obo/GO_0015816) (glycine transport), [GO:2000785](http://purl.obolibrary.org/obo/GO_2000785) (regulation of autophagosome assembly), [GO:0002507](http://purl.obolibrary.org/obo/GO_0002507) (tolerance induction), [GO:0070698](http://purl.obolibrary.org/obo/GO_0070698) (type I activin receptor binding), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:2000786](http://purl.obolibrary.org/obo/GO_2000786) (positive regulation of autophagosome assembly), [GO:0002509](http://purl.obolibrary.org/obo/GO_0002509) (central tolerance induction to self antigen), [GO:0032375](http://purl.obolibrary.org/obo/GO_0032375) (negative regulation of cholesterol transport), [GO:0032376](http://purl.obolibrary.org/obo/GO_0032376) (positive regulation of cholesterol transport), [GO:0015813](http://purl.obolibrary.org/obo/GO_0015813) (L-glutamate transport), [GO:0015811](http://purl.obolibrary.org/obo/GO_0015811) (L-cystine transport), [GO:0015810](http://purl.obolibrary.org/obo/GO_0015810) (aspartate transport), [GO:0015871](http://purl.obolibrary.org/obo/GO_0015871) (choline transport), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0055012](http://purl.obolibrary.org/obo/GO_0055012) (ventricular cardiac muscle cell differentiation), [GO:0043024](http://purl.obolibrary.org/obo/GO_0043024) (ribosomal small subunit binding), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0045685](http://purl.obolibrary.org/obo/GO_0045685) (regulation of glial cell differentiation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process), [GO:0043027](http://purl.obolibrary.org/obo/GO_0043027) (cysteine-type endopeptidase inhibitor activity involved in apoptotic process), [GO:0001225](http://purl.obolibrary.org/obo/GO_0001225) (RNA polymerase II transcription coactivator binding), [GO:0043029](http://purl.obolibrary.org/obo/GO_0043029) (T cell homeostasis), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0002554](http://purl.obolibrary.org/obo/GO_0002554) (serotonin secretion by platelet), [GO:0003886](http://purl.obolibrary.org/obo/GO_0003886) (DNA (cytosine-5-)-methyltransferase activity), [GO:0003887](http://purl.obolibrary.org/obo/GO_0003887) (DNA-directed DNA polymerase activity), [GO:0070640](http://purl.obolibrary.org/obo/GO_0070640) (vitamin D3 metabolic process), [GO:0043032](http://purl.obolibrary.org/obo/GO_0043032) (positive regulation of macrophage activation), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0070644](http://purl.obolibrary.org/obo/GO_0070644) (vitamin D response element binding), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0055004](http://purl.obolibrary.org/obo/GO_0055004) (atrial cardiac myofibril assembly), [GO:0055005](http://purl.obolibrary.org/obo/GO_0055005) (ventricular cardiac myofibril assembly), [GO:0015868](http://purl.obolibrary.org/obo/GO_0015868) (purine ribonucleotide transport), [GO:0015867](http://purl.obolibrary.org/obo/GO_0015867) (ATP transport), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:2000793](http://purl.obolibrary.org/obo/GO_2000793) (cell proliferation involved in heart valve development), [GO:0015866](http://purl.obolibrary.org/obo/GO_0015866) (ADP transport), [GO:0055008](http://purl.obolibrary.org/obo/GO_0055008) (cardiac muscle tissue morphogenesis), [GO:2000794](http://purl.obolibrary.org/obo/GO_2000794) (regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0055009](http://purl.obolibrary.org/obo/GO_0055009) (atrial cardiac muscle tissue morphogenesis), [GO:0015884](http://purl.obolibrary.org/obo/GO_0015884) (folic acid transport), [GO:0055020](http://purl.obolibrary.org/obo/GO_0055020) (positive regulation of cardiac muscle fiber development), [GO:0015881](http://purl.obolibrary.org/obo/GO_0015881) (creatine transport), [GO:0043034](http://purl.obolibrary.org/obo/GO_0043034) (costamere), [GO:0002572](http://purl.obolibrary.org/obo/GO_0002572) (pro-T cell differentiation), [GO:0043039](http://purl.obolibrary.org/obo/GO_0043039) (tRNA aminoacylation), [GO:0002573](http://purl.obolibrary.org/obo/GO_0002573) (myeloid leukocyte differentiation), [GO:0002574](http://purl.obolibrary.org/obo/GO_0002574) (thrombocyte differentiation), [GO:0002575](http://purl.obolibrary.org/obo/GO_0002575) (basophil chemotaxis), [GO:0003896](http://purl.obolibrary.org/obo/GO_0003896) (DNA primase activity), [GO:0002566](http://purl.obolibrary.org/obo/GO_0002566) (somatic diversification of immune receptors via somatic mutation), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0043044](http://purl.obolibrary.org/obo/GO_0043044) (ATP-dependent chromatin remodeling), [GO:0044375](http://purl.obolibrary.org/obo/GO_0044375) (regulation of peroxisome size), [GO:0043043](http://purl.obolibrary.org/obo/GO_0043043) (peptide biosynthetic process), [GO:0055013](http://purl.obolibrary.org/obo/GO_0055013) (cardiac muscle cell development), [GO:0070633](http://purl.obolibrary.org/obo/GO_0070633) (transepithelial transport), [GO:0055014](http://purl.obolibrary.org/obo/GO_0055014) (atrial cardiac muscle cell development), [GO:0055015](http://purl.obolibrary.org/obo/GO_0055015) (ventricular cardiac muscle cell development), [GO:0015879](http://purl.obolibrary.org/obo/GO_0015879) (carnitine transport), [GO:0055016](http://purl.obolibrary.org/obo/GO_0055016) (hypochord development), [GO:0015876](http://purl.obolibrary.org/obo/GO_0015876) (acetyl-CoA transport), [GO:0070635](http://purl.obolibrary.org/obo/GO_0070635) (nicotinamide riboside hydrolase activity), [GO:0015851](http://purl.obolibrary.org/obo/GO_0015851) (nucleobase transport), [GO:0001208](http://purl.obolibrary.org/obo/GO_0001208) (histone H2A-H2B dimer displacement), [GO:0043046](http://purl.obolibrary.org/obo/GO_0043046) (DNA methylation involved in gamete generation), [GO:0043045](http://purl.obolibrary.org/obo/GO_0043045) (DNA methylation involved in embryo development), [GO:0001207](http://purl.obolibrary.org/obo/GO_0001207) (histone displacement), [GO:0001206](http://purl.obolibrary.org/obo/GO_0001206) (transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0043048](http://purl.obolibrary.org/obo/GO_0043048) (dolichyl monophosphate biosynthetic process), [GO:0001205](http://purl.obolibrary.org/obo/GO_0001205) (transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0043047](http://purl.obolibrary.org/obo/GO_0043047) (single-stranded telomeric DNA binding), [GO:0003870](http://purl.obolibrary.org/obo/GO_0003870) (5-aminolevulinate synthase activity), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0003872](http://purl.obolibrary.org/obo/GO_0003872) (6-phosphofructokinase activity), [GO:0002532](http://purl.obolibrary.org/obo/GO_0002532) (production of molecular mediator involved in inflammatory response), [GO:0003863](http://purl.obolibrary.org/obo/GO_0003863) (3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity), [GO:0002534](http://purl.obolibrary.org/obo/GO_0002534) (cytokine production involved in inflammatory response), [GO:0003865](http://purl.obolibrary.org/obo/GO_0003865) (3-oxo-5-alpha-steroid 4-dehydrogenase activity), [GO:0003867](http://purl.obolibrary.org/obo/GO_0003867) (4-aminobutyrate transaminase activity), [GO:0003868](http://purl.obolibrary.org/obo/GO_0003868) (4-hydroxyphenylpyruvate dioxygenase activity), [GO:0002539](http://purl.obolibrary.org/obo/GO_0002539) (prostaglandin production involved in inflammatory response), [GO:0055025](http://purl.obolibrary.org/obo/GO_0055025) (positive regulation of cardiac muscle tissue development), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0055026](http://purl.obolibrary.org/obo/GO_0055026) (negative regulation of cardiac muscle tissue development), [GO:0070664](http://purl.obolibrary.org/obo/GO_0070664) (negative regulation of leukocyte proliferation), [GO:0015846](http://purl.obolibrary.org/obo/GO_0015846) (polyamine transport), [GO:0070669](http://purl.obolibrary.org/obo/GO_0070669) (response to interleukin-2), [GO:0070668](http://purl.obolibrary.org/obo/GO_0070668) (positive regulation of mast cell proliferation), [GO:0015842](http://purl.obolibrary.org/obo/GO_0015842) (aminergic neurotransmitter loading into synaptic vesicle), [GO:0031094](http://purl.obolibrary.org/obo/GO_0031094) (platelet dense tubular network), [GO:0031091](http://purl.obolibrary.org/obo/GO_0031091) (platelet alpha granule), [GO:0031092](http://purl.obolibrary.org/obo/GO_0031092) (platelet alpha granule membrane), [GO:0031098](http://purl.obolibrary.org/obo/GO_0031098) (stress-activated protein kinase signaling cascade), [GO:0044387](http://purl.obolibrary.org/obo/GO_0044387) (negative regulation of protein kinase activity by regulation of protein phosphorylation), [GO:0043056](http://purl.obolibrary.org/obo/GO_0043056) (forward locomotion), [GO:0044389](http://purl.obolibrary.org/obo/GO_0044389) (ubiquitin-like protein ligase binding), [GO:0002551](http://purl.obolibrary.org/obo/GO_0002551) (mast cell chemotaxis), [GO:0031090](http://purl.obolibrary.org/obo/GO_0031090) (organelle membrane), [GO:0003883](http://purl.obolibrary.org/obo/GO_0003883) (CTP synthase activity), [GO:0002553](http://purl.obolibrary.org/obo/GO_0002553) (histamine secretion by mast cell), [GO:0001222](http://purl.obolibrary.org/obo/GO_0001222) (transcription corepressor binding), [GO:0003874](http://purl.obolibrary.org/obo/GO_0003874) (6-pyruvoyltetrahydropterin synthase activity), [GO:0002543](http://purl.obolibrary.org/obo/GO_0002543) (activation of blood coagulation via clotting cascade), [GO:0043060](http://purl.obolibrary.org/obo/GO_0043060) (meiotic metaphase I plate congression), [GO:0001221](http://purl.obolibrary.org/obo/GO_0001221) (transcription cofactor binding), [GO:0003876](http://purl.obolibrary.org/obo/GO_0003876) (AMP deaminase activity), [GO:0003877](http://purl.obolibrary.org/obo/GO_0003877) (ATP adenylyltransferase activity), [GO:0070650](http://purl.obolibrary.org/obo/GO_0070650) (actin filament bundle distribution), [GO:0002548](http://purl.obolibrary.org/obo/GO_0002548) (monocyte chemotaxis), [GO:0070651](http://purl.obolibrary.org/obo/GO_0070651) (nonfunctional rRNA decay), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0070654](http://purl.obolibrary.org/obo/GO_0070654) (sensory epithelium regeneration), [GO:0071985](http://purl.obolibrary.org/obo/GO_0071985) (multivesicular body sorting pathway), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), [GO:0031088](http://purl.obolibrary.org/obo/GO_0031088) (platelet dense granule membrane), [GO:0015858](http://purl.obolibrary.org/obo/GO_0015858) (nucleoside transport), [GO:0055038](http://purl.obolibrary.org/obo/GO_0055038) (recycling endosome membrane), [GO:0070653](http://purl.obolibrary.org/obo/GO_0070653) (high-density lipoprotein particle receptor binding), [GO:0071988](http://purl.obolibrary.org/obo/GO_0071988) (protein localization to spindle pole body), 

**Class expressions from DL-Learner:**

- Thing 97.19%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 77.97%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 60.28%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) 60.25%
- [GO:0065007](http://purl.obolibrary.org/obo/GO_0065007) (biological regulation) 58.33%
- [GO:0050789](http://purl.obolibrary.org/obo/GO_0050789) (regulation of biological process) 56.42%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 55.68%
- [GO:0050794](http://purl.obolibrary.org/obo/GO_0050794) (regulation of cellular process) 54.38%
- [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity) 54.10%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 53.40%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 52.74%
- [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) 52.17%
- [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process) 52.11%
- [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process) 51.89%
- [GO:0071704](http://purl.obolibrary.org/obo/GO_0071704) (organic substance metabolic process) 51.88%


